target,target_id,target_gene_symbol,target_uniprot,target_ligand,target_ligand_id,target_ligand_gene_symbol,target_ligand_uniprot,target_ligand_pubchem_sid,target_species,ligand,ligand_id,ligand_gene_symbol,ligand_species,ligand_pubchem_sid,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_units,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id,SMILES
15-LOX-1,1388,ALOX15,P16050,,,,,,Human,compound 34 [PMID: 20866075],8751,,,252827409,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,<,,,,20866075,COc1ccc(cc1)C(=O)OCC#CCSc1nnc(o1)c1cccc2c1cccc2
15-LOX-2,1389,ALOX15B,O15296,,,,,,Human,compound 21n [PMID: 17656086],8750,,,252827408,Inhibitor,Inhibition,,f,f,,pIC50,0,7.289999962,0,IC50,0,51,0,=,,,,17656086,COc1ccc(cc1)c1nc([nH]c1CCNS(=O)(=O)N([C@@H]1CCN(C1)C(c1ccc(cc1)F)C)CC)c1cccs1
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,11896604,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,In a direct kinase activity measuring phosphorylation od a small peptide substrate mimetic,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,t,,pIC50,0,7.590000153,0,IC50,0,26,0,=,In a direct kinase activity measuring phosphorylation od a small peptide substrate mimetic,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
4-1BB,1878,TNFRSF9,Q07011,,,,,,Human,4-1BB ligand,5081,TNFSF9,Human,178101774,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
4-aminobutyrate aminotransferase,2464,ABAT,P80404,,,,,,Human,4-acryloylphenol,8841,,,252827498,Inhibitor,Inhibition,,f,f,,pIC50,0,5.260000229,0,IC50,0,5480,0,=,,,,16290145,C=CC(=O)c1ccc(cc1)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9397179,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,10.3,0,9.4,,0,0,0,,,,,1386736,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,9.7,0,9.1,,0,0,0,,,,,1386736,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,7-methoxy-1-naphthylpiperazine,6,,,135649861,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9397179,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,f,,pKi,9.399999619,0,8.399999619,Ki,3.980000019,0,0.398000002,=,,,,1386736,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,asenapine,22,,,135650779,Agonist,Full agonist,,f,,,pKi,8.3,0,8,,0,0,0,,,,,9760039,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,BMY-14802,8,,,135650007,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,9760039,Fc1ccc(cc1)C(CCCN1CCN(CC1)c1ncc(cn1)F)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,clozapine,38,,,135650115,Agonist,Full agonist,,f,,,pKi,6.9,0,6.8,,0,0,0,,,,,9760039,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,,,pKi,0,6.9,0,-,0,0,0,=,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Partial agonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,12784105,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,BMY-7378,9,,,135650009,Agonist,Partial agonist,,f,,,pIC50,8,0,6.8,,0,0,0,,,,,9048968,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,buspirone,36,,,135650035,Agonist,Partial agonist,,f,t,,pKi,8,0,7.699999809,-,0,0,0,=,,,,1386736,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,9760039,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9760039,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,7.9,0,7.7,,0,0,0,,,,,9397179,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,1565658,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,1557407,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,8.8,0,7.7,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKd,8.4,0,7.5,-,0,0,0,=,,,,1565658,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,8.1,0,-,0,0,0,=,,,,1557407,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,9,0,7.4,-,0,0,0,=,,,,10431754,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,7.5,0,7.3,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-(nonyloxy)-tryptamine,106,,,135649844,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,10513577,CCCCCCCCCOc1ccc2c(c1)c(CCN)c[nH]2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,7-methoxy-1-naphthylpiperazine,6,,,135649861,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9397179,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,-,0,0,0,=,,,,9303569,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,alniditan,120,,,135649920,Agonist,Full agonist,,f,,,pKi,9,0,8.8,,0,0,0,,,,,8967979,C(NC[C@H]1CCc2c(O1)cccc2)CCNC1=NCCCN1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12784105,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,asenapine,22,,,135650779,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,8.7,0,8.1,,0,0,0,,,,,1565658,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,clozapine,38,,,135650115,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,"BMS 181,101",108,,,135650000,Agonist,Partial agonist,,f,,,pKi,8.1,0,7.6,,0,0,0,,,,,11040052,COc1cncnc1N1CCN(CC1)CCCc1c[nH]c2c1cc(F)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,5-HT-moduline,137,,,135651962,Allosteric modulator,Negative,,t,,,pIC50,0,11.9,0,,0,0,0,,,,,9774213,
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,5-OH-DPAT,128,,,135649845,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,1557407,CCCN(C1CCc2c(C1)cccc2O)CCC
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,8.2,0,8.1,,0,0,0,,,,,9397179,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,6.2,0,5.7,,0,0,0,,,,,1565658,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,9.2,0,8.6,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,9,0,8,,0,0,0,,,,,10431754,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,8.7,0,7.4,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,7-methoxy-1-naphthylpiperazine,6,,,135649861,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9397179,O=C(OCC1OC1)NCC[Si]([Si](C)(C)C)(C)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,7.3,0,6.9,,0,0,0,,,,,10193663,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,alniditan,120,,,135649920,Agonist,Full agonist,,f,,,pKi,9.4,0,8.7,,0,0,0,,,,,9605573,C(NC[C@H]1CCc2c(O1)cccc2)CCNC1=NCCCN1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,6.6,0,6.1,,0,0,0,,,,,8967979,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,7.2,0,-,0,0,0,=,,,,12784105,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,asenapine,22,,,135650779,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,8.6,0,8.5,,0,0,0,,,,,1565658,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,clozapine,38,,,135650115,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,cabergoline,37,,,135652674,Agonist,Partial agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,5-HT-moduline,137,,,135651962,Allosteric modulator,Negative,,t,,,pIC50,0,12,0,,0,0,0,,,,,9774213,
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,bufotenine,144,,,135650030,Antagonist,Antagonist,,f,,,pKi,8,0,7.7,,0,0,0,,,,,8967979,CN(CCc1c[nH]c2c1cc(O)cc2)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-BODMT,8422,,,252166632,Agonist,Agonist,,f,f,,pKi,0,6.619999886,0,Ki,0,240,0,=,,,,21422162,CCCC(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8380639,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,5.5,0,5.1,,0,0,0,,,,,8863519,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-fluorotryptamine,146,,,135649833,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,14744596,NCCc1c[nH]c2c1cc(F)cc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8.2,0,8,,0,0,0,,,,,1608964,NCCc1c[nH]c2c1cc(O)cc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-MeO-DMT,145,,,135649836,Agonist,Full agonist,,f,,,pKi,6.3,0,6.1,,0,0,0,,,,,8380639,COc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,6.2,0,5.5,,0,0,0,,,,,8863519,NCCc1c[nH]c2c1cc(OC)cc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8380639,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,7,0,6.9,,0,0,0,,,,,8380639,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,asenapine,22,,,135650779,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,BRL-54443,3927,,,178100756,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,0,CN1CCC(CC1)c1c[nH]c2c1cc(O)cc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,clozapine,38,,,135650115,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Antagonist,Antagonist,,f,,,pKi,7,0,6.7,,0,0,0,,,,,8863519,N1CCN(CC1)c1cccc2c1cccc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-BODMT,8422,,,252166632,Agonist,Agonist,,f,t,,pKi,0,8.43999958,0,Ki,0,3.599999905,0,=,,,,21422162,CCCC(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8380639,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8380639,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,8384716,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8,0,7.7,,0,0,0,,,,,15900510,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pIC50,0,7.2,0,,0,0,0,,,,,8384716,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,f,,pKd,0,8,0,-,0,0,0,=,,,,8380639,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-MeO-DMT,145,,,135649836,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8380639,COc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8380639,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,8380639,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,8380639,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,BRL-54443,3927,,,178100756,Agonist,Full agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,0,CN1CCC(CC1)c1c[nH]c2c1cc(O)cc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,clozapine,38,,,135650115,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8380639,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,6.5,0,6,-,0,0,0,=,,,,11040033,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKd,0,8.9,0,-,0,0,0,=,,,,8534270,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8.4,0,6,-,0,0,0,=,,,,15322733,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8114677,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,8114677,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,15322733,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,AL-37350A,160,,,135649913,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,12954071,C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,11040033,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,15322733,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12784105,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,8.1,0,7.5,,0,0,0,,,,,12784105,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,brolamfetamine,163,,,135650198,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9655845,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,brolamfetamine,163,,,135650198,Agonist,Full agonist,,f,,,pKi,9.2,0,8.9,,0,0,0,,,,,15322733,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,BW723C86,161,,,135650041,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,15322733,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,15322733,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,agomelatine,198,,,135649906,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,12750432,COc1ccc2c(c1)c(CCNC(=O)C)ccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,amesergide,199,,,135649933,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8114677,O=C([C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,amesergide,199,,,135649933,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8114677,O=C([C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,f,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,10379421,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,8876023,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,amoxapine,201,,,135649941,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8876023,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,apomorphine,33,,,135649950,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,asenapine,22,,,135650779,Antagonist,Antagonist,,f,t,,pKi,0,10.22000027,0,Ki,0,0.059999999,0,=,,,,18308814,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,BF-1,8424,,,252166634,Antagonist,Antagonist,,f,f,,pKi,0,8.550000191,0,-,0,0,0,=,,,,25666387,CCOc1ccc2c(c1)Sc1c(C2=C2CCN(CC2)C)c(OC)ccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,blonanserin,7670,,,223366005,Antagonist,Antagonist,,f,t,,pKi,0,9.090000153,0,Ki,0,0.810000002,0,=,,,,15686911,CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,bufotenine,144,,,135650030,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8663249,CN(CCc1c[nH]c2c1cc(O)cc2)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,2233697,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,compound 3b [PMID:28943244],9825,,,0,Antagonist,Antagonist,,f,t,,pKi,0,10.64999962,0,Ki,0,0.022399999,0,=,,,,28943244,COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,AC-90179,174,,,135649884,Antagonist,Inverse agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,15102927,COc1ccc(cc1)CC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9655845,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,t,,pKi,0,8.100000381,0,-,0,0,0,=,,,,12629531,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,t,,pKi,9,0,7.599999905,-,0,0,0,=,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,9655845,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8450835,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8078486,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,6.9,0,6.7,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8.4,0,7.9,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,8,0,,0,0,0,,,,,8450835,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8450835,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,8450835,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,15322733,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,AL-37350A,160,,,135649913,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12954071,C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,8.3,0,7.9,,0,0,0,,,,,15322733,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8450835,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,brolamfetamine,163,,,135650198,Agonist,Full agonist,,f,,,pKi,7.6,0,7.4,,0,0,0,,,,,15322733,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,BW723C86,161,,,135650041,Agonist,Full agonist,,f,f,,pKi,8.600000381,0,7.300000191,Ki,50.09999847,0,2.50999999,=,,,,15322733,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,15322733,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,1-naphthylpiperazine,3,,,135649669,Antagonist,Antagonist,,f,,,pKi,8.4,0,8.3,,0,0,0,,,,,8078486,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Antagonist,Antagonist,,f,,,pKi,9,0,8.4,,0,0,0,,,,,8078486,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,agomelatine,198,,,135649906,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12750432,COc1ccc2c(c1)c(CCNC(=O)C)ccc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,amesergide,199,,,135649933,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8450835,O=C([C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C)NC1CCCCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,apomorphine,33,,,135649950,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,BF-1,8424,,,252166634,Antagonist,Antagonist,,f,t,,pKi,0,10.05000019,0,-,0,0,0,=,,,,25666387,CCOc1ccc2c(c1)Sc1c(C2=C2CCN(CC2)C)c(OC)ccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,bromocriptine,35,,,135650026,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,8.8,0,8,,0,0,0,,,,,9732398,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,6.7,0,5.2,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,7.9,0,6.7,,0,0,0,,,,,11104741,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8.6,0,6.8,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,5-MeO-DMT,145,,,135649836,Agonist,Full agonist,,f,,,pKi,7,0,6.2,,0,0,0,,,,,10217294,COc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9282936,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,7.8,0,6.7,,0,0,0,,,,,10611640,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,15322733,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,AL-37350A,160,,,135649913,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12954071,C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,8.6,0,6.9,,0,0,0,,,,,15322733,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12629531,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,brolamfetamine,163,,,135650198,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9282936,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,brolamfetamine,163,,,135650198,Agonist,Full agonist,,f,,,pKi,8.9,0,6.8,,0,0,0,,,,,15322733,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,BW723C86,161,,,135650041,Agonist,Full agonist,,f,,,pKi,7.1,0,6.9,,0,0,0,,,,,15322733,CC(Cc1c[nH]c2c1cc(OCc1cccs1)cc2)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,15322733,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,agomelatine,198,,,135649906,Antagonist,Antagonist,,f,f,,pKi,0,6.199999809,0,-,0,0,0,=,,,,12750432,COc1ccc2c(c1)c(CCNC(=O)C)ccc2
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,Ki,0,8,0,=,,,,10379421,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,amoxapine,201,,,135649941,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,8876023,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,apomorphine,33,,,135649950,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,8.2,0,7.6,,0,0,0,,,,,12629531,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,AC-90179,174,,,135649884,Antagonist,Inverse agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9395253,COc1ccc(cc1)CC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,8.7,0,7.4,,0,0,0,,,,,9732398,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,1-phenylbiguanide,2284,,,135649670,Agonist,Agonist,,f,,,pEC50,0,4.1,0,EC50,0,80000,0,=,,,,8848005,NC(=Nc1ccccc1)N=C(N)N
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,1-phenylbiguanide,2284,,,135649670,Agonist,Agonist,,f,,,pKi,5.6,0,4.7,-,0,0,0,=,,,,7565620,NC(=Nc1ccccc1)N=C(N)N
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Agonist,,f,,,pKi,6.7,0,6,-,0,0,0,=,,,,7565620,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Agonist,,f,,,pEC50,5.6,0,5.5,EC50,3100,0,2500,=,,,,9950429,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Agonist,,t,,,pEC50,6.4,0,5.5,-,0,0,0,=,,,,9950429,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Agonist,,t,,,pKi,6.9,0,6.5,-,0,0,0,=,,,,9463477,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,1-phenylbiguanide,2284,,,135649670,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,-,0,0,0,=,,,,7790853,NC(=Nc1ccccc1)N=C(N)N
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,1-phenylbiguanide,2284,,,135649670,Agonist,Partial agonist,,f,,,pEC50,0,4.5,0,-,0,0,0,=,,,,7984286,NC(=Nc1ccccc1)N=C(N)N
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,Ca<sup>2+</sup>,707,,,135652731,Allosteric modulator,Negative,"Decreased single channel conductance, increased channel activation rate, increased deactivation rate, increased desensitization rate, decrease in agonist apparent affinity.",t,,100-10000,-,0,0,0,,0,0,0,,,,,7620711,
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Allosteric modulator,Negative,"Decreased single channel conductance, increased channel activation rate, increased deactivation rate, increased desensitization rate, decrease in agonist apparent affinity.",t,,100-10000,-,0,0,0,,0,0,0,,,,,9508827,
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,5-hydroxyindole,2295,,,135649835,Allosteric modulator,Positive,"decreased desensitization rate, decreased deactivation rate, increased apparent affinty of 5-HT.",f,,1000-10000,-,0,0,0,,0,0,0,,,,,10457085,Oc1ccc2c(c1)cc[nH]2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,alosetron,2296,,,135649921,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,Ki,0,0.316000015,0,=,,,,17652911,O=C1N(CCc2c1c1ccccc1n2C)Cc1nc[nH]c1C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,azasetron,2285,,,135649974,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,11489465,Clc1cc2N(C)C(=O)COc2c(c1)C(=O)NC1CN2CCC1CC2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,AZD0328,7697,,,223366030,Antagonist,Antagonist,,f,f,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,21919481,c1cnc2c(c1)C[C@]1(O2)CN2CCC1CC2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,cilansetron,2297,,,135650097,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,17652911,O=C1[C@H](CCc2c1c1cccc3c1n2CCC3)Cn1ccnc1C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,cocaine,2286,,,135652677,Antagonist,Antagonist,,f,,,pKi,5.4,0,5.1,,0,0,0,,,,,11489465,COC(=O)[C@H]1[C@H](C[C@H]2N([C@@H]1CC2)C)OC(=O)c1ccccc1
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,bilobalide,2366,,,135652670,Channel blocker,None,,f,,,pIC50,0,3.33,0,IC50,0,470000,0,=,,,,21505038,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,1-phenylbiguanide,2284,,,135649670,Agonist,Agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,11489465,NC(=Nc1ccccc1)N=C(N)N
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,2-methyl-5-HT,218,,,135649706,Agonist,Agonist,,f,,,pEC50,0,4.9,0,-,0,0,0,=,,,,9950429,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Agonist,,t,f,,pEC50,5.800000191,0,4.800000191,-,0,0,0,=,,,,9950429,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Agonist,,t,f,,pKi,0,6,0,-,0,0,0,=,,,,11489465,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,azasetron,2285,,,135649974,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11489465,Clc1cc2N(C)C(=O)COc2c(c1)C(=O)NC1CN2CCC1CC2
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,cocaine,2286,,,135652677,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,11489465,COC(=O)[C@H]1[C@H](C[C@H]2N([C@@H]1CC2)C)OC(=O)c1ccccc1
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,bilobalide,2366,,,135652670,Channel blocker,None,,f,,,pIC50,0,2.51,0,IC50,0,3100000,0,=,,,,21059362,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,f,,pKd,0,7.699999809,0,-,0,0,0,=,,,,8813606,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,f,,pKd,8.800000191,0,8.399999619,-,0,0,0,=,,,,10646498,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,7.2,0,,0,0,0,,,,,8946946,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,7,0,5.9,,0,0,0,,,,,15466450,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,8.2,0,6.7,,0,0,0,,,,,7796807,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8946946,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,7.4,0,6.3,,0,0,0,,,,,7796807,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,6.8,0,5.6,,0,0,0,,,,,9349523,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,15466450,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,6.6,0,5.6,,0,0,0,,,,,8813606,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,BIMU 1,233,,,135649997,Agonist,Full agonist,,f,,,pKi,8.4,0,6.4,,0,0,0,,,,,9603189,CCn1c(=O)n(c2c1cccc2)C(=O)NC1CC2CC[C@@H](C1)N2C
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,BIMU 1,233,,,135649997,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8946946,CCn1c(=O)n(c2c1cccc2)C(=O)NC1CC2CC[C@@H](C1)N2C
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,BIMU 8,234,,,135649998,Agonist,Full agonist,,f,f,,pKi,0,7.300000191,0,Ki,0,50.09999847,0,=,,,,9351641,CN1[C@@H]2CC[C@H]1CC(C2)NC(=O)n1c(=O)n(c2c1cccc2)C(C)C
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,BIMU 8,234,,,135649998,Agonist,Full agonist,,f,,,pKi,7.8,0,7.1,,0,0,0,,,,,9225293,CN1[C@@H]2CC[C@H]1CC(C2)NC(=O)n1c(=O)n(c2c1cccc2)C(C)C
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,BIMU 8,234,,,135649998,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8946946,CN1[C@@H]2CC[C@H]1CC(C2)NC(=O)n1c(=O)n(c2c1cccc2)C(C)C
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,cisapride,240,,,135650104,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8946946,COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,cisapride,240,,,135650104,Agonist,Partial agonist,,f,t,,pKi,7.400000095,0,6.400000095,-,0,0,0,=,,,,9349523,COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,cisapride,240,,,135650104,Agonist,Partial agonist,,f,,,pKi,8,0,6.8,,0,0,0,,,,,8813606,COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,7.7,0,7.6,,0,0,0,,,,,7988681,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,7.8,0,7.3,,0,0,0,,,,,8450829,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>5A</sub> receptor,10,Htr5a,P35364,,,,,,Rat,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,7682702,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>5A</sub> receptor,10,Htr5a,P35364,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,6.6,0,,0,0,0,,,,,7682702,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,6.6,0,6,,0,0,0,,,,,8450829,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,6.9,0,6.7,,0,0,0,,,,,7988681,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8450829,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,5.7,0,5.6,,0,0,0,,,,,7988681,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,bufotenine,144,,,135650030,Antagonist,Antagonist,,f,,,pKi,6,0,5.3,,0,0,0,,,,,8450829,CN(CCc1c[nH]c2c1cc(O)cc2)C
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11343685,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,6.5,0,6,,0,0,0,,,,,7988681,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,7680751,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,2-methyl-5-HT,218,,,135649706,Agonist,Full agonist,,f,,,pKi,7.3,0,6.2,,0,0,0,,,,,9225298,Cc1c(CCN)c2c([nH]1)ccc(c2)O
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-benzyloxytryptamine,265,,,135649825,Agonist,Full agonist,,f,,,pKi,7.2,0,6.5,,0,0,0,,,,,7680751,NCCc1c[nH]c2c1cc(OCc1ccccc1)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8522988,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,6.7,0,5.5,,0,0,0,,,,,7680751,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,7.9,0,6.6,,0,0,0,,,,,7680751,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,f,,pKd,0,7.900000095,0,-,0,0,0,=,,,,9225298,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,7.5,0,6.8,,0,0,0,,,,,8522988,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-MeO-DMT,145,,,135649836,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9798944,COc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,8.4,0,6.9,,0,0,0,,,,,7680751,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8522988,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,&alpha;-methyl-5-HT,152,,,135649924,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9798944,CC(Cc1c[nH]c2c1cc(O)cc2)N
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10327430,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8522988,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,CGS-12066,109,,,135650081,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,7680751,CN1CCN(CC1)c1nc2cc(ccc2n2c1ccc2)C(F)(F)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,BRL-15572,10,,,135650023,Agonist,Partial agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9303567,Clc1cccc(c1)N1CCN(CC1)CC(C(c1ccccc1)c1ccccc1)O
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9798944,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,2-bromo-LSD,272,,,135649696,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,7680751,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)CC
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,&alpha;-ergocryptine,271,,,135652665,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9798944,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.5,,0,0,0,,,,,7680751,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.9,,0,0,0,,,,,8522988,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,amoxapine,201,,,135649941,Antagonist,Antagonist,,f,,,pKi,8.2,0,7.5,,0,0,0,,,,,7680751,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,amoxapine,201,,,135649941,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8522988,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,bufotenine,144,,,135650030,Antagonist,Antagonist,,f,,,pKi,8.4,0,7,,0,0,0,,,,,9225298,CN(CCc1c[nH]c2c1cc(O)cc2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,cerlapirdine,7356,,,178103928,Antagonist,Antagonist,,f,t,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,0,CN(CCCOc1ccc2c(c1)c([nH]n2)S(=O)(=O)c1cccc2c1cccc2)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7908055,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,7.8,0,7.7,,0,0,0,,,,,8522988,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,8.1,0,7.8,,0,0,0,,,,,8522988,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,8.4,0,7.5,,0,0,0,,,,,9732398,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,AS-19,8433,,,252166643,Agonist,Agonist,,f,t,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,23541835,CN([C@H]1CCc2c(C1)cccc2c1c(C)nn(c1C)C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,7.7,0,7.5,,0,0,0,,,,,8394362,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,1-naphthylpiperazine,3,,,135649669,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8226867,N1CCN(CC1)c1cccc2c1cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,2-MPP,280,,,135649708,Agonist,Full agonist,,f,,,pKi,6.9,0,6.6,,0,0,0,,,,,8394362,COc1ccccc1N1CCNCC1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,9.9,0,9.5,,0,0,0,,,,,8394362,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,10,0,9,,0,0,0,,,,,11414657,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,5-CT,4,,,135649828,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8394987,NCCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,f,,pKi,9.199999809,0,8.699999809,-,0,0,0,=,,,,8394362,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,8.3,0,,0,0,0,,,,,8394987,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,9.6,0,8.1,,0,0,0,,,,,12527336,NCCc1c[nH]c2c1cc(O)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,5-MeO-DMT,145,,,135649836,Agonist,Full agonist,,f,,,pKi,7.7,0,7.4,,0,0,0,,,,,8394362,COc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8394987,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,9.2,0,8.8,,0,0,0,,,,,8394362,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,5-MeOT,107,,,135649837,Agonist,Full agonist,,f,,,pKi,9.5,0,8.3,,0,0,0,,,,,11414657,NCCc1c[nH]c2c1cc(OC)cc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,7.6,0,6.3,,0,0,0,,,,,11414657,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8394987,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,8-OH-DPAT,7,,,135649864,Agonist,Full agonist,,f,,,pKi,7.5,0,7.3,,0,0,0,,,,,8394362,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,aripiprazole,34,,,135649956,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,10327430,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,bromocriptine,35,,,135650026,Agonist,Full agonist,,f,,,pKi,8,0,7.3,,0,0,0,,,,,8394362,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,bufotenine,144,,,135650030,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8394987,CN(CCc1c[nH]c2c1cc(O)cc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,cisapride,240,,,135650104,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,8394987,COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,buspirone,36,,,135650035,Agonist,Partial agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8397408,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,capeserod,29,,,135651059,Agonist,Partial agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,12130738,Nc1c(Cl)cc(c2c1OCCO2)c1nn(c(=O)o1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,2-bromo-LSD,272,,,135649696,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8394987,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)CC
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,2-bromo-LSD,272,,,135649696,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8226867,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)CC
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8394987,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,,,pKi,7,0,6.9,,0,0,0,,,,,8394362,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,amoxapine,201,,,135649941,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7908055,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,buspirone,36,,,135650035,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8394987,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8394987,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8397408,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,7908055,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,8394987,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Inverse agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,15821958,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8394987,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,7.8,0,7.2,,0,0,0,,,,,15821958,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Inverse agonist,,f,,,pKi,8.2,0,7.2,,0,0,0,,,,,8997630,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
5-LOX,1385,ALOX5,P09917,,,,,,Human,5-LOX activating protein,5183,ALOX5AP,Human,178101873,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
5-LOX,1385,ALOX5,P09917,,,,,,Human,CJ13610,5169,,,178101859,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,15197110,Cc1nccn1c1ccc(cc1)Sc1cccc(c1)C1(CCOCC1)C(=O)N
ABCA1,756,ABCA1,O95477,,,,,,Human,bihelical apoA-I mimetic peptide 5A,9183,,,315661263,None,Binding,The 5A sequence was able to solubilize phospholipid vesicles and stimulated cholesterol and phospholipid efflux by the ABCA1 transporter with high specificity but no specific binding data was reported,f,f,,-,0,0,0,-,0,0,0,=,,,,18805791,[NH3]CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)C)CCC(=O)O)CCCC[NH3])C)CCCC[NH3])CCC(=O)O)C)C)CCCC[NH3])CC(=O)O)Cc1ccc(cc1)O)C)C)CCCC[NH3])C)Cc1c[nH]c2c1cccc2)CC(=O)O)Cc1ccccc1)C)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](CC(=O)O)N)CC(C)C)CCCC[NH3])C)Cc1ccccc1)Cc1ccc(cc1)O)CC(=O)O)CCCC[NH3])C)CCC(=O)O)CCCC[NH3])CC(C)C
ABCC5,783,ABCC5,O15440,,,,,,Human,compound 2 [PMID: 22380603],8829,,,252827486,Inhibitor,Inhibition,,f,f,,pKi,0,7.190000057,0,Ki,0,65.30000305,0,=,,,,22380603,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)Nc1ccc(c(c1)C(=O)O)O)C
ABCC9,2746,ABCC9,O60706,,,,,,Human,compound 13b [PMID: 19101153],8808,,,252827466,Allosteric modulator,Positive,Compound 13b is a channel opener.,f,f,,pEC50,0,6.170000076,0,EC50,0,670,0,=,,,,19101153,N#Cc1ccc2c(c1)[C@@H](n1oc3c(c1=O)ccc(c3)Cl)[C@@H](C(O2)(C)C)O
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,asciminib,8962,,,310264743,Allosteric modulator,Negative,,f,f,,pIC50,9.520000458,0,8.619999886,IC50,2.400000095,0,0.300000012,=,Two assays used: a radiometric filter-binding assay and microfluidic mobility shift technology (Caliper assay).,,,0,O[C@@H]1CCN(C1)c1ncc(cc1c1ccn[nH]1)C(=O)Nc1ccc(cc1)OC(Cl)(F)F
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,bafetinib,7906,,,249565589,Inhibitor,Inhibition,,f,t,,pIC50,8.239999771,0,7.590000153,IC50,26,0,5.800000191,=,,,,17376680,CN([C@H]1CCN(C1)Cc1ccc(cc1C(F)(F)F)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cncnc1)C)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,BO1,8963,,,315661099,Inhibitor,Inhibition,,f,f,,pKi,7.360000134,0,7,Ki,100,0,44,=,,,,18078752,Fc1ccc(cc1)CSc1nnc(s1)NC(=O)c1ccc(cc1)F
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,12543790,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,compound 24 [PMID: 23441572],8147,,,249565827,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,23441572,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cncc2n1ccn2)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
"ABL proto-oncogene 2, non-receptor tyrosine kinase",1924,ABL2,P42684,,,,,,Human,compound 24 [PMID: 23441572],8147,,,249565827,Inhibitor,Inhibition,,f,f,,pIC50,9,0,8.699999809,IC50,2,0,1,=,,,,23441572,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cncc2n1ccn2)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,BW284C51,6600,,,178103213,Inhibitor,Inhibition,,f,,,pIC50,0,7.7,0,-,0,0,0,=,,,,12675140,C=CC[N+](c1ccc(cc1)CCC(=O)CCc1ccc(cc1)[N+](CC=C)(C)C)(C)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,"compound 2f [Jiang <i>et al.</i>, 2018]",9810,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.18999958,0,IC50,0,6.5,0,=,,,,0,COc1nc(sc1C(=O)NCCCNc1c2CCCCc2nc2c1cccc2)c1ccnc(c1)NC(=O)C1CC1
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 15a [PMID: 16242323],6724,,,178103335,Inhibitor,Inhibition,,f,,,pIC50,0,7.85,0,IC50,0,14,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(ccc(c2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 15b [PMID: 16242323],6725,,,178103336,Inhibitor,Inhibition,,f,,,pIC50,0,8.08,0,IC50,0,8.3,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 16 [PMID: 16242323],6726,,,178103337,Inhibitor,Inhibition,,f,,,pIC50,0,8.27,0,IC50,0,5.4,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)NC2=C(C=CNC2C(C)C)C(C)C)c(c2c1nccc2)c1cccc(c1)OC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 18a [PMID: 16242323],6727,,,178103338,Inhibitor,Inhibition,,f,,,pIC50,0,6.42,0,IC50,0,382,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)CN)C(C)C)c(c2c1nccc2)c1cccc(c1)OC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 18b [PMID: 16242323],6728,,,178103339,Inhibitor,Inhibition,,f,,,pIC50,0,6.17,0,IC50,0,680,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)CN(C)C)C(C)C)c(c2c1nccc2)c1cccc(c1)OC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 22c [PMID: 16242323],6730,,,178103341,Inhibitor,Inhibition,,f,,,pIC50,0,7.21,0,IC50,0,61,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)CN)C(C)C)c(c2c1nccc2)c1cccc(c1)OCCCO.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 22d [PMID: 16242323],6731,,,178103342,Inhibitor,Inhibition,,f,,,pIC50,0,7.37,0,IC50,0,43,0,=,,,,16242323,OCCOc1cccc(c1)c1c(NC(=O)Nc2c(ccc(c2C(C)C)N)C(C)C)c(=O)n(c2c1cccn2)CCCC.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 26a [PMID: 16242323],6732,,,178103343,Inhibitor,Inhibition,,f,,,pIC50,0,6.34,0,IC50,0,452,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OCCCC(C)C
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 26b [PMID: 16242323],6733,,,178103344,Inhibitor,Inhibition,,f,,,pIC50,0,6.37,0,IC50,0,427,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OCCCN1CCCC1.Cl.Cl
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,compound 26c [PMID: 16242323],6734,,,178103345,Inhibitor,Inhibition,,f,,,pIC50,0,6.27,0,IC50,0,540,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OCCCC1CCCCC1.Cl.Cl
Acetyl-CoA carboxylase 1,1263,ACACA,Q13085,,,,,,Human,compound 21 [PMID: 23981033],8884,,,252827541,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,23981033,COc1ccc2c(n1)cc(cc2)C(=O)N1CCC2(CC1)NC(=O)c1c(C2)cn(n1)C(C)(C)C
Acetyl-CoA carboxylase 2,1264,ACACB,O00763,,,,,,Human,compound 21 [PMID: 23981033],8884,,,252827541,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23981033,COc1ccc2c(n1)cc(cc2)C(=O)N1CCC2(CC1)NC(=O)c1c(C2)cn(n1)C(C)(C)C
ACKR3,80,Ackr3,O89039,,,,,,Rat,adrenomedullin,697,Adm,Rat,135651601,Agonist,Agonist,Dose dependant increase of cAMP,t,f,,pEC50,0,7,0,EC50,0,100,0,=,,,,8554605,
ACKR3,80,Ackr3,O89039,,,,,,Rat,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Agonist,Dose dependant increase of cAMP,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,,,,8554605,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Agonist,,t,,,pKi,0,8.4,0,-,0,0,0,=,,,,23341447,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Agonist,,t,,,pEC50,9.1,0,8.5,-,0,0,0,=,,,,23341447,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL21,811,CCL21,Human,135651670,Agonist,Agonist,,t,,,pKi,0,6.9,0,-,0,0,0,=,,,,23341447,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL21,811,CCL21,Human,135651670,Agonist,Agonist,,t,,,pEC50,8.5,0,7.9,-,0,0,0,=,,,,23341447,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL25,817,CCL25,Human,135651677,Agonist,Agonist,,t,,,pKi,0,7.6,0,-,0,0,0,=,,,,23341447,
ACKR4,315,ACKR4,Q9NPB9,,,,,,Human,CCL25,817,CCL25,Human,135651677,Agonist,Agonist,,t,,,pEC50,8.3,0,7.9,-,0,0,0,=,,,,23341447,
acrosin,2327,ACR,P10323,,,,,,Human,compound 9 [PMID: 3514912],8559,,,252166760,Inhibitor,Inhibition,,f,t,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,3514912,O=C(c1ccc(cc1)N=C(N)N)Oc1ccc(cc1)C
activin A receptor type 1,1785,ACVR1,Q04771,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.269999981,0,IC50,0,53.40000153,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
activin A receptor type 1,1785,ACVR1,Q04771,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
activin A receptor type 1,1785,ACVR1,Q04771,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
activin A receptor type 1B,1787,ACVR1B,P36896,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,f,,pIC50,0,6.489999771,0,IC50,0,326,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
activin A receptor type 1B,1787,ACVR1B,P36896,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,183,0,=,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
activin A receptor type 2A,1791,ACVR2A,P27037,,,,,,Human,bimagrumab,8086,,,249565766,Antibody,Binding,,f,f,,pKd,0,9.359999657,0,Kd,0,0.433999985,0,=,Binding affinity of clone MOR08159,,,0,
activin A receptor type 2B,1792,ACVR2B,Q13705,,,,,,Human,bimagrumab,8086,,,249565766,Antibody,Binding,,f,t,,pKd,0,11.76000023,0,Kd,0,0.00173,0,=,Binding affinity of clone MOR08159,,,0,
activin A receptor type IL,1784,ACVRL1,P37023,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.380000114,0,IC50,0,42.09999847,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
activin A receptor type IL,1784,ACVRL1,P37023,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
activin A receptor type IL,1784,ACVRL1,P37023,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
Activin receptors,2588,ACVR1B|ACVR2A|ACVR2B|ACVR1C,P27037|P36896|Q13705|Q8NER5,,,,,,Human,activin A,4857,INHBA,Human,178101558,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Activin receptors,2588,ACVR1B|ACVR2A|ACVR2B|ACVR1C,P27037|P36896|Q13705|Q8NER5,,,,,,Human,activin AB,4858,INHBA|INHBB,Human,178101559,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Activin receptors,2588,ACVR1B|ACVR2A|ACVR2B|ACVR1C,P27037|P36896|Q13705|Q8NER5,,,,,,Human,activin B,4859,INHBB,Human,178101560,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
acylaminoacyl-peptide hydrolase,2328,APEH,P13798,,,,,,Human,ARI-3099,8563,,,252166764,Inhibitor,Inhibition,,f,f,,pIC50,0,6.980000019,0,IC50,0,104,0,=,Substrate (Ac-Ala-AMC) assay.,,,24997602,OB([C@@H]1CCCN1C(=O)[C@H](NC(=O)c1ccncc1)C)O
ADAM10,1658,ADAM10,O14672,,,,,,Human,compound 25 [PMID: 18068976],8568,,,252166769,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,18068976,ONC(=O)C1(CCN(CC1)C(=O)OC1CCCC1O)CS(=O)(=O)N1CCC(CC1)c1ccccc1C
ADAM17,1662,ADAM17,P78536,,,,,,Human,apratastat,6482,,,178103096,Inhibitor,Inhibition,,f,,,pIC50,0,7.7,0,IC50,0,20,0,,,,,16426848,OCC#CCOc1ccc(cc1)S(=O)(=O)N1CCSC([C@@H]1C(=O)NO)(C)C
ADAM17,1662,ADAM17,P78536,,,,,,Human,BMS-561392,6509,,,178103123,Inhibitor,Inhibition,,f,,,pIC50,0,8.7,0,IC50,0,2,0,,,,,19095454,ONC(=O)[C@H](N1CC[C@@](C1=O)(N)c1ccc(cc1)OCc1cc(C)nc2c1cccc2)CC(C)C
ADAMTS1,1674,ADAMTS1,Q9UHI8,,,,,,Human,compound 12c [PMID: 16516466],8663,,,252166863,Inhibitor,Inhibition,,f,f,,pKi,0,6.110000134,0,Ki,0,776,0,=,,,,16516466,ONC(=O)CC1(CCNCC1)NC(=O)c1ccc(cc1)OCc1cc(C)nc2c1cccc2
ADAMTS4,1677,ADAMTS4,O75173,,,,,,Human,compound 15c [PMID: 21536437],8553,,,252166754,Inhibitor,Inhibition,,f,t,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,21536437,O=CN(C1(CCN(CC1)C(=O)C1CCC1)CS(=O)(=O)N1CCC(CC1)CCc1ccc(cc1C)Cl)O
ADAMTS5,1678,ADAMTS5,Q9UNA0,,,,,,Human,compound 15c [PMID: 21536437],8553,,,252166754,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,21536437,O=CN(C1(CCN(CC1)C(=O)C1CCC1)CS(=O)(=O)N1CCC(CC1)CCc1ccc(cc1C)Cl)O
Adenosine kinase,1231,ADK,P55263,,,,,,Human,A134974,5130,,,178101822,Inhibitor,Inhibition,,f,,,pIC50,0,10.2,0,IC50,0,0.0631,0,,,,,11160637,N[C@H]1C[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)I
Adenosine kinase,1231,ADK,P55263,,,,,,Human,ABT702,5131,,,178101823,Inhibitor,Inhibition,,f,,,pIC50,0,8.8,0,IC50,0,1.58,0,,,,,11082453,Brc1cccc(c1)c1cc(nc2c1c(N)ncn2)c1ccc(nc1)N1CCOCC1
adenylyl cyclase 1,1278,,,,,,,,Bovine,compound 45 [PMID: 8709105],8809,,,252827467,Activator,Activation,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,Measuring competitive inhibition of [<sup>125 I</sup>]6-IHPP-forskolin binding to adenylate cyclase 1.,,,8709105,C=C[C@@]1(C)CC(=O)[C@]2([C@@](O1)(C)[C@@H](OC(=O)C)[C@H]([C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C)OC(=O)NCCc1ccccn1)O
ADGRG3,188,ADGRG3,Q86Y34,,,,,,Human,beclometasone dipropionate,5894,,,178102517,Agonist,Full agonist,,f,,,pEC50,0,8.5,0,EC50,0,3.1,0,=,,,,22575658,CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC
ADGRL1,206,Adgrl1,O88917,,,,,,Rat,&alpha;-latrotoxin,5897,,,178102520,Agonist,Full agonist,,f,,,pKd,9.8,0,9.6,Kd,0.26,0,0.16,=,,,,9208860,
ADGRL2,207,Adgrl2,O88923,,,,,,Rat,&alpha;-latrotoxin,5897,,,178102520,Agonist,Full agonist,,f,,,pKd,0,8.85,0,Kd,0,1.4,0,=,,,,10026162,
advanced glycosylation end-product specific receptor,2843,AGER,Q15109,,,,,,Human,azeliragon,8317,,,252166529,Antagonist,Antagonist,,f,t,,pIC50,0,6,0,IC50,0,1000,0,~,,,,25368578,CCCCc1nc(cn1c1ccc(cc1)Oc1ccc(cc1)Cl)c1ccc(cc1)OCCCN(CC)CC
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,Akt inhibitor VIII,5921,,,178102544,Allosteric modulator,Negative,,f,t,,pIC50,0,7.239999771,0,IC50,0,58,0,=,,,,15664853,O=c1[nH]c2c(n1C1CCN(CC1)Cc1ccc(cc1)c1nc3cc4[nH]cnc4cc3nc1c1ccccc1)cccc2
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,A-443654,8204,,,249565884,Inhibitor,Inhibition,,f,t,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,,,,15956255,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,A-674563,5655,,,178102283,Inhibitor,Inhibition,,f,t,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,15956255,N[C@@H](Cc1ccccc1)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,A-674563,5655,,,178102283,Inhibitor,Inhibition,,f,t,,pKd,0,7.119999886,0,Kd,0,76,0,=,,,,22037378,N[C@@H](Cc1ccccc1)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,afuresertib,7890,,,249565581,Inhibitor,Inhibition,,f,t,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,,,,24978597,NC[C@@H](NC(=O)c1sc(c(c1)c1c(Cl)cnn1C)Cl)Cc1cccc(c1)F
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,capivasertib,7709,,,223366042,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,23394218,OCC[C@@H](c1ccc(cc1)Cl)NC(=O)C1(N)CCN(CC1)c1ncnc2c1cc[nH]2
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,Akt inhibitor VIII,5921,,,178102544,Allosteric modulator,Negative,,f,t,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,15664853,O=c1[nH]c2c(n1C1CCN(CC1)Cc1ccc(cc1)c1nc3cc4[nH]cnc4cc3nc1c1ccccc1)cccc2
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,A-443654,8204,,,249565884,Inhibitor,Inhibition,,f,f,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,~,,,,15956255,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,afuresertib,7890,,,249565581,Inhibitor,Inhibition,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,24978597,NC[C@@H](NC(=O)c1sc(c(c1)c1c(Cl)cnn1C)Cl)Cc1cccc(c1)F
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,capivasertib,7709,,,223366042,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,23394218,OCC[C@@H](c1ccc(cc1)Cl)NC(=O)C1(N)CCN(CC1)c1ncnc2c1cc[nH]2
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,Akt inhibitor VIII,5921,,,178102544,Allosteric modulator,Negative,,f,f,,pIC50,0,5.670000076,0,IC50,0,2119,0,=,,,,15664853,O=c1[nH]c2c(n1C1CCN(CC1)Cc1ccc(cc1)c1nc3cc4[nH]cnc4cc3nc1c1ccccc1)cccc2
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,A-443654,8204,,,249565884,Inhibitor,Inhibition,,f,f,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,~,,,,15956255,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,afuresertib,7890,,,249565581,Inhibitor,Inhibition,,f,t,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,,,,24978597,NC[C@@H](NC(=O)c1sc(c(c1)c1c(Cl)cnn1C)Cl)Cc1cccc(c1)F
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,capivasertib,7709,,,223366042,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,23394218,OCC[C@@H](c1ccc(cc1)Cl)NC(=O)C1(N)CCN(CC1)c1ncnc2c1cc[nH]2
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
Alanine/serine/cysteine transporter 2,874,SLC1A5,Q15758,,,,,,Human,benzylcysteine,4501,,,178101229,Inhibitor,Inhibition,,f,f,,pKi,0,3.109999895,0,Ki,0,780000,0,=,,,,15107471,N[C@H](C(=O)O)CSCc1ccccc1
Alanine/serine/cysteine transporter 2,874,SLC1A5,Q15758,,,,,,Human,benzylserine,4500,,,178101228,Inhibitor,Inhibition,,f,f,,pKi,0,3.049999952,0,Ki,0,900000,0,=,,,,15107471,N[C@H](C(=O)O)COCc1ccccc1
aldehyde dehydrogenase 5 family member A1,2466,ALDH5A1,P51649,,,,,,Human,4-acryloylphenol,8841,,,252827498,Inhibitor,Inhibition,,f,t,,pIC50,0,6.460000038,0,IC50,0,350,0,=,,,,16290145,C=CC(=O)c1ccc(cc1)O
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,AK198,8637,,,252166837,Inhibitor,Inhibition,,f,f,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,25919404,OC(=O)COc1cc(Cl)ccc1C(=O)NCc1ccc(cc1F)N
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,alectinib,7739,,,223366072,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,22225917,CCc1cc2C(=O)c3c4ccc(cc4[nH]c3C(c2cc1N1CCC(CC1)N1CCOCC1)(C)C)C#N
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,AZD3463,7706,,,223366039,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,,,,0,COc1cc(ccc1Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)N1CCC(CC1)N
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,brigatinib,7741,,,223366074,Inhibitor,Inhibition,,f,t,,pKi,0,10.05000019,0,Ki,0,0.090000004,0,=,Wild type ALK,,,21502504,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1P(=O)(C)C)Cl)N1CCC(CC1)N(C)C
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,brigatinib,7741,,,223366074,Inhibitor,Inhibition,,f,t,,pIC50,9.430000305,0,9.210000038,IC50,0.620000005,0,0.370000005,=,,,,21502504,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1P(=O)(C)C)Cl)N1CCC(CC1)N(C)C
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,CEP-37440,9698,,,348353657,Inhibitor,Inhibition,,f,f,,pIC50,0,8.510000229,0,IC50,0,3.099999905,0,=,,,,27527804,OCCN1CCN(CC1)[C@H]1CCCc2c(C1)ccc(c2OC)Nc1ncc(c(n1)Nc1ccccc1C(=O)NC)Cl
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,ceritinib,7397,,,178103969,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,23742252,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 15 [PMID: 24900237],8220,,,249565900,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,24900237,CCN1C(=O)CCCc2c1ccc(c2OC)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 5g [PMID: 20483621],8207,,,249565887,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,20483621,CN1CCN(CC1)c1ccc(cn1)c1cnc2c(c1)N(CCN2)Cc1cc(Cl)ccc1Cl
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 5m [PMID: 20483621],8206,,,249565886,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,20483621,Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccc(cc1)C(=O)N1CCC(CC1)N1CCCC1)C(F)(F)F
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 5n [PMID: 20483621],8208,,,249565888,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,20483621,Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccnc(c1)N1CCNCC1)C(F)(F)F
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,A61603,480,,,135649874,Agonist,Full agonist,,f,,,pIC50,8.4,0,7.8,-,0,0,0,=,,,,9249248,Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,f,,pKi,6.5,0,6.300000191,-,0,0,0,=,,,,7651358,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,(+)-adrenaline,4450,,,135651431,Agonist,Full agonist,,f,,,pKi,0,5,0,-,0,0,0,=,,,,7651358,CNC[C@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,5-methylurapidil,489,,,135649841,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.9,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,5-methylurapidil,489,,,135649841,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,11331292,COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,A-119637,490,,,135649867,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,A-119637,490,,,135649867,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,A-123189,491,,,135649868,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,A-123189,491,,,135649868,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,alfuzosin,7109,,,178103686,Antagonist,Antagonist,,f,t,,pKi,0,8.100000381,0,Ki,0,8.199999809,0,=,,,,10812954,COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,BMY-7378,9,,,135650009,Antagonist,Antagonist,,f,,,pKi,7,0,6.9,,0,0,0,,,,,11459121,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,BMY-7378,9,,,135650009,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,cabergoline,37,,,135652674,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11459121,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,,,pKi,0,6.5,0,,0,0,0,,,,,7651358,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,(+)-adrenaline,4450,,,135651431,Agonist,Full agonist,,f,,,pKi,0,5.1,0,-,0,0,0,=,,,,7651358,CNC[C@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,5-methylurapidil,489,,,135649841,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.2,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,A-119637,490,,,135649867,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,A-123189,491,,,135649868,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,AH 11110,8461,,,252166671,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,-,0,0,0,=,,,,8764344,OC(CC(=N)N1CCCCC1)COc1ccccc1c1ccccc1.Cl
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,alfuzosin,7109,,,178103686,Antagonist,Antagonist,,f,t,,pKi,0,8.600000381,0,Ki,0,2.799999952,0,=,,,,7658428,COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,BMY-7378,9,,,135650009,Antagonist,Antagonist,,f,,,pKi,7.5,0,7,,0,0,0,,,,,11459121,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11459121,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,6-fluoro-noradrenaline,510,,,135649849,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,7969082,NCC(c1cc(O)c(cc1F)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,t,,pKi,0,7.199999809,0,-,0,0,0,=,,,,7651358,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,,,pKi,0,6.3,0,-,0,0,0,=,,,,7969082,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,(+)-adrenaline,4450,,,135651431,Agonist,Full agonist,,f,,,pKi,0,6,0,-,0,0,0,=,,,,7651358,CNC[C@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,&alpha;-methylnoradrenaline,508,,,135649925,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,7969082,C[C@@H]([C@@H](c1ccc(c(c1)O)O)O)N
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,amidephrine,514,,,135649935,Agonist,Full agonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,7969082,CNCC(c1cccc(c1)NS(=O)(=O)C)O
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,cirazoline,515,,,135650103,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,7969082,C1CN=C(N1)COc1ccccc1C1CC1
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,clonidine,516,,,135650112,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,7969082,Clc1cccc(c1NC1=NCCN1)Cl
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,5-methylurapidil,489,,,135649841,Antagonist,Antagonist,,f,,,pKi,8,0,7.1,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,A-119637,490,,,135649867,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,A-119637,490,,,135649867,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,A-123189,491,,,135649868,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,A-123189,491,,,135649868,Antagonist,Antagonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,alfuzosin,7109,,,178103686,Antagonist,Antagonist,,f,t,,pKi,0,8.399999619,0,Ki,0,3.599999905,0,=,,,,10812954,COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,BMY-7378,9,,,135650009,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.7,-,0,0,0,=,,,,11459121,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,BMY-7378,9,,,135650009,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,11354357,COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,11459121,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,apraclonidine,7117,,,178103694,Agonist,Agonist,,f,t,,pKi,0,8.5,0,Ki,0,2.900000095,0,=,,,,8784451,Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,t,,pKi,7.400000095,0,5.800000191,-,0,0,0,=,,,,9824686,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,brimonidine,520,,,135650022,Agonist,Full agonist,,f,t,,pKi,8.699999809,0,6.699999809,-,0,0,0,=,,,,9824686,Brc1c(ccc2c1nccn2)NC1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,clonidine,516,,,135650112,Agonist,Partial agonist,,f,t,,pKi,9.199999809,0,7.199999809,-,0,0,0,=,,,,9824686,Clc1cccc(c1NC1=NCCN1)Cl
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,"5-(N,N-hexamethylene)-amiloride",1192,,,135650351,Allosteric modulator,Negative,,f,,,pKd,0,2.5,0,,0,0,0,,,,,1325028,NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,ARC-239,524,,,135649952,Antagonist,Antagonist,,f,,,pKi,6.8,0,5.5,,0,0,0,,,,,7996470,COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,BRL 44408,525,,,135650025,Antagonist,Antagonist,,f,f,,pKi,8.800000191,0,8.199999809,-,0,0,0,=,,,,7996470,CC1N(CC2=NCCN2)Cc2c1cccc2
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,bromocriptine,35,,,135650026,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,cabergoline,37,,,135652674,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,6.6,0,5.9,,0,0,0,,,,,1353247,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Agonist,,t,f,,pKi,0,5.199999809,0,-,0,0,0,=,,,,9605427,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,brimonidine,520,,,135650022,Agonist,Partial agonist,,f,t,,pKi,8.300000191,0,6,-,0,0,0,=,,,,9824686,Brc1c(ccc2c1nccn2)NC1=NCCN1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,clonidine,516,,,135650112,Agonist,Partial agonist,,f,t,,pKi,9.5,0,6.699999809,-,0,0,0,=,,,,9824686,Clc1cccc(c1NC1=NCCN1)Cl
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,apomorphine,33,,,135649950,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,ARC-239,524,,,135649952,Antagonist,Antagonist,,f,,,pKi,8.6,0,6.8,-,0,0,0,=,,,,7996470,COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,BRL 44408,525,,,135650025,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7996470,CC1N(CC2=NCCN2)Cc2c1cccc2
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,bromocriptine,35,,,135650026,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,cabergoline,37,,,135652674,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,8.3,0,7.2,,0,0,0,,,,,1353247,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Agonist,,t,f,,pKi,0,5.800000191,0,-,0,0,0,=,,,,9605427,CNC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,apraclonidine,7117,,,178103694,Agonist,Agonist,,f,t,,pKi,0,7.519999981,0,Ki,0,30,0,=,,,,8784451,Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,brimonidine,520,,,135650022,Agonist,Partial agonist,,f,t,,pKi,7.599999905,0,5.699999809,-,0,0,0,=,,,,9824686,Brc1c(ccc2c1nccn2)NC1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,clonidine,516,,,135650112,Agonist,Partial agonist,,f,,,pKi,7.8,0,6,,0,0,0,,,,,9824686,Clc1cccc(c1NC1=NCCN1)Cl
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,t,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,15771415,C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)C(=O)CCC1(C)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,t,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,15771415,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)C(=O)CCC1(C)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,apomorphine,33,,,135649950,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,ARC-239,524,,,135649952,Antagonist,Antagonist,,f,,,pKi,8.4,0,6.7,-,0,0,0,=,,,,7996470,COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,BRL 44408,525,,,135650025,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,7996470,CC1N(CC2=NCCN2)Cc2c1cccc2
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,bromocriptine,35,,,135650026,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,cabergoline,37,,,135652674,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.9,,0,0,0,,,,,1353247,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
Aminopeptidase A,1559,DNPEP,Q9ULA0,,,,,,Human,compound 9 [PMID: 1738140],8677,,,252166877,Inhibitor,Inhibition,,f,t,,pKi,0,6.289999962,0,Ki,0,510,0,=,,,,1738140,O[C@H](C(=O)NCCC(C)C)[C@@H](Cc1ccccc1)N
Aminopeptidase N,1560,,,,,,,,Pig,BTB07018,9669,,,348353628,Inhibitor,Inhibition,,f,f,,pKi,0,5.710000038,0,Ki,0,1950,0,=,,,,28964831,Cc1ccc(cc1)C(=O)NN/C(=N/S(=O)(=O)c1ccc(cc1)n1nc(cc1c1cccs1)C(F)(F)F)/N1CCCC1
Aminopeptidase N,1560,ANPEP,P15144,,,,,,Human,BTB07018,9669,,,348353628,Inhibitor,Inhibition,,f,f,,pKi,0,6,0,Ki,0,1010,0,=,Inhibition of APN <i>in vitro</i>.,,,28964831,Cc1ccc(cc1)C(=O)NN/C(=N/S(=O)(=O)c1ccc(cc1)n1nc(cc1c1cccs1)C(F)(F)F)/N1CCCC1
Aminopeptidase N,1560,ANPEP,P15144,,,,,,Human,compound 1a [PMID: 25692029],9091,,,315661176,Inhibitor,Inhibition,,f,f,,pKi,0,8.539999962,0,Ki,0,2.900000095,0,=,,,,25692029,C[C@@H](C(=O)O)NC(=O)[C@@H](CP(=O)([C@@H](N)C)O)Cc1ccc(cc1)c1ccccc1
Aminopeptidase N,1560,ANPEP,P15144,,,,,,Human,compound I3 [PMID: 23428964],8565,,,252166766,Inhibitor,Inhibition,,f,t,,pKi,0,9.460000038,0,Ki,0,0.349999994,0,=,,,,23428964,O=C1Cc2c(ccc(c2CCC1N)Br)c1ccccc1
Aminopeptidase N,1560,Anpep,P97449,,,,,,Mouse,compound I3 [PMID: 23428964],8565,,,252166766,Inhibitor,Inhibition,,f,f,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,23428964,O=C1Cc2c(ccc(c2CCC1N)Br)c1ccccc1
AMP kinase,1540,,,,,,,,Human,acadesine,5133,,,178101825,Activator,Activation,,f,,,-,0,0,0,-,0,0,0,=,,,,7744080,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(c1N)C(=O)N
AMP kinase,1540,,,,,,,,Human,adenosine 5'-monophosphate,2455,,,53801012,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(O)O
AMP kinase,1540,,,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
AMP kinase,1540,,,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,39.90000153,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q9R1W5|Q9WUP0,,,,,,Mouse,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,14609735,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pKi,9.2,0,8.3,-,0,0,0,=,,,,9620797,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,t,,,pIC50,9.3,0,8.7,,0,0,0,,,,,10854696,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,8.3,0,7.5,-,0,0,0,=,,,,21658025,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Full agonist,,t,,,pIC50,0,6.6,0,,0,0,0,,,,,10767413,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pKd,0,6,0,,0,0,0,,,,,9620797,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,AM-(11-50) (rat),704,,,135651988,Agonist,Full agonist,,t,,,pIC50,0,8.4,0,,0,0,0,,,,,11556887,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,&beta;-CGRP,696,Calcb,Rat,135651626,Agonist,Full agonist,,t,,,pIC50,6.8,0,6.7,,0,0,0,,,,,10854696,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pKi,7.7,0,7.3,,0,0,0,,,,,9620797,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,&alpha;-CGRP-(8-37) (human),700,,,135651981,Antagonist,Antagonist,,f,,,pKi,7,0,5,,0,0,0,,,,,9620797,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,&alpha;-CGRP-(8-37) (rat),701,,,135651982,Antagonist,Antagonist,,f,,,pIC50,7.1,0,7,,0,0,0,,,,,10854696,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q63118|Q9JHJ1,,,,,,Rat,AM-(20-50) (rat),705,,,135651989,Antagonist,Antagonist,,t,,,pIC50,8.5,0,7,,0,0,0,,,,,10854696,
AM<sub>1</sub> receptor,49,Calcrl|Ramp2,Q9R1W5|Q9WUP0,,,,,,Mouse,AM-(20-50) (rat),705,,,135651989,Antagonist,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,14609735,
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,AM-(22-52) (human),706,,,135651990,Antagonist,Antagonist,,f,f,,pKi,7.800000191,0,7,Ki,100,0,15.80000019,=,,,,12970090,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pKi,9,0,8.3,-,0,0,0,=,,,,11693189,
AM<sub>2</sub> receptor,50,Calcrl|Ramp3,Q9R1W5|Q9WUP1,,,,,,Mouse,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,14609735,
AM<sub>2</sub> receptor,50,Ramp3|Calcrl,Q63118|Q9JJ73,,,,,,Rat,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,,0,0,0,,,,,10854696,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,10.1,0,8.9,-,0,0,0,=,,,,21658025,
AM<sub>2</sub> receptor,50,Ramp3|Calcrl,Q63118|Q9JJ73,,,,,,Rat,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Full agonist,,t,,,pIC50,0,7.7,0,,0,0,0,,,,,10854696,
AM<sub>2</sub> receptor,50,Calcrl|Ramp3,Q9R1W5|Q9WUP1,,,,,,Mouse,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Full agonist,,t,,,pIC50,7.6,0,7.3,-,0,0,0,=,,,,14609735,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pKi,6.8,0,6.5,,0,0,0,,,,,11693189,
AM<sub>2</sub> receptor,50,Ramp3|Calcrl,Q63118|Q9JJ73,,,,,,Rat,&beta;-CGRP,696,Calcb,Rat,135651626,Agonist,Full agonist,,t,,,pIC50,0,7.7,0,,0,0,0,,,,,10854696,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pIC50,7.5,0,7,,0,0,0,,,,,11693189,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,&alpha;-CGRP-(8-37) (human),700,,,135651981,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11693189,
AM<sub>2</sub> receptor,50,Calcrl|Ramp3,Q9R1W5|Q9WUP1,,,,,,Mouse,&alpha;-CGRP-(8-37) (rat),701,,,135651982,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,14609735,
AM<sub>2</sub> receptor,50,Ramp3|Calcrl,Q63118|Q9JJ73,,,,,,Rat,&alpha;-CGRP-(8-37) (rat),701,,,135651982,Antagonist,Antagonist,,t,,,pIC50,0,8.4,0,,0,0,0,,,,,10854696,
AM<sub>2</sub> receptor,50,Calcrl|Ramp3,Q9R1W5|Q9WUP1,,,,,,Mouse,AM-(20-50) (rat),705,,,135651989,Antagonist,Antagonist,,f,,,pIC50,7.4,0,7.3,,0,0,0,,,,,14609735,
AM<sub>2</sub> receptor,50,Ramp3|Calcrl,Q63118|Q9JJ73,,,,,,Rat,AM-(20-50) (rat),705,,,135651989,Antagonist,Antagonist,,t,,,pIC50,0,7.8,0,,0,0,0,,,,,10854696,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,AM-(22-52) (human),706,,,135651990,Antagonist,Antagonist,,t,,,pKi,6.8,0,6.5,,0,0,0,,,,,11693189,
"amylase, alpha 2A (pancreatic)",2596,,,,,,,,Pig,acarbose,6791,,,178103397,Inhibitor,Inhibition,,f,f,,pIC50,0,4.449999809,0,IC50,0,35500,0,=,,,,23102653,OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H]([C@@H]([C@H]2O)O)O)[C@@H]([C@H]([C@@H]1O[C@H]1O[C@H](C)[C@H]([C@@H]([C@H]1O)O)N[C@H]1C=C(CO)[C@H]([C@@H]([C@H]1O)O)O)O)O
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pEC50,8.4,0,6.5,,0,0,0,,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,0,8,0,-,0,0,0,=,,,,21658025,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,f,,pEC50,10.80000019,0,8.699999809,-,0,0,0,=,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,amylin,687,IAPP,Human,135651612,Agonist,Full agonist,,t,f,,pEC50,9.710000038,0,9,EC50,1,0,0.194000006,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,amylin,688,Iapp|Iapp,Mouse|Rat,135651613,Agonist,Full agonist,,f,f,,pEC50,10.69999981,0,8.979999542,EC50,1.047000051,0,0.0199,=,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pEC50,0,9.2,0,,0,0,0,,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,calcitonin,685,CALCA,Human,135651700,Agonist,Full agonist,,t,,,pEC50,11.3,0,8.9,-,0,0,0,=,,,,15692146,
AMY<sub>1</sub> receptor,44,Calcr|Ramp1,P32214|Q9JJ74,,,,,,Rat,calcitonin (salmon),6973,,,178103552,Agonist,Full agonist,,f,f,,pKi,0,9,0,-,0,0,0,=,,,,10385705,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,AC187,689,,,135651967,Antagonist,Antagonist,,f,f,,pKi,0,8.020000458,0,-,0,0,0,=,,,,15692146,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)[C@H](O)C)CC(=O)N)CO)[C@H](O)C)CC(=O)N)[C@H](O)C)CCCNC(=N)N)Cc1ccc(cc1)O)[C@H](O)C)CCC(=O)N)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)C)CC(C)C)CCCCN)CC(C)C)CO)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1nc[nH]c1
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,&alpha;-CGRP-(8-37) (human),700,,,135651981,Antagonist,Antagonist,,f,,,pKB,0,6.62,0,-,0,0,0,=,,,,15692146,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pEC50,0,9.2,0,,0,0,0,,,,,12565884,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,0,6,0,-,0,0,0,=,,,,21658025,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pEC50,9.7,0,6.2,,0,0,0,,,,,15692146,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,amylin,687,IAPP,Human,135651612,Agonist,Full agonist,,t,f,,pEC50,9.109999657,0,8.270000458,EC50,5.369999886,0,0.776000023,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,amylin,688,Iapp|Iapp,Mouse|Rat,135651613,Agonist,Full agonist,,f,f,,pEC50,9.899999619,0,8.470000267,EC50,3.388000011,0,0.125,=,,,,14722252,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,calcitonin,685,CALCA,Human,135651700,Agonist,Full agonist,,t,,,pEC50,0,11.4,0,,0,0,0,,,,,11033437,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pEC50,8.3,0,6.9,,0,0,0,,,,,15692146,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,0,7,0,-,0,0,0,~,,,,21658025,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pEC50,9.7,0,7.6,,0,0,0,,,,,15692146,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,amylin,687,IAPP,Human,135651612,Agonist,Full agonist,,t,f,,pEC50,9.600000381,0,8.899999619,EC50,1.258000016,0,0.250999987,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,amylin,688,Iapp|Iapp,Mouse|Rat,135651613,Agonist,Full agonist,,f,f,,pEC50,10.80000019,0,8.600000381,-,0,0,0,=,,,,15692146,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pEC50,0,7.7,0,,0,0,0,,,,,15692146,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,calcitonin,685,CALCA,Human,135651700,Agonist,Full agonist,,t,,,pEC50,10.6,0,8,,0,0,0,,,,,11033437,
AMY<sub>3</sub> receptor,46,Calcr|Ramp3,P32214|Q9JJ73,,,,,,Rat,calcitonin (salmon),6973,,,178103552,Agonist,Full agonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,10385705,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,AC187,689,,,135651967,Antagonist,Antagonist,,f,f,,pKi,0,7.679999828,0,-,0,0,0,=,,,,15692146,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)[C@H](O)C)CC(=O)N)CO)[C@H](O)C)CC(=O)N)[C@H](O)C)CCCNC(=N)N)Cc1ccc(cc1)O)[C@H](O)C)CCC(=O)N)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)C)CC(C)C)CCCCN)CC(C)C)CO)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1nc[nH]c1
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,&alpha;-CGRP-(8-37) (human),700,,,135651981,Antagonist,Antagonist,,f,,,pKB,0,6.17,0,-,0,0,0,=,,,,15692146,
Androgen receptor,628,AR,P10275,,,,,,Human,andarine,7849,,,223366179,Agonist,Agonist,,f,t,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,19432422,CC(=O)Nc1ccc(cc1)OC[C@@](C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-])(O)C
Androgen receptor,628,Ar,P15207,,,,,,Rat,androstenedione,2860,,,135649946,Agonist,Agonist,,f,,,pIC50,0,8.56,0,,0,0,0,,,,,14565775,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2=O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,apalutamide,9043,,,315661128,Antagonist,Antagonist,,f,t,,pIC50,0,6.909999847,0,IC50,0,122,0,=,,,,20218717,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C21CCC2)c1cnc(c(c1)C(F)(F)F)C#N
Androgen receptor,628,AR,P10275,,,,,,Human,bicalutamide,2863,,,135649993,Antagonist,Antagonist,,f,t,,pKi,0,7.71999979,0,Ki,0,19,0,=,,,,16420057,N#Cc1ccc(cc1C(F)(F)F)NC(=O)C(CS(=O)(=O)c1ccc(cc1)F)(O)C
Androgen receptor,628,AR,P10275,,,,,,Human,bicalutamide,2863,,,135649993,Antagonist,Antagonist,,f,t,,pIC50,0,6,0,IC50,0,1000,0,=,,,,20218717,N#Cc1ccc(cc1C(F)(F)F)NC(=O)C(CS(=O)(=O)c1ccc(cc1)F)(O)C
Androgen receptor,628,AR,P10275,,,,,,Human,bisphenol A,7865,,,223366195,Antagonist,Antagonist,,f,f,,pIC50,0,5.230000019,0,IC50,0,5900,0,=,,,,23768907,CC(c1ccc(cc1)O)(c1ccc(cc1)O)C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,benazepril,6374,,,178102992,Inhibitor,Inhibition,,f,t,,pIC50,0,8.800000191,0,IC50,0,1.700000048,0,=,,,,2999394,CCOC(=O)[C@@H](N[C@H]1CCc2c(N(C1=O)CC(=O)O)cccc2)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,benazeprilat,6375,,,178102993,Inhibitor,Inhibition,,f,t,,pIC50,0,6.599999905,0,IC50,0,280,0,=,,,,17506720,OC(=O)CN1C(=O)[C@H](CCc2c1cccc2)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,captopril,5158,,,178101850,Inhibitor,Inhibition,,f,t,,pKi,0,8.399999619,0,Ki,0,3.980000019,0,=,,,,9187274,SC[C@H](C(=O)N1CCC[C@H]1C(=O)O)C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,cilazapril,6459,,,178103074,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCOC(=O)[C@@H](N[C@H]1CCCN2N(C1=O)[C@@H](CCC2)C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,,,,,,,,Rabbit,cilazaprilat,6461,,,178103075,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,1.899999976,0,=,,,,2527528,OC(=O)[C@@H](N[C@H]1CCCN2N(C1=O)[C@@H](CCC2)C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme 2,1614,ACE2,Q9BYF1,,,,,,Human,compound 28 [PMID: 18324760],6555,,,178103169,Inhibitor,Inhibition,,f,t,,pKi,0,9.899999619,0,Ki,0,0.129999995,0,=,,,,18324760,CC(C[C@@H](C(=O)N1CCC[C@@H]1P(=O)(C[C@H](C(=O)O)Cc1ccccc1)O)NC(=O)C)C
Angiotensin-converting enzyme 2,1614,ACE2,Q9BYF1,,,,,,Human,Abz-Ser-Pro-Tyr(NO<sub>2</sub>)-OH,5132,,,178101824,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,12531198,
apelin receptor,36,APLNR,P35414,,,,,,Human,apelin-17,3556,APLN|Apln|Apln,Human|Mouse|Rat,135651622,Agonist,Agonist,,t,f,,pIC50,9,0,7.900000095,-,0,0,0,=,,,,12603839,
apelin receptor,36,APLNR,P35414,,,,,,Human,apelin receptor early endogenous ligand,7930,APELA,Human,249565613,Agonist,Agonist,,t,t,,pKd,0,9.289999962,0,Kd,0,0.50999999,0,=,,,,25995451,
apelin receptor,36,APLNR,P35414,,,,,,Human,CMF-019,9448,,,329968388,Agonist,Biased agonist,,f,f,,pEC50,0,10,0,-,0,0,0,=,,,,27475715,CCC(n1c(Cc2cccs2)nc2c1ccc(c2)C(=O)N[C@H](CC(=O)O)CC(C)C)CC
apelin receptor,36,APLNR,P35414,,,,,,Human,apelin-13,605,APLN|Apln|Apln,Human|Mouse|Rat,135651621,Agonist,Full agonist,,t,,,pIC50,9.5,0,8.8,-,0,0,0,=,,,,10777510,NCCCC[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CCSC)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)N)N)CCCN=C(N)N)CCCN=C(N)N)CC(C)C)CO
apelin receptor,36,APLNR,P35414,,,,,,Human,apelin-36,606,APLN,Human,135651624,Agonist,Full agonist,,t,t,,pIC50,8.600000381,0,8.199999809,-,0,0,0,=,,,,10777510,
apelin receptor,36,APLNR,P35414,,,,,,Human,compound 1 [PMID: 25241924],7801,,,223366132,Agonist,Full agonist,,f,f,,pEC50,0,7.5,0,EC50,0,33.70000076,0,=,,,,25241924,
apelin receptor,36,APLNR,P35414,,,,,,Human,ALX40-4C,607,,,135651987,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,12667811,NC(=N)NCCC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)C)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N
AQP1,688,AQP1,P29972,,,,,,Human,Ag<sup>+</sup>,4126,,,178100948,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
Arginase I,1244,ARG1,P05089,,,,,,Human,2(<i>S</i>)-amino-6-boronohexanoic acid,5107,,,178101800,Inhibitor,Inhibition,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,0,OB(CCCC[C@@H](C(=O)O)N)O
Arginase I,1244,ARG1,P05089,,,,,,Human,A1P,8806,,,252827464,Inhibitor,Inhibition,,f,t,,pKi,0,5.400000095,0,Ki,0,4000,0,=,Measured using an enzyme kinetics assay.,,,20441173,OC(=O)[C@H](CCCn1ccnc1N)N
Arginase I,1244,ARG1,P05089,,,,,,Human,A1P,8806,,,252827464,Inhibitor,Inhibition,,f,f,,pKd,0,5.699999809,0,Kd,0,2000,0,=,Dissociation constant measured using surface plasmon resonance assay.,,,20441173,OC(=O)[C@H](CCCn1ccnc1N)N
Arginase I,1244,ARG1,P05089,,,,,,Human,compound 9 [PMID: 23472952],9017,,,315661102,Inhibitor,Inhibition,,f,f,,pIC50,0,6.650000095,0,IC50,0,223,0,=,,,,23472952,OB(CCCC[C@](C(=O)O)(CCN1CCCCC1)N)O
Arginase II,1245,ARG2,P78540,,,,,,Human,2(<i>S</i>)-amino-6-boronohexanoic acid,5107,,,178101800,Inhibitor,Inhibition,,f,f,,pKi,0,8.069999695,0,Ki,0,8.5,0,=,,,,11478904,OB(CCCC[C@@H](C(=O)O)N)O
Arginase II,1245,ARG2,P78540,,,,,,Human,compound 9 [PMID: 23472952],9017,,,315661102,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,509,0,=,,,,23472952,OB(CCCC[C@](C(=O)O)(CCN1CCCCC1)N)O
ASIC1,684,Asic1,P55926,,,,,,Rat,A-317567,4116,,,178100938,Channel blocker,None,ASIC1a,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,~,,,,16061325,NC(=N)c1ccc2c(c1)ccc(c2)C1CC1c1ccc2c(c1)C(C(C)C)N(CC2)C
ASIC1,684,ASIC1,P78348,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,ASIC1b,f,,,pIC50,4.68,0,4.64,IC50,23000,0,21000,,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
ASIC1,684,ASIC1,P78348,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,ASIC1a,f,,,pIC50,0,5,0,IC50,0,10000,0,,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
ASIC1,684,ASIC1,P78348,,,,,,Human,benzamil,4145,,,178100966,Channel blocker,None,ASIC1a,f,,,pIC50,0,5,0,IC50,0,10000,0,,,,,0,NC(=NCc1ccccc1)NC(=O)c1nc(Cl)c(nc1N)N
ASIC2,685,ASIC2,Q16515,,,,,,Human,A-317567,4116,,,178100938,Channel blocker,None,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,~,,,,0,NC(=N)c1ccc2c(c1)ccc(c2)C1CC1c1ccc2c(c1)C(C(C)C)N(CC2)C
ASIC2,685,ASIC2,Q16515,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,,f,,,pIC50,0,4.6,0,IC50,0,28000,0,,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
ASIC2,685,ASIC2,Q16515,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,pIC50,0,3,0,IC50,0,1000000,0,~,,,,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,agmatine,4127,,,178100949,Activator,None,at pH 7.4,f,,,pEC50,0,2,0,EC50,0,9800000,0,~,,,,0,NCCCCN=C(N)N
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,arcaine,4137,,,178100959,Activator,None,at pH 7.4,f,,,pEC50,0,2.9,0,EC50,0,1200000,0,~,,,,0,NC(=NCCCCN=C(N)N)N
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,A-317567,4116,,,178100938,Channel blocker,None,,f,,,pIC50,0,5,0,IC50,0,10000,0,~,,,,0,NC(=N)c1ccc2c(c1)ccc(c2)C1CC1c1ccc2c(c1)C(C(C)C)N(CC2)C
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,transient component only - sustained component enhanced by 200&mu;M amiloride at pH 4,f,,,pIC50,4.8,0,4.2,IC50,63000,0,16000,,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,APETx2,4135,,,178100957,Channel blocker,None,transient component only,f,,,pIC50,0,7.2,0,IC50,0,63,0,,,,,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,aspirin,4139,,,178100961,Channel blocker,None,sustained component,f,,,pIC50,0,4,0,IC50,0,92000,0,=,,,,11588175,CC(=O)Oc1ccccc1C(=O)O
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,2-chloroadenosine,372,,,135651395,Agonist,Agonist,,f,,,pKi,0,8.17,0,Ki,0,6.7,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,7.14,0,Ki,0,73,0,=,,,,14662005,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,adenosine,2844,,,135651426,Agonist,Agonist,,t,t,,pKi,0,7,0,Ki,0,100,0,~,,,,14662005,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,apadenoson,3290,,,178100331,Agonist,Agonist,,f,,,pKi,0,7.11,0,Ki,0,77,0,=,,,,16518376,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#CC[C@@H]1CC[C@H](CC1)C(=O)OC)nc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,BAY 60-6583,3289,,,178100330,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,17632123,N#Cc1c(N)nc(c(c1c1ccc(cc1)OCC1CC1)C#N)SCC(=O)N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,binodenoson,5595,,,178102230,Agonist,Agonist,,f,,,pKi,0,4.32,0,Ki,0,48000,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,CCPA,374,,,135651453,Agonist,Agonist,,f,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,CGS 21680,375,,,135650083,Agonist,Agonist,,f,,,pKi,0,5.74,0,Ki,0,1800,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,6.55,0,Ki,0,280,0,=,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>1</sub> receptor,18,Adora1,Q60612,,,,,,Mouse,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,7.46,0,Ki,0,35,0,=,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,6.66,0,Ki,0,220,0,=,,,,16518376,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,2-chloroadenosine,372,,,135651395,Agonist,Full agonist,,f,,,pKi,5.6,0,5.2,-,0,0,0,=,,,,7798201,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,2-hexynyl-NECA,373,,,135649703,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12109910,CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,5-Cl-5-deoxy-(&plusmn;)-ENBA,6560,,,178103174,Agonist,Full agonist,,f,,,pKi,0,9.29,0,Ki,0,0.51,0,=,,,,19317449,ClCC1OC(C(C1O)O)n1cnc2c1ncnc2NC1CC2CC1CC2
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,CCPA,374,,,135651453,Agonist,Full agonist,,f,,,pKi,8.1,0,7.7,-,0,0,0,=,,,,16020631,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,CGS 21680,375,,,135650083,Agonist,Full agonist,,f,,,pKi,6.4,0,5.8,-,0,0,0,=,,,,15476669,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,8-cyclopentyltheophylline,385,,,135650136,Antagonist,Antagonist,,f,,,pKi,8,0,7.5,,0,0,0,,,,,9827575,Cn1c2nc([nH]c2c(=O)n(c1=O)C)C1CCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,AS100,381,,,135649958,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,16219300,CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc(c(c1)Cl)Cl
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,AS70,382,,,135649961,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,16219300,CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)N1CCN(CC1)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,AS99,383,,,135649966,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,16219300,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc(c(c1)C)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,6.43,0,Ki,0,369,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>1</sub> receptor,18,Adora1,Q60612,,,,,,Mouse,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,5.02,0,Ki,0,9583,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,caffeine,407,,,135652675,Antagonist,Antagonist,,f,,,pKi,4.39,0,4.36,Ki,44000,0,41000,=,,,,8182711,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,caffeine,407,,,135652675,Antagonist,Antagonist,,f,t,,pKi,4.96999979,0,4.349999905,Ki,44900,0,10700,=,,,,8469419,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,0,8.46,0,Ki,0,3.5,0,=,,,,9933143,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,0,8.19,0,Ki,0,6.4,0,=,,,,0,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,2-chloroadenosine,372,,,135651395,Agonist,Agonist,,f,,,pKi,0,7.12,0,Ki,0,76,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,6.51,0,Ki,0,310,0,=,,,,15822182,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,adenosine,2844,,,135651426,Agonist,Agonist,,f,,,pKi,0,6.82,0,Ki,0,150,0,=,,,,14662005,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,apadenoson,3290,,,178100331,Agonist,Agonist,,f,,,pKi,0,9.3,0,Ki,0,0.5,0,=,,,,11406470,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#CC[C@@H]1CC[C@H](CC1)C(=O)OC)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,BAY 60-6583,3289,,,178100330,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,17632123,N#Cc1c(N)nc(c(c1c1ccc(cc1)OCC1CC1)C#N)SCC(=O)N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,binodenoson,5595,,,178102230,Agonist,Agonist,,f,,,pKi,0,6.57,0,Ki,0,270,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,CCPA,374,,,135651453,Agonist,Agonist,,f,,,pKi,0,6.02,0,Ki,0,950,0,=,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,CGS 21680,375,,,135650083,Agonist,Agonist,,f,,,pKi,0,7.72,0,Ki,0,19,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,6.33,0,Ki,0,470,0,=,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>2A</sub> receptor,19,Adora2a,Q60613,,,,,,Mouse,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,~,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,5.27,0,Ki,0,5360,0,=,,,,16518376,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,compound 4g [PMID: 22220592],9236,,,315661311,Agonist,Agonist,,f,t,,pKi,0,8.109999657,0,Ki,0,7.760000229,0,=,,,,22220592,Nc1nnc(c(n1)c1ccccc1)c1cc(C)nc(c1)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,2-chloroadenosine,372,,,135651395,Agonist,Full agonist,,f,,,pKi,6.8,0,6.7,-,0,0,0,=,,,,7775460,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,2-hexynyl-NECA,373,,,135649703,Agonist,Full agonist,,f,,,pKi,8.3,0,8.2,-,0,0,0,=,,,,12109910,CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,AB-MECA,416,,,135649875,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,9459566,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(cc1)N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,APNEA,417,,,135649949,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,9920286,OCC1OC(C(C1O)O)n1cnc2c1ncnc2NCCc1ccc(cc1)N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CCPA,374,,,135651453,Agonist,Full agonist,,f,,,pKi,0,5.6,0,-,0,0,0,=,,,,9459566,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CGS 21680,375,,,135650083,Agonist,Full agonist,,f,f,,pKi,8.100000381,0,6.699999809,Ki,199,0,7.940000057,=,,,,15476669,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CGS 24012,418,,,135650084,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,7775460,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCC(c1ccccc1C)c1cc(OC)cc(c1)OC
A<sub>2A</sub> receptor,19,Adora2a,Q60613,,,,,,Mouse,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,5.08,0,Ki,0,8393,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,6.18,0,Ki,0,654,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,caffeine,407,,,135652675,Antagonist,Antagonist,,f,,,pKi,4.49,0,4.32,Ki,48000,0,32500,=,,,,1658821,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,caffeine,407,,,135652675,Antagonist,Antagonist,,f,t,,pKi,5.599999905,0,4.599999905,-,0,0,0,=,,,,9920286,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,9.4,0,7.7,-,0,0,0,=,,,,9459566,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,4.82,0,Ki,0,15000,0,=,,,,15822182,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,5.29,0,Ki,0,5100,0,=,,,,14662005,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,BAY 60-6583,3289,,,178100330,Agonist,Agonist,,f,,,pKi,8.52,0,8,Ki,10,0,3,=,,,,17353435,N#Cc1c(N)nc(c(c1c1ccc(cc1)OCC1CC1)C#N)SCC(=O)N
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,BAY 60-6583,3289,,,178100330,Agonist,Agonist,,f,,,pKi,0,6.48,0,Ki,0,330,0,=,,,,17632123,N#Cc1c(N)nc(c(c1c1ccc(cc1)OCC1CC1)C#N)SCC(=O)N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,binodenoson,5595,,,178102230,Agonist,Agonist,,f,,,pKi,0,3.37,0,Ki,0,430000,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,CGS 21680,375,,,135650083,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,2-chloroadenosine,372,,,135651395,Agonist,Full agonist,,f,,,pKi,5,0,4.6,-,0,0,0,=,,,,10496952,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,2-hexynyl-NECA,373,,,135649703,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,16219300,CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AB-NECA,434,,,135649876,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10496952,CCNC(=O)C(=O)Nc1nc(Nc2ccccc2)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CCPA,374,,,135651453,Agonist,Full agonist,,f,,,pKi,4.7,0,4.4,-,0,0,0,=,,,,10496952,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CGS 21680,375,,,135650083,Agonist,Full agonist,,f,,,pKi,5,0,3.4,-,0,0,0,=,,,,10496952,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,3-isobutyl-8-pyrrolidinoxanthine,447,,,135650407,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,11705449,CC(Cn1c(=O)[nH]c(=O)c2c1nc([nH]2)N1CCCC1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,alloxazine,456,,,135649917,Antagonist,Antagonist,,f,,,pKi,6.3,0,5.7,,0,0,0,,,,,11266650,O=c1[nH]c2nc3ccccc3nc2c(=O)[nH]1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS100,381,,,135649958,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,16219300,CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc(c(c1)Cl)Cl
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS101,437,,,135649959,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c\3/cc([nH]n3C)OC(=O)CNc3ccc(c(c3)OC)OC)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS101,437,,,135649959,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c3/cc([nH]n3C)OC(=O)CNc3ccc(c(c3)OC)OC)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS16,438,,,135649960,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c\3/cc([nH]n3C)NC(=O)Cc3ccc(cc3)OCc3ccccc3)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS16,438,,,135649960,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c3/cc([nH]n3C)NC(=O)Cc3ccc(cc3)OCc3ccccc3)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS70,382,,,135649961,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,16219300,CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)N1CCN(CC1)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS74,439,,,135649962,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c/3\o[nH]c(c3)OCC(=O)Nc3ccc4c(c3)OCO4)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS74,439,,,135649962,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c/3o[nH]c(c3)OCC(=O)Nc3ccc4c(c3)OCO4)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS94,440,,,135649963,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,16219300,CCOC(=O)c1ccc(cc1)NC(=O)COc1c/c(=C\2/N=c3c(=N2)c(=O)n(c(=O)n3CCC)CCC)/n([nH]1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS94,440,,,135649963,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,16219300,CCOC(=O)c1ccc(cc1)NC(=O)COc1c/c(=C2/N=c3c(=N2)c(=O)n(c(=O)n3CCC)CCC)/n([nH]1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS95,441,,,135649964,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c\3/cc([nH]n3C)OCC(=O)Nc3ccc(cc3)C(=O)O)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS95,441,,,135649964,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16219300,CCCn1c2=N/C(=c3/cc([nH]n3C)OCC(=O)Nc3ccc(cc3)C(=O)O)/N=c2c(=O)n(c1=O)CCC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS96,442,,,135649965,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,16219300,C=CCn1c2=N/C(=c\3/cc([nH]n3C)OCC(=O)N3CCN(CC3)c3ccccc3)/N=c2c(=O)n(c1=O)CC=C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS96,442,,,135649965,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,16219300,C=CCn1c2=N/C(=c3/cc([nH]n3C)OCC(=O)N3CCN(CC3)c3ccccc3)/N=c2c(=O)n(c1=O)CC=C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,AS99,383,,,135649966,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,16219300,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc(c(c1)C)C
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,8.07,0,Ki,0,8.58,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,8.63,0,Ki,0,2.36,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,BW-A1433,443,,,135650042,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10496952,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,caffeine,407,,,135652675,Antagonist,Antagonist,,f,t,,pKi,4.980000019,0,4.46999979,Ki,33800,0,10400,=,,,,19569717,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,caffeine,407,,,135652675,Antagonist,Antagonist,,f,,,pKi,0,4.89,0,Ki,0,13000,0,=,,,,8135856,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,caffeine,407,,,135652675,Antagonist,Antagonist,,f,,,pKi,0,4.52,0,Ki,0,30000,0,=,,,,8135856,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,8.1,0,6,-,0,0,0,=,,,,9459566,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,f,,pA2,0,7.800000191,0,-,0,0,0,=,,,,8937736,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,0,8.04,0,Ki,0,9.07,0,=,,,,19141710,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,2-chloroadenosine,372,,,135651395,Agonist,Agonist,,f,,,pKi,0,5.72,0,Ki,0,1890,0,=,,,,8022403,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,2'-Me-CCPA,5591,,,178102226,Agonist,Agonist,,f,,,pKi,0,5.3,0,Ki,0,5000,0,=,,,,9572897,OC[C@H]1O[C@H]([C@]([C@@H]1O)(C)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,2-phenylethylyl-adenosine derivative,5600,,,178102235,Agonist,Agonist,,f,,,pKi,0,9.36,0,Ki,0,0.44,0,=,,,,19839592,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#Cc1ccccc1)nc2NC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,6.54,0,Ki,0,290,0,=,,,,15822182,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,adenosine,2844,,,135651426,Agonist,Agonist,,t,,,pKi,0,5.19,0,Ki,0,6500,0,=,,,,14662005,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,apadenoson,3290,,,178100331,Agonist,Agonist,,f,,,pKi,0,7.35,0,Ki,0,45,0,=,,,,16518376,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#CC[C@@H]1CC[C@H](CC1)C(=O)OC)nc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,BAY 60-6583,3289,,,178100330,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,17632123,N#Cc1c(N)nc(c(c1c1ccc(cc1)OCC1CC1)C#N)SCC(=O)N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,binodenoson,5595,,,178102230,Agonist,Agonist,,f,,,pKi,0,6.04,0,Ki,0,903,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,CCPA,374,,,135651453,Agonist,Agonist,,f,,,pKi,0,6.63,0,Ki,0,237,0,=,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,CGS 21680,375,,,135650083,Agonist,Agonist,,f,,,pKi,0,6.23,0,Ki,0,584,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,9.48,0,Ki,0,0.33,0,=,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>3</sub> receptor,21,Adora3,Q61618,,,,,,Mouse,Cl-IB-MECA,457,,,135650107,Agonist,Agonist,,f,,,pKi,0,9.74,0,Ki,0,0.18,0,=,,,,0,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,2-hexynyl-NECA,373,,,135649703,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12109910,CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,AB-MECA,416,,,135649875,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9459566,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(cc1)N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,CCPA,374,,,135651453,Agonist,Full agonist,,f,,,pKi,0,7.4,0,-,0,0,0,=,,,,9459566,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,CGS 21680,375,,,135650083,Agonist,Full agonist,,f,,,pKi,7.2,0,6,-,0,0,0,=,,,,15476669,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,Cl-IB-MECA,457,,,135650107,Agonist,Full agonist,,f,,,pKi,8.9,0,8,-,0,0,0,=,,,,10731034,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)I
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>3</sub> receptor,21,Adora3,Q61618,,,,,,Mouse,ATL802,5616,,,178102250,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)C1CC1)c1ccc(nc1)N(C(=O)c1ccc(nc1)C(F)(F)F)C
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,BW-A1433,443,,,135650042,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7929142,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,BW-A1433,443,,,135650042,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8234299,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,caffeine,407,,,135652675,Antagonist,Antagonist,,f,t,,pKi,0,4.880000114,0,Ki,0,13300,0,=,,,,0,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,caffeine,407,,,135652675,Antagonist,Antagonist,,f,,,pKi,0,4,0,Ki,0,100000,0,>,,,,19569717,Cn1cnc2c1c(=O)n(C)c(=O)n2C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,CGS 15943,384,,,135650082,Antagonist,Antagonist,,f,,,pKi,7.9,0,7,-,0,0,0,=,,,,9459566,Clc1ccc2c(c1)c1nc(nn1c(n2)N)c1ccco1
"ATB<sup>0,+</sup>",937,SLC6A14,Q9UN76,,,,,,Human,"&alpha;-methyl-D,L-tryptophan",4693,,,178101406,Inhibitor,Inhibition,,f,,,pIC50,0,3.6,0,IC50,0,250000,0,,,,,18522536,OC(=O)C(Cc1c[nH]c2c1cccc2)(N)C
ATM serine/threonine kinase,1934,ATM,Q13315,,,,,,Human,berzosertib,8003,,,249565683,Inhibitor,Inhibition,,f,f,,pKi,0,7.46999979,0,Ki,0,34,0,=,,,,23222511,CNCc1ccc(cc1)c1noc(c1)c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C(C)C
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,compound 33 [PMID: 26230603],8732,,,252827390,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,-,0,0,0,=,,,,26230603,O=c1[nH]c2c(nccc2cc1C)N[C@@H]1CCNC[C@H]1OCC1CCS(=O)(=O)CC1
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,compound 57 [PMID: 26155854],8640,,,252166840,Inhibitor,Inhibition,,f,f,,pIC50,0,5.900000095,0,-,0,0,0,=,,,,26155854,Cc1cncc(c1)c1cnc(c2c1cc(C)c(=O)[nH]2)NC1CCNCC1
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,compound 60 [PMID: 26155854],8641,,,252166841,Inhibitor,Inhibition,,f,f,,pIC50,0,5.900000095,0,-,0,0,0,=,,,,26155854,COc1cncc(c1)c1cnc(c2c1cc(C)c(=O)[nH]2)NC1CCNCC1
"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",2594,ABCC8,Q09428,,,,,,Human,chlorpropamide,6801,,,178103407,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
ATR serine/threonine kinase,1935,ATR,Q13535,,,,,,Human,AZ20,8477,,,252166686,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,ATR immunoprecipitated from HeLa cells.,,,23394205,C[C@@H]1COCCN1c1cc(nc(n1)c1cccc2c1cc[nH]2)C1(CC1)S(=O)(=O)C
ATR serine/threonine kinase,1935,ATR,Q13535,,,,,,Human,AZD6738,9390,,,328083492,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of isolated enzyme,,,26517239,C[C@@H]1COCCN1c1cc(nc(n1)c1ccnc2c1cc[nH]2)C1(CC1)[S@@](=O)(=N)C
ATR serine/threonine kinase,1935,ATR,Q13535,,,,,,Human,berzosertib,8003,,,249565683,Inhibitor,Inhibition,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,<,,,,23222511,CNCc1ccc(cc1)c1noc(c1)c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C(C)C
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,angiotensin A,6894,AGT,Human,178103476,Agonist,Full agonist,IP accumulation in hAT1 expressing CHO cells,t,,,pEC50,0,8.170000076,0,-,0,0,0,=,,,,21464395,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,angiotensin A,6894,AGT,Human,178103476,Agonist,Full agonist,IP accumulation in hAT1 expressing CHO cells,t,,,pKi,0,8.800000191,0,-,0,0,0,=,,,,21464395,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,angiotensin II,2504,AGT|Agt|Agt,Human|Mouse|Rat,53801076,Agonist,Full agonist,,t,f,,pIC50,9.300000191,0,9,-,0,0,0,=,,,,10193788,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1nc[nH]c1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,angiotensin III,585,AGT|Agt|Agt,Human|Mouse|Rat,135651616,Agonist,Full agonist,,t,f,,pIC50,8.5,0,8.399999619,-,0,0,0,=,,,,0,NC(=NCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)C(C)C)Cc1ccc(cc1)O)C(C)C)NC(=O)[C@H](CC(=O)O)N)N
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,angiotensin A,6894,AGT,Human,178103476,Agonist,Partial agonist,calcium release in rat VSMC,t,,,pIC50,0,9.539999962,0,-,0,0,0,=,,,,17138938,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,angiotensin IV,5368,AGT|Agt|Agt,Human|Mouse|Rat,178102027,Agonist,Partial agonist,,t,,,pEC50,0,5.900000095,0,-,0,0,0,=,,,,12006574,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,5-butyl-methyl immidazole carboxylate 30,6917,,,178103499,Antagonist,Antagonist,,f,,,pA2,0,7.829999924,0,-,0,0,0,=,,,,22889560,CCCCc1cnc(n1Cc1ccc(cc1)c1ccccc1C)C(=O)O
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,5-butyl-methyl immidazole carboxylate 30,6917,,,178103499,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,-,0,0,0,=,,,,22889560,CCCCc1cnc(n1Cc1ccc(cc1)c1ccccc1C)C(=O)O
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,5-oxo-1-2-4-oxadiazol biphenyl,6913,,,178103495,Antagonist,Antagonist,,f,f,,pKi,0,8.989999771,0,Ki,0,1.029999971,0,=,,,,22410249,CCC[C@H](N(C(=O)CC)Cc1ccc(cc1)c1ccccc1c1noc(=O)[nH]1)C(=O)O
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,5-oxo-1-2-4-oxadiazol biphenyl,6913,,,178103495,Antagonist,Antagonist,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.600000024,0,=,,,,22410249,CCC[C@H](N(C(=O)CC)Cc1ccc(cc1)c1ccccc1c1noc(=O)[nH]1)C(=O)O
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,azilsartan,6901,,,178103483,Antagonist,Antagonist,,f,f,,pIC50,8.130000114,0,8.079999924,IC50,8.399999619,0,7.400000095,=,,,,24742498,CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1[nH]oc(=O)n1)c(ccc2)C(=O)O
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,candesartan,587,,,135650050,Antagonist,Antagonist,,f,t,,pIC50,9.720000267,0,9.489999771,IC50,0.319999993,0,0.189999998,=,,,,10193788,CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,angiotensin-(1-7),582,AGT|Agt|Agt,Human|Mouse|Rat,135651614,Agonist,Agonist,,t,f,,pIC50,0,6.610000134,0,IC50,0,246,0,=,,,,21542804,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,angiotensin A,6894,AGT,Human,178103476,Agonist,Agonist,,f,,,pIC50,0,9.920000076,0,-,0,0,0,=,,,,17138938,
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,angiotensin A,6894,AGT,Human,178103476,Agonist,Agonist,,f,,,pKi,0,8.640000343,0,Ki,0,2.299999952,0,=,,,,21464395,
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,angiotensin II,2504,AGT|Agt|Agt,Human|Mouse|Rat,53801076,Agonist,Full agonist,,t,f,,pKd,0,10.19999981,0,-,0,0,0,=,,,,2775266,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1nc[nH]c1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,angiotensin III,585,AGT|Agt|Agt,Human|Mouse|Rat,135651616,Agonist,Full agonist,,t,f,,pKd,0,10.39999962,0,-,0,0,0,=,,,,8242249,NC(=NCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)C(C)C)Cc1ccc(cc1)O)C(C)C)NC(=O)[C@H](CC(=O)O)N)N
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,CGP42112,3944,,,178100771,Agonist,Full agonist,,f,,,pIC50,0,9.630000114,0,IC50,0,0.232999995,0,=,,,,21542804,CC[C@@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cccnc1)Cc1ccc(cc1)O)CCCCNC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)Cc1[nH]cnc1)C
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,compound 21 [PMID: 22802221],6918,,,178103500,Agonist,Full agonist,,f,f,,pEC50,0,4.800000191,0,-,0,0,0,=,,,,22802221,CCCCOC(=O)NS(=O)(=O)c1sc(cc1c1ccc(cc1)Cn1cncc1)CC(C)C
AT<sub>2</sub> receptor,35,Agtr2,P35351,,,,,,Rat,compound 21 [PMID: 22802221],6918,,,178103500,Agonist,Full agonist,,f,f,,pEC50,5.800000191,0,5.599999905,-,0,0,0,=,,,,22802221,CCCCOC(=O)NS(=O)(=O)c1sc(cc1c1ccc(cc1)Cn1cncc1)CC(C)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,alisertib,7790,,,223366121,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,19320489,COc1cccc(c1C1=NCc2c(c3c1cc(Cl)cc3)nc(nc2)Nc1ccc(c(c1)OC)C(=O)O)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,AMG-900,8060,,,249565740,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,20935223,Cc1csc(c1)c1nnc(c2c1cccc2)Nc1ccc(cc1)Oc1ncccc1c1ccnc(n1)N
aurora kinase A,1936,AURKA,O14965,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,~,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,~,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,aurora kinase inhibitor II,5930,,,178102553,Inhibitor,Inhibition,,f,t,,pIC50,0,6.510000229,0,IC50,0,310,0,=,,,,18077363,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)NC(=O)c1ccccc1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,aurora kinase inhibitor III,5931,,,178102554,Inhibitor,Inhibition,,f,t,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,17157005,O=C(C1CC1)Nc1cccc(c1)Nc1nccc(n1)Nc1cccc(c1)C(F)(F)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,barasertib,7332,,,178103904,Inhibitor,Inhibition,,f,f,,pIC50,0,5.860000134,0,IC50,0,1368,0,=,,,,17495131,CCN(CCOP(=O)(O)O)CCCOc1ccc2c(c1)ncnc2Nc1n[nH]c(c1)CC(=O)Nc1cccc(c1)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,compound 10 [PMID: 19402633],8466,,,252166676,Inhibitor,Inhibition,,f,t,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,19402633,CCN1CCN(CC1)C(=O)Cc1ccc(cc1)Nc1ncc(c(n1)Nc1ccc(cc1)C(=O)Nc1ccccc1Cl)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,compound 16 [PMID: 18945615],8178,,,249565858,Inhibitor,Inhibition,,f,f,,pIC50,0,7.03000021,0,IC50,0,93,0,=,,,,18945615,O=c1[nH]cnc2c1cc([nH]2)c1ccnc(c1)/C=C/c1ccc(cc1)CN1CCOCC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,compound 25 [PMID: 20855207],8159,,,249565839,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,<,,,,20855207,C[C@@H]1O[C@H](C)CN(C1)[C@@H](c1nsc(c1)Nc1nc(C)cn2c1ncc2c1c[nH]nc1)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,compound 38 [PMID: 20817473],8768,,,252827426,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,20817473,O=C(c1ccc(cc1)N1CCOCC1)Nc1n[nH]c2c1sc(c2)C(=O)N[C@@H](c1ccccc1)CN1CCCC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,compound 46 [PMID: 16451062],8355,,,252166567,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,16451062,OCC1CCN(CC1)CCCOc1cc2ncnc(c2cc1OC)Nc1ncc(s1)CC(=O)Nc1cccc(c1)F
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,AMG-900,8060,,,249565740,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,20935223,Cc1csc(c1)c1nnc(c2c1cccc2)Nc1ccc(cc1)Oc1ncccc1c1ccnc(n1)N
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,~,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,~,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,aurora kinase inhibitor II,5930,,,178102553,Inhibitor,Inhibition,,f,f,,pIC50,0,5.900000095,0,IC50,0,1250,0,=,,,,18077363,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)NC(=O)c1ccccc1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,barasertib,7332,,,178103904,Inhibitor,Inhibition,,f,t,,pIC50,0,9.430000305,0,IC50,0,0.370000005,0,=,,,,17495131,CCN(CCOP(=O)(O)O)CCCOc1ccc2c(c1)ncnc2Nc1n[nH]c(c1)CC(=O)Nc1cccc(c1)F
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,barasertib-hQPA,5663,,,178102291,Inhibitor,Inhibition,,f,t,,pKd,0,8.340000153,0,Kd,0,4.599999905,0,=,,,,22037378,OCCN(CCCOc1ccc2c(c1)ncnc2Nc1[nH]nc(c1)CC(=O)Nc1cccc(c1)F)CC
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,barasertib-hQPA,5663,,,178102291,Inhibitor,Inhibition,This data refers to Compound 7 in Table 7 of the listed reference.,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,19320489,OCCN(CCCOc1ccc2c(c1)ncnc2Nc1[nH]nc(c1)CC(=O)Nc1cccc(c1)F)CC
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,compound 10 [PMID: 19402633],8466,,,252166676,Inhibitor,Inhibition,,f,f,,pIC50,0,5.46999979,0,IC50,0,3400,0,=,,,,19402633,CCN1CCN(CC1)C(=O)Cc1ccc(cc1)Nc1ncc(c(n1)Nc1ccc(cc1)C(=O)Nc1ccccc1Cl)F
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,compound 1 [PMID: 21742770],8190,,,249565870,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,23256033,COc1cc(ccc1N1CCN(CC1)C)Nc1ccc2c(n1)n(nc2)c1ccc(cc1)OC
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,compound 25 [PMID: 20855207],8159,,,249565839,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,<,,,,20855207,C[C@@H]1O[C@H](C)CN(C1)[C@@H](c1nsc(c1)Nc1nc(C)cn2c1ncc2c1c[nH]nc1)C
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,compound 38 [PMID: 20817473],8768,,,252827426,Inhibitor,Inhibition,,f,f,,pIC50,0,7.349999905,0,IC50,0,45,0,=,,,,20817473,O=C(c1ccc(cc1)N1CCOCC1)Nc1n[nH]c2c1sc(c2)C(=O)N[C@@H](c1ccccc1)CN1CCCC1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,compound 46 [PMID: 16451062],8355,,,252166567,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,<,,,,16451062,OCC1CCN(CC1)CCCOc1cc2ncnc(c2cc1OC)Nc1ncc(s1)CC(=O)Nc1cccc(c1)F
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,AMG-900,8060,,,249565740,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,20935223,Cc1csc(c1)c1nnc(c2c1cccc2)Nc1ccc(cc1)Oc1ncccc1c1ccnc(n1)N
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,compound 38 [PMID: 20817473],8768,,,252827426,Inhibitor,Inhibition,,f,f,,pIC50,0,7.210000038,0,IC50,0,62,0,=,,,,20817473,O=C(c1ccc(cc1)N1CCOCC1)Nc1n[nH]c2c1sc(c2)C(=O)N[C@@H](c1ccccc1)CN1CCCC1
autotaxin,2901,Enpp2,Q64610,,,,,,Rat,BI-2545,9791,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,29259743,O=C(N1C[C@@H]2[C@H](C1)[C@@H]2CNC(=O)c1ccc2c(c1)nn[nH]2)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F
autotaxin,2901,ENPP2,Q13822,,,,,,Human,BI-2545,9791,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,29259743,O=C(N1C[C@@H]2[C@H](C1)[C@@H]2CNC(=O)c1ccc2c(c1)nn[nH]2)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F
AXL receptor tyrosine kinase,1835,AXL,P30530,,,,,,Human,BMS-777607,7953,,,249565636,Inhibitor,Inhibition,,f,f,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,19260711,CCOc1ccn(c(=O)c1C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)c1ccc(cc1)F
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,AT-406,7729,,,223366062,Antagonist,Antagonist,,f,t,,pKi,0,8.720000267,0,Ki,0,1.899999976,0,=,Competitive inhibition of human cIAP1 BIR3 domain expressed in <i>Escherichia coli</i>.,,,21443232,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)CC(C)C)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,AZD5582,7710,,,223366043,Antagonist,Antagonist,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,24320998,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@H](OCC#CC#CCO[C@@H]2Cc3c([C@@H]2NC(=O)[C@@H]2CCCN2C(=O)[C@H](C2CCCCC2)NC(=O)[C@@H](NC)C)cccc3)Cc2c1cccc2)C1CCCCC1)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,birinapant,7432,,,178104004,Antagonist,Antagonist,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,23225169,CC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc1c([nH]c2c1ccc(c2)F)c1[nH]c2c(c1C[C@@H]1C[C@@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC)C)CC)O)ccc(c2)F)O)NC(=O)[C@@H](NC)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,BV-6,7914,,,249565597,Inhibitor,Inhibition,,f,t,,pKd,7.539999962,0,6.340000153,Kd,460,0,29,=,Assayed using expressed cIAP1 BIR2-BIR3 domain construct,,,18022362,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)NCCCCCCNC(=O)[C@H](C(c1ccccc1)c1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C1CCCCC1)NC(=O)[C@@H](NC)C)C1CCCCC1)C
baculoviral IAP repeat containing 3,2792,BIRC3,Q13489,,,,,,Human,AT-406,7729,,,223366062,Antagonist,Antagonist,,f,f,,pKi,0,8.289999962,0,Ki,0,5.099999905,0,=,Competitive inhibition of human cIAP2 BIR3 domain expressed in <i>Escherichia coli</i>.,,,21443232,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)CC(C)C)C
baculoviral IAP repeat containing 3,2792,BIRC3,Q13489,,,,,,Human,AZD5582,7710,,,223366043,Antagonist,Antagonist,,f,t,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,24320998,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@H](OCC#CC#CCO[C@@H]2Cc3c([C@@H]2NC(=O)[C@@H]2CCCN2C(=O)[C@H](C2CCCCC2)NC(=O)[C@@H](NC)C)cccc3)Cc2c1cccc2)C1CCCCC1)C
baculoviral IAP repeat containing 5,2795,BIRC5,O15392,,,,,,Human,compound III [PMID: 24080463],8825,,,252827482,Inhibitor,Inhibition,,f,f,,pIC50,0,4.599999905,0,IC50,0,25000,0,=,,,,24080463,CCN(CCOc1cc(CCCCc2ccc(c(c2)OCCN(CC)CC)OCCN(CC)CC)ccc1OCCN(CC)CC)CC
BAFF receptor,1886,TNFRSF13C,Q96RJ3,,,,,,Human,BAFF,5069,TNFSF13B,Human,178101762,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Basolateral Na-K-Cl symporter,969,SLC12A2,P55011,,,,,,Human,bumetanide,4837,,,178101539,Inhibitor,Inhibition,,f,f,,pIC50,0,5.599999905,0,-,0,0,0,=,,,,11882915,CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pKi,7.49,0,7.47,Ki,34,0,32,=,,,,10454496,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pKi,7.68,0,7.47,Ki,34,0,21,=,,,,10454496,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pIC50,8.75,0,8.43,IC50,3.7,0,1.77,=,,,,21729729,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,bantag-1,6176,,,178102797,Antagonist,Antagonist,,f,,,pIC50,5.48,0,5,IC50,10000,0,3300,=,,,,20096642,CC(C[C@@H](C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)C[C@@H]([C@@H](NC([C@@H](N(C(=O)[C@H](CC1=CC=CCC1)NC(=O)OC(C)(C)C)C)Cc1c[nH]c[nH+]1)O)CC1CCCCC1)O)C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,bombesin,616,,,135652044,Agonist,Agonist,,f,,,pIC50,10.15,0,9.77,IC50,0.17,0,0.07,=,,,,21729729,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pKi,0,8.39,0,Ki,0,4.1,0,=,,,,7838118,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pKi,8.85,0,7.36,Ki,44,0,1.4,=,,,,10454496,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,bombesin,616,,,135652044,Agonist,Full agonist,,f,,,pKi,9.05,0,8.17,Ki,6.8,0,0.9,=,,,,7838118,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,"[(3-Ph-Pr<sup>6</sup>), His<sup>7</sup>,D-Ala<sup>11</sup>,D-Pro<sup>13</sup>,&psi;13-14),Phe<sup>14</sup>]bombesin-(6-14)",627,,,135651959,Antagonist,Antagonist,,f,,,pIC50,0,12,0,IC50,0,0.001,0,=,,,,8446610,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[(3-Ph-Pr<sup>6</sup>), His<sup>7</sup>,D-Ala<sup>11</sup>,D-Pro<sup>13</sup>,&psi;13-14),Phe<sup>14</sup>]bombesin-(6-14)",627,,,135651959,Antagonist,Antagonist,,f,f,,pIC50,0,9.199999809,0,-,0,0,0,=,,,,8446610,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,Ac-GRP-(20-26)-methylester,625,,,135652319,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,Ac-GRP-(20-26)-methylester,625,,,135652319,Antagonist,Antagonist,,f,f,,pIC50,0,8.399999619,0,-,0,0,0,=,,,,2544588,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,bantag-1,6176,,,178102797,Antagonist,Antagonist,,f,,,pIC50,5.36,0,5,IC50,10000,0,4400,=,,,,20096642,CC(C[C@@H](C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)C[C@@H]([C@@H](NC([C@@H](N(C(=O)[C@H](CC1=CC=CCC1)NC(=O)OC(C)(C)C)C)Cc1c[nH]c[nH+]1)O)CC1CCCCC1)O)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,bag-1,6188,,,178102809,Agonist,Agonist,,f,f,,pIC50,0,7.739999771,0,IC50,0,18.29999924,0,=,,,,20096642,CCC(Cc1cnc([nH]1)CCc1ccc(cc1)c1ccccn1)(C)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,bag-2,6189,,,178102810,Agonist,Agonist,,f,f,,pIC50,0,7.019999981,0,IC50,0,96,0,=,,,,20096642,OC(=O)c1ccccc1c1ccc(cc1)CCc1ncc([nH]1)CC1CCCC1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 17c [PMID: 25497965],8507,,,252166715,Agonist,Agonist,,f,t,,pEC50,0,7.920000076,0,EC50,0,12,0,=,,,,25497965,CC(CC(=O)Oc1cccc(c1)CC(=O)N1CCNc2c([C@H]1CC(=O)O)ccc(n2)C(F)(F)F)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 22e [PMID: 20167483],8504,,,252166712,Agonist,Agonist,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,20167483,CCC(Cc1c[nH]c(n1)CCc1ccc(cc1)c1ccccc1C(=O)O)(C)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 8a [PMID: 24900283],8503,,,252166711,Agonist,Agonist,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,24900283,Cc1c(C)ccc2c1N(Cc1c(N2)nc(cc1)C(F)(F)F)S(=O)(=O)c1ccc(cc1)C(C)(C)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 9f [PMID: 24412111],8508,,,252166716,Agonist,Agonist,,f,t,,pEC50,0,7.769999981,0,EC50,0,17,0,=,,,,24412111,CC(CCOc1cccc(c1)CC(=O)N1CCNc2c([C@H]1CC(=O)O)ccc(n2)C(F)(F)F)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 9g [PMID: 24412111],8509,,,252166717,Agonist,Agonist,,f,t,,pEC50,0,8.770000458,0,EC50,0,1.700000048,0,=,,,,24412111,OC(=O)C[C@H]1N(CCNc2c1ccc(n2)C(F)(F)F)C(=O)Cc1cccc(c1)Oc1ccc(nc1)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,Ac-Phe-Trp-Ala-His(&tau;BZL)-Nip-Gly-Arg-NH<sub>2</sub>,6191,,,178102812,Agonist,Full agonist,,f,,,pEC50,8.16,0,6.4,EC50,398,0,6.9,=,,,,15635635,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,Ac-Phe-Trp-Ala-His(&tau;BZL)-Nip-Gly-Arg-NH<sub>2</sub>,6191,,,178102812,Agonist,Full agonist,,f,,,pIC50,7.31,0,6.24,IC50,572,0,49,=,,,,20438784,
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,bag-1,6188,,,178102809,Agonist,Full agonist,,f,,,pIC50,0,8.16,0,IC50,0,6.9,0,=,,,,20096642,CCC(Cc1cnc([nH]1)CCc1ccc(cc1)c1ccccn1)(C)C
BB<sub>3</sub> receptor,40,Brs3,Q8K418,,,,,,Rat,bag-1,6188,,,178102809,Agonist,Full agonist,,f,,,pIC50,0,8.62,0,IC50,0,2.4,0,=,,,,20096642,CCC(Cc1cnc([nH]1)CCc1ccc(cc1)c1ccccn1)(C)C
BB<sub>3</sub> receptor,40,Brs3,Q8K418,,,,,,Rat,bag-2,6189,,,178102810,Agonist,Full agonist,,f,,,pIC50,0,7.99,0,IC50,0,10.3,0,=,,,,20096642,OC(=O)c1ccccc1c1ccc(cc1)CCc1ncc([nH]1)CC1CCCC1
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,bag-2,6189,,,178102810,Agonist,Full agonist,,f,,,pIC50,0,8.18,0,IC50,0,6.6,0,=,,,,20096642,OC(=O)c1ccccc1c1ccc(cc1)CCc1ncc([nH]1)CC1CCCC1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,compound 21b [PMID: 12723954],630,,,135650671,Agonist,Full agonist,,f,,,pEC50,10.2,0,9.2,,0,0,0,,,,,12723954,O=C(N[C@@H](C(=O)NCCc1ccccc1)Cc1c[nH]c2c1cccc2)NNc1ccc(cc1)Cl
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,bantag-1,6176,,,178102797,Antagonist,Antagonist,,f,,,pIC50,0,8.09,0,IC50,0,8.1,0,=,,,,20096642,CC(C[C@@H](C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)C[C@@H]([C@@H](NC([C@@H](N(C(=O)[C@H](CC1=CC=CCC1)NC(=O)OC(C)(C)C)C)Cc1c[nH]c[nH+]1)O)CC1CCCCC1)O)C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,bantag-1,6176,,,178102797,Antagonist,Antagonist,,f,f,,pIC50,8.699999809,0,8.600000381,IC50,2.5,0,2,=,,,,20096642,CC(C[C@@H](C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)C[C@@H]([C@@H](NC([C@@H](N(C(=O)[C@H](CC1=CC=CCC1)NC(=O)OC(C)(C)C)C)Cc1c[nH]c[nH+]1)O)CC1CCCCC1)O)C
BB<sub>3</sub> receptor,40,Brs3,Q8K418,,,,,,Rat,bantag-1,6176,,,178102797,Antagonist,Antagonist,,f,,,pIC50,0,8.77,0,IC50,0,1.7,0,=,,,,20096642,CC(C[C@@H](C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)C[C@@H]([C@@H](NC([C@@H](N(C(=O)[C@H](CC1=CC=CCC1)NC(=O)OC(C)(C)C)C)Cc1c[nH]c[nH+]1)O)CC1CCCCC1)O)C
B cell CLL/lymphoma 6,2957,BCL6,P41182,,,,,,Human,compound 8c [PMID: 28760529],9671,,,348353630,Inhibitor,Binding,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,In a cell-free ELISA system measuring ability to inhibit BCL6 BTB domain-NCoR interaction.,,,28760529,O=C1CCc2c(N1)ccc(c2)Nc1cc(OC2CCOCC2)c(cc1Cl)[N+](=O)[O-]
B cell CLL/lymphoma 6,2957,BCL6,P41182,,,,,,Human,compound 8c [PMID: 28760529],9671,,,348353630,Inhibitor,Binding,,f,f,,pIC50,0,6.139999866,0,IC50,0,720,0,=,In a cell-based mammalian two-hybrid system assessing inhibition of protein-protein interaction between BCL6 BTB domain and BCoR.,,,28760529,O=C1CCc2c(N1)ccc(c2)Nc1cc(OC2CCOCC2)c(cc1Cl)[N+](=O)[O-]
B cell maturation antigen,1889,TNFRSF17,Q02223,,,,,,Human,APRIL,5068,TNFSF13,Human,178101761,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
B cell maturation antigen,1889,TNFRSF17,Q02223,,,,,,Human,BAFF,5069,TNFSF13B,Human,178101762,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
"BCL2, apoptosis regulator",2844,BCL2,P10415,,,,,,Human,ABT-737,8320,,,252166532,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1,0,<,,,,17256834,CN(CC[C@@H](Nc1ccc(cc1[N+](=O)[O-])S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1c1ccc(cc1)Cl)CSc1ccccc1)C
Bcl-2-like 1,2845,BCL2L1,Q07817,,,,,,Human,ABT-737,8320,,,252166532,Antagonist,Antagonist,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,<,,,,17256834,CN(CC[C@@H](Nc1ccc(cc1[N+](=O)[O-])S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1c1ccc(cc1)Cl)CSc1ccccc1)C
Bcl-2-like 2,2846,BCL2L2,Q92843,,,,,,Human,ABT-737,8320,,,252166532,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1,0,<,,,,17256834,CN(CC[C@@H](Nc1ccc(cc1[N+](=O)[O-])S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1c1ccc(cc1)Cl)CSc1ccccc1)C
beta adrenergic receptor kinase 1,1466,GRK2,P25098,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,7.380000114,0,IC50,0,42,0,=,Inhibition of tubulin phosphorylation by balanol.,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
beta adrenergic receptor kinase 1,1466,GRK2,P25098,,,,,,Human,compound 101 [PMID: 21596927],8437,,,252166647,Inhibitor,Inhibition,,f,t,,pIC50,0,7.269999981,0,IC50,0,54,0,=,,,,21596927,O=C(c1cccc(c1)NCc1nnc(n1C)c1ccncc1)NCc1ccccc1C(F)(F)F
beta adrenergic receptor kinase 1,1466,GRK2,P25098,,,,,,Human,compound 1o [PMID: 24210504],8143,,,249565823,Inhibitor,Inhibition,,f,f,,pIC50,0,6.340000153,0,IC50,0,460,0,=,,,,24210504,Nc1ncc(cc1c1nc2c(o1)cc(cc2)N1CCCC1)c1cnn(c1)C1CCNCC1
beta adrenergic receptor kinase 2,1467,GRK3,P35626,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
beta adrenergic receptor kinase 2,1467,GRK3,P35626,,,,,,Human,compound 101 [PMID: 21596927],8437,,,252166647,Inhibitor,Inhibition,,f,t,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,21596927,O=C(c1cccc(c1)NCc1nnc(n1C)c1ccncc1)NCc1ccccc1C(F)(F)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,AZ3971,7804,,,223366135,Inhibitor,Competitive,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,0,COc1c(C)cc(cc1C)[C@@]1(N=C(c2c1nccn2)N)c1cccc(c1)c1cncnc1
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,AZ-4217,6939,,,178103521,Inhibitor,Competitive,,f,t,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,23761903,CC#Cc1cncc(c1)c1cccc(c1)[C@]1(N=C(c2c1cccc2F)N)c1cc(C)c(=O)n(c1)CC
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,AZD3839,6931,,,178103513,Inhibitor,Competitive,,f,t,,pKi,0,7.579999924,0,Ki,0,26.10000038,0,=,,,,23048024,FC(c1nccc(c1)[C@@]1(NC(c2c1cccc2F)N)c1cccc(c1)c1cncnc1)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,compound 11d  [PMID: 23981898],6946,,,178103528,Inhibitor,Competitive,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23981898,COC[C@H](C(F)(F)F)Oc1cc(C[C@@H]2C[S@@](=O)C[C@@H]([C@H]2O)NCc2cccc(c2)C(C)(C)C)cc(c1N)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,compound 16 [PMID: 23412139],8698,,,252166898,Inhibitor,Competitive,,f,t,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,,,,23412139,CC#Cc1cncc(c1)c1cc(c(s1)[C@]1(C)CC(=O)N(C(=N1)N)C)Cl
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,compound 2 [PMID: 22911925],6950,,,178103532,Inhibitor,Competitive,,f,t,,pIC50,0,8.260000229,0,IC50,0,5.5,0,=,,,,22911925,CO[C@@H](C(=O)N[C@H]([C@@H](CN[C@H]1CC2(CCC2)Oc2c1cc(cn2)CC(C)(C)C)O)Cc1cccc(c1)c1nccs1)C
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,AMG-8718,9639,,,340590269,Inhibitor,Inhibition,,f,t,,pIC50,0,9.149999619,0,IC50,0,0.699999988,0,=,,,,25363711,NC1=N[C@]2(CO1)c1cc(C#CC3(C)COC3)cnc1Oc1c2cc(cc1)c1cccnc1F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,Compound 12 [PMID:28626832],9823,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,3.299999952,0,IC50,0,500000,0,=,,,,28626832,CN(c1nc(nc2c1cccc2)N1CCCC1)C
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,compound 13 [PMID: 23412139],8399,,,252166609,Inhibitor,Inhibition,,f,t,,pKi,0,8.109999657,0,Ki,0,7.800000191,0,=,,,,23412139,CC#Cc1cncc(c1)c1csc(c1)[C@]1(C)CC(=O)N(C(=N1)N)C
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,compound J [PMID: 21907142],7854,,,223366184,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,21907142,Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]1(C)CCSC(=N1)N)F
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,compound 3 [PMID: 27347366],9337,,,318164856,Inhibitor,Inhibition,,f,t,,pKi,0,10.51000023,0,Ki,0,0.030999999,0,=,,,,27347366,CCC[C@@H]([C@@H](C(=O)NCC(C)C)NC[C@H]([C@@H](NC(=O)c1cccc(c1)C(=O)N([C@@H](c1ccccc1)C)C)Cc1ccccc1)O)O
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,compound J [PMID: 21907142],7854,,,223366184,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,21907142,Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]1(C)CCSC(=N1)N)F
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,abediterol,9326,,,318164845,Agonist,Agonist,,f,f,,pIC50,0,7.440000057,0,IC50,0,36.20000076,0,=,Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.,,,22588259,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Agonist,,t,f,,pKi,6,0,5.400000095,-,0,0,0,=,,,,2849109,CNC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,arformoterol,7479,,,187051782,Agonist,Agonist,,f,f,,pKi,0,6.5,0,Ki,0,319,0,=,,,,20655218,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,CGP 12177,532,,,135650065,Agonist,Partial agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,10079020,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,acebutolol,7107,,,178103684,Antagonist,Antagonist,,f,t,,pKi,0,6.400000095,0,Ki,0,422,0,=,,,,0,CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,atenolol,548,,,135649971,Antagonist,Antagonist,,f,t,,pKi,7.599999905,0,6.699999809,-,0,0,0,=,,,,15060759,OC(COc1ccc(cc1)CC(=O)N)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,betaxolol,549,,,135649987,Antagonist,Antagonist,,f,t,,pKi,0,8.800000191,0,-,0,0,0,=,,,,10079020,OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,bupranolol,550,,,135650033,Antagonist,Antagonist,,f,t,,pKi,9,0,7.300000191,-,0,0,0,=,,,,10079020,OC(COc1cc(C)ccc1Cl)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,carvedilol,551,,,135650057,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,-,0,0,0,=,,,,10411574,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,CGP 12177,532,,,135650065,Antagonist,Antagonist,,f,,,pKi,9.3,0,8.8,,0,0,0,,,,,15060759,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,CGP 20712A,541,,,135650066,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,8.5,Ki,3.160000086,0,0.629999995,=,,,,10079020,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,cicloprolol,552,,,135650095,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,10079020,OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,arformoterol,7479,,,187051782,Agonist,Agonist,,f,t,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,,,,15324892,O=CNc1cc(ccc1O)[C@H](CN[C@@H](Cc1ccc(cc1)OC)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,abediterol,9326,,,318164845,Agonist,Full agonist,,f,t,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.,,,22588259,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Full agonist,,t,f,,pKi,6.199999809,0,6,-,0,0,0,=,,,,2849109,CNC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,alprenolol,563,,,135649926,Antagonist,Antagonist,,f,t,,pKi,0,9,0,-,0,0,0,=,,,,15655528,C=CCc1ccccc1OCC(CNC(C)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,atenolol,548,,,135649971,Antagonist,Antagonist,,f,,,pKi,6,0,5.6,,0,0,0,,,,,10079020,OC(COc1ccc(cc1)CC(=O)N)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,betaxolol,549,,,135649987,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10079020,OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,bupranolol,550,,,135650033,Antagonist,Antagonist,,f,t,,pKi,9.100000381,0,8.300000191,-,0,0,0,=,,,,10079020,OC(COc1cc(C)ccc1Cl)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,Adrb2,P10608,,,,,,Rat,butoxamine,9809,,,0,Antagonist,Antagonist,,f,f,,pKB,0,6.449999809,0,KB,0,355,0,=,,,,15908513,COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC
&beta;<sub>2</sub>-adrenoceptor,29,Adrb2,P10608,,,,,,Rat,butoxamine,9809,,,0,Antagonist,Antagonist,,f,f,,pKi,6.510000229,0,6.329999924,Ki,468,0,309,=,,,,1968985,COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,carazolol,569,,,135650054,Antagonist,Antagonist,,f,f,,pKi,0,9.899999619,0,Ki,0,0.114,0,=,,,,18829308,OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,carvedilol,551,,,135650057,Antagonist,Antagonist,,f,t,,pKi,9.899999619,0,9.399999619,-,0,0,0,=,,,,15655528,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,CGP 12177,532,,,135650065,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,10079020,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,cicloprolol,552,,,135650095,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10079020,OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,abediterol,9326,,,318164845,Agonist,Agonist,,f,f,,pIC50,0,5.519999981,0,IC50,0,3001,0,=,,,,22588259,O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,(-)-adrenaline,479,,,135651430,Agonist,Agonist,,t,f,,pKi,0,3.900000095,0,-,0,0,0,=,,,,14730417,CNC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,CL316243,3462,,,178100458,Agonist,Agonist,,f,,,pKi,0,5.2,0,-,0,0,0,=,,,,11249148,C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,CL316243,3462,,,178100458,Agonist,Agonist,binding,f,f,,pKi,0,5.900000095,0,Ki,0,0,0,=,,,,17717109,C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,CL316243,3462,,,178100458,Agonist,Agonist,cAMP accumulation,f,f,,pEC50,9.800000191,0,8.699999809,-,0,0,0,=,,,,17717109,C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,amibegron,568,,,135651081,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,7903415,CCOC(=O)COc1ccc2c(c1)C[C@H](CC2)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,BRL 37344,567,,,135650024,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8719421,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,BRL 37344,567,,,135650024,Agonist,Full agonist,,f,f,,pKi,7,0,6.400000095,Ki,398,0,100,=,,,,8719421,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,BRL 37344,567,,,135650024,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8719421,C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,carazolol,569,,,135650054,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,Ki,0,1.99000001,0,=,,,,8719421,OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,carazolol,569,,,135650054,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8719421,OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,carazolol,569,,,135650054,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8719421,OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,CGP 12177,532,,,135650065,Agonist,Partial agonist,,f,f,,pKi,7.300000191,0,6.099999905,Ki,794,0,50.09999847,=,,,,10079020,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,CGP 12177,532,,,135650065,Agonist,Partial agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8719421,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,CGP 12177,532,,,135650065,Agonist,Partial agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8719421,OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,bupranolol,550,,,135650033,Antagonist,Antagonist,,f,t,,pKi,7.300000191,0,6.800000191,-,0,0,0,=,,,,10079020,OC(COc1cc(C)ccc1Cl)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,carvedilol,551,,,135650057,Antagonist,Antagonist,,f,t,,pKi,0,9.399999619,0,-,0,0,0,=,,,,10411574,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,CGP 20712A,541,,,135650066,Antagonist,Antagonist,,f,,,pKi,5.7,0,5.1,,0,0,0,,,,,10079020,OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,compound 31 [PMID: 24915291],8148,,,249565828,Inhibitor,Inhibition,,f,f,,pIC50,0,8.569999695,0,IC50,0,2.700000048,0,=,,,,24915291,C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.380000114,0,IC50,0,4.199999809,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,68,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,12R-HETE,3405,,,135651371,Agonist,Full agonist,,t,,,pKi,0,7.5,0,Ki,0,30,0,=,,,,9177352,CCCCC/C=C\C[C@H](/C=C/C=C\C/C=C\CCCC(=O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,12R-HETE,3405,,,135651371,Agonist,Full agonist,,t,,,pKi,0,7.5,0,Ki,0,30,0,=,,,,9177352,CCCCC/C=CC[C@H](/C=C/C=CC/C=CCCCC(=O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,20-hydroxy-LTB<sub>4</sub>,3399,,,135651386,Agonist,Full agonist,,t,,,pKi,0,8.1,0,Ki,0,7.6,0,=,,,,9177352,OCCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,20-hydroxy-LTB<sub>4</sub>,3399,,,135651386,Agonist,Full agonist,,t,,,pKi,0,8.1,0,Ki,0,7.6,0,=,,,,9177352,OCCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,BIIL 260,6154,,,178102775,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.700000048,0,=,,,,11259574,Oc1ccc(cc1)C(c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(=N)N)(C)C
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,BIIL 260,6154,,,178102775,Antagonist,Antagonist,,f,,,pIC50,0,8.54,0,IC50,0,2.9,0,=,,,,11259574,Oc1ccc(cc1)C(c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(=N)N)(C)C
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-hydroxyheptadecatrienoic acid,6159,,,178102780,Agonist,Full agonist,,t,,,pEC50,0,7.72,0,EC50,0,19,0,=,,,,18378794,CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-hydroxyheptadecatrienoic acid,6159,,,178102780,Agonist,Full agonist,,t,,,pEC50,0,7.72,0,EC50,0,19,0,=,,,,18378794,CCCCC[C@@H](/C=C/C=C/C/C=CCCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-hydroxyheptadecatrienoic acid,6159,,,178102780,Agonist,Full agonist,,t,,,pIC50,0,8.55,0,IC50,0,2.8,0,=,,,,18378794,CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-hydroxyheptadecatrienoic acid,6159,,,178102780,Agonist,Full agonist,,t,,,pIC50,0,8.55,0,IC50,0,2.8,0,=,,,,18378794,CCCCC[C@@H](/C=C/C=C/C/C=CCCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,CAY10583,6161,,,178102782,Agonist,Full agonist,,f,,,pEC50,0,7.7,0,EC50,0,20,0,=,,,,15866883,CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O
BLT<sub>2</sub> receptor,268,Ltb4r2,Q9JJL9,,,,,,Mouse,CAY10583,6161,,,178102782,Agonist,Full agonist,,f,,,pKi,0,8.52,0,Ki,0,3,0,=,,,,15866883,CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-epi LTB<sub>4</sub>,6160,,,178102781,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC/C=C\C[C@@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12-epi LTB<sub>4</sub>,6160,,,178102781,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC/C=CC[C@@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12S-HETE,3404,,,135651372,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,12S-HETE,3404,,,135651372,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC/C=CC[C@@H](/C=C/C=CC/C=CCCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,15S-HETE,3401,,,135651378,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,15S-HETE,3401,,,135651378,Agonist,Partial agonist,,t,,,pEC50,0,7.52,0,EC50,0,30,0,>,,,,11278893,CCCCC[C@@H](/C=C/C=CC/C=CC/C=CCCCC(=O)O)O
BMP2 inducible kinase,1941,BMP2K,Q9NSY1,,,,,,Human,compound 5m [PMID: 20483621],8206,,,249565886,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,20483621,Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccc(cc1)C(=O)N1CCC(CC1)N1CCCC1)C(F)(F)F
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,BMX-IN-1,9269,,,315661344,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,23594111,C=CC(=O)Nc1cc(ccc1C)n1c(=O)ccc2c1c1cc(ccc1nc2)c1ccc(cc1)NS(=O)(=O)C
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,compound 31 [PMID: 24915291],8148,,,249565828,Inhibitor,Inhibition,,f,f,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,24915291,C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,9.149999619,0,IC50,0,0.709999979,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.599999905,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
bone morphogenetic protein 1,2333,BMP1,P13497,,,,,,Human,compound 2 [PMID: 11934595],8562,,,252166763,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,11934595,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1ccc2c(c1)OCO2)Cc1cccs1
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-10,4875,BMP10,Human,178101575,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-2,4881,BMP2,Human,178101581,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-4,4883,BMP4,Human,178101583,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-5,4884,BMP5,Human,178101584,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-6,4885,BMP6,Human,178101585,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-7,4886,BMP7,Human,178101586,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-8A,4887,BMP8A,Human,178101587,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-8B,4888,BMP8B,Human,178101588,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Bone morphogenetic protein receptors,2586,BMPR1A|BMPR1B|ACVR1|ACVR2A|ACVR2B|ACVRL1|BMPR2,O00238|P27037|P36894|P37023|Q04771|Q13705|Q13873,,,,,,Human,BMP-9,4889,GDF2,Human,178101589,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
bone morphogenetic protein receptor type 2,1794,BMPR2,Q13873,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,15.89999962,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
bone morphogenetic protein receptor type IA,1786,BMPR1A,P36894,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.980000019,0,IC50,0,10.39999962,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
bone morphogenetic protein receptor type IA,1786,BMPR1A,P36894,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
bone morphogenetic protein receptor type IA,1786,BMPR1A,P36894,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
bone morphogenetic protein receptor type IB,1789,BMPR1B,O00238,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60.90000153,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
bone morphogenetic protein receptor type IB,1789,BMPR1B,O00238,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
bone morphogenetic protein receptor type IB,1789,BMPR1B,O00238,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,AZ628,8475,,,252166684,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,18020980,N#CC(c1cccc(c1)C(=O)Nc1ccc(c(c1)Nc1ccc2c(c1)c(=O)n(cn2)C)C)(C)C
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,CCT196969,9815,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,25500121,O=C(Nc1cc(nn1c1ccccc1)C(C)(C)C)Nc1ccc(cc1F)Oc1ccnc2c1ncc(=O)[nH]2
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,CCT241161,9814,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,25500121,CSc1cc(ccc1NC(=O)Nc1cc(nn1c1ccccc1)C(C)(C)C)Oc1ccnc2c1ncc(=O)[nH]2
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,CEP-32496,7880,,,223366209,Inhibitor,Inhibition,,f,f,,pKd,0,7.440000057,0,Kd,0,36,0,=,Inhibition of wild type BRAF activity.,,,22168626,COc1cc2c(ncnc2cc1OC)Oc1cccc(c1)NC(=O)Nc1noc(c1)C(C(F)(F)F)(C)C
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,CHIR-265,5674,,,178102301,Inhibitor,Inhibition,,f,t,,pKd,0,5.920000076,0,Kd,0,1200,0,=,,,,22037378,Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2c1ccc(c2)Oc1ccnc(c1)c1[nH]cc(n1)C(F)(F)F
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,compound 2 [PMID: 26061392],8548,,,252166749,Inhibitor,Inhibition,,f,f,,pKd,0,6.349999905,0,Kd,0,444,0,=,,,,26061392,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1cn(c2c1cc(cn2)c1ccc(cc1)Cl)Cc1cc(OC)c(cc1N(=O)=O)OC)F
Branched chain amino acid transaminase 2,2893,BCAT2,O15382,,,,,,Human,compound 27 [PMID: 26938474],9084,,,315661169,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,199,0,=,,,,26938474,O=C(c1sc2c(c1C)c(=O)[nH]cn2)Nc1nncs1
Branched chain amino acid transaminase 2,2893,BCAT2,O15382,,,,,,Human,compound 42 [PMID: 26938474],9085,,,315661170,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1585,0,=,,,,26938474,O=C1N(CCc2c1cccc2)c1ccc(cc1)c1cc[nH]n1
bromodomain adjacent to zinc finger domain 2A,2721,BAZ2A,Q9UIF9,,,,,,Human,BAZ2-ICR,8571,,,252166772,Inhibitor,Inhibition,,f,t,,pKd,0,6.960000038,0,Kd,0,109,0,=,Isothermal titration calorimetry (ITC) assay,,,25719566,N#Cc1ccc(cc1)c1n(cnc1c1cnn(c1)C)CCc1cnn(c1)C
bromodomain adjacent to zinc finger domain 2B,2722,BAZ2B,Q9UIF8,,,,,,Human,BAZ2-ICR,8571,,,252166772,Inhibitor,Inhibition,,f,f,,pKd,0,6.769999981,0,Kd,0,170,0,=,Isothermal titration calorimetry (ITC) assay,,,25719566,N#Cc1ccc(cc1)c1n(cnc1c1cnn(c1)C)CCc1cnn(c1)C
bromodomain adjacent to zinc finger domain 2B,2722,BAZ2B,Q9UIF8,,,,,,Human,compound 1 [PMID: 25719566],8302,,,252166514,Inhibitor,Inhibition,,f,f,,pIC50,0,4.599999905,0,IC50,0,26000,0,=,,,,25719566,N#Cc1ccc(cc1)c1n(cnc1c1ccccc1)CCn1nnc(c1)C
bromodomain adjacent to zinc finger domain 2B,2722,BAZ2B,Q9UIF8,,,,,,Human,compound 7 [PMID: 25719566],8306,,,252166518,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1100,0,=,,,,25719566,N#Cc1ccc(cc1)c1n(cnc1c1cnn(c1)C)CCn1nnc(c1)C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,compound 1 [PMID: 25408830],7809,,,223366140,None,Binding,,f,t,,pIC50,0,5,0,IC50,0,10000,0,=,,,,25408830,NC(=O)c1ccc2c(c1)n(C)c(=O)n2C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,compound 2 [PMID: 25408830],7810,,,223366141,None,Binding,,f,t,,pIC50,0,5.599999905,0,IC50,0,2511,0,=,,,,25408830,Cc1ccc(c(c1)C)S(=O)(=O)Nc1ccc2c(c1)n(C)c(=O)n2C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,compound 34 [PMID: 25974391],8396,,,252166607,None,Binding,,f,t,,pKd,0,6.860000134,0,Kd,0,137,0,=,,,,25974391,COc1ccc(cc1)Oc1cc2c(cc1NS(=O)(=O)c1ccc(c(c1)OC)OC)n(c(=O)n2C)C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,compound 3 [PMID: 25408830],7811,,,223366142,None,Binding,,f,t,,pIC50,0,4.300000191,0,IC50,0,50118,0,>,,,,25408830,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(c(=O)n2C)C
bromodomain containing 1,2724,BRD1,O95696,,,,,,Human,BAY-299,9524,,,336446910,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,In a <i>BROMOscan&reg;</i> assay.,,,0,OCCCc1ccc2c3c1cccc3c(=O)n(c2=O)c1cc2c(cc1C)n(c(=O)n2C)C
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,BIC1,7510,,,187051812,Inhibitor,Inhibition,,f,f,,pKd,0,4.550000191,0,Kd,0,28000,0,=,Binding to recombinant BRD2-BD1 protein.,,,21513886,Cn1c(=S)n(c2c1cccc2)CCSc1nc2c([nH]1)cccc2
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,compound 36 [PMID: 24000170],7521,,,187051822,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(C(=O)N1)c1ccccc1OC(F)(F)F
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,compound 38 [PMID: 24000170],7522,,,187051823,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,501,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(Cc2ccccc2)C(=O)N1
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,compound 4d [PMID: 21851057],7516,,,187051818,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,Inhibition of binding to recombinant BRD2-BD1.,,,21851057,CCOc1cc(cc(c1)c1c(C)noc1C)C(O)C
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,compound 36 [PMID: 24000170],7521,,,187051822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,501,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(C(=O)N1)c1ccccc1OC(F)(F)F
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,compound 38 [PMID: 24000170],7522,,,187051823,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,251,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(Cc2ccccc2)C(=O)N1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,BI-2536,5666,,,178102294,Inhibitor,Inhibition,,f,f,,pKd,0,7.429999828,0,Kd,0,37,0,=,Assayed using recombinant BRD4-BD1.,,,24584101,CC[C@H]1N(C2CCCC2)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)NC1CCN(CC1)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,BzT-7,7515,,,187051817,Inhibitor,Inhibition,,f,f,,pKd,0,6.190000057,0,Kd,0,640,0,=,Measuring the dissociation constant for the compound's interaction with BD1 of BRD4.,,,22137933,Clc1ccc2c(c1)c(nn(c1n2c(C)nn1)C)c1ccccc1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,"compound 15 [Hay <i>et al</i>., 2013]",7528,,,187051829,Inhibitor,Inhibition,,f,f,,pIC50,0,5.900000095,0,IC50,0,1258,0,=,,,,0,Cc1onc(c1c1ccc2c(c1)C(O)(CC2)c1ccccc1)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 1 [PMID: 25408830],7809,,,223366140,Inhibitor,Inhibition,,f,t,,pIC50,0,4.099999905,0,IC50,0,79430,0,=,,,,25408830,NC(=O)c1ccc2c(c1)n(C)c(=O)n2C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 2 [PMID: 25408830],7810,,,223366141,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,25408830,Cc1ccc(c(c1)C)S(=O)(=O)Nc1ccc2c(c1)n(C)c(=O)n2C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 36 [PMID: 24000170],7521,,,187051822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,631,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(C(=O)N1)c1ccccc1OC(F)(F)F
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 38 [PMID: 24000170],7522,,,187051823,Inhibitor,Inhibition,,f,f,,pIC50,0,6.5,0,IC50,0,316,0,=,,,,24000170,COc1nc2c(cc1c1c(C)noc1C)ncc1c2C(Cc2ccccc2)C(=O)N1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 3 [PMID: 25408830],7811,,,223366142,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79.40000153,0,=,,,,25408830,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(c(=O)n2C)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 4d [PMID: 21851057],7516,,,187051818,Inhibitor,Inhibition,,f,f,,pIC50,0,5.320000172,0,IC50,0,4800,0,=,Inhibition of binding to recombinant BRD4-BD1.,,,21851057,CCOc1cc(cc(c1)c1c(C)noc1C)C(O)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 7d [PMID: 25703523],8304,,,252166516,Inhibitor,Inhibition,,f,f,,pKd,0,5.329999924,0,Kd,0,4651,0,=,,,,25703523,COc1ccc(cc1c1nc(N)nc2c1[nH]cn2)Br
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,compound 9 [PMID: 23517011],7517,,,187051819,Inhibitor,Inhibition,,f,f,,pIC50,0,6.429999828,0,IC50,0,371,0,=,Measured using a bead-based fluorescent proximity assay assessing BRD4-BD1 interaction with acetylated histone.,,,23517011,CC(=O)Oc1cc(cc(c1)c1c(C)noc1C)C(c1ccccc1)O
bromodomain containing 7,2726,BRD7,Q9NPI1,,,,,,Human,BI-9564,8950,,,310264731,Inhibitor,Inhibition,,f,f,,pKd,0,6.619999886,0,Kd,0,239,0,=,,,,0,COc1cc(CN(C)C)c(cc1c1cn(C)c(=O)c2c1ccnc2)OC
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,BI-7273,9146,,,315661231,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,26914985,COc1cc(cc(c1CN(C)C)OC)c1cn(C)c(=O)c2c1ccnc2
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,BI-9564,8950,,,310264731,Inhibitor,Inhibition,,f,f,,pKd,0,7.849999905,0,Kd,0,14,0,=,,,,0,COc1cc(CN(C)C)c(cc1c1cn(C)c(=O)c2c1ccnc2)OC
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,compound 50 [PMID: 24313754],8824,,,252827481,Inhibitor,Inhibition,,f,f,,pIC50,0,6.5,0,IC50,0,316,0,=,,,,24313754,Cc1nnc2n1nc(c1ccc(c(c1)NS(=O)(=O)C)N1CCOCC1)c1c2cccc1
BR serine/threonine kinase 1,1946,BRSK1,Q8TDC3,,,,,,Human,CCT244747,8215,,,249565895,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,23082860,N#Cc1ncc(nc1O[C@@H](CN(C)C)C)Nc1ncc(c(c1)OC)c1cnn(c1)C
BR serine/threonine kinase 2,1947,BRSK2,Q8IWQ3,,,,,,Human,CCT244747,8215,,,249565895,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,23082860,N#Cc1ncc(nc1O[C@@H](CN(C)C)C)Nc1ncc(c(c1)OC)c1cnn(c1)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,t,,pIC50,0,8.289999962,0,IC50,0,5.099999905,0,=,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,t,,pEC50,0,8,0,EC50,0,10,0,<,,,,0,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,BGB-3111,9591,,,340590222,Inhibitor,Inhibition,,f,f,,pIC50,0,9.770000458,0,IC50,0,0.170000002,0,=,,,,0,C=CC(=O)N1CCC[C@H](C1)n1nc(c(c1N)C(=O)N)c1ccc(cc1)Oc1ccccc1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,CGI1746,8066,,,249565746,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,21113169,Cc1c(cccc1c1cn(C)c(=O)c(n1)Nc1ccc(cc1)C(=O)N1CCOCC1)NC(=O)c1ccc(cc1)C(C)(C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,CGI560,9264,,,315661339,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,22394077,O=C(c1ccc(cc1)C(C)(C)C)Nc1cccc(c1)c1nc(Nc2ccccc2)c2n(c1)ccn2
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,CNX-774,9266,,,315661341,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,22621397,C=CC(=O)Nc1cccc(c1)Nc1nc(ncc1F)Nc1ccc(cc1)Oc1ccnc(c1)C(=O)NC
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.460000038,0,IC50,0,3.5,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,compound 31 [PMID: 24915291],8148,,,249565828,Inhibitor,Inhibition,,f,t,,pIC50,0,8.359999657,0,IC50,0,5,0,=,,,,24915291,C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,compound 36 [PMID: 21958547],9391,,,328083493,Inhibitor,Inhibition,,f,t,,pIC50,0,8.710000038,0,IC50,0,1.929999948,0,=,,,,21958547,CN(C/C=C/C(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,t,,pIC50,0,8.359999657,0,IC50,0,4.400000095,0,<,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,CHMFL-BTK-11,9516,,,336446903,Inhibitor,Irreversible inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,26.81999969,0,=,,,,28352114,C=CC(=O)Nc1cc(ccc1C)N1C(=O)CCc2c1c1cc(ccc1nc2)n1cccn1
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,bradykinin,649,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651637,Agonist,Full agonist,,t,,,pKi,5.3,0,5.1,-,0,0,0,=,,,,10422787,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,bradykinin,649,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651637,Agonist,Full agonist,,t,,,pKi,0,4,0,-,0,0,0,=,,,,9111052,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,bradykinin,649,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651637,Agonist,Full agonist,,t,,,pKi,0,6.7,0,-,0,0,0,=,,,,8856107,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"Ac-Lys-[MeAla<sup>6</sup>,Leu<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",651,,,135651970,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9276157,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,B-10356,652,,,135652005,Antagonist,Antagonist,,f,,,pKi,10.2,0,8.8,,0,0,0,,,,,16368899,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,B-9430,653,,,135652006,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9276157,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,B-9430,653,,,135652006,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9276157,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,B-9858,654,,,135652007,Antagonist,Antagonist,,f,,,pKi,10.4,0,8.7,-,0,0,0,=,,,,10422787,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,B-9858,654,,,135652007,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9276157,
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,B-9858,654,,,135652007,Antagonist,Antagonist,,f,,,pKi,8.7,0,8.4,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,B-9958,655,,,135652008,Antagonist,Antagonist,,f,f,,pKi,10.28999996,0,9.199999809,Ki,0.629999995,0,0.050999999,=,,,,16368899,
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,chroman 28,664,,,135650091,Antagonist,Antagonist,,f,,,pIC50,8.5,0,8.3,,0,0,0,,,,,17243660,O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,chroman 28,664,,,135650091,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,17243660,O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,compound 11 [PMID: 12812482],665,,,135650119,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12812482,O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,compound 11 [PMID: 12812482],665,,,135650119,Antagonist,Antagonist,,f,,,pKi,0,10.5,0,,0,0,0,,,,,12812482,O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,compound 12 [PMID: 12723943],666,,,135650120,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12723943,CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,compound 12 [PMID: 12723943],666,,,135650120,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,12723943,CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,bradykinin,649,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651637,Agonist,Full agonist,,t,,,pIC50,0,9.3,0,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,bradykinin,649,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651637,Agonist,Full agonist,,t,,,pIC50,9.3,0,7,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>2</sub> receptor,42,Bdkrb2,P25023,,,,,,Rat,anatibant,679,,,135649943,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,10596852,Cc1cc(C)c2c(n1)c(ccc2)OCc1c(Cl)ccc(c1Cl)S(=O)(=O)N1CCC[C@H]1C(=O)NCCCNC(=O)c1ccc(cc1)C(=N)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,anatibant,679,,,135649943,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.309999943,0,=,,,,10596852,Cc1cc(C)c2c(n1)c(ccc2)OCc1c(Cl)ccc(c1Cl)S(=O)(=O)N1CCC[C@H]1C(=O)NCCCNC(=O)c1ccc(cc1)C(=N)N
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,B-9430,653,,,135652006,Antagonist,Antagonist,,f,,,pKi,9.5,0,8.5,,0,0,0,,,,,9276157,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,B-9430,653,,,135652006,Antagonist,Antagonist,,f,,,pKi,9.6,0,8.6,,0,0,0,,,,,9276157,
B<sub>2</sub> receptor,42,Bdkrb2,P25023,,,,,,Rat,bradyzide,680,,,135650020,Antagonist,Antagonist,,f,,,pKi,9.5,0,9.2,,0,0,0,,,,,10694205,CN(CCN(C)C)CCNC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NNC(=S)NC(c1ccccc1)c1ccccc1
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,bradyzide,680,,,135650020,Antagonist,Antagonist,,f,,,pKi,6.5,0,6.3,,0,0,0,,,,,10694205,CN(CCN(C)C)CCNC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NNC(=S)NC(c1ccccc1)c1ccccc1
B<sup>0</sup>AT1,939,SLC6A19,Q695T7,,,,,,Human,benzatropine,7601,,,223365936,Inhibitor,Inhibition,,f,f,,pIC50,0,4.360000134,0,IC50,0,44000,0,=,,,,28176326,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,BAY-320,9126,,,315661211,Inhibitor,Inhibition,,f,f,,pIC50,0,6.170000076,0,IC50,0,680,0,=,Measuring inhibition of the recombinant catalytic domain of human Bub1 (amino acids 704?1085).,,,26885717,CCOc1cc(F)c(c(c1)F)Cn1nc(c(c1C1CC1)C)c1ncc(c(n1)Nc1ccncc1)OC
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,BAY-524,9127,,,315661212,Inhibitor,Inhibition,,f,f,,pIC50,0,6.349999905,0,IC50,0,450,0,=,Measuring inhibition of the recombinant catalytic domain of human Bub1 (amino acids 704?1085).,,,26885717,CCOc1cc(F)c(c(c1)F)Cn1nc(c(c1OC)C)c1ncc(c(n1)Nc1ccncc1)OC
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,compound 2-1-1 [PMID: 24900824],8109,,,249565789,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24900824,CCOc1cc(F)c(c(c1)F)Cn1nc(c2c1CCC2)c1ncc(c(n1)Nc1ccncc1)OC
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,compound 2-13-1 [PMID: 24900824],8112,,,249565792,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,24900824,NC(=O)c1cnccc1Nc1nc(ncc1OCCS(=O)(=O)C)c1nn(c2c1CCC2)Cc1ccccc1F
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,compound 2-3-1 [PMID: 24900824],8111,,,249565791,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,24900824,CCOc1cc(F)c(c(c1)F)Cn1nc(c2c1CCC2)c1ncc(c(n1)Nc1ccncc1)OCCN(C)C
BUB1 mitotic checkpoint serine/threonine kinase,1949,BUB1,O43683,,,,,,Human,compound 2-3-2 [PMID: 24900824],8110,,,249565790,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,24900824,CCOc1cc(F)c(c(c1)F)Cn1nc(c2c1CCC2)c1ncc(c(n1)Nc1ccncc1)OCC1(CO)COC1
butyrylcholinesterase,2471,BCHE,P06276,,,,,,Human,bambuterol,6601,,,178103214,Inhibitor,Inhibition,,f,,,pIC50,0,8.5,0,-,0,0,0,=,,,,12675140,O=C(N(C)C)Oc1cc(cc(c1)OC(=O)N(C)C)C(CNC(C)(C)C)O
C3a receptor,31,C3AR1,Q16581,,,,,,Human,compound 17 [PMID: 24257095],9449,,,329968389,Agonist,Agonist,,f,f,,pEC50,0,8.100000381,0,-,0,0,0,=,,,,24257095,CC(C[C@@H](c1occ(n1)C(=O)N[C@H](C(=O)O)CCCN=C(N)N)NC(=O)c1c[nH]c2c1cccc2)C
C3a receptor,31,C3AR1,Q16581,,,,,,Human,Ac-RHYPLWR,8380,,,252166592,Agonist,Full agonist,,f,f,,pEC50,0,5.960000038,0,EC50,0,1100,0,=,,,,25446428,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,C3a,3640,C3,Human,135651638,Agonist,Full agonist,,t,,,pEC50,0,7.3,0,EC50,0,53,0,=,,,,20527893,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,compound 21 [PMID: 25259874],8381,,,252166593,Agonist,Full agonist,,f,f,,pEC50,0,7.699999809,0,EC50,0,20,0,=,,,,25259874,O=C(c1nc([nH]c1C)C(c1ccccc1)c1ccccc1)N[C@H](C(=O)O)CCCNC(=N)N
C3a receptor,31,C3AR1,Q16581,,,,,,Human,compound 4 [PMID: 25259874],8384,,,252166596,Antagonist,Antagonist,,f,f,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,,,,25259874,NC(=N)NCCC[C@@H](C(=O)O)NC(=O)CSCC(c1ccccc1)c1ccccc1
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,C5a,573,C5,Human,135651643,Agonist,Full agonist,,t,,,pIC50,9.2,0,9.1,-,0,0,0,=,,,,15661745,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,C5a,573,C5,Human,135651643,Agonist,Full agonist,,f,,,pEC50,9,0,8,EC50,10,0,1,=,,,,10602324,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,C5a des-Arg,574,C5,Human,178100215,Agonist,Partial agonist,,t,,,pIC50,6.4,0,6.2,-,0,0,0,=,,,,15661745,
C5a<sub>1</sub> receptor,32,C5ar1,P30993,,,,,,Mouse,A8<sup>&Delta;71-73</sup>,5780,,,178102405,Antagonist,Antagonist,,f,,,pIC50,0,7.57,0,IC50,0,27,0,=,,,,14570896,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,AcPhe-Orn-Pro-D-Cha-Trp-Arg,3853,,,178100692,Antagonist,Antagonist,,f,,,pIC50,0,7.9,0,-,0,0,0,=,,,,9719594,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,avacopan,9450,,,329968390,Antagonist,Antagonist,,f,f,,pIC50,0,9.699999809,0,-,0,0,0,=,,,,27768695,O=C([C@H]1CCCN([C@H]1c1ccc(cc1)NC1CCCC1)C(=O)c1c(C)cccc1F)Nc1ccc(c(c1)C(F)(F)F)C
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,C089,5779,,,178102404,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,IC50,0,201,0,=,,,,7930622,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,CHIPS,3724,,,178100597,Antagonist,Antagonist,,f,f,,pKd,0,9,0,-,0,0,0,=,,,,15153520,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,C5a des-Arg,574,C5,Human,178100215,Agonist,Agonist,,t,,,pIC50,7.9,0,7.4,IC50,36.5,0,12,=,,,,11773063,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,C5a hexapeptide analogue,5768,,,178102393,Agonist,Agonist,,f,,,pIC50,0,4.74,0,IC50,0,18000,0,=,,,,12899627,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,C5a,573,C5,Human,135651643,Agonist,Full agonist,,t,,,pIC50,8.6,0,8,IC50,9.5,0,2.5,=,,,,11773063,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,C5a,573,C5,Human,135651643,Agonist,Full agonist,,t,,,pEC50,0,8.85,0,EC50,0,1.4,0,=,,,,0,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,C5a des-Arg,574,C5,Human,178100215,Agonist,Full agonist,,t,,,pEC50,0,8.64,0,EC50,0,2.3,0,=,,,,0,
C5a<sub>2</sub> receptor,33,C5ar2,Q8BW93,,,,,,Mouse,A8<sup>&Delta;71-73</sup>,5780,,,178102405,Antagonist,Antagonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,~,,,,14570896,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,CHIPS-(28-149),5770,,,178102395,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,IC50,0,274,0,=,,,,17258808,
CaCC,708,ANO1,Q5XXA6,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,,t,,,-,0,0,0,,0,0,0,,,,intracellular,0,
CaCC,708,ANO1,Q5XXA6,,,,,,Human,9-anthroic acid,4113,,,178100935,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1c2ccccc2cc2c1cccc2
calcium/calmodulin dependent protein kinase ID,1953,CAMK1D,Q8IU85,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,7.039999962,0,IC50,0,92,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
calcium/calmodulin-dependent protein kinase II delta subunit,1558,CAMK2D,Q13557,,,,,,Human,compound 15b [PMID: 18334293],8157,,,249565837,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,18334293,Clc1cccc(c1)Nc1nccc(n1)c1cccc(c1)N1CCNCC1
calcium/calmodulin-dependent protein kinase II delta subunit,1558,CAMK2D,Q13557,,,,,,Human,compound 27 [PMID: 18337095],8158,,,249565838,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,18337095,NCCc1cn(c2c1cccc2)C1=C(C(=O)NC1=O)c1c[nH]c2c1cc(Cl)cc2
calcium/calmodulin-dependent protein kinase II gamma subunit,1557,CAMK2G,Q13555,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,184,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
Calmodulin-dependent kinase II,1554,,,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Calmodulin-dependent kinase II,1554,,,,,,,,Human,compound 20 [PMID: 22136433],8156,,,249565836,Inhibitor,Inhibition,,f,f,,pIC50,0,7.079999924,0,IC50,0,83,0,=,,,,22136433,N#CC1c2c3ccc(c(c3n(c2C(=O)NC21CCNCC2)C)Cl)Cl
calpain 1,2336,,,,,,,,Pig,compound 4b [PMID: 20690647],8614,,,252166815,Inhibitor,Inhibition,,f,f,,pKi,0,7.639999866,0,Ki,0,23,0,=,,,,20690647,CCC(C(=O)C(=O)NCCCn1cnc2c1nc(OC)nc2N)NC(=O)[C@@H](NC(=O)OCc1ccccc1)CC(C)C
calpain 2,2337,CAPN2,P17655,,,,,,Human,compound 19 [PMID: 8831774],8569,,,252166770,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,8831774,CCC(C(=O)C(=O)NCC(c1ccccc1)O)NC(=O)C(NC(=O)OCc1ccccc1)CC(C)C
calpain 2,2337,,,,,,,,Pig,compound 5a [PMID: 20690647],8615,,,252166816,Inhibitor,Inhibition,,f,f,,pKi,0,7.170000076,0,Ki,0,68,0,=,,,,20690647,CC(C[C@@H](C(=O)NC(C(=O)C(=O)NCCCn1cnc2c1ncnc2N)Cc1ccccc1)NC(=O)OCc1ccccc1)C
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,f,,pKi,0,6.599999905,0,Ki,0,250,0,=,,,,15546717,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,benzolamide,6920,,,178103502,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,15686894,O=S(=O)(c1ccccc1)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,brinzolamide,6797,,,178103403,Inhibitor,Inhibition,,f,f,,pKi,0,4.349999905,0,Ki,0,45000,0,=,,,,23965175,COCCCN1C[C@H](NCC)c2c(S1(=O)=O)sc(c2)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,chlorthalidone,7147,,,178103722,Inhibitor,Inhibition,,f,f,,pKi,0,6.460000038,0,Ki,0,348,0,=,,,,0,Clc1ccc(cc1S(=O)(=O)N)C1(O)N=C(c2c1cccc2)O
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,f,,pKi,0,8.239999771,0,Ki,0,5.699999809,0,=,,,,15686894,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,benzolamide,6920,,,178103502,Inhibitor,Inhibition,,f,f,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,,,,15686894,O=S(=O)(c1ccccc1)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,brinzolamide,6797,,,178103403,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,15686894,COCCCN1C[C@H](NCC)c2c(S1(=O)=O)sc(c2)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,celecoxib,2892,,,178100241,Inhibitor,Inhibition,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,23965175,Cc1ccc(cc1)c1cc(nn1c1ccc(cc1)S(=O)(=O)N)C(F)(F)F
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,chlorthalidone,7147,,,178103722,Inhibitor,Inhibition,,f,t,,pKi,0,8.350000381,0,Ki,0,4.5,0,=,,,,19119014,Clc1ccc(cc1S(=O)(=O)N)C1(O)N=C(c2c1cccc2)O
carbonic anhydrase 13,2748,Car13,Q9D6N1,,,,,,Mouse,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,f,,pKi,0,7.769999981,0,Ki,0,17,0,=,,,,20605094,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,f,,pKi,7.599999905,0,7.389999866,Ki,41,0,25,=,,,,15454239,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,brinzolamide,6797,,,178103403,Inhibitor,Inhibition,,f,f,,pKi,0,4.150000095,0,Ki,0,70000,0,=,,,,1460006,COCCCN1C[C@H](NCC)c2c(S1(=O)=O)sc(c2)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,chlorthalidone,7147,,,178103722,Inhibitor,Inhibition,,f,f,,pKi,0,5.380000114,0,Ki,0,4130,0,=,,,,19119014,Clc1ccc(cc1S(=O)(=O)N)C1(O)N=C(c2c1cccc2)O
carbonic anhydrase 4,2599,CA4,P22748,,,,,,Human,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,f,,pKi,7.599999905,0,7.130000114,Ki,74,0,25,=,,,,15603956,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 4,2599,CA4,P22748,,,,,,Human,chlorthalidone,7147,,,178103722,Inhibitor,Inhibition,,f,f,,pKi,0,6.710000038,0,Ki,0,196,0,=,,,,19119014,Clc1ccc(cc1S(=O)(=O)N)C1(O)N=C(c2c1cccc2)O
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,acetazolamide,6792,,,178103398,Inhibitor,Inhibition,,f,t,,pKi,0,8.600000381,0,Ki,0,2.5,0,=,,,,20605094,CC(=O)Nc1nnc(s1)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,brinzolamide,6797,,,178103403,Inhibitor,Inhibition,,f,t,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,,,,23965175,COCCCN1C[C@H](NCC)c2c(S1(=O)=O)sc(c2)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,chlorthalidone,7147,,,178103722,Inhibitor,Inhibition,,f,t,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,,,,19119014,Clc1ccc(cc1S(=O)(=O)N)C1(O)N=C(c2c1cccc2)O
carboxyl ester lipase,2872,,,,,,,,Pig,compound 10f [PMID: 24556381],8602,,,252166803,Inhibitor,Inhibition,,f,f,,pIC50,0,5.880000114,0,IC50,0,1330,0,=,,,,24556381,Clc1ccc2c(c1)c(cc(n2)c1c[nH]c2c1cccc2)c1ccccc1
carboxyl ester lipase,2872,,,,,,,,Pig,compound 10l [PMID: 24556381],8603,,,252166804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,1980,0,=,,,,24556381,[O-][N+](=O)c1ccc2c(c1)c(cc(n2)c1c[nH]c2c1cccc2)c1ccccc1
Carboxypeptidase A1 (pancreatic),1587,CPA1,P15085,,,,,,Human,compound 1b [PMID: 18078750],8627,,,252166827,Inhibitor,Inhibition,,f,f,,pKi,0,6.510000229,0,Ki,0,310,0,=,,,,18078750,S[C@@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)c1ccccc1)Cc1ccccc1
Carboxypeptidase B1 (tissue),1593,CPB1,P15086,,,,,,Human,compound 3 [PMID: 14640538],8675,,,252166875,Inhibitor,Inhibition,,f,f,,pIC50,0,8.090000153,0,IC50,0,8.199999809,0,=,,,,14640538,SCC(C(=O)O)CSCCN=C(N)N
Carboxypeptidase B1 (tissue),1593,CPB1,P15086,,,,,,Human,compound 4 [PMID: 19954973],8623,,,252166824,Inhibitor,Inhibition,,f,f,,pKi,0,7.570000172,0,Ki,0,27,0,=,,,,19954973,NCCO[C@H](C(=O)O)Cc1ncn(c1)c1ccccc1
Carboxypeptidase B2 (plasma),1594,CPB2,Q96IY4,,,,,,Human,compound 3 [PMID: 14640538],8675,,,252166875,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,14640538,SCC(C(=O)O)CSCCN=C(N)N
Carboxypeptidase B2 (plasma),1594,CPB2,Q96IY4,,,,,,Human,compound 4 [PMID: 19954973],8623,,,252166824,Inhibitor,Inhibition,,f,t,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,,,,19954973,NCCO[C@H](C(=O)O)Cc1ncn(c1)c1ccccc1
Carboxypeptidase M,1596,CPM,P14384,,,,,,Human,compound 3 [PMID: 14640538],8675,,,252166875,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,14640538,SCC(C(=O)O)CSCCN=C(N)N
"Carboxypeptidase N, polypeptide 1",1597,CPN1,P15169,,,,,,Human,compound 3 [PMID: 14640538],8675,,,252166875,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,14640538,SCC(C(=O)O)CSCCN=C(N)N
casein kinase 1 alpha 1,1995,CSNK1A1,P48729,,,,,,Human,compound 14 [PMID: 24900428],8154,,,249565834,Inhibitor,Inhibition,,f,f,,pIC50,0,6.349999905,0,IC50,0,442,0,=,,,,24900428,COc1cnc(cc1c1cc2c([nH]1)CCNC2=O)COc1ccc(cc1C)F
casein kinase 1 delta,1997,CSNK1D,P48730,,,,,,Human,compound 14 [PMID: 24900428],8154,,,249565834,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,24900428,COc1cnc(cc1c1cc2c([nH]1)CCNC2=O)COc1ccc(cc1C)F
casein kinase 1 gamma 1,1999,CSNK1G1,Q9HCP0,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
casein kinase 1 gamma 2,2000,CSNK1G2,P78368,,,,,,Human,compound 14 [PMID: 24900428],8154,,,249565834,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,24900428,COc1cnc(cc1c1cc2c([nH]1)CCNC2=O)COc1ccc(cc1C)F
casein kinase 1 gamma 3,2001,CSNK1G3,Q9Y6M4,,,,,,Human,compound 14k [PMID: 21982499],8214,,,249565894,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 0.5&mu;M compound.,,,21982499,Clc1ccccc1Nc1nc2c(cccc2c2c1ccnc2)c1[nH]cnn1
Casein kinase 2,1548,,,,,,,,Human,casein kinase II inhibitor III,5941,,,178102564,Inhibitor,Inhibition,,f,t,,pIC50,0,6.960000038,0,IC50,0,110,0,=,,,,17133643,OC(=O)/C=C/c1cc(Br)c(c(c1Br)Br)Br
Casein kinase 2,1548,,,,,,,,Human,compound 2 [PMID: 22560567],8115,,,249565795,Inhibitor,Inhibition,,f,f,,pIC50,7.71999979,0,7.570000172,IC50,27,0,19,=,,,,22560567,Oc1ccc(cc1C)c1nc(=O)[nH]c(c1)c1ccccc1
Casein kinase 2,1548,,,,,,,,Human,compound 5b [PMID: 24900464],8171,,,249565851,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24900464,N#Cc1cnn2c1nc(cc2NC1CC1)c1c[nH]c2c1cc(cc2)NC(=O)C
"casein kinase 2, alpha 1 polypeptide subunit",1549,CSNK2A1,P68400,,,,,,Human,compound 1a [PMID: 24900749],8128,,,249565808,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,24900749,N#Cc1cnn2c1nc(Nc1ccc(c(c1)NC(=O)C)C)cc2NC1CC1
"casein kinase 2, alpha 1 polypeptide subunit",1549,CSNK2A1,P68400,,,,,,Human,compound 2c [PMID: 22115617],8140,,,249565820,Inhibitor,Inhibition,,f,f,,pKi,0,7.079999924,0,Ki,0,83,0,=,,,,22115617,OC(=O)Cn1c(nc2c1c(Br)c(Br)c(c2Br)Br)N(C)C
"casein kinase 2, alpha prime polypeptide subunit",1550,CSNK2A2,P19784,,,,,,Human,compound 2c [PMID: 22115617],8140,,,249565820,Inhibitor,Inhibition,,f,t,,pKi,0,7.679999828,0,Ki,0,21,0,=,,,,22115617,OC(=O)Cn1c(nc2c1c(Br)c(Br)c(c2Br)Br)N(C)C
Caspase 1,1617,CASP1,P29466,,,,,,Human,AS101,437,,,135649959,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,17572009,CCCn1c2=N/C(=c\3/cc([nH]n3C)OC(=O)CNc3ccc(c(c3)OC)OC)/N=c2c(=O)n(c1=O)CCC
Caspase 1,1617,CASP1,P29466,,,,,,Human,AS101,437,,,135649959,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,17572009,CCCn1c2=N/C(=c3/cc([nH]n3C)OC(=O)CNc3ccc(c(c3)OC)OC)/N=c2c(=O)n(c1=O)CCC
Caspase 2,1618,CASP2,P42575,,,,,,Human,compound 4 [PMID: 12408711],8628,,,252166828,Inhibitor,Inhibition,,f,f,,pKi,0,6.019999981,0,Ki,0,960,0,=,,,,12408711,O=C[C@@H](NC(=O)c1ccc(nc1)CNS(=O)(=O)c1cccc(c1)C(=O)O)CC(=O)O
Caspase 3,1619,CASP3,P42574,,,,,,Human,Ac-DEVD-CHO,6527,,,178103141,Inhibitor,Inhibition,,f,,,pIC50,0,9.8,0,IC50,0,0.16,0,,,,,20541849,O=C[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(=O)O)CCC(=O)O)CC(=O)O
Caspase 3,1619,CASP3,P42574,,,,,,Human,AZ10417808,5143,,,178101835,Inhibitor,Inhibition,,f,f,,pKi,0,6.610000134,0,Ki,0,247,0,=,,,,12490620,C=CCNC(=O)c1cc(cc2c1[nH]c(Nc1ccc(c(c1)Cl)Cl)nc2=O)[N+](=O)[O-]
Caspase 3,1619,CASP3,P42574,,,,,,Human,compound 4 [PMID: 12408711],8628,,,252166828,Inhibitor,Inhibition,,f,t,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,12408711,O=C[C@@H](NC(=O)c1ccc(nc1)CNS(=O)(=O)c1cccc(c1)C(=O)O)CC(=O)O
Caspase 4,1620,CASP4,P49662,,,,,,Human,casp 4 inhib,8635,,,252166835,Inhibitor,Inhibition,,f,f,,pKi,0,5.400000095,0,Ki,0,4000,0,=,,,,11384246,O=C1N(C)c2c(C1=O)cc(cc2)[N+](=O)[O-]
Caspase 6,1622,CASP6,P55212,,,,,,Human,Ac-VEID-CHO,8566,,,252166767,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,19326941,O=C[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)C)CCC(=O)O)CC(=O)O
Caspase 7,1623,CASP7,P55210,,,,,,Human,compound 4 [PMID: 12408711],8628,,,252166828,Inhibitor,Inhibition,,f,f,,pKi,0,6.889999866,0,Ki,0,130,0,=,,,,12408711,O=C[C@@H](NC(=O)c1ccc(nc1)CNS(=O)(=O)c1cccc(c1)C(=O)O)CC(=O)O
Caspase 8,1624,CASP8,Q14790,,,,,,Human,compound 4 [PMID: 12408711],8628,,,252166828,Inhibitor,Inhibition,,f,f,,pKi,0,6.059999943,0,Ki,0,880,0,=,,,,12408711,O=C[C@@H](NC(=O)c1ccc(nc1)CNS(=O)(=O)c1cccc(c1)C(=O)O)CC(=O)O
CaS receptor,54,Casr,P48442,,,,,,Rat,Ca<sup>2+</sup>,707,,,135652731,Agonist,Full agonist,,t,,,pKd,0,2.5,0,,0,0,0,,,,,7816802,
CaS receptor,54,CASR,P41180,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Agonist,Full agonist,,t,,,pKd,0,2.4,0,,0,0,0,,,,,7531693,
CaS receptor,54,Casr,Q9QY96,,,,,,Mouse,Ca<sup>2+</sup>,707,,,135652731,Agonist,Full agonist,,t,,,pKd,0,2.5,0,,0,0,0,,,,,16199532,
CaS receptor,54,CASR,P41180,,,,,,Human,ATF 936,9475,,,329968415,Allosteric modulator,Negative,,f,f,,pIC50,0,8.899999619,0,-,0,0,0,=,Inhibition of 2.5 mM Ca<sup>2+</sup>-mediated Ca<sup>2+</sup><sub>i</sub> release,,,20158186,C#CCOc1ccc2c(c1)c(nc(=O)n2Cc1ccccc1)c1ccc(cc1)C(C)C
CaS receptor,54,CASR,P41180,,,,,,Human,calhex 231,714,,,135650048,Allosteric modulator,Negative,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,Inhibition of 9mM Ca<sup>2+</sup><sub>o</sub>-mediated IP accumulation,,,14506236,Clc1ccc(cc1)C(=O)N[C@H]1CCCC[C@@H]1N[C@@H](c1cccc2c1cccc2)C
CaS receptor,54,CASR,P41180,,,,,,Human,AC265347,3947,,,178100774,Allosteric modulator,Positive,,f,f,,pEC50,8.100000381,0,7.599999905,-,0,0,0,=,,,,21239511,Cc1ccc(c(c1)C)C(c1nc2c(s1)cccc2)(O)C
CaS receptor,54,CASR,P41180,,,,,,Human,AC265347,3947,,,178100774,Allosteric modulator,Positive,,f,f,,pKB,6.400000095,0,6.300000191,-,0,0,0,=,Ca<sup>2+</sup><sub>i</sub> release,,,25220431,Cc1ccc(c(c1)C)C(c1nc2c(s1)cccc2)(O)C
CaS receptor,54,CASR,P41180,,,,,,Human,calindol,719,,,135650049,Allosteric modulator,Positive,,f,f,,pKd,6.5,0,6,-,0,0,0,=,,,,15149704,C[C@H](c1cccc2c1cccc2)NCc1cc2c([nH]1)cccc2
CaS receptor,54,CASR,P41180,,,,,,Human,calindol,719,,,135650049,Allosteric modulator,Positive,,f,f,,pKB,0,6.300000191,0,-,0,0,0,=,Ca<sup>2+</sup><sub>i</sub> release,,,25220431,C[C@H](c1cccc2c1cccc2)NCc1cc2c([nH]1)cccc2
CaS receptor,54,CASR,P41180,,,,,,Human,cinacalcet,3308,,,178100343,Allosteric modulator,Positive,,f,t,,pEC50,0,7.300000191,0,EC50,0,51,0,=,,,,14593085,C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F
CaS receptor,54,CASR,P41180,,,,,,Human,cinacalcet,3308,,,178100343,Allosteric modulator,Positive,,f,f,,pKB,6.599999905,0,5.900000095,-,0,0,0,=,Ca<sup>2+</sup><sub>i</sub> release,,,22210744,C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F
CaS receptor,54,Casr,P48442,,,,,,Rat,1-arylmethylpyrrolidin-2-yl ethanol amine,711,,,135649657,Antagonist,Antagonist,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,16216508,N#Cc1cccc(c1)CN1CCC[C@@H]1[C@@H](CNC(Cc1cc2c(s1)cccc2)(C)C)O
CaS receptor,54,CASR,P41180,,,,,,Human,2-methyl-3-phenethyl-3H-pyrimidin-4-one,713,,,135649705,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15863312,CCc1c(C)[nH]/c(=C\2/C=CC=CC2=O)/n(c1=O)CCc1ccccc1F
CaS receptor,54,CASR,P41180,,,,,,Human,2-methyl-3-phenethyl-3H-pyrimidin-4-one,713,,,135649705,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15863312,CCc1c(C)[nH]/c(=C2/C=CC=CC2=O)/n(c1=O)CCc1ccccc1F
CaS receptor,54,Casr,P48442,,,,,,Rat,compound 17 [PMID: 15300839],715,,,135650672,Antagonist,Antagonist,,f,,,pIC50,0,5.3,0,,0,0,0,,,,,15300839,COc1ccc(cc1)S(=O)(=O)N[C@@H]1CCCC[C@H]1NC(c1cccc2c1cccc2)C
CaS receptor,54,CASR,P41180,,,,,,Human,compound (S)-3h [PMID: 15686947],712,,,135650122,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,15686947,N#Cc1c(cccc1Cl)OC[C@@H](CN1CCC[C@H]1Cc1ccccc1)O
Ca<sub>v</sub>1.1,528,Cacna1s,Q02789,,,,,,Mouse,BAYK 8644,2511,,,53801066,Activator,None,,f,,0.5-10,-,0,0,0,,0,0,0,,,,,2155469,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,calciseptine,4149,,,178100970,Channel blocker,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Ca<sub>v</sub>1.1,528,Cacna1s,Q02485,,,,,,Rat,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,2458429,
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,BAYK 8644,2511,,,53801066,Activator,None,,f,,5,-,0,0,0,,0,0,0,,,,,7514140,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,calciseptine,4149,,,178100970,Channel blocker,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Ca<sub>v</sub>1.2,529,,,,,,,,Rabbit,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,f,,pIC50,6,0,5.699999809,-,0,0,0,=,,,,9176282,
Ca<sub>v</sub>1.3,530,Cacna1d,P27732,,,,,,Rat,BAYK 8644,2511,,,53801066,Activator,None,,f,,1,-,0,0,0,,0,0,0,,,,,11487617,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,BAYK 8644,2511,,,53801066,Activator,None,,f,,5,-,0,0,0,,0,0,0,,,,,10929716,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.3,530,,,,,,,,None,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,,200,-,0,0,0,,0,0,0,,,,,11435619,
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,amlodipine,6981,,,178103560,Gating inhibitor,Inhibition,,f,f,,pIC50,0,7.199999809,0,IC50,0,60.09999847,0,=,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,,,19029287,NCCOCC1=C(C(=O)OCC)C(C(=C(N1)C)C(=O)OC)c1ccccc1Cl
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,azidopine,6980,,,178103559,Gating inhibitor,Inhibition,,f,f,,pIC50,0,9.199999809,0,IC50,0,0.649999976,0,=,Recombinant Cav1.3 calcium channel complexes expressed in tsA201-cells,,,19029287,CCOC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)C(=O)OCCNC(=O)c1ccc(cc1)N=[N+]=[N-])C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,BAYK 8644,2511,,,53801066,Activator,None,,f,,510,-,0,0,0,,0,0,0,,,,,12853422,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.4,531,Cacna1f,Q9JIS7,,,,,,Mouse,BAYK 8644,2511,,,53801066,Activator,None,,f,,1,-,0,0,0,,0,0,0,,,,,14744918,COC(=O)C1=C(C)NC(=C(C1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>2.1,532,,,,,,,,Rabbit,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,pIC50,6.3,0,6,,0,0,0,,,,,0,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,cilnidipine,7767,,,223366100,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.699999809,0,-,0,0,0,=,,,,9067302,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC/C=C/c1ccccc1)C
Ca<sub>v</sub>2.3,534,CACNA1E,Q15878,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,8071363,
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,t,,,pIC50,0,5.4,0,,0,0,0,,,,,11742980,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,t,,,pIC50,0,5.4,0,,0,0,0,,,,,11742980,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,ABT-639,7721,,,223366054,Channel blocker,Pore blocker,,f,f,,pIC50,0,5,0,-,0,0,0,=,,,,24726441,Fc1cc(Cl)c(cc1S(=O)(=O)Nc1ccccc1F)C(=O)N1CCN2[C@@H](C1)CCC2
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,11742980,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,11742980,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,ABT-639,7721,,,223366054,Channel blocker,Pore blocker,,f,f,,pIC50,0,5.599999905,0,-,0,0,0,=,,,,24726441,Fc1cc(Cl)c(cc1S(=O)(=O)Nc1ccccc1F)C(=O)N1CCN2[C@@H](C1)CCC2
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,11742980,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,11742980,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,ABT-639,7721,,,223366054,Channel blocker,Pore blocker,,f,f,,pIC50,0,5,0,-,0,0,0,=,,,,24726441,Fc1cc(Cl)c(cc1S(=O)(=O)Nc1ccccc1F)C(=O)N1CCN2[C@@H](C1)CCC2
Cathepsin A,1581,CTSA,P10619,,,,,,Human,boceprevir,7876,,,223366205,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,0,O=C(NC(C)(C)C)N[C@@H](C(C)(C)C)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C
Cathepsin A,1581,CTSA,P10619,,,,,,Human,compound 8a [PMID: 22861813],7891,,,223366214,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,22861813,OC(=O)C[C@@H](c1ccccc1C)NC(=O)c1[nH]n(c(=O)c1)c1ccccc1F
cathepsin C,2344,CTSC,P53634,,,,,,Human,AZD7986,9412,,,328083514,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,3.980000019,0,=,In vitro enzyme assay,,,27690432,N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
cathepsin C,2344,CTSC,P53634,,,,,,Human,AZD7986,9412,,,328083514,Inhibitor,Inhibition,,f,t,,pKd,0,8.600000381,0,Kd,0,2.5,0,=,Surface plasmon resonance direct binding assay,,,27690432,N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
cathepsin C,2344,Ctsc,P80067,,,,,,Rat,AZD7986,9412,,,328083514,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,19.89999962,0,=,In vitro enzyme assay,,,27690432,N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
cathepsin C,2344,Ctsc,P97821,,,,,,Mouse,AZD7986,9412,,,328083514,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25.10000038,0,=,In vitro enzyme assay,,,27690432,N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
cathepsin C,2344,CTSC,P53634,,,,,,Human,compound 3d [PMID: 3941405],8622,,,252166823,Inhibitor,Inhibition,,f,f,,pKi,0,5.570000172,0,Ki,0,2700,0,=,,,,3941405,NCC(=O)NC(Cc1ccccc1)C#N
cathepsin D,2345,CTSD,P07339,,,,,,Human,compound 1 [PMID: 10498202],6541,,,178103155,Inhibitor,Inhibition,,f,,,pIC50,0,9.2,0,IC50,0,0.7,0,,,,,10498202,COc1cc(Br)c(cc1OC)C(=O)N[C@H]([C@H](CN(C(=O)CCN1C(=O)c2c(C1=O)cccc2)CCc1ccc(cc1Cl)Cl)O)Cc1cccc(c1)Oc1ccccc1
cathepsin D,2345,CTSD,P07339,,,,,,Human,compound 3 [PMID: 8410973],8634,,,252166834,Inhibitor,Inhibition,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,8410973,C=CC[C@@H](C(=O)N[C@H](C(=O)C(C(=O)NCCN1CCOCC1)(F)F)CC1CCCCC1)NC(=O)[C@@H](NS(=O)(=O)N1CCOCC1)Cc1ccccc1
cathepsin E,2346,CTSE,P14091,,,,,,Human,compound 2 [PMID: 8410973],6566,,,178103180,Inhibitor,Inhibition,,f,,,pKi,0,10,0,Ki,0,0.1,0,,,,,8410973,CC[C@@H](CNC(=O)C([C@@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NS(=O)(=O)N1CCOCC1)Cc1ccccc1)CC=C)CC1CCCCC1)O)(F)F)C
cathepsin E,2346,CTSE,P14091,,,,,,Human,compound 3 [PMID: 8410973],8634,,,252166834,Inhibitor,Inhibition,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,8410973,C=CC[C@@H](C(=O)N[C@H](C(=O)C(C(=O)NCCN1CCOCC1)(F)F)CC1CCCCC1)NC(=O)[C@@H](NS(=O)(=O)N1CCOCC1)Cc1ccccc1
cathepsin F,2347,CTSF,Q9UBX1,,,,,,Human,compound (R)-26 [PMID: 22686657],6535,,,178103149,Inhibitor,Inhibition,,f,f,,pKi,0,7.679999828,0,Ki,0,21,0,=,,,,22686657,N#CN(N(C(=O)[C@H](CS(=O)(=O)CC(C)C)NC(=O)c1ccccc1)C)C
cathepsin G,2348,CTSG,P08311,,,,,,Human,compound 1 [PMID: 11425539],6542,,,178103156,Inhibitor,Inhibition,,f,,,pIC50,0,9.4,0,IC50,0,0.39,0,,,,,11425539,O=C1N(Cc2ccccc2)C(=O)N1Cc1ccccc1
cathepsin G,2348,CTSG,P08311,,,,,,Human,compound 4g [PMID: 22595175],8626,,,252166826,Inhibitor,Inhibition,,f,f,,pIC50,0,4.849999905,0,IC50,0,14200,0,=,,,,22595175,COc1ccc(cc1)C(=O)N1C(=O)OC(C1=O)(C)C
cathepsin H,2349,CTSH,P09668,,,,,,Human,compound 1b [PMID: 16290936],8613,,,252166814,Inhibitor,Inhibition,,f,f,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,16290936,CCCC[C@H](NC(=O)O[C@H](Cc1ccccc1)C)C=O
cathepsin H,2349,CTSH,P09668,,,,,,Human,compound 1e [PMID: 27285276],9550,,,336446936,Inhibitor,Inhibition,,f,f,,pIC50,0,6.360000134,0,IC50,0,440,0,=,,,,27285276,Clc1ccc(cc1)/C=N/NC(=O)c1ccccc1
cathepsin K,2350,CTSK,P43235,,,,,,Human,balicatib,7861,,,223366191,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,20218623,CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N
cathepsin K,2350,CTSK,P43235,,,,,,Human,compound 1b [PMID: 16290936],8613,,,252166814,Inhibitor,Inhibition,,f,t,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,16290936,CCCC[C@H](NC(=O)O[C@H](Cc1ccccc1)C)C=O
cathepsin L,2351,,,,,,,,Rat,CAA0225,6532,,,178103146,Inhibitor,Inhibition,,f,,,pIC50,0,8.7,0,IC50,0,1.9,0,,,,,19252298,O=C([C@H](Cc1ccccc1)NC(=O)[C@H]1O[C@@H]1C(=O)NCCc1ccc(cc1)O)NCc1ccccc1
cathepsin S,2353,CTSS,P25774,,,,,,Human,compound (R)-26 [PMID: 22686657],6535,,,178103149,Inhibitor,Inhibition,,f,,,pKi,0,9.3,0,Ki,0,0.55,0,,,,,22686657,N#CN(N(C(=O)[C@H](CS(=O)(=O)CC(C)C)NC(=O)c1ccccc1)C)C
cathepsin V,2352,CTSV,O60911,,,,,,Human,citibrasine,8561,,,252166762,Inhibitor,Inhibition,,f,f,,pKi,0,6.699999809,0,Ki,0,200,0,=,,,,21277783,COc1c(OC)c(OC)c2c(c1O)c(=O)c1c(n2C)c(O)ccc1
CatSper1,388,Catsper1,Q91ZR5,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Inhibition,,f,f,,pIC50,0,3.700000048,0,IC50,0,200000,0,=,Whole cell patch clamp,,,16467839,
CatSper2,389,Catsper2,A2ARP9,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Inhibition,,f,,,pIC50,0,3.7,0,IC50,0,200000,0,=,Whole cell patch clamp.,,,21642646,
CatSper3,390,Catsper3,Q80W99,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,,,pIC50,0,3.7,0,IC50,0,200000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CatSper4,391,Catsper4,Q8BVN3,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,,,pIC50,0,3.7,0,IC50,0,200000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,ajulemic acid,9772,,,0,Agonist,Agonist,,f,f,,pKi,0,7.489999771,0,Ki,0,32.29999924,0,=,,,,23865723,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C(=O)O)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,AM11542,9612,,,340590242,Agonist,Agonist,,f,f,,pKi,0,9.960000038,0,Ki,0,0.109999999,0,=,,,,28678776,BrCCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,AM2201,9705,,,348353664,Agonist,Agonist,,f,f,,pEC50,0,7.420000076,0,EC50,0,38,0,=,,,,25921407,FCCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,AM2201,9705,,,348353664,Agonist,Agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,Binding affinity <i>vs</i>. rat forebrain membranes.,,,0,FCCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,AM7499,9257,,,315661332,Agonist,Agonist,,f,f,,pKi,0,8.619999886,0,Ki,0,2.400000095,0,=,,,,27367336,CCCCOC(=O)C(c1cc(O)c2c(c1)OC([C@H]1[C@H]2C[C@H](CO)CC1)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,AM841,9613,,,340590243,Agonist,Agonist,,f,f,,pKi,0,8.93999958,0,Ki,0,1.139999986,0,=,,,,28678776,S=C=NCCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,BMS-202,9607,,,340590237,Agonist,Agonist,,f,f,,pIC50,0,6.989999771,0,IC50,0,102,0,=,,,,25921407,COc1nc(OCc2cccc(c2C)c2ccccc2)ccc1CNCCNC(=O)C
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,2-arachidonoylglycerol,729,,,135651394,Agonist,Full agonist,,t,,,pKi,7.2,0,6.3,,0,0,0,,,,,7605349,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,2-arachidonoylglycerol,729,,,135651394,Agonist,Full agonist,,t,,,pKi,7.2,0,6.3,,0,0,0,,,,,7605349,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)OC(CO)CO
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,arachidonyl-2-chloroethylamide,738,,,135651443,Agonist,Full agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,10336536,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCCl
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,arachidonyl-2-chloroethylamide,738,,,135651443,Agonist,Full agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,10336536,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCCl
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,arachidonylcyclopropylamide,739,,,135651444,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,10336536,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC1CC1
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,arachidonylcyclopropylamide,739,,,135651444,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,10336536,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NC1CC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,anandamide,2364,,,135651438,Agonist,Partial agonist,,t,,,pKi,7,0,6.3,,0,0,0,,,,,7565624,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,anandamide,2364,,,135651438,Agonist,Partial agonist,,t,,,pKi,7,0,6.3,,0,0,0,,,,,7565624,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,cannabinol,740,,,135650052,Agonist,Partial agonist,,f,f,,pKi,6.5,0,6,-,0,0,0,=,,,,7565624,CCCCCc1cc(O)c2c(c1)OC(c1c2cc(C)cc1)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,cannabidiol,4150,,,178100971,Allosteric modulator,Negative,,f,f,,-,0,0,0,-,0,0,0,=,,,,26218440,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,AM251,3317,,,178100351,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,10052983,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,AM281,741,,,135649928,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,Ki,0,12.60000038,0,=,,,,11741201,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCOCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,AM6538,9338,,,328083441,Antagonist,Antagonist,,f,t,,pKi,0,8.340000153,0,Ki,0,4.599999905,0,=,"Competition binding assay using [<sup>3</sup>H]-CP55,940",,,27768894,[O-][N+](=O)OCCC#Cc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,compound 70 [PMID: 26161824],8706,,,252166906,Antagonist,Antagonist,,f,t,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,26161824,N#CCCC#Cc1ccc(cc1)c1c(CO)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCOCC1
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,ajulemic acid,9772,,,0,Agonist,Agonist,,f,f,,pKi,0,6.769999981,0,Ki,0,170,0,=,,,,23865723,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C(=O)O)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,AM1241,3316,,,178100350,Agonist,Agonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,16894349,CN1CCCCC1Cn1cc(c2c1cccc2)C(=O)c1cc(ccc1I)N(=O)=O
CB<sub>2</sub> receptor,57,Cnr2,P47936,,,,,,Mouse,AM2201,9705,,,348353664,Agonist,Agonist,,f,f,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,Binding affinity <i>vs</i>. mouse spleen membranes.,,,0,FCCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,AM2201,9705,,,348353664,Agonist,Agonist,,f,f,,pEC50,0,7.230000019,0,EC50,0,58.79999924,0,=,,,,25921407,FCCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>2</sub> receptor,57,Cnr2,P47936,,,,,,Mouse,AM7499,9257,,,315661332,Agonist,Agonist,,f,f,,pKi,0,10,0,Ki,0,0.100000001,0,=,,,,27367336,CCCCOC(=O)C(c1cc(O)c2c(c1)OC([C@H]1[C@H]2C[C@H](CO)CC1)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,AM7499,9257,,,315661332,Agonist,Agonist,,f,f,,pKi,0,8.510000229,0,Ki,0,3.099999905,0,=,,,,27367336,CCCCOC(=O)C(c1cc(O)c2c(c1)OC([C@H]1[C@H]2C[C@H](CO)CC1)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,BMS-202,9607,,,340590237,Agonist,Agonist,,f,f,,pEC50,0,6.880000114,0,EC50,0,131,0,=,,,,25921407,COc1nc(OCc2cccc(c2C)c2ccccc2)ccc1CNCCNC(=O)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,2-arachidonoylglycerol,729,,,135651394,Agonist,Partial agonist,,t,,,pKi,6.8,0,5.8,,0,0,0,,,,,7605349,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,2-arachidonoylglycerol,729,,,135651394,Agonist,Partial agonist,,t,,,pKi,6.8,0,5.8,,0,0,0,,,,,7605349,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)OC(CO)CO
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,anandamide,2364,,,135651438,Agonist,Partial agonist,,t,,,pKi,6.4,0,5.7,,0,0,0,,,,,7565624,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,anandamide,2364,,,135651438,Agonist,Partial agonist,,t,,,pKi,6.4,0,5.7,,0,0,0,,,,,7565624,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,AM-630,750,,,135649929,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,,,,10188977,COc1ccc(cc1)C(=O)c1c(C)n(c2c1ccc(c2)I)CCN1CCOCC1
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,CE-326597,9055,,,315661140,Agonist,Agonist,,f,t,,pIC50,0,7.5,0,IC50,0,31.70000076,0,=,,,,20851601,CC(N(C(=O)CN1c2ccccc2n2c([C@@H](C1=O)Cc1c[nH]c3c1cccc3)nnc2c1ccccc1)Cc1ccccc1)C
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,A-71623,858,,,135651964,Agonist,Full agonist,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.980000019,0,=,,,,1636779,OC(=O)C[C@@H](C(=O)N([C@H](C(=O)N)Cc1ccccc1)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)OC(C)(C)C)CCCCNC(=O)Nc1ccccc1C
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,ARL-15849,859,,,135651999,Agonist,Full agonist,,f,,,pKi,0,10.5,0,,0,0,0,,,,,9476993,
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CCK-33,860,CCK,Human,135651648,Agonist,Full agonist,,f,,,pKd,0,9.3,0,-,0,0,0,=,,,,6256771,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)CCSC)c1ccc(cc1)OS(=O)(=O)O)CC(=O)O)CCCNC(=N)N)CC(=O)O)CO)C(CC)C)CCCNC(=N)N)Cc1nc[nH]c1)CO)CC(=O)O)CC(C)C)CC(=O)N)CCC(=O)N)CC(C)C)CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCCCN)N)C)CO)CCCNC(=N)N)CCSC)CO
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CCK-4,861,CCK,Human,135651650,Agonist,Full agonist,,f,,,pIC50,0,5.3,0,-,0,0,0,=,,,,1975695,CSCCC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)C(Cc1c[nH]c2c1cccc2)N
CCK<sub>1</sub> receptor,76,Cckar,O08786,,,,,,Mouse,CCK-58,862,CCK,Dog,135652053,Agonist,Full agonist,,f,,,pIC50,0,9.2,0,-,0,0,0,=,,,,12370550,
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CCK-8,864,CCK|Cck|Cck,Human|Mouse|Rat,135651651,Agonist,Full agonist,,t,,,pIC50,0,7.2,0,,0,0,0,,,,,1975695,CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)OS(=O)(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CCK-8,864,CCK|Cck|Cck,Human|Mouse|Rat,135651651,Agonist,Full agonist,,t,,,pIC50,0,9.9,0,,0,0,0,,,,,1975695,CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)OS(=O)(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CI-1015,872,,,135650092,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,9438020,O=C(N[C@@](C(=O)N[C@H]1CCCC[C@@H]1O)(Cc1c[nH]c2c1cccc2)C)OC12CC3CC(C2)CC(C1)C3
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,CI-988,873,,,135650093,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,1975695,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)CCC(=O)O
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,A-71378,894,,,135651963,Agonist,Full agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,8914862,CCCC[C@@H](C(=O)NC(=O)c1ccccc1C[C@H](NC(=O)[C@H](CC(=O)O)NC)C)NC(=O)N(C(=O)CNC(=O)[C@@H](NC(=O)CCc1ccc(cc1)OS(=O)(=O)O)CCCC)Cc1c[nH]c2c1cccc2
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,ARL-15849,859,,,135651999,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9476993,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,BBL-454,895,,,135652010,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,14698161,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,BC-254,896,,,135652011,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1614411,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,BC-264,897,,,135652012,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,14698161,CCCC[C@H](NC(=O)[C@H](Cc1ccc(cc1)OS(=O)(=O)O)NC(=O)OC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CC(=O)N)C)CCCC)CC(=O)O)Cc1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,CCK-33,860,CCK,Human,135651648,Agonist,Full agonist,,t,,,pIC50,0,8.8,0,,0,0,0,,,,,8349705,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)CCSC)c1ccc(cc1)OS(=O)(=O)O)CC(=O)O)CCCNC(=N)N)CC(=O)O)CO)C(CC)C)CCCNC(=N)N)Cc1nc[nH]c1)CO)CC(=O)O)CC(C)C)CC(=O)N)CCC(=O)N)CC(C)C)CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCCCN)N)C)CO)CCCNC(=N)N)CCSC)CO
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,CCK-4,861,CCK,Human,135651650,Agonist,Full agonist,,t,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,8349705,CSCCC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)C(Cc1c[nH]c2c1cccc2)N
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,CCK-58,862,CCK,Dog,135652053,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,-,0,0,0,=,,,,12370550,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,CCK-8,864,CCK|Cck|Cck,Human|Mouse|Rat,135651651,Agonist,Full agonist,,t,,,pIC50,10,0,9.9,,0,0,0,,,,,7681836,CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)OS(=O)(=O)O
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,AG-041R,901,,,135649902,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11738246,CCOC(CN1c2ccccc2[C@@](C1=O)(CC(=O)Nc1ccc(cc1)C)NC(=O)Nc1ccc(cc1)C)OCC
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,CI-1015,872,,,135650092,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,9438020,O=C(N[C@@](C(=O)N[C@H]1CCCC[C@@H]1O)(Cc1c[nH]c2c1cccc2)C)OC12CC3CC(C2)CC(C1)C3
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,CI-988,873,,,135650093,Antagonist,Antagonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,1975695,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)CCC(=O)O
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,CI-988,873,,,135650093,Antagonist,Antagonist,,f,,,pIC50,0,9.1,0,,0,0,0,,,,,8914862,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)CCC(=O)O
CCR1,58,CCR1,P32246,,,,,,Human,CCL13,770,CCL13,Human,135651657,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR1,58,CCR1,P32246,,,,,,Human,CCL8,772,CCL8,Human,135651694,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR1,58,CCR1,P32246,,,,,,Human,BP-CCL3,752,,,135652047,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,11170631,
CCR1,58,CCR1,P32246,,,,,,Human,CCL14,753,CCL14,Human,135651658,Agonist,Full agonist,,t,,,pKi,0,7.4,0,-,0,0,0,=,,,,12381680,
CCR1,58,CCR1,P32246,,,,,,Human,CCL15,754,CCL15,Human,135651659,Agonist,Full agonist,,t,,,pIC50,0,7.9,0,-,0,0,0,=,,,,9346309,
CCR1,58,CCR1,P32246,,,,,,Human,CCL23,755,CCL23,Human,135651673,Agonist,Full agonist,,t,,,pKi,0,8.9,0,-,0,0,0,=,,,,12381680,
CCR1,58,CCR1,P32246,,,,,,Human,CCL3,756,CCL3,Human,135651684,Agonist,Full agonist,,t,,,pKi,10.2,0,7.8,-,0,0,0,=,,,,12381680,
CCR1,58,CCR1,P32246,,,,,,Human,CCL5,758,CCL5,Human,135651690,Agonist,Full agonist,,t,,,pKi,8.2,0,6.8,-,0,0,0,=,,,,9624164,
CCR1,58,CCR1,P32246,,,,,,Human,CCL7,759,CCL7,Human,135651693,Agonist,Full agonist,,t,,,pKi,0,8.1,0,-,0,0,0,=,,,,12381680,
CCR1,58,CCR1,P32246,,,,,,Human,BMS-817399,9497,,,336446899,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,Displacement of [<sup>125</sup>I]MIP-1&alpha; from CCR1 in human THP-1 cells.,,,25101488,O=C(CC(O)(C)C)N[C@@H](C(=O)N1CC[C@](C(C1)(C)C)(O)c1ccc(cc1)Cl)C(C)C
CCR1,58,CCR1,P32246,,,,,,Human,BX 471,767,,,135650045,Antagonist,Antagonist,,f,f,,pKi,9,0,8.199999809,Ki,6.309999943,0,1,=,,,,10748002,NC(=O)Nc1cc(Cl)ccc1OCC(=O)N1CCN(C[C@H]1C)Cc1ccc(cc1)F
CCR1,58,CCR1,P32246,,,,,,Human,CCL18,4382,CCL18,Human,178101190,Antagonist,Antagonist,,f,f,,pIC50,6.099999905,0,6.079999924,IC50,825,0,803,=,,,,23951310,
CCR1,58,CCR1,P32246,,,,,,Human,CCL4,757,CCL4,Human,135651687,Antagonist,Antagonist,,t,,,pKi,7.8,0,7.1,-,0,0,0,=,,,,12381680,
CCR1,58,CCR1,P32246,,,,,,Human,compound 2b-1 [PMID: 12614873],3696,,,178100585,Antagonist,Antagonist,,f,,,pIC50,0,8.7,0,-,0,0,0,=,,,,12614873,NC[C@@H]1CCCN(C1)C(=O)c1ccc2c(c1)C(C(=O)NC1CCN(CC1)CC1=CCCCCCCC1)c1c(O2)cccc1
CCR10,67,CCR10,P46092,,,,,,Human,CCL27,3646,CCL27,Human,135651679,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,10725697,
CCR10,67,CCR10,P46092,,,,,,Human,CCL28,3649,CCL28,Human,135651681,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR10,67,Ccr10,Q9JL21,,,,,,Mouse,BI-6901,9714,,,348353673,Antagonist,Antagonist,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,27692854,N#Cc1cccn1CC[C@H](C(=O)N1CCC(CC1)C)NS(=O)(=O)c1cccc2c1cc[nH]2
CCR10,67,CCR10,P46092,,,,,,Human,BI-6901,9714,,,348353673,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,27692854,N#Cc1cccn1CC[C@H](C(=O)N1CCC(CC1)C)NS(=O)(=O)c1cccc2c1cc[nH]2
CCR2,59,CCR2,P41597,,,,,,Human,CCL13,770,CCL13,Human,135651657,Agonist,Full agonist,,t,,,pIC50,8.7,0,8.6,-,0,0,0,=,,,,9276730,
CCR2,59,CCR2,P41597,,,,,,Human,CCL16,1272,CCL16,Human,135651660,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR2,59,CCR2,P41597,,,,,,Human,CCL2,771,CCL2,Human,135651664,Agonist,Full agonist,,t,,,pIC50,10.2,0,9.3,-,0,0,0,=,,,,9276730,
CCR2,59,CCR2,P41597,,,,,,Human,CCL7,759,CCL7,Human,135651693,Agonist,Full agonist,,t,,,pIC50,8.7,0,8.4,-,0,0,0,=,,,,9276730,
CCR2,59,CCR2,P41597,,,,,,Human,CCL8,772,CCL8,Human,135651694,Agonist,Full agonist,,t,,,pIC50,0,8.6,0,-,0,0,0,=,,,,12554737,
CCR2,59,CCR2,P41597,,,,,,Human,CCL11,769,CCL11,Human,135651654,Agonist,Partial agonist,,t,,,pIC50,7.7,0,7.1,-,0,0,0,=,,,,12554737,
CCR2,59,CCR2,P41597,,,,,,Human,CCR2-RA-[R],9431,,,328083531,Allosteric modulator,Antagonist,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,<,Antagonism of <sup>125</sup>I-MCP-1 binding to THP-1 cells,,,0,Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C
CCR2,59,CCR2,P41597,,,,,,Human,AZD2423,7825,,,223366156,Allosteric modulator,Negative,,f,t,,pIC50,0,8.590000153,0,IC50,0,2.599999905,0,=,,,,0,O=C(N1CCN(CC1)C(=O)[C@@H]1NCCN(C1)C(C)C)Nc1ccc(c(c1)F)Cl
CCR2,59,CCR2,P41597,,,,,,Human,BMS-681,9430,,,328083530,Antagonist,Antagonist,,f,t,,pIC50,0,9.149999619,0,IC50,0,0.699999988,0,=,,,,25893046,CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C
CCR2,59,CCR2,P41597,,,,,,Human,CCL24,775,CCL24,Human,135651675,Antagonist,Antagonist,,t,,,pIC50,0,6.2,0,,0,0,0,,,,,15207250,
CCR2,59,CCR2,P41597,,,,,,Human,CCL26,776,CCL26,Human,135651678,Antagonist,Antagonist,,t,,,pIC50,0,8.5,0,-,0,0,0,=,,,,15207250,
CCR3,60,CCR3,P51677,,,,,,Human,CCL11,787,Ccl11,Mouse,135651656,Agonist,Full agonist,,f,,,pKi,10,0,9.5,-,0,0,0,=,,,,8642344,
CCR3,60,CCR3,P51677,,,,,,Human,CCL11,769,CCL11,Human,135651654,Agonist,Full agonist,,t,,,pKi,10,0,9.7,-,0,0,0,=,,,,8642344,
CCR3,60,CCR3,P51677,,,,,,Human,CCL11,769,CCL11,Human,135651654,Agonist,Full agonist,,t,f,,pIC50,9,0,8.699999809,IC50,1.99000001,0,1,=,,,,9276730,
CCR3,60,CCR3,P51677,,,,,,Human,CCL13,770,CCL13,Human,135651657,Agonist,Full agonist,,t,,,pIC50,10.3,0,8.7,-,0,0,0,=,,,,9276730,
CCR3,60,CCR3,P51677,,,,,,Human,CCL15,754,CCL15,Human,135651659,Agonist,Full agonist,,t,,,pIC50,0,8.6,0,-,0,0,0,=,,,,9346309,
CCR3,60,CCR3,P51677,,,,,,Human,CCL2,771,CCL2,Human,135651664,Agonist,Full agonist,,t,,,pKi,7.8,0,7.2,,0,0,0,,,,,8642344,
CCR3,60,CCR3,P51677,,,,,,Human,CCL24,775,CCL24,Human,135651675,Agonist,Full agonist,,t,,,pIC50,9.4,0,8,-,0,0,0,=,,,,15207250,
CCR3,60,CCR3,P51677,,,,,,Human,CCL26,776,CCL26,Human,135651678,Agonist,Full agonist,,t,,,pIC50,8.9,0,7.9,-,0,0,0,=,,,,15207250,
CCR3,60,CCR3,P51677,,,,,,Human,CCL28,3649,CCL28,Human,135651681,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,CCL5,758,CCL5,Human,135651690,Agonist,Full agonist,,t,f,,pKi,9.300000191,0,8.5,-,0,0,0,=,,,,8642344,
CCR3,60,CCR3,P51677,,,,,,Human,CCL7,759,CCL7,Human,135651693,Agonist,Full agonist,,t,,,pKi,9.2,0,8.6,-,0,0,0,=,,,,8642344,
CCR3,60,CCR3,P51677,,,,,,Human,CCL8,772,CCL8,Human,135651694,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,AZD3778,7679,,,223366014,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.300000191,0,=,Assay using sodium salt  of the compound,,,23031591,Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl
CCR3,60,CCR3,P51677,,,,,,Human,BMS compound 87b,3492,,,178100481,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,12067561,CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O
CCR3,60,CCR3,P51677,,,,,,Human,CCL18,4382,CCL18,Human,178101190,Antagonist,Antagonist,,f,f,,pIC50,8.5,0,6.5,IC50,317.6000061,0,2.900000095,=,,,,23951310,
CCR3,60,CCR3,P51677,,,,,,Human,banyu (I),796,,,135649979,Antagonist,Inverse agonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,12450563,O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N
CCR4,61,CCR4,P51679,,,,,,Human,CCL17,797,CCL17,Human,135651661,Agonist,Full agonist,,t,,,pIC50,0,8.7,0,-,0,0,0,=,,,,9430724,
CCR4,61,CCR4,P51679,,,,,,Human,CCL22,798,CCL22,Human,135651672,Agonist,Full agonist,,t,,,pIC50,0,9.2,0,-,0,0,0,=,,,,9430724,
CCR4,61,Ccr4,,,,,,,Rat,AZD1678,9679,,,348353638,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,28947948,COc1nc(F)cnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,CCR4,P51679,,,,,,Human,AZD1678,9679,,,348353638,Antagonist,Antagonist,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,28947948,COc1nc(F)cnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,,,,,,,,Dog,AZD1678,9679,,,348353638,Antagonist,Antagonist,,f,f,,pIC50,0,8.5,0,IC50,0,3.160000086,0,=,,,,28947948,COc1nc(F)cnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,Ccr4,P51680,,,,,,Mouse,AZD1678,9679,,,348353638,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,28947948,COc1nc(F)cnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,Ccr4,P51680,,,,,,Mouse,AZD2098,9678,,,348353637,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,28947948,COc1nccnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,,,,,,,,Dog,AZD2098,9678,,,348353637,Antagonist,Antagonist,,f,f,,pIC50,0,7.599999905,0,IC50,0,25.10000038,0,=,,,,28947948,COc1nccnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,CCR4,P51679,,,,,,Human,AZD2098,9678,,,348353637,Antagonist,Antagonist,,f,f,,pIC50,0,7.800000191,0,IC50,0,15.80000019,0,=,,,,28947948,COc1nccnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,Ccr4,,,,,,,Rat,AZD2098,9678,,,348353637,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,28947948,COc1nccnc1NS(=O)(=O)c1cccc(c1Cl)Cl
CCR4,61,CCR4,P51679,,,,,,Human,compound 8ic [PMID: 19081254],9478,,,329968418,Antagonist,Antagonist,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,19081254,COc1cc2c(NC3CCCCCC3)nc(nc2cc1OC)N1CCC(CC1)N1CCCCC1
CCR5,62,CCR5,P51681,,,,,,Human,BP-CCL3,752,,,135652047,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,11170631,
CCR5,62,CCR5,P51681,,,,,,Human,CCL11,769,CCL11,Human,135651654,Agonist,Full agonist,,t,,,pIC50,0,7.7,0,-,0,0,0,=,,,,10477718,
CCR5,62,CCR5,P51681,,,,,,Human,CCL13,770,CCL13,Human,135651657,Agonist,Full agonist,,t,,,pKi,0,9.1,0,-,0,0,0,,,,,9790730,
CCR5,62,CCR5,P51681,,,,,,Human,CCL14,753,CCL14,Human,135651658,Agonist,Full agonist,,t,,,pKi,0,7.2,0,-,0,0,0,=,,,,16298345,
CCR5,62,CCR5,P51681,,,,,,Human,CCL16,1272,CCL16,Human,135651660,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,CCL2,771,CCL2,Human,135651664,Agonist,Full agonist,,t,,,pKi,0,7.5,0,-,0,0,0,=,,,,16298345,
CCR5,62,CCR5,P51681,,,,,,Human,CCL3,756,CCL3,Human,135651684,Agonist,Full agonist,,t,,,pKi,8.9,0,8,-,0,0,0,=,,,,11170631,
CCR5,62,CCR5,P51681,,,,,,Human,CCL4,757,CCL4,Human,135651687,Agonist,Full agonist,,t,,,pKi,9.6,0,9.4,-,0,0,0,=,,,,16298345,
CCR5,62,CCR5,P51681,,,,,,Human,CCL5,758,CCL5,Human,135651690,Agonist,Full agonist,,t,,,pKi,9.7,0,9.2,-,0,0,0,=,,,,10318947,
CCR5,62,CCR5,P51681,,,,,,Human,CCL8,772,CCL8,Human,135651694,Agonist,Full agonist,,t,,,pKi,0,9.3,0,-,0,0,0,=,,,,9790730,
CCR5,62,CCR5,P51681,,,,,,Human,ancriviroc,804,,,135649944,Antagonist,Antagonist,,f,,,pKi,8.7,0,7.8,-,0,0,0,=,,,,16476734,CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-]
CCR5,62,CCR5,P51681,,,,,,Human,ancriviroc,804,,,135649944,Antagonist,Antagonist,,f,,,pKi,8.7,0,7.8,-,0,0,0,=,,,,16476734,CCO/N=C(c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-]
CCR5,62,CCR5,P51681,,,,,,Human,aplaviroc,805,,,135649948,Antagonist,Antagonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,16476734,CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O
CCR5,62,CCR5,P51681,,,,,,Human,AZD5672,7686,,,223366021,Antagonist,Antagonist,,f,f,,pIC50,0,9.590000153,0,IC50,0,0.25999999,0,=,Displacement of [125I]MIP-1&alpha; from human recombinant CCR5 expressed in CHO cells,,,22266038,CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C
CCR5,62,CCR5,P51681,,,,,,Human,BMS-681,9430,,,328083530,Antagonist,Antagonist,,f,t,,pIC50,0,8.619999886,0,IC50,0,2.400000095,0,=,,,,25893046,CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C
CCR5,62,CCR5,P51681,,,,,,Human,CCL7,759,CCL7,Human,135651693,Antagonist,Antagonist,,t,,,pKi,0,7.5,0,-,0,0,0,=,,,,16298345,
CCR5,62,CCR5,P51681,,,,,,Human,cenicriviroc,801,,,135651229,Antagonist,Antagonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,16251299,CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC
CCR6,63,CCR6,P51684,,,,,,Human,beta-defensin 4A,3648,DEFB4A|DEFB4B,Human,178100546,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,10521347,
CCR6,63,CCR6,P51684,,,,,,Human,CCL20,808,CCL20,Human,135651668,Agonist,Full agonist,,t,,,pIC50,8.5,0,7.9,-,0,0,0,=,,,,9169459,
CCR6,63,CCR6,P51684,,,,,,Human,CCL20-SEAP(His)<sub>6</sub>,809,,,135652054,Agonist,Full agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,9169459,
CCR7,64,CCR7,P32248,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Agonist,,t,f,,pIC50,9,0,7.699999809,-,0,0,0,=,,,,9153236,
CCR7,64,CCR7,P32248,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Agonist,,t,f,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,10512740,
CCR7,64,Ccr7,P47774,,,,,,Mouse,CCL19,4417,Ccl19,Mouse,135651662,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,11148224,
CCR7,64,CCR7,P32248,,,,,,Human,CCL21,811,CCL21,Human,135651670,Agonist,Agonist,,t,f,,pIC50,0,9.300000191,0,-,0,0,0,=,,,,9507024,
CCR7,64,Ccr7,P47774,,,,,,Mouse,Ccl21a,8651,Ccl21a,Mouse,252166851,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,11148224,
CCR7,64,Ccr7,P47774,,,,,,Mouse,Ccl21b,8652,Ccl21b,Mouse,252166852,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,11148224,
CCR7,64,CCR7,P32248,,,,,,Human,Ccl21b,8652,Ccl21b,Mouse,252166852,Agonist,Agonist,,t,f,,pKd,0,9.869999886,0,Kd,0,0.134000003,0,=,,,,10512740,
CCR7,64,CCR7,P32248,,,,,,Human,Ccl21b,8652,Ccl21b,Mouse,252166852,Agonist,Agonist,,t,f,,pIC50,0,8.329999924,0,IC50,0,4.699999809,0,=,,,,16904643,
CCR8,65,Ccr8,P56484,,,,,,Mouse,CCL8,4415,Ccl8,Mouse,135651695,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR8,65,CCR8,P51685,,,,,,Human,CCL1,812,CCL1,Human,135651653,Agonist,Full agonist,,t,,,pIC50,9.8,0,8.5,-,0,0,0,=,,,,11154210,
CCR9,66,CCR9,P51686,,,,,,Human,CCL25,817,CCL25,Human,135651677,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR9,66,CCR9,P51686,,,,,,Human,CCL25,817,CCL25,Human,135651677,Agonist,Full agonist,,t,,,pIC50,0,0,0,,0,0,0,,,,,0,
CCR9,66,CCR9,P51686,,,,,,Human,compound 24 [PMID: 26987013 ],9252,,,315661327,Antagonist,Antagonist,,f,f,,pKi,0,8.220000267,0,Ki,0,6,0,=,FLIPR calcium assay using MOLT4 cells,,,26987013,O=C1c2c(ccc(c2C(=O)N1c1ccc[n+](c1C)[O-])Cl)NS(=O)(=O)c1ccc(cc1)C(C)(C)C
CCRL2,78,CCRL2,O00421,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Unknown,,t,,,pIC50,0,7.36,0,,0,0,0,,,,,20002784,
CD19,2764,CD19,P15391,,,,,,Human,blinatumomab,7384,,,178103956,Antibody,Binding,,f,f,,pKd,0,9,0,Kd,0,1,0,=,Binding of the single-chain Fv portion of blinatumomab to CD19.,,,12209608,
CD2,2600,CD2,P06729,,,,,,Human,alefacept,6787,,,178103393,Antagonist,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,12089534,
CD27,1876,CD27,P26842,,,,,,Human,CD70,5079,CD70,Human,178101772,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
CD30,1877,TNFRSF8,P28908,,,,,,Human,brentuximab vedotin,6772,,,178103378,Antibody,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
CD30,1877,TNFRSF8,P28908,,,,,,Human,CD30 ligand,5080,TNFSF8,Human,178101773,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
CD3e,2742,CD3E,P07766,,,,,,Human,blinatumomab,7384,,,178103956,Antibody,Binding,,f,f,,pKd,0,7,0,Kd,0,100,0,=,Binding of the single-chain Fv portion of blinatumomab to CD3.,,,12209608,
CD3e,2742,CD3E,P07766,,,,,,Human,catumaxomab,7385,,,178103957,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,20190561,
CD40,1874,CD40,P25942,,,,,,Human,CFZ533,9802,,,0,Antibody,Binding,,f,t,,pKd,0,9.159999847,0,Kd,0,0.689999998,0,=,Measured using a Biacore assay.,,,0,
CD40,1874,CD40,P25942,,,,,,Human,CD40 ligand,5077,CD40LG,Human,178101770,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
CD52,2602,CD52,P31358,,,,,,Human,alemtuzumab,6770,,,178103376,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,9593475,
CD80,2744,CD80,P33681,,,,,,Human,abatacept,6891,,,178103473,Inhibitor,Inhibition,,f,t,,pKd,0,7.920000076,0,Kd,0,12,0,~,Measuring binding of <sup>125</sup>I-labeled B7Ig fusion protein to immobilized abatacept.,,,23899231,
CD80,2744,CD80,P33681,,,,,,Human,belatacept,6892,,,178103474,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,IC<sub>50</sub>= 0.009&micro;g/mL,,,19300198,
CD86,2745,CD86,P42081,,,,,,Human,abatacept,6891,,,178103473,Inhibitor,Inhibition,,f,t,,pKd,0,7.920000076,0,Kd,0,12,0,~,Measuring binding of <sup>125</sup>I-labeled B7Ig fusion protein to immobilized abatacept.,,,23899231,
CD86,2745,CD86,P42081,,,,,,Human,belatacept,6892,,,178103474,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,IC<sub>50</sub>= 0.120&micro;g/mL,,,19300198,
CDC42 binding protein kinase alpha,1507,CDC42BPA,Q5VT25,,,,,,Human,compound 11d [DOI: 10.1039/c0md00194e],8197,,,249565877,Inhibitor,Inhibition,,f,f,,pIC50,0,7.130000114,0,IC50,0,74,0,=,,,,0,OCCCOc1cc(ccc1NC(=O)[C@@H]1COc2c(C1)cc(cc2)OC)c1c[nH]nc1
CDC42 binding protein kinase beta,1508,CDC42BPB,Q9Y5S2,,,,,,Human,A-443654,8204,,,249565884,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,19465931,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
CDC like kinase 1,1990,Clk1,P22518,,,,,,Mouse,Cdc2-like kinase inhibitor,5942,,,178102565,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,18077363,COc1ccc2c(c1)n(CC)/c(=C/C(=O)C)/s2
CDC like kinase 1,1990,Clk1,P22518,,,,,,Mouse,Cdc2-like kinase inhibitor,5942,,,178102565,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,18077363,COc1ccc2c(c1)n(CC)/c(=C/C(=O)C)/s2
CDC like kinase 1,1990,CLK1,P49759,,,,,,Human,compound 17 [PMID: 23642479],8161,,,249565841,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,23642479,Clc1cc(CNc2nccc(n2)c2ccc3c(c2)OCO3)cc(c1)Cl
CDC like kinase 1,1990,CLK1,P49759,,,,,,Human,compound 2 [PMID: 22560567],8115,,,249565795,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,21295469,Oc1ccc(cc1C)c1nc(=O)[nH]c(c1)c1ccccc1
CDC like kinase 1,1990,Clk1,P22518,,,,,,Mouse,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,7.210000038,0,IC50,0,61,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
CDC like kinase 2,1991,Clk2,O35491,,,,,,Mouse,Cdc2-like kinase inhibitor,5942,,,178102565,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,18077363,COc1ccc2c(c1)n(CC)/c(=C/C(=O)C)/s2
CDC like kinase 2,1991,CLK2,P49760,,,,,,Human,compound 17 [PMID: 23642479],8161,,,249565841,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,23642479,Clc1cc(CNc2nccc(n2)c2ccc3c(c2)OCO3)cc(c1)Cl
CDC like kinase 2,1991,Clk2,O35491,,,,,,Mouse,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
CDC like kinase 3,1992,Clk3,O35492,,,,,,Mouse,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,6.260000229,0,IC50,0,550,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
CDC like kinase 4,1993,CLK4,Q9HAZ1,,,,,,Human,compound 17 [PMID: 23642479],8161,,,249565841,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23642479,Clc1cc(CNc2nccc(n2)c2ccc3c(c2)OCO3)cc(c1)Cl
CDC like kinase 4,1993,Clk4,O35493,,,,,,Mouse,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,7.210000038,0,IC50,0,61,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
"CECR2, histone acetyl-lysine reader",2733,CECR2,Q9BXF3,,,,,,Human,compound 50 [PMID: 24313754],8824,,,252827481,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,158,0,=,,,,24313754,Cc1nnc2n1nc(c1ccc(c(c1)NS(=O)(=O)C)N1CCOCC1)c1c2cccc1
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 18 [PMID: 20873740],8191,,,249565871,Inhibitor,Inhibition,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,20873740,Nc1nccc(n1)c1[nH]c(c(c1)C(=O)N)c1ccccc1
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 1 [PMID: 24793884],8218,,,249565898,Inhibitor,Inhibition,,f,f,,pIC50,0,6.489999771,0,IC50,0,323,0,=,,,,24793884,CCOC(=O)c1sc(nc1O)c1ccncc1
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 2 [PMID: 22560567],8115,,,249565795,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,22560567,Oc1ccc(cc1C)c1nc(=O)[nH]c(c1)c1ccccc1
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 74 [PMID: 24793884],8219,,,249565899,Inhibitor,Inhibition,,f,f,,pIC50,0,8.420000076,0,IC50,0,3.769999981,0,=,,,,24793884,Clc1ccc(c(c1)Cl)c1nc(sc1C(=O)N)c1ccnc(n1)N
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 77 [PMID: 24793884],8217,,,249565897,Inhibitor,Inhibition,,f,f,,pIC50,0,8.170000076,0,IC50,0,6.809999943,0,=,,,,24793884,COc1ccc(c(c1)Cl)c1nc(sc1C(=O)N)c1ccnc(n1)N
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
CFTR,707,CFTR,P13569,,,,,,Human,apigenin,4136,,,178100958,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1)c1cc(=O)c2c(o1)cc(cc2O)O
CFTR,707,CFTR,P13569,,,,,,Human,capsaicin,2486,,,53801090,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
CFTR,707,CFTR,P13569,,,,,,Human,CBIQ,4152,,,178100973,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Clc1nccc2c1ccc1c2cccc1
CFTR,707,CFTR,P13569,,,,,,Human,CFTR<sub>inh</sub>-172,4153,,,178100974,Channel blocker,None,intracellular application prolongs mean closed time,f,f,,-,0,0,0,-,0,0,0,=,,,intracellular,0,S=C1SC(=Cc2ccc(cc2)C(=O)O)C(=O)N1c1cccc(c1)C(F)(F)F
CGRP receptor,48,Calcrl|Ramp1,Q9R1W5|Q9WTJ5,,,,,,Mouse,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,14609735,
CGRP receptor,48,Ramp1|Calcrl,Q63118|Q9JJ74,,,,,,Rat,adrenomedullin,697,Adm,Rat,135651601,Agonist,Full agonist,,t,,,pIC50,8.8,0,6.8,,0,0,0,,,,,10854696,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pKi,0,8.1,0,,0,0,0,,,,,9620797,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,9.1,0,7.5,-,0,0,0,=,,,,21658025,
CGRP receptor,48,Ramp1|Calcrl,Q63118|Q9JJ74,,,,,,Rat,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Full agonist,,t,,,pIC50,8.9,0,8.2,,0,0,0,,,,,10854696,
CGRP receptor,48,Calcrl|Ramp1,Q9R1W5|Q9WTJ5,,,,,,Mouse,&alpha;-CGRP,695,Calca|Calca,Mouse|Rat,135651609,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,-,0,0,0,=,,,,14609735,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pKi,10,0,9.7,-,0,0,0,=,,,,9620797,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pKi,11,0,9.9,-,0,0,0,=,,,,9620797,
CGRP receptor,48,Ramp1|Calcrl,Q63118|Q9JJ74,,,,,,Rat,&beta;-CGRP,696,Calcb,Rat,135651626,Agonist,Full agonist,,t,,,pIC50,9.3,0,8.2,,0,0,0,,,,,10854696,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,&alpha;-CGRP-(8-37) (human),700,,,135651981,Antagonist,Antagonist,,f,,,pKi,9.6,0,9.2,,0,0,0,,,,,9620797,
CGRP receptor,48,Ramp1|Calcrl,Q63118|Q9JJ74,,,,,,Rat,&alpha;-CGRP-(8-37) (rat),701,,,135651982,Antagonist,Antagonist,,t,,,pIC50,8.9,0,8.2,,0,0,0,,,,,10854696,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,atogepant,9730,,,0,Antagonist,Antagonist,,f,f,,pKi,0,10.81999969,0,Ki,0,0.015,0,=,"In a recombinant receptor binding assay, antagonising <sup>125</sup>I-CGRP binding.",,,0,O=C(c1cnc2c(c1)C[C@@]1(C2)C(=O)Nc2c1cccn2)N[C@H]1C[C@H]([C@H](N(C1=O)CC(F)(F)F)C)c1c(F)ccc(c1F)F
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,compound 49 [PMID: 24405707],8992,,,310264770,Antagonist,Antagonist,,f,f,,pKi,0,10.52000046,0,Ki,0,0.029999999,0,=,Binding assay with cell membranes treated with <sup>125</sup>I-CGRP.,,,24405707,O=C(N1CCC(CC1)N1CCC2C(NC1=O)C=CC=C2)C[C@@H]1S[C@@H](N(C1=O)CCC(C)(C)C)c1cccc(c1N1CCN(CC1)C(C)(C)C)F
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,8.149999619,0,7.460000038,IC50,35,0,7,=,,,,15486189,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,AZD7762,7713,,,223366046,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,22551018,NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)c1cccc(c1)F
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,510,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,f,,pIC50,0,6.079999924,0,IC50,0,830,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,CCT241533,8044,,,249565724,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,21239475,COc1cc2[nH]/c(=C/3\C=C(F)C=CC3=O)/nc(c2cc1OC)N[C@@H]1CNC[C@H]1C(O)(C)C
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,CCT241533,8044,,,249565724,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,21239475,COc1cc2[nH]/c(=C/3C=C(F)C=CC3=O)/nc(c2cc1OC)N[C@@H]1CNC[C@H]1C(O)(C)C
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,CCT244747,8215,,,249565895,Inhibitor,Inhibition,,f,f,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,,,,23082860,N#Cc1ncc(nc1O[C@@H](CN(C)C)C)Nc1ncc(c(c1)OC)c1cnn(c1)C
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,CCT245737,9187,,,315661266,Inhibitor,Inhibition,,f,t,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,27167172,N#Cc1cnc(cn1)Nc1ncc(c(c1)NC[C@H]1CNCCO1)C(F)(F)F
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,CHIR-124,9365,,,328083467,Inhibitor,Inhibition,,f,f,,pIC50,0,9.489999771,0,IC50,0,0.319999993,0,=,,,,16603354,Clc1ccc2=NC(=O)C(=c3[nH]c4c([nH]3)cccc4)C(=c2c1)N[C@@H]1CN2CCC1CC2
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,compound 25 [PMID: 20855207],8159,,,249565839,Inhibitor,Inhibition,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,=,,,,20855207,C[C@@H]1O[C@H](C)CN(C1)[C@@H](c1nsc(c1)Nc1nc(C)cn2c1ncc2c1c[nH]nc1)C
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,f,,pIC50,0,5.980000019,0,IC50,0,1040,0,=,,,,10786669,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,AZD7762,7713,,,223366046,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,,,,22551018,NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)c1cccc(c1)F
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,CCT241533,8044,,,249565724,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21239475,COc1cc2[nH]/c(=C/3\C=C(F)C=CC3=O)/nc(c2cc1OC)N[C@@H]1CNC[C@H]1C(O)(C)C
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,CCT241533,8044,,,249565724,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21239475,COc1cc2[nH]/c(=C/3C=C(F)C=CC3=O)/nc(c2cc1OC)N[C@@H]1CNC[C@H]1C(O)(C)C
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,CCT245737,9187,,,315661266,Inhibitor,Inhibition,,f,f,,pIC50,0,5.610000134,0,IC50,0,2440,0,=,,,,27167172,N#Cc1cnc(cn1)Nc1ncc(c(c1)NC[C@H]1CNCCO1)C(F)(F)F
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,Chk2 inhibitor II,5954,,,178102577,Inhibitor,Inhibition,,f,t,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,18077363,Clc1ccc(cc1)Oc1ccc(cc1)c1nc2c([nH]1)cc(cc2)C(=O)N
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,chemerin,2945,RARRES2,Human,135651892,Agonist,Full agonist,,t,,,pKd,0,8.31,0,Kd,0,4.9,0,=,,,,18165312,
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,chemerin,2945,RARRES2,Human,135651892,Agonist,Full agonist,,t,f,,pEC50,8.520000458,0,7.599999905,EC50,4.5,0,3,=,,,,18165312,
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,chemerin,2945,RARRES2,Human,135651892,Agonist,Full agonist,,f,f,,pEC50,0,8.010000229,0,EC50,0,9.699999809,0,=,In a &beta;-arrestin recruitment assay.,,,25437209,
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,chemerin C-terminal peptide,3422,,,178100428,Agonist,Full agonist,,f,f,,pKd,8.149999619,0,7.619999886,Kd,24,0,7.099999905,=,,,,18165312,
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,&alpha;-NETA,9781,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,6.429999828,0,IC50,0,375,0,=,Antagonism of chemerin-stimulated &beta;-arrestin 2 recruitment to CMKLR1 in a cellular assay.,,,25437209,O=C(c1cccc2c1cccc2)CC[N+](C)(C)C
chemerin receptor 2,82,GPR1,P46091,,,,,,Human,chemerin C-terminal peptide,3422,,,178100428,Agonist,Agonist,,f,,,pEC50,0,9,0,EC50,0,1,0,=,,,,18165312,
chemerin receptor 2,82,GPR1,P46091,,,,,,Human,chemerin,2945,RARRES2,Human,135651892,Agonist,Full agonist,,t,,,pEC50,9.6,0,8.8,EC50,0,0.24,0,=,,,,18165312,
chemerin receptor 2,82,GPR1,P46091,,,,,,Human,chemerin,2945,RARRES2,Human,135651892,Agonist,Full agonist,,t,,,pKd,0,8.28,0,Kd,0,5.3,0,=,,,,18165312,
"chitinase, acidic",2982,Chia1,Q91XA9,,,,,,Mouse,compound 7f [PMID: 29283260],9780,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,29283260,CC(CN(C1CCN(CC1)c1[nH]nc(n1)N)CCc1ccc(cc1)Cl)C
"chitinase, acidic",2982,CHIA,Q9BZP6,,,,,,Human,compound 7f [PMID: 29283260],9780,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,29283260,CC(CN(C1CCN(CC1)c1[nH]nc(n1)N)CCc1ccc(cc1)Cl)C
choline O-acetyltransferase,2480,Chat,Q03059,,,,,,Mouse,compound 2 [PMID: 3351860],8807,,,252827465,Inhibitor,Inhibition,,f,f,,pIC50,0,6.46999979,0,IC50,0,340,0,=,,,,3351860,C[n+]1ccc(cc1)/C=C/c1cccc2c1cccc2
chymase 1,2340,CMA1,P23946,,,,,,Human,compound 7f [PMID: 29191554],9794,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,8.899999619,0,=,,,,29191554,CC[C@H](c1ccc(c(c1)N)C(=O)O)NC(=O)N1C/C(=N/Oc2ccccc2)/NC[C@H](C1=O)Cc1cc(Cl)ccc1OC
chymotrypsin C,2341,CTRC,Q99895,,,,,,Human,compound 20 [PMID: 12372533],8555,,,252166756,Inhibitor,Inhibition,,f,f,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,12372533,OC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@H]2[C@](O1)(C)[C@H]1C[C@@H](C2)C1(C)C)CCc1ccc(cc1)F)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)O)N
Ciliary neutrophic factor receptor,2313,LIFR|IL6ST|CNTFR,P40189|P26992|P42702,,,,,,Human,ciliary neurotrophic factor,4897,CNTF,Human,178101597,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
ClC-1,698,CLCN1,P35523,,,,,,Human,9-anthroic acid,4113,,,178100935,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1c2ccccc2cc2c1cccc2
ClC-1,698,CLCN1,P35523,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
ClC-2,699,CLCN2,P51788,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
ClC-2,699,CLCN2,P51788,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
ClC-2,699,CLCN2,P51788,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
ClC-4,703,CLCN4,P51793,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,pIC50,0,4.2,0,IC50,0,68000,0,,,,,18658230,
ClC-Ka,700,CLCNKA,P51800,,,,,,Human,3-phenyl-CPP,4104,,,178100927,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C(Cc1ccccc1)Oc1ccc(cc1)Cl
ClC-Kb,701,CLCNKB,P51801,,,,,,Human,3-phenyl-CPP,4104,,,178100927,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C(Cc1ccccc1)Oc1ccc(cc1)Cl
CNGA2,395,Cnga2,Q00195,,,,,,Rat,all-<i>trans</i>-retinal,2350,,,135651434,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.57,0,,0,0,0,,,,,12034887,O=C/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C
CNGA2,395,Cnga2,Q00195,,,,,,Rat,all-<i>trans</i>-retinal,2350,,,135651434,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.57,0,,0,0,0,,,,,12034887,O=C/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)C)C
CNGA2,395,Cnga2,Q00195,,,,,,Rat,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Gating inhibitor,Antagonist,,f,,,pIC50,8.5,0,7.7,,0,0,0,,,,,7511217,
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,BIIB021,9258,,,315661333,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,<i>In vitro</i> methylation of H3 (1-25).,,,0,COc1c(C)cnc(c1C)Cn1cnc2c1nc(N)nc2Cl
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,BMS pyrazole inhibitor 7f,7030,,,178103609,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,19419866,O=C([C@@H](N)C)NCc1cccc(c1)n1nc(cc1c1nnc(o1)c1cccc2c1scn2)C(F)(F)F
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,compound 17f [PMID: 19632837],7031,,,178103610,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,19632837,CNCCN1CCC(CC1)c1cc(C)c2c(c1)[nH]c(n2)c1c(OC)cccc1OC
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,argatroban,6385,,,178103001,Inhibitor,Inhibition,,f,t,,pKi,0,7.699999809,0,Ki,0,19,0,=,,,,9361377,NC(=NCCC[C@@H](C(=O)N1CC[C@H](C[C@@H]1C(=O)O)C)NS(=O)(=O)c1cccc2c1NCC(C2)C)N
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,AR-H067637,7688,,,223366023,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,Assay using purified human &alpha;-thrombin,,,19492147,FC(Oc1cc(Cl)cc(c1)[C@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)O)F
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,AZ12971554,7727,,,223366060,Inhibitor,Inhibition,,f,t,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,0,O=C([C@@H]1CC=NN1C(=O)[C@@H](c1ccc(cc1)F)O)NCc1cc(Cl)ccc1n1cnnn1
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,bivalirudin,6470,,,178103084,Inhibitor,Inhibition,,f,t,,pKi,0,8.600000381,0,Ki,0,2.559999943,0,=,,,,1290488,CC[C@@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N)CCCNC(=N)N)CC(=O)N)Cc1ccccc1)CCC(=O)O)CCC(=O)O)C
coagulation factor IX,2364,F9,P00740,,,,,,Human,compound 57 [PMID: 20121197],6550,,,178103164,Inhibitor,Inhibition,,f,,,pIC50,0,8.7,0,IC50,0,2,0,,,,,20121197,CC(CNCc1ccccc1NC(=O)OCC(c1ccccc1)Oc1cccc2c1cc(s2)C(=N)N)C
coagulation factor VII,2363,F7,P08709,,,,,,Human,compound 11 [PMID: 16413183],8493,,,252166701,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,100,0,~,K<sub>i</sub> calculated from fold selectivity for KLKB1.,,,16413183,OC(=O)CC(C1=C/C(=c/2\[nH]c3c([nH]2)ccc(c3)C(=N)N)/C(=O)C(=C1)c1cccc(c1)C(=O)N)C(=O)O
coagulation factor VII,2363,F7,P08709,,,,,,Human,compound 11 [PMID: 16413183],8493,,,252166701,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,100,0,~,K<sub>i</sub> calculated from fold selectivity for KLKB1.,,,16413183,OC(=O)CC(C1=C/C(=c/2[nH]c3c([nH]2)ccc(c3)C(=N)N)/C(=O)C(=C1)c1cccc(c1)C(=O)N)C(=O)O
coagulation factor VII,2363,F7,P08709,,,,,,Human,compound 1 [PMID: 16650987],6552,,,178103166,Inhibitor,Inhibition,,f,,,pKi,0,9,0,Ki,0,1,0,,,,,16650987,NC(=O)NCc1ccc(c(c1)C1=CC(=C/C(=c/2\[nH]c3c([nH]2)ccc(c3)C(=N)N)/C1=O)C(C(=O)O)CC(=O)O)O
coagulation factor VII,2363,F7,P08709,,,,,,Human,compound 1 [PMID: 16650987],6552,,,178103166,Inhibitor,Inhibition,,f,,,pKi,0,9,0,Ki,0,1,0,,,,,16650987,NC(=O)NCc1ccc(c(c1)C1=CC(=C/C(=c/2[nH]c3c([nH]2)ccc(c3)C(=N)N)/C1=O)C(C(=O)O)CC(=O)O)O
coagulation factor X,2359,F10,P00742,,,,,,Human,apixaban,6390,,,178103006,Inhibitor,Inhibition,,f,t,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,,,,18315548,COc1ccc(cc1)n1nc(c2c1C(=O)N(CC2)c1ccc(cc1)N1CCCCC1=O)C(=O)N
coagulation factor X,2359,F10,P00742,,,,,,Human,betrixaban,9602,,,340590232,Inhibitor,Inhibition,,f,t,,pKi,0,9.930000305,0,Ki,0,0.116999999,0,=,Inhibition of human factor Xa.,,,19297154,COc1ccc(c(c1)C(=O)Nc1ccc(cn1)Cl)NC(=O)c1ccc(cc1)C(=N)N(C)C
coagulation factor XI,2360,F11,P03951,,,,,,Human,alpha-ketothiazole analogue 36,6549,,,178103163,Inhibitor,Inhibition,,f,,,pIC50,0,7.5,0,IC50,0,30,0,,,,,18053726,O=C(N[C@@H](c1ccc(cc1)Br)C)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)c1nccs1)CCCN=C(N)N)C(C)C)CCCNC(=O)N
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,AMG820,9106,,,315661191,Antibody,Binding,,f,t,,pKd,0,9.260000229,0,Kd,0,0.550000012,0,<,,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,cabiralizumab,9107,,,315661192,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,AC710,8095,,,249565775,Inhibitor,Inhibition,,f,f,,pKd,0,8.800000191,0,Kd,0,1.570000052,0,=,,,,24900421,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(cc1)NC(=O)Nc1noc(c1)C(C)(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,ARRY-382,9108,,,315661193,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,AZD6495,7711,,,223366044,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,19114305,CCOc1cc2ncc(c(c2cc1N1CCN(CC1)C)Nc1ccc(cc1F)F)C(=O)N
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,BLZ945,8250,,,249565930,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,24498562,CNC(=O)c1nccc(c1)Oc1ccc2c(c1)sc(n2)N[C@@H]1CCCC[C@H]1O
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,CC-223,8914,,,310264695,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28,0,=,,,,26083478,COC1CCC(CC1)N1C(=O)CNc2c1nc(cn2)c1ccc(nc1)C(O)(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,f,,pIC50,0,6.960000038,0,IC50,0,110,0,=,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
complement C1s,2335,C1S,P09871,,,,,,Human,compound 28 [PMID: 16460935],8619,,,252166820,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,16460935,CSc1sc(cc1S(=O)(=O)c1cc(Br)c2c(c1)ncn2Cc1cc(F)ccc1F)C(=N)N
complement factor B,2339,CFB,P00751,,,,,,Human,compound 51 [PMID: 19743866],8653,,,252166853,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,19743866,NC(=NCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)C)CC(C)C)CC(C)(C)C)CC(C)C)NC(=O)C)N
conserved helix-loop-helix ubiquitous kinase,1989,CHUK,O15111,,,,,,Human,BMS-345541,5669,,,178102297,Allosteric modulator,Negative,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,12403772,NCCNc1nc2ccc(cc2n2c1ncc2C)C
conserved helix-loop-helix ubiquitous kinase,1989,CHUK,O15111,,,,,,Human,BAY 61-3606,9693,,,348353652,Inhibitor,Inhibition,,f,f,,pKi,0,7.349999905,0,Ki,0,45,0,=,,,,26930276,COc1cc(ccc1OC)c1nc(Nc2ncccc2C(=O)N)n2c(c1)ncc2
conserved helix-loop-helix ubiquitous kinase,1989,CHUK,O15111,,,,,,Human,compound 47 [PMID: 28737909],9646,,,340590276,Inhibitor,Inhibition,,f,t,,pKi,0,6.190000057,0,Ki,0,650,0,=,,,,28737909,OCc1ccc(cc1)c1nc(N)nc2c1c(C#N)c[nH]2
Constitutive androstane receptor,607,NR1I3,Q14994,,,,,,Human,"5&beta;-pregnane-3,20-dione",2759,,,135650851,Agonist,Agonist,,f,,,pEC50,0,6.17,0,,0,0,0,,,,,10748001,O=C1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Constitutive androstane receptor,607,NR1I3,Q14994,,,,,,Human,CITCO,2758,,,135650106,Agonist,Agonist,,f,f,,pEC50,0,7.300000191,0,-,0,0,0,=,,,,12611900,Clc1ccc(cc1)c1nc2n(c1/C=N/OCc1ccc(c(c1)Cl)Cl)ccs2
Constitutive androstane receptor,607,NR1I3,Q14994,,,,,,Human,clotrimazole,2330,,,135650114,Antagonist,Antagonist,,f,,,pIC50,0,6.16,0,,0,0,0,,,,,10748001,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
Constitutive androstane receptor,607,Nr1i3,Q3V008,,,,,,Mouse,androstanol,2760,,,135649945,Antagonist,Inverse agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,9783588,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2)C)C
Constitutive androstane receptor,607,Nr1i3,Q3V008,,,,,,Mouse,androstenol,2761,,,135651439,Antagonist,Inverse agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,9783588,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC=C2)C)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,aspirin,4139,,,178100961,Inhibitor,Inhibition,,f,t,,pIC50,0,3.25,0,IC50,0,560100,0,=,,,,19884005,CC(=O)Oc1ccccc1C(=O)O
COX-1 ,1375,PTGS1,P23219,,,,,,Human,bromfenac,7131,,,178103707,Inhibitor,Inhibition,,f,t,,pIC50,0,8.069999695,0,IC50,0,8.479999542,0,=,,,,0,OC(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br
COX-1 ,1375,PTGS1,P23219,,,,,,Human,celecoxib,2892,,,178100241,Inhibitor,Inhibition,,f,f,,pIC50,0,4,0,IC50,0,100000,0,=,,,,29031075,Cc1ccc(cc1)c1cc(nn1c1ccc(cc1)S(=O)(=O)N)C(F)(F)F
COX-1 ,1375,PTGS1,P23219,,,,,,Human,compound 12a [PMID: 29031075],9684,,,348353643,Inhibitor,Inhibition,,f,f,,pIC50,0,3.980000019,0,IC50,0,104000,0,=,,,,29031075,Clc1ccc(cc1)C(=O)n1c2ccc(cc2c2c1CCCC2=O)S(=O)(=O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,aspirin,4139,,,178100961,Inhibitor,Inhibition,,f,t,,pIC50,0,5.619999886,0,IC50,0,2400,0,=,,,,22386242,CC(=O)Oc1ccccc1C(=O)O
COX-2 ,1376,PTGS2,P35354,,,,,,Human,benzquinamide,7124,,,178103701,Inhibitor,Inhibition,,f,t,,pIC50,0,8.319999695,0,IC50,0,4.800000191,0,=,,,,0,CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC
COX-2 ,1376,PTGS2,P35354,,,,,,Human,carprofen,7141,,,178103717,Inhibitor,Inhibition,,f,t,,pIC50,0,6.989999771,0,IC50,0,102,0,=,Inhibition of COX-2-induced conversion of arachadonic acid to 12-HHT.,,,21873070,OC(=O)C(c1ccc2c(c1)[nH]c1c2cc(cc1)Cl)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,celecoxib,2892,,,178100241,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,29031075,Cc1ccc(cc1)c1cc(nn1c1ccc(cc1)S(=O)(=O)N)C(F)(F)F
COX-2 ,1376,PTGS2,P35354,,,,,,Human,celecoxib,2892,,,178100241,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,12643942,Cc1ccc(cc1)c1cc(nn1c1ccc(cc1)S(=O)(=O)N)C(F)(F)F
COX-2 ,1376,PTGS2,P35354,,,,,,Human,compound 12a [PMID: 29031075],9684,,,348353643,Inhibitor,Inhibition,,f,f,,pIC50,0,6.639999866,0,IC50,0,230,0,=,,,,29031075,Clc1ccc(cc1)C(=O)n1c2ccc(cc2c2c1CCCC2=O)S(=O)(=O)C
cPLA<sub>2</sub>-4A,1424,PLA2G4A,P47712,,,,,,Human,compound 57 [PMID: 16610804],8771,,,252827429,Inhibitor,Inhibition,,f,f,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,Inhibition of human isolated cPLA<sub>2</sub>-4A in a lipid vesicle assay.,,,16610804,CCCCCCCCCCOc1ccc(cc1)OCC(=O)Cn1cc(c2c1ccc(c2)C(=O)O)C(=O)OC
CREB binding protein,2734,CREBBP,Q92793,,,,,,Human,compound 50 [PMID: 24313754],8824,,,252827481,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,631,0,=,,,,24313754,Cc1nnc2n1nc(c1ccc(c(c1)NS(=O)(=O)C)N1CCOCC1)c1c2cccc1
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,&alpha;-helical CRF,923,,,135651984,Antagonist,Antagonist,,f,,,pKd,7.8,0,7.3,,0,0,0,,,,,9918582,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,antalarmin,3489,,,178100478,Antagonist,Antagonist,,f,f,,pKi,9,0,8.300000191,Ki,5.010000229,0,1,=,,,,8940412,CCCCN(c1nc(C)nc2c1c(C)c(n2c1c(C)cc(cc1C)C)C)CC
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,astressin,925,,,135652001,Antagonist,Antagonist,,f,,,pKd,8.8,0,7.7,,0,0,0,,,,,9851694,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](CC)C)CCC(=O)O)CCCC)CC(C)C)CCCCN)CCCNC(=N)N)CC(=O)N)CCC(=O)N)C)CC(C)C)CCC(=O)N)CCC(=O)O)C)CCCNC(=N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CCC(=O)O
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,&alpha;-helical CRF,923,,,135651984,Antagonist,Antagonist,,f,,,pKd,9.1,0,9,,0,0,0,,,,,9918582,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,&alpha;-helical CRF,923,,,135651984,Antagonist,Antagonist,,f,,,pKd,8.4,0,8.3,,0,0,0,,,,,9918582,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,antisauvagine,931,,,135651993,Antagonist,Antagonist,,f,f,,pKd,9.600000381,0,8.800000191,Kd,1.580000043,0,0.25,=,,,,11123370,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,astressin,925,,,135652001,Antagonist,Antagonist,,f,,,pKd,8.9,0,8.8,,0,0,0,,,,,11123370,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](CC)C)CCC(=O)O)CCCC)CC(C)C)CCCCN)CCCNC(=N)N)CC(=O)N)CCC(=O)N)C)CC(C)C)CCC(=O)N)CCC(=O)O)C)CCCNC(=N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CCC(=O)O
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,astressin,925,,,135652001,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,9918582,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](CC)C)CCC(=O)O)CCCC)CC(C)C)CCCCN)CCCNC(=N)N)CC(=O)N)CCC(=O)N)C)CC(C)C)CCC(=O)N)CCC(=O)O)C)CCCNC(=N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CCC(=O)O
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,astressin,925,,,135652001,Antagonist,Antagonist,,f,,,pKd,8.8,0,8.6,,0,0,0,,,,,9918582,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](CC)C)CCC(=O)O)CCCC)CC(C)C)CCCCN)CCCNC(=N)N)CC(=O)N)CCC(=O)N)C)CC(C)C)CCC(=O)N)CCC(=O)O)C)CCCNC(=N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CCC(=O)O
"c-ros oncogene 1, receptor tyrosine kinase",1840,ROS1,P08922,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,f,,pKi,0,10.69999981,0,Ki,0,0.02,0,=,Value calculated from tight-binding (Morrison) equation for competitive inhibitors tested in a Pfizer mobility shift assay.,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
C-terminal Src kinase,1994,CSK,P41240,,,,,,Human,apatinib,7648,,,223365983,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,530,0,=,Assay used apatinib mesylate (YN968D1),,,21443688,N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C
CT receptor,43,CALCR,P30988,,,,,,Human,adrenomedullin,683,ADM,Human,135651602,Agonist,Full agonist,,t,,,pEC50,7.7,0,6.7,,0,0,0,,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,adrenomedullin 2/intermedin,684,ADM2,Human,135651604,Agonist,Full agonist,,t,,,pEC50,0,6.5,0,,0,0,0,,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,&alpha;-CGRP,681,CALCA,Human,135651608,Agonist,Full agonist,,t,,,pEC50,8.4,0,6.2,,0,0,0,,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,amylin,688,Iapp|Iapp,Mouse|Rat,135651613,Agonist,Full agonist,,f,,,pEC50,9.5,0,7,,0,0,0,,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,amylin,687,IAPP,Human,135651612,Agonist,Full agonist,,t,f,,pEC50,9.199999809,0,8,-,0,0,0,=,,,,9487987,
CT receptor,43,CALCR,P30988,,,,,,Human,&beta;-CGRP,682,CALCB,Human,135651627,Agonist,Full agonist,,t,,,pEC50,0,7.2,0,,0,0,0,,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,calcitonin,685,CALCA,Human,135651700,Agonist,Full agonist,,t,t,,pEC50,11.19999981,0,9,-,0,0,0,=,,,,15692146,
CT receptor,43,CALCR,P30988,,,,,,Human,calcitonin (salmon),6973,,,178103552,Agonist,Full agonist,,f,t,,pEC50,11.10000038,0,7.599999905,-,0,0,0,=,,,,14623894,
CT receptor,43,CALCR,P30988,,,,,,Human,AC187,689,,,135651967,Antagonist,Antagonist,,f,f,,pKi,0,7.150000095,0,-,0,0,0,=,,,,15692146,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)[C@H](O)C)CC(=O)N)CO)[C@H](O)C)CC(=O)N)[C@H](O)C)CCCNC(=N)N)Cc1ccc(cc1)O)[C@H](O)C)CCC(=O)N)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)C)CC(C)C)CCCCN)CC(C)C)CO)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1nc[nH]c1
Cx23,714,GJE1,A6NN92,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx23,714,GJE1,A6NN92,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx25,715,GJB7,Q6PEY0,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx25,715,GJB7,Q6PEY0,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx26,716,GJB2,P29033,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx26,716,GJB2,P29033,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx30,717,GJB6,O95452,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx30,717,GJB6,O95452,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx30.2,718,GJC3,Q8NFK1,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx30.2,718,GJC3,Q8NFK1,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx30.3,719,GJB4,Q9NTQ9,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx30.3,719,GJB4,Q9NTQ9,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx31,720,GJB3,O75712,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx31,720,GJB3,O75712,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx31.1,721,GJB5,O95377,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx31.1,721,GJB5,O95377,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx31.9,722,GJD3,Q8N144,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx31.9,722,GJD3,Q8N144,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx32,723,GJB1,P08034,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx32,723,GJB1,P08034,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx36,724,GJD2,Q9UKL4,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx36,724,GJD2,Q9UKL4,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx37,725,GJA4,P35212,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx37,725,GJA4,P35212,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx40,726,GJA5,P36382,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx40,726,GJA5,P36382,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx40.1,727,GJD4,Q96KN9,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx40.1,727,GJD4,Q96KN9,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx43,728,GJA1,P17302,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx43,728,GJA1,P17302,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx45,729,GJC1,P36383,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx45,729,GJC1,P36383,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx46,730,GJA3,Q9Y6H8,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx46,730,GJA3,Q9Y6H8,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx47,731,GJC2,Q5T442,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx47,731,GJC2,Q5T442,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx50,732,GJA8,P48165,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx50,732,GJA8,P48165,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx59,733,GJA9,P57773,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx59,733,GJA9,P57773,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Cx62,734,GJA10,Q969M2,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Cx62,734,GJA10,Q969M2,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Inhibitor,None,blocked by raising external Ca<sup>2+</sup>,t,,,-,0,0,0,,0,0,0,,,,extracellular,0,
CXCR1,68,CXCR1,P25024,,,,,,Human,AZD5069,8948,,,310264729,Antagonist,Antagonist,,f,f,,pIC50,0,6.900000095,0,IC50,0,125,0,=,Measuring displacement of CXCL8 binding to recombinant CXCR1 in HEK cell membrane preparations.,,,25736418,OC[C@@H]([C@H](Oc1nc(SCc2cccc(c2F)F)nc(c1)NS(=O)(=O)N1CCC1)C)O
CXCR2,69,CXCR2,P25025,,,,,,Human,AZD5069,8948,,,310264729,Antagonist,Antagonist,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.790000021,0,=,Measuring displacement of CXCL8 binding to recombinant CXCR2 in HEK cell membrane preparations.,,,25736418,OC[C@@H]([C@H](Oc1nc(SCc2cccc(c2F)F)nc(c1)NS(=O)(=O)N1CCC1)C)O
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL13,770,CCL13,Human,135651657,Agonist,Full agonist,,t,,,pKi,0,7.2,0,-,0,0,0,,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL19,810,CCL19,Human,135651663,Agonist,Full agonist,,t,,,pKi,0,5.9,0,,0,0,0,,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL20,808,CCL20,Human,135651668,Agonist,Full agonist,,t,,,pKi,0,6.8,0,,0,0,0,,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL5,758,CCL5,Human,135651690,Agonist,Full agonist,,t,,,pKi,0,6.4,0,,0,0,0,,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL11,769,CCL11,Human,135651654,Antagonist,Antagonist,,t,,,pKi,0,7.2,0,-,0,0,0,=,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CCL7,759,CCL7,Human,135651693,Antagonist,Antagonist,,t,,,pKi,0,6.6,0,-,0,0,0,=,,,,9660793,
CXCR4,71,CXCR4,P61073,,,,,,Human,ALX40-4C,607,,,135651987,Agonist,Partial agonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,794,0,=,,,,11923301,NC(=N)NCCC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)C)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,1-azakenpaullone,8018,,,249565698,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,CDK1/cyclin B complex in assay,,,14698171,O=C1Nc2cccnc2c2c(C1)c1cc(Br)ccc1[nH]2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,15486189,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,aloisine A,5924,,,178102547,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,CDK1 in association with cyclin B,,,12519061,CCCCc1c(=C2C=CC(=O)C=C2)[nH]c2c1[nH]ccn2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,alsterpaullone,5925,,,178102548,Inhibitor,Inhibition,,f,t,,pIC50,0,7.460000038,0,IC50,0,35,0,=,CDK1 in association with cyclin B,,,10998059,O=C1Nc2ccccc2c2c(C1)c1cc(ccc1[nH]2)[N+](=O)[O-]
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,alsterpaullone 2-cyanoethyl,5926,,,178102549,Inhibitor,Inhibition,,f,t,,pIC50,0,9.640000343,0,IC50,0,0.230000004,0,=,CDK1 in association with cyclin B,,,18077363,N#CCCc1ccc2c(c1)c1[nH]c3c(c1CC(=O)N2)cc(cc3)[N+](=O)[O-]
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,aminopurvalanol A,5927,,,178102550,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,CDK1 in association with cyclin B,,,18077363,OC[C@@H](C(C)C)Nc1nc(Nc2cc(N)cc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,aurora kinase/Cdk inhibitor,5932,,,178102555,Inhibitor,Inhibition,,f,t,,pIC50,0,8.18999958,0,IC50,0,6.400000095,0,=,CDK1 in association with cyclin B,,,15974571,Fc1cccc(c1C(=O)n1nc(nc1N)Nc1ccc(cc1)S(=O)(=O)N)F
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,AZD5438,8473,,,252166682,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,CDK1/cyclin B1 complex.,,,19509270,CC(n1c(C)ncc1c1ccnc(n1)Nc1ccc(cc1)S(=O)(=O)C)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,BMS-265246,8051,,,249565731,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,21216932,CCCCOc1c(cnc2c1cn[nH]2)C(=O)c1c(F)cc(cc1F)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,bohemine,5938,,,178102561,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1100,0,=,CDK1/cyclin B complexes purified from sf9 cells,,,11896531,OCCCNc1nc(NCc2ccccc2)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk1/2 inhibitor III,5946,,,178102569,Inhibitor,Inhibition,,f,t,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,CDK1/cyclin B complex,,,15974571,Fc1cccc(c1NC(=S)n1nc(nc1N)Nc1ccc(cc1)S(=O)(=O)N)F
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk1/5 inhibitor,5947,,,178102570,Inhibitor,Inhibition,,f,t,,pIC50,0,6.21999979,0,IC50,0,600,0,=,CDK1/cyclin B complex,,,18077363,Nc1[nH]nc2c1nc1ccccc1n2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk1 inhibitor,5944,,,178102567,Inhibitor,Inhibition,,f,t,,pIC50,0,5.239999771,0,IC50,0,5800,0,=,CDK1/cyclin B complex,,,18077363,O=C1Nc2c(/C/1=C\c1c(Cl)[nH]c3c1cccc3)cccc2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk1 inhibitor,5944,,,178102567,Inhibitor,Inhibition,,f,t,,pIC50,0,5.239999771,0,IC50,0,5800,0,=,CDK1/cyclin B complex,,,18077363,O=C1Nc2c(/C/1=Cc1c(Cl)[nH]c3c1cccc3)cccc2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk2 inhibitor III,5948,,,178102571,Inhibitor,Inhibition,,f,f,,pIC50,0,5.380000114,0,IC50,0,4200,0,=,CDK1/cyclin B complex,,,18077363,OCCN(c1nc(NCc2ccc(cc2)OC)c2c(n1)n(cn2)C(C)C)CCO
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,f,,pIC50,0,5.179999828,0,IC50,0,6600,0,=,CDK1/cyclin B complex used in assay,,,16170024,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,Cdk4 inhibitor,5950,,,178102573,Inhibitor,Inhibition,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,CDK1/cyclin B complex,,,12747775,Brc1ccc2c(c1)[nH]c1c2c2c(=O)[nH]c(=O)c2c2c1[nH]c1c2cccc1
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,CGP74514A,5945,,,178102568,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,9990463,CCn1cnc2c1nc(N[C@@H]1CCCC[C@@H]1N)nc2Nc1cccc(c1)Cl
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,CHIR-99021,8014,,,249565694,Inhibitor,Inhibition,,f,f,,pIC50,0,5.059999943,0,IC50,0,8800,0,=,,,,12606497,N#Cc1ccc(nc1)NCCNc1ncc(c(n1)c1ccc(cc1Cl)Cl)c1ncc([nH]1)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,compound 52 [PMID: 9677190],5955,,,178102578,Inhibitor,Inhibition,,f,f,,pIC50,0,6.46999979,0,IC50,0,340,0,=,CDK1/cyclin B complex,,,9677190,OCCNc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,CDK1/cyclin B complex,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,compound 9b [PMID: 18986805],8160,,,249565840,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,18986805,CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C
cyclin dependent kinase 18,1971,CDK18,Q07002,,,,,,Human,compound 77 [PMID: 24793884],8217,,,249565897,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,COc1ccc(c(c1)Cl)c1nc(sc1C(=O)N)c1ccnc(n1)N
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,CCT251545,8945,,,310264726,Inhibitor,Inhibition,,f,t,,pKd,0,8.600000381,0,Kd,0,2.539999962,0,=,CDK19/cyclin C.,,,26502155,Cn1ncc(c1)c1ccc(cc1)c1cncc(c1N1CCC2(CC1)CCNC2=O)Cl
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,"compound 51 [Mallinger <i>et al</i>., 2016]",9170,,,315661253,Inhibitor,Inhibition,,f,t,,pIC50,0,8.25,0,IC50,0,5.599999905,0,=,,,,27326329,COC1CN(C1)C(=O)c1ccc2c(n1)c(cnc2N)c1ccc(cc1)c1cnn(c1)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,aloisine,5923,,,178102546,Inhibitor,Inhibition,,f,t,,pKi,0,9.279999733,0,Ki,0,0.529999971,0,=,Measuring inhibition of CDK2 in association with cyclin E,,,22289061,CCCCc1c([nH]c2c1nccn2)c1ccc(cc1)OC
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,aloisine A,5924,,,178102547,Inhibitor,Inhibition,,f,t,,pIC50,0,6.920000076,0,IC50,0,120,0,=,CDK2 in association with cyclin A,,,12519061,CCCCc1c(=C2C=CC(=O)C=C2)[nH]c2c1[nH]ccn2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,alvocidib,5680,,,178102307,Inhibitor,Inhibition,,f,t,,pIC50,7,0,6.400000095,IC50,400,0,100,=,,,,8674031,CN1CC[C@@H]([C@@H](C1)O)c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,aminopurvalanol A,5927,,,178102550,Inhibitor,Inhibition,,f,t,,pIC50,0,7.550000191,0,IC50,0,28,0,=,CDK2 in association with cyclin E,,,18077363,OC[C@@H](C(C)C)Nc1nc(Nc2cc(N)cc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,t,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,aurora kinase/Cdk inhibitor,5932,,,178102555,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,CDK2 in association with cyclin A,,,15974571,Fc1cccc(c1C(=O)n1nc(nc1N)Nc1ccc(cc1)S(=O)(=O)N)F
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,AZD5438,8473,,,252166682,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,CDK2/cyclin E complex.,,,19509270,CC(n1c(C)ncc1c1ccnc(n1)Nc1ccc(cc1)S(=O)(=O)C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BMS-265246,8051,,,249565731,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,21216932,CCCCOc1c(cnc2c1cn[nH]2)C(=O)c1c(F)cc(cc1F)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BMS-387032,5670,,,178102298,Inhibitor,Inhibition,,f,t,,pKd,0,7.159999847,0,Kd,0,69,0,=,,,,22037378,O=C(C1CCNCC1)Nc1ncc(s1)SCc1ncc(o1)C(C)(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,bohemine,5938,,,178102561,Inhibitor,Inhibition,,f,t,,pIC50,0,6.21999979,0,IC50,0,600,0,=,CDK2/cyclin E complexes purified from sf9 cells.,,,11896531,OCCCNc1nc(NCc2ccccc2)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BS-181,9405,,,328083507,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,880,0,=,Evaluated using purified recombinant CDK2/cycE complex and measuring free ATP remaining in the reaction using a luciferase assay.,,,19638587,NCCCCCCNc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,f,,pIC50,0,6.369999886,0,IC50,0,430,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,f,,pIC50,0,6.190000057,0,IC50,0,650,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk1/2 inhibitor III,5946,,,178102569,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,CDK2/cyclin A complex,,,15974571,Fc1cccc(c1NC(=S)n1nc(nc1N)Nc1ccc(cc1)S(=O)(=O)N)F
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk2 inhibitor III,5948,,,178102571,Inhibitor,Inhibition,,f,t,,pIC50,0,6.300000191,0,IC50,0,500,0,=,CDK2/cyclin E complex,,,0,OCCN(c1nc(NCc2ccc(cc2)OC)c2c(n1)n(cn2)C(C)C)CCO
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,t,,pIC50,0,6.389999866,0,IC50,0,410,0,=,CDK2/cyclin A complex used in assay,,,16170024,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk4 inhibitor,5950,,,178102573,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,520,0,=,CDK2/cyclin E complex,,,12747775,Brc1ccc2c(c1)[nH]c1c2c2c(=O)[nH]c(=O)c2c2c1[nH]c1c2cccc1
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk4 inhibitor II,5951,,,178102574,Inhibitor,Inhibition,,f,f,,pIC50,0,4,0,IC50,0,100000,0,>,CDK2/cyclin A complex used in assay,,,10632371,COc1ccc(c2c1[nH]c1ccccc1c2=S)OC
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,Cdk4 inhibitor III,5952,,,178102575,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,>,CDK2/cyclin A complex,,,10743948,Cc1ccc(cc1)NC1=CC(=O)c2c(C1=O)nc(s2)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,compound 3 [PMID: 19097791],8185,,,249565865,Inhibitor,Inhibition,,f,t,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,19097791,COc1cc(ccc1O)c1ccc2c(c1)[nH]nc2c1nc2c([nH]1)cccc2N1CCN(CC1)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,6.860000134,0,IC50,0,138,0,=,CDK2/cyclin A complex,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,compound 9b [PMID: 18986805],8160,,,249565840,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,18986805,CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,None,,f,f,,pKd,0,7.519999981,0,Kd,0,30,0,=,,,,22037378,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,abemaciclib,7382,,,178103954,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,CDK4/cyclin D1 complex expressed in and purified from insect cells. Assays used the methanesulfonate salt of the compound.,,,24919854,CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,alvocidib,5680,,,178102307,Inhibitor,Inhibition,,f,t,,pKi,0,7.190000057,0,Ki,0,65,0,=,,,,8674031,CN1CC[C@@H]([C@@H](C1)O)c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,f,,pIC50,0,5.260000229,0,IC50,0,5500,0,=,CDK4/cyclin D complex used in assay,,,16170024,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,Cdk4 inhibitor,5950,,,178102573,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,76,0,=,CDK4/cyclin D1 complex,,,12747775,Brc1ccc2c(c1)[nH]c1c2c2c(=O)[nH]c(=O)c2c2c1[nH]c1c2cccc1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,Cdk4 inhibitor II,5951,,,178102574,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,200,0,=,CDK4/cyclin D1 complex used in assay,,,10632371,COc1ccc(c2c1[nH]c1ccccc1c2=S)OC
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,Cdk4 inhibitor III,5952,,,178102575,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,CDK4/cyclin D1 complex,,,10743948,Cc1ccc(cc1)NC1=CC(=O)c2c(C1=O)nc(s2)C
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,compound 9b [PMID: 18986805],8160,,,249565840,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,18986805,CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,1-azakenpaullone,8018,,,249565698,Inhibitor,Inhibition,,f,f,,pIC50,0,5.380000114,0,IC50,0,4200,0,=,CDK5/p25 complex in assay,,,14698171,O=C1Nc2cccnc2c2c(C1)c1cc(Br)ccc1[nH]2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,aloisine A,5924,,,178102547,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,CDK5 p35,,,12519061,CCCCc1c(=C2C=CC(=O)C=C2)[nH]c2c1[nH]ccn2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,aminopurvalanol A,5927,,,178102550,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,CDK5 p35,,,18077363,OC[C@@H](C(C)C)Nc1nc(Nc2cc(N)cc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,Cdk1/5 inhibitor,5947,,,178102570,Inhibitor,Inhibition,,f,t,,pIC50,0,6.400000095,0,IC50,0,400,0,=,CDK5(p25),,,18077363,Nc1[nH]nc2c1nc1ccccc1n2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15000,0,=,CDK5/p25 complex used in assay,,,16170024,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,abemaciclib,7382,,,178103954,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,CDK6/cyclin D1 complex expressed in and purified from insect cells. Assays used the methanesulfonate salt of the compound.,,,24919854,CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,Cdk/Crk inhibitor,5943,,,178102566,Inhibitor,Inhibition,,f,f,,pIC50,0,6.550000191,0,IC50,0,282,0,=,CDK6/cyclin D3 complex,,,18077363,OCCOc1ccc(cc1)Cc1nc(=O)c2c(n1)n([nH]c2C(C)C)c1c(Cl)cccc1Cl
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,BS-181,9405,,,328083507,Inhibitor,Inhibition,,f,t,,pIC50,0,7.679999828,0,IC50,0,21,0,=,Evaluated using purified recombinant CDK7/CycH/MAT1 complex and measuring free ATP remaining in the reaction using a luciferase assay.,,,19638587,NCCCCCCNc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,f,,pIC50,0,5.409999847,0,IC50,0,3900,0,=,CDK7/cyclin H complex used in assay,,,16170024,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,Cdk/Crk inhibitor,5943,,,178102566,Inhibitor,Inhibition,,f,t,,pIC50,0,7.150000095,0,IC50,0,71,0,=,CDK7/cyclin H,,,18077363,OCCOc1ccc(cc1)Cc1nc(=O)c2c(n1)n([nH]c2C(C)C)c1c(Cl)cccc1Cl
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,CCT251545,8945,,,310264726,Inhibitor,Inhibition,,f,t,,pKd,0,8.420000076,0,Kd,0,3.799999952,0,=,CDK8/cyclin C.,,,26502155,Cn1ncc(c1)c1ccc(cc1)c1cncc(c1N1CCC2(CC1)CCNC2=O)Cl
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,compound 1 [PMID: 24793884],8218,,,249565898,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,CCOC(=O)c1sc(nc1O)c1ccncc1
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,"compound 20 [Bergeron <i>et al</i>., 2016]",9171,,,315661254,Inhibitor,Inhibition,,f,t,,pIC50,0,7.760000229,0,IC50,0,17.39999962,0,=,,,,27326333,CNc1nccc(n1)N1CC[C@@H](C1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)CN1CCOCC1
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,"compound 51 [Mallinger <i>et al</i>., 2016]",9170,,,315661253,Inhibitor,Inhibition,,f,t,,pIC50,0,8.289999962,0,IC50,0,5.099999905,0,=,,,,27326329,COC1CN(C1)C(=O)c1ccc2c(n1)c(cnc2N)c1ccc(cc1)c1cnn(c1)C
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,AT-7519,5662,,,178102290,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,,,,19174555,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,AZD5438,8473,,,252166682,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,CDK9/cyclin T complex.,,,19509270,CC(n1c(C)ncc1c1ccnc(n1)Nc1ccc(cc1)S(=O)(=O)C)C
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,compound 18 [PMID: 20873740],8191,,,249565871,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,394,0,=,,,,20873740,Nc1nccc(n1)c1[nH]c(c(c1)C(=O)N)c1ccccc1
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28,0,=,CDK9/cyclin T complex,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
cyclin dependent kinase like 1,1982,CDKL1,Q00532,,,,,,Human,compound 9b [PMID: 18986805],8160,,,249565840,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,18986805,CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C
CYP11A1,1358,,,,,,,,Hamster,aminoglutethimide,7054,,,178103633,Inhibitor,Inhibition,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,=,Measuring inhibition of progesterone synthesis in hamster ovarian slices as an indicatior of CYP11A1 activity.,,,1825337,CCC1(CCC(=O)NC1=O)c1ccc(cc1)N
CYP11B1,1359,,,,,,,,Bovine,azalanstat,8799,,,252827457,Inhibitor,Inhibition,,f,f,,pKi,0,7.460000038,0,Ki,0,35,0,=,,,,8340925,Nc1ccc(cc1)SC[C@@H]1CO[C@](O1)(CCc1ccc(cc1)Cl)Cn1ccnc1
CYP17A1,1361,CYP17A1,P05093,,,,,,Human,abiraterone,6745,,,178103356,Inhibitor,Inhibition,,f,t,,pIC50,8.399999619,0,7.099999905,-,0,0,0,=,,,,7608911,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC=C2c2cccnc2)C)C1)C
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,aminoglutethimide,7054,,,178103633,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,19470632,CCC1(CCC(=O)NC1=O)c1ccc(cc1)N
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,anastrozole,5137,,,178101829,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,20413308,N#CC(c1cc(cc(c1)C(C#N)(C)C)Cn1ncnc1)(C)C
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,azalanstat,8799,,,252827457,Inhibitor,Inhibition,,f,f,,pKi,0,8.119999886,0,Ki,0,7.599999905,0,=,,,,8340925,Nc1ccc(cc1)SC[C@@H]1CO[C@](O1)(CCc1ccc(cc1)Cl)Cn1ccnc1
CYP1A1,1318,CYP1A1,P04798,,,,,,Human,5H3'FPE,8748,,,252827406,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,23600958,C#CCOc1cccc(c1)c1cc(=O)c2c(o1)cccc2O
CYP1A1,1318,CYP1A1,P04798,,,,,,Human,chrysin,8789,,,252827447,Inhibitor,Inhibition,,f,f,,pKi,0,7.380000114,0,Ki,0,42,0,=,,,,21482471,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccccc1
CYP1A2,1319,CYP1A2,P05177,,,,,,Human,5H3'FPE,8748,,,252827406,Inhibitor,Inhibition,,f,f,,pIC50,0,6.380000114,0,IC50,0,420,0,=,,,,23600958,C#CCOc1cccc(c1)c1cc(=O)c2c(o1)cccc2O
CYP1B1,1320,CYP1B1,Q16678,,,,,,Human,5H3'FPE,8748,,,252827406,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,23600958,C#CCOc1cccc(c1)c1cc(=O)c2c(o1)cccc2O
CYP1B1,1320,CYP1B1,Q16678,,,,,,Human,chrysin,8789,,,252827447,Inhibitor,Inhibition,,f,f,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,21482471,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccccc1
CYP21A2,1364,,,,,,,,Rat,"(2S,4S)-ketoconazole",8871,,,252827528,Inhibitor,Inhibition,,f,f,,pIC50,0,5.349999905,0,IC50,0,4460,0,=,,,,1495014,Clc1ccc(c(c1)Cl)[C@@]1(OC[C@@H](O1)COc1ccc(cc1)N1CCN(CC1)C(=O)C)Cn1cncc1
CYP24A1,1365,CYP24A1,Q07973,,,,,,Human,compound 3a [PMID: 15615534],8819,,,252827476,Inhibitor,Inhibition,,f,f,,pIC50,0,8.130000114,0,IC50,0,7.400000095,0,=,,,,15615534,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCS(=O)(=N)c2ccccc2)C)C)/C1
CYP24A1,1365,CYP24A1,Q07973,,,,,,Human,compound 4d [PMID: 20655626],8852,,,252827509,Inhibitor,Inhibition,,f,f,,pIC50,0,4.789999962,0,IC50,0,16300,0,=,,,,20655626,COc1ccc2c(c1)CCC(C2=O)Cc1ccccc1Br
CYP26A1,1366,CYP26A1,O43174,,,,,,Human,compound 5 [PMID: 21838328],8790,,,252827448,Inhibitor,Inhibition,,f,t,,pIC50,0,9.460000038,0,IC50,0,0.349999994,0,=,Measuring retinoic acid metabolism in a cell-free microsomal assay.,,,21838328,CCOC(=O)C(C(n1cncc1)c1ccc(cc1)Nc1ccc2c(c1)cccc2)(C)C
CYP27A1,1369,CYP27A1,Q02318,,,,,,Human,compound 4d [PMID: 20655626],8852,,,252827509,Inhibitor,Inhibition,,f,t,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,20655626,COc1ccc2c(c1)CCC(C2=O)Cc1ccccc1Br
CYP2A6,1321,CYP2A6,P11509,,,,,,Human,compound 23 [PMID: 17125252],8756,,,252827414,Inhibitor,Inhibition,,f,f,,pKi,0,6.21999979,0,Ki,0,600,0,=,,,,17125252,NCc1ccc(s1)c1ccccc1
CYP2A6,1321,CYP2A6,P11509,,,,,,Human,compound 38a [PMID: 15634016],8755,,,252827413,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,15634016,NCc1ccc(s1)c1cccnc1
CYP2A6,1321,CYP2A6,P11509,,,,,,Human,compound 39a [PMID: 15634016],8754,,,252827412,Inhibitor,Inhibition,,f,f,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,15634016,NCc1ccc(o1)c1cccnc1
CYP2C18,1327,CYP2C18,P33260,,,,,,Human,compound 9 [PMID: 11606127],8833,,,252827490,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,11606127,Nc1ccc(cc1)S(=O)(=O)N(c1ccnn1c1ccccc1)C(C)C
CYP2C19,1328,CYP2C19,P33261,,,,,,Human,compound 30 [PMID: 22239545],8749,,,252827407,Inhibitor,Inhibition,,f,t,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,22239545,Cc1ccc2c(c1)[nH]c(n2)SCc1ccccn1
CYP2C19,1328,CYP2C19,P33261,,,,,,Human,"compound 51 [Crosignani <i>et al.</i>, 2011]",8777,,,252827435,Inhibitor,Inhibition,,f,f,,pIC50,0,7.289999962,0,IC50,0,51,0,=,,,,0,CCC(=O)N(c1cc(F)cc(c1)c1nn[nH]n1)Cc1ccc(cc1)OC(F)(F)F
CYP2C8,1325,CYP2C8,P10632,,,,,,Human,"compound 51 [Crosignani <i>et al.</i>, 2011]",8777,,,252827435,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,0,CCC(=O)N(c1cc(F)cc(c1)c1nn[nH]n1)Cc1ccc(cc1)OC(F)(F)F
CYP2C9,1326,CYP2C9,P11712,,,,,,Human,compound 3 [PMID: 18255300],8747,,,252827405,Inhibitor,Inhibition,,f,f,,pKi,0,8.380000114,0,Ki,0,4.199999809,0,=,,,,18255300,CCCc1oc2ccccc2c(=O)c1C(=O)c1cc(I)c(c(c1)I)O
CYP2C9,1326,CYP2C9,P11712,,,,,,Human,"compound 51 [Crosignani <i>et al.</i>, 2011]",8777,,,252827435,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,0,CCC(=O)N(c1cc(F)cc(c1)c1nn[nH]n1)Cc1ccc(cc1)OC(F)(F)F
CYP2D6,1329,CYP2D6,P10635,,,,,,Human,ajmalicine,8746,,,252827404,Inhibitor,Inhibition,,f,f,,pKi,0,8.479999542,0,Ki,0,3.299999952,0,=,,,,8487254,COC(=O)C1=CO[C@H]([C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1)C
CYP2E1,1330,CYP2E1,P05181,,,,,,Human,compound 23 [PMID: 17125252],8756,,,252827414,Inhibitor,Inhibition,,f,f,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,17125252,NCc1ccc(s1)c1ccccc1
CYP2J2,1332,CYP2J2,P51589,,,,,,Human,compound 4 [PMID: 16495056],8832,,,252827489,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,Measuring CYP2J2-induced inhibition ebastine hydroxylation.,,,16495056,CCCc1ccc(cc1)C(=O)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,AMG-337,8913,,,310264694,Inhibitor,Inhibition,,f,f,,pIC50,0,4.300000191,0,IC50,0,50000,0,=,,,,19819693,COc1cnc2c(c1)nccc2NCc1nnc2n1nc(cc2)c1snc(c1)C
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,BMS-536924,9386,,,328083488,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,16134929,Clc1cccc(c1)C(CNC1=CC=NC(=O)C1=c1[nH]c2c([nH]1)cc(cc2C)N1CCOCC1)O
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,compound 1a [PMID: 18573659],8872,,,252827529,Inhibitor,Inhibition,,f,f,,pIC50,0,5.71999979,0,IC50,0,1900,0,=,,,,18573659,Brc1cc(ccc1OC1CCNCC1)CN1CC[C@@H](C1)NC(=O)c1ccc(c(c1)Cl)Cl
CYP3A4,1337,,,,,,,,None,azalanstat,8799,,,252827457,None,None,,f,f,,pKi,0,7.550000191,0,Ki,0,28,0,=,,,,8340925,Nc1ccc(cc1)SC[C@@H]1CO[C@](O1)(CCc1ccc(cc1)Cl)Cn1ccnc1
CYP4F2,1344,CYP4F2,P78329,,,,,,Human,17-octadecynoic acid,8851,,,252827508,Inhibitor,Inhibition,,f,f,,pKi,0,5.920000076,0,Ki,0,1200,0,=,,,,2997155,C#CCCCCCCCCCCCCCCCC(=O)O
CYP51A1,1374,CYP51A1,Q16850,,,,,,Human,azalanstat,8799,,,252827457,Inhibitor,Inhibition,,f,t,,pKi,0,9.100000381,0,Ki,0,0.790000021,0,=,,,,8340925,Nc1ccc(cc1)SC[C@@H]1CO[C@](O1)(CCc1ccc(cc1)Cl)Cn1ccnc1
CYP5A1,1353,TBXAS1,P24557,,,,,,Human,compound 10a [PMID: 1447738],8753,,,252827411,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,1447738,OC(=O)CCC(CCCc1cccnc1)CCCCNS(=O)(=O)c1ccc(cc1)F
CYP5A1,1353,TBXAS1,P24557,,,,,,Human,compound 7p [PMID: 7861416],8795,,,252827453,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,7861416,OC(=O)CCC=CCC1COC(OC1c1cccnc1)C(Oc1ccc(cc1)Br)(C)C
CYP8A1,1356,PTGIS,Q16647,,,,,,Human,compound 7p [PMID: 7861416],8795,,,252827453,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,<,,,,7861416,OC(=O)CCC=CCC1COC(OC1c1cccnc1)C(Oc1ccc(cc1)Br)(C)C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,BayCysLT<sub>2</sub>,6196,,,178102817,Antagonist,Antagonist,against LTD<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in COS-7 cells,f,,,pA2,0,6.4,0,-,0,0,0,=,,,,21753081,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOc1ccccc1)C(=O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,,,pIC50,0,6.36,0,IC50,0,440,0,=,,,,11093801,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,,,pIC50,0,6.36,0,IC50,0,440,0,=,,,,11093801,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,,,,20423349,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,,,,20423349,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,"against [<sup>3</sup>H]LTD<sub>4</sub> COS-7, HEK-293 or CHO cells",f,,,pIC50,6.4,0,6.22,IC50,597,0,400,=,,,,10851239,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,"against [<sup>3</sup>H]LTD<sub>4</sub> COS-7, HEK-293 or CHO cells",f,,,pIC50,6.4,0,6.22,IC50,597,0,400,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,Ca<sup>2+</sup> mobilization assay in HEK-293 cells,f,,,pEC50,0,7.04,0,EC50,0,92,0,=,,,,11093801,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,Ca<sup>2+</sup> mobilization assay in HEK-293 cells,f,,,pEC50,0,7.04,0,EC50,0,92,0,=,,,,11093801,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pEC50,0,7.16,0,EC50,0,69,0,=,,,,20423349,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Agonist,Partial agonist,aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pEC50,0,7.16,0,EC50,0,69,0,=,,,,20423349,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BayCysLT<sub>2</sub>,6196,,,178102817,Antagonist,Antagonist,against 30-300nM LTD<sub>4</sub> arrestin assay in C2C12 myofibroblasts,f,f,,pIC50,7.28000021,0,6.559999943,IC50,274,0,53,=,,,,21903747,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOc1ccccc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BayCysLT<sub>2</sub>,6196,,,178102817,Antagonist,Antagonist,against LTD<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in COS-7 cells,f,,,pA2,0,8.3,0,-,0,0,0,=,,,,21753081,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOc1ccccc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BayCysLT<sub>2</sub>,6196,,,178102817,Antagonist,Antagonist,against LTC<sub>4</sub> and LTD<sub>4</sub> Ca<sup>2+</sup> mobilisation assays in HUVEC,f,,,pA2,0,8.4,0,-,0,0,0,=,,,,21753081,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOc1ccccc1)C(=O)O
CysLT<sub>2</sub> receptor,270,Cysltr2,Q924T9,,,,,,Rat,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against LTC<sub>4</sub> and LTD<sub>4</sub> induced contraction in smooth muscle preparation,f,f,,pA2,7.699999809,0,6.800000191,-,0,0,0,=,,,,7698171,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,Cysltr2,Q924T9,,,,,,Rat,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against LTC<sub>4</sub> and LTD<sub>4</sub> induced contraction in smooth muscle preparation,f,f,,pA2,7.699999809,0,6.800000191,-,0,0,0,=,,,,7698171,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in HEK-293,f,,,pIC50,0,6.52,0,IC50,0,300,0,=,,,,11093801,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in HEK-293,f,,,pIC50,0,6.52,0,IC50,0,300,0,=,,,,11093801,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> - LTC<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,7.74,0,7.72,IC50,19,0,18,=,,,,20423349,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> - LTC<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,7.74,0,7.72,IC50,19,0,18,=,,,,20423349,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against LTD<sub>4</sub> and LTC<sub>4</sub> human pulmonary vein contraction,f,,,pKB,6.7,0,6.5,-,0,0,0,=,,,,1331415,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against LTD<sub>4</sub> and LTC<sub>4</sub> human pulmonary vein contraction,f,,,pKB,6.7,0,6.5,-,0,0,0,=,,,,1331415,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 300nM LTD<sub>4</sub> &beta;-arrestin Assay in C2C12 myofibroblasts,f,,,pIC50,0,5.34,0,IC50,0,4600,0,=,,,,21903747,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,BAYu9773,3381,,,178100399,Antagonist,Antagonist,against 300nM LTD<sub>4</sub> &beta;-arrestin Assay in C2C12 myofibroblasts,f,,,pIC50,0,5.34,0,IC50,0,4600,0,=,,,,21903747,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)Sc1ccc(cc1)C(=O)O
Cystathionine &beta;-synthase,1443,CBS,P35520,,,,,,Human,aminooxyacetic acid,5136,,,178101828,Inhibitor,Inhibition,,f,f,,pIC50,0,5.070000172,0,IC50,0,8520,0,=,,,,23488457,NOCC(=O)O
Cystathionine &gamma;-lyase,1444,CTH,P32929,,,,,,Human,aminoethoxyvinylglycine,8860,,,252827517,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,23488457,N[C@H](C(=O)O)/C=C/OCCN
Cystathionine &gamma;-lyase,1444,CTH,P32929,,,,,,Human,aminooxyacetic acid,5136,,,178101828,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1090,0,=,,,,23488457,NOCC(=O)O
Cystathionine &gamma;-lyase,1444,CTH,P32929,,,,,,Human,&beta;-Cyano-L-alanine,8859,,,252827516,Inhibitor,Inhibition,,f,f,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,,,,23488457,N[C@H](C(=O)O)CC#N
DAT,927,SLC6A3,Q01959,,,,,,Human,atomoxetine,7118,,,178103695,Inhibitor,Inhibition,,f,f,,pKd,0,5.96999979,0,Kd,0,1080,0,=,,,,9871604,CNCC[C@H](c1ccccc1)Oc1ccccc1C
DAT,927,Slc6a3,P23977,,,,,,Rat,benzatropine,7601,,,223365936,Inhibitor,Inhibition,,f,f,,pKi,0,6.929999828,0,Ki,0,118,0,=,"Displacement of  [<sup>3</sup>H]WIN35,428 binding to homogenised rat caudate putamen.",,,7562926,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,bupropion,7135,,,178103711,Inhibitor,Inhibition,,f,t,,pIC50,0,6.349999905,0,IC50,0,443,0,=,,,,19821577,Clc1cccc(c1)C(=O)C(NC(C)(C)C)C
DAT,927,SLC6A3,Q01959,,,,,,Human,clomipramine,2398,,,135650111,Inhibitor,Inhibition,,f,f,,pKd,0,5.659999847,0,Kd,0,2190,0,=,,,,9537821,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
DAT,927,Slc6a3,P23977,,,,,,Rat,cocaine,2286,,,135652677,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,89.09999847,0,=,,,,15566309,COC(=O)[C@H]1[C@H](C[C@H]2N([C@@H]1CC2)C)OC(=O)c1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,compound 58 [PMID: 25037917],8520,,,252166722,Inhibitor,Inhibition,,f,f,,pIC50,0,5.210000038,0,IC50,0,6100,0,=,,,,25037917,Clc1cccc(c1)c1ccc(cc1)C(=O)N1C2CCC1CN(C2)c1ncccn1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,ADL5747,9003,,,310264781,Agonist,Agonist,,f,t,,pKi,0,8.569999695,0,Ki,0,2.700000048,0,=,,,,19694468,CCN(C(=O)c1ccc(c(c1)O)C1=CC2(CCNCC2)Oc2c1cccc2)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,ADL5859,9004,,,310264782,Agonist,Agonist,,f,t,,pKi,0,9.079999924,0,Ki,0,0.839999974,0,=,,,,18788723,CCN(C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2c1c(O)ccc2)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,AR-M1000390,9005,,,310264783,Agonist,Agonist,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.889999986,0,=,,,,0,CCN(C(=O)c1ccc(cc1)C(=C1CCNCC1)c1ccccc1)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,AR-M1000390,9005,,,310264783,Agonist,Agonist,,f,t,,pKi,0,6.96999979,0,Ki,0,106,0,=,,,,12875901,CCN(C(=O)c1ccc(cc1)C(=C1CCNCC1)c1ccccc1)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,AZD7268,7824,,,223366155,Agonist,Agonist,,f,t,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,0,OCCN(C(=O)c1ccc(cc1)C(=C1CCN(CC1)Cc1cscn1)c1cccc2c1nccc2)C
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,BW373U86,9002,,,310264780,Agonist,Agonist,,f,f,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,8246159,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,BW373U86,9002,,,310264780,Agonist,Agonist,,f,t,,pKi,0,9.489999771,0,Ki,0,0.319999993,0,=,,,,18788723,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,&alpha;-neoendorphin,1600,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651611,Agonist,Full agonist,,t,,,pIC50,0,8,0,,0,0,0,,,,,8393575,
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Full agonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,8114680,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Full agonist,,t,,,pKi,0,8.3,0,-,0,0,0,=,,,,9686407,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,(-)-bremazocine,1603,,,135650021,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9686407,CC[C@]12CCN([C@@H](C2(C)C)Cc2c1cc(O)cc2)CC1(O)CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,BU08028,9294,,,318164813,Agonist,Partial agonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.590000033,0,=,,,,21177476,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(CC)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,BMS-986187,9748,,,0,Allosteric modulator,Positive,BMS-986187 significantly increased the binding affinity of Leu-Enkephalin from 221 nM to 7 nM,f,f,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,0,O=C1CC(C)(C)CC2=C1C(c1ccc(cc1)OCc1ccccc1C)C1=C(O2)CC(CC1=O)(C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,alvimopan,7471,,,187051774,Antagonist,Antagonist,,f,f,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,18313920,OC(=O)CNC(=O)[C@@H](Cc1ccccc1)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,AT-076,8870,,,252827527,Antagonist,Antagonist,,f,f,,pKi,0,7.710000038,0,Ki,0,19.60000038,0,=,Radioligand binding assay,,,9686407,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CCC(CC1)c1cccc(c1)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,&beta;-FNA,1631,,,135649986,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9686407,COC(=O)/C=C/C(=O)N[C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8114680,O=C1/C(=C\c2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8114680,O=C1/C(=Cc2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,O=C1/C(=C\c2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,O=C1/C(=Cc2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,BNTX,1634,,,135650013,Antagonist,Inverse agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,10516632,O=C1/C(=C\c2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,BNTX,1634,,,135650013,Antagonist,Inverse agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,10516632,O=C1/C(=Cc2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
diacylglycerol O-acyltransferase 1,2821,DGAT1,O75907,,,,,,Human,AZD7687,7827,,,223366158,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,80,0,=,Measured using purified human DGAT1,,,23116186,OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)c1nc(C(=O)N)c(nc1C)C
diacylglycerol O-acyltransferase 1,2821,DGAT1,O75907,,,,,,Human,compound 23n [PMID: 24900877],7832,,,223366163,Inhibitor,Inhibition,,f,t,,pIC50,0,7.190000057,0,IC50,0,64,0,=,,,,24900877,CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2c1ccc(c2)c1ccc(cc1)[C@@H]1CC[C@H](CC1)CC(=O)O
diacylglycerol O-acyltransferase 1,2821,DGAT1,O75907,,,,,,Human,compound 5B [PMID: 25349648],7831,,,223366162,Inhibitor,Inhibition,,f,t,,pIC50,0,8.409999847,0,IC50,0,3.900000095,0,=,,,,25349648,OC(=O)[C@@H]1CC[C@H](CC1)OC1CCN(CC1)c1ccc(cn1)c1nc2c([nH]1)ccc(c2)C(F)(F)F
dihydrofolate reductase,2603,DHFR,P00374,,,,,,Human,compound 9 [PMID: 15615544],8890,,,310264671,Inhibitor,Inhibition,,f,f,,pKi,0,10.47000027,0,Ki,0,0.034000002,0,=,,,,15615544,OC(=O)CC[C@H](N1Cc2c(C1=O)ccc(c2)NCc1cnc2c(n1)c(N)nc(n2)N)C(=O)O
Dipeptidase 1,1393,,,,,,,,Unknown,cilastatin,5166,,,178101856,Inhibitor,Inhibition,,f,t,,pKi,0,5.960000038,0,Ki,0,1100,0,=,,,,3495664,OC(=O)[C@H](CSCCCC/C=C(/C(=O)O)\NC(=O)[C@H]1CC1(C)C)N
Dipeptidase 1,1393,,,,,,,,Unknown,cilastatin,5166,,,178101856,Inhibitor,Inhibition,,f,t,,pKi,0,5.960000038,0,Ki,0,1100,0,=,,,,3495664,OC(=O)[C@H](CSCCCC/C=C(/C(=O)O)NC(=O)[C@H]1CC1(C)C)N
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,begelomab,8691,,,252166891,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,~,,,,0,
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,alogliptin,6319,,,178102937,Inhibitor,Inhibition,,f,t,,pIC50,0,8.5,0,IC50,0,3.400000095,0,=,,,,22475866,N#Cc1ccccc1Cn1c(cc(=O)n(c1=O)C)N1CCC[C@H](C1)N
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,compound 1 [Xiao <i>et al.</i> 2014],8301,,,252166513,Inhibitor,Inhibition,,f,t,,pIC50,0,6.599999905,0,IC50,0,232.8000031,0,=,,,,0,NCc1c2ccccc2n(c1c1ccc(cc1Cl)Cl)S(=O)(=O)C
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,compound 24dd [PMID: 20684603],8550,,,252166751,Inhibitor,Inhibition,,f,t,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,20684603,NCc1c(C)nc2n(c1c1ccc(cc1Cl)Cl)cc(n2)C(=O)NCCc1ccccn1
dipeptidyl peptidase 8,2356,DPP8,Q6V1X1,,,,,,Human,1G244,8551,,,252166752,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,19439267,N[C@H](C(=O)N1Cc2c(C1)cccc2)CC(=O)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F
dipeptidyl peptidase 8,2356,DPP8,Q6V1X1,,,,,,Human,compound 18 [PMID: 15664838],6536,,,178103150,Inhibitor,Inhibition,,f,t,,pIC50,0,7.900000095,0,IC50,0,14,0,=,,,,15664838,NC(C(=O)N1Cc2c(C1)cccc2)CC(=O)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F
dipeptidyl peptidase 8,2356,DPP8,Q6V1X1,,,,,,Human,compound 24dd [PMID: 20684603],8550,,,252166751,Inhibitor,Inhibition,,f,f,,pKi,0,6.570000172,0,Ki,0,270,0,=,,,,20684603,NCc1c(C)nc2n(c1c1ccc(cc1Cl)Cl)cc(n2)C(=O)NCCc1ccccn1
dipeptidyl peptidase 9,2357,DPP9,Q86TI2,,,,,,Human,1G244,8551,,,252166752,Inhibitor,Inhibition,,f,f,,pIC50,0,7.28000021,0,IC50,0,53,0,=,,,,19439267,N[C@H](C(=O)N1Cc2c(C1)cccc2)CC(=O)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F
dipeptidyl peptidase 9,2357,DPP9,Q86TI2,,,,,,Human,compound 24dd [PMID: 20684603],8550,,,252166751,Inhibitor,Inhibition,,f,f,,pKi,0,6.71999979,0,Ki,0,190,0,=,,,,20684603,NCc1c(C)nc2n(c1c1ccc(cc1Cl)Cl)cc(n2)C(=O)NCCc1ccccn1
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,"2,2-difluoromevalonate 5-diphosphate",3213,,,135649680,Inhibitor,Competitive,,f,,,pIC50,0,5.12,0,IC50,0,7500,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,17888661,OC(=O)C(C(CCOP(=O)(OP(=O)(O)O)O)(O)C)(F)F
diphosphomevalonate decarboxylase,642,MVD,P53602,,,,,,Human,6-fluoromevalonate 5-diphosphate,3205,,,135649848,Inhibitor,Competitive,,f,,,pKi,0,7.21,0,Ki,0,62,0,=,"recombinant enzyme expressed in E coli, purified, in vitro spectrophotometric assay",,,18823933,FCC(OP(=O)(OP(=O)(O)O)O)CC(CC(=O)O)(O)C
diphosphomevalonate decarboxylase,642,MVD,P53602,,,,,,Human,6-fluoromevalonate pyrophosphate,7996,,,249565676,Inhibitor,Competitive,,f,f,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,0,FC[C@](CC(=O)O)(CCOP(=O)(OP(=O)(O)O)O)O
diphosphomevalonate decarboxylase,642,MVD,P53602,,,,,,Human,"analog 3 [Vlattas <i>et al.</i>, 1996]",7994,,,249565674,Inhibitor,Competitive,,f,f,,pKi,0,6.119999886,0,Ki,0,750,0,=,,,,0,CN(CC(=O)O)CCOP(=O)(OP(=O)(O)O)O
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,compound 18 [PMID: 17888661],3212,,,135649661,Inhibitor,Competitive,,f,,,pIC50,0,4.1,0,IC50,0,80000,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,17888661,P=POCCC(CC)(O)C
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,compound 19 [PMID: 17888661],3211,,,135649660,Inhibitor,Competitive,,f,,,pIC50,0,3.92,0,IC50,0,120000,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,17888661,P=POCCC(C(C)C)(O)C
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,2-fluoromevalonate 5-diphosphate,3204,,,135649701,Inhibitor,Irreversible inhibition,,f,,,pKi,0,5.52,0,Ki,0,3020,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,16626865,OC(=O)C(C(CCOP(=O)(OP(=O)(O)O)O)(O)C)F
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,compound 4 [PMID: 26191369],8733,,,252827391,Inhibitor,Inhibition,,f,f,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,26191369,O=C(Nc1cccc(c1)F)NCc1ccc(c(c1)NC(=O)c1cnc2n1cccc2)C
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,compound 6j [PMID: 27219676],9230,,,315661305,Inhibitor,Inhibition,,f,t,,pIC50,0,8.029999733,0,IC50,0,9.399999619,0,=,Inhibition of kinase activity in a TR-FRET assay,,,27219676,Cc1ncn(c1)c1cc(NC(=O)c2ccc3c(c2)CN(C[C@@H]3C)c2cncnc2)cc(c1)C(F)(F)F
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,compound 6j [PMID: 27219676],9230,,,315661305,Inhibitor,Inhibition,,f,t,,pKd,0,8.329999924,0,Kd,0,4.699999809,0,=,Binding affinity,,,27219676,Cc1ncn(c1)c1cc(NC(=O)c2ccc3c(c2)CN(C[C@@H]3C)c2cncnc2)cc(c1)C(F)(F)F
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,compound 7k [PMID: 23521020],8164,,,249565844,Inhibitor,Inhibition,,f,t,,pIC50,0,8.640000343,0,IC50,0,2.289999962,0,=,,,,23521020,Clc1cccc(c1)NC(=O)c1ccc(c(c1)C#Cc1cnc2n(c1)ncc2)C
DMT1,967,SLC11A2,P49281,,,,,,Human,compound 6b [PMID: 22749870],8814,,,252827472,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,,,,22749870,NC(=N)SCc1cc(F)ccc1Sc1ccc(cc1CSC(=N)N)[N+](=O)[O-]
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
DNA methyltransferase 1,2605,DNMT1,P26358,,,,,,Human,bromo-deaza-SAH,7018,,,178103597,Inhibitor,Inhibition,,f,f,,pKi,0,6.019999981,0,Ki,0,950,0,=,,,,23433670,OC(=O)[C@H](CCSC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)Br)N
DNA topoisomerase I,2636,,,,,,,,Bovine,compound 19 [PMID: 7707314],8892,,,310264673,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28,0,=,Concentration of compound required  to produce approximately 50% fragmentation of P-32 end- labeled DNA in  the presence of calf thymus topoisomerase I.,,,7707314,CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4cnc(cc4c(c3Cn1c2=O)C)Br
DNA topoisomerase I,2636,,,,,,,,Bovine,compound 5z [PMID: 8410981],8893,,,310264674,Inhibitor,Inhibition,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,Inhibition of pBR322 DNA cleavage  by calf thymus DNA topoisomerase I.,,,8410981,CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4cc5OCOc5cc4cc3Cn1c2=O
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,bromo-deaza-SAH,7018,,,178103597,Inhibitor,Inhibition,,f,f,,pKi,0,7.420000076,0,Ki,0,38,0,=,,,,23433670,OC(=O)[C@H](CCSC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)Br)N
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,bromo-deaza-SAH,7018,,,178103597,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,77,0,=,,,,23433670,OC(=O)[C@H](CCSC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)Br)N
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,"compound 13 [Chen <i>et al.</i>, 2016]",9205,,,315661281,Inhibitor,Inhibition,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,Scintillation proximity assay result,,,0,CNc1ccnc(n1)Nc1ccc2c(c1)n(c(c2)C)c1ccccc1Oc1cnc2c(c1)ncn2C
doublecortin like kinase 1,2005,DCLK1,O15075,,,,,,Human,compound 5g [PMID: 20483621],8207,,,249565887,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,20483621,CN1CCN(CC1)c1ccc(cn1)c1cnc2c(c1)N(CCN2)Cc1cc(Cl)ccc1Cl
doublecortin like kinase 3,2007,DCLK3,Q9C098,,,,,,Human,compound 5n [PMID: 20483621],8208,,,249565888,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,0,Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccnc(c1)N1CCNCC1)C(F)(F)F
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9579725,CCCCC/C=C\C=C\1/[C@@H](C/C=C\CCCC(=O)O)C=CC1=O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9579725,CCCCC/C=CC=C1/[C@@H](C/C=CCCCC(=O)O)C=CC1=O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
DP<sub>1</sub> receptor,338,Ptgdr,P70263,,,,,,Mouse,BW 245C,1878,,,135650040,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9313928,OC(=O)CCCCCCC1C(=O)NC(=O)N1CCC(C1CCCCC1)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,BW 245C,1878,,,135650040,Agonist,Full agonist,,f,f,,pKi,9.399999619,0,8.399999619,-,0,0,0,=,,,,10448933,OC(=O)CCCCCCC1C(=O)NC(=O)N1CCC(C1CCCCC1)O
DP<sub>1</sub> receptor,338,Ptgdr,Q9R261,,,,,,Rat,BW 245C,1878,,,135650040,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,10448933,OC(=O)CCCCCCC1C(=O)NC(=O)N1CCC(C1CCCCC1)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,10634944,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,BWA868C,1897,,,135650043,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,8.600000381,-,0,0,0,=,,,,7642548,OC(=O)CCCCCCC1N(NCC(C2CCCCC2)O)C(=O)N(C1=O)Cc1ccccc1
DP<sub>1</sub> receptor,338,Ptgdr,P70263,,,,,,Mouse,BWA868C,1897,,,135650043,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9313928,OC(=O)CCCCCCC1N(NCC(C2CCCCC2)O)C(=O)N(C1=O)Cc1ccccc1
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"13,14-dihydro-15-keto-PGD<sub>2</sub>",1900,,,135649648,Agonist,Full agonist,,f,,,pKi,7.7,0,7.5,,0,0,0,,,,,12721327,CCCCCC(=O)CC[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"13,14-dihydro-15-keto-PGD<sub>2</sub>",1900,,,135649648,Agonist,Full agonist,,f,,,pKi,7.7,0,7.5,,0,0,0,,,,,12721327,CCCCCC(=O)CC[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"13,14-dihydro-15-keto-PGD<sub>2</sub>",1900,,,135649648,Agonist,Full agonist,,f,f,,pKi,8.5,0,7.400000095,Ki,39.79999924,0,3.160000086,=,,,,12721327,CCCCCC(=O)CC[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"13,14-dihydro-15-keto-PGD<sub>2</sub>",1900,,,135649648,Agonist,Full agonist,,f,f,,pKi,8.5,0,7.400000095,Ki,39.79999924,0,3.160000086,=,,,,12721327,CCCCCC(=O)CC[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"13,14-dihydro-15-keto-PGF<sub>2&alpha;</sub>",1901,,,135651373,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,12466225,CCCCCC(=O)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"13,14-dihydro-15-keto-PGF<sub>2&alpha;</sub>",1901,,,135651373,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,12466225,CCCCCC(=O)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"15-deoxy-&Delta;<sup>12,14</sup>-PGD<sub>2</sub>",1904,,,135651376,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12721327,CCCCC/C=C/C=C\1/C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"15-deoxy-&Delta;<sup>12,14</sup>-PGD<sub>2</sub>",1904,,,135651376,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12721327,CCCCC/C=C/C=C1/C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12466225,CCCCC/C=C\C=C\1/[C@@H](C/C=C\CCCC(=O)O)C=CC1=O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12466225,CCCCC/C=CC=C1/[C@@H](C/C=CCCCC(=O)O)C=CC1=O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12721327,CCCCC/C=C\C=C\1/[C@@H](C/C=C\CCCC(=O)O)C=CC1=O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,"15-deoxy-&Delta;<sup>12,14</sup>-PGJ<sub>2</sub>",1877,,,53801020,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12721327,CCCCC/C=CC=C1/[C@@H](C/C=CCCCC(=O)O)C=CC1=O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,15(<i>R</i>)-15-methyl-PGD<sub>2</sub>,1902,,,135649652,Agonist,Full agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,12721327,CCCCC[C@](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)(O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,15(<i>R</i>)-15-methyl-PGD<sub>2</sub>,1902,,,135649652,Agonist,Full agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,12721327,CCCCC[C@](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)(O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,15(<i>S</i>)-15-methyl-PGD<sub>2</sub>,1903,,,135649653,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12466225,CCCCC[C@@](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)(O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,15(<i>S</i>)-15-methyl-PGD<sub>2</sub>,1903,,,135649653,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12466225,CCCCC[C@@](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)(O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,AZD1981,7680,,,223366015,Antagonist,Antagonist,,f,t,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,Displacement of [<sup>3</sup>H]PGD<sub>2</sub> from human CRTH2 receptor,,,21944852,CC(=O)Nc1cccc2c1c(Sc1ccc(cc1)Cl)c(n2CC(=O)O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,CAY 10471,1905,,,135650058,Antagonist,Antagonist,,f,f,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,15715457,OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,CAY 10471,1905,,,135650058,Antagonist,Antagonist,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,15715457,OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"compound 51 [Crosignani <i>et al.</i>, 2011]",8777,,,252827435,Antagonist,Antagonist,,f,f,,pKi,0,8.159999847,0,Ki,0,6.900000095,0,=,,,,0,CCC(=O)N(c1cc(F)cc(c1)c1nn[nH]n1)Cc1ccc(cc1)OC(F)(F)F
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,A68930,6077,,,178102698,Agonist,Agonist,,f,,,pEC50,0,6.82,0,EC50,0,151.1,0,=,,,,16318870,NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)c1ccccc1
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,A77636,9637,,,340590267,Agonist,Full agonist,,f,f,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,17067639,NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,(+)-ADTN,932,,,135649897,Agonist,Full agonist,,f,,,pKi,6.4,0,5.3,,0,0,0,,,,,12388666,NC1CCc2c(C1)cc(c(c2)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,apomorphine,33,,,135649950,Agonist,Full agonist,,f,,,pKi,6.2,0,5.3,,0,0,0,,,,,1826762,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Partial agonist,,t,f,,pKi,0,5,0,-,0,0,0,=,,,,1826762,NCCc1c[nH]c2c1cc(O)cc2
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,8.5,0,6.5,,0,0,0,,,,,1826762,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,1826762,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,1826762,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,benzquinamide,7124,,,178103701,Agonist,Agonist,,f,t,,pKi,0,5.400000095,0,Ki,0,3964,0,=,,,,22711801,CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,compound 3 [PMID: 23134120],9190,,,315661269,Agonist,Agonist,,f,f,,pKi,0,6.929999828,0,Ki,0,118,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,7-OH-DPAT,950,,,135649862,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7990123,CCCN(C1CCc2c(C1)cc(cc2)O)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,7-OH-DPAT,950,,,135649862,Agonist,Full agonist,,f,,,pKi,7.6,0,5.6,,0,0,0,,,,,8301582,CCCN(C1CCc2c(C1)cc(cc2)O)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,7-trans-OH-PIPAT,951,,,135649863,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,7990123,I/C=C\CN([C@@H]1CCc2c(C1)c(O)ccc2)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,7-trans-OH-PIPAT,951,,,135649863,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,7990123,I/C=CCN([C@@H]1CCc2c(C1)c(O)ccc2)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Full agonist,,f,t,,pKi,8.300000191,0,7.300000191,-,0,0,0,=,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,t,,pKi,7.5,0,5.699999809,-,0,0,0,=,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,1975644,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Partial agonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,23279866,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,aripiprazole,34,,,135649956,Agonist,Partial agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,10617689,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,aripiprazole,34,,,135649956,Agonist,Partial agonist,,f,t,,pEC50,0,7.420000076,0,EC50,0,38,0,=,Measuring cAMP production via the Gi-coupled signaling pathway,,,22025698,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,brexpiprazole,7672,,,223366007,Agonist,Partial agonist,,f,f,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,24947465,O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,1975644,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,cabergoline,37,,,135652674,Agonist,Partial agonist,,f,t,,pKi,9.199999809,0,9,-,0,0,0,=,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,cariprazine,7671,,,223366006,Agonist,Partial agonist,,f,f,,pKi,0,8.239999771,0,Ki,0,5.699999809,0,=,Binding affinity to human dopamine D2L receptor,,,22537450,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,amisulpride,963,,,135649938,Antagonist,Antagonist,,f,t,,pKi,8,0,7.900000095,-,0,0,0,=,,,,1354163,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,amisulpride,963,,,135649938,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,1975644,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,asenapine,22,,,135650779,Antagonist,Antagonist,,f,t,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,,,,18308814,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,benperidol,9215,,,315661291,Antagonist,Antagonist,,f,f,,pKi,0,10.56999969,0,Ki,0,0.027000001,0,=,,,,9577836,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,blonanserin,7670,,,223366005,Antagonist,Antagonist,,f,t,,pKi,0,9.850000381,0,Ki,0,0.140000001,0,=,,,,15686911,CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,8.7,0,7.5,,0,0,0,,,,,8301582,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,7.6,0,7,,0,0,0,,,,,8301582,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,1975644,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,1975644,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,t,,pKi,6.900000095,0,5.800000191,-,0,0,0,=,,,,8301582,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,compound 3 [PMID: 23134120],9190,,,315661269,Agonist,Agonist,,f,f,,pKi,0,6.769999981,0,Ki,0,168,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,7-OH-DPAT,950,,,135649862,Agonist,Full agonist,,f,f,,pKi,8.399999619,0,7.099999905,Ki,79.40000153,0,3.980000019,=,,,,8301582,CCCN(C1CCc2c(C1)cc(cc2)O)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,7-trans-OH-PIPAT,951,,,135649863,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,7990123,I/C=C\CN([C@@H]1CCc2c(C1)c(O)ccc2)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,7-trans-OH-PIPAT,951,,,135649863,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,7990123,I/C=CCN([C@@H]1CCc2c(C1)c(O)ccc2)CCC
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,bromocriptine,35,,,135650026,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,1975644,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,t,,pKi,7.599999905,0,6.099999905,-,0,0,0,=,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,1975644,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,BP 897,7625,,,223365960,Agonist,Partial agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,10432116,COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Partial agonist,,f,t,,pKi,8.199999809,0,7.099999905,-,0,0,0,=,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,cabergoline,37,,,135652674,Agonist,Partial agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,cariprazine,7671,,,223366006,Agonist,Partial agonist,,f,f,,pKi,0,10.05000019,0,Ki,0,0.090000004,0,=,Binding affinity to human dopamine D3 receptor,,,22537450,O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,(+)-AJ76,970,,,135649912,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,1975644,CCCN[C@@H]1CCc2c([C@@H]1C)cccc2OC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(+)-AJ76,970,,,135649912,Antagonist,Antagonist,,f,,,pKi,6.2,0,5.9,,0,0,0,,,,,1354163,CCCN[C@@H]1CCc2c([C@@H]1C)cccc2OC
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,amisulpride,963,,,135649938,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1975644,CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.3,,0,0,0,,,,,7576010,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,8,0,6.7,,0,0,0,,,,,8301582,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.2,,0,0,0,,,,,8301582,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,1975644,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,1975644,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,6.3,0,5.2,,0,0,0,,,,,8301582,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,A412997,3301,,,178100338,Agonist,Agonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.900000095,0,=,,,,16153699,O=C(Nc1cccc(c1)C)CN1CCC(CC1)c1ccccn1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,A412997,3301,,,178100338,Agonist,Full agonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.900000095,0,=,,,,16153699,O=C(Nc1cccc(c1)C)CN1CCC(CC1)c1ccccn1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,ABT-670,8439,,,252166649,Agonist,Full agonist,,f,t,,pKi,0,5.840000153,0,Ki,0,1445,0,=,,,,17149874,Cc1cccc(c1)C(=O)NCN1CCC(CC1)c1cccc[n+]1[O-]
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,t,,pKi,0,8.399999619,0,-,0,0,0,=,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,cabergoline,37,,,135652674,Agonist,Partial agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,A-381393,8441,,,252166651,Antagonist,Antagonist,,f,t,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,15992586,Cc1ccc(cc1C)N1CCN(CC1)Cc1nc2c([nH]1)cccc2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,aripiprazole,34,,,135649956,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10617689,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,benperidol,9215,,,315661291,Antagonist,Antagonist,,f,f,,pKi,0,10.18000031,0,Ki,0,0.066,0,=,,,,9577836,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,bromocriptine,35,,,135650026,Antagonist,Antagonist,,f,t,,pKi,0,6.400000095,0,-,0,0,0,=,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8967990,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,8102973,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8102973,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,A68930,6077,,,178102698,Agonist,Agonist,,f,,,pEC50,0,6.6,0,EC50,0,251.4,0,=,,,,16318870,NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)c1ccccc1
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Agonist,Full agonist,,t,,,pKi,0,5.5,0,,0,0,0,,,,,1826762,NCCc1c[nH]c2c1cc(O)cc2
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,(+)-ADTN,932,,,135649897,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,1826762,NC1CCc2c(C1)cc(c(c2)O)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,beta-ergocriptine,988,,,135649985,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,1826762,CC[C@@H]([C@@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,bromocriptine,35,,,135650026,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,12388666,CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,cabergoline,37,,,135652674,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12388666,C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,apomorphine,33,,,135649950,Agonist,Partial agonist,,f,,,pKi,7.8,0,6.4,,0,0,0,,,,,12388666,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,(+)-butaclamol,62,,,135650036,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,1826762,O[C@]1(CCN2[C@@H](C1)c1cccc3c1[C@@H](C2)c1ccccc1CC3)C(C)(C)C
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,1826762,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,1826762,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,compound 17 [PMID: 23642479],8161,,,249565841,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23642479,Clc1cc(CNc2nccc(n2)c2ccc3c(c2)OCO3)cc(c1)Cl
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,t,,pIC50,0,7.550000191,0,IC50,0,28,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,compound 68 [PMID: 24900699],8165,,,249565845,Inhibitor,Inhibition,,f,t,,pIC50,0,9.800000191,0,IC50,0,0.159999996,0,=,,,,24900699,COC(=N)c1nc2c(s1)c1c(ncnc1cc2)Nc1ccc(cc1F)Br
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,compound 72 [WO2013026806],8166,,,249565846,Inhibitor,Inhibition,,f,t,,pIC50,0,9.659999847,0,IC50,0,0.219999999,0,=,,,,0,COC(=N)c1nc2c(s1)c1c(ncnc1cc2)Nc1ccc(cc1)Cl
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,AZ191,9268,,,315661343,Inhibitor,Inhibition,,f,t,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,25738750,COc1cc(ccc1Nc1nccc(n1)c1cn(c2c1ccnc2)C)N1CCN(CC1)C
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,compound 17 [PMID: 23642479],8161,,,249565841,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,23642479,Clc1cc(CNc2nccc(n2)c2ccc3c(c2)OCO3)cc(c1)Cl
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,7.139999866,0,IC50,0,72,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,compound 68 [PMID: 24900699],8165,,,249565845,Inhibitor,Inhibition,,f,t,,pIC50,0,9.619999886,0,IC50,0,0.239999995,0,=,,,,24900699,COC(=N)c1nc2c(s1)c1c(ncnc1cc2)Nc1ccc(cc1F)Br
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,compound 72 [WO2013026806],8166,,,249565846,Inhibitor,Inhibition,,f,t,,pIC50,0,9.550000191,0,IC50,0,0.280000001,0,=,,,,0,COC(=N)c1nc2c(s1)c1c(ncnc1cc2)Nc1ccc(cc1)Cl
dual specificity tyrosine phosphorylation regulated kinase 2,2011,DYRK2,Q92630,,,,,,Human,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,6.889999866,0,IC50,0,130,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
dual specificity tyrosine phosphorylation regulated kinase 2,2011,DYRK2,Q92630,,,,,,Human,compound 5b [PMID: 24900464],8171,,,249565851,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,24900464,N#Cc1cnn2c1nc(cc2NC1CC1)c1c[nH]c2c1cc(cc2)NC(=O)C
dual specificity tyrosine phosphorylation regulated kinase 3,2012,DYRK3,O43781,,,,,,Human,compound 1a [PMID: 24900749],8128,,,249565808,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,24900749,N#Cc1cnn2c1nc(Nc1ccc(c(c1)NC(=O)C)C)cc2NC1CC1
dual specificity tyrosine phosphorylation regulated kinase 3,2012,DYRK3,O43781,,,,,,Human,compound 3b [PMID: 23454515],8127,,,249565807,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,180,0,=,,,,23454515,NCCOCCOCCOCCOc1ccc(cc1)NC1=N/C(=Cc2ccc3c(c2)OCO3)/C(=O)N1
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,anacardic acid,6999,,,178103578,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,=,,,,12624111,C=CC/C=C/C/C=C/CCCCCCCc1cccc(c1C(=O)O)O
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,C646,7004,,,178103583,Inhibitor,Inhibition,,f,f,,pKi,0,6.400000095,0,Ki,0,400,0,=,,,,20534345,CC1=NN(C(=O)/C/1=C\c1ccc(o1)c1cc(C)c(cc1[N+](=O)[O-])C)c1ccc(cc1)C(=O)O
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,C646,7004,,,178103583,Inhibitor,Inhibition,,f,f,,pKi,0,6.400000095,0,Ki,0,400,0,=,,,,20534345,CC1=NN(C(=O)/C/1=Cc1ccc(o1)c1cc(C)c(cc1[N+](=O)[O-])C)c1ccc(cc1)C(=O)O
Ecto-5'-Nucleotidase,1232,NT5E,P21589,,,,,,Human,&alpha;&beta;-methyleneADP,5092,,,178101785,Inhibitor,Inhibition,,f,,,pIC50,0,8.7,0,-,0,0,0,=,,,,1169962,O[C@@H]1[C@@H](COP(=O)(CP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
ectonucleoside triphosphate diphosphohydrolase 1,2888,Entpd1,P97687,,,,,,Rat,ARL 67156,9030,,,315661115,Inhibitor,Inhibition,,f,f,,pKi,0,4.570000172,0,Ki,0,27000,0,=,,,,18630897,CCN(c1ncnc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Br)Br)O)O)CC
egl-9 family hypoxia inducible factor 1,2833,EGLN1,Q9GZT9,,,,,,Human,compound 6ee [PMID: 22364528],8796,,,252827454,Inhibitor,Inhibition,,f,f,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,22364528,O=c1nc[nH]c(c1)N1C(=O)N(C(=O)C21CCN(CC2)Cc1ncccc1C)c1ccc(cc1)c1ccc(cc1)c1[nH]ncc1
egl-9 family hypoxia inducible factor 2,2832,EGLN2,Q96KS0,,,,,,Human,compound 6ee [PMID: 22364528],8796,,,252827454,Inhibitor,Inhibition,,f,f,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,22364528,O=c1nc[nH]c(c1)N1C(=O)N(C(=O)C21CCN(CC2)Cc1ncccc1C)c1ccc(cc1)c1ccc(cc1)c1[nH]ncc1
egl-9 family hypoxia inducible factor 3,2834,EGLN3,Q9H6Z9,,,,,,Human,compound 6ee [PMID: 22364528],8796,,,252827454,Inhibitor,Inhibition,,f,f,,pIC50,0,8.460000038,0,IC50,0,3.5,0,=,,,,22364528,O=c1nc[nH]c(c1)N1C(=O)N(C(=O)C21CCN(CC2)Cc1ncccc1C)c1ccc(cc1)c1ccc(cc1)c1[nH]ncc1
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,alpha1-proteinase inhibitor,7487,,,187051790,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,alvelestat,6476,,,178103090,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,9.399999619,0,=,,,,21791628,O=C(c1cc(c(n(c1=O)c1cccc(c1)C(F)(F)F)C)c1ccnn1C)NCc1ccc(cn1)S(=O)(=O)C
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,BAY-678,8956,,,310264737,Inhibitor,Inhibition,,f,t,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,26083237,N#Cc1ccc(cn1)[C@H]1NC(=O)C(C(=C1C(=O)C)C)c1cccc(c1)C(F)(F)F
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,compound 10f [PMID: 24556381],8602,,,252166803,Inhibitor,Inhibition,,f,f,,pIC50,0,5.369999886,0,IC50,0,4220,0,=,,,,24556381,Clc1ccc2c(c1)c(cc(n2)c1c[nH]c2c1cccc2)c1ccccc1
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,compound 10l [PMID: 24556381],8603,,,252166804,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,630,0,=,,,,24556381,[O-][N+](=O)c1ccc2c(c1)c(cc(n2)c1c[nH]c2c1cccc2)c1ccccc1
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,compound 4g [PMID: 22595175],8626,,,252166826,Inhibitor,Inhibition,,f,f,,pIC50,0,4.989999771,0,IC50,0,10200,0,=,,,,22595175,COc1ccc(cc1)C(=O)N1C(=O)OC(C1=O)(C)C
embryonic ectoderm development,2487,EED,O75530,,,,,,Human,A-395,9525,,,336446911,Inhibitor,Binding,,f,f,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,28135237,CN([C@H]1CN(C[C@@H]1c1ccc(cc1)N1CCN(CC1)S(=O)(=O)C)C1CCc2c1c(F)ccc2)C
ENaC&alpha;&beta;&gamma;,742,SCNN1B|SCNN1G|SCNN1A,P37088|P51168|P51170,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,,f,t,,pIC50,7,0,6.699999809,IC50,200,0,100,=,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
ENaC&alpha;&beta;&gamma;,742,SCNN1B|SCNN1G|SCNN1A,P37088|P51168|P51170,,,,,,Human,benzamil,4145,,,178100966,Channel blocker,None,,f,f,,pIC50,0,8,0,IC50,0,10,0,~,,,,0,NC(=NCc1ccccc1)NC(=O)c1nc(Cl)c(nc1N)N
endoglin (CD105),2895,ENG,P17813,,,,,,Human,carotuximab,9098,,,315661183,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,0,
Endoplasmic reticulum aminopeptidase 1,1566,ERAP1,Q9NZ08,,,,,,Human,compound 17 [PMID: 23916253],8666,,,252166866,Inhibitor,Inhibition,,f,f,,pIC50,0,5.590000153,0,IC50,0,2600,0,=,,,,23916253,NCCCC[C@@H](C(=O)O)NC(=O)c1ccc(c(c1)NC(=O)[C@H](CCc1ccccc1)N)N
Endoplasmic reticulum aminopeptidase 1,1566,ERAP1,Q9NZ08,,,,,,Human,compound 2g [PMID: 27390066],9682,,,348353641,Inhibitor,Inhibition,,f,f,,pKi,0,6.28000021,0,Ki,0,530,0,=,,,,27390066,OC(=O)C(CP(=O)(C(CCc1ccc(cc1)[N+](=O)[O-])N)O)Cc1ccccc1
Endoplasmic reticulum aminopeptidase 1,1566,ERAP1,Q9NZ08,,,,,,Human,compound 3v [PMID: 27390066],9683,,,348353642,Inhibitor,Inhibition,,f,f,,pKi,0,3.599999905,0,Ki,0,250000,0,>,,,,27390066,COc1ccc(cc1)CCNCC(P(=O)(O)O)N
Endoplasmic reticulum aminopeptidase 2,1567,ERAP2,Q6P179,,,,,,Human,compound 17 [PMID: 23916253],8666,,,252166866,Inhibitor,Inhibition,,f,f,,pIC50,0,5.050000191,0,IC50,0,8900,0,=,,,,23916253,NCCCC[C@@H](C(=O)O)NC(=O)c1ccc(c(c1)NC(=O)[C@H](CCc1ccccc1)N)N
Endoplasmic reticulum aminopeptidase 2,1567,ERAP2,Q6P179,,,,,,Human,compound 2g [PMID: 27390066],9682,,,348353641,Inhibitor,Inhibition,,f,f,,pKi,0,6.820000172,0,Ki,0,150,0,=,,,,27390066,OC(=O)C(CP(=O)(C(CCc1ccc(cc1)[N+](=O)[O-])N)O)Cc1ccccc1
Endoplasmic reticulum aminopeptidase 2,1567,ERAP2,Q6P179,,,,,,Human,compound 3v [PMID: 27390066],9683,,,348353642,Inhibitor,Inhibition,,f,t,,pKi,0,6.210000038,0,Ki,0,620,0,=,,,,27390066,COc1ccc(cc1)CCNCC(P(=O)(O)O)N
endoplasmic reticulum to nucleus signaling 1,2020,ERN1,O75460,,,,,,Human,compound 34 [PMID: 24749861],8129,,,249565809,Inhibitor,Inhibition,,f,f,,pIC50,0,7.329999924,0,IC50,0,47,0,=,Inhibition of RNAse activity.,,,24749861,O=Cc1c(O)ccc2c1oc(=O)c1c2CCN(C1)C(=N)N
Endothelin-converting enzyme 1,1615,ECE1,P42892,,,,,,Human,compound 22 [PMID: 19899765],6562,,,178103176,Inhibitor,Inhibition,,f,f,,pKi,0,5.920000076,0,Ki,0,1200,0,=,,,,19899765,O=C(N[C@H](P(=O)(CC(C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)Cc1ccccc1)O)Cc1ccccc1)OCc1ccccc1
Endothelin-converting enzyme 2,1616,ECE2,O60344,,,,,,Human,compound 1 [PMID: 18507370],8673,,,252166873,Inhibitor,Inhibition,,f,t,,pIC50,0,5.190000057,0,IC50,0,6420,0,=,,,,18507370,Oc1ccccc1/C=C\c1ccc2c(n1)cccc2
Endothelin-converting enzyme 2,1616,ECE2,O60344,,,,,,Human,compound 1 [PMID: 18507370],8673,,,252166873,Inhibitor,Inhibition,,f,t,,pIC50,0,5.190000057,0,IC50,0,6420,0,=,,,,18507370,Oc1ccccc1/C=Cc1ccc2c(n1)cccc2
EPH receptor A1,1821,EPHA1,P21709,,,,,,Human,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,t,,pIC50,0,5.639999866,0,IC50,0,2300,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A1,1821,EPHA1,P21709,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.539999962,0,IC50,0,2.900000095,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A2,1822,Epha2,Q03145,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.659999847,0,IC50,0,2200,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A2,1822,EPHA2,P29317,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.640000343,0,IC50,0,2.299999952,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A2,1822,EPHA2,P29317,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
EPH receptor A3,1823,Epha3,P29319,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A3,1823,EPHA3,P29320,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A3,1823,EPHA3,P29320,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
EPH receptor A4,1824,Epha4,Q03137,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.570000172,0,IC50,0,2700,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A4,1824,EPHA4,P54764,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A5,1825,Epha5,P54757,,,,,,Rat,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.619999886,0,IC50,0,2400,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A5,1825,EPHA5,P54756,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A6,1826,Epha6,Q62413,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A7,1827,Epha7,Q61772,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A7,1827,EPHA7,Q15375,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,5.949999809,0,IC50,0,1118,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor A7,1827,EPHA7,Q15375,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,8.380000114,0,IC50,0,4.199999809,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
EPH receptor A8,1828,Epha8,O09127,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor A8,1828,EPHA8,P29322,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor B1,1830,Ephb1,P09759,,,,,,Rat,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.420000076,0,IC50,0,3800,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor B1,1830,EPHB1,P54762,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor B2,1831,Ephb2,P54763,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.420000076,0,IC50,0,3800,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor B2,1831,EPHB2,P29323,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor B3,1832,Ephb3,P54754,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.360000134,0,IC50,0,4400,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor B3,1832,EPHB3,P54753,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor B4,1833,Ephb4,P54761,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.360000134,0,IC50,0,4400,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
EPH receptor B4,1833,EPHB4,P54760,,,,,,Human,compound 66 [PMID: 19788238],8141,,,249565821,Inhibitor,Inhibition,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.600000024,0,=,,,,19788238,COc1ccccc1n1c(cn2c1nc1c2c(=O)[nH]c(=O)n1C)c1cc(O)ccc1C
EPH receptor B6,1834,Ephb6,O08644,,,,,,Mouse,compound 20 [PMID: 23489211],8124,,,249565804,Inhibitor,Inhibition,,f,f,,pIC50,0,5.239999771,0,IC50,0,5800,0,=,,,,23489211,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C)C)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,cetuximab,6882,,,178103464,Antibody,Binding,,f,t,,pKd,0,9.409999847,0,Kd,0,0.389999986,0,=,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AEE788,7643,,,223365978,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,15256466,CCN1CCN(CC1)Cc1ccc(cc1)c1cc2c([nH]1)ncnc2N[C@@H](c1ccccc1)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,afatinib,5667,,,178102295,Inhibitor,Inhibition,,f,t,,pIC50,9.300000191,0,7.960000038,IC50,11,0,0.5,=,,,,20550212,CN(C/C=C/C(=O)Nc1cc2c(ncnc2cc1O[C@@H]1COCC1)Nc1ccc(c(c1)Cl)F)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,afatinib,5667,,,178102295,Inhibitor,Inhibition,,f,t,,pKd,0,9.600000381,0,Kd,0,0.25,0,=,,,,22037378,CN(C/C=C/C(=O)Nc1cc2c(ncnc2cc1O[C@@H]1COCC1)Nc1ccc(c(c1)Cl)F)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG 112,5913,,,178102536,Inhibitor,Inhibition,,f,t,,pIC50,0,6.900000095,0,IC50,0,125,0,=,Measuring inhibition of substrate phosphorylation.,,,2552117,N#C/C(=C\c1ccc(cc1)O)/C(=C(C#N)C#N)N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG 112,5913,,,178102536,Inhibitor,Inhibition,,f,t,,pIC50,0,6.900000095,0,IC50,0,125,0,=,Measuring inhibition of substrate phosphorylation.,,,2552117,N#C/C(=Cc1ccc(cc1)O)/C(=C(C#N)C#N)N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG1478,4862,,,178101563,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,10090785,COc1cc2c(ncnc2cc1OC)Nc1cccc(c1)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG 490,5916,,,178102539,Inhibitor,Inhibition,,f,t,,pIC50,0,6.400000095,0,IC50,0,400,0,=,Inhibition of substrate phosphorylation.,,,1676428,N#C/C(=C\c1ccc(c(c1)O)O)/C(=O)NCc1ccccc1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG 490,5916,,,178102539,Inhibitor,Inhibition,,f,t,,pIC50,0,6.400000095,0,IC50,0,400,0,=,Inhibition of substrate phosphorylation.,,,1676428,N#C/C(=Cc1ccc(c(c1)O)O)/C(=O)NCc1ccccc1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,AG 9,5917,,,178102540,Inhibitor,Inhibition,,f,t,,pKi,0,3.400000095,0,Ki,0,400000,0,>,Measuring phosphorylation of the EGFR exogenous substrate polyGAT [poly(Glu<sub>6</sub>Ala<sub>3</sub>Tyr)],,,2552117,COc1ccc(cc1)C=C(C#N)C#N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,BMS-599626,7647,,,223365982,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,19821562,O=C(Nc1cn2c(c1C)c(ncn2)Nc1ccc2c(c1)cnn2Cc1cccc(c1)F)OC[C@@H]1COCCN1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,BMS-690514,7879,,,223366208,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,20166197,COc1cccc(c1)Nc1ncnn2c1c(cc2)CN1CC[C@H]([C@@H](C1)O)N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,BPIQ-I,5939,,,178102562,Inhibitor,Inhibition,,f,t,,pIC50,0,10.60000038,0,IC50,0,0.025,0,=,,,,8632415,Brc1cccc(c1)Nc1ncnc2c1cc1ncn(c1c2)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,brigatinib,7741,,,223366074,Inhibitor,Inhibition,,f,f,,pIC50,0,6.889999866,0,IC50,0,129,0,=,,,,21502504,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1P(=O)(C)C)Cl)N1CCC(CC1)N(C)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,canertinib,5675,,,178102302,Inhibitor,Inhibition,,f,t,,pKd,0,9.720000267,0,Kd,0,0.189999998,0,=,,,,22037378,C=CC(=O)Nc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,canertinib,5675,,,178102302,Inhibitor,Inhibition,,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,Inhibition of kinase activity,,,10753475,C=CC(=O)Nc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,compound 56 [PMID: 8568816],5956,,,178102579,Inhibitor,Inhibition,,f,t,,pIC50,0,11.22000027,0,IC50,0,0.006,0,=,,,,8568816,CCOc1cc2c(ncnc2cc1OCC)Nc1cccc(c1)Br
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,amphiregulin,4864,AREG,Human,178101565,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,betacellulin,4873,BTC,Human,178101574,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epoxide hydrolase 2,2970,EPHX2,P34913,,,,,,Human,BI-1935,9717,,,348353676,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,In a biochemical h-sEH binding assay.,,,19758802,CCOCCn1cc(ccc1=O)C(=O)Nc1ccc(cn1)n1nc(cc1C(F)(F)F)c1cccnc1
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9537820,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9537820,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,8.1,0,-,0,0,0,=,,,,11999132,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,8.1,0,-,0,0,0,=,,,,11999132,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,10634944,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,6.1,0,5.9,,0,0,0,,,,,10634944,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,6.1,0,5.9,,0,0,0,,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,6,0,5.9,,0,0,0,,,,,10634944,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9537820,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)(C)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O)(C)C
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9537820,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9537820,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9537820,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)CCC[C@H](O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9537820,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)CCC[C@H](O)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8078484,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)CCC[C@H](O)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8078484,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)CCC[C@H](O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,AH13205,1928,,,135649907,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9313928,CCCCCC(c1ccc(cc1)C1CCC(=O)C1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,AH13205,1928,,,135649907,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10462542,CCCCCC(c1ccc(cc1)C1CCC(=O)C1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,f,,pKi,7,0,5.900000095,-,0,0,0,=,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,9537820,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9313928,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,compound 1 [PMID: 20080612],5819,,,178102444,Allosteric modulator,Positive,,f,,,-,0,0,0,-,0,0,0,=,,,,20080612,CCOC(=O)c1c(sc2c1CCCCC2)NC(=O)c1ccco1
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9537820,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9313928,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,AH6809,1896,,,135649910,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,10634944,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,beraprost,1967,,,135649983,Agonist,Agonist,,f,f,,pKi,0,6.170000076,0,Ki,0,680,0,=,,,,17545310,CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,8.37,0,Ki,0,4.3,0,=,,,,9537820,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,8.37,0,Ki,0,4.3,0,=,,,,9537820,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,8.43,0,Ki,0,3.7,0,=,,,,9313928,OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,17-phenyl-<i>&omega;</i>-trinor-PGE<sub>2</sub>,1912,,,135651383,Agonist,Full agonist,,f,,,pKi,0,8.43,0,Ki,0,3.7,0,=,,,,9313928,OC(=O)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,4.93,0,Ki,0,11800,0,=,,,,9537820,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,5.78,0,Ki,0,1643,0,=,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7.51,0,Ki,0,31,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7.51,0,Ki,0,31,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,7.85,0,Ki,0,14,0,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,7.85,0,Ki,0,14,0,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,,,pKi,0,6.77,0,Ki,0,170,0,=,,,,9313928,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,cicaprost,1917,,,135650094,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,6.59,0,Ki,0,255,0,=,,,,10634944,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pEC50,0,6.66,0,EC50,0,221,0,=,,,,9694973,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pEC50,0,6.66,0,EC50,0,221,0,=,,,,9694973,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,8.36,0,Ki,0,4.4,0,=,,,,10634944,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,8.36,0,Ki,0,4.4,0,=,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Partial agonist,,f,,,pKi,0,8.82,0,Ki,0,1.5,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Partial agonist,,f,,,pKi,0,8.72,0,Ki,0,1.9,0,=,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)(C)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Partial agonist,,f,,,pKi,0,8.72,0,Ki,0,1.9,0,=,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O)(C)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,AH6809,1896,,,135649910,Antagonist,Antagonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,5.8,0,Ki,0,1600,0,=,,,,10634944,CC(Oc1ccc2c(c1)oc1c(c2=O)cc(cc1)C(=O)O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Agonist,,f,,,pEC50,0,9.33,0,EC50,0,0.47,0,=,,,,19584306,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,beraprost,1967,,,135649983,Agonist,Agonist,,f,f,,pKi,0,5.139999866,0,Ki,0,7200,0,=,,,,17545310,CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,10952683,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,11-deoxy-PGE<sub>1</sub>,1925,,,135651369,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,11-deoxy-PGE<sub>2</sub>,1945,,,135649645,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1C/C=C\CCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,11-deoxy-PGE<sub>2</sub>,1945,,,135649645,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1CCC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,"13,14-dihydro-PGE<sub>1</sub>",1946,,,135651374,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,10952683,CCCCC[C@@H](CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)(C)C
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,"16,16-dimethyl-PGE<sub>2</sub>",1926,,,135651380,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9313928,CCCCC([C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O)(C)C
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9537820,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)CCC[C@H](O)C
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,19(<i>R</i>)-OH-PGE<sub>2</sub>,1947,,,135651384,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9537820,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)CCC[C@H](O)C
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,1-OH-PGE<sub>1</sub>,1944,,,135651385,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9313928,O[C@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)CCCC(O)C
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,9537820,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10634944,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9537820,OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9537820,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,5.6,0,4.9,,0,0,0,,,,,10634944,OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,5.6,0,4.9,,0,0,0,,,,,10634944,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,10634944,OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,10634944,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,AH23848 (racemic),1950,,,135649909,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,9537820,OC(=O)CC/C=C/CCC1C(OCc2ccc(cc2)c2ccccc2)CC(=O)C1N1CCOCC1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,BGC201531,3380,,,178100398,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,Ki,0,12.60000038,0,=,,,,19154437,COc1ccc(nc1)c1ccc(cc1)OCC1CC(OC1C)C(=O)NS(=O)(=O)c1ccccc1C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,CJ-042794,5857,,,178102481,Antagonist,Antagonist,,f,,,pKi,0,8.51,0,Ki,0,3.1,0,=,,,,18031725,Clc1ccc(c(c1)C(=O)N[C@H](c1ccc(cc1)C(=O)O)C)Oc1ccc(cc1)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,AEE788,7643,,,223365978,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,15256466,CCN1CCN(CC1)Cc1ccc(cc1)c1cc2c([nH]1)ncnc2N[C@@H](c1ccccc1)C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,afatinib,5667,,,178102295,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,18408761,CN(C/C=C/C(=O)Nc1cc2c(ncnc2cc1O[C@@H]1COCC1)Nc1ccc(c(c1)Cl)F)C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,BMS-599626,7647,,,223365982,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,22,0,=,,,,19821562,O=C(Nc1cn2c(c1C)c(ncn2)Nc1ccc2c(c1)cnn2Cc1cccc(c1)F)OC[C@@H]1COCCN1
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,BMS-690514,7879,,,223366208,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,20166197,COc1cccc(c1)Nc1ncnn2c1c(cc2)CN1CC[C@H]([C@@H](C1)O)N
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,canertinib,5675,,,178102302,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,Inhibition of ErbB2 autophosphorylation,,,10753475,C=CC(=O)Nc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,AEE788,7643,,,223365978,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,15256466,CCN1CCN(CC1)Cc1ccc(cc1)c1cc2c([nH]1)ncnc2N[C@@H](c1ccccc1)C
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,BMS-599626,7647,,,223365982,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,19821562,O=C(Nc1cn2c(c1C)c(ncn2)Nc1ccc2c(c1)cnn2Cc1cccc(c1)F)OC[C@@H]1COCCN1
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.190000057,0,IC50,0,65,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,betacellulin,4873,BTC,Human,178101574,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Erythrocyte urea transporter,982,SLC14A1,Q13336,,,,,,Human,compound 1a [PMID: 23597791],8881,,,252827538,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,~,,,,23597791,CCc1ccc(cc1)S(=O)(=O)c1nnn2c1nc(NCc1cccs1)c1c2ccs1
Erythrocyte urea transporter,982,Slc14a1,Q8VHL0,,,,,,Mouse,compound 1a [PMID: 23597791],8881,,,252827538,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,23597791,CCc1ccc(cc1)S(=O)(=O)c1nnn2c1nc(NCc1cccs1)c1c2ccs1
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,17&beta;-estradiol,1013,,,135651381,Agonist,Agonist,,t,t,,pKi,0,9.819999695,0,-,0,0,0,=,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Agonist,,f,,,pKi,0,9.85,0,,0,0,0,,,,,9048584,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Agonist,,f,,,pKi,0,9.85,0,,0,0,0,,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,AC-186,8897,,,310264678,Agonist,Agonist,,f,f,,pEC50,0,5.300000191,0,EC50,0,5000,0,=,Measured using Receptor Selection and Amplification Technology (R-SAT).,,,23898966,Oc1ccc(cc1)C1(CCC(CC1)(F)F)c1ccccc1F
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,,,pKi,0,9.85,0,,0,0,0,,,,,9048584,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,,,pKi,0,9.85,0,,0,0,0,,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16307879,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16307879,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,bazedoxifene,7355,,,178103927,Antagonist,Antagonist,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,11356100,Oc1ccc2c(c1)c(C)c(n2Cc1ccc(cc1)OCCN1CCCCCC1)c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,clomiphene,4159,,,178100979,Antagonist,Antagonist,,f,t,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,0,CCN(CCOc1ccc(cc1)C(=C(c1ccccc1)Cl)c1ccccc1)CC
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,17&beta;-estradiol,1013,,,135651381,Agonist,Agonist,,t,,,pKi,0,9.34,0,,0,0,0,,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,AC-186,8897,,,310264678,Agonist,Agonist,,f,t,,pEC50,0,8.220000267,0,EC50,0,6,0,=,Measured using Receptor Selection and Amplification Technology (R-SAT).,,,23898966,Oc1ccc(cc1)C1(CCC(CC1)(F)F)c1ccccc1F
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,bisphenol A,7865,,,223366195,Agonist,Partial agonist,,f,f,,pEC50,0,5.960000038,0,EC50,0,1100,0,=,,,,23768907,CC(c1ccc(cc1)O)(c1ccc(cc1)O)C
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,9048584,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Antagonist,Antagonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,bazedoxifene,7355,,,178103927,Antagonist,Antagonist,,f,t,,pIC50,0,7.070000172,0,IC50,0,85,0,=,,,,11356100,Oc1ccc2c(c1)c(C)c(n2Cc1ccc(cc1)OCCN1CCCCCC1)c1ccc(cc1)O
Estrogen-related receptor-&alpha;,622,ESRRA,P11474,,,,,,Human,biochanin A,2829,,,135649823,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,COc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&alpha;,622,Esrra,O08580,,,,,,Mouse,chlordane,2831,,,135650085,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,10493499,ClC1CC2C(C1Cl)C1(C(C2(Cl)C(=C1Cl)Cl)(Cl)Cl)Cl
Estrogen-related receptor-&alpha;,622,ESRRA,P11474,,,,,,Human,compound 1a [PMID: 17556356],2833,,,135650147,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.699999809,0,-,0,0,0,=,,,,17556356,Cc1ccc(cc1)n1cc(c2c1cccc2)CNCC1CCCCC1
Estrogen-related receptor-&beta;,623,ESRRB,O95718,,,,,,Human,biochanin A,2829,,,135649823,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,COc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,biochanin A,2829,,,135649823,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,COc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Inverse agonist,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,16307879,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Inverse agonist,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,16307879,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Inverse agonist,,f,f,,pKd,0,7.460000038,0,Kd,0,35,0,=,,,,11447273,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,4-hydroxytamoxifen,2817,,,135649800,Agonist,Inverse agonist,,f,f,,pKd,0,7.460000038,0,Kd,0,35,0,=,,,,11447273,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,ambrisentan,3951,,,178100778,Antagonist,Antagonist,,f,t,,pIC50,0,7.659999847,0,IC50,0,21.70000076,0,=,,,,15139756,COC([C@@H](C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,ambrisentan,3951,,,178100778,Antagonist,Antagonist,,f,,,pA2,0,7.1,0,-,0,0,0,=,,,,15139756,COC([C@@H](C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,atrasentan,3487,,,178100477,Antagonist,Antagonist,,f,t,,pKi,0,10.47000027,0,Ki,0,0.034000002,0,=,CHO cells expressing human ET<sub>A</sub> receptor.,,,8632312,CCCCN(C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(cc1)OC)C(=O)O)c1ccc2c(c1)OCO2)CCCC
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,atrasentan,3487,,,178100477,Antagonist,Antagonist,,f,f,,pA2,10.5,0,9.199999809,-,0,0,0,=,,,,8632312,CCCCN(C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(cc1)OC)C(=O)O)c1ccc2c(c1)OCO2)CCCC
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,avosentan,8260,,,249565940,Antagonist,Antagonist,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,0,COc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cn1)C)c1ccncc1
ET<sub>A</sub> receptor,219,Ednra,P26684,,,,,,Rat,bosentan,3494,,,178100482,Antagonist,Antagonist,,f,f,,pA2,0,7.199999809,0,-,0,0,0,=,,,,8035319,OCCOc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ncccn1
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,BQ123,997,,,135652048,Antagonist,Antagonist,,f,f,,pA2,7.400000095,0,6.900000095,Ki,0,0,0,=,,,,7647976,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)CC(=O)O)C(C)C)C
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,"[Ala<sup>1,3,11,15</sup>]ET-1",3837,,,178100680,Agonist,Full agonist,,f,f,,pKd,9.199999809,0,8.699999809,Kd,1.820000052,0,0.643000007,=,,,,1472961,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,BQ 3020,3859,,,178100698,Agonist,Full agonist,,f,f,,pKi,0,9.699999809,0,Ki,0,0.180000007,0,=,,,,7733918,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C(C)C)[C@H](CC)C)CC(=O)O)CC(C)C)Cc1nc[nH]c1)C)Cc1ccccc1)Cc1ccc(cc1)O)C(C)C)C)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CCSC)CC(=O)O
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,A192621,1009,,,135649870,Antagonist,Antagonist,,f,f,,pKd,0,8.100000381,0,Kd,0,7.940000057,0,=,,,,10479298,CCCOc1ccc(cc1)[C@@H]1N(CC(=O)Nc2c(CC)cccc2CC)C[C@@H]([C@H]1C(=O)O)c1ccc2c(c1)OCO2
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,ambrisentan,3951,,,178100778,Antagonist,Antagonist,,f,f,,pIC50,0,5.920000076,0,IC50,0,1190,0,=,,,,15139756,COC([C@@H](C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,atrasentan,3487,,,178100477,Antagonist,Antagonist,,f,f,,pKi,0,6.860000134,0,Ki,0,138,0,=,CHO cells expressing human ET<sub>B</sub> receptor.,,,8676339,CCCCN(C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(cc1)OC)C(=O)O)c1ccc2c(c1)OCO2)CCCC
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,bosentan,3494,,,178100482,Antagonist,Antagonist,,f,t,,pKi,0,7.099999905,0,Ki,0,80,0,=,,,,12502366,OCCOc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ncccn1
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,bosentan,3494,,,178100482,Antagonist,Antagonist,,f,,,pA2,0,6,0,-,0,0,0,=,,,,8035319,OCCOc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ncccn1
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,BQ788,1010,,,135650019,Antagonist,Antagonist,,f,f,,pKd,8,0,7.900000095,Kd,12.60000038,0,10,=,,,,8904635,CCCC[C@@H](N(C(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@H](C)CCC[C@@H]1C)C(=O)[C@@H](Cc1cn(c2c1cccc2)C(=O)OC)N)C(=O)O
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,BQ788,1010,,,135650019,Antagonist,Antagonist,,f,,,pKd,0,7.5,0,,0,0,0,,,,,8904635,CCCC[C@@H](N(C(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@H](C)CCC[C@@H]1C)C(=O)[C@@H](Cc1cn(c2c1cccc2)C(=O)OC)N)C(=O)O
euchromatic histone lysine methyltransferase 1,2651,EHMT1,Q9H9B1,,,,,,Human,A-366,8238,,,249565918,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,38,0,=,,,,24900801,COc1cc2c(cc1OCCCN1CCCC1)N=C(C12CCC1)N
euchromatic histone lysine methyltransferase 1,2651,EHMT1,Q9H9B1,,,,,,Human,BIX-01294,7014,,,178103593,Inhibitor,Inhibition,,f,f,,pIC50,0,4.420000076,0,IC50,0,38000,0,=,,,,17289593,COc1cc2nc(nc(c2cc1OC)NC1CCN(CC1)Cc1ccccc1)N1CCCN(CC1)C
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,A-366,8238,,,249565918,Inhibitor,Inhibition,,f,t,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,24900801,COc1cc2c(cc1OCCCN1CCCC1)N=C(C12CCC1)N
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,BIX-01294,7014,,,178103593,Inhibitor,Inhibition,,f,f,,pIC50,0,5.769999981,0,IC50,0,1700,0,=,Antibody-based detection of <i>in vitro</i> methylation.,,,17289593,COc1cc2nc(nc(c2cc1OC)NC1CCN(CC1)Cc1ccccc1)N1CCCN(CC1)C
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,BRD9539,7375,,,178103947,Inhibitor,Inhibition,,f,f,,pIC50,0,5.199999809,0,IC50,0,6300,0,=,,,,22536950,O=C(c1ccccc1)Nc1nc2c(n1CCCc1ccccc1)ccc(c2)C(=O)O
eukaryotic elongation factor 2 kinase,2014,EEF2K,O00418,,,,,,Human,compound 34 [PMID: 20189382],8743,,,252827401,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,20189382,NC(=O)c1sc2c(c1N)c(c1ccco1)c1c(n2)CCCCCCC1
eukaryotic translation initiation factor 2 alpha kinase 1,2015,EIF2AK1,Q9BQI3,,,,,,Human,compound 27 [PMID: 19854648],8168,,,249565848,Inhibitor,Inhibition,,f,t,,pIC50,0,8.199999809,0,IC50,0,6.309999943,0,=,,,,19854648,COc1cc2c3[nH]nc(c3C(=O)c2cc1OC)NCc1c(Cl)cccc1Cl
eukaryotic translation initiation factor 2 alpha kinase 2,2016,EIF2AK2,P19525,,,,,,Human,Cdk2 inhibitor IV,5949,,,178102572,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,21632247,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC
eukaryotic translation initiation factor 2 alpha kinase 4,2018,EIF2AK4,Q9P2K8,,,,,,Human,compound A127 [WO2013110309],8169,,,249565849,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,24900825,OCCOC(c1ccc(cc1)n1nnc2c1cnc(n2)Nc1ccn(n1)CC)(C)C
Eythropoietin receptor,1718,EPOR,P19235,,,,,,Human,cibinetide,9677,,,348353636,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OC[C@@H](C(=O)N[C@H](C(=O)O)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)O)CCC(=O)N)CC(C)C)CCC(=O)O)CCCN=C(N)N)C)CC(C)C)CC(=O)N
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,22R-hydroxycholesterol,2742,,,135651388,Agonist,Agonist,,t,,,pEC50,0,5.5,0,,0,0,0,,,,,16371446,CC(CC[C@H]([C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)O)C
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,chenodeoxycholic acid,608,,,135651455,Agonist,Agonist,,t,t,,pEC50,0,5.300000191,0,-,0,0,0,=,,,,10334993,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
Farnesoid X receptor,603,,,,,,,,None,cholic acid,609,,,135651459,Agonist,Agonist,,t,,,pEC50,5,0,4,,0,0,0,,,,,10334993,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
Farnesoid X receptor-&beta;,604,Nr1h5,,,,,,,Mouse,cholesten,2802,,,135651456,Agonist,Agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,12529392,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2[C@]1(C)CCCC2)C)C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,alendronate,3141,,,135649795,Inhibitor,Inhibition,,f,t,,pIC50,0,6.340000153,0,IC50,0,460,0,=,,,,10620343,NCCCC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,alendronate,3141,,,135649795,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,<i>In vitro</i> inhibition of recombinant human protein expressed in <i>E coli</i>.,,,11160603,NCCCC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,cimadronate,3174,,,135651341,Inhibitor,Inhibition,,f,,,pKi,0,7.2,0,Ki,0,62.4,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21,,,18327899,OP(=O)(C(P(=O)(O)O)NC1CCCCC1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,cimadronate,3174,,,135651341,Inhibitor,Inhibition,,f,,,pIC50,0,7.21,0,IC50,0,61.1,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)NC1CCCCC1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,cimadronate,3174,,,135651341,Inhibitor,Inhibition,,f,,,pIC50,0,6.44,0,IC50,0,365.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21,,,18327899,OP(=O)(C(P(=O)(O)O)NC1CCCCC1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,cimadronate,3174,,,135651341,Inhibitor,Inhibition,,f,,,pKi,0,8,0,Ki,0,10,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)NC1CCCCC1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,compound 2 [PMID: 18295483],3156,,,135649659,Inhibitor,Inhibition,,f,,,pIC50,0,5.1,0,IC50,0,8000,0,=,Inhibition of human FPPS,,,18295483,OC1=C(C(=O)Nc2ccc(cc2)C2CCCCC2)C(=O)N(C1)Cc1ccccc1
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,compound 31 [PMID: 17963374],3152,,,135650357,Inhibitor,Inhibition,,f,,,pIC50,0,6.5,0,,0,0,0,=,"Inhibition of human FPPS, measured through inhibition of tumour cell growth in NCI-H460 cell line . Not a direct enzyme inhibition assay. ",,,17963374,CCCCCCCCCC[S+](CC(P(=O)(O)O)P(=O)(O)[O-])C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,compound 5e [PMID: 17975902],3169,,,135649662,Inhibitor,Inhibition,,f,,,pIC50,0,7.79,0,IC50,0,16.4,0,=,Inhibition of human cloned FPPS expressed in Escherichia col BL2 (DE3),,,17975902,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)F)O
"farnesyltransferase, CAAX box, beta",2826,FNTB,P49356,,,,,,Human,BMS-214662,8026,,,249565706,Inhibitor,Inhibition,,f,t,,pIC50,0,8.869999886,0,IC50,0,1.350000024,0,=,,,,11020273,N#Cc1ccc2c(c1)CN([C@@H](CN2Cc1[nH]cnc1)Cc1ccccc1)S(=O)(=O)c1cccs1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,BIA 10-2474,9001,,,310264779,Inhibitor,Inhibition,,f,f,,pIC50,7.300000191,0,7.150000095,IC50,70,0,50,=,Inhibition of human FAAH expressed in HEK293T cells.,,,28596366,[O-][n+]1cccc(c1)c1ncn(c1)C(=O)N(C1CCCCC1)C
Fatty acid amide hydrolase,1400,Faah,P97612,,,,,,Rat,BIA 10-2474,9001,,,310264779,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,~,This value is an extrapolated estimate from % inhibition data provided in Table 1 of the referenced patent.,,,0,[O-][n+]1cccc(c1)c1ncn(c1)C(=O)N(C1CCCCC1)C
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,BIA 10-2639,9603,,,340590233,Inhibitor,Inhibition,,f,f,,pIC50,7.300000191,0,7.150000095,IC50,70,0,50,=,<i>In situ</i> inhibition in HEK3293T cells expressing human FAAH.,,,28596366,CN(C(=O)n1cnc(c1)c1cccnc1)C1CCCCC1
Fatty acid amide hydrolase,1400,Faah,P97612,,,,,,Rat,"compound 19y [Kiss <i>et al</i>., 2011]",9013,,,310264791,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Measured in rat brain homogenate.,,,0,Clc1ccc(cc1)Oc1oc(=O)n(n1)c1ccc(c(c1)O)O
fatty acid binding protein 3,2533,FABP3,P05413,,,,,,Human,compound 13 [PMID: 17502136],8797,,,252827455,Inhibitor,Inhibition,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,17502136,Clc1ccc(c(c1)Cl)COc1c(cccc1C(=O)O)OCc1ccc(cc1Cl)Cl
fatty acid binding protein 4,2534,FABP4,P15090,,,,,,Human,compound 13 [PMID: 17502136],8797,,,252827455,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,17502136,Clc1ccc(c(c1)Cl)COc1c(cccc1C(=O)O)OCc1ccc(cc1Cl)Cl
fatty acid binding protein 5,2535,FABP5,Q01469,,,,,,Human,compound 13 [PMID: 17502136],8797,,,252827455,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,17502136,Clc1ccc(c(c1)Cl)COc1c(cccc1C(=O)O)OCc1ccc(cc1Cl)Cl
Fatty acid transport protein 1,1108,SLC27A1,Q6PCB7,,,,,,Human,compound 5k [PMID: 23528296],8801,,,252827459,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,23528296,Fc1ccc(nc1)N1CCN(CC1)CC(=O)Nc1nc2c(s1)CCCC2
Fatty acid transport protein 4,1111,SLC27A4,Q6P1M0,,,,,,Human,compound 1l [PMID: 16644217],8810,,,252827468,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,16644217,CCCC/C=C/COC(=O)C1=C(C)NC(=O)NC1c1ccc(cc1)[N+](=O)[O-]
FER tyrosine kinase,2022,FER,P16591,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7.070000172,0,IC50,0,85,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
FER tyrosine kinase,2022,FER,P16591,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
"FES proto-oncogene, tyrosine kinase",2023,FES,P07332,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,99,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
"FES proto-oncogene, tyrosine kinase",2023,FES,P07332,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,AMG-837,6485,,,178103099,Agonist,Agonist,,f,,,pEC50,0,8.5,0,-,0,0,0,=,,,,22859723,CC#C[C@H](c1ccc(cc1)OCc1cccc(c1)c1ccc(cc1)C(F)(F)F)CC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,compound 4 [PMID: 27074625],9148,,,315661233,Agonist,Agonist,,f,t,,pKd,8.399999619,0,8.130000114,Kd,7.400000095,0,4,=,,,,27074625,OC(=O)CCc1ccc(cc1F)OCc1cccc(c1)c1ccc(cc1C)OCCOCCNc1ccc(c2=NCN=c12)N(O)[O]
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,f,,pEC50,5.699999809,0,4.599999905,-,0,0,0,=,,,,12496284,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,f,,pEC50,5.699999809,0,4.599999905,-,0,0,0,=,,,,12496284,CC/C=CC/C=CC/C=CCCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,compound B [PMID:18477808],3367,,,178100391,Agonist,Full agonist,,f,,,pEC50,0,6.1,0,-,0,0,0,=,,,,18477808,O=C1NC(=O)C(S1)Cc1ccc(cc1C)Oc1ncc(cc1Cl)C(F)(F)F
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,1-methylcyclopropanecarboxylic acid,6500,,,178103114,Agonist,Agonist,,t,f,,pEC50,0,2.599999905,0,-,0,0,0,=,,,,21220428,OC(=O)C1(C)CC1
FFA2 receptor,226,Ffar2,Q76EI6,,,,,,Rat,compound 1 [PMID: 23589301],6488,,,178103102,Agonist,Agonist,,f,,,pEC50,0,7.1,0,-,0,0,0,=,,,,23589301,OC(=O)CC(C(=O)N(c1scc(n1)c1cc(Cl)ccc1Cl)C1CC1)Cc1ccccc1
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,acetic acid,1058,,,135651422,Agonist,Full agonist,,t,f,,pEC50,4.599999905,0,3.099999905,-,0,0,0,=,,,,12496283,CC(=O)O
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,butyric acid,1059,,,135650039,Agonist,Full agonist,,t,f,,pEC50,4.599999905,0,2.900000095,-,0,0,0,=,,,,12496283,CCCC(=O)O
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,AMG7703,5803,,,178102428,Allosteric modulator,Positive,,f,,,pEC50,6.35,0,5.9,EC50,1270,0,450,=,,,,18818303,CC([C@H](C(=O)Nc1nccs1)c1ccc(cc1)Cl)C
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,CATPB,6487,,,178103101,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,23066016,OC(=O)C[C@@H](NC(=O)Cc1cccc(c1)Cl)Cc1ccc(cc1)C(F)(F)F
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,1-methylcyclopropanecarboxylic acid,6500,,,178103114,Agonist,Full agonist,,t,f,,pEC50,0,3.900000095,0,-,0,0,0,=,,,,21220428,OC(=O)C1(C)CC1
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,acetic acid,1058,,,135651422,Agonist,Full agonist,,f,f,,pEC50,3.900000095,0,2.799999952,-,0,0,0,=,,,,12496283,CC(=O)O
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,butyric acid,1059,,,135650039,Agonist,Full agonist,,t,f,,pEC50,4.900000095,0,3.799999952,-,0,0,0,=,,,,12496283,CCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,compound A [PMID 24997608],8418,,,252166628,Agonist,Agonist,,f,t,,pEC50,0,7.619999886,0,EC50,0,0,0,=,Fluorometric calcium assay using FLIPR methodology.,,,24997608,OC(=O)CC1CCC2(CC1)CCN(CC2)c1cc(ccc1Cl)OC(F)(F)F
FFA4 receptor,127,Ffar4,Q2AC31,,,,,,Rat,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,f,,pEC50,0,5.059999943,0,-,0,0,0,=,,,,18320172,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O
FFA4 receptor,127,Ffar4,Q2AC31,,,,,,Rat,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,f,,pEC50,0,5.059999943,0,-,0,0,0,=,,,,18320172,CC/C=CC/C=CC/C=CCCCCCCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,,,pEC50,0,5.5,0,-,0,0,0,=,,,,22519963,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,&alpha;-linolenic acid,1049,,,135651436,Agonist,Full agonist,,t,,,pEC50,0,5.5,0,-,0,0,0,=,,,,22519963,CC/C=CC/C=CC/C=CCCCCCCCC(=O)O
"FGR proto-oncogene, Src family tyrosine kinase",2024,FGR,P09769,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,f,,pIC50,0,6.159999847,0,IC50,0,697,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
"FGR proto-oncogene, Src family tyrosine kinase",2024,FGR,P09769,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
"FGR proto-oncogene, Src family tyrosine kinase",2024,FGR,P09769,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
fibroblast activation protein alpha,2365,FAP,Q12884,,,,,,Human,ARI-3099,8563,,,252166764,Inhibitor,Inhibition,,f,t,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,23594271,OB([C@@H]1CCCN1C(=O)[C@H](NC(=O)c1ccncc1)C)O
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,anlotinib,9601,,,340590231,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,<i>in vitro</i> activity,,,0,COc1cc2c(ccnc2cc1OCC1(N)CC1)Oc1ccc2c(c1F)cc([nH]2)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,t,,pIC50,9.149999619,0,8.300000191,IC50,5,0,0.699999988,<,,,,26080733,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,BGJ-398,7877,,,223366206,Inhibitor,Inhibition,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,,,,21936542,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,BLU9931,8862,,,252827519,Inhibitor,Inhibition,,f,f,,pIC50,0,6.230000019,0,IC50,0,591,0,=,,,,25776529,C=CC(=O)Nc1cccc(c1Nc1ncc2c(n1)ccc(c2)c1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,brivanib,5671,,,178102299,Inhibitor,Inhibition,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,22037378,C[C@H](COc1cn2c(c1C)c(ncn2)Oc1ccc2c(c1F)cc([nH]2)C)O
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,brivanib,5671,,,178102299,Inhibitor,Inhibition,,f,f,,pIC50,0,6.829999924,0,IC50,0,148,0,=,,,,16570908,C[C@H](COc1cn2c(c1C)c(ncn2)Oc1ccc2c(c1F)cc([nH]2)C)O
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.06000042,0,IC50,0,8.699999809,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,compound 7r [PMID: 26080733],8639,,,252166839,Inhibitor,Inhibition,,f,f,,pIC50,0,8.539999962,0,IC50,0,2.900000095,0,=,,,,26080733,CCN1CCN(CC1)c1ccc(cc1)C(=O)Nc1n[nH]c2c1ccc(c2)c1cccc(c1F)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,0,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,BGJ-398,7877,,,223366206,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,21936542,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,BLU9931,8862,,,252827519,Inhibitor,Inhibition,,f,f,,pIC50,0,6.309999943,0,IC50,0,493,0,=,,,,25776529,C=CC(=O)Nc1cccc(c1Nc1ncc2c(n1)ccc(c2)c1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,0,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,BGJ-398,7877,,,223366206,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,21936542,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,BLU9931,8862,,,252827519,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,25776529,C=CC(=O)Nc1cccc(c1Nc1ncc2c(n1)ccc(c2)c1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,f,,pIC50,0,6.940000057,0,IC50,0,115,0,=,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,f,,pIC50,0,6.78000021,0,IC50,0,165,0,=,,,,0,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,BGJ-398,7877,,,223366206,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,21936542,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,BLU9931,8862,,,252827519,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,25776529,C=CC(=O)Nc1cccc(c1Nc1ncc2c(n1)ccc(c2)c1c(Cl)c(OC)cc(c1Cl)OC)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,anlotinib,9601,,,340590231,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,<i>In vitro</i> activity,,,0,COc1cc2c(ccnc2cc1OCC1(N)CC1)Oc1ccc2c(c1F)cc([nH]2)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,brivanib,5671,,,178102299,Inhibitor,Inhibition,,f,f,,pIC50,0,6.420000076,0,IC50,0,380,0,=,,,,16570908,C[C@H](COc1cn2c(c1C)c(ncn2)Oc1ccc2c(c1F)cc([nH]2)C)O
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,Cdk1/2 inhibitor III,5946,,,178102569,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,15974571,Fc1cccc(c1NC(=S)n1nc(nc1N)Nc1ccc(cc1)S(=O)(=O)N)F
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,6.360000134,0,Ki,0,440,0,=,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.140000343,0,IC50,0,7.199999809,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,AC710,8095,,,249565775,Inhibitor,Inhibition,,f,t,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,,,,24900421,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(cc1)NC(=O)Nc1noc(c1)C(C)(C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,AKN-028,7969,,,249565652,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,22864397,Nc1ncc(nc1Nc1ccc2c(c1)cc[nH]2)c1ccncc1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,t,,pKi,0,6.920000076,0,Ki,0,120,0,=,Inhibition of wild type FLT3,,,18820131,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,t,,pIC50,0,6.28000021,0,IC50,0,520,0,=,,,,17638907,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,t,,pKd,0,9.100000381,0,Kd,0,0.790000021,0,=,,,,22037378,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,BMS-690514,7879,,,223366208,Inhibitor,Inhibition,,f,f,,pIC50,0,6.960000038,0,IC50,0,110,0,=,,,,20166197,COc1cccc(c1)Nc1ncnn2c1c(cc2)CN1CC[C@H]([C@@H](C1)O)N
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,ceritinib,7397,,,178103969,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,23742252,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,compound 14k [PMID: 21982499],8214,,,249565894,Inhibitor,Inhibition,,f,f,,pIC50,0,6.980000019,0,IC50,0,104,0,=,,,,21982499,Clc1ccccc1Nc1nc2c(cccc2c2c1ccnc2)c1[nH]cnn1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.680000305,0,IC50,0,2.099999905,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,compound 5e [PMID: 28580438],9712,,,348353671,Inhibitor,Inhibition,,f,t,,pKd,0,8.43999958,0,Kd,0,3.599999905,0,=,Measured using the Z-LYTE Kinase Assay Kit and wild type FLT3.,,,28580438,CC(Nc1ccnc(n1)Nc1cccc(c1)c1cccnc1)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,t,,pIC50,0,9.069999695,0,IC50,0,0.850000024,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,anlotinib,9601,,,340590231,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,<i>In vitro</i> activity,,,0,COc1cc2c(ccnc2cc1OCC1(N)CC1)Oc1ccc2c(c1F)cc([nH]2)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,CC-223,8914,,,310264695,Inhibitor,Inhibition,,f,f,,pIC50,0,6.190000057,0,IC50,0,651,0,=,,,,26083478,COC1CCC(CC1)N1C(=O)CNc2c1nc(cn2)c1ccc(nc1)C(O)(C)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
Folate hydrolase (prostate-specific membrane antigen) 1,1606,FOLH1,Q04609,,,,,,Human,capromab,6878,,,178103460,Antibody,Binding,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
Folate hydrolase (prostate-specific membrane antigen) 1,1606,FOLH1,Q04609,,,,,,Human,compound 8d [PMID: 15027864],8659,,,252166859,Inhibitor,Inhibition,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,15027864,O=C(N[C@H](C(=O)O)CCC(=O)O)N[C@H](C(=O)O)Cc1ccc(cc1)O
FPR1,222,FPR1,P21462,,,,,,Human,AG-09/1,5833,,,178102458,Agonist,Full agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,19903830,COc1ccc2c(c1)nc([nH]2)SCC(=O)Nc1ccc(cc1)[N+](=O)[O-]
FPR1,222,FPR1,P21462,,,,,,Human,AG-11/03,5832,,,178102457,Agonist,Full agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,22127612,COc1ccc2c(c1)nc([nH]2)SCC(=O)Nc1ccc(cc1)SC
FPR1,222,FPR1,P21462,,,,,,Human,AG-14,5835,,,178102460,Agonist,Full agonist,,f,,,pEC50,0,7.4,0,-,0,0,0,=,,,,17229869,COc1cc(/C=N/NC(=O)c2ccc3c(c2)OCO3)ccc1OCc1ccccc1
FPR1,222,Fpr1,P33766,,,,,,Mouse,annexin I,1031,ANXA1,Human,135651619,Agonist,Full agonist,,f,,,pEC50,0,6.6,0,-,0,0,0,=,,,,17948261,
FPR1,222,FPR1,P21462,,,,,,Human,annexin I-(2-26),1044,ANXA1,Human,135651620,Agonist,Full agonist,,f,,,pEC50,6.1,0,5.8,-,0,0,0,=,,,,10882119,
FPR1,222,FPR1,P21462,,,,,,Human,compound R-(-)-5f [PMID: 22607879],5834,,,178102459,Agonist,Full agonist,,f,f,,pEC50,0,6,0,EC50,0,940,0,=,,,,22607879,COc1cccc(c1)Cc1cc(C)nn(c1=O)[C@@H](C(=O)Nc1ccc(cc1)Br)c1ccccc1
FPR1,222,FPR1,P21462,,,,,,Human,3570-0208 [PMID:19807662],5828,,,178102453,Antagonist,Antagonist,,f,,,pKi,0,7,0,-,0,0,0,=,,,,19807662,CCc1cc2c(cc1OC(=O)C)oc(c(c2=O)c1nc2c(n1C)cccc2)C
FPR1,222,FPR1,P21462,,,,,,Human,BVT173187,5825,,,178102450,Antagonist,Antagonist,,f,,,pIC50,0,7,0,-,0,0,0,=,,,,22410002,Cc1ccc(c(c1)NC(=O)c1cc(Cl)cc(c1O)Cl)Cl
FPR1,222,FPR1,P21462,,,,,,Human,chenodeoxycholic acid,608,,,135651455,Antagonist,Antagonist,,f,,,pKi,0,4,0,-,0,0,0,=,,,,11211928,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
FPR2/ALX,223,FPR2,P25090,,,,,,Human,ACT-389949,9511,,,329968450,Agonist,Agonist,,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,FPR2/ALX internalization into monocytes.,,,27730665,Cc1cccc(c1)c1oc(nc1C(=O)Nc1cnn(n1)Cc1occ(n1)C(F)(F)C)C
FPR2/ALX,223,FPR2,P25090,,,,,,Human,AG-26,6268,,,178102888,Agonist,Full agonist,,f,,,pEC50,0,6.3,0,-,0,0,0,=,,,,19903830,COc1ccc(cc1)CCNC(=O)Nc1ccc(cc1)Cl
FPR2/ALX,223,FPR2,P25090,,,,,,Human,amyloid &beta;,4865,APP,Human,178101566,Agonist,Full agonist,,f,f,,pEC50,0,7,0,-,0,0,0,=,,,,11316806,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,annexin I,1031,ANXA1,Human,135651619,Agonist,Full agonist,,t,,,pKd,0,6.5,0,-,0,0,0,=,,,,12368905,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,annexin I-(2-26),1044,ANXA1,Human,135651620,Agonist,Full agonist,,f,,,pEC50,6.05,0,5.77,-,0,0,0,=,,,,10882119,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,aspirin triggered lipoxin A4,3933,,,135651445,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC[C@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,aspirin triggered lipoxin A4,3933,,,135651445,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC[C@H](/C=C/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,aspirin-triggered resolvin D1,6239,,,178102860,Agonist,Full agonist,,t,f,,pEC50,0,11.10000038,0,-,0,0,0,=,,,,22449948,CC/C=C\C[C@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](C/C=C\CCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,aspirin-triggered resolvin D1,6239,,,178102860,Agonist,Full agonist,,t,f,,pEC50,0,11.10000038,0,-,0,0,0,=,,,,22449948,CC/C=CC[C@H](/C=C/C=CC=CC=C[C@H]([C@H](C/C=CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,ATLa2,3383,,,178100400,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,15056011,OC(=O)CCC[C@@H]([C@@H](/C=C/C=C/C=C\C=C\[C@@H](COc1ccc(cc1)F)C)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,ATLa2,3383,,,178100400,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,15056011,OC(=O)CCC[C@@H]([C@@H](/C=C/C=C/C=CC=C[C@@H](COc1ccc(cc1)F)C)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,CGEN-855A,6241,,,178102862,Agonist,Full agonist,,f,,,pIC50,0,6.72,0,IC50,0,189,0,=,,,,19023040,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,CGEN-855A,6241,,,178102862,Agonist,Full agonist,,f,,,pKi,0,7.27,0,Ki,0,54.1,0,=,,,,19023040,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,compound R-(-)-5f [PMID: 22607879],5834,,,178102459,Agonist,Full agonist,,f,f,,pEC50,0,6.269999981,0,EC50,0,540,0,=,,,,22607879,COc1cccc(c1)Cc1cc(C)nn(c1=O)[C@@H](C(=O)Nc1ccc(cc1)Br)c1ccccc1
FPR2/ALX,223,FPR2,P25090,,,,,,Human,compound 1754-31 [PMID: 23788657],6263,,,178102883,Antagonist,Antagonist,,f,,,pIC50,0,7.09,0,-,0,0,0,=,,,,23788657,CC([C@H]1CNC(=O)C(=O)N1C[C@@H]1CCCN1C[C@H](N1C[C@@H](Cc2ccc(cc2)O)N(C(=O)C1=O)CC1CCCCC1)Cc1ccc2c(c1)cccc2)C
FPR3,224,FPR3,P25089,,,,,,Human,annexin I-(2-26),1044,ANXA1,Human,135651620,Agonist,Full agonist,,t,,,pEC50,7,0,5,,0,0,0,,,,,15187149,
FP receptor,344,PTGFR,P43088,,,,,,Human,AL12180,3386,,,178100403,Agonist,Agonist,,f,f,,pEC50,7.900000095,0,7.699999809,EC50,22,0,14,=,,,,17076623,OC(=O)CC/C=C\CC[C@@H]1[C@@H](/C=C/[C@H](COc2cccc(c2)Cl)O)OC[C@@H]1O
FP receptor,344,PTGFR,P43088,,,,,,Human,AL12180,3386,,,178100403,Agonist,Agonist,,f,f,,pEC50,7.900000095,0,7.699999809,EC50,22,0,14,=,,,,17076623,OC(=O)CC/C=CCC[C@@H]1[C@@H](/C=C/[C@H](COc2cccc(c2)Cl)O)OC[C@@H]1O
FP receptor,344,PTGFR,P43088,,,,,,Human,"13,14-dihydro-16-<i>m</i>-chlorophenoxy-<i>w</i>-tetranor-PGF<sub>1&alpha;</sub>",1955,,,135649649,Agonist,Full agonist,,f,,,pIC50,9,0,8.6,,0,0,0,,,,,10715159,O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,bimatoprost,1958,,,135649995,Agonist,Full agonist,,f,t,,pIC50,0,5.300000191,0,IC50,0,5011,0,=,,,,12606640,CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,bimatoprost,1958,,,135649995,Agonist,Full agonist,,f,t,,pIC50,0,5.300000191,0,IC50,0,5011,0,=,,,,12606640,CCNC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,bimatoprost (free acid form),1959,,,135649996,Agonist,Full agonist,,f,t,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,10952685,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,bimatoprost (free acid form),1959,,,135649996,Agonist,Full agonist,,f,t,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,10952685,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
FP receptor,344,PTGFR,P43088,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,6.5,0,6.4,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
FP receptor,344,PTGFR,P43088,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,6.5,0,6.4,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
FP receptor,344,PTGFR,P43088,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
FP receptor,344,Ptgfr,P43118,,,,,,Rat,AL-8810,1956,,,135649914,Agonist,Partial agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10454504,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H]([C@@H]1/C=C/[C@@H](C1Cc2c(C1)cccc2)O)F
FP receptor,344,Ptgfr,P43118,,,,,,Rat,AL-8810,1956,,,135649914,Agonist,Partial agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10454504,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@@H]([C@@H]1/C=C/[C@@H](C1Cc2c(C1)cccc2)O)F
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,AL-8810,1956,,,135649914,Agonist,Partial agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10454504,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H]([C@@H]1/C=C/[C@@H](C1Cc2c(C1)cccc2)O)F
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,AL-8810,1956,,,135649914,Agonist,Partial agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10454504,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@@H]([C@@H]1/C=C/[C@@H](C1Cc2c(C1)cccc2)O)F
FP receptor,344,PTGFR,P43088,,,,,,Human,AS604872,3424,,,178100429,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,Ki,0,35,0,=,,,,17618756,O=C([C@@H]1SCCN1S(=O)(=O)c1ccc(cc1)c1ccccc1)N[C@@H](c1ccccn1)c1ccccc1
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pEC50,0,6,0,EC50,0,1000,0,>,,,,0,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
fyn related Src family tyrosine kinase,2025,FRK,P42685,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,CGS8216,4156,,,178100977,Agonist,Inverse agonist,,f,f,,pKi,0,10.30000019,0,Ki,0,0.050000001,0,=,,,,10633039,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,&alpha;3IA,4094,,,178100917,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COc1ccc(cc1)c1cc(C(=O)OC)c(=O)n(c1c1ccncc1)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,&alpha;5IA,4095,,,178100918,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cn1nnc(c1)COc1nn2c(nnc2c2c1cccc2)c1noc(c1)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,alprazolam,7111,,,178103688,Allosteric modulator,Positive,,f,f,,pEC50,0,7.429999828,0,EC50,0,37,0,=,,benzodiazepine site,,12408715,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,clonazepam,6963,,,178103544,Allosteric modulator,Positive,,f,t,,pKi,0,8.899999619,0,Ki,0,1.269999981,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;1&gamma;2.,,,2551039,O=C1CN=C(c2c(N1)ccc(c2)[N+](=O)[O-])c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,CGS8216,4156,,,178100977,Agonist,Inverse agonist,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,,,,10633039,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,&alpha;3IA,4094,,,178100917,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COc1ccc(cc1)c1cc(C(=O)OC)c(=O)n(c1c1ccncc1)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,&alpha;5IA,4095,,,178100918,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cn1nnc(c1)COc1nn2c(nnc2c2c1cccc2)c1noc(c1)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,alprazolam,7111,,,178103688,Allosteric modulator,Positive,,f,f,,pEC50,0,7.920000076,0,EC50,0,12,0,=,,benzodiazepine site,,12408715,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,AZD7325,7712,,,223366045,Allosteric modulator,Positive,,f,t,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,0,CCCNC(=O)c1nnc2c(c1N)cccc2c1c(F)cccc1OC
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,clonazepam,6963,,,178103544,Allosteric modulator,Positive,,f,t,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;2&beta;1&gamma;2.,,,2551039,O=C1CN=C(c2c(N1)ccc(c2)[N+](=O)[O-])c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,CGS8216,4156,,,178100977,Agonist,Inverse agonist,,f,f,,pKi,0,9.920000076,0,Ki,0,0.119999997,0,=,,,,10633039,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,&alpha;5IA,4095,,,178100918,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cn1nnc(c1)COc1nn2c(nnc2c2c1cccc2)c1noc(c1)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,&alpha;3IA,4094,,,178100917,Allosteric modulator,None,higher affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COc1ccc(cc1)c1cc(C(=O)OC)c(=O)n(c1c1ccncc1)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,alprazolam,7111,,,178103688,Allosteric modulator,Positive,,f,f,,pEC50,0,7.159999847,0,EC50,0,69,0,=,,benzodiazepine site,,12408715,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,AZD7325,7712,,,223366045,Allosteric modulator,Positive,,f,t,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,0,CCCNC(=O)c1nnc2c(c1N)cccc2c1c(F)cccc1OC
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,clonazepam,6963,,,178103544,Allosteric modulator,Positive,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;3&beta;1&gamma;2.,,,2551039,O=C1CN=C(c2c(N1)ccc(c2)[N+](=O)[O-])c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,CGS8216,4156,,,178100977,Agonist,Inverse agonist,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,10633039,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,&alpha;3IA,4094,,,178100917,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COc1ccc(cc1)c1cc(C(=O)OC)c(=O)n(c1c1ccncc1)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,&alpha;5IA,4095,,,178100918,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cn1nnc(c1)COc1nn2c(nnc2c2c1cccc2)c1noc(c1)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,alprazolam,7111,,,178103688,Allosteric modulator,Positive,,f,f,,pEC50,0,8,0,EC50,0,10,0,=,,benzodiazepine site,,12408715,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,CGS8216,4156,,,178100977,Agonist,Inverse agonist,,f,f,,pKi,0,7.769999981,0,Ki,0,17,0,=,,,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,bretazenil,4146,,,178100967,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1ncn2c1[C@@H]1CCCN1C(=O)c1c2cccc1Br)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,5&alpha;-pregnan-3&alpha;-ol-20-one,4108,,,178100930,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,bicuculline,2312,,,135652669,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
GABA<sub>A</sub> receptor &rho;1 subunit,420,Gabrr1,P50572,,,,,,Rat,CACA,4148,,,178100969,Agonist,Agonist,,f,f,,pEC50,0,4.130000114,0,EC50,0,74000,0,=,,,,8386310,NC/C=C\C(=O)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,Gabrr1,P50572,,,,,,Rat,CACA,4148,,,178100969,Agonist,Agonist,,f,f,,pEC50,0,4.130000114,0,EC50,0,74000,0,=,,,,8386310,NC/C=CC(=O)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,5-Me-IAA,4107,,,178100929,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Cc1nc[nH]c1CC(=O)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,aza-THIP,4143,,,178100965,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Oc1n[nH]c2c1CCNC2
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,5-Me-IAA,4107,,,178100929,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Cc1nc[nH]c1CC(=O)O
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,aza-THIP,4143,,,178100965,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Oc1n[nH]c2c1CCNC2
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,5-Me-IAA,4107,,,178100929,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Cc1nc[nH]c1CC(=O)O
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,aza-THIP,4143,,,178100965,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,Oc1n[nH]c2c1CCNC2
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,3-APPA,1081,,,135649732,Agonist,Agonist,,f,f,,pIC50,0,5.599999905,0,-,0,0,0,=,,,,9069281,NCCC[P+](=O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,(-)-baclofen,1064,,,135649977,Agonist,Full agonist,,f,,,pIC50,4.6,0,4.4,-,0,0,0,=,,,,9069281,NC[C@@H](c1ccc(cc1)Cl)CC(=O)O
GABA<sub>B1</sub>,240,GABBR1,Q9UBS5,,,,,,Human,CGP 47656,1066,,,135650071,Agonist,Full agonist,,f,,,pIC50,5,0,4.8,,0,0,0,,,,,9069281,NCCCP(=O)(C(F)F)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,2-hydroxy-saclofen,1068,,,135649709,Antagonist,Antagonist,,f,,,pIC50,0,4.1,0,,0,0,0,,,,,9069281,NCC(c1ccc(cc1)Cl)(CS(=O)(=O)O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 35348,1069,,,135650067,Antagonist,Antagonist,,f,,,pIC50,4.8,0,4.6,-,0,0,0,=,,,,9069281,NCCCP(=O)(C(OCC)OCC)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 54626A,1070,,,135650072,Antagonist,Antagonist,,f,,,pIC50,8.8,0,8.7,,0,0,0,,,,,9069281,O[C@H](CP(=O)(CC1CCCCC1)O)CN[C@H](c1ccc(c(c1)Cl)Cl)C
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 56999A,1071,,,135650075,Antagonist,Antagonist,,f,,,pIC50,9.2,0,9.1,,0,0,0,,,,,9069281,O[C@H](CP(=O)(CC1CCCCC1)O)CN[C@@H](c1cccc(c1)C(=O)O)C
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 62349,1072,,,135650076,Antagonist,Antagonist,,f,,,pIC50,9,0,8.8,-,0,0,0,=,,,,9069281,COc1ccc(cc1)CP(=O)(C[C@H](CN([C@@H](c1cccc(c1)C(=O)O)C)C)O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 64213,1073,,,135650077,Antagonist,Antagonist,,f,,,pIC50,8.6,0,8.5,,0,0,0,,,,,9069281,O=C(CCc1ccc(c(c1)I)O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,CGP 71872,1074,,,135650079,Antagonist,Antagonist,,f,,,pIC50,8.4,0,8.3,,0,0,0,,,,,9069281,[N-]=[N+]=Nc1cc(O)c(cc1I)C(=O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B2</sub>,241,Gabbr2,O88871,,,,,,Rat,CGP7930,1079,,,135650080,Allosteric modulator,Positive,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,15126507,OCC(Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C)(C)C
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,3-APPA,1081,,,135649732,Agonist,Agonist,,f,f,,pIC50,0,9.699999809,0,-,0,0,0,=,,,,0,NCCC[P+](=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,3-APMPA,1080,,,135649731,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,0,NCCCP(=O)(O)C
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,3-APMPA,1080,,,135649731,Agonist,Full agonist,,f,,,pKi,0,5.1,0,-,0,0,0,=,,,,11082110,NCCCP(=O)(O)C
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,3-APPA,1081,,,135649732,Agonist,Full agonist,,f,,,pKi,7.2,0,5.2,-,0,0,0,=,,,,12663046,NCCC[P+](=O)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,baclofen,1084,,,135649976,Agonist,Full agonist,,f,t,,pKi,6.199999809,0,4.300000191,-,0,0,0,=,,,,11082110,NCC(c1ccc(cc1)Cl)CC(=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,(-)-baclofen,1064,,,135649977,Agonist,Full agonist,,f,f,,pIC50,0,8.5,0,-,0,0,0,=,,,,0,NC[C@@H](c1ccc(cc1)Cl)CC(=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,CGP 44532,1082,,,135650069,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,-,0,0,0,=,,,,0,CP(=O)(C[C@@H](CN)O)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,compound 14 [PMID: 25050158],8539,,,252166741,Allosteric modulator,Negative,,f,f,,pIC50,0,4.420000076,0,IC50,0,37900,0,=,Negative modulation of GABA-induced IP3 production.,,,25050158,OC(=O)C(=O)/C=C/c1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,2-hydroxy-saclofen,1068,,,135649709,Antagonist,Antagonist,,f,,,pIC50,0,4.1,0,-,0,0,0,=,,,,9069281,NCC(c1ccc(cc1)Cl)(CS(=O)(=O)O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,CGP 35348,1069,,,135650067,Antagonist,Antagonist,,f,,,pIC50,0,5.4,0,,0,0,0,,,,,12037141,NCCCP(=O)(C(OCC)OCC)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,CGP 35348,1069,,,135650067,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,-,0,0,0,=,,,,11082110,NCCCP(=O)(C(OCC)OCC)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,CGP 36742,1085,,,135650068,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,12037141,CCCCP(=O)(CCCN)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,CGP 46381,1086,,,135650070,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11082110,NCCCP(=O)(CC1CCCCC1)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,CGP 54626A,1070,,,135650072,Antagonist,Antagonist,,f,,,pKi,8.2,0,8.1,,0,0,0,,,,,11082110,O[C@H](CP(=O)(CC1CCCCC1)O)CN[C@H](c1ccc(c(c1)Cl)Cl)C
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,CGP 55845,1088,,,135650073,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,-,0,0,0,=,,,,11082110,O[C@H](CP(=O)(Cc1ccccc1)O)CN[C@H](c1ccc(c(c1)Cl)Cl)C
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,CGP 55845,1088,,,135650073,Antagonist,Antagonist,,f,,,pIC50,0,9.8,0,-,0,0,0,=,,,,12037141,O[C@H](CP(=O)(Cc1ccccc1)O)CN[C@H](c1ccc(c(c1)Cl)Cl)C
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,CGP 62349,1072,,,135650076,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.5,-,0,0,0,=,,,,11082110,COc1ccc(cc1)CP(=O)(C[C@H](CN([C@@H](c1cccc(c1)C(=O)O)C)C)O)O
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,alarin,6123,Galp,Rat,178102744,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,20880399,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,"2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide",3486,,,178100476,Antagonist,Antagonist,,f,f,,pIC50,0,5.570000172,0,IC50,0,2700,0,=,,,,10896115,O=S1(=O)CCS(=O)(=O)C=C1
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pIC50,0,8.31,0,IC50,0,4.9,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,10.09,0,9.16,Ki,0.69,0,0.082,=,,,,9808667,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,9.02,0,8.7,Ki,2,0,0.96,=,,,,9271210,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,9.55,0,7.8,Ki,16,0,0.28,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pIC50,8.98,0,8.2,IC50,6.3,0,1.04,=,,,,9168941,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,alarin,6123,Galp,Rat,178102744,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,20880399,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,9.25,0,7.72,Ki,19,0,0.56,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,0,7.85,0,Ki,0,14,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pEC50,0,8.03,0,EC50,0,9.33,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.7,Ki,2,0,0.63,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pIC50,0,8.08,0,IC50,0,8.39,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pIC50,8.44,0,7.64,IC50,23,0,3.6,=,,,,9427506,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,alarin,6123,Galp,Rat,178102744,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,20880399,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,"[Ala<sup>6</sup>, D-Trp<sup>8</sup>]galanin-(1-15)-ol",6146,,,178102767,Antagonist,Antagonist,,f,,,pKi,0,7.75,0,Ki,0,17.9,0,=,,,,9405385,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,9.12,0,8.35,Ki,4.47,0,0.75,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,C7,3861,,,178100700,Antagonist,Antagonist,,f,,,pKi,0,8.08,0,Ki,0,8.31,0,=,,,,9722565,
&gamma;-Glutamyl carboxylase,1268,GGCX,P38435,,,,,,Human,anisindione,6960,,,178103541,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)C1C(=O)c2c(C1=O)cccc2
GAT1,929,SLC6A1,P30531,,,,,,Human,CI-966,4612,,,178101332,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,260,0,=,,,,7851497,OC(=O)C1=CCCN(C1)CCOC(c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(F)(F)F
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,"(2E, 6E)-farnesylbisphosphonate",3200,,,135649700,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,Inhibition of GST-tagged human recombinant GGDPS expressed in BL21 gold bacteria,,,17905588,C/C(=C\CC/C(=C/CC(P(=O)(O)O)P(=O)(O)O)/C)/CCC=C(C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,"(2E, 6E)-farnesylbisphosphonate",3200,,,135649700,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,Inhibition of GST-tagged human recombinant GGDPS expressed in BL21 gold bacteria,,,17905588,C/C(=CCC/C(=C/CC(P(=O)(O)O)P(=O)(O)O)/C)/CCC=C(C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,3-azageranylgeranyl diphosphate,3199,,,135649733,Inhibitor,Inhibition,,f,,,pIC50,0,6.85,0,IC50,0,140,0,=,Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).,,,12014956,CN(CC/C=C(/CC/C=C(/CCC=C(C)C)\C)\C)CCOP(=O)(OP(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,3-azageranylgeranyl diphosphate,3199,,,135649733,Inhibitor,Inhibition,,f,,,pIC50,0,6.85,0,IC50,0,140,0,=,Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).,,,12014956,CN(CC/C=C(/CC/C=C(/CCC=C(C)C)C)C)CCOP(=O)(OP(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-252,3198,,,135650015,Inhibitor,Inhibition,,f,,,pIC50,0,6.14,0,IC50,0,720,0,=,Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).,,,12014956,CCCCCCCCCC(P(=O)(O)O)(P(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-252,3198,,,135650015,Inhibitor,Inhibition,,f,,,pIC50,0,6.15,0,IC50,0,710,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCC(P(=O)(O)O)(P(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-608,7977,,,249565660,Inhibitor,Inhibition,,f,f,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,17535895,OC(P(=O)(O)O)(P(=O)(O)O)Cc1cccc(c1)c1cccc(c1)c1ccccc1
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-628,3188,,,135650016,Inhibitor,Inhibition,,f,,,pIC50,0,6.14,0,IC50,0,720,0,=,Inhibition of human GGPPS; radiometric assay,,,17535895,OP(=O)(C(P(=O)(O)O)(Cc1cccc(c1)c1ccc(cc1)c1ccccc1)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-628,3188,,,135650016,Inhibitor,Inhibition,,f,,,pIC50,0,6.14,0,IC50,0,720,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,OP(=O)(C(P(=O)(O)O)(Cc1cccc(c1)c1ccc(cc1)c1ccccc1)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-629,7976,,,249565659,Inhibitor,Inhibition,,f,f,,pKi,0,6.960000038,0,Ki,0,110,0,=,,,,17535895,OP(=O)(C(P(=O)(O)O)(Cc1cccc(c1)c1cccc2c1oc1c2cccc1)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-675,7975,,,249565658,Inhibitor,Inhibition,,f,f,,pKi,0,7.150000095,0,Ki,0,70,0,=,,,,17535895,OP(=O)(C(P(=O)(O)O)(Cc1cccc(c1)c1cccc(c1)NS(=O)(=O)c1ccc2c(c1)cccc2)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-676,7978,,,249565661,Inhibitor,Inhibition,,f,f,,pKi,0,6.960000038,0,Ki,0,110,0,=,,,,17535895,OP(=O)(C(P(=O)(O)O)(COc1cccc(c1)c1cccc(c1)c1ccccc1)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-715,3196,,,135650017,Inhibitor,Inhibition,,f,,,pIC50,0,6.55,0,IC50,0,280,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCOc1ccc[n+](c1)CC(P(=O)(O)O)P(=O)(O)[O-]
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,BPH-742,3189,,,135650018,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCCC[P+](CC(P(=O)(O)O)P(=O)(O)[O-])(C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 11 [PMID: 18800762],3191,,,135650200,Inhibitor,Inhibition,,f,,,pIC50,0,5.6,0,-,0,0,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCCC(P(=O)(O)O)(P(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 12  [PMID: 12014956],3192,,,135649719,Inhibitor,Inhibition,,f,,,pIC50,0,6.51,0,IC50,0,310,0,=,Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).,,,12014956,CN(CC/C=C(/CCC=C(C)C)\C)CCCOP(=O)(OP(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 12  [PMID: 12014956],3192,,,135649719,Inhibitor,Inhibition,,f,,,pIC50,0,6.51,0,IC50,0,310,0,=,Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase).,,,12014956,CN(CC/C=C(/CCC=C(C)C)C)CCCOP(=O)(OP(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 14 [PMID: 18800762],3194,,,135649714,Inhibitor,Inhibition,,f,,,pIC50,0,6.55,0,IC50,0,280,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCOc1cc(c[n+](c1)C)CC(P(=O)(O)O)P(=O)(O)[O-]
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 16 [PMID: 18800762],3195,,,135649698,Inhibitor,Inhibition,,f,,,pIC50,0,6.46,0,IC50,0,350,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCCCN(CC(P(=O)(O)O)P(=O)(O)O)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 19 [PMID: 18800762],3193,,,135649686,Inhibitor,Inhibition,,f,,,pIC50,0,6.23,0,IC50,0,590,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,CCCCCCCCCCOc1cccc(c1)CC(P(=O)(O)O)(P(=O)(O)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 47 [PMID: 18800762],3197,,,135649650,Inhibitor,Inhibition,,f,,,pIC50,0,4.56,0,IC50,0,27540,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,Clc1ccc(c(c1)Cl)CC(P(=O)(O)O)(P(=O)(O)O)Cc1ccc(cc1Cl)Cl
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,compound 51 [PMID: 18800762],3186,,,135649702,Inhibitor,Inhibition,,f,,,pIC50,0,4.1,0,-,0,0,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,NC(=N)NCC(P(=O)(O)O)(P(=O)(O)O)O
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,Abbott 14c,5871,,,178102495,Antagonist,Antagonist,,f,,,pIC50,0,8.15,0,IC50,0,7,0,=,,,,16854051,O=C(NC(C)(C)C)Nc1ccc(cc1)c1c(N)nc(nc1COCc1ccccc1)N
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,BIM 28163,1101,,,135652042,Antagonist,Antagonist,,f,,,pKi,0,8.09,0,Ki,0,8.1,0,=,,,,15339248,
GHRH receptor,247,GHRHR,Q02643,,,,,,Human,BIM28011,3857,,,178100696,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8993400,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,"[Ac-Tyr<sup>1</sup>, D-Arg<sup>2</sup>]GHRH-(1-29)-NH<sub>2</sub> (human)",1125,,,135651975,Antagonist,Antagonist,,f,,,pKi,8.5,0,8.3,,0,0,0,,,,,9892695,
GLP-1 receptor,249,Glp1r,P32301,,,,,,Rat,albiglutide,7386,,,178103958,Agonist,Agonist,,f,f,,pEC50,0,7.699999809,0,EC50,0,20,0,=,,,,15331566,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,BETP,7585,,,223365920,Allosteric modulator,Positive,,f,f,,pEC50,0,9.899999619,0,-,0,0,0,=,,,,24997604,CCS(=O)c1nc(cc(n1)C(F)(F)F)c1cccc(c1)OCc1ccccc1
GluA1,444,GRIA1,P42261,,,,,,Human,AMPA,4131,,,178100953,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA1,444,GRIA1,P42261,,,,,,Human,aniracetam,4133,,,178100955,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)C(=O)N1CCCC1=O
GluA1,444,GRIA1,P42261,,,,,,Human,ATPO,4141,,,178100963,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(noc1C(C)(C)C)OCP(=O)(O)O)N
GluA1,444,GRIA1,P42261,,,,,,Human,argiotoxin,4138,,,178100960,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NC(=NCCC[C@@H](C(=O)NCCCNCCCNCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N)N)N
GluA2,445,GRIA2,P42262,,,,,,Human,AMPA,4131,,,178100953,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA2,445,GRIA2,P42262,,,,,,Human,aniracetam,4133,,,178100955,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)C(=O)N1CCCC1=O
GluA2,445,GRIA2,P42262,,,,,,Human,ATPO,4141,,,178100963,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(noc1C(C)(C)C)OCP(=O)(O)O)N
GluA2,445,GRIA2,P42262,,,,,,Human,argiotoxin,4138,,,178100960,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NC(=NCCC[C@@H](C(=O)NCCCNCCCNCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N)N)N
GluA3,446,GRIA3,P42263,,,,,,Human,AMPA,4131,,,178100953,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA3,446,GRIA3,P42263,,,,,,Human,aniracetam,4133,,,178100955,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)C(=O)N1CCCC1=O
GluA3,446,GRIA3,P42263,,,,,,Human,ATPO,4141,,,178100963,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(noc1C(C)(C)C)OCP(=O)(O)O)N
GluA3,446,GRIA3,P42263,,,,,,Human,argiotoxin,4138,,,178100960,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NC(=NCCC[C@@H](C(=O)NCCCNCCCNCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N)N)N
GluA4,447,GRIA4,P48058,,,,,,Human,AMPA,4131,,,178100953,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA4,447,GRIA4,P48058,,,,,,Human,aniracetam,4133,,,178100955,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)C(=O)N1CCCC1=O
GluA4,447,GRIA4,P48058,,,,,,Human,ATPO,4141,,,178100963,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(noc1C(C)(C)C)OCP(=O)(O)O)N
GluA4,447,GRIA4,P48058,,,,,,Human,argiotoxin,4138,,,178100960,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NC(=NCCC[C@@H](C(=O)NCCCNCCCNCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N)N)N
glucagon receptor,251,GCGR,P47871,,,,,,Human,adomeglivant,9479,,,329968419,Antagonist,Antagonist,,f,f,,pKi,0,8.180000305,0,Ki,0,6.659999847,0,=,,,,26681715,OC(=O)CCNC(=O)c1ccc(cc1)[C@@H](Oc1cc(C)c(c(c1)C)c1ccc(cc1)C(C)(C)C)CCC(F)(F)F
glucagon receptor,251,GCGR,P47871,,,,,,Human,BAY27-9955,3491,,,178100480,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,11719833,CCCc1c(cc(c(c1c1ccc(cc1)F)C(O)C)C(C)C)C(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,AZD7594,9325,,,318164844,Agonist,Agonist,,f,f,,pEC50,0,9.050000191,0,EC50,0,0.899999976,0,=,Measuring displacement of <sup>3</sup>H-dexamethasone from the human GR in a competition radioligand binding assay.,,,28937774,C[C@@H]([C@@H](c1ccc2c(c1)OCCO2)Oc1ccc2c(c1)cnn2c1cccc(c1)C(=O)N[C@H]1COCC1)NC(=O)C(F)(F)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,benzodrocortisone,9731,,,0,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@]1(CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C)OC(=O)c1ccccc1
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,BI 653048,9715,,,348353674,Agonist,Agonist,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,25516791,CCS(=O)(=O)c1ncc2c(c1)cc([nH]2)C[C@@](C(F)(F)F)(CC(c1ccc(cc1C(=O)N)F)(C)C)O
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,budesonide,7434,,,178104006,Agonist,Agonist,,f,t,,pEC50,0,7.909999847,0,EC50,0,12.39999962,0,=,,,,21880489,CCCC1O[C@H]2[C@](O1)(C(=O)CO)[C@@]1([C@@H](C2)[C@@H]2CCC3=CC(=O)C=C[C@@]3([C@H]2[C@H](C1)O)C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,budesonide,7434,,,178104006,Agonist,Agonist,,f,f,,pEC50,0,7.420000076,0,EC50,0,38,0,=,,,,28937774,CCCC1O[C@H]2[C@](O1)(C(=O)CO)[C@@]1([C@@H](C2)[C@@H]2CCC3=CC(=O)C=C[C@@]3([C@H]2[C@H](C1)O)C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,C108297,9180,,,315661262,Agonist,Agonist,,f,f,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,,,,18226897,COCCOC[C@@]12Cc3cnn(c3C=C2CCN(C1)S(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ccc(cc1)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,ciclesonide,7469,,,187051772,Agonist,Agonist,,f,t,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,15878996,O=C(C(C)C)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1CCC1=CC(=O)C=C[C@]21C)C1CCCCC1
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,clobetasol propionate,7062,,,178103641,Agonist,Agonist,,f,t,,pKi,0,9.180000305,0,Ki,0,0.662,0,=,,,,0,CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F)C(=O)CCl
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,beclometasone,7059,,,178103638,Agonist,Full agonist,,f,t,,pKi,0,8.430000305,0,Ki,0,3.74000001,0,=,,,,0,OCC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,betamethasone,7061,,,178103640,Agonist,Full agonist,,f,t,,pIC50,0,8.109999657,0,IC50,0,7.739999771,0,=,,,,0,OCC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,AZD9567,9812,,,0,Agonist,Partial agonist,,f,t,,pIC50,0,8.420000076,0,IC50,0,3.799999952,0,=,Binding to human GR <i>in vitro </i>.,,,29424542,CC([C@@H]([C@@H](c1ccccc1)OC1=CC2C(C=C1)N(N=C2)c1ccc(=O)n(c1)C)NC(=O)C(F)(F)C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,AZD9567,9812,,,0,Agonist,Partial agonist,,f,t,,pEC50,0,7.960000038,0,EC50,0,11,0,=,In a cellular transactivation assay.,,,29424542,CC([C@@H]([C@@H](c1ccccc1)OC1=CC2C(C=C1)N(N=C2)c1ccc(=O)n(c1)C)NC(=O)C(F)(F)C)C
Glucokinase,2798,GCK,P35557,,,,,,Human,AZD1656,7701,,,223366034,Activator,Activation,,f,t,,pEC50,0,7.239999771,0,EC50,0,57,0,=,,,,0,COC[C@@H](Oc1cc(Oc2ncc(nc2)C(=O)N2CCC2)cc(c1)C(=O)Nc1ncc(nc1)C)C
Glucose transporter  1,875,SLC2A1,P11166,,,,,,Human,compound 30 [PMID: 22468970],8885,,,310264666,Allosteric modulator,Negative,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,22468970,O=C1S/C(=Cc2ccc(c(c2)C(F)(F)F)O)/C(=O)N1CC(CC(F)(F)F)(CC(F)(F)F)C
"glucosidase alpha, acid",2611,GAA,P10253,,,,,,Human,1-deoxynojirimycin,4642,,,178101359,Inhibitor,Inhibition,,f,f,,pKi,0,6.820000172,0,Ki,0,150,0,=,,,,0,OC[C@H]1NC[C@@H]([C@H]([C@@H]1O)O)O
GluK1,450,GRIK1,P39086,,,,,,Human,8-deoxy-neodysiherbaine,4112,,,178100934,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1COC2C(C1)O[C@@](C2)(C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-]
GluK1,450,GRIK1,P39086,,,,,,Human,ATPA,4140,,,178100962,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[NH3+]C(C(=O)[O-])Cc1c(o[nH]c1=O)C(C)(C)C
GluK1,450,GRIK1,P39086,,,,,,Human,concanavalin A,4162,,,178100982,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluK1,450,GRIK1,P39086,,,,,,Human,"2,4-epi-neodysiherbaine",4102,,,178100925,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@]1(CC2C(O1)[C@@H](O)[C@H](CO2)O)C(=O)[O-])[NH3+]
GluK1,450,GRIK1,P39086,,,,,,Human,ACET,4123,,,178100945,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N[C@H](C(=O)O)Cn1cc(C)c(=O)n(c1=O)Cc1cc(sc1C(=O)O)c1ccccc1
GluK2,451,GRIK2,Q13002,,,,,,Human,concanavalin A,4162,,,178100982,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluK2,451,GRIK2,Q13002,,,,,,Human,"2,4-epi-neodysiherbaine",4102,,,178100925,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@]1(CC2C(O1)[C@@H](O)[C@H](CO2)O)C(=O)[O-])[NH3+]
GluN1,455,GRIN1,Q05586,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,compound 8 [PMID: 17562362},8886,,,310264667,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,17562362,OC(=O)CN(S(=O)(=O)C)c1c(Cl)c(C)cc2c1[nH]c(=O)c(=O)[nH]2
GluN2A,456,GRIN2A,Q12879,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=C\C(C(=O)O)N)/CP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=CC(C(=O)O)N)/CP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,conantokin-G,4161,,,178100981,Antagonist,Antagonist,GluN2B > GluN2D = GluN2C = GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)CCC(=O)O)CC(C(=O)O)C(=O)O)CC(C(=O)O)C(=O)O)CC(C)C)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(=O)N)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(C)C)CCCNC(=N)N)CC(C(=O)O)C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,amantidine,4128,,,178100950,Channel blocker,None,GluN2C = GluN2D &ge; GluN2B &ge; GluN2A,f,t,,-,0,0,0,-,0,0,0,=,,,,0,NC12CC3CC(C2)CC(C1)C3
GluN2B,457,GRIN2B,Q13224,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=C\C(C(=O)O)N)/CP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=CC(C(=O)O)N)/CP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,conantokin-G,4161,,,178100981,Antagonist,Antagonist,GluN2B > GluN2D = GluN2C = GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)CCC(=O)O)CC(C(=O)O)C(=O)O)CC(C(=O)O)C(=O)O)CC(C)C)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(=O)N)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(C)C)CCCNC(=N)N)CC(C(=O)O)C(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,amantidine,4128,,,178100950,Channel blocker,None,GluN2C = GluN2D &ge; GluN2B &ge; GluN2A,f,t,,-,0,0,0,-,0,0,0,=,,,,0,NC12CC3CC(C2)CC(C1)C3
GluN2C,458,GRIN2C,Q14957,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=C\C(C(=O)O)N)/CP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=CC(C(=O)O)N)/CP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,conantokin-G,4161,,,178100981,Antagonist,Antagonist,GluN2B > GluN2D = GluN2C = GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)CCC(=O)O)CC(C(=O)O)C(=O)O)CC(C(=O)O)C(=O)O)CC(C)C)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(=O)N)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(C)C)CCCNC(=N)N)CC(C(=O)O)C(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,amantidine,4128,,,178100950,Channel blocker,None,GluN2C = GluN2D &ge; GluN2B &ge; GluN2A,f,t,,pIC50,0,4.650000095,0,IC50,0,22500,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,NC12CC3CC(C2)CC(C1)C3
GluN2D,459,GRIN2D,O15399,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=C\C(C(=O)O)N)/CP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,CGP37849,4154,,,178100975,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,C/C(=CC(C(=O)O)N)/CP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,conantokin-G,4161,,,178100981,Antagonist,Antagonist,GluN2B > GluN2D = GluN2C = GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)CCC(=O)O)CC(C(=O)O)C(=O)O)CC(C(=O)O)C(=O)O)CC(C)C)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(=O)N)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(C)C)CCCNC(=N)N)CC(C(=O)O)C(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,amantidine,4128,,,178100950,Channel blocker,None,GluN2C = GluN2D &ge; GluN2B &ge; GluN2A,f,t,,-,0,0,0,-,0,0,0,=,,,,0,NC12CC3CC(C2)CC(C1)C3
glutaminase,2891,GLS,O94925,,,,,,Human,CB-839,9053,,,315661138,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,0,O=C(Nc1ccc(nn1)CCCCc1nnc(s1)NC(=O)Cc1ccccn1)Cc1cccc(c1)OC(F)(F)F
Glutamyl aminopeptidase,1568,Enpep,P16406,,,,,,Mouse,compound 40 [PMID: 10602705],8630,,,252166830,Inhibitor,Inhibition,,f,t,,pKi,0,9.06000042,0,Ki,0,0.873000026,0,=,,,,10602705,CC[C@H]([C@@H](C(=O)N1CCC([C@H]1C(=O)O)C(=O)O)NC(=O)[C@@H]([C@@H](CCS(=O)(=O)O)N)S)C
glutathione-disulfide reductase,2613,,,,,,,,None,carmustine,6800,,,178103406,Inhibitor,Inhibition,,f,t,,pIC50,0,4.150000095,0,IC50,0,71000,0,=,The enzyme inhibition assay uses purified <i>S. cerevisiae</i> glutathione reductase,,,19668867,ClCCNC(=O)N(CCCl)N=O
Glycine Receptor (All subtypes),428,,,,,,,,Human,&beta;-alanine,2365,,,135651448,Agonist,Partial agonist,,f,,,pEC50,0,4.3,0,,0,0,0,,,,,9009272,NCCC(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pIC50,0,3.6,0,,0,0,0,,,,,10428078,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
Glycine Receptor (All subtypes),428,,,,,,,,None,"5,7-dichlorokynurenic acid",2361,,,135649822,Subunit-specific,Inhibition,2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,14645455,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,None,alkylbenzene sulfonate,2362,,,135649915,Subunit-specific,Inhibition,2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,9435157,CCCCCCC(c1ccc(cc1)S(=O)(=O)O)CCCCC
Glycine Receptor (All subtypes),428,,,,,,,,None,atropine,320,,,135652667,Subunit-specific,Inhibition,2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,10428078,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
Glycine Receptor (All subtypes),428,,,,,,,,None,bilobalide,2366,,,135652670,Subunit-specific,Inhibition,2 > 1 > 2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,16805834,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
Glycine Receptor (All subtypes),428,,,,,,,,None,colchicine,2367,,,135650118,Subunit-specific,Inhibition,2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,9681937,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)OC
Glycine Receptor (All subtypes),428,,,,,,,,None,&alpha;-Emtbl,2363,,,135649922,Subunit-specific,Mixed,"Potentiation :
2 ,  1,    3<br>
inhibition: 3",f,,>100,-,0,0,0,,0,0,0,,,,,10860922,CC1(CC)CCSC1=O
Glycine Receptor (All subtypes),428,,,,,,,,None,anandamide,2364,,,135651438,Subunit-specific,Potentiation,"&alpha;1 and &alpha;1&beta; only, no effect on &alpha;2 or &alpha;3",f,,<0.01,pEC50,0,7.2,0,,0,0,0,,,,,18755158,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
Glycine Receptor (All subtypes),428,,,,,,,,None,anandamide,2364,,,135651438,Subunit-specific,Potentiation,"&alpha;1 and &alpha;1&beta; only, no effect on &alpha;2 or &alpha;3",f,,<0.01,pEC50,0,7.2,0,,0,0,0,,,,,18755158,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,anandamide,2364,,,135651438,Allosteric modulator,Potentiation,,f,f,,pEC50,0,7.400000095,0,EC50,0,38,0,=,,,,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,anandamide,2364,,,135651438,Allosteric modulator,Potentiation,,f,f,,pEC50,0,7.400000095,0,EC50,0,38,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,bilobalide,2366,,,135652670,Antagonist,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,0,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,colchicine,2367,,,135650118,Antagonist,Antagonist,,f,f,,pIC50,0,3.5,0,IC50,0,324000,0,=,,,,0,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)OC
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,"5,7-dichlorokynurenic acid",2361,,,135649822,Antagonist,Antagonist,,f,f,,pIC50,0,3.700000048,0,IC50,0,188000,0,=,,,,0,Clc1cc(Cl)c2c(c1)[nH]c(cc2=O)C(=O)O
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,bilobalide,2366,,,135652670,Antagonist,Antagonist,,f,f,,pIC50,0,5.099999905,0,IC50,0,8000,0,=,,,,0,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,colchicine,2367,,,135650118,Antagonist,Antagonist,,f,f,,pIC50,0,4.199999809,0,IC50,0,64000,0,=,,,,0,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)OC
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,"(12E,20Z,18S)-8-hydroxyvariabilin",4072,,,178100895,Antagonist,Antagonist,,f,f,,pIC50,0,5.199999809,0,IC50,0,7000,0,=,,,,0,C/C(=C\CCC(CCCc1cocc1)(O)C)/CCC[C@@H](/C=C/1\OC(=O)C(=C1O)C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,"(12E,20Z,18S)-8-hydroxyvariabilin",4072,,,178100895,Antagonist,Antagonist,,f,f,,pIC50,0,5.199999809,0,IC50,0,7000,0,=,,,,0,C/C(=CCCC(CCCc1cocc1)(O)C)/CCC[C@@H](/C=C/1OC(=O)C(=C1O)C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,bilobalide,2366,,,135652670,Antagonist,Antagonist,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,3.700000048,0,IC50,0,204000,0,=,,,,0,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,bilobalide,2366,,,135652670,Antagonist,Antagonist,when co-expressed with the &alpha;2 subunit,f,f,,pIC50,0,4.300000191,0,IC50,0,50000,0,=,,,,0,O=C1O[C@@H]2[C@@]3(C1)C(=O)O[C@H]1[C@]3([C@](C2)(O)C(C)(C)C)[C@@H](O)C(=O)O1
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,aloisine A,5924,,,178102547,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,12519061,CCCCc1c(=C2C=CC(=O)C=C2)[nH]c2c1[nH]ccn2
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,AZD1080,7819,,,223366150,Inhibitor,Inhibition,,f,t,,pKi,0,8.159999847,0,Ki,0,6.900000095,0,=,,,,23410232,N#Cc1ccc2c(c1)/C(=c\1/ccc(c[nH]1)CN1CCOCC1)/C(=O)N2
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,AZD1080,7819,,,223366150,Inhibitor,Inhibition,,f,t,,pKi,0,8.159999847,0,Ki,0,6.900000095,0,=,,,,23410232,N#Cc1ccc2c(c1)/C(=c1/ccc(c[nH]1)CN1CCOCC1)/C(=O)N2
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,CHIR-98014,8016,,,249565696,Inhibitor,Inhibition,,f,t,,pIC50,0,9.18999958,0,IC50,0,0.649999976,0,=,,,,12606497,Clc1ccc(c(c1)Cl)c1nc(NCCNc2ccc(c(n2)N)[N+](=O)[O-])ncc1n1cncc1
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,CHIR-99021,8014,,,249565694,Inhibitor,Inhibition,,f,t,,pIC50,0,8.010000229,0,IC50,0,9.800000191,0,=,,,,12606497,N#Cc1ccc(nc1)NCCNc1ncc(c(n1)c1ccc(cc1Cl)Cl)c1ncc([nH]1)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,1-azakenpaullone,8018,,,249565698,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,14698171,O=C1Nc2cccnc2c2c(C1)c1cc(Br)ccc1[nH]2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,15486189,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,alsterpaullone,5925,,,178102548,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,10998059,O=C1Nc2ccccc2c2c(C1)c1cc(ccc1[nH]2)[N+](=O)[O-]
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,alsterpaullone 2-cyanoethyl,5926,,,178102549,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,18077363,N#CCCc1ccc2c(c1)c1[nH]c3c(c1CC(=O)N2)cc(cc3)[N+](=O)[O-]
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,AZD1080,7819,,,223366150,Inhibitor,Inhibition,,f,t,,pKi,0,7.510000229,0,Ki,0,31,0,=,,,,23410232,N#Cc1ccc2c(c1)/C(=c\1/ccc(c[nH]1)CN1CCOCC1)/C(=O)N2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,AZD1080,7819,,,223366150,Inhibitor,Inhibition,,f,t,,pKi,0,7.510000229,0,Ki,0,31,0,=,,,,23410232,N#Cc1ccc2c(c1)/C(=c1/ccc(c[nH]1)CN1CCOCC1)/C(=O)N2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,AZD2858,8478,,,252166687,Inhibitor,Inhibition,,f,t,,pKi,0,8.31000042,0,Ki,0,4.900000095,0,=,,,,22489897,CN1CCN(CC1)S(=O)(=O)c1ccc(cc1)c1cnc(c(n1)C(=O)Nc1cccnc1)N
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,f,,pIC50,0,6.210000038,0,IC50,0,620,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,f,,pIC50,0,5.130000114,0,IC50,0,7400,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,Cdk1/5 inhibitor,5947,,,178102570,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,18077363,Nc1[nH]nc2c1nc1ccccc1n2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,Cdk/Crk inhibitor,5943,,,178102566,Inhibitor,Inhibition,,f,f,,pIC50,0,6.119999886,0,IC50,0,754,0,=,,,,18077363,OCCOc1ccc(cc1)Cc1nc(=O)c2c(n1)n([nH]c2C(C)C)c1c(Cl)cccc1Cl
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,CHIR-98014,8016,,,249565696,Inhibitor,Inhibition,,f,t,,pIC50,0,9.239999771,0,IC50,0,0.579999983,0,=,,,,12606497,Clc1ccc(c(c1)Cl)c1nc(NCCNc2ccc(c(n2)N)[N+](=O)[O-])ncc1n1cncc1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,CHIR-99021,8014,,,249565694,Inhibitor,Inhibition,,f,t,,pIC50,0,8.170000076,0,IC50,0,6.699999809,0,=,,,,12606497,N#Cc1ccc(nc1)NCCNc1ncc(c(n1)c1ccc(cc1Cl)Cl)c1ncc([nH]1)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,"compound 2f [Jiang <i>et al.</i>, 2018]",9810,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.179999828,0,IC50,0,66,0,=,,,,0,COc1nc(sc1C(=O)NCCCNc1c2CCCCc2nc2c1cccc2)c1ccnc(c1)NC(=O)C1CC1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,compound 2 [PMID: 22560567],8115,,,249565795,Inhibitor,Inhibition,,f,f,,pIC50,0,7.760000229,0,IC50,0,17.20000076,0,=,,,,21295469,Oc1ccc(cc1C)c1nc(=O)[nH]c(c1)c1ccccc1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,compound 4g [PMID: 2680437],9198,,,340590210,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,Evaluated in a Kinase-Glo assay.,,,26804375,O=c1oc2c(n1Cc1nnn(c1)c1ccccc1Cl)nccc2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,compound 52 [PMID: 9677190],5955,,,178102578,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,18077363,OCCNc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,compound 5b [PMID: 24900464],8171,,,249565851,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,24900464,N#Cc1cnn2c1nc(cc2NC1CC1)c1c[nH]c2c1cc(cc2)NC(=O)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,6.840000153,0,IC50,0,146,0,=,,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
glypican 3,2959,GPC3,P51654,,,,,,Human,codrituzumab,8406,,,252166616,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,20847643,
GlyT1,935,SLC6A9,P48067,,,,,,Human,bitopertin,7546,,,223365882,Inhibitor,Inhibition,,f,t,,pEC50,0,7.519999981,0,EC50,0,30,0,=,,,,20491477,Fc1cc(cnc1N1CCN(CC1)C(=O)c1cc(ccc1O[C@H](C(F)(F)F)C)S(=O)(=O)C)C(F)(F)F
GlyT2,936,SLC6A5,Q9Y345,,,,,,Human,ALX 1393,4622,,,178101340,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,Fc1cccc(c1)C(c1ccccc1OCc1ccccc1)OC[C@@H](C(=O)O)N
GlyT2,936,SLC6A5,Q9Y345,,,,,,Human,ALX 1405,4767,,,178101476,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,
GlyT2,936,SLC6A5,Q9Y345,,,,,,Human,bitopertin,7546,,,223365882,Inhibitor,Inhibition,,f,f,,pEC50,0,4.519999981,0,EC50,0,30000,0,>,,,,20491477,Fc1cc(cnc1N1CCN(CC1)C(=O)c1cc(ccc1O[C@H](C(F)(F)F)C)S(=O)(=O)C)C(F)(F)F
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,alarelin,9342,,,328083445,Agonist,Full agonist,,f,f,,pKd,9.699999809,0,9.399999619,Kd,0.400000006,0,0.200000003,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,alarelin,9342,,,328083445,Agonist,Full agonist,,f,f,,pKi,9.300000191,0,9.050000191,Ki,0.899999976,0,0.5,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,Gnrhr,Q01776,,,,,,Mouse,buserelin,3860,,,178100699,Agonist,Full agonist,,f,f,,pEC50,10.05000019,0,9.340000153,EC50,0.460000008,0,0.090000004,=,,,,26774084,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,buserelin,3860,,,178100699,Agonist,Full agonist,,f,f,,pKd,10.39999962,0,9.520000458,Kd,0.300000012,0,0.039999999,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,buserelin,3860,,,178100699,Agonist,Full agonist,,f,f,,pEC50,0,10.52000046,0,EC50,0,0.029999999,0,=,,,,26774084,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,buserelin,3860,,,178100699,Agonist,Full agonist,,f,f,,pKi,10,0,9.399999619,Ki,0.400000006,0,0.100000001,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"5-(N,N-hexamethylene)-amiloride",1192,,,135650351,Allosteric modulator,Negative,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,18344315,NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,CMPD-1,1179,,,135650116,Allosteric modulator,Negative,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,17176055,COc1cc(OC)c(c(c1)OC)NC(=O)c1ccc(o1)Cc1cc2c(cc1C)C(C)(C)CCC2(C)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,abarelix,1188,,,135651965,Antagonist,Antagonist,,f,t,,pKi,9.489999771,0,9.100000381,Ki,0.790000021,0,0.319999993,=,,,,17095587,OC[C@@H](C(=O)N([C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)CC(=O)N)Cc1ccc(cc1)O)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"[Ac-D-2Nal<sup>1</sup>,D4CPA<sup>2</sup>,D-3Pal<sup>3,6</sup>,Leu<sup>8</sup>, D-Ala<sup>10</sup>]GnRH-II",5583,,,178102218,Antagonist,Antagonist,,f,f,,pIC50,0,9.180000305,0,IC50,0,0.660000026,0,=,,,,19638591,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,antarelix,1189,,,135651992,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,9300077,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@@H]1C(=O)NC(C(=O)N)C)CCCCNC(C)C)CC(C)C)CCCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,cetrorelix,1190,,,135652055,Antagonist,Antagonist,,f,t,,pIC50,0,8.699999809,0,IC50,0,1.980000019,0,=,,,,11861490,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(cc1)Cl)NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,cetrorelix,1190,,,135652055,Antagonist,Antagonist,,f,t,,pKi,10,0,9.300000191,-,0,0,0,=,,,,17095587,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(cc1)Cl)NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,CMPD-1,1179,,,135650116,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12606616,COc1cc(OC)c(c(c1)OC)NC(=O)c1ccc(o1)Cc1cc2c(cc1C)C(C)(C)CCC2(C)C
GPBA receptor,37,Gpbar1,Q80SS6,,,,,,Mouse,compound 15 [PMID: 25411721],9078,,,315661163,Agonist,Agonist,,f,f,,pEC50,0,7.519999981,0,-,0,0,0,=,Assessed in a cAMP production assay in Jurkat cells expressing exogenous mGPBAR1.,,,25411721,Fc1ccc(c(c1)C)N(C(=O)c1ccncc1C)Cc1cccc2c1cc([nH]2)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,compound 15 [PMID: 25411721],9078,,,315661163,Agonist,Agonist,,f,f,,pEC50,0,9.420000076,0,-,0,0,0,=,Assessed in a cAMP production assay in Jurkat cells expressing exogenous hGPBAR1.,,,25411721,Fc1ccc(c(c1)C)N(C(=O)c1ccncc1C)Cc1cccc2c1cc([nH]2)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,betulinic acid,3945,,,178100772,Agonist,Full agonist,,f,f,,pEC50,0,5.980000019,0,EC50,0,1040,0,=,,,,19911773,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]1CC[C@H]3[C@@]([C@]1(C)CC2)(C)CC[C@@H]1[C@]3(C)CC[C@@H](C1(C)C)O)C(=O)O
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,chenodeoxycholic acid,608,,,135651455,Agonist,Full agonist,,t,,,pEC50,0,5.4,0,,0,0,0,,,,,12419312,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,cholic acid,609,,,135651459,Agonist,Full agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,12419312,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
GPER,221,GPER1,Q99527,,,,,,Human,17&beta;-estradiol,1013,,,135651381,Agonist,Full agonist,,t,,,pKi,8.5,0,8.2,,0,0,0,,,,,15705806,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
GPRC6 receptor,55,Gprc6a,Q8K4Z6,,,,,,Mouse,calindol,719,,,135650049,Allosteric modulator,Negative,,f,f,,pIC50,0,5,0,IC50,0,10000,0,~,This is an inferred IC50 based on 10&micro;M of the compound inhibiting maximum L-ornithine-induced activation of GPCR6 by approximately 50% (see Fig 1B in reference).,,,19836834,C[C@H](c1cccc2c1cccc2)NCc1cc2c([nH]1)cccc2
G protein-coupled receptor kinase 1,1465,GRK1,Q15835,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.46999979,0,IC50,0,340,0,=,,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
G protein-coupled receptor kinase 4,1468,GRK4,P32298,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.590000153,0,IC50,0,260,0,=,Measuring inhibition of human GRK-4-mediated phosphorylation of bovine tubulin dimers.,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
G protein-coupled receptor kinase 5,1469,GRK5,P34947,,,,,,Human,compound 1o [PMID: 24210504],8143,,,249565823,Inhibitor,Inhibition,,f,t,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,24210504,Nc1ncc(cc1c1nc2c(o1)cc(cc2)N1CCCC1)c1cnn(c1)C1CCNCC1
G protein-coupled receptor kinase 6,1470,GRK6,P43250,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.309999943,0,IC50,0,490,0,=,,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
G protein-coupled receptor kinase 7,1471,GRK7,Q8WTQ7,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,180,0,=,,,,20128603,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
granzyme B,2369,GZMB,P10144,,,,,,Human,compound 20 [PMID:12127536],8650,,,252166850,Inhibitor,Inhibition,,f,t,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,12127536,CC[C@@H]([C@H](N(C(=O)C)C)C(=O)N[C@H]1CCc2c3N(C1=O)[C@@H](Cc3ccc2)C(=O)N[C@H](C(=O)c1nnc(o1)c1ccccc1)CC(=O)O)C
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,cenderitide,9066,,,315661151,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,23272242,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,A-71915,4856,,,178101557,Antagonist,Antagonist,,f,,,pKi,9.5,0,9.2,Ki,0.63,0,0.32,=,,,,1680722,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,anantin,4866,,,178101567,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,1826288,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,"[Asu7,23']&beta;-ANP-(7-28)",4852,,,178101553,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,Ki,0,31,0,=,,,,2542088,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,atrial natriuretic peptide,4869,NPPA,Human,178101570,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,8700153,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,brain natriuretic peptide,4890,NPPB,Human,178101590,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,8700153,
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,ataciguat,5141,,,178101833,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,16332991,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1)S(=O)(=O)N1CCOCC1)NS(=O)(=O)c1ccc(s1)Cl
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,BAY412272,5146,,,178101838,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,11242081,Fc1ccccc1Cn1nc(c2c1nccc2)c1ncc(c(n1)N)C1CC1
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,cinaciguat,5168,,,178101858,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,apo-GC-1,,12086987,OC(=O)CCCCN(Cc1ccc(cc1)C(=O)O)CCc1ccccc1OCc1ccc(cc1)CCc1ccccc1
"Guanylyl cyclase, &alpha;<sub>2</sub>&beta;<sub>1</sub>",2897,GUCY1B1|GUCY1A2,P33402|Q02153,,,,,,Human,cinaciguat,5168,,,178101858,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,apo-GC-2,,12086987,OC(=O)CCCCN(Cc1ccc(cc1)C(=O)O)CCc1ccccc1OCc1ccc(cc1)CCc1ccccc1
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,cenderitide,9066,,,315661151,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,23272242,
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,compound C10 [PMID: 24297249],9162,,,315661245,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,24297249,Clc1ccc(cc1)C(c1ccccc1)N1CCNCC1
Haem oxygenase 1,1441,Hmox1,P06762,,,,,,Rat,compound 1 [PMID: 16821802],8873,,,252827530,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,Enzyme isolated from rat spleen.,,,16821802,C[C@@H]1CO[C@@](O1)(CCc1ccc(cc1)Cl)Cn1cncc1
Haem oxygenase 1,1441,HMOX1,P09601,,,,,,Human,compound 1 [PMID: 16821802],8873,,,252827530,Inhibitor,Inhibition,,f,f,,pKi,0,5.820000172,0,Ki,0,1500,0,=,Enzyme isolated from human spleen.,,,16821802,C[C@@H]1CO[C@@](O1)(CCc1ccc(cc1)Cl)Cn1cncc1
Haem oxygenase 2,1442,Hmox2,P23711,,,,,,Rat,compound 1 [PMID: 16821802],8873,,,252827530,Inhibitor,Inhibition,,f,f,,pIC50,0,3.519999981,0,IC50,0,305000,0,=,Enzyme isolated from rat brain.,,,16821802,C[C@@H]1CO[C@@](O1)(CCc1ccc(cc1)Cl)Cn1cncc1
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,compound 2 [PMID: 24486398],8467,,,252166677,Agonist,Agonist,,f,f,,pEC50,0,7.239999771,0,-,0,0,0,=,,,,24486398,C[C@@H]1CC[C@H](CC1)C(=O)Nc1nc(c(s1)CC(=O)N1CCN(CC1)C)c1cccs1
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,"3,5-dihydroxybenzoic acid",5783,,,178102408,Agonist,Full agonist,,f,,,pEC50,0,3.72,0,EC50,0,191000,0,=,,,,22434674,Oc1cc(O)cc(c1)C(=O)O
HCA<sub>1</sub> receptor,311,Hcar1,Q8C131,,,,,,Mouse,"3,5-dihydroxybenzoic acid",5783,,,178102408,Agonist,Full agonist,,f,,,pEC50,0,3.76,0,EC50,0,172000,0,=,,,,22434674,Oc1cc(O)cc(c1)C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,butyric acid,1059,,,135650039,Agonist,Agonist,,t,f,,pEC50,0,2.799999952,0,-,0,0,0,=,,,,0,CCCC(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,3-pyridine-acetic acid,1590,,,135651409,Agonist,Full agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,12522134,OC(=O)Cc1cccnc1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,"(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid",1589,,,135649821,Agonist,Full agonist,,f,,,pEC50,0,7.3,0,,0,0,0,,,,,17358052,Brc1scc(c1)C1(C)OC(=CC1=O)C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,5-methyl nicotinic acid,1592,,,135649840,Agonist,Full agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,12522134,Cc1cc(cnc1)C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,acifran,1595,,,135649889,Agonist,Full agonist,,f,,,pEC50,5.9,0,5.7,,0,0,0,,,,,12522134,OC(=O)C1=CC(=O)C(O1)(C)c1ccccc1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,acipimox,1596,,,135649890,Agonist,Full agonist,,f,f,,pEC50,5.599999905,0,5.199999809,EC50,6310,0,2510,=,,,,12522134,[O-][n+]1cc(ncc1C)C(=O)O
HCA<sub>2</sub> receptor,312,Hcar2,Q9EP66,,,,,,Mouse,&beta;-D-hydroxybutyric acid,1593,,,135649984,Agonist,Full agonist,,t,,,pEC50,0,3.5,0,,0,0,0,,,,,15929991,C[C@H](CC(=O)O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,&beta;-D-hydroxybutyric acid,1593,,,135649984,Agonist,Full agonist,,t,f,,pEC50,0,3.099999905,0,-,0,0,0,=,,,,15929991,C[C@H](CC(=O)O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,cinnamic acid,3203,,,135650101,Agonist,Full agonist,,f,,,pEC50,0,3.62,0,EC50,0,240000,0,=,,,,19136666,OC(=O)/C=C/c1ccccc1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound (+)17a [PMID: 20363624],5790,,,178102415,Agonist,Full agonist,,f,,,pEC50,0,7.35,0,EC50,0,45,0,=,,,,20363624,n1nnc([nH]1)c1n[nH]c2c1CC1C2C1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 21 [PMID: 21185185],5789,,,178102414,Agonist,Full agonist,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,21185185,C[C@@H]1CCC(=C(C1)NC(=O)[C@H](Cc1onc(n1)c1ccc(cn1)F)N)C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 2g [PMID: 19309152],5791,,,178102416,Agonist,Full agonist,,f,,,pIC50,0,7.89,0,IC50,0,13,0,=,,,,19309152,O=C(Nc1ccccc1C(=O)O)CCc1cnn2c1CCc1c2ccc(c1)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 8f [PMID: 20615702],5793,,,178102418,Agonist,Full agonist,,f,,,pIC50,0,6.41,0,IC50,0,390,0,=,,,,20615702,OC(=O)c1n[nH]c2c1CC(C2)c1ccnn1C
HCA<sub>2</sub> receptor,312,Hcar2,Q80Z39,,,,,,Rat,5-butyl-1H-pyrazole-3-carboxylic acid,1591,,,135649826,Agonist,Partial agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12930155,CCCCc1cc(n[nH]1)C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 1q  [PMID: 18029181],5792,,,178102417,Agonist,Partial agonist,,f,,,pIC50,0,6.85,0,IC50,0,140,0,=,,,,18029181,Oc1ccc2c(c1)ncc(n2)N1CCN(CC1)C(=O)Nc1ccccc1C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 42 [PMID: 22420767],5794,,,178102419,Allosteric modulator,Positive,,f,,,pEC50,0,5.59,0,EC50,0,2600,0,=,,,,22420767,ClC1CCC(CC1Cl)c1cnn2c1ncc(c2C)C(=O)NCCOc1ccccc1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,compound 9n [PMID: 18752940],5795,,,178102420,Allosteric modulator,Positive,,f,,,pEC50,0,6.77,0,EC50,0,170,0,=,,,,18752940,C[C@@H](NC(=O)c1cnc2n(c1C)ncc2c1ccc(cc1)C(C)C)COc1ccccc1
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,2-hydroxyoctanoic acid,5796,,,178102421,Agonist,Full agonist,,f,,,pEC50,0,5.4,0,EC50,0,4000,0,=,,,,19561068,CCCCCCC(C(=O)O)O
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,3-hydroxyoctanoic acid,2933,,,135651406,Agonist,Full agonist,,t,,,pEC50,0,5.1,0,EC50,0,8000,0,=,,,,19561068,CCCCC[C@@H](CC(=O)O)O
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,4-(<i>n</i>-propyl)amino-3-nitrobenzoic acid,5801,,,178102426,Agonist,Full agonist,,f,,,pEC50,0,7.52,0,EC50,0,30,0,=,,,,17931863,CCCNc1ccc(cc1[N+](=O)[O-])C(=O)O
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,"5-methyl-5-(5-methylthiophen-3-yl)-4-oxo-4,5-dihydrofuran-2-carboxylic acid",1599,,,135649839,Agonist,Full agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,17358052,Cc1scc(c1)C1(C)OC(=CC1=O)C(=O)O
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,acifran,1595,,,135649889,Agonist,Full agonist,,f,,,pEC50,5.2,0,4.7,,0,0,0,,,,,12522134,OC(=O)C1=CC(=O)C(O1)(C)c1ccccc1
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,compound 5b [PMID: 17358052],1598,,,135649832,Agonist,Full agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,17358052,CCC1(OC(=CC1=O)C(=O)O)c1ccccc1
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,compound 6o [PMID: 19524438],5800,,,178102425,Agonist,Full agonist,,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,,,,19524438,OC(=O)c1n[nH]c(c1)N(Cc1cscc1)Cc1cscc1
"HCK proto-oncogene, Src family tyrosine kinase",2032,HCK,P08631,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
HCN1,400,HCN1,O60741,,,,,,Human,cilobradine,2355,,,135650098,Channel blocker,Antagonist,,f,,,pIC50,0,5.9,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC
HCN1,400,Hcn1,O88704,,,,,,Mouse,clonidine,516,,,135650112,Channel blocker,Antagonist,,f,,,pIC50,0,4.4,0,,0,0,0,,,,,17261653,Clc1cccc(c1NC1=NCCN1)Cl
HCN2,401,HCN2,Q9UL51,,,,,,Human,cilobradine,2355,,,135650098,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC
HCN2,401,Hcn2,O88703,,,,,,Mouse,clonidine,516,,,135650112,Channel blocker,Antagonist,,f,,,pIC50,0,5.1,0,,0,0,0,,,,,17261653,Clc1cccc(c1NC1=NCCN1)Cl
HCN3,402,HCN3,Q9P1Z3,,,,,,Human,cilobradine,2355,,,135650098,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,cilobradine,2355,,,135650098,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC
HCN4,403,Hcn4,O70507,,,,,,Mouse,clonidine,516,,,135650112,Channel blocker,Antagonist,,f,,,pIC50,0,5,0,,0,0,0,,,,,17261653,Clc1cccc(c1NC1=NCCN1)Cl
heat shock protein 90 alpha family class A member 1,2905,HSP90AA1,P07900,,,,,,Human,alvespimycin,9828,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,18929486,CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(C2=O)NC(=O)/C(=C/C=C[C@@H]([C@H](/C(=C/[C@@H]([C@H]1O)C)/C)OC(=O)N)OC)/C
heat shock protein 90 alpha family class A member 1,2905,HSP90AA1,P07900,,,,,,Human,BIIB021,9258,,,315661333,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,24332488,COc1c(C)cnc(c1C)Cn1cnc2c1nc(N)nc2Cl
heat shock protein 90 beta family member 1,2904,HSP90B1,P14625,,,,,,Human,compound 18c [PMID: 25901531],9227,,,315661302,Inhibitor,Inhibition,,f,t,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,25901531,CC(NCCCn1c(Sc2cc(Cl)cc(c2)Cl)nc2c1ncnc2N)C
Hepatocyte nuclear factor-4-&alpha;,608,HNF4A,P41235,,,,,,Human,BI6015,6695,,,178103306,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,22840769,O=N(=O)c1ccc(c(c1)S(=O)(=O)n1c(C)nc2c1cccc2)C
herpes virus entry mediator,1887,TNFRSF14,Q92956,,,,,,Human,B and T lymphocyte attenuator,4891,BTLA,Human,178101591,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Histidine decarboxylase,1274,HDC,P19113,,,,,,Human,AMA,5134,,,178101826,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,ONCC[S+](C[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,abexinostat,8366,,,252166578,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,16731764,ONC(=O)c1ccc(cc1)OCCNC(=O)c1oc2c(c1CN(C)C)cccc2
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pKi,0,10.39999962,0,Ki,0,0.039999999,0,=,,,,20139990,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,7.389999866,0,EC50,0,41,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,9.069999695,0,Ki,0,0.850000024,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,butyric acid,1059,,,135650039,Inhibitor,Inhibition,,f,f,,pIC50,0,4.800000191,0,IC50,0,16000,0,=,,,,21874153,CCCC(=O)O
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,CHR-3996,8391,,,252166602,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21080647,ONC(=O)c1cnc(nc1)N1C[C@@H]2[C@H](C1)[C@H]2NCc1ccc2c(n1)ccc(c2)F
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,citarinostat,9426,,,328083526,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,,,,27926524,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1Cl)c1ccccc1
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28.20000076,0,=,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,bufexamac,7498,,,187051800,Inhibitor,Inhibition,,f,f,,pKd,0,4.909999847,0,Kd,0,12300,0,=,,,,21258344,CCCCOc1ccc(cc1)CC(=O)NO
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pKi,0,9.920000076,0,Ki,0,0.119999997,0,=,,,,20139990,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pEC50,0,6.920000076,0,EC50,0,120,0,=,,,,17868033,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,9.069999695,0,Ki,0,0.850000024,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,6.900000095,0,EC50,0,125,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,f,,pIC50,0,6.619999886,0,IC50,0,238,0,=,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,butyric acid,1059,,,135650039,Inhibitor,Inhibition,,f,f,,pIC50,0,4.920000076,0,IC50,0,12000,0,=,,,,21874153,CCCC(=O)O
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,CHR-3996,8391,,,252166602,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,21080647,ONC(=O)c1cnc(nc1)N1C[C@@H]2[C@H](C1)[C@H]2NCc1ccc2c(n1)ccc(c2)F
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,citarinostat,9426,,,328083526,Inhibitor,Inhibition,,f,f,,pIC50,0,7.349999905,0,IC50,0,45,0,=,,,,27926524,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1Cl)c1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,abexinostat,8366,,,252166578,Inhibitor,Inhibition,,f,f,,pIC50,0,8.090000153,0,IC50,0,8.199999809,0,=,,,,16731764,ONC(=O)c1ccc(cc1)OCCNC(=O)c1oc2c(c1CN(C)C)cccc2
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pEC50,0,7.369999886,0,EC50,0,43,0,=,,,,17868033,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pKi,0,9.590000153,0,Ki,0,0.25999999,0,=,,,,20139990,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pEC50,0,7.519999981,0,EC50,0,30,0,=,,,,17868033,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,7.519999981,0,EC50,0,30,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,<,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,butyric acid,1059,,,135650039,Inhibitor,Inhibition,,f,f,,pIC50,0,5.050000191,0,IC50,0,9000,0,=,,,,21874153,CCCC(=O)O
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,CHR-3996,8391,,,252166602,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,21080647,ONC(=O)c1cnc(nc1)N1C[C@@H]2[C@H](C1)[C@H]2NCc1ccc2c(n1)ccc(c2)F
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,citarinostat,9426,,,328083526,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,27926524,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1Cl)c1ccccc1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,6.420000076,0,Ki,0,380,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,6.940000057,0,EC50,0,115,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,6.760000229,0,Ki,0,175,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,CHR-3996,8391,,,252166602,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,21080647,ONC(=O)c1cnc(nc1)N1C[C@@H]2[C@H](C1)[C@H]2NCc1ccc2c(n1)ccc(c2)F
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,7.090000153,0,EC50,0,82,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,<,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,bufexamac,7498,,,187051800,Inhibitor,Inhibition,,f,f,,pKd,0,4.96999979,0,Kd,0,10700,0,=,,,,21258344,CCCCOc1ccc(cc1)CC(=O)NO
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,CHR-3996,8391,,,252166602,Inhibitor,Inhibition,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,21080647,ONC(=O)c1cnc(nc1)N1C[C@@H]2[C@H](C1)[C@H]2NCc1ccc2c(n1)ccc(c2)F
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,citarinostat,9426,,,328083526,Inhibitor,Inhibition,,f,t,,pIC50,0,8.590000153,0,IC50,0,2.599999905,0,=,,,,27926524,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1Cl)c1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,compound 16 [PMID: 20947351],7057,,,178103636,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,20947351,ONC(=O)CCCCC[C@@H](C(=O)NC1CCCC1)NC(=O)OC(C)(C)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,compound 7d [PMID: 19111466],7056,,,178103635,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,19111466,ONC(=O)c1ccc(cc1)CN1[C@H](Cc2cccs2)C(=O)Nc2c1cccc2
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,7.170000076,0,EC50,0,67,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,7.119999886,0,Ki,0,75,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pEC50,0,6.239999771,0,EC50,0,575,0,=,,,,17868033,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,apicidin,7495,,,187051797,Inhibitor,Inhibition,,f,f,,pKi,0,7.309999943,0,Ki,0,49,0,=,,,,20139990,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,6.670000076,0,EC50,0,216,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,BML-281,9664,,,348353623,Inhibitor,Inhibition,,f,f,,pIC50,0,5.090000153,0,IC50,0,8104,0,=,,,,18642892,ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,butyric acid,1059,,,135650039,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15000,0,=,,,,21874153,CCCC(=O)O
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,citarinostat,9426,,,328083526,Inhibitor,Inhibition,,f,f,,pIC50,0,6.860000134,0,IC50,0,137,0,=,,,,27926524,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1Cl)c1ccccc1
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pEC50,0,6.889999866,0,EC50,0,128,0,=,,,,17868033,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,belinostat,7496,,,187051798,Inhibitor,Inhibition,,f,f,,pKi,0,6.599999905,0,Ki,0,250,0,=,,,,20139990,ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc1ccccc1
homeodomain interacting protein kinase 2,2034,HIPK2,Q9H2X6,,,,,,Human,compound 1a [PMID: 24900749],8128,,,249565808,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,24900749,N#Cc1cnn2c1nc(Nc1ccc(c(c1)NC(=O)C)C)cc2NC1CC1
homeodomain interacting protein kinase 2,2034,HIPK2,Q9H2X6,,,,,,Human,compound 5b [PMID: 24900464],8171,,,249565851,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,24900464,N#Cc1cnn2c1nc(cc2NC1CC1)c1c[nH]c2c1cc(cc2)NC(=O)C
HPGD,1384,HPGD,P15428,,,,,,Human,compound 3 [PMID: 21650226],8745,,,252827403,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,21650226,O=C1NC(=O)/C(=C/c2ccc(c(c2)Cl)OCCC2CCCCC2)/S1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,2-(3-bromophenyl)histamine,1194,,,135649684,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,12626648,NCCc1cnc([nH]1)c1cccc(c1)Br
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,2-(3-chlorophenyl)histamine,1195,,,135649685,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,12626648,NCCc1cnc([nH]1)c1cccc(c1)Cl
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,2-(3-iodophenyl)histamine,1196,,,135649687,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12626648,NCCc1cnc([nH]1)c1cccc(c1)I
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,2-pyridylethylamine,1197,,,135649712,Agonist,Full agonist,,f,,,pKi,0,3.7,0,,0,0,0,,,,,15206929,NCCc1ccccn1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,2-(2-thiazolyl)ethanamine,1193,,,135649682,Agonist,Partial agonist,,f,,,pKi,0,5.34,0,,0,0,0,,,,,12626648,NCCc1nccs1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,9-OH-risperidone,67,,,135649866,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8935801,OC1CCc2n(C1)c(=O)c(c(n2)C)CCN1CCC(CC1)c1noc2c1ccc(c2)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,A-317920,1216,,,135649872,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,12606603,O=C([C@H](NC(=O)c1ccco1)C)N1CCN(CC1)CCCOc1ccc(cc1)C(=O)C1CC1
H<sub>1</sub> receptor,262,,,,,,,,Bovine,alimemazine,7237,,,178103811,Antagonist,Antagonist,,f,f,,pKi,0,9.140000343,0,Ki,0,0.720000029,0,=,Inhibition of [<sup>3</sup>H]mepyramine binding to bovine brain membrane preparations <i>in vitro</i>.,,,2884340,CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,Antagonism of [<sup>3</sup>H]mepyramine binding,,,16782354,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,aripiprazole,34,,,135649956,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12629531,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,arpromidine,1221,,,135649957,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,16394198,NC(=NCCCc1[nH]cnc1)NCCC(c1ccccn1)c1ccc(cc1)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,asenapine,22,,,135650779,Antagonist,Antagonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,astemizole,2603,,,135649968,Antagonist,Antagonist,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,12747773,COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,AZD3778,7679,,,223366014,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,Assayed using the sodium salt of the compound,,,23031591,Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,azelastine,7121,,,178103698,Antagonist,Antagonist,,f,t,,pKi,0,8.899999619,0,Ki,0,1.25999999,0,=,,,,21381763,CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,BU-E 47,1219,,,135650029,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12626648,NC(=NCCCc1[nH]cnc1)NCCC(c1ccccn1)c1ccc(cc1)Cl
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,chlorpheniramine,6976,,,178103555,Antagonist,Antagonist,,f,t,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,21381763,CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(-)-chlorpheniramine,1213,,,135650086,Antagonist,Antagonist,,f,f,,pKi,6.699999809,0,6.400000095,-,0,0,0,=,,,,12065734,CN(CC[C@@H](c1ccccn1)c1ccc(cc1)Cl)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(+)-chlorpheniramine,1210,,,135650087,Antagonist,Antagonist,,f,f,,pKi,8.600000381,0,8.300000191,-,0,0,0,=,,,,7925364,CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,chlorpromazine,83,,,135650088,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12629531,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,clemastine,6063,,,178102684,Antagonist,Antagonist,,f,t,,pKi,0,10.31000042,0,Ki,0,0.048999999,0,=,,,,0,Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,clobenpropit,1223,,,135650109,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,12606603,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,9.6,0,8.8,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,conessine,8981,,,310264761,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,A-349821,1217,,,135649873,Antagonist,Inverse agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,15294456,CO[C@H]([C@H]([C@H](C(OC(=O)C)[2H])OC(=O)C)OC)[C@@H](OC(=O)C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,ABT-239,1218,,,135649878,Antagonist,Inverse agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,15608078,N#Cc1ccc(cc1)c1ccc2c(c1)cc(o2)CCN1CCC[C@H]1C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,cetirizine,1222,,,135650064,Antagonist,Inverse agonist,,f,t,,pKi,0,8.199999809,0,-,0,0,0,=,,,,7925364,OC(=O)COCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,amthamine,4025,,,178100851,Agonist,Full agonist,,f,,,pEC50,0,6.4,0,EC50,0,450,0,=,,,,19072936,NCCc1sc(nc1C)N
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,arpromidine,1221,,,135649957,Agonist,Full agonist,,f,,,pKi,8,0,6.3,,0,0,0,,,,,16394198,NC(=NCCCc1[nH]cnc1)NCCC(c1ccccn1)c1ccc(cc1)F
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,burimamide,1229,,,135650034,Agonist,Full agonist,,f,,,pEC50,5.7,0,5.6,,0,0,0,,,,,9681472,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8692899,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,cimetidine,1231,,,135650099,Antagonist,Antagonist,,f,t,,pKi,0,6.849999905,0,Ki,0,140,0,=,,,,23466604,N#CNC(=NC)NCCSCc1nc[nH]c1C
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,cimetidine,1231,,,135650099,Antagonist,Antagonist,,f,f,,pKi,0,5.900000095,0,-,0,0,0,=,,,,9384502,N#CNC(=NC)NCCSCc1nc[nH]c1C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,clobenpropit,1223,,,135650109,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,12606603,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,conessine,8981,,,310264761,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,ABT-239,1218,,,135649878,Antagonist,Inverse agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,15608078,N#Cc1ccc(cc1)c1ccc2c(c1)cc(o2)CCN1CCC[C@H]1C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,cipralisant,1244,,,135650808,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12393057,CC(CCC#C[C@@H]1C[C@H]1c1[nH]cnc1)(C)C
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,cipralisant,1244,,,135650808,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12393057,CC(CCC#C[C@@H]1C[C@H]1c1[nH]cnc1)(C)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,A-304121,1258,,,135649871,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12606603,C[C@H](C(=O)N1CCN(CC1)CCCOc1ccc(cc1)C(=O)C1CC1)N
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,A-304121,1258,,,135649871,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12606603,C[C@H](C(=O)N1CCN(CC1)CCCOc1ccc(cc1)C(=O)C1CC1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,A-317920,1216,,,135649872,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12606603,O=C([C@H](NC(=O)c1ccco1)C)N1CCN(CC1)CCCOc1ccc(cc1)C(=O)C1CC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,A-317920,1216,,,135649872,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12606603,O=C([C@H](NC(=O)c1ccco1)C)N1CCN(CC1)CCCOc1ccc(cc1)C(=O)C1CC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,A331440,4023,,,178100849,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,-,0,0,0,=,,,,15033391,N#Cc1ccc(cc1)c1ccc(cc1)OCCCN1CC[C@H](C1)N(C)C
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11714875,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,11714875,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,f,,pKi,7.300000191,0,6.699999809,-,0,0,0,=,,,,12606603,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,,,pKi,9.3,0,8.4,,0,0,0,,,,,12606603,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,,,pKi,9.4,0,9.1,,0,0,0,,,,,15341517,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,clobenpropit,1223,,,135650109,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12706455,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,clobenpropit,1223,,,135650109,Antagonist,Antagonist,,f,,,pKi,9.8,0,8.9,,0,0,0,,,,,12606603,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,clobenpropit,1223,,,135650109,Antagonist,Antagonist,,f,f,,pKi,9.409999847,0,8.409999847,Ki,3.900000095,0,0.389999986,=,,,,12606603,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,10869375,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,conessine,8981,,,310264761,Antagonist,Antagonist,,f,f,,pKi,0,8.300000191,0,-,0,0,0,=,,,,26084539,CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,A-349821,1217,,,135649873,Antagonist,Inverse agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,15294456,CO[C@H]([C@H]([C@H](C(OC(=O)C)[2H])OC(=O)C)OC)[C@@H](OC(=O)C)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,A-349821,1217,,,135649873,Antagonist,Inverse agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,15294456,CO[C@H]([C@H]([C@H](C(OC(=O)C)[2H])OC(=O)C)OC)[C@@H](OC(=O)C)C
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,ABT-239,1218,,,135649878,Antagonist,Inverse agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,15608078,N#Cc1ccc(cc1)c1ccc2c(c1)cc(o2)CCN1CCC[C@H]1C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,ABT-239,1218,,,135649878,Antagonist,Inverse agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,15608078,N#Cc1ccc(cc1)c1ccc2c(c1)cc(o2)CCN1CCC[C@H]1C
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,2-(3-bromophenyl)histamine,1194,,,135649684,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15947036,NCCc1cnc([nH]1)c1cccc(c1)Br
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,2-methylhistamine,1268,,,135649707,Agonist,Full agonist,,f,,,pKi,6.6,0,6.1,,0,0,0,,,,,15947036,OCCN1CN(CO)C(=S)N(C1)CO
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,4-methylhistamine,1269,,,135649802,Agonist,Full agonist,,f,f,,pKi,8.199999809,0,7.300000191,Ki,50.09999847,0,6.309999943,=,,,,15947036,Cc1c(CCN)nc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,CCL16,1272,CCL16,Human,135651660,Agonist,Full agonist,,t,,,pIC50,0,8.1,0,,0,0,0,,,,,15265943,
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,clobenpropit,1223,,,135650109,Agonist,Partial agonist,,f,f,,pKi,8.300000191,0,7.400000095,Ki,39.79999924,0,5.010000229,=,,,,12606603,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,clobenpropit,1223,,,135650109,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,-,0,0,0,=,,,,11561071,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,clobenpropit,1223,,,135650109,Agonist,Partial agonist,,f,,,pKi,0,7.8,0,-,0,0,0,=,,,,11561071,Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,11561071,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.7,,0,0,0,,,,,11179434,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,burimamide,1229,,,135650034,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,11561071,CNC(=S)NCCCCc1cccc2c1cn[nH]2
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,ciproxifan,1265,,,135650102,Antagonist,Antagonist,,f,f,,pKi,0,5.730000019,0,-,0,0,0,=,,,,12606603,O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.2,,0,0,0,,,,,11179434,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,11561071,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,clozapine,38,,,135650115,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,11561071,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,conessine,8981,,,310264761,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C
H<sub>v</sub>1,746,HVCN1,Q96D96,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,pIC50,0,5,0,IC50,0,10000,0,~,,,,0,
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,atorvastatin,2949,,,135649972,Inhibitor,Competitive,,f,,,pIC50,0,8.94,0,IC50,0,1.16,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,atorvastatin,2949,,,135649972,Inhibitor,Competitive,,f,t,,pKi,0,7.849999905,0,Ki,0,14,0,=,In vitro inhibition of HMG-CoA reductase,,,16128575,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,atorvastatin,2949,,,135649972,Inhibitor,Competitive,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,11349148,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,cerivastatin,2950,,,135650063,Inhibitor,Competitive,,f,,,pIC50,0,8.45,0,IC50,0,3.54,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,COCc1c(c2ccc(cc2)F)c(/C=C/[C@H](C[C@H](CC(=O)O)O)O)c(nc1C(C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,cerivastatin,2950,,,135650063,Inhibitor,Competitive,,f,t,,pKi,0,8.239999771,0,Ki,0,5.699999809,0,=,In vitro inhibition of HMG-CoA reductase,,,16128575,COCc1c(c2ccc(cc2)F)c(/C=C/[C@H](C[C@H](CC(=O)O)O)O)c(nc1C(C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,cerivastatin,2950,,,135650063,Inhibitor,Competitive,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,Inhibition of HMG-CoA reductase,,,15686906,COCc1c(c2ccc(cc2)F)c(/C=C/[C@H](C[C@H](CC(=O)O)O)O)c(nc1C(C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,5-ketodihydromevinolin,3013,,,135649776,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,In vitro inhibition of HMG-CoA reductase,,,3656359,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C[C@H]2C1[C@@H](CCC(=O)C[C@H](CC(=O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,atorvastatin lactone,2957,,,135649818,Inhibitor,Inhibition,,f,,,pIC50,0,8.16,0,IC50,0,6.99,0,=,Inhibition of HMG-CoA reductase,,,1992137,O[C@@H]1C[C@@H](CCn2c(C(C)C)c(c(c2c2ccc(cc2)F)c2ccccc2)C(=O)Nc2ccccc2)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,BMY-21950,2981,,,135649775,Inhibitor,Inhibition,,f,,,pIC50,0,7.89,0,IC50,0,13,0,=,In vitro inhibition of HMG-CoA reductase ,,,1992149,O[C@@H](C[C@H](/C=C/C(=C(c1ccc(cc1)F)c1ccc(cc1)F)c1nnnn1C)O)CC(=O)[O-].[Na+]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,BMY 22089,2973,,,135649806,Inhibitor,Inhibition,,f,,,pIC50,0,7.62,0,IC50,0,24,0,=,In vitro inhibition of HMG-CoA reductase,,,2231596,O[C@@H]1CC(=O)O[C@H](C1)/C=C/C(=C(c1ccc(cc1)F)c1ccc(cc1)F)c1nnnn1C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 11dd [PMID: 1656041],3017,,,135649771,Inhibitor,Inhibition,,f,,,pIC50,0,6.42,0,IC50,0,380,0,=,In vitro inhibition of HMG-CoA reductase,,,1656041,OC(C[C@H](CC(=O)[O-])O)COc1c(cc2c(c1C(C)C)cccc2)C(c1ccc(cc1)F)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 11ff [PMID: 1656041],3016,,,135649769,Inhibitor,Inhibition,,f,,,pIC50,0,8.57,0,IC50,0,2.7,0,=,In vitro inhibition of HMG-CoA reductase,,,1656041,OC(C[C@H](CC(=O)[O-])O)COc1c(cc(cc1c1ccc(cc1)F)C(C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 11jj [PMID: 1656041],3015,,,135649768,Inhibitor,Inhibition,,f,,,pIC50,0,9.3,0,IC50,0,0.5,0,=,Inhibition of HMG-CoA reductase,,,1656041,OC(C[C@H](CC(=O)[O-])O)COc1c(cc(cc1c1ccc(cc1)F)Sc1ccc(cc1)F)C(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 11nn [PMID: 1656041],3014,,,135649770,Inhibitor,Inhibition,,f,,,pIC50,0,7.3,0,IC50,0,50,0,=,Inhibition of HMG-CoA reductase,,,1656041,OC(C[C@H](CC(=O)[O-])O)COc1c(nc2c(c1C(C)C)cccc2)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 11nn [PMID: 1656041],3014,,,135649770,Inhibitor,Inhibition,,f,,,pIC50,0,6.6,0,IC50,0,250,0,=,Inhibition of HMG-CoA reductase,,,1656041,OC(C[C@H](CC(=O)[O-])O)COc1c(nc2c(c1C(C)C)cccc2)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 13b [PMID: 18412317],2988,,,135649764,Inhibitor,Inhibition,,f,,,pIC50,0,9.3,0,IC50,0,0.5,0,=,In vitro inhibition of HMG-CoA reductase ,,,18412317,O[C@@H](C[C@H](CC(=O)[O-])O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(c1nnnn1C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 13b [PMID: 2153213],3005,,,135649750,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,In vitro inhibition of HMG-CoA reductase,,,2153213,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(cn(c1C(C)C)c1ccccc1)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 13g [PMID: 2153213],3002,,,135649753,Inhibitor,Inhibition,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(C(C)C)n(c(c1c1ccc(cc1)F)C)c1ccccc1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 13 [PMID: 1992149],2983,,,135649773,Inhibitor,Inhibition,,f,,,pIC50,0,6.32,0,IC50,0,480,0,=,In vitro inhibition of HMG-CoA reductase ,,,1992149,O[C@H](CC(/C=C/c1c(nc2c(c1c1ccc(cc1)F)cc(cc2)Cl)C(C)C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 16f [PMID: 18155906],3011,,,135649748,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of HMGCoA reductase,,,18155906,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(c2ccc(cc2)F)c(c(c1C(C)C)S(=O)(=O)Nc1cccc(c1)CC(=O)N)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 17 [PMID: 15686906],3000,,,135649744,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,Inhibition of HMG-CoA reductase,,,15686906,O[C@H](C[C@H](/C=C/n1c(nc(c1c1ccc(cc1)F)c1ccc(cc1)F)C(C)C)O)CC(=O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 17 [PMID: 3701793],2974,,,135649805,Inhibitor,Inhibition,,f,,,pIC50,0,7.07,0,IC50,0,85,0,=,In vitro inhibition of HMG-CoA reductase,,,3701793,O[C@@H]1CC(OC(=O)C1)CC1c2cc(F)ccc2c2c1c(Cl)cc(c2)Cl
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 18 [PMID: 1875346],3028,,,135649676,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,In vitro inhibition of HMG-CoA reductase ,,,1875346,CCC(C(=O)O[C@H]1C[C@@H](C)[C@H]([C@H]2C1[C@@H](CCC1C[C@@H](O)CC(=O)O1)[C@H](CC2)C)OC(=O)NCc1ccccc1)(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 18 [PMID: 8426367],2961,,,135649644,Inhibitor,Inhibition,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,Inhibition of HMG-CoA reductase,,,8426367,CC(CCC[C@H]([C@H]1CC[C@@]2([C@]1(C)CCC1C2=CCC2[C@]1(C)CC[C@@H](C2(C)C)O)C(=O)C)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 18t [PMID: 8246237],2996,,,135649761,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,Inhibition of HMG-CoA reductase,,,8246237,O[C@@H](C[C@H](CC(=O)[O-])O)/C=C/c1c2CCCC(c2nn1c1ccc(cc1)F)Cc1ccc(cc1)c1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 1a [PMID: 2153213],2987,,,135649765,Inhibitor,Inhibition,,f,,,pIC50,0,9.08,0,IC50,0,0.83,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@H](C[C@@H](/C=C/c1c(cn(c1C)c1ccccc1)c1ccc(cc1)F)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 1e [PMID: 2153213],2991,,,135649762,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@H](C[C@@H](/C=C/c1c(C(C)C)n(cc1c1ccc(cc1)F)C(C)C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 1f [PMID: 2153213],2990,,,135649763,Inhibitor,Inhibition,,f,f,,pIC50,0,6.96999979,0,IC50,0,106,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@H](C[C@@H](/C=C/c1c(cn(c1C(C)C)c1ccccc1)c1ccc(cc1)F)O)CC(=O)O
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,"compound 1 [Patel <i>et al</i>., 1991]",3009,,,135649747,Inhibitor,Inhibition,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,In vitro inhibition of HMG-CoA reductase,,,0,CCC[C@@H]1CC[C@@H]([C@@H]([C@H]1COC(=O)C(CC)(C)C)CC[C@H](C[C@H](CC(=O)O)O)O)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 1 [PMID: 1895299],2975,,,135649783,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,In vitro inhibition of HMG-CoA reductase,,,1895299,CC[C@@H](C(=O)O[C@@H]1C[C@@H](C)C=C2C1[C@@H](CC[C@H](C[C@@H](CC(=O)[O-])O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 25d [PMID: 19502059],2997,,,135649760,Inhibitor,Inhibition,,f,,,pIC50,0,6.82,0,IC50,0,150,0,=,In vitro inhibition of HMG-CoA reductase ,,,19502059,CCC(c1ccccc1)(c1ccc(c(c1)c1ccc(cc1)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)CC
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 25 [PMID: 2296027],2965,,,135649814,Inhibitor,Inhibition,,f,,,pIC50,0,7.5,0,IC50,0,32,0,=,In vitro inhibition of HMG-CoA reductase,,,2296027,O[C@H]1C[C@H](CCc2c(nn(c2c2ccc(cc2)F)c2ccc(cc2)F)C(C)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 28 [PMID: 8246233],2985,,,135649767,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of HMG-CoA reductase,,,8246233,O[C@H](C[C@@H](/C=C/n1c(nc(c1c1ccc(cc1)F)c1cccnc1)C(C)C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 29f [PMID: 17560788],2959,,,135649793,Inhibitor,Inhibition,,f,,,pIC50,0,9.07,0,IC50,0,0.85,0,=,Inhibition of HMG-CoA reductase,,,17560788,CCn1c(C(=O)NCc2ccc(cc2)C(=O)[O-])c(c(c1CC[C@H](C[C@H](CC(=O)[O-])O)O)c1ccc(cc1)F)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 29 [PMID: 1527791],3029,,,135649675,Inhibitor,Inhibition,,f,,,pIC50,0,5.85,0,IC50,0,1400,0,=,Inhibition of HMG-CoA reductase,,,1527791,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C[C@H]2[C@H]1[C@@H](CCC1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 29 [PMID: 15686906],2995,,,135649758,Inhibitor,Inhibition,,f,f,,pIC50,0,6.980000019,0,-,0,0,0,=,Inhibition of HMG-CoA reductase,,,15686906,O[C@H](C[C@@H](/C=C/n1c(cc(c1c1ccc(cc1)F)c1ccc(cc1)F)C(C)C)O)CC(=O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 29 [PMID: 2296027],2964,,,135649815,Inhibitor,Inhibition,,f,,,pIC50,0,6.8,0,IC50,0,158,0,=,In vitro inhibition of HMG-CoA reductase,,,2296027,O[C@H]1C[C@H](CCc2c(nn(c2c2ccc(cc2)F)Cc2ccccc2)C(C)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 2c [PMID: 2153213],3004,,,135649751,Inhibitor,Inhibition,,f,,,pIC50,0,9.24,0,IC50,0,0.57,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(C)n(c(c1c1ccc(cc1)F)C)c1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 2d [PMID: 2153213],3003,,,135649752,Inhibitor,Inhibition,,f,,,pIC50,0,9.57,0,IC50,0,0.27,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(C)n(cc1c1ccc(cc1)F)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,"compound 2 [Dreyer <i>et al</i>., 1991]",7991,,,249565672,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,0,O[C@@H](C[C@H](CC(=O)O)O)CCc1c(Cl)cc(cc1OCc1ccccc1)Cl
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 2f [PMID: 2153213],3007,,,135649746,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,Inhibition of HMG-CoA reductase,,,2153213,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(C(C)C)n(cc1c1ccc(cc1)F)C1CCCCC1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 2g [PMID: 2296036],2971,,,135649812,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,In vitro inhibition of HMG-CoA reductase,,,2296036,O[C@H]1CC(=O)OC(C1)/C=C/c1c(nc(cc1c1ccc(cc1)F)C(C)(C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 2t [PMID: 2296036],2972,,,135649811,Inhibitor,Inhibition,,f,,,pIC50,0,8.32,0,IC50,0,4.8,0,=,Inhibition of HMG-CoA reductase,,,2296036,O[C@@H]1C[C@@H](/C=C/c2c(nc(nc2c2ccc(cc2)F)C(C)C)C(C)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 33 [PMID: 17574412],3010,,,135649755,Inhibitor,Inhibition,,f,,,pIC50,0,9.7,0,IC50,0,0.2,0,=,Inhibition of HMG-CoA reductase,,,17574412,N#Cc1ccc(cc1)CNC(=O)c1c(c2ccccc2)c(c(n1C(C)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)c1ccc(cc1)F
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 35 [PMID: 8246233],2999,,,135649756,Inhibitor,Inhibition,,f,,,pIC50,0,8.59,0,IC50,0,2.6,0,=,In vitro inhibition of HMG-CoA reductase,,,8246233,O[C@H](C[C@@H](/C=C/c1c(nc(n1c1ccc(cc1)F)c1ccccc1)C(C)C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,"compound 3 [Dreyer <i>et al</i>., 1991]",7993,,,315661095,Inhibitor,Inhibition,,f,f,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,0,OC(=O)C[C@@H](CP(=O)(CCc1c(Cl)cc(cc1OCc1ccccc1)Cl)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 3h [PMID: 8246234],2956,,,135650588,Inhibitor,Inhibition,,f,,,pIC50,0,9.52,0,IC50,0,0.3,0,=,In vitro inhibition of HMG-CoA reductase,,,8246234,COC(=O)C[C@@H](C[C@@H](/C=C/n1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccc(cc1)F)Br)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 3j [PMID: 2231594],2979,,,135649780,Inhibitor,Inhibition,,f,,,pIC50,0,8.92,0,IC50,0,1.2,0,=,In vitro inhibition of HMG-CoA reductase,,,2231594,OC(=O)C[C@@H](CP(=O)(OCc1c(cc(cc1c1ccc(c(c1)C)F)C)C(C)C)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 3k [PMID: 2231594],2978,,,135649779,Inhibitor,Inhibition,,f,,,pIC50,0,8.42,0,IC50,0,3.8,0,=,In vitro inhibition of HMG-CoA reductase,,,2231594,OC(=O)C[C@@H](CP(=O)(CCc1c(cc(cc1c1ccc(c(c1)C)F)C)C(C)C)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 3q [PMID: 2231594],2977,,,135649781,Inhibitor,Inhibition,,f,,,pIC50,0,8.72,0,IC50,0,1.9,0,=,Inhibition of HMG-CoA reductase,,,2231594,OC(=O)C[C@@H](CP(=O)(/C=C/c1c(C(C)C)c2c(n1c1ccc(cc1)F)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 3u [PMID: 2231594],2976,,,135649782,Inhibitor,Inhibition,,f,,,pIC50,0,8.68,0,IC50,0,2.1,0,=,Inhibition of HMG-CoA reductase,,,2231594,OC(=O)C[C@@H](CP(=O)(/C=C/C1=C(c2ccc(cc2)F)c2c(C31CCCC3)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 41 [PMID: 17574411],3006,,,135649749,Inhibitor,Inhibition,,f,,,pIC50,0,9.52,0,IC50,0,0.3,0,=,Inhibition of HMG-CoA reductase,,,17574411,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(c2ccc(cc2)F)c2c(n1C(C)C)C(=O)N(CCC2)c1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 42 [PMID: 17574411],3001,,,135649754,Inhibitor,Inhibition,,f,,,pIC50,0,8.72,0,IC50,0,1.9,0,=,Inhibition of HMG-CoA reductase,,,17574411,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(c2ccc(cc2)F)c2c(n1C(C)C)c(=O)n(c1c2cccc1)c1cccc(c1)F
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,"compound 4 [Balasubramanian <i>et al.</i>, 1992]",2962,,,178100249,Inhibitor,Inhibition,,f,,,pIC50,0,5.4,0,IC50,0,4100,0,=,,,,0,OC(CC(/C=C/C(=C1c2ccc(cc2c2c1ccc(c2)F)F)c1nnnn1C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 4d [PMID: 2296036],2969,,,135649807,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,In vitro inhibition of HMG-CoA reductase,,,2296036,CCc1nc(cc(c1CCC1C[C@@H](O)CC(=O)O1)c1ccc(cc1)F)c1ccccc1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 4ff [PMID: 1656041],2970,,,135649809,Inhibitor,Inhibition,,f,,,pIC50,0,8.75,0,IC50,0,1.8,0,=,Inhibition of cellular activity,,,1656041,O[C@@H]1CC(COc2c(cc(cc2c2ccc(cc2)F)C(C)C)C(C)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 4i [PMID: 2296036],2968,,,135649808,Inhibitor,Inhibition,,f,,,pIC50,0,6.43,0,IC50,0,370,0,=,Inhibition of HMG-CoA reductase,,,2296036,O[C@@H]1CC(CCc2c(nc(cc2c2ccc(cc2)F)c2ccccc2)C(C)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 4p [PMID: 1895299],3019,,,135649743,Inhibitor,Inhibition,,f,,,pIC50,0,9.26,0,IC50,0,0.55,0,=,In vitro inhibition of HMG-CoA reductase,,,1895299,CCc1c(c2ccc(cc2)F)c(/C=C/P(=O)(C[C@@H](CC(=O)[O-])O)[O-])c(nc1c1ccccc1)C(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 4rr [PMID: 1656041],2967,,,135649810,Inhibitor,Inhibition,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,Inhibition of HMG-CoA reductase,,,1656041,O[C@@H]1C[C@@H](COc2c(C)cc(cc2C(C2CCCCC2)Cl)C)OC(=O)C1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 50 [PMID: 18072721],3008,,,135649745,Inhibitor,Inhibition,,f,,,pIC50,0,8.82,0,IC50,0,1.5,0,=,In vitro inhibition of HMG-CoA reductase,,,18072721,O[C@@H](C[C@H](CC(=O)[O-])O)CCc1c(C(C)C)c(nn1c1ccc(cc1)F)C(=O)N([C@@H](c1ccccc1)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 5ab [PMID: 8246233],2994,,,135649759,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,In vitro inhibition of HMG-CoA reductase,,,8246233,O[C@H](C[C@@H](/C=C/n1c(nc(c1C(C)C)c1ccc(cc1)F)c1ccc(cc1)F)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,"compound 6a [Patil <i>et al.</i>, 1989]",2963,,,135649831,Inhibitor,Inhibition,,f,,,pIC50,0,6.3,0,IC50,0,500,0,=,Inhibition of HMGCoA reductase,,,0,CCCCCCCCC#CC#C/C=C/CCCC(=O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 6v [PMID: 1895299],3018,,,135649742,Inhibitor,Inhibition,,f,,,pIC50,0,8.92,0,IC50,0,1.2,0,=,In vitro inhibition of HMG-CoA reductase,,,1895299,O[C@@H](CP(=O)(OCc1c(nc2c(c1c1ccc(cc1)F)CCCc1c2cccc1)C(C)C)[O-])CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 74 [PMID: 1656041],2982,,,135649774,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,In vitro inhibition of HMG-CoA reductase,,,1656041,O[C@H](CC(/C=C/c1c(nc(cc1c1ccc(cc1)F)C(C)(C)C)C(C)C)O)CC(=O)[O-]
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 7 [PMID: 2909732],3020,,,135649741,Inhibitor,Inhibition,,f,,,pIC50,0,8.89,0,IC50,0,1.3,0,=,Inhibition of HMG-CoA reductase,,,2909732,O[C@@H](CC(=O)O)CC(=O)CCc1ccccc1
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 8b [PMID: 1992138],2966,,,135649813,Inhibitor,Inhibition,,f,,,pIC50,0,7.6,0,IC50,0,25,0,=,Inhibition of HMG-CoA reductase,,,1992138,O[C@H]1CC(=O)O[C@@H](C1)/C=C/c1c(nc2c(c1c1ccc(cc1)F)cc(cc2)Cl)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,"compound 9a [Patil <i>et al.</i>, 1989]",2958,,,135649790,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,Inhibition of HMG-CoA reductase,,,0,CCCCCCCCC#CC#CC1OC1CCCC(=O)O
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,compound 9 [PMID: 1992149],2984,,,135649772,Inhibitor,Inhibition,,f,,,pIC50,0,8.16,0,IC50,0,6.99,0,=,In vitro inhibition of HMG-CoA reductase,,,1597859,O[C@H](C[C@@H](/C=C/c1c(nn(c1c1ccc(cc1)F)c1cnccn1)C(C)C)O)CC(=O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 9 [PMID: 1992149],2984,,,135649772,Inhibitor,Inhibition,,f,,,pIC50,0,8.18,0,IC50,0,6.6,0,=,In vitro inhibition of HMG-CoA reductase,,,1992149,O[C@H](C[C@@H](/C=C/c1c(nn(c1c1ccc(cc1)F)c1cnccn1)C(C)C)O)CC(=O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,compound 9 [PMID: 7932551],3030,,,135649730,Inhibitor,Inhibition,,f,,,pIC50,0,6.7,0,IC50,0,200,0,=,Inhibition of HMG-CoA reductase,,,7932551,CC[C@@H](C(=O)O[C@H]1C[C@H]2[C@H]([C@H]3[C@@]1(C)C(CC[C@@H]1C[C@@H](O)CC(=O)O1)CC3)CC[C@H]1[C@]2(C)CC[C@H](C1)O)C
hydroxysteroid 11-beta dehydrogenase 1,2763,HSD11B1,P28845,,,,,,Human,ABT-384,7357,,,178103929,Inhibitor,Inhibition,,f,t,,pKi,0,8.050000191,0,Ki,0,9,0,=,,,,16996734,O=C(C(N1CCN(CC1)c1ccc(cn1)C(F)(F)F)(C)C)NC1C2CC3CC1CC(C2)(C3)C(=O)N
hydroxysteroid 11-beta dehydrogenase 1,2763,HSD11B1,P28845,,,,,,Human,AZD4017,7695,,,223366028,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,22691057,CCCSc1nc(ccc1C(=O)NC1CCCCC1)N1CCC[C@H](C1)CC(=O)O
hydroxysteroid 11-beta dehydrogenase 1,2763,HSD11B1,P28845,,,,,,Human,AZD8329,7715,,,223366048,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,0,O=C(c1cnn(c1C(C)(C)C)c1ccc(cc1)C(=O)O)NC1C2CC3CC1CC(C2)C3
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,1-oleoyl glycerol,5756,,,178102381,Agonist,Agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,21778222,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,1-oleoyl glycerol,5756,,,178102381,Agonist,Agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,21778222,CCCCCCCC/C=CCCCCCCCC(=O)OCC(CO)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,1-palmitoyl-lysophosphatidylcholine,5650,,,178102278,Agonist,Agonist,,f,,,pEC50,0,5.8,0,-,0,0,0,=,,,,15607732,CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,1-stearoyl-lysophosphatidylcholine,5651,,,178102279,Agonist,Agonist,,f,,,pEC50,0,5.5,0,-,0,0,0,=,,,,15607732,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OCC[N+](C)(C)C)[O-])O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,2-oleoyl glycerol,5112,,,178101805,Agonist,Agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,21778222,CCCCCCCC/C=C\CCCCCCCC(=O)OC(CO)CO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,2-oleoyl glycerol,5112,,,178101805,Agonist,Agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,21778222,CCCCCCCC/C=CCCCCCCCC(=O)OC(CO)CO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,AR231453,5653,,,178102281,Agonist,Agonist,,f,,,pEC50,0,8.2,0,-,0,0,0,=,,,,17289847,O=N(=O)c1c(ncnc1N1CCC(CC1)c1onc(n1)C(C)C)Nc1ccc(cc1F)S(=O)(=O)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,AS1269574,4027,,,178100853,Agonist,Agonist,,f,f,,pEC50,0,5.599999905,0,-,0,0,0,=,,,,20804735,OCCNc1cc(C)nc(n1)c1ccc(cc1)Br
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,AS1535907,5722,,,178102348,Agonist,Agonist,,f,,,pEC50,5.9,0,5.3,-,0,0,0,=,,,,20937249,Brc1ccc(cc1)c1nc(NCCc2ccc[n+](c2)[O-])cc(n1)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,AS1907417,5723,,,178102349,Agonist,Agonist,,f,,,pEC50,0,6,0,-,0,0,0,=,,,,20816753,OC(=O)CCCC1CCN(CC1)c1nc(nc2c1CS(=O)(=O)C2)C1CCC1
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 1 [PMID: 21273063],5745,,,178102371,Agonist,Agonist,,f,,,pEC50,0,5.44,0,EC50,0,3600,0,=,,,,21273063,O=C(N1CCC(CC1)C1CCN(CC1)c1cccnc1)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 1 [PMID: 21939274],5743,,,178102369,Agonist,Agonist,,f,,,pEC50,0,6.1,0,EC50,0,786,0,=,,,,21939274,N#Cc1cc(cnc1N1CCN(CC1)C(=O)OC(C)C)c1ccc2c(c1)nccn2
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 20f [PMID: 21536438],5750,,,178102376,Agonist,Agonist,,f,,,pEC50,0,7.74,0,EC50,0,18,0,=,,,,21536438,O=C(N1[C@H]2CC[C@H]1CC(C2)Oc1ncnc(c1C)Oc1cccnc1C)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 23 [PMID: 21444206],5740,,,178102366,Agonist,Agonist,,f,,,pEC50,0,9.22,0,EC50,0,0.6,0,=,,,,21444206,O=C(N1CCC(CC1)Oc1ncnc2c1[nH]c(=O)n2c1ccc(cc1F)S(=O)(=O)C)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 29a [PMID: 21444206],5741,,,178102367,Agonist,Agonist,,f,,,pEC50,0,9.15,0,EC50,0,0.7,0,=,,,,21444206,O=C(N1CCC(CC1)Oc1ncnc2c1onc2c1ccc(cc1)S(=O)(=O)C)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 2 [PMID: 21939274],5744,,,178102370,Agonist,Agonist,,f,,,pEC50,0,8.77,0,EC50,0,1.7,0,=,,,,21939274,N#Cc1cc(cnc1N1CCC(CC1)c1onc(n1)C(C)C)c1ccc(c(c1)C)C#N
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 36j [PMID: 21536438],5755,,,178102380,Agonist,Agonist,,f,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,21536438,N#Cc1ccc(c(c1)Cl)Nc1ncnc(c1C)OC1C[C@@H]2CC[C@@H](C1)N2S(=O)(=O)C1CC1
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 36 [PMID: 21273063],5747,,,178102373,Agonist,Agonist,,f,,,pEC50,0,7.72,0,EC50,0,19,0,=,,,,21273063,C#Cc1nc(C)cc(n1)N1CCC(CC1)C1CCN(CC1)c1ncc(nc1)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 3a [PMID: 21444206],5737,,,178102363,Agonist,Agonist,,f,,,pEC50,0,8.96,0,EC50,0,1.1,0,=,,,,21444206,O=C(N1CCC(CC1)Oc1ncnc2c1cnn2c1ccc(cc1)S(=O)(=O)C)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 3j [PMID: 21444206],5738,,,178102364,Agonist,Agonist,,f,,,pEC50,0,9.05,0,EC50,0,0.9,0,=,,,,21444206,O=C(N1CCC(CC1)Oc1ncnc2c1cnn2c1ccc(cc1F)S(=O)(=O)C)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 3 [PMID: 21310611],5724,,,178102350,Agonist,Agonist,,f,,,pEC50,0,7.1,0,-,0,0,0,=,,,,21310611,O=C(Cc1c(F)ccc(c1F)F)NC[C@H](C1CCN(CC1)C(=O)OC1(C)CC1)F
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 42 [PMID: 22545772],5735,,,178102361,Agonist,Agonist,,f,,,pEC50,0,8.1,0,EC50,0,8,0,=,,,,22545772,N#Cc1cnccc1COc1cnc(nc1)N1CCN(C[C@@H]1C)c1noc(n1)C(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 58 [PMID: 21273063],5748,,,178102374,Agonist,Agonist,,f,,,pEC50,0,8.4,0,EC50,0,4,0,=,,,,21273063,Clc1cnc(nc1)N1CCC(CC1)[C@H]1C[C@H]1CCOc1ccc(cn1)S(=O)(=O)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,compound 8g [PMID: 21444206],5739,,,178102365,Agonist,Agonist,,f,,,pEC50,0,9.3,0,EC50,0,0.5,0,=,,,,21444206,O=C(N1CCC(CC1)Sc1ncnc2c1cnn2c1ccc(cc1F)S(=O)(=O)C)OC(C)(C)C
<i>GPR132</i>,128,GPR132,Q9UNW8,,,,,,Human,9-hydroxyoctadecadienoic acid,5567,,,178102204,Agonist,Full agonist,,t,,,pEC50,0,5.7,0,EC50,0,2000,0,=,,,,16236715,CCCCC/C=C\C=C\[C@H](CCCCCCCC(=O)O)O
<i>GPR132</i>,128,GPR132,Q9UNW8,,,,,,Human,9-hydroxyoctadecadienoic acid,5567,,,178102204,Agonist,Full agonist,,t,,,pEC50,0,5.7,0,EC50,0,2000,0,=,,,,16236715,CCCCC/C=CC=C[C@H](CCCCCCCC(=O)O)O
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,compound 1a [PMID: 24900311],7799,,,223366130,Agonist,Full agonist,,f,f,,pEC50,0,7.409999847,0,EC50,0,39,0,=,,,,24900311,COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2
<i>GPR142</i>,132,GPR142,Q7Z601,,,,,,Human,"compound 33 [Toda <i>et al.</i>, 2013]",8791,,,252827449,Agonist,Agonist,,f,f,,pEC50,0,7.659999847,0,EC50,0,22,0,=,,,,24900747,CCOCc1c(cnn1c1ncc(c(n1)N1CCCCC1)C)C(=O)NCc1cncn1C
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ASN02563583,5517,,,178102160,Agonist,Agonist,,f,,,pEC50,0,9.96,0,EC50,0,0.109,0,=,,,,21744154,COc1ccc(cc1)n1c(nnc1c1ccccc1OC)SC(C(=O)Nc1ccccc1)C
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ASN04421891,5518,,,178102161,Agonist,Agonist,,f,,,pEC50,0,8.44,0,EC50,0,3.67,0,=,,,,21744154,COCCn1nnnc1C(c1cc2cc(OC)ccc2[nH]c1=O)N(Cc1ccccc1)CCc1ccccc1
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ASN04450772,5519,,,178102162,Agonist,Agonist,,f,,,pEC50,0,8.93,0,EC50,0,1.18,0,=,,,,21744154,COc1ccc(cc1)CNC(=O)C(N(C(=O)c1snc(c1N)C(=O)N)Cc1ccco1)c1ccc(cc1)O
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ASN04885796,5520,,,178102163,Agonist,Agonist,,f,,,pEC50,0,9.96,0,EC50,0,0.109,0,=,,,,21744154,COc1ccc(cc1)N(C(c1ccc(cc1)F)C(=O)NCC1CCCO1)C(=O)Cn1nnc2c1cccc2
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ASN06917370,5524,,,178102167,Agonist,Agonist,,f,,,pEC50,0,9.57,0,EC50,0,0.268,0,=,,,,21744154,O=C(N1CCC(CC1)c1nc(=O)c2c([nH]1)n(nn2)Cc1ccccc1Cl)Nc1ccc(cc1)C(F)(F)F
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,,,pEC50,0,7.43,0,EC50,0,37,0,=,,,,21773766,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,cangrelor,1776,,,135650051,Antagonist,Antagonist,,f,,,pIC50,0,8.92,0,IC50,0,1.2,0,=,,,,18974869,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
<i>GPR182</i>,146,Gpr182,P31392,,,,,,Rat,adrenomedullin,697,Adm,Rat,135651601,Agonist,Partial agonist,,t,,,pEC50,0,8.15,0,EC50,0,7,0,=,,,,7592696,
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,25-hydroxycholesterol,2885,,,135651392,Agonist,Agonist,,t,,,pEC50,0,6.9,0,EC50,0,127,0,=,,,,21796211,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCCC(O)(C)C)C)C)C1)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,27-hydroxycholesterol,2752,,,135651393,Agonist,Agonist,,t,,,pEC50,0,5.52,0,EC50,0,3029,0,=,,,,21796211,OC[C@@H](CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,"7&alpha;,27-dihydroxycholesterol",4353,,,178101170,Agonist,Agonist,,t,,,pEC50,0,8.89,0,EC50,0,1.3,0,=,,,,21796211,OC[C@@H](CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](O)C=C2[C@]1(C)CC[C@@H](C2)O)C)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,7&alpha;-hydroxycholesterol,4351,,,178101168,Agonist,Agonist,,t,,,pEC50,0,7.09,0,EC50,0,82,0,=,,,,21796211,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](O)C=C2[C@]1(C)CC[C@@H](C2)O)C)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,"7&beta;, 25-dihydroxycholesterol",4355,,,178101172,Agonist,Agonist,,t,,,pEC50,0,8.68,0,EC50,0,2.1,0,=,,,,21796211,O[C@H]1CC[C@]2(C(=C[C@@H]([C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCCC(O)(C)C)C)C)O)C1)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,"7&beta;, 27-dihydroxycholesterol",4354,,,178101171,Agonist,Agonist,,t,,,pEC50,0,7.29,0,EC50,0,51,0,=,,,,21796211,OC[C@@H](CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@@H](O)C=C2[C@]1(C)CC[C@@H](C2)O)C)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,7&beta;-hydroxycholesterol,4352,,,178101169,Agonist,Agonist,,t,,,pEC50,0,5.75,0,EC50,0,1763,0,=,,,,21796211,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@@H](O)C=C2[C@]1(C)CC[C@@H](C2)O)C)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,"7&alpha;,25-dihydroxycholesterol",4350,,,178101167,Agonist,Full agonist,,t,,,pIC50,9.62,0,7.15,IC50,70,0,0.242,=,,,,21796211,O[C@H]1CC[C@]2(C(=C[C@H]([C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCCC(O)(C)C)C)C)O)C1)C
<i>GPR183</i>,81,GPR183,P32249,,,,,,Human,"7&alpha;,25-dihydroxycholesterol",4350,,,178101167,Agonist,Full agonist,,t,,,pEC50,9.85,0,8.1,EC50,8,0,0.14,=,,,,21796211,O[C@H]1CC[C@]2(C(=C[C@H]([C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCCC(O)(C)C)C)C)O)C1)C
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,abnormal cannabidiol,5526,,,178102169,Agonist,Agonist,,f,,,pEC50,0,6.08,0,EC50,0,835.7,0,=,,,,21595653,CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,arachidonylcyclopropylamide,739,,,135651444,Agonist,Agonist,,f,,,pEC50,0,4.87,0,EC50,0,13500,0,=,,,,21595653,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NC1CC1
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,arachidonylcyclopropylamide,739,,,135651444,Agonist,Agonist,,f,,,pEC50,0,4.87,0,EC50,0,13500,0,=,,,,21595653,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NC1CC1
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,anandamide,2364,,,135651438,Agonist,Full agonist,,f,,,pEC50,0,5.42,0,EC50,0,3830,0,=,,,,21595653,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,anandamide,2364,,,135651438,Agonist,Full agonist,,f,,,pEC50,0,5.42,0,EC50,0,3830,0,=,,,,21595653,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,AM251,3317,,,178100351,Agonist,Partial agonist,,f,,,pEC50,0,4.02,0,EC50,0,96400,0,=,,,,21595653,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,cannabidiol,4150,,,178100971,Agonist,Partial agonist,,f,,,pEC50,0,4.29,0,EC50,0,51100,0,=,,,,21595653,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
<i>GPR19</i>,90,GPR19,Q15760,,,,,,Human,adropin,9573,ENHO,Human,336446959,Agonist,Agonist,,f,f,,pEC50,0,8.109999657,0,EC50,0,7.699999809,0,=,In a TGF&alpha;-shedding assay using synthetic adropin.,,,28476646,
<i>GPR31</i>,98,Gpr31c,F8VQN3,,,,,,Mouse,12S-[<sup>3</sup>H]HETE,5508,,,178102154,Agonist,Agonist,,f,,,pKd,0,8.31,0,Kd,0,4.87,0,=,,,,21712392,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O
<i>GPR31</i>,98,Gpr31c,F8VQN3,,,,,,Mouse,12S-[<sup>3</sup>H]HETE,5508,,,178102154,Agonist,Agonist,,f,,,pKd,0,8.31,0,Kd,0,4.87,0,=,,,,21712392,CCCCC/C=CC[C@@H](/C=C/C=CC/C=CCCCC(=O)O)O
<i>GPR31</i>,98,Gpr31c,F8VQN3,,,,,,Mouse,12S-HETE,3404,,,135651372,Agonist,Full agonist,,t,,,pEC50,0,9.55,0,EC50,0,0.28,0,=,,,,21712392,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O
<i>GPR31</i>,98,Gpr31c,F8VQN3,,,,,,Mouse,12S-HETE,3404,,,135651372,Agonist,Full agonist,,t,,,pEC50,0,9.55,0,EC50,0,0.28,0,=,,,,21712392,CCCCC/C=CC[C@@H](/C=C/C=CC/C=CCCCC(=O)O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,t,,,pEC50,7.52,0,7.3,-,0,0,0,=,,,,20361937,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,t,,,pEC50,7.52,0,7.3,-,0,0,0,=,,,,20361937,CCCCCCCC/C=CCCCCCCCC(=O)OC(COP(=O)(O)O)CO
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,bumetanide,4837,,,178101539,Agonist,Agonist,,f,,,pEC50,5.54,0,5,-,0,0,0,=,,,,22236570,CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,compound 83 [PMID: 23888932],9742,,,0,Agonist,Agonist,,f,f,,pKi,0,9.229999542,0,Ki,0,0.589999974,0,=,In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.,,,23888932,COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,CID2745687,9741,,,0,Antagonist,Antagonist,,f,f,,pKi,0,7.889999866,0,Ki,0,12.80000019,0,=,Antagonism of the GPR35 response to 1 &mu;M pamoic acid in a &beta;arrestin2-GFP trafficking assay.,,,20826425,COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,CID2745687,9741,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,Antagonism of zaprinast-mediated activation of GPR35 in a &beta;-arrestin assay.,,,23888932,COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,CID2745687,9741,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,4.980000019,0,IC50,0,10400,0,=,Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.,,,23888932,COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,CID2745687,9741,,,0,Antagonist,Antagonist,,f,f,,pKi,0,7.369999886,0,Ki,0,42.20000076,0,=,In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.,,,23888932,COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F
<i>GPR39</i>,105,GPR39,O43194,,,,,,Human,compound 15 [PMID: 25313322],7803,,,223366134,Agonist,Full agonist,,f,f,,pEC50,0,9.100000381,0,EC50,0,0.800000012,0,=,,,,25313322,CNc1nc(NCc2ccc(cc2Cl)Cl)cc(n1)c1ccccn1
<i>GPR39</i>,105,GPR39,O43194,,,,,,Human,compound 1 [PMID: 24900608],7800,,,223366131,Agonist,Full agonist,,f,f,,pEC50,7.199999809,0,4.900000095,EC50,12000,0,59,=,,,,24900608,N#Cc1ccc(nc1)N1CCN(CC1)Cc1cn2c(n1)ccc(c2)Cl
<i>GPR52</i>,108,GPR52,Q9Y2T5,,,,,,Human,compound 7a [PMID: 24884590],8840,,,252827497,Agonist,Agonist,,f,f,,pEC50,0,7.550000191,0,EC50,0,28.20000076,0,=,,,,24884590,OCCNC(=O)c1cccc(c1)c1cccc2c1cc(o2)Cc1cccc(c1)C(F)(F)F
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonoylglycerol,729,,,135651394,Agonist,Agonist,,t,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,17876302,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonoylglycerol,729,,,135651394,Agonist,Agonist,,t,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,17876302,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)OC(CO)CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonyl glyceryl ether,5545,,,178102187,Agonist,Agonist,,f,,,pEC50,0,8,0,EC50,0,10,0,=,,,,17876302,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CO)CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonyl glyceryl ether,5545,,,178102187,Agonist,Agonist,,f,,,pEC50,0,8,0,EC50,0,10,0,=,,,,17876302,CCCCC/C=CC/C=CC/C=CC/C=CCCCCOC(CO)CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,abnormal cannabidiol,5526,,,178102169,Agonist,Agonist,,f,,,pEC50,5.71,0,5.51,EC50,3102,0,1944,=,,,,17876302,CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,abnormal cannabidiol,5526,,,178102169,Agonist,Agonist,,t,,,pEC50,0,8.6,0,EC50,0,2.5,0,=,,,,17704827,CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,AM251,3317,,,178100351,Agonist,Agonist,,f,f,,pEC50,7.409999847,0,5.019999981,EC50,9600,0,39,=,,,,17876302,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,anandamide,2364,,,135651438,Agonist,Agonist,,t,,,pEC50,0,7.74,0,EC50,0,18,0,=,,,,17876302,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,anandamide,2364,,,135651438,Agonist,Agonist,,t,,,pEC50,0,7.74,0,EC50,0,18,0,=,,,,17876302,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,CID1172084,5564,,,178102202,Agonist,Agonist,,f,,,pEC50,6.8,0,6.74,EC50,180,0,159,=,,,,21534610,COc1ccc2c(c1)n1c(SCC(=O)Nc3scc(n3)c3ccc(cc3)F)nnc1c(c2)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,CID1792197,5563,,,178102201,Agonist,Agonist,,f,,,pEC50,6.96,0,6.92,EC50,120,0,110,=,,,,21534610,COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,CID2440433,5565,,,178102203,Agonist,Agonist,,f,,,pEC50,6.6,0,6.57,EC50,270,0,250,=,,,,21534610,O=C(c1cc(ccc1N1CCCC1)S(=O)(=O)N(C)C)N1CCN(CC1)c1cccc(c1C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonoylglycerolphosphoinositol,4029,,,178100855,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,18845565,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(COP(=O)(OC1C(O)C(O)C(C(C1O)O)O)[O-])CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,2-arachidonoylglycerolphosphoinositol,4029,,,178100855,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,18845565,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)OC(COP(=O)(OC1C(O)C(O)C(C(C1O)O)O)[O-])CO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,AM281,741,,,135649928,Antagonist,Antagonist,,f,,,pIC50,8.52,0,7.87,IC50,13.6,0,3,=,,,,17876302,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCOCC1
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,cannabidiol,4150,,,178100971,Antagonist,Antagonist,,f,,,pIC50,6.46,0,6.35,IC50,445,0,350,=,,,,17876302,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,CID16020046,6577,,,178103191,Antagonist,Antagonist,apparent pA<sub>2</sub>,f,f,,pA2,0,7.300000191,0,-,0,0,0,=,,,,23639801,Oc1cccc(c1)C1N(c2ccc(cc2)C(=O)O)C(=O)c2c1c(n[nH]2)c1ccc(cc1)C
<i>GPR75</i>,115,GPR75,O95800,,,,,,Human,CCL5,758,CCL5,Human,135651690,Agonist,Full agonist,,t,,,pEC50,0,9.59,0,EC50,0,0.26,0,=,,,,17001303,
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,2-hydroxy capric acid,5847,,,178102471,Agonist,Full agonist,,f,,,pEC50,0,4.5,0,EC50,0,31000,0,=,,,,23449982,CCCCCCCCC(C(=O)O)O
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,2-hydroxylauric acid,5849,,,178102473,Agonist,Full agonist,,f,,,pEC50,0,5,0,EC50,0,9900,0,=,,,,23449982,CCCCCCCCCCC(C(=O)O)O
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,3-hydroxy capric acid,5848,,,178102472,Agonist,Full agonist,,f,,,pEC50,0,3.6,0,EC50,0,230000,0,=,,,,23449982,CCCCCCCC(CC(=O)O)O
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,3-hydroxylauric acid,5850,,,178102474,Agonist,Full agonist,,f,,,pEC50,0,4.9,0,EC50,0,13000,0,=,,,,23449982,CCCCCCCCCC(CC(=O)O)O
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,6-n-octylaminouracil,5846,,,178102470,Agonist,Full agonist,,f,,,pEC50,0,7,0,EC50,0,105,0,=,,,,23449982,CCCCCCCCNc1cc(=O)[nH]c(=O)[nH]1
<i>GPR88</i>,123,GPR88,Q9GZN0,,,,,,Human,compound 2 [PMID: 24793972],7798,,,223366129,Agonist,Full agonist,,f,f,,pEC50,0,6.21999979,0,EC50,0,600,0,=,,,,24793972,CCCc1ccc(cc1)c1ccc(cc1)N(C(=O)[C@@H]1C[C@H]1c1ccccn1)C[C@H]([C@H](CC)C)N
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,compound 4g [PMID: 21316219],8211,,,249565891,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,21316219,O=C(c1ccccc1)Cc1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1nccc2
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,compound 7 [PMID: 22464456],8172,,,249565852,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,22464456,CCC(c1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1sc(c2)C(F)F)(CC)O
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,angiotensin-(1-7),582,AGT|Agt|Agt,Human|Mouse|Rat,135651614,Agonist,Agonist,,f,f,,pKi,0,7.309999943,0,Ki,0,49.20000076,0,=,,,,21670420,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,angiotensin-(1-7),582,AGT|Agt|Agt,Human|Mouse|Rat,135651614,Agonist,Agonist,,f,,,pIC50,0,8.16,0,IC50,0,6.9,0,=,,,,12829792,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
<i>MAS1</i>,150,Mas1,P12526,,,,,,Rat,AR234960,7039,,,178103618,Agonist,Full agonist,,f,f,,pEC50,6.769999981,0,5.769999981,EC50,1710,0,170,=,,,,22003054,COc1cc(ccc1S(=O)(=O)N1CC(C(C1)c1cccc(c1)F)CN1CCN(CC1)c1ccccn1)[N+](=O)[O-]
<i>MAS1</i>,150,MAS1,P04201,,,,,,Human,AR234960,7039,,,178103618,Agonist,Full agonist,,f,f,,pEC50,6.460000038,0,6.139999866,EC50,720,0,350,=,,,,22003054,COc1cc(ccc1S(=O)(=O)N1CC(C(C1)c1cccc(c1)F)CN1CCN(CC1)c1ccccn1)[N+](=O)[O-]
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,AVE 0991,5579,,,178102215,Agonist,Full agonist,,f,f,,pIC50,0,7.320000172,0,IC50,0,47.5,0,=,,,,15326087,CCNC(=O)NS(=O)(=O)c1sc(cc1c1ccc(cc1)Cn1c(nc(c1C=O)OC)c1ccccc1)CC(C)C
<i>MAS1</i>,150,MAS1,P04201,,,,,,Human,CGEN-856,7041,,,178103620,Agonist,Full agonist,,f,f,,pEC50,0,6.239999771,0,EC50,0,570,0,=,,,,18854305,
<i>MAS1</i>,150,MAS1,P04201,,,,,,Human,CGEN-857,7040,,,178103619,Agonist,Full agonist,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,18854305,
<i>MAS1</i>,150,MAS1,P04201,,,,,,Human,AR244555,7042,,,178103621,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.730000019,0,IC50,0,186,0,=,,,,22003054,C=CCCN1CCC2(CC1)CN(c1c2cc(Cl)cc1)C(=O)c1c(F)cccc1F
<i>MAS1</i>,150,Mas1,P12526,,,,,,Rat,AR244555,7042,,,178103621,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.460000038,0,IC50,0,348,0,=,,,,22003054,C=CCCN1CCC2(CC1)CN(c1c2cc(Cl)cc1)C(=O)c1c(F)cccc1F
<i>MAS1</i>,150,MAS1,P04201,,,,,,Human,AR305352,7043,,,178103622,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.78000021,0,IC50,0,166,0,=,,,,22003054,
<i>MAS1</i>,150,Mas1,P12526,,,,,,Rat,AR305352,7043,,,178103622,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.489999771,0,IC50,0,320,0,=,,,,22003054,
<i>MRGPRD</i>,152,Mrgprd,Q91ZB8,,,,,,Mouse,&beta;-alanine,2365,,,135651448,Agonist,Agonist,,f,,,pEC50,0,4.36,0,EC50,0,44000,0,=,,,,15037633,NCCC(=O)O
<i>MRGPRD</i>,152,Mrgprd,Q7TN41,,,,,,Rat,&beta;-alanine,2365,,,135651448,Agonist,Agonist,,f,,,pEC50,0,4.85,0,EC50,0,14000,0,=,,,,15037633,NCCC(=O)O
<i>MRGPRD</i>,152,MRGPRD,Q8TDS7,,,,,,Human,&beta;-alanine,2365,,,135651448,Agonist,Full agonist,,t,,,pEC50,0,4.8,0,EC50,0,15000,0,=,,,,15037633,NCCC(=O)O
<i>MRGPRX1</i>,156,MRGPRX1,Q96LB2,,,,,,Human,chloroquine,5535,,,178102177,Agonist,Agonist,,f,,,pEC50,0,3.53,0,EC50,0,297000,0,=,,,,20004959,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC
<i>MRGPRX1</i>,156,MRGPRX1,Q96LB2,,,,,,Human,bovine adrenal medulla peptide 8-22,4058,PENK,Human,178100882,Agonist,Full agonist,,t,,,pEC50,7.8,0,5.3,-,0,0,0,=,,,,15163697,
<i>MRGPRX1</i>,156,MRGPRX1,Q96LB2,,,,,,Human,bovine adrenal medulla peptide 8-22,4058,PENK,Human,178100882,Agonist,Full agonist,,t,,,pKd,0,7.99,0,Kd,0,10.2,0,=,,,,11850634,
<i>MRGPRX1</i>,156,MRGPRX1,Q96LB2,,,,,,Human,bovine adrenal medulla peptide 8-22,4058,PENK,Human,178100882,Agonist,Full agonist,,t,,,pKi,0,7.68,0,Ki,0,21,0,=,,,,11850634,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,compound 48/80,5531,,,178102173,Agonist,Agonist,,f,f,,pEC50,0,5.739999771,0,EC50,0,1800,0,=,,,,28288109,CNCCc1cc(Cc2cc(CCNC)ccc2OC)c(c(c1)Cc1cc(CCNC)ccc1OC)OC
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,compound 2 [PMID: 19230660],5530,,,178102172,Agonist,Full agonist,,f,,,pEC50,0,6.5,0,-,0,0,0,=,,,,19230660,CN1CCCN(CC1)C(=O)c1ccc2c(c1)nc1n2[C@@H](C(C)C)C(=O)Nc2c1cc(cc2)NC1CCCCCC1
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,1-methyl-L-tryptophan,8225,,,249565905,Inhibitor,Inhibition,,f,f,,pKi,0,4.369999886,0,Ki,0,42300,0,=,,,,24099220,OC(=O)[C@H](Cc1cn(c2c1cccc2)C)N
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,amg-1,8227,,,249565907,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,21835273,O=C(Nc1ccc2c(c1)OCO2)CSc1nnc2n1c(cs2)c1ccc(cc1)C
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,beta-carboline,8222,,,249565902,Inhibitor,Inhibition,,f,f,,pKi,0,0.920000017,0,Ki,0,120000000,0,=,,,,21269836,c1ccc2c(c1)[nH]c1c2ccnc1
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,compound 5i [PMID: 24099220],8223,,,249565903,Inhibitor,Inhibition,,f,t,,pKi,0,7.269999981,0,Ki,0,54,0,=,,,,24099220,[O-][N+](=O)c1ccc2c(c1)C(=O)c1n2c(=O)c2c(n1)cccc2
Inducible NOS,1250,NOS2,P35228,,,,,,Human,1400W,5102,,,178101795,Inhibitor,Inhibition,,f,,,pIC50,0,8.2,0,IC50,0,6.31,0,,,,,9030556,NCc1cccc(c1)C/N=C(/N)\C
Inducible NOS,1250,NOS2,P35228,,,,,,Human,1400W,5102,,,178101795,Inhibitor,Inhibition,,f,,,pIC50,0,8.2,0,IC50,0,6.31,0,,,,,9030556,NCc1cccc(c1)C/N=C(/N)C
Inducible NOS,1250,NOS2,P35228,,,,,,Human,2-amino-4-methylpyridine,5111,,,178101804,Inhibitor,Inhibition,,f,,,pIC50,0,7.4,0,IC50,0,39.8,0,,,,,8937711,Cc1ccnc(c1)N
Inducible NOS,1250,NOS2,P35228,,,,,,Human,aminoguanidine,5135,,,178101827,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,1378415,NNC(=N)N
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,BMS-345541,5669,,,178102297,Allosteric modulator,Negative,,f,t,,pKd,0,6.889999866,0,Kd,0,130,0,=,,,,22037378,NCCNc1nc2ccc(cc2n2c1ncc2C)C
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,BMS-345541,5669,,,178102297,Allosteric modulator,Negative,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,12403772,NCCNc1nc2ccc(cc2n2c1ncc2C)C
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,BI605906,9357,,,328083459,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,0,CCC(c1cc(nc2c1c(N)c(s2)C(=O)N)N1CCC(CC1)S(=O)(=O)C)(F)F
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,compound 47 [PMID: 28737909],9646,,,340590276,Inhibitor,Inhibition,,f,f,,pKi,0,5.639999866,0,Ki,0,2300,0,=,,,,28737909,OCc1ccc(cc1)c1nc(N)nc2c1c(C#N)c[nH]2
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,amlexanox,7113,,,178103690,Inhibitor,Inhibition,,f,f,,pIC50,6,0,5.699999809,IC50,2000,0,1000,=,Inhibition of substrate phosphorylation.,,,23396211,CC(c1ccc2c(c1)c(=O)c1c(o2)nc(c(c1)C(=O)O)N)C
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,compound 17d [PMID: 23099093],8196,,,249565876,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,23099093,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,compound II [PMID: 21329883],9579,,,336446965,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,In a biochemical assay using purified recombinant enzyme.,,,21329883,COc1ccc(cc1)N1N=CC2C1N=C(N=C2)Nc1cc(OC)c(c(c1)OCCCN1CCN(CC1)C)OC
<i>N</i>-Acylethanolamine acid amidase,1402,NAAA,Q02083,,,,,,Human,CCP,5161,,,178101852,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5010,0,,,,,14686878,CCCCCCCCCCCCCCCNC(=O)C1CCCCC1
<i>N</i>-Acylethanolamine acid amidase,1402,NAAA,Q02083,,,,,,Human,compound 6 [PMID: 25874594],9178,,,315661261,Inhibitor,Irreversible inhibition,,f,t,,pIC50,0,5.460000038,0,IC50,0,3500,0,=,,,,25874594,O=C(N[C@H]1CNC1=O)OCCCCC1CCCCC1
"<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 1",1247,DDAH1,O94760,,,,,,Human,compound 2e [PMID: 19013076],8830,,,252827487,Inhibitor,Inhibition,,f,f,,pKi,0,5.699999809,0,Ki,0,2000,0,=,,,,19013076,NC(=NCCC[C@@H](C(=O)O)N)CC=C
INPP5A,1453,INPP5A,Q14642,,,,,,Human,"compound 5 [Noble <i>et al.</i>, 1992]",8844,,,252827501,Inhibitor,Inhibition,,f,f,,pKi,0,5.889999866,0,Ki,0,1300,0,=,Using 5-phosphatase from human erythrocyte membranes.,,,0,OC1C(OP(=S)(O)O)C(OP(=S)(O)O)C(C(C1O)OP(=O)(O)O)O
INPP5D,1455,INPP5D,Q92835,,,,,,Human,3 alpha-aminocholestane,9564,,,336446950,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,20200281,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2[C@]1(C)CC[C@H](C2)N)C)C
INPPL1,1459,INPPL1,O15357,,,,,,Human,AS1949490,8878,,,252827535,Inhibitor,Inhibition,,f,f,,pIC50,0,6.210000038,0,IC50,0,620,0,=,IMeasured in a high-throughput screening assay.,,,19694723,Clc1ccc(cc1)COc1ccsc1C(=O)N[C@H](c1ccccc1)C
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,AG 1024,5912,,,178102535,Inhibitor,Inhibition,,f,t,,pIC50,0,4.739999771,0,IC50,0,18000,0,=,,,,9075698,N#CC(=Cc1cc(Br)c(c(c1)C(C)(C)C)O)C#N
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,AZD3463,7706,,,223366039,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,,,,0,COc1cc(ccc1Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)N1CCC(CC1)N
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,581,0,=,,,,0,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,BMS-536924,9386,,,328083488,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,16134929,Clc1cccc(c1)C(CNC1=CC=NC(=O)C1=c1[nH]c2c([nH]1)cc(cc2C)N1CCOCC1)O
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,BMS-754807,7952,,,249565635,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19778024,Fc1ccc(cn1)NC(=O)[C@]1(C)CCCN1c1nc(Nc2n[nH]c(c2)C2CC2)c2n(n1)ccc2
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,brigatinib,7741,,,223366074,Inhibitor,Inhibition,,f,f,,pIC50,0,7.610000134,0,IC50,0,24.60000038,0,=,,,,27144831,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1P(=O)(C)C)Cl)N1CCC(CC1)N(C)C
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,ceritinib,7397,,,178103969,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,23742252,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
Insulin receptor,1800,INSR,P06213,,,,,,Human,BMS-536924,9386,,,328083488,Inhibitor,Inhibition,,f,f,,pIC50,0,7.139999866,0,IC50,0,73,0,=,,,,16134929,Clc1cccc(c1)C(CNC1=CC=NC(=O)C1=c1[nH]c2c([nH]1)cc(cc2C)N1CCOCC1)O
Insulin receptor,1800,INSR,P06213,,,,,,Human,brigatinib,7741,,,223366074,Inhibitor,Inhibition,,f,f,,pIC50,0,6.710000038,0,IC50,0,196,0,=,,,,27144831,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1P(=O)(C)C)Cl)N1CCC(CC1)N(C)C
Insulin receptor,1800,INSR,P06213,,,,,,Human,ceritinib,7397,,,178103969,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,23742252,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
Insulin receptor,1800,INSR,P06213,,,,,,Human,compound 15 [PMID: 24900237],8220,,,249565900,Inhibitor,Inhibition,,f,f,,pIC50,0,6.21999979,0,IC50,0,597,0,=,,,,24900237,CCN1C(=O)CCCc2c1ccc(c2OC)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
integrin &alpha;4&beta;1,2580,ITGA4|ITGB1,P05556|P13612,,,,,,Human,BIO1211,6589,,,178103202,Inhibitor,Inhibition,,f,,,pIC50,9,0,8.3,-,0,0,0,=,,,,10072689,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)CC(=O)O)NC(=O)Cc1ccc(cc1)NC(=O)Nc1ccccc1C)C
integrin &alpha;IIb&beta;3,2579,ITGA2B|ITGB3,P05106|P17301,,,,,,Human,abciximab,6584,,,178103197,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
integrin &alpha;L&beta;2,2582,ITGAL|ITGB2,P05107|P20701,,,,,,Human,A286982,6592,,,178103205,Inhibitor,Inhibition,,f,,,pIC50,7.5,0,7.4,-,0,0,0,=,,,,11052808,O=C(N1CCN(CC1)C(=O)C)/C=C/c1ccc(c(c1)N(=O)=O)Sc1ccccc1C(C)C
"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",2451,ITGAL,P20701,,,,,,Human,BI-1950,9719,,,348353678,Inhibitor,Binding,,f,f,,pKd,0,8.050000191,0,Kd,0,9,0,=,Inhibition of LFA-1 binding to ICAM-1 <i>in vitro</i>.,,,0,N#Cc1ccc(cc1)C[C@]1(C)C(=O)N(c2n1c(cn2)C(=O)N[C@H](C(=O)NC1(CC1)c1ccccn1)C)c1cc(Cl)c(c(c1)Cl)F
"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",2451,ITGAL,P20701,,,,,,Human,BIRT 377,9720,,,348353679,Inhibitor,Binding,,f,f,,pKd,0,7.590000153,0,Kd,0,25.79999924,0,=,,,,10553036,Brc1ccc(cc1)C[C@@]1(C)N(C)C(=O)N(C1=O)c1cc(Cl)cc(c1)Cl
integrin &alpha;V&beta;3,2583,ITGAV|ITGB3,P05106|P06756,,,,,,Human,cilengitide,6597,,,178103210,Inhibitor,Inhibition,,f,,,pIC50,0,8.5,0,-,0,0,0,=,,,,11855984,OC(=O)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N(C(=O)[C@H](NC1=O)Cc1ccccc1)C)C(C)C
integrin linked kinase,2041,ILK,Q13418,,,,,,Human,compound 22 [PMID: 21823616],8116,,,249565796,Inhibitor,Inhibition,,f,t,,pIC50,0,6.21999979,0,IC50,0,600,0,=,,,,21823616,CNC(=O)CCc1nn(c(c1)c1ccc(cc1)c1ccc(cc1)C(F)(F)F)c1ccc(cc1)N1CCNCC1
interferon &alpha;/&beta;  receptor 1,1723,IFNAR1,P17181,,,,,,Human,anifrolumab,8258,,,249565938,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,,,,0,
Interleukin-15 receptor,2302,IL2RG|IL15RA|IL2RB,P31785|P14784|Q13261,,,,,,Human,ALT-803,9615,,,340590245,Agonist,Agonist,,f,f,,pIC50,0,12.30000019,0,IC50,0,0.0005,0,~,Binding of rhIL-15N72D to hIL-15R <i>in vitro</i>.,,,19710453,
Interleukin 17 receptor A,1738,IL17RA,Q96F46,,,,,,Human,brodalumab,7540,,,187051841,Antibody,Binding,,f,t,,pKd,0,9.159999847,0,Kd,0,0.689999998,0,=,,,,0,
interleukin 1 receptor associated kinase 1,2042,IRAK1,P51617,,,,,,Human,compound 1 [WO2012007375],8084,,,249565764,Inhibitor,Inhibition,,f,f,,pIC50,0,7.260000229,0,IC50,0,55,0,=,,,,0,NCC1CCN(CC1)c1ccc(cc1NC(=O)c1cnn2c1ncc(c2)O)Cl
interleukin 1 receptor associated kinase 1,2042,IRAK1,P51617,,,,,,Human,compound 7 [WO2012007375],8085,,,249565765,Inhibitor,Inhibition,,f,f,,pIC50,0,6.010000229,0,IC50,0,983,0,=,,,,0,NCCN(c1ncc2c(n1)c(cs2)C(=O)Nc1cc2cccnc2cc1OC)C
interleukin 1 receptor associated kinase 3,2044,IRAK3,Q9Y616,,,,,,Human,compound R-16 [PMID: 21967808],8213,,,249565893,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21967808,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,compound 1 [WO2012007375],8084,,,249565764,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,0,NCC1CCN(CC1)c1ccc(cc1NC(=O)c1cnn2c1ncc(c2)O)Cl
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,compound 7 [WO2012007375],8085,,,249565765,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,0,NCCN(c1ncc2c(n1)c(cs2)C(=O)Nc1cc2cccnc2cc1OC)C
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,AF12198,4861,,,178101562,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,8940020,
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,anakinra,6972,,,178103551,Inhibitor,Inhibition,,f,t,,pKd,0,7.820000172,0,Kd,0,15,0,=,,,,1834644,
Interleukin-2 receptor,2297,IL2RG|IL2RA|IL2RB,P31785|P01589|P14784,,,,,,Human,AF12198,4861,,,178101562,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,8940020,
Interleukin-2 receptor subunit &alpha;,1695,IL2RA,P01589,,,,,,Human,basiliximab,6879,,,178103461,Antibody,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin 5 receptor, &alpha; subunit",1706,IL5RA,Q01344,,,,,,Human,benralizumab,7674,,,223366009,Antibody,Binding,,f,f,,pKd,0,8.670000076,0,Kd,0,2.130000114,0,=,,,,0,
IP receptor,345,PTGIR,P43119,,,,,,Human,beraprost,1967,,,135649983,Agonist,Agonist,,f,f,,pKi,0,7.409999847,0,Ki,0,39,0,=,,,,17545310,CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
IP receptor,345,Ptgir,P43253,,,,,,Rat,beraprost,1967,,,135649983,Agonist,Agonist,,f,f,,pKi,0,7.71999979,0,Ki,0,19,0,=,,,,17545310,CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,AFP-07,1962,,,135649901,Agonist,Full agonist,,f,f,,pIC50,0,8.5,0,IC50,0,3.160000086,0,=,,,,9112287,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C(F)(F)/C(=C/CCCC(=O)O)/O2)O
IP receptor,345,Ptgir,P43252,,,,,,Mouse,beraprost,1967,,,135649983,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9313928,CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,BMY 45778,1963,,,135650008,Agonist,Full agonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,9156364,OC(=O)COc1cccc(c1)c1ocnc1c1nc(c(o1)c1ccccc1)c1ccccc1
IP receptor,345,PTGIR,P43119,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
IP receptor,345,PTGIR,P43119,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
IP receptor,345,PTGIR,P43119,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
IP receptor,345,Ptgir,P43252,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
IP receptor,345,Ptgir,P43252,,,,,,Mouse,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
IP receptor,345,Ptgir,P43252,,,,,,Mouse,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9313928,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,cicaprost,1917,,,135650094,Agonist,Full agonist,,f,f,,pKi,0,7.800000191,0,-,0,0,0,=,,,,10634944,CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,BAY-73-1449,5851,,,178102475,Antagonist,Antagonist,,f,,,pIC50,0,10,0,IC50,0,0.1,0,<,,,,18603238,OC(=O)[C@@H](Nc1ncnc(c1)c1ccc(cc1)OCc1ccccc1)Cc1ccccc1
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,adenophostin A,4124,,,178100946,Activator,None,pharmacological; nM range,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)n1cnc2c1ncnc2N
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,ATP,1713,,,135651446,Activator,None,< mM range,t,,,-,0,0,0,-,0,0,0,=,,,cytosolic,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,,t,,<750,-,0,0,0,-,0,0,0,=,,,cytosolic,0,
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,caffeine,407,,,135652675,Antagonist,Antagonist,mM range,f,,,-,0,0,0,,0,0,0,,,,,0,Cn1cnc2c1c(=O)n(C)c(=O)n2C
IP<sub>3</sub>R2,744,ITPR2,Q14571,,,,,,Human,adenophostin A,4124,,,178100946,Activator,None,pharmacological; nM range,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)n1cnc2c1ncnc2N
IP<sub>3</sub>R2,744,ITPR2,Q14571,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,nM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
IP<sub>3</sub>R3,745,ITPR3,Q14573,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,nM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
"isocitrate dehydrogenase (NADP(+)) 1, cytosolic",2884,IDH1,O75874,,,,,,Human,AGI-5198,9240,,,315661315,Inhibitor,Inhibition,,f,t,,pKi,0,4.889999866,0,Ki,0,13000,0,=,,,,0,Fc1cccc(c1)N(C(c1ccccc1C)C(=O)NC1CCCCC1)C(=O)Cn1ccnc1C
<i>TAAR4P </i>,169,Taar4,Q5QD15,,,,,,Mouse,&beta;-phenylethylamine,2144,,,135652016,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,,,,16878137,NCCc1ccccc1
<i>TAAR4P </i>,169,Taar4,Q923Y7,,,,,,Rat,&beta;-phenylethylamine,2144,,,135652016,Agonist,Partial agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,20559446,NCCc1ccccc1
<i>TAS2R31</i>,674,TAS2R31,P59538,,,,,,Human,6-methoxysakuranetin,9111,,,315661196,Antagonist,Antagonist,,f,f,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,,,,21650152,COc1cc2O[C@@H](CC(=O)c2c(c1OC)O)c1ccc(cc1)O
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,AZD1480,5933,,,178102556,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,21138246,Fc1cnc(nc1)[C@@H](Nc1ncc(c(n1)Nc1[nH]nc(c1)C)Cl)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,baricitinib,7792,,,223366123,Inhibitor,Inhibition,,f,t,,pIC50,0,8.229999542,0,IC50,0,5.900000095,0,=,,,,20363976,N#CCC1(CN(C1)S(=O)(=O)CC)n1ncc(c1)c1ncnc2c1cc[nH]2
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,BMS-911543,7954,,,249565637,Inhibitor,Inhibition,,f,f,,pIC50,0,6.449999809,0,IC50,0,356,0,=,,,,22015772,CCn1c(cc2c1nc(Nc1nn(c(c1)C)C)c1c2n(C)cn1)C(=O)N(C1CC1)C1CC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,compound 19a [PMID: 24359159],6977,,,178103556,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,24359159,Fc1cnc(nc1)[C@@H](Nc1nc(Nc2ncn(c2)C)c2c(n1)[nH]cc2)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,compound 5e [PMID: 28580438],9712,,,348353671,Inhibitor,Inhibition,,f,f,,pKd,0,7.550000191,0,Kd,0,28,0,=,Measured using the JAK1 JH2 domain-pseudokinase.,,,28580438,CC(Nc1ccnc(n1)Nc1cccc(c1)c1cccnc1)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,AC430,9177,,,315661260,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Fc1ccc(cc1)[C@H](c1nc(Nc2n[nH]c(c2)C)c2c(n1)cccc2)O
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,AZ960,8476,,,252166685,Inhibitor,Inhibition,,f,t,,pKi,0,9.350000381,0,Ki,0,0.449999988,0,=,,,,18775810,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cc1)F)C)Nc1n[nH]c(c1)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,AZD1480,5933,,,178102556,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,18775810,Fc1cnc(nc1)[C@@H](Nc1ncc(c(n1)Nc1[nH]nc(c1)C)Cl)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,baricitinib,7792,,,223366123,Inhibitor,Inhibition,,f,t,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,,,,20363976,N#CCC1(CN(C1)S(=O)(=O)CC)n1ncc(c1)c1ncnc2c1cc[nH]2
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,BMS-911543,7954,,,249565637,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22015772,CCn1c(cc2c1nc(Nc1nn(c(c1)C)C)c1c2n(C)cn1)C(=O)N(C1CC1)C1CC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,CEP-33779,9387,,,328083489,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,22594690,CN1CCN(CC1)c1cccc(c1)Nc1nn2c(n1)c(ccc2)c1ccc(cc1)S(=O)(=O)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,compound 19a [PMID: 24359159],6977,,,178103556,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,24359159,Fc1cnc(nc1)[C@@H](Nc1nc(Nc2ncn(c2)C)c2c(n1)[nH]cc2)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,AZD1480,5933,,,178102556,Inhibitor,Inhibition,,f,f,,pIC50,0,5.440000057,0,IC50,0,3630,0,=,,,,18775810,Fc1cnc(nc1)[C@@H](Nc1ncc(c(n1)Nc1[nH]nc(c1)C)Cl)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,BMS-911543,7954,,,249565637,Inhibitor,Inhibition,,f,f,,pIC50,0,7.139999866,0,IC50,0,73,0,=,,,,22015772,CCn1c(cc2c1nc(Nc1nn(c(c1)C)C)c1c2n(C)cn1)C(=O)N(C1CC1)C1CC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,CEP-33779,9387,,,328083489,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,22594690,CN1CCN(CC1)c1cccc(c1)Nc1nn2c(n1)c(ccc2)c1ccc(cc1)S(=O)(=O)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,compound 19a [PMID: 24359159],6977,,,178103556,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,24359159,Fc1cnc(nc1)[C@@H](Nc1nc(Nc2ncn(c2)C)c2c(n1)[nH]cc2)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
kallikrein B1,2379,KLKB1,P03952,,,,,,Human,compound 11 [PMID: 16413183],8493,,,252166701,Inhibitor,Inhibition,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,16413183,OC(=O)CC(C1=C/C(=c/2\[nH]c3c([nH]2)ccc(c3)C(=N)N)/C(=O)C(=C1)c1cccc(c1)C(=O)N)C(=O)O
kallikrein B1,2379,KLKB1,P03952,,,,,,Human,compound 11 [PMID: 16413183],8493,,,252166701,Inhibitor,Inhibition,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,16413183,OC(=O)CC(C1=C/C(=c/2[nH]c3c([nH]2)ccc(c3)C(=N)N)/C(=O)C(=C1)c1cccc(c1)C(=O)N)C(=O)O
kallikrein related peptidase 14,2866,KLK14,Q9P0G3,,,,,,Human,compound 3 [PMID: 23849879],8488,,,252166696,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1290,0,=,,,,23849879,Cc1ccc(cc1)C(=O)n1nc(nc1N)c1cccnc1
kallikrein related peptidase 14,2866,KLK14,Q9P0G3,,,,,,Human,compound 4d [PMID: 25489658],8483,,,252166691,Inhibitor,Inhibition,,f,f,,pIC50,0,5.539999962,0,IC50,0,2900,0,=,,,,25489658,BrCc1ccc2c(c1)cc(c(=O)o2)C(=O)Oc1cccc(c1)Cl
kallikrein related peptidase 3,2373,KLK3,P07288,,,,,,Human,compound 20 [PMID: 23692593],8486,,,252166694,Inhibitor,Inhibition,,f,t,,pKi,0,7.139999866,0,Ki,0,72,0,=,PSA isolated from human seminal plasma.,,,23692593,CCCC[C@@H](C(=O)N[C@@H](B(O)O)CCCBr)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CCCCCN)CO)CCC(=O)N
kallikrein related peptidase 4,2374,KLK4,Q9Y5K2,,,,,,Human,compound 33 [PMID: 19908842],8874,,,252827531,Inhibitor,Inhibition,,f,f,,pIC50,0,5.010000229,0,IC50,0,9772,0,=,,,,19908842,N#Cc1nc(Nc2cc(F)cc(c2)F)c2c(n1)n(cn2)CC(F)F
kallikrein related peptidase 5,2375,KLK5,Q9Y337,,,,,,Human,compound 3 [PMID: 23849879],8488,,,252166696,Inhibitor,Inhibition,,f,f,,pIC50,0,6.570000172,0,IC50,0,270,0,=,,,,23849879,Cc1ccc(cc1)C(=O)n1nc(nc1N)c1cccnc1
kallikrein related peptidase 5,2375,KLK5,Q9Y337,,,,,,Human,compound 4d [PMID: 25489658],8483,,,252166691,Inhibitor,Inhibition,,f,f,,pIC50,0,6.039999962,0,IC50,0,920,0,=,,,,25489658,BrCc1ccc2c(c1)cc(c(=O)o2)C(=O)Oc1cccc(c1)Cl
kallikrein related peptidase 6,2376,KLK6,Q92876,,,,,,Human,compound 5 {PMID: 24900446],8655,,,252166855,Inhibitor,Inhibition,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,,,,24900446,COc1ccc2c(c1)cc(cc2)S(=O)(=O)N([C@H]1CCN(C1=O)Cc1ccc(s1)C(=N)N)Cc1ccccc1
kallikrein related peptidase 7,2377,KLK7,P49862,,,,,,Human,compound 3 [PMID: 23849879],8488,,,252166696,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,23849879,Cc1ccc(cc1)C(=O)n1nc(nc1N)c1cccnc1
kallikrein related peptidase 7,2377,KLK7,P49862,,,,,,Human,compound 4d [PMID: 25489658],8483,,,252166691,Inhibitor,Inhibition,,f,t,,pIC50,0,7.190000057,0,IC50,0,64,0,=,,,,25489658,BrCc1ccc2c(c1)cc(c(=O)o2)C(=O)Oc1cccc(c1)Cl
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,ADL5747,9003,,,310264781,Agonist,Agonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,19694468,CCN(C(=O)c1ccc(c(c1)O)C1=CC2(CCNCC2)Oc2c1cccc2)CC
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,ADL5859,9004,,,310264782,Agonist,Agonist,,f,f,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,18788723,CCN(C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2c1c(O)ccc2)CC
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,AR-M1000390,9005,,,310264783,Agonist,Agonist,,f,f,,pIC50,0,5.130000114,0,IC50,0,7470,0,=,,,,0,CCN(C(=O)c1ccc(cc1)C(=C1CCNCC1)c1ccccc1)CC
&kappa; receptor,318,,,,,,,,Guinea pig,asimadoline,9279,,,318164798,Agonist,Agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,Displacement of [3H]- 69593 from K opioid receptors from guinea pig cerebellum.,,,0,O[C@H]1CCN(C1)C[C@@H](N(C(=O)C(c1ccccc1)c1ccccc1)C)c1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,BU08028,9294,,,318164813,Agonist,Agonist,,f,f,,pKi,0,8.25,0,Ki,0,5.630000114,0,=,,,,21177476,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(CC)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,BW373U86,9002,,,310264780,Agonist,Agonist,,f,f,,pKi,0,7.46999979,0,Ki,0,34,0,=,,,,8246159,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,BW373U86,9002,,,310264780,Agonist,Agonist,,f,f,,pKi,0,6.889999866,0,Ki,0,130,0,=,,,,18788723,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,7.190000057,0,Ki,0,64,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,&alpha;-neoendorphin,1600,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651611,Agonist,Full agonist,,t,,,pKi,10,0,8.9,,0,0,0,,,,,8240268,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,&alpha;-neoendorphin,1600,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651611,Agonist,Full agonist,,t,,,pKi,10.2,0,8.3,,0,0,0,,,,,7869844,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,&alpha;-neoendorphin,1600,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651611,Agonist,Full agonist,,t,,,pIC50,0,10,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8234341,
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,&beta;-neoendorphin,1644,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651635,Agonist,Full agonist,,t,,,pKi,0,9.1,0,,0,0,0,,,,,8234341,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,&beta;-neoendorphin,1644,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651635,Agonist,Full agonist,,t,,,pKi,0,7.9,0,,0,0,0,,,,,7624359,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,(-)-bremazocine,1603,,,135650021,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,8393575,CC[C@]12CCN([C@@H](C2(C)C)Cc2c1cc(O)cc2)CC1(O)CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Partial agonist,,t,,,pKi,7.9,0,6.3,-,0,0,0,=,,,,9686407,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Partial agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,(-)-bremazocine,1603,,,135650021,Agonist,Partial agonist,,f,,,pKi,0,10.5,0,,0,0,0,,,,,9686407,CC[C@]12CCN([C@@H](C2(C)C)Cc2c1cc(O)cc2)CC1(O)CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,butorphanol,7591,,,223365926,Agonist,Partial agonist,,f,t,,pKi,0,9.920000076,0,Ki,0,0.119999997,0,=,Displacement of [<sup>3</sup>H]U69593 from human &kappa; opioid receptor expressed in CHO cells.,,,18674902,Oc1ccc2c(c1)[C@]13CCCC[C@]3([C@@H](C2)N(CC1)CC1CCC1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,compound 3 [PMID: 23134120],9190,,,315661269,Agonist,Partial agonist,,f,f,,pKi,0,8.229999542,0,Ki,0,5.900000095,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,compound 3 [PMID: 23134120],9190,,,315661269,Agonist,Partial agonist,,f,f,,pEC50,0,7.460000038,0,EC50,0,35,0,=,Measuring stimulation of [<sup>35</sup>S]GTP&gamma;S binding.,,,23134120,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,5'-guanidinonaltrindole,1669,,,135650307,Antagonist,Antagonist,,f,f,,pKi,9.899999619,0,9.739999771,-,0,0,0,=,,,,10822054,NC(=Nc1ccc2c(c1)c1C[C@@]3(O)[C@H]4Cc5c6[C@]3([C@H](c1[nH]2)Oc6c(O)cc5)CCN4CC1CC1)N
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,alvimopan,7471,,,187051774,Antagonist,Antagonist,,f,f,,pKi,0,7,0,Ki,0,100,0,=,,,,18313920,OC(=O)CNC(=O)[C@@H](Cc1ccccc1)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,AT-076,8870,,,252827527,Antagonist,Antagonist,,f,f,,pKi,0,8.93999958,0,Ki,0,1.139999986,0,=,Radioligand binding assay,,,9686407,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CCC(CC1)c1cccc(c1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,&beta;-FNA,1631,,,135649986,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,9686407,COC(=O)/C=C/C(=O)N[C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,O=C1/C(=C\c2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,O=C1/C(=Cc2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,buprenorphine,1670,,,135652673,Antagonist,Antagonist,,f,t,,pKi,10.19999981,0,9.100000381,-,0,0,0,=,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(C)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
kelch like ECH-associated protein 1,2757,KEAP1,Q14145,,,,,,Human,bardoxolone,2717,,,135650061,None,Binding,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,Measuring inhibition of KEAP1 binding to Cul3 using an AlphaScreen bead-based proximity assay.,,,24896564,N#CC1=C[C@@]2(C)[C@H](C(C1=O)(C)C)CC[C@@]1(C2=CC(=O)[C@H]2[C@@]1(C)CC[C@@]1([C@H]2CC(C)(C)CC1)C(=O)O)C
Kidney-specific Na-K-Cl symporter,968,SLC12A1,Q13621,,,,,,Human,bumetanide,4837,,,178101539,Inhibitor,Inhibition,,f,t,,pIC50,0,6.480000019,0,-,0,0,0,=,,,,11882915,CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,AEE788,7643,,,223365978,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,77,0,=,,,,15256466,CCN1CCN(CC1)Cc1ccc(cc1)c1cc2c([nH]1)ncnc2N[C@@H](c1ccccc1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,altiratinib,9174,,,315661257,Inhibitor,Inhibition,,f,f,,pIC50,0,8.039999962,0,IC50,0,9.199999809,0,=,,,,0,O=C(C1CC1)Nc1nccc(c1)Oc1cc(F)c(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,anlotinib,9601,,,340590231,Inhibitor,Inhibition,,f,f,,pIC50,0,7.349999905,0,IC50,0,45,0,=,<i>In vitro</i> activity,,,0,COc1cc2c(ccnc2cc1OCC1(N)CC1)Oc1ccc2c(c1F)cc([nH]2)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,apatinib,7648,,,223365983,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,Assay used apatinib mesylate (YN968D1),,,21443688,N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,<i>In vitro</i> inhibition of KDR.,,,17638907,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,axitinib,5659,,,178102287,Inhibitor,Inhibition,,f,t,,pIC50,0,9.600000381,0,IC50,0,0.25,0,=,,,,20869793,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,axitinib,5659,,,178102287,Inhibitor,Inhibition,,f,t,,pKd,0,8.229999542,0,Kd,0,5.900000095,0,=,,,,22037378,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,AZD4547,7707,,,223366040,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,0,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BGJ-398,7877,,,223366206,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,180,0,=,,,,21936542,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BIBF-1202,8096,,,249565776,Inhibitor,Inhibition,,f,f,,pKd,0,8.539999962,0,Kd,0,2.900000095,0,=,,,,22037378,CN1CCN(CC1)CC(=O)N(c1ccc(cc1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)O)/c1ccccc1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BIBF-1202,8096,,,249565776,Inhibitor,Inhibition,,f,f,,pKd,0,8.539999962,0,Kd,0,2.900000095,0,=,,,,22037378,CN1CCN(CC1)CC(=O)N(c1ccc(cc1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)O)/c1ccccc1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BMS-690514,7879,,,223366208,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,20166197,COc1cccc(c1)Nc1ncnn2c1c(cc2)CN1CC[C@H]([C@@H](C1)O)N
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,brivanib,5671,,,178102299,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,16570908,C[C@H](COc1cn2c(c1C)c(ncn2)Oc1ccc2c(c1F)cc([nH]2)C)O
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1100,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,f,,pIC50,0,6.389999866,0,IC50,0,410,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,cabozantinib,5887,,,178102511,Inhibitor,Inhibition,,f,t,,pIC50,0,9.5,0,IC50,0,0.349999994,0,=,,,,21926191,COc1cc2c(ccnc2cc1OC)Oc1ccc(cc1)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pKd,0,8.960000038,0,Kd,0,1.100000024,0,=,,,,22037378,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,t,,pIC50,0,8.770000458,0,IC50,0,1.679999948,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.380000114,0,IC50,0,4.199999809,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
kinesin-5,2788,KIF11,P52732,,,,,,Human,AZD4877,7708,,,223366041,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,Measured as inhibition of ATPase activity of a 369 amino acid N-terminal  fragment of hKIF11,,,21899292,NCCCN(C(c1nc2snc(c2c(=O)n1Cc1ccccc1)C)C(C)C)C(=O)c1ccc(cc1)C
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,4-fluorobenzoyl-FGLRW-NH2,4014,,,178100840,Agonist,Full agonist,,f,,,pEC50,0,9.2,0,EC50,0,0.69,0,=,,,,18302161,
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,AC710,8095,,,249565775,Inhibitor,Inhibition,,f,f,,pKd,0,9,0,Kd,0,1,0,=,,,,24900421,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(cc1)NC(=O)Nc1noc(c1)C(C)(C)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,AKN-028,7969,,,249565652,Inhibitor,Inhibition,,f,t,,pIC50,0,7.539999962,0,IC50,0,29,0,=,Inhibition of KIT autophosphorylation in human AML M07 cells which overexpress KIT,,,22864397,Nc1ncc(nc1Nc1ccc2c(c1)cc[nH]2)c1ccncc1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,apatinib,7648,,,223365983,Inhibitor,Inhibition,,f,f,,pIC50,0,6.369999886,0,IC50,0,429,0,=,Assay used apatinib mesylate (YN968D1),,,21443688,N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,<i>In vitro</i> inhibition of c-Kit,,,17638907,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,BLZ945,8250,,,249565930,Inhibitor,Inhibition,,f,f,,pIC50,0,5.409999847,0,IC50,0,3880,0,=,,,,24498562,CNC(=O)c1nccc(c1)Oc1ccc2c(c1)sc(n2)N[C@@H]1CCCC[C@H]1O
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,CHMFL-KIT-8140,9301,,,318164820,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,27545040,CCC(=O)NCC1CCN(CC1)c1ccc(cc1C(F)(F)F)NC(=O)Nc1cccc(c1)Oc1cnc2c(c1)cc(c(c2)OC)OC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,compound 7k [PMID: 23521020],8164,,,249565844,Inhibitor,Inhibition,,f,f,,pIC50,0,8.31000042,0,IC50,0,4.889999866,0,=,,,,23521020,Clc1cccc(c1)NC(=O)c1ccc(c(c1)C#Cc1cnc2n(c1)ncc2)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,studied at 1-10 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,10880510,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,studied at 1-10 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,10880510,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>13.1,523,,,,,,,,None,arachidonic acid,2391,,,135651442,Activator,None,studied at  ~5 &micro;M,t,f,1000,-,0,0,0,-,0,0,0,=,,,,25148687,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>13.1,523,,,,,,,,None,arachidonic acid,2391,,,135651442,Activator,None,studied at  ~5 &micro;M,t,f,1000,-,0,0,0,-,0,0,0,=,,,,25148687,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>13.1,523,,,,,,,,None,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
K<sub>2P</sub>16.1,525,KCNK16,Q96T55,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,1000,-,0,0,0,,0,0,0,,,,,11263999,
K<sub>2P</sub>16.1,525,KCNK16,Q96T55,,,,,,Human,chloroform,2503,,,178100227,Channel blocker,None,,f,,700-800,-,0,0,0,,0,0,0,,,,,11263999,ClC(Cl)Cl
K<sub>2P</sub>17.1,526,KCNK17,Q96T54,,,,,,Human,chloroform,2503,,,178100227,Channel blocker,None,,f,,700-900,-,0,0,0,,0,0,0,,,,,11263999,ClC(Cl)Cl
K<sub>2P</sub>18.1,527,,,,,,,,None,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,2500-3000,-,0,0,0,,0,0,0,,,,,0,
K<sub>2P</sub>18.1,527,KCNK18,Q7Z418,,,,,,Human,arachidonic acid,2391,,,135651442,Inhibitor,None,studied at 10-50 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,12754259,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>18.1,527,KCNK18,Q7Z418,,,,,,Human,arachidonic acid,2391,,,135651442,Inhibitor,None,studied at 10-50 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,12754259,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Activation,studied at ~1-10 &micro;M,t,f,,pEC50,0,5,0,EC50,0,10000,0,=,,,,9687497,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Activation,studied at ~1-10 &micro;M,t,f,,pEC50,0,5,0,EC50,0,10000,0,=,,,,9687497,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,chloroform,2503,,,178100227,Activator,None,studied at 1-5 mM,f,f,8000,-,0,0,0,-,0,0,0,=,,,,10321245,ClC(Cl)Cl
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2700,0,=,,,,11226154,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2700,0,=,,,,11226154,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,None,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,~,,,,11226154,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,None,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,~,,,,11226154,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
K<sub>2P</sub>3.1,515,Kcnk3,O54912,,,,,,Rat,angiotensin II,2504,AGT|Agt|Agt,Human|Mouse|Rat,53801076,Channel blocker,None,,f,,0.01,-,0,0,0,,0,0,0,,,,,10847588,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1nc[nH]c1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,f,,,pIC50,0,1,0,,0,0,0,,,,,11226154,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,f,,,pIC50,0,1,0,,0,0,0,,,,,11226154,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,,pIC50,0,0.3,0,,0,0,0,,,,,0,
K<sub>2P</sub>4.1,516,KCNK4,Q9NYG8,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,studied at 1-10 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,9628867,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>4.1,516,KCNK4,Q9NYG8,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,studied at 1-10 &micro;M,t,f,,-,0,0,0,-,0,0,0,=,,,,9628867,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>4.1,516,Kcnk4,,,,,,,Rat,arachidonic acid,2391,,,135651442,Activator,Positive,,t,f,5-50,-,0,0,0,-,0,0,0,=,,,,7623282,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>2P</sub>4.1,516,Kcnk4,,,,,,,Rat,arachidonic acid,2391,,,135651442,Activator,Positive,,t,f,5-50,-,0,0,0,-,0,0,0,=,,,,7623282,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>2P</sub>4.1,516,Kcnk4,,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,2000,-,0,0,0,,0,0,0,,,,,7623282,
K<sub>2P</sub>5.1,517,Kcnk5,,,,,,,Mouse,clofilium,2507,,,53801073,Channel blocker,None,,f,,,pIC50,0,4.6,0,,0,0,0,,,,,11560934,CCCCCCC[N+](CCCCc1ccc(cc1)Cl)(CC)CC
K<sub>2P</sub>6.1,518,Kcnk6,,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,10-100,pIC50,0,0,0,,0,0,0,,,,,10887187,
K<sub>2P</sub>9.1,520,KCNK9,Q9NPC2,,,,,,Human,anandamide,2364,,,135651438,Inhibitor,None,studied at 1-10 &micro;M,f,f,,-,0,0,0,-,0,0,0,=,,,,10747866,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
K<sub>2P</sub>9.1,520,KCNK9,Q9NPC2,,,,,,Human,anandamide,2364,,,135651438,Inhibitor,None,studied at 1-10 &micro;M,f,f,,-,0,0,0,-,0,0,0,=,,,,10747866,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,17&beta;-estradiol,1013,,,135651381,Activator,None,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,10489376,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,6.519999981,0,6.21999979,EC50,600,0,300,=,,,,8781233,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,CM-TPMF,9314,,,318164833,Activator,Agonist,,f,f,,pEC50,0,7.619999886,0,EC50,0,24,0,=,,,,22046005,CON=CNc1nn2c(n1)nccc2C(Oc1ccc(cc1C)Cl)C
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,bicuculline,2312,,,135652669,Channel blocker,Antagonist,,f,f,,pIC50,0,4.800000191,0,IC50,0,16000,0,=,,,,10696100,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,B-TPMF,9315,,,318164834,Gating inhibitor,Antagonist,,f,f,,pEC50,0,7.510000229,0,EC50,0,31,0,=,,,,22046005,CON=CNc1nn2c(n1)nccc2C(Oc1ccc(cc1)C(C)(C)C)C
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,apamin,2311,,,135651994,Inhibitor,None,,f,f,,pIC50,8.479999542,0,7.920000076,IC50,12,0,3.299999952,=,,,,10683185,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,6.5,0,6.199999809,-,0,0,0,=,,,,9774106,
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,6.400000095,0,6.099999905,-,0,0,0,=,,,,8781233,
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,chlorzoxazone,2322,,,135650089,Activator,None,,f,f,,pEC50,4.099999905,0,3,-,0,0,0,=,,,,10712246,Clc1ccc2c(c1)[nH]c(=O)o2
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,apamin,2311,,,135651994,Channel blocker,Antagonist,,f,f,,pIC50,10.19999981,0,10.10000038,-,0,0,0,=,,,,8781233,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,bicuculline,2312,,,135652669,Channel blocker,Antagonist,,f,f,,pIC50,0,4.599999905,0,-,0,0,0,=,,,,10696100,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,apamin,2311,,,135651994,Inhibitor,None,,f,f,,pKd,0,9.399999619,0,Kd,0,0.300000012,0,=,,,,10713270,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,0,6.199999809,0,-,0,0,0,=,,,,11245600,
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,f,f,,pEC50,6.5,0,6,-,0,0,0,=,,,,9774106,
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,apamin,2311,,,135651994,Channel blocker,Antagonist,,f,f,,pIC50,9.199999809,0,8.899999619,-,0,0,0,=,,,,11245600,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,apamin,2311,,,135651994,Inhibitor,None,,f,f,,pIC50,9.100000381,0,7.900000095,IC50,13.19999981,0,0.800000012,=,,,,11369031,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,f,,,pEC50,7,0,6.1,,0,0,0,,,,,9326665,
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,chlorzoxazone,2322,,,135650089,Activator,Agonist,,f,t,,pEC50,0,4,0,EC50,0,100000,0,=,,,,10712246,Clc1ccc2c(c1)[nH]c(=O)o2
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,Inhibition,,f,f,,pKd,0,8.5,0,-,0,0,0,=,,,,10961988,
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,charybdotoxin-GLU32 analog,2329,,,135652059,Channel blocker,Inhibition,,f,f,,pKd,0,7.5,0,-,0,0,0,=,,,,10625664,
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,clotrimazole,2330,,,135650114,Channel blocker,Inhibition,,f,f,,pKd,7.619999886,0,6.409999847,-,0,0,0,=,,,,9326665,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,compound <i>rac</i>-16 [PMID: 15603962],2333,,,135650590,Channel blocker,Inhibition,,f,f,,pIC50,8,0,7.900000095,-,0,0,0,=,,,,15379997,COC(=O)C1=C(C)CC2=C(C1c1ccc(c(c1)C(F)(F)F)Cl)C(=O)OC2
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,f,,pIC50,8.699999809,0,7.599999905,IC50,28,0,2,=,,,,9380751,
K<sub>ir</sub>1.1,429,KCNJ1,P48048,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,1000,-,0,0,0,-,0,0,0,=,,,,7929082,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,100,pIC50,4.199999809,0,2.299999952,-,0,0,0,=,,,,7680431,
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,1-100,pKd,5.599999905,0,3.900000095,-,0,0,0,=,,,,11454958,
K<sub>ir</sub>2.2,431,Kcnj12,P52188,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Gating inhibitor,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9592090,
K<sub>ir</sub>2.2,431,Kcnj12,P52187,,,,,,Mouse,Ba<sup>2+</sup>,2344,,,135652729,Gating inhibitor,Antagonist,,f,f,50,-,0,0,0,-,0,0,0,=,,,,8083233,
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Agonist,,t,,,pEC50,0,6.35,0,,0,0,0,,,,,11306688,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Agonist,,t,,,pEC50,0,6.35,0,,0,0,0,,,,,11306688,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,3-500,pIC50,0,4.989999771,0,-,0,0,0,=,,,,12032359,
K<sub>ir</sub>2.3,432,Kcnj4,P52189,,,,,,Mouse,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,,5-500,pIC50,0,5.19,0,,0,0,0,,,,,8013643,
K<sub>ir</sub>2.4,433,KCNJ14,Q9UNX9,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,,pKd,0,3.319999933,0,-,0,0,0,=,,,,10942728,
K<sub>ir</sub>2.4,433,Kcnj14,O70596,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,,1-1000,pKi,4.18,0,3.41,,0,0,0,,,,,9592090,
K<sub>ir</sub>3.1,434,Kcnj3,P63251,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,K<sub>ir</sub>3.1 expressed in <i>Xenopus oocytes</i>,f,f,,pIC50,0,4.699999809,0,-,0,0,0,=,,,,8234283,
K<sub>ir</sub>3.1,434,Kcnj3,P63251,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,,100-250,-,0,0,0,,0,0,0,,,,,8234283,
K<sub>ir</sub>3.1,434,KCNJ3,P48549,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,,100-300,-,0,0,0,,0,0,0,,,,,8804710,
K<sub>ir</sub>3.1,434,KCNJ3,P48549,,,,,,Human,AZD2927,7704,,,223366037,Channel blocker,None,,f,t,,pIC50,0,5.900000095,0,IC50,0,1300,0,=,,,,0,OC1CN(C1)C[C@@H](N(C(=O)c1ccc(c(c1)C)F)C)C(C)C
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,amitriptyline,200,,,135649939,Channel blocker,Antagonist,,f,,,pIC50,0,4,0,,0,0,0,,,,,15150531,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,clomipramine,2398,,,135650111,Channel blocker,Antagonist,,f,,,pIC50,0,4.4,0,,0,0,0,,,,,15150531,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
K<sub>ir</sub>3.2,435,,,,,,,,None,bupivacaine,2397,,,135650032,Gating inhibitor,Antagonist,,f,,,pIC50,4.2,0,4,,0,0,0,,,,,11353868,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,clozapine,38,,,135650115,Gating inhibitor,Antagonist,,f,f,,pEC50,0,3.799999952,0,-,0,0,0,=,,,,10780978,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,arachidonic acid,2391,,,135651442,Activator,Agonist,,f,,10-100,-,0,0,0,,0,0,0,,,,,2492640,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,arachidonic acid,2391,,,135651442,Activator,Agonist,,f,,10-100,-,0,0,0,,0,0,0,,,,,2492640,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,amitriptyline,200,,,135649939,Channel blocker,Antagonist,,f,,,pIC50,0,3.6,0,,0,0,0,,,,,15150531,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,,,pEC50,0,3.3,0,,0,0,0,,,,,7877685,
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,clomipramine,2398,,,135650111,Channel blocker,Antagonist,,f,,,pIC50,0,3.6,0,,0,0,0,,,,,15150531,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
K<sub>ir</sub>3.4,437,KCNJ5,P48544,,,,,,Human,AZD2927,7704,,,223366037,Channel blocker,None,,f,t,,pIC50,0,5.900000095,0,IC50,0,1300,0,=,,,,0,OC1CN(C1)C[C@@H](N(C(=O)c1ccc(c(c1)C)F)C)C(C)C
K<sub>ir</sub>4.1,438,Kcnj10,P49655,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,3-1000,-,0,0,0,-,0,0,0,=,,,,10856114,
K<sub>ir</sub>4.2,439,Kcnj15,O88932,,,,,,Mouse,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,K<sub>ir</sub>4.2 expressed in <i>Xenopus oocytes</i>,f,f,10-100,-,0,0,0,-,0,0,0,=,,,,9882736,
K<sub>ir</sub>5.1,440,Kcnj16,P52191,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,K<sub>ir</sub>5.1 expressed with PSD-95,f,f,3000,-,0,0,0,-,0,0,0,=,,,,11988170,
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,ATP,1713,,,135651446,Activator,Agonist,,t,,1000,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,ATP,1713,,,135651446,Gating inhibitor,Antagonist,,t,,1000-3000,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,ATP,1713,,,135651446,Gating inhibitor,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,7502040,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
K<sub>ir</sub>7.1,443,KCNJ13,O60928,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Antagonist,,f,f,,pKi,0,3.200000048,0,-,0,0,0,=,,,,9620703,
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,bithionol,2338,,,135649999,Activator,Agonist,,f,f,,pEC50,6,0,5,-,0,0,0,=,,,,16876206,Clc1cc(Sc2cc(Cl)cc(c2O)Cl)c(c(c1)Cl)O
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,Cl<sup>-</sup>,2339,,,135652733,Activator,Agonist,,t,,8000,-,0,0,0,,0,0,0,,,,,12628167,
K<sub>Na</sub>1.1,385,KCNT1,Q5JUK3,,,,,,Human,clofilium,2507,,,53801073,Channel blocker,Antagonist,,f,f,109,-,0,0,0,-,0,0,0,=,,,,23271893,CCCCCCC[N+](CCCCc1ccc(cc1)Cl)(CC)CC
K<sub>Na</sub>1.1,385,Kcnt1,Q6ZPR4,,,,,,Mouse,Ca<sup>2+</sup>,707,,,135652731,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,16446508,
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,Ca<sup>2+</sup>,707,,,135652731,Gating inhibitor,Antagonist,,t,,0-3.0,-,0,0,0,,0,0,0,,,,,10196543,
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,bepridil,2337,,,135649982,Gating inhibitor,None,,f,f,,pIC50,6,0,5,-,0,0,0,=,,,,16876206,CC(COCC(N1CCCC1)CN(c1ccccc1)Cc1ccccc1)C
K<sub>Na</sub>1.2,386,Kcnt2,Q6UVM4,,,,,,Rat,Cl<sup>-</sup>,2339,,,135652733,Activator,Agonist,,t,,3000-130000,-,0,0,0,,0,0,0,,,,,14684870,
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,clofilium,2507,,,53801073,Channel blocker,Antagonist,,f,f,109,-,0,0,0,-,0,0,0,=,,,,23271893,CCCCCCC[N+](CCCCc1ccc(cc1)Cl)(CC)CC
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,Inhibition,,f,f,,pIC50,0,3,0,-,0,0,0,=,,,,14684870,
K<sub>Na</sub>1.2,386,Kcnt2,Q6UVM4,,,,,,Rat,ATP,1713,,,135651446,Gating inhibitor,None,,t,f,<5000,-,0,0,0,-,0,0,0,=,,,,14684870,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,astemizole,2603,,,135649968,Channel blocker,None,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,15365094,COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2
K<SUB>v</SUB>10.1,570,Kcnh1,Q63472,,,,,,Rat,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Channel blocker,None,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,8790430,
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,clofilium,2507,,,53801073,Channel blocker,None,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,12522086,CCCCCCC[N+](CCCCc1ccc(cc1)Cl)(CC)CC
K<SUB>v</SUB>1.1,538,Kcna1,P10499,,,,,,Rat,&alpha;-dendrotoxin,2563,,,135651983,Channel blocker,None,,f,f,,pEC50,9,0,7.699999809,EC50,20,0,0.959999979,=,,,,7517498,
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,capsaicin,2486,,,53801090,Channel blocker,None,,f,f,,pIC50,0,4.5,0,-,0,0,0,=,,,,7517498,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,A-935142,7661,,,223365996,Activator,None,,f,f,20,-,0,0,0,-,0,0,0,=,,,,19426677,OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)c1cc([nH]n1)C(F)(F)F
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,AZD3778,7679,,,223366014,Channel blocker,Inhibition,,f,f,,pIC50,0,4.800000191,0,IC50,0,15800,0,=,,,,23031591,Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,astemizole,2603,,,135649968,Channel blocker,None,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,10376921,COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2
K<SUB>v</SUB>11.1,572,Kcnh2,O08962,,,,,,Rat,BeKm-1,2610,,,135652014,Channel blocker,None,,f,f,,pKd,0,7.699999809,0,-,0,0,0,=,,,,16497878,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,BeKm-1,2610,,,135652014,Channel blocker,None,,f,f,,pKd,0,8.199999809,0,-,0,0,0,=,,,,15137031,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,cisapride,240,,,135650104,Channel blocker,None,,f,f,,pIC50,0,7.400000095,0,IC50,0,44.5,0,=,,,,9395068,COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,APETx-1,2609,,,135651995,Gating inhibitor,Inhibition,,f,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,12815161,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,APETx-1,2609,,,135651995,Gating inhibitor,None,,f,,,pKd,0,7.4,0,,0,0,0,,,,,17473056,
K<SUB>v</SUB>11.2,573,Kcnh6,O54853,,,,,,Rat,BeKm-1,2610,,,135652014,Gating inhibitor,None,,f,,,pKd,0,8.1,0,,0,0,0,,,,,9390998,
K<SUB>v</SUB>11.3,574,Kcnh7,O54852,,,,,,Rat,BeKm-1,2610,,,135652014,Channel blocker,Pore blocker,,f,f,,pKd,0,7.900000095,0,-,0,0,0,=,,,,17097705,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,&alpha;-dendrotoxin,2563,,,135651983,Channel blocker,None,,f,f,,pIC50,9.399999619,0,7.800000191,IC50,17,0,0.379999995,=,,,,7517498,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,&alpha;-KTx 13.2,2550,,,135651985,Channel blocker,None,,f,,,pKd,0,7,0,,0,0,0,,,,,11527374,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,BgK,2551,,,135652021,Channel blocker,None,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,9063464,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,,,pKd,0,7.9,0,,0,0,0,,,,,7517498,
K<SUB>v</SUB>1.2,539,KCNA2,P16389,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Pore blocker,,f,f,,pIC50,0,5.599999905,0,IC50,0,2700,0,=,,,,8938728,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
K<SUB>v</SUB>1.2,539,KCNA2,P16389,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,Pore blocker,,f,f,,pIC50,0,5.599999905,0,IC50,0,2700,0,=,,,,8938728,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,capsaicin,2486,,,53801090,Channel blocker,Pore blocker,,f,f,,pKd,0,4.400000095,0,Kd,0,45000,0,=,,,,7517498,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
K<SUB>v</SUB>12.1,575,KCNH8,Q96L42,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,,pIC50,0,3.7,0,,0,0,0,,,,,12890647,
K<SUB>v</SUB>12.1,575,Kcnh8,P59111,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Gating inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,1 mM Cd<sup>2+</sup> slows activation 5-fold and shifts V0.5 for activation by +35 mV,,,19580749,
K<SUB>v</SUB>1.3,540,Kcna3,P16390,,,,,,Mouse,5-(4-phenoxybutoxy)psoralen,2554,,,135649819,Channel blocker,None,,f,,,pEC50,0,8.7,0,,0,0,0,,,,,16099841,O=c1ccc2c(o1)cc1c(c2OCCCCOc2ccccc2)cco1
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,f,,pKd,9.699999809,0,7.5,-,0,0,0,=,,,,10961988,
K<SUB>v</SUB>1.3,540,Kcna3,P15384,,,,,,Rat,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,,,pKd,0,8.6,0,,0,0,0,,,,,7517498,
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,bupivacaine,2397,,,135650032,Channel blocker,None,,f,,,pKd,0,5.4,0,,0,0,0,,,,,9400387,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,clofilium,2507,,,53801073,Channel blocker,None,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,7838129,CCCCCCC[N+](CCCCc1ccc(cc1)Cl)(CC)CC
K<SUB>v</SUB>1.6,543,KCNA6,P17658,,,,,,Human,&alpha;-dendrotoxin,2563,,,135651983,Channel blocker,None,,f,f,,pIC50,0,7.699999809,0,IC50,0,19.89999962,0,=,,,,2347305,
K<SUB>v</SUB>1.6,543,KCNA6,P17658,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,,,pIC50,0,9,0,,0,0,0,,,,,2347305,
K<SUB>v</SUB>1.7,544,KCNA7,Q96RP8,,,,,,Human,amiodarone,2566,,,135649937,Channel blocker,None,,f,,,pKd,0,4.5,0,,0,0,0,,,,,11896454,CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,capsaicin,2486,,,53801090,Channel blocker,None,,f,,,pIC50,0,4.6,0,,0,0,0,,,,,9488722,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,,pIC50,0,2.3,0,,0,0,0,,,,,10836990,
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,charybdotoxin,2328,,,135652058,Channel blocker,None,,f,,,pIC50,0,7,0,,0,0,0,,,,,10836990,
K<SUB>v</SUB>2.1,546,KCNB1,Q14721,,,,,,Human,"3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol",2569,,,53801045,Channel blocker,None,,f,,,pIC50,0,6,0,,0,0,0,,,,,14722253,Oc1cccc(c1O)C1CC2CC1CC2
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,,,pKd,0,4.9,0,-,0,0,0,=,,,Intracellular,8341271,
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,Ba<sup>2+</sup>,2344,,,135652729,Channel blocker,None,,f,f,,pKd,0,1.5,0,-,0,0,0,=,,,Extracellular,8341271,
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,capsaicin,2486,,,53801090,Channel blocker,None,,f,,,pIC50,0,3.8,0,,0,0,0,,,,,7517498,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
K<SUB>v</SUB>4.2,553,Kcnd2,Q63881,,,,,,Rat,arachidonic acid,2391,,,135651442,Channel blocker,None,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,,,,10503950,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
K<SUB>v</SUB>4.2,553,Kcnd2,Q63881,,,,,,Rat,arachidonic acid,2391,,,135651442,Channel blocker,None,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,,,,10503950,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
K<SUB>v</SUB>4.3,554,Kcnd3,Q9Z0V1,,,,,,Mouse,bupivacaine,2397,,,135650032,Channel blocker,None,,f,,,pIC50,0,4,0,,0,0,0,,,,,17220193,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
K<SUB>v</SUB>4.3,554,Kcnd3,Q9Z0V1,,,,,,Mouse,bupivacaine,2397,,,135650032,Channel blocker,None,,f,,,pIC50,0,4.5,0,,0,0,0,,,,,17016508,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,"(3<i>R</i>,4<i>S</i>)-293B",2589,,,53801037,Channel blocker,Antagonist,,f,f,,pIC50,5,0,4.789999962,IC50,16400,0,10000,=,,,,16909339,CCS(=O)(=O)N([C@@H]1[C@@H](O)C(C)(C)Oc2c1cc(cc2)C#N)C
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,"3<i>S</i>,4<i>R</i>-293B",8610,,,252166811,Channel blocker,Antagonist,,f,f,,pIC50,0,4.519999981,0,IC50,0,30100,0,=,,,,11739240,CCS(=O)(=O)N([C@H]1[C@H](O)C(C)(C)Oc2c1cc(cc2)C#N)C
K<SUB>v</SUB>7.1,560,Kcnq1,P97414,,,,,,Mouse,azimilide,2588,,,53801039,Channel blocker,None,,f,f,,pIC50,0,5.300000191,0,-,0,0,0,=,,,,9313924,CN1CCN(CC1)CCCCN1C(=O)CN(C1=O)/N=C/c1ccc(o1)c1ccc(cc1)Cl
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,bepridil,2337,,,135649982,Channel blocker,None,,f,,,pIC50,0,5,0,,0,0,0,,,,,11245603,CC(COCC(N1CCCC1)CN(c1ccccc1)Cc1ccccc1)C
LAG3 (CD223),2932,LAG3,P18627,,,,,,Human,BMS-986016,9536,,,336446922,Antibody,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,"29-methylidene-2,3-oxidosqualene",6719,,,178103330,Inhibitor,Inhibition,,f,,,pIC50,0,9.52,0,IC50,0,0.3,0,=,,,,9003518,C/C=C\CC/C(=C\CC/C(=C/CC/C=C(/CC/C=C(/CCC1OC1(C)C)\C)\C)/C)/CC=C
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,"29-methylidene-2,3-oxidosqualene",6719,,,178103330,Inhibitor,Inhibition,,f,,,pIC50,0,9.52,0,IC50,0,0.3,0,=,,,,9003518,C/C=CCC/C(=CCC/C(=C/CC/C=C(/CC/C=C(/CCC1OC1(C)C)C)C)/C)/CC=C
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 10 [PMID: 22533316],6717,,,178103328,Inhibitor,Inhibition,,f,,,pIC50,0,7.54,0,IC50,0,28.7,0,=,,,,22533316,OC1CCN(CC1)C(=O)[C@@H]1CC[C@H](CC1)CCN(C(=O)Oc1ccc(cc1)Cl)C
lanosterol synthase,2434,LSS,P48449,,,,,,Human,"compound 1 [Gotteland <i>et al</i>., 1997]",6722,,,178103333,Inhibitor,Inhibition,,f,,,pIC50,0,7.15,0,IC50,0,70,0,=,,,,0,CCN(Cc1cccc(c1)OCc1scc(c1)c1cscc1)CC#Cc1ccccc1
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 1 [PMID: 22533316],6709,,,178103320,Inhibitor,Inhibition,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,,,,22533316,C=CCN(Cc1ccc(cc1)c1ccc(cc1)C(=O)c1ccc(cc1)Br)C.Cl
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 3 [PMID: 22533316],6711,,,178103322,Inhibitor,Inhibition,,f,,,pIC50,0,7.75,0,IC50,0,17.8,0,=,,,,22533316,OCCN(CCCCOc1ccc2c(c1)snc2c1ccc(cc1)Br)CC
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,compound 3 [PMID: 9003518],6720,,,178103331,Inhibitor,Inhibition,,f,,,pIC50,0,7.3,0,IC50,0,50,0,=,,,,9003518,CC(CCC=C(C)C)SCC/C(=C/CC/C=C(/CC/C=C(/CCC1OC1(C)C)C)C)/C
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,"compound 4a [Marquart <i>et al.</i>, 1994]",6707,,,178103318,Inhibitor,Inhibition,,f,,,pIC50,0,6.37,0,IC50,0,430,0,=,,,,0,CCCCCCCCCC[C@H]1CC[C@@H]2N(C1)CCC[C@H]2O
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,"compound 4b [Marquart <i>et al.</i>, 1994]",6708,,,178103319,Inhibitor,Inhibition,,f,,,pIC50,0,6.77,0,IC50,0,170,0,=,,,,0,CCCCCCCCCC[C@@H]1CC[C@@H]2N(C1)CCC[C@H]2O
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 4 [PMID: 22533316],6712,,,178103323,Inhibitor,Inhibition,,f,,,pIC50,0,8.54,0,IC50,0,2.9,0,=,,,,22533316,C=CCN(CCCCOc1ccc2c(c1)snc2c1ccc(cc1)Br)C
lanosterol synthase,2434,Lss,P48450,,,,,,Rat,compound 4 [PMID: 9003518],6721,,,178103332,Inhibitor,Inhibition,,f,,,pIC50,0,9.59,0,IC50,0,0.26,0,=,,,,9003518,C/C(=CCCC=C(CC/C=C(/CCC1OC1(C)C)C)C)/CCCSCCC=C(C)C
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 5 [PMID: 22533316],6715,,,178103326,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,22533316,OCCN(CCCC#C[C@@H]1CC[C@H](CC1)N(C(=O)Oc1ccc(cc1)Cl)C)CC
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 6 [PMID: 22533316],6714,,,178103325,Inhibitor,Inhibition,,f,,,pIC50,0,8.11,0,IC50,0,7.8,0,=,,,,22533316,CCCN(CCCC#C[C@@H]1CC[C@H](CC1)N(C(=O)Oc1ccc(cc1)Cl)C)C
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 7 [PMID: 22533316],6713,,,178103324,Inhibitor,Inhibition,,f,,,pIC50,0,7.9,0,IC50,0,12.7,0,=,,,,22533316,OCCN(C[C@@H]1CC[C@H](CC1)CCN(C(=O)Oc1ccc(cc1)C(F)(F)F)C)CC
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 8 [PMID: 22533316],6716,,,178103327,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,,,,22533316,C=CCN(CCCCC[C@@H]1CC[C@H](CC1)N(C(=O)Oc1ccc(cc1)C(F)(F)F)C)C
lanosterol synthase,2434,LSS,P48449,,,,,,Human,compound 9 [PMID: 22533316],6718,,,178103329,Inhibitor,Inhibition,,f,,,pIC50,0,7.95,0,IC50,0,11.2,0,=,,,,22533316,OCCN(CCCCC[C@@H]1CC[C@H](CC1)N(S(=O)(=O)c1ccc(cc1)C(F)(F)F)C)C
large tumor suppressor kinase 2,1516,LATS2,Q9NRM7,,,,,,Human,compound 35 [PMID: 20684608],8209,,,249565889,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 3&mu;M compound.,,,20684608,COc1ccc2c(c1)C[C@@H](NC2)C(=O)Nc1ccc(cc1OCC1CCN(CC1)C)c1c[nH]nc1
L-Aromatic amino-acid decarboxylase ,1271,DDC,P20711,,,,,,Human,3-hydroxybenzylhydrazine,5116,,,178101809,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NNCc1cccc(c1)O
L-Aromatic amino-acid decarboxylase ,1271,DDC,P20711,,,,,,Human,benserazide,5150,,,178101842,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,22384042,OCC(C(=O)NNCc1ccc(c(c1O)O)O)N
L-Aromatic amino-acid decarboxylase ,1271,DDC,P20711,,,,,,Human,carbidopa,5159,,,178101851,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,NN[C@](C(=O)O)(Cc1ccc(c(c1)O)O)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,15486189,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pEC50,0,6,0,EC50,0,1000,0,>,,,,0,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,CCT196969,9815,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,25500121,O=C(Nc1cc(nn1c1ccccc1)C(C)(C)C)Nc1ccc(cc1F)Oc1ccnc2c1ncc(=O)[nH]2
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,CCT241161,9814,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,25500121,CSc1cc(ccc1NC(=O)Nc1cc(nn1c1ccccc1)C(C)(C)C)Oc1ccnc2c1ncc(=O)[nH]2
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 19a [PMID: 21855335],8186,,,249565866,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,180,0,=,,,,21855335,Clc1cc(ccc1C(=O)N1CCNCC1(C)C)Nc1nc(cn2c1ncc2c1c[nH]nc1)C1CC1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 23 [PMID: 17600705],8146,,,249565826,Inhibitor,Inhibition,,f,t,,pIC50,0,8.069999695,0,IC50,0,8.5,0,=,,,,17600705,Oc1ccc(c(c1)Nc1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 30 [PMID: 17280833],8193,,,249565873,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,17280833,c1ccc(cc1)c1c(oc2c1c(NCCc1ccccc1)ncn2)c1ccc(cc1)OCCN1CCCC1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 36 [PMID: 21958547],9391,,,328083493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.110000134,0,IC50,0,772,0,=,,,,21958547,CN(C/C=C/C(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,compound 7 [PMID: 22464456],8172,,,249565852,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39.20000076,0,=,,,,22464456,CCC(c1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1sc(c2)C(F)F)(CC)O
L-Cysteine:2-oxoglutarate aminotransferase,1445,KYAT1,Q16773,,,,,,Human,"compound 3 [Tuttle <i>et al</i>., 2013]",8815,,,252827473,Inhibitor,Inhibition,,f,f,,pIC50,0,5.690000057,0,IC50,0,2040,0,=,,,,0,O=C1[C@@H](N)Cc2c(N1O)ccc(c2)Oc1ccccc1
legumain,2380,LGMN,Q99538,,,,,,Human,compound 7u [PMID: 24775305],8633,,,252166833,Inhibitor,Inhibition,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,,,,24775305,CCOc1cccc(c1)c1ccc(cc1)COC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C#N
Leucine aminopeptidase 3,1569,,,,,,,,Bovine,bestatin,5151,,,178101843,Inhibitor,Inhibition,,f,f,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,8422382,O[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)[C@@H](Cc1ccccc1)N
Leucyl-cysteinyl aminopeptidase,1570,LNPEP,Q9UIQ6,,,,,,Human,compound 17 [PMID: 23916253],8666,,,252166866,Inhibitor,Inhibition,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,,,,23916253,NCCCC[C@@H](C(=O)O)NC(=O)c1ccc(c(c1)NC(=O)[C@H](CCc1ccccc1)N)N
Leukemia inhibitory factor receptor,2314,LIFR|IL6ST,P40189|P42702,,,,,,Human,cardiotrophin-1,4906,CTF1,Human,178101605,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
leukocyte immunoglobulin like receptor A4 (CD85g),2896,LILRA4,P59901,,,,,,Human,anti-ILT7 antibody,9124,,,315661209,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
leukocyte receptor tyrosine kinase,1838,LTK,P29376,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
Leukotriene A<sub>4</sub> hydrolase,1395,LTA4H,P09960,,,,,,Human,bestatin,5151,,,178101843,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,1846352,O[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)[C@@H](Cc1ccccc1)N
Leukotriene A<sub>4</sub> hydrolase,1395,LTA4H,P09960,,,,,,Human,compound 1a [PMID: 25692029],9091,,,315661176,Inhibitor,Inhibition,,f,f,,pKi,0,8.270000458,0,Ki,0,5.400000095,0,=,,,,25692029,C[C@@H](C(=O)O)NC(=O)[C@@H](CP(=O)([C@@H](N)C)O)Cc1ccc(cc1)c1ccccc1
Leukotriene C4 synthase,1391,LTC4S,Q16873,,,,,,Human,compound 39 [PMID: 23623673],8875,,,252827532,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,>,,,,23623673,Fc1cccc(c1c1nc2c([nH]1)c(=O)[nH]c1c2ccc(c1)c1ccccc1)Cl
LIM domain kinase 1,2054,LIMK1,P53667,,,,,,Human,compound 14 [PMID: 19831390],8151,,,249565831,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,19831390,N#CNC(=Nc1cccc(c1)Br)N1CCN(C[C@@H]1C)c1ncnc2c1c(C)c[nH]2
LIM domain kinase 1,2054,LIMK1,P53667,,,,,,Human,compound 30 [PMID: 22902653],8118,,,249565798,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,22902653,CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
LIM domain kinase 1,2054,LIMK1,P53667,,,,,,Human,compound 31 [PMID: 22902653],8117,,,249565797,Inhibitor,Inhibition,,f,t,,pIC50,0,7.239999771,0,IC50,0,58,0,=,,,,22902653,CCNC(=O)Nc1ncc(s1)c1cc(nc(n1)c1cnccn1)c1c(C)cc(cc1C)OC
LIM domain kinase 1,2054,LIMK1,P53667,,,,,,Human,compound 35 [PMID: 22902653],8119,,,249565799,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,22902653,COc1cc(Cl)c(c(c1)Cl)c1cc(nc(n1)c1cnccn1)c1cnc(s1)NC(=O)C
LIM domain kinase 2,2055,LIMK2,P53671,,,,,,Human,compound 14 [PMID: 19831390],8151,,,249565831,Inhibitor,Inhibition,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,,,,19831390,N#CNC(=Nc1cccc(c1)Br)N1CCN(C[C@@H]1C)c1ncnc2c1c(C)c[nH]2
LIM domain kinase 2,2055,LIMK2,P53671,,,,,,Human,compound 22m [PMID: 19831390],8153,,,249565833,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,19831390,OCCNC(=O)c1cccc(c1)N=C(N1CCN(C[C@@H]1C)c1ncnc2c1c(C)c[nH]2)NC#N
LIM domain kinase 2,2055,LIMK2,P53671,,,,,,Human,compound 30 [PMID: 22902653],8118,,,249565798,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,22902653,CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
LIM domain kinase 2,2055,LIMK2,P53671,,,,,,Human,compound 31 [PMID: 22902653],8117,,,249565797,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,22902653,CCNC(=O)Nc1ncc(s1)c1cc(nc(n1)c1cnccn1)c1c(C)cc(cc1C)OC
LIM domain kinase 2,2055,LIMK2,P53671,,,,,,Human,compound 35 [PMID: 22902653],8119,,,249565799,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,22902653,COc1cc(Cl)c(c(c1)Cl)c1cc(nc(n1)c1cnccn1)c1cnc(s1)NC(=O)C
"lipase E, hormone sensitive type",2593,LIPE,Q05469,,,,,,Human,compound 41 [PMID: 15026062],6702,,,178103313,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,,,,,15026062,O=C(C1CCC(CC1)C(C)(C)C)Nc1ccc(cc1)OC(=O)NN1CCOCC1
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,22R-hydroxycholesterol,2742,,,135651388,Agonist,Agonist,,t,,,pEC50,0,5.3,0,,0,0,0,,,,,8878485,CC(CC[C@H]([C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)O)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,"24(S), 25-epoxycholesterol",2751,,,135651390,Agonist,Agonist,,t,f,,pEC50,6.5,0,5.400000095,-,0,0,0,=,,,,9874807,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CC[C@@H]2OC2(C)C)C)C)C1)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,24(S)-hydroxycholesterol,2750,,,135651391,Agonist,Agonist,,t,,,pEC50,0,5.4,0,-,0,0,0,=,,,,9013544,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CC[C@@H](C(C)C)O)C)C)C1)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,27-hydroxycholesterol,2752,,,135651393,Agonist,Agonist,,t,,,pEC50,0,7.1,0,,0,0,0,,,,,11504730,OC[C@@H](CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,acetyl-podocarpic dimer,2753,,,135649888,Agonist,Agonist,,f,,,pEC50,0,9,0,,0,0,0,,,,,11790770,CC(=O)Oc1ccc2c(c1)[C@@]1(C)CCC[C@]([C@@H]1CC2)(C)C(=O)OC(=O)[C@@]1(C)CCC[C@]2([C@H]1CCc1c2cc(cc1)OC(=O)C)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,AZ12260493,7725,,,223366058,Agonist,Agonist,,f,t,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,0,O=C1C(=C(S(=O)(=O)N1C(C)(C)C)c1ccccc1)Nc1ccc(cc1)N1CCCCC1
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,22R-hydroxycholesterol,2742,,,135651388,Agonist,Agonist,,t,,,pEC50,0,5.52,0,,0,0,0,,,,,8878485,CC(CC[C@H]([C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)O)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,"24(S), 25-epoxycholesterol",2751,,,135651390,Agonist,Agonist,,t,f,,pEC50,7.035999775,0,5.519999981,-,0,0,0,=,,,,9013544,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CC[C@@H]2OC2(C)C)C)C)C1)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,24(S)-hydroxycholesterol,2750,,,135651391,Agonist,Agonist,,t,,,pEC50,0,5.5,0,,0,0,0,,,,,9013544,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CC[C@@H](C(C)C)O)C)C)C1)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,27-hydroxycholesterol,2752,,,135651393,Agonist,Agonist,,t,,,pEC50,0,7.15,0,,0,0,0,,,,,11504730,OC[C@@H](CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,acetyl-podocarpic dimer,2753,,,135649888,Agonist,Agonist,,f,,,pEC50,0,9,0,,0,0,0,,,,,11790770,CC(=O)Oc1ccc2c(c1)[C@@]1(C)CCC[C@]([C@@H]1CC2)(C)C(=O)OC(=O)[C@@]1(C)CCC[C@]2([C@H]1CCc1c2cc(cc1)OC(=O)C)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,AZ12260493,7725,,,223366058,Agonist,Agonist,,f,t,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,0,O=C1C(=C(S(=O)(=O)N1C(C)(C)C)c1ccccc1)Nc1ccc(cc1)N1CCCCC1
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10922489,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10922489,CCCCCCCC/C=CCCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,alkyl OMPT,2913,,,135649916,Agonist,Agonist,,f,f,,pEC50,6.199999809,0,6.099999905,-,0,0,0,=,,,,16892372,CCCCCCCC/C=C\CCCCCCCCOC[C@@H](COP(=S)(O)O)OC
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,alkyl OMPT,2913,,,135649916,Agonist,Agonist,,f,f,,pEC50,6.199999809,0,6.099999905,-,0,0,0,=,,,,16892372,CCCCCCCC/C=CCCCCCCCCOC[C@@H](COP(=S)(O)O)OC
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,AM095,6988,,,178103567,Antagonist,Antagonist,,f,t,,pIC50,6.099999905,0,6,-,0,0,0,=,,,,21159750,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1)C)C
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,AM095,6988,,,178103567,Antagonist,Antagonist,,f,f,,pIC50,0,6.110000134,0,IC50,0,778,0,=,,,,21159750,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1)C)C
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,AM966,2905,,,135649931,Antagonist,Antagonist,,f,f,,pIC50,7.800000191,0,6.699999809,IC50,199,0,15.80000019,=,,,,21159750,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pEC50,0,7.7,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,anti-BrP-LPA,6987,,,178103566,Antagonist,Antagonist,,f,f,,pKi,0,6.119999886,0,Ki,0,752,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](C[C@@H](P(=O)(O)O)Br)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,anti-BrP-LPA,6987,,,178103566,Antagonist,Antagonist,,f,f,,pIC50,0,5.679999828,0,IC50,0,2079,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](C[C@@H](P(=O)(O)O)Br)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,BMS-986020,9498,,,329968437,Antagonist,Antagonist,,f,t,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,0,O=C(O[C@@H](c1ccccc1)C)Nc1c(C)noc1c1ccc(cc1)c1ccc(cc1)C1(CC1)C(=O)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,BrP-LPA,6985,,,178103564,Antagonist,Antagonist,,f,f,,pIC50,0,5.340000153,0,IC50,0,4520,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,BrP-LPA,6985,,,178103564,Antagonist,Antagonist,,f,f,,pKi,0,6.090000153,0,Ki,0,805,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,10922489,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,10922489,CCCCCCCC/C=CCCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pIC50,0,5.8,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pIC50,0,4.6,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,BrP-LPA,6985,,,178103564,Antagonist,Antagonist,,f,f,,pKi,0,6.610000134,0,Ki,0,245,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,BrP-LPA,6985,,,178103564,Antagonist,Antagonist,,f,f,,pIC50,0,6.329999924,0,IC50,0,468,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,compound 15 [PMID: 18178086],6993,,,178103572,Antagonist,Antagonist,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,18178086,C[C@H](Nc1ncnc2c1scc2C)CN1CCN(CC1)S(=C)(=C)c1ccc(c(c1)Cl)Cl
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,10922489,CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,2-oleoyl-LPA,2936,,,135649710,Agonist,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,10922489,CCCCCCCC/C=CCCCCCCCC(=O)OC(COP(=O)(O)O)CO
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,alkyl OMPT,2913,,,135649916,Agonist,Agonist,,f,,,pEC50,0,7.21,0,-,0,0,0,=,,,,16892372,CCCCCCCC/C=C\CCCCCCCCOC[C@@H](COP(=S)(O)O)OC
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,alkyl OMPT,2913,,,135649916,Agonist,Agonist,,f,,,pEC50,0,7.21,0,-,0,0,0,=,,,,16892372,CCCCCCCC/C=CCCCCCCCCOC[C@@H](COP(=S)(O)O)OC
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,&alpha;-fluoromethylenephosphonate,2915,,,135649923,Agonist,Agonist,,f,,,pEC50,0,9.3,0,,0,0,0,,,,,15857137,CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)F)OC
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,compound 12 [PMID: 19800804],6989,,,178103568,Antagonist,Antagonist,,f,f,,pIC50,0,5.519999981,0,IC50,0,2992,0,=,,,,19800804,Cc1ccc(cc1)Oc1ccc2c(c1)C(=O)N(C2=O)C(=O)O
LPA<sub>4</sub> receptor,94,LPAR4,Q99677,,,,,,Human,[1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate,6991,,,178103570,Antagonist,Antagonist,,f,f,,pIC50,0,6.579999924,0,IC50,0,266,0,=,,,,18781939,CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O[Na])O)Br)O
LPA<sub>4</sub> receptor,94,LPAR4,Q99677,,,,,,Human,AM966,2905,,,135649931,Antagonist,Antagonist,,f,,,pIC50,0,5.1,0,,0,0,0,,,,,20649573,OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1Cl)C)C
LPA<sub>5</sub> receptor,124,Lpar5,,,,,,,Rat,alkyl glycerol phosphate 18:1,6994,,,178103573,Agonist,Full agonist,,f,f,,pEC50,0,8.699999809,0,EC50,0,2,0,=,,,,19366702,CCCCCCCCCCCCCCCCCCOC[C@@H](COP(=O)(O)O)O
L-Phenylalanine hydroxylase ,1240,Pah,P04176,,,,,,Rat,&alpha;-methylphenylalanine,5093,,,178101786,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,944951,OC(=O)C(Cc1ccccc1)(N)C
L-Tryptophan hydroxylase 1,1241,TPH1,P17752,,,,,,Human,6-fluorotryptophan,5126,,,178101819,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,6457252,OC(=O)C(Cc1c[nH]c2c1ccc(c2)F)N
L-Tryptophan hydroxylase 1,1241,TPH1,P17752,,,,,,Human,&alpha;-propyldopacetamide,5095,,,178101788,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCC(c1ccc(c(c1)O)O)C(=O)N
L-Tryptophan hydroxylase 2,1242,TPH2,Q8IWU9,,,,,,Human,6-fluorotryptophan,5126,,,178101819,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,6457252,OC(=O)C(Cc1c[nH]c2c1ccc(c2)F)N
L-Tryptophan hydroxylase 2,1242,TPH2,Q8IWU9,,,,,,Human,&alpha;-propyldopacetamide,5095,,,178101788,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CCCC(c1ccc(c(c1)O)O)C(=O)N
L-Tyrosine hydroxylase ,1243,TH,P07101,,,,,,Human,3-chlorotyrosine,5114,,,178101807,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1ccc(c(c1)Cl)O)N
L-Tyrosine hydroxylase ,1243,TH,P07101,,,,,,Human,3-iodotyrosine,5117,,,178101810,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1ccc(c(c1)I)O)N
L-Tyrosine hydroxylase ,1243,TH,P07101,,,,,,Human,alpha-methyltyrosine,6956,,,178103538,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1)C[C@@](C(=O)O)(N)C
L-Tyrosine hydroxylase ,1243,TH,P07101,,,,,,Human,&alpha;-propyldopacetamide,5095,,,178101788,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCC(c1ccc(c(c1)O)O)C(=O)N
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,0,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,bafetinib,7906,,,249565589,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,17376680,CN([C@H]1CCN(C1)Cc1ccc(cc1C(F)(F)F)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cncnc1)C)C
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,compound 23 [PMID: 17600705],8146,,,249565826,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,17600705,Oc1ccc(c(c1)Nc1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,compound 36 [PMID: 21958547],9391,,,328083493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,624,0,=,,,,21958547,CN(C/C=C/C(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,anacardic acid,6999,,,178103578,Inhibitor,Inhibition,,f,f,,pIC50,0,5.070000172,0,IC50,0,8500,0,=,,,,0,C=CC/C=C/C/C=C/CCCCCCCc1cccc(c1C(=O)O)O
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,compound 1 [PMID: 15724976],7507,,,187051809,Inhibitor,Inhibition,,f,f,,pIC50,0,8.289999962,0,IC50,0,5.099999905,0,=,ELISA assay measuring binding to the KAT2B (PCAF) bromodomain (GST-tagged protein containing amino acid residues 719-832) .,,,15724976,[NH3+]CCCNc1ccccc1[N+](=O)[O-]
lysine demethylase 4A,2675,KDM4A,O75164,,,,,,Human,compound 6a [PMID: 18942826],8744,,,252827402,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,=,FDH (formaldehyde dehydrogenase) coupled assay.,,,18942826,OC(=O)c1ccnc(c1)C(=O)O
lysine demethylase 4E,2679,KDM4E,B2RXH2,,,,,,Human,compound 6a [PMID: 18942826],8744,,,252827402,Inhibitor,Inhibition,,f,f,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,FDH (formaldehyde dehydrogenase) coupled assay.,,,18942826,OC(=O)c1ccnc(c1)C(=O)O
lysine methyltransferase 5B,2717,KMT5B,Q4FZB7,,,,,,Human,A-196,8949,,,310264730,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,<i>In vitro</i> activity.,,,0,Clc1cc2c(nnc(c2cc1Cl)NC1CCCC1)c1ccncc1
lysine methyltransferase 5C,2718,KMT5C,Q86Y97,,,,,,Human,A-196,8949,,,310264730,Inhibitor,Inhibition,,f,f,,pIC50,0,6.840000153,0,IC50,0,144,0,=,<i>In vitro</i> activity.,,,0,Clc1cc2c(nnc(c2cc1Cl)NC1CCCC1)c1ccncc1
macrophage stimulating 1 receptor,1816,MST1R,Q04912,,,,,,Human,BMS-777607,7953,,,249565636,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,19260711,CCOc1ccn(c(=O)c1C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)c1ccc(cc1)F
Malonyl-CoA decarboxylase,1275,MLYCD,O95822,,,,,,Human,compound 10h [PMID: 20832306],8779,,,252827437,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,20832306,NC(=O)C1(CCN(CC1)c1ncc(s1)C(C(F)(F)F)(C(F)(F)F)O)c1cccc(c1)C(=O)O
maltase-glucoamylase,2627,Mgam,,,,,,,Mouse,acarbose,6791,,,178103397,Inhibitor,Inhibition,,f,f,,pKi,8.050000191,0,7.550000191,Ki,28,0,9,=,Affinity measured across splice variants of mouse MGAM catalytic subunit ctMGAM,,,21669536,OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H]([C@@H]([C@H]2O)O)O)[C@@H]([C@H]([C@@H]1O[C@H]1O[C@H](C)[C@H]([C@@H]([C@H]1O)O)N[C@H]1C=C(CO)[C@H]([C@@H]([C@H]1O)O)O)O)O
MATE2,1217,SLC47A2,Q86VL8,,,,,,Human,cimetidine,1231,,,135650099,Inhibitor,Inhibition,,f,,,pKi,0,5.1,0,Ki,0,7300,0,=,,,,19164462,N#CNC(=NC)NCCSCc1nc[nH]c1C
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,chlorpromazine,83,,,135650088,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,extracellular,0,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,t,,,-,0,0,0,,0,0,0,,,,intracellular,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,t,,,-,0,0,0,,0,0,0,,,,intracellular,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,Ac-hMCH-(6-16)-NH2,1290,,,135651969,Agonist,Full agonist,,f,,,pIC50,9.9,0,9.7,,0,0,0,,,,,12009900,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,C3,1291,,,135652051,Agonist,Full agonist,,f,,,pKi,8.9,0,8.7,,0,0,0,,,,,11561073,NCCCCC(C(=O)NC(C(=O)NC(C(=O)O)C)C)NC(=O)C(NC(=O)C(NC(=O)C(OC1C(O)C(CO)OC(C1NC(=O)C)OP(=O)(OP(=O)(OCC1OC(C(C1O)O)n1ccc(=O)[nH]c1=O)O)O)C)C)CCC(=O)O
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,compound 2 [PMID: 11375253],1292,,,135652061,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"4-arylphthalazin-1(2H)-3,4-Di-F",7753,,,223366086,Antagonist,Antagonist,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22137790,CC(=O)Nc1cccc(c1)C1CCN(CC1)CCCn1nc(c2ccc(c(c2)F)F)c2c(c1=O)cccc2
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,7-fluorochromone-2-carboxamide,1303,,,135649860,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,17064075,Fc1ccc2c(c1)oc(cc2=O)C(=O)NC1CCN(CC1)Cc1ccc2c(c1)OCO2
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,ATC0065,1304,,,135649969,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.8,,0,0,0,,,,,15677346,Brc1ccc(c(c1)OC(F)(F)F)CCN[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,ATC0175,1305,,,135649970,Antagonist,Antagonist,,f,f,,pIC50,8.100000381,0,7.900000095,IC50,13.5,0,7.230000019,=,,,,15677346,O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"[Ava<sup>9,10</sup>,Ava<sup>14,15</sup>]-Ac-hMCH<sub>6-16</sub>-NH2",1307,,,135652062,Antagonist,Antagonist,,f,,,pIC50,7.5,0,7,,0,0,0,,,,,12009900,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,AZ13483342,7735,,,223366068,Antagonist,Antagonist,,f,t,,pIC50,8.069999695,0,7.820000172,IC50,15,0,8.600000381,=,,,,17532215,COc1ccc2c(c1)c(C)cc(n2)NCCCNCc1cscc1
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,compound 17 [PMID: 17125263],1306,,,135650121,Antagonist,Antagonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,17125263,Clc1ccc(cc1)c1cc2c(s1)c(=O)n(cn2)c1ccc2c(c1)ccc(c2)CN1CCCCC1
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,compound 4b [PMID: 19683441],7755,,,223366088,Antagonist,Antagonist,,f,t,,pIC50,0,8.319999695,0,IC50,0,4.789999962,0,=,,,,19683441,CCO/N=C(c1ccc(c(c1)F)F)/c1ccc(cn1)CN1CCC2(CC1)OCc1c2cc(=O)n(c1)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,compound (<i>R</i>)-10h [PMID: 22490048],7754,,,223366087,Antagonist,Antagonist,,f,t,,pIC50,0,8.800000191,0,IC50,0,1.580000043,0,=,,,,22490048,CC(=O)NCCN[C@@H](c1cnc2c(c1)ccc(c2C)NC(=O)c1ccc(cc1)OCC1CC1)C
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,Ac-hMCH-(6-16)-NH2,1290,,,135651969,Agonist,Full agonist,,f,,,pIC50,8.8,0,8.4,,0,0,0,,,,,12009900,
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,ATC0065,1304,,,135649969,Antagonist,Antagonist,,f,,,pIC50,5.9,0,5.8,,0,0,0,,,,,15677346,Brc1ccc(c(c1)OC(F)(F)F)CCN[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,"[Ava<sup>9,10</sup>,Ava<sup>14,15</sup>]-Ac-hMCH<sub>6-16</sub>-NH2",1307,,,135652062,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,12009900,
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,compound 38 [PMID: 22123324],7757,,,223366090,Antagonist,Antagonist,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22123324,CCCN[C@@H]1CC2(c3c1cccc3)CCN(CC2)Cc1ccc2c(c1)c1ccccc1n2C(=O)N
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,ACTH,3633,POMC,Human,135651598,Agonist,Agonist,,f,f,,pKi,0,8.600000381,0,Ki,0,2.5,0,=,,,,7774675,
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,afamelanotide,1324,,,135652322,Agonist,Full agonist,,f,,,pIC50,0,10,0,,0,0,0,,,,,12007532,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C(C)C)CCCCN)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)Cc1ccc(cc1)O)CO
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,&alpha;-MSH,1320,POMC|Pomc|Pomc,Human|Mouse|Rat,135651610,Agonist,Full agonist,,t,,,pIC50,0,8.4,0,,0,0,0,,,,,12007532,
MC<sub>1</sub> receptor,282,Mc1r,Q01727,,,,,,Mouse,agouti,1329,a,Mouse,135651606,Antagonist,Inverse agonist,,t,,,pKd,0,8.6,0,,0,0,0,,,,,7935841,
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,ASIP [90-132 (L89Y)],1327,,,135652000,Antagonist,Inverse agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,11705773,
MC<sub>2</sub> receptor,283,Mc2r,Q64326,,,,,,Mouse,ACTH,1331,Pomc|Pomc,Mouse|Rat,135651599,Agonist,Full agonist,,t,,,pKd,0,9.8,0,-,0,0,0,=,,,,8754753,
MC<sub>2</sub> receptor,283,Mc2r,Q64326,,,,,,Mouse,ACTH-(1-24),1330,,,135651974,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,8754753,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,ACTH-(11-24),1332,,,135651973,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,8754753,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,ASIP [90-132 (L89Y)],1327,,,135652000,Antagonist,Inverse agonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,11705773,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,ACTH,3633,POMC,Human,135651598,Agonist,Agonist,,f,f,,pKi,0,7.059999943,0,Ki,0,86.90000153,0,=,,,,7774675,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,afamelanotide,1324,,,135652322,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,10493100,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C(C)C)CCCCN)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)Cc1ccc(cc1)O)CO
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,&alpha;-MSH,1320,POMC|Pomc|Pomc,Human|Mouse|Rat,135651610,Agonist,Full agonist,,t,,,pKi,8.4,0,8,,0,0,0,,,,,10358030,
MC<sub>3</sub> receptor,284,Mc3r,P33033,,,,,,Mouse,agouti,1329,a,Mouse,135651606,Antagonist,Inverse agonist,,t,,,pIC50,0,6.7,0,,0,0,0,,,,,9454589,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,agouti-related protein,1335,AGRP,Human,135651607,Antagonist,Inverse agonist,,t,,,pIC50,0,7.7,0,,0,0,0,,,,,9819197,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,ACTH,3633,POMC,Human,135651598,Agonist,Agonist,,f,f,,pKi,0,6.159999847,0,Ki,0,693,0,=,,,,8884876,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,afamelanotide,1324,,,135652322,Agonist,Full agonist,,f,,,pKi,8.8,0,8.5,,0,0,0,,,,,10493100,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C(C)C)CCCCN)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)Cc1ccc(cc1)O)CO
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,&alpha;-MSH,1320,POMC|Pomc|Pomc,Human|Mouse|Rat,135651610,Agonist,Full agonist,,t,,,pKi,8,0,7.4,,0,0,0,,,,,10493100,
MC<sub>4</sub> receptor,285,Mc4r,P56450,,,,,,Mouse,agouti,1329,a,Mouse,135651606,Antagonist,Inverse agonist,,t,,,pKd,0,7.3,0,,0,0,0,,,,,9454589,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,agouti-related protein,1335,AGRP,Human,135651607,Antagonist,Inverse agonist,,t,,,pIC50,0,9.3,0,,0,0,0,,,,,9299416,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,ACTH,3633,POMC,Human,135651598,Agonist,Agonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,7774675,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,afamelanotide,1324,,,135652322,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,12007532,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C(C)C)CCCCN)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)Cc1ccc(cc1)O)CO
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,&alpha;-MSH,1320,POMC|Pomc|Pomc,Human|Mouse|Rat,135651610,Agonist,Full agonist,,t,,,pKd,0,6.9,0,,0,0,0,,,,,12007532,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH<sub>2</sub>,1342,,,135651968,Antagonist,Antagonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,12904077,
MC<sub>5</sub> receptor,286,Mc5r,P41149,,,,,,Mouse,agouti,1329,a,Mouse,135651606,Antagonist,Inverse agonist,,t,,,pKd,0,4.9,0,,0,0,0,,,,,9454589,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,agouti-related protein,1335,AGRP,Human,135651607,Antagonist,Inverse agonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,9892020,
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,t,,pKi,0,7.769999981,0,Ki,0,17,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,AZD8055,7714,,,223366047,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,23375793,OCc1cc(ccc1OC)c1ccc2c(n1)nc(nc2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,berzosertib,8003,,,249565683,Inhibitor,Inhibition,,f,f,,pKi,0,6,0,Ki,0,1000,0,>,,,,23222511,CNCc1ccc(cc1)c1noc(c1)c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,bimiralisib,8383,,,252166595,Inhibitor,Inhibition,,f,t,,pKd,0,7.920000076,0,Kd,0,12,0,=,,,,0,Nc1ncc(c(c1)C(F)(F)F)c1nc(nc(n1)N1CCOCC1)N1CCOCC1
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,CC-223,8914,,,310264695,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,26083478,COC1CCC(CC1)N1C(=O)CNc2c1nc(cn2)c1ccc(nc1)C(O)(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,CH5132799,7743,,,223366076,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,21316229,Nc1ncc(cn1)c1nc(nc2c1CCN2S(=O)(=O)C)N1CCOCC1
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,compound 11j [PMID: 23021994],8827,,,252827484,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,23021994,CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
"membrane bound transcription factor peptidase, site 1",2381,MBTPS1,Q14703,,,,,,Human,compound 7b [PMID: 17583500],8828,,,252827485,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,17583500,O=C(N(C1CNCC1)CCc1ccccc1Cl)c1ccc(cc1)CN1CCCC(C1)c1ccccc1C
"MER proto-oncogene, tyrosine kinase",1837,MERTK,Q12866,,,,,,Human,BMS-777607,7953,,,249565636,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,19260711,CCOc1ccn(c(=O)c1C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)c1ccc(cc1)F
Methionyl aminopeptidase 1,1572,METAP1,P53582,,,,,,Human,compound 14 [PMID: 23634668],8557,,,252166758,Inhibitor,Inhibition,,f,t,,pEC50,0,7.03000021,0,EC50,0,93,0,=,In the presence of Co<sup<2+</sup>.,,,23634668,CC(=O)N[C@H](C(=O)N1CCN(CC1)c1nc(nc2c1cccc2)c1ccccn1)Cc1ccccc1
Methionyl aminopeptidase 2,1573,METAP2,P50579,,,,,,Human,beloranib,8445,,,252166655,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,17446235,CO[C@@H]1[C@@H](CC[C@@]2([C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)CO2)OC(=O)/C=C/c1ccc(cc1)OCCN(C)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,alectinib,7739,,,223366072,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,>,,,,22225917,CCc1cc2C(=O)c3c4ccc(cc4[nH]c3C(c2cc1N1CCC(CC1)N1CCOCC1)(C)C)C#N
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,altiratinib,9174,,,315661257,Inhibitor,Inhibition,,f,f,,pIC50,0,8.569999695,0,IC50,0,2.700000048,0,=,,,,0,O=C(C1CC1)Nc1nccc(c1)Oc1cc(F)c(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,AM7,8292,,,252166504,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,18055465,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)c1cnc(n(c1=O)C)Cc1ccccc1
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,AMG-337,8913,,,310264694,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,Biochemically assessed value.,,,19819693,COc1cnc2c(c1)nccc2NCc1nnc2n1nc(cc2)c1snc(c1)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,BMS-777607,7953,,,249565636,Inhibitor,Inhibition,,f,t,,pIC50,0,8.409999847,0,IC50,0,3.900000095,0,=,,,,19260711,CCOc1ccn(c(=O)c1C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)c1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,cabozantinib,5887,,,178102511,Inhibitor,Inhibition,,f,t,,pIC50,0,8.899999619,0,IC50,0,1.299999952,0,=,,,,21926191,COc1cc2c(ccnc2cc1OC)Oc1ccc(cc1)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,capmatinib,7904,,,249565587,Inhibitor,Inhibition,,f,t,,pIC50,0,9.890000343,0,IC50,0,0.129999995,0,=,,,,21918175,CNC(=O)c1ccc(cc1F)c1cnc2n(n1)c(cn2)Cc1ccc2c(c1)cccn2
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,compound 16 [PMID: 18945615],8178,,,249565858,Inhibitor,Inhibition,,f,f,,pIC50,0,7.070000172,0,IC50,0,85,0,=,,,,18945615,O=c1[nH]cnc2c1cc([nH]2)c1ccnc(c1)/C=C/c1ccc(cc1)CN1CCOCC1
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,compound 1o [PMID: 24210504],8143,,,249565823,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,24210504,Nc1ncc(cc1c1nc2c(o1)cc(cc2)N1CCCC1)c1cnn(c1)C1CCNCC1
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,compound 27 [PMID: 21123062],8210,,,249565890,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,21123062,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)N(CC)C(=O)CCC2(C)C)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,compound R-16 [PMID: 21967808],8213,,,249565893,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,21967808,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,6.1,0,5.5,,0,0,0,,,,,12695537,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,"3,5-DHPG",1367,,,135649729,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12695537,OC(=O)C(c1cc(O)cc(c1)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,"3,5-dimethyl PPP",3397,,,178100410,Allosteric modulator,Negative,,f,f,,pIC50,0,7.800000191,0,IC50,0,15.80000019,0,=,,,,12470711,CCCOC(=O)c1[nH]c(c(c1C)C(=O)OC(C(C)(C)C)C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,A-794278,6354,,,178102972,Allosteric modulator,Negative,,f,,,pKi,0,8.27,0,Ki,0,5.4,0,=,,,,18054908,CN(c1ccnc2c1c1ncn(c(=O)c1s2)C1CCCCCC1)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,A-794278,6354,,,178102972,Allosteric modulator,Negative,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,16279797,CN(c1ccnc2c1c1ncn(c(=O)c1s2)C1CCCCCC1)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,A-794282,6211,,,178102832,Allosteric modulator,Negative,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,16279797,CCc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,A-794282,6211,,,178102832,Allosteric modulator,Negative,,f,,,pIC50,0,8.33,0,IC50,0,4.7,0,=,,,,18054908,CCc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,A-841720,3953,,,178100780,Allosteric modulator,Negative,,f,,,pIC50,9,0,8.98,IC50,1.05,0,1,=,,,,18054908,CN(c1ccnc2c1c1ncn(c(=O)c1s2)N1CCCCCC1)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,A-841720,3953,,,178100780,Allosteric modulator,Negative,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,16279797,CN(c1ccnc2c1c1ncn(c(=O)c1s2)N1CCCCCC1)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,A-850002,6355,,,178102973,Allosteric modulator,Negative,,f,,,pIC50,0,7.37,0,IC50,0,43,0,=,,,,16279797,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(cnc1)N(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,A-850002,6355,,,178102973,Allosteric modulator,Negative,,f,,,pIC50,0,7.39,0,IC50,0,40.9,0,=,,,,18054908,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(cnc1)N(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,BAY 367620,1381,,,135649980,Allosteric modulator,Negative,,f,f,,pKi,0,9.470000267,0,Ki,0,0.340000004,0,=,,,,11306677,C=C1C[C@H]2[C@](C1)(Cc1ccc3c(c1)cccc3)C(=O)OC2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,BAY 367620,1381,,,135649980,Allosteric modulator,Negative,,f,f,,pIC50,8,0,6.800000191,IC50,158,0,10,=,,,,12695537,C=C1C[C@H]2[C@](C1)(Cc1ccc3c(c1)cccc3)C(=O)OC2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,CFMMC,6340,,,178102958,Allosteric modulator,Negative,,f,,,pIC50,0,7.3,0,IC50,0,50,0,=,,,,19559036,Cc1c(OCCN2CCOCC2)cc2c(c1F)c(=O)c(co2)C1CCCCC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,CFMTI,6341,,,178102959,Allosteric modulator,Negative,,f,,,pIC50,0,8.59,0,IC50,0,2.6,0,=,,,,19359526,O=C1N(Cc2c1ccc(c2)c1nnn(c1C)c1cccnc1F)C1CC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 10i [PMID: 23084894],6365,,,178102983,Allosteric modulator,Negative,,f,,,pIC50,0,8.22,0,IC50,0,6,0,=,,,,23084894,COc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ncn1)NC1CC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 11c [PMID: 17929793],6343,,,178102961,Allosteric modulator,Negative,,f,,,pIC50,0,8.31,0,IC50,0,4.9,0,=,,,,17929793,COc1ccc(cc1)N1C=NC2C(C1=O)Sc1c2c2NCCc2cn1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 11c [PMID: 17929793],6343,,,178102961,Allosteric modulator,Negative,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,17929793,COc1ccc(cc1)N1C=NC2C(C1=O)Sc1c2c2NCCc2cn1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 11q [PMID: 19433355],6214,,,178102835,Allosteric modulator,Negative,,f,,,pIC50,0,9.05,0,IC50,0,0.9,0,=,,,,19433355,C#CCNc1ccnc2c1c1ncn(c(=O)c1s2)c1ccc(cc1)Cl
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 11q [PMID: 19433355],6214,,,178102835,Allosteric modulator,Negative,,f,,,pKi,0,8.46,0,Ki,0,3.5,0,=,,,,19433355,C#CCNc1ccnc2c1c1ncn(c(=O)c1s2)c1ccc(cc1)Cl
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 11s [PMID: 19433355],6215,,,178102836,Allosteric modulator,Negative,,f,,,pIC50,0,8.68,0,IC50,0,2.1,0,=,,,,19433355,C#CCNc1ccnc2c1c1ncn(c(=O)c1s2)c1ccc(cc1)OC
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 11s [PMID: 19433355],6215,,,178102836,Allosteric modulator,Negative,,f,,,pKi,0,8.33,0,Ki,0,4.7,0,=,,,,19433355,C#CCNc1ccnc2c1c1ncn(c(=O)c1s2)c1ccc(cc1)OC
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 12e [PMID: 22266036],6357,,,178102975,Allosteric modulator,Negative,,f,,,pKi,0,8.28,0,Ki,0,5.2,0,=,,,,22266036,COc1ccc(cc1)n1ccc2c(c1=O)sc1c2c(ccn1)NC1CC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 12e [PMID: 22266036],6357,,,178102975,Allosteric modulator,Negative,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,22266036,COc1ccc(cc1)n1ccc2c(c1=O)sc1c2c(ccn1)NC1CC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 22 [PMID: 17276684],6358,,,178102976,Allosteric modulator,Negative,,f,,,pKi,0,8.44,0,Ki,0,3.6,0,=,,,,17276684,Cc1cc2[nH]c3c(c2cc1OCc1ccccc1)CCNC3=O
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 22 [PMID: 17276684],6358,,,178102976,Allosteric modulator,Negative,,f,,,pIC50,0,6.78,0,IC50,0,167,0,=,,,,17276684,Cc1cc2[nH]c3c(c2cc1OCc1ccccc1)CCNC3=O
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 22 [PMID: 19289283],6349,,,178102967,Allosteric modulator,Negative,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,,,,19289283,OCCOCCNc1ncc2c(c1)c(ncn2)NC1Cc2c(C1)cccc2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 23c [PMID: 17929793],6345,,,178102963,Allosteric modulator,Negative,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,,,,17929793,COc1ccc(cc1)n1cnc2c(c1=O)sc1c2c2NCCOc2cn1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 23c [PMID: 17929793],6345,,,178102963,Allosteric modulator,Negative,,f,,,pKi,0,9.4,0,Ki,0,0.4,0,=,,,,17929793,COc1ccc(cc1)n1cnc2c(c1=O)sc1c2c2NCCOc2cn1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 23e [PMID: 17929793],6346,,,178102964,Allosteric modulator,Negative,,f,,,pKi,0,8.82,0,Ki,0,1.5,0,=,,,,17929793,Clc1ccc(cc1)n1cnc2c(c1=O)sc1c2c2NCCOc2cn1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 23e [PMID: 17929793],6346,,,178102964,Allosteric modulator,Negative,,f,,,pIC50,0,8.54,0,IC50,0,2.9,0,=,,,,17929793,Clc1ccc(cc1)n1cnc2c(c1=O)sc1c2c2NCCOc2cn1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 23h [PMID: 17929793],6338,,,178102956,Allosteric modulator,Negative,,f,,,pKi,0,8.82,0,Ki,0,1.5,0,=,,,,17929793,C[C@H]1CNc2c(O1)cnc1c2c2ncn(c(=O)c2s1)c1ccc(cc1)Cl
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 23h [PMID: 17929793],6338,,,178102956,Allosteric modulator,Negative,,f,,,pIC50,0,8.66,0,IC50,0,2.2,0,=,,,,17929793,C[C@H]1CNc2c(O1)cnc1c2c2ncn(c(=O)c2s1)c1ccc(cc1)Cl
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 23i [PMID: 17929793],6348,,,178102966,Allosteric modulator,Negative,,f,,,pIC50,0,8.85,0,IC50,0,1.4,0,=,,,,17929793,C[C@@H]1CNc2c(O1)cnc1c2c2ncn(c(=O)c2s1)c1ccc(cc1)Cl
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 24 [PMID: 20346665],6209,,,178102830,Allosteric modulator,Negative,,f,,,pIC50,0,8.68,0,IC50,0,2.1,0,=,,,,20346665,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)N
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 24 [PMID: 20346665],6209,,,178102830,Allosteric modulator,Negative,,f,,,pKi,0,6.94,0,Ki,0,115,0,=,,,,20346665,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 24 [PMID: 20346665],6209,,,178102830,Allosteric modulator,Negative,,f,,,pKi,0,6.94,0,Ki,0,115,0,=,,,,20346665,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)N
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 27 [PMID: 20346665],6210,,,178102831,Allosteric modulator,Negative,,f,,,pIC50,0,7.57,0,IC50,0,27,0,=,,,,20346665,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 27 [PMID: 20346665],6210,,,178102831,Allosteric modulator,Negative,,f,,,pKi,0,8.1,0,Ki,0,7.9,0,=,,,,20346665,Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 29 [PMID: 17064898],6208,,,178102829,Allosteric modulator,Negative,,f,,,pKi,0,8.03,0,Ki,0,9.3,0,=,,,,17064898,OCC1CCN(CC1)c1ncc(nc1)C(=O)NC1CCCCC1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 29 [PMID: 17064898],6208,,,178102829,Allosteric modulator,Negative,,f,,,pIC50,0,8.05,0,IC50,0,9,0,=,,,,17064898,OCC1CCN(CC1)c1ncc(nc1)C(=O)NC1CCCCC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 2f [PMID: 17532216],6342,,,178102960,Allosteric modulator,Negative,,f,,,pKi,0,6.9,0,Ki,0,127,0,=,,,,17532216,Clc1ccc(cc1)n1c(C)nc2c(c1=O)cnn2c1ccc(cc1)S(=O)(=O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 32 [PMID: 19289283],6351,,,178102969,Allosteric modulator,Negative,,f,,,pIC50,0,8.22,0,IC50,0,6,0,=,,,,19289283,C1CCCC(CC1)Nc1ncnc2c1cc(OCCN1CCOCC1)nc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 3 [PMID: 12470711],6364,,,178102982,Allosteric modulator,Negative,,f,,,pIC50,0,7.8,0,IC50,0,16,0,=,,,,12470711,CCCOC(=O)c1[nH]c(c(c1C)C(=O)OCC(C)(C)C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 9a [PMID: 22266036],6356,,,178102974,Allosteric modulator,Negative,,f,,,pIC50,0,8.2,0,IC50,0,6.3,0,=,,,,22266036,COc1ccc(cc1)n1ccc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 9a [PMID: 22266036],6356,,,178102974,Allosteric modulator,Negative,,f,,,pKi,0,8.44,0,Ki,0,3.6,0,=,,,,22266036,COc1ccc(cc1)n1ccc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,compound 9n [PMID: 23084894],6362,,,178102980,Allosteric modulator,Negative,,f,,,pIC50,0,8.15,0,IC50,0,7,0,=,,,,23084894,COc1ccc(c(c1)F)n1cnc2c(c1=O)sc1c2c(ncn1)N(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 3a [PMID: 16099654],6205,,,178102826,Allosteric modulator,Positive,,f,,,pEC50,0,7.19,0,EC50,0,65,0,=,,,,16099654,O=C(C1c2ccccc2Oc2c1cccc2)Nc1noc(n1)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,compound 4b [PMID: 16099654],6206,,,178102827,Allosteric modulator,Positive,,f,,,pEC50,0,7.19,0,EC50,0,65,0,=,,,,16099654,CCn1nnc(n1)NC(=O)C1c2ccccc2Oc2c1cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,3-MATIDA,3396,,,178100409,Antagonist,Antagonist,,f,f,,pIC50,0,5.199999809,0,IC50,0,6300,0,=,,,,12015200,OC(=O)c1cc(c(s1)C(C(=O)O)N)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,AIDA,1376,,,135649911,Antagonist,Antagonist,,f,,,pKi,0,4,0,,0,0,0,,,,,12695537,OC(=O)c1ccc2c(c1)CCC2(N)C(=O)O
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,AIDA,1376,,,135649911,Antagonist,Antagonist,,f,f,,pA2,0,4.199999809,0,-,0,0,0,=,,,,9152378,OC(=O)c1ccc2c(c1)CCC2(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,5.4,0,5,,0,0,0,,,,,9504391,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,10530814,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,"(2<i>R</i>,3<i>R</i>)-APDC",1392,,,135649704,Agonist,Full agonist,,f,,,pKi,0,5,0,,0,0,0,,,,,10530814,OC(=O)[C@@H]1NC[C@@](C1)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 2 [PMID: 21105727],6222,,,178102843,Allosteric modulator,Negative,,f,,,pIC50,0,6.1,0,IC50,0,800,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)Cl
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 2 [PMID: 21105727],6222,,,178102843,Allosteric modulator,Negative,,f,,,pKi,0,6,0,Ki,0,1000,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)Cl
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 3 [PMID: 21105727],6223,,,178102844,Allosteric modulator,Negative,,f,,,pIC50,0,5.82,0,IC50,0,1500,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 3 [PMID: 21105727],6223,,,178102844,Allosteric modulator,Negative,,f,,,pKi,0,6.22,0,Ki,0,600,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 4 [PMID: 21105727],6224,,,178102845,Allosteric modulator,Negative,,f,,,pKi,0,6.1,0,Ki,0,800,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)OC
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 4 [PMID: 21105727],6224,,,178102845,Allosteric modulator,Negative,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)OC
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,"2,2,2-TEMPS",6329,,,178102947,Allosteric modulator,Positive,,f,,,pEC50,0,7.85,0,EC50,0,14,0,=,,,,15149652,CCCC(Oc1cccc(c1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,3-MPPTS,1401,,,135649739,Allosteric modulator,Positive,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,12852748,COc1ccccc1Oc1cccc(c1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,4-APPES,6258,,,178102878,Allosteric modulator,Positive,,f,,,pEC50,0,5.65,0,EC50,0,2260,0,=,,,,15717213,CCS(=O)(=O)N(c1ccc(cc1)Oc1ccc(cc1)C(=O)N)Cc1cccnc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,4-MPPTS,1402,,,135649803,Allosteric modulator,Positive,,f,,,pIC50,0,5.8,0,-,0,0,0,=,,,,12852748,COc1ccccc1Oc1ccc(cc1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,AZD8529,7678,,,223366013,Allosteric modulator,Positive,,f,t,,pEC50,0,6.710000038,0,EC50,0,195,0,=,,,,0,Cc1cc(cc2c1C(=O)N(C2)Cc1ccc(cc1)OC(F)(F)F)c1onc(n1)CN1CCNCC1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,biphenylindanone A,3954,,,178100781,Allosteric modulator,Positive,,f,,,pEC50,0,7,0,EC50,0,111,0,=,,,,16046122,Cc1c(OCc2cccc(c2)c2ccc(cc2)C(=O)O)cc2c(c1C)C(=O)C(C2)C1CCCC1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,CBiPES,3372,,,178100395,Allosteric modulator,Positive,,f,,,pEC50,0,7,0,EC50,0,92.8,0,=,,,,15717213,N#Cc1ccc(cc1)c1cccc(c1)N(S(=O)(=O)CC)Cc1cccnc1
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,compound 14a [PMID: 18812259],6254,,,178102874,Allosteric modulator,Positive,,f,,,pEC50,0,7.6,0,EC50,0,26,0,=,,,,18812259,Clc1ccc(nc1)COC[C@@H]1[C@@H]2[C@H]1CN(C2)Cc1nc2c(n1C)cccc2
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,compound 14c [PMID: 18812259],6255,,,178102875,Allosteric modulator,Positive,,f,,,pEC50,0,7.5,0,EC50,0,30,0,=,,,,18812259,Cn1c(CN2C[C@@H]3[C@H](C2)[C@H]3COCc2ccc(cn2)C(F)(F)F)nc2c1cccc2
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,compound 14 [PMID: 21155570],6323,,,178102941,Allosteric modulator,Positive,,f,,,pEC50,0,6.77,0,EC50,0,170,0,=,,,,21155570,OC(=O)c1cc(ccc1Cl)c1cccc(c1)COc1ccc2c(c1)sn(c2=O)C1CCCC1
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,compound 19 [PMID: 18812259],6256,,,178102876,Allosteric modulator,Positive,,f,,,pEC50,0,7.2,0,EC50,0,64,0,=,,,,18812259,Clc1cccc(c1)COC[C@@H]1[C@@H]2[C@H]1CN(C2)Cc1nc2c(n1C)cccn2
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 34 [PMID: 20409708],6321,,,178102939,Allosteric modulator,Positive,,f,,,pEC50,0,7.08,0,EC50,0,84,0,=,,,,20409708,N#Cc1cccc(c1)N1C[C@H](OC1=O)COc1ccc(cc1)C(C)(C)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,compound 48 [PMID: 22364337],6320,,,178102938,Allosteric modulator,Positive,,f,,,pEC50,0,6.44,0,EC50,0,361,0,=,,,,22364337,CCCCn1ccc(c(c1=O)C#N)c1ccc(c(c1)F)Oc1ccnc(c1)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,&alpha;-methylserine-O-phosphate,1398,,,135650668,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,9504391,OC(=O)C(COP(=O)(O)O)(N)C
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,10884552,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10530814,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,"(2<i>R</i>,3<i>R</i>)-APDC",1392,,,135649704,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,10530814,OC(=O)[C@@H]1NC[C@@](C1)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,compound 2 [PMID: 21105727],6222,,,178102843,Allosteric modulator,Positive,,f,,,pEC50,0,4.9,0,EC50,0,13400,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)Cl
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,compound 3 [PMID: 21105727],6223,,,178102844,Allosteric modulator,Positive,,f,,,pEC50,0,5.1,0,EC50,0,8900,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)C
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,compound 4 [PMID: 21105727],6224,,,178102845,Allosteric modulator,Positive,,f,,,pEC50,0,4.98,0,EC50,0,10400,0,=,,,,21105727,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccc(cc1)OC
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,ACPT-I,1408,,,135649891,Agonist,Full agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,9301676,OC(=O)[C@@H]1C[C@](C[C@@H]1C(=O)O)(N)C(=O)O
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,ADX88178,6238,,,178102859,Allosteric modulator,Positive,,f,,,pKi,0,7.4,0,Ki,0,39,0,=,,,,22787118,Cc1ccnc(n1)Nc1sc(c(n1)c1c[nH]nc1)C
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,ADX88178,6238,,,178102859,Allosteric modulator,Positive,,f,,,pEC50,0,8.5,0,EC50,0,3.5,0,=,,,,22787118,Cc1ccnc(n1)Nc1sc(c(n1)c1c[nH]nc1)C
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,ADX88178,6238,,,178102859,Allosteric modulator,Positive,,f,,,pEC50,0,8.04,0,EC50,0,9.1,0,=,,,,22787118,Cc1ccnc(n1)Nc1sc(c(n1)c1c[nH]nc1)C
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,compound 11 [PMID: 20638279],6235,,,178102856,Allosteric modulator,Positive,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,,,,20638279,Nc1nccc(n1)/C=C/c1ccccc1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,compound 1 [PMID: 22465637],6236,,,178102857,Allosteric modulator,Positive,,f,,,pEC50,0,6.7,0,EC50,0,220,0,=,,,,22465637,c1ccc(cc1)N1NCC(C1)c1ccnc2c1cccc2
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,compound 22a [PMID: 21688779],6231,,,178102852,Allosteric modulator,Positive,,f,,,pEC50,0,8.1,0,EC50,0,9,0,=,,,,21688779,c1ccc(nc1)Nc1sc2c(n1)c1c[nH]nc1CCC2
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,compound 7 [PMID: 20638279],6232,,,178102853,Allosteric modulator,Positive,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,,,,20638279,c1ccc(nc1)Nc1scc(n1)c1c[nH]nc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,11080213,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CHPG,1417,,,135650090,Agonist,Full agonist,,f,f,,pIC50,0,3.400000095,0,-,0,0,0,=,,,,11080213,OC(=O)C(c1cc(O)ccc1Cl)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,"3,5-DHPG",1367,,,135649729,Agonist,Partial agonist,,f,,,pIC50,0,5.4,0,,0,0,0,,,,,11080213,OC(=O)C(c1cc(O)cc(c1)O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,alloswitch-1,8543,,,252166744,Allosteric modulator,Negative,,f,t,,pIC50,0,8.069999695,0,IC50,0,8.600000381,0,=,Inhibition of agonist-induced IP accumulation.,,,25173999,COc1cc(/N=N/c2ccccn2)ccc1NC(=O)c1ccccc1Cl
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,AZD6538,6440,,,178103056,Allosteric modulator,Negative,,f,,,pIC50,0,7.87,0,IC50,0,13.4,0,=,,,,23046966,N#Cc1ccc(nc1)c1noc(n1)c1cc(F)cc(c1)C#N
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,AZD6538,6440,,,178103056,Allosteric modulator,Negative,,f,,,pKi,0,7.55,0,Ki,0,28,0,=,,,,23046966,N#Cc1ccc(nc1)c1noc(n1)c1cc(F)cc(c1)C#N
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,AZD9272,6439,,,178103055,Allosteric modulator,Negative,,f,,,pIC50,0,8.12,0,IC50,0,7.6,0,=,,,,23046966,N#Cc1cc(F)cc(c1)c1onc(n1)c1ccc(cn1)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,AZD9272,6439,,,178103055,Allosteric modulator,Negative,,f,,,pKi,0,8.42,0,Ki,0,3.8,0,=,,,,23046966,N#Cc1cc(F)cc(c1)c1onc(n1)c1ccc(cn1)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,basimglurant,9309,,,318164828,Allosteric modulator,Negative,,f,f,,pKi,0,7.440000057,0,Ki,0,36,0,=,Reduction of antagonist MPEP binding to mGlu<sub>5</sub> receptors <i>in vitro</i>,,,25565255,Fc1ccc(cc1)n1c(C)nc(c1C)C#Cc1ccnc(c1)Cl
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,BOMA,1421,,,135650014,Allosteric modulator,Negative,,f,,,pKi,0,8.5,0,,0,0,0,,,,,14697765,N#CCc1ccc(cc1OC)c1nc2c(o1)cccc2
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,Br-5MPEPy,6397,,,178103013,Allosteric modulator,Negative,,f,,,pKi,0,6.52,0,Ki,0,300,0,=,,,,16155210,Cc1ccc(nc1)C#Cc1cncc(c1)Br
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 10 [PMID: 15482906],6450,,,178103066,Allosteric modulator,Negative,,f,,,pKi,0,7.92,0,Ki,0,12,0,=,,,,15482906,Fc1cc(Oc2cccnc2)cc(c1)n1nnc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 10 [PMID: 15482906],6450,,,178103066,Allosteric modulator,Negative,,f,,,pIC50,0,8.17,0,IC50,0,6.7,0,=,,,,15482906,Fc1cc(Oc2cccnc2)cc(c1)n1nnc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 10 [PMID: 15482908],6449,,,178103065,Allosteric modulator,Negative,,f,,,pIC50,0,7.11,0,IC50,0,77,0,=,,,,15482908,N#Cc1cc(F)cc(c1)n1nnc(n1)c1[nH]cc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 10 [PMID: 15482908],6449,,,178103065,Allosteric modulator,Negative,,f,,,pKi,0,7.72,0,Ki,0,19,0,=,,,,15482908,N#Cc1cc(F)cc(c1)n1nnc(n1)c1[nH]cc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 11a [PMID: 14697765],6426,,,178103042,Allosteric modulator,Negative,,f,,,pKi,0,6.8,0,Ki,0,159,0,=,,,,14697765,COc1cc(ccc1c1ccccn1)C1Nc2c(O1)cccc2
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 11a [PMID: 14697765],6426,,,178103042,Allosteric modulator,Negative,,f,,,pIC50,0,7.4,0,IC50,0,41,0,=,,,,14697765,COc1cc(ccc1c1ccccn1)C1Nc2c(O1)cccc2
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 13 [PMID: 15686941],6447,,,178103063,Allosteric modulator,Negative,,f,,,pIC50,0,7.55,0,IC50,0,28,0,=,,,,15686941,Cc1cnc(c(n1)C(=O)Nc1ccccn1)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 16a [PMID: 14697765],6427,,,178103043,Allosteric modulator,Negative,,f,,,pKi,0,7.04,0,Ki,0,91,0,=,,,,14697765,COc1cc(ccc1c1ccccn1)c1nc2n(c1)cccc2
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 16a [PMID: 14697765],6427,,,178103043,Allosteric modulator,Negative,,f,,,pIC50,0,7.66,0,IC50,0,22,0,=,,,,14697765,COc1cc(ccc1c1ccccn1)c1nc2n(c1)cccc2
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 16m [PMID: 19931453],6429,,,178103045,Allosteric modulator,Negative,,f,,,pKi,0,7.42,0,Ki,0,38,0,=,,,,19931453,CC[C@@H]1CCCCN1C(=O)c1cnc(c(c1)Cl)Nc1ccc(nc1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 16m [PMID: 19931453],6429,,,178103045,Allosteric modulator,Negative,,f,,,pIC50,0,7.49,0,IC50,0,32,0,=,,,,19931453,CC[C@@H]1CCCCN1C(=O)c1cnc(c(c1)Cl)Nc1ccc(nc1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 18 [PMID: 17723296],6443,,,178103059,Allosteric modulator,Negative,,f,,,pIC50,0,9.14,0,IC50,0,0.72,0,=,,,,17723296,COc1cc(C#N)cc(c1)c1ncc2c(n1)nc(cc2)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 18 [PMID: 21927650],6442,,,178103058,Allosteric modulator,Negative,,f,,,pKi,0,6.32,0,Ki,0,477,0,=,,,,21927650,N#Cc1cc(F)cc(c1)c1ccc2c(c1)NC(S2)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 18 [PMID: 21927650],6442,,,178103058,Allosteric modulator,Negative,,f,,,pIC50,0,7.21,0,IC50,0,61,0,=,,,,21927650,N#Cc1cc(F)cc(c1)c1ccc2c(c1)NC(S2)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 20 [PMID: 16439120],6371,,,178102989,Allosteric modulator,Negative,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,16439120,N#Cc1cc(C)cc(n1)OCc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 23 [PMID: 17590335],6444,,,178103060,Allosteric modulator,Negative,,f,,,pKi,0,7.66,0,Ki,0,22,0,=,,,,17590335,N#Cc1cc(F)cc(c1)c1ccc2c(c1)nc(cc2)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 23 [PMID: 17590335],6444,,,178103060,Allosteric modulator,Negative,,f,,,pIC50,0,9.1,0,IC50,0,0.8,0,=,,,,17590335,N#Cc1cc(F)cc(c1)c1ccc2c(c1)nc(cc2)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 24d [PMID: 23357634],6366,,,178102984,Allosteric modulator,Negative,,f,,,pKi,0,7.52,0,Ki,0,30,0,=,,,,23357634,CC(=O)N[C@H]1CCC[C@@]2(C1)CN=C(O2)c1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 24d [PMID: 23357634],6366,,,178102984,Allosteric modulator,Negative,,f,,,pIC50,0,7.64,0,IC50,0,23,0,=,,,,23357634,CC(=O)N[C@H]1CCC[C@@]2(C1)CN=C(O2)c1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 24 [PMID: 23374867],6419,,,178103035,Allosteric modulator,Negative,,f,,,pIC50,0,7.72,0,IC50,0,19,0,=,,,,23374867,CCCc1cccc(n1)c1c(snc1c1ccc2c(c1)cn(n2)C)NC(=O)[C@@H]1C[C@H]1C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 26 [PMID: 16439120],6372,,,178102990,Allosteric modulator,Negative,,f,,,pKi,0,8,0,Ki,0,10,0,=,,,,16439120,N#Cc1cc(OCc2ccnc(c2)C)nc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 27 [PMID: 20598884],6437,,,178103053,Allosteric modulator,Negative,,f,,,pKi,0,6.69,0,Ki,0,206,0,=,,,,20598884,N#Cc1cc(F)cc(c1)C(=O)Nc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 27 [PMID: 20598884],6437,,,178103053,Allosteric modulator,Negative,,f,,,pIC50,0,7.35,0,IC50,0,45,0,=,,,,20598884,N#Cc1cc(F)cc(c1)C(=O)Nc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 29b [PMID: 20809633],6430,,,178103046,Allosteric modulator,Negative,,f,,,pKi,0,7.77,0,Ki,0,17,0,=,,,,20809633,C#Cc1cc(F)cc(c1)N1CCCc2c(C1)nc(o2)c1ccccn1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 29b [PMID: 20809633],6430,,,178103046,Allosteric modulator,Negative,,f,,,pIC50,0,7.8,0,IC50,0,16,0,=,,,,20809633,C#Cc1cc(F)cc(c1)N1CCCc2c(C1)nc(o2)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 30 [PMID: 21757343],6407,,,178103023,Allosteric modulator,Negative,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,21757343,Clc1cccc(c1)c1ncc(c(c1)C)[C@H]1CCCN1C(=O)c1nccs1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 30 [PMID: 21757343],6407,,,178103023,Allosteric modulator,Negative,,f,,,pIC50,0,7.77,0,IC50,0,17,0,=,,,,21757343,Clc1cccc(c1)c1ncc(c(c1)C)[C@H]1CCCN1C(=O)c1nccs1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 30 [PMID: 21757343],6407,,,178103023,Allosteric modulator,Negative,,f,,,pKi,0,7.92,0,Ki,0,12,0,=,,,,21757343,Clc1cccc(c1)c1ncc(c(c1)C)[C@H]1CCCN1C(=O)c1nccs1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 36 [PMID: 17936624],6445,,,178103061,Allosteric modulator,Negative,,f,,,pIC50,0,7.29,0,IC50,0,51.7,0,=,,,,17936624,COc1cc(OC)cc(c1)c1ncc2c(c1)nc(cc2)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 41 [PMID: 23434029],6420,,,178103036,Allosteric modulator,Negative,,f,,,pEC50,0,7.89,0,EC50,0,13,0,=,,,,23434029,Fc1ccc(cc1)n1c(C)nc(c1C)C(=O)Nc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 42 [PMID: 17189691],6446,,,178103062,Allosteric modulator,Negative,,f,,,pIC50,0,7.22,0,IC50,0,60,0,=,,,,17189691,O=C(C1CC=Cc2c1[nH]c(=O)o2)Nc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 42 [PMID: 17189691],6446,,,178103062,Allosteric modulator,Negative,,f,,,pKi,0,7.02,0,Ki,0,95,0,=,,,,17189691,O=C(C1CC=Cc2c1[nH]c(=O)o2)Nc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 53 [PMID: 23434029],6451,,,178103067,Allosteric modulator,Negative,,f,,,pIC50,0,7.4,0,IC50,0,40,0,=,,,,23434029,Clc1nccc(n1)NC(=O)c1nc(n(c1C)c1ccccc1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 8 [PMID: 15482908],6448,,,178103064,Allosteric modulator,Negative,,f,,,pKi,0,7.85,0,Ki,0,14,0,=,,,,15482908,N#Cc1cc(F)cc(c1)n1nnc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 8 [PMID: 15482908],6448,,,178103064,Allosteric modulator,Negative,,f,,,pIC50,0,8.41,0,IC50,0,3.9,0,=,,,,15482908,N#Cc1cc(F)cc(c1)n1nnc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 8 [PMID: 20598884],6436,,,178103052,Allosteric modulator,Negative,,f,,,pKi,0,6.99,0,Ki,0,102,0,=,,,,20598884,N#Cc1cc(F)cc(c1)C(=O)Nc1scc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,compound 8 [PMID: 20598884],6436,,,178103052,Allosteric modulator,Negative,,f,,,pIC50,0,7.23,0,IC50,0,59,0,=,,,,20598884,N#Cc1cc(F)cc(c1)C(=O)Nc1scc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,5-MPEP,1419,,,135649842,Allosteric modulator,Neutral,,f,,,pKi,0,6.4,0,,0,0,0,,,,,16155210,Cc1ccc(nc1)C#Cc1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,"3,3'-difluorobenzaldazine",1424,,,135650175,Allosteric modulator,Positive,,f,,,pIC50,8.5,0,5.6,-,0,0,0,=,,,,14747613,Fc1cccc(c1)/C=N/N=C/c1cccc(c1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,5PAM523,6414,,,178103030,Allosteric modulator,Positive,,f,,,pKi,0,5.7,0,Ki,0,2000,0,=,,,,23291536,Fc1ccc(cc1)C(=O)N1C[C@H](CC[C@H]1C)c1noc(n1)c1ccc(cn1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,5PAM523,6414,,,178103030,Allosteric modulator,Positive,,f,,,pEC50,0,6.51,0,EC50,0,311,0,=,,,,23291536,Fc1ccc(cc1)C(=O)N1C[C@H](CC[C@H]1C)c1noc(n1)c1ccc(cn1)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,5PAM523,6414,,,178103030,Allosteric modulator,Positive,,f,,,pEC50,0,6.7,0,EC50,0,201,0,=,,,,23291536,Fc1ccc(cc1)C(=O)N1C[C@H](CC[C@H]1C)c1noc(n1)c1ccc(cn1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,ADX-47273,1420,,,135649898,Allosteric modulator,Positive,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,0,Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1onc(n1)c1ccc(cc1)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,ADX-47273,1420,,,135649898,Allosteric modulator,Positive,,f,,,pEC50,0,6.8,0,EC50,0,157,0,=,,,,22884720,Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1onc(n1)c1ccc(cc1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,ADX-47273,1420,,,135649898,Allosteric modulator,Positive,,f,,,pKi,0,5.44,0,Ki,0,3650,0,=,,,,22884720,Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1onc(n1)c1ccc(cc1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,ADX-47273,1420,,,135649898,Allosteric modulator,Positive,,f,,,pEC50,0,7.26,0,EC50,0,55,0,=,,,,22884720,Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1onc(n1)c1ccc(cc1)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CDPPB,1422,,,135650062,Allosteric modulator,Positive,,f,,,pEC50,8,0,7.6,-,0,0,0,=,,,,15608073,N#Cc1cccc(c1)C(=O)Nc1cc(nn1c1ccccc1)c1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,CDPPB,1422,,,135650062,Allosteric modulator,Positive,,f,,,pEC50,0,7.7,0,,0,0,0,,,,,15537338,N#Cc1cccc(c1)C(=O)Nc1cc(nn1c1ccccc1)c1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,compound 47 [PMID: 21295468],6406,,,178103022,Allosteric modulator,Positive,,f,,,pEC50,0,7.3,0,EC50,0,50.1,0,=,,,,21295468,CN1CCOc2c1ncc(c2)COc1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,ACDPP,3388,,,178100405,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,-,0,0,0,=,,,,15686941,O=C(c1nc(Cl)c(nc1N)N(C)C)Nc1cccnc1
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,1-benzyl-APDC,1436,,,135649658,Agonist,Full agonist,,f,f,,pEC50,0,4.699999809,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1C[C@](CN1Cc1ccccc1)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pEC50,0,4.2,0,,0,0,0,,,,,0,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pEC50,0,4.7,0,,0,0,0,,,,,9144651,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,ACPT-I,1408,,,135649891,Agonist,Full agonist,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,0,OC(=O)[C@@H]1C[C@](C[C@@H]1C(=O)O)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,&alpha;-methylserine-O-phosphate,1398,,,135650668,Antagonist,Antagonist,,f,,,pEC50,0,4.1,0,,0,0,0,,,,,12769621,OC(=O)C(COP(=O)(O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,0,3.1,0,,0,0,0,,,,,11138847,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pKi,0,3,0,,0,0,0,,,,,11138847,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>7</sub> receptor,295,Grm7,P35400,,,,,,Rat,ADX71743,6217,,,178102838,Allosteric modulator,Negative,,f,,,pIC50,0,7.1,0,IC50,0,88,0,=,,,,23257312,CCc1nc2c(o1)CC(CC2=O)c1ccc(cc1C)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,ADX71743,6217,,,178102838,Allosteric modulator,Negative,,f,f,,pIC50,0,7.199999809,0,IC50,0,63,0,=,,,,23257312,CCc1nc2c(o1)CC(CC2=O)c1ccc(cc1C)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,AMN082,1441,,,135649940,Allosteric modulator,Positive,,f,,,pEC50,6.8,0,6.5,-,0,0,0,=,,,,16339898,C(NC(c1ccccc1)c1ccccc1)CNC(c1ccccc1)c1ccccc1
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,&alpha;-methylserine-O-phosphate,1398,,,135650668,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,11138847,OC(=O)C(COP(=O)(O)O)(N)C
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pEC50,0,4.3,0,,0,0,0,,,,,9016353,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,"(1<i>S</i>,3<i>R</i>)-ACPD",1365,,,135649666,Agonist,Full agonist,,f,,,pEC50,0,4.4,0,,0,0,0,,,,,9473604,OC(=O)[C@@H]1CC[C@@](C1)(N)C(=O)O
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,ACPT-I,1408,,,135649891,Agonist,Partial agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,10771029,OC(=O)[C@@H]1C[C@](C[C@@H]1C(=O)O)(N)C(=O)O
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,AZ12216052,6216,,,178102837,Allosteric modulator,Positive,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,,,,20385173,CCC(c1ccc(cc1)NC(=O)CSCc1ccc(cc1)Br)C
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,&alpha;-methylserine-O-phosphate,1398,,,135650668,Antagonist,Antagonist,,f,,,pIC50,0,5.3,0,,0,0,0,,,,,12769621,OC(=O)C(COP(=O)(O)O)(N)C
microtubule affinity regulating kinase 1,2097,MARK1,Q9P0L2,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,10786669,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
microtubule affinity regulating kinase 3,2099,MARK3,P27448,,,,,,Human,compound 17d [PMID: 23099093],8196,,,249565876,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,23099093,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1
Microtubule associated serine/threonine kinase 3,1512,MAST3,O60307,,,,,,Human,compound 35 [PMID: 23916259],8842,,,252827499,Inhibitor,Inhibition,,f,f,,pIC50,0,6.619999886,0,IC50,0,240,0,=,,,,23916259,OC1CCC(CC1)Nc1nc2ccc(cc2n2c1ncc2)C(=O)NC1(CC1)c1ccccc1
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,aldosterone,2872,,,135651432,Agonist,Agonist,,t,,,pIC50,10,0,9.8,-,0,0,0,=,,,,8282004,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C=O)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,AZD9567,9812,,,0,Agonist,Agonist,,f,f,,pIC50,0,4.420000076,0,IC50,0,38000,0,>,,,,29424542,CC([C@@H]([C@@H](c1ccccc1)OC1=CC2C(C=C1)N(N=C2)c1ccc(=O)n(c1)C)NC(=O)C(F)(F)C)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,benzodrocortisone,9731,,,0,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@]1(CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C)OC(=O)c1ccccc1
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,budesonide,7434,,,178104006,Agonist,Agonist,,f,f,,pEC50,0,7.849999905,0,EC50,0,14,0,=,,,,28937774,CCCC1O[C@H]2[C@](O1)(C(=O)CO)[C@@]1([C@@H](C2)[C@@H]2CCC3=CC(=O)C=C[C@@]3([C@H]2[C@H](C1)O)C)C
Mitochondrial adenine nucleotide translocator 1,1062,SLC25A4,P12235,,,,,,Human,bongkrek acid,4689,,,53801038,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CO[C@@H](/C(=C\C=C(\C(=O)O)/C)/C)C/C=C\C=C\CC/C=C/C[C@@H](/C=C/C(=C\C(=O)O)/CC(=O)O)C
Mitochondrial adenine nucleotide translocator 1,1062,SLC25A4,P12235,,,,,,Human,bongkrek acid,4689,,,53801038,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CO[C@@H](/C(=CC=C(C(=O)O)/C)/C)C/C=CC=CCC/C=C/C[C@@H](/C=C/C(=CC(=O)O)/CC(=O)O)C
Mitochondrial adenine nucleotide translocator 1,1062,SLC25A4,P12235,,,,,,Human,carboxyatractyloside,4572,,,178101293,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1O[C@@H](O[C@@H]2CC(C(=O)O)(C(=O)O)[C@@H]3[C@](C2)(C)[C@@H]2CC[C@@H]4C[C@@]2(CC3)[C@@H](O)C4=C)[C@@H]([C@H]([C@@H]1OS(=O)(=O)O)OS(=O)(=O)O)OC(=O)CC(C)C
Mitochondrial citrate transporter,1051,SLC25A1,P53007,,,,,,Human,"1,2,3-benzenetricarboxylic acid",4701,,,178101413,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1c(cccc1C(=O)O)C(=O)O
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,CHIR-99021,8014,,,249565694,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,12606497,N#Cc1ccc(nc1)NCCNc1ncc(c(n1)c1ccc(cc1Cl)Cl)c1ncc([nH]1)C
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,brimapitide,9101,,,315661186,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,~,Alphascreen kinase assay result,,,0,
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.019999981,0,IC50,0,95,0,=,,,,17292828,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,acumapimod,9203,,,315661279,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,<,,,,0,N#Cc1cccc(c1)C(=O)c1cnn(c1N)c1cc(ccc1C)C(=O)NC1CC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,AZD6703,7687,,,223366022,Inhibitor,Inhibition,,f,t,,pIC50,0,7.809999943,0,IC50,0,15.57999992,0,=,,,,22608965,CN1CCN(CC1)c1ccc2c(c1)c(=O)n(cn2)c1cc(ccc1C)C(=O)NC1CC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,BMS-582949,7838,,,223366169,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,20804198,CCCNC(=O)c1cn2c(c1C)c(ncn2)Nc1cc(ccc1C)C(=O)NC1CC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,CBS-3595,9610,,,340590240,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,<i>In vitro</i> determination.,,,28613871,CSc1nc(c(n1C)c1ccnc(c1)NC(=O)C)c1ccc(cc1)F
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,compound 12 [PMID: 22521646],8125,,,249565805,Inhibitor,Inhibition,,f,t,,pIC50,0,9.18999958,0,IC50,0,0.639999986,0,=,,,,22521646,Fc1cc(cc(c1C)c1ccn2c(c1)nnc2C1(C)CC1)C(=O)NC1CC1
mitogen-activated protein kinase 15,2090,MAPK15,Q8TD08,,,,,,Human,BS-194,8176,,,249565856,Inhibitor,Inhibition,,f,f,,pIC50,0,6.480000019,0,IC50,0,330,0,=,,,,21080703,OC[C@@H]([C@@H](CO)O)Nc1cc(NCc2ccccc2)n2c(n1)c(cn2)C(C)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,BIX02188,8064,,,249565744,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,810,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)N)/c1ccccc1)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,BIX02188,8064,,,249565744,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,810,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)N)/c1ccccc1)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,compound 35 [PMID: 23916259],8842,,,252827499,Inhibitor,Inhibition,,f,f,,pIC50,0,7.039999962,0,IC50,0,92,0,=,,,,23916259,OC1CCC(CC1)Nc1nc2ccc(cc2n2c1ncc2)C(=O)NC1(CC1)c1ccccc1
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,compound 16 [PMID: 17480064],8177,,,249565857,Inhibitor,Inhibition,,f,t,,pIC50,0,8.069999695,0,IC50,0,8.5,0,=,,,,17480064,O=C1NCCc2c1cc([nH]2)c1ccnc(c1)c1cnc2c(c1)cccc2
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,compound 16 [PMID: 18945615],8178,,,249565858,Inhibitor,Inhibition,,f,t,,pIC50,0,7.289999962,0,IC50,0,51,0,=,,,,18945615,O=c1[nH]cnc2c1cc([nH]2)c1ccnc(c1)/C=C/c1ccc(cc1)CN1CCOCC1
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,t,,pIC50,0,6.409999847,0,IC50,0,390,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,compound 8 [PMID: 17480064],8763,,,252827421,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,171,0,=,,,,17480064,O=C1NCCc2c1cc([nH]2)c1ccncc1
mitogen-activated protein kinase-activated protein kinase 3,2095,MAPKAPK3,Q16644,,,,,,Human,compound 16 [PMID: 17480064],8177,,,249565857,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,17480064,O=C1NCCc2c1cc([nH]2)c1ccnc(c1)c1cnc2c(c1)cccc2
mitogen-activated protein kinase-activated protein kinase 5,2096,MAPKAPK5,Q8IW41,,,,,,Human,compound 16 [PMID: 17480064],8177,,,249565857,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,810,0,=,,,,17480064,O=C1NCCc2c1cc([nH]2)c1ccnc(c1)c1cnc2c(c1)cccc2
mitogen-activated protein kinase-activated protein kinase 5,2096,MAPKAPK5,Q8IW41,,,,,,Human,compound 16 [PMID: 18945615],8178,,,249565858,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,18945615,O=c1[nH]cnc2c1cc([nH]2)c1ccnc(c1)/C=C/c1ccc(cc1)CN1CCOCC1
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,binimetinib,7921,,,249565604,Allosteric modulator,Negative,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,0,OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1F)Br)F
mitogen-activated protein kinase kinase 1,2062,,,,,,,,Rabbit,CI-1040,5676,,,178102303,Allosteric modulator,Negative,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,10998351,Ic1ccc(c(c1)Cl)Nc1c(ccc(c1F)F)C(=O)NOCC1CC1
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,CI-1040,5676,,,178102303,Allosteric modulator,Negative,,f,t,,pKd,0,6.920000076,0,Kd,0,120,0,=,,,,22037378,Ic1ccc(c(c1)Cl)Nc1c(ccc(c1F)F)C(=O)NOCC1CC1
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,cobimetinib,7626,,,223365961,Allosteric modulator,Negative,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,Biochemical assay measuring MEK-induced phosphorylation of ERK residues T202 and Y204.,,,0,Ic1ccc(c(c1)F)Nc1c(ccc(c1F)F)C(=O)N1CC(C1)(O)[C@@H]1CCCCN1
mitogen-activated protein kinase kinase 2,2063,MAP2K2,P36507,,,,,,Human,binimetinib,7921,,,249565604,Allosteric modulator,Negative,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,0,OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1F)Br)F
mitogen-activated protein kinase kinase 2,2063,MAP2K2,P36507,,,,,,Human,cobimetinib,7626,,,223365961,Allosteric modulator,Negative,,f,t,,pIC50,0,6.699999809,0,IC50,0,199,0,=,,,,0,Ic1ccc(c(c1)F)Nc1c(ccc(c1F)F)C(=O)N1CC(C1)(O)[C@@H]1CCCCN1
mitogen-activated protein kinase kinase 5,2066,MAP2K5,Q13163,,,,,,Human,BIX02188,8064,,,249565744,Inhibitor,Inhibition,,f,t,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)N)/c1ccccc1)C
mitogen-activated protein kinase kinase 5,2066,MAP2K5,Q13163,,,,,,Human,BIX02188,8064,,,249565744,Inhibitor,Inhibition,,f,t,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)N)/c1ccccc1)C
mitogen-activated protein kinase kinase 5,2066,MAP2K5,Q13163,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
mitogen-activated protein kinase kinase 5,2066,MAP2K5,Q13163,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
mitogen-activated protein kinase kinase 7,2068,MAP2K7,O14733,,,,,,Human,cobimetinib,7626,,,223365961,Allosteric modulator,Negative,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,0,Ic1ccc(c(c1)F)Nc1c(ccc(c1F)F)C(=O)N1CC(C1)(O)[C@@H]1CCCCN1
mitogen-activated protein kinase kinase kinase 10,2070,MAP3K10,Q02779,,,,,,Human,CEP-1374,8173,,,249565853,Inhibitor,Inhibition,,f,f,,pIC50,8.699999809,0,7.289999962,IC50,51,0,2,=,,,,24044867,CCSCc1ccc2c(c1)c1c3C(=O)NCc3c3c4c1n2[C@H]1C[C@]([C@](O1)(n4c1c3cc(cc1)CSCC)C)(O)C(=O)OC
mitogen-activated protein kinase kinase kinase 11,2071,MAP3K11,Q16584,,,,,,Human,CEP-1374,8173,,,249565853,Inhibitor,Inhibition,,f,f,,pIC50,8.220000267,0,7.639999866,IC50,23,0,6,=,,,,24044867,CCSCc1ccc2c(c1)c1c3C(=O)NCc3c3c4c1n2[C@H]1C[C@]([C@](O1)(n4c1c3cc(cc1)CSCC)C)(O)C(=O)OC
mitogen-activated protein kinase kinase kinase 11,2071,MAP3K11,Q16584,,,,,,Human,compound 8 [PMID: 24044867],8195,,,249565875,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,24044867,COc1cc(cc(c1OC)OC)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
mitogen-activated protein kinase kinase kinase 14,2074,MAP3K14,Q99558,,,,,,Human,compound 31 [PMID: 23374866],8174,,,249565854,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,23374866,COCCOc1cnc(nc1c1c[nH]c2c1cc(C#CC(O)(C)C)cc2)N
mitogen-activated protein kinase kinase kinase 19,2076,MAP3K19,Q56UN5,,,,,,Human,compound 1 [PMID: 24793884],8218,,,249565898,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,CCOC(=O)c1sc(nc1O)c1ccncc1
mitogen-activated protein kinase kinase kinase 3,2078,MAP3K3,Q99759,,,,,,Human,compound 5n [PMID: 20483621],8208,,,249565888,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,20483621,Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccnc(c1)N1CCNCC1)C(F)(F)F
mitogen-activated protein kinase kinase kinase 5,2080,MAP3K5,Q99683,,,,,,Human,compound 10 [PMID: 23147077],8133,,,249565813,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,23147077,O=C(c1ccc(cc1)C(C)(C)C)Nc1cn2c(n1)ccc(c2)n1cncc1
mitogen-activated protein kinase kinase kinase 6,2081,MAP3K6,O95382,,,,,,Human,compound 10 [PMID: 23147077],8133,,,249565813,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,510,0,=,,,,23147077,O=C(c1ccc(cc1)C(C)(C)C)Nc1cn2c(n1)ccc(c2)n1cncc1
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,5Z-7-oxozeaenol,8077,,,249565757,Inhibitor,Inhibition,,f,t,,pIC50,8.050000191,0,6.519999981,IC50,300,0,9,=,Assayed using TAK1/TAB1 (TAK1-binding protein 1) fusion protein for full enzymatic activity. Inhibition of kinase activity.,,,23272696,COc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@@H](OC(=O)c2c(c1)O)C
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,5Z-7-oxozeaenol,8077,,,249565757,Inhibitor,Inhibition,,f,t,,pIC50,8.050000191,0,6.519999981,IC50,300,0,9,=,Assayed using TAK1/TAB1 (TAK1-binding protein 1) fusion protein for full enzymatic activity. Inhibition of kinase activity.,,,23272696,COc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=CC[C@@H](OC(=O)c2c(c1)O)C
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,compound 12 [PMID: 27448772],9453,,,329968393,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,In a biochemical assay.,,,27448772,CN1CCN(CC1)C(=O)c1cccc(c1OC(C)C)NC(=O)c1csc2c1nc[nH]c2=O
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,compound 17d [PMID: 23099093],8196,,,249565876,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,23099093,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,compound 25 [PMID: 28038940],9700,,,348353659,Inhibitor,Inhibition,,f,f,,pIC50,0,8.619999886,0,IC50,0,2.400000095,0,=,In a biochemical enzyme activity assay.,,,28038940,COCCn1ncc(c1)Nc1ncc(c(n1)Oc1ccccc1NC(=O)C=C)Cl
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,compound 5 [PMID: 28038940],9699,,,348353658,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,In a biochemical enzyme activity assay.,,,28038940,C=CC(=O)Nc1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1)N1CCN(CC1)C
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,f,,pIC50,0,6.630000114,0,IC50,0,232,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,CEP-1374,8173,,,249565853,Inhibitor,Inhibition,,f,t,,pIC50,9,0,7.420000076,IC50,38,0,1,=,,,,24044867,CCSCc1ccc2c(c1)c1c3C(=O)NCc3c3c4c1n2[C@H]1C[C@]([C@](O1)(n4c1c3cc(cc1)CSCC)C)(O)C(=O)OC
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
mitogen-activated protein kinase kinase kinase kinase 2,2086,MAP4K2,Q12851,,,,,,Human,BAY 61-3606,9693,,,348353652,Inhibitor,Inhibition,,f,f,,pIC50,0,7.949999809,0,IC50,0,11.30000019,0,=,,,,22815993,COc1cc(ccc1OC)c1nc(Nc2ncccc2C(=O)N)n2c(c1)ncc2
mitogen-activated protein kinase kinase kinase kinase 3,2087,MAP4K3,Q8IVH8,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
mitogen-activated protein kinase kinase kinase kinase 4,2088,MAP4K4,O95819,,,,,,Human,compound 21 [PMID: 23312943],8135,,,249565815,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,23312943,CN(C1CCC(CC1)Nc1nc(ncc1c1onc(c1)C)Nc1cc(Cl)cc(c1)Cl)C
mitogen-activated protein kinase kinase kinase kinase 4,2088,MAP4K4,O95819,,,,,,Human,compound 26 [PMID: 24673130],8134,,,249565814,Inhibitor,Inhibition,,f,t,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,24673130,Fc1cccc(c1)c1ccc2c(n1)c(N)ncn2
mitogen-activated protein kinase kinase kinase kinase 5,2089,MAP4K5,Q9Y4K4,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
MMP1,1628,MMP1,P03956,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,7.25,0,IC50,0,56,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP1,1628,MMP1,P03956,,,,,,Human,cipemastat,6466,,,178103080,Inhibitor,Inhibition,,f,,,pKi,0,8.5,0,Ki,0,3,0,,,,,11890658,ONC(=O)[C@H]([C@H](C(=O)N1CCCCC1)CC1CCCC1)CN1C(=O)N(C(C1=O)(C)C)C
MMP10,1634,MMP10,P09238,,,,,,Human,CM-352,8259,,,249565939,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,25686022,ONC(=O)[C@]1(CCC2(C1)CCNCC2)S(=O)(=O)c1ccc(cc1)Oc1ccc(cc1)C(=O)NC
MMP11,1635,MMP11,P24347,,,,,,Human,compound 10 [PMID: 18790648],8665,,,252166865,Inhibitor,Inhibition,,f,t,,pKi,0,6.639999866,0,Ki,0,230,0,=,,,,18790648,COc1ccccc1SC[C@@H](C(=O)N[C@H](C(=O)N)Cc1c[nH]c2c1cccc2)CP(=O)([C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)O
MMP12,1636,MMP12,P39900,,,,,,Human,AZD1236,7844,,,223366174,Inhibitor,Inhibition,,f,t,,pIC50,0,8.210000038,0,IC50,0,6.099999905,0,=,,,,0,O=C1NC(=O)[C@@](N1)(C)CS(=O)(=O)N1CCC(CC1)Oc1ccc(cn1)Cl
MMP12,1636,MMP12,P39900,,,,,,Human,AZD6605,7823,,,223366154,Inhibitor,Inhibition,,f,t,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,,,,0,FC(C(Oc1ccc(cc1)OC1CCN(CC1)S(=O)(=O)C[C@@]1(C)NC(=O)NC1=O)(F)F)F
MMP12,1636,MMP12,P39900,,,,,,Human,compound 1 [PMID: 24900526],7870,,,249565575,Inhibitor,Inhibition,,f,t,,pIC50,0,6.539999962,0,IC50,0,290,0,=,,,,24900526,OC(=O)CNS(=O)(=O)c1ccc(cc1)c1ccccc1
MMP12,1636,MMP12,P39900,,,,,,Human,compound 20 [PMID: 22153340],6568,,,178103182,Inhibitor,Inhibition,,f,f,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,22153340,CC([C@@H](C(=O)O)NS(=O)(=O)c1ccc2c(c1)oc1c2cc(cc1)c1ccc(o1)C)C
MMP12,1636,MMP12,P39900,,,,,,Human,compound 5  [PMID: 24900526],7869,,,223366199,Inhibitor,Inhibition,This is the prodrug,f,f,,pIC50,0,4.889999866,0,IC50,0,13000,0,=,,,,24900526,COc1ccc(cc1)S(=O)(=O)N(C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1)CC(C)C)CC(=O)O
MMP13,1637,MMP13,P45452,,,,,,Human,AZD6605,7823,,,223366154,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,0,FC(C(Oc1ccc(cc1)OC1CCN(CC1)S(=O)(=O)C[C@@]1(C)NC(=O)NC1=O)(F)F)F
MMP13,1637,MMP13,P45452,,,,,,Human,CL82198,5170,,,178101860,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1cc2c(o1)cccc2)NCCCCN1CCOCC1
MMP13,1637,MMP13,P45452,,,,,,Human,compound 15 [PMID: 22017539],8636,,,252166836,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22017539,CCOC(=O)c1[nH]c2c(c1)cc(cc2)c1cc(nn1C)C(=O)NCc1ccc(cc1)C(=O)O
MMP13,1637,MMP13,P45452,,,,,,Human,compound 1 [PMID: 17935984],6526,,,178103140,Inhibitor,Inhibition,,f,f,,pIC50,0,9.199999809,0,IC50,0,0.600000024,0,=,,,,17935984,CCOCCC1(Oc2ccc(cc2)Oc2ccc(cc2)F)C(=O)NC(=O)NC1=O
MMP14,1638,MMP14,P50281,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP14,1638,MMP14,P50281,,,,,,Human,compound 29e [PMID: 23631440],8578,,,252166779,Inhibitor,Inhibition,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,23631440,S[C@H]1CN(C[C@@H]1NS(=O)(=O)c1ccc(cc1)Oc1ccccc1)C(=O)CCCCCNC(=O)C
MMP2,1629,MMP2,P08253,,,,,,Human,ARP100,5140,,,178101832,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,16483784,ONC(=O)CN(S(=O)(=O)c1ccc(cc1)c1ccccc1)OC(C)C
MMP2,1629,MMP2,P08253,,,,,,Human,AZD6605,7823,,,223366154,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,0,FC(C(Oc1ccc(cc1)OC1CCN(CC1)S(=O)(=O)C[C@@]1(C)NC(=O)NC1=O)(F)F)F
MMP2,1629,MMP2,P08253,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP25,1647,MMP25,Q9NPA2,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP3,1630,MMP3,P08254,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP3,1630,MMP3,P08254,,,,,,Human,CM-352,8259,,,249565939,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,25686022,ONC(=O)[C@]1(CCC2(C1)CCNCC2)S(=O)(=O)c1ccc(cc1)Oc1ccc(cc1)C(=O)NC
MMP8,1632,MMP8,P22894,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP9,1633,MMP9,P14780,,,,,,Human,andecaliximab,9510,,,329968449,Antibody,Binding,,f,t,,pIC50,0,9.659999847,0,IC50,0,0.217999995,0,=,,,,25961845,
MMP9,1633,MMP9,P14780,,,,,,Human,AZD1236,7844,,,223366174,Inhibitor,Inhibition,,f,t,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,0,O=C1NC(=O)[C@@](N1)(C)CS(=O)(=O)N1CCC(CC1)Oc1ccc(cn1)Cl
MMP9,1633,MMP9,P14780,,,,,,Human,AZD6605,7823,,,223366154,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,0,FC(C(Oc1ccc(cc1)OC1CCN(CC1)S(=O)(=O)C[C@@]1(C)NC(=O)NC1=O)(F)F)F
MMP9,1633,MMP9,P14780,,,,,,Human,CGS-27023A,8846,,,252827503,Inhibitor,Inhibition,,f,f,,pIC50,0,8.319999695,0,IC50,0,4.800000191,0,=,,,,21514700,ONC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)OC)Cc1cccnc1)C(C)C
MMP9,1633,MMP9,P14780,,,,,,Human,compound 1a [PMID: 15055993],6514,,,178103128,Inhibitor,Inhibition,,f,t,,pKi,0,10.19999981,0,Ki,0,0.059999999,0,=,,,,15055993,ONC(=O)[C@H]1[C@@H](O)[C@H](O)[C@H](CN1S(=O)(=O)c1ccc(cc1)Oc1ccccc1)O
MMP9,1633,MMP9,P14780,,,,,,Human,compound 29e [PMID: 23631440],8578,,,252166779,Inhibitor,Inhibition,,f,f,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,23631440,S[C@H]1CN(C[C@@H]1NS(=O)(=O)c1ccc(cc1)Oc1ccccc1)C(=O)CCCCCNC(=O)C
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,befloxatone,6637,,,178103250,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,10333983,COC[C@H]1CN(C(=O)O1)c1ccc(cc1)OCC[C@H](C(F)(F)F)O
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,clorgiline,6636,,,178103249,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,C#CCN(CCCOc1ccc(cc1Cl)Cl)C
Monocarboxylate transporter 1,988,SLC16A1,P53985,,,,,,Human,compound 30 [PMID: 16455256],8813,,,252827471,Inhibitor,Inhibition,Compound 30 is a channel blocker.,f,f,,pKi,0,8.319999695,0,Ki,0,4.800000191,0,=,,,,16455256,CC(Cn1c2sc(c(c2c(=O)n(c1=O)C)C(=O)N1CC[C@H](C1)O)Cc1ccnc2c1cccc2)C
Monocarboxylate transporter 2,990,SLC16A7,O60669,,,,,,Human,7ACC2,8818,,,252827475,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,24095010,CN(c1ccc2c(c1)oc(=O)c(c2)C(=O)O)Cc1ccccc1
motilin receptor,297,MLNR,O43193,,,,,,Human,alemcinal,1444,,,135649877,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,-,0,0,0,=,,,,15764739,CCN([C@H]1C[C@@H](C)O[C@H]([C@@H]1O)O[C@@H]1[C@@H](C)[C@H](O[C@@H]2O[C@@H](C)C[C@](C2)(C)OC)[C@@H](C)C(=O)O[C@@H]([C@@H]([C@@H]([C@H](C2=C(C[C@@]1(C)O2)C)C)O)C)CC)C
motilin receptor,297,MLNR,O43193,,,,,,Human,azithromycin,6510,,,178103124,Agonist,Full agonist,,f,,,pEC50,0,5.5,0,-,0,0,0,=,,,,23190027,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](CN([C@@H]([C@H]([C@]1(C)O)O)C)C)C)(C)O
motilin receptor,297,MLNR,O43193,,,,,,Human,"[Bpa<sup>1</sup>,Ile<sup>13</sup>]motilin (human)",1452,,,135652045,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11461914,
motilin receptor,297,MLNR,O43193,,,,,,Human,camicinal,4035,,,178100860,Agonist,Full agonist,,f,t,,pEC50,0,7.900000095,0,-,0,0,0,=,,,,19374732,C[C@@H]1NCCN(C1)Cc1ccc(cc1)CC(=O)N1CCC(CC1)Nc1cccc(c1)F
mPGES1,1377,PTGES,O14684,,,,,,Human,compound 30 [PMID: 15953724],8812,,,252827470,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,15953724,Clc1ccc(cc1)Cn1c(CC(C(=O)O)(C)C)c(c2c1ccc(c2)c1ccc(c(c1)F)c1ccccc1C)C
mPGES1,1377,PTGES,O14684,,,,,,Human,compound 39 [PMID: 23623673],8875,,,252827532,Inhibitor,Inhibition,,f,t,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,23623673,Fc1cccc(c1c1nc2c([nH]1)c(=O)[nH]c1c2ccc(c1)c1ccccc1)Cl
mPGES1,1377,PTGES,O14684,,,,,,Human,compound 44 [PMID: 19748780],8761,,,252827419,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,19748780,N#Cc1cc(F)cc(c1c1nc2c([nH]1)c1ccc(cc1c1c2ccc(c1)OCCC1CC1)CC(O)(C)C)C#N
mPGES1,1377,Ptges,,,,,,,Rat,compound III [PMID: 24045148],9709,,,348353668,Inhibitor,Inhibition,,f,f,,pIC50,0,6.050000191,0,IC50,0,900,0,=,<i>Vs.</i> recombinant rat mPGES-1.,,,24045148,O=C(C1CCN(CC1)c1nc2c(n1C(C)C)cc(c(c2)C)C)NC1CCCC1
mPGES1,1377,PTGES,O14684,,,,,,Human,compound III [PMID: 24045148],9709,,,348353668,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,<i>Vs.</i> recombinant human mPGES-1.,,,24045148,O=C(C1CCN(CC1)c1nc2c(n1C(C)C)cc(c(c2)C)C)NC1CCCC1
mPGES1,1377,PTGES,O14684,,,,,,Human,compound III [PMID: 24045148],9709,,,348353668,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,180,0,=,<i>Vs.</i> recombinant human mPGES-1.,,,0,O=C(C1CCN(CC1)c1nc2c(n1C(C)C)cc(c(c2)C)C)NC1CCCC1
mPGES1,1377,Ptges,,,,,,,Rat,compound III [PMID: 24045148],9709,,,348353668,Inhibitor,Inhibition,,f,f,,pIC50,0,6.039999962,0,IC50,0,920,0,=,<i>Vs.</i> recombinant rat mPGES-1.,,,0,O=C(C1CCN(CC1)c1nc2c(n1C(C)C)cc(c(c2)C)C)NC1CCCC1
mPGES2,1378,PTGES2,Q9H7Z7,,,,,,Human,compound 30 [PMID: 15953724],8812,,,252827470,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15953724,Clc1ccc(cc1)Cn1c(CC(C(=O)O)(C)C)c(c2c1ccc(c2)c1ccc(c(c1)F)c1ccccc1C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,cevimeline,9658,,,348353617,Agonist,Agonist,,f,f,,pKi,0,5.309999943,0,Ki,0,4850,0,=,Displacement of [<sup>3</sup>H]QNB from cloned receptor.,,,9399977,CC1SCC2(O1)CN1CCC2CC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AC-42,289,,,135649882,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,16207821,CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,(+)-aceclidine,286,,,135649887,Agonist,Full agonist,,f,,,pEC50,0,5.4,0,,0,0,0,,,,,8968358,CC(=O)O[C@@H]1C[NH+]2CCC1CC2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,0,5,0,,0,0,0,,,,,12235229,CC(=O)OCC[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,4.9,0,4.3,,0,0,0,,,,,7651370,CC(=O)OCC[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,arecaidine propargyl ester,295,,,135649955,Agonist,Full agonist,,f,f,,pKi,0,6.400000095,0,-,0,0,0,=,,,,9224827,CN1CC(=CCC1)C(=O)OCC#C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,arecoline,296,,,135652666,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9224827,COC(=O)C1=CCCN(C1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,bethanechol,297,,,135649988,Agonist,Full agonist,,f,f,,pKi,0,4,0,-,0,0,0,=,,,,9224827,CC(C[N+](C)(C)C)OC(=O)N
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,bethanechol,297,,,135649988,Agonist,Full agonist,,f,,,pKi,0,3.7,0,,0,0,0,,,,,2537406,CC(C[N+](C)(C)C)OC(=O)N
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,carbachol,298,,,135650055,Agonist,Full agonist,,f,,,pKi,0,3.9,0,,0,0,0,,,,,12235229,NC(=O)OCC[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,carbachol,298,,,135650055,Agonist,Full agonist,,f,f,,pKi,5.300000191,0,3.200000048,-,0,0,0,=,,,,9224827,NC(=O)OCC[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,(-)-aceclidine,288,,,135649886,Agonist,Partial agonist,,f,,,pEC50,0,5,0,,0,0,0,,,,,8968358,CC(=O)O[C@H]1C[NH+]2CCC1CC2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,arecoline,296,,,135652666,Agonist,Partial agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,2537406,COC(=O)C1=CCCN(C1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AZD6088,7822,,,223366153,Agonist,Partial agonist,,f,t,,pEC50,0,8.300000191,0,EC50,0,5,0,=,,,,0,CCOC(=O)N1CCC(CC1)(C)N1CCC(CC1)N1C(=O)N[C@@H]2[C@@H]1CCCC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AC-42,289,,,135649882,Allosteric modulator,Negative,,f,,,pKi,0,6.2,0,,0,0,0,,,,,16207821,CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,alcuronium,341,,,135652664,Allosteric modulator,Negative,,f,,,pKd,0,5,0,,0,0,0,,,,,9224827,C=CC[N+]12CC[C@@]34[C@@H]2C[C@@H](C(=CCO)C1)C1=CN2c5ccccc5[C@]56[C@@H]2C(=CN([C@H]31)c1c4cccc1)[C@H]1C[C@@H]6[N+](CC1=CCO)(CC5)CC=C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Neutral,,f,f,,pKd,0,4.5,0,-,0,0,0,=,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Neutral,,f,,,pKd,0,3.2,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,AC-260584,334,,,135649881,Allosteric modulator,Positive,,f,,,pIC50,0,5.9,0,,0,0,0,,,,,16959945,CCCCC1CCN(CC1)CCCN1C(=O)COc2c1ccc(c2)F
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,benzoquinazolinone 12,8549,,,252166750,Allosteric modulator,Positive,,f,f,,pKB,0,6.599999905,0,-,0,0,0,=,,,,25326383,O[C@H]1CCCC[C@@H]1n1cnc2c(c1=O)cc(c1c2cccc1)Cc1ccc(nc1)c1cnn(c1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,BQCA,5436,,,178102088,Allosteric modulator,Positive,,f,f,,pKB,4.800000191,0,4,-,0,0,0,=,,,,19717450,OC(=O)c1c(=O)[nH]c2c(c1Cc1ccccc1)cccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Positive,,f,f,,pKd,5.800000191,0,4.5,Kd,30000,0,1780,=,,,,9224827,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Positive,,f,f,,pKd,0,3.200000048,0,-,0,0,0,=,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,clozapine,38,,,135650115,Allosteric modulator,Positive,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,16959945,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,clozapine,38,,,135650115,Allosteric modulator,Positive,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,14595031,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,1325587,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,-,0,0,0,=,,,,1994002,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,aclidinium,7449,,,178104021,Antagonist,Antagonist,,f,f,,pIC50,0,9.850000381,0,IC50,0,0.140000001,0,=,Human M1 receptors expressed in CHO-K1 cells,,,19653626,O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AE9C90CB,8586,,,252166787,Antagonist,Antagonist,,f,f,,pKi,0,9.699999809,0,-,0,0,0,=,,,,20590605,CN(C(=O)C(c1ccccc1)(c1ccccc1)O)C[C@@H]1[C@H]2[C@@H]1CNC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AFDX384,3264,,,178100307,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,1994002,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,Alexa-488-telenzepine,8600,,,252166801,Antagonist,Antagonist,,f,f,,pKd,0,9.300000191,0,-,0,0,0,=,,,,20133736,O=C(c1ccc(c(c1)C(=O)[O-])c1c2ccc(c(c2oc2c1ccc(=[NH2+])c2S([O-])([O-])[O-])S([O-])([O-])[O-])N)NCCCCCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2[nH]c(=O)c2c1c(C)sc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,7.829999924,0,Ki,0,14.69999981,0,=,,,,8100134,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,AQ-RA 741,8584,,,252166785,Antagonist,Antagonist,,f,f,,pKi,7.5,0,7.199999809,-,0,0,0,=,,,,1994002,CCN(CCCCC1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,t,,pKi,9.600000381,0,8.5,-,0,0,0,=,,,,3443095,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,9.7,0,9,,0,0,0,,,,,12235229,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,benzatropine,7601,,,223365936,Antagonist,Antagonist,,f,f,,pKi,0,9.020000458,0,Ki,0,0.949999988,0,=,Displacement binding experiment using homogenised rat caudate putamen.,,,7562926,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,biperiden,7128,,,178103704,Antagonist,Antagonist,,f,t,,pKd,0,9.319999695,0,Kd,0,0.479999989,0,=,,,,1346637,OC(C1CC2CC1C=C2)(c1ccccc1)CCN1CCCCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,BODIPY-pirenzepine,8604,,,252166805,Antagonist,Antagonist,,f,f,,pKi,0,7,0,-,0,0,0,=,,,,19451648,O=C(CCc1ccc(n1B(F)F)/C=C/1\C=CC(=N1)c1cccs1)NCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,BODIPY-pirenzepine,8604,,,252166805,Antagonist,Antagonist,,f,f,,pKi,0,7,0,-,0,0,0,=,,,,19451648,O=C(CCc1ccc(n1B(F)F)/C=C/1C=CC(=N1)c1cccs1)NCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,cevimeline,9658,,,348353617,Agonist,Agonist,,f,f,,pKi,0,6.070000172,0,Ki,0,854,0,=,Displacement of [<sup>3</sup>H]QNB from cloned receptor.,,,9399977,CC1SCC2(O1)CN1CCC2CC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,(+)-aceclidine,286,,,135649887,Agonist,Full agonist,,f,,,pEC50,6.4,0,6.2,,0,0,0,,,,,8968358,CC(=O)O[C@@H]1C[NH+]2CCC1CC2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,0,6.4,0,,0,0,0,,,,,9454790,CC(=O)OCC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,6.5,0,4.3,,0,0,0,,,,,7651370,CC(=O)OCC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,arecaidine propargyl ester,295,,,135649955,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9224827,CN1CC(=CCC1)C(=O)OCC#C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,arecoline,296,,,135652666,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9224827,COC(=O)C1=CCCN(C1)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,bethanechol,297,,,135649988,Agonist,Full agonist,,f,t,,pKi,0,4,0,-,0,0,0,=,,,,9224827,CC(C[N+](C)(C)C)OC(=O)N
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,carbachol,298,,,135650055,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9454790,NC(=O)OCC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,carbachol,298,,,135650055,Agonist,Full agonist,,f,,,pKi,5.7,0,4.2,,0,0,0,,,,,12235229,NC(=O)OCC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,(-)-aceclidine,288,,,135649886,Agonist,Partial agonist,,f,,,pEC50,5.7,0,5.6,,0,0,0,,,,,8968358,CC(=O)O[C@H]1C[NH+]2CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,alcuronium,341,,,135652664,Allosteric modulator,Negative,,f,f,,pKd,6.900000095,0,6.099999905,-,0,0,0,=,,,,9224827,C=CC[N+]12CC[C@@]34[C@@H]2C[C@@H](C(=CCO)C1)C1=CN2c5ccccc5[C@]56[C@@H]2C(=CN([C@H]31)c1c4cccc1)[C@H]1C[C@@H]6[N+](CC1=CCO)(CC5)CC=C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Negative,,f,,,pKd,0,4.3,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Negative,,f,,,pKd,0,3.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Positive,,f,,,pKd,4.6,0,4.3,,0,0,0,,,,,9224827,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Positive,,f,,,pKd,0,3.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,f,,pKi,0,8.300000191,0,-,0,0,0,=,,,,9454790,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,1325587,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,aclidinium,7449,,,178104021,Antagonist,Antagonist,,f,f,,pIC50,0,9.770000458,0,IC50,0,0.170000002,0,=,,,,19653626,O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,AE9C90CB,8586,,,252166787,Antagonist,Antagonist,,f,f,,pKi,0,8.600000381,0,-,0,0,0,=,,,,20590605,CN(C(=O)C(c1ccccc1)(c1ccccc1)O)C[C@@H]1[C@H]2[C@@H]1CNC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,AFDX384,3264,,,178100307,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,-,0,0,0,=,,,,1994002,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,Alexa-488-telenzepine,8600,,,252166801,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,23357106,O=C(c1ccc(c(c1)C(=O)[O-])c1c2ccc(c(c2oc2c1ccc(=[NH2+])c2S([O-])([O-])[O-])S([O-])([O-])[O-])N)NCCCCCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2[nH]c(=O)c2c1c(C)sc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,7.929999828,0,Ki,0,11.80000019,0,=,,,,8100134,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,AQ-RA 741,8584,,,252166785,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,-,0,0,0,=,,,,1994002,CCN(CCCCC1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,t,,pKi,9.199999809,0,7.800000191,-,0,0,0,=,,,,3443095,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,9.1,0,9,,0,0,0,,,,,1325587,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,benzatropine,7601,,,223365936,Antagonist,Antagonist,,f,f,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,Displacement binding assay using homogenised rat caudate putamen.,,,7562926,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,biperiden,7128,,,178103704,Antagonist,Antagonist,,f,f,,pKd,0,8.199999809,0,Kd,0,6.300000191,0,=,,,,1346637,OC(C1CC2CC1C=C2)(c1ccccc1)CCN1CCCCC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,cevimeline,9658,,,348353617,Agonist,Agonist,,f,f,,pKi,0,5.590000153,0,Ki,0,2575,0,=,Displacement of [<sup>3</sup>H]QNB from cloned receptor.,,,9399977,CC1SCC2(O1)CN1CCC2CC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,(+)-aceclidine,286,,,135649887,Agonist,Full agonist,,f,,,pEC50,0,5.7,0,,0,0,0,,,,,8968358,CC(=O)O[C@@H]1C[NH+]2CCC1CC2
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,0,5.6,0,,0,0,0,,,,,12235229,CC(=O)OCC[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,5.4,0,4.5,,0,0,0,,,,,7651370,CC(=O)OCC[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,arecaidine propargyl ester,295,,,135649955,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9224827,CN1CC(=CCC1)C(=O)OCC#C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,arecoline,296,,,135652666,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,9224827,COC(=O)C1=CCCN(C1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,bethanechol,297,,,135649988,Agonist,Full agonist,,f,t,,pKi,0,4.199999809,0,-,0,0,0,=,,,,9224827,CC(C[N+](C)(C)C)OC(=O)N
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,carbachol,298,,,135650055,Agonist,Full agonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,12235229,NC(=O)OCC[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,carbachol,298,,,135650055,Agonist,Full agonist,,f,t,,pKi,4.400000095,0,4,-,0,0,0,=,,,,12235229,NC(=O)OCC[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,(-)-aceclidine,288,,,135649886,Agonist,Partial agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,8968358,CC(=O)O[C@H]1C[NH+]2CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,alcuronium,341,,,135652664,Allosteric modulator,Negative,,f,,,pKd,0,5.8,0,,0,0,0,,,,,9224827,C=CC[N+]12CC[C@@]34[C@@H]2C[C@@H](C(=CCO)C1)C1=CN2c5ccccc5[C@]56[C@@H]2C(=CN([C@H]31)c1c4cccc1)[C@H]1C[C@@H]6[N+](CC1=CCO)(CC5)CC=C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Negative,,f,,,pKd,4,0,3.6,,0,0,0,,,,,9224827,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Neutral,,f,,,pKd,0,2.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Positive,,f,,,pKd,0,2.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,-,0,0,0,=,,,,1325587,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,-,0,0,0,=,,,,1994002,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,aclidinium,7449,,,178104021,Antagonist,Antagonist,,f,t,,pIC50,0,9.770000458,0,IC50,0,0.170000002,0,=,,,,19653626,O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,AE9C90CB,8586,,,252166787,Antagonist,Antagonist,,f,f,,pKi,0,9.899999619,0,-,0,0,0,=,,,,20590605,CN(C(=O)C(c1ccccc1)(c1ccccc1)O)C[C@@H]1[C@H]2[C@@H]1CNC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,AFDX384,3264,,,178100307,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,-,0,0,0,=,,,,1994002,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,7.889999866,0,Ki,0,12.80000019,0,=,,,,8100134,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,AQ-RA 741,8584,,,252166785,Antagonist,Antagonist,,f,f,,pKi,7.300000191,0,7.199999809,-,0,0,0,=,,,,1994002,CCN(CCCCC1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,t,,pKi,9.800000191,0,8.899999619,-,0,0,0,=,,,,3443095,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,9.3,0,8.7,,0,0,0,,,,,12235229,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,biperiden,7128,,,178103704,Antagonist,Antagonist,,f,f,,pKd,0,8.409999847,0,Kd,0,3.900000095,0,=,,,,1346637,OC(C1CC2CC1C=C2)(c1ccccc1)CCN1CCCCC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,clidinium,366,,,135650108,Antagonist,Antagonist,,f,t,,pKi,0,9.600000381,0,-,0,0,0,=,,,,16847442,O=C(C(c1ccccc1)(c1ccccc1)O)OC1C[N+]2(C)CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,cevimeline,9658,,,348353617,Agonist,Agonist,,f,f,,pKi,0,5.989999771,0,Ki,0,1012,0,=,Displacement of [<sup>3</sup>H]QNB from cloned receptor.,,,9399977,CC1SCC2(O1)CN1CCC2CC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,(+)-aceclidine,286,,,135649887,Agonist,Full agonist,,f,,,pEC50,0,5.4,0,,0,0,0,,,,,8968358,CC(=O)O[C@@H]1C[NH+]2CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,5.6,0,4.5,,0,0,0,,,,,7651370,CC(=O)OCC[N+](C)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,arecaidine propargyl ester,295,,,135649955,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9224827,CN1CC(=CCC1)C(=O)OCC#C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,arecoline,296,,,135652666,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9224827,COC(=O)C1=CCCN(C1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,bethanechol,297,,,135649988,Agonist,Full agonist,,f,f,,pKi,0,4,0,-,0,0,0,=,,,,9224827,CC(C[N+](C)(C)C)OC(=O)N
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,carbachol,298,,,135650055,Agonist,Full agonist,,f,f,,pKi,4.900000095,0,4.300000191,-,0,0,0,=,,,,9224827,NC(=O)OCC[N+](C)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,(-)-aceclidine,288,,,135649886,Agonist,Partial agonist,,f,,,pEC50,0,4.8,0,,0,0,0,,,,,8968358,CC(=O)O[C@H]1C[NH+]2CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,alcuronium,341,,,135652664,Allosteric modulator,Negative,,f,,,pKd,0,5.6,0,,0,0,0,,,,,9224827,C=CC[N+]12CC[C@@]34[C@@H]2C[C@@H](C(=CCO)C1)C1=CN2c5ccccc5[C@]56[C@@H]2C(=CN([C@H]31)c1c4cccc1)[C@H]1C[C@@H]6[N+](CC1=CCO)(CC5)CC=C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Negative,,f,,,pKd,6,0,4.7,,0,0,0,,,,,9224827,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Neutral,,f,,,pKd,0,3.6,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Positive,,f,,,pKd,0,3.6,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,1325587,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,1994002,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,AE9C90CB,8586,,,252166787,Antagonist,Antagonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,20590605,CN(C(=O)C(c1ccccc1)(c1ccccc1)O)C[C@@H]1[C@H]2[C@@H]1CNC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,AFDX384,3264,,,178100307,Antagonist,Antagonist,,f,,,pKi,0,8,0,-,0,0,0,=,,,,1994002,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,8.140000343,0,Ki,0,7.199999809,0,=,,,,8100134,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,AQ-RA 741,8584,,,252166785,Antagonist,Antagonist,,f,f,,pKi,8.199999809,0,7.800000191,-,0,0,0,=,,,,1994002,CCN(CCCCC1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,9.5,0,8.7,,0,0,0,,,,,3443095,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,1325587,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,biperiden,7128,,,178103704,Antagonist,Antagonist,,f,f,,pKd,0,8.619999886,0,Kd,0,2.400000095,0,=,,,,1346637,OC(C1CC2CC1C=C2)(c1ccccc1)CCN1CCCCC1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,(+)-aceclidine,286,,,135649887,Agonist,Full agonist,,f,,,pEC50,0,5.5,0,,0,0,0,,,,,8968358,CC(=O)O[C@@H]1C[NH+]2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,acetylcholine,294,,,135651424,Agonist,Full agonist,,t,,,pKi,0,6.1,0,,0,0,0,,,,,12235229,CC(=O)OCC[N+](C)(C)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,carbachol,298,,,135650055,Agonist,Full agonist,,f,f,,pKi,0,4.900000095,0,-,0,0,0,=,,,,10323594,NC(=O)OCC[N+](C)(C)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,(-)-aceclidine,288,,,135649886,Agonist,Partial agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,8968358,CC(=O)O[C@H]1C[NH+]2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,brucine,342,,,135652672,Allosteric modulator,Negative,,f,,,pKd,0,2.9,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CCN2[C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Negative,,f,,,pKd,0,2.3,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,brucine <i>N</i>-oxide,343,,,135650027,Allosteric modulator,Positive,,f,,,pKd,0,2.3,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N@@+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)[O-]
M<sub>5</sub> receptor,17,Chrm5,P08911,,,,,,Rat,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,1325587,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,4-DAMP,307,,,135649797,Antagonist,Antagonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,1994002,O=C(C(c1ccccc1)c1ccccc1)OC1CC[N+](CC1)(C)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,AE9C90CB,8586,,,252166787,Antagonist,Antagonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,20590605,CN(C(=O)C(c1ccccc1)(c1ccccc1)O)C[C@@H]1[C@H]2[C@@H]1CNC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,AFDX384,3264,,,178100307,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,-,0,0,0,=,,,,1994002,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,amitriptyline,200,,,135649939,Antagonist,Antagonist,,f,t,,pKi,0,7.800000191,0,Ki,0,15.69999981,0,=,,,,8100134,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,AQ-RA 741,8584,,,252166785,Antagonist,Antagonist,,f,f,,pKi,7.800000191,0,6.099999905,-,0,0,0,=,,,,1994002,CCN(CCCCC1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>5</sub> receptor,17,Chrm5,P08911,,,,,,Rat,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,1325587,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,atropine,320,,,135652667,Antagonist,Antagonist,,f,,,pKi,9.7,0,9.3,,0,0,0,,,,,2704370,OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,biperiden,7128,,,178103704,Antagonist,Antagonist,,f,f,,pKd,0,8.199999809,0,Kd,0,6.300000191,0,=,,,,1346637,OC(C1CC2CC1C=C2)(c1ccccc1)CCN1CCCCC1
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,2-iodo-melatonin,1343,,,135651396,Agonist,Full agonist,,f,f,,pKi,11,0,10.19999981,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)I
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,"2-methoxy-&alpha;,&beta;-didehydro-agomelatine",7775,,,223366108,Agonist,Full agonist,,f,f,,pKi,0,10.5,0,Ki,0,0.029999999,0,=,,,,23265885,COc1ccc2c(c1/C=C/NC(=O)C)cc(cc2)OC
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,2-[<sup>125</sup>I]melatonin,1344,,,135651404,Agonist,Full agonist,,f,,,pKd,10.7,0,9.9,Kd,0.119,0,0.0213,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)[125I]
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,5-HEAT,1345,,,135649834,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11068946,OCCOc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,6-Cl-MLT,1346,,,135649846,Agonist,Full agonist,,f,f,,pKi,9.199999809,0,7.900000095,-,0,0,0,=,,,,12764576,COc1cc2c(CCNC(=O)C)c[nH]c2cc1Cl
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,6-hydroxymelatonin,1347,,,135649850,Agonist,Full agonist,,f,f,,pKi,9.199999809,0,8.899999619,-,0,0,0,=,,,,10696085,COc1cc2c(CCNC(=O)C)c[nH]c2cc1O
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,agomelatine,198,,,135649906,Agonist,Full agonist,,f,t,,pKi,10.39999962,0,10,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)ccc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,AAE-M-PBP-amine,8289,,,252166501,Agonist,Partial agonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,22927210,CC(=O)NCCN(c1cccc(c1)OCCCCc1ccccc1)C
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,CBOBNEA,7778,,,223366111,Agonist,Partial agonist,,f,f,,pKi,0,9.300000191,0,Ki,0,0.550000012,0,=,,,,20444610,CC(=O)NCCc1cccc2c1cc(OCCCCOc1ccc(cc1)c1ccc(cc1)C(=O)O)cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,4P-PDOT,1358,,,135649804,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.2,,0,0,0,,,,,12764576,CCC(=O)NC1Cc2ccccc2C(C1)c1ccccc1
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,AZD7325,7712,,,223366045,Antagonist,Antagonist,,f,f,,pIC50,0,6.900000095,0,IC50,0,126,0,=,,,,0,CCCNC(=O)c1nnc2c(c1N)cccc2c1c(F)cccc1OC
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,2-iodo-melatonin,1343,,,135651396,Agonist,Full agonist,,f,f,,pKi,10.30000019,0,9.699999809,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)I
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,2-[<sup>125</sup>I]melatonin,1344,,,135651404,Agonist,Full agonist,,f,,,pKd,10,0,9.7,Kd,0.186,0,0.107,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)[125I]
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,6-Cl-MLT,1346,,,135649846,Agonist,Full agonist,,f,f,,pKi,9.800000191,0,9.399999619,-,0,0,0,=,,,,12764576,COc1cc2c(CCNC(=O)C)c[nH]c2cc1Cl
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,6-hydroxymelatonin,1347,,,135649850,Agonist,Full agonist,,f,f,,pKi,8.800000191,0,8.300000191,-,0,0,0,=,,,,10696085,COc1cc2c(CCNC(=O)C)c[nH]c2cc1O
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,agomelatine,198,,,135649906,Agonist,Full agonist,,f,t,,pKi,10.5,0,9.899999619,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)ccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,BOMPPA,7924,,,249565607,Agonist,Full agonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,23228808,CCC(=O)NCCCc1cc(OC)ccc1Cc1cccc(c1)OC
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,CIFEA,7780,,,223366113,Agonist,Full agonist,,f,f,,pKi,0,10.89999962,0,-,0,0,0,=,,,,21473625,CC(=O)NCCC1=C(CC2CCCCC2)Cc2c1c1CCOc1cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,5-methoxy-luzindole,1364,,,135649838,Agonist,Partial agonist,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,9089668,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)Cc1ccccc1
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,2-(indolin-1yl)-melatonin,7782,,,223366115,Antagonist,Antagonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,19193160,COc1ccc2c(c1)c(CCNC(=O)C)c([nH]2)CN1CCc2c1cccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,4P-PDOT,1358,,,135649804,Antagonist,Antagonist,,f,f,,pKi,9.409999847,0,8.800000191,Ki,1.580000043,0,0.389999986,=,,,,12764576,CCC(=O)NC1Cc2ccccc2C(C1)c1ccccc1
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,5-HEAT,1345,,,135649834,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,11068946,OCCOc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
Multidrug and toxin extrusion,1216,SLC47A1,Q96FL8,,,,,,Human,cimetidine,1231,,,135650099,Inhibitor,Inhibition,,f,,,pKi,0,6,0,Ki,0,1100,0,=,,,,19164462,N#CNC(=NC)NCCSCc1nc[nH]c1C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,ADL5747,9003,,,310264781,Agonist,Agonist,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,19694468,CCN(C(=O)c1ccc(c(c1)O)C1=CC2(CCNCC2)Oc2c1cccc2)CC
&mu; receptor,319,OPRM1,P35372,,,,,,Human,ADL5859,9004,,,310264782,Agonist,Agonist,,f,f,,pKi,0,7.489999771,0,Ki,0,32,0,=,,,,18788723,CCN(C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2c1c(O)ccc2)CC
&mu; receptor,319,OPRM1,P35372,,,,,,Human,AR-M1000390,9005,,,310264783,Agonist,Agonist,,f,f,,pIC50,0,5.420000076,0,IC50,0,3800,0,=,,,,0,CCN(C(=O)c1ccc(cc1)C(=C1CCNCC1)c1ccccc1)CC
&mu; receptor,319,,,,,,,,Guinea pig,BU72,9363,,,328083465,Agonist,Agonist,,f,f,,pIC50,0,9.819999695,0,IC50,0,0.150000006,0,=,Measuring displacement of [<sup>3</sup>H]DAMGO from brain membranes isolated from Hartley guinea pigs.,,,0,CO[C@@]12C=C[C@@]34[C@@]5([C@@H]1N[C@H]([C@]2(C)C3)c1ccccc1)CCN(C4Cc1c5cc(O)cc1)C
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,BW373U86,9002,,,310264780,Agonist,Agonist,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,8246159,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BW373U86,9002,,,310264780,Agonist,Agonist,,f,f,,pKi,0,6.590000153,0,Ki,0,260,0,=,,,,18788723,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)O)c1ccc(cc1)C(=O)N(CC)CC
&mu; receptor,319,OPRM1,P35372,,,,,,Human,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,8.619999886,0,Ki,0,2.400000095,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,compound 3 [PMID: 23134120],9190,,,315661269,Agonist,Agonist,,f,f,,pKi,0,6.079999924,0,Ki,0,826,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CC1)CCc1ccccc1
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,&beta;-endorphin,1643,POMC,Human,135651630,Agonist,Full agonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,8114680,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,codeine,1673,,,135650117,Agonist,Full agonist,,f,t,,pKi,0,6.900000095,0,-,0,0,0,=,,,,9686407,COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BU08028,9294,,,318164813,Agonist,Partial agonist,,f,f,,pKi,0,8.670000076,0,Ki,0,2.140000105,0,=,,,,21177476,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(CC)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,buprenorphine,1670,,,135652673,Agonist,Partial agonist,,f,t,,pKi,0,8.800000191,0,-,0,0,0,=,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(C)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,butorphanol,7591,,,223365926,Agonist,Partial agonist,,f,t,,pKi,0,9.920000076,0,Ki,0,0.119999997,0,=,Displacement of [<sup>3H</sup>]DAMGO from human &mu; opioid receptor expressed in CHO cells.,,,18674902,Oc1ccc2c(c1)[C@]13CCCC[C@]3([C@@H](C2)N(CC1)CC1CCC1)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986123,9159,,,315661242,Allosteric modulator,Neutral,,f,f,,pKB,0,6,0,KB,0,1000,0,=,,,,23754417,COc1ccc(cc1N(O)[O])C1SCCN1S(=O)(=O)c1ccc(cc1)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986124,9160,,,315661243,Allosteric modulator,Neutral,,f,f,,pKB,0,5.699999809,0,KB,0,2000,0,=,,,,23754417,COc1cc(Br)ccc1C1SCCN1S(=O)(=O)c1ccc(cc1)Cl
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986121,9156,,,315661240,Allosteric modulator,Positive,,f,f,,pKB,0,5.699999809,0,KB,0,2000,0,=,,,,23754417,Clc1cccc(c1Nc1scc(n1)c1ccc(cc1)N(O)[O])Cl
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986121,9156,,,315661240,Allosteric modulator,Positive,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,23754417,Clc1cccc(c1Nc1scc(n1)c1ccc(cc1)N(O)[O])Cl
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986122,9157,,,315661241,Allosteric modulator,Positive,,f,f,,pEC50,0,5.519999981,0,EC50,0,3000,0,=,,,,23754417,COc1ccc(cc1Br)C1SCCN1S(=O)(=O)c1ccc(cc1)Cl
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BMS-986122,9157,,,315661241,Allosteric modulator,Positive,,f,f,,pKB,0,5.300000191,0,KB,0,5000,0,=,,,,23754417,COc1ccc(cc1Br)C1SCCN1S(=O)(=O)c1ccc(cc1)Cl
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,BMS-986187,9748,,,0,Allosteric modulator,Positive,"In the presence of 10 M BMS-986187, the affinity of the -OR agonist DAMGO was enhanced 11-fold from 724 nM to 63 nM.",f,f,,pKi,0,7.199999809,0,Ki,0,63,0,=,,,,29233847,O=C1CC(C)(C)CC2=C1C(c1ccc(cc1)OCc1ccccc1C)C1=C(O2)CC(CC1=O)(C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,alvimopan,7471,,,187051774,Antagonist,Antagonist,,f,t,,pKi,0,9.329999924,0,Ki,0,0.469999999,0,=,,,,18313920,OC(=O)CNC(=O)[C@@H](Cc1ccccc1)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,AT-076,8870,,,252827527,Antagonist,Antagonist,,f,f,,pKi,0,8.779999733,0,Ki,0,1.669999957,0,=,Radioligand binding assay,,,9686407,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CCC(CC1)c1cccc(c1)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,&beta;-FNA,1631,,,135649986,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9686407,COC(=O)/C=C/C(=O)N[C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,&beta;-FNA,1631,,,135649986,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,8114680,COC(=O)/C=C/C(=O)N[C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9686407,O=C1/C(=C\c2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,BNTX,1634,,,135650013,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9686407,O=C1/C(=Cc2ccccc2)/C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,(-)-bremazocine,1603,,,135650021,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,9686407,CC[C@]12CCN([C@@H](C2(C)C)Cc2c1cc(O)cc2)CC1(O)CC1
muscle associated receptor tyrosine kinase,1847,MUSK,O15146,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,f,,pIC50,0,6.650000095,0,IC50,0,224,0,=,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
muscle associated receptor tyrosine kinase,1847,MUSK,O15146,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.78000021,0,Ki,0,1650,0,=,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
myeloperoxidase,2789,MPO,P05164,,,,,,Human,AZD5904,7728,,,223366061,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,200,0,=,Inhibition of the chlorination activity of MPO,,,21880720,O=c1[nH]c(=S)n(c2c1[nH]cn2)C[C@H]1CCCO1
myeloperoxidase,2789,MPO,P05164,,,,,,Human,compound 28 [PMID: 28671460],9670,,,348353629,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,28671460,COc1ccc2c(c1)nc(nc2C)N=C(N)N
myosin light chain kinase,1552,MYLK,Q15746,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,156362,
myosin light chain kinase 2,1553,MYLK2,Q9H1R3,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,156362,
Na-Cl symporter,970,SLC12A3,P55017,,,,,,Human,chlorothiazide,4835,,,178101537,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cc2NC=NS(=O)(=O)c2cc1S(=O)(=O)N
Na<sub>vi</sub>2.1,750,NALCN,Q8IZF0,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,,pIC50,0,3.8,0,IC50,0,150000,0,,,,,0,
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,batrachotoxin,2619,,,135652668,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,6.400000095,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,8.199999809,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,6.5,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,cangitoxin II,7568,,,223365904,Gating inhibitor,Slows inactivation,Inhibits inactivation,f,f,,pEC50,0,6.800000191,0,EC50,0,165,0,=,hole-cell voltage clamp of human Na<sub>v</sub>1.1 expressed in human embryonic kidney cell line HEK293.,,,21802465,
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,batrachotoxin,2619,,,135652668,Activator,Agonist,,f,f,,pKd,0,9.100000381,0,Kd,0,0.79400003,0,=,,,,9811906,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,aconitine,2617,,,135652663,Activator,Partial agonist,,f,f,,pKd,0,5.900000095,0,-,0,0,0,=,,,,6114956,COC[C@@]12CN(CC)C3[C@]4([C@@H]2[C@@H](OC)[C@@H]3[C@@]2([C@@H]3[C@H]4C[C@@]([C@@H]3OC(=O)c3ccccc3)([C@H]([C@@H]2O)OC)O)OC(=O)C)[C@H](C[C@H]1O)OC
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,&beta;-scorpion toxin Css IV,2620,,,135652018,Activator,Partial agonist,,f,,,pKd,0,9.7,0,,0,0,0,,,,,9808476,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,5.699999809,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,&alpha;-scorpion toxin 2,2618,,,135651986,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pKd,0,8.699999809,0,-,0,0,0,=,,,,8663157,
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,&alpha;-scorpion toxin 2,2618,,,135651986,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,9.100000381,0,-,0,0,0,=,,,,14978247,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,8.100000381,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,5.800000191,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,batrachotoxin,2619,,,135652668,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6.099999905,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,5.800000191,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,&beta;-scorpion toxin TiTX&gamma;,2627,,,135652019,Activator,Agonist,,f,,0.05,-,0,0,0,,0,0,0,,,,,9048656,
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,batrachotoxin,2619,,,135652668,Activator,Full agonist,,f,f,5,-,0,0,0,-,0,0,0,=,,,,9482942,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,7.5,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,,f,f,,pEC50,7.300000191,0,7,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6.099999905,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,batrachotoxin,2619,,,135652668,Activator,Full agonist,,f,f,,pKd,0,7.599999905,0,Kd,0,25.10000038,0,=,,,,2431264,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,aconitine,2617,,,135652663,Activator,Partial agonist,,f,f,30-100,-,0,0,0,-,0,0,0,=,,,,11826163,COC[C@@]12CN(CC)C3[C@]4([C@@H]2[C@@H](OC)[C@@H]3[C@@]2([C@@H]3[C@H]4C[C@@]([C@@H]3OC(=O)c3ccccc3)([C@H]([C@@H]2O)OC)O)OC(=O)C)[C@H](C[C@H]1O)OC
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,amiodarone,2566,,,135649937,Channel blocker,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,2546697,CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,bupivacaine,2397,,,135650032,Channel blocker,Pore blocker,Blockade of inactivated channel,f,f,,pIC50,0,5.659999847,0,IC50,0,2180,0,=,,,,25692452,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,bupivacaine,2397,,,135650032,Channel blocker,Pore blocker,Open-channel block,f,f,,pIC50,0,4.159999847,0,IC50,0,69500,0,=,,,,25692452,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,7.199999809,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,&alpha;-scorpion toxin 2,2618,,,135651986,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pKd,0,7.699999809,0,-,0,0,0,=,,,,8663157,
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,7.300000191,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,6.5,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,batrachotoxin,2619,,,135652668,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,&beta;-scorpion toxin Cn2,2632,,,135652017,Activator,None,,f,,0.3-0.01,-,0,0,0,,0,0,0,,,,,16702217,
Na<sub>v</sub>1.6,583,Scn8a,Q9WTU3,,,,,,Mouse,"4,9-anhydro-tetrodotoxin",5730,,,178102356,Channel blocker,Inhibition,,f,,,pIC50,0,7.8,0,-,0,0,0,=,,,,17522141,OCC1(O)C2OC3(OC1C1C4(C2O)C3OC1NC(=[NH2+])N4)O
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,AFT-II,2613,,,135651976,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6.5,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,ATX-II,2614,,,135652003,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6.699999809,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,Bc-III,2615,,,135652013,Gating inhibitor,Slows inactivation,,f,f,,pEC50,0,6,0,-,0,0,0,=,,,,15169781,
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,batrachotoxin,2619,,,135652668,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Pore blocker,,f,f,,pIC50,0,3,0,-,0,0,0,=,,,,7720699,
Na<sub>v</sub>1.8,585,SCN10A,Q9Y5Y9,,,,,,Human,batrachotoxin,2619,,,135652668,Activator,None,,f,,510,-,0,0,0,,0,0,0,,,,,15527793,CN1CCO[C@@]23[C@](C1)(C[C@@H](O)[C@]14C3=CC[C@H]3[C@]4(C)CC[C@](O1)(O)C3)C(=CC2)[C@@H](OC(=O)c1c(C)c[nH]c1C)C
Na<sub>v</sub>1.8,585,Scn10a,Q62968,,,,,,Rat,A-803467,5734,,,178102360,Channel blocker,None,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,,,,17483457,COc1cc(cc(c1)OC)NC(=O)c1ccc(o1)c1ccc(cc1)Cl
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,cANF<sup>4-23</sup>,4892,,,178101592,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,2823385,
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,AP811,4870,,,178101571,Antagonist,Antagonist,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,10987424,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NC[C@H](CC)C)CCCNC(=N)N)CC(=O)O)NC(=O)[C@@H](NC(=O)Cc1ccc(cc1)NC(=O)c1ccc2c(c1)cccc2)CCCNC(=N)C)C
nemo like kinase,2125,NLK,Q9UBE8,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pIC50,0,5.789999962,0,IC50,0,1611,0,=,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
nerve growth factor receptor,1888,NGFR,P08138,,,,,,Human,BDNF,4872,BDNF,Human,178101573,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
NET,926,SLC6A2,P23975,,,,,,Human,amitriptyline,200,,,135649939,Inhibitor,Inhibition,,f,t,,pKi,0,6.480000019,0,Ki,0,333,0,=,,,,23602445,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
NET,926,SLC6A2,P23975,,,,,,Human,amoxapine,201,,,135649941,Inhibitor,Inhibition,,f,t,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,0,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
NET,926,SLC6A2,P23975,,,,,,Human,atomoxetine,7118,,,178103695,Inhibitor,Inhibition,,f,t,,pKd,0,8.68999958,0,Kd,0,2.029999971,0,=,,,,9871604,CNCC[C@H](c1ccccc1)Oc1ccccc1C
NET,926,SLC6A2,P23975,,,,,,Human,bupropion,7135,,,178103711,Inhibitor,Inhibition,,f,t,,pKi,0,6.360000134,0,Ki,0,441,0,=,,,,19442525,Clc1cccc(c1)C(=O)C(NC(C)(C)C)C
NET,926,SLC6A2,P23975,,,,,,Human,citalopram,7547,,,223365883,Inhibitor,Inhibition,,f,f,,pKi,0,3,0,Ki,0,1000000,0,>,Inhibition of [<sup>3</sup>H]dopamine uptake at human NET expressed in COS7 cells.,,,23168018,N#Cc1ccc2c(c1)COC2(CCCN(C)C)c1ccc(cc1)F
NET,926,SLC6A2,P23975,,,,,,Human,clomipramine,2398,,,135650111,Inhibitor,Inhibition,,f,t,,pKd,0,7.420000076,0,Kd,0,38,0,=,,,,9537821,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
Neuronal NOS,1251,NOS1,P29475,,,,,,Human,3-bromo-7NI,5113,,,178101806,Inhibitor,Inhibition,,f,,,pIC50,6.5,0,6.1,IC50,794,0,316,,,,,7544863,[O-][N+](=O)c1cccc2c1n[nH]c2Br
Neuronal NOS,1251,NOS1,P29475,,,,,,Human,7NI,5127,,,178101820,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,,,,,7693279,[O-][N+](=O)c1cccc2c1[nH]nc2
Neuronal NOS,1251,Nos1,P29476,,,,,,Rat,compound 14j [PMID: 27050842],9147,,,315661232,Inhibitor,Inhibition,,f,f,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,27050842,CNCCCc1cncc(c1)CCc1cc(C)cc(n1)N
Neuronal NOS,1251,NOS1,P29475,,,,,,Human,compound 14j [PMID: 27050842],9147,,,315661232,Inhibitor,Inhibition,,f,t,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,27050842,CNCCCc1cncc(c1)CCc1cc(C)cc(n1)N
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,AZD1332,7700,,,223366033,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,NIH3T3 cells over expressing TrkA,,,0,CC(Oc1n[nH]c(c1)Nc1nc(ncc1Cl)NC(c1ccc(cn1)F)C)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,AZD1332,7700,,,223366033,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,NIH3T3 cells over expressing TrkB,,,0,CC(Oc1n[nH]c(c1)Nc1nc(ncc1Cl)NC(c1ccc(cn1)F)C)C
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,compound 8e [PMID: 24432909],8137,,,249565817,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24432909,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C
neurotrophic receptor tyrosine kinase 3,1819,NTRK3,Q16288,,,,,,Human,AZD1332,7700,,,223366033,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,NIH3T3 cells over expressing TrkC,,,0,CC(Oc1n[nH]c(c1)Nc1nc(ncc1Cl)NC(c1ccc(cn1)F)C)C
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,candoxatril,6492,,,178103106,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COCCOC[C@@H](C(=O)Oc1ccc2c(c1)CCC2)CC1(CCCC1)C(=O)N[C@@H]1CC[C@@H](CC1)C(=O)O
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,candoxatrilat,6491,,,178103105,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,28,0,=,,,,10669559,COCCOC[C@@H](C(=O)O)CC1(CCCC1)C(=O)N[C@@H]1CC[C@@H](CC1)C(=O)O
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,compound 1a [PMID: 25692029],9091,,,315661176,Inhibitor,Inhibition,,f,f,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,25692029,C[C@@H](C(=O)O)NC(=O)[C@@H](CP(=O)([C@@H](N)C)O)Cc1ccc(cc1)c1ccccc1
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,compound 1b [PMID: 18078750],8627,,,252166827,Inhibitor,Inhibition,,f,t,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,18078750,S[C@@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)c1ccccc1)Cc1ccccc1
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,&alpha;-bungarotoxin,3964,,,178100790,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,&alpha;-conotoxin RgIA,4008,,,178100834,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,&alpha;-bungarotoxin,3964,,,178100790,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,&alpha;-conotoxin GI,3983,,,178100809,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC[C@@H]1NC(=O)[C@H](Cc2cccc(c2)O)NC(=O)[C@H](Cc2[nH]cnc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@H](NC1=O)C(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N2)C)NC(=O)[C@H](CCC(=O)O)N
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,&alpha;-conotoxin MI,3999,,,178100825,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,atracurium,9537,,,336446923,Antagonist,Antagonist,,f,f,,pIC50,0,7.010000229,0,IC50,0,97,0,=,Antagonism of ACh activation of &alpha;1&beta;1&epsilon;&delta; nACh receptors expressed in <i>Xenopus</i> oocytes.,,,16931985,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,&alpha;-conotoxin AuIB,3973,,,178100799,Antagonist,Antagonist,&alpha;3&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCC(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)Cc1ccccc1)C)[C@H](O)C)CC(=O)N)C(=O)N)CO)Cc1ccc(cc1)O)CCC3
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,&alpha;-conotoxin-GIC,4009,,,178100835,Antagonist,Antagonist,&alpha;3&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,&alpha;-conotoxin MII,3970,,,178100796,Antagonist,Antagonist,&alpha;3&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,&alpha;-conotoxin PnIA,3982,,,178100808,Antagonist,Antagonist,&alpha;3&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCC(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)C)C)CC(=O)N)CC(=O)N)C(=O)N)CO)CC(C)C)CCC3
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,&alpha;-conotoxin TxIA,4011,,,178100837,Antagonist,Antagonist,&alpha;3&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,atracurium,9537,,,336446923,Antagonist,Antagonist,,f,f,,pIC50,9.050000191,0,7.940000057,IC50,11.60000038,0,0.899999976,=,"Antagonism of ACh activation of human &alpha;3&beta;2 or &alpha;3&beta;4 nACh receptors expressed in <i>Xenopus</i> oocytes, at different ACh concentrations.",,,16931985,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,A-867744,3986,,,178100812,Channel blocker,None,&alpha;3&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,19389923,CCC(=O)c1cc(n(c1C)c1ccc(cc1)S(=O)(=O)N)c1ccc(cc1)Cl
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,atracurium,9537,,,336446923,Antagonist,Antagonist,,f,f,,pIC50,8.100000381,0,7.679999828,IC50,21.10000038,0,7.900000095,=,"Antagonism of ACh activation of human &alpha;4&beta;2 nACh receptors expressed in <i>Xenopus</i> oocytes, at different ACh concentrations.",,,16931985,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,A-867744,3986,,,178100812,Channel blocker,None,&alpha;4&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,19389923,CCC(=O)c1cc(n(c1C)c1ccc(cc1)S(=O)(=O)N)c1ccc(cc1)Cl
nicotinic acetylcholine receptor &alpha;5 subunit,466,CHRNA5,P30532,,,,,,Human,&alpha;-conotoxin-GIC,4009,,,178100835,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;5 subunit,466,CHRNA5,P30532,,,,,,Human,&alpha;-conotoxin MII,3970,,,178100796,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;5 subunit,466,CHRNA5,P30532,,,,,,Human,&alpha;-conotoxin PnIA,3982,,,178100808,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCC(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)C)C)CC(=O)N)CC(=O)N)C(=O)N)CO)CC(C)C)CCC3
nicotinic acetylcholine receptor &alpha;5 subunit,466,CHRNA5,P30532,,,,,,Human,&alpha;-conotoxin TxIA,4011,,,178100837,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,&alpha;-conotoxin MII,3970,,,178100796,Antagonist,Antagonist,&alpha;6&beta;2*,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,"&alpha;-conotoxin MII [H9A, L15A]",4010,,,178100836,Antagonist,Antagonist,&alpha;6&beta;2&beta;3,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,&alpha;-conotoxin PIA,3985,,,178100811,Antagonist,Antagonist,&alpha;6/&alpha;3&beta;2&beta;3 chimera,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,AQW051,7371,,,178103943,Agonist,Agonist,[125I]- bungarotoxin binding assay,f,f,,pKi,0,7.570000172,0,Ki,0,27,0,=,,,,0,Cc1ccc(cc1)c1ccc(cn1)O[C@H]1CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,4BP-TQS,3962,,,178100788,Agonist,Full agonist,allosteric,f,f,,-,0,0,0,-,0,0,0,=,,,,21436053,Brc1ccc(cc1)C1Nc2ccc(cc2C2C1CC=C2)S(=O)(=O)N
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,A-582941,3995,,,178100821,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,17898229,CN1CC2C(C1)CN(C2)c1ccc(nn1)c1ccccc1
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,AZD0328,7697,,,223366030,Agonist,Full agonist,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,21919481,c1cnc2c(c1)C[C@]1(O2)CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,bradanicline,3969,,,178100795,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,19482012,O=C(c1cc2c(o1)cccc2)N[C@@H]1C2CCN([C@H]1Cc1cccnc1)CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,A-867744,3986,,,178100812,Allosteric modulator,Positive,(&alpha;7)<sub>5</sub>:Type 2; also blocks &alpha;3&beta;4 and &alpha;4&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,19389923,CCC(=O)c1cc(n(c1C)c1ccc(cc1)S(=O)(=O)N)c1ccc(cc1)Cl
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,&alpha;-bungarotoxin,3964,,,178100790,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,&alpha;-conotoxin ArIB,4007,,,178100833,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,&alpha;-conotoxin ImI,3965,,,178100791,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,atracurium,9537,,,336446923,Antagonist,Antagonist,,f,f,,pIC50,8.25,0,7.889999866,IC50,13,0,5.599999905,=,"Antagonism of ACh activation of human &alpha;7 nACh receptors expressed in <i>Xenopus</i> oocytes, at different ACh concentrations.",,,16931985,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,&alpha;-bungarotoxin,3964,,,178100790,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,&alpha;-bungarotoxin,3964,,,178100790,Antagonist,Antagonist,(&alpha;9)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,&alpha;-conotoxin RgIA,4008,,,178100834,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
NIMA related kinase 1,2114,NEK1,Q96PY6,,,,,,Human,compound 31 [PMID: 20936789],8180,,,249565860,Inhibitor,Inhibition,,f,t,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,20936789,COc1cc(cc(c1OC)OC)c1cnc(c(n1)N1CC[C@H]([C@H]([C@H]1C)C)C(=O)O)N
NIMA related kinase 11,2116,NEK11,Q8NG66,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.809999943,0,Ki,0,1549,0,>,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
NIMA related kinase 2,2117,NEK2,P51955,,,,,,Human,compound 2 [PMID: 21627121],8149,,,249565829,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,<,,,,21627121,ClCC(=O)c1ccc2c(c1)/C(=C/c1ccc[nH]1)/C(=O)N2
NIMA related kinase 2,2117,NEK2,P51955,,,,,,Human,compound 31 [PMID: 20936789],8180,,,249565860,Inhibitor,Inhibition,,f,f,,pIC50,0,6.639999866,0,IC50,0,230,0,=,,,,20936789,COc1cc(cc(c1OC)OC)c1cnc(c(n1)N1CC[C@H]([C@H]([C@H]1C)C)C(=O)O)N
NIMA related kinase 3,2118,NEK3,P51956,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.78000021,0,Ki,0,1667,0,>,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
NIMA related kinase 6,2121,NEK6,Q9HC98,,,,,,Human,compound 22 [PMID: 20462760],8205,,,249565885,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 3&mu;M compound.,,,20462760,O=C(C(c1ccccc1)NC1CC1)Nc1cc2cc[nH]c(=O)c2cc1Cl
NIMA related kinase 7,2122,NEK7,Q8TDX7,,,,,,Human,compound 22 [PMID: 20462760],8205,,,249565885,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 3&mu;M compound.,,,20462760,O=C(C(c1ccccc1)NC1CC1)Nc1cc2cc[nH]c(=O)c2cc1Cl
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,aprepitant,3490,,,178100479,Antagonist,Antagonist,,f,t,,pKi,0,10.05000019,0,Ki,0,0.090000004,0,=,,,,9804700,Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,befetupitant,5759,,,178102384,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,16332435,O=C(C(c1cc(cc(c1)C(F)(F)F)C(F)(F)F)(C)C)N(c1cnc(cc1c1ccccc1C)N1CCOCC1)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,casopitant,5758,,,178102383,Antagonist,Antagonist,,f,f,,pKi,0,9.399999619,0,-,0,0,0,=,,,,20533894,Fc1ccc(c(c1)C)[C@H]1C[C@H](CCN1C(=O)N([C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)C)N1CCN(CC1)C(=O)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,[&beta;Ala<sup>8</sup>]neurokinin A-(4-10),2112,,,135652015,Agonist,Full agonist,,f,f,,pKd,0,6,0,-,0,0,0,=,,,,7682062,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,AZD2624,5775,,,178102400,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,0,CC[C@@H](c1ccccc1)NC(=O)c1c(NS(=O)(=O)C)c(nc2c1cccc2)c1ccccc1
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,compound 5d [PMID: 25815150],9008,,,310264786,Agonist,Full agonist,,f,f,,pEC50,0,10.07999992,0,EC50,0,0.082999997,0,=,,,,25815150,NC(=N)NCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)Cc1cccs1)Cc1ccc(cc1)F
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,compound 8d [PMID: 24999562],7926,,,249565609,Agonist,Full agonist,,f,f,,pEC50,9,0,8,-,0,0,0,=,,,,24999562,NC(=N)NCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc2c(c1)cccc2)NC(=O)CCc1cccnc1)Cc1ccccc1
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,compound 6b [PMID: 24999562],7927,,,249565610,Agonist,Full agonist,,f,f,,pEC50,9,0,8,-,0,0,0,=,,,,24999562,NC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC1CCCCC1)CC(C)C)CCC(C)C
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,compound NRA 4 [PMID: 25262941],9010,,,310264788,Agonist,Full agonist,,f,f,,pEC50,0,4.849999905,0,EC50,0,14000,0,=,,,,25262941,Brc1ccc(c(c1)c1oc2ccccc2c(=O)c1O)F
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ac-RYYRIK-NH<sub>2</sub>,1679,,,135651971,Agonist,Agonist,,f,f,,pEC50,0,5.099999905,0,-,0,0,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,9353393,
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ac-RYYRWK-NH<sub>2</sub>,1680,,,135651972,Agonist,Agonist,,f,f,,pEC50,0,8.680000305,0,EC50,0,2.099999905,0,=,,,,9353393,
NOP receptor,320,OPRL1,P41146,,,,,,Human,AT-403,9747,,,0,Agonist,Agonist,,f,f,,pKi,0,8.960000038,0,Ki,0,1.100000024,0,=,,,,29232769,CNC(=O)CC1C(=O)N(c2c1cccc2)C1CCN(CC1)[C@@H]1CC[C@@H](CC1)C(C)C
NOP receptor,320,OPRL1,P41146,,,,,,Human,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pEC50,0,7.889999866,0,EC50,0,13,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
NOP receptor,320,Oprl1,P35370,,,,,,Rat,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,cebranopadol,8866,,,252827523,Agonist,Agonist,,f,f,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,Radioligand binding assay,,,24713140,Fc1ccc2c(c1)c1CCOC3(c1[nH]2)CCC(CC3)(N(C)C)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,[Arg<sup>14</sup>Lys<sup>15</sup>]N/OFQ,1689,,,135651996,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11097863,
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ac-RYYRIK-NH<sub>2</sub>,1679,,,135651971,Agonist,Partial agonist,,f,f,,pKi,9.100000381,0,8.819999695,Ki,1.5,0,0.790000021,=,,,,9353393,
NOP receptor,320,Oprl1,P35377,,,,,,Mouse,Ac-RYYRIK-NH<sub>2</sub>,1679,,,135651971,Agonist,Partial agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9353393,
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ac-RYYRWK-NH<sub>2</sub>,1680,,,135651972,Agonist,Partial agonist,,f,f,,pKi,10,0,9.149999619,Ki,0.709999979,0,0.100000001,=,,,,9353393,
NOP receptor,320,Oprl1,P35377,,,,,,Mouse,Ac-RYYRWK-NH<sub>2</sub>,1680,,,135651972,Agonist,Partial agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9353393,
NOP receptor,320,OPRL1,P41146,,,,,,Human,BU08028,9294,,,318164813,Agonist,Partial agonist,,f,f,,pKi,0,8.069999695,0,Ki,0,8.460000038,0,=,,,,21177476,CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(CC)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
NOP receptor,320,OPRL1,P41146,,,,,,Human,AT-076,8870,,,252827527,Antagonist,Antagonist,,f,f,,pKi,0,8.760000229,0,Ki,0,1.75,0,=,Radioligand binding assay,,,25635572,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CCC(CC1)c1cccc(c1)O
NOP receptor,320,OPRL1,P41146,,,,,,Human,compound 24 [PMID: 16451050],7361,,,178103933,Antagonist,Antagonist,,f,f,,pKi,0,9.619999886,0,Ki,0,0.239999995,0,=,,,,19445927,O=C([C@H]1CCCN1Cc1ccccc1)NCCCN1CCC2(CC1)OCc1c2cccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,compound 24 [PMID: 16451050],7361,,,178103933,Antagonist,Antagonist,,f,f,,pIC50,10,0,9.569999695,IC50,0.270000011,0,0.100000001,=,,,,19445927,O=C([C@H]1CCCN1Cc1ccccc1)NCCCN1CCC2(CC1)OCc1c2cccc1
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,Ava3,3855,,,178100694,Agonist,Full agonist,,f,f,,pKi,9.430000305,0,9.369999886,Ki,0.430000007,0,0.370000005,=,,,,17486669,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,Ava5,3856,,,178100695,Agonist,Full agonist,,f,f,,pKi,9,0,8.800000191,Ki,1.590000033,0,1.00999999,=,,,,17486669,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,1DMe,1477,,,135651955,Agonist,Full agonist,,f,,,pKi,9,0,8.1,,0,0,0,,,,,11024015,CC(C[C@H](N(C(=O)[C@H](Cc1ccc(cc1)O)N)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CCC(=O)N)CCC(=O)N)Cc1ccccc1)C
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,AC262620,4017,,,178100843,Antagonist,Antagonist,,f,,,pKi,8.1,0,7.7,-,0,0,0,=,,,,20354177,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,AC262970,4018,,,178100844,Antagonist,Antagonist,,f,,,pKi,8.1,0,7.4,-,0,0,0,=,,,,20354177,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,BIBP3226,1485,,,135649992,Antagonist,Antagonist,,f,,,pKi,7.8,0,7,,0,0,0,,,,,11024015,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)O
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,1DMe,1477,,,135651955,Agonist,Full agonist,,f,,,pKi,9.7,0,8.5,,0,0,0,,,,,11024015,CC(C[C@H](N(C(=O)[C@H](Cc1ccc(cc1)O)N)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CCC(=O)N)CCC(=O)N)Cc1ccccc1)C
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,AC263093,4020,,,178100846,Agonist,Full agonist,,f,f,,pEC50,5.900000095,0,5.199999809,-,0,0,0,=,,,,20354177,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,BIBP3226,1485,,,135649992,Antagonist,Antagonist,,f,,,pKi,7.1,0,5.9,,0,0,0,,,,,11024015,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)O
NTS<sub>1</sub> receptor,309,Ntsr1,O88319,,,,,,Mouse,ABS-201,5308,,,178101990,Agonist,Full agonist,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,22459147,NCCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccc(cc1)O)CCCNC(=N)N)C
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,ABS-212,5307,,,178101989,Agonist,Full agonist,,f,,,pIC50,0,7.64,0,IC50,0,23,0,=,,,,20481538,
NUAK family kinase 1,2129,NUAK1,O60285,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
NUAK family kinase 1,2129,NUAK1,O60285,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,NuaK1 is reported by its synonym ARK5 in the referencing article.,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
nuclear receptor coactivator 1,2693,NCOA1,Q15788,,,,,,Human,compound 26 [PMID: 21733693],8783,,,252827441,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,21733693,CC(c1sc(c(n1)c1ccc(c(c1)NS(=O)(=O)c1c(F)cccc1F)F)c1ccnc(n1)Nc1ccc(nc1)N1CCOCC1)C
OATP2A1,1223,Slco2a1,Q00910,,,,,,Rat,bromocresol green,4530,,,178101251,Inhibitor,Inhibition,Inhibition of PGF<sub>2&alpha;</sub> uptake in PGT-expressing HeLa cells,f,f,,pKi,0,5.440000057,0,Ki,0,3600,0,=,,,,7754369,Brc1cc(c(c(c1O)Br)C)C1(OS(=O)(=O)c2c1cccc2)c1cc(Br)c(c(c1C)Br)O
OATP2A1,1223,Slco2a1,Q00910,,,,,,Rat,bromsulphthalein,4506,,,178101233,Inhibitor,Inhibition,Inhibition of PGF<sub>2&alpha;</sub> uptake in PGT-expressing HeLa cells,f,f,,pKi,0,5.239999771,0,Ki,0,5800,0,=,,,,7754369,Brc1c(Br)c(Br)c2c(c1Br)C(=O)OC2(c1ccc(c(c1)S(=O)(=O)[O-])O)c1ccc(c(c1)S(=O)(=O)[O-])O.[Na+].[Na+]
Organic anion transporter 3,1027,SLC22A8,Q8TCC7,,,,,,Human,cephalothin,8798,,,252827456,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,11909604,CC(=O)OCC1=C(C(=O)O)N2[C@H](SC1)[C@@H](C2=O)NC(=O)Cc1cccs1
Organic anion transporter 4,1030,SLC22A11,Q9NSA0,,,,,,Human,cephalothin,8798,,,252827456,Inhibitor,Inhibition,,f,f,,pKi,0,6.699999809,0,Ki,0,200,0,=,,,,11909604,CC(=O)OCC1=C(C(=O)O)N2[C@H](SC1)[C@@H](C2=O)NC(=O)Cc1cccs1
Organic cation transporter 1,1019,SLC22A1,O15245,,,,,,Human,clonidine,516,,,135650112,Inhibitor,Inhibition,,f,f,,pKi,0,6.260000229,0,Ki,0,550,0,=,,,,9655880,Clc1cccc(c1NC1=NCCN1)Cl
Ornithine decarboxylase,1276,ODC1,P11926,,,,,,Human,APA,5139,,,178101831,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,,,,1573631,NCCCON
OT receptor,369,OXTR,P30559,,,,,,Human,arginine vasotocin,2169,,,135652004,Agonist,Full agonist,,t,,,pKi,0,9.4,0,,0,0,0,,,,,7774575,
OT receptor,369,Oxtr,P70536,,,,,,Rat,atosiban,2213,,,135652002,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12660315,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
OT receptor,369,OXTR,P30559,,,,,,Human,atosiban,2213,,,135652002,Antagonist,Antagonist,,f,,,pKi,7.6,0,6,,0,0,0,,,,,10519430,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
OT receptor,369,OXTR,P30559,,,,,,Human,compound 37 [PMID: 16250654],2239,,,135650179,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,16250654,CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C
OX40,1873,TNFRSF4,P43489,,,,,,Human,compound 1 [PMID: 24930776],9092,,,315661177,None,Binding,,f,f,,pIC50,0,5.920000076,0,IC50,0,1200,0,=,,,,24930776,Nc1ccc(c(c1)N)/N=N\c1ccc2c(c1)c(O)c(c(c2)S(=O)(=O)O)/N=N/c1ccc(c(c1)S(=O)(=O)O)/N=N/c1ccc(cc1N)N
OX40,1873,TNFRSF4,P43489,,,,,,Human,compound 1 [PMID: 24930776],9092,,,315661177,None,Binding,,f,f,,pIC50,0,5.920000076,0,IC50,0,1200,0,=,,,,24930776,Nc1ccc(c(c1)N)/N=Nc1ccc2c(c1)c(O)c(c(c2)S(=O)(=O)O)/N=N/c1ccc(c(c1)S(=O)(=O)O)/N=N/c1ccc(cc1N)N
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-15-HETE,6167,,,178102788,Agonist,Full agonist,,t,,,pEC50,0,7.7,0,EC50,0,20,0,=,,,,7803484,CCCCC[C@@H](/C=C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-15-HETE,6167,,,178102788,Agonist,Full agonist,,t,,,pEC50,0,7.7,0,EC50,0,20,0,=,,,,7803484,CCCCC[C@@H](/C=C/C=CC/C=CC=CC(=O)CCCC(=O)O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-20-HETE,6169,,,178102790,Agonist,Full agonist,,t,,,pEC50,0,6.5,0,EC50,0,340,0,=,,,,8598482,OCCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-20-HETE,6169,,,178102790,Agonist,Full agonist,,t,,,pEC50,0,6.5,0,EC50,0,340,0,=,,,,8598482,OCCCCC/C=CC/C=CC/C=CC=CC(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-C20:3,3392,,,135651414,Agonist,Full agonist,,t,,,pEC50,0,8,0,EC50,0,10,0,=,,,,18292294,CCCCCCCC/C=C\C/C=C\C=C/C(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-C20:3,3392,,,135651414,Agonist,Full agonist,,t,,,pEC50,0,8,0,EC50,0,10,0,=,,,,18292294,CCCCCCCC/C=CC/C=CC=C/C(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-ETE,3391,,,135651415,Agonist,Full agonist,,t,,,pEC50,8.5,0,8.3,EC50,5,0,3.1,=,,,,7797484,CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-ETE,3391,,,135651415,Agonist,Full agonist,,t,,,pEC50,8.5,0,8.3,EC50,5,0,3.1,=,,,,7797484,CCCCC/C=CC/C=CC/C=CC=CC(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-ODE,6164,,,178102785,Agonist,Full agonist,,t,,,pEC50,0,8,0,EC50,0,10,0,=,,,,18287092,CCCCCCCCC/C=C\C=C\C(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-ODE,6164,,,178102785,Agonist,Full agonist,,t,,,pEC50,0,8,0,EC50,0,10,0,=,,,,18287092,CCCCCCCCC/C=CC=CC(=O)CCCC(=O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5S-HETE,3390,,,135651416,Agonist,Full agonist,,t,,,pEC50,7.2,0,6.5,EC50,300,0,60,=,,,,7803484,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5S-HETE,3390,,,135651416,Agonist,Full agonist,,t,,,pEC50,7.2,0,6.5,EC50,300,0,60,=,,,,7803484,CCCCC/C=CC/C=CC/C=CC=C[C@H](CCCC(=O)O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5S-HPETE,2483,,,53801093,Agonist,Full agonist,,t,,,pEC50,0,7,0,EC50,0,100,0,=,,,,16039985,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5S-HPETE,2483,,,53801093,Agonist,Full agonist,,t,,,pEC50,0,7,0,EC50,0,100,0,=,,,,16039985,CCCCC/C=CC/C=CC/C=CC=C[C@H](CCCC(=O)O)OO
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid,6174,,,178102795,Antagonist,Antagonist,,f,,,pIC50,0,6.4,0,IC50,0,400,0,=,,,,23581530,CCCCCCc1cc2c(n1C(=O)CCCC(=O)O)cc(cc2)Cl
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-12-HETE,6171,,,178102792,Antagonist,Antagonist,,t,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,9920859,CCCCC/C=C\C[C@@H](/C=C/C=C\C=C\C(=O)CCCC(=O)O)O
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,5-oxo-12-HETE,6171,,,178102792,Antagonist,Antagonist,,t,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,9920859,CCCCC/C=CC[C@@H](/C=C/C=CC=CC(=O)CCCC(=O)O)O
oxidative stress responsive 1,2132,OXSR1,O95747,,,,,,Human,compound 74 [PMID: 24793884],8219,,,249565899,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,Clc1ccc(c(c1)Cl)c1nc(sc1C(=O)N)c1ccnc(n1)N
oxoglutarate receptor,162,OXGR1,Q96P68,,,,,,Human,&alpha;-ketoglutaric acid,3636,,,178100543,Agonist,Full agonist,,t,,,pEC50,4.49,0,3.3,EC50,69000,0,32000,=,,,,15141213,OC(=O)CCC(=O)C(=O)O
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,compound 26 [PMID: 26267383],9305,,,318164824,Agonist,Agonist,,f,f,,pEC50,0,5.789999962,0,EC50,0,1616,0,=,,,,26267383,COc1ccc(cc1S(=O)(=O)Nc1cccc(c1)NCCNC(=O)c1cccc(c1)C)c1cccc(c1)C(=O)N(C)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,"[Ala<sup>11</sup>, D-Leu<sup>15</sup>]orexin-B",1700,,,135651978,Agonist,Full agonist,,f,f,,pEC50,7.300000191,0,6.099999905,-,0,0,0,=,,,,12467628,
OX<sub>1</sub> receptor,321,Hcrtr1,P56718,,,,,,Rat,ACT-335827,9122,,,315661207,Antagonist,Antagonist,,f,f,,pIC50,8.149999619,0,7.599999905,IC50,25,0,7,=,,,,23589487,COc1cc(ccc1OC)C[C@H]1c2cc(OC)c(cc2CCN1[C@H](c1ccccc1)C(=O)NC(C)C)OC
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,ACT-335827,9122,,,315661207,Antagonist,Antagonist,,f,t,,pIC50,8.220000267,0,8.050000191,IC50,9,0,6,=,,,,23589487,COc1cc(ccc1OC)C[C@H]1c2cc(OC)c(cc2CCN1[C@H](c1ccccc1)C(=O)NC(C)C)OC
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,ACT-462206,9303,,,318164822,Antagonist,Antagonist,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,25147058,COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(c1)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,almorexant,2886,,,135649893,Antagonist,Antagonist,,f,f,,pIC50,0,7.900000095,0,IC50,0,12.60000038,0,=,,,,17259994,CNC(=O)[C@H](N1CCc2c([C@@H]1CCc1ccc(cc1)C(F)(F)F)cc(c(c2)OC)OC)c1ccccc1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,compound 11 [PMID: 15261275],9415,,,328083517,Antagonist,Antagonist,,f,f,,pKi,0,5.300000191,0,Ki,0,5012,0,>,Radioligand displacement assay using [<sup>125</sup>I]-orexin A as radio ligand.,,,15261275,O=C(Nc1ccc(cc1Cl)Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,compound 1 [PMID: 15261275],1702,,,135649647,Antagonist,Antagonist,,f,,,pKi,6.1,0,5.3,,0,0,0,,,,,15261275,O=C(Nc1ccccc1Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,compound 26 [PMID: 26267383],9305,,,318164824,Agonist,Agonist,,f,t,,pEC50,0,7.639999866,0,EC50,0,23,0,=,,,,26267383,COc1ccc(cc1S(=O)(=O)Nc1cccc(c1)NCCNC(=O)c1cccc(c1)C)c1cccc(c1)C(=O)N(C)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,"[Ala<sup>11</sup>, D-Leu<sup>15</sup>]orexin-B",1700,,,135651978,Agonist,Full agonist,,f,f,,pEC50,9.899999619,0,7.599999905,-,0,0,0,=,,,,12467628,
OX<sub>2</sub> receptor,322,Hcrtr2,P56719,,,,,,Rat,ACT-335827,9122,,,315661207,Antagonist,Antagonist,,f,f,,pIC50,6.199999809,0,5.989999771,IC50,1030,0,630,=,,,,23589487,COc1cc(ccc1OC)C[C@H]1c2cc(OC)c(cc2CCN1[C@H](c1ccccc1)C(=O)NC(C)C)OC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,ACT-335827,9122,,,315661207,Antagonist,Antagonist,,f,f,,pIC50,6.570000172,0,6.329999924,IC50,471,0,271,=,,,,23589487,COc1cc(ccc1OC)C[C@H]1c2cc(OC)c(cc2CCN1[C@H](c1ccccc1)C(=O)NC(C)C)OC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,ACT-462206,9303,,,318164822,Antagonist,Antagonist,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,25147058,COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(c1)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,almorexant,2886,,,135649893,Antagonist,Antagonist,,f,f,,pIC50,0,8.100000381,0,IC50,0,7.940000057,0,=,,,,17259994,CNC(=O)[C@H](N1CCc2c([C@@H]1CCc1ccc(cc1)C(F)(F)F)cc(c(c2)OC)OC)c1ccccc1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,compound 11 [PMID: 15261275],9415,,,328083517,Antagonist,Antagonist,,f,t,,pKi,0,8.300000191,0,Ki,0,5.010000229,0,=,Radioligand displacement assay using [<sup>125</sup>I]-orexin A as radio ligand.,,,15261275,O=C(Nc1ccc(cc1Cl)Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,compound 1 [PMID: 15261275],1702,,,135649647,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.8,,0,0,0,,,,,15261275,O=C(Nc1ccccc1Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,compound 3 [PMID: 26191365],8936,,,310264717,Allosteric modulator,Negative,,f,t,,pKd,0,8.149999619,0,Kd,0,7,0,=,Binding affinity constant for the unphosphorylated kinase.,,,26191365,FC(CN1C2C=CC(=CC2N=C(C2C1C=CC(=C2)Cl)NC1CCN(C1)C(=O)NC(C)C)F)F
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,31,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pKi,5.349999905,0,5.269999981,Ki,5420,0,4500,=,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,compound 3 [PMID: 26191365],8936,,,310264717,Allosteric modulator,Negative,,f,f,,pKd,0,6.400000095,0,Kd,0,400,0,=,,,,26191365,FC(CN1C2C=CC(=CC2N=C(C2C1C=CC(=C2)Cl)NC1CCN(C1)C(=O)NC(C)C)F)F
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pIC50,0,6.010000229,0,IC50,0,970,0,=,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
p21 (RAC1) activated kinase 3,2135,PAK3,O75914,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
p21 (RAC1) activated kinase 4,2136,PAK4,O96013,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.5,0,=,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
p21 (RAC1) activated kinase 5,2138,PAK5,Q9P286,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
p21 (RAC1) activated kinase 6,2137,PAK6,Q9NQU5,,,,,,Human,compound 4 [PMID: 24432870],8941,,,310264722,Inhibitor,Inhibition,,f,f,,pIC50,0,6.900000095,0,IC50,0,126,0,=,,,,26191365,OCC(C#Cc1ccc2c(c1)n(c1ncnc(n1)N)c(n2)C)(O)C
P2X1,478,P2RX1,P51575,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,7.25,0,EC50,0,56,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X1,478,P2RX1,P51575,,,,,,Human,&alpha;&beta;-meATP,4093,,,178100916,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H](COP(=O)(CP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X1,478,P2RX1,P51575,,,,,,Human,BzATP,1757,,,135651449,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2X2,479,P2rx2,P49653,,,,,,Rat,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,5.849999905,0,EC50,0,1400,0,=,,,,18600475,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X3,480,P2RX3,P56373,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,6.46999979,0,EC50,0,340,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X3,480,P2RX3,P56373,,,,,,Human,&alpha;&beta;-meATP,4093,,,178100916,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H](COP(=O)(CP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X3,480,P2RX3,P56373,,,,,,Human,BzATP,1757,,,135651449,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2X3,480,P2RX3,P56373,,,,,,Human,A317491,4115,,,178100937,Antagonist,Antagonist,,f,,,pIC50,0,7.5,0,IC50,0,31,0,~,,,,12482951,O=C(c1cc(C(=O)O)c(cc1C(=O)O)C(=O)O)N([C@H]1CCCc2c1cccc2)Cc1cccc(c1)Oc1ccccc1
P2X3,480,P2RX3,P56373,,,,,,Human,AF-219,9540,,,336446926,Antagonist,Antagonist,,f,f,,pIC50,0,8.5,0,-,0,0,0,=,,,,26686393,COc1cc(C(C)C)c(cc1S(=O)(=O)N)Oc1cnc(nc1N)N
P2X3,480,P2RX3,P56373,,,,,,Human,AF353,4125,,,178100947,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,~,,,,20590629,COc1cc(C(C)C)c(cc1I)Oc1cnc(nc1N)N
P2X3,480,P2RX3,P56373,,,,,,Human,AF-906,9538,,,336446924,Antagonist,Antagonist,,f,f,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,26686393,OCC(Nc1ncc(c(n1)N)Oc1cc(I)c(cc1C(C)C)OC)CO
P2X4,481,P2RX4,Q99571,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,6.300000191,0,EC50,0,500,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X4,481,P2rx4,Q9JJX6,,,,,,Mouse,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X4,481,P2RX4,Q99571,,,,,,Human,5-BDBD,9541,,,336446927,Antagonist,Antagonist,,f,f,,pIC50,6,0,5,-,0,0,0,=,,,,23253448,Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1c2cccc1
P2X4,481,P2RX4,Q99571,,,,,,Human,BX-430,9543,,,336446929,Antagonist,Antagonist,,f,f,,pIC50,6,0,5,-,0,0,0,=,,,,23253448,O=C(Nc1c(Br)cc(cc1Br)C(C)C)Nc1cccnc1
P2X5,482,P2rx5,P51578,,,,,,Rat,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X6,483,P2rx6,P51579,,,,,,Rat,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X7,484,P2RX7,Q99572,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,3.109999895,0,EC50,0,780000,0,=,,,,12213051,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X7,484,P2rx7,Q9Z1M0,,,,,,Mouse,BzATP,1757,,,135651449,Agonist,Agonist,,f,f,,pEC50,0,4,0,EC50,0,100000,0,=,Measuring agonist-stimulated  P2X7 receptor-mediated changes in intracellular calcium concentration.,,,19558545,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2X7,484,P2RX7,Q99572,,,,,,Human,BzATP,1757,,,135651449,Agonist,Agonist,,f,f,,pEC50,0,5.329999924,0,EC50,0,4677,0,=,Measuring agonist-stimulated  P2X7 receptor-mediated changes in intracellular calcium concentration.,,,19558545,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2X7,484,P2rx7,Q64663,,,,,,Rat,BzATP,1757,,,135651449,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,=,Measuring agonist-stimulated  P2X7 receptor-mediated changes in intracellular calcium concentration.,,,19558545,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2X7,484,P2RX7,Q99572,,,,,,Human,AZ10606120,9021,,,315661106,Allosteric modulator,Negative,,f,t,,-,0,0,0,-,0,0,0,=,,,,18071294,OCCNCCNc1ccc2c(n1)cccc2NC(=O)CC12CC3CC(C2)CC(C1)C3
P2X7,484,P2RX7,Q99572,,,,,,Human,AZ10606120,9021,,,315661106,Allosteric modulator,Negative,,f,f,,-,0,0,0,-,0,0,0,=,,,,18071294,OCCNCCNc1ccc2c(n1)cccc2NC(=O)CC12CC3CC(C2)CC(C1)C3
P2X7,484,P2RX7,Q99572,,,,,,Human,AZ11645373,4142,,,178100964,Allosteric modulator,Negative,,f,f,,-,0,0,0,-,0,0,0,=,,,,17031385,O=C1SCC(=O)N1C(CCc1ccncc1)COc1ccc(cc1)c1cccc(c1)[N+](=O)[O-]
P2X7,484,P2RX7,Q99572,,,,,,Human,chelerythrine,5953,,,178102576,Allosteric modulator,Negative,,f,f,,pIC50,0,5.25,0,IC50,0,5600,0,=,Inhibition of ATP-induced 86Rb+ (K<sup>+</sup>) efflux in human B-lymphocytes,,,15210579,COc1c(OC)ccc2c1c[n+](C)c1c2ccc2c1cc1OCOc1c2
P2X7,484,P2RX7,Q99572,,,,,,Human,A438079,4118,,,178100940,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,IC50,0,125,0,~,,,,17471177,Clc1c(Cl)cccc1c1nnnn1Cc1cccnc1
P2X7,484,P2RX7,Q99572,,,,,,Human,A740003,4119,,,178100941,Antagonist,Antagonist,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,16982702,N#CN/C(=N/C(C(C)(C)C)NC(=O)Cc1ccc(c(c1)OC)OC)/Nc1cccc2c1cccn2
P2X7,484,P2RX7,Q99572,,,,,,Human,A804598,4121,,,178100943,Antagonist,Antagonist,,f,,,pIC50,0,8,0,IC50,0,10,0,~,,,,0,N#CNC(=N[C@H](c1ccccc1)C)Nc1cccc2c1cccn2
P2X7,484,P2RX7,Q99572,,,,,,Human,A839977,4122,,,178100944,Antagonist,Antagonist,,f,,,pIC50,0,7.7,0,IC50,0,20,0,~,,,,17471177,Clc1cccc(c1Cl)n1nnnc1NCc1ccccc1Oc1ccccn1
P2X7,484,P2RX7,Q99572,,,,,,Human,AZ10606120,9021,,,315661106,Antagonist,Antagonist,,f,t,,pKd,0,8.850000381,0,Kd,0,1.399999976,0,=,Measuring binding of [<sup>3</sup>H]-AZ10606120 to human P2X7 receptors,,,18071294,OCCNCCNc1ccc2c(n1)cccc2NC(=O)CC12CC3CC(C2)CC(C1)C3
P2X7,484,P2rx7,Q64663,,,,,,Rat,AZ10606120,9021,,,315661106,Antagonist,Antagonist,,f,f,,pKd,0,8.720000267,0,Kd,0,1.899999976,0,=,Measuring binding of [<sup>3</sup>H]-AZ10606120 to rat P2X7 receptors,,,18071294,OCCNCCNc1ccc2c(n1)cccc2NC(=O)CC12CC3CC(C2)CC(C1)C3
P2X7,484,P2rx7,Q64663,,,,,,Rat,AZ11657312 (salt free),7722,,,223366055,Antagonist,Antagonist,,f,f,,pA2,0,7.800000191,0,-,0,0,0,=,,,,0,O=C(CC12CC3CC(C2)CC(C1)C3)Nc1cc(ccc1C)C(=O)N1CC2CNCC(C1)O2
P2X7,484,P2RX7,Q99572,,,,,,Human,AZ11657312 (salt free),7722,,,223366055,Antagonist,Antagonist,,f,t,,pA2,0,6.099999905,0,-,0,0,0,=,,,,0,O=C(CC12CC3CC(C2)CC(C1)C3)Nc1cc(ccc1C)C(=O)N1CC2CNCC(C1)O2
P2X7,484,P2RX7,Q99572,,,,,,Human,brilliant blue G,4147,,,178100968,Antagonist,Antagonist,,f,,,pIC50,0,8,0,IC50,0,10,0,~,,,,10860929,CCOc1ccc(cc1)Nc1ccc(cc1)/C(=C\1/C=C/C(=[N+](\Cc2cccc(c2)S(=O)(=O)[O-])/CC)/C=C1C)/c1ccc(cc1C)N(Cc1ccc(cc1)S(=O)(=O)[O-])CC.[Na+]
P2X7,484,P2RX7,Q99572,,,,,,Human,brilliant blue G,4147,,,178100968,Antagonist,Antagonist,,f,,,pIC50,0,8,0,IC50,0,10,0,~,,,,10860929,CCOc1ccc(cc1)Nc1ccc(cc1)/C(=C1/C=C/C(=[N+](Cc2cccc(c2)S(=O)(=O)[O-])/CC)/C=C1C)/c1ccc(cc1C)N(Cc1ccc(cc1)S(=O)(=O)[O-])CC.[Na+]
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,2MeSATP,1711,,,135651403,Agonist,Full agonist,,f,,,pEC50,4.3,0,3.7,,0,0,0,,,,,10578132,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,ADP&beta;S,1755,,,135651428,Agonist,Full agonist,,f,,,pEC50,4.5,0,3.8,,0,0,0,,,,,10578132,O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,AR-C67085,1756,,,135649953,Agonist,Full agonist,,f,f,,pEC50,0,8.520000458,0,-,0,0,0,=,,,,10578132,CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,ATP,1713,,,135651446,Agonist,Full agonist,,t,f,,pEC50,5.599999905,0,4.199999809,EC50,0,0,0,=,,,,10578132,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,ATP&gamma;S,1714,,,135651447,Agonist,Full agonist,,f,f,,pEC50,5.5,0,4.900000095,-,0,0,0,=,,,,10578132,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)([O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,BzATP,1757,,,135651449,Agonist,Full agonist,,f,,,pEC50,5.1,0,5,,0,0,0,,,,,10578132,O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,2MeSADP,1710,,,135651401,Agonist,Full agonist,,f,f,,pKi,0,9.199999809,0,-,0,0,0,=,,,,15199474,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ADP,1712,,,135651427,Agonist,Full agonist,,t,f,,pKi,0,5.900000095,0,-,0,0,0,=,,,,15199474,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ADP&beta;S,1755,,,135651428,Agonist,Full agonist,,f,f,,pIC50,0,8.600000381,0,-,0,0,0,=,,,,11502873,O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,2MeSAMP,1764,,,135651402,Antagonist,Antagonist,,f,f,,pIC50,0,5.400000095,0,-,0,0,0,=,,,,11502873,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,Ap<sub>4</sub>A,1732,,,135651441,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,AR-C67085,1756,,,135649953,Antagonist,Antagonist,,f,,,pKd,0,8.2,0,-,0,0,0,=,,,,23495690,CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ARL66096,3384,,,178100401,Antagonist,Antagonist,,f,f,,pIC50,0,7.949999809,0,-,0,0,0,=,,,,7582510,CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,AZD1283,7360,,,178103932,Antagonist,Antagonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,24670650,CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,BX 048,1766,,,135650044,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,18539312,CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,BX 667,1767,,,135650046,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,18539312,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,cangrelor,1776,,,135650051,Antagonist,Antagonist,,f,f,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,12213051,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,cangrelor,1776,,,135650051,Antagonist,Antagonist,,f,,,pIC50,0,8,0,-,0,0,0,=,,,,11502873,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,clopidogrel (active metabolite),1772,,,135649894,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15199474,COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,clopidogrel (active metabolite),1772,,,135649894,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15199474,COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=CC(=O)O)/C1)S
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,compound 20o [PMID: 22984835],5906,,,178102529,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,Ki,0,7.7,0,=,,,,22984835,CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,compound 4 [PMID: 22984835],5905,,,178102528,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,Ki,0,139,0,=,,,,22984835,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,compound 4 [PMID: 23083103],6148,,,178102769,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,-,0,0,0,=,,,,23083103,O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,2MeSADP,1710,,,135651401,Agonist,Full agonist,,f,f,,pIC50,0,9,0,-,0,0,0,=,,,,12815166,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,2MeSATP,1711,,,135651403,Agonist,Full agonist,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,12815166,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,ADP,1712,,,135651427,Agonist,Full agonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,ADP&beta;S,1755,,,135651428,Agonist,Full agonist,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,ATP,1713,,,135651446,Agonist,Full agonist,,t,,,pIC50,0,5.4,0,,0,0,0,,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,ATP&gamma;S,1714,,,135651447,Agonist,Full agonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)([O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,2MeSAMP,1764,,,135651402,Antagonist,Antagonist,,f,f,,pIC50,0,5.599999905,0,-,0,0,0,=,,,,12815166,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,Ap<sub>4</sub>A,1732,,,135651441,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,-,0,0,0,=,,,,12815166,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,cangrelor,1776,,,135650051,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,-,0,0,0,=,,,,12815166,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,2-thio-UDP,6202,,,178102823,Agonist,Full agonist,,f,f,,pEC50,0,8.720000267,0,EC50,0,1.919999957,0,=,,,,19902968,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=S
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,&alpha;.&beta;-methylene-2-thio-UDP,6203,,,178102824,Agonist,Full agonist,,f,f,,pEC50,0,9.039999962,0,EC50,0,0.920000017,0,=,,,,19902968,C[C@@H]1[C@@H](COP(=O)(CP(=O)(O)O)O)O[C@H]([C@@H]1C)n1ccc(=O)[nH]c1=S
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,2-Cl-ADP(&alpha;-BH<sub>3</sub>),8447,,,252166657,Agonist,Agonist,,f,f,,pEC50,0,8.149999619,0,EC50,0,7,0,=,,,,23751098,O[C@@H]1[C@@H](CO[P@@](=O)(OP(=O)(O)O)[B-])O[C@H]([C@@H]1O)n1cnc2c1nc(Cl)nc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,ADP&beta;S,1755,,,135651428,Agonist,Agonist,,f,f,,pEC50,0,7.300000191,0,EC50,0,49.90000153,0,=,,,,11502873,O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,2MeSADP,1710,,,135651401,Agonist,Full agonist,,f,f,,pIC50,7,0,5.400000095,-,0,0,0,=,,,,9154346,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,ADP,1712,,,135651427,Agonist,Full agonist,,t,,,pIC50,7.2,0,6.2,,0,0,0,,,,,9154346,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,,,,,,,,Turkey,compound 3a [PMID: 22873688],5911,,,178102534,Agonist,Full agonist,,f,,,pEC50,0,7.4,0,EC50,0,38,0,=,,,,22873688,CSc1nc(N)c2c(n1)n(cn2)C1O[C@@H]([C@@H]([C@@H]1O)O)CO[P@@](=O)(OP(=O)(O)O)[BH3-]
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,"2',3'-ddATP",1709,,,135651389,Agonist,Partial agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,9154346,Nc1ncnc2c1ncn2[C@H]1CC[C@H](O1)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,2MeSATP,1711,,,135651403,Agonist,Partial agonist,,f,,,pIC50,7.6,0,6.4,,0,0,0,,,,,9154346,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,ATP,1713,,,135651446,Agonist,Partial agonist,,t,,,pIC50,7.8,0,6.1,,0,0,0,,,,,9154346,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,ATP&gamma;S,1714,,,135651447,Agonist,Partial agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,9154346,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)([O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,"2,2'-pyridylisatogen tosylate",1729,,,135649681,Allosteric modulator,Negative,,f,f,,pIC50,0,7.800000191,0,-,0,0,0,=,,,,15193995,[O-][N+]1=C(c2ccccn2)C(=O)c2c1cccc2.Cc1ccc(cc1)S(=O)(=O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,BMS compound 16 [PMID:23368907],5808,,,178102433,Allosteric modulator,Negative,,f,f,,pKi,0,6.920000076,0,Ki,0,120,0,=,Inhibition of [<sup>3</sup>H]2MeSADP binding to P2Y<sub>1</sub> receptors expressed in COS-7 cells.,,,25822790,O=C(Nc1cccnc1Oc1ccccc1C(C)(C)C)Nc1ccc(cc1)OC(F)(F)F
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,2-chloroadenosine-5-triphosphate,1716,,,135649697,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9547364,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1nc(Cl)nc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,2MeSATP,1711,,,135651403,Antagonist,Antagonist,,f,f,,pKi,0,5.199999809,0,-,0,0,0,=,,,,9547364,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,A2P5P,1717,,,135651419,Antagonist,Antagonist,,f,,,pEC50,0,5.8,0,,0,0,0,,,,,8913364,O[C@@H]1[C@@H](COP(=O)(O)O)O[C@H]([C@@H]1OP(=O)(O)O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,adenosine-3'-5'-bisphosphate,1718,,,135651420,Antagonist,Antagonist,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,8913364,O[C@@H]1[C@H](OP(=O)(O)O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,ATP,1713,,,135651446,Antagonist,Antagonist,,t,,,pKi,0,4.8,0,,0,0,0,,,,,9547364,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,BMS compound 4c,5901,,,178102524,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,Ki,0,7,0,=,,,,23668989,CC(c1ccccc1Oc1ncccc1Nc1nnc(s1)c1ccc(cc1)C(F)(F)F)(C)C
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,2-thioUTP,3398,,,178100411,Agonist,Agonist,,f,f,,pEC50,0,7.300000191,0,EC50,0,50,0,=,,,,17125260,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=S
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,4-thio-UTP,1730,,,135651410,Agonist,Full agonist,,f,,,pEC50,0,7.5,0,,0,0,0,,,,,16475938,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=S)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,5BrUTP,1731,,,135651412,Agonist,Full agonist,,f,,,pEC50,0,5.7,0,,0,0,0,,,,,8564228,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cc(Br)c(=O)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,Ap<sub>4</sub>A,1732,,,135651441,Agonist,Full agonist,,f,f,,pEC50,0,6.099999905,0,-,0,0,0,=,,,,11711032,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,ATP,1713,,,135651446,Agonist,Full agonist,,t,f,,pEC50,7.099999905,0,6.639999866,EC50,0,0,0,=,,,,8564228,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,AR-C118925XX,5907,,,178102530,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,~,,,,15231488,Cc1ccc2c(c1)C=Cc1c(C2c2cn(Cc3ccc(o3)C(=O)Nc3nnn[nH]3)c(=O)[nH]c2=S)ccc(c1)C
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,AR-C126313,1738,,,135649951,Antagonist,Antagonist,,f,f,,pEC50,0,6,0,-,0,0,0,=,,,,17302398,Clc1ccc2c(c1)C=Cc1c(C2c2cn(C)c(=O)[nH]c2=S)ncs1
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,ATP,1713,,,135651446,Agonist,Agonist,,t,f,,pEC50,0,5.369999886,0,EC50,0,4300,0,=,,,,21193033,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,2-amino-uridine-5'-monophosphate,6201,,,178102822,Agonist,Partial agonist,,f,,,pEC50,0,5.3,0,EC50,0,4980,0,=,,,,21417463,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1ccc(=O)nc1N)COP(=O)(O)O
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,Ap<sub>4</sub>A,1732,,,135651441,Agonist,Partial agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,ATP,1713,,,135651446,Agonist,Partial agonist,,t,f,,pEC50,6.300000191,0,5.699999809,EC50,0,0,0,=,,,,9647463,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,ATP,1713,,,135651446,Antagonist,Antagonist,,f,f,,pKd,0,6.199999809,0,-,0,0,0,=,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,3-phenacyl-UDP,1745,,,135651408,Agonist,Full agonist,,f,f,,pEC50,0,7.199999809,0,-,0,0,0,=,,,,17125260,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1ccc(=O)n(c1=O)CC(=O)c1ccccc1)COP(=O)(OP(=O)(O)O)O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,2MeSATP,1711,,,135651403,Agonist,Partial agonist,,f,,,pEC50,0,4,0,,0,0,0,,,,,8670200,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,5BrUTP,1731,,,135651412,Agonist,Partial agonist,,f,,,pEC50,0,6.1,0,,0,0,0,,,,,8670200,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cc(Br)c(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,ADP,1712,,,135651427,Agonist,Partial agonist,,f,,,pEC50,0,4.5,0,,0,0,0,,,,,8670200,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,[Ac-His<sup>1</sup>]PACAP-27,2263,,,53801015,Agonist,Agonist,,f,,,pKi,0,8.3,0,Ki,0,5,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,[Ac-His<sup>1</sup>]PACAP-27,2263,,,53801015,Agonist,Agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pEC50,0,5.8,0,EC50,0,1582,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,4.7,0,IC50,0,20000,0,=,Inhibition of [125I]-Ac-His1-PACAP-27 binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,BAY 55-9837,2269,,,135652009,Agonist,Agonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,>,inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,11978642,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
PAF receptor,334,PTAFR,P25105,,,,,,Human,2-<i>O</i>-ethyl-PAF C-16,1829,,,135651397,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,7594622,CCCCCCCCCCCCCCCCOCC(COP(=O)(OCC[N+](C)(C)C)O)OCC
PAF receptor,334,PTAFR,P25105,,,,,,Human,2-<i>O</i>-methyl-PAF C-18,1830,,,135651398,Agonist,Full agonist,,f,,,pIC50,0,5.8,0,,0,0,0,,,,,7594622,CCCCCCCCCCCCCCCCC(COCC(OC(=O)C)COP(=O)(OCC[N+](C)(C)C)[O-])C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,10-OBn-7&alpha;-F-gingkolide B,1835,,,135652650,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12570381,O=C1OC2C3([C@H]1OCc1ccccc1)C([C@@H](C1C43[C@@](O2)(C(=O)O1)[C@@]1([C@H](C4O)OC(=O)C1C)O)F)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,10-OBn-epi-ginkgolide C,1838,,,135652651,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12570381,O=C1OC2C3([C@H]1OCc1ccccc1)C([C@@H](C1C43[C@@](O2)(C(=O)O1)[C@@]1([C@H](C4O)OC(=O)C1C)O)O)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,10-OBn-ginkgolide B,1836,,,135652652,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12570381,O=C1OC2C3([C@H]1OCc1ccccc1)C(CC1C43[C@@](O2)(C(=O)O1)[C@@]1([C@H](C4O)OC(=O)C1C)O)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,10-OBn-ginkgolide C,1837,,,135652653,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12570381,O=C1OC2C3([C@H]1OCc1ccccc1)C([C@H](C1C43[C@@](O2)(C(=O)O1)[C@@]1([C@H](C4O)OC(=O)C1C)O)O)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-Cl-ginkgolide B,1840,,,135652654,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12570381,O=C1O[C@@H]2[C@@](C1C)(O)[C@]13C4(C2O)C(OC3=O)C(C(C24C(O1)OC(=O)[C@@H]2O)C(C)(C)C)Cl
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-F-ginkgolide B,1841,,,135652655,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,12570381,O=C1O[C@@H]2[C@@](C1C)(O)[C@]13C4(C2O)C(OC3=O)C(C(C24C(O1)OC(=O)[C@@H]2O)C(C)(C)C)F
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-NHEt-ginkgolide B,1844,,,135652656,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12570381,CCN[C@H]1C(C(C)(C)C)C23C45C1OC(=O)[C@@]5(OC2OC(=O)[C@@H]3O)[C@@]1([C@H](C4O)OC(=O)C1C)O
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-NHMe-ginkgolide B,1845,,,135652657,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12570381,CN[C@@H]1C2OC(=O)[C@@]34C2(C2(C1C(C)(C)C)C(O3)OC(=O)[C@@H]2O)C(O)[C@H]1[C@]4(O)C(C(=O)O1)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-NH<sub>2</sub>-ginkgolide B,1843,,,135652658,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,12570381,O=C1O[C@@H]2[C@@](C1C)(O)[C@]13C4(C2O)C(OC3=O)[C@H](C(C24C(O1)OC(=O)[C@@H]2O)C(C)(C)C)N
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-N<sub>3</sub>-ginkgolide B,1842,,,135652659,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,12570381,[N-]=[N]=N[C@H]1C(C(C)(C)C)C23C45C1OC(=O)[C@@]5(OC2OC(=O)[C@@H]3O)[C@@]1([C@H](C4O)OC(=O)C1C)O
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-OAc-ginkgolide B,1846,,,135652660,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,12570381,CC(=O)OC1C(C(C)(C)C)C23C45C1OC(=O)[C@@]5(OC2OC(=O)[C@@H]3O)[C@@]1([C@H](C4O)OC(=O)C1C)O
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7&alpha;-OCOCH<sub>2</sub>Ph-ginkgolide B,1847,,,135652661,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,12570381,O=C(O[C@H]1C(C(C)(C)C)C23C45C1OC(=O)[C@@]5(OC2OC(=O)[C@@H]3O)[C@@]1([C@H](C4O)OC(=O)C1C)O)Cc1ccccc1
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,7-epi-ginkgolide C,1848,,,135652662,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,12570381,O=C1O[C@@H]2[C@@](C1C)(O)[C@]13C4(C2O)C(OC3=O)[C@@H](C(C24C(O1)OC(=O)[C@@H]2O)C(C)(C)C)O
PAF receptor,334,PTAFR,P25105,,,,,,Human,ABT-299,1849,,,135649879,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,8667228,CC(=O)OC[n+]1cccc(c1)[C@H]1SCc2n1ccc2C(=O)c1cn(c2c1ccc(c2)c1ccc(cc1)F)C(=O)N(C)C.[Cl-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,ABT-491,1850,,,135649880,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,-,0,0,0,=,,,,9151941,C#Cc1cccc2c1c(cn2C(=O)N(C)C)C(=O)c1ccc(c(c1)F)Cn1c(C)nc2c1ccnc2
PAF receptor,334,PTAFR,P25105,,,,,,Human,apafant,1860,,,135649947,Antagonist,Antagonist,,f,f,,pKi,7.5,0,5.199999809,-,0,0,0,=,,,,8798529,O=C(N1CCOCC1)CCc1sc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
PAF receptor,334,PTAFR,P25105,,,,,,Human,bepafant,6078,,,178102699,Antagonist,Antagonist,Inhibition of PAF-induced platelet or neutrophil aggregation.,f,,,pIC50,6.49,0,6.08,IC50,830,0,320,=,,,,2262914,O=C(C1Cc2c(C1)c1c(s2)n2c(C)nnc2CN=C1c1ccccc1Cl)N1CCOCC1
PAF receptor,334,PTAFR,P25105,,,,,,Human,bepafant,6078,,,178102699,Antagonist,Antagonist,Induction of apoptosis in human NB4 (acute promyelocytic leukemia) cells.,f,,,pIC50,6.52,0,3.6,IC50,250000,0,300,=,,,,2170626,O=C(C1Cc2c(C1)c1c(s2)n2c(C)nnc2CN=C1c1ccccc1Cl)N1CCOCC1
PAF receptor,334,PTAFR,P25105,,,,,,Human,BN 50739,1851,,,135650010,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8380690,COc1ccc(cc1OC)SCC(=S)N1CCc2c(C1)sc1c2C(=NCc2n1c(C)nn2)c1ccccc1Cl
PAR1,347,F2R,P25116,,,,,,Human,atopaxar,4048,,,178100872,Antagonist,Antagonist,,f,,,pIC50,0,7.72,0,IC50,0,19,0,=,,,,21300059,CCOc1c(OCC)cc2c(c1F)C(=N)N(C2)CC(=O)c1cc(N2CCOCC2)c(c(c1)C(C)(C)C)OC
PAR2,348,F2RL1,P55085,,,,,,Human,2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH<sub>2 </sub>,4050,,,178100874,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,18477767,
PAR2,348,F2RL1,P55085,,,,,,Human,2-furoyl-LIGRL[N[<sup>3</sup>H]propionyl]-O-NH<sub>2</sub>,4049,,,178100873,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,18477767,
PAR2,348,F2RL1,P55085,,,,,,Human,AC264613,9460,,,329968400,Agonist,Agonist,,f,f,,pEC50,0,7.5,0,EC50,0,31.60000038,0,=,,,,18720984,Brc1cccc(c1)/C(=N/NC(=O)[C@@H]1C(=O)NC[C@H]1c1ccccc1)/C
PAR2,348,F2RL1,P55085,,,,,,Human,AC-55541,9456,,,329968396,Agonist,Agonist,,f,f,,pEC50,0,6.699999809,0,EC50,0,199,0,=,,,,18720984,Brc1cccc(c1)/C(=N/NC(=O)C(c1n[nH]c(=O)c2c1cccc2)NC(=O)c1ccccc1)/C
PAR2,348,F2RL1,P55085,,,,,,Human,AC-98170,9457,,,329968397,Agonist,Agonist,,f,f,,pEC50,0,5.199999809,0,EC50,0,6310,0,=,,,,18720984,O=C([C@@H]1C(=O)NC[C@H]1c1ccccc1)N/N=C(/c1cccs1)\C
PAR2,348,F2RL1,P55085,,,,,,Human,AC-98170,9457,,,329968397,Agonist,Agonist,,f,f,,pEC50,0,5.199999809,0,EC50,0,6310,0,=,,,,18720984,O=C([C@@H]1C(=O)NC[C@H]1c1ccccc1)N/N=C(/c1cccs1)C
PAR2,348,F2RL1,P55085,,,,,,Human,AY77,9455,,,329968395,Agonist,Agonist,,f,f,,pEC50,0,7.480000019,0,EC50,0,33,0,=,,,,26819675,
PAR2,348,F2RL1,P55085,,,,,,Human,2-furoyl-LIGRLO-amide,3851,,,178100691,Agonist,Full agonist,,f,f,,pKi,0,5.400000095,0,-,0,0,0,=,,,,14976230,
PAR2,348,F2RL1,P55085,,,,,,Human,AZ3451,9560,,,336446946,Allosteric modulator,Negative,,f,t,,pKd,0,7.869999886,0,Kd,0,13.5,0,=,In a BIACORE assay.,,,28445455,N#Cc1ccc(cc1)NC(=O)c1ccc2c(c1)nc(n2[C@H](C1CCCCC1)C)c1cc2OCOc2cc1Br
PAR2,348,F2RL1,P55085,,,,,,Human,AZ3451,9560,,,336446946,Allosteric modulator,Negative,,f,t,,pIC50,0,8.270000458,0,IC50,0,5.400000095,0,=,"In a FLIPR calcium accumulation assay, vs. SLIGRL activation.",,,28445455,N#Cc1ccc(cc1)NC(=O)c1ccc2c(c1)nc(n2[C@H](C1CCCCC1)C)c1cc2OCOc2cc1Br
PAR2,348,F2RL1,P55085,,,,,,Human,AZ3451,9560,,,336446946,Allosteric modulator,Negative,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,Antagonism of SLIGRL-NH2-induced IP1 formation.,,,28445455,N#Cc1ccc(cc1)NC(=O)c1ccc2c(c1)nc(n2[C@H](C1CCCCC1)C)c1cc2OCOc2cc1Br
PAR2,348,F2RL1,P55085,,,,,,Human,AZ7188,9586,,,340590217,Antagonist,Antagonist,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,Antagonism of SLIGRL-NH2-induced IP1 formation.,,,28445455,O=CN1c2ccccc2CC1c1c[nH]c2c1cccc2
PAR2,348,F2RL1,P55085,,,,,,Human,AZ8838,9585,,,340590216,Antagonist,Antagonist,,f,t,,pKd,0,6.460000038,0,Kd,0,344,0,=,Saturation binding of [<sup>3</sup>H]-AZ8838 antagonist to wild-type PAR2.,,,28445455,CCCc1cc(F)ccc1[C@@H](c1ncc[nH]1)O
PAR2,348,F2RL1,P55085,,,,,,Human,AZ8838,9585,,,340590216,Antagonist,Antagonist,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,Measuring SLIGRL-NH2-induced IP1 formation,,,28445455,CCCc1cc(F)ccc1[C@@H](c1ncc[nH]1)O
PAR2,348,F2RL1,P55085,,,,,,Human,AZ8838,9585,,,340590216,Antagonist,Antagonist,,f,f,,pIC50,0,5.639999866,0,IC50,0,2300,0,=,In a FLIPR assay measuring SLIGRL-NH2-induced calcium mobilisation.,,,28445455,CCCc1cc(F)ccc1[C@@H](c1ncc[nH]1)O
PAR2,348,F2RL1,P55085,,,,,,Human,C391,9570,,,336446956,Antagonist,Antagonist,,f,f,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,Antagonism of peptidomimetic-induced PAR2 Ca2+ signalling in 16HBE14o- cells.,,,26140338,NCCCC[C@H](N1CC2N(CC1=O)C(=O)[C@H](CN2C(=O)c1ccco1)NC(=O)CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CC(C)C
PAR2,348,F2RL1,P55085,,,,,,Human,C391,9570,,,336446956,Antagonist,Antagonist,,f,f,,pIC50,0,4.840000153,0,IC50,0,14300,0,=,Antagonism of 2-at-LIGRL-NH2-induced ERK phosphorylation in 16HBE14o- cells.,,,26140338,NCCCC[C@H](N1CC2N(CC1=O)C(=O)[C@H](CN2C(=O)c1ccco1)NC(=O)CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CC(C)C
PAR4,350,F2RL3,Q96RI0,,,,,,Human,AYPGKF-NH2,4061,,,178100885,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
"pepsinogen 5, group I (pepsinogen A)",2390,PGA5,P0DJD9,,,,,,Human,compound 3 [PMID: 8410973],8634,,,252166834,Inhibitor,Inhibition,,f,f,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,8410973,C=CC[C@@H](C(=O)N[C@H](C(=O)C(C(=O)NCCN1CCOCC1)(F)F)CC1CCCCC1)NC(=O)[C@@H](NS(=O)(=O)N1CCOCC1)Cc1ccccc1
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,4-AMBA,4702,,,178101414,Inhibitor,Inhibition,,f,f,,pKi,0,5.519999981,0,Ki,0,3000,0,=,,,,15930458,NCc1ccc(cc1)C(=O)O
peptidyl arginine deiminase 3,2878,PADI3,Q9ULW8,,,,,,Human,Cl-amidine,8685,,,252166885,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 2.34x10<sup>3</sup> M<sup>-1</sup> min<sup>-1</sup>,,,25742366,ClCC(=N)NCCC[C@@H](C(=O)N)NC(=O)c1ccccc1
peptidyl arginine deiminase 3,2878,PADI3,Q9ULW8,,,,,,Human,compound 14b [PMID: 25742366],8684,,,252166884,Inhibitor,Irreversible inhibition,,f,t,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 1.56x10<sup>4</sup> M<sup>-1</sup> min<sup>-1</sup>,,,25742366,ClCC(NCCCC1NC(=O)N(C1O)Cc1cccc(c1)c1ccccc1Cl)N
peptidyl arginine deiminase 3,2878,,,,,,,,None,compound 3 [PMID: 24440480],8682,,,252166882,Inhibitor,Irreversible inhibition,,f,f,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 1.8x10<sup>3</sup> M<sup>-1</sup> min<sup>-1</sup>,,,24440480,NC1=CC(=O)c2c(C1=O)nc(cc2)c1ccccn1
peptidyl arginine deiminase 4,2877,PADI4,Q9UM07,,,,,,Human,Cl-amidine,8685,,,252166885,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 1.77x10<sup>3</sup> M<sup>-1</sup> min<sup>-1</sup>,,,25742366,ClCC(=N)NCCC[C@@H](C(=O)N)NC(=O)c1ccccc1
peptidyl arginine deiminase 4,2877,PADI4,Q9UM07,,,,,,Human,compound 14b [PMID: 25742366],8684,,,252166884,Inhibitor,Irreversible inhibition,,f,f,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 1.46x10<sup>3</sup> M<sup>-1</sup> min<sup>-1</sup>,,,25742366,ClCC(NCCCC1NC(=O)N(C1O)Cc1cccc(c1)c1ccccc1Cl)N
peptidyl arginine deiminase 4,2877,,,,,,,,None,compound 3 [PMID: 24440480],8682,,,252166882,Inhibitor,Irreversible inhibition,,f,f,,-,0,0,0,-,0,0,0,=,K<sub>inact</sub>/K<sub>I</sub> = 5.7x10<sup>3</sup> M<sup>-1</sup> min<sup>-1</sup>,,,24440480,NC1=CC(=O)c2c(C1=O)nc(cc2)c1ccccn1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,8S-HETE,2679,,,135651417,Agonist,Agonist,,t,,,pKd,0,7,0,,0,0,0,,,,,9113986,CCCCC/C=C\C/C=C\C=C\[C@H](C/C=C\CCCC(=O)O)O
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,8S-HETE,2679,,,135651417,Agonist,Agonist,,t,,,pKd,0,7,0,,0,0,0,,,,,9113986,CCCCC/C=CC/C=CC=C[C@H](C/C=CCCCC(=O)O)O
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,AD-5061,2663,,,135649895,Agonist,Agonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,11095972,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,AZD4619,7821,,,223366152,Agonist,Agonist,,f,t,,pEC50,0,7.099999905,0,EC50,0,80,0,=,,,,0,Cc1ccc(cc1)CCSC(C(=O)O)Cc1ccc(cc1)CCOc1ccc(cc1)OS(=O)(=O)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,bezafibrate,2668,,,135649989,Agonist,Agonist,,f,t,,pEC50,0,4.300000191,0,-,0,0,0,=,,,,15293980,Clc1ccc(cc1)C(=O)NCCc1ccc(cc1)OC(C(=O)O)(C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,ciprofibrate,3438,,,178100438,Agonist,Agonist,,f,t,,pEC50,0,6.050000191,0,EC50,0,900,0,=,Transactivation of a GAL4-PPAR&alpha; ligand binding domain construct.,,,22381047,OC(=O)C(Oc1ccc(cc1)C1CC1(Cl)Cl)(C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,clofibrate,2667,,,135650110,Agonist,Agonist,,f,t,,pIC50,0,4.25,0,-,0,0,0,=,,,,9836620,CCOC(=O)C(Oc1ccc(cc1)Cl)(C)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,"15-deoxy-&Delta;-12,14-prostaglandin J2",2692,,,135651375,Agonist,Full agonist,,t,,,pIC50,0,6.3,0,,0,0,0,,,,,9113987,CCCCC/C=C/C=C/1\[C@@H](C/C=C\CCCC(=O)O)C=CC1=O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,"15-deoxy-&Delta;-12,14-prostaglandin J2",2692,,,135651375,Agonist,Full agonist,,t,,,pIC50,0,6.3,0,,0,0,0,,,,,9113987,CCCCC/C=C/C=C/1[C@@H](C/C=CCCCC(=O)O)C=CC1=O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,AD-5061,2663,,,135649895,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,11095972,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,AD5075,2701,,,135649896,Agonist,Full agonist,,f,,,pKi,0,7.66,0,,0,0,0,,,,,10037770,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC(c1nc(oc1C)c1ccccc1)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,BADGE,2708,,,135649978,Agonist,Full agonist,,f,,,pKd,0,4,0,,0,0,0,,,,,11030710,CC(c1ccc(cc1)OC1OC1)(c1ccc(cc1)OC1OC1)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,ciglitazone,2711,,,135650096,Agonist,Full agonist,,f,,,pEC50,0,4.599999905,0,-,0,0,0,=,,,,9836620,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCCCC1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,bardoxolone,2717,,,135650061,Agonist,Partial agonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,11043571,N#CC1=C[C@@]2(C)[C@H](C(C1=O)(C)C)CC[C@@]1(C2=CC(=O)[C@H]2[C@@]1(C)CC[C@@]1([C@H]2CC(C)(C)CC1)C(=O)O)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,BADGE,2708,,,135649978,Antagonist,Antagonist,,f,,,pKi,0,4,0,-,0,0,0,=,,,,10636887,CC(c1ccc(cc1)OC1OC1)(c1ccc(cc1)OC1OC1)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,bexarotene,2807,,,135650520,Antagonist,Antagonist,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,~,Measured using a TR-FRET competitive displacement assay.,,,26451138,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(=O)O)C(C)(C)CCC2(C)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,CDDO-Me,3443,,,178100443,Antagonist,Antagonist,,f,,,pKi,0,6.900000095,0,Ki,0,130,0,=,,,,11043571,N#CC1=C[C@@]2(C)[C@H](C(C1=O)(C)C)CC[C@@]1(C2=CC(=O)[C@H]2[C@@]1(C)CC[C@@]1([C@H]2CC(C)(C)CC1)C(=O)OC)C
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,compound 28 [PMID: 24387221],8793,,,252827451,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,183,0,=,,,,24387221,C[C@H]1Cc2c(N1C(=O)Cc1nc(=O)cc([nH]1)N1CCOCC1)cccc2
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,7.510000229,0,Ki,0,31,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,alpelisib,7955,,,249565638,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,23726034,NC(=O)[C@@H]1CCCN1C(=O)Nc1nc(c(s1)c1ccnc(c1)C(C(F)(F)F)(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,AMG319,8917,,,310264698,Inhibitor,Inhibition,,f,f,,pIC50,0,4.480000019,0,IC50,0,33000,0,=,,,,25469863,Fc1ccc2c(c1)nc(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccn1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,t,,pIC50,0,8.319999695,0,IC50,0,4.800000191,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,AZD6482,8059,,,249565739,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,870,0,=,,,,22906130,Cc1cc([C@H](Nc2ccccc2C(=O)O)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,AZD8186,8527,,,252166729,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,,,,25398829,Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,AZD8835,8915,,,310264696,Inhibitor,Inhibition,,f,t,,pIC50,0,8.210000038,0,IC50,0,6.199999809,0,=,,,,26475521,OCCC(=O)N1CCC(CC1)c1nn(c(n1)c1cnc(c(n1)c1nnc(o1)C(C)(C)C)N)CC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,BGT-226,7951,,,249565634,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,22357447,COc1ccc(cn1)c1ccc2c(c1)c1c(cn2)n(c(=O)n1c1ccc(c(c1)C(F)(F)F)N1CCNCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,bimiralisib,8383,,,252166595,Inhibitor,Inhibition,,f,t,,pKd,0,8.819999695,0,Kd,0,1.5,0,=,,,,0,Nc1ncc(c(c1)C(F)(F)F)c1nc(nc(n1)N1CCOCC1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,buparlisib,7878,,,223366207,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,24900266,Nc1ncc(c(c1)C(F)(F)F)c1cc(nc(n1)N1CCOCC1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,CH5132799,7743,,,223366076,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,21316229,Nc1ncc(cn1)c1nc(nc2c1CCN2S(=O)(=O)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,compound 11j [PMID: 23021994],8827,,,252827484,Inhibitor,Inhibition,,f,f,,pIC50,0,7.039999962,0,IC50,0,92,0,=,,,,23021994,CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,compound 28 [PMID: 24387221],8793,,,252827451,Inhibitor,Inhibition,,f,f,,pIC50,0,5.809999943,0,IC50,0,1539,0,=,,,,24387221,C[C@H]1Cc2c(N1C(=O)Cc1nc(=O)cc([nH]1)N1CCOCC1)cccc2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,alpelisib,7955,,,249565638,Inhibitor,Inhibition,,f,f,,pIC50,0,5.920000076,0,IC50,0,1200,0,=,,,,23726034,NC(=O)[C@@H]1CCCN1C(=O)Nc1nc(c(s1)c1ccnc(c1)C(C(F)(F)F)(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,AMG319,8917,,,310264698,Inhibitor,Inhibition,,f,f,,pIC50,0,5.570000172,0,IC50,0,2700,0,=,,,,25469863,Fc1ccc2c(c1)nc(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccn1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,AZD6482,8059,,,249565739,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,22906130,Cc1cc([C@H](Nc2ccccc2C(=O)O)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,AZD8186,8527,,,252166729,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,25398829,Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,AZD8835,8915,,,310264696,Inhibitor,Inhibition,,f,f,,pIC50,0,6.369999886,0,IC50,0,431,0,=,,,,26475521,OCCC(=O)N1CCC(CC1)c1nn(c(n1)c1cnc(c(n1)c1nnc(o1)C(C)(C)C)N)CC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,BGT-226,7951,,,249565634,Inhibitor,Inhibition,,f,t,,pIC50,0,7.199999809,0,IC50,0,63,0,=,,,,22357447,COc1ccc(cn1)c1ccc2c(c1)c1c(cn2)n(c(=O)n1c1ccc(c(c1)C(F)(F)F)N1CCNCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,bimiralisib,8383,,,252166595,Inhibitor,Inhibition,,f,t,,pKd,0,7.960000038,0,Kd,0,11,0,=,,,,0,Nc1ncc(c(c1)C(F)(F)F)c1nc(nc(n1)N1CCOCC1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,CH5132799,7743,,,223366076,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,,,,21316229,Nc1ncc(cn1)c1nc(nc2c1CCN2S(=O)(=O)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,compound 28 [PMID: 24387221],8793,,,252827451,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,24387221,C[C@H]1Cc2c(N1C(=O)Cc1nc(=O)cc([nH]1)N1CCOCC1)cccc2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,alpelisib,7955,,,249565638,Inhibitor,Inhibition,,f,f,,pIC50,0,6.539999962,0,IC50,0,290,0,=,,,,23726034,NC(=O)[C@@H]1CCCN1C(=O)Nc1nc(c(s1)c1ccnc(c1)C(C(F)(F)F)(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,AMG319,8917,,,310264698,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,25469863,Fc1ccc2c(c1)nc(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccn1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,t,,pIC50,0,8.170000076,0,IC50,0,6.699999809,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,AZD6482,8059,,,249565739,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,,,,22906130,Cc1cc([C@H](Nc2ccccc2C(=O)O)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,AZD8186,8527,,,252166729,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,25398829,Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,AZD8835,8915,,,310264696,Inhibitor,Inhibition,,f,t,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,,,,26475521,OCCC(=O)N1CCC(CC1)c1nn(c(n1)c1cnc(c(n1)c1nnc(o1)C(C)(C)C)N)CC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,bimiralisib,8383,,,252166595,Inhibitor,Inhibition,,f,t,,pKd,0,7.599999905,0,Kd,0,25,0,=,,,,0,Nc1ncc(c(c1)C(F)(F)F)c1nc(nc(n1)N1CCOCC1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,CH5132799,7743,,,223366076,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,21316229,Nc1ncc(cn1)c1nc(nc2c1CCN2S(=O)(=O)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,compound 28 [PMID: 24387221],8793,,,252827451,Inhibitor,Inhibition,,f,f,,pIC50,0,6.329999924,0,IC50,0,468,0,=,,,,24387221,C[C@H]1Cc2c(N1C(=O)Cc1nc(=O)cc([nH]1)N1CCOCC1)cccc2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,alpelisib,7955,,,249565638,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,23726034,NC(=O)[C@@H]1CCCN1C(=O)Nc1nc(c(s1)c1ccnc(c1)C(C(F)(F)F)(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,AMG319,8917,,,310264698,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,850,0,=,,,,25469863,Fc1ccc2c(c1)nc(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccn1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,AZD6482,8059,,,249565739,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1090,0,=,,,,22906130,Cc1cc([C@H](Nc2ccccc2C(=O)O)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,AZD8186,8527,,,252166729,Inhibitor,Inhibition,,f,f,,pIC50,0,6.170000076,0,IC50,0,675,0,=,,,,25398829,Fc1cc(cc(c1)F)N[C@@H](c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,AZD8835,8915,,,310264696,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,26475521,OCCC(=O)N1CCC(CC1)c1nn(c(n1)c1cnc(c(n1)c1nnc(o1)C(C)(C)C)N)CC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,berzosertib,8003,,,249565683,Inhibitor,Inhibition,,f,f,,pKi,0,6.659999847,0,Ki,0,220,0,=,,,,23222511,CNCc1ccc(cc1)c1noc(c1)c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,BGT-226,7951,,,249565634,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,22357447,COc1ccc(cn1)c1ccc2c(c1)c1c(cn2)n(c(=O)n1c1ccc(c(c1)C(F)(F)F)N1CCNCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,bimiralisib,8383,,,252166595,Inhibitor,Inhibition,,f,t,,pKd,0,7.599999905,0,Kd,0,25,0,=,,,,0,Nc1ncc(c(c1)C(F)(F)F)c1nc(nc(n1)N1CCOCC1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,CH5132799,7743,,,223366076,Inhibitor,Inhibition,,f,f,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,21316229,Nc1ncc(cn1)c1nc(nc2c1CCN2S(=O)(=O)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,compound 11j [PMID: 23021994],8827,,,252827484,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,23021994,CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,compound 82 [PMID: 21332118],8805,,,252827463,Inhibitor,Inhibition,,f,f,,pIC50,0,8.329999924,0,IC50,0,4.699999809,0,=,,,,21332118,CC(=O)Nc1nc2c(s1)cc(cc2)c1cnc(c(c1)NS(=O)(=O)c1ccc(cc1)F)Cl
phosphatidylinositol 4-kinase type 2 alpha,2498,PI4K2A,Q9BTU6,,,,,,Human,adenosine,2844,,,135651426,Inhibitor,Inhibition,,f,,,pIC50,5,0,4.5,-,0,0,0,=,,,,21704602,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
phosphatidylinositol 4-kinase type 2 beta,2499,PI4K2B,Q8TCG2,,,,,,Human,adenosine,2844,,,135651426,Inhibitor,Inhibition,,f,,,pIC50,5,0,4.5,-,0,0,0,=,,,,21704602,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,2288,PIK3C2G,O75747,,,,,,Human,compound 28 [PMID: 24387221],8793,,,252827451,Inhibitor,Inhibition,,f,f,,pIC50,0,5.420000076,0,IC50,0,3812,0,=,,,,24387221,C[C@H]1Cc2c(N1C(=O)Cc1nc(=O)cc([nH]1)N1CCOCC1)cccc2
phosphodiesterase 10A,1310,PDE10A,Q9Y233,,,,,,Human,compound 19 [PMID: 22142545],8758,,,252827416,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,22142545,COc1cc(C)c2c(c1)c(CN1CCOCC1)c1c(n2)n[nH]c1C
phosphodiesterase 10A,1310,PDE10A,Q9Y233,,,,,,Human,compound 27 [PMID: 22142545],8757,,,252827415,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,22142545,COc1cc(C)c2c(c1)c(CN1CCOCCC1)c1c(n2)n[nH]c1C
phosphodiesterase 11A,1311,PDE11A,Q9HCR9,,,,,,Human,BC11-38,6559,,,178103173,Inhibitor,Inhibition,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,22284362,CCCSc1nc2CCSc2c(=O)n1c1ccccc1
phosphodiesterase 1A,1294,PDE1A,P54750,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,,,-,0,0,0,,0,0,0,,,,,0,
phosphodiesterase 1B,1295,PDE1B,Q01064,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,,,-,0,0,0,,0,0,0,,,,,0,
phosphodiesterase 1C,1296,PDE1C,Q14123,,,,,,Human,calmodulin,2351,CALM1|CALM2|CALM3,Human,135652052,Activator,Activation,,t,,,-,0,0,0,,0,0,0,,,,,0,
phosphodiesterase 2A,1297,PDE2A,O00408,,,,,,Human,BAY607550,5147,,,178101839,Inhibitor,Inhibition,,f,,,pIC50,8.8,0,8.3,IC50,5.01,0,1.58,,,,,15555642,COc1cc(ccc1OC)Cc1nc(=O)c2n([nH]1)c(nc2C)[C@H]([C@H](O)C)CCCc1ccccc1
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,anagrelide,7114,,,178103691,Inhibitor,Inhibition,,f,t,,pIC50,7.269999981,0,7.090000153,IC50,82,0,54,=,,,,1321910,OC1=NC2=Nc3c(CN2C1)c(Cl)c(cc3)Cl
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,cilostamide,5167,,,178101857,Inhibitor,Inhibition,,f,,,pIC50,0,7.5,0,IC50,0,31.6,0,,,,,10644042,O=C(N(C1CCCCC1)C)CCCOc1ccc2c(c1)ccc(=O)[nH]2
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,cilostazol,7148,,,178103723,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,10644042,O=C1CCc2c(N1)ccc(c2)OCCCCc1nnnn1C1CCCCC1
phosphodiesterase 3B,1299,PDE3B,Q13370,,,,,,Human,cilostamide,5167,,,178101857,Inhibitor,Inhibition,,f,,,pIC50,0,7.3,0,IC50,0,50.1,0,,,,,10644042,O=C(N(C1CCCCC1)C)CCCOc1ccc2c(c1)ccc(=O)[nH]2
phosphodiesterase 3B,1299,PDE3B,Q13370,,,,,,Human,cilostazol,7148,,,178103723,Inhibitor,Inhibition,,f,t,,pIC50,0,6.420000076,0,IC50,0,380,0,=,,,,10644042,O=C1CCc2c(N1)ccc(c2)OCCCCc1nnnn1C1CCCCC1
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,apremilast,7372,,,178103944,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,Potency against recombinant human PDE4A1A isoform in a TR-FRET assay.,,,24882690,CCOc1cc(ccc1OC)[C@H](N1C(=O)c2c(C1=O)c(ccc2)NC(=O)C)CS(=O)(=O)C
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,CDP840,9330,,,318164849,Inhibitor,Inhibition,,f,f,,pKi,0,8.010000229,0,Ki,0,9.699999809,0,=,Inhibition of [<sup>3</sup>H]-R-rolipram binding to recombinant human PDE-4 isoenzyme,,,9631241,COc1ccc(cc1OC1CCCC1)[C@@H](c1ccccc1)Cc1ccncc1
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,apremilast,7372,,,178103944,Inhibitor,Inhibition,,f,t,,pIC50,7.570000172,0,7.369999886,IC50,43,0,27,=,Potency against recombinant human PDE4B1 and B2 isoforms in a TR-FRET assay.,,,24882690,CCOc1cc(ccc1OC)[C@H](N1C(=O)c2c(C1=O)c(ccc2)NC(=O)C)CS(=O)(=O)C
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,CBS-3595,9610,,,340590240,Inhibitor,Inhibition,,f,f,,pIC50,0,5.71999979,0,IC50,0,1900,0,=,Determined against the PDE4B1 splice variant.,,,28613871,CSc1nc(c(n1C)c1ccnc(c1)NC(=O)C)c1ccc(cc1)F
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,CDP840,9330,,,318164849,Inhibitor,Inhibition,,f,f,,pKi,0,8.069999695,0,Ki,0,8.5,0,=,Inhibition of [<sup>3</sup>H]-R-rolipram binding to recombinant human PDE4B2 isoenzyme,,,9631241,COc1ccc(cc1OC1CCCC1)[C@@H](c1ccccc1)Cc1ccncc1
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,apremilast,7372,,,178103944,Inhibitor,Inhibition,,f,t,,pIC50,0,6.929999828,0,IC50,0,118,0,=,Potency against recombinant human PDE4C1 isoform in a TR-FRET assay.,,,24882690,CCOc1cc(ccc1OC)[C@H](N1C(=O)c2c(C1=O)c(ccc2)NC(=O)C)CS(=O)(=O)C
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,CDP840,9330,,,318164849,Inhibitor,Inhibition,,f,f,,pKi,0,7.71999979,0,Ki,0,18.89999962,0,=,Inhibition of [<sup>3</sup>H]-R-rolipram binding to recombinant human PDE4C2 isoenzyme,,,9631241,COc1ccc(cc1OC1CCCC1)[C@@H](c1ccccc1)Cc1ccncc1
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,apremilast,7372,,,178103944,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,Potency against recombinant human PDE4D2 isoform in a TR-FRET assay.,,,24882690,CCOc1cc(ccc1OC)[C@H](N1C(=O)c2c(C1=O)c(ccc2)NC(=O)C)CS(=O)(=O)C
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,CBS-3595,9610,,,340590240,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,Determined against the PDE4D3 splice variant.,,,28613871,CSc1nc(c(n1C)c1ccnc(c1)NC(=O)C)c1ccc(cc1)F
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,CDP840,9330,,,318164849,Inhibitor,Inhibition,,f,f,,pKi,0,8.149999619,0,Ki,0,7.099999905,0,=,Inhibition of [<sup>3</sup>H]-R-rolipram binding to recombinant human PDE4D3 isoenzyme,,,9631241,COc1ccc(cc1OC1CCCC1)[C@@H](c1ccccc1)Cc1ccncc1
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,compound 53 [PMID: 19631533],8811,,,252827469,Inhibitor,Inhibition,,f,t,,pIC50,0,10.30000019,0,IC50,0,0.050000001,0,=,,,,19631533,CCCOCCn1c2cc(ncc2nc(c1=O)NCc1cnccn1)c1ccc(nc1)OC
phosphodiesterase 6A,1312,PDE6A,P16499,,,,,,Human,compound 53 [PMID: 19631533],8811,,,252827469,Inhibitor,Inhibition,,f,f,,pIC50,0,8.010000229,0,IC50,0,9.800000191,0,=,,,,19631533,CCCOCCn1c2cc(ncc2nc(c1=O)NCc1cnccn1)c1ccc(nc1)OC
phosphodiesterase 7A,1305,PDE7A,Q13946,,,,,,Human,BRL50481,5154,,,178101846,Inhibitor,Inhibition,,f,,,pIC50,6.8,0,6.7,-,0,0,0,=,,,,15371556,Cc1ccc(cc1S(=O)(=O)N(C)C)[N+](=O)[O-]
phosphodiesterase 7B,1306,PDE7B,Q9NP56,,,,,,Human,BRL50481,5154,,,178101846,Inhibitor,Inhibition,,f,,,pIC50,0,4.9,0,-,0,0,0,=,,,,20228279,Cc1ccc(cc1S(=O)(=O)N(C)C)[N+](=O)[O-]
phosphomevalonate kinase,641,Pmvk,Q5RK24,,,,,,Rat,cinnamic acid,3203,,,135650101,Inhibitor,Competitive,,f,,,pKi,0,2.42,0,Ki,0,3850000,0,=,"extracted from rat liver, in vitro assay",,,226078,OC(=O)/C=C/c1ccccc1
phosphomevalonate kinase,641,Pmvk,Q5RK24,,,,,,Rat,3-hydroxy-3-methyl-6-phosphohexanoic acid,3202,,,135649736,Inhibitor,Inhibition,,f,,,pKi,0,3.84,0,Ki,0,145000,0,=,,,,0,OC(=O)CC(CCCP(=O)(O)O)(O)C
phosphorylase kinase catalytic subunit gamma 1,2145,PHKG1,Q16816,,,,,,Human,A-443654,8204,,,249565884,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,19465931,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cncc(c1)c1ccc2c(c1)c(C)n[nH]2
phosphorylase kinase catalytic subunit gamma 2,2147,PHKG2,P15735,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.210000038,0,IC50,0,6.099999905,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,Akt inhibitor X,5922,,,178102545,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1280,0,=,,,,0,CCN(CCCCN1c2ccccc2Oc2c1cc(Cl)cc2)CC
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,10.77000046,0,Ki,0,0.017000001,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1\SC(=O)NC1=O
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,10.77000046,0,Ki,0,0.017000001,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1SC(=O)NC1=O
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,compound 14k [PMID: 21982499],8214,,,249565894,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,21982499,Clc1ccccc1Nc1nc2c(cccc2c2c1ccnc2)c1[nH]cnn1
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,compound 20 [PMID: 22136433],8156,,,249565836,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,22136433,N#CC1c2c3ccc(c(c3n(c2C(=O)NC21CCNCC2)C)Cl)Cl
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,compound 2 [PMID: 22560567],8115,,,249565795,Inhibitor,Inhibition,,f,f,,pIC50,0,6.480000019,0,IC50,0,332,0,=,,,,22560567,Oc1ccc(cc1C)c1nc(=O)[nH]c(c1)c1ccccc1
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1\SC(=O)NC1=O
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1SC(=O)NC1=O
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,compound 14k [PMID: 21982499],8214,,,249565894,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,21982499,Clc1ccccc1Nc1nc2c(cccc2c2c1ccnc2)c1[nH]cnn1
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,9.640000343,0,Ki,0,0.230000004,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1\SC(=O)NC1=O
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,AZD1208,7698,,,223366031,Inhibitor,Inhibition,,f,t,,pKi,0,9.640000343,0,Ki,0,0.230000004,0,=,,,,24900629,N[C@@H]1CCCN(C1)c1c(cccc1c1ccccc1)/C=C/1SC(=O)NC1=O
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,compound 14k [PMID: 21982499],8214,,,249565894,Inhibitor,Inhibition,,f,f,,pIC50,0,7.070000172,0,IC50,0,86,0,=,,,,21982499,Clc1ccccc1Nc1nc2c(cccc2c2c1ccnc2)c1[nH]cnn1
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,compound 1a [PMID: 24900749],8128,,,249565808,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,24900749,N#Cc1cnn2c1nc(Nc1ccc(c(c1)NC(=O)C)C)cc2NC1CC1
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,compound 20 [PMID: 22136433],8156,,,249565836,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,22136433,N#CC1c2c3ccc(c(c3n(c2C(=O)NC21CCNCC2)C)Cl)Cl
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,cimetidine,1231,,,135650099,Inhibitor,Inhibition,,f,f,,pKi,0,3.299999952,0,Ki,0,500000,0,>,,,,16099839,N#CNC(=NC)NCCSCc1nc[nH]c1C
plasminogen,2394,PLG,P00747,,,,,,Human,6-aminocaproic acid,6574,,,178103188,Inhibitor,Binding,,f,t,,pIC50,0,4.400000095,0,IC50,0,40000,0,=,Measuring inhibition of fibrinolysis in plasma.,,,24900876,NCCCCCC(=O)O
plasminogen,2394,PLG,P00747,,,,,,Human,aprotinin,6570,BPTI,Bovine,178103184,Inhibitor,Binding,,f,t,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,17666018,
plasminogen,2394,PLG,P00747,,,,,,Human,bis-triazole derivative 10,6537,,,178103151,Inhibitor,Inhibition,,f,,,pKi,0,9.1,0,Ki,0,0.77,0,,,,,22276953,O=C([C@H]1NC(=O)[C@@H](Cc2nnn(c2)Cc2cc(Cn3cc(C1)nn3)ccc2)NS(=O)(=O)Cc1ccccc1)NCc1ccc(cc1)C(=N)N
"plasminogen activator, urokinase",2393,PLAU,P00749,,,,,,Human,compound 4 [PMID: 18163548],6545,,,178103159,Inhibitor,Inhibition,,f,,,pIC50,0,7.7,0,IC50,0,20,0,,,,,18163548,OC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](NS(=O)(=O)Cc1ccccc1)CO
Plasmodium falciparum N-Myristoyltransferase,2955,NMT,Q8ILW6,,,,,,Plasmodium falciparum 3D7,Compound 34c [PMID 24641010],9647,,,340590277,Inhibitor,Inhibition,The parasite EC50 against  Pfal was 305 nM,f,t,,pKi,0,8.100000381,0,Ki,0,8,0,=,,,,24641010,Cn1nc(c(c1C)Cc1nnc(o1)c1sc2c(c1OC1CCNCC1)cccc2)C
Plasmodium falciparum phenylalanine--tRNA ligase alpha subunit,2954,cPheRS,Q8I246,,,,,,Plasmodium falciparum 3D7,BRD3444,9648,,,340590278,Inhibitor,Inhibition,,f,t,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,27602946,OC[C@H]1N2CCCCN(C[C@H]2[C@H]1c1ccc(cc1)C#Cc1ccccc1)C(=O)Nc1ccc(cc1)OC
PLA<sub>2</sub>-G5,1430,PLA2G5,P39877,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,compound 37 [PMID: 29193967],9797,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,29193967,N#Cc1cc(ccc1Oc1ccc(c(c1)C(F)(F)F)Cl)NS(=O)(=O)c1ccc(cc1)N
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,AC710,8095,,,249565775,Inhibitor,Inhibition,,f,f,,pKd,0,8.890000343,0,Kd,0,1.299999952,0,=,,,,24900421,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(cc1)NC(=O)Nc1noc(c1)C(C)(C)C
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,AC710,8095,,,249565775,Inhibitor,Inhibition,,f,f,,pKd,0,9,0,Kd,0,1,0,=,,,,24900421,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(cc1)NC(=O)Nc1noc(c1)C(C)(C)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,AGL 2043,5918,,,178102541,Inhibitor,Inhibition,,f,t,,pIC50,0,7.050000191,0,IC50,0,90,0,=,Using purified human PDGFR&beta;,,,12670652,Cn1c(C)nc2c1cc1ncc(nc1c2)c1cccs1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,BLZ945,8250,,,249565930,Inhibitor,Inhibition,,f,f,,pIC50,0,5.230000019,0,IC50,0,5860,0,=,,,,24498562,CNC(=O)c1nccc(c1)Oc1ccc2c(c1)sc(n2)N[C@@H]1CCCC[C@H]1O
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,cediranib,5664,,,178102292,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15899831,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,compound 5e [PMID: 28580438],9712,,,348353671,Inhibitor,Inhibition,,f,f,,pKd,0,7.550000191,0,Kd,0,28,0,=,,,,28580438,CC(Nc1ccnc(n1)Nc1cccc(c1)c1cccnc1)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
PLC&gamma;1,1407,,,,,,,,Bovine,compound 5 [PMID: 10869194],8843,,,252827500,Inhibitor,Inhibition,,f,f,,pIC50,0,5.019999981,0,IC50,0,9500,0,=,,,,10869194,O=C(C[C@@]12CC[C@@]3([C@H](C1=CC[C@H]1[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)[C@@H](C)[C@@H](CC3)C)C(=O)O)/C=C/c1ccc(cc1)O
PLC&gamma;2,1408,PLCG2,P16885,,,,,,Human,CCT129957,8820,,,252827477,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,Average IC50 (n=3),,,19303309,O=C(c1cc2c([nH]1)c(ccc2)[N+](=O)[O-])NCCc1ccccc1
PLD1,1433,PLD1,Q13393,,,,,,Human,compound 69 [PMID: 19136975],8782,,,252827440,Inhibitor,Inhibition,,f,t,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,19136975,C[C@H](NC(=O)c1ccc2c(c1)cccc2)CN1CCC(CC1)n1c(=O)[nH]c2c1ccc(c2)Cl
PLD2,1434,PLD2,O14939,,,,,,Human,ADP-ribosylation factor 1,5305,ARF1,Human,178101987,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
PLD2,1434,PLD2,O14939,,,,,,Human,compound 69 [PMID: 19136975],8782,,,252827440,Inhibitor,Inhibition,,f,f,,pIC50,0,6.03000021,0,IC50,0,933,0,=,,,,19136975,C[C@H](NC(=O)c1ccc2c(c1)cccc2)CN1CCC(CC1)n1c(=O)[nH]c2c1ccc(c2)Cl
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,BI-2536,5666,,,178102294,Inhibitor,Inhibition,,f,t,,pIC50,0,9.079999924,0,IC50,0,0.829999983,0,=,,,,17291758,CC[C@H]1N(C2CCCC2)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)NC1CCN(CC1)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,BI-2536,5666,,,178102294,Inhibitor,Inhibition,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,23103095,CC[C@H]1N(C2CCCC2)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)NC1CCN(CC1)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,compound 2 [PMID: 19097784],8646,,,252166846,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19097784,COc1cc2c(cc1OC)ncn2c1cc(c(s1)C(=C)N)OCc1ccccc1C(F)(F)F
polo like kinase 2,2169,PLK2,Q9NYY3,,,,,,Human,BI-2536,5666,,,178102294,Inhibitor,Inhibition,,f,f,,pIC50,0,8.460000038,0,IC50,0,3.5,0,=,,,,17291758,CC[C@H]1N(C2CCCC2)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)NC1CCN(CC1)C
polo like kinase 3,2170,PLK3,Q9H4B4,,,,,,Human,BI-2536,5666,,,178102294,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,17291758,CC[C@H]1N(C2CCCC2)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)NC1CCN(CC1)C
polo like kinase 4,2171,PLK4,O00444,,,,,,Human,axitinib,5659,,,178102287,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,23829549,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1
polo like kinase 4,2171,PLK4,O00444,,,,,,Human,CFI-400945,8063,,,249565743,Inhibitor,Inhibition,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,25043604,COc1ccc2c(c1)[C@]1(CC1c1ccc3c(c1)[nH]nc3/C=C/c1ccc(cc1)CN1C[C@H](C)O[C@@H](C1)C)C(=O)N2
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,AG14361,8094,,,249565774,Inhibitor,Inhibition,,f,t,,pKi,0,8.239999771,0,Ki,0,5.800000191,0,=,,,,12519059,CN(Cc1ccc(cc1)c1nc2c3n1CCNC(=O)c3ccc2)C
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,compound 10b [PMID: 26222319],8731,,,252827389,Inhibitor,Inhibition,,f,f,,pKd,0,7.059999943,0,Kd,0,87,0,=,,,,26222319,COCCCN1Cc2c(C1=O)c(ccc2)C(=O)N
poly(ADP-ribose) polymerase 2,2772,PARP2,Q9UGN5,,,,,,Human,compound 10b [PMID: 26222319],8731,,,252827389,Inhibitor,Inhibition,,f,f,,pKd,0,6.900000095,0,Kd,0,125,0,=,,,,26222319,COCCCN1Cc2c(C1=O)c(ccc2)C(=O)N
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,17&beta;-estradiol,1013,,,135651381,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,10628745,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,3-keto-lithocholic acid,2766,,,135651407,Agonist,Agonist,,t,,,pEC50,0,4.8,0,,0,0,0,,,,,11248085,OC(=O)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@H]2[C@]1(C)CCC(=O)C2)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,"5&beta;-cholestane-3&alpha;,7&alpha;,12&alpha;-triol",2803,,,135651411,Agonist,Agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,12509506,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)[C@@H](O)C[C@H]1[C@H]2[C@H](O)C[C@H]2[C@]1(C)CC[C@H](C2)O)C)C
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,"5&beta;-cholestane-3&alpha;,7&alpha;,12&alpha;-triol",2803,,,135651411,Agonist,Agonist,,f,,,pEC50,0,5.5,0,,0,0,0,,,,,12569201,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)[C@@H](O)C[C@H]1[C@H]2[C@H](O)C[C@H]2[C@]1(C)CC[C@H](C2)O)C)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,"5&beta;-pregnane-3,20-dione",2759,,,135650851,Agonist,Agonist,,f,,,pIC50,0,6.4,0,IC50,0,400,0,=,,,,10628745,O=C1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,clotrimazole,2330,,,135650114,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,9770465,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
presenilin 1,2402,PSEN1,P49768,,,,,,Human,CHF-5074,7339,,,178103911,Inhibitor,Binding,,f,t,,pEC50,0,4.400000095,0,EC50,0,40000,0,=,,,,22061640,OC(=O)C1(CC1)c1ccc(c(c1)F)c1ccc(c(c1)Cl)Cl
presenilin 1,2402,PSEN1,P49768,,,,,,Human,avagacestat,6489,,,178103103,Inhibitor,Inhibition,,f,t,,pIC50,0,9.5,0,IC50,0,0.300000012,0,=,,,,0,NC(=O)[C@H](N(S(=O)(=O)c1ccc(cc1)Cl)Cc1ccc(cc1F)c1nocn1)CCC(F)(F)F
presenilin 1,2402,PSEN1,P49768,,,,,,Human,AZ4800,7805,,,223366136,Inhibitor,Inhibition,,f,t,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,22334705,COc1cc(ccc1n1cnc(c1)C)Nc1nc2CCOCc2c(n1)COC1CCCC1
presenilin 1,2402,PSEN1,P49768,,,,,,Human,begacestat,6979,,,178103558,Inhibitor,Inhibition,,f,t,,pEC50,0,7.829999924,0,EC50,0,14.80000019,0,=,,,,19671883,OC[C@H](C(C(F)(F)F)C(F)(F)F)NS(=O)(=O)c1ccc(s1)Cl
progastricsin,2391,PGC,P20142,,,,,,Human,compound 3 [PMID: 8410973],8634,,,252166834,Inhibitor,Inhibition,,f,f,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,8410973,C=CC[C@@H](C(=O)N[C@H](C(=O)C(C(=O)NCCN1CCOCC1)(F)F)CC1CCCCC1)NC(=O)[C@@H](NS(=O)(=O)N1CCOCC1)Cc1ccccc1
Progesterone receptor,627,PGR,P06401,,,,,,Human,AZD9567,9812,,,0,Agonist,Agonist,,f,f,,pIC50,0,5.28000021,0,IC50,0,5300,0,=,,,,29424542,CC([C@@H]([C@@H](c1ccccc1)OC1=CC2C(C=C1)N(N=C2)c1ccc(=O)n(c1)C)NC(=O)C(F)(F)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,budesonide,7434,,,178104006,Agonist,Agonist,,f,f,,pEC50,0,7.150000095,0,EC50,0,71,0,=,,,,28937774,CCCC1O[C@H]2[C@](O1)(C(=O)CO)[C@@]1([C@@H](C2)[C@@H]2CCC3=CC(=O)C=C[C@@]3([C@H]2[C@H](C1)O)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,budesonide,7434,,,178104006,Agonist,Agonist,,f,f,,pEC50,0,7.550000191,0,EC50,0,28,0,=,,,,28937774,CCCC1O[C@H]2[C@](O1)(C(=O)CO)[C@@]1([C@@H](C2)[C@@H]2CCC3=CC(=O)C=C[C@@]3([C@H]2[C@H](C1)O)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,19-Apr,8662,,,252166862,Antagonist,Antagonist,,f,f,,pIC50,0,6.239999771,0,IC50,0,580,0,=,,,,23579486,F[C@H]1CC[C@]2(C(=CCC3C2CC[C@]2(C3CC[C@H]([C@@H]2F)C)C)C1)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,asoprisnil,2883,,,135649967,Antagonist,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,21854761,COC[C@]1(OC)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)/C=N/O)C1=C3CCC(=O)C=C3CC[C@@H]21
programmed cell death 1 (CD279),2760,PDCD1,Q15116,,,,,,Human,BGB-A317,9592,,,340590223,Antibody,Binding,,f,t,,pKd,0,9.819999695,0,Kd,0,0.150000006,0,=,,,,0,
Prolactin receptor,1721,PRLR,P16471,,,,,,Human,choriomammotropin,4893,CSH1|CSH2,Human,178101593,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Prolactin receptor,1721,PRLR,P16471,,,,,,Human,chorionic somatomammotropin hormone-like 1 ,4894,CSHL1,Human,178101594,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Prolylcarboxypeptidase,1584,PRCP,P42785,,,,,,Human,compound 35 [PMID: 24157366],8554,,,252166755,Inhibitor,Inhibition,,f,t,,pIC50,0,10.10000038,0,IC50,0,0.079000004,0,=,,,,24157366,Brc1ccc(cc1)[C@@H]1C[C@@H](CC[C@H]1C(=O)NC(c1ccnc(c1)F)c1ccc(cc1)Cl)N1CCOCC1
prolyl endopeptidase,2395,PREP,P48147,,,,,,Human,ARI-3531,8564,,,252166765,Inhibitor,Inhibition,,f,t,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,23594271,OB([C@H]1CCCN1C(=O)[C@@H](C(C)C)NC(=O)c1ccncc1)O
prolyl endopeptidase like,2870,Prepl,Q8C167,,,,,,Mouse,compound 8 [PMID: 21692504],8491,,,252166699,Inhibitor,Inhibition,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,In a substrate free assay.,,,21692504,N#Cc1c(=O)[nH]c(c2c1CCC2)CC(C)C
proprotein convertase subtilisin/kexin type 9,2388,PCSK9,Q8NBP7,,,,,,Human,alirocumab,6744,,,178103355,Inhibitor,Inhibition,,f,t,,pKd,0,9.420000076,0,Kd,0,0.377000004,0,=,,,,0,
proprotein convertase subtilisin/kexin type 9,2388,PCSK9,Q8NBP7,,,,,,Human,bococizumab,7730,,,223366063,Inhibitor,Inhibition,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,=,Affinity for hPCSK9 measured using proprietary BIACore&reg; technology.,,,0,
PROT,938,SLC6A7,Q99884,,,,,,Human,compound 58 [PMID: 25037917],8520,,,252166722,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,25037917,Clc1cccc(c1)c1ccc(cc1)C(=O)N1C2CCC1CN(C2)c1ncccn1
proteasome subunit beta 1,2404,PSMB1,P20618,,,,,,Human,compound 3b [PMID: 24946214],8618,,,252166819,Inhibitor,Inhibition,,f,f,,pKi,0,6.619999886,0,Ki,0,240,0,=,,,,24946214,CC(C[C@@H](B(O)O)NC(=O)CCn1ccc2c(c1=O)cccc2)C
proteasome subunit beta 2,2405,,,,,,,,None,compound 5b [PMID: 16686537],8616,,,252166817,Inhibitor,Inhibition,,f,f,,pKi,0,6.519999981,0,Ki,0,300,0,=,,,,16686537,O=C[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)CC(C)C)CC(C)C)CC(C)C
proteasome subunit beta 5,2406,PSMB5,P28074,,,,,,Human,bortezomib,6391,,,178103007,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,19428245,CC(C[C@@H](B(O)O)NC(=O)[C@@H](NC(=O)c1cnccn1)Cc1ccccc1)C
proteasome subunit beta 5,2406,PSMB5,P28074,,,,,,Human,carfilzomib,7420,,,178103992,Inhibitor,Inhibition,,f,f,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,,,,19348473,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)[C@@]1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN1CCOCC1)CCc1ccccc1)C
proteasome subunit beta 5,2406,,,,,,,,Bovine,compound 3b [PMID: 24946214],8618,,,252166819,Inhibitor,Inhibition,,f,f,,pKi,0,8.289999962,0,Ki,0,5.099999905,0,=,Inhibition of chymotrypsin-like activity.,,,24946214,CC(C[C@@H](B(O)O)NC(=O)CCn1ccc2c(c1=O)cccc2)C
proteasome subunit beta 5,2406,PSMB5,P28074,,,,,,Human,compound 5b [PMID: 16686537],8616,,,252166817,Inhibitor,Inhibition,,f,f,,pKi,0,8.430000305,0,Ki,0,3.700000048,0,=,Inhibition of the chymotrypsin-like activity of proteasome macropain.,,,16686537,O=C[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)CC(C)C)CC(C)C)CC(C)C
protein arginine methyltransferase 1 ,1252,PRMT1,Q99873,,,,,,Human,AMI-1,7028,,,178103607,Inhibitor,Inhibition,,f,f,,pIC50,0,5.059999943,0,IC50,0,8810,0,=,,,,15056663,O=C(Nc1ccc2c(c1)cc(cc2O)S(=O)(=O)O)Nc1ccc2c(c1)cc(cc2O)S(=O)(=O)O
protein arginine methyltransferase 1 ,1252,PRMT1,Q99873,,,,,,Human,C21,7037,,,178103616,Inhibitor,Inhibition,,f,f,,pIC50,0,5.739999771,0,IC50,0,1800,0,=,,,,21838253,
protein arginine methyltransferase 3,1254,PRMT3,O60678,,,,,,Human,compound 1 [PMID: 22795084],7032,,,178103611,Inhibitor,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,IC<sub>50</sub> was measured using a SAHH (S-adenosylhomocysteine hydrolase)-coupled <i>in vitro</i> assay.,,,22795084,O=C(Nc1ccc2c(c1)snn2)NCCC1=CCCCC1
protein arginine methyltransferase 5 ,1256,PRMT5,O14744,,,,,,Human,cmp5 [PMID: 25742700],8288,,,252166500,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,25742700,CCn1c2ccc(cc2c2c1cccc2)CNCc1cccnc1
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,C21,7037,,,178103616,Inhibitor,Inhibition,,f,f,,pIC50,0,5.059999943,0,IC50,0,8800,0,=,,,,21838253,
proteinase 3,2401,PRTN3,P24158,,,,,,Human,azapro-3,9221,,,315661297,Inhibitor,Inhibition,,f,f,,pKi,0,5.820000172,0,Ki,0,1500,0,=,,,,22209715,
proteinase 3,2401,PRTN3,P24158,,,,,,Human,compound 11 [PMID: 29442501],9819,,,0,Inhibitor,Inhibition,,f,t,,pKi,0,8.270000458,0,Ki,0,5.400000095,0,=,Inhibition of human PR3 <i>in vitro</i>.,,,29442501,CCCC(P(=O)(Oc1ccc(cc1)Cl)Oc1ccc(cc1)Cl)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)CCCCC1SC[C@H]2[C@@H]1NC(=O)N2)Cc1ccc(cc1)O)CC(=O)O
proteinase 3,2401,PRTN3,P24158,,,,,,Human,compound 4g [PMID: 22595175],8626,,,252166826,Inhibitor,Inhibition,,f,t,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,,,,22595175,COc1ccc(cc1)C(=O)N1C(=O)OC(C1=O)(C)C
"protein C, inactivator of coagulation factors Va and VIIIa",2396,PROC,P04070,,,,,,Human,compound 37 [PMID: 24418773],8612,,,252166813,Inhibitor,Inhibition,,f,t,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,24418773,OC(=O)CN[C@@H](C(=O)N[C@H](C(=O)NCc1ccc(cc1)C(=N)N)Cc1ccc(cc1)N)CC1CCCCC1
protein kinase A,1694,Prkar1a|Prkar2a|Prkar2b|Prkacb|Prkaca|Prkar1b,P27791|P68182|P09456|P81377|P12368|P12369,,,,,,Rat,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,15486189,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase A,1694,Prkar1a|Prkar2a|Prkar2b|Prkacb|Prkaca|Prkar1b,P27791|P68182|P09456|P81377|P12368|P12369,,,,,,Rat,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,10.39999962,0,IC50,0,0.039999999,0,=,Inhibition of PKA extracted from rat brain homogenate.,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,BX-795,8006,,,249565686,Inhibitor,Inhibition,,f,f,,pIC50,0,6.079999924,0,IC50,0,840,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,BX-912,8007,,,249565687,Inhibitor,Inhibition,,f,f,,pIC50,0,6.960000038,0,IC50,0,110,0,=,,,,15772071,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,chelerythrine,5953,,,178102576,Inhibitor,Inhibition,,f,f,,pIC50,0,6.050000191,0,IC50,0,900,0,=,,,,18077363,COc1c(OC)ccc2c1c[n+](C)c1c2ccc2c1cc1OCOc1c2
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,compound 1 [PMID: 21742770],8190,,,249565870,Inhibitor,Inhibition,,f,f,,pIC50,0,6.710000038,0,IC50,0,196,0,=,,,,23256033,COc1cc(ccc1N1CCN(CC1)C)Nc1ccc2c(n1)n(nc2)c1ccc(cc1)OC
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,f,,pIC50,0,6.570000172,0,IC50,0,270,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,8022414,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.539999962,0,IC50,0,34,0,=,,,,8022414,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,bisindolylmaleimide IV,5937,,,178102560,Inhibitor,Inhibition,,f,t,,pIC50,0,6.670000076,0,IC50,0,212,0,=,PKC&beta;2 isoform,,,15380221,O=C1NC(=O)C(=C1c1c[nH]c2c1cccc2)c1c[nH]c2c1cccc2
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,CGP53353,5163,,,178101854,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,398,0,=,,,,9121494,Fc1ccc(cc1)Nc1cc2C(=O)NC(=O)c2cc1Nc1ccc(cc1)F
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,f,,pIC50,0,6.230000019,0,IC50,0,590,0,=,,,,8022414,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,530,0,=,,,,8022414,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,chelerythrine,5953,,,178102576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,18077363,COc1c(OC)ccc2c1c[n+](C)c1c2ccc2c1cc1OCOc1c2
protein kinase C eta,1487,PRKCH,P24723,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,7-hydroxystaurosporine,7907,,,249565590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,8022414,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3[C@H](NC1=O)O
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C theta,1488,PRKCQ,Q04759,,,,,,Human,compound 41 [PMID: 25000588],9349,,,328083451,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,In a biochemical enzyme activity assay,,,25000588,O=C1NN=C2N([C@@H]1C)c1cc(NC3(C)CNC3)c(cc1OC2)C(F)(F)F
protein kinase C zeta,1491,PRKCZ,Q05513,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,7744003,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
protein kinase C zeta,1491,PRKCZ,Q05513,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,7744003,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
protein kinase C zeta,1491,PRKCZ,Q05513,,,,,,Human,balanol,8142,,,249565822,Inhibitor,Inhibition,,f,f,,pIC50,0,5.230000019,0,IC50,0,5900,0,=,,,,8978850,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O
protein kinase C zeta,1491,PRKCZ,Q05513,,,,,,Human,compound 3 [PMID: 19097791],8185,,,249565865,Inhibitor,Inhibition,,f,t,,pIC50,0,8.649999619,0,IC50,0,2.25999999,0,=,,,,19097791,COc1cc(ccc1O)c1ccc2c(c1)[nH]nc2c1nc2c([nH]1)cccc2N1CCN(CC1)C
protein kinase D1,1489,PRKD1,Q15139,,,,,,Human,BPKDi,9370,,,328083472,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,In a biochemical enzyme assay.,,,20018189,NC(=O)c1cc(nc(c1)c1ccnc(c1)NC1CCCCC1)N1CCNCC1
protein kinase D1,1489,PRKD1,Q15139,,,,,,Human,compound 13c [PMID: 20684591],9681,,,348353640,Inhibitor,Inhibition,,f,f,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,Measuring inhibition of synthetic substrate phosphorylation in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.,,,20684591,C1CCC(CC1)Nc1nccc(c1)c1cc2cnccc2c(n1)N1CCNCC1
protein kinase D2,2173,PRKD2,Q9BZL6,,,,,,Human,BPKDi,9370,,,328083472,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,In a biochemical enzyme assay.,,,20018189,NC(=O)c1cc(nc(c1)c1ccnc(c1)NC1CCCCC1)N1CCNCC1
protein kinase D3,2174,PRKD3,O94806,,,,,,Human,BPKDi,9370,,,328083472,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,In a biochemical enzyme assay.,,,20018189,NC(=O)c1cc(nc(c1)c1ccnc(c1)NC1CCCCC1)N1CCNCC1
Protein kinase G (PKG) 2,1493,PRKG2,Q13237,,,,,,Human,compound 32 [PMID: 20471253],8184,,,249565864,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,20471253,O=C([C@@H]1CNC[C@H]1c1ccc(cc1)Cl)Nc1cc2cc[nH]c(=O)c2cc1Cl
protein kinase N1,1520,PKN1,Q16512,,,,,,Human,compound 20 [PMID: 22136433],8156,,,249565836,Inhibitor,Inhibition,,f,f,,pIC50,0,6.510000229,0,IC50,0,310,0,=,,,,22136433,N#CC1c2c3ccc(c(c3n(c2C(=O)NC21CCNCC2)C)Cl)Cl
protein kinase N2,1521,PKN2,Q16513,,,,,,Human,compound 32 [PMID: 20471253],8184,,,249565864,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,20471253,O=C([C@@H]1CNC[C@H]1c1ccc(cc1)Cl)Nc1cc2cc[nH]c(=O)c2cc1Cl
protein phosphatase methylesterase 1,2875,PPME1,Q9Y570,,,,,,Human,ABL127,8608,,,252166809,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,24997602,COC(=O)N1N(C(=O)OC)C(=O)[C@@]1(C1CCCC1)c1ccccc1
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,CEP-37440,9698,,,348353657,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,27527804,OCCN1CCN(CC1)[C@H]1CCCc2c(C1)ccc(c2OC)Nc1ncc(c(n1)Nc1ccccc1C(=O)NC)Cl
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,compound 30 [PMID: 23414845],7864,,,223366194,Inhibitor,Inhibition,,f,t,,pIC50,0,6.190000057,0,IC50,0,640,0,=,,,,23414845,Cn1ncc2c1c1cc(NCc3ccc(cc3)C(C)(C)C)ccc1N(S2(=O)=O)C
protein tyrosine kinase 2 beta,2181,PTK2B,Q14289,,,,,,Human,aloisine,5923,,,178102546,Inhibitor,Inhibition,,f,f,,pKi,0,6.03000021,0,Ki,0,933,0,=,,,,22289061,CCCCc1c([nH]c2c1nccn2)c1ccc(cc1)OC
protein tyrosine kinase 6,2182,PTK6,Q13882,,,,,,Human,compound 19a [PMID: 21855335],8186,,,249565866,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,21855335,Clc1cc(ccc1C(=O)N1CCNCC1(C)C)Nc1nc(cn2c1ncc2c1c[nH]nc1)C1CC1
"protein tyrosine phosphatase, non-receptor type 1",2976,PTPN1,P18031,,,,,,Human,"compound 7b [Haftchenary <i>et al.</i>, 2013]",8850,,,252827507,Inhibitor,Inhibition,,f,f,,pIC50,0,5.309999943,0,IC50,0,4900,0,=,,,,0,O=C(N(c1ccc(c(c1)O)C(=O)O)Cc1ccc(cc1)C1CCCCC1)CN(S(=O)(=O)c1cccc2c1cccc2N(C)C)C
Proton-coupled Amino acid Transporter 1,1161,SLC36A1,Q7Z2H8,,,,,,Human,5-hydroxy-L-tryptophan,4671,,,178101386,Inhibitor,Inhibition,,f,,,pKi,0,3,0,Ki,0,900000,0,,,,,16126914,OC(=O)[C@H](Cc1c[nH]c2c1cc(O)cc2)N
Proton-coupled Amino acid Transporter 1,1161,SLC36A1,Q7Z2H8,,,,,,Human,5-hydroxytryptamine,5,,,135651413,Inhibitor,Inhibition,,f,,,pKi,0,2.2,0,Ki,0,5700000,0,,,,,16126914,NCCc1c[nH]c2c1cc(O)cc2
Proton-coupled Amino acid Transporter 2,1162,SLC36A2,Q495M3,,,,,,Human,5-hydroxy-L-tryptophan,4671,,,178101386,Inhibitor,Inhibition,,f,,,pIC50,0,2.8,0,IC50,0,1600000,0,,,,,20691150,OC(=O)[C@H](Cc1c[nH]c2c1cc(O)cc2)N
Proton-coupled Amino acid Transporter 2,1162,SLC36A2,Q495M3,,,,,,Human,"&alpha;-methyl-D,L-tryptophan",4693,,,178101406,Inhibitor,Inhibition,,f,,,pIC50,0,2.5,0,IC50,0,3500000,0,,,,,20691150,OC(=O)C(Cc1c[nH]c2c1cccc2)(N)C
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,abaloparatide,8299,,,252166511,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,24078470,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ala<sup>1,12</sup>,Aib<sup>3</sup>,Gln<sup>10</sup>,hArg<sup>11</sup>,Trp<sup>14,</sup>Arg<sup>19</sup>]PTH-(1-21)-NH2 (human)",5575,,,178102211,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,-,0,0,0,=,,,,18946036,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ala<sup>1,12</sup>,Aib<sup>3</sup>,Gln<sup>10</sup>,hArg<sup>11</sup>,Trp<sup>14</sup>,Arg<sup>19</sup>]PTH-(1-28)-NH2 (human)",5574,,,178102210,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,-,0,0,0,=,,,,18946036,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ala<sup>1,12</sup>,Aib<sup>3</sup>,Gln<sup>10</sup>,hArg<sup>11</sup>,Trp<sup>14</sup>,Arg<sup>19</sup>]PTH-(1-34)-NH2",5573,,,178102209,Agonist,Full agonist,,f,,,pIC50,0,8.7,0,-,0,0,0,=,,,,18946036,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ala<sup>1,12</sup>,Aib<sup>3</sup>,Gln<sup>10</sup>,hArg<sup>11</sup>,Trp<sup>14</sup>]PTH-(1-14)-NH2",5576,,,178102212,Agonist,Full agonist,,f,,,pIC50,0,4.5,0,-,0,0,0,=,,,,18946036,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,[Arg<sup>19</sup>]PTH-(1-34) (human),1792,,,135651998,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,7896796,
Puromycin-sensitive aminopeptidase,1575,NPEPPS,P55786,,,,,,Human,ANTAQ,8671,,,252166871,Inhibitor,Inhibition,,f,t,,pIC50,0,5.539999962,0,IC50,0,2900,0,=,,,,12467622,O=c1[nH]c2ccccc2c(=O)n1c1c2ccccc2cc2c1cccc2
Px1,735,PANX1,Q96RD7,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Px2,736,PANX2,Q96RD6,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
Px3,737,PANX3,Q96QZ0,,,,,,Human,carbenoxolone,4151,,,178100972,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
pyruvate dehydrogenase kinase 1,2915,PDK1,Q15118,,,,,,Human,AZD7545,9362,,,328083464,Inhibitor,Inhibition,,f,f,,pIC50,0,7.429999828,0,IC50,0,36.79999924,0,=,In a biochemical enzyme assay,,,14641019,CN(C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(c(c1)Cl)NC(=O)[C@](C(F)(F)F)(O)C)C
pyruvate dehydrogenase kinase 2,2142,PDK2,Q15119,,,,,,Human,AZD7545,9362,,,328083464,Inhibitor,Inhibition,,f,f,,pIC50,0,8.18999958,0,IC50,0,6.400000095,0,=,In a biochemical enzyme assay,,,14641019,CN(C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(c(c1)Cl)NC(=O)[C@](C(F)(F)F)(O)C)C
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,compound 25e [PMID: 25875054],9443,,,329968383,Antagonist,Antagonist,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,24937104,CN(Cc1ccc2c(c1)C(C)CN(C2)C(=O)c1cc2c(n1C)cnc(c2)Br)C
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,CCT196969,9815,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,25500121,O=C(Nc1cc(nn1c1ccccc1)C(C)(C)C)Nc1ccc(cc1F)Oc1ccnc2c1ncc(=O)[nH]2
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,CCT241161,9814,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,25500121,CSc1cc(ccc1NC(=O)Nc1cc(nn1c1ccccc1)C(C)(C)C)Oc1ccnc2c1ncc(=O)[nH]2
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,CEP-32496,7880,,,223366209,Inhibitor,Inhibition,,f,f,,pKd,0,7.409999847,0,Kd,0,39,0,=,,,,22168626,COc1cc2c(ncnc2cc1OC)Oc1cccc(c1)NC(=O)Nc1noc(c1)C(C(F)(F)F)(C)C
RAR-related orphan receptor-&alpha;,598,RORA,P35398,,,,,,Human,7-hydroxycholesterol,3432,,,178100434,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,14622968,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2C(O)C=C2[C@]1(C)CC[C@@H](C2)O)C)C
RAR-related orphan receptor-&alpha;,598,RORA,P35398,,,,,,Human,CD2314,8906,,,310264687,Agonist,Agonist,,f,f,,pKd,0,5.420000076,0,Kd,0,3760,0,>,,,,19470764,OC(=O)c1csc(c1)c1ccc2c(c1)cc1c(c2)C(C)(C)CCC1(C)C
RAR-related orphan receptor-&alpha;,598,RORA,P35398,,,,,,Human,cholesterol,2718,,,135651457,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,8858107,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)C
RAR-related orphan receptor-&alpha;,598,RORA,P35398,,,,,,Human,cholesterol sulphate,2738,,,135651458,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,12467577,CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O)C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,CD2314,8906,,,310264687,Agonist,Agonist,,f,t,,pKd,0,6.840000153,0,Kd,0,145,0,=,,,,19470764,OC(=O)c1csc(c1)c1ccc2c(c1)cc1c(c2)C(C)(C)CCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,12958591,C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)C(=O)CCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)C(=O)CCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12958591,C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)C(=O)CCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,all-trans-4-oxo-retinoic acid,2741,,,135649918,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)C(=O)CCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,12958591,C/C(=C\C=C\C(=C\C(=O)O)\C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,pIC50,0,10.4,0,,0,0,0,,,,,12958591,C/C(=C\C=C\C(=C\C(=O)O)\C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,pIC50,0,10.4,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
RAR-related orphan receptor-&gamma;,600,RORC,P51449,,,,,,Human,25-hydroxycholesterol,2885,,,135651392,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,20203100,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCCC(O)(C)C)C)C)C1)C
RAR-related orphan receptor-&gamma;,600,RORC,P51449,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,12958591,C/C(=C\C=C\C(=C\C(=O)O)\C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
RAR-related orphan receptor-&gamma;,600,RORC,P51449,,,,,,Human,ALRT 1550,2740,,,135649927,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/c1cc(cc(c1)C(C)(C)C)C(C)(C)C
Ras converting CAAX endopeptidase 1,2412,RCE1,Q9Y256,,,,,,Human,CID16197121,8579,,,252166780,Inhibitor,Inhibition,Activity reported as AU50,f,t,,pIC50,0,6.730000019,0,IC50,0,186,0,=,,,,0,OCCC[C@@H]1[C@@H](OCC)OC(=C[C@H]1c1csc2c1cccc2)C(=O)Nc1ccccc1
Ras converting CAAX endopeptidase 1,2412,RCE1,Q9Y256,,,,,,Human,compound 3 [PMID: 17942791],8556,,,252166757,Inhibitor,Inhibition,,f,t,,pIC50,0,5.050000191,0,IC50,0,9000,0,=,,,,17942791,OC(=O)c1ccc(cc1)NC(c1ccc2c(c1O)nccc2)c1ccccc1
"RB binding protein 9, serine hydrolase",2874,RBBP9,O75884,,,,,,Human,Ala(1-naph)-Pro-CN,8607,,,252166808,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,880,0,=,,,,24997602,N#C[C@@H]1CCCN1C(=O)[C@H](Cc1cccc2c1cccc2)N
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,6.00E+11,9749,,,0,Inhibitor,Inhibition,,f,t,,pKd,0,6.400000095,0,Kd,0,400,0,=,Binding constant measured at 37<sup>o</sup>C.,,,29018243,COc1cc2OC(O)(CC(=O)c2c(c1)O)c1ccc(cc1)OCc1ccccc1
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,compound 21 [PMID: 24900635],8187,,,249565867,Inhibitor,Inhibition,,f,t,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,24900635,O=C(Nc1cc(ccc1F)C(F)(F)F)Nc1cccc(c1)c1c[nH]c2c1cc(cn2)c1cccc(c1)N
Reduced folate transporter 1,1014,SLC19A1,P41440,,,,,,Human,compound 9 [PMID: 15615544],8890,,,310264671,Inhibitor,Inhibition,,f,f,,pKi,0,6.550000191,0,Ki,0,280,0,=,Inhibition of [<sup>3</sup>H]methotrexate uptake by CCRF-CEM (human T lymphoblast) cells.,,,15615544,OC(=O)CC[C@H](N1Cc2c(C1=O)ccc(c2)NCc1cnc2c(n1)c(N)nc(n2)N)C(=O)O
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione",8726,,,252827384,Inhibitor,Inhibition,,f,f,,pIC50,0,5.090000153,0,IC50,0,8200,0,=,,,,24041654,Fc1cccc(c1)N1NC(=O)/C(=C\2/C(=O)Nc3c2cccc3)/C1=O
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione",8726,,,252827384,Inhibitor,Inhibition,,f,f,,pIC50,0,5.090000153,0,IC50,0,8200,0,=,,,,24041654,Fc1cccc(c1)N1NC(=O)/C(=C2/C(=O)Nc3c2cccc3)/C1=O
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione",8728,,,252827386,Inhibitor,Inhibition,,f,f,,pIC50,0,4.739999771,0,IC50,0,18300,0,=,,,,24041654,Fc1ccc(cc1)N1C(=S)NC(=O)/C(=C\c2ccc(s2)C)/C1=O
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione",8728,,,252827386,Inhibitor,Inhibition,,f,f,,pIC50,0,4.739999771,0,IC50,0,18300,0,=,,,,24041654,Fc1ccc(cc1)N1C(=S)NC(=O)/C(=Cc2ccc(s2)C)/C1=O
regulator of G-protein signaling 4,2811,Rgs4,P49799,,,,,,Rat,5nd,8723,,,252827381,Inhibitor,Inhibition,,f,f,,pIC50,0,4.550000191,0,IC50,0,28000,0,=,Inhibition of G&alpha;<sub>o</sub> binding.,,,19463173,
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione",8727,,,252827385,Inhibitor,Inhibition,,f,f,,pIC50,0,4.559999943,0,IC50,0,27500,0,=,,,,24041654,O=C1NC(=S)N(C(=O)/C/1=C\c1cccs1)c1ccccc1F
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione",8727,,,252827385,Inhibitor,Inhibition,,f,f,,pIC50,0,4.559999943,0,IC50,0,27500,0,=,,,,24041654,O=C1NC(=S)N(C(=O)/C/1=Cc1cccs1)c1ccccc1F
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione",8729,,,252827387,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15300,0,=,,,,24041654,Brc1ccc(s1)/C=C\1/C(=O)NC(=S)N(C1=O)C
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,"(5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione",8729,,,252827387,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15300,0,=,,,,24041654,Brc1ccc(s1)/C=C1/C(=O)NC(=S)N(C1=O)C
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-4986,8721,,,252827379,Inhibitor,Inhibition,,f,f,,pIC50,5.380000114,0,4.739999771,IC50,18000,0,4200,=,Inhibition of G&alpha;<sub>o</sub> binding.,,,17012620,CO/S(=N/S(=O)(=O)c1ccc(cc1)Cl)/c1ccc(cc1)[N+](=O)[O-]
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-50014,7784,,,249565573,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30.10000038,0,=,Inhibition of G&alpha;<sub>o</sub> binding.,,,21329361,Cc1ccc(cc1)n1sc(=O)n(c1=O)Cc1ccc(cc1)F
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-63802,8724,,,252827382,Inhibitor,Inhibition,,f,f,,pIC50,5.71999979,0,5.050000191,IC50,9000,0,1900,=,"Inhibition of G&alpha;<sub>o</sub> binding. The higher affinity value was measured using TR-FRET, the lower value using flow cytometry protein interaction assay (FCPIA).",,,20571077,N#C/C(=C\c1c(Oc2cccc(c2)C)nc2n(c1=O)cccc2C)/c1nc2c(s1)cccc2
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-63802,8724,,,252827382,Inhibitor,Inhibition,,f,f,,pIC50,5.71999979,0,5.050000191,IC50,9000,0,1900,=,"Inhibition of G&alpha;<sub>o</sub> binding. The higher affinity value was measured using TR-FRET, the lower value using flow cytometry protein interaction assay (FCPIA).",,,20571077,N#C/C(=Cc1c(Oc2cccc(c2)C)nc2n(c1=O)cccc2C)/c1nc2c(s1)cccc2
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-63808,8725,,,252827383,Inhibitor,Inhibition,,f,f,,pIC50,5.849999905,0,5,IC50,10000,0,1400,=,"Inhibition of G&alpha;<sub>o</sub> binding. The higher affinity value was measured using TR-FRET, the lower value using flow cytometry protein interaction assay (FCPIA).",,,20571077,N#C/C(=C\c1c(Oc2ccc(cc2)F)nc2n(c1=O)cccc2C)/c1nc2c(s1)cccc2
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,CCG-63808,8725,,,252827383,Inhibitor,Inhibition,,f,f,,pIC50,5.849999905,0,5,IC50,10000,0,1400,=,"Inhibition of G&alpha;<sub>o</sub> binding. The higher affinity value was measured using TR-FRET, the lower value using flow cytometry protein interaction assay (FCPIA).",,,20571077,N#C/C(=Cc1c(Oc2ccc(cc2)F)nc2n(c1=O)cccc2C)/c1nc2c(s1)cccc2
regulator of G-protein signaling 8,2813,RGS8,P57771,,,,,,Human,CCG-50014,7784,,,249565573,Inhibitor,Inhibition,,f,f,,pIC50,0,4.960000038,0,IC50,0,11000,0,=,Inhibition of G&alpha;o binding,,,21329361,Cc1ccc(cc1)n1sc(=O)n(c1=O)Cc1ccc(cc1)F
renin,2413,REN,P00797,,,,,,Human,aliskiren,4812,,,178101514,Inhibitor,Inhibition,,f,t,,pIC50,0,9.199999809,0,IC50,0,0.600000024,0,=,,,,18307734,COCCCOc1cc(ccc1OC)C[C@H](C(C)C)C[C@@H]([C@H](C[C@H](C(=O)NCC(C(=O)N)(C)C)C(C)C)O)N
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,adapalene,5429,,,178102082,Agonist,Agonist,,f,f,,pKi,0,5.960000038,0,Ki,0,1100,0,=,Binding affinity to RAR&alpha; using [<sup>3</sup>H]CD 367 as radioligand.,,,8544175,COc1ccc(cc1C12CC3CC(C2)CC(C1)C3)c1ccc2c(c1)ccc(c2)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,AGN193836,2649,,,135649904,Agonist,Agonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,12372520,O=C(c1cc(F)c(c(c1)F)C(=O)O)Nc1cc2c(c(c1O)Br)C(C)(C)CCC2(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,alitretinoin,2645,,,135651418,Agonist,Agonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,3184125,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,BMS753,2650,,,135650006,Agonist,Agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,10421757,O=C(c1ccc2c(c1)C(C)(C)C(=O)C2(C)C)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,CD666,2652,,,53801005,Agonist,Agonist,,f,,,pKd,0,5.65,0,,0,0,0,,,,,1323296,OC(c1ccc2c(c1)C(C)(C)CCC2(C)C)/C=C/c1ccc(cc1)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,BMS614,2643,,,135650004,Antagonist,Antagonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,10882070,O=C(c1ccc2c(c1)C(=CCC2(C)C)c1cnc2c(c1)cccc2)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,AGN193109,2640,,,135649903,Antagonist,Inverse agonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,8798442,Cc1ccc(cc1)C1=CCC(c2c1cc(cc2)C#Cc1ccc(cc1)C(=O)O)(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,BMS493,2641,,,135650003,Antagonist,Inverse agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,11805839,OC(=O)c1ccc(cc1)/C=C/c1ccc2c(c1)C(=CCC2(C)C)C#Cc1ccccc1
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,adapalene,5429,,,178102082,Agonist,Agonist,,f,t,,pKi,0,7.46999979,0,Ki,0,34,0,=,Binding affinity to RAR&beta; using [<sup>3</sup>H]CD 367 as radioligand.,,,8544175,COc1ccc(cc1C12CC3CC(C2)CC(C1)C3)c1ccc2c(c1)ccc(c2)C(=O)O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,alitretinoin,2645,,,135651418,Agonist,Agonist,,f,t,,pKi,0,9.699999809,0,-,0,0,0,=,,,,10964567,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,BMS641,2651,,,135650005,Agonist,Agonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,15319780,Clc1cc(ccc1/C=C/c1ccc2c(c1)C(=CCC2(C)C)c1ccccc1)C(=O)O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,CD666,2652,,,53801005,Agonist,Agonist,,f,,,pKd,0,5.64,0,,0,0,0,,,,,1323296,OC(c1ccc2c(c1)C(C)(C)CCC2(C)C)/C=C/c1ccc(cc1)C(=O)O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,AC261066,4054,,,178100878,Agonist,Full agonist,,f,,,pEC50,8.1,0,7.9,-,0,0,0,=,,,,16302793,CCCCOCCOc1nc(sc1C)c1ccc(c(c1)F)C(=O)O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,AC55649,4055,,,178100879,Agonist,Full agonist,,f,f,,pEC50,7.300000191,0,6.900000095,-,0,0,0,=,Affinity for RAR&beta;2 isoform.,,,16302793,CCCCCCCCc1ccc(cc1)c1ccc(cc1)C(=O)O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,AGN193109,2640,,,135649903,Antagonist,Inverse agonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,8798442,Cc1ccc(cc1)C1=CCC(c2c1cc(cc2)C#Cc1ccc(cc1)C(=O)O)(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,BMS493,2641,,,135650003,Antagonist,Inverse agonist,,f,,,pIC50,0,8.54,0,,0,0,0,,,,,11805839,OC(=O)c1ccc(cc1)/C=C/c1ccc2c(c1)C(=CCC2(C)C)C#Cc1ccccc1
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,adapalene,5429,,,178102082,Agonist,Agonist,,f,t,,pKi,0,6.889999866,0,Ki,0,130,0,=,Binding affinity to RAR&gamma; using [<sup>3</sup>H]CD 367 as radioligand.,,,8544175,COc1ccc(cc1C12CC3CC(C2)CC(C1)C3)c1ccc2c(c1)ccc(c2)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,AHPN,3431,,,178100433,Agonist,Agonist,,f,,,pKi,0,7.11,0,Ki,0,77,0,=,,,,8544175,Oc1ccc(cc1C12CC3CC(C2)CC(C1)C3)c1ccc2c(c1)ccc(c2)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,alitretinoin,2645,,,135651418,Agonist,Agonist,,f,t,,pKd,0,9,0,-,0,0,0,=,,,,10964567,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,BMS270394,2653,,,135650002,Agonist,Agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10964567,O[C@H](c1ccc2c(c1)C(C)(C)CCC2(C)C)C(=O)Nc1ccc(cc1F)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,CD666,2652,,,53801005,Agonist,Agonist,,f,,,pKd,0,7.17,0,,0,0,0,,,,,1323296,OC(c1ccc2c(c1)C(C)(C)CCC2(C)C)/C=C/c1ccc(cc1)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,AGN193109,2640,,,135649903,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,8798442,Cc1ccc(cc1)C1=CCC(c2c1cc(cc2)C#Cc1ccc(cc1)C(=O)O)(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,BMS493,2641,,,135650003,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,11805839,OC(=O)c1ccc(cc1)/C=C/c1ccc2c(c1)C(=CCC2(C)C)C#Cc1ccccc1
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,CD2665,2654,,,135650059,Antagonist,Antagonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,9187263,COCCOCOc1cc2ccc(cc2cc1C12CC3CC(C2)CC(C1)C3)c1ccc(cc1)C(=O)O
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)\C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,alitretinoin,2645,,,135651418,Agonist,Agonist,,t,,,pIC50,8.199999809,0,7.099999905,-,0,0,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,bexarotene,2807,,,135650520,Agonist,Agonist,,f,t,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,10637371,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,,,,,,,,None,CD3254,2810,,,135650060,Agonist,Agonist,,f,f,,pIC50,0,8.5,0,-,0,0,0,=,,,,11805839,OC(=O)/C=C/c1ccc(c(c1)c1cc2c(cc1C)C(C)(C)CCC2(C)C)O
Retinoid X receptor-&beta;,611,Rxrb,P28704,,,,,,Mouse,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pIC50,0,8.44,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)\C
Retinoid X receptor-&beta;,611,Rxrb,P28704,,,,,,Mouse,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pIC50,0,8.44,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)C
Retinoid X receptor-&beta;,611,,,,,,,,None,alitretinoin,2645,,,135651418,Agonist,Agonist,,t,,,pIC50,8.2,0,6.9,,0,0,0,,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&beta;,611,RXRB,P28702,,,,,,Human,bexarotene,2807,,,135650520,Agonist,Agonist,,f,t,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,10637371,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&gamma;,612,,,,,,,,None,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)\C
Retinoid X receptor-&gamma;,612,,,,,,,,None,AGN194204,2811,,,135649905,Agonist,Agonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,11428923,OC(=O)/C=C(/C=C/C1CC1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)C
Retinoid X receptor-&gamma;,612,RXRG,P48443,,,,,,Human,alitretinoin,2645,,,135651418,Agonist,Agonist,,t,,,pIC50,8,0,7,,0,0,0,,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&gamma;,612,RXRG,P48443,,,,,,Human,bexarotene,2807,,,135650520,Agonist,Agonist,,f,t,,pIC50,0,7.539999962,0,-,0,0,0,=,,,,10637371,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(=O)O)C(C)(C)CCC2(C)C
retinol binding protein 4,2549,RBP4,P02753,,,,,,Human,A1120,8792,,,252827450,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,Measured using a FRET assay to monitor human RBP4?transthyretin interaction.,,,24835984,O=C(N1CCC(CC1)c1ccccc1C(F)(F)F)Nc1ccccc1C(=O)O
ret proto-oncogene,2185,RET,P07949,,,,,,Human,apatinib,7648,,,223365983,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,Assay used apatinib mesylate (YN968D1),,,21443688,N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,AST-487,5661,,,178102289,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,880,0,=,<i>In vitro</i> inhibition of wild type RET.,,,17638907,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC
ret proto-oncogene,2185,RET,P07949,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,compound 1d [PMID: 21493067],8123,,,249565803,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,21493067,N#Cc1cc(F)c(nc1N[C@H](c1ccc(cn1)F)C)Nc1n[nH]c(c1)C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
Rev-Erb-&beta;,597,NR1D2,Q14995,,,,,,Human,cobalt protoporphyrin IX,8902,,,310264683,Antagonist,Antagonist,,f,f,,pKd,0,5.590000153,0,Kd,0,2560,0,=,,,,24872411,C=CC1=C(C)C2=NC1=Cc1[n-]c(c(c1C)CCC(=O)O)C=C1N=C(C=c3[n-]c(=C2)c(C=C)c3C)C(=C1CCC(=O)O)C.[Co+2]
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,compound 22 [PMID: 20462760],8205,,,249565885,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,,,,20462760,O=C(C(c1ccccc1)NC1CC1)Nc1cc2cc[nH]c(=O)c2cc1Cl
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,compound 35 [PMID: 20684608],8209,,,249565889,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,20684608,COc1ccc2c(c1)C[C@@H](NC2)C(=O)Nc1ccc(cc1OCC1CCN(CC1)C)c1c[nH]nc1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,compound 11d [DOI: 10.1039/c0md00194e],8197,,,249565877,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,0,OCCCOc1cc(ccc1NC(=O)[C@@H]1COc2c(C1)cc(cc2)OC)c1c[nH]nc1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,compound 22 [PMID: 20462760],8205,,,249565885,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,20462760,O=C(C(c1ccccc1)NC1CC1)Nc1cc2cc[nH]c(=O)c2cc1Cl
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,compound 32 [PMID: 20471253],8184,,,249565864,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,20471253,O=C([C@@H]1CNC[C@H]1c1ccc(cc1)Cl)Nc1cc2cc[nH]c(=O)c2cc1Cl
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,compound 35 [PMID: 20684608],8209,,,249565889,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,20684608,COc1ccc2c(c1)C[C@@H](NC2)C(=O)Nc1ccc(cc1OCC1CCN(CC1)C)c1c[nH]nc1
ribonucleotide reductase catalytic subunit M1,2630,RRM1,P23921,,,,,,Human,clofarabine,6802,,,178103408,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,Inhibition of K562 cell growth,,,1707752,OC[C@H]1O[C@H]([C@H]([C@@H]1O)F)n1cnc2c1nc(Cl)nc2N
ribonucleotide reductase regulatory subunit M2,2631,RRM2,P31350,,,,,,Human,clofarabine,6802,,,178103408,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,Inhibition of growth of K562 cells,,,1707752,OC[C@H]1O[C@H]([C@H]([C@@H]1O)F)n1cnc2c1nc(Cl)nc2N
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,BI-D1870,8038,,,249565718,Inhibitor,Inhibition,,f,t,,pIC50,0,7.510000229,0,IC50,0,31,0,=,,,,17040210,CC(CCN1C(C)C(=O)N(c2c1nc(nc2)Nc1cc(F)c(c(c1)F)O)C)C
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,compound 33 [PMID: 19364658],8163,,,249565843,Inhibitor,Inhibition,,f,f,,pIC50,0,6.539999962,0,IC50,0,290,0,=,,,,19364658,Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
ribosomal protein S6 kinase A2,1529,RPS6KA2,Q15349,,,,,,Human,BI-D1870,8038,,,249565718,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,17040210,CC(CCN1C(C)C(=O)N(c2c1nc(nc2)Nc1cc(F)c(c(c1)F)O)C)C
ribosomal protein S6 kinase A2,1529,RPS6KA2,Q15349,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
ribosomal protein S6 kinase A3,1528,RPS6KA3,P51812,,,,,,Human,BI-D1870,8038,,,249565718,Inhibitor,Inhibition,,f,t,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,17040210,CC(CCN1C(C)C(=O)N(c2c1nc(nc2)Nc1cc(F)c(c(c1)F)O)C)C
ribosomal protein S6 kinase A3,1528,RPS6KA3,P51812,,,,,,Human,BIX 02565,8039,,,249565719,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,22056746,CN(CCCn1c(NC(=O)c2ccc3c(c2)n2[C@H](C)CCNC(=O)c2c3)nc2c1cccc2)C
ribosomal protein S6 kinase A3,1528,RPS6KA3,P51812,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
ribosomal protein S6 kinase A3,1528,RPS6KA3,P51812,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
ribosomal protein S6 kinase A4,1524,RPS6KA4,O75676,,,,,,Human,compound 8 [PMID: 17480064],8763,,,252827421,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3010,0,=,,,,17480064,O=C1NCCc2c1cc([nH]2)c1ccncc1
ribosomal protein S6 kinase A5,1523,RPS6KA5,O75582,,,,,,Human,compound 24 [PMID: 15955699],8131,,,249565811,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,15955699,CCn1c(nc2c1c(CN1CCNCC1)cnc2)c1nonc1N
ribosomal protein S6 kinase A6,1530,RPS6KA6,Q9UK32,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,f,,pIC50,8,0,7.519999981,IC50,30,0,10,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
ribosomal protein S6 kinase A6,1530,RPS6KA6,Q9UK32,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,f,,pIC50,8,0,7.519999981,IC50,30,0,10,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
ribosomal protein S6 kinase A6,1530,RPS6KA6,Q9UK32,,,,,,Human,BI-D1870,8038,,,249565718,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,17040210,CC(CCN1C(C)C(=O)N(c2c1nc(nc2)Nc1cc(F)c(c(c1)F)O)C)C
ribosomal protein S6 kinase A6,1530,RPS6KA6,Q9UK32,,,,,,Human,compound 25b [PMID: 22564207],8139,,,249565819,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,22564207,COc1c(ccc2c1CC[C@H](CC2)N1CCOCC1)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
ribosomal protein S6 kinase B1,1525,RPS6KB1,P23443,,,,,,Human,compound 1 [PMID: 20005102],8181,,,249565861,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,20005102,N[C@@H](Cc1c[nH]c2c1cccc2)COc1cnc(c(c1)c1ccc2c(c1)c(C)[nH]n2)c1cocc1
RTP Type B,1851,PTPRB,P23467,,,,,,Human,compound 13e [PMID: 16759857],8786,,,252827444,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,16759857,Cc1noc(n1)C(c1onc(n1)C)(Cc1ccc(cc1)NS(=O)(=O)O)CCCc1ccccc1
RTP Type G,1856,PTPRG,P23470,,,,,,Human,compound 1 [PMID: 21882820],8831,,,252827488,Inhibitor,Inhibition,,f,f,,pKi,0,5.599999905,0,Ki,0,2500,0,=,,,,21882820,OC(=O)c1sccc1SCc1ccc(c(c1)Cl)Cl
RTP Type M,1860,PTPRM,P28827,,,,,,Human,compound 8a [PMID: 23713581],8856,,,252827513,Inhibitor,Inhibition,,f,f,,pIC50,0,5.150000095,0,IC50,0,7000,0,=,,,,23713581,CCCNC(=O)COc1ccc(cc1)c1oc2c(c1C#Cc1cccc(c1)Cl)cc(c(c2)O)C(=O)O
RTP Type S,1866,PTPRS,Q13332,,,,,,Human,"compound 7b [Haftchenary <i>et al.</i>, 2013]",8850,,,252827507,Inhibitor,Inhibition,,f,f,,pIC50,0,5.440000057,0,IC50,0,3600,0,=,,,,0,O=C(N(c1ccc(c(c1)O)C(=O)O)Cc1ccc(cc1)C1CCCCC1)CN(S(=O)(=O)c1cccc2c1cccc2N(C)C)C
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,A(4-24)(B7-24)H2,8346,,,252166558,Agonist,Full agonist,,f,f,,pKd,0,6.989999771,0,-,0,0,0,=,,,,21878627,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,A(4-24)(B7-24)H2,8346,,,252166558,Agonist,Full agonist,,f,f,,pEC50,0,8.220000267,0,-,0,0,0,=,,,,21878627,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,A(4-24)(F23A)H2,8349,,,252166561,Agonist,Full agonist,,f,f,,pKi,0,9.170000076,0,-,0,0,0,=,,,,23024363,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,A(4-24)(F23A)H2,8349,,,252166561,Agonist,Full agonist,,f,f,,pEC50,0,9.819999695,0,-,0,0,0,=,,,,23024363,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,(B7-33)H2,9321,,,318164840,Agonist,Full agonist,,f,f,,pKi,0,5.5,0,-,0,0,0,=,,,,0,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,B-R13/17K H2 relaxin,4371,,,178101185,Antagonist,Antagonist,,f,f,,pEC50,6.699999809,0,5.659999847,-,0,0,0,=,,,,20043231,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,B-R13/17K H2 relaxin,4371,,,178101185,Antagonist,Antagonist,,f,f,,pKi,6.289999962,0,5.03000021,-,0,0,0,=,,,,20043231,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(10-24)INSL3,8330,,,252166542,Antagonist,Antagonist,,f,f,,pKi,0,8.670000076,0,-,0,0,0,=,,,,18434306,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(4-24)(B7-24)H2,8346,,,252166558,Antagonist,Antagonist,,f,f,,pEC50,0,6,0,-,0,0,0,=,,,,21878627,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(4-24)(B7-24)H2,8346,,,252166558,Antagonist,Antagonist,,f,f,,pKi,0,6,0,-,0,0,0,=,,,,21878627,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(9-26)INSL3,8329,,,252166541,Antagonist,Antagonist,,f,f,,pKi,0,9.140000343,0,-,0,0,0,=,,,,18434306,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(C10/15S)INSL3,8331,,,252166543,Antagonist,Antagonist,,f,f,,pKi,0,8.590000153,0,-,0,0,0,=,,,,20570702,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,A(&Delta;10/15C)INSL3,8332,,,252166544,Antagonist,Antagonist,,f,f,,pKi,0,8.319999695,0,-,0,0,0,=,,,,20570702,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,135PAM1,8343,,,252166555,Allosteric modulator,Positive,,f,f,,pEC50,0,6.119999886,0,-,0,0,0,=,,,,22347403,COc1ccc2c(c1)c(CCN(C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F)Cc1ccc(c(c1)Cl)Cl)c[nH]2
RyR1,747,RYR1,P21817,,,,,,Human,ATP,1713,,,135651446,Activator,None,endogenous; mM range,t,f,,-,0,0,0,-,0,0,0,=,,,cytosolic,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
RyR1,747,RYR1,P21817,,,,,,Human,caffeine,407,,,135652675,Activator,None,pharmacological; mM range,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Cn1cnc2c1c(=O)n(C)c(=O)n2C
RyR1,747,RYR1,P21817,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,endogenous,t,f,,-,0,0,0,-,0,0,0,=,,,luminal,0,
RyR1,747,RYR1,P21817,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,endogenous; &mu;M range,t,f,,-,0,0,0,-,0,0,0,=,,,cytosolic,0,
RyR1,747,RYR1,P21817,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Antagonist,Antagonist,,t,,>100,-,0,0,0,-,0,0,0,=,,,cytosolic,0,
RyR2,748,RYR2,Q92736,,,,,,Human,ATP,1713,,,135651446,Activator,None,endogenous; mM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
RyR2,748,RYR2,Q92736,,,,,,Human,caffeine,407,,,135652675,Activator,None,pharmacological; mM range,f,,,-,0,0,0,,0,0,0,,,,,0,Cn1cnc2c1c(=O)n(C)c(=O)n2C
RyR2,748,RYR2,Q92736,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,endogenous; &mu;M range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
RyR2,748,RYR2,Q92736,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,endogenous,t,,,-,0,0,0,,0,0,0,,,,luminal,0,
RyR2,748,RYR2,Q92736,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Antagonist,Antagonist,,t,,>1000,-,0,0,0,,0,0,0,,,,cytosolic,0,
RyR3,749,RYR3,Q15413,,,,,,Human,ATP,1713,,,135651446,Activator,None,endogenous; mM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
RyR3,749,RYR3,Q15413,,,,,,Human,caffeine,407,,,135652675,Activator,None,pharmacological; mM range,f,,,-,0,0,0,,0,0,0,,,,,0,Cn1cnc2c1c(=O)n(C)c(=O)n2C
RyR3,749,RYR3,Q15413,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,endogenous; &mu;M range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
RyR3,749,RYR3,Q15413,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Antagonist,Antagonist,,t,,>1000,-,0,0,0,,0,0,0,,,,cytosolic,0,
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,A-971432,9496,,,329968436,Agonist,Agonist,,f,f,,pIC50,0,6.440000057,0,IC50,0,362,0,=,,,,26509640,OC(=O)C1CN(C1)Cc1ccc(cc1)OCc1ccc(c(c1)Cl)Cl
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,AFD(R),2937,,,135649899,Agonist,Agonist,,f,f,,pEC50,8.800000191,0,8.399999619,-,0,0,0,=,,,,11967257,CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,amiselimod phosphate,9491,,,329968431,Agonist,Agonist,,f,f,,pEC50,0,10.11999989,0,EC50,0,0.075000003,0,=,In an intracellular Ca<sup>2+</sup> mobilization assay.,,,27714763,CCCCCCCOc1ccc(cc1C(F)(F)F)CC[C@](COP(=O)(O)O)(CO)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,ASP4058,9569,,,336446955,Agonist,Agonist,,f,t,,pIC50,0,8.130000114,0,IC50,0,7.400000095,0,=,In a GTP&gamma;S binding assay.,,,25347187,C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,AUY954,2925,,,135649973,Agonist,Agonist,,f,f,,pEC50,0,8.920000076,0,EC50,0,1.200000048,0,=,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,AUY954,2925,,,135649973,Agonist,Agonist,,f,f,,pEC50,0,9.050000191,0,EC50,0,0.899999976,0,=,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,cenerimod,9824,,,0,Agonist,Agonist,,f,t,,pEC50,0,9,0,EC50,0,1,0,=,,,,29226621,OC[C@@H](COc1c(C)cc(cc1CC)c1noc(n1)c1cc(OC)nc(c1)C1CCCC1)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,compound 26 [PMID: 16190743],2929,,,135649942,Agonist,Agonist,,f,,,pIC50,0,9.22,0,,0,0,0,,,,,16190743,CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,compound 43 [PMID: 26751273],9492,,,329968432,Agonist,Agonist,,f,t,,pEC50,0,8.800000191,0,-,0,0,0,=,In &beta;-arrestin and receptor internalisation assays.,,,26751273,OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C
S1P<sub>2</sub> receptor,276,S1pr2,P52592,,,,,,Mouse,AUY954,2925,,,135649973,Agonist,Agonist,,f,,,pEC50,5,0,4.7,,0,0,0,,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,compound 43 [PMID: 26751273],9492,,,329968432,Agonist,Agonist,,f,f,,pEC50,0,4.5,0,EC50,0,31628,0,<,In a S1P<sub>2</sub>R yeast reporter assay.,,,26751273,OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,compound 16 [PMID: 26794040],9223,,,315661299,Antagonist,Antagonist,,f,t,,pIC50,0,8.090000153,0,IC50,0,8.199999809,0,=,,,,26794040,Fc1ccc(cc1)Oc1cc(Oc2ccc(cc2)C(C(=O)O)(C)C)cc(c1)NC(=O)N1CCC(C1)(O)CC(C)C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,AFD(R),2937,,,135649899,Agonist,Agonist,,f,f,,pEC50,9.399999619,0,7.800000191,-,0,0,0,=,,,,11967257,CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,ASP4058,9569,,,336446955,Agonist,Agonist,,f,f,,pEC50,0,6.039999962,0,EC50,0,920,0,=,In a GTP&gamma;S binding assay.,,,25347187,C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2
S1P<sub>3</sub> receptor,277,S1pr3,Q9Z0U9,,,,,,Mouse,AUY954,2925,,,135649973,Agonist,Agonist,,f,f,,pEC50,5.960000038,0,5.900000095,-,0,0,0,=,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,compound 26 [PMID: 16190743],2929,,,135649942,Agonist,Agonist,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,16190743,CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,compound 43 [PMID: 26751273],9492,,,329968432,Agonist,Agonist,,f,f,,pEC50,0,5.099999905,0,EC50,0,7943,0,=,In a GTP&gamma;S assay.,,,26751273,OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,AFD(R),2937,,,135649899,Agonist,Agonist,,f,f,,pEC50,8.399999619,0,8.300000191,-,0,0,0,=,,,,11967257,CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,ASP4058,9569,,,336446955,Agonist,Agonist,,f,f,,pEC50,0,5.639999866,0,EC50,0,2300,0,=,In a GTP&gamma;S binding assay.,,,25347187,C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2
S1P<sub>4</sub> receptor,278,S1pr4,Q9Z0L1,,,,,,Mouse,AUY954,2925,,,135649973,Agonist,Agonist,,f,,,pEC50,6,0,5,,0,0,0,,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,compound 26 [PMID: 16190743],2929,,,135649942,Agonist,Agonist,,f,,,pIC50,0,7.15,0,,0,0,0,,,,,16190743,CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,compound 43 [PMID: 26751273],9492,,,329968432,Agonist,Agonist,,f,f,,pEC50,0,4.400000095,0,EC50,0,39810,0,<,In an aequorin calcium accumulation assay.,,,26751273,OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,compound 5c [PMID: 27894870],9495,,,329968435,Agonist,Agonist,,f,t,,pEC50,0,6.809999943,0,EC50,0,154,0,=,In a cAMP assay.,,,27894870,OC(=O)CCCNCc1cc2c(s1)c(ccc2)c1ccc2c(c1)cccc2
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,compound 5c [PMID: 27894870],9495,,,329968435,Agonist,Agonist,,f,t,,pEC50,0,6.699999809,0,EC50,0,200,0,=,In a GTP&gamma;S binding assay.,,,27894870,OC(=O)CCCNCc1cc2c(s1)c(ccc2)c1ccc2c(c1)cccc2
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,A-971432,9496,,,329968436,Agonist,Agonist,,f,t,,pEC50,0,8.239999771,0,EC50,0,5.699999809,0,=,In a GTP&gamma;S assay using membranes from S1P<sub>5</sub>-transfected HEK293 cells.,,,26509640,OC(=O)C1CN(C1)Cc1ccc(cc1)OCc1ccc(c(c1)Cl)Cl
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,A-971432,9496,,,329968436,Agonist,Agonist,,f,t,,pEC50,0,8.390000343,0,EC50,0,4.099999905,0,=,In a forskolin-induced cAMP inhibition assay in S1P<sub>5</sub>-transfected CHO cells.,,,26509640,OC(=O)C1CN(C1)Cc1ccc(cc1)OCc1ccc(c(c1)Cl)Cl
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,AFD(R),2937,,,135649899,Agonist,Agonist,,f,f,,pEC50,9.699999809,0,8,-,0,0,0,=,,,,11967257,CCCCCCCOc1ccc(cc1)CC[C@](COP(=O)(O)O)(N)C
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,ASP4058,9569,,,336446955,Agonist,Agonist,,f,t,,pEC50,0,8.119999886,0,EC50,0,7.5,0,=,In a GTP&gamma;S binding assay.,,,25347187,C[C@@H](C(F)(F)F)Oc1ccc(cc1C(F)(F)F)c1onc(n1)c1ccc2c(c1)nc[nH]2
S1P<sub>5</sub> receptor,279,S1pr5,Q91X56,,,,,,Mouse,AUY954,2925,,,135649973,Agonist,Agonist,,f,,,pEC50,0,6.5,0,,0,0,0,,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,AUY954,2925,,,135649973,Agonist,Agonist,,f,f,,pEC50,0,6.46999979,0,EC50,0,340,0,=,,,,17114004,OC(=O)CCNCc1ccc2c(c1)cc(s2)c1ccc(c(c1)C(F)(F)F)c1ccccc1
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,compound 26 [PMID: 16190743],2929,,,135649942,Agonist,Agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,16190743,CC(Cc1ccc(cc1)c1onc(n1)c1ccc(cc1)CN1CC(C1)C(=O)O)C
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,compound 43 [PMID: 26751273],9492,,,329968432,Agonist,Agonist,,f,f,,pEC50,0,7.78000021,0,EC50,0,16.60000038,0,=,In an aequorin calcium accumulation assay.,,,26751273,OC(=O)CCN1CCc2c(C1)c(C)n(n2)c1nnc(s1)c1ccc(c(c1)Cl)OC(C)C
S-Adenosylhomocysteine hydrolase,1233,AHCY,P23526,,,,,,Human,3-deazaadenosine,5115,,,178101808,Inhibitor,Inhibition,,f,,,pIC50,0,8.5,0,IC50,0,3.16,0,,,,,7470463,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ccnc2N
salt inducible kinase 1,2197,SIK1,P57059,,,,,,Human,ARN-3236,9581,,,340590212,Inhibitor,Inhibition,,f,f,,pIC50,0,7.670000076,0,IC50,0,21.60000038,0,=,In an <i>in vitro</i> enzymatic assay.,,,26590148,COc1cc(OC)ccc1c1c[nH]c2c1c(ccn2)c1cscc1
salt inducible kinase 1,2197,SIK1,P57059,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,25351958,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
salt inducible kinase 1,2197,SIK1,P57059,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,8.260000229,0,IC50,0,5.5,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
salt inducible kinase 2,2198,SIK2,Q9H0K1,,,,,,Human,ARN-3236,9581,,,340590212,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,In an <i>in vitro</i> enzymatic assay.,,,26590148,COc1cc(OC)ccc1c1c[nH]c2c1c(ccn2)c1cscc1
salt inducible kinase 2,2198,SIK2,Q9H0K1,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,25351958,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
secretin receptor,252,Sctr,P23811,,,,,,Rat,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,7.7,0,IC50,0,20,0,=,Inhibition of [125I]Tyr25 secretin binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
secretin receptor,252,Sctr,P23811,,,,,,Rat,"[Bpa<sup>6</sup>,Tyr<sup>10</sup>]secretin-27 (rat)",1154,,,135652046,Agonist,Full agonist,,f,,,pKd,0,7.6,0,,0,0,0,,,,,10383421,
secretin receptor,252,SCTR,P47872,,,,,,Human,"[(CH<sub>2</sub>NH)<sup>4,5</sup>]secretin",3755,,,178100608,Antagonist,Antagonist,,f,f,,pKi,0,5.300000191,0,Ki,0,5010,0,=,,,,1702423,
serine protease 1,2397,PRSS1,P07477,,,,,,Human,camostat,6432,,,178103048,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50.59999847,0,=,,,,7629790,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C
serine protease 1,2397,PRSS1,P07477,,,,,,Human,compound 9 [PMID: 3514912],8559,,,252166760,Inhibitor,Inhibition,,f,f,,pIC50,0,7.710000038,0,IC50,0,19.5,0,=,,,,3514912,O=C(c1ccc(cc1)N=C(N)N)Oc1ccc(cc1)C
serine protease 3,2399,PRSS3,P35030,,,,,,Human,BPTI-K15R/R17G,7897,,,315661094,Inhibitor,Inhibition,,f,f,,pKi,0,8.229999542,0,Ki,0,5.900000095,0,=,,,,21806544,
serine protease 8,2400,PRSS8,Q16651,,,,,,Human,B3C,7859,,,223366189,Inhibitor,Inhibition,,f,t,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,18752942,NCCCC[C@@H](C(c1nc2c(o1)cccc2)(O)O)NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@H](NC(=O)OCc1ccccc1)CCc1ccccc1)OCc1ccc(cc1)C
serine/threonine kinase 10,2211,STK10,O94804,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,None,,f,f,,pIC50,0,7.28000021,0,IC50,0,52,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
serine/threonine kinase 16,2213,STK16,O75716,,,,,,Human,compound 27 [PMID: 21123062],8210,,,249565890,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21123062,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)N(CC)C(=O)CCC2(C)C)F
serine/threonine kinase 17a,2214,STK17A,Q9UEE5,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1\N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
serine/threonine kinase 17a,2214,STK17A,Q9UEE5,,,,,,Human,AT-9283,7949,,,249565632,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,19143567,O=C(Nc1c[nH][nH]/c/1=C/1N=c2c(=N1)ccc(c2)CN1CCOCC1)NC1CC1
serine/threonine kinase 24,2217,STK24,Q9Y6E0,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.409999847,0,IC50,0,3.900000095,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
serine/threonine kinase 3,2219,STK3,Q13188,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
serine/threonine kinase 31,2220,STK31,Q9BXU1,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.849999905,0,Ki,0,1422,0,>,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
serine/threonine kinase 32B,1538,STK32B,Q9NY57,,,,,,Human,compound 74 [PMID: 24793884],8219,,,249565899,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,Clc1ccc(c(c1)Cl)c1nc(sc1C(=O)N)c1ccnc(n1)N
serine/threonine kinase 33,2221,STK33,Q9BYT3,,,,,,Human,compound 1 [PMID: 21742770],8190,,,249565870,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,21742770,COc1cc(ccc1N1CCN(CC1)C)Nc1ccc2c(n1)n(nc2)c1ccc(cc1)OC
Serine/threonine kinase 38,1517,STK38,Q15208,,,,,,Human,compound 35 [PMID: 20684608],8209,,,249565889,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 3&mu;M compound.,,,20684608,COc1ccc2c(c1)C[C@@H](NC2)C(=O)Nc1ccc(cc1OCC1CCN(CC1)C)c1c[nH]nc1
Serine/threonine kinase 38 like,1518,STK38L,Q9Y2H1,,,,,,Human,compound 27 [PMID: 21123062],8210,,,249565890,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21123062,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)N(CC)C(=O)CCC2(C)C)F
serine/threonine kinase 4,2225,STK4,Q13043,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,191,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
serine/threonine kinase 4,2225,STK4,Q13043,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
serine/threonine kinase 4,2225,STK4,Q13043,,,,,,Human,compound 38 [PMID: 20817473],8768,,,252827426,Inhibitor,Inhibition,,f,f,,pIC50,0,6.389999866,0,IC50,0,412,0,=,,,,20817473,O=C(c1ccc(cc1)N1CCOCC1)Nc1n[nH]c2c1sc(c2)C(=O)N[C@@H](c1ccccc1)CN1CCCC1
serine/threonine-protein kinase NIM1,2291,NIM1K,Q8IY84,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,>,,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
SERT,928,SLC6A4,P31645,,,,,,Human,amitriptyline,200,,,135649939,Inhibitor,Inhibition,,f,t,,pKi,0,6.849999905,0,Ki,0,141,0,=,,,,23602445,CN(CCC=C1c2ccccc2CCc2c1cccc2)C
SERT,928,SLC6A4,P31645,,,,,,Human,amoxapine,201,,,135649941,Inhibitor,Inhibition,,f,t,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,0,Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
SERT,928,SLC6A4,P31645,,,,,,Human,atomoxetine,7118,,,178103695,Inhibitor,Inhibition,,f,f,,pKd,0,8.050000191,0,Kd,0,8.899999619,0,=,,,,9871604,CNCC[C@H](c1ccccc1)Oc1ccccc1C
SERT,928,SLC6A4,P31645,,,,,,Human,citalopram,7547,,,223365883,Inhibitor,Inhibition,,f,t,,pKi,0,8.359999657,0,Ki,0,4.380000114,0,=,Displacement of [<sup>3</sup>H]citalopram from human SERT expressed in HEK293 cells.,,,18487050,N#Cc1ccc2c(c1)COC2(CCCN(C)C)c1ccc(cc1)F
SERT,928,SLC6A4,P31645,,,,,,Human,clomipramine,2398,,,135650111,Inhibitor,Inhibition,,f,t,,pKi,0,9.680000305,0,Ki,0,0.209999993,0,=,,,,9537821,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
SERT,928,SLC6A4,P31645,,,,,,Human,clomipramine,2398,,,135650111,Inhibitor,Inhibition,,f,t,,pKd,0,9.550000191,0,Kd,0,0.280000001,0,=,,,,9537821,CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C
serum/glucocorticoid regulated kinase 1,1534,SGK1,O00141,,,,,,Human,compound 14n [PMID: 25589934],9423,,,328083523,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,at low (10&mu;M) ATP concentration,,,25589934,Clc1ccc(c(c1)S(=O)(=O)Nc1ccc(cc1)c1cnc2c(n1)n[nH]c2N)F
serum/glucocorticoid regulated kinase family member 3,1536,SGK3,Q96BR1,,,,,,Human,compound 14n [PMID: 25589934],9423,,,328083523,Inhibitor,Inhibition,,f,f,,pIC50,0,5.510000229,0,IC50,0,3100,0,=,at high (500&mu;M) ATP concentration,,,25589934,Clc1ccc(c(c1)S(=O)(=O)Nc1ccc(cc1)c1cnc2c(n1)n[nH]c2N)F
SET and MYND domain containing 2,2714,SMYD2,Q9NRG4,,,,,,Human,AZ505,7021,,,178103600,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,,,,21782458,O=C1COc2c(N1)c(O)ccc2CCNCCN(C(=O)CCNCCc1ccc(c(c1)Cl)Cl)C1CCCCC1
SET and MYND domain containing 2,2714,SMYD2,Q9NRG4,,,,,,Human,BAY-598,8953,,,310264734,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,Measuring inhibition of methylation of p53K370 <i>in vitro</i>,,,0,N#C/N=C(\N1C[C@@H](C(=N1)c1ccc(c(c1)Cl)Cl)N(C(=O)CO)CC)/Nc1cccc(c1)OC(F)F
SET and MYND domain containing 2,2714,SMYD2,Q9NRG4,,,,,,Human,BAY-598,8953,,,310264734,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,Measuring inhibition of methylation of p53K370 <i>in vitro</i>,,,0,N#C/N=C(N1C[C@@H](C(=N1)c1ccc(c(c1)Cl)Cl)N(C(=O)CO)CC)/Nc1cccc(c1)OC(F)F
"SGK2, serine/threonine kinase 2",1535,SGK2,Q9HBY8,,,,,,Human,compound 14n [PMID: 25589934],9423,,,328083523,Inhibitor,Inhibition,,f,f,,pIC50,0,6.889999866,0,IC50,0,128,0,=,at high (500&mu;M) ATP concentration,,,25589934,Clc1ccc(c(c1)S(=O)(=O)Nc1ccc(cc1)c1cnc2c(n1)n[nH]c2N)F
SHP,636,NR0B2,Q15466,,,,,,Human,compound 10 [PMID: 18759424],8838,,,252827495,None,Binding,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,18759424,OC(=O)/C=C/c1ccc(c(c1)Cl)c1ccc(c(c1)C12CC3CC(C2)(CC(C1)(C3)C)C)O
&sigma;2,2553,,,,,,,,Guinea pig,"1,3-ditolylguanidine",6684,,,178103296,Agonist,Full agonist,,f,f,,pKi,0,7.400000095,0,Ki,0,39.86999893,0,=,,,,16463398,NC(=Nc1ccccc1C)Nc1ccccc1C
sigma non-opioid intracellular receptor 1,2552,,,,,,,,Guinea pig,"1,3-ditolylguanidine",6684,,,178103296,Agonist,Full agonist,,f,f,,pKi,0,7.449999809,0,Ki,0,35.45000076,0,=,,,,16463398,NC(=Nc1ccccc1C)Nc1ccccc1C
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,BD-1047,6680,,,178103292,Antagonist,Antagonist,,f,f,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,8566098,CN(CCc1ccc(c(c1)Cl)Cl)CCN(C)C
SIK family kinase 3,2199,SIK3,Q9Y2K2,,,,,,Human,ARN-3236,9581,,,340590212,Inhibitor,Inhibition,,f,f,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,In an <i>in vitro</i> enzymatic assay.,,,26590148,COc1cc(OC)ccc1c1c[nH]c2c1c(ccn2)c1cscc1
SIK family kinase 3,2199,SIK3,Q9Y2K2,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,25351958,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,compound 17 [PMID: 23570514],8778,,,252827436,Inhibitor,Inhibition,,f,f,,pIC50,0,8.170000076,0,IC50,0,6.699999809,0,=,,,,23570514,O=C(c1ccc(s1)C(=O)OC(C)(C)C)NCCC1CCN(CC1)c1ncnc2c1sc(c2)C(=O)N
sirtuin 2,2708,SIRT2,Q8IXJ6,,,,,,Human,AGK2,8099,,,249565779,Inhibitor,Inhibition,,f,f,,pIC50,5.809999943,0,4.460000038,IC50,35000,0,1560,=,,,,17588900,N#C/C(=C\c1ccc(o1)c1cc(Cl)ccc1Cl)/C(=O)Nc1cccc2c1cccn2
sirtuin 2,2708,SIRT2,Q8IXJ6,,,,,,Human,AGK2,8099,,,249565779,Inhibitor,Inhibition,,f,f,,pIC50,5.809999943,0,4.460000038,IC50,35000,0,1560,=,,,,17588900,N#C/C(=Cc1ccc(o1)c1cc(Cl)ccc1Cl)/C(=O)Nc1cccc2c1cccn2
sirtuin 2,2708,SIRT2,Q8IXJ6,,,,,,Human,compound 17 [PMID: 23570514],8778,,,252827436,Inhibitor,Inhibition,,f,f,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,23570514,O=C(c1ccc(s1)C(=O)OC(C)(C)C)NCCC1CCN(CC1)c1ncnc2c1sc(c2)C(=O)N
sirtuin 2,2708,SIRT2,Q8IXJ6,,,,,,Human,compound 86 [PMID: 26982234],9251,,,315661326,Inhibitor,Inhibition,,f,t,,pKi,0,7.139999866,0,Ki,0,73,0,=,,,,26982234,O=C(c1ccc(cc1)N1CCOCC1)Nc1cccc(c1)COc1cncc(c1)C(=O)N
sirtuin 3,2709,SIRT3,Q9NTG7,,,,,,Human,compound 17 [PMID: 23570514],8778,,,252827436,Inhibitor,Inhibition,,f,f,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,,,,23570514,O=C(c1ccc(s1)C(=O)OC(C)(C)C)NCCC1CCN(CC1)c1ncnc2c1sc(c2)C(=O)N
sirtuin 5,2711,SIRT5,Q9NXA8,,,,,,Human,"compound 2 [Maurer <i>et al.</i>, 2012]",8823,,,252827480,Inhibitor,Inhibition,,f,t,,pIC50,0,5.639999866,0,IC50,0,2300,0,=,,,,0,C=CCN1C(=S)NC(=O)/C(=Cc2ccc(o2)c2cccc(c2Cl)Cl)/C1=O
sirtuin 6,2712,SIRT6,Q8N6T7,,,,,,Human,AKK(thioAc)LM<sup>21</sup>,8816,,,252827474,Inhibitor,Inhibition,,f,f,,pIC50,0,4.329999924,0,IC50,0,47000,0,=,,,,0,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCSC)CC(C)C)CCCCNC(=S)C)NC(=O)[C@@H](N)C
"SMG1, nonsense mediated mRNA decay associated PI3K related kinase",2201,SMG1,Q96Q15,,,,,,Human,compound 11j [PMID: 23021994],8827,,,252827484,Inhibitor,Inhibition,,f,t,,pIC50,0,9.960000038,0,IC50,0,0.109999999,0,=,,,,23021994,CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
SMO,239,SMO,Q99835,,,,,,Human,AZD8542,7716,,,223366049,Antagonist,Antagonist,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,0,Cn1cnc(c1)c1cc(NC(=O)c2ccc(cc2)OCc2ccccn2)c(cc1C)C
SMO,239,Smo,P56726,,,,,,Mouse,AZD8542,7716,,,223366049,Antagonist,Antagonist,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,0,Cn1cnc(c1)c1cc(NC(=O)c2ccc(cc2)OCc2ccccn2)c(cc1C)C
Sodium/bile acid and sulphated solute cotransporter 2,960,SLC10A2,Q12908,,,,,,Human,264W94,6529,,,178103143,Inhibitor,Inhibition,,f,,,pIC50,0,7.32,0,IC50,0,48,0,=,,,,14552767,CCCC[C@@]1(CC)N[C@H](c2ccccc2)c2c(S(=O)(=O)C1)cc(c(c2)OC)OC
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,canagliflozin,4582,,,178101303,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,684,0,=,,,,22355316,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,canagliflozin,4582,,,178101303,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4.400000095,0,=,,,,22355316,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/hydrogen exchanger 1,948,Slc9a1,P26431,,,,,,Rat,amiloride,2421,,,135649936,Inhibitor,Inhibition,,f,f,,pKi,6,0,5.800000191,Ki,1600,0,1000,=,,,,12832126,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
Sodium/hydrogen exchanger 2,949,,,,,,,,Rabbit,amiloride,2421,,,135649936,Inhibitor,Inhibition,,f,f,,pKi,7.099999905,0,6.300000191,Ki,500,0,80,=,,,,12832126,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
Sodium/hydrogen exchanger 3,950,Slc9a3,P26433,,,,,,Rat,amiloride,2421,,,135649936,Inhibitor,Inhibition,,f,f,,pKi,0,4,0,Ki,0,100000,0,>,,,,12832126,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
Sodium/hydrogen exchanger 5,952,SLC9A5,Q14940,,,,,,Human,amiloride,2421,,,135649936,Inhibitor,Inhibition,,f,f,,pKi,0,4.679999828,0,Ki,0,21000,0,=,,,,12832126,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
Sodium/nucleoside cotransporter 2,1115,SLC28A2,O43868,,,,,,Human,compound 48 [PMID: 25815140],8485,,,252166693,Inhibitor,Inhibition,,f,f,,pIC50,0,6.190000057,0,IC50,0,640,0,=,,,,25815140,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1c(NCc2ccc(cc2)c2ccccc2)nc2c1ncnc2N
sodium/potassium-transporting ATPase subunit &alpha;-1,833,ATP1A1,P05023,,,,,,Human,acetyldigitoxin,6794,,,178103400,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]2[C@@H]3CC[C@]3([C@]2(O)CC[C@@H]3C2=CC(=O)OC2)C)C)O[C@@H]([C@H]1O)C
Solute carrier family 28 member 3,1116,SLC28A3,Q9HAS3,,,,,,Human,compound 16 [PMID: 19097778],8837,,,252827494,Inhibitor,Inhibition,,f,f,,pKi,0,5.539999962,0,Ki,0,2880,0,=,,,,19097778,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)Oc1cc(O)cc(c1C(=O)CCc1ccc(cc1)O)O
sphingomyelin synthase 1,2520,SGMS1,Q86VZ5,,,,,,Human,compound 1j [PMID: 26314925],8835,,,252827492,Inhibitor,Inhibition,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,26314925,O=C(NCc1ccc(cc1)Br)COc1ccc(cc1)S(=O)(=O)NCCc1ccccc1
sphingomyelin synthase 2,2521,SGMS2,Q8NHU3,,,,,,Human,compound D24 [PMID: 24374347],8834,,,252827491,Inhibitor,Inhibition,,f,f,,pIC50,0,4.909999847,0,IC50,0,12400,0,=,,,,24374347,N#CC(c1ccccc1OCc1ccccc1)Nc1ccccc1OC
sphingosine-1-phosphate lyase 1,2522,SGPL1,O95470,,,,,,Human,compound 31 [PMID: 24809814],8465,,,252166675,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,24809814,N#Cc1ccc(nc1)N1CCN(C[C@H]1C)c1nnc(c2c1cc(Cl)cc2)Cc1ccccc1
sphingosine kinase 2,2205,SPHK2,Q9NRA0,,,,,,Human,ABC294640,6624,,,178103237,Inhibitor,Inhibition,,f,t,,pKi,0,5.010000229,0,Ki,0,9800,0,=,,,,20061445,Clc1ccc(cc1)C12CC3CC(C1)CC(C2)(C3)C(=O)NCc1ccncc1
sPLA<sub>2</sub>-10,1422,PLA2G10,O15496,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
sPLA<sub>2</sub>-1B,1416,PLA2G1B,P04054,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,7.079999924,0,IC50,0,84,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
sPLA<sub>2</sub>-1B,1416,PLA2G1B,P04054,,,,,,Human,compound 28xvii [PMID: 8809154],8764,,,252827422,Inhibitor,Inhibition,,f,f,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,Measured using a chromogenic assay.,,,8809154,CCc1c(C(=O)C(=O)N)c2n(c1Cc1ccccc1Cc1ccccc1)cccc2OCC(=O)O
sPLA<sub>2</sub>-2A,1417,PLA2G2A,P14555,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
sPLA<sub>2</sub>-2D,1418,PLA2G2D,Q9UNK4,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
sPLA<sub>2</sub>-2E,1419,PLA2G2E,Q9NZK7,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
sPLA<sub>2</sub>-2F,1420,PLA2G2F,Q9BZM2,,,,,,Human,compound 12e [PMID: 18605714],8787,,,252827445,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,18605714,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)c1ccccc1cc2OCC(=O)O
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,apitolisib,7888,,,249565579,Inhibitor,Inhibition,,f,f,,pIC50,0,6.869999886,0,IC50,0,134,0,=,,,,21981714,O=C(N1CCN(CC1)Cc1sc2c(c1C)nc(nc2N1CCOCC1)c1cnc(nc1)N)[C@@H](O)C
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,BAY 61-3606,9693,,,348353652,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,25.5,0,=,,,,22815993,COc1cc(ccc1OC)c1nc(Nc2ncccc2C(=O)N)n2c(c1)ncc2
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,compound 23 [PMID: 17600705],8146,,,249565826,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,17600705,Oc1ccc(c(c1)Nc1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,compound 7 [PMID: 22464456],8172,,,249565852,Inhibitor,Inhibition,,f,f,,pIC50,0,6.449999809,0,IC50,0,358.2000122,0,=,,,,22464456,CCC(c1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1sc(c2)C(F)F)(CC)O
squalene monooxygenase,2433,SQLE,Q14534,,,,,,Human,compound 1b [PMID: 9871762],8794,,,252827452,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,9871762,CCN(Cc1cccc(c1)OCCN(S(=O)(=O)c1cccs1)C)C/C=C/C#CC(C)(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole,3136,,,135649655,Inhibitor,Inhibition,,f,f,,pIC50,0,7.179999828,0,IC50,0,66,0,=,<i>in vitro</i>. Rat and human liver microsomes assayed using the Amin technique.,,,15498666,C=CCc1c(OCCCNC(C)C)ccc2c1[nH]c1c2cccc1
squalene synthase ,645,FDFT1,P37268,,,,,,Human,1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole,3136,,,135649655,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,<i>in vitro</i>. Rat and human liver microsomes assayed using the Amin technique.,,,15498666,C=CCc1c(OCCCNC(C)C)ccc2c1[nH]c1c2cccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one,3135,,,135649656,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,<i>in vitro</i>. Rat and human liver microsomes assayed using the Amin technique.,,,15498666,C=CCc1c(OCCCNC(C)C)ccc2c1c(=O)c1c(o2)cccc1
squalene synthase ,645,FDFT1,P37268,,,,,,Human,1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one,3135,,,135649656,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,<i>in vitro</i>. Rat and human liver microsomes assayed using the Amin technique.,,,15498666,C=CCc1c(OCCCNC(C)C)ccc2c1c(=O)c1c(o2)cccc1
squalene synthase ,645,FDFT1,P37268,,,,,,Human,BPH-830,3121,,,135649720,Inhibitor,Inhibition,,f,f,,pKi,0,6.28000021,0,Ki,0,530,0,=,Inhibition of human recombinant squalene synthase expressed in Escherichia coli cells assessed as conversion of [3H]FPP to squalene by liquid scintillation,,,19456099,O=C(CP(=O)(O)O)NCCCc1cccc(c1)Oc1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 10 [PMID: 18754614],3075,,,135649721,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,OC1(OCC2N(C1)CCCC2)c1ccc(cc1)c1nc2c(s1)cccc2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 11 [PMID: 7473541],3096,,,135650242,Inhibitor,Inhibition,,f,,,pIC50,0,5.85,0,IC50,0,1400,0,=,Inhibition of rat microsomal squalene synthase,,,7473541,CCOC(=O)c1ccc(cc1)OCC(CNC(C)C)O
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 12 [PMID: 20299227],3134,,,135649820,Inhibitor,Inhibition,,f,f,,pIC50,0,4.75,0,IC50,0,17680,0,=,Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting,,,20299227,OP(=O)(C(P(=O)(O)O)CCCCOc1nonc1c1ccccc1)O
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 12 [Wattanasin <i>et al.,</i>1997]",3130,,,135649683,Inhibitor,Inhibition,,f,,,pIC50,0,6.77,0,IC50,0,170,0,=,The compound was tested for inhibition of purified rat hepatic squalene synthase in the presence of 1.2 mM NADPH and 1.0 mM inorganic pyrophosphate. In vitro assay. ,,,0,C/C(=C\COc1cccc(c1)CNC(=O)N(C(C(=O)[O-])(C)C)O)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 12 [Wattanasin <i>et al.,</i>1997]",3130,,,135649683,Inhibitor,Inhibition,,f,,,pIC50,0,6.77,0,IC50,0,170,0,=,The compound was tested for inhibition of purified rat hepatic squalene synthase in the presence of 1.2 mM NADPH and 1.0 mM inorganic pyrophosphate. In vitro assay. ,,,0,C/C(=CCOc1cccc(c1)CNC(=O)N(C(C(=O)[O-])(C)C)O)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 12 [Wattanasin <i>et al.,</i>1997]",3130,,,135649683,Inhibitor,Inhibition,,f,,,pIC50,0,6.64,0,IC50,0,230,0,=,Inhibitory activity against squalene synthase using rat liver microsomal assay,,,0,C/C(=C\COc1cccc(c1)CNC(=O)N(C(C(=O)[O-])(C)C)O)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 12 [Wattanasin <i>et al.,</i>1997]",3130,,,135649683,Inhibitor,Inhibition,,f,,,pIC50,0,6.64,0,IC50,0,230,0,=,Inhibitory activity against squalene synthase using rat liver microsomal assay,,,0,C/C(=CCOc1cccc(c1)CNC(=O)N(C(C(=O)[O-])(C)C)O)/CCC=C(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 13 [PMID: 19456099],3127,,,135649668,Inhibitor,Inhibition,,f,,,pKi,0,6.28,0,Ki,0,520,0,=,Inhibition of human recombinant squalene synthase expressed in Escherichia coli cells assessed as conversion of [3H]FPP to squalene by liquid scintillation,,,19456099,O=C(C(P(=O)(O)O)(C)C)NCCCc1cccc(c1)Oc1ccccc1
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 14 [PMID: 19191557],3125,,,135649688,Inhibitor,Inhibition,,f,,,pIC50,0,5.43,0,IC50,0,3700,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,[O-]P(=O)(C(S(=O)(=O)[O-])Cc1cccc(c1)Oc1ccccc1)[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 14 [PMID: 9871507],3106,,,135649674,Inhibitor,Inhibition,,f,,,pIC50,0,6.62,0,IC50,0,240,0,=,Compound was tested for inhibition of squalene synthase from rat liver microsomes using [3H]-Farnesyl pyrophosphate (FPP) as substrate,,,9871507,CCCN(C(=O)[C@H]1C[C@H]([C@]([C@H]1C(=O)O)(CC(=O)O)C(=O)O)C(=O)N(Cc1ccc(cc1)Oc1ccccc1)CCC)Cc1ccc(cc1)Oc1ccccc1
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 15a [PMID: 22464687],7578,,,223365913,Inhibitor,Inhibition,,f,f,,pIC50,0,8.899999619,0,IC50,0,1.299999952,0,=,,,,22464687,COc1cccc(c1OC)[C@H]1O[C@H](CC(=O)N2CCC(CC2)CC(=O)O)c2n(c3c1cc(Cl)cc3)ccc2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 15 [Biller <i>et al.</i>, 1993]",3131,,,135649784,Inhibitor,Inhibition,,f,,,pIC50,0,6.9,0,IC50,0,125,0,=,Tested for inhibitory potency against rat liver microsomal squalene synthase,,,0,CC(=CCC/C(=C/c1ccc(cc1)COCP(=O)(CP(=O)(O)O)O)/C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 15 [PMID: 19456099],3120,,,135649665,Inhibitor,Inhibition,,f,,,pKi,0,6.52,0,Ki,0,300,0,=,Inhibition of human recombinant squalene synthase expressed in Escherichia coli cells assessed as conversion of [3H]FPP to squalene by liquid scintillation,,,19456099,ONC(=O)C(P(=O)(O)O)CCCc1cccc(c1)Oc1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 15 [PMID: 8709131],3092,,,135649734,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,C(=C\c1ccc(cc1)c1ccccc1)/C1CN2CCC1CC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 15 [PMID: 8709131],3092,,,135649734,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,C(=Cc1ccc(cc1)c1ccccc1)/C1CN2CCC1CC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 16a [Sharratt <i>et al.</i>, 1994]",3107,,,135649713,Inhibitor,Inhibition,,f,,,pIC50,0,7.96,0,IC50,0,11,0,=,In vitro inhibitory concentration against squalene synthase from male rat liver microsomes,,,0,CC[C@@H](C[C@@H](/C=C/C(=O)OC[C@]1(O[C@](CCC(=C)[C@H]([C@@H](Cc2ccccc2)C)OC(=O)C)(O[C@@H]([C@@]1(O)C(=O)O)C(=O)O)C(=O)N)C(=O)O)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 17 [PMID: 18754614],3076,,,135649690,Inhibitor,Inhibition,,f,,,pIC50,0,5.22,0,IC50,0,6000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,CN1CCOC(C1)(O)c1ccc(cc1)c1ccc(cc1)Br
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 17 [PMID: 8709131],3093,,,135649716,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,C(C1CN2CCC1CC2)Cc1ccc(cc1)c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 17 [Shechter <i>et al</i>., 1996]",3061,,,135649799,Inhibitor,Inhibition,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,Inhibitory activity against rat hepatic squalene synthase,,,0,C[N+](CCCCS(=O)(=O)[O-])(CCCCCCCCCc1ccccc1)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 18 [PMID: 18754614],3071,,,135649691,Inhibitor,Inhibition,,f,,,pIC50,0,5.4,0,IC50,0,4000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,CN1CC(O)(OC2C1CCCC2)c1ccc(cc1)c1ccc(cc1)Br
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 19 [PMID: 18754614],3074,,,135649722,Inhibitor,Inhibition,,f,,,pIC50,0,5.52,0,IC50,0,3000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,Brc1ccc(cc1)c1ccc(cc1)C1(O)OCC2N(C1)CCCC2
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 19 [PMID: 19191557],3124,,,135649794,Inhibitor,Inhibition,,f,,,pIC50,0,4.93,0,IC50,0,11700,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,CCn1c2ccc(cc2c2c1cccc2)CCCC(S(=O)(=O)[O-])P(=O)([O-])[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 19 [PMID: 7473541],3112,,,135649740,Inhibitor,Inhibition,,f,,,pIC50,0,10.3,0,IC50,0,0.05,0,=,Inhibition of rat microsomal squalene synthase,,,7473541,C=CCc1cc(ccc1OCCCNC(C)C)OC(=O)CC
squalene synthase ,645,FDFT1,P37268,,,,,,Human,"compound 1c [Brown <i>et al.</i>, 1997]",3105,,,135650241,Inhibitor,Inhibition,,f,,,pKi,0,7.37,0,Ki,0,43,0,=,Tested for its inhibitory activity against human microsomal quinuclidine squalene synthase (SQS),,,0,CCOC(=O)CCc1ccc(c(c1)CC=C)C#CC1(O)CN2CCC1CC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 1e [Brown <i>et al</i>., 1997]",3089,,,135650589,Inhibitor,Inhibition,,f,,,pKi,0,8.7,0,Ki,0,2,0,=,Tested for its inhibitory activity against rat microsomal quinuclidine squalene synthase (SQS),,,0,C=CCc1cc(CCCC(=O)OC)ccc1C#CC1(O)CN2CCC1CC2
squalene synthase ,645,FDFT1,P37268,,,,,,Human,"compound 1 [Overhand <i>et al</i>., 1997]",3065,,,135649735,Inhibitor,Inhibition,,f,,,pIC50,0,7.74,0,IC50,0,18,0,=,Inhibition of Squalene Synthase,,,0,C/C(=C\CC/C(=C/CC(P(=O)([O-])[O-])P(=O)([O-])[O-])/C)/CCC=C(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,"compound 1 [Overhand <i>et al</i>., 1997]",3065,,,135649735,Inhibitor,Inhibition,,f,,,pIC50,0,7.74,0,IC50,0,18,0,=,Inhibition of Squalene Synthase,,,0,C/C(=CCC/C(=C/CC(P(=O)([O-])[O-])P(=O)([O-])[O-])/C)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 1 [PMID: 8496942],3109,,,135650229,Inhibitor,Inhibition,,f,f,,pIC50,0,5.199999809,0,IC50,0,6900,0,=,Inhibitory activity against squalene synthetase in rat liver microsomal assay,,,8496942,CN(CC/C=C(/CCC=C(C)C)\C)/C=N/C/C=C(/CC/C=C(/CCC=C(C)C)\C)\C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 1 [PMID: 8496942],3109,,,135650229,Inhibitor,Inhibition,,f,f,,pIC50,0,5.199999809,0,IC50,0,6900,0,=,Inhibitory activity against squalene synthetase in rat liver microsomal assay,,,8496942,CN(CC/C=C(/CCC=C(C)C)C)/C=N/C/C=C(/CC/C=C(/CCC=C(C)C)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 1 [PMID: 8496942],3109,,,135650229,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,Inhibitory activity against squalene synthetase in the presence of inorganic pyrophosphate in rat liver microsomal assay,,,8496942,CN(CC/C=C(/CCC=C(C)C)\C)/C=N/C/C=C(/CC/C=C(/CCC=C(C)C)\C)\C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 1 [PMID: 8496942],3109,,,135650229,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,Inhibitory activity against squalene synthetase in the presence of inorganic pyrophosphate in rat liver microsomal assay,,,8496942,CN(CC/C=C(/CCC=C(C)C)C)/C=N/C/C=C(/CC/C=C(/CCC=C(C)C)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 20 [PMID: 20299227],3133,,,135649817,Inhibitor,Inhibition,,f,,,pIC50,0,5.43,0,IC50,0,3710,0,=,Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting,,,20299227,OC(P(=O)(O)O)(P(=O)(O)O)CCCCOc1nonc1S(=O)(=O)c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 20 [PMID: 7473541],3114,,,135649724,Inhibitor,Inhibition,,f,,,pIC50,0,9.22,0,IC50,0,0.6,0,=,Inhibition of rat microsomal squalene synthase,,,7473541,C=CCc1cc(OCCCC)ccc1OCCCNC(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 20 [Shechter <i>et al</i>., 1996]",3062,,,135649798,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,Inhibitory activity against rat hepatic squalene synthase,,,0,[O-]S(=O)(=O)CCCC[N+](CCCCCc1ccc(cc1)c1ccccc1)(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 21 [PMID: 19191557],3119,,,135649789,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,Fc1ccccc1Oc1cccc(c1)CCCC(S(=O)(=O)[O-])P(=O)([O-])[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 21 [PMID: 7473541],3115,,,135649725,Inhibitor,Inhibition,,f,f,,pIC50,0,11.39999962,0,-,0,0,0,=,Inhibition of rat microsomal squalene synthase,,,7473541,C=CCc1cc(ccc1OCCCNC(C)C)c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 23 [PMID: 8709131],3095,,,135649717,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,OC1(CN2CCC1CC2)C#Cc1ccc(cc1)c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 28 [PMID: 7473541],3113,,,135650222,Inhibitor,Inhibition,,f,,,pIC50,0,9.7,0,IC50,0,0.2,0,=,Inhibition of rat microsomal squalene synthase,,,7473541,C=CCc1cc(CO/N=C/C)ccc1OCCCNC(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 2a (+) [PMID: 8709131],3102,,,135649726,Inhibitor,Inhibition,,f,,,pIC50,0,8.15,0,IC50,0,7,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,OC1(CN2CCC1CC2)c1ccc(cc1)c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 2d [PMID: 7629799],3060,,,135649847,Inhibitor,Inhibition,,f,,,pIC50,0,8.59,0,IC50,0,2.6,0,=,Inhibition rat liver microsomal squalene synthase,,,7629799,C/C(=CCCCCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 2e [PMID: 7629799],3064,,,135649859,Inhibitor,Inhibition,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,Inhibition rat liver microsomal squalene synthase,,,7629799,C/C(=CCCCCCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 32 [PMID: 19191557],3123,,,135649786,Inhibitor,Inhibition,,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,[O-]P(=O)(C(S(=O)(=O)[O-])CCCc1cccc(c1)Oc1ccc2c(c1)cco2)[O-]
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 35 [PMID: 19191557],3122,,,135649785,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,Fc1ccc(cc1)Oc1ccc(c(c1)CCCC(S(=O)(=O)[O-])P(=O)([O-])[O-])F
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 3a [PMID: 12238936],3085,,,135649679,Inhibitor,Inhibition,,f,,,pIC50,0,7.82,0,IC50,0,15,0,=,Inhibition of squalene synthase from human hepatoma cells (HepG2). *this value also obtained for rat liver enzyme for this compound,,,12238936,COc1cccc(c1OC)[C@H]1O[C@H](CC(=O)NCC(=O)O)C(=O)N(c2c1cc(Cl)cc2)CC(CO)(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 3f [PMID: 12238936],3111,,,135649715,Inhibitor,Inhibition,,f,,,pIC50,0,7.82,0,IC50,0,15,0,=,Inhibition of squalene synthase from human hepatoma cells (HepG2),,,12238936,COc1cccc(c1OC)[C@H]1O[C@H](CC(=O)NCCC(=O)O)C(=O)N(c2c1cc(Cl)cc2)CC(CO)(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 3f [PMID: 7966163],3116,,,135649851,Inhibitor,Inhibition,,f,,,pIC50,0,9.89,0,IC50,0,0.13,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CC(=O)O[C@@H]([C@@H](Cc1ccccc1)C)C(=C)CCC12OC(C(=O)O)C(C(O1)([C@@H]([C@H]2O)OC(=O)CCCCCCCCCCOc1ccccc1)C(=O)O)(O)C(=O)O
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 3 [PMID: 19191557],3126,,,135649671,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,FC(c1ccc(cc1)c1ccc(cc1)CCCC(P(=O)([O-])[O-])P(=O)([O-])[O-])(F)F
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 4 [Brinkman <i>et al</i>., 1996]",3097,,,135649693,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,10,0,=,Compound was tested for inhibitory activity against squalene synthase using rat liver microsomal assay,,,0,CC(c1ccccc1)CNCCOc1ccc(cc1)OCc1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 4e [PMID: 7966163],3090,,,135649852,Inhibitor,Inhibition,,f,,,pIC50,0,10.15,0,IC50,0,0.07,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CC(=O)O[C@@H]([C@@H](Cc1ccccc1)C)C(=C)CCC12OC(C(=O)O)C(C(O1)([C@@H]([C@H]2O)OC(=O)NCCCCCCCCCCCOc1ccccc1)C(=O)O)(O)C(=O)O
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 4g [PMID: 17709461],3077,,,135650240,Inhibitor,Inhibition,,f,,,pIC50,0,6.18,0,IC50,0,660,0,=,Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21(DE3 pLysS) by liquid scintillation counter,,,17709461,CCOC(=O)Cc1ccc(cc1)C#CC1(O)CN2CCC1CC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 4 [PMID: 18754614],3080,,,135649728,Inhibitor,Inhibition,,f,,,pIC50,0,5.15,0,IC50,0,7000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,OC1(OCC2N(C1)CCCC2)c1ccc(cc1)c1cccs1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 4 [PMID: 8576905],3129,,,135649830,Inhibitor,Inhibition,,f,,,pIC50,0,7.82,0,IC50,0,15,0,=,Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]-FPP as radioligand,,,8576905,C/C(=CCCCC(S(=O)(=O)[O-])P(=O)([O-])[O-])/CC/C=C(/CCC=C(C)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 4 [PMID: 8709131],3094,,,135649727,Inhibitor,Inhibition,,f,,,pIC50,0,7.96,0,IC50,0,11,0,=,In vitro inhibition against rat microsomal squalene synthase (SS),,,8709131,c1ccc(cc1)c1ccc(cc1)C1CN2CCC1CC2
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 4q [PMID: 7650673],3108,,,135649788,Inhibitor,Inhibition,,f,,,pIC50,0,7.22,0,IC50,0,60,0,=,In vitro ability to inhibit cholesterol biosynthesis in HepG2 cells in culture from [14C]-mevalonate.,,,7650673,CCN(Cc1cccc(c1)OC[Si](c1ccc(cc1)C#N)(C)C)C/C=C/C#CC(C)(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 5d [PMID: 7966163],3082,,,135649856,Inhibitor,Inhibition,,f,,,pIC50,0,10.4,0,IC50,0,0.04,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CCCCCCCCCCOC(=O)O[C@@H]1[C@@H](O)C2(OC1(C(=O)O)C(O)(C(=O)O)C(O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 5d [PMID: 7966163],3091,,,135649854,Inhibitor,Inhibition,,f,,,pIC50,0,10.4,0,IC50,0,0.04,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CC(=O)O[C@@H]([C@@H](Cc1ccccc1)C)C(=C)CCC12OC(C(=O)O)C(C(O1)([C@@H]([C@H]2O)OC(=O)OCCCCCCCCCCCOc1ccccc1)C(=O)O)(O)C(=O)O
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 5j [PMID: 9216829],3099,,,135649673,Inhibitor,Inhibition,,f,,,pIC50,0,7.89,0,IC50,0,13,0,=,In vitro inhibitory activity against Squalene Synthase. Enzyme from rat liver microsomes. ,,,9216829,CCCCN(C(=O)[C@@H]1[C@H](C(=O)O)[C@H]([C@H]1C(=O)N(Cc1ccc(cc1)Oc1ccccc1)CCCC)C(=O)O)Cc1ccc(cc1)Oc1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 5m [PMID: 9216829],3098,,,135649672,Inhibitor,Inhibition,,f,,,pIC50,0,7.85,0,IC50,0,14,0,=,In vitro inhibitory activity against Squalene Synthase,,,9216829,CC(CN(C(=O)[C@@H]1[C@H](C(=O)O)[C@H]([C@H]1C(=O)N(Cc1ccc(cc1)Oc1ccccc1)CC(C)C)C(=O)O)Cc1ccc(cc1)Oc1ccccc1)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 5 [PMID: 18754614],3081,,,135649801,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,CN1CCOC(C1)(O)c1ccc(cc1)c1cccs1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 6 [Biller <i>et al.</i>, 1991]",3132,,,135650358,Inhibitor,Inhibition,,f,,,pKi,0,7.43,0,Ki,0,37,0,=,Tested for inhibitory potency against rat liver microsomal squalene synthase,,,0,C/C(=CCOCP(=O)(CP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 6c [PMID: 7966163],3083,,,135649857,Inhibitor,Inhibition,,f,,,pIC50,0,9.92,0,IC50,0,0.12,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CCCCCCCCCCCCO[C@@H]1[C@@H](O)C2(OC1(C(=O)O)C(O)(C(=O)O)C(O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 6d [PMID: 7966163],3086,,,135649855,Inhibitor,Inhibition,,f,,,pIC50,0,10.05,0,IC50,0,0.09,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CCCCCCCCCCCCCCO[C@@H]1[C@@H](O)C2(OC1(C(=O)O)C(O)(C(=O)O)C(O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 6g [PMID: 7966163],3118,,,135649853,Inhibitor,Inhibition,,f,,,pIC50,0,10.22,0,IC50,0,0.06,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CC(=O)O[C@@H]([C@@H](Cc1ccccc1)C)C(=C)CCC12OC(C(=O)O)C(C(O1)([C@@H]([C@H]2O)OCCCCCCCCCCCOc1ccccc1)C(=O)O)(O)C(=O)O
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 6 [PMID: 7629799],3063,,,135649792,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,[O-]P(=O)(C(P(=O)([O-])[O-])CCCc1ccc(cc1)c1ccccc1)[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 6 [PMID: 7629799],3063,,,135649792,Inhibitor,Inhibition,,f,,,pIC50,0,9.15,0,IC50,0,0.7,0,=,Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]-FPP as radioligand,,,8576905,[O-]P(=O)(C(P(=O)([O-])[O-])CCCc1ccc(cc1)c1ccccc1)[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 6 [PMID: 7629799],3063,,,135649792,Inhibitor,Inhibition,,f,,,pIC50,0,9.15,0,IC50,0,0.7,0,=,Inhibition rat liver microsomal squalene synthase. In vivo assay ,,,7629799,[O-]P(=O)(C(P(=O)([O-])[O-])CCCc1ccc(cc1)c1ccccc1)[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 7 [Brinkman <i>et al</i>., 1996]",3067,,,135649981,Inhibitor,Inhibition,,f,,,pIC50,0,8.05,0,IC50,0,9,0,=,Compound was tested for inhibitory activity against squalene synthase using rat liver microsomal assay,,,0,C(NCc1ccccc1)COc1ccc(cc1)/C=C/c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 7 [PMID: 18754614],3079,,,135649723,Inhibitor,Inhibition,,f,,,pIC50,0,5.15,0,IC50,0,7000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,Brc1ccc(s1)c1ccc(cc1)C1(O)OCC2N(C1)CCCC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 7 [PMID: 8496919],3100,,,135650866,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,Tested for inhibitory activity against squalene synthetase in the presence of inorganic pyrophosphate (PPi),,,8496919,C/C(=CCNCc1cccnc1)/CC/C=C(/CCC=C(C)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,"compound 8 [Brinkman <i>et al</i>., 1996]",3066,,,135649694,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,Compound was tested for inhibitory activity against squalene synthase using rat liver microsomal assay,,,0,CC(c1ccccc1)CNCCOc1ccc(cc1)/C=C/c1ccccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 8 [PMID: 18754614],3078,,,135649689,Inhibitor,Inhibition,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,CN1CCOC(C1)(O)c1ccc(cc1)c1nc2c(s1)cccc2
squalene synthase ,645,FDFT1,P37268,,,,,,Human,compound 8 [PMID: 19191557],3128,,,135649787,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation",,,19191557,[O-]P(=O)(C(S(=O)(=O)[O-])CCCc1cccc(c1)Oc1ccccc1Cc1ccccc1)[O-]
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,compound 9 [PMID: 18754614],3072,,,135649692,Inhibitor,Inhibition,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,Inhibition of squalene synthase in rat liver microsome measured by convertion of [3H]FPP to squalene,,,18754614,CN1CC(O)(OC2C1CCCC2)c1ccc(cc1)c1ccc(s1)Br
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pEC50,0,6,0,EC50,0,1000,0,>,,,,0,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,17721511,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,CCT196969,9815,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,25500121,O=C(Nc1cc(nn1c1ccccc1)C(C)(C)C)Nc1ccc(cc1F)Oc1ccnc2c1ncc(=O)[nH]2
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,CCT241161,9814,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,25500121,CSc1cc(ccc1NC(=O)Nc1cc(nn1c1ccccc1)C(C)(C)C)Oc1ccnc2c1ncc(=O)[nH]2
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,compound 2 [PMID: 15546730],8136,,,249565816,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,15546730,Cc1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(n1)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,compound 36 [PMID: 21958547],9391,,,328083493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.53000021,0,IC50,0,298,0,=,,,,21958547,CN(C/C=C/C(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,compound 8h [PMID: 22765894],8175,,,249565855,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,22765894,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,2207,SRMS,Q9H3Y6,,,,,,Human,compound 66 [PMID: 21802293],8212,,,249565892,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21802293,COc1n[nH]c2c1cc(cn2)NC(=O)c1c(F)ccc(c1F)NS(=O)(=O)c1cccc(c1)F
SRSF protein kinase 1,2208,SRPK1,Q96SB4,,,,,,Human,compound 13 [PMID: 15925511],8188,,,249565868,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,15925511,OC(=O)c1ccc2c(c1)cc1c(c2)nc(c(n1)c1cccs1)c1cccs1
SRSF protein kinase 3,2210,SRPK3,Q9UPE1,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.760000229,0,Ki,0,1736,0,>,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,BIM 23050,2003,,,135652027,Agonist,Full agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,8100350,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,8.6,0,8.2,,0,0,0,,,,,8769372,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,8.4,0,8.3,,0,0,0,,,,,8769372,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>1</sub> receptor,355,Sstr1,P28646,,,,,,Rat,CH 275,2006,,,135652057,Agonist,Full agonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,9166718,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,CH 275,2006,,,135652057,Agonist,Full agonist,,f,,,pIC50,8.7,0,8.3,,0,0,0,,,,,9600011,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,BIM 23454,2026,,,135652040,Antagonist,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,11897676,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,BIM 23627,2027,,,135652041,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,11897676,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,BIM 23027,2033,,,135652024,Agonist,Agonist,,f,,,pIC50,0,9.7,0,IC50,0,0.2,0,=,,,,9121614,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23027,2033,,,135652024,Agonist,Agonist,,f,f,,pIC50,0,10.85000038,0,IC50,0,0.014,0,=,,,,8646408,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,AM3,5635,,,178102264,Agonist,Full agonist,,f,,,pIC50,0,8.64,0,IC50,0,2.3,0,=,,,,20956465,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,9.4,0,7,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23027,2033,,,135652024,Agonist,Full agonist,,f,,,pIC50,12,0,10.2,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23030,2034,,,135652025,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23030,2034,,,135652025,Agonist,Full agonist,,f,,,pKi,7.9,0,7.7,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23034,2035,,,135652026,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23034,2035,,,135652026,Agonist,Full agonist,,f,,,pIC50,0,11.7,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,8.8,0,8.1,,0,0,0,,,,,8769372,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pKi,6.7,0,6.2,,0,0,0,,,,,8769372,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23059,2037,,,135652031,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23059,2037,,,135652031,Agonist,Full agonist,,f,,,pIC50,0,11.1,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23060,2038,,,135652032,Agonist,Full agonist,,f,,,pIC50,0,10.9,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23060,2038,,,135652032,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23066,2039,,,135652033,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pIC50,0,9.8,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23197,2041,,,135652036,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,9045884,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BOC-ATE,2042,,,135652043,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,,0,0,0,,,,,15709181,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,9.1,0,8.6,,0,0,0,,,,,8769372,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,"AC-178,335",2065,,,135651966,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9804621,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,analog 30 [PMID:18543899],5647,,,178102275,Antagonist,Antagonist,,f,,,pIC50,0,8.77,0,IC50,0,1.7,0,=,,,,18543899,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,analog 31 [PMID:18543899],5648,,,178102276,Antagonist,Antagonist,,f,,,pIC50,0,9.15,0,IC50,0,0.7,0,=,,,,18543899,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,analog 32 [PMID:18543899],7763,,,223366096,Antagonist,Antagonist,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,18543899,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,analog 3 [PMID:18543899],5646,,,178102274,Antagonist,Antagonist,,f,,,pIC50,0,9.12,0,IC50,0,0.75,0,=,,,,18543899,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BASS antagonist,5644,,,178102272,Antagonist,Antagonist,,f,,,pKi,0,9.52,0,Ki,0,0.3,0,=,,,,8863814,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23454,2026,,,135652040,Antagonist,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,11897676,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,BIM 23627,2027,,,135652041,Antagonist,Antagonist,,f,f,,pIC50,0,8.199999809,0,-,0,0,0,=,,,,11897676,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9600011,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23030,2034,,,135652025,Agonist,Full agonist,,f,,,pKi,7.8,0,7.2,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23034,2035,,,135652026,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23034,2035,,,135652026,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23050,2003,,,135652027,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23050,2003,,,135652027,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9600011,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,9.7,0,8.4,,0,0,0,,,,,8769372,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,9166718,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pKi,7.2,0,6.9,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pIC50,0,10.7,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23058,2068,,,135652030,Agonist,Full agonist,,f,,,pIC50,0,10.4,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23058,2068,,,135652030,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23059,2037,,,135652031,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23066,2039,,,135652033,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9600011,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23197,2041,,,135652036,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,9045884,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,BIM 23295,2069,,,135652038,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9600011,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"BN-81,644",2070,,,135650011,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11520208,CCCCC1(CCCC)N[C@H](Cc2c1[nH]c1c2cccc1)c1ncc([nH]1)c1ccccc1
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"BN-81,674",2071,,,135650012,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,11520208,CCCCCC1(CCCCC)N[C@H](Cc2c1[nH]c1c2cccc1)c1ncc([nH]1)c1ccccc1
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BOC-ATE,2042,,,135652043,Agonist,Full agonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,15709181,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,9.3,0,8.8,,0,0,0,,,,,9650799,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23454,2026,,,135652040,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,11897676,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,BIM 23627,2027,,,135652041,Antagonist,Antagonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,11897676,
SST<sub>4</sub> receptor,358,Sstr4,P49660,,,,,,Mouse,&beta;<sup>3</sup>-tetrapeptide,2078,,,135652020,Agonist,Full agonist,,f,,,pKd,7.5,0,7.2,,0,0,0,,,,,12595949,NCCCC[C@H](NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C[C@H](Cc1cccc(c1)O)NC(=O)C)CC(=O)N[C@@H]1CC(=O)O[C@@H]1C
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,&beta;<sup>3</sup>-tetrapeptide,2078,,,135652020,Agonist,Full agonist,,f,,,pKd,7.8,0,7.3,,0,0,0,,,,,12595949,NCCCC[C@H](NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C[C@H](Cc1cccc(c1)O)NC(=O)C)CC(=O)N[C@@H]1CC(=O)O[C@@H]1C
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,8.6,0,8.2,,0,0,0,,,,,9650799,
SST<sub>4</sub> receptor,358,Sstr4,P30937,,,,,,Rat,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,9166718,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,BIM 23068,2040,,,135652034,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,7988476,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,BIM 23295,2069,,,135652038,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9600011,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,8.8,0,8.6,,0,0,0,,,,,9650799,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,analog 32 [PMID:18543899],7763,,,223366096,Antagonist,Antagonist,,f,f,,pIC50,0,6.340000153,0,IC50,0,455,0,=,,,,18543899,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,BIM 23454,2026,,,135652040,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,11897676,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,BIM 23627,2027,,,135652041,Antagonist,Antagonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,11897676,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,9.4,0,8.4,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,BIM 23023,2032,,,135652023,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,BIM 23030,2034,,,135652025,Agonist,Full agonist,,f,,,pKi,8,0,7.1,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23030,2034,,,135652025,Agonist,Full agonist,,f,,,pKi,7.4,0,5.6,,0,0,0,,,,,10598788,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23050,2003,,,135652027,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7988476,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23052,2004,,,135652028,Agonist,Full agonist,,f,f,,pKi,9.600000381,0,7.400000095,-,0,0,0,=,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pKd,7.9,0,7.5,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23056,2036,,,135652029,Agonist,Full agonist,,f,,,pKi,8.3,0,6.7,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23059,2037,,,135652031,Agonist,Full agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,7988476,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23060,2038,,,135652032,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,7988476,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23197,2041,,,135652036,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,9045884,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,BIM 23268,2083,,,135652037,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)Cc1ccccc1)C(=O)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23268,2083,,,135652037,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)Cc1ccccc1)C(=O)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,BIM 23313,2084,,,135652039,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23313,2084,,,135652039,Agonist,Full agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BOC-ATE,2042,,,135652043,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,15709181,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,8.9,0,8,,0,0,0,,,,,10818261,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,CGP 23996,2005,,,135652056,Agonist,Full agonist,,f,,,pKi,8.7,0,6.6,,0,0,0,,,,,9650799,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,"AC-178,335",2065,,,135651966,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9804621,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23056,2036,,,135652029,Antagonist,Antagonist,,f,,,pKi,8.3,0,7.4,Ki,0,0,0,=,,,,0,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23454,2026,,,135652040,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,11897676,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,BIM 23627,2027,,,135652041,Antagonist,Antagonist,,f,f,,pIC50,0,7.099999905,0,-,0,0,0,=,,,,11897676,
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,compound 5g [PMID: 21571530],5514,,,178102158,Antagonist,Antagonist,,f,,,pIC50,0,7.46,0,IC50,0,35,0,=,,,,21571530,O=C(NCc1onc(c1)c1ccc(c(c1)C(F)(F)F)F)CCCc1ccc2c(n1)nccc2
succinate receptor,166,Sucnr1,Q6IYF9,,,,,,Rat,compound 5g [PMID: 21571530],5514,,,178102158,Antagonist,Antagonist,,f,,,pIC50,0,6.87,0,IC50,0,135,0,=,,,,21571530,O=C(NCc1onc(c1)c1ccc(c(c1)C(F)(F)F)F)CCCc1ccc2c(n1)nccc2
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,compound 7e [PMID: 21571530],5515,,,178102159,Antagonist,Antagonist,,f,,,pIC50,0,6.74,0,IC50,0,180,0,=,,,,21571530,O=C(NCCCCc1nnc(o1)c1ccc(c(c1)Cl)OC(F)(F)F)CCCc1ccc2c(n1)nccc2
sugen kinase 110,2290,SGK110,P0C264,,,,,,Human,compound R-16 [PMID: 21967808],8213,,,249565893,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21967808,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F
SUMO specific peptidase 1,2414,SENP1,Q9P0U3,,,,,,Human,compound 8e [PMID: 23044371],8780,,,252827438,Inhibitor,Inhibition,,f,f,,pIC50,0,5.730000019,0,IC50,0,1856,0,=,,,,23044371,Clc1ccc(cc1)C(=O)COC(=O)c1ccc(cc1)NC(=O)c1cccc(c1)OCc1ccccc1
suppression of tumorigenicity 14,2418,ST14,Q9Y5Y6,,,,,,Human,compound 3 [PMID: 23849879],8488,,,252166696,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,570,0,=,,,,23849879,Cc1ccc(cc1)C(=O)n1nc(nc1N)c1cccnc1
suppression of tumorigenicity 14,2418,ST14,Q9Y5Y6,,,,,,Human,compound 4d [PMID: 25489658],8483,,,252166691,Inhibitor,Inhibition,,f,f,,pIC50,0,5.849999905,0,IC50,0,1420,0,=,,,,25489658,BrCc1ccc2c(c1)cc(c(=O)o2)C(=O)Oc1cccc(c1)Cl
suppressor of variegation 3-9 homolog 1,2715,SUV39H1,O43463,,,,,,Human,chaetocin,8388,,,252166599,Inhibitor,Inhibition,,f,t,,pIC50,6.960000038,0,6.099999905,IC50,800,0,110,=,,,,16408017,OCC12SSC3(N(C1=O)C1Nc4c(C1(C3)C13CC56N(C3Nc3c1cccc3)C(=O)C(SS5)(N(C6=O)C)CO)cccc4)C(=O)N2C
synaptic vesicle glycoprotein 2A,2634,Sv2a,Q02563,,,,,,Rat,brivaracetam,9041,,,315661126,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,"<i>In vitro</i> inhibitory activity against [<sup>3</sup>H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding site, in rat brain homogenate.",,,14736235,CCC[C@H]1CN(C(=O)C1)[C@H](C(=O)N)CC
TACI,1885,,,,,,,,None,APRIL,5068,TNFSF13,Human,178101761,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
TACI,1885,TNFRSF13B,O14836,,,,,,Human,BAFF,5069,TNFSF13B,Human,178101762,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,amlexanox,7113,,,178103690,Inhibitor,Inhibition,,f,f,,pIC50,6,0,5.699999809,IC50,2000,0,1000,=,Inhibition of substrate phosphorylation.,,,23396211,CC(c1ccc2c(c1)c(=O)c1c(o2)nc(c(c1)C(=O)O)N)C
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,AZ13102909,9577,,,336446963,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,<i>In vitro</i> biochemical assay.,,,24962318,COc1ccc(cc1)c1ccc(cc1)C1NC2C(=N1)C(=C(C=N2)C(=O)N)NNCCCNC(=O)C1CCCCC1
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,compound 17d [PMID: 23099093],8196,,,249565876,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,23099093,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,compound II [PMID: 21329883],9579,,,336446965,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,In a biochemical assay using purified recombinant enzyme.,,,21329883,COc1ccc(cc1)N1N=CC2C1N=C(N=C2)Nc1cc(OC)c(c(c1)OCCCN1CCN(CC1)C)OC
TAO kinase 1,2233,TAOK1,Q7L7X3,,,,,,Human,compound 18 [PMID: 20873740],8191,,,249565871,Inhibitor,Inhibition,,f,f,,pIC50,0,6.380000114,0,IC50,0,420,0,=,,,,20873740,Nc1nccc(n1)c1[nH]c(c(c1)C(=O)N)c1ccccc1
TAO kinase 3,2235,TAOK3,Q9H2K8,,,,,,Human,compound 1 [PMID: 24793884],8218,,,249565898,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24793884,CCOC(=O)c1sc(nc1O)c1ccncc1
TAO kinase 3,2235,TAOK3,Q9H2K8,,,,,,Human,compound 89S [PMID: 19115845],8114,,,249565794,Inhibitor,Inhibition,,f,f,,pIC50,0,6.900000095,0,IC50,0,126,0,=,,,,19115845,FCC[C@H]1CNC(=O)c2c1[nH]c(c2)c1ccnc(n1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,2-phenyl-propylamine,5510,,,178102156,Agonist,Agonist,,f,f,,pEC50,6.980000019,0,6.489999771,EC50,325,0,104,=,,,,17038507,NCC(c1ccccc1)C
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,3-iodothyronamine,2145,,,135649737,Agonist,Full agonist,,t,,,pEC50,7,0,6.5,-,0,0,0,=,,,,15146179,NCCc1ccc(cc1)Oc1ccc(c(c1)I)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,3-iodothyronamine,2145,,,135649737,Agonist,Full agonist,,t,,,pEC50,7.9,0,7.5,-,0,0,0,=,,,,15146179,NCCc1ccc(cc1)Oc1ccc(c(c1)I)O
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,&beta;-phenylethylamine,2144,,,135652016,Agonist,Full agonist,,t,,,pEC50,7,0,6.2,-,0,0,0,=,,,,11459929,NCCc1ccccc1
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,&beta;-phenylethylamine,2144,,,135652016,Agonist,Full agonist,,t,,,pEC50,7.4,0,6.3,-,0,0,0,=,,,,17218486,NCCc1ccccc1
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,&beta;-phenylethylamine,2144,,,135652016,Agonist,Full agonist,,t,,,pEC50,6.6,0,6.4,,0,0,0,,,,,17218486,NCCc1ccccc1
TATA-box binding protein associated factor 1,2231,TAF1,P21675,,,,,,Human,BAY-299,9524,,,336446910,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,In a <i>BROMOscan&reg;</i> assay.,,,0,OCCCc1ccc2c3c1cccc3c(=O)n(c2=O)c1cc2c(cc1C)n(c(=O)n2C)C
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,7.03000021,0,IC50,0,93,0,=,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,compound 31 [PMID: 24915291],8148,,,249565828,Inhibitor,Inhibition,,f,f,,pIC50,0,8.090000153,0,IC50,0,8.199999809,0,=,,,,24915291,C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.199999809,0,IC50,0,6.300000191,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,altiratinib,9174,,,315661257,Inhibitor,Inhibition,,f,f,,pIC50,0,8.619999886,0,IC50,0,2.400000095,0,=,,,,0,O=C(C1CC1)Nc1nccc(c1)Oc1cc(F)c(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,CEP-11981,8189,,,249565869,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,22148921,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,compound 5 [PMID: 17618114],9348,,,328083450,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,17618114,COc1ccc2c(c1)ccc(c2)c1nc([nH]c1c1ccncc1)c1ccc(cc1)S(=O)C
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,compound 8h [PMID: 21561767],8170,,,249565850,Inhibitor,Inhibition,,f,f,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,21561767,OCCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc(n1C)C(=O)NC)C
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,angiopoietin-1,4867,ANGPT1,Human,178101568,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,angiopoietin-4,4868,ANGPT4,Human,178101569,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
testis-specific kinase 1,2239,TESK1,Q15569,,,,,,Human,compound 30 [PMID: 22902653],8118,,,249565798,Inhibitor,Inhibition,,f,f,,pIC50,0,5.949999809,0,IC50,0,1133,0,=,,,,22902653,CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
testis-specific kinase 1,2239,TESK1,Q15569,,,,,,Human,compound 31 [PMID: 22902653],8117,,,249565797,Inhibitor,Inhibition,,f,f,,pIC50,0,6.340000153,0,IC50,0,455,0,=,,,,22902653,CCNC(=O)Nc1ncc(s1)c1cc(nc(n1)c1cnccn1)c1c(C)cc(cc1C)OC
testis-specific kinase 1,2239,TESK1,Q15569,,,,,,Human,compound 35 [PMID: 22902653],8119,,,249565799,Inhibitor,Inhibition,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,>,,,,22902653,COc1cc(Cl)c(c(c1)Cl)c1cc(nc(n1)c1cnccn1)c1cnc(s1)NC(=O)C
testis-specific kinase 2,2240,TESK2,Q96S53,,,,,,Human,compound 30 [PMID: 22902653],8118,,,249565798,Inhibitor,Inhibition,,f,f,,pIC50,0,6.380000114,0,IC50,0,415,0,=,,,,22902653,CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
testis-specific kinase 2,2240,TESK2,Q96S53,,,,,,Human,compound 31 [PMID: 22902653],8117,,,249565797,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,252,0,=,,,,22902653,CCNC(=O)Nc1ncc(s1)c1cc(nc(n1)c1cnccn1)c1c(C)cc(cc1C)OC
testis-specific kinase 2,2240,TESK2,Q96S53,,,,,,Human,compound 35 [PMID: 22902653],8119,,,249565799,Inhibitor,Inhibition,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,>,,,,22902653,COc1cc(Cl)c(c(c1)Cl)c1cc(nc(n1)c1cnccn1)c1cnc(s1)NC(=O)C
testis specific serine kinase 1B,2257,TSSK1B,Q9BXA7,,,,,,Human,ceritinib,7397,,,178103969,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,23742252,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
testis specific serine kinase 2,2258,TSSK2,Q96PF2,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,7.510000229,0,IC50,0,30.60000038,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
thymidylate synthetase,2642,TYMS,P04818,,,,,,Human,capecitabine,6799,,,178103405,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,10631692,CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C
TLR2,1752,TLR2,O60603,,,,,,Human,compound 13 [PMID: 23098072],8888,,,310264669,Agonist,Agonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,23098072,CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)CSC[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N)CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CCSC1CC(=O)N(C1=O)CCNC(=O)CCCCC[N+]1=C(/C=C/C=C/C=C\2/Cc3c(N2CC)ccc(c3)S(=O)(=O)[O-])Cc2c1ccc(c2)S(=O)(=O)[O-]
TLR2,1752,TLR2,O60603,,,,,,Human,compound 13 [PMID: 23098072],8888,,,310264669,Agonist,Agonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,23098072,CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)CSC[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N)CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CCSC1CC(=O)N(C1=O)CCNC(=O)CCCCC[N+]1=C(/C=C/C=C/C=C2/Cc3c(N2CC)ccc(c3)S(=O)(=O)[O-])Cc2c1ccc(c2)S(=O)(=O)[O-]
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,852A,9025,,,315661110,Agonist,Agonist,,f,f,,pEC50,0,5.579999924,0,EC50,0,2657,0,=,,,,23265901,CCc1nc2c(n1CCCCNS(=O)(=O)C)c1ccccc1nc2N
TLR7,1757,Tlr7,P58681,,,,,,Mouse,852A,9025,,,315661110,Agonist,Agonist,,f,f,,pEC50,0,5.210000038,0,EC50,0,6224,0,=,,,,23265901,CCc1nc2c(n1CCCCNS(=O)(=O)C)c1ccccc1nc2N
TLR8,1758,TLR8,Q9NR97,,,,,,Human,3M-002,9270,,,315661345,Agonist,Agonist,,f,t,,pEC50,0,5.880000114,0,EC50,0,1320,0,=,Assessed as ability to activate NF-&kappa;B in HEK293 cells expressing human TLR8.,,,22924757,CCCc1nc2c(s1)c1ccccc1nc2N
TLR8,1758,TLR8,Q9NR97,,,,,,Human,"compound 12p [Larson <i>et al.</i>, 2017]",9690,,,348353649,Agonist,Agonist,,f,t,,pEC50,0,5.300000191,0,EC50,0,4980,0,=,,,,0,NCCn1c(CCCC)nc2c1c1ccc(cc1nc2N)C(=O)OC
TPC1,392,TPCN1,Q9ULQ1,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Inhibition,,f,f,,pIC50,0,3.74000001,0,IC50,0,180000,0,=,,,,24776928,
TP receptor,346,Tbxa2r,P34978,,,,,,Rat,AGN192093,3387,,,178100404,Agonist,Agonist,,f,f,,pEC50,0,8.899999619,0,EC50,0,1.299999952,0,=,,,,8882612,CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCCO)C2)O
TP receptor,346,Tbxa2r,P34978,,,,,,Rat,AGN192093,3387,,,178100404,Agonist,Agonist,,f,f,,pEC50,0,8.899999619,0,EC50,0,1.299999952,0,=,,,,8882612,CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=CCCCCO)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,"10,10-difluoro TXA<sub>2</sub>",6069,,,178102690,Agonist,Full agonist,,f,,,pKd,0,7,0,Kd,0,100,0,=,,,,2748606,CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2(F)F)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,"10,10-difluoro TXA<sub>2</sub>",6069,,,178102690,Agonist,Full agonist,,f,,,pKd,0,7,0,Kd,0,100,0,=,,,,2748606,CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=CCCCC(=O)O)C2(F)F)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,AGN 191976,6071,,,178102692,Agonist,Full agonist,,f,,,pEC50,0,7.8,0,EC50,0,16,0,=,,,,8882612,CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,AGN 191976,6071,,,178102692,Agonist,Full agonist,,f,,,pEC50,0,7.8,0,EC50,0,16,0,=,,,,8882612,CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,butaprost (free acid form),1892,,,135650038,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10634944,CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,carbacyclin,1893,,,135650056,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=CCCCC(=O)O)/C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,carbocyclic thromboxane A2,1970,,,135650139,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,1434130,CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=C\CCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,carbocyclic thromboxane A2,1970,,,135650139,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,1434130,CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,cloprostenol,1894,,,135650113,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10634944,OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
TP receptor,346,TBXA2R,P21731,,,,,,Human,AH23848,1949,,,135649908,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10634944,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1
TRAF2 and NCK interacting kinase,2244,TNIK,Q9UKE5,,,,,,Human,compound 5 [PMID: 23232060],8192,,,249565872,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,23232060,COc1cc(ccc1N1CCN(CC1)C)Nc1nccc(c1)c1cc(C#N)ccc1OC
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,580,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,BIX02189,9380,,,328083482,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,580,0,=,,,,18834865,CN(Cc1cccc(c1)N/C(=C/1C(=O)Nc2c1ccc(c2)C(=O)N(C)C)/c1ccccc1)C
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,f,,pIC50,0,6.75,0,IC50,0,178,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,compound 13r [PMID: 23639540],8144,,,249565824,Inhibitor,Inhibition,,f,f,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,23639540,CN1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,compound 15b [PMID: 16539403],8194,,,249565874,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,16539403,OCCCn1cnc2c1cc(cc2)c1c2CCCn2nc1c1ccccn1
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,compound 13a [PMID: 23639540],8155,,,249565835,Inhibitor,Inhibition,,f,t,,pIC50,0,8.859999657,0,IC50,0,1.370000005,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,compound 13d [PMID: 23639540],8120,,,249565800,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,23639540,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1ccnc2c1cccc2
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,compound 15b [PMID: 16539403],8194,,,249565874,Inhibitor,Inhibition,,f,f,,pIC50,0,6.449999809,0,IC50,0,352,0,=,,,,16539403,OCCCn1cnc2c1cc(cc2)c1c2CCCn2nc1c1ccccn1
transmembrane protein 173,2902,TMEM173,Q86WV6,,,,,,Human,2'3'-cGAMP,9207,,,315661283,Agonist,Agonist,,f,f,,pKd,8.420000076,0,8.340000153,Kd,4.590000153,0,3.789999962,=,,,,23747010,Nc1nc(=O)c2c([nH]1)n(cn2)[C@@H]1O[C@H]2[C@H]([C@H]1OP(=O)(O)OC[C@@H]1[C@@H](OP(=O)(OC2)O)[C@H]([C@@H](O1)n1cnc2c1ncnc2N)O)O
transmembrane serine protease 11D,2420,TMPRSS11D,O60235,,,,,,Human,compound 5 [PMID: 21741839],8670,,,252166870,Inhibitor,Inhibition,,f,f,,pKi,0,7.71999979,0,Ki,0,19,0,=,,,,21741839,NC(=NCCC[C@H](C(=O)N1CCC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)NS(=O)(=O)Cc1ccccc1)N
transmembrane serine protease 2,2421,TMPRSS2,O15393,,,,,,Human,compound 5 [PMID: 21741839],8670,,,252166870,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,21741839,NC(=NCCC[C@H](C(=O)N1CCC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)NS(=O)(=O)Cc1ccccc1)N
TRH<sub>1</sub> receptor,363,Trhr,Q01717,,,,,,Rat,chlordiazepoxide,3370,,,178100393,Antagonist,Antagonist,,f,f,,pKi,0,4.820000172,0,Ki,0,15000,0,=,,,,2566295,CNC1=Nc2ccc(cc2C(=[N+](C1)[O-])c1ccccc1)Cl
TRH<sub>1</sub> receptor,363,Trhr,P21761,,,,,,Mouse,chlordiazepoxide,3370,,,178100393,Antagonist,Antagonist,,f,f,,pKi,0,4.699999809,0,Ki,0,20000,0,=,,,,2175902,CNC1=Nc2ccc(cc2C(=[N+](C1)[O-])c1ccccc1)Cl
tripartite motif containing 24,2252,TRIM24,O15164,,,,,,Human,compound 34 [PMID: 25974391],8396,,,252166607,Inhibitor,Binding,,f,t,,pKd,0,6.650000095,0,Kd,0,222,0,=,,,,25974391,COc1ccc(cc1)Oc1cc2c(cc1NS(=O)(=O)c1ccc(c(c1)OC)OC)n(c(=O)n2C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,"1,6-hexamethylene diisocyanate",6291,,,178102911,Activator,Activation,This compound also activates mouse TRPA1,f,,,pEC50,0,5.6,0,-,0,0,0,=,Calcium imaging,,,19036859,O=C=NCCCCCCN=C=O
TRPA1,485,TRPA1,O75762,,,,,,Human,1'-acetoxychavicol acetate,6298,,,178102918,Activator,Activation,,f,,,pEC50,0,6.8,0,-,0,0,0,=,FlexStation 2 Calcium imaging,,,20699565,C=C[C@@H](c1ccc(cc1)OC(=O)C)OC(=O)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,2-iodoacetamide,6271,,,178102891,Activator,Activation,,f,,,pEC50,0,3.45,0,EC50,0,357000,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,17237762,NC(=O)CI
TRPA1,485,,,,,,,,Unknown,2-pentenal,2417,,,135649711,Activator,Activation,,f,f,,pEC50,0,5.300000191,0,EC50,0,5000,0,=,,,,20356305,CC/C=C/C=O
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,4-hydroxynonenal,6274,,,178102894,Activator,Activation,,t,,,pEC50,0,4.6,0,EC50,0,0,0,=,Calcium imaging,,,17684094,CCCCCC(/C=C/C=O)O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,4-oxo-nonenal,6283,,,178102903,Activator,Activation,,t,,,pEC50,0,5.7,0,-,0,0,0,=,Calcium imaging,,,18322093,CCCCCC(=O)/C=C/C=O
TRPA1,485,TRPA1,O75762,,,,,,Human,acetaldehyde,6277,,,178102897,Activator,Activation,,f,,,pEC50,0,4.1,0,-,0,0,0,=,Calcium imaging,,,17970723,CC=O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,acetaldehyde,6277,,,178102897,Activator,Activation,,f,,,pEC50,0,2.9,0,-,0,0,0,=,Calcium imaging,,,17970723,CC=O
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,allyl isothiocyanate,2420,,,135649919,Activator,Activation,,f,,,pEC50,0,5,0,-,0,0,0,=,,,,14712238,C=CCN=C=S
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,allyl isothiocyanate,2420,,,135649919,Activator,Activation,,f,,,pEC50,0,4.7,0,-,0,0,0,=,,,,15046718,C=CCN=C=S
TRPA1,485,TRPA1,O75762,,,,,,Human,apomorphine,33,,,135649950,Activator,Activation,Apomorphine blocks TRPA1 at 100&micro;M,f,,,pEC50,0,5.1,0,-,0,0,0,=,"Calcium imaging, patch clamp",,,23220749,CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
TRPA1,485,TRPA1,O75762,,,,,,Human,artepillin C,6302,,,178102921,Activator,Activation,,f,,,pEC50,0,5.74,0,EC50,0,1800,0,=,Calcium imaging,,,23133611,CC(=CCc1cc(/C=C/C(=O)O)cc(c1O)CC=C(C)C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,auranofin,6306,,,178102925,Activator,Activation,,f,,,pEC50,0,6,0,-,0,0,0,=,Calcium imaging,,,23220116,CC[P+]([Au-]S[C@@H]1O[C@H](COC(=O)C)[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC(=O)C)(CC)CC
TRPA1,485,TRPA1,O75762,,,,,,Human,benzoquinone,6307,,,178102926,Activator,Activation,,f,,,pEC50,0,6.4,0,-,0,0,0,=,Calcium imaging,,,22109525,O=C1C=CC(=O)C=C1
TRPA1,485,TRPA1,O75762,,,,,,Human,benzyl bromide,6294,,,178102914,Activator,Activation,This compound also activates mouse TRPA1,f,,,pEC50,0,4.9,0,-,0,0,0,=,Calcium imaging,,,19036859,BrCc1ccccc1
TRPA1,485,TRPA1,O75762,,,,,,Human,bromoacetone,6293,,,178102913,Activator,Activation,This compound also activates mouse TRPA1,f,,,pEC50,0,6,0,-,0,0,0,=,Calcium imaging,,,19036859,CC(=O)CBr
TRPA1,485,TRPA1,O75762,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Activator,Activation,,f,,,pEC50,0,5.85,0,EC50,0,1400,0,=,Sodium and calcium imaging,,,19416844,
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Activator,Activation,,f,,,pEC50,0,5.68,0,EC50,0,2100,0,=,,,,19416844,
TRPA1,485,TRPA1,O75762,,,,,,Human,chlorobenzylidene malononitrile,4158,,,178100978,Activator,Activation,covalent,f,f,,pEC50,0,6.699999809,0,EC50,0,199,0,=,Calcium imaging,,,18501939,N#CC(=Cc1ccccc1Cl)C#N
TRPA1,485,TRPA1,O75762,,,,,,Human,chloropicrin,6292,,,178102912,Activator,Activation,This compound also activates mouse TRPA1,f,,,pEC50,0,6.7,0,-,0,0,0,=,Calcium imaging,,,19036859,ClC([N+](=O)[O-])(Cl)Cl
TRPA1,485,TRPA1,O75762,,,,,,Human,acrolein,2418,,,135649892,Activator,Agonist,covalent,f,f,,pEC50,0,5.300000191,0,EC50,0,5011,0,=,,,,16564016,C=CC=O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,allicin,2419,,,135651433,Activator,Agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,15916949,C=CCSS(=O)CC=C
TRPA1,485,TRPA1,O75762,,,,,,Human,allicin,2419,,,135651433,Activator,Agonist,covalent,f,f,,pEC50,0,5.099999905,0,EC50,0,7943,0,=,,,,16103371,C=CCSS(=O)CC=C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,cinnamaldehyde,2423,,,135650100,Activator,Agonist,covalent,f,f,,pEC50,0,4.199999809,0,EC50,0,63000,0,=,,,,15046718,O=C/C=C/c1ccccc1
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,amiloride,2421,,,135649936,Channel blocker,Inhibition,,f,,,pIC50,0,3.3,0,-,0,0,0,=,,,,15843607,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
TRPA1,485,TRPA1,O75762,,,,,,Human,AP18,4134,,,178100956,Channel blocker,Inhibition,,f,,,pIC50,0,5.5,0,IC50,0,3100,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)\C
TRPA1,485,TRPA1,O75762,,,,,,Human,AP18,4134,,,178100956,Channel blocker,Inhibition,,f,,,pIC50,0,5.5,0,IC50,0,3100,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,camphor,2422,,,135652676,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.2,0,,0,0,0,,,,,16829128,O=C1CC2C(C1(C)CC2)(C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,A-967079,6280,,,178102900,Gating inhibitor,Inhibition,This compoud also acts as a gating inhibitor at the rat and mouse TRPA1.,f,,,pIC50,0,7.2,0,-,0,0,0,=,Calcium imaging,,,21402443,CC/C(=N\O)/C(=C/c1ccc(cc1)F)/C
TRPA1,485,TRPA1,O75762,,,,,,Human,A-967079,6280,,,178102900,Gating inhibitor,Inhibition,This compoud also acts as a gating inhibitor at the rat and mouse TRPA1.,f,,,pIC50,0,7.2,0,-,0,0,0,=,Calcium imaging,,,21402443,CC/C(=NO)/C(=C/c1ccc(cc1)F)/C
TRPA1,485,TRPA1,O75762,,,,,,Human,AP18,4134,,,178100956,Gating inhibitor,Inhibition,,f,,,pIC50,0,5.51,0,IC50,0,3100,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)\C
TRPA1,485,TRPA1,O75762,,,,,,Human,AP18,4134,,,178100956,Gating inhibitor,Inhibition,,f,,,pIC50,0,5.51,0,IC50,0,3100,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,AP18,4134,,,178100956,Gating inhibitor,Inhibition,,f,,,pIC50,0,5.35,0,IC50,0,4500,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)\C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,AP18,4134,,,178100956,Gating inhibitor,Inhibition,,f,,,pIC50,0,5.35,0,IC50,0,4500,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,18086313,O/N=C(/C(=C/c1ccc(cc1)Cl)/C)C
TRPC1,486,TRPC1,P48995,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,11301024,NCCOB(c1ccccc1)c1ccccc1
TRPC2,487,Trpc2,Q9R244,,,,,,Mouse,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,50,-,0,0,0,-,0,0,0,=,,,,14642279,NCCOB(c1ccccc1)c1ccccc1
TRPC3,488,TRPC3,Q13507,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,,pIC50,0,5,0,IC50,0,10000,0,=,,,,15933213,NCCOB(c1ccccc1)c1ccccc1
TRPC3,488,TRPC3,Q13507,,,,,,Human,BTP2,2438,,,135650028,Channel blocker,Antagonist,,f,f,,pIC50,0,6.5,0,IC50,0,300,0,=,,,,15647288,O=C(c1snnc1C)Nc1ccc(cc1)n1nc(cc1C(F)(F)F)C(F)(F)F
TRPC3,488,TRPC3,Q13507,,,,,,Human,ACAA,2443,,,135649885,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCc1ccc(cc1)/C=C/C(=O)Nc1ccccc1C(=O)O
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCOB(c1ccccc1)c1ccccc1
TRPC5,490,Trpc5,Q9QX29,,,,,,Mouse,Ca<sup>2+</sup>,707,,,135652731,Activator,Activation,Internal calcium,f,,,pEC50,0,6,0,-,0,0,0,=,,,,19398778,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,at negative potentials,t,f,,pEC50,0,6.199999809,0,EC50,0,635,0,=,,,intracellular,0,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,15806115,NCCOB(c1ccccc1)c1ccccc1
TRPC5,490,Trpc5,Q9QX29,,,,,,Mouse,bromoenol lactone,5149,,,178101841,Channel blocker,Inhibition,,f,,,pIC50,0,4.97,0,-,0,0,0,=,,,,21795434,Br/C=C/1\CCC(C(=O)O1)c1cccc2c1cccc2
TRPC5,490,Trpc5,Q9QX29,,,,,,Mouse,bromoenol lactone,5149,,,178101841,Channel blocker,Inhibition,,f,,,pIC50,0,4.97,0,-,0,0,0,=,,,,21795434,Br/C=C/1CCC(C(=O)O1)c1cccc2c1cccc2
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,BTP2,2438,,,135650028,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1snnc1C)Nc1ccc(cc1)n1nc(cc1C(F)(F)F)C(F)(F)F
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,chlorpromazine,83,,,135650088,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,20-HETE,4103,,,178100926,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,20-HETE,4103,,,178100926,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
TRPC6,491,Trpc6,Q61143,,,,,,Mouse,amiloride,2421,,,135649936,Channel blocker,Antagonist,,f,f,,pIC50,0,3.900000095,0,IC50,0,129000,0,=,,,,11179201,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
TRPC6,491,Trpc6,Q61143,,,,,,Mouse,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,Antagonist,,f,f,,pIC50,0,3.599999905,0,IC50,0,253000,0,=,,,,11179201,
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCOB(c1ccccc1)c1ccccc1
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,ACAA,2443,,,135649885,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCc1ccc(cc1)/C=C/C(=O)Nc1ccccc1C(=O)O
TRPC7,492,TRPC7,Q9HCX4,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCOB(c1ccccc1)c1ccccc1
TRPC7,492,TRPC7,Q9HCX4,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
TRPM2,494,TRPM2,O94759,,,,,,Human,ADP ribose,2444,,,135651429,Activator,Agonist,,t,f,,pEC50,4.400000095,0,3.900000095,EC50,125983,0,39800,=,,,intracellular,11385575,O=C[C@@H]([C@@H]([C@@H](COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N)O)O)O)O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,cADPR,2445,,,135651450,Activator,Agonist,,t,f,,pEC50,0,5,0,EC50,0,10000,0,=,,,intracellular,16601673,O[C@@H]1[C@H](O)[C@@H]2O[C@H]1n1cnc3c(c1=N)ncn3[C@@H]1O[C@H](COP(=O)(OP(=O)(OC2)O)O)[C@H]([C@H]1O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,perhaps <i>via</i> calmodulin,t,f,,-,0,0,0,-,0,0,0,=,,,intracellular,0,
TRPM2,494,TRPM2,O94759,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Potentiation,,t,f,1030,-,0,0,0,-,0,0,0,=,,,,11804595,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,arachidonic acid,2391,,,135651442,Activator,Potentiation,,t,f,1030,-,0,0,0,-,0,0,0,=,,,,11804595,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,820,0,=,,,,18204483,NCCOB(c1ccccc1)c1ccccc1
TRPM2,494,TRPM2,O94759,,,,,,Human,ACAA,2443,,,135649885,Channel blocker,Antagonist,,f,f,,pIC50,0,5.800000191,0,IC50,0,1700,0,=,,,,16604090,CCCCCc1ccc(cc1)/C=C/C(=O)Nc1ccccc1C(=O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,clotrimazole,2330,,,135650114,Channel blocker,Antagonist,,f,f,330,-,0,0,0,-,0,0,0,=,,,,15549272,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,2-APB,2433,,,135649695,Gating inhibitor,Antagonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,15806115,NCCOB(c1ccccc1)c1ccccc1
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,BTP2,2438,,,135650028,Activator,Agonist,,f,f,,pEC50,0,8.100000381,0,EC50,0,8,0,=,,,,16407466,O=C(c1snnc1C)Nc1ccc(cc1)n1nc(cc1C(F)(F)F)C(F)(F)F
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,6.300000191,0,3.900000095,EC50,140000,0,500,=,,,intracellular,15590641,
TRPM4,496,Trpm4,Q7TN37,,,,,,Mouse,ATP,1713,,,135651446,Channel blocker,Antagonist,,t,,,pIC50,0,6.1,0,,0,0,0,,,,,15670874,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,ATP,1713,,,135651446,Channel blocker,Antagonist,,t,,,pIC50,0,5.8,0,,0,0,0,,,,,14758478,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,9-phenanthrol,4114,,,178100936,Channel blocker,None,,f,f,,pIC50,4.78000021,0,4.639999866,IC50,22800,0,16700,=,,,,18297105,Oc1cc2ccccc2c2c1cccc2
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,adenosine,2844,,,135651426,Channel blocker,None,,f,f,,pIC50,0,3.200000048,0,IC50,0,630000,0,=,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,adenosine 5'-monophosphate,2455,,,53801012,Gating inhibitor,Antagonist,,t,,,pIC50,0,4.7,0,,0,0,0,,,,,14758478,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(O)O
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,ADP,1712,,,135651427,Gating inhibitor,Antagonist,,t,,,pIC50,0,5.7,0,,0,0,0,,,,,14758478,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,AMP-PNP,2456,,,135651437,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,14758478,O[C@@H]1[C@@H](COP(=O)(OP(=O)(NP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,ATP,1713,,,135651446,Gating inhibitor,Antagonist,,t,,,pIC50,0,4.9,0,,0,0,0,,,,,14758478,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,clotrimazole,2330,,,135650114,Gating inhibitor,Antagonist,,f,f,110,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
TRPM5,497,Trpm5,Q9JJH7,,,,,,Mouse,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,t,f,,pEC50,6.199999809,0,4.5,EC50,30000,0,700,=,,,intracellular,15670874,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,2-APB,2433,,,135649695,Activator,Agonist,Potentiation,f,f,,pEC50,3.700000048,0,3.400000095,EC50,380000,0,205000,=,,,,16636202,NCCOB(c1ccccc1)c1ccccc1
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Channel blocker,None,inward current mediated by monovalent cations is blocked,t,f,,pIC50,5.318999767,0,5.268000126,IC50,5400,0,4800,=,,,,0,
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,2-APB,2433,,,135649695,Activator,Activation,,f,f,>1000,-,0,0,0,-,0,0,0,=,,,,11385574,NCCOB(c1ccccc1)c1ccccc1
TRPM7,499,TRPM7,Q96QT4,,,,,,Human,ATP,1713,,,135651446,Activator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,intracellular,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,2-APB,2433,,,135649695,Channel blocker,Inhibition,Reversible inhibition,f,f,,pIC50,0,3.75,0,IC50,0,178000,0,=,,,,16636202,NCCOB(c1ccccc1)c1ccccc1
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,carvacrol,2497,,,53801081,Channel blocker,Inhibition,Reversible inhibition,f,f,,pIC50,0,3.519999981,0,IC50,0,300000,0,=,,,,19135721,CC(c1ccc(c(c1)O)C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,2-APB,2433,,,135649695,Channel blocker,Antagonist,,f,f,,pIC50,5.099999905,0,4.900000095,-,0,0,0,=,,,,15194687,NCCOB(c1ccccc1)c1ccccc1
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,BCTC,2460,,,53801006,Channel blocker,Antagonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,"Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8",,,14757700,O=C(N1CCN(CC1)c1ncccc1Cl)Nc1ccc(cc1)C(C)(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,capsazepine,2461,,,135650053,Channel blocker,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,18000,0,=,,,,14757700,Clc1ccc(cc1)CCNC(=S)N1CCCc2c(C1)cc(O)c(c2)O
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,5-benzyloxytryptamine,265,,,135649825,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCc1c[nH]c2c1cc(OCc1ccccc1)cc2
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,ACAA,2443,,,135649885,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCc1ccc(cc1)/C=C/C(=O)Nc1ccccc1C(=O)O
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,AMTB,4132,,,178100954,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,18562636,NCCCN(C(=O)c1ccccc1OCc1cccc(c1)C)Cc1cccs1
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,anandamide,2364,,,135651438,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,cannabidiol,4150,,,178100971,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,clotrimazole,2330,,,135650114,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccccc1C(n1cncc1)(c1ccccc1)c1ccccc1
TRPP1,504,PKD2,Q13563,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,None,,f,,0.1-1000,pEC50,0,6,0,-,0,0,0,=,,,Intracellular,11854751,
TRPP1,504,PKD2,Q13563,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,,100,-,0,0,0,,0,0,0,,,,,16396967,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,f,,5000,-,0,0,0,-,0,0,0,=,,,Intracellular,10517637,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Activator,Agonist,,f,,1,-,0,0,0,-,0,0,0,=,,,Extracellular,10517637,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,citric acid,2478,,,135651460,Activator,Agonist,,f,,15000-30000,pEC50,0,1.7,0,,0,0,0,,,,,16891422,OC(=O)C(CC(=O)O)(CC(=O)O)O
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,,f,f,,pIC50,0,3.799999952,0,IC50,0,143000,0,=,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,benzamil,4145,,,178100966,Channel blocker,None,,f,f,,pIC50,0,6,0,IC50,0,1100,0,=,,,,0,NC(=NCc1ccccc1)NC(=O)c1nc(Cl)c(nc1N)N
TRPV1,507,Trpv1,O35433,,,,,,Rat,12S-HPETE,2481,,,53800990,Activator,Agonist,,t,f,,pEC50,0,5.099999905,0,EC50,0,7940,0,=,,,,10823958,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)OO
TRPV1,507,Trpv1,O35433,,,,,,Rat,12S-HPETE,2481,,,53800990,Activator,Agonist,,t,f,,pEC50,0,5.099999905,0,EC50,0,7940,0,=,,,,10823958,CCCCC/C=CC[C@@H](/C=C/C=CC/C=CCCCC(=O)O)OO
TRPV1,507,Trpv1,O35433,,,,,,Rat,15S-HPETE,2482,,,135651379,Activator,Agonist,,t,f,,pEC50,0,5.099999905,0,EC50,0,7940,0,=,,,,10823958,CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)OO
TRPV1,507,Trpv1,O35433,,,,,,Rat,15S-HPETE,2482,,,135651379,Activator,Agonist,,t,f,,pEC50,0,5.099999905,0,EC50,0,7940,0,=,,,,10823958,CCCCC[C@@H](/C=C/C=CC/C=CC/C=CCCCC(=O)O)OO
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,2-APB,2433,,,135649695,Activator,Agonist,,f,,,pEC50,3.9,0,3.7,,0,0,0,,,,,15194687,NCCOB(c1ccccc1)c1ccccc1
TRPV1,507,Trpv1,O35433,,,,,,Rat,5S-HPETE,2483,,,53801093,Activator,Agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,10823958,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO
TRPV1,507,Trpv1,O35433,,,,,,Rat,5S-HPETE,2483,,,53801093,Activator,Agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,10823958,CCCCC/C=CC/C=CC/C=CC=C[C@H](CCCC(=O)O)OO
TRPV1,507,Trpv1,O35433,,,,,,Rat,allicin,2419,,,135651433,Activator,Agonist,,f,,,pEC50,4.6,0,3.9,,0,0,0,,,,,15916949,C=CCSS(=O)CC=C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,anandamide,2364,,,135651438,Activator,Agonist,,t,,,pEC50,0,5.9,0,,0,0,0,,,,,10694225,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,anandamide,2364,,,135651438,Activator,Agonist,,t,,,pEC50,0,5.9,0,,0,0,0,,,,,10694225,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
TRPV1,507,Trpv1,O35433,,,,,,Rat,anandamide,2364,,,135651438,Activator,Agonist,,t,,,pEC50,0,5.3,0,,0,0,0,,,,,10440374,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO
TRPV1,507,Trpv1,O35433,,,,,,Rat,anandamide,2364,,,135651438,Activator,Agonist,,t,,,pEC50,0,5.3,0,,0,0,0,,,,,10440374,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCO
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,arvanil,2485,,,53801091,Activator,Agonist,,f,,,pEC50,0,9.6,0,,0,0,0,,,,,15489017,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,arvanil,2485,,,53801091,Activator,Agonist,,f,,,pEC50,0,9.6,0,,0,0,0,,,,,15489017,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,Trpv1,O35433,,,,,,Rat,capsaicin,2486,,,53801090,Activator,Agonist,,f,,,pEC50,0,6.1,0,,0,0,0,,,,,9349813,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,capsaicin,2486,,,53801090,Activator,Agonist,,f,t,,pEC50,0,7.5,0,EC50,0,31.60000038,0,=,,,,15306801,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,capsaicin,2486,,,53801090,Activator,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,15489017,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,5S-HETE,3390,,,135651416,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,5S-HETE,3390,,,135651416,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC=C[C@H](CCCC(=O)O)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,camphor,2422,,,135652676,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CC2C(C1(C)CC2)(C)C
TRPV1,507,Trpv1,O35433,,,,,,Rat,asivatrep,9621,,,340590251,Antagonist,Antagonist,,f,f,,pIC50,0,8.210000038,0,IC50,0,6.199999809,0,=,Antagonism of capsaicin-induced calcium influx in isolated primary rat spinal dorsal root ganglia cells.,,,0,CCCc1nc(ccc1/C=C/C(=O)N[C@@H](c1cc(F)c(c(c1)F)NS(=O)(=O)C)C)C(F)(F)F
TRPV1,507,Trpv1,O35433,,,,,,Rat,BCTC,2460,,,53801006,Channel blocker,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,12721338,O=C(N1CCN(CC1)c1ncccc1Cl)Nc1ccc(cc1)C(C)(C)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,BCTC,2460,,,53801006,Channel blocker,Antagonist,,f,f,,pIC50,0,7.5,0,IC50,0,34.90000153,0,=,,,,24055075,O=C(N1CCN(CC1)c1ncccc1Cl)Nc1ccc(cc1)C(C)(C)C
TRPV1,507,Trpv1,O35433,,,,,,Rat,capsazepine,2461,,,135650053,Channel blocker,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,11226139,Clc1ccc(cc1)CCNC(=S)N1CCCc2c(C1)cc(O)c(c2)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,capsazepine,2461,,,135650053,Channel blocker,Antagonist,,f,f,,pIC50,0,7.400000095,0,IC50,0,39,0,=,,,,11226139,Clc1ccc(cc1)CCNC(=S)N1CCCc2c(C1)cc(O)c(c2)O
TRPV1,507,Trpv1,O35433,,,,,,Rat,agatoxin 489,2484,,,53801092,Channel blocker,Inhibition,,f,,,pKi,0,6.5,0,-,0,0,0,=,,,,16300403,NCCCNCCCCNCCCNCCCN(CCCNC(=O)Cc1c[nH]c2c1cccc2)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,AMG 9810,6347,,,178102965,Channel blocker,Inhibition,,f,,,pIC50,0,7.8,0,-,0,0,0,=,,,,15615864,O=C(Nc1ccc2c(c1)OCCO2)/C=C/c1ccc(cc1)C(C)(C)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,2-APB,2433,,,135649695,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCOB(c1ccccc1)c1ccccc1
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,5'-iodoresiniferatoxin,4109,,,178100931,Channel blocker,None,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.900000095,0,=,,,,0,COc1cc(CC(=O)OCC2=C[C@H]3[C@H]4O[C@]5(O[C@]3([C@H]3[C@@](C2)(O)C(=O)C(=C3)C)[C@@H](C[C@@]4(O5)C(=C)C)C)Cc2ccccc2)cc(c1O)I
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,6-iodo-nordihydrocapsaicin,4110,,,178100932,Channel blocker,None,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,0,COc1cc(CNC(=O)CCCCCC(C)C)c(cc1O)I
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,A425619,4117,,,178100939,Channel blocker,None,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15837819,O=C(Nc1cccc2c1ccnc2)NCc1ccc(cc1)C(F)(F)F
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,A778317,4120,,,178100942,Channel blocker,None,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,17660385,O=C(Nc1cccc2c1ccnc2)N[C@@H]1CCc2c1ccc(c2)C(C)(C)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,allicin,2419,,,135651433,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C=CCSS(=O)CC=C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,AMG517,4129,,,178100951,Channel blocker,None,,f,f,,pIC50,0,9,0,IC50,0,0.899999976,0,=,,,,20307063,CC(=O)Nc1sc2c(n1)c(ccc2)Oc1ncnc(c1)c1ccc(cc1)C(F)(F)F
TRPV1,507,Trpv1,O35433,,,,,,Rat,AMG628,4130,,,178100952,Channel blocker,None,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.700000048,0,=,,,,17585751,CC(=O)Nc1sc2c(n1)c(ccc2)Oc1ncnc(c1)N1CCN(CC1)[C@@H](c1ccc(cc1)F)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,AZD1386,7820,,,223366151,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,0,O=C1NC(=O)C2(N1)c1cc(Cl)cc(c1N(C2=O)Cc1cccc(c1)C(F)(F)F)C
TRPV2,508,TRPV2,Q9Y5S1,,,,,,Human,cannabidiol,4150,,,178100971,Activator,Activation,,f,,,pEC50,0,4.5,0,EC50,0,31700,0,=,,,,18550765,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,cannabidiol,4150,,,178100971,Activator,Activation,,f,,,pEC50,0,5.43,0,EC50,0,3700,0,=,,,,18550765,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,cannabinol,740,,,135650052,Activator,Activation,,f,,,pEC50,0,4.11,0,EC50,0,77000,0,=,,,,18550765,CCCCCc1cc(O)c2c(c1)OC(c1c2cc(C)cc1)(C)C
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,2-APB,2433,,,135649695,Activator,Agonist,,f,f,,pEC50,3.900000095,0,3.799999952,EC50,160000,0,129000,=,,,,15194687,NCCOB(c1ccccc1)c1ccccc1
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,2-APB,2433,,,135649695,Activator,None,,f,f,,pEC50,0,5,0,EC50,0,10000,0,=,,,,17395593,NCCOB(c1ccccc1)c1ccccc1
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,citral,6327,,,178102945,Channel blocker,Inhibition,,f,,500,-,0,0,0,-,0,0,0,=,,,,18461159,O=C/C=C(/CCC=C(C)C)\C
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,citral,6327,,,178102945,Channel blocker,Inhibition,,f,,500,-,0,0,0,-,0,0,0,=,,,,18461159,O=C/C=C(/CCC=C(C)C)C
TRPV2,508,TRPV2,Q9Y5S1,,,,,,Human,amiloride,2421,,,135649936,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=NC(=O)c1nc(Cl)c(nc1N)N)N
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,6-tert-butyl-<i>m</i>-cresol,4111,,,178100933,Activator,Activation,,f,f,,pEC50,0,3.430000067,0,EC50,0,370000,0,=,Two-electrode voltage-clamp,,,17420775,Cc1ccc(c(c1)O)C(C)(C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,borneol,6413,,,178103029,Activator,Activation,,f,,,pEC50,0,2.46,0,EC50,0,3450000,0,=,Two-electrode voltage-clamp,,,17420775,O[C@H]1C[C@@H]2C([C@@]1(C)CC2)(C)C
TRPV3,509,Trpv3,,,,,,,Rat,cannabidiol,4150,,,178100971,Activator,Activation,,f,,,pEC50,0,5.43,0,EC50,0,3700,0,=,Calcium imaging,,,21726418,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,carveol,6417,,,178103033,Activator,Activation,,f,,,pEC50,0,2.52,0,EC50,0,3030000,0,=,,,,17420775,CC(=C)C1CC=C(C(C1)O)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,citral,6327,,,178102945,Activator,Activation,,f,,,pKd,0,3.03,0,Kd,0,926000,0,=,Patch clamp electrophysiology,,,18461159,O=C/C=C(/CCC=C(C)C)\C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,citral,6327,,,178102945,Activator,Activation,,f,,,pKd,0,3.03,0,Kd,0,926000,0,=,Patch clamp electrophysiology,,,18461159,O=C/C=C(/CCC=C(C)C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,cinnamaldehyde,2423,,,135650100,Activator,Agonist,,f,,500-5000,-,0,0,0,-,0,0,0,=,,,,16829128,O=C/C=C/c1ccccc1
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,2-APB,2433,,,135649695,Activator,Full agonist,,f,f,,pEC50,0,4.599999905,0,EC50,0,25100,0,=,Patch clamp electrophysiology,,,15175387,NCCOB(c1ccccc1)c1ccccc1
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,camphor,2422,,,135652676,Activator,Full agonist,,f,f,1000-2000,-,0,0,0,-,0,0,0,=,Patch clamp electrophysiology,,,15746429,O=C1CC2C(C1(C)CC2)(C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,carvacrol,2497,,,53801081,Activator,Full agonist,,f,f,500,-,0,0,0,-,0,0,0,=,Patch clamp electrophysiology,,,16617338,CC(c1ccc(c(c1)O)C)C
TRPV3,509,TRPV3,Q8NET8,,,,,,Human,compound 74a [PMID: 27077528],9145,,,315661230,Antagonist,Antagonist,,f,t,,pIC50,0,6.420000076,0,IC50,0,380,0,=,,,,27077528,O[C@@H]([C@@]1(C[C@](C1)(C)O)c1nccc(c1)C(C)(C)C)c1ccccn1
TRPV3,509,TRPV3,Q8NET8,,,,,,Human,aspirin-triggered resolvin D1,6239,,,178102860,Channel blocker,Inhibition,,f,,,pIC50,0,6.4,0,IC50,0,398,0,=,Calcium imaging,,,21718307,CC/C=C\C[C@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](C/C=C\CCC(=O)O)O)O)O
TRPV3,509,TRPV3,Q8NET8,,,,,,Human,aspirin-triggered resolvin D1,6239,,,178102860,Channel blocker,Inhibition,,f,,,pIC50,0,6.4,0,IC50,0,398,0,=,Calcium imaging,,,21718307,CC/C=CC[C@H](/C=C/C=CC=CC=C[C@H]([C@H](C/C=CCCC(=O)O)O)O)O
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,4&alpha;-PDH,4105,,,178100928,Activator,Activation,,f,f,,pEC50,0,7.099999905,0,EC50,0,79.40000153,0,=,,,,19361196,CCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)CCCCC)C3(C)C)C=C(C[C@@]1([C@H]2C=C(C1=O)C)O)CO
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,4&alpha;-PDD,2500,,,53801079,Activator,Agonist,,f,f,0.3,-,0,0,0,-,0,0,0,=,,,,12970074,CCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)CCCCCCCCC)C3(C)C)C=C(C[C@@]1([C@H]2C=C(C1=O)C)O)CO
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,4&alpha;-PDD,2500,,,53801079,Activator,Agonist,,f,,,pEC50,0,6.7,0,-,0,0,0,=,,,,11827975,CCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)CCCCCCCCC)C3(C)C)C=C(C[C@@]1([C@H]2C=C(C1=O)C)O)CO
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,"5,6-epoxyeicosatrienoic acid",6304,,,178102923,Activator,Agonist,,t,f,,pEC50,0,6.900000095,0,-,0,0,0,=,,,,12879072,CCCCC/C=C\C/C=C\C/C=C\CC1OC1CCCC(=O)O
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,"5,6-epoxyeicosatrienoic acid",6304,,,178102923,Activator,Agonist,,t,f,,pEC50,0,6.900000095,0,-,0,0,0,=,,,,12879072,CCCCC/C=CC/C=CC/C=CCC1OC1CCCC(=O)O
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,bisandrographolide,2502,,,53801077,Activator,Agonist,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,16899456,OC[C@]1(C)[C@H](O)CC[C@@]2([C@@H]1CCC(=C)[C@H]2/C=C/C1=CC(OC1=O)C(C1=CCOC1=O)C[C@@H]1C(=C)CC[C@H]2[C@@]1(C)CC[C@H]([C@@]2(C)CO)O)C
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,citric acid,2478,,,135651460,Activator,Agonist,,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,12692122,OC(=O)C(CC(=O)O)(CC(=O)O)O
TRPV6,512,TRPV6,Q9H1D0,,,,,,Human,2-APB,2433,,,135649695,Activator,Potentiation,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCOB(c1ccccc1)c1ccccc1
TRPV6,512,TRPV6,Q9H1D0,,,,,,Human,Cd<sup>2+</sup>,2440,,,135652732,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TSH receptor,255,TSHR,P16473,,,,,,Human,compound 8b [PMID: 22408719],9113,,,315661198,Agonist,Agonist,,f,f,,pEC50,0,7.739999771,0,EC50,0,18,0,=,,,,22408719,COc1ccc(cc1CSc1ccc(cc1)NC(=O)C)C1Nc2cccc(c2C(=O)N1Cc1ccccc1)O
TTK protein kinase,2264,TTK,P33981,,,,,,Human,AZ3146,9400,,,328083502,Inhibitor,Inhibition,,f,t,,pIC50,0,7.460000038,0,IC50,0,35,0,~,<i>In vitro</i> assay using a His-tagged catalytic domain fragment of MPS1 (amino acids 510?857).,,,20624899,COc1cc(ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C)OC1CCN(CC1)C
TTK protein kinase,2264,TTK,P33981,,,,,,Human,compound 27f [PMID: 25625617],9238,,,315661313,Inhibitor,Inhibition,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,Biochemical assay,,,25625617,O=C(c1ccc(cc1)c1cnc2n1nc(cc2NCC1CCOCC1)NC(C(F)(F)F)(C)C)NC1CC1
TTK protein kinase,2264,TTK,P33981,,,,,,Human,compound 34h [PMID: 27055065],9169,,,315661252,Inhibitor,Inhibition,,f,f,,pIC50,8.300000191,0,7.960000038,IC50,11,0,5,=,,,,27055065,COc1cc(ccc1Nc1ncc2c(n1)c(ncc2)N[C@H](C(C)(C)C)C)c1cnn(c1)C
tubulin beta 3 class III,2752,TUBB3,Q13509,,,,,,Human,combretastatin A4,8854,,,252827511,Inhibitor,Inhibition,,f,f,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,Measuring cytotoxicity in cells expressing TUBB3 using the sulforhodamine B colorimetric assay.,,,23895532,COc1cc(/C=C\c2ccc(c(c2)O)OC)cc(c1OC)OC
tubulin beta 3 class III,2752,TUBB3,Q13509,,,,,,Human,combretastatin A4,8854,,,252827511,Inhibitor,Inhibition,,f,f,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,Measuring cytotoxicity in cells expressing TUBB3 using the sulforhodamine B colorimetric assay.,,,23895532,COc1cc(/C=Cc2ccc(c(c2)O)OC)cc(c1OC)OC
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,cabazitaxel,6798,,,178103404,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)OC(C)(C)C)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,colchicine,2367,,,135650118,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,16504507,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)OC
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,acalabrutinib,8912,,,310264693,Inhibitor,Inhibition,,f,f,,pIC50,0,6.429999828,0,IC50,0,368,0,=,,,,26641137,CC#CC(=O)N1CCC[C@H]1c1nc(c2n1ccnc2N)c1ccc(cc1)C(=O)Nc1ccccn1
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,compound 23 [PMID: 17600705],8146,,,249565826,Inhibitor,Inhibition,,f,f,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,17600705,Oc1ccc(c(c1)Nc1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,compound 31 [PMID: 24915291],8148,,,249565828,Inhibitor,Inhibition,,f,f,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,,,,24915291,C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,compound 38 [PMID: 24915291],8145,,,249565825,Inhibitor,Inhibition,,f,f,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,24915291,C=CC(=O)NCC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,compound 7 [PMID: 22464456],8172,,,249565852,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,77.5,0,=,,,,22464456,CCC(c1ccc2c(c1)[nH]c(c2)c1n[nH]c2c1sc(c2)C(F)F)(CC)O
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,compound 9 [PMID: 26006010],9761,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.389999866,0,IC50,0,41,0,=,,,,26006010,N#C/C(=CC(N(C1COC1)C)(C)C)/C(=O)N1CCC[C@H]1Cn1nc(c2c1ncnc2N)c1ccc(cc1F)Oc1ccccc1
TYRO3 protein tyrosine kinase,1836,TYRO3,Q06418,,,,,,Human,BMS-777607,7953,,,249565636,Inhibitor,Inhibition,,f,f,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,,,,19260711,CCOc1ccn(c(=O)c1C(=O)Nc1ccc(c(c1)F)Oc1ccnc(c1Cl)N)c1ccc(cc1)F
TYRO3 protein tyrosine kinase,1836,TYRO3,Q06418,,,,,,Human,compound 21 [PMID: 23312943],8135,,,249565815,Inhibitor,Inhibition,,f,t,,pIC50,0,9.149999619,0,IC50,0,0.699999988,0,=,,,,23312943,CN(C1CCC(CC1)Nc1nc(ncc1c1onc(c1)C)Nc1cc(Cl)cc(c1)Cl)C
tyrosinase,2643,,,,,,,,Unknown,compound 7 [PMID: 21334791],8785,,,252827443,Inhibitor,Inhibition,,f,f,,pIC50,0,6.429999828,0,IC50,0,370,0,=,,,,21334791,Oc1ccc(c(c1)O)CCc1ccc(cc1O)O
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,BMS-911543,7954,,,249565637,Inhibitor,Inhibition,,f,f,,pIC50,0,7.179999828,0,IC50,0,66,0,=,,,,22015772,CCn1c(cc2c1nc(Nc1nn(c(c1)C)C)c1c2n(C)cn1)C(=O)N(C1CC1)C1CC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,cerdulatinib,8957,,,310264738,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,25253883,CCS(=O)(=O)N1CCN(CC1)c1ccc(cc1)Nc1ncc(c(n1)NC1CC1)C(=O)N
tyrosine kinase non receptor 2,2246,TNK2,Q07912,,,,,,Human,bosutinib,5710,,,178102336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.569999695,0,IC50,0,2.700000048,0,=,,,,19039322,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
tyrosine kinase non receptor 2,2246,TNK2,Q07912,,,,,,Human,compound 30 [PMID: 17280833],8193,,,249565873,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,17280833,c1ccc(cc1)c1c(oc2c1c(NCCc1ccccc1)ncn2)c1ccc(cc1)OCCN1CCCC1
tyrosine kinase with immunoglobulin like and EGF like domains 1,1841,TIE1,P35590,,,,,,Human,compound R-16 [PMID: 21967808],8213,,,249565893,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21967808,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F
ubiquitin C-terminal hydrolase L3,2427,UCHL3,P15374,,,,,,Human,compound 6 [PMID: 17948018],8660,,,252166860,Inhibitor,Inhibition,,f,t,,pIC50,0,6.21999979,0,IC50,0,600,0,=,,,,17948018,O=C1CC(=O)c2c1c(Cl)c(c(c2Cl)Cl)Cl
unc-51 like autophagy activating kinase 1,2271,ULK1,O75385,,,,,,Human,compound R-16 [PMID: 21967808],8213,,,249565893,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,21967808,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F
unc-51 like kinase 3,2273,ULK3,Q6PHR2,,,,,,Human,compound 15 [PMID: 24900237],8220,,,249565900,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24900237,CCN1C(=O)CCCc2c1ccc(c2OC)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)Cl
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,[3-iodo-Tyr<sup>6</sup>]U-II-(4-11) (human),9436,,,329968376,Agonist,Agonist,,f,f,,pEC50,0,8.699999809,0,-,0,0,0,=,,,,12943190,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,AC-7954,2151,,,135649883,Agonist,Full agonist,,f,f,,pKi,0,6.599999905,0,-,0,0,0,=,,,,12408704,CN(CCC1(OC(=O)c2c(C1)cccc2)c1ccc(cc1)Cl)C
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,[Bz-Phe6]U-II (human),2159,,,135652049,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,12495432,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,BIM 23127,2162,,,135652035,Antagonist,Antagonist,,f,,,pKd,0,6.7,0,,0,0,0,,,,,12770925,
UT receptor,365,Uts2r,P49684,,,,,,Rat,[Cha<sup>6</sup>]U-II-(4-11),9439,,,329968379,Antagonist,Antagonist,,f,f,,pKi,0,6.400000095,0,-,0,0,0,=,,,,17125276,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,compound 1a [PMID: 18573659],8872,,,252827529,Antagonist,Antagonist,,f,t,,pKi,0,8.399999619,0,Ki,0,4,0,=,Ligand binding.,,,18573659,Brc1cc(ccc1OC1CCNCC1)CN1CC[C@@H](C1)NC(=O)c1ccc(c(c1)Cl)Cl
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide,2161,,,135651961,Antagonist,Inverse agonist,,f,,,pKd,0,8.4,0,-,0,0,0,=,,,,12535707,
Vesicular acetylcholine transporter,1013,SLC18A3,Q16572,,,,,,Human,aminobenzovesamicol,4768,,,178101477,Inhibitor,Inhibition,,f,,,pKi,0,10.9,0,Ki,0,0.013,0,,,,,7702637,Ic1cccc(c1)CN1CC[C@H]([C@@H](C1)N1CCC(CC1)c1ccccc1)O
Vesicular nucleotide transporter,1010,SLC17A9,Q9BYT1,,,,,,Human,clodronic acid,9605,,,340590235,Inhibitor,Inhibition,,f,f,,pIC50,0,7.809999943,0,IC50,0,15.60000038,0,=,Using a quantitative transport assay system involving proteoliposomes containing only expressed and purified protein.,,,0,ClC(P(=O)(O)O)(P(=O)(O)O)Cl
Vitamin D receptor,605,VDR,P11473,,,,,,Human,"1,25-dihydroxyvitamin D3",2779,,,135651370,Agonist,Agonist,,t,t,,pKd,9.199999809,0,8.899999619,-,0,0,0,=,,,,7976510,O[C@H]1C[C@H](O)C(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(O)(C)C)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,"1,25-dihydroxyvitamin D3",2779,,,135651370,Agonist,Agonist,,t,t,,pKd,9.199999809,0,8.899999619,-,0,0,0,=,,,,7976510,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(O)(C)C)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,2MD,2776,,,135651400,Agonist,Agonist,,f,,,pEC50,0,10,0,,0,0,0,,,,,9804706,C[C@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=C\C=C1C[C@@H](O)C(=C)[C@@H](C1)O)CCCC(O)(C)C
Vitamin D receptor,605,VDR,P11473,,,,,,Human,2MD,2776,,,135651400,Agonist,Agonist,,f,,,pEC50,0,10,0,,0,0,0,,,,,9804706,C[C@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=CC=C1C[C@@H](O)C(=C)[C@@H](C1)O)CCCC(O)(C)C
Vitamin D receptor,605,VDR,P11473,,,,,,Human,3-keto-lithocholic acid,2766,,,135651407,Agonist,Agonist,,t,,,pKi,0,6.54,0,,0,0,0,,,,,12016314,OC(=O)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@H]2[C@]1(C)CCC(=O)C2)C
Vitamin D receptor,605,VDR,P11473,,,,,,Human,calcipotriol,2778,,,135650047,Agonist,Agonist,,f,t,,pKd,0,9.300000191,0,-,0,0,0,=,,,,7976510,O[C@H]1C[C@H](O)C(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@H](C2CC2)O)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,calcipotriol,2778,,,135650047,Agonist,Agonist,,f,t,,pKd,0,9.300000191,0,-,0,0,0,=,,,,7976510,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@H](C2CC2)O)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,"calcitriol-26,23-lactone",2786,,,135651451,Agonist,Agonist,,t,,,pKd,0,7.5,0,,0,0,0,,,,,6572492,O[C@H]1C[C@H](O)C(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](C[C@@H]2OC(=O)[C@](C2)(C)O)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,"calcitriol-26,23-lactone",2786,,,135651451,Agonist,Agonist,,t,,,pKd,0,7.5,0,,0,0,0,,,,,6572492,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](C[C@@H]2OC(=O)[C@](C2)(C)O)C)C)/C1
vitamin K epoxide reductase complex subunit 1,2645,Vkorc1,Q6TEK4,,,,,,Rat,acenocoumarol,9015,,,315661100,Inhibitor,Inhibition,,f,f,,pIC50,0,6.110000134,0,IC50,0,770,0,=,,,,17275317,CC(=O)CC(c1c(=O)oc2c(c1O)cccc2)c1ccc(cc1)[N+](=O)[O-]
vitamin K epoxide reductase complex subunit 1,2645,VKORC1,Q9BQB6,,,,,,Human,alitretinoin,2645,,,135651418,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,10327215,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,f,,pEC50,0,7.599999905,0,EC50,0,25.60000038,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,f,,pEC50,0,10.19999981,0,EC50,0,0.057,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.400000095,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,f,,pEC50,0,9.399999619,0,EC50,0,0.400000006,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,7.2,0,IC50,0,60,0,=,Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor,,,9437714,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,BAY 55-9837,2269,,,135652009,Agonist,Agonist,,f,,,pEC50,0,7,0,EC50,0,100,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,11978642,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,BAY 55-9837,2269,,,135652009,Agonist,Agonist,,f,,,pIC50,0,5.1,0,IC50,0,8700,0,=,inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,11978642,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pEC50,0,5.9,0,EC50,0,1222,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pKi,0,5.6,0,Ki,0,2352,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Ala<sup>11,22,28</sup>]VIP",2278,,,135651977,Agonist,Agonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,[Arg<sup>16</sup>]chicken secretin,3293,,,135651997,Agonist,Agonist,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,BAY 55-9837,2269,,,135652009,Agonist,Agonist,,f,,,pIC50,0,7.2,0,IC50,0,60,0,=,inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,11978642,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,BAY 55-9837,2269,,,135652009,Agonist,Agonist,,f,,,pEC50,0,9.4,0,EC50,0,0.4,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,11978642,
VRAC,710,,,,,,,,Human,"1,9-dideoxyforskolin",4100,,,178100923,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C=C[C@@]1(C)CC(=O)[C@H]2[C@@](O1)(C)[C@@H](OC(=O)C)[C@H]([C@@H]1[C@]2(C)CCCC1(C)C)O
VRAC,710,,,,,,,,Human,9-anthroic acid,4113,,,178100935,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1c2ccccc2cc2c1cccc2
VRAC,710,,,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,t,,,-,0,0,0,,0,0,0,,,,,0,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
VRAC,710,,,,,,,,Human,arachidonic acid,2391,,,135651442,Channel blocker,None,,t,,,-,0,0,0,,0,0,0,,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)O
VRAC,710,,,,,,,,Human,carbenoxolone,4151,,,178100972,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C)CCC(=O)O
VRAC,710,,,,,,,,Human,clomiphene,4159,,,178100979,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCN(CCOc1ccc(cc1)C(=C(c1ccccc1)Cl)c1ccccc1)CC
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,arginine vasotocin,2169,,,135652004,Agonist,Full agonist,,t,,,pKi,0,8.3,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,arginine vasotocin,2169,,,135652004,Agonist,Full agonist,,t,,,pKi,0,8.5,0,,0,0,0,,,,,7774575,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,3-N<sub>3</sub>-Phpa-LVA,2193,,,135651958,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,9334232,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,atosiban,2213,,,135652002,Antagonist,Antagonist,,f,,,pKi,8.5,0,8.3,,0,0,0,,,,,10519430,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,arginine vasotocin,2169,,,135652004,Agonist,Full agonist,,t,,,pKi,0,8,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,atosiban,2213,,,135652002,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.2,,0,0,0,,,,,12660315,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,arginine vasotocin,2169,,,135652004,Agonist,Full agonist,,t,,,pKi,8.2,0,7.6,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,atosiban,2213,,,135652002,Antagonist,Antagonist,,f,,,pKi,6,0,5.5,,0,0,0,,,,,12660315,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
WEE1 G2 checkpoint kinase,2278,WEE1,P30291,,,,,,Human,AZD1775,7702,,,223366035,Inhibitor,Inhibition,,f,t,,pIC50,0,8.289999962,0,IC50,0,5.179999828,0,=,,,,0,C=CCn1c(=O)c2c(n1c1cccc(n1)C(O)(C)C)nc(nc2)Nc1ccc(cc1)N1CCN(CC1)C
WNK lysine deficient protein kinase 2,2281,WNK2,Q9Y3S1,,,,,,Human,compound 25 [PMID: 17935989],8122,,,249565802,Inhibitor,Inhibition,,f,f,,pKi,0,5.820000172,0,Ki,0,1518,0,>,,,,17935989,N#Cc1ncc2nc1OCCCCOc1c(NC(=O)N2)cc(Cl)c(c1)NCc1cncs1
WNK lysine deficient protein kinase 3,2282,WNK3,Q9BYP7,,,,,,Human,compound 2c [PMID: 24900538],8138,,,249565818,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,99.80000305,0,=,,,,24900538,CC(Oc1[nH]nc(c1)n1cnc2c1nc(cc2)N[C@H](c1ccc(cn1)F)C)C
xanthine dehydrogenase,2646,XDH,P47989,,,,,,Human,allopurinol,6795,,,178103401,Inhibitor,Inhibition,,f,t,,pIC50,0,5.380000114,0,IC50,0,4200,0,=,,,,8691450,O=c1ncnc2c1c[nH][nH]2
xanthine dehydrogenase,2646,XDH,P47989,,,,,,Human,allopurinol,6795,,,178103401,Inhibitor,Inhibition,,f,t,,pKi,0,5.150000095,0,Ki,0,7000,0,=,,,,8691450,O=c1ncnc2c1c[nH][nH]2
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,AT-406,7729,,,223366062,Antagonist,Antagonist,,f,f,,pKi,0,7.179999828,0,Ki,0,66.40000153,0,=,Competitive inhibition of human XIAP BIR3 domain expressed in <i>Escherichia coli</i>.,,,21443232,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)CC(C)C)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,AZD5582,7710,,,223366043,Antagonist,Antagonist,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,24320998,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@H](OCC#CC#CCO[C@@H]2Cc3c([C@@H]2NC(=O)[C@@H]2CCCN2C(=O)[C@H](C2CCCCC2)NC(=O)[C@@H](NC)C)cccc3)Cc2c1cccc2)C1CCCCC1)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,birinapant,7432,,,178104004,Antagonist,Antagonist,,f,f,,pKd,0,7.349999905,0,Kd,0,45,0,=,,,,23225169,CC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc1c([nH]c2c1ccc(c2)F)c1[nH]c2c(c1C[C@@H]1C[C@@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC)C)CC)O)ccc(c2)F)O)NC(=O)[C@@H](NC)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,BV-6,7914,,,249565597,Inhibitor,Inhibition,,f,t,,pKd,0,8.890000343,0,Kd,0,1.299999952,0,=,Assayed using expressed XIAP BIR2-BIR3 domain construct,,,18022362,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)NCCCCCCNC(=O)[C@H](C(c1ccccc1)c1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C1CCCCC1)NC(=O)[C@@H](NC)C)C1CCCCC1)C
X-prolyl aminopeptidase 1,1578,XPNPEP1,Q9NQW7,,,,,,Human,apstatin,8803,,,252827461,Inhibitor,Inhibition,,f,f,,pIC50,0,4.679999828,0,IC50,0,21000,0,=,,,,10395480,C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](Cc1ccccc1)N)O
X-prolyl aminopeptidase 2,1579,XPNPEP2,O43895,,,,,,Human,apstatin,8803,,,252827461,Inhibitor,Inhibition,,f,t,,pIC50,0,5.539999962,0,IC50,0,2900,0,=,,,,10395480,C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](Cc1ccccc1)N)O
X-prolyl aminopeptidase 2,1579,XPNPEP2,O43895,,,,,,Human,apstatin,8803,,,252827461,Inhibitor,Inhibition,,f,t,,pKi,0,6.190000057,0,Ki,0,640,0,=,,,,10395480,C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](Cc1ccccc1)N)O
X-prolyl aminopeptidase 2,1579,XPNPEP2,O43895,,,,,,Human,compound 6 [PMID: 10395480],8632,,,252166832,Inhibitor,Inhibition,,f,f,,pIC50,0,6.639999866,0,IC50,0,230,0,=,,,,10395480,CC(C[C@@H]([C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C)O)N)C
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (pig)",1522,,,135651980,Agonist,Full agonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,12069595,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,BIBO3304,1528,,,135649991,Antagonist,Antagonist,,f,f,,pIC50,0,9.5,0,IC50,0,0.379999995,0,=,,,,9806339,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)CNC(=O)N
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,BIBO3304,1528,,,135649991,Antagonist,Antagonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,10694200,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)CNC(=O)N
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,BIBP3226,1485,,,135649992,Antagonist,Antagonist,,f,f,,pKi,8.5,0,7.900000095,-,0,0,0,=,,,,9145427,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)O
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,BIBP3226,1485,,,135649992,Antagonist,Antagonist,,f,f,,pKi,9.329999924,0,8.119999886,Ki,7.599999905,0,0.469999999,=,,,,7562541,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)O
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (pig)",1522,,,135651980,Agonist,Full agonist,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,12069595,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,C2-NPY (pig),1534,,,135652050,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,BIIE0246,1547,,,135649994,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11408607,NC(=NCCC[C@@H](C(=O)NCCn1c(=O)n(n(c1=O)c1ccccc1)c1ccccc1)NC(=O)CC1(CCCC1)CC(=O)N1CCN(CC1)C1c2ccccc2NC(=O)c2c1cccc2)N
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,BIIE0246,1547,,,135649994,Antagonist,Antagonist,,f,f,,pIC50,0,8.5,0,IC50,0,3.299999952,0,=,,,,10611450,NC(=NCCC[C@@H](C(=O)NCCn1c(=O)n(n(c1=O)c1ccccc1)c1ccccc1)NC(=O)CC1(CCCC1)CC(=O)N1CCN(CC1)C1c2ccccc2NC(=O)c2c1cccc2)N
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (pig)",1522,,,135651980,Agonist,Full agonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,12069595,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY",1560,,,135651979,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12890716,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (pig)",1522,,,135651980,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,-,0,0,0,=,,,,12069595,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"[Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (pig)",1522,,,135651980,Agonist,Full agonist,,f,f,,pIC50,0,8.199999809,0,-,0,0,0,=,,,,12069595,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,CGP 71683A,1562,,,135650078,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12890716,Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2
ZAC ,587,ZACN,Q401N2,,,,,,Human,Ca<sup>2+</sup>,707,,,135652731,Antagonist,Antagonist,,f,f,,pIC50,0,2.029999971,0,-,0,0,0,=,,,,26872532,
ZAK sterile alpha motif and leucine zipper containing kinase AZK,2289,ZAK,Q9NYL2,,,,,,Human,compound 15b [PMID: 16539403],8194,,,249565874,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,708,0,=,,,,16539403,OCCCn1cnc2c1cc(cc2)c1c2CCCn2nc1c1ccccn1
zeta chain of T cell receptor associated protein kinase 70,2285,ZAP70,P43403,,,,,,Human,aloisine,5923,,,178102546,Inhibitor,Inhibition,,f,f,,pKi,0,5.579999924,0,Ki,0,2630,0,=,,,,22289061,CCCCc1c([nH]c2c1nccn2)c1ccc(cc1)OC
,0,,,5-LOX activating protein,5183,ALOX5AP,P20292,178101873,Human,BI 665915,9716,,,348353675,Inhibitor,Binding,,f,f,,pIC50,0,8.770000458,0,IC50,0,1.700000048,0,=,,,,25671290,O=C(N(C)C)Cn1ncc(c1)c1onc(n1)C(c1ccc(cc1)c1cnc(nc1)N)(C1CC1)C
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,aducanumab,8325,,,252166537,Antibody,Binding,,f,t,,pEC50,0,9.399999619,0,EC50,0,0.400000006,0,=,Binding to recombinamt human A&beta; 1-42,,,0,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,bapineuzumab,6930,,,178103512,Antibody,Binding,Binding of soluble amyloid &beta;(1-40),f,t,,pKd,0,7.050000191,0,Kd,0,89,0,=,,,,23416764,
,0,,,apixaban,6390,,,178103006,Human,andexanet alfa,7576,,,223365912,Inhibitor,Binding,,f,f,,pKd,0,9.239999771,0,Kd,0,0.579999983,0,=,"Enzyme assays using purified human plasma fXa, inhibited by apixaban.",,,23455714,
,0,,,atacicept,9517,,,336446904,Human,BAFF,5069,TNFSF13B,Human,178101762,None,Binding,,f,t,,pKd,10.05000019,0,9.869999886,Kd,0.135000005,0,0.090000004,=,Competitive binding to [<sup>125</sup>I]BAFF.,,,0,
,0,,,BAFF,5069,TNFSF13B,Q9Y275,178101762,Human,belimumab,6887,,,178103469,Antibody,Binding,,f,t,,pEC50,0,10.61999989,0,EC50,0,0.024,0,=,Binding affinity to immobilised BLyS,,,14613291,
,0,,,blisibimod,9518,,,336446905,Human,BAFF,5069,TNFSF13B,Human,178101762,None,Binding,,f,t,,pKd,0,11.39999962,0,Kd,0,0.004,0,=,Binding to human AGP3 (=BAFF),,,0,
,0,,,CD70,5079,CD70,P32970,178101772,Human,ARGX-110,9778,,,0,Antibody,Binding,,f,f,,pKd,0,10.72000027,0,Kd,0,0.018999999,0,=,Equilibrium dissociation constant determined by surface plasmon resonance analysis using a hCD70-coated sensor chip.,,,0,
,0,,,complement C3,9414,C3,,328083516,Human,compstatin,9218,,,315661294,Inhibitor,Inhibition,,f,f,,pKd,0,6.889999866,0,Kd,0,130,0,=,,,,8752942,CC[C@@H]([C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2[nH]cnc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)C(C)C)CCC(=O)N)CC(=O)O)Cc1c[nH]c2c1cccc2)Cc1[nH]cnc1)C(=O)N[C@H](C(=O)N)[C@H](O)C)N)C
,0,,,FGF-23,9291,FGF23,Q9GZV9,318164810,Human,burosumab,9292,,,318164811,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,IL-12B,5002,IL12B,P29460,178101699,Human,briakinumab,9213,,,315661289,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,,,,0,
,0,,,IL-15,4981,IL15,P40933,178101678,Human,compound 76 [PMID: 28657314],9609,,,340590239,Antagonist,Antagonist,,f,f,,pKd,0,4.659999847,0,Kd,0,21800,0,=,By SPR binding to the IL-15 superagonist RLI.,,,28657314,CCOC(=O)c1cccc(c1)NC(=O)CCCCCCCSc1nnc(n1C)Cc1nn(C)c(=O)c2c1cccc2
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,bimekizumab,9411,,,328083513,Antibody,Binding,,f,t,,pKd,0,10.68000031,0,Kd,0,0.021,0,=,Biacore assay using recombinant human IL-17A,,,0,
,0,,,IL-17F,5873,IL17F,Q96PD4,178102497,Human,bimekizumab,9411,,,328083513,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,IL-1&beta;,4974,IL1B,P01584,178101672,Human,canakinumab,6773,,,178103379,Antibody,Binding,,f,t,,pKd,0,10.46000004,0,Kd,0,0.035,0,=,,,,0,
,0,,,IL-23A,4989,IL23A,,178101686,Human,brazikumab,9293,,,318164812,Antibody,Binding,,f,t,,pKd,0,11.39999962,0,Kd,0,0.004,0,<,Measured using KinExA technology (a kinetic exclusion assay),,,0,
,0,,,IL-6,4998,IL6,P05231,178101695,Human,clazakizumab,9195,,,315661274,Antibody,Binding,,f,t,,pKd,0,10.30000019,0,Kd,0,0.050000001,0,<,,,,0,
,0,,,phosphatidylserine,3638,,,135651545,Human,bavituximab,8002,,,249565682,Antibody,Binding,,f,t,,pKd,0,9.399999619,0,Kd,0,0.400000006,0,=,,,,14760060,
,0,,,programmed cell death 1 ligand 1,9606,CD274,Q9NZQ7,340590236,Human,atezolizumab,7990,,,249565671,Antibody,Binding,,f,t,,pKd,10,0,9,Kd,1,0,0.100000001,=,,,,0,
,0,,,programmed cell death 1 ligand 1,9606,CD274,Q9NZQ7,340590236,Human,avelumab,8735,,,252827393,Antibody,Binding,,f,t,,pIC50,0,10.14999962,0,IC50,0,0.071000002,0,=,Measuring inhibition of PD-1 binding to PD-L1.,,,0,
,0,,,programmed cell death 1 ligand 1,9606,CD274,Q9NZQ7,340590236,Human,BMS-1166,9608,,,340590238,None,Binding,,f,f,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,28613862,N#Cc1cccc(c1)COc1cc(OCc2cccc(c2C)c2ccc3c(c2)OCCO3)c(cc1CN1C[C@@H](C[C@@H]1C(=O)O)O)Cl
,0,,,programmed cell death 1 ligand 1,9606,CD274,Q9NZQ7,340590236,Human,BMS-202,9607,,,340590237,None,Binding,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,28613862,COc1nc(OCc2cccc(c2C)c2ccccc2)ccc1CNCCNC(=O)C
,0,,,rivaroxaban,6388,,,178103004,Human,andexanet alfa,7576,,,223365912,Inhibitor,Binding,,f,f,,pKd,0,8.819999695,0,Kd,0,1.529999971,0,=,"Enzyme assays using purified human plasma fXa, inhibited by rivaroxaban.",,,23455714,
,0,,,sclerostin,3704,SOST,Q9BQB4,178100593,Human,BPS-804,9202,,,315661278,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,adalimumab,4860,,,178101561,Antibody,Binding,,f,t,,pKd,0,8,0,Kd,0,10,0,=,,,,0,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,certolizumab pegol,6774,,,178103380,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,Note IC90 value of 3ng/ml is provided,,,17636564,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,compound 1 [PMID: 28611375],9673,,,348353632,Inhibitor,Binding,,f,f,,pKd,0,5.320000172,0,Kd,0,4790,0,=,Low affinity binding site identified using gravimetric measurements made by surface acoustic wave (SAW) sensors.,,,28611375,O=C(N1CCN(CC1)Cc1ccccc1)CN(S(=O)(=O)c1ccccc1)c1cccc(c1C)Cl
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,compound 1 [PMID: 28611375],9673,,,348353632,Inhibitor,Binding,,f,f,,pKd,0,8.640000343,0,Kd,0,2.309999943,0,=,High affinity binding site identified using gravimetric measurements made by surface acoustic wave (SAW) sensors.,,,28611375,O=C(N1CCN(CC1)Cc1ccccc1)CN(S(=O)(=O)c1ccccc1)c1cccc(c1C)Cl
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,aflibercept,6786,,,178103392,Antagonist,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,24179482,
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,bevacizumab,6771,,,178103377,Antibody,Binding,,f,t,,pIC50,8.300000191,0,8,IC50,10,0,5,=,,,,0,
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,brolucizumab,8713,,,252827371,Antibody,Binding,,f,t,,pKd,0,8.800000191,0,Kd,0,1.590000033,0,=,,,,0,
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,abicipar pegol,8371,,,252166583,Inhibitor,Inhibition,,f,t,,pKd,0,11.69999981,0,Kd,0,0.002,0,=,,,,23218689,
,0,,,von Willebrand factor,6755,VWF,P04275,178103366,Human,caplacizumab,9123,,,315661208,Antibody,Binding,,f,t,,pKd,0,8.520000458,0,Kd,0,3.099999905,0,=,,,,0,
12S-LOX,1387,ALOX12,P18054,,,,,,Human,ML355,8752,,,252827410,Inhibitor,Inhibition,,f,t,,pIC50,0,6.46999979,0,IC50,0,340,0,=,,,,24393039,COc1cccc(c1O)CNc1ccc(cc1)S(=O)(=O)Nc1nc2c(s1)cccc2
15-LOX-1,1388,ALOX15,P16050,,,,,,Human,PKUMDL_MH_1001,9141,,,315661226,Allosteric modulator,Positive,,f,f,,pKd,0,5.409999847,0,Kd,0,3900,0,=,"Determined by surface plasmon
resonance (SPR).",,,26290290,CN1CCN(CC1)CC(=O)N1N=C2C(C1c1ccccc1)CCC/C/2=Cc1ccccc1
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,GSK2334470,8008,,,249565688,Inhibitor,Inhibition,,f,t,,pIC50,0,8.600000381,0,IC50,0,2.50999999,0,=,,,,21341675,CNc1nc(cc(n1)c1ccc2c(c1)[nH]nc2N)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,OSU-03012,8005,,,249565685,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,15205346,NCC(=O)Nc1ccc(cc1)n1nc(cc1c1ccc2c(c1)ccc1c2cccc1)C(F)(F)F
3-phosphoinositide dependent protein kinase 1,1519,PDPK1,O15530,,,,,,Human,PHT-427,8009,,,249565689,Inhibitor,Inhibition,,f,t,,pKi,0,5.28000021,0,Ki,0,5200,0,=,Assay using purified recombinant pleckstrin homology domain of human PDK1,,,20197390,CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1
4-aminobutyrate aminotransferase,2464,ABAT,P80404,,,,,,Human,CPP-115,8284,,,252166496,Inhibitor,Inhibition,,f,t,,pKi,0,5.010000229,0,Ki,0,9700,0,=,,,,22168767,OC(=O)[C@H]1CC(=C(F)F)[C@H](C1)N
4F2hc,890,SLC3A2,P08195,,,,,,Human,IGN523,8737,,,252827395,Antibody,Binding,,f,t,,pKd,0,8.890000343,0,Kd,0,1.299999952,0,=,,,,0,
4-hydroxyphenylpyruvate dioxygenase,2621,,,,,,,,Pig,nitisinone,6834,,,178103440,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,10853644,O=C1CCCC(=O)C1C(=O)c1ccc(cc1[N+](=O)[O-])C(F)(F)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,flibanserin,8182,,,249565862,Agonist,Agonist,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,12177684,O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,frovatriptan,7191,,,178103766,Agonist,Agonist,,f,f,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,9986723,CN[C@H]1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LP-12,8434,,,252166644,Agonist,Agonist,,f,f,,pKi,0,7.21999979,0,Ki,0,60.90000153,0,=,,,,17649988,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LP-211,8436,,,252166646,Agonist,Agonist,,f,f,,pKi,0,6.730000019,0,Ki,0,188,0,=,,,,18800769,N#Cc1ccc(cc1)CNC(=O)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LP-44,8435,,,252166645,Agonist,Agonist,,f,f,,pKi,0,7.28000021,0,Ki,0,52.70000076,0,=,,,,17649988,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,CP 93129,11,,,135650131,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9205951,O=c1ccc2c([nH]1)c(c[nH]2)C1=CCNCC1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,eletriptan,40,,,135650227,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10193663,CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,FG-5893,13,,,135650260,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9760039,COC(=O)c1cccnc1N1CCN(CC1)CCCC(c1ccc(cc1)F)c1ccc(cc1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,flesinoxan,1,,,135650267,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9760039,OC[C@H]1COc2c(O1)cccc2N1CCN(CC1)CCNC(=O)c1ccc(cc1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,"L-694,247",15,,,135650478,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9205951,NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,"L-772,405",16,,,135650493,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,10585208,OC[C@@H](c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,lisuride,43,,,135650525,Agonist,Full agonist,,f,,,pKi,9.8,0,9.7,,0,0,0,,,,,9550290,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,"LY 165,163",18,,,135650543,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,9760039,Nc1ccc(cc1)CCN1CCN(CC1)c1cccc(c1)C(F)(F)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LY293284,19,,,135650546,Agonist,Full agonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,11101361,CCCN([C@H]1Cc2c[nH]c3c2c(C1)c(cc3)C(=O)C)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LY334370,20,,,135650551,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,15900510,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,12213075,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,nafadotride,44,,,135650679,Agonist,Full agonist,,f,,,pKi,0,7.3,0,-,0,0,0,=,,,,9760039,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,naratriptan,45,,,135650691,Agonist,Full agonist,,f,,,pKi,7.6,0,7.1,,0,0,0,,,,,9205951,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,NLX-101,3924,,,178100753,Agonist,Full agonist,,f,,,pKi,0,8.6,0,-,0,0,0,=,,,,19154445,Cc1cnc(nc1)CNCC1(F)CCN(CC1)C(=O)c1ccc(c(c1)Cl)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,ocaperidone,46,,,135650754,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9065439,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,olanzapine,47,,,135650756,Agonist,Full agonist,,f,,,pKi,5.8,0,5.6,,0,0,0,,,,,9760039,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,quetiapine,50,,,135650869,Agonist,Full agonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,9760039,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,10431754,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,rizatriptan,51,,,135650905,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,10193663,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9760039,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,S-14506,24,,,135650958,Agonist,Full agonist,,f,,,pKi,9.7,0,9.6,,0,0,0,,,,,9760039,COc1ccc2c(c1)c(ccc2)N1CCN(CC1)CCNC(=O)c1ccc(cc1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,S-14671,25,,,135650959,Agonist,Full agonist,,f,,,pKi,10.5,0,10.2,,0,0,0,,,,,9760039,COc1ccc2c(c1)c(ccc2)N1CCN(CC1)CCNC(=O)c1cccs1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,spiroxatrine,53,,,135651066,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9760039,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,fluparoxan,41,,,135650272,Agonist,Partial agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10611634,Fc1cccc2c1O[C@H]1CNC[C@@H]1O2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,7.2,0,7.1,,0,0,0,,,,,9397179,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,ipsapirone,42,,,135650411,Agonist,Partial agonist,,f,,,pKi,8.8,0,8.6,,0,0,0,,,,,9760039,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1
5-HT<sub>1A</sub> receptor,1,Htr1a,P19327,,,,,,Rat,lurasidone,7461,,,187051764,Agonist,Partial agonist,,f,f,,pKi,0,8.170000076,0,Ki,0,6.75,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,piribedil,49,,,135650833,Agonist,Partial agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,9.9,0,9.4,,0,0,0,,,,,10431754,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(R)-UH 301,3218,,,135650952,Agonist,Partial agonist,,f,,,pKi,0,8.6,0,Ki,0,2.74,0,=,,,,9760039,CCCN([C@@H]1CCc2c(C1)c(O)ccc2F)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,S-15535,26,,,135650960,Agonist,Partial agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9550290,C1COc2c(O1)cccc2N1CCN(CC1)C1Cc2c(C1)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,S 16924,167,,,135650961,Agonist,Partial agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9732398,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,SB 216641,28,,,135650988,Agonist,Partial agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,RS-30199,104,,,135650942,Allosteric modulator,Positive,,f,f,,pKi,7.5,0,7.099999905,-,0,0,0,=,,,,9707291,CN1CCc2c3C(C1)CCCc3ccc2Cl
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,cyamemazine,84,,,135650143,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,-,0,0,0,=,,,,12527336,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,fluspirilene,85,,,135650278,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,"GR 125,743",69,,,135650311,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9205951,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(c(c1)C)c1ccncc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,"GR 218,231",70,,,135650317,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10869410,CCCN([C@@H]1CCc2c(C1)ccc(c2)CS(=O)(=O)c1ccc(cc1)OC)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,5.8,0,5.7,,0,0,0,,,,,9760039,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>1A</sub> receptor,1,Htr1a,P19327,,,,,,Rat,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8997630,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,11750183,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,<i>p</i>-MPPI,68,,,135650409,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15628665,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)I)c1ccccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(<i>R</i>)-flurocarazolol,65,,,135650898,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11512051,FCC(NC[C@H](COc1cccc2c1c1ccccc1[nH]2)O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(<i>S</i>)-flurocarazolol,66,,,135651039,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,11512051,FCC(NC[C@@H](COc1cccc2c1c1ccccc1[nH]2)O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,1386736,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,6.980000019,0,Ki,0,105,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,8.1,0,7.8,,0,0,0,,,,,9760039,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,NAN 190,73,,,135650690,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,9760039,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9760039,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,pindolol,91,,,135650827,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9550290,OC(COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,pipamperone,92,,,135650830,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8935801,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,pizotifen,93,,,135650835,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9205951,CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(-)-propranolol,63,,,135650859,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9205951,O[C@H](COc1cccc2c1cccc2)CNC(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,p-[<sup>18</sup>F]MPPF,3227,,,178100284,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,16330560,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)[18F])c1ncccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,raclopride,94,,,135650880,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9760039,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,Rec 15/3079,74,,,135650892,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,11714892,COc1ccccc1N1CCN(CC1)CCN(c1ccccc1[N+](=O)[O-])C(=O)C1CCCCC1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,repinotan,95,,,135650895,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,9495870,O=C1c2ccccc2S(=O)(=O)N1CCCCNC[C@H]1CCc2c(O1)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,6.5,0,6.4,,0,0,0,,,,,9760039,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>1A</sub> receptor,1,Htr1a,P19327,,,,,,Rat,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8997630,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pIC50,5.5,0,5.2,,0,0,0,,,,,9048968,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,robalzotan,72,,,135650677,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0.630999982,0,=,,,,9336327,NC(=O)c1ccc(c2c1C[C@H](CO2)N(C1CCC1)C1CCC1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,SB 272183,75,,,135651002,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11454652,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,SB 649915,76,,,135651013,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,15887956,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,SB 714786,77,,,135651017,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,15887956,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,SDZ-216525,78,,,135651033,Antagonist,Antagonist,,f,,,pIC50,8.2,0,7.8,,0,0,0,,,,,9048968,COC(=O)c1[nH]c2c(c1)c(ccc2)N1CCN(CC1)CCCCN1C(=O)c2c(S1(=O)=O)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.4,,0,0,0,,,,,9760039,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,8.8,0,6.7,,0,0,0,,,,,1386736,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,frovatriptan,7191,,,178103766,Agonist,Agonist,,f,t,,pKi,0,7.989999771,0,Ki,0,10.30000019,0,=,,,,9986723,CN[C@H]1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,CP-122288,110,,,135650124,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,9303569,CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)C[C@H]1CCCN1C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,CP94253,3221,,,178100280,Agonist,Full agonist,,f,,,pKi,0,8.7,0,Ki,0,2,0,=,,,,0,CCCOc1ccc2c(n1)c(c[nH]2)C1=CCNCC1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,dihydroergotamine,121,,,135650182,Agonist,Full agonist,,f,,,pKi,9.2,0,8,,0,0,0,,,,,8863519,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,dipropyl-5-CT,122,,,135650195,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1565658,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,eletriptan,40,,,135650227,Agonist,Full agonist,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,10193663,CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,"L-694,247",15,,,135650478,Agonist,Full agonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0.629999995,0,=,,,,10513577,NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,"L-772,405",16,,,135650493,Agonist,Full agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,10585208,OC[C@@H](c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,lysergol,123,,,135650564,Agonist,Full agonist,,f,,,pKi,8.9,0,7.5,,0,0,0,,,,,1565658,OC[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,olanzapine,47,,,135650756,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9632357,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,1557407,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>1B</sub> receptor,2,Htr1b,P28564,,,,,,Rat,donitriptan,39,,,135650207,Agonist,Partial agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,9.8,0,9,,0,0,0,,,,,9397179,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,"L-775,606",114,,,135650494,Agonist,Partial agonist,,f,,,pKi,6.9,0,6.3,,0,0,0,,,,,11040052,Fc1cccc(c1)CCN1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,naratriptan,45,,,135650691,Agonist,Partial agonist,,f,t,,pKi,0,8.100000381,0,-,0,0,0,=,,,,10193663,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,rizatriptan,51,,,135650905,Agonist,Partial agonist,,f,t,,pKi,0,6.900000095,0,-,0,0,0,=,,,,10193663,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,6,0,5.8,,0,0,0,,,,,10431754,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB 216641,28,,,135650988,Agonist,Partial agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,cyanopindolol,132,,,135650144,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,1557407,N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,GR 127935,14,,,135650312,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,10513577,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,GR-55562,113,,,135650319,Antagonist,Antagonist,,f,,,pKB,0,7.4,0,-,0,0,0,=,,,,11888546,CN(CCCc1cc(ccc1O)C(=O)Nc1ccc(cc1)c1ccncc1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,GR-55562,113,,,135650319,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,10513577,CN(CCCc1cc(ccc1O)C(=O)Nc1ccc(cc1)c1ccncc1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,(<i>R</i>)-flurocarazolol,65,,,135650898,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,11512051,FCC(NC[C@H](COc1cccc2c1c1ccccc1[nH]2)O)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,(<i>S</i>)-flurocarazolol,66,,,135651039,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11512051,FCC(NC[C@@H](COc1cccc2c1c1ccccc1[nH]2)O)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pIC50,5.4,0,5.2,,0,0,0,,,,,9303569,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,1557407,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8863519,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,7.6,0,6.6,,0,0,0,,,,,1565658,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,1557407,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,ocaperidone,46,,,135650754,Antagonist,Antagonist,,f,,,pIC50,7.2,0,6.9,,0,0,0,,,,,9605573,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,(-)-pindolol,127,,,135650828,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,1557407,O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,pipamperone,92,,,135650830,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8935801,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.5,,0,0,0,,,,,1565658,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,t,,pKi,7.300000191,0,6.599999905,-,0,0,0,=,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pIC50,6.5,0,6,,0,0,0,,,,,9303569,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB 272183,75,,,135651002,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11454652,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB 649915,76,,,135651013,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,15887956,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB 714786,77,,,135651017,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,15887956,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,1557407,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Inverse agonist,,f,,,pKi,8.5,0,7.1,,0,0,0,,,,,8863519,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Inverse agonist,,f,f,,pKi,8.600000381,0,8.199999809,Ki,6.309999943,0,2.50999999,=,,,,9776361,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,SB236057,3231,,,135650997,Antagonist,Inverse agonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.309999943,0,=,,,,10443589,CCN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1nnc(o1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,ergotamine,149,,,135650239,Agonist,Agonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,10715164,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,frovatriptan,7191,,,178103766,Agonist,Agonist,,f,t,,pKi,0,8.359999657,0,Ki,0,4.400000095,0,=,,,,9986723,CN[C@H]1Cc2c(CC1)[nH]c1c2cc(cc1)C(=N)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,"L-694,247",15,,,135650478,Agonist,Agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,9855638,NCCc1c[nH]c2c1cc(cc2)c1onc(n1)Cc1ccc(cc1)NS(=O)(=O)C
5-HT<sub>1D</sub> receptor,3,,,,,,,,Gorilla,PNU109291,3228,,,178100285,Agonist,Agonist,,f,,,pKi,0,9.1,0,Ki,0,0.9,0,=,,,,9632349,CNC(=O)c1ccc2c(c1)CCO[C@H]2CCN1CCN(CC1)c1ccc(cc1)OC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,CP-122288,110,,,135650124,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,9303569,CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)C[C@H]1CCCN1C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,dihydroergotamine,121,,,135650182,Agonist,Full agonist,,f,t,,pKi,9.899999619,0,9.199999809,-,0,0,0,=,,,,9605573,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,dimethyltryptamine,141,,,135650188,Agonist,Full agonist,,f,,,pKi,7.3,0,7,,0,0,0,,,,,8967979,CN(CCc1c[nH]c2c1cccc2)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,dipropyl-5-CT,122,,,135650195,Agonist,Full agonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,1565658,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1D</sub> receptor,3,Htr1d,P28565,,,,,,Rat,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,eletriptan,40,,,135650227,Agonist,Full agonist,,f,t,,pKi,0,8.899999619,0,Ki,0,1.25999999,0,=,,,,10193663,CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,lysergic acid,139,,,135650563,Agonist,Full agonist,,f,,,pKi,9,0,8.8,,0,0,0,,,,,8967979,CN1C[C@@H](C=C2C1Cc1c[nH]c3c1c2ccc3)C(=O)O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,lysergol,123,,,135650564,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,1565658,OC[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,naratriptan,45,,,135650691,Agonist,Full agonist,,f,t,,pKi,9,0,8.399999619,-,0,0,0,=,,,,10193663,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,olanzapine,47,,,135650756,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,quetiapine,50,,,135650869,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8935801,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,rizatriptan,51,,,135650905,Agonist,Full agonist,,f,t,,pKi,0,7.900000095,0,-,0,0,0,=,,,,10193663,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,1652050,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,9.1,0,8.6,,0,0,0,,,,,9397179,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,9632357,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,7.2,0,7,,0,0,0,,,,,10431754,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 216641,28,,,135650988,Agonist,Partial agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,cyanopindolol,132,,,135650144,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,1652050,N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,fluspirilene,85,,,135650278,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,GR 127935,14,,,135650312,Antagonist,Antagonist,,f,,,pKi,8.6,0,8.3,,0,0,0,,,,,8967979,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,1652050,Clc1cccc(c1)N1CCNCC1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.4,,0,0,0,,,,,9303569,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,"L-772,405",16,,,135650493,Antagonist,Antagonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,10585208,OC[C@@H](c1ccc(cc1)F)NC1CCN(CC1)CCCc1c[nH]c2c1cc(cc2)n1cnnc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.6,,0,0,0,,,,,9303569,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.4,,0,0,0,,,,,1565658,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,ocaperidone,46,,,135650754,Antagonist,Antagonist,,f,,,pKi,8.8,0,8.7,,0,0,0,,,,,8967979,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,pipamperone,92,,,135650830,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8935801,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,1565658,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,t,,pKi,8,0,7.800000191,-,0,0,0,=,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8967979,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9776361,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 272183,75,,,135651002,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,11454652,CN1CCN(CC1)c1cc2c(cc1Cl)CCN2C(=O)Nc1ccc(c2c1cccc2)c1ccncc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 277011-A,143,,,135651003,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,10945872,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 649915,76,,,135651013,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,15887956,O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,SB 714786,77,,,135651017,Antagonist,Antagonist,,f,f,,pKi,0,9.100000381,0,Ki,0,0.79400003,0,=,,,,15887956,Cc1ccc2c(n1)cccc2OCCN1CCN(CC1)Cc1cccc2c1nccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,6,0,5.5,,0,0,0,,,,,1565658,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Inverse agonist,,f,,,pKi,8.2,0,7.3,,0,0,0,,,,,8957260,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,dihydroergotamine,121,,,135650182,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8863519,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,DOI,147,,,135650202,Agonist,Full agonist,,f,,,pKi,5.8,0,5.5,,0,0,0,,,,,8380639,COc1cc(I)c(cc1CC(N)C)OC
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,eletriptan,40,,,135650227,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10193663,CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,ergometrine,148,,,135650238,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,14744596,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,ergotamine,149,,,135650239,Agonist,Full agonist,,f,,,pKi,6.3,0,6.2,,0,0,0,,,,,1608964,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,lysergol,123,,,135650564,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8863519,OC[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,naratriptan,45,,,135650691,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,10193663,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,olanzapine,47,,,135650756,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,quetiapine,50,,,135650869,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8935801,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,rizatriptan,51,,,135650905,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10193663,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,14744596,Clc1cccc(c1)N1CCNCC1
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,fluspirilene,85,,,135650278,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,6.1,0,5.6,,0,0,0,,,,,8863519,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,7,0,6.7,,0,0,0,,,,,8863519,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,methylergonovine,150,,,135650591,Antagonist,Antagonist,,f,,,pKi,7.2,0,7,,0,0,0,,,,,8380639,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.5,,0,0,0,,,,,8863519,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,5.5,0,5.4,,0,0,0,,,,,8863519,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,dihydroergotamine,121,,,135650182,Agonist,Full agonist,,f,,,pKi,7.1,0,6.6,,0,0,0,,,,,15900510,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,dipropyl-5-CT,122,,,135650195,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,8380639,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,DOI,147,,,135650202,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,8380639,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,eletriptan,40,,,135650227,Agonist,Full agonist,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,10193663,CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,ergotamine,149,,,135650239,Agonist,Full agonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,8384716,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,ergotamine,149,,,135650239,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8380639,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,lasmiditan,3928,,,178100757,Agonist,Full agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,20855361,CN1CCC(CC1)C(=O)c1cccc(n1)NC(=O)c1c(F)cc(cc1F)F
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,LY334370,20,,,135650551,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,Ki,0,1.99000001,0,=,,,,15900510,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.309999943,0,=,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,naratriptan,45,,,135650691,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,15900510,CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,olanzapine,47,,,135650756,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,quetiapine,50,,,135650869,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8935801,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,rizatriptan,51,,,135650905,Agonist,Full agonist,,f,,,pKi,6.8,0,6.4,,0,0,0,,,,,15900510,CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,7.2,0,6.4,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,NAN 190,73,,,135650690,Agonist,Partial agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,8380639,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8380639,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,8384716,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8380639,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,methylergonovine,150,,,135650591,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8380639,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,15900510,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,8384716,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LP-12,8434,,,252166644,Agonist,Agonist,,f,f,,pKi,0,5.829999924,0,Ki,0,1464,0,=,,,,17649988,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LP-44,8435,,,252166645,Agonist,Agonist,,f,f,,pKi,0,6.489999771,0,Ki,0,326,0,=,,,,17649988,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,relenopride,8427,,,252166637,Agonist,Agonist,,f,f,,pKi,0,6.21999979,0,Ki,0,600,0,=,,,,25316608,COc1cc(N)c(cc1C(=O)NCC1CCN(CC1)CC[C@@H](c1ccc(cc1)F)OC(=O)N)Cl
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,DOI,147,,,135650202,Agonist,Full agonist,,f,f,,pKi,9.199999809,0,7.400000095,Ki,39.79999924,0,0.630999982,=,,,,8534270,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,DOI,147,,,135650202,Agonist,Full agonist,,f,f,,pKi,0,7.099999905,0,-,0,0,0,=,,,,11040033,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,(+)-DOI,153,,,135650203,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@@H](N)C)OC
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,DOM,164,,,135650205,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9655845,COc1cc(C)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,ergometrine,148,,,135650238,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8114677,OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,GR 127935,14,,,135650312,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,<i>N</i>-1-isopropyl-5-MeOT,158,,,135650392,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8114677,NCCc1cn(c2c1cc(OC)cc2)C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,<i>N</i>-1-isopropyl-5-MeOT,158,,,135650392,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8114677,NCCc1cn(c2c1cc(OC)cc2)C(C)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,<i>N</i>-1-isopropyltryptamine,159,,,135650393,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8114677,NCCc1cn(c2c1cccc2)C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,<i>N</i>-1-isopropyltryptamine,159,,,135650393,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8114677,NCCc1cn(c2c1cccc2)C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,9.3,0,9.2,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12954071,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pEC50,0,6.8,0,,0,0,0,,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,(+)-LSD,154,,,135650537,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,15322733,CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12213075,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,8663249,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,methylergonovine,150,,,135650591,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,methylergonovine,150,,,135650591,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11104741,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,MK-212,165,,,135650614,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15322733,Clc1cncc(n1)N1CCNCC1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,Org 12962,170,,,135650777,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15322733,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ORG-37684,171,,,135650778,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15322733,COc1ccc2c(c1O[C@@H]1CNCC1)CCC2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pindolol,91,,,135650827,Agonist,Full agonist,,f,,,pKi,0,5,0,,0,0,0,,,,,15322733,OC(COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,quetiapine,50,,,135650869,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8935801,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,5.5,0,5,-,0,0,0,=,,,,12388666,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,quipazine,173,,,135650875,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15322733,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,Ro 60-0175,166,,,135650920,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,15322733,C[C@@H](Cn1ccc2c1cc(Cl)c(c2)F)N
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15322733,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,S 16924,167,,,135650961,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9732398,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 216641,28,,,135650988,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ergotamine,149,,,135650239,Agonist,Partial agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,15322733,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,ergotamine,149,,,135650239,Agonist,Partial agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11104741,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,7.5,0,6.8,,0,0,0,,,,,15322733,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,11104741,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,methysergide,134,,,135650596,Agonist,Partial agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11104741,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,cyamemazine,84,,,135650143,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,12527336,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,duloxetine,202,,,135650212,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,11750180,CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,EGIS-7625,176,,,135650223,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,15107597,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-]
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,EGIS-7625,176,,,135650223,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,15107597,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-]
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,flibanserin,8182,,,249565862,Antagonist,Antagonist,,f,t,,pKi,0,7.309999943,0,Ki,0,49,0,=,,,,12177684,O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,fluoxetine,203,,,135650270,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11104741,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,fluspirilene,85,,,135650278,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,glemanserin,186,,,135650574,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,15322733,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9655845,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,t,,pKi,7.300000191,0,6.699999809,-,0,0,0,=,,,,8935801,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,f,,pKi,9.699999809,0,8.100000381,Ki,7.940000057,0,0.199000001,=,,,,15322733,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,9,0,8.6,,0,0,0,,,,,11040033,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,"L-741,626",177,,,135650487,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10869410,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,lumateperone,9099,,,315661184,Antagonist,Antagonist,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,25120104,Fc1ccc(cc1)C(=O)CCCN1CCC2C(C1)c1cccc3c1N2CCN3C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,lurasidone,7461,,,187051764,Antagonist,Antagonist,,f,f,,pKi,0,8.68999958,0,Ki,0,2.029999971,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY063518,178,,,135650540,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8845011,NC(=N)N/N=C(c1ccc(s1)Cl)/c1ccccc1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,LY108742,179,,,135650541,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,8114677,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)cn3C)C)O
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,LY215840,180,,,135650544,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8114677,CN1C[C@@H](CC2[C@H]1Cc1cn(c3c1c2ccc3)C(C)C)C(=O)N[C@H]1CCC[C@H]1O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY215840,180,,,135650544,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8114677,CN1C[C@@H](CC2[C@H]1Cc1cn(c3c1c2ccc3)C(C)C)C(=O)N[C@H]1CCC[C@H]1O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY314228,181,,,135650547,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8845011,CCCc1c(COc2ccc(cc2)/C=N/N=C(N)N)ccc(c1O)C(=O)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY320954,182,,,135650549,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8845011,CCCc1c(COc2ccc(cc2)/C=N/N=C(N)N)ccc(c1O)C(=O)CC
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,LY53857,183,,,135650560,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8114677,CC(C(O)C)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY53857,183,,,135650560,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8114677,CC(C(O)C)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,LY86057,184,,,135650561,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,8114677,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,LY86057,184,,,135650561,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8114677,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,7.260000229,0,Ki,0,55,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,7.5,0,7,,0,0,0,,,,,15322733,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,8114677,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,15322733,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,15322733,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,9.5,0,8.4,,0,0,0,,,,,9655845,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,9,0,8.4,,0,0,0,,,,,9655845,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,t,,pKi,9.600000381,0,7.699999809,-,0,0,0,=,,,,10611634,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,t,,pKi,0,7.159999847,0,Ki,0,69,0,=,,,,15771415,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,molindone,207,,,135650621,Antagonist,Antagonist,,f,t,,pKi,0,6.5,0,-,0,0,0,=,,,,12629531,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,nefazodone,7247,,,178103821,Antagonist,Antagonist,,f,t,,pKi,0,8.239999771,0,Ki,0,5.800000191,0,=,,,,21823597,CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,norfluoxetine,208,,,135650734,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,11104741,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,t,,pKi,8.899999619,0,8.600000381,-,0,0,0,=,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,perospirone,7556,,,223365892,Antagonist,Antagonist,,f,f,,pKi,0,4.739999771,0,Ki,0,18000,0,=,,,,1060115,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pimozide,90,,,135650825,Antagonist,Antagonist,,f,t,,pKi,7.699999809,0,7.099999905,-,0,0,0,=,,,,12629531,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pindolol,91,,,135650827,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,15322733,OC(COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pipamperone,92,,,135650830,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,8935801,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,quetiapine,50,,,135650869,Antagonist,Antagonist,,f,t,,pKi,7,0,6.400000095,-,0,0,0,=,,,,12629531,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9655845,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11040033,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,10188965,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,RS-102221,187,,,135650934,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9225287,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,RS-102221,187,,,135650934,Antagonist,Antagonist,,f,,,pKi,6,0,5.5,,0,0,0,,,,,15322733,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,RS-127445,188,,,135650939,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15322733,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,sarpogrelate,210,,,135650981,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12738034,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 206553,189,,,135650985,Antagonist,Antagonist,,f,,,pKi,5.8,0,5.6,,0,0,0,,,,,15322733,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 215505,190,,,135650987,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10188965,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 221284,191,,,135650990,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,15322733,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,15322733,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 228357,192,,,135650995,Antagonist,Antagonist,,f,,,pKi,7,0,6.9,,0,0,0,,,,,10188965,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 242084,193,,,135650998,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.1,,0,0,0,,,,,15322733,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SB 243213,194,,,135650999,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10737744,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,SDZ SER-082,195,,,135651035,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,15322733,CN1CC[C@H]2[C@@H](C1)c1cccc3c1N(C2)CC3
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,sergolexole,211,,,135651036,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,8114677,CO[C@@H]1CC[C@H](CC1)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,sergolexole,211,,,135651036,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8114677,CO[C@@H]1CC[C@H](CC1)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,t,,pKi,9.399999619,0,9.199999809,-,0,0,0,=,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,9.4,0,7.8,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,9.2,0,9,,0,0,0,,,,,11040033,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,spiramide,175,,,135649934,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,15322733,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,loxapine,205,,,135650533,Antagonist,Inverse agonist,,f,t,,pKi,0,8.100000381,0,-,0,0,0,=,,,,12629531,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,pimavanserin,8423,,,252166633,Antagonist,Inverse agonist,,f,t,,pKi,0,9.300000191,0,-,0,0,0,=,Ki determined in membrane radioligand binding assay.,,,15102927,CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,risperidone,96,,,135650903,Antagonist,Inverse agonist,,f,t,,pKi,10,0,9.300000191,-,0,0,0,=,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,relenopride,8427,,,252166637,Agonist,Agonist,,f,f,,pKi,0,7.510000229,0,Ki,0,31,0,=,,,,25316608,COc1cc(N)c(cc1C(=O)NCC1CCN(CC1)CC[C@@H](c1ccc(cc1)F)OC(=O)N)Cl
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,dihydroergocryptine,282,,,135650181,Agonist,Biased agonist,,f,f,,pKi,0,7.480000019,0,-,0,0,0,=,Biased for &beta;-arrestin signalling.,,,23519215,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,Lysergide,17,,,135650536,Agonist,Biased agonist,,f,f,,pKi,0,8.430000305,0,-,0,0,0,=,Biased for &beta;-arrestin sihnalling.,,,23519215,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,DOI,147,,,135650202,Agonist,Full agonist,,f,f,,pKi,0,7.599999905,0,-,0,0,0,=,,,,8078486,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,DOI,147,,,135650202,Agonist,Full agonist,,f,f,,pKi,7.699999809,0,7.599999905,Ki,25.10000038,0,19.89999962,=,,,,9933142,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(+)-DOI,153,,,135650203,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@@H](N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,7.4,0,7.3,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12954071,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pKi,0,6.8,0,-,0,0,0,=,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pEC50,0,6,0,-,0,0,0,=,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(+)-LSD,154,,,135650537,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,15322733,CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12213075,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,MK-212,165,,,135650614,Agonist,Full agonist,,f,,,pKi,6.8,0,6.2,,0,0,0,,,,,15322733,Clc1cncc(n1)N1CCNCC1
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,MK-212,165,,,135650614,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8450835,Clc1cncc(n1)N1CCNCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,norfenfluramine,215,,,135650839,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11104741,CC(Cc1cccc(c1)C(F)(F)F)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(-)-norfenfluramine,217,,,135650732,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11104741,C[C@H](Cc1cccc(c1)C(F)(F)F)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,(+)-norfenfluramine,216,,,135650733,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11104741,C[C@@H](Cc1cccc(c1)C(F)(F)F)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,Org 12962,170,,,135650777,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,15322733,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,ORG-37684,171,,,135650778,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,15322733,COc1ccc2c(c1O[C@@H]1CNCC1)CCC2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,pindolol,91,,,135650827,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,15322733,OC(COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,6.5,0,5,-,0,0,0,=,,,,12388666,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,quipazine,173,,,135650875,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,15322733,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,quipazine,173,,,135650875,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8450835,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,Ro 60-0175,166,,,135650920,Agonist,Full agonist,,f,f,,pKi,0,8.300000191,0,Ki,0,5.010000229,0,=,,,,15322733,C[C@@H](Cn1ccc2c1cc(Cl)c(c2)F)N
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,8450835,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15322733,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,S 16924,167,,,135650961,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9732398,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,ergotamine,149,,,135650239,Agonist,Partial agonist,,f,,,pKi,8.9,0,8.5,,0,0,0,,,,,15322733,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8450835,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,8.5,0,7.4,,0,0,0,,,,,15322733,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,methylergonovine,150,,,135650591,Agonist,Partial agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,methysergide,134,,,135650596,Agonist,Partial agonist,,f,t,,pKi,9.399999619,0,8,-,0,0,0,=,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,methysergide,134,,,135650596,Agonist,Partial agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8450835,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 216641,28,,,135650988,Agonist,Partial agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,EGIS-7625,176,,,135650223,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,15107597,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-]
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,fluoxetine,203,,,135650270,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11104741,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,glemanserin,186,,,135650574,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,15322733,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,6.4,0,5.8,,0,0,0,,,,,9459568,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.1,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,8450835,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,"L-741,626",177,,,135650487,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10869410,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,lisuride,43,,,135650525,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,LY53857,183,,,135650560,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.8,,0,0,0,,,,,9459568,CC(C(O)C)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,LY53857,183,,,135650560,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8450835,CC(C(O)C)OC(=O)[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C(C)C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,LY86057,184,,,135650561,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8450835,CC(C(OC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C)O
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,melatonin,224,,,135651518,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,12750432,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8450835,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,8.8,0,8.5,,0,0,0,,,,,15322733,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,15322733,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8450835,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.7,,0,0,0,,,,,15322733,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,7.900000095,-,0,0,0,=,,,,15322733,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8450835,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,norfluoxetine,208,,,135650734,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11104741,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,piboserod,225,,,135650823,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,11504648,CCCCN1CCC(CC1)CNC(=O)c1c2OCCCn2c2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,piboserod,225,,,135650823,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,15466450,CCCCN1CCC(CC1)CNC(=O)c1c2OCCCn2c2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,pindolol,91,,,135650827,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,15322733,OC(COc1cccc2c1cc[nH]2)CNC(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,piribedil,49,,,135650833,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8450835,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,8.4,0,7.8,,0,0,0,,,,,9459568,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.7,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,8450835,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,RS-102221,187,,,135650934,Antagonist,Antagonist,,f,,,pKi,6.1,0,6,,0,0,0,,,,,15322733,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,RS-127445,188,,,135650939,Antagonist,Antagonist,,f,f,,pKi,9.489999771,0,9,Ki,1,0,0.319999993,=,,,,15322733,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,sarpogrelate,210,,,135650981,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12738034,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 204741,221,,,135650984,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,15322733,O=C(Nc1snc(c1)C)Nc1ccc2c(c1)ccn2C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 206553,189,,,135650985,Antagonist,Antagonist,,f,,,pKi,8.5,0,7.6,,0,0,0,,,,,15322733,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 215505,190,,,135650987,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,10188965,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 221284,191,,,135650990,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,15322733,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,15322733,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 228357,192,,,135650995,Antagonist,Antagonist,,f,,,pKi,8.1,0,8,,0,0,0,,,,,10188965,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 242084,193,,,135650998,Antagonist,Antagonist,,f,,,pKi,7,0,6.8,,0,0,0,,,,,15322733,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 243213,194,,,135650999,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,10737744,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SB 277011-A,143,,,135651003,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,10945872,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,SDZ SER-082,195,,,135651035,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,15322733,CN1CC[C@H]2[C@@H](C1)c1cccc3c1N(C2)CC3
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,6.5,0,5.9,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8450835,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,spiramide,175,,,135649934,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15322733,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.3,,0,0,0,,,,,9459568,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Agonist,,f,t,,pIC50,0,8.239999771,0,IC50,0,5.800000191,0,=,IP accumulation assay.,,,0,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,DOI,147,,,135650202,Agonist,Full agonist,,f,f,,pKi,8.600000381,0,7.199999809,Ki,63.09999847,0,2.50999999,=,,,,9933142,COc1cc(I)c(cc1CC(N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,(+)-DOI,153,,,135650203,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@@H](N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,8.7,0,7.4,,0,0,0,,,,,15322733,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,(<i>R</i>)-DOI,157,,,135650418,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12954071,COc1cc(I)c(cc1C[C@H](N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pEC50,0,8.1,0,,0,0,0,,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,lorcaserin,2941,,,135650530,Agonist,Full agonist,,f,,,pKi,0,7.8,0,-,0,0,0,=,,,,18252809,Clc1ccc2c(c1)[C@@H](C)CNCC2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,(+)-LSD,154,,,135650537,Agonist,Full agonist,,f,,,pKi,9,0,8.2,,0,0,0,,,,,15322733,CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,8.6,0,8.2,,0,0,0,,,,,10611640,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,methylergonovine,150,,,135650591,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11104741,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,methylergonovine,150,,,135650591,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,MK-212,165,,,135650614,Agonist,Full agonist,,f,,,pKi,7,0,5.6,,0,0,0,,,,,15322733,Clc1cncc(n1)N1CCNCC1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,Org 12962,170,,,135650777,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,15322733,FC(c1ccc(nc1Cl)N1CCNCC1)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,ORG-37684,171,,,135650778,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,15322733,COc1ccc2c(c1O[C@@H]1CNCC1)CCC2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Full agonist,,f,,,pKi,6.8,0,6.3,,0,0,0,,,,,10217294,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,5.5,0,5,-,0,0,0,=,,,,12388666,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,quipazine,173,,,135650875,Agonist,Full agonist,,f,,,pKi,7.3,0,5.9,,0,0,0,,,,,15322733,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,Ro 60-0175,166,,,135650920,Agonist,Full agonist,,f,f,,pKi,8.199999809,0,7.699999809,Ki,19.89999962,0,6.309999943,=,,,,15322733,C[C@@H](Cn1ccc2c1cc(Cl)c(c2)F)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,15322733,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,S 16924,167,,,135650961,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9732398,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,ergotamine,149,,,135650239,Agonist,Partial agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11104741,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,ergotamine,149,,,135650239,Agonist,Partial agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,15322733,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,8.5,0,6.5,,0,0,0,,,,,15322733,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,11104741,Clc1cccc(c1)N1CCNCC1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,8.3,0,7.9,-,0,0,0,=,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,methysergide,134,,,135650596,Agonist,Partial agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,11104741,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 216641,28,,,135650988,Agonist,Partial agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9303567,COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,cyamemazine,84,,,135650143,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,12527336,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,duloxetine,202,,,135650212,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,11750180,CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,EGIS-7625,176,,,135650223,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,15107597,Nc1cc(N2CCN(CC2)Cc2ccccc2)c(cc1C)[N+](=O)[O-]
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,fluoxetine,203,,,135650270,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11104741,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,FR260010,3223,,,178100281,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1.100000024,0,=,,,,17074317,Cc1ncn(c1)c1cccc(c1)Nc1ncnc2c1CCc1c2cccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,glemanserin,186,,,135650574,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,15322733,OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,idalopirdine,8689,,,252166889,Antagonist,Antagonist,,f,f,,pKi,0,6.599999905,0,Ki,0,250,0,=,,,,24878269,Fc1ccc2c(c1)[nH]cc2CCNCc1cccc(c1)OCC(C(F)F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,7.5,0,6.8,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,LY334362,231,,,135650550,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8845011,NC(=N/N=C/c1cccc(c1)OCc1ccc(cc1)C(=O)c1ccccc1)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,6.389999866,0,Ki,0,412,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9282936,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,t,,pKi,9.100000381,0,8.600000381,-,0,0,0,=,,,,15322733,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,9.4,0,8.8,,0,0,0,,,,,8876023,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,f,,pKi,0,7.409999847,0,Ki,0,39,0,=,,,,15771415,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,norfluoxetine,208,,,135650734,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11104741,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,9.6,0,8.2,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,RS-102221,187,,,135650934,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,8.300000191,Ki,5.010000229,0,3.980000019,=,,,,15322733,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,RS-102221,187,,,135650934,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9225287,COc1cc(OC)c(cc1C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O)NS(=O)(=O)c1ccc(cc1)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,RS-127445,188,,,135650939,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,15322733,Nc1nc(cc(n1)c1ccc(c2c1cccc2)F)C(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,sarpogrelate,210,,,135650981,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,12738034,COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 204741,221,,,135650984,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,15322733,O=C(Nc1snc(c1)C)Nc1ccc2c(c1)ccn2C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 206553,189,,,135650985,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.8,,0,0,0,,,,,15322733,O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 215505,190,,,135650987,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,10188965,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1cccc2c1cccn2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 221284,191,,,135650990,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,15322733,CSc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cccnc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9776361,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 224289,130,,,135650993,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,15322733,CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 228357,192,,,135650995,Antagonist,Antagonist,,f,,,pKi,9.1,0,9,,0,0,0,,,,,10188965,COc1cc2CCN(c2cc1C(F)(F)F)C(=O)Nc1cc(F)cc(c1)c1cccnc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 242084,193,,,135650998,Antagonist,Antagonist,,f,f,,pKi,9,0,8.199999809,Ki,6.309999943,0,1,=,,,,15322733,O=C(N1CCc2c1cc(Cl)c(c2)C)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SB 243213,194,,,135650999,Antagonist,Antagonist,,f,,,pEC50,0,9,0,,0,0,0,,,,,10737744,O=C(N1CCc2c1cc(c(c2)C)C(F)(F)F)Nc1ccc(nc1)Oc1cccnc1C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,SDZ SER-082,195,,,135651035,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,15322733,CN1CC[C@H]2[C@@H](C1)c1cccc3c1N(C2)CC3
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,6.2,0,5.6,,0,0,0,,,,,15322733,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,spiramide,175,,,135649934,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,15322733,Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,loxapine,205,,,135650533,Antagonist,Inverse agonist,,f,t,,pKi,8,0,7.800000191,-,0,0,0,=,,,,12629531,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,mesulergine,206,,,135650580,Antagonist,Inverse agonist,,f,,,pKi,9.3,0,8.7,,0,0,0,,,,,12527336,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,mesulergine,206,,,135650580,Antagonist,Inverse agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9282936,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,metergoline,133,,,135650581,Antagonist,Inverse agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,15322733,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Inverse agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15322733,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,mianserin,135,,,135650606,Antagonist,Inverse agonist,,f,t,,pKi,9.199999809,0,8.300000191,-,0,0,0,=,,,,10611634,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Inverse agonist,,f,t,,pKi,8.399999619,0,8.100000381,-,0,0,0,=,,,,12629531,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,risperidone,96,,,135650903,Antagonist,Inverse agonist,,f,,,pKi,7.6,0,7.5,,0,0,0,,,,,12629531,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,sertindole,98,,,135651037,Antagonist,Inverse agonist,,f,t,,pKi,9.199999809,0,9,-,0,0,0,=,,,,12629531,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
5-HT<sub>3</sub>A,379,Htr3a,P35563,,,,,,Rat,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pEC50,6.9,0,6.7,-,0,0,0,=,,,,9756382,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pEC50,5.8,0,5.4,EC50,4000,0,1600,=,,,,9950429,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pKi,7.2,0,6.6,-,0,0,0,=,,,,7565620,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>A,379,Htr3a,P35563,,,,,,Rat,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,7565620,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>A,379,Htr3a,P35563,,,,,,Rat,SR57227A,4316,,,178101133,Agonist,Agonist,,f,f,,pEC50,0,5.400000095,0,EC50,0,3600,0,=,,,,8891244,NC1CCN(CC1)c1cccc(n1)Cl
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,quipazine,173,,,135650875,Agonist,Partial agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11489465,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Allosteric modulator,Negative,Decrease in agonist apparent affinity. ,t,,1000-10000,-,0,0,0,,0,0,0,,,,,10582123,
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Allosteric modulator,Negative,decrease in agonist apparent affinity. ,t,,1000-10000,-,0,0,0,,0,0,0,,,,,7620711,
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,ethanol,2299,,,135651485,Allosteric modulator,Positive,"increased channel activation rate, decreased desensitisation rate, decreased deactivation rate.",f,,30000-300000,-,0,0,0,,0,0,0,,,,,16257471,CCO
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,granisetron,2300,,,135650322,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,8.600000381,Ki,2.5,0,1.5,~,,,,7565620,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)c1nn(c2c1cccc2)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,(<i>R</i>)-zacopride,2288,,,135650420,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11489465,COc1cc(N)c(cc1C(=O)N[C@H]1CN2CCC1CC2)Cl
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,(<i>S</i>)-zacopride,2289,,,135650429,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,11489465,COc1cc(N)c(cc1C(=O)N[C@@H]1CN2CCC1CC2)Cl
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,metoclopramide,241,,,135650598,Antagonist,Antagonist,,f,t,,pKi,6.449999809,0,6,Ki,1030,0,354,=,,,,11489465,CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,ondansetron,2290,,,135650761,Antagonist,Antagonist,,f,t,,pKi,8.300000191,0,7.800000191,Ki,15,0,5,~,,,,7565620,O=C1C(CCc2c1c1ccccc1n2C)Cn1ccnc1C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,palonosetron,7486,,,187051789,Antagonist,Antagonist,,f,t,,pKi,0,10.48999977,0,Ki,0,0.032000002,0,=,,,,20724042,O=C1N(C[C@@H]2c3c1cccc3CCC2)[C@@H]1CN2CCC1CC2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,ramosetron,2301,,,135650885,Antagonist,Antagonist,,f,,,pKi,0,10,0,,0,0,0,,,,,17652911,O=C(c1cn(c2c1cccc2)C)[C@@H]1CCc2c(C1)[nH]cn2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,ricasetron,2302,,,135650899,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11489465,CN1[C@@H]2CC[C@H]1C[C@H](C2)NC(=O)N1CC(c2c1cccc2)(C)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,diltiazem,2298,,,135650185,Channel blocker,None,,f,,,pIC50,0,4.68,0,IC50,0,21000,0,=,,,,21505038,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,diltiazem,2298,,,135650185,Channel blocker,None,,f,,,pIC50,5.26,0,4.15,IC50,71400,0,5500,=,,,,10457085,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,,f,,,pIC50,0,3.14,0,IC50,0,730000,0,=,,,,21505038,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,picrotoxin,4051,,,178100875,Channel blocker,None,,f,,,pIC50,4.5,0,4.4,-,0,0,0,=,,,,14625088,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,,,pIC50,0,4.96,0,IC50,0,11000,0,=,,,,21505038,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pKi,0,7,0,-,0,0,0,=,,,,11489465,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,<i>meta</i>-chlorphenylbiguanide,2287,,,135650380,Agonist,Agonist,,f,,,pEC50,0,5.7,0,-,0,0,0,=,,,,9950429,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,quipazine,173,,,135650875,Agonist,Agonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,11489465,N1CCN(CC1)c1ccc2c(n1)cccc2
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,(<i>R</i>)-zacopride,2288,,,135650420,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,11489465,COc1cc(N)c(cc1C(=O)N[C@H]1CN2CCC1CC2)Cl
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,(<i>S</i>)-zacopride,2289,,,135650429,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,11489465,COc1cc(N)c(cc1C(=O)N[C@@H]1CN2CCC1CC2)Cl
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,metoclopramide,241,,,135650598,Antagonist,Antagonist,,f,t,,pKi,0,5.699999809,0,-,0,0,0,=,,,,11489465,CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,ondansetron,2290,,,135650761,Antagonist,Antagonist,,f,t,,pKi,0,7.800000191,0,-,0,0,0,=,,,,11489465,O=C1C(CCc2c1c1ccccc1n2C)Cn1ccnc1C
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,,f,,,pIC50,0,2.41,0,IC50,0,3900000,0,=,,,,21059362,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
5-HT<sub>3</sub>AB,378,Htr3b|Htr3a,P23979|Q9JHJ5,,,,,,Mouse,picrotoxin,4051,,,178100875,Channel blocker,None,,f,,,pIC50,0,2.9,0,-,0,0,0,=,,,,15814570,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,,,pIC50,0,4.2,0,IC50,0,63000,0,=,,,,21059362,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,RS67506,3230,,,178100287,Agonist,Agonist,,f,f,,pEC50,0,8.800000191,0,EC50,0,1.580000043,0,=,,,,8903510,COc1cc(N)c(cc1C(=O)CCC1CCN(CC1)CCNS(=O)(=O)C)Cl
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,metoclopramide,241,,,135650598,Agonist,Full agonist,,f,t,,pKi,0,6,0,-,0,0,0,=,,,,8946946,CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,mosapride,242,,,135650625,Agonist,Full agonist,,f,,,pKi,6.9,0,6.2,,0,0,0,,,,,10646498,CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,renzapride,244,,,135650894,Agonist,Full agonist,,f,,,pKi,7.6,0,6.6,,0,0,0,,,,,8813606,COc1cc(N)c(cc1C(=O)N[C@H]1CCN2C[C@@H]1CCC2)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,renzapride,244,,,135650894,Agonist,Full agonist,,f,,,pKi,6.8,0,5.9,,0,0,0,,,,,7796807,COc1cc(N)c(cc1C(=O)N[C@H]1CCN2C[C@@H]1CCC2)Cl
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,renzapride,244,,,135650894,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8946946,COc1cc(N)c(cc1C(=O)N[C@H]1CCN2C[C@@H]1CCC2)Cl
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,SC 53116,238,,,135651022,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8946946,COc1cc(N)c(cc1C(=O)NC[C@@H]1CCN2[C@H]1CCC2)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,ML 10302,235,,,135650619,Agonist,Partial agonist,,f,f,,pKi,9,0,7.900000095,Ki,12.60000038,0,1,=,,,,9603189,COc1cc(N)c(cc1C(=O)OCCN1CCCCC1)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,PF-04995274,9059,,,315661144,Agonist,Partial agonist,,f,f,,pKi,0,9.819999695,0,Ki,0,0.150000006,0,=,Measured at the 5-HT<sub>4d</sub> receptor.,,,22974325,OC1(CCOCC1)CN1CCC(CC1)COc1noc2c1c(ccc2)O[C@H]1COCC1
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,prucalopride,243,,,135650861,Agonist,Partial agonist,,f,,,pKi,8.6,0,7,,0,0,0,,,,,10646498,COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,relenopride,8427,,,252166637,Agonist,Partial agonist,,f,t,,pKi,0,8.300000191,0,Ki,0,4.960000038,0,=,,,,25316608,COc1cc(N)c(cc1C(=O)NCC1CCN(CC1)CC[C@@H](c1ccc(cc1)F)OC(=O)N)Cl
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,RS 57639,236,,,135650945,Agonist,Partial agonist,,f,,,pKi,8.9,0,8.6,,0,0,0,,,,,9225293,COc1cc(N)c(cc1C(=O)OCC1CCN(CC1)CCCc1ccc2c(c1)OCCO2)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,RS 67333,237,,,135650947,Agonist,Partial agonist,,f,,,pKi,8.7,0,8.2,,0,0,0,,,,,10683202,CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,DAU 6285,246,,,135650161,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9351641,COc1ccc2c(c1)n(C(=O)OC1CC3CCC(C1)N3C)c(=O)[nH]2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,DAU 6285,246,,,135650161,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8946946,COc1ccc2c(c1)n(C(=O)OC1CC3CCC(C1)N3C)c(=O)[nH]2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,GR 113808,247,,,135650309,Antagonist,Antagonist,,f,f,,pKi,10.30000019,0,9.289999962,Ki,0.50999999,0,0.050000001,=,,,,9349523,O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,GR 113808,247,,,135650309,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,8946946,O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,GR 113808,247,,,135650309,Antagonist,Antagonist,,f,,,pKi,8.7,0,8.4,,0,0,0,,,,,9225293,O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,GR 125487,248,,,135650310,Antagonist,Antagonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,8946946,COc1[nH]c2c(c1C(=O)OCC1CCN(CC1)CCNS(=O)(=O)C)cc(cc2)F
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,GR 125487,248,,,135650310,Antagonist,Antagonist,,f,,,pKi,10.7,0,9.8,,0,0,0,,,,,9349523,COc1[nH]c2c(c1C(=O)OCC1CCN(CC1)CCNS(=O)(=O)C)cc(cc2)F
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,ML 10375,249,,,135650620,Antagonist,Antagonist,,f,,,pKi,10,0,8.8,,0,0,0,,,,,15466450,COc1cc(N)c(cc1C(=O)OCCN1CC(C)CC(C1)C)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,piboserod,225,,,135650823,Antagonist,Antagonist,,f,,,pKi,10.4,0,8.8,,0,0,0,,,,,15466450,CCCCN1CCC(CC1)CNC(=O)c1c2OCCCn2c2c1cccc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,RS 100235,250,,,135650932,Antagonist,Antagonist,,f,f,,pKi,12.19999981,0,8.699999809,Ki,1.99000001,0,0.00063,=,,,,9351641,COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,RS 39604,254,,,135650943,Antagonist,Antagonist,,f,,,pKi,8.7,0,8.2,,0,0,0,,,,,10683202,COc1cc(N)c(cc1C(=O)OCCCN1CCCCC1)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,SB 203186,255,,,135650982,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.7,,0,0,0,,,,,11218067,O=C(c1c[nH]c2c1cccc2)OCCN1CCCCC1
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,SB 204070,256,,,135650983,Antagonist,Antagonist,,f,f,,pKi,10.40999985,0,9.800000191,Ki,0.159999996,0,0.039000001,=,,,,9349523,CCCCN1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,SB 204070,256,,,135650983,Antagonist,Antagonist,,f,,,pKi,9.5,0,8.9,,0,0,0,,,,,9225293,CCCCN1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,SB 207710,257,,,135650986,Antagonist,Antagonist,,f,,,pKi,10.3,0,10.1,,0,0,0,,,,,11218067,CCCCN1CCC(CC1)COC(=O)c1cc(I)c(c2c1OCCO2)N
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,SDZ 205557,258,,,135651032,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.6,,0,0,0,,,,,9225293,CCN(CCOC(=O)c1cc(Cl)c(cc1OC)N)CC
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,SDZ 205557,258,,,135651032,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,7498967,CCN(CCOC(=O)c1cc(Cl)c(cc1OC)N)CC
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,RO 116 1148,252,,,135650937,Antagonist,Inverse agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,11976337,CCCCN1CCC(CC1)CNC(=O)c1cccc2c1OCCO2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,RS 116 0086,251,,,135650936,Antagonist,Inverse agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11976337,CCCCN1CCC(CC1)COC(=O)c1cccc2c1OCCO2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,donitriptan,39,,,135650207,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,lysergic acid,139,,,135650563,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8549774,CN1C[C@@H](C=C2C1Cc1c[nH]c3c1c2ccc3)C(=O)O
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,7988681,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8450829,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>5A</sub> receptor,10,Htr5a,P35364,,,,,,Rat,ergotamine,149,,,135650239,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,7682702,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,ergotamine,149,,,135650239,Antagonist,Antagonist,,f,,,pKi,8.7,0,8,,0,0,0,,,,,7988681,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,ergotamine,149,,,135650239,Antagonist,Antagonist,,f,,,pKi,8.4,0,7.4,,0,0,0,,,,,8450829,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,7988681,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7988681,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>5A</sub> receptor,10,Htr5a,P35364,,,,,,Rat,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,7682702,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8450829,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.5,,0,0,0,,,,,7988681,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>5A</sub> receptor,10,Htr5a,P35364,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,7682702,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.3,,0,0,0,,,,,8450829,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,7988681,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,(-)-propranolol,63,,,135650859,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,7988681,O[C@H](COc1cccc2c1cccc2)CNC(C)C
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,11343685,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11343685,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,SB 699551,264,,,135651015,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.300000191,0,=,,,,16002289,CN(CCN(C(=O)CCC1CCCC1)Cc1ccc(cc1)c1ccc(cc1)CNCCc1ccccc1)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,EMD-386088,8428,,,252166638,Agonist,Agonist,,f,t,,pIC50,0,8.130000114,0,IC50,0,7.400000095,0,=,,,,16055331,Clc1ccc2c(c1)c(C1=CCNCC1)c([nH]2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,dimethyltryptamine,141,,,135650188,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8522988,CN(CCc1c[nH]c2c1cccc2)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,DM-1451,267,,,135650196,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10327430,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1ccc(c(c1Cl)Cl)O
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,ergotamine,149,,,135650239,Agonist,Full agonist,,f,,,pKi,8.6,0,8,,0,0,0,,,,,9730917,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,ergotamine,149,,,135650239,Agonist,Full agonist,,f,,,pKi,8.6,0,7,,0,0,0,,,,,9225298,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,7680751,Clc1cccc(c1)N1CCNCC1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,lergotrile,270,,,135650513,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7680751,N#CC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c([nH]3)Cl
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,"LY 165,163",18,,,135650543,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,7680751,Nc1ccc(cc1)CCN1CCN(CC1)c1cccc(c1)C(F)(F)F
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,8.7,0,7.8,,0,0,0,,,,,9225298,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,Lysergide,17,,,135650536,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9730917,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,OPC 4392,268,,,135650775,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10327430,Cc1cccc(c1C)N1CCN(CC1)CCCOc1ccc2c(c1)[nH]c(=O)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,7680751,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8522988,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,S 16924,167,,,135650961,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9732398,Fc1ccc(cc1)C(=O)CC1CCN(C1)CCOc1cccc2c1OCCO2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,donitriptan,39,,,135650207,Agonist,Partial agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,10381763,NCCc1c[nH]c2c1cc(OCC(=O)N1CCN(CC1)c1ccc(cc1)C#N)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,E6801,3217,,,178100278,Agonist,Partial agonist,,f,f,,pKi,0,8.699999809,0,Ki,0,1.899999976,0,=,,,,15771424,CN(CCc1c[nH]c2c1cc(cc2)NS(=O)(=O)c1c(Cl)nc2n1ccs2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,GR 127935,14,,,135650312,Agonist,Partial agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9303567,COc1ccc(cc1N1CCN(CC1)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,8.3,0,7.5,,0,0,0,,,,,7680751,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,8.1,0,8,,0,0,0,,,,,9730917,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8522988,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,7680751,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,dihydroergocristine,278,,,135652679,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,9798944,CN1CC(CC2C1Cc1c[nH]c3c1c2ccc3)C(=O)NC1(OC2(N(C1=O)C(Cc1ccccc1)C(=O)N1C2CCC1)O)C(C)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,dihydroergotamine,121,,,135650182,Antagonist,Antagonist,,f,,,pKi,8.3,0,7.9,,0,0,0,,,,,7680751,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,duloxetine,202,,,135650212,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,11750180,CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,fluoxetine,203,,,135650270,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,7680751,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,ICI 169369,273,,,135650368,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8522988,CN(CCSc1nc2ccccc2cc1c1ccccc1)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,idalopirdine,8689,,,252166889,Antagonist,Antagonist,,f,t,,pKi,0,9.079999924,0,Ki,0,0.829999983,0,=,,,,24878269,Fc1ccc2c(c1)[nH]cc2CCNCc1cccc(c1)OCC(C(F)F)(F)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,11750183,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,8997630,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,intepirdine,9444,,,329968384,Antagonist,Antagonist,,f,t,,pKi,0,9.770000458,0,Ki,0,0.170000002,0,=,"HeLa cell membrane assay, displacing [<sup>3</sup>H]LSD",,,24878269,O=S(=O)(c1cnc2c(c1)cccc2N1CCNCC1)c1ccccc1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,5.8,0,5.1,,0,0,0,,,,,7680751,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,5.7,0,5.4,,0,0,0,,,,,8522988,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.4,,0,0,0,,,,,8522988,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,7.5,0,6.6,,0,0,0,,,,,7680751,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,9.4,0,8.2,,0,0,0,,,,,8522988,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,9.4,0,7.5,,0,0,0,,,,,7680751,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.4,,0,0,0,,,,,7680751,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.5,,0,0,0,,,,,8522988,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,7.3,0,6.9,,0,0,0,,,,,8522988,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.9,,0,0,0,,,,,7680751,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,7908055,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8522988,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,7.8,0,6.5,,0,0,0,,,,,7680751,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,7.4,0,7,,0,0,0,,,,,8522988,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,Ro 04-6790,274,,,135650909,Antagonist,Antagonist,,f,,,pKi,7.6,0,7.4,,0,0,0,,,,,9730917,CNc1nc(NC)nc(c1)NS(=O)(=O)c1ccc(cc1)N
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,Ro 04-6790,274,,,135650909,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.3,,0,0,0,,,,,9730917,CNc1nc(NC)nc(c1)NS(=O)(=O)c1ccc(cc1)N
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,Ro 63-0563,275,,,135650921,Antagonist,Antagonist,,f,,,pKi,8,0,7.8,,0,0,0,,,,,9730917,CNc1cc(cc(n1)NC)NS(=O)(=O)c1ccc(cc1)N
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,Ro 63-0563,275,,,135650921,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,7.900000095,Ki,12.60000038,0,3.980000019,=,,,,9730917,CNc1cc(cc(n1)NC)NS(=O)(=O)c1ccc(cc1)N
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,SB258585,3232,,,178100288,Antagonist,Antagonist,,f,f,,pKi,0,8.529999733,0,-,0,0,0,=,,,,10928963,COc1ccc(cc1N1CCN(CC1)C)NS(=O)(=O)c1ccc(cc1)I
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,SB 271046,276,,,135651001,Antagonist,Antagonist,,f,f,,pKi,0,8.899999619,0,Ki,0,1.25999999,0,=,,,,9925723,COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,SB357134,3235,,,135651006,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,-,0,0,0,=,,,,11140733,COc1ccc(cc1N1CCNCC1)S(=O)(=O)Nc1cc(Br)cc(c1Br)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,SB399885,3241,,,178100292,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,17069795,COc1ccc(cc1N1CCNCC1)S(=O)(=O)Nc1cc(Cl)cc(c1OC)Cl
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,7908055,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,fluperlapine,279,,,135650274,Antagonist,Inverse agonist,,f,,,pKi,7.5,0,7.3,,0,0,0,,,,,8522988,CN1CCN(CC1)C1=Nc2cc(F)ccc2Cc2c1cccc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,fluperlapine,279,,,135650274,Antagonist,Inverse agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,7908055,CN1CCN(CC1)C1=Nc2cc(F)ccc2Cc2c1cccc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Inverse agonist,,f,,,pKi,7.4,0,7.3,,0,0,0,,,,,15821958,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,fluphenazine,204,,,135650275,Antagonist,Inverse agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,7908055,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,loxapine,205,,,135650533,Antagonist,Inverse agonist,,f,,,pKi,7.8,0,7.2,,0,0,0,,,,,7680751,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,loxapine,205,,,135650533,Antagonist,Inverse agonist,,f,,,pKi,7.6,0,7.4,,0,0,0,,,,,8522988,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,olanzapine,47,,,135650756,Antagonist,Inverse agonist,,f,,,pKi,8.6,0,7.6,,0,0,0,,,,,8997630,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Inverse agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8522988,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,perphenazine,209,,,135650810,Antagonist,Inverse agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,7908055,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Inverse agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,15821958,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,risperidone,96,,,135650903,Antagonist,Inverse agonist,,f,,,pKi,6.4,0,6,,0,0,0,,,,,8997630,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,LP-12,8434,,,252166644,Agonist,Agonist,,f,t,,pKi,0,9.890000343,0,Ki,0,0.129999995,0,=,,,,17649988,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,LP-211,8436,,,252166646,Agonist,Agonist,,f,f,,pKi,0,9.239999771,0,Ki,0,0.579999983,0,=,,,,18800769,N#Cc1ccc(cc1)CNC(=O)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,LP-44,8435,,,252166645,Agonist,Agonist,,f,t,,pKi,0,9.659999847,0,Ki,0,0.219999999,0,=,,,,17649988,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,dipropyl-5-CT,122,,,135650195,Agonist,Full agonist,,f,,,pKi,8.4,0,8.2,,0,0,0,,,,,9298538,CCCN(CCC)CCc1c[nH]c2c1cc(cc2)C(=O)N
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,DM-1451,267,,,135650196,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,10327430,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1ccc(c(c1Cl)Cl)O
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,E55888,3929,,,178100758,Agonist,Full agonist,,f,,,pKi,0,8.6,0,-,0,0,0,=,,,,19118950,CN(CCc1cccc(c1)c1c(C)nn(c1C)C)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,EMDT,12,,,135650228,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10715164,CCc1[nH]c2c(c1CCN(C)C)cc(cc2)OC
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,<i>m</i>-chlorophenylpiperazine,142,,,135650382,Agonist,Full agonist,,f,,,pKi,6.6,0,6.4,,0,0,0,,,,,8394362,Clc1cccc(c1)N1CCNCC1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,lisuride,43,,,135650525,Agonist,Full agonist,,f,,,pKi,9.3,0,8.2,,0,0,0,,,,,8394362,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,(+)-LSD,154,,,135650537,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8397408,CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,LY344864,21,,,135650553,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,9395253,CN(C1CCc2c(C1)c1cc(ccc1[nH]2)NC(=O)c1ccc(cc1)F)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,OPC 4392,268,,,135650775,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,10327430,Cc1cccc(c1C)N1CCN(CC1)CCCOc1ccc2c(c1)[nH]c(=O)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,9,0,8.3,,0,0,0,,,,,8394362,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,RU 24969,23,,,135650950,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8394987,COc1ccc2c(c1)c(c[nH]2)C1=CCNCC1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,oleamide,284,,,135651530,Allosteric modulator,Negative,,f,,,pKd,0,8.6,0,,0,0,0,,,,,10571256,CCCCCCCC/C=CCCCCCCCC(=O)N
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,cyamemazine,84,,,135650143,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12527336,N#Cc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8226867,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.1,,0,0,0,,,,,8394362,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,dihydroergocryptine,282,,,135650181,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8394987,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,dihydroergocryptine,282,,,135650181,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8397408,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,dihydroergotamine,121,,,135650182,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8397408,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,dihydroergotamine,121,,,135650182,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8226867,CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,DR-4004,8431,,,252166641,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,10052959,O=C1Nc2c3C1(CCCCN1CCC(=CC1)c1ccccc1)CCCc3ccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,ergotamine,149,,,135650239,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8394987,O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8394987,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.3,,0,0,0,,,,,9298538,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.3,,0,0,0,,,,,8997630,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,11750183,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8997630,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,JNJ-18038683,8432,,,252166642,Antagonist,Antagonist,,f,t,,pKi,0,8.199999809,0,-,0,0,0,=,,,,22570363,Clc1ccc(cc1)c1nn(c2c1CCNCC2)Cc1ccccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,6.5,0,5.9,,0,0,0,,,,,11414657,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.6,,0,0,0,,,,,8394362,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8394987,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,loxapine,205,,,135650533,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.8,,0,0,0,,,,,7908055,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,lurasidone,7461,,,187051764,Antagonist,Antagonist,,f,t,,pKi,0,9.31000042,0,Ki,0,0.495000005,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,8.2,0,7.5,,0,0,0,,,,,11414657,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,8.2,0,7.7,,0,0,0,,,,,8394362,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,mesulergine,206,,,135650580,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8394987,CN1C[C@H](C[C@H]2[C@H]1Cc1cn(c3c1c2ccc3)C)NS(=O)(=O)N(C)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,8.7,0,7.2,,0,0,0,,,,,8394362,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.2,,0,0,0,,,,,11414657,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,metergoline,133,,,135650581,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,8394987,O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,9.4,0,9,,0,0,0,,,,,8394362,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8394987,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,methiothepin,89,,,135650584,Antagonist,Antagonist,,f,,,pKi,9.4,0,8.4,,0,0,0,,,,,11414657,CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.1,,0,0,0,,,,,11414657,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8394987,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,methysergide,134,,,135650596,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8394362,CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,7.6,0,7.3,,0,0,0,,,,,9298538,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8394987,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,7.4,0,7,,0,0,0,,,,,8394362,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,MPDT,71,,,135650627,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10715164,COc1ccc2c(c1)c(CCN(C)C)c([nH]2)c1ccccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9720804,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,,,pKi,7,0,6.8,,0,0,0,,,,,8997630,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,pimozide,90,,,135650825,Antagonist,Antagonist,,f,f,,pKi,0,9.300000191,0,-,0,0,0,=,,,,7908055,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,pirenperone,283,,,135650831,Antagonist,Antagonist,,f,,,pKi,8.5,0,8.2,,0,0,0,,,,,9298538,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,7.4,0,6.8,,0,0,0,,,,,11414657,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.7,,0,0,0,,,,,8394362,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,SB 207710,257,,,135650986,Antagonist,Antagonist,,f,,,pKi,5.5,0,5.3,,0,0,0,,,,,11414657,CCCCN1CCC(CC1)COC(=O)c1cc(I)c(c2c1OCCO2)N
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,SB269970,3233,,,178100289,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.6,-,0,0,0,=,,,,10807680,CC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1cccc(c1)O
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,SB656104,3237,,,135651014,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,Ki,0,1.9,0,=,,,,12392747,Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8394987,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,8,0,7,,0,0,0,,,,,11414657,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,8,0,7.7,,0,0,0,,,,,7908055,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,fluperlapine,279,,,135650274,Antagonist,Inverse agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15821958,CN1CCN(CC1)C1=Nc2cc(F)ccc2Cc2c1cccc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,fluperlapine,279,,,135650274,Antagonist,Inverse agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,7908055,CN1CCN(CC1)C1=Nc2cc(F)ccc2Cc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Inverse agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,15821958,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,fluphenazine,204,,,135650275,Antagonist,Inverse agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,7908055,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Inverse agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,15821958,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,perphenazine,209,,,135650810,Antagonist,Inverse agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,7908055,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,risperidone,96,,,135650903,Antagonist,Inverse agonist,,f,,,pKd,9,0,8.9,,0,0,0,,,,,8997630,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,risperidone,96,,,135650903,Antagonist,Inverse agonist,,f,,,pKi,8.7,0,8.3,,0,0,0,,,,,15821958,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,SB 258719,281,,,135651000,Antagonist,Inverse agonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,,,,9720804,CC1CCN(CC1)CC[C@H](N(S(=O)(=O)c1cccc(c1)C)C)C
5-LOX,1385,ALOX5,P09917,,,,,,Human,PF-04191834,9054,,,315661139,Inhibitor,Inhibition,,f,t,,pIC50,0,6.639999866,0,IC50,0,229,0,=,,,,20378715,Cn1nccc1c1ccc(cc1)Sc1cccc(c1)C1(CCOCC1)C(=O)N
"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",2937,PFKFB3,Q16875,,,,,,Human,PFK15,9562,,,336446948,Inhibitor,Inhibition,,f,t,,pIC50,0,6.679999828,0,IC50,0,207,0,=,Inhibition of kinase activity in a biochemical assay.,,,23674815,O=C(c1ccncc1)C=Cc1ccc2c(n1)cccc2
ABCA1,756,ABCA1,O95477,,,,,,Human,probucol,7277,,,178103851,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,"Inhibition of cholesterol efflux from normal human skin fibroblasts, but not from fibroblasts negative in ABCA1.",,,15514211,CC(Sc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C)(Sc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C)C
ABCB11,778,ABCB11,O95342,,,,,,Human,glycochenodeoxycholic acid,4545,,,178101266,None,Binding,,f,f,,pKi,0,5.150000095,0,Ki,0,7000,0,=,Measuring competitive inhibition of taurocholate uptake.,,,12404239,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)NCC(=O)O)C)C)O)C
ABCC2,780,ABCC2,Q92887,,,,,,Human,PAK-104P,8776,,,252827434,Inhibitor,Inhibition,,f,f,,pKi,0,5.429999828,0,Ki,0,3700,0,=,,,,10570049,C[C@@H]1C[C@@H](C)OP(=O)(O1)c1c(C)nc(c(c1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1)C
ABCC4,782,ABCC4,O15439,,,,,,Human,estradiol disulfate,8802,,,252827460,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,12523936,OS(=O)(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2OS(=O)(=O)O)C
ABCC5,783,ABCC5,O15440,,,,,,Human,sildenafil,4743,,,178101454,Inhibitor,Inhibition,,f,f,,pKi,0,5.920000076,0,Ki,0,1200,0,=,,,,22380603,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
ABCG2,792,ABCG2,Q9UNQ0,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,,f,f,,pKi,0,6.300000191,0,Ki,0,500,0,=,Inhibition of ABCG2-ATPase activity induced by substrate binding.,,,11437380,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,dasatinib,5678,,,178102305,Inhibitor,Inhibition,,f,t,,pIC50,0,9.600000381,0,IC50,0,0.270000011,0,=,,,,23279183,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,6.320000172,0,IC50,0,479,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,GNF-5,8065,,,249565745,Inhibitor,Inhibition,,f,t,,pIC50,0,6.659999847,0,IC50,0,220,0,=,Inhibition of wild-type Abl <i>in vitro</i>.,,,20072125,OCCNC(=O)c1cccc(c1)c1ncnc(c1)Nc1ccc(cc1)OC(F)(F)F
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,imatinib,5687,,,178102314,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,220,0,=,,,,17376680,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,KW-2449,5691,,,178102318,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,19541823,O=C(c1ccc(cc1)/C=C/c1[nH]nc2c1cccc2)N1CCNCC1
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,nilotinib,5697,,,178102324,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,15,0,=,,,,15930265,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,PD-173955,5699,,,178102326,Inhibitor,Inhibition,,f,t,,pKd,0,9.239999771,0,Kd,0,0.579999983,0,=,,,,22037378,CSc1cccc(c1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,PD-173955,5699,,,178102326,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,~,,,,12154025,CSc1cccc(c1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,PF-114,9792,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,9.31000042,0,IC50,0,0.49000001,0,=,Inhibition of native ABL kinase activity.,,,25394714,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1nnc2n1cccc2)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,ponatinib,5890,,,178102513,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8.600000381,0,=,,,,20513156,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,rebastinib,9173,,,315661256,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,21481795,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1cc(nn1c1ccc2c(c1)cccn2)C(C)(C)C
"ABL proto-oncogene 1, non-receptor tyrosine kinase",1923,ABL1,P00519,,,,,,Human,saracatinib,7731,,,223366064,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,17064066,CN1CCN(CC1)CCOc1cc(OC2CCOCC2)c2c(c1)ncnc2Nc1c(Cl)ccc2c1OCO2
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,donepezil,6599,,,178103212,Inhibitor,Inhibition,,f,t,,pIC50,8.300000191,0,7.699999809,-,0,0,0,=,,,,16570913,COc1cc2c(cc1OC)CC(C2=O)CC1CCN(CC1)Cc1ccccc1
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,echothiophate,9074,,,315661159,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCOP(=O)(SCC[N+](C)(C)C)OC
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,edrophonium,9073,,,315661158,Inhibitor,Inhibition,,f,f,,pKi,0,6.699999809,0,Ki,0,200,0,=,Using the chloride salt,,,9301662,CC[N+](c1cccc(c1)O)(C)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,galantamine,6693,,,178103304,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,12182861,COc1ccc2c3c1O[C@@H]1[C@@]3(CCN(C2)C)C=C[C@@H](C1)O
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,neostigmine,8993,,,310264771,Inhibitor,Inhibition,,f,f,,pIC50,0,7.349999905,0,IC50,0,45,0,=,Inhibition of ACHE activity in human serum.,,,17888667,O=C(N(C)C)Oc1cccc(c1)[N+](C)(C)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,physostigmine,6598,,,178103211,Inhibitor,Inhibition,,f,t,,pIC50,7.800000191,0,7.599999905,-,0,0,0,=,,,,16570913,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN([C@@H]1N2C)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,pralidoxime,7597,,,223365932,Inhibitor,Inhibition,,f,t,,pIC50,0,3.099999905,0,IC50,0,878000,0,=,Inhibition of human recombinant AChE by modified Ellman's method.,,,21215642,O/N=C/c1cccc[n+]1C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,pyridostigmine,8994,,,310264772,Inhibitor,Inhibition,,f,f,,pIC50,0,6.440000057,0,IC50,0,360,0,=,Inhibition of human erythrocyte ACHE activity by a modified Ellman assay.,,,20627738,C[n+]1cccc(c1)OC(=O)N(C)C
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,rivastigmine,6602,,,178103215,Inhibitor,Inhibition,,f,t,,pIC50,0,5.400000095,0,IC50,0,4150,0,=,,,,16570913,CCN(C(=O)Oc1cccc(c1)[C@@H](N(C)C)C)C
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,SM-32504,6723,,,178103334,Inhibitor,Inhibition,,f,,,pIC50,0,7.96,0,IC50,0,11,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cccc2C(C)C)C(C)C)c(c2c1nccc2)c1cccc(c1)OC
acetyl-CoA acetyltransferase 1,2435,Acat1,P17764,,,,,,Rat,SMP-797,6729,,,178103340,Inhibitor,Inhibition,,f,,,pIC50,0,7.68,0,IC50,0,21,0,=,,,,16242323,CCCCn1c(=O)c(NC(=O)Nc2c(cc(cc2C(C)C)N)C(C)C)c(c2c1nccc2)c1cccc(c1)OCCCO
ACKR3,80,ACKR3,P25106,,,,,,Human,CXCL12&alpha;,4358,CXCL12,Human,135651881,Agonist,Agonist,,t,,,pEC50,7.9,0,7.52,-,0,0,0,=,,,,20956518,
ACKR3,80,ACKR3,P25106,,,,,,Human,plerixafor,844,,,135649932,Agonist,Agonist,,f,,,pEC50,0,6.85,0,,0,0,0,,,,,20956518,C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1
ACKR3,80,ACKR3,P25106,,,,,,Human,CXCL11,836,CXCL11,Human,135651708,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
activin A receptor type 1,1785,ACVR1,Q04771,,,,,,Human,LDN-214117,8481,,,252166689,Inhibitor,Inhibition,,f,t,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,25101911,COc1cc(cc(c1OC)OC)c1cc(cnc1C)c1ccc(cc1)N1CCNCC1
activin A receptor type 1,1785,ACVR1,Q04771,,,,,,Human,ML347,8121,,,249565801,Inhibitor,Inhibition,,f,t,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,23639540,COc1ccc(cc1)c1cnc2n(c1)ncc2c1cccc2c1cccn2
activin A receptor type 1C,1790,ACVR1C,Q8NER5,,,,,,Human,SB-431542,8216,,,249565896,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,23130626,NC(=O)c1ccc(cc1)c1[nH]c(c(n1)c1ccccn1)c1ccc2c(c1)OCO2
activin A receptor type IL,1784,ACVRL1,P37023,,,,,,Human,LDN-214117,8481,,,252166689,Inhibitor,Inhibition,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,25101911,COc1cc(cc(c1OC)OC)c1cc(cnc1C)c1ccc(cc1)N1CCNCC1
activin A receptor type IL,1784,ACVRL1,P37023,,,,,,Human,ML347,8121,,,249565801,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,23639540,COc1ccc(cc1)c1cnc2n(c1)ncc2c1cccc2c1cccn2
Activin receptors,2588,ACVR1B|ACVR2A|ACVR2B|ACVR1C,P27037|P36896|Q13705|Q8NER5,,,,,,Human,inhibin A,5010,INHA|INHBA,Human,178101707,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
acyloxyacyl hydrolase,2873,AOAH,P28039,,,,,,Human,JZL195,8606,,,252166807,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,24997602,O=C(N1CCN(CC1)Cc1cccc(c1)Oc1ccccc1)Oc1ccc(cc1)[N+](=O)[O-]
ADAM10,1658,ADAM10,O14672,,,,,,Human,GI254023X,9687,,,348353646,Inhibitor,Inhibition,,f,t,,pIC50,0,5.28000021,0,IC50,0,5300,0,=,,,,20197648,CNC(=O)[C@H](C(C)(C)C)NC(=O)[C@@H]([C@@H](N(C=O)O)C)CCCc1ccccc1
ADAM10,1658,ADAM10,O14672,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.090000153,0,IC50,0,8.100000381,0,=,Measured in an <i>in vitro</i> assay.,,,15546732,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
ADAM12,1660,ADAM12,O43184,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.229999542,0,IC50,0,5.929999828,0,=,Measured in a cell-based assay.,,,15546732,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
ADAM17,1662,ADAM17,P78536,,,,,,Human,GI254023X,9687,,,348353646,Inhibitor,Inhibition,,f,f,,pIC50,0,3.269999981,0,IC50,0,541000,0,=,,,,20197648,CNC(=O)[C@H](C(C)(C)C)NC(=O)[C@@H]([C@@H](N(C=O)O)C)CCCc1ccccc1
ADAM17,1662,ADAM17,P78536,,,,,,Human,IK-862,8680,,,252166880,Inhibitor,Inhibition,,f,t,,pKi,0,9.25,0,Ki,0,0.560000002,0,=,,,,18790648,ONC(=O)[C@H](N1CC[C@@](C1=O)(C)c1ccc(cc1)OCc1cc(C)nc2c1cccc2)C
ADAM17,1662,ADAM17,P78536,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.5,0,=,Measured in an <i>in vitro</i> assay.,,,15546732,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
ADAM17,1662,,,,,,,,Pig,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,7.920000076,0,Ki,0,12,0,=,Partially purified enzyme from pancreas.,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
ADAM33,1673,ADAM33,Q9BZ11,,,,,,Human,IK-862,8680,,,252166880,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,18790648,ONC(=O)[C@H](N1CC[C@@](C1=O)(C)c1ccc(cc1)OCc1cc(C)nc2c1cccc2)C
ADAM33,1673,ADAM33,Q9BZ11,,,,,,Human,INCB3619,8679,,,252166879,Inhibitor,Inhibition,,f,f,,pIC50,0,5.989999771,0,IC50,0,1026,0,=,,,,18790648,ONC(=O)[C@H]1CC2(CC2)CN([C@@H]1C(=O)N1CCC(=CC1)c1ccccc1)C(=O)OC
ADAM8,1656,ADAM8,P78325,,,,,,Human,INCB3619,8679,,,252166879,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,18790648,ONC(=O)[C@H]1CC2(CC2)CN([C@@H]1C(=O)N1CCC(=CC1)c1ccccc1)C(=O)OC
ADAM9,1657,ADAM9,Q13443,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,Measured in an <i>in vitro</i> assay.,,,15546732,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
Adenosine deaminase,1230,ADA,P00813,,,,,,Human,EHNA,5179,,,178101869,Inhibitor,Inhibition,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,849330,CCCCCC[C@H](n1cnc2c1ncnc2[NH3+])[C@H](O)C.[Cl-]
Adenosine deaminase,1230,ADA,P00813,,,,,,Human,pentostatin,4805,,,178101507,Inhibitor,Inhibition,,f,t,,pIC50,0,10.80000019,0,-,0,0,0,=,,,,849330,OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2c1NC=NC[C@H]2O
adenylyl cyclase 5,1282,ADCY5,O95622,,,,,,Human,NKY80,5233,,,178101917,Inhibitor,Inhibition,,f,t,,pIC50,0,5.150000095,0,-,0,0,0,=,,,,11602596,Nc1ncc2c(n1)CC(CC2=O)c1ccco1
adenylyl cyclase 6,1283,ADCY6,O43306,,,,,,Human,NKY80,5233,,,178101917,Inhibitor,Inhibition,,f,f,,pIC50,0,4.800000191,0,-,0,0,0,=,,,,24006339,Nc1ncc2c(n1)CC(CC2=O)c1ccco1
ADGRB1,174,ADGRB1,O14514,,,,,,Human,phosphatidylserine,3638,,,135651545,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,17960134,CCCC(=O)O[C@@H](COP(=O)(OC[C@@H](C(=O)O)N)O)COC(=O)CC
ADGRL1,206,Adgrl1,O88917,,,,,,Rat,LTX<sup>(N4C)</sup>,5898,,,178102521,Agonist,Full agonist,,f,,,pKd,0,9.6,0,Kd,0,0.26,0,=,,,,12782639,
ADGRL1,206,Adgrl1,O88917,,,,,,Rat,lasso D,5899,,,178102522,Agonist,Partial agonist,,t,,,pKd,0,8.8,0,Kd,0,1.7,0,=,,,,21724987,
ADGRL3,208,Adgrl3,Q9Z173,,,,,,Rat,FLRT3,5900,Flrt3,Rat,178102523,Agonist,Full agonist,,t,,,pKd,0,7.8,0,Kd,0,14.7,0,=,,,,22405201,
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,miransertib,9429,,,328083529,Allosteric modulator,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,27305487,Nc1ncccc1c1nc2c(n1c1ccc(cc1)C1(N)CCC1)nc(cc2)c1ccccc1
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,MK-2206,7945,,,249565628,Allosteric modulator,Negative,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,0,O=c1[nH]nc2n1ccc1c2cc(c(n1)c1ccc(cc1)C1(N)CCC1)c1ccccc1
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,t,,pKd,0,8.659999847,0,Kd,0,2.200000048,0,=,,,,22037378,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,ipatasertib,7887,,,249565578,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22934575,CC(NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2c1[C@H](C)C[C@H]2O)c1ccc(cc1)Cl)C
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,miransertib,9429,,,328083529,Allosteric modulator,Inhibition,,f,t,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,27305487,Nc1ncccc1c1nc2c(n1c1ccc(cc1)C1(N)CCC1)nc(cc2)c1ccccc1
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,MK-2206,7945,,,249565628,Allosteric modulator,Negative,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,0,O=c1[nH]nc2n1ccc1c2cc(c(n1)c1ccc(cc1)C1(N)CCC1)c1ccccc1
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,ipatasertib,7887,,,249565578,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,22934575,CC(NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2c1[C@H](C)C[C@H]2O)c1ccc(cc1)Cl)C
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,PHT-427,8009,,,249565689,Inhibitor,Inhibition,,f,t,,pKi,0,5.570000172,0,Ki,0,2670,0,=,Assay using purified recombinant pleckstrin homology domain of human Akt2,,,20197390,CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,miransertib,9429,,,328083529,Allosteric modulator,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,27305487,Nc1ncccc1c1nc2c(n1c1ccc(cc1)C1(N)CCC1)nc(cc2)c1ccccc1
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,MK-2206,7945,,,249565628,Allosteric modulator,Negative,,f,t,,pIC50,0,7.190000057,0,IC50,0,65,0,=,,,,0,O=c1[nH]nc2n1ccc1c2cc(c(n1)c1ccc(cc1)C1(N)CCC1)c1ccccc1
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,ipatasertib,7887,,,249565578,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,22934575,CC(NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2c1[C@H](C)C[C@H]2O)c1ccc(cc1)Cl)C
Alanine/serine/cysteine transporter 2,874,Slc1a5,,,,,,,Rat,p-nitrophenyl glutamyl anilide,4508,,,178101235,Inhibitor,Inhibition,,f,f,,pKi,0,4.260000229,0,Ki,0,55000,0,=,,,,15670919,O=C(Nc1ccc(cc1)[N+](=O)[O-])CC[C@@H](C(=O)[O-])[NH3+]
aldehyde dehydrogenase 2 family member,2595,Aldh2,P11884,,,,,,Rat,disulfiram,7168,,,178103743,Inhibitor,Inhibition,,f,f,,pIC50,0,4.440000057,0,IC50,0,36400,0,=,,,,10974203,CCN(C(=S)SSC(=S)N(CC)CC)CC
aldehyde dehydrogenase 2 family member,2595,ALDH2,P05091,,,,,,Human,prunetin,6919,,,178103501,Inhibitor,Inhibition,<i>In vitro</i> inhibition of recombinant human mitochondrial alcohol dehydrogenase,f,f,,pKi,0,6.349999905,0,Ki,0,450,0,=,,,,18613661,COc1cc(O)c2c(c1)occ(c2=O)c1ccc(cc1)O
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,lidorestat,7411,,,178103983,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,<i>In vitro</i> inhibition of recombinant human aldose reductase expressed in <i>E coli</i>.,,,15857120,OC(=O)Cn1cc(c2c1cccc2)Cc1sc2c(n1)c(F)c(cc2F)F
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,sorbinil,7415,,,178103987,Inhibitor,Inhibition,,f,f,,pIC50,0,5.269999981,0,IC50,0,5400,0,=,,,,10882376,Fc1cc2[C@]3(CCOc2cc1)NC(=O)NC3=O
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,crizotinib,4903,,,178101602,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,21812414,Nc1ncc(cc1O[C@@H](c1c(Cl)ccc(c1Cl)F)C)c1cnn(c1)C1CCNCC1
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,ensartinib,8959,,,310264740,Inhibitor,Inhibition,,f,f,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,<,Result from DiscoveRx KINOMEscan&reg; selectivity screen.,,,21613408,CN1CCN(CC1)C(=O)c1ccc(cc1)NC(=O)c1nnc(c(c1)O[C@@H](c1c(Cl)ccc(c1Cl)F)C)N
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,GSK-1838705A,5683,,,178102310,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,19825801,CNC(=O)c1c(cccc1F)Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2c1cc[nH]2
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,lorlantinib,7476,,,187051779,Inhibitor,Inhibition,,f,t,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,Note that this is inhibition of the ALK L1196M mutant enzyme.,,,24819116,N#Cc1n(C)nc2c1c1cnc(c(c1)O[C@H](C)c1c(C(=O)N(C2)C)ccc(c1)F)N
ALK receptor tyrosine kinase,1839,ALK,Q9UM73,,,,,,Human,NVP-TAE684,5714,,,178102340,Inhibitor,Inhibition,,f,t,,pKd,0,8.960000038,0,Kd,0,1.100000024,0,=,,,,22037378,COc1cc(ccc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)N1CCC(CC1)N1CCN(CC1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,dabuzalgron,3469,,,178100463,Agonist,Agonist,,f,,,pKi,0,7.4,0,-,0,0,0,=,,,,14678390,Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,methoxamine,483,,,135650587,Agonist,Full agonist,,f,t,,pKi,5.199999809,0,5,-,0,0,0,=,,,,7651358,COc1ccc(c(c1)C(C(N)C)O)OC
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,f,,pKi,6.400000095,0,5.800000191,-,0,0,0,=,,,,7651358,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Full agonist,,f,t,,pKi,8.199999809,0,8,-,0,0,0,=,,,,7651358,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,phenylephrine,485,,,135650819,Agonist,Full agonist,,f,t,,pKi,5.400000095,0,5.199999809,-,0,0,0,=,,,,10433504,CNC[C@@H](c1cccc(c1)O)O
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,NS-49,481,,,135650746,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8719417,NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,rho-TIA,507,,,135652438,Allosteric modulator,Negative,,f,,,pKi,0,5,0,Ki,0,10000,0,=,,,,12824165,
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,diazepam,3364,,,178100389,Allosteric modulator,Positive,,f,f,,pKi,0,4.099999905,0,Ki,0,85700,0,=,,,,10565838,Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,(+)-cyclazosin,486,,,135650146,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8917649,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,11459121,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,doxazosin,7170,,,178103745,Antagonist,Antagonist,,f,t,,pKi,0,9.300000191,0,Ki,0,0.537,0,=,,,,0,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,indoramin,501,,,135650391,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9249248,O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,KMUP-1,8896,,,310264677,Antagonist,Antagonist,,f,f,,pKi,0,7.690000057,0,-,0,0,0,=,,,,17639498,Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,lisuride,43,,,135650525,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11459121,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,NAN 190,73,,,135650690,Antagonist,Antagonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,11459121,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,f,,pA2,0,7.400000095,0,-,0,0,0,=,Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.,,,18542932,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11331292,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,t,,pKi,0,8.600000381,0,-,0,0,0,=,,,,7651358,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,piribedil,49,,,135650833,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,&rho;-Da1a,6663,,,178103275,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,9.199999809,Ki,0,0,0,=,,,,20015090,
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11459121,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,Ro-70-0004,497,,,135650925,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,10369480,Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,RS-100329,7381,,,178103953,Antagonist,Antagonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,10369480,O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,RS-17053,495,,,135650941,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,9.199999809,-,0,0,0,=,,,,9249248,Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,silodosin,493,,,135650458,Antagonist,Antagonist,,f,t,,pKi,0,10.39999962,0,-,0,0,0,=,,,,7651358,OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,SNAP5089,498,,,135651060,Antagonist,Antagonist,,f,,,pKi,9.4,0,8.8,-,0,0,0,=,,,,10812954,COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,S(+)-niguldipine,487,,,135650717,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,11331292,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,S(+)-niguldipine,487,,,135650717,Antagonist,Antagonist,,f,,,pKi,10,0,9.1,-,0,0,0,=,,,,9249248,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11459121,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,prazosin,503,,,135650849,Antagonist,Inverse agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11331292,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,prazosin,503,,,135650849,Antagonist,Inverse agonist,,f,t,,pKi,9.899999619,0,9,-,0,0,0,=,,,,9249248,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,methoxamine,483,,,135650587,Agonist,Full agonist,,f,,,pKi,0,4,0,,0,0,0,,,,,7651358,COc1ccc(c(c1)C(C(N)C)O)OC
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,,,pKi,0,6.2,0,,0,0,0,,,,,7651358,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,7651358,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,phenylephrine,485,,,135650819,Agonist,Full agonist,,f,t,,pIC50,7.5,0,6.300000191,-,0,0,0,=,,,,9249248,CNC[C@@H](c1cccc(c1)O)O
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,NS-49,481,,,135650746,Agonist,Partial agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,8719417,NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O
&alpha;<sub>1B</sub>-adrenoceptor,23,Adra1b,P15823,,,,,,Rat,rho-TIA,507,,,135652438,Allosteric modulator,Negative,,f,,,pIC50,0,9.1,0,IC50,0,0.8,0,=,,,,15680270,
&alpha;<sub>1B</sub>-adrenoceptor,23,Adra1b,P15823,,,,,,Rat,lorazepam,5884,,,178102508,Allosteric modulator,Positive,,f,f,,pKi,0,3.799999952,0,Ki,0,170000,0,=,,,,10565838,Clc1ccc2c(c1)C(=NC(C(=O)N2)O)c1ccccc1Cl
&alpha;<sub>1B</sub>-adrenoceptor,23,Adra1b,P15823,,,,,,Rat,midazolam,3342,,,178100372,Allosteric modulator,Positive,,f,f,,pKi,0,3.700000048,0,Ki,0,183000,0,=,,,,10565838,Clc1ccc2c(c1)C(=NCc1n2c(C)nc1)c1ccccc1F
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11459121,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,doxazosin,7170,,,178103745,Antagonist,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.813000023,0,=,,,,0,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,indoramin,501,,,135650391,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9249248,O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,Adra1b,P15823,,,,,,Rat,KMUP-1,8896,,,310264677,Antagonist,Antagonist,,f,f,,pKi,0,6.940000057,0,-,0,0,0,=,,,,17639498,Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C
&alpha;<sub>1B</sub>-adrenoceptor,23,Adra1b,P15823,,,,,,Rat,L-765314,506,,,135650492,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9548811,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,L-765314,506,,,135650492,Antagonist,Antagonist,,f,f,,pKi,0,7.699999809,0,-,0,0,0,=,,,,9548811,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,11459121,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,NAN 190,73,,,135650690,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11459121,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,t,,pKi,0,7.5,0,-,0,0,0,=,,,,7651358,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,Rec 15/2615,8459,,,252166669,Antagonist,Antagonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,9190864,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,rho-TIA,507,,,135652438,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15194691,
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11459121,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,Ro-70-0004,497,,,135650925,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10369480,Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,silodosin,493,,,135650458,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,7651358,OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,S(+)-niguldipine,487,,,135650717,Antagonist,Antagonist,,f,,,pKi,7.7,0,6.7,,0,0,0,,,,,9249248,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11459121,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,(+)-cyclazosin,486,,,135650146,Antagonist,Inverse agonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,8917649,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,prazosin,503,,,135650849,Antagonist,Inverse agonist,,f,t,,pKi,9.899999619,0,9.600000381,-,0,0,0,=,,,,9249248,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,spiperone,99,,,135651064,Antagonist,Inverse agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,indanidine,512,,,135651040,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,7969082,Cn1nc2c(c1)c(ccc2)NC1=NCCN1
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,methoxamine,483,,,135650587,Agonist,Full agonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,7969082,COc1ccc(c(c1)C(C(N)C)O)OC
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,methoxamine,483,,,135650587,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,7651358,COc1ccc(c(c1)C(C(N)C)O)OC
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,,,pKi,0,6.3,0,-,0,0,0,=,,,,7969082,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,f,,pKi,0,7.400000095,0,-,0,0,0,=,,,,7651358,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,phenylephrine,485,,,135650819,Agonist,Full agonist,,f,f,,pKi,0,5.900000095,0,-,0,0,0,=,,,,7969082,CNC[C@@H](c1cccc(c1)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,SKF 89748,511,,,135651057,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,7969082,COc1ccc(c2c1CC(N)CC2)SC
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,St 587,513,,,135651089,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,7969082,Clc1ccc(cc1NC1=NCCN1)C(F)(F)F
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,NS-49,481,,,135650746,Agonist,Partial agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,8719417,NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7969082,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,7651358,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,11459121,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,dapiprazole,7155,,,178103730,Antagonist,Antagonist,,f,t,,pKi,0,8.399999619,0,Ki,0,4.090000153,0,=,,,,0,Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,doxazosin,7170,,,178103745,Antagonist,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.813000023,0,=,,,,0,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,indoramin,501,,,135650391,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9249248,O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,KMUP-1,8896,,,310264677,Antagonist,Antagonist,,f,f,,pKi,0,7.690000057,0,-,0,0,0,=,,,,17639498,Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,labetalol,7207,,,178103782,Antagonist,Antagonist,,f,t,,pKi,0,6.599999905,0,Ki,0,256,0,=,,,,0,CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,mianserin,135,,,135650606,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,11459121,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,NAN 190,73,,,135650690,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11459121,COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,f,,pA2,0,6.400000095,0,-,0,0,0,=,Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat aorta.,,,18542932,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,11459121,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,ritanserin,97,,,135650904,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,Ro-70-0004,497,,,135650925,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10369480,Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,RS-100329,7381,,,178103953,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,10369480,O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,RS-17053,495,,,135650941,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9249248,Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,silodosin,493,,,135650458,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,7651358,OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,SKF 105854,518,,,135651047,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,7568329,CN1CCc2c3c(C1)c(Br)oc3ccc2Cl
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,S(+)-niguldipine,487,,,135650717,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9249248,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11459121,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11459121,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,(+)-cyclazosin,486,,,135650146,Antagonist,Inverse agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8917649,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,(+)-cyclazosin,486,,,135650146,Antagonist,Inverse agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8917649,COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Inverse agonist,,f,t,,pKi,0,8.199999809,0,-,0,0,0,=,,,,7651358,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,prazosin,503,,,135650849,Antagonist,Inverse agonist,,f,t,,pKi,10.19999981,0,9.5,-,0,0,0,=,,,,9249248,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,guanabenz,5443,,,178102094,Agonist,Agonist,,f,t,,pIC50,0,7.400000095,0,IC50,0,41,0,=,,,,0,NC(=N/N=C/c1c(Cl)cccc1Cl)N
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,f,,pKi,7.400000095,0,5.599999905,-,0,0,0,=,,,,9824686,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,dexmedetomidine,521,,,135650174,Agonist,Partial agonist,,f,t,,pKi,9.600000381,0,7.599999905,-,0,0,0,=,,,,9824686,Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,guanfacine,522,,,135650327,Agonist,Partial agonist,,f,t,,pKi,7.300000191,0,7.099999905,-,0,0,0,=,,,,9605427,O=C(Cc1c(Cl)cccc1Cl)N=C(N)N
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,t,,pKi,8.600000381,0,8,Ki,10,0,2.799999952,=,,,,9605427,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,ethylisopropylamiloride,4186,,,178101005,Allosteric modulator,Positive,,f,,,pKd,0,1.8,0,-,0,0,0,=,,,,1325028,CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,lisuride,43,,,135650525,Antagonist,Antagonist,,f,,,pKi,0,10.3,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,lurasidone,7461,,,187051764,Antagonist,Antagonist,,f,f,,pKi,0,7.400000095,0,Ki,0,40.70000076,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,t,,pKi,0,7.699999809,0,Ki,0,20,0,=,Inhibition of [<sup>3</sup>H]rauwolscine binding.,,,15771415,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,t,,pIC50,0,7.099999905,0,IC50,0,85.11000061,0,=,,,,10636247,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,1353247,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,piribedil,49,,,135650833,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,prazosin,503,,,135650849,Antagonist,Antagonist,,f,,,pKi,6.5,0,5.3,,0,0,0,,,,,7996470,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7996470,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,RX821002,526,,,135650954,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,7996470,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,7996470,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,guanabenz,5443,,,178102094,Agonist,Agonist,,f,t,,pIC50,0,6.800000191,0,IC50,0,149,0,=,,,,0,NC(=N/N=C/c1c(Cl)cccc1Cl)N
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,dexmedetomidine,521,,,135650174,Agonist,Full agonist,,f,t,,pKi,9.699999809,0,7.5,-,0,0,0,=,,,,9824686,Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,guanfacine,522,,,135650327,Agonist,Full agonist,,f,t,,pKi,6.5,0,5.800000191,-,0,0,0,=,,,,9605427,O=C(Cc1c(Cl)cccc1Cl)N=C(N)N
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Partial agonist,,t,t,,pKi,6,0,5.400000095,-,0,0,0,=,,,,9824686,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,,,pKi,6.2,0,5.5,,0,0,0,,,,,9605427,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Partial agonist,,f,,,pKi,6.2,0,5.2,-,0,0,0,=,,,,9605427,CNCC(c1ccc(c(c1)O)O)O
&alpha;<sub>2B</sub>-adrenoceptor,26,Adra2b,P19328,,,,,,Rat,imiloxan,3470,,,178100464,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,-,0,0,0,=,,,,1970500,CCn1ccnc1CC1COc2c(O1)cccc2
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,lisuride,43,,,135650525,Antagonist,Antagonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,t,,pIC50,0,6.699999809,0,IC50,0,223.8699951,0,=,,,,10636247,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,phenoxybenzamine,7268,,,178103842,Antagonist,Antagonist,,f,t,,pKi,0,8.5,0,Ki,0,3.5,0,=,,,,1834671,ClCCN(C(COc1ccccc1)C)Cc1ccccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,1353247,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,prazosin,503,,,135650849,Antagonist,Antagonist,,f,,,pKi,7.5,0,6.4,-,0,0,0,=,,,,7996470,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,7996470,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,RX821002,526,,,135650954,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7996470,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7996470,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,guanabenz,5443,,,178102094,Agonist,Agonist,,f,t,,pIC50,0,5.960000038,0,IC50,0,1106,0,=,,,,0,NC(=N/N=C/c1c(Cl)cccc1Cl)N
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,dexmedetomidine,521,,,135650174,Agonist,Full agonist,,f,t,,pKi,9.300000191,0,7,-,0,0,0,=,,,,9824686,Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,t,,pKi,6.800000191,0,5.699999809,-,0,0,0,=,,,,9824686,NC[C@@H](c1ccc(c(c1)O)O)O
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Full agonist,,f,,,pKi,6.2,0,5.8,-,0,0,0,=,,,,9605427,CNCC(c1ccc(c(c1)O)O)O
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,guanfacine,522,,,135650327,Agonist,Partial agonist,,f,t,,pKi,6.199999809,0,5.400000095,-,0,0,0,=,,,,9605427,O=C(Cc1c(Cl)cccc1Cl)N=C(N)N
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,oxymetazoline,124,,,135650785,Agonist,Partial agonist,,f,f,,pKi,0,6.699999809,0,-,0,0,0,=,,,,9605427,Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,JP1302,3930,,,178100759,Antagonist,Antagonist,,f,,,pKB,0,7.8,0,-,0,0,0,=,,,,17220913,CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,lisuride,43,,,135650525,Antagonist,Antagonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,lurasidone,7461,,,187051764,Antagonist,Antagonist,,f,f,,pKi,0,7.96999979,0,Ki,0,10.80000019,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,Inhibition of [<sup>3</sup>H]rauwolscine binding.,,,15771415,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,mirtazapine,7241,,,178103815,Antagonist,Antagonist,,f,t,,pIC50,0,6.699999809,0,IC50,0,199.5299988,0,=,,,,10636247,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,phentolamine,502,,,135650818,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.6,,0,0,0,,,,,1353247,Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,piribedil,49,,,135650833,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,prazosin,503,,,135650849,Antagonist,Antagonist,,f,,,pKi,8,0,6.7,-,0,0,0,=,,,,7996470,COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,rauwolscine,136,,,135652710,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,7996470,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,RX821002,526,,,135650954,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,7996470,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,spiroxatrine,53,,,135651066,Antagonist,Antagonist,,f,f,,pKi,0,9,0,-,0,0,0,=,,,,7996470,O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,mofegiline,9754,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,Inhibition of recombinant hSSAO/VAP-1.,,,23943052,NC/C(=C/F)/CCc1ccc(cc1)F
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,19.95000076,0,=,,,,20690686,NNCCc1ccccc1
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,PXS-4728A,9346,,,328083448,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,25889951,NC/C(=CF)/COc1ccc(cc1)C(=O)NC(C)(C)C
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,PXS-4681A,9753,,,0,Inhibitor,Irreversible inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,Inhibition of recombinant hSSAO.,,,23943052,NC/C(=CF)/COc1ccc(cc1)S(=O)(=O)N
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,PXS-4681A,9753,,,0,Inhibitor,Irreversible inhibition,,f,t,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,23943052,NC/C(=CF)/COc1ccc(cc1)S(=O)(=O)N
Aminopeptidase N,1560,,,,,,,,Pig,JFD00064,9668,,,348353627,Inhibitor,Inhibition,,f,f,,pKi,0,5.539999962,0,Ki,0,2900,0,=,,,,28964831,N#Cc1c(ccc2c1ccc1c2cccc1)Cc1cc(C#N)c2c(c1)c1ccccc1cc2
Aminopeptidase N,1560,ANPEP,P15144,,,,,,Human,JFD00064,9668,,,348353627,Inhibitor,Inhibition,,f,f,,pKi,0,5.699999809,0,Ki,0,2010,0,=,Inhibition of APN <i>in vitro</i>.,,,28964831,N#Cc1c(ccc2c1ccc1c2cccc1)Cc1cc(C#N)c2c(c1)c1ccccc1cc2
AMP kinase,1540,,,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,t,,pIC50,0,7.389999866,0,IC50,0,41,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
"amyloid P component, serum",2839,APCS,P02743,,,,,,Human,dezamizumab,8255,,,249565935,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,20962779,
"amyloid P component, serum",2839,APCS,P02743,,,,,,Human,CPHPC,8256,,,249565936,Inhibitor,Binding,,f,t,,pIC50,0,6.050000191,0,IC50,0,900,0,=,,,,14998318,OC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,pramlintide,7482,,,187051785,Agonist,Agonist,,f,f,,pEC50,9.449999809,0,9.359999657,EC50,0.43599999,0,0.354999989,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,"[Cys(Et)2,7]&alpha;-CGRP (human)",693,,,135652077,Agonist,Full agonist,,f,,,pEC50,8.4,0,7.8,,0,0,0,,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,CT-(8-32) (salmon),690,,,135652065,Antagonist,Antagonist,,f,f,,pKi,0,7.78000021,0,-,0,0,0,=,,,,15692146,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,olcegepant,702,,,135649990,Antagonist,Antagonist,,f,f,,pKd,0,7.199999809,0,-,0,0,0,=,,,,26125036,NCCCC[C@@H](C(=O)N1CCN(CC1)c1ccncc1)NC(=O)[C@H](NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)Cc1cc(Br)c(c(c1)Br)O
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,pramlintide,7482,,,187051785,Agonist,Agonist,,f,f,,pEC50,8.859999657,0,8.640000343,EC50,2.289999962,0,1.379999995,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,pramlintide,7482,,,187051785,Agonist,Agonist,,f,f,,pEC50,9.279999733,0,9.050000191,EC50,0.890999973,0,0.519999981,=,Measuring ligand-induced cAMP production in COS and HEK293 cells.,,,24169554,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,CT-(8-32) (salmon),690,,,135652065,Antagonist,Antagonist,,f,f,,pKi,0,7.920000076,0,-,0,0,0,=,,,,15692146,
Androgen receptor,628,Ar,P15207,,,,,,Rat,danazol,6942,,,178103524,Agonist,Agonist,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,7355922,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=Cc3c(C[C@]12C)cno3
Androgen receptor,628,Ar,P15207,,,,,,Rat,dihydrotestosterone,2856,,,135651474,Agonist,Agonist,,t,,,pIC50,0,8.65,0,,0,0,0,,,,,14565775,O=C1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,dihydrotestosterone,2856,,,135651474,Agonist,Agonist,,t,,,pKd,0,9.3,0,Kd,0,0.5,0,=,,,,2911578,O=C1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,dromostanolone propionate,6947,,,178103529,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)C[C@@H](C)C(=O)C2
Androgen receptor,628,AR,P10275,,,,,,Human,ethylestrenol,6948,,,178103530,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CCCC[C@H]12
Androgen receptor,628,AR,P10275,,,,,,Human,fluoxymesterone,2861,,,135650271,Agonist,Agonist,,f,t,,pKi,0,8.239999771,0,Ki,0,5.699999809,0,=,,,,17439112,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@]2(F)[C@@H](O)C[C@]2([C@H]1CC[C@]2(C)O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,methyltrienolone,2857,,,135650595,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,,,,10076535,O=C1CCC2=C3C=C[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C)O)C
Androgen receptor,628,Ar,P15207,,,,,,Rat,methyltrienolone,2857,,,135650595,Agonist,Agonist,,f,f,,pIC50,0,8.510000229,0,-,0,0,0,=,,,,14565775,O=C1CCC2=C3C=C[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C)O)C
Androgen receptor,628,AR,P10275,,,,,,Human,mibolerone,2859,,,135650607,Agonist,Agonist,,f,f,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,10852459,O=C1CC[C@H]2C(=C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C)C
Androgen receptor,628,Ar,P15207,,,,,,Rat,mibolerone,2859,,,135650607,Agonist,Agonist,,f,f,,pIC50,0,8.800000191,0,-,0,0,0,=,,,,14565775,O=C1CC[C@H]2C(=C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,nandrolone,6949,,,178103531,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
Androgen receptor,628,AR,P10275,,,,,,Human,methyltestosterone,6945,,,178103527,Agonist,Full agonist,Androgen receptor promoter activity in luciferase reporter assay,f,t,,pEC50,0,9.659999847,0,EC50,0,0.219999999,0,=,22Rv1 human prostate cells transfected with hAR and luciferase reporter plasmid driven by the androgen response element.,,,24177288,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,cyproterone acetate,2865,,,135650153,Antagonist,Antagonist,,f,t,,pKi,0,7.849999905,0,Ki,0,14,0,=,,,,9484511,CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2C=C(C2=CC(=O)[C@H]3[C@@H]([C@]12C)C3)Cl)C(=O)C
Androgen receptor,628,AR,P10275,,,,,,Human,enzalutamide,6812,,,178103418,Antagonist,Antagonist,,f,t,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,19359544,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(c(c1)C(F)(F)F)C#N
Androgen receptor,628,AR,P10275,,,,,,Human,flutamide,6943,,,178103525,Antagonist,Antagonist,Displacement of <sup>3</sup>[H] testosterone from wild-type androgen receptors,f,t,,pKi,0,5.429999828,0,Ki,0,3700,0,=,,,,18571420,O=C(C(C)C)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-]
Androgen receptor,628,AR,P10275,,,,,,Human,galeterone,8638,,,252166838,Antagonist,Antagonist,,f,f,,pIC50,0,6.420000076,0,IC50,0,384,0,=,,,,15828836,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC=C2n2cnc3c2cccc3)C)C1)C
Androgen receptor,628,AR,P10275,,,,,,Human,hydroxyflutamide,2862,,,135650359,Antagonist,Antagonist,,f,f,,pEC50,0,6.599999905,0,EC50,0,254,0,=,,,,10076535,O=C(C(O)(C)C)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O
Androgen receptor,628,AR,P10275,,,,,,Human,mifepristone,2805,,,135650608,Antagonist,Antagonist,,f,,,pKi,0,9.19,0,Ki,0,0.65,0,=,,,,15293993,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Androgen receptor,628,AR,P10275,,,,,,Human,nilutamide,2864,,,135650719,Antagonist,Antagonist,,f,t,,pIC50,7.119999886,0,7.070000172,IC50,85,0,75,=,,,,9111629,O=C1NC(C(=O)N1c1ccc(c(c1)C(F)(F)F)[N+](=O)[O-])(C)C
Androgen receptor,628,AR,P10275,,,,,,Human,PF-03882845,9061,,,315661146,Antagonist,Antagonist,,f,f,,pIC50,0,5.050000191,0,IC50,0,8910,0,=,,,,24738581,N#Cc1ccc(cc1Cl)N1N=C2[C@@H]([C@@H]1C1CCCC1)CCc1c2ccc(c1)C(=O)O
Androgen receptor,628,AR,P10275,,,,,,Human,PF0998425,6698,,,178103309,Antagonist,Antagonist,,f,,,pIC50,7.5,0,7.1,-,0,0,0,=,,,,18921992,N#Cc1ccc(cc1C(F)(F)F)[C@H]1CCCC[C@H]1O
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,enalapril,6322,,,178102940,Inhibitor,Inhibition,,f,t,,pIC50,0,4.300000191,0,IC50,0,50000,0,=,,,,7527095,CCOC(=O)[C@@H](N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,enalaprilat,6332,,,178102950,Inhibitor,Inhibition,,f,t,,pIC50,0,7.5,0,IC50,0,34,0,=,,,,7527095,OC(=O)[C@@H](N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,fasidotril,6501,,,178103115,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CC(=O)SC[C@H](C(=O)N[C@H](C(=O)OCc1ccccc1)C)Cc1ccc2c(c1)OCO2
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,fasidotrilat,6502,,,178103116,Inhibitor,Inhibition,,f,,,pKi,0,8,0,Ki,0,9.8,0,,,,,16789888,SC[C@H](C(=O)N[C@H](C(=O)O)C)Cc1ccc2c(c1)OCO2
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,fosinopril,6456,,,178103071,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCC(=O)O[C@H](C(C)C)O[P@@](=O)(CC(=O)N1C[C@@H](C[C@H]1C(=O)O)C1CCCCC1)CCCCc1ccccc1
Angiotensin-converting enzyme,1613,,,,,,,,Rabbit,fosinoprilat,6457,,,178103072,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,11,0,=,,,,2481187,O=C(N1C[C@@H](C[C@H]1C(=O)O)C1CCCCC1)CP(=O)(CCCCc1ccccc1)O
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,imidapril,6377,,,178102995,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCOC(=O)[C@@H](N[C@H](C(=O)N1C(=O)N(C[C@H]1C(=O)O)C)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,imidaprilat,6378,,,178102996,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,17547476,C[C@@H](C(=O)N1C(=O)N(C[C@H]1C(=O)O)C)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,lisinopril,6360,,,178102978,Inhibitor,Inhibition,,f,t,,pKi,0,9.399999619,0,Ki,0,0.360000014,0,=,,,,9187274,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,lisinopril-tryptophan,7893,,,223366216,Inhibitor,Inhibition,C-domain assay,f,t,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,,,,20233165,NCCCC[C@@H](C(=O)N[C@@H](C(=O)O)Cc1c[nH]c2c1cccc2)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,moexipril,6571,,,178103185,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2cc(OC)c(cc2C[C@H]1C(=O)O)OC)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,,,,,,,,Rabbit,moexiprilat,6572,,,178103186,Inhibitor,Inhibition,,f,,,pIC50,0,8.2,0,IC50,0,6.5,0,,,,,9079232,COc1cc2C[C@@H](C(=O)O)N(Cc2cc1OC)C(=O)[C@@H](N[C@H](C(=O)O)CCc1ccccc1)C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,perindopril,6367,,,178102985,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCC[C@@H](C(=O)OCC)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,perindoprilat,6373,,,178102991,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1.049999952,0,=,,,,17716647,CCC[C@@H](C(=O)O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C
Angiotensin-converting enzyme,1613,,,,,,,,Guinea pig,quinapril,6350,,,178102968,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8.300000191,0,=,,,,6323223,CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,quinaprilat,6352,,,178102970,Inhibitor,Inhibition,,f,t,,pIC50,0,8.5,0,IC50,0,2.900000095,0,=,,,,1995872,OC(=O)[C@@H](N[C@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,ramipril,6339,,,178102957,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,26,0,=,,,,6097265,CCOC(=O)[C@@H](N[C@H](C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,ramiprilat,6344,,,178102962,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4.199999809,0,=,,,,6097265,OC(=O)[C@@H](N[C@H](C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,RXP-407,7894,,,223366217,Inhibitor,Inhibition,N-domain selective inhibition,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,22628311,OC(=O)C[C@@H](C(=O)N[C@H](P(=O)(C[C@H](C(=O)N[C@H](C(=O)N)C)C)O)Cc1ccccc1)NC(=O)C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,spirapril,6575,,,178103189,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCOC(=O)[C@@H](N[C@H](C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,spiraprilat,6576,,,178103190,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,2544729,C[C@@H](C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme 2,1614,ACE2,Q9BYF1,,,,,,Human,MLN-4760,7866,,,223366196,Inhibitor,Inhibition,,f,t,,pIC50,0,9.359999657,0,IC50,0,0.439999998,0,=,,,,18324760,CC(C[C@@H](C(=O)O)N[C@H](C(=O)O)Cc1cncn1Cc1cc(Cl)cc(c1)Cl)C
Anti-M&uuml;llerian hormone receptors,2589,BMPR1A|AMHR2|BMPR1B|ACVR1,O00238|P36894|Q04771|Q16671,,,,,,Human,M&uuml;llerian inhibiting substance,6686,AMH,Human,178103298,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
apelin receptor,36,APLNR,P35414,,,,,,Human,E339-3D6,6187,,,178102808,Agonist,Agonist,,f,,,pKi,0,6.4,0,-,0,0,0,=,,,,20040517,[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F.CCN(c1ccc2c(c1)oc1c(c2c2ccc(cc2S(=O)(=O)O)S(=O)(=O)NCCCCCCCCCCCCNC(=O)NCCCCC(C(=O)NC(C(=O)NC2CC[NH+](CC2)C)Cc2cn(c[n+]2C)Cc2ccccc2)NC(=O)CC2=CSC(=N)[NH+]2C)ccc(=[N+](CC)CC)c1)CC
apelin receptor,36,APLNR,P35414,,,,,,Human,Elabela/Toddler-11,8526,APELA,Human,252166728,Agonist,Agonist,,t,f,,pIC50,0,7.199999809,0,-,0,0,0,=,,,,0,
apelin receptor,36,APLNR,P35414,,,,,,Human,Elabela/Toddler-21,8525,APELA,Human,252166727,Agonist,Agonist,,t,f,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,0,
apelin receptor,36,APLNR,P35414,,,,,,Human,Elabela/Toddler-32,8524,APELA,Human,252166726,Agonist,Agonist,,t,f,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,0,
apelin receptor,36,APLNR,P35414,,,,,,Human,MM07,8523,,,252166725,Agonist,Biased agonist,,f,f,,pEC50,0,9.5,0,-,0,0,0,=,,,,25712721,
apelin receptor,36,APLNR,P35414,,,,,,Human,cyclo apelin-12 (1-12),6313,,,178102932,Agonist,Full agonist,,f,f,,pEC50,0,6.300000191,0,EC50,0,493.1700134,0,=,,,,18813863,
apelin receptor,36,APLNR,P35414,,,,,,Human,cyclo apelin-12 (7-12),6311,,,178102930,Agonist,Full agonist,,f,,,pEC50,0,7.1,0,EC50,0,78.62,0,=,,,,18813863,
apelin receptor,36,APLNR,P35414,,,,,,Human,cyclourea apelin-12 (1-7),6312,,,178102931,Agonist,Full agonist,,f,f,,pEC50,0,6.800000191,0,EC50,0,144.2700043,0,=,,,,18813863,
apelin receptor,36,APLNR,P35414,,,,,,Human,ML233,6314,,,178102933,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,22834038,CC1=CC(=O)C(=C/C/1=NOS(=O)(=O)c1ccccc1)C1CCCCC1
apelin receptor,36,APLNR,P35414,,,,,,Human,[Pyr<sup>1</sup>]apelin-13,599,APLN|Apln|Apln,Human|Mouse|Rat,135651872,Agonist,Full agonist,,t,f,,pIC50,8.800000191,0,7,-,0,0,0,=,,,,11336787,
apelin receptor,36,APLNR,P35414,,,,,,Human,ML221,6282,,,178102902,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,23010269,O=C(c1ccc(cc1)[N+](=O)[O-])Oc1coc(cc1=O)CSc1ncccn1
apelin receptor,36,APLNR,P35414,,,,,,Human,MM54,6186,,,178102807,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,7.099999905,0,=,,,,21560248,
AQP0,687,MIP,P30301,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP1,688,AQP1,P29972,,,,,,Human,cyclic GMP,2347,,,135651454,Activator,None,,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
AQP1,688,AQP1,P29972,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP10,697,AQP10,Q96PS8,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP2,689,AQP2,P41181,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP3,690,AQP3,Q92482,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,also inhibited by acid pH,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP5,692,AQP5,P55064,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP6,693,AQP6,Q13520,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP7,694,AQP7,O14520,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP8,695,AQP8,O94778,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
AQP9,696,AQP9,O43315,,,,,,Human,Hg<sup>2+</sup>,4215,,,178101032,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
AQP9,696,AQP9,O43315,,,,,,Human,phloretin,4285,,,178101102,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Oc1ccc(cc1)CCC(=O)c1c(O)cc(cc1O)O
"A-Raf proto-oncogene, serine/threonine kinase",1933,ARAF,P10398,,,,,,Human,lifirafenib,8958,,,310264739,Inhibitor,Inhibition,,f,f,,pIC50,0,8.25,0,IC50,0,5.599999905,0,=,,,,26208524,O=C1CCc2c(N1)nccc2Oc1ccc2c(c1)[C@@H]1[C@H](O2)[C@H]1c1nc2c([nH]1)cc(cc2)C(F)(F)F
"A-Raf proto-oncogene, serine/threonine kinase",1933,ARAF,P10398,,,,,,Human,LY3009120,8943,,,310264724,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,26343583,CNc1ncc2c(n1)nc(c(c2)c1cc(NC(=O)NCCC(C)(C)C)c(cc1C)F)C
Arginyl aminopeptidase,1564,,,,,,,,None,Lys-thiol,8667,,,252166867,Inhibitor,Inhibition,,f,t,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,3111463,NCCCCC(C(=O)O)S
ASIC1,684,ASIC1,P78348,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,ASIC1a,t,,,pEC50,6.8,0,6.2,EC50,630,0,160,~,,,Extracellular,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,ASIC1b,t,,,pEC50,6.2,0,5.1,EC50,8000,0,630,~,,,Extracellular,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,ethylisopropylamiloride,4186,,,178101005,Channel blocker,None,ASIC1a,f,,,pIC50,0,5,0,IC50,0,10000,0,,,,,0,CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C
ASIC1,684,Asic1,P55926,,,,,,Rat,flurbiprofen,4194,,,178101011,Channel blocker,None,ASIC1a,f,f,,pIC50,0,3.5,0,IC50,0,350000,0,=,,,,11588175,OC(=O)C(c1ccc(c(c1)F)c1ccccc1)C
ASIC1,684,ASIC1,P78348,,,,,,Human,ibuprofen,2713,,,135650365,Channel blocker,None,ASIC1a,f,,,pIC50,0,3.5,0,IC50,0,350000,0,~,,,,0,CC(Cc1ccc(cc1)C(C(=O)O)C)C
ASIC1,684,ASIC1,P78348,,,,,,Human,nafamostat,4262,,,178101079,Channel blocker,None,ASIC1a,f,,,pIC50,0,4.9,0,IC50,0,13000,0,~,,,,0,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
ASIC1,684,ASIC1,P78348,,,,,,Human,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,None,ASIC1a,f,,,pIC50,0,3.2,0,IC50,0,600000,0,~,,,,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Channel blocker,None,ASIC1b,f,,,pIC50,0,5.8,0,IC50,0,1500,0,~,,,,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Channel blocker,None,ASIC1a,f,,,pIC50,0,5.4,0,IC50,0,4000,0,~,,,,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,psalmotoxin 1,4292,,,178101109,Channel blocker,None,ASIC1a,f,,,pIC50,0,9,0,IC50,0,0.9,0,,,,,0,
ASIC2,685,ASIC2,Q16515,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,,t,,,pEC50,5,0,4.1,EC50,80000,0,10000,~,,,Extracellular,0,
ASIC2,685,ASIC2,Q16515,,,,,,Human,nafamostat,4262,,,178101079,Channel blocker,None,,f,,,pIC50,0,4.2,0,IC50,0,70000,0,~,,,,0,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,GMQ,4203,,,178101020,Activator,None,largly non-desensitizing; at pH 7.4,f,,,pEC50,0,3,0,EC50,0,1000000,0,~,,,,0,NC(=N)Nc1nc2ccccc2c(n1)C
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,sustained component,t,,,pEC50,4.3,0,3.5,EC50,350000,0,50000,~,,,Extracellular,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,transient component,t,,,pEC50,6.7,0,6.2,EC50,630,0,200,~,,,Extracellular,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,diclofenac,2714,,,135650177,Channel blocker,None,sustained component,f,,,pIC50,0,4,0,IC50,0,92000,0,,,,,0,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,None,,f,,,pIC50,0,4.4,0,IC50,0,40000,0,,,,,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,nafamostat,4262,,,178101079,Channel blocker,None,transient component,f,,,pIC50,0,5.6,0,IC50,0,2500,0,~,,,,0,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,salicylic acid,4306,,,178101123,Channel blocker,None,sustained component,f,,,pIC50,0,3.6,0,IC50,0,260000,0,,,,,0,OC(=O)c1ccccc1O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,"CP608,039",5598,,,178102233,Agonist,Agonist,,f,,,pKi,0,5.14,0,Ki,0,7300,0,=,,,,16518376,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1N)O)n1cnc2c1ncnc2NCc1cc(Cl)ccc1COc1onc(c1)C
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,GR79236,3288,,,178100329,Agonist,Agonist,,f,f,,pKi,0,8.510000229,0,Ki,0,3.099999905,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1CCC[C@@H]1O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,GS9667,5593,,,178102228,Agonist,Agonist,,f,,,pKi,0,7.26,0,Ki,0,55,0,=,,,,19012505,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N[C@@H]1CCC[C@H]1O)CSc1ccccc1F
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,HEMADO,5599,,,178102234,Agonist,Agonist,,f,,,pKi,0,6.48,0,Ki,0,330,0,=,,,,12109910,CCCCC#Cc1nc(NC)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,6.59,0,Ki,0,260,0,=,,,,16518376,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,6.98,0,Ki,0,105,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>1</sub> receptor,18,Adora1,Q60612,,,,,,Mouse,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,7.8,0,Ki,0,15.8,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,4.83,0,Ki,0,14900,0,=,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>1</sub> receptor,18,Adora1,Q60612,,,,,,Mouse,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,4.98,0,Ki,0,10500,0,=,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Agonist,,f,,,pKi,0,9.07,0,Ki,0,0.85,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,NECA,377,,,135650706,Agonist,Agonist,,f,,,pKi,0,8.29,0,Ki,0,5.1,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,piclidenoson,422,,,135650362,Agonist,Agonist,,f,,,pKi,0,7.29,0,Ki,0,51,0,=,,,,16518376,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,regadenoson,5596,,,178102231,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,(R)-PIA,414,,,135651557,Agonist,Agonist,,f,,,pKi,0,8.92,0,Ki,0,1.2,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,cyclopentyladenosine,380,,,135650148,Agonist,Full agonist,,f,f,,pKi,9.399999619,0,6.5,-,0,0,0,=,,,,7798201,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,"(<i>R,S</i>)-PHPNECA",369,,,135650422,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@H]([C@H]1O)O)n1cnc2c1nc(C#CC(c1ccccc1)O)nc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,NECA,377,,,135650706,Agonist,Full agonist,,f,,,pKi,8.2,0,5.3,-,0,0,0,=,,,,7798201,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PENECA,378,,,135650805,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#Cc1ccccc1)nc2N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,(R)-PIA,414,,,135651557,Agonist,Full agonist,,f,,,pKi,8.7,0,6.4,-,0,0,0,=,,,,7798201,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,(S)-PIA,415,,,135651063,Agonist,Full agonist,,f,,,pKi,6,0,4.6,,0,0,0,,,,,7798201,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H](Cc1ccccc1)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,LUF5831,376,,,135650538,Agonist,Partial agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16444290,OCCSc1nc(N)c(c(c1C#N)c1ccc(cc1)O)C#N
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PD81723,9445,,,329968385,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,2174510,Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,CPFPX,5603,,,178102237,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,Ki,0,1.26,0,=,,,,12408725,[18F]CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,CPFPX,5603,,,178102237,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,Ki,0,0.63,0,=,,,,12408725,[18F]CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,CSC,5609,,,178102243,Antagonist,Antagonist,,f,,,pKi,0,4.55,0,Ki,0,28000,0,=,,,,8496902,Clc1cccc(c1)/C=C/c1nc2c(n1C)c(=O)n(c(=O)n2C)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,CVT-6883,5615,,,178102249,Antagonist,Antagonist,,f,,,pKi,0,5.71,0,Ki,0,1940,0,=,,,,18321039,CCCn1c(=O)c2nc([nH]c2n(c1=O)CC)c1cnn(c1)Cc1cccc(c1)C(F)(F)F
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,Ki,0,2.51,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,7.400000095,Ki,39.79999924,0,0.629999995,=,,,,9920910,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,9.74,0,9,Ki,1,0,0.18,=,,,,16902942,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,DU172,9530,,,336446916,Antagonist,Antagonist,,f,f,,pKi,0,7.400000095,0,-,0,0,0,=,,,,28235198,CCCn1c(=O)n(CCCNC(=O)c2ccc(cc2)S(=O)(=O)F)c2c(c1=O)nc([nH]2)C1CCCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,FK-453,5606,,,178102240,Antagonist,Antagonist,,f,,,pKi,0,7.74,0,Ki,0,18,0,=,,,,16518376,OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,flavanone,408,,,135650264,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,8691424,O=C1CC(Oc2c1cccc2)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,flavone,409,,,135650265,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,O=c1cc(oc2c1cccc2)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,FR194921,387,,,135650289,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,15351792,CN1CCC(CC1)n1nc(ccc1=O)c1c(nn2c1cccc2)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,galangin,410,,,135650295,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8691424,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,isobutylmethylxanthine,388,,,135650363,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,7798201,CC(Cn1c(=O)n(C)c(=O)c2c1nc[nH]2)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,0,6.08,0,Ki,0,841,0,=,,,,21303899,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,0,6.64,0,Ki,0,230,0,=,,,,21303899,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,KF26777,5618,,,178102252,Antagonist,Antagonist,,f,,,pKi,0,5.74,0,Ki,0,1800,0,=,,,,12063073,CCCn1c2nc([nH]c2c2=NCCn2c1=O)c1ccc(cc1)Br
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,L-97-1,389,,,135650505,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,16020631,OCCN(CCn1c(Cc2ccccc2)nc2c1c(=O)n(CCC)c(=O)n2CCc1ccc(cc1)N)CC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,LAS38096,5617,,,178102251,Antagonist,Antagonist,,f,,,pKi,0,5.55,0,Ki,0,2821,0,=,,,,17469811,n1ccc(nc1)c1cnc(nc1c1ccco1)Nc1cccnc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,LUF5962,9813,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,7.130000114,0,-,0,0,0,=,,,,29486053,C1CCC(C1)c1[nH]c2c(n1)nc(nc2c1ccccc1)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,LUF5981,5607,,,178102241,Antagonist,Antagonist,,f,,,pKi,0,9.05,0,Ki,0,0.9,0,=,,,,17300165,C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,morin,411,,,135650623,Antagonist,Antagonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,8691424,Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRE 2029F20,390,,,135650630,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,-,0,0,0,=,,,,16219300,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRE 3008F20,459,,,135650631,Antagonist,Antagonist,,f,,,pKi,6,0,5.9,-,0,0,0,=,,,,16219300,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1041,392,,,135650633,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8691424,CCOc1cc(OCC)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1042,393,,,135650634,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8691424,CCCOc1cc(OCCC)c2c(c1)oc(c(c2=O)OCCC)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1062,394,,,135650635,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,8691424,COc1ccc2c(c1)C(=O)C(C(O2)(C#Cc1ccccc1)c1ccccc1)O
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1065,395,,,135650636,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,8691424,COc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1066,396,,,135650637,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,8691424,CCOc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1084,397,,,135650639,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,8691424,CCCOc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1086,398,,,135650640,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,8691424,CCOc1ccc(c(c1)OCC)c1oc2cc(OCC)cc(c2c(=O)c1OCC)OCC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1093,399,,,135650642,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8691424,CCOc1cc(O)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1132,400,,,135650644,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8691424,O=c1c(Cl)c(oc2c1cccc2)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,Ki,0,40100,0,=,,,,0,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,4.81,0,Ki,0,15600,0,=,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,6.39,0,Ki,0,403,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,7.77,0,Ki,0,16.8,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS923,401,,,135650666,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,8691424,COc1ccc(c(c1)OC)c1oc2cc(OC)cc(c2c(=O)c1OC)OC
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MRS928,402,,,135650667,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8691424,COc1cc(OC)c2c(c1)oc(c(c2=O)OC)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,0,6.05,0,Ki,0,900,0,=,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,Ki,0,2500,0,=,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,preladenant,5614,,,178102248,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,18221214,COCCOc1ccc(cc1)N1CCN(CC1)CCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,5.77,0,Ki,0,1700,0,=,,,,12517430,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,6.09,0,Ki,0,805,0,=,,,,12139454,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,5.79,0,Ki,0,1640,0,=,,,,12517430,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,6.36,0,Ki,0,440,0,=,,,,12517430,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,PSB1115,3286,,,178100327,Antagonist,Antagonist,,f,,,pKi,0,5.66,0,Ki,0,2200,0,=,,,,8230124,CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PSB1115,3286,,,178100327,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,11906291,CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)O
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,9.9,0,Ki,0,0.124,0,=,,,,14563788,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,9.72,0,7.9,Ki,12.6,0,0.19,=,,,,9191953,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,9.14,0,8.1,Ki,8,0,0.72,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,sakuranetin,412,,,135652713,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,8691424,COc1cc2O[C@@H](CC(=O)c2c(c1)O)c1ccc(cc1)O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,SCH442416,3283,,,178100324,Antagonist,Antagonist,,f,,,pKi,0,5.95,0,Ki,0,1110,0,=,,,,16518376,COc1ccc(cc1)CCCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,SCH 58261,403,,,135651030,Antagonist,Antagonist,,f,,,pKi,6.3,0,6.1,-,0,0,0,=,,,,8300561,Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,ST-1535,5613,,,178102247,Antagonist,Antagonist,,f,,,pKi,0,7.14,0,Ki,0,71.8,0,=,,,,16250647,CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,cyclopentyladenosine,380,,,135650148,Agonist,Agonist,,f,,,pKi,0,6.02,0,Ki,0,950,0,=,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,GR79236,3288,,,178100329,Agonist,Agonist,,f,,,pKi,0,5.89,0,Ki,0,1300,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1CCC[C@@H]1O
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,GS9667,5593,,,178102228,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19012505,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N[C@@H]1CCC[C@H]1O)CSc1ccccc1F
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,HEMADO,5599,,,178102234,Agonist,Agonist,,f,,,pKi,0,5.92,0,Ki,0,1200,0,=,,,,12109910,CCCCC#Cc1nc(NC)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,5.63,0,Ki,0,2330,0,=,,,,16518376,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,5.97,0,Ki,0,1080,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>2A</sub> receptor,19,Adora2a,Q60613,,,,,,Mouse,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,4.98,0,Ki,0,10400,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>2A</sub> receptor,19,Adora2a,Q60613,,,,,,Mouse,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Agonist,,f,,,pKi,0,6.34,0,Ki,0,460,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,NECA,377,,,135650706,Agonist,Agonist,,f,f,,pKi,0,8.010000229,0,Ki,0,9.699999809,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,regadenoson,5596,,,178102231,Agonist,Agonist,,f,t,,pKi,0,6.539999962,0,Ki,0,290,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,(R)-PIA,414,,,135651557,Agonist,Agonist,,f,,,pKi,0,6.66,0,Ki,0,220,0,=,,,,8441759,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CV-1674,419,,,135650140,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9920286,OCC1OC(C(C1O)O)n1cnc2c1nc(nc2N)c1ccc(cc1)OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CV-1808,420,,,135650141,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9920286,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Nc1ccccc1)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,cyclopentyladenosine,380,,,135650148,Agonist,Full agonist,,f,,,pKi,0,6.1,0,-,0,0,0,=,,,,15476669,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,"(<i>R,S</i>)-PHPNECA",369,,,135650422,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@H]([C@H]1O)O)n1cnc2c1nc(C#CC(c1ccccc1)O)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,metrifudil,426,,,135650601,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9920286,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccccc1C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9920286,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,NECA,377,,,135650706,Agonist,Full agonist,,f,,,pKi,8.7,0,6.9,-,0,0,0,=,,,,15476669,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,PENECA,378,,,135650805,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#Cc1ccccc1)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,piclidenoson,422,,,135650362,Agonist,Full agonist,,f,,,pKi,6.3,0,5.6,-,0,0,0,=,,,,9459566,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,(R)-PIA,414,,,135651557,Agonist,Full agonist,,f,,,pKi,6.2,0,6,,0,0,0,,,,,15476669,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,(S)-PIA,415,,,135651063,Agonist,Full agonist,,f,,,pKi,5.1,0,5,,0,0,0,,,,,9459566,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H](Cc1ccccc1)C
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,CPFPX,5603,,,178102237,Antagonist,Antagonist,,f,,,pKi,0,6.09,0,Ki,0,812,0,=,,,,12408725,[18F]CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CPFPX,5603,,,178102237,Antagonist,Antagonist,,f,,,pKi,0,6.03,0,Ki,0,940,0,=,,,,12408725,[18F]CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CPX,427,,,135650137,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7775460,CCCn1c(=O)n(CCC)c2c(c1=O)[nH]cn2
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,CSC,5609,,,178102243,Antagonist,Antagonist,,f,,,pKi,0,7.27,0,Ki,0,54,0,=,,,,8496902,Clc1cccc(c1)/C=C/c1nc2c(n1C)c(=O)n(c(=O)n2C)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,CVT-6883,5615,,,178102249,Antagonist,Antagonist,,f,,,pKi,0,5.48,0,Ki,0,3280,0,=,,,,18321039,CCCn1c(=O)c2nc([nH]c2n(c1=O)CC)c1cnn(c1)Cc1cccc(c1)C(F)(F)F
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,Ki,0,398,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.6,-,0,0,0,=,,,,9459566,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.3,Ki,500,0,157,=,,,,12014951,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,FK-453,5606,,,178102240,Antagonist,Antagonist,,f,,,pKi,0,5.89,0,Ki,0,1300,0,=,,,,16518376,OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,flavone,409,,,135650265,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,O=c1cc(oc2c1cccc2)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,galangin,410,,,135650295,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8691424,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccccc1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,8.66,0,8.35,Ki,4.46,0,2.2,=,,,,18723354,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,7.92,0,7.04,Ki,91.2,0,12,=,,,,17300165,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,KF 17837S,428,,,135650455,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9179373,CCCn1c(=O)n(CCC)c(=O)c2c1nc(n2C)c1ccc(c(c1)OC)OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,KF26777,5618,,,178102252,Antagonist,Antagonist,,f,,,pKi,0,6.33,0,Ki,0,470,0,=,,,,12063073,CCCn1c2nc([nH]c2c2=NCCn2c1=O)c1ccc(cc1)Br
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,LAS38096,5617,,,178102251,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,17469811,n1ccc(nc1)c1cnc(nc1c1ccco1)Nc1cccnc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,LUF5981,5607,,,178102241,Antagonist,Antagonist,,f,,,pKi,0,6.71,0,Ki,0,194,0,=,,,,17300165,C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,morin,411,,,135650623,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,8691424,Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRE 2029F20,390,,,135650630,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,14998332,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRE 3008F20,459,,,135650631,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,-,0,0,0,=,,,,16219300,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1041,392,,,135650633,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,CCOc1cc(OCC)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1042,393,,,135650634,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,CCCOc1cc(OCCC)c2c(c1)oc(c(c2=O)OCCC)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1065,395,,,135650636,Antagonist,Antagonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,8691424,COc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1066,396,,,135650637,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,8691424,CCOc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1084,397,,,135650639,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,8691424,CCCOc1c2c(=O)cc(oc2cc2c1cco2)/C=C/c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1086,398,,,135650640,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,8691424,CCOc1ccc(c(c1)OCC)c1oc2cc(OCC)cc(c2c(=O)c1OCC)OCC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1088,429,,,135650641,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,8691424,Clc1ccc2c(c1)c(=O)c(c(o2)c1ccccc1)Cl
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1093,399,,,135650642,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8691424,CCOc1cc(O)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1132,400,,,135650644,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,8691424,O=c1c(Cl)c(oc2c1cccc2)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,5.44,0,Ki,0,3660,0,=,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,5.69,0,Ki,0,2050,0,=,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,Ki,0,503,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,6.21,0,Ki,0,612,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS923,401,,,135650666,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,8691424,COc1ccc(c(c1)OC)c1oc2cc(OC)cc(c2c(=O)c1OC)OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MRS928,402,,,135650667,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,8691424,COc1cc(OC)c2c(c1)oc(c(c2=O)OC)c1ccccc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,8.27,0,7.84,Ki,14.5,0,5.38,=,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,0,8.09,0,Ki,0,8.04,0,=,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,preladenant,5614,,,178102248,Antagonist,Antagonist,,f,,,pKi,0,9.05,0,Ki,0,0.9,0,=,,,,18221214,COCCOc1ccc(cc1)N1CCN(CC1)CCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,5.57,0,Ki,0,2700,0,=,,,,12517430,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,5.22,0,Ki,0,6040,0,=,,,,12139454,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,5.89,0,Ki,0,1280,0,=,,,,12517430,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,5.68,0,Ki,0,2100,0,=,,,,12517430,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,PSB1115,3286,,,178100327,Antagonist,Antagonist,,f,,,pKi,0,4.62,0,Ki,0,24000,0,=,,,,8230124,CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)O
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,6.26,0,Ki,0,552,0,=,,,,16902942,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,6.01,0,Ki,0,980,0,=,,,,16902942,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,6.97,0,6.2,Ki,637,0,108,=,,,,14532289,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,6.42,0,6.29,Ki,510,0,380,=,,,,9191953,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,sakuranetin,412,,,135652713,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,8691424,COc1cc2O[C@@H](CC(=O)c2c(c1)O)c1ccc(cc1)O
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,SCH442416,3283,,,178100324,Antagonist,Antagonist,,f,,,pKi,10.3,0,8.4,Ki,0,0,0,=,,,,11087559,COc1ccc(cc1)CCCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,SCH 58261,403,,,135651030,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.3,-,0,0,0,=,,,,9933143,Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,ST-1535,5613,,,178102247,Antagonist,Antagonist,,f,,,pKi,0,8.18,0,Ki,0,6.6,0,=,,,,16250647,CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,GS9667,5593,,,178102228,Agonist,Agonist,,f,,,pKi,0,4.3,0,Ki,0,50000,0,>,,,,19012505,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N[C@@H]1CCC[C@H]1O)CSc1ccccc1F
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,HEMADO,5599,,,178102234,Agonist,Agonist,,f,,,pKi,0,4.52,0,Ki,0,30000,0,>,,,,12109910,CCCCC#Cc1nc(NC)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Agonist,,f,,,pKi,0,3.8,0,Ki,0,160000,0,=,,,,6253037,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,NECA,377,,,135650706,Agonist,Agonist,,f,,,pKi,0,5.72,0,Ki,0,1900,0,=,,,,0,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,regadenoson,5596,,,178102231,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,(R)-PIA,414,,,135651557,Agonist,Agonist,,f,,,pKi,0,4.72,0,Ki,0,19000,0,=,,,,8135856,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,cyclopentyladenosine,380,,,135650148,Agonist,Full agonist,,f,,,pKi,4.7,0,4.5,-,0,0,0,=,,,,10496952,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,NECA,377,,,135650706,Agonist,Full agonist,,f,,,pKi,6.9,0,5.7,-,0,0,0,=,,,,16219300,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,piclidenoson,422,,,135650362,Agonist,Full agonist,,f,,,pKi,4.9,0,4.3,-,0,0,0,=,,,,10496952,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,(R)-PIA,414,,,135651557,Agonist,Full agonist,,f,,,pKi,5.5,0,3.8,-,0,0,0,=,,,,16219300,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,(S)-PIA,415,,,135651063,Agonist,Full agonist,,f,,,pKi,5.2,0,4.2,,0,0,0,,,,,16219300,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H](Cc1ccccc1)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CPX,427,,,135650137,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10496952,CCCn1c(=O)n(CCC)c2c(c1=O)[nH]cn2
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,CSC,5609,,,178102243,Antagonist,Antagonist,,f,,,pKi,0,5.09,0,Ki,0,8200,0,=,,,,0,Clc1cccc(c1)/C=C/c1nc2c(n1C)c(=O)n(c(=O)n2C)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,CVT-6883,5615,,,178102249,Antagonist,Antagonist,,f,,,pKi,0,7.66,0,Ki,0,22,0,=,,,,18321039,CCCn1c(=O)c2nc([nH]c2n(c1=O)CC)c1cnn(c1)Cc1cccc(c1)C(F)(F)F
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,DAX,444,,,135650162,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,11266650,C=CCn1c2nc([nH]c2c(=O)n(c1=O)CC=C)C1CCCCC1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,DEPX,445,,,135650169,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,10496952,CCn1c2nc([nH]c2c(=O)n(c1=O)CC)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,Ki,0,3981,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,Ki,0,501,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,7.3,0,6.9,-,0,0,0,=,,,,16020631,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,0,7.06,0,Ki,0,86.2,0,=,,,,19141710,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,6.73,0,6.7,Ki,200,0,186,=,,,,12014951,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,FK-453,5606,,,178102240,Antagonist,Antagonist,,f,,,pKi,0,6.01,0,Ki,0,980,0,=,,,,16518376,OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,I-ABOPX,446,,,135650361,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10496952,CCCn1c(=O)c2[nH]c(nc2n(c1=O)Cc1ccc(c(c1)I)N)c1ccc(cc1)OCC(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,21303899,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,KF26777,5618,,,178102252,Antagonist,Antagonist,,f,,,pKi,0,6.21,0,Ki,0,620,0,=,,,,12063073,CCCn1c2nc([nH]c2c2=NCCn2c1=O)c1ccc(cc1)Br
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,LAS38096,5617,,,178102251,Antagonist,Antagonist,,f,,,pKi,0,7.77,0,Ki,0,17,0,=,,,,17469811,n1ccc(nc1)c1cnc(nc1c1ccco1)Nc1cccnc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,LUF5981,5607,,,178102241,Antagonist,Antagonist,,f,,,pKi,0,6.52,0,Ki,0,300,0,>,,,,14663020,C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRE 2029F20,390,,,135650630,Antagonist,Antagonist,,f,,,pKi,8.5,0,8.26,-,0,0,0,=,,,,16219300,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRE 3008F20,459,,,135650631,Antagonist,Antagonist,,f,,,pKi,5.8,0,5.7,-,0,0,0,=,,,,16219300,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRS1220,448,,,135650648,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,15194002,O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>2B</sub> receptor,20,,,,,,,,Unknown,MRS1706,3287,,,178100328,Antagonist,Antagonist,,f,,,pKi,0,8.86,0,-,0,0,0,=,,,,10737749,CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,8.47,0,Ki,0,3.39,0,=,,,,19141710,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2B</sub> receptor,20,Adora2b,P29276,,,,,,Rat,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,7.89,0,7.78,Ki,16.6,0,12.8,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,11266650,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,5.54,0,5,Ki,10000,0,2900,=,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,OSIP339391,450,,,135650781,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,15194002,CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,pentoxifylline,7095,,,178103673,Antagonist,Antagonist,,f,f,,pKi,0,5.289999962,0,Ki,0,5180,0,=,,,,12014951,CC(=O)CCCCn1c(=O)c2n(C)cnc2n(c1=O)C
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,preladenant,5614,,,178102248,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,18221214,COCCOc1ccc(cc1)N1CCN(CC1)CCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,PSB-0788,6561,,,178103175,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,-,0,0,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)Cc1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,5.68,0,Ki,0,2100,0,=,,,,12139454,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,5.68,0,Ki,0,2100,0,=,,,,12139454,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,PSB1115,3286,,,178100327,Antagonist,Antagonist,,f,,,pKi,0,7.27,0,Ki,0,53.4,0,=,,,,11906291,CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,6.73,0,Ki,0,187,0,=,,,,16458010,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKd,0,9.39,0,Kd,0,0.403,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKd,0,9.45,0,Kd,0,0.351,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,9.26,0,Ki,0,0.553,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,0,6.53,0,Ki,0,296,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,SCH442416,3283,,,178100324,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,COc1ccc(cc1)CCCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,SCH 58261,403,,,135651030,Antagonist,Antagonist,,f,,,pKi,6.5,0,6,-,0,0,0,=,,,,11093773,Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,ST-1535,5613,,,178102247,Antagonist,Antagonist,,f,,,pKi,0,6.45,0,Ki,0,352.3,0,=,,,,16250647,CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,"CP608,039",5598,,,178102233,Agonist,Agonist,,f,,,pKi,0,8.24,0,Ki,0,5.8,0,=,,,,12919933,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1N)O)n1cnc2c1ncnc2NCc1cc(Cl)ccc1COc1onc(c1)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,GS9667,5593,,,178102228,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,19012505,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N[C@@H]1CCC[C@H]1O)CSc1ccccc1F
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,HEMADO,5599,,,178102234,Agonist,Agonist,,f,,,pKi,0,8.96,0,Ki,0,1.1,0,=,,,,12109910,CCCCC#Cc1nc(NC)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,9.54,0,Ki,0,0.29,0,=,,,,16518376,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>3</sub> receptor,21,Adora3,Q61618,,,,,,Mouse,MRS3558,5601,,,178102236,Agonist,Agonist,,f,,,pKi,0,8.83,0,Ki,0,1.49,0,=,,,,0,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NCc1cccc(c1)Cl
A<sub>3</sub> receptor,21,Adora3,Q61618,,,,,,Mouse,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,7.61,0,Ki,0,24.4,0,=,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS5151,5622,,,178102256,Agonist,Agonist,,f,,,pKi,0,8.62,0,Ki,0,2.38,0,=,,,,18424135,CNC(=O)[C@]12C[C@@H]2[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1C#CCCCC(=O)O)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS5698,8421,,,252166631,Agonist,Agonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,22559880,CNC(=O)[C@@]12C[C@@H]1[C@H]([C@@H]([C@@H]2O)O)n1cnc2c1nc(C#Cc1ccc(c(c1)F)F)nc2NCc1cccc(c1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Agonist,,f,,,pKi,0,5.99,0,Ki,0,1025,0,=,,,,8617970,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,N(6)-cyclohexyladenosine,423,,,135650675,Agonist,Agonist,,f,,,pKi,0,6.75,0,Ki,0,176,0,=,,,,8022403,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,regadenoson,5596,,,178102231,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,cyclopentyladenosine,380,,,135650148,Agonist,Full agonist,,f,,,pKi,7.4,0,7,-,0,0,0,=,,,,8234299,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,I-ABA,458,,,135650360,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8234299,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(c(c1)I)N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,"(<i>R,S</i>)-PHPNECA",369,,,135650422,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@H]([C@H]1O)O)n1cnc2c1nc(C#CC(c1ccccc1)O)nc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MPC-MECA,460,,,135650626,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10779381,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(cc1)OC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRE 3008F20,459,,,135650631,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,10779381,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,NECA,377,,,135650706,Agonist,Full agonist,,f,,,pKi,6.9,0,6.6,-,0,0,0,=,,,,7929142,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,NECA,377,,,135650706,Agonist,Full agonist,,f,,,pKi,8.4,0,7.5,-,0,0,0,=,,,,8234299,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PENECA,378,,,135650805,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12109910,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#Cc1ccccc1)nc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,piclidenoson,422,,,135650362,Agonist,Full agonist,,f,,,pKi,9.2,0,8.7,-,0,0,0,=,,,,9459566,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,(R)-PIA,414,,,135651557,Agonist,Full agonist,,f,,,pKi,8.1,0,7.1,-,0,0,0,=,,,,8234299,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,(R)-PIA,414,,,135651557,Agonist,Full agonist,,f,,,pKi,6.8,0,6.6,-,0,0,0,=,,,,7929142,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,(S)-PIA,415,,,135651063,Agonist,Full agonist,,f,,,pKi,7.4,0,6.3,,0,0,0,,,,,8234299,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H](Cc1ccccc1)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,LUF6000,9446,,,329968386,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,16722654,Clc1ccc(cc1Cl)Nc1nc2ccccc2c2c1[nH]c(n2)C1CCCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,LUF6096,9447,,,329968387,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,19161279,O=C(C1CCCCC1)Nc1cc(Nc2ccc(c(c2)Cl)Cl)nc2c1cccc2
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,CSC,5609,,,178102243,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,8022403,Clc1cccc(c1)/C=C/c1nc2c(n1C)c(=O)n(c(=O)n2C)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,CVT-6883,5615,,,178102249,Antagonist,Antagonist,,f,,,pKi,0,5.97,0,Ki,0,1070,0,=,,,,18321039,CCCn1c(=O)c2nc([nH]c2n(c1=O)CC)c1cnn(c1)Cc1cccc(c1)C(F)(F)F
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,derenofylline,3281,,,178100322,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,Ki,0,200,0,=,,,,17558436,O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,dexniguldipine,463,,,135650907,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8709132,COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,7.6,0,4.37,Ki,0,0,0,=,,,,7929142,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,DPCPX,386,,,135650209,Antagonist,Antagonist,,f,,,pKi,6.61,0,5.4,Ki,3960,0,243,=,,,,8234299,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,FK-453,5606,,,178102240,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,=,,,,16518376,OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,flavanone,408,,,135650264,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,8691424,O=C1CC(Oc2c1cccc2)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,flavone,409,,,135650265,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,8691424,O=c1cc(oc2c1cccc2)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,galangin,410,,,135650295,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,I-ABOPX,446,,,135650361,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8234299,CCCn1c(=O)c2[nH]c(nc2n(c1=O)Cc1ccc(c(c1)I)N)c1ccc(cc1)OCC(=O)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,istradefylline,5608,,,178102242,Antagonist,Antagonist,,f,,,pKi,0,5.35,0,Ki,0,4470,0,=,,,,21303899,COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,KF26777,5618,,,178102252,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,Ki,0,0.2,0,=,,,,12063073,CCCn1c2nc([nH]c2c2=NCCn2c1=O)c1ccc(cc1)Br
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,LAS38096,5617,,,178102251,Antagonist,Antagonist,,f,,,pKi,0,5.98,0,Ki,0,1043,0,=,,,,17469811,n1ccc(nc1)c1cnc(nc1c1ccco1)Nc1cccnc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,LUF5981,5607,,,178102241,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,Ki,0,637,0,=,,,,17300165,C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRE 2029F20,390,,,135650630,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,14998332,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRE 3008F20,459,,,135650631,Antagonist,Antagonist,,f,,,pKi,9.5,0,9,-,0,0,0,=,,,,16219300,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRE 3010F20,465,,,135650632,Antagonist,Antagonist,,f,f,,pKi,0,9.300000191,0,-,0,0,0,=,,,,10779381,CCCn1cc2c(n1)N=C(C1C2=NC(=N1)C1CCCO1)NC(=O)Nc1cccc(c1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1041,392,,,135650633,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8691424,CCOc1cc(OCC)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1042,393,,,135650634,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8691424,CCCOc1cc(OCCC)c2c(c1)oc(c(c2=O)OCCC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1067,466,,,135650638,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8691424,CC(Oc1cc(C)ccc1c1oc2ccc(cc2c(=O)c1Cl)Cl)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1088,429,,,135650641,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8691424,Clc1ccc2c(c1)c(=O)c(c(o2)c1ccccc1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1093,399,,,135650642,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8691424,CCOc1cc(O)c2c(c1)oc(c(c2=O)OCC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1097,467,,,135650643,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9364471,CCOC(=O)C1=C(C)NC(=C(C1/C=C/c1ccccc1)C(=O)OCC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1177,468,,,135650645,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8863790,Clc1ccc2c(c1)c1nc(nn1c(n2)NC(=O)c1ccccc1)c1ccco1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1186,469,,,135650646,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8863790,CCC(=O)Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,9364471,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,MRS1191,470,,,135650647,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,-,0,0,0,=,,,,9703464,CCOC(=O)C1=C(C)NC(=C(C1C#Cc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1220,448,,,135650648,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,8.199999809,Ki,6.309999943,0,0.629999995,=,,,,9364471,O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1476,471,,,135650649,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,-,0,0,0,=,,,,9703464,CCOC(=O)c1c(nc(c(c1CC)C(=O)SCC)CC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1486,472,,,135650650,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9703464,CCOC(=O)c1c(CC)c(C(=O)SCC)c(nc1c1ccccc1)CCC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1505,473,,,135650651,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9703464,CCCOC(=O)c1c(nc(c(c1CC)C(=O)SCCC)CC)c1cccc(c1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,f,,pKi,0,7.699999809,0,Ki,0,19.89999962,0,=,,,,9703464,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,6.95,0,Ki,0,113,0,=,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>3</sub> receptor,21,Adora3,Q61618,,,,,,Mouse,MRS1523,474,,,135650652,Antagonist,Antagonist,,f,,,pKi,0,6.14,0,Ki,0,731,0,=,,,,0,CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS1754,449,,,135650653,Antagonist,Antagonist,,f,,,pKi,0,6.24,0,Ki,0,570,0,=,,,,10737749,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MRS928,402,,,135650667,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8691424,COc1cc(OC)c2c(c1)oc(c(c2=O)OC)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,MSX-2,5610,,,178102244,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,10669571,OCCCn1c(=O)n(CC#C)c(=O)c2c1nc(n2C)/C=C/c1cccc(c1)OC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,nicardipine,2559,,,135650714,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8709132,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,preladenant,5614,,,178102248,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,18221214,COCCOc1ccc(cc1)N1CCN(CC1)CCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB-10,5619,,,178102253,Antagonist,Antagonist,,f,,,pKi,0,9.36,0,Ki,0,0.441,0,=,,,,12139454,CC[C@H]1N=c2n(C1)c(=O)n(c1c2[nH]c(n1)c1cc(Cl)cc(c1Cl)Cl)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKd,0,8.31,0,Kd,0,4.9,0,=,,,,11814828,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB-11,5620,,,178102254,Antagonist,Antagonist,,f,,,pKi,0,8.63,0,Ki,0,2.34,0,=,,,,12517430,CC[C@@H]1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB1115,3286,,,178100327,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,11906291,CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,5.64,0,Ki,0,2300,0,=,,,,16902942,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,PSB36,3285,,,178100326,Antagonist,Antagonist,,f,,,pKi,0,5.19,0,Ki,0,6500,0,=,,,,16902942,OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,PSB603,3284,,,178100325,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,rolofylline,5604,,,178102238,Antagonist,Antagonist,,f,,,pKi,0,5.36,0,Ki,0,4390,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,sakuranetin,412,,,135652713,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,8691424,COc1cc2O[C@@H](CC(=O)c2c(c1)O)c1ccc(cc1)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,SCH442416,3283,,,178100324,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16518376,COc1ccc(cc1)CCCn1ncc2c1nc(N)n1c2nc(n1)c1ccco1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,SCH 58261,403,,,135651030,Antagonist,Antagonist,,f,,,pKi,0,5.92,0,Ki,0,1200,0,=,,,,16518376,Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,ST-1535,5613,,,178102247,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,16250647,CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1
ATM serine/threonine kinase,1934,ATM,Q13315,,,,,,Human,CP466722,9359,,,328083461,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,18794134,COc1cc2c(cc1OC)ncnc2n1nc(nc1N)c1ccccn1
ATM serine/threonine kinase,1934,ATM,Q13315,,,,,,Human,KU-55933,5928,,,178102551,Inhibitor,Inhibition,,f,t,,pKi,0,8.659999847,0,Ki,0,2.200000048,0,=,,,,15604286,O=c1cc(oc(c1)c1cccc2c1Sc1ccccc1S2)N1CCOCC1
ATM serine/threonine kinase,1934,ATM,Q13315,,,,,,Human,KU-55933,5928,,,178102551,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,15604286,O=c1cc(oc(c1)c1cccc2c1Sc1ccccc1S2)N1CCOCC1
ATM serine/threonine kinase,1934,ATM,Q13315,,,,,,Human,KU-60019,8041,,,249565721,Inhibitor,Inhibition,,f,t,,pIC50,0,8.199999809,0,IC50,0,6.300000191,0,=,,,,19808981,O=C(Nc1ccc2c(c1)Cc1c(S2)c(ccc1)c1cc(=O)cc(o1)N1CCOCC1)CN1C[C@H](C)O[C@@H](C1)C
ATP4A,849,ATP4A,P20648,,,,,,Human,esomeprazole,5488,,,178102135,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc2c(c1)[nH]c(n2)[S@@](=O)Cc1ncc(c(c1C)OC)C
ATP4A,849,ATP4A,P20648,,,,,,Human,omeprazole,4279,,,178101096,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc2c(c1)nc([nH]2)S(=O)Cc1ncc(c(c1C)OC)C
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,GSK8814,9521,,,336446907,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50.09999847,0,=,By TR-FRET assay.,,,27530368,CO[C@H]1CNC[C@H]([C@@H]1Nc1ncc(c2c1[nH]c(=O)c(c2)C)c1cncc(c1)C)OCC1CCC(CC1)(F)F
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,GSK8814,9521,,,336446907,Inhibitor,Inhibition,,f,t,,pKd,0,8.100000381,0,Kd,0,8,0,=,By isothermal titration calorimetry (ICT) assay.,,,27530368,CO[C@H]1CNC[C@H]([C@@H]1Nc1ncc(c2c1[nH]c(=O)c(c2)C)c1cncc(c1)C)OCC1CCC(CC1)(F)F
"ATPase family, AAA domain containing 2",2719,ATAD2,Q6PL18,,,,,,Human,GSK8814,9521,,,336446907,Inhibitor,Inhibition,,f,t,,pKi,0,8.899999619,0,Ki,0,1.25,0,=,By <i>Bromosphere</i> assay using full length endogenous protein.,,,27530368,CO[C@H]1CNC[C@H]([C@@H]1Nc1ncc(c2c1[nH]c(=O)c(c2)C)c1cncc(c1)C)OCC1CCC(CC1)(F)F
"ATPase family, AAA domain containing 2B",2720,ATAD2B,Q9ULI0,,,,,,Human,GSK8814,9521,,,336446907,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,19.89999962,0,=,By TR-FRET assay.,,,27530368,CO[C@H]1CNC[C@H]([C@@H]1Nc1ncc(c2c1[nH]c(=O)c(c2)C)c1cncc(c1)C)OCC1CCC(CC1)(F)F
"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",2594,ABCC8,Q09428,,,,,,Human,repaglinide,6841,,,178103447,Inhibitor,Inhibition,,f,t,,pIC50,0,6.96999979,0,IC50,0,106,0,=,,,,15380228,CCOc1cc(ccc1C(=O)O)CC(=O)N[C@H](c1ccccc1N1CCCCC1)CC(C)C
ATR serine/threonine kinase,1935,ATR,Q13535,,,,,,Human,dactolisib,7950,,,249565633,Inhibitor,Inhibition,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,21552262,N#CC(c1ccc(cc1)n1c(=O)n(c2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2)C)(C)C
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"L-162,313",3936,,,178100764,Agonist,Full agonist,,f,,,pIC50,7.92,0,7.85,IC50,14.2,0,11.9,=,,,,7829475,CCCCOC(=O)NS(=O)(=O)c1sc(cc1c1ccc(cc1)Cn1c(CC)nc2c1nc(C)cc2C)CC(C)C
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"L-163,101",6895,,,178103477,Agonist,Partial agonist,,f,,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,9383393,CCc1nc2c(n1Cc1ccc(cc1)c1cc(ccc1S(=O)(=O)NC(=O)c1ccccc1)CC(C)C)nc(cc2C)C
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,"[Sar<sup>1</sup>,Cha<sup>4</sup>]Ang-II",6903,,,178103485,Agonist,Partial agonist,,f,,,pKd,0,7.119999886,0,Kd,0,75.90000153,0,=,,,,11901215,
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,"[Sar<sup>1</sup>,Cha<sup>8</sup>]Ang-II",6904,,,178103486,Agonist,Partial agonist,,f,,,pKd,0,9.329999924,0,Kd,0,0.469999999,0,=,,,,11901215,
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,"[Sar<sup>1</sup>,Ile<sup>8</sup>]Ang-II",6905,,,178103487,Agonist,Partial agonist,,f,,,pEC50,0,8.819999695,0,EC50,0,1.5,0,=,,,,7499361,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,eprosartan,588,,,135650236,Antagonist,Antagonist,,f,t,,pIC50,8.800000191,0,8.399999619,IC50,3.980000019,0,1.580000043,=,,,,1309870,CCCCc1ncc(n1Cc1ccc(cc1)C(=O)O)/C=C(/C(=O)O)Cc1cccs1
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,EXP3174,586,,,135650248,Antagonist,Antagonist,,f,f,,pIC50,9.489999771,0,7.400000095,IC50,39.79999924,0,0.319999993,=,,,,10193788,CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)C(=O)O)Cl
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,forasartan,6896,,,178103478,Antagonist,Antagonist,,f,,,pIC50,8.600000381,0,8.199999809,IC50,6.900000095,0,2.799999952,=,,,,7505365,CCCCc1nc(nn1Cc1ccc(nc1)c1ccccc1c1n[nH]nn1)CCCC
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,irbesartan,589,,,135650414,Antagonist,Antagonist,,f,t,,pIC50,8.800000191,0,8.699999809,IC50,1.99000001,0,1.580000043,=,,,,10193788,CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,losartan,590,,,135650532,Antagonist,Antagonist,,f,t,,pIC50,8.699999809,0,7.400000095,IC50,39.79999924,0,1.99000001,=,,,,8372104,CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,LY301875,6909,,,178103491,Antagonist,Antagonist,,f,,,pIC50,0,8.229999542,0,-,0,0,0,=,,,,11303957,CCCCCC[C@@H](C(=O)N1C[C@H](C[C@H]1C(=O)O)Oc1ccc(cc1)C(=O)O)n1cnc(c1)NC(=O)c1ccccc1S(=O)(=O)O
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,LY303336,6910,,,178103492,Antagonist,Antagonist,,f,,,pIC50,0,8.279999733,0,-,0,0,0,=,,,,11303957,CCCCCC[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)O)Oc1ccc(cc1)C(=O)O)n1cnc(c1)NC(=O)c1ccccc1S(=O)(=O)O
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"N,N`-bis-alkyl butylimmidazole 12b",6911,,,178103493,Antagonist,Antagonist,,f,,,pIC50,0,8.069999695,0,IC50,0,8.5,0,=,,,,23376252,CCCCc1n([c+]nc1Cc1ccc(cc1)c1ccccc1c1nnn(n1)[Na])Cc1ccc(cc1)c1ccccc1c1nnn(n1)[Na].[Br-]
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,olmesartan,591,,,135650757,Antagonist,Antagonist,,f,t,,pIC50,0,8.100000381,0,-,0,0,0,=,,,,11451212,CCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)C(=O)OCc1oc(=O)oc1C)C(O)(C)C
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,saprisartan,6899,,,178103481,Antagonist,Antagonist,,f,f,,pKi,0,9.100000381,0,-,0,0,0,=,,,,7853190,CCc1nc(c(n1Cc1ccc2c(c1)c(Br)c(o2)c1ccccc1NS(=O)(=O)C(F)(F)F)C(=O)N)C1CC1
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"[Sar<sup>1</sup>,Ala<sup>8</sup>]Ang-II",6915,,,178103497,Antagonist,Antagonist,,f,,,pKd,0,9.050000191,0,Kd,0,0.899999976,0,=,,,,11901215,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"[Sar<sup>1</sup>,Gly<sup>4</sup>,Gly<sup>8</sup>]Ang-II",6916,,,178103498,Antagonist,Antagonist,,f,,,pKd,0,6.510000229,0,Kd,0,310,0,=,,,,11901215,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"[Sar<sup>1</sup>,Ile<sup>4</sup>,Ile<sup>8</sup>]Ang-II",6914,,,178103496,Antagonist,Antagonist,,f,,,pKd,0,6.510000229,0,Kd,0,310,0,=,,,,12949261,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,"[Sar<sup>1</sup>,Ile<sup>8</sup>]Ang-II",6905,,,178103487,Antagonist,Antagonist,,f,,,pKd,0,9.430000305,0,Kd,0,0.370000005,0,=,,,,11901215,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,sparsentan,8448,,,252166658,Antagonist,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,16220969,CCCCC1=NC2(C(=O)N1Cc1ccc(c(c1)COCC)c1ccccc1S(=O)(=O)Nc1noc(c1C)C)CCCC2
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,novokinin,6893,,,178103475,Agonist,Agonist,,f,,,pKi,0,8.130000114,0,Ki,0,7.349999905,0,=,,,,18207609,
AT<sub>2</sub> receptor,35,Agtr2,P35351,,,,,,Rat,[p-aminoPhe6]ang II,595,,,135652377,Agonist,Full agonist,,f,f,,pKd,9.409999847,0,9.100000381,Kd,0.790000021,0,0.389999986,=,,,,2194459,
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,EMA401,8374,,,252166586,Antagonist,Antagonist,,f,t,,pIC50,9.300000191,0,8.5,IC50,0,0,0,=,,,,24507377,COc1ccc2c(c1OCc1ccccc1)C[C@H](N(C2)C(=O)C(c1ccccc1)c1ccccc1)C(=O)O
AT<sub>2</sub> receptor,35,Agtr2,P35351,,,,,,Rat,PD123177,596,,,135650791,Antagonist,Antagonist,,f,f,,pIC50,9.489999771,0,8.5,IC50,3.160000086,0,0.319999993,=,,,,2590220,OC(=O)C1Cc2c(CN1C(=O)C(c1ccccc1)c1ccccc1)ncn2Cc1ccc(c(c1)C)N
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,PD123319,597,,,135650792,Antagonist,Antagonist,,f,f,,pKd,9.199999809,0,8.699999809,Kd,1.99000001,0,0.629999995,=,,,,2402226,OC(=O)[C@@H]1Cc2c(CN1C(=O)C(c1ccccc1)c1ccccc1)ncn2Cc1ccc(c(c1)C)N(C)C
AT<sub>2</sub> receptor,35,Agtr2,P35351,,,,,,Rat,saralasin,598,,,135652450,Antagonist,Antagonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,2590220,CNCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)O)C)Cc1[nH]cnc1)C(C)C)Cc1ccc(cc1)O)C(C)C)CCCN=C(N)N
aurora kinase A,1936,AURKA,O14965,,,,,,Human,danusertib,7937,,,249565620,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,17125279,CO[C@@H](C(=O)N1Cc2c(C1)[nH]nc2NC(=O)c1ccc(cc1)N1CCN(CC1)C)c1ccccc1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,GSK1070916,8358,,,252166570,Inhibitor,Inhibition,,f,f,,pKi,0,6.309999943,0,Ki,0,490,0,=,,,,20420387,CCn1nc(c(c1)c1ccnc2c1cc([nH]2)c1cccc(c1)CN(C)C)c1ccc(cc1)NC(=O)N(C)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,GSK143,9388,,,328083490,Inhibitor,Inhibition,,f,f,,pIC50,0,8.319999695,0,IC50,0,4.800000191,0,=,Enzyme inhibition assay using recombinant human protein,,,21903390,N[C@@H]1COCC[C@@H]1Nc1ncc(c(n1)Nc1ccc(cc1)C)C(=O)N
aurora kinase A,1936,AURKA,O14965,,,,,,Human,GSK2334470,8008,,,249565688,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,21341675,CNc1nc(cc(n1)c1ccc2c(c1)[nH]nc2N)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,GSK-3 inhibitor XIII,5976,,,178102599,Inhibitor,Inhibition,,f,f,,pKi,0,7.239999771,0,Ki,0,58,0,=,,,,19447622,Cc1[nH]nc(c1)Nc1nc(nc2c1cccc2)c1ccccc1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,KW-2449,5691,,,178102318,Inhibitor,Inhibition,,f,f,,pIC50,0,7.320000172,0,IC50,0,48,0,=,,,,19541823,O=C(c1ccc(cc1)/C=C/c1[nH]nc2c1cccc2)N1CCNCC1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,MK-5108,8061,,,249565741,Inhibitor,Inhibition,,f,t,,pIC50,0,10.18999958,0,IC50,0,0.064000003,0,=,,,,20053775,OC(=O)C1(CCC(CC1)Oc1cccc(c1F)Cl)Cc1cccc(n1)Nc1nccs1
aurora kinase A,1936,AURKA,O14965,,,,,,Human,MLN-8054,5696,,,178102323,Inhibitor,Inhibition,,f,t,,pIC50,9,0,8.399999619,IC50,4,0,1,=,,,,17360485,Clc1ccc2c(c1)C(=NCc1c2nc(nc1)Nc1ccc(cc1)C(=O)O)c1c(F)cccc1F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,MLN-8054,5696,,,178102323,Inhibitor,Inhibition,,f,t,,pKd,0,8.18999958,0,Kd,0,6.5,0,=,,,,22037378,Clc1ccc2c(c1)C(=NCc1c2nc(nc1)Nc1ccc(cc1)C(=O)O)c1c(F)cccc1F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,PF-562271,9381,,,328083483,Inhibitor,Inhibition,,f,f,,pIC50,0,6.840000153,0,IC50,0,145,0,=,,,,18339875,O=C1Nc2c(C1)cc(cc2)Nc1ncc(c(n1)NCc1cccnc1N(S(=O)(=O)C)C)C(F)(F)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,Rho kinase inhibitor IV,6033,,,178102655,Inhibitor,Inhibition,,f,f,,pIC50,0,5.630000114,0,IC50,0,2350,0,=,,,,16213195,NCC(=O)N1CCCN([C@H](C1)C)S(=O)(=O)c1cccc2c1c(C)cnc2
aurora kinase A,1936,AURKA,O14965,,,,,,Human,SNS-314,9397,,,328083499,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,18678489,O=C(Nc1ncc(s1)CCNc1ncnc2c1scc2)Nc1cccc(c1)Cl
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,danusertib,7937,,,249565620,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,17125279,CO[C@@H](C(=O)N1Cc2c(C1)[nH]nc2NC(=O)c1ccc(cc1)N1CCN(CC1)C)c1ccccc1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,GSK1070916,8358,,,252166570,Inhibitor,Inhibition,,f,t,,pKi,0,9.420000076,0,Ki,0,0.379999995,0,=,,,,20420387,CCn1nc(c(c1)c1ccnc2c1cc([nH]2)c1cccc(c1)CN(C)C)c1ccc(cc1)NC(=O)N(C)C
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,GSK2334470,8008,,,249565688,Inhibitor,Inhibition,,f,f,,pIC50,0,5.5,0,IC50,0,3160,0,=,,,,21341675,CNc1nc(cc(n1)c1ccc2c(c1)[nH]nc2N)N1C[C@H](CC[C@H]1C)C(=O)NC1CCCCC1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,hesperadin,8354,,,252166566,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,12707311,CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(c1ccccc1)/Nc1ccc(cc1)CN1CCCCC1)/C(=O)N2
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,KW-2449,5691,,,178102318,Inhibitor,Inhibition,,f,f,,pIC50,0,7.320000172,0,IC50,0,48,0,=,,,,19541823,O=C(c1ccc(cc1)/C=C/c1[nH]nc2c1cccc2)N1CCNCC1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,MK-5108,8061,,,249565741,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14.10000038,0,=,,,,20053775,OC(=O)C1(CCC(CC1)Oc1cccc(c1F)Cl)Cc1cccc(n1)Nc1nccs1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,MLN-8054,5696,,,178102323,Inhibitor,Inhibition,,f,f,,pIC50,0,8.029999733,0,IC50,0,9.300000191,0,=,,,,19402633,Clc1ccc2c(c1)C(=NCc1c2nc(nc1)Nc1ccc(cc1)C(=O)O)c1c(F)cccc1F
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,SNS-314,9397,,,328083499,Inhibitor,Inhibition,,f,t,,pIC50,0,7.510000229,0,IC50,0,31,0,=,,,,18678489,O=C(Nc1ncc(s1)CCNc1ncnc2c1scc2)Nc1cccc(c1)Cl
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,danusertib,7937,,,249565620,Inhibitor,Inhibition,,f,t,,pIC50,0,7.210000038,0,IC50,0,61,0,=,,,,17125279,CO[C@@H](C(=O)N1Cc2c(C1)[nH]nc2NC(=O)c1ccc(cc1)N1CCN(CC1)C)c1ccccc1
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,GSK1070916,8358,,,252166570,Inhibitor,Inhibition,,f,t,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,20420387,CCn1nc(c(c1)c1ccnc2c1cc([nH]2)c1cccc(c1)CN(C)C)c1ccc(cc1)NC(=O)N(C)C
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,MK-5108,8061,,,249565741,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12.10000038,0,=,,,,20053775,OC(=O)C1(CCC(CC1)Oc1cccc(c1F)Cl)Cc1cccc(n1)Nc1nccs1
autotaxin,2901,ENPP2,Q13822,,,,,,Human,example 1.11 [WO2014139978],9143,,,315661228,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,0,O=C(N1C[C@H]2[C@H](C1)CN(C2)C(=O)c1ccc(c(c1)F)S(=O)(=O)N)OCc1ccc(cc1)OC(F)(F)F
autotaxin,2901,ENPP2,Q13822,,,,,,Human,example 2 [WO2013054185],9144,,,315661229,Inhibitor,Inhibition,,f,f,,pIC50,0,8.590000153,0,IC50,0,2.589999914,0,=,,,,0,Fc1ccc(cc1)CC1=NN=CC2C1CN(CC2)C(=O)CCc1nc2c(s1)cccc2
autotaxin,2901,Enpp2,Q64610,,,,,,Rat,example 31 (24) [WO2012005227],9762,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,Evaluated in an <i>in vitro</i> biochemical ATX assay.,,,29197066,OC(=O)[C@@H]1CC[C@H](CC1)CC(=O)N1CCc2c(C1)n(Cc1ccc(cc1F)Cl)c1c2cccn1
autotaxin,2901,Enpp2,Q64610,,,,,,Rat,example 31 (24) [WO2012005227],9762,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,Evaluated in a rat whole blood assay.,,,29197066,OC(=O)[C@@H]1CC[C@H](CC1)CC(=O)N1CCc2c(C1)n(Cc1ccc(cc1F)Cl)c1c2cccn1
autotaxin,2901,ENPP2,Q13822,,,,,,Human,GLPG1690,9561,,,336446947,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,Inhibition of substrate (LPC) conversion to LPA.,,,28414242,CCc1nc2n(c1N(c1sc(c(n1)c1ccc(cc1)F)C#N)C)cc(cc2C)N1CCN(CC1)CC(=O)N1CC(C1)O
autotaxin,2901,ENPP2,Q13822,,,,,,Human,PF-8380,9142,,,315661227,Inhibitor,Inhibition,,f,f,,pIC50,8.770000458,0,8.550000191,IC50,2.799999952,0,1.700000048,=,Assessed using ATX&beta; isoform.,,,20392816,O=C(c1ccc2c(c1)oc(=O)[nH]2)CCN1CCNCC1
AXL receptor tyrosine kinase,1835,AXL,P30530,,,,,,Human,LDC1267,8247,,,249565927,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,24553136,CCOc1cn(nc1C(=O)Nc1ccc(c(c1)F)Oc1ccnc2c1cc(OC)c(c2)OC)c1ccc(cc1C)F
AXL receptor tyrosine kinase,1835,AXL,P30530,,,,,,Human,growth arrest specific protein 6,4935,GAS6,Human,178101633,None,None,,t,,,-,0,0,0,,0,0,0,,,,,8939948,
AXL receptor tyrosine kinase,1835,AXL,P30530,,,,,,Human,protein S,5050,PROS1,Human,178101745,None,None,,t,,,-,0,0,0,,0,0,0,,,,,7867073,
B7-H3 (CD276),2938,,,,,,,,Monkey,enoblituzumab,9589,,,340590220,Antibody,Binding,,f,f,,pKd,0,7.650000095,0,Kd,0,22.5,0,=,By surface plasmon resonance (SPR) assay.,,,22615450,
B7-H3 (CD276),2938,CD276,Q5ZPR3,,,,,,Human,enoblituzumab,9589,,,340590220,Antibody,Binding,,f,t,,pKd,0,7.610000134,0,Kd,0,24.5,0,=,By surface plasmon resonance (SPR) assay,,,22615450,
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,GDC-0152,7733,,,223366066,Antagonist,Antagonist,,f,t,,pKi,0,7.769999981,0,Ki,0,17,0,=,BIR3 domain of hcIAP1 (BIRC2),,,22413863,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1c1ccccc1)C1CCCCC1)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,SM-337,7732,,,223366065,Antagonist,Antagonist,,f,t,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,Fluorescence polarization assay using hcIAP-1 BIR3 domain (residues 253-363),,,19049347,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)Cc1ccccc1)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,LCL161,7912,,,249565595,Inhibitor,Inhibition,,f,t,,pIC50,0,7.239999771,0,IC50,0,58,0,=,Assay uses recombinantly expressed BIR3 domain of cIAP1,,,24083782,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1c1scc(n1)C(=O)c1ccc(cc1)F)C1CCCCC1)C
baculoviral IAP repeat containing 2,2791,BIRC2,Q13490,,,,,,Human,SM-122,8855,,,252827512,Inhibitor,Inhibition,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,19049347,CN[C@H](C(=O)N[C@H]1CCCC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C
baculoviral IAP repeat containing 3,2792,BIRC3,Q13489,,,,,,Human,GDC-0152,7733,,,223366066,Antagonist,Antagonist,,f,t,,pKi,0,7.369999886,0,Ki,0,43,0,=,BIR3 domain of hcIPA2 (BIRC3),,,22413863,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1c1ccccc1)C1CCCCC1)C
baculoviral IAP repeat containing 3,2792,BIRC3,Q13489,,,,,,Human,SM-337,7732,,,223366065,Antagonist,Antagonist,,f,t,,pKi,0,8.380000114,0,Ki,0,4.199999809,0,=,Fluorescence polarization assay using hcIAP2 BIR3 domain (residues 238-349),,,19049347,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)Cc1ccccc1)C
baculoviral IAP repeat containing 3,2792,BIRC3,Q13489,,,,,,Human,SM-122,8855,,,252827512,Inhibitor,Inhibition,,f,f,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,19049347,CN[C@H](C(=O)N[C@H]1CCCC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C
baculoviral IAP repeat containing 7,2794,BIRC7,Q96CA5,,,,,,Human,GDC-0152,7733,,,223366066,Antagonist,Antagonist,,f,t,,pKi,0,7.849999905,0,Ki,0,14,0,=,BIR domain of hML-IAP (BIRC7),,,22413863,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1c1ccccc1)C1CCCCC1)C
Basolateral Na-K-Cl symporter,969,SLC12A2,P55011,,,,,,Human,furosemide,4839,,,178101541,Inhibitor,Inhibition,,f,f,,pIC50,0,5.130000114,0,-,0,0,0,=,,,,11882915,OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N
Basolateral Na-K-Cl symporter,969,SLC12A2,P55011,,,,,,Human,piretanide,4742,,,178101453,Inhibitor,Inhibition,,f,f,,pIC50,0,5.619999886,0,-,0,0,0,=,,,,11882915,OC(=O)c1cc(N2CCCC2)c(c(c1)S(=O)(=O)N)Oc1ccccc1
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pKi,9.7,0,7.8,-,0,0,0,=,,,,10454496,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pIC50,9.68,0,9.49,IC50,0.32,0,0.21,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,gastrin-releasing peptide,612,GRP,Human,135651760,Agonist,Full agonist,,f,,,pKi,6.39,0,6.36,Ki,440,0,403,=,,,,10454496,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,gastrin releasing peptide(14-27) (human),6175,,,178102796,Agonist,Full agonist,,t,,,pIC50,6.91,0,6.83,IC50,148,0,123,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,gastrin releasing peptide(14-27) (human),6175,,,178102796,Agonist,Full agonist,,f,,,pIC50,0,6.64,0,IC50,0,230,0,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,9325344,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pIC50,6.53,0,6.51,IC50,309,0,295,=,,,,0,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pIC50,0,6.84,0,IC50,0,145,0,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,litorin,617,,,135652270,Agonist,Full agonist,,f,,,pKi,0,8.15,0,Ki,0,7,0,=,,,,9325344,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,MK-5046,6170,,,178102791,Agonist,Full agonist,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,23892571,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,neuromedin B,613,NMB|Nmb|Nmb|NMB,Human|Mouse|Pig|Rat,135651812,Agonist,Full agonist,,t,f,,pKi,10.30000019,0,8.100000381,Ki,7.900000095,0,0.050000001,=,,,,18055507,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,neuromedin B (1-30) (human),6163,,,178102784,Agonist,Full agonist,,f,,,pIC50,9.7,0,9.52,IC50,0.304,0,0.198,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,[Phe<sup>13</sup>]bombesin,615,,,135652393,Agonist,Full agonist,,f,,,pKi,8.22,0,6.46,Ki,350,0,6,=,,,,10454496,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pIC50,8.64,0,8.63,IC50,2.34,0,2.3,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pIC50,0,7.69,0,IC50,0,20.4,0,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pKi,0,7.33,0,Ki,0,47,0,=,,,,9325344,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,ranatensin,618,,,135652431,Agonist,Full agonist,,f,,,pKi,0,7.89,0,Ki,0,13,0,=,,,,9325344,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,ranatensin,618,,,135652431,Agonist,Full agonist,,f,,,pIC50,8.83,0,8.35,IC50,4.47,0,1.48,=,,,,21729729,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pIC50,9.75,0,9.59,IC50,0.26,0,0.178,=,,,,21729729,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pKi,0,6.34,0,Ki,0,460,0,=,,,,9325344,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pIC50,0,8.99,0,IC50,0,1.02,0,=,,,,21729729,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,f,,pIC50,6.559999943,0,6.21999979,IC50,605,0,275,=,,,,19463875,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,997,0,=,,,,7901752,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,f,,pKi,7.230000019,0,6.659999847,Ki,220,0,59,=,,,,10454496,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,"D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH<sub>2  </sub>",6172,,,178102793,Antagonist,Antagonist,,f,,,pIC50,6.33,0,6.2,IC50,630,0,468,=,,,,19463875,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,dNal-<i>cyc</i>(Cys-Tyr-dTrp-Orn-Val)-Nal-NH<sub>2</sub>,3871,,,178100708,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,"[D-Phe<sup>6</sup>, Leu<sup>13</sup>, Cpa<sup>14</sup>,&psi;13-14]bombesin-(6-14)",3840,,,178100682,Antagonist,Antagonist,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,19463875,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,JMV594,624,,,135652227,Antagonist,Antagonist,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,11463790,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,JMV641,3889,,,178100725,Antagonist,Antagonist,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,,,,11463790,
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,kuwanon H,622,,,135652700,Antagonist,Antagonist,,f,,,pKi,0,5.19,0,Ki,0,6500,0,=,,,,7646517,CC(=CCc1c(O)ccc(c1O)C(=O)[C@H]1[C@@H](CC(=C[C@@H]1c1c(O)cc(c2c1oc(c1ccc(cc1O)O)c(c2=O)CC=C(C)C)O)C)c1ccc(cc1O)O)C
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,PD 165929,620,,,135650801,Antagonist,Antagonist,,f,f,,pKd,0,8.199999809,0,Kd,0,6.309999943,0,=,,,,0,O=C(N[C@](C(=O)NCC1(CCCCC1)c1ccccn1)(Cc1c[nH]c2c1cccc2)C)Nc1c(cccc1C(C)C)C(C)C
BB<sub>1</sub> receptor,38,Nmbr,P24053,,,,,,Rat,PD 168368,621,,,135650803,Antagonist,Antagonist,,f,,,pIC50,7.41,0,7.35,IC50,45,0,39,=,,,,10454496,O=C(N[C@](C(=O)NCC1(CCCCC1)c1ccccn1)(Cc1c[nH]c2c1cccc2)C)Nc1ccc(cc1)[N+](=O)[O-]
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,PD 168368,621,,,135650803,Antagonist,Antagonist,,f,f,,pIC50,9.600000381,0,9.289999962,IC50,0.50999999,0,0.25,=,,,,19463875,O=C(N[C@](C(=O)NCC1(CCCCC1)c1ccccn1)(Cc1c[nH]c2c1cccc2)C)Nc1ccc(cc1)[N+](=O)[O-]
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,PD 176252,626,,,135650804,Antagonist,Antagonist,,f,f,,pIC50,9.770000458,0,9.279999733,IC50,0.529999971,0,0.170000002,=,,,,19463875,COc1ccc(nc1)C1(CCCCC1)CNC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)Nc1ccc(cc1)[N+](=O)[O-])C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,litorin,617,,,135652270,Agonist,Agonist,,f,,,pIC50,9.27,0,8.57,IC50,2.69,0,0.54,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,(D-Ala<sup>11</sup>]bombesin,6179,,,178102800,Agonist,Full agonist,,f,,,pIC50,9.27,0,9.15,IC50,0.71,0,0.54,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pKi,8,0,7.82,Ki,15,0,10,=,,,,10454496,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pIC50,10.32,0,10.07,IC50,0.085,0,0.048,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,gastrin-releasing peptide,612,GRP,Human,135651760,Agonist,Full agonist,,f,,,pIC50,9.96,0,9.92,IC50,0.12,0,0.11,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,gastrin-releasing peptide,612,GRP,Human,135651760,Agonist,Full agonist,,t,f,,pKi,8.210000038,0,6.340000153,Ki,453,0,6.199999809,=,,,,10454496,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,gastrin-releasing peptide,612,GRP,Human,135651760,Agonist,Full agonist,,f,,,pKi,0,7.74,0,Ki,0,18,0,=,,,,7838118,
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,gastrin-releasing peptide,612,GRP,Human,135651760,Agonist,Full agonist,,f,,,pKi,8.91,0,8.6,Ki,2.5,0,1.24,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,gastrin releasing peptide(14-27) (human),6175,,,178102796,Agonist,Full agonist,,t,f,,pIC50,9.770000458,0,9.720000267,IC50,0.189999998,0,0.170000002,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pIC50,0,6.92,0,IC50,0,120,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pIC50,6.43,0,6.28,IC50,524,0,372,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[Leu<sup>8</sup>]-phyllolitorin,6168,,,178102789,Agonist,Full agonist,,f,,,pKi,0,6.38,0,Ki,0,420,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,litorin,617,,,135652270,Agonist,Full agonist,,f,,,pKi,0,8.22,0,Ki,0,6,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,litorin,617,,,135652270,Agonist,Full agonist,,f,,,pIC50,0,8.78,0,IC50,0,1.66,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,MK-5046,6170,,,178102791,Agonist,Full agonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,>,,,,23892571,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,neuromedin B,613,NMB|Nmb|Nmb|NMB,Human|Mouse|Pig|Rat,135651812,Agonist,Full agonist,,f,,,pIC50,7.52,0,7.42,IC50,38,0,30.1,=,,,,21729729,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,neuromedin B,613,NMB|Nmb|Nmb|NMB,Human|Mouse|Pig|Rat,135651812,Agonist,Full agonist,,t,,,pKi,8.13,0,6.36,Ki,437,0,7.4,=,,,,10454496,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,neuromedin B,613,NMB|Nmb|Nmb|NMB,Human|Mouse|Pig|Rat,135651812,Agonist,Full agonist,,f,,,pKi,7.38,0,6.64,Ki,230,0,42,=,,,,7838118,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,neuromedin B,613,NMB|Nmb|Nmb|NMB,Human|Mouse|Pig|Rat,135651812,Agonist,Full agonist,,f,,,pKi,0,6.61,0,Ki,0,248,0,=,,,,10454496,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,neuromedin B (1-30) (human),6163,,,178102784,Agonist,Full agonist,,f,,,pIC50,7.82,0,7.74,IC50,18.2,0,15.31,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,neuromedin C,6178,,,178102799,Agonist,Full agonist,,t,f,,pIC50,0,9.850000381,0,IC50,0,0.140000001,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,neuromedin C,6178,,,178102799,Agonist,Full agonist,,f,,,pIC50,0,7.31,0,IC50,0,49,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,neuromedin C,6178,,,178102799,Agonist,Full agonist,,f,,,pKi,0,7.7,0,Ki,0,20,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[Phe<sup>13</sup>]bombesin,615,,,135652393,Agonist,Full agonist,,f,,,pKi,8.74,0,7.55,Ki,28,0,1.8,=,,,,10454496,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[Phe<sup>13</sup>]bombesin,615,,,135652393,Agonist,Full agonist,,f,,,pKi,0,9.11,0,Ki,0,0.77,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pIC50,0,6.72,0,IC50,0,190,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pKi,0,6.62,0,Ki,0,240,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,phyllolitorin,6166,,,178102787,Agonist,Full agonist,,f,,,pIC50,0,5.52,0,IC50,0,3000,0,>,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,ranatensin,618,,,135652431,Agonist,Full agonist,,f,,,pKi,0,8.7,0,Ki,0,2,0,=,,,,9325344,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,ranatensin,618,,,135652431,Agonist,Full agonist,,f,,,pIC50,0,8.97,0,IC50,0,1.08,0,=,,,,21729729,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,ranatensin,618,,,135652431,Agonist,Full agonist,,f,,,pIC50,8.65,0,8.5,IC50,3.16,0,2.24,=,,,,21729729,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pIC50,6.96,0,6.72,IC50,190,0,110,=,,,,21729729,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pKi,0,7.51,0,Ki,0,31,0,=,,,,9325344,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,Rhodei-litorin,6165,,,178102786,Agonist,Full agonist,,f,,,pIC50,0,7.63,0,IC50,0,23.2,0,=,,,,21729729,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Arg<sup>1</sup>,D-Trp<sup>7,9</sup>,Leu<sup>11</sup>]substance P",6184,,,178102805,Antagonist,Antagonist,,f,,,pIC50,6.1,0,5.75,IC50,1780,0,794,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,"[D-Arg<sup>1</sup>,D-Trp<sup>7,9</sup>,Leu<sup>11</sup>]substance P",6184,,,178102805,Antagonist,Antagonist,,f,,,pKi,0,4.95,0,Ki,0,11300,0,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,f,,pIC50,5.610000134,0,5.340000153,IC50,4570,0,2460,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,,,pKi,6.77,0,6.67,Ki,216,0,170,=,,,,10454496,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,,,pIC50,5.61,0,5.34,IC50,4570,0,2460,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH<sub>2  </sub>",6172,,,178102793,Antagonist,Antagonist,,f,,,pIC50,5.46,0,5,IC50,10000,0,3470,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[D-Phe<sup>12</sup>]bombesin,6181,,,178102802,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[D-Phe<sup>6</sup>]bombesin(6-13)methyl ester,6180,,,178102801,Antagonist,Antagonist,,f,,,pIC50,9.05,0,8.4,IC50,3.98,0,0.89,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[D-Phe<sup>6</sup>]bombesin(6-13)methyl ester,6180,,,178102801,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,10454496,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[D-Phe<sup>6</sup>]bombesin(6-13)methyl ester,6180,,,178102801,Antagonist,Antagonist,,f,,,pKi,0,8,0,Ki,0,10,0,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[D-Phe<sup>6</sup>]bombesin(6-13)propylamide,6182,,,178102803,Antagonist,Antagonist,,f,,,pIC50,9.41,0,8.58,IC50,2.63,0,0.39,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[D-Phe<sup>6</sup>]bombesin(6-13)propylamide,6182,,,178102803,Antagonist,Antagonist,,f,,,pKi,0,8.22,0,Ki,0,6,0,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Phe<sup>6</sup>, Leu<sup>13</sup>, Cpa<sup>14</sup>,&psi;13-14]bombesin-(6-14)",3840,,,178100682,Antagonist,Antagonist,,f,t,,pKi,0,9.800000191,0,-,0,0,0,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,"[D-Phe<sup>6</sup>, Leu<sup>13</sup>, Cpa<sup>14</sup>,&psi;13-14]bombesin-(6-14)",3840,,,178100682,Antagonist,Antagonist,,f,,,pKi,0,7.38,0,Ki,0,42,0,=,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Phe<sup>6</sup>, Leu<sup>13</sup>, Cpa<sup>14</sup>,&psi;13-14]bombesin-(6-14)",3840,,,178100682,Antagonist,Antagonist,,f,f,,pIC50,8.909999847,0,8.869999886,IC50,1.350000024,0,1.230000019,=,,,,19463875,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,"[D-Pro<sup>4</sup>,D-Trp<sup>7,9,10</sup>]substance P (4-11)",6185,,,178102806,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,10353842,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Pro<sup>4</sup>,D-Trp<sup>7,9,10</sup>]substance P (4-11)",6185,,,178102806,Antagonist,Antagonist,,f,,,pIC50,5.42,0,5,IC50,10000,0,3800,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Tpi<sup>6</sup>, Leu<sup>13</sup> &psi;(CH<sub>2</sub>NH)-Leu<sup>14</sup>]bombesin-(6-14)",6183,,,178102804,Antagonist,Antagonist,,f,f,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,19463875,CC(C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1NCc2c(C1)c1ccccc1[nH]2)CCC(=O)N)C)CN[C@H](C(=O)N)CC(C)C)C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[D-Tpi<sup>6</sup>, Leu<sup>13</sup> &psi;(CH<sub>2</sub>NH)-Leu<sup>14</sup>]bombesin-(6-14)",6183,,,178102804,Antagonist,Antagonist,,f,,,pIC50,8.88,0,8.8,IC50,1.58,0,1.32,=,,,,19463875,CC(C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1NCc2c(C1)c1ccccc1[nH]2)CCC(=O)N)C)CN[C@H](C(=O)N)CC(C)C)C
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,"[D-Tpi<sup>6</sup>, Leu<sup>13</sup> &psi;(CH<sub>2</sub>NH)-Leu<sup>14</sup>]bombesin-(6-14)",6183,,,178102804,Antagonist,Antagonist,,f,,,pIC50,0,8,0,-,0,0,0,=,,,,1726427,CC(C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1NCc2c(C1)c1ccccc1[nH]2)CCC(=O)N)C)CN[C@H](C(=O)N)CC(C)C)C
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,JMV594,624,,,135652227,Antagonist,Antagonist,,f,t,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,10231715,
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,JMV641,3889,,,178100725,Antagonist,Antagonist,,f,t,,pIC50,0,9.340000153,0,IC50,0,0.460000008,0,=,,,,11463790,
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,kuwanon H,622,,,135652700,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,7646517,CC(=CCc1c(O)ccc(c1O)C(=O)[C@H]1[C@@H](CC(=C[C@@H]1c1c(O)cc(c2c1oc(c1ccc(cc1O)O)c(c2=O)CC=C(C)C)O)C)c1ccc(cc1O)O)C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[Leu<sup>14</sup>, &psi; 13-14)]bombesin",629,,,135652262,Antagonist,Antagonist,,f,,,pIC50,8.11,0,8.09,IC50,8.12,0,7.7,=,,,,19463875,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,"[Leu<sup>14</sup>, &psi; 13-14)]bombesin",629,,,135652262,Antagonist,Antagonist,,f,,,pKi,0,8.11,0,Ki,0,7.7,0,=,,,,7838118,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,PD 168368,621,,,135650803,Antagonist,Antagonist,,f,,,pKi,7.82,0,7.52,Ki,30,0,15,=,,,,10454496,O=C(N[C@](C(=O)NCC1(CCCCC1)c1ccccn1)(Cc1c[nH]c2c1cccc2)C)Nc1ccc(cc1)[N+](=O)[O-]
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,PD 168368,621,,,135650803,Antagonist,Antagonist,,f,,,pIC50,5.93,0,5.76,IC50,1738,0,1172,=,,,,19463875,O=C(N[C@](C(=O)NCC1(CCCCC1)c1ccccn1)(Cc1c[nH]c2c1cccc2)C)Nc1ccc(cc1)[N+](=O)[O-]
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,PD 176252,626,,,135650804,Antagonist,Antagonist,,f,f,,pIC50,6.769999981,0,6.670000076,IC50,213,0,170,=,,,,19463875,COc1ccc(nc1)C1(CCCCC1)CNC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)Nc1ccc(cc1)[N+](=O)[O-])C
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,PD 176252,626,,,135650804,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,9873586,COc1ccc(nc1)C1(CCCCC1)CNC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)Nc1ccc(cc1)[N+](=O)[O-])C
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,MK-5046,6170,,,178102791,Agonist,Agonist,,f,f,,pKi,8.430000305,0,7.739999771,-,0,0,0,=,,,,23892571,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,MK-7725,8502,,,252166710,Agonist,Agonist,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,24900461,FC(Oc1ccc(cc1)S(=O)(=O)N1Cc2ccc(nc2Nc2c1c(ccc2)c1noc(n1)C(O)(C)C)C(F)(F)F)(F)F
BB<sub>3</sub> receptor,40,Brs3,Q8K418,,,,,,Rat,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,10454496,
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pKi,0,8.82,0,Ki,0,1.5,0,=,,,,10454496,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[D-Phe<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",632,,,135652124,Agonist,Full agonist,,f,,,pKi,8.38,0,8.05,Ki,8.9,0,4.2,=,,,,9325344,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[D-Tyr<sup>6</sup>,Apa-4Cl<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",3946,,,178100773,Agonist,Full agonist,,f,,,pKi,0,8.1,0,Ki,0,8,0,=,,,,15102928,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[D-Tyr<sup>6</sup>,Apa-4Cl<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",3946,,,178100773,Agonist,Full agonist,,f,,,pIC50,8.85,0,7.4,IC50,40,0,1.4,=,,,,20438784,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[D-Tyr<sup>6</sup>,(R)-APA<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",633,,,135652125,Agonist,Full agonist,,f,,,pIC50,8.37,0,7.53,IC50,29.5,0,4.3,=,,,,20438784,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[D-Tyr<sup>6</sup>,(R)-APA<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",633,,,135652125,Agonist,Full agonist,,f,,,pKi,0,8.39,0,Ki,0,4.1,0,=,,,,11112777,
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,MK-5046,6170,,,178102791,Agonist,Full agonist,,f,,,pKi,0,8.8,0,Ki,0,1.6,0,=,,,,21036912,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,MK-5046,6170,,,178102791,Agonist,Full agonist,,f,,,pEC50,0,7.6,0,EC50,0,25,0,=,,,,24900253,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,MK-5046,6170,,,178102791,Agonist,Full agonist,,f,,,pIC50,7.57,0,6.8,IC50,160,0,27,=,,,,23892571,FC([C@@](c1ccc(cc1)n1cccn1)(Cc1ncc([nH]1)CC1(CC1)C(F)(F)F)O)(F)F
BB<sub>3</sub> receptor,40,Brs3,Q8K418,,,,,,Rat,"phenylacetyl-Ala,DTrp-phenthylamide",6192,,,178102813,Agonist,Full agonist,,f,,,pEC50,0,6.96,0,EC50,0,109.9,0,=,,,,19580790,CC(C(=O)NC(C(=O)NCCc1ccccc1)Cc1c[nH]c2c1cccc2)NC(=O)c1ccccc1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"phenylacetyl-Ala,DTrp-phenthylamide",6192,,,178102813,Agonist,Full agonist,,f,,,pIC50,5.5,0,5,IC50,10000,0,3162,=,,,,20438784,CC(C(=O)NC(C(=O)NCCc1ccccc1)Cc1c[nH]c2c1cccc2)NC(=O)c1ccccc1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"phenylacetyl-Ala,DTrp-phenthylamide",6192,,,178102813,Agonist,Full agonist,,f,,,pEC50,8.92,0,7.85,EC50,14.15,0,1.2,=,,,,12212809,CC(C(=O)NC(C(=O)NCCc1ccccc1)Cc1c[nH]c2c1cccc2)NC(=O)c1ccccc1
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,"phenylacetyl-Ala,DTrp-phenthylamide",6192,,,178102813,Agonist,Full agonist,,f,,,pEC50,0,7.48,0,EC50,0,33.3,0,=,,,,19580790,CC(C(=O)NC(C(=O)NCCc1ccccc1)Cc1c[nH]c2c1cccc2)NC(=O)c1ccccc1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub>,635,,,135652119,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,9325344,
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,ML-18,8505,,,252166713,Antagonist,Antagonist,,f,f,,pIC50,0,5.320000172,0,IC50,0,4800,0,=,,,,25554218,COc1ccc(cc1)C1(CCCCC1)CNC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)Nc1ccc(cc1)[N+](=O)[O-]
B cell CLL/lymphoma 6,2957,BCL6,P41182,,,,,,Human,FX1,9672,,,348353631,Inhibitor,Binding,,f,t,,pKd,0,5.150000095,0,Kd,0,7000,0,=,Binding of compound to BCL6 BTB domain using microscale thermophoresis.,,,27482887,OC(=O)CCN1C(=S)S/C(=C/2C(=O)NC3C2C=C(Cl)C=C3)/C1=O
"BCL2, apoptosis regulator",2844,BCL2,P10415,,,,,,Human,navitoclax,8319,,,252166531,Antagonist,Antagonist,,f,t,,pKi,0,9,0,Ki,0,1,0,<,,,,18841882,Clc1ccc(cc1)C1=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(c(c2)S(=O)(=O)C(F)(F)F)N[C@@H](CSc2ccccc2)CCN2CCOCC2)CC(CC1)(C)C
Bcl-2-like 1,2845,BCL2L1,Q07817,,,,,,Human,navitoclax,8319,,,252166531,Antagonist,Antagonist,,f,t,,pKi,0,9,0,Ki,0,1,0,<,,,,18841882,Clc1ccc(cc1)C1=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(c(c2)S(=O)(=O)C(F)(F)F)N[C@@H](CSc2ccccc2)CCN2CCOCC2)CC(CC1)(C)C
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,lanabecestat,7789,,,223366120,Inhibitor,Competitive,,f,t,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,24900397,CC#Cc1cncc(c1)c1ccc2c(c1)[C@]1(N=C(C(=N1)C)N)C1(C2)CCC(CC1)OC
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,LY2811376,6936,,,178103518,Inhibitor,Competitive,,f,t,,pIC50,0,6.619999886,0,IC50,0,239,0,=,,,,22090477,NC1=N[C@](CCS1)(C)c1cc(c2cncnc2)c(cc1F)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,LY2886721,6475,,,178103089,Inhibitor,Competitive,,f,t,,pIC50,0,7.699999809,0,IC50,0,20.29999924,0,=,,,,0,Fc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]12COC[C@H]2CSC(=N1)N)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,oxazine 89,6944,,,178103526,Inhibitor,Competitive,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,23590342,N#Cc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]1(C)N=C(N)O[C@@H](C1)C(F)(F)F)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,elenbecestat,9818,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,0,C[C@H]1OC[C@]2([C@@H]1CSC(=N2)N)c1cc(ccc1F)NC(=O)c1cnc(cn1)C(F)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,example 2 [WO2013004676],7852,,,223366182,Inhibitor,Inhibition,,f,t,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,24900681,Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]12N=C(N)SCC[C@@H]2C1)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,NB-360,9822,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,26336937,N#Cc1cnc(c(c1)C)C(=O)Nc1ccc(c(c1)[C@]1(C)CO[C@@](C(=N1)N)(C)C(F)(F)F)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,PF-06684511,9831,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,9.149999619,0,IC50,0,0.699999988,0,=,,,,29356535,FC[C@H]1OC[C@]2([C@@H]1CSC(=N2)N)c1cc(ccc1F)NC(=O)c1cnc(cn1)OC
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,RO5508887,9821,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,25164658,N#Cc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]1(C)N=C(N)OCC1(F)F)F
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,example 20 [WO2010128058],7853,,,223366183,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Fluorescent-peptide cleavage assay for BACE2 inhibition.,,,0,Clc1cnc(nc1)C(=O)Nc1cccc(c1)[C@]1(C)CC(=O)N(C(=N1)N)C
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,example 2 [WO2013004676],7852,,,223366182,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,24900681,Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]12N=C(N)SCC[C@@H]2C1)F
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,example 41 [WO2012028563],7855,,,223366185,Inhibitor,Inhibition,,f,t,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,0,Cc1csc(n1)[C@H]1CCCN1C(=O)c1cc(cc(c1)N(S(=O)(=O)C)C)C(=O)N[C@H]([C@@H](CNCc1cccc(c1)OC(F)(F)F)O)Cc1ccccc1
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,example 92 [WO2012095521],7856,,,223366186,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,0,FC[C@]1(COCC(=N1)N)c1cc(ccc1F)NC(=O)c1ncc(cc1C)Cl
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,example 98 [WO2011020806],6540,,,178103154,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,23506624,Clc1cnc(c(c1)C)C(=O)Nc1ccc(c(c1)[C@]1(C)COCC(=N1)N)F
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,hydroxyethylamine transition-state inhibitor 1,8688,,,252166888,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,=,,,,16305800,Cc1cccc(c1)CNC[C@H]([C@@H](NC(=O)C1=Cc2ccccc2Oc2c1cccc2)Cc1ccccc1)O
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,NB-360,9822,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,26336937,N#Cc1cnc(c(c1)C)C(=O)Nc1ccc(c(c1)[C@]1(C)CO[C@@](C(=N1)N)(C)C(F)(F)F)F
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,RO5508887,9821,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,25164658,N#Cc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]1(C)N=C(N)OCC1(F)F)F
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,indacaterol,7455,,,187051758,Agonist,Agonist,,f,f,,pKi,0,6.699999809,0,Ki,0,180,0,=,,,,22932315,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,mirabegron,7445,,,178104017,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,,,,17293563,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Agonist,,t,f,,pKi,6,0,5.5,-,0,0,0,=,,,,2849109,NC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,(-)-Ro 363,5571,,,178102207,Agonist,Agonist,,f,,,pKi,0,8,0,-,0,0,0,=,,,,9117106,COc1cc(CCNCC(COc2ccc(c(c2)O)O)O)ccc1OC
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,solabegron,9512,,,329968451,Agonist,Agonist,,f,f,,pEC50,0,5.400000095,0,-,0,0,0,=,,,,16640337,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,isoprenaline,536,,,135650431,Agonist,Full agonist,,f,t,,pKi,7,0,6.599999905,-,0,0,0,=,,,,8982677,CC(NCC(c1ccc(c(c1)O)O)O)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,noradrenaline,484,,,135651526,Agonist,Full agonist,,t,,,pKi,0,6,0,-,0,0,0,=,,,,2849109,NCC(c1ccc(c(c1)O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Full agonist,,f,,,pKi,0,6,0,-,0,0,0,=,,,,2849109,CNCC(c1ccc(c(c1)O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,denopamine,534,,,135650167,Agonist,Partial agonist,,f,f,,pKi,0,5.800000191,0,Ki,0,1584,0,=,,,,10531390,COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,dobutamine,535,,,135650199,Agonist,Partial agonist,,f,t,,pKi,0,5.5,0,-,0,0,0,=,,,,10531390,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,pindolol,91,,,135650827,Agonist,Partial agonist,,f,t,,pKi,0,9.300000191,0,Ki,0,0.519999981,0,=,,,,17804228,OC(COc1cccc2c1cc[nH]2)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,prenalterol,537,,,135650853,Agonist,Partial agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,10531390,O[C@H](COc1ccc(cc1)O)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,esmolol,7178,,,178103753,Antagonist,Antagonist,,f,t,,pKi,0,6.900000095,0,Ki,0,113.6999969,0,=,,,,0,COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,H87/07,542,,,135650344,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,10079020,COCCOc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,labetalol,7207,,,178103782,Antagonist,Antagonist,,f,t,,pKi,0,8.199999809,0,Ki,0,5.840000153,0,=,,,,0,CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,levobetaxolol,8035,,,249565715,Antagonist,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.75999999,0,=,,,,11572462,O[C@H](COc1ccc(cc1)CCOCC1CC1)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,levobunolol,570,,,135650031,Antagonist,Antagonist,,f,t,,pKi,0,8.399999619,0,Ki,0,3.99000001,0,=,,,,0,O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,LK 204-545,544,,,135650529,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,10079020,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,metoprolol,553,,,135650599,Antagonist,Antagonist,,f,t,,pKi,7.599999905,0,7,-,0,0,0,=,,,,10079020,COCCc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,nadolol,554,,,135650678,Antagonist,Antagonist,,f,t,,pKi,0,6.900000095,0,-,0,0,0,=,,,,10411574,OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,,,,,,,,Rabbit,nebivolol,7246,,,178103820,Antagonist,Antagonist,,f,f,,pIC50,8.699999809,0,8.100000381,-,0,0,0,=,,,,2462161,OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,NIHP,545,,,135650718,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10079020,OCCCc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,NIP,546,,,135650720,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,10079020,OC(COc1ccccc1)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,practolol,555,,,135650846,Antagonist,Antagonist,,f,t,,pKi,6.800000191,0,6.099999905,-,0,0,0,=,,,,10079020,OC(COc1ccc(cc1)NC(=O)C)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,propafenone,2561,,,135650856,Antagonist,Antagonist,,f,t,,pKi,0,6.699999809,0,Ki,0,205,0,=,,,,0,CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,(-)-propranolol,63,,,135650859,Antagonist,Antagonist,,f,t,,pKi,8.899999619,0,8.199999809,-,0,0,0,=,,,,15060759,O[C@H](COc1cccc2c1cccc2)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,sotalol,7297,,,178103870,Antagonist,Antagonist,,f,t,,pKi,0,6.099999905,0,Ki,0,833,0,=,,,,0,CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,SR59230A,547,,,135651082,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,10411574,CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,fenoterol,557,,,135650257,Agonist,Agonist,,f,t,,pKi,0,6.900000095,0,Ki,0,126,0,=,,,,24454993,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,formoterol,3465,,,178100459,Agonist,Agonist,,f,t,,pEC50,0,10.07999992,0,-,0,0,0,=,,,,20590599,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,indacaterol,7455,,,187051758,Agonist,Agonist,,f,t,,pKi,0,7.800000191,0,Ki,0,15.89999962,0,=,,,,22932315,CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,mirabegron,7445,,,178104017,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,,,,17293563,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Agonist,,t,f,,pKi,4.800000191,0,4.599999905,-,0,0,0,=,,,,2849109,NC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,olodaterol,7543,,,187051844,Agonist,Agonist,,f,t,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,20371707,COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,orciprenaline,7250,,,178103824,Agonist,Agonist,,f,t,,pKd,0,5.320000172,0,Kd,0,4810,0,=,,,,19168263,OC(c1cc(O)cc(c1)O)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,procaterol,3464,,,53801069,Agonist,Agonist,,f,t,,pEC50,0,8.430000305,0,-,0,0,0,=,,,,20590599,CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,solabegron,9512,,,329968451,Agonist,Agonist,,f,f,,pEC50,0,5.900000095,0,-,0,0,0,=,,,,16640337,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,isoprenaline,536,,,135650431,Agonist,Full agonist,,f,t,,pKi,0,6.400000095,0,-,0,0,0,=,,,,8982677,CC(NCC(c1ccc(c(c1)O)O)O)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,noradrenaline,484,,,135651526,Agonist,Full agonist,,t,,,pKi,0,5.4,0,,0,0,0,,,,,15102946,NCC(c1ccc(c(c1)O)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,salmeterol,559,,,135650978,Agonist,Full agonist,,f,t,,pEC50,0,9.920000076,0,EC50,0,0.119999997,0,=,,,,20590599,OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,dobutamine,535,,,135650199,Agonist,Partial agonist,,f,t,,pKi,0,6.199999809,0,-,0,0,0,=,,,,15102946,CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,ephedrine,556,,,135650234,Agonist,Partial agonist,,f,t,,pKi,0,5.599999905,0,-,0,0,0,=,,,,9295336,CN[C@H]([C@@H](c1ccccc1)O)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,levosalbutamol,9816,,,0,Agonist,Partial agonist,,f,f,,pKi,0,5.25,0,Ki,0,5623,0,=,Measuring displacement of [<sup>3</sup>H]-DHA from recombinant human &beta;<sub>2</sub> adrenoceptors expressed in HEK293T cells.,,,22182578,OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,pindolol,91,,,135650827,Agonist,Partial agonist,,f,t,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,17804228,OC(COc1cccc2c1cc[nH]2)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,salbutamol,558,,,135650977,Agonist,Partial agonist,,f,t,,pKi,6.099999905,0,5.800000191,Ki,1580,0,794,=,,,,10531390,OCc1cc(ccc1O)C(CNC(C)(C)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,labetalol,7207,,,178103782,Antagonist,Antagonist,,f,t,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,0,CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,levobetaxolol,8035,,,249565715,Antagonist,Antagonist,,f,f,,pKi,0,7.489999771,0,Ki,0,32.59999847,0,=,,,,11572462,O[C@H](COc1ccc(cc1)CCOCC1CC1)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,levobunolol,570,,,135650031,Antagonist,Antagonist,,f,t,,pKi,0,9.260000229,0,Ki,0,0.550000012,0,=,,,,0,O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,LK 204-545,544,,,135650529,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,10079020,N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,metoprolol,553,,,135650599,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10079020,COCCc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,nadolol,554,,,135650678,Antagonist,Antagonist,,f,t,,pKi,8.600000381,0,7,-,0,0,0,=,,,,15655528,OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,NIHP,545,,,135650718,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10079020,OCCCc1ccc(cc1)OCC(CNC(C)C)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,NIP,546,,,135650720,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,10079020,OC(COc1ccccc1)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,propafenone,2561,,,135650856,Antagonist,Antagonist,,f,f,,pKi,0,7.440000057,0,Ki,0,36,0,=,,,,0,CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,propranolol,564,,,135650858,Antagonist,Antagonist,,f,t,,pKi,9.5,0,9.100000381,-,0,0,0,=,,,,10079020,OC(COc1cccc2c1cccc2)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,sotalol,7297,,,178103870,Antagonist,Antagonist,,f,t,,pKi,0,6.53000021,0,Ki,0,298,0,=,,,,0,CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,SR59230A,547,,,135651082,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,10411574,CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,ICI 118551,543,,,135650367,Antagonist,Inverse agonist,,f,,,pKi,9.5,0,9.2,-,0,0,0,=,,,,10079020,CC(N[C@H]([C@H](COc1ccc(c2c1CCC2)C)O)C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,L742791,3467,,,178100461,Agonist,Agonist,,f,,,pEC50,0,8.8,0,EC50,0,1.6,0,=,,,,9873496,O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,mirabegron,7445,,,178104017,Agonist,Agonist,,f,t,,pEC50,0,7.650000095,0,EC50,0,22.39999962,0,=,,,,17293563,O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,SB251023,3468,,,178100462,Agonist,Agonist,,f,,,pEC50,0,7.14,0,-,0,0,0,=,,,,11959793,O[C@H](COc1ccc(cc1)O)CNC1(CCCC1)Cc1ccc(cc1)OCP(=O)(c1ccccc1)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,solabegron,9512,,,329968451,Agonist,Agonist,,f,t,,pEC50,0,8.399999619,0,-,0,0,0,=,,,,16640337,Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,isoprenaline,536,,,135650431,Agonist,Full agonist,,f,,,pKi,5.3,0,4.2,,0,0,0,,,,,8719421,CC(NCC(c1ccc(c(c1)O)O)O)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,isoprenaline,536,,,135650431,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,8719421,CC(NCC(c1ccc(c(c1)O)O)O)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,isoprenaline,536,,,135650431,Agonist,Full agonist,,f,,,pKi,6.2,0,5.1,,0,0,0,,,,,8982677,CC(NCC(c1ccc(c(c1)O)O)O)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,L 755507,3931,,,178100760,Agonist,Full agonist,,f,,,pEC50,0,10.1,0,-,0,0,0,=,,,,20590599,CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,,,pKi,0,3.8,0,-,0,0,0,=,,,,14744619,NC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,,,pKi,0,4.2,0,-,0,0,0,=,,,,14744619,NC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,(-)-noradrenaline,505,,,135651527,Agonist,Full agonist,,t,f,,pKi,6.300000191,0,4.699999809,-,0,0,0,=,,,,9131260,NC[C@@H](c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Full agonist,,t,,,pKi,0,5.3,0,,0,0,0,,,,,8719421,CNCC(c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Full agonist,,t,,,pKi,4.7,0,3.9,,0,0,0,,,,,8719421,CNCC(c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,(&plusmn;)-adrenaline,509,,,135651547,Agonist,Full agonist,,t,,,pKi,0,5.3,0,,0,0,0,,,,,8719421,CNCC(c1ccc(c(c1)O)O)O
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,ICI 118551,543,,,135650367,Antagonist,Antagonist,,f,,,pKi,6.6,0,5.8,,0,0,0,,,,,10079020,CC(N[C@H]([C@H](COc1ccc(c2c1CCC2)C)O)C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,L748328,3463,,,53801070,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,Ki,0,3.700000048,0,=,,,,10411574,O[C@H](COc1cccc(c1)S(=O)(=O)N)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,L-748337,3932,,,178100761,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,-,0,0,0,=,,,,10411574,O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,levobunolol,570,,,135650031,Antagonist,Antagonist,,f,f,,pKi,6.300000191,0,6.199999809,-,0,0,0,=,,,,14744619,O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,levobunolol,570,,,135650031,Antagonist,Antagonist,,f,t,,pKi,0,6.800000191,0,Ki,0,160,0,=,,,,14744619,O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,levobunolol,570,,,135650031,Antagonist,Antagonist,,f,f,,pKi,0,6.400000095,0,-,0,0,0,=,,,,14744619,O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,nadolol,554,,,135650678,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10411574,OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,propranolol,564,,,135650858,Antagonist,Antagonist,,f,f,,pKi,6.599999905,0,6.5,-,0,0,0,=,,,,14744619,OC(COc1cccc2c1cccc2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,propranolol,564,,,135650858,Antagonist,Antagonist,,f,f,,pKi,0,6.400000095,0,-,0,0,0,=,,,,14744619,OC(COc1cccc2c1cccc2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,propranolol,564,,,135650858,Antagonist,Antagonist,,f,t,,pKi,7.199999809,0,6.300000191,-,0,0,0,=,,,,10079020,OC(COc1cccc2c1cccc2)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,SR59230A,547,,,135651082,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,6.900000095,-,0,0,0,=,,,,10411574,CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O
BGT1,932,Slc6a12,P31651,,,,,,Mouse,LU32-176B,4756,,,178101466,Inhibitor,Inhibition,,f,f,,pIC50,0,4,0,IC50,0,100000,0,=,,,,15550575,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCNC1CCCc2c1c(O)no2
BGT1,932,Slc6a12,P31651,,,,,,Mouse,NNC052090,4610,,,178101330,Inhibitor,Inhibition,,f,f,,pKi,0,5.900000095,0,Ki,0,1400,0,=,,,,9134205,COc1ccccc1C1(O)CCN(CC1)CCCn1c2ccccc2c2c1cccc2
BGT1,932,SLC6A12,P48065,,,,,,Human,(R)-EF-1520,6512,,,178103126,Inhibitor,Inhibition,,f,f,,pIC50,4.659999847,0,3.74000001,IC50,180000,0,22000,=,,,,0,CN([C@@H]1CCCc2c1c(O)no2)CCC=C(c1sccc1C)c1sccc1C
BGT1,932,SLC6A12,P48065,,,,,,Human,(R/S) EF-1500,4583,,,178101304,Inhibitor,Inhibition,,f,,,pIC50,0,4.9,0,IC50,0,26000,0,,,,,0,Cc1ccsc1C(=CCCNC1CCCc2c1c(O)no2)c1sccc1C
BGT1,932,SLC6A12,P48065,,,,,,Human,(S)-EF-1520,6513,,,178103127,Inhibitor,Inhibition,,f,f,,pIC50,4.46999979,0,3.599999905,IC50,250000,0,34000,=,,,,0,CN([C@H]1CCCc2c1c(O)no2)CCC=C(c1sccc1C)c1sccc1C
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,8.270000458,0,IC50,0,5.400000095,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,22394077,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,f,,pIC50,0,6.900000095,0,IC50,0,125,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,LTB<sub>4</sub>,2487,,,53801088,Agonist,Full agonist,,t,,,pKi,0,9.4,0,Ki,0,0.38,0,=,,,,0,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,CP105696,3368,,,178100392,Antagonist,Antagonist,,f,,,pIC50,0,8.1,0,IC50,0,8.42,0,=,,,,7714764,OC(=O)C1(CCCC1)c1ccc2c(c1)OC[C@@H]([C@H]2O)Cc1ccc(cc1)c1ccccc1
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,CP-195543,6155,,,178102776,Antagonist,Antagonist,,f,,,pIC50,0,8.62,0,IC50,0,2.4,0,=,,,,9618393,O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,CP-195543,6155,,,178102776,Antagonist,Antagonist,,f,,,pKi,0,8.17,0,Ki,0,6.8,0,=,,,,9618393,O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,etalocib,2948,,,178100247,Antagonist,Antagonist,,f,,,pIC50,9.3,0,7.5,IC50,32,0,0.5,=,,,,9862783,CCCc1c(OCCCOc2cc(O)c(cc2CC)c2ccc(cc2)F)cccc1Oc1ccccc1C(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,etalocib,2948,,,178100247,Antagonist,Antagonist,,f,,,pKi,0,7.75,0,Ki,0,17.6,0,=,,,,9862783,CCCc1c(OCCCOc2cc(O)c(cc2CC)c2ccc(cc2)F)cccc1Oc1ccccc1C(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,LY255283,3351,,,178100381,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,Ki,0,260,0,=,,,,1659282,CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,ONO-4057,6157,,,178102778,Antagonist,Antagonist,,f,,,pIC50,6.15,0,5.52,IC50,3000,0,700,=,,,,1332129,COc1ccc(cc1)/C=C/CCCCOc1cccc(c1CCC(=O)O)OCCCCC(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,ONO-4057,6157,,,178102778,Antagonist,Antagonist,,f,,,pKi,0,8.43,0,Ki,0,3.7,0,=,,,,1332129,COc1ccc(cc1)/C=C/CCCCOc1cccc(c1CCC(=O)O)OCCCCC(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,RO5101576,6158,,,178102779,Antagonist,Antagonist,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,,,,20214997,OC(=O)CCc1c(CCCCCCOc2cc(cc(c2)c2ccc3c(c2)OCO3)c2ccsc2)cccc1OCCCC(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,SC-41930,6156,,,178102777,Antagonist,Antagonist,,f,,,pIC50,0,6.1,0,IC50,0,808,0,=,,,,7786309,CCCc1c(OCCCOc2ccc(c(c2CCC)OC)C(=O)C)ccc2c1OC(CC2)C(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,SC-41930,6156,,,178102777,Antagonist,Antagonist,,f,,,pKi,0,7.77,0,Ki,0,17,0,=,,,,7786309,CCCc1c(OCCCOc2ccc(c(c2CCC)OC)C(=O)C)ccc2c1OC(CC2)C(=O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,CP-195543,6155,,,178102776,Agonist,Partial agonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,,,,11278893,O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,LTB<sub>4</sub>,2487,,,53801088,Agonist,Partial agonist,,t,,,pEC50,0,6.85,0,EC50,0,142,0,=,,,,18378794,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,LTB<sub>4</sub>,2487,,,53801088,Agonist,Partial agonist,,t,,,pIC50,0,7.6,0,IC50,0,25,0,=,,,,18378794,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,LTB<sub>4</sub>,2487,,,53801088,Agonist,Partial agonist,,t,,,pKd,0,7.64,0,Kd,0,22.7,0,=,,,,10934230,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,CP-195543,6155,,,178102776,Antagonist,Antagonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,,,,11278893,O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,LY255283,3351,,,178100381,Antagonist,Antagonist,,f,,,pIC50,7.1,0,6,IC50,1000,0,87,=,,,,11278893,CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,22394077,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
BMX non-receptor tyrosine kinase,1942,BMX,P51813,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
bone morphogenetic protein receptor type IA,1786,BMPR1A,P36894,,,,,,Human,LDN-214117,8481,,,252166689,Inhibitor,Inhibition,,f,f,,pIC50,0,5.929999828,0,IC50,0,1171,0,=,,,,25101911,COc1cc(cc(c1OC)OC)c1cc(cnc1C)c1ccc(cc1)N1CCNCC1
bone morphogenetic protein receptor type IA,1786,BMPR1A,P36894,,,,,,Human,ML347,8121,,,249565801,Inhibitor,Inhibition,,f,f,,pIC50,0,4.96999979,0,IC50,0,10800,0,=,,,,23639540,COc1ccc(cc1)c1cnc2n(c1)ncc2c1cccc2c1cccn2
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,dabrafenib,6494,,,178103108,Inhibitor,Inhibition,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,,,,0,Nc1nccc(n1)c1sc(nc1c1cccc(c1F)NS(=O)(=O)c1c(F)cccc1F)C(C)(C)C
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,GDC-0879,5681,,,178102308,Inhibitor,Inhibition,,f,t,,pIC50,9.890000343,0,9.720000267,IC50,0.189999998,0,0.129999995,=,,,,22037378,OCCn1cc(c(n1)c1ccncc1)c1ccc2c(c1)CC/C/2=NO
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,L779450,9129,,,315661214,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,16260133,Oc1cc(ccc1Cl)c1nc([nH]c1c1ccncc1)c1ccccc1
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,lifirafenib,8958,,,310264739,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,Inhibition of wild type BRAF kinase domain (aa416-766),,,26208524,O=C1CCc2c(N1)nccc2Oc1ccc2c(c1)[C@@H]1[C@H](O2)[C@H]1c1nc2c([nH]1)cc(cc2)C(F)(F)F
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,LY3009120,8943,,,310264724,Inhibitor,Inhibition,,f,f,,pIC50,0,8.039999962,0,IC50,0,9.100000381,0,=,,,,26343583,CNc1ncc2c(n1)nc(c(c2)c1cc(NC(=O)NCCC(C)(C)C)c(cc1C)F)C
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,PLX-4720,5703,,,178102330,Inhibitor,Inhibition,,f,t,,pKd,0,6.480000019,0,Kd,0,330,0,=,,,,22037378,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(Cl)cn2)F
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,PLX-4720,5703,,,178102330,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,18287029,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(Cl)cn2)F
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,PLX8394,9131,,,315661216,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,26466569,F[C@@H]1CCN(C1)S(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1cnc(nc1)C1CC1)F
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,regorafenib,5891,,,178102514,Inhibitor,Inhibition,,f,t,,pIC50,0,7.550000191,0,IC50,0,28,0,=,,,,22222036,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,SB590885,9389,,,328083491,Inhibitor,Inhibition,,f,f,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,In a cell-free assay,,,17145850,"O=NC1=c2cc/c(=c/3
c([nH]c3=c3cc[nH]cc3)c3ccc(cc3)OCCN(C)C)/cc2CC1"
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
bromodomain adjacent to zinc finger domain 2A,2721,BAZ2A,Q9UIF9,,,,,,Human,GSK2801,8233,,,249565913,Inhibitor,Inhibition,,f,t,,pKd,0,6.590000153,0,Kd,0,257,0,=,Isothermal titration calorimetry (ITC) assay,,,0,CCCOc1ccn2c(c1)c(cc2C(=O)C)c1ccccc1S(=O)(=O)C
bromodomain adjacent to zinc finger domain 2B,2722,BAZ2B,Q9UIF8,,,,,,Human,GSK2801,8233,,,249565913,Inhibitor,Binding,,f,t,,pKd,0,6.869999886,0,Kd,0,136,0,=,Isothermal titration calorimetry (ITC) assay,,,0,CCCOc1ccn2c(c1)c(cc2C(=O)C)c1ccccc1S(=O)(=O)C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,NI-57,8573,,,252166774,None,Binding,,f,t,,pKd,0,7.510000229,0,Kd,0,31,0,=,"Isothermal titration calorimetry (ITC) assay, measuring binding to BRPF1B isoform.",,,0,COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(c(=O)n2C)C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,OF-1,9523,,,336446909,None,Binding,,f,f,,pKd,0,7,0,Kd,0,100,0,=,"By isothermal titration calorimetry, using the BRPF1B isoform.",,,0,COc1cc2c(cc1NS(=O)(=O)c1ccc(cc1C)Br)n(c(=O)n2C)C
bromodomain and PHD finger containing 1,2730,BRPF1,P55201,,,,,,Human,PFI-4,8575,,,252166776,None,Binding,,f,t,,pKd,0,7.889999866,0,Kd,0,13,0,=,Isothermal titration calorimetry (ITC) assay measuring binding to the BRPF1B isoform.,,,0,COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(c(=O)n2C)C
bromodomain and PHD finger containing 3,2731,BRPF3,Q9ULD4,,,,,,Human,NI-57,8573,,,252166774,None,Binding,,f,f,,pKd,0,6.389999866,0,Kd,0,408,0,=,,,,0,COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(c(=O)n2C)C
bromodomain and PHD finger containing 3,2731,BRPF3,Q9ULD4,,,,,,Human,OF-1,9523,,,336446909,None,Binding,,f,f,,pKd,0,5.619999886,0,Kd,0,2400,0,=,By isothermal titration calorimetry.,,,0,COc1cc2c(cc1NS(=O)(=O)c1ccc(cc1C)Br)n(c(=O)n2C)C
bromodomain containing 1,2724,BRD1,O95696,,,,,,Human,NI-57,8573,,,252166774,Inhibitor,Binding,,f,f,,pKd,0,6.96999979,0,Kd,0,108,0,=,,,,0,COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(c(=O)n2C)C
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,RVX 208,7034,,,178103613,Antagonist,Antagonist,,f,f,,pIC50,0,7.050000191,0,IC50,0,90,0,=,Measured using a TR-FRET assay to evaluate binding to BD2 of BRD2.,,,24391744,OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,ET bromodomain inhibitor,7808,,,223366139,Inhibitor,Inhibition,"The higher affinity interaction is with the BRD2-BD1 domain, the lower affinity with the BRD2-BD2 domain",f,t,,pKd,5.050000191,0,4.769999981,Kd,17000,0,9000,=,,,,25323695,COC(=O)[C@@H]([C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC)CC
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,GW841819X,7514,,,187051816,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,29.89999962,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD2.,,,21568322,O=C(NC1N=C(c2ccccc2)c2c(n3c1nnc3C)cccc2)OCc1ccccc1
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,I-BET151,7518,,,187051820,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,21964340,COc1cc2c(cc1c1c(C)noc1C)ncc1c2n(c(=O)[nH]1)[C@@H](c1ccccn1)C
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pKd,0,5.849999905,0,Kd,0,1410,0,=,,,,24533473,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,ME bromodomain inhibitor,7807,,,223366138,Inhibitor,Inhibition,"The higher affinity interaction is with the BRD2-BD2 domain, the lower affinity with the BRD2-BD1 domain",f,t,,pKd,6.519999981,0,5.820000172,Kd,1500,0,300,=,,,,25323695,COC(=O)[C@@H]([C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC)C
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,molibresib,7033,,,178103612,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32.5,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD2.,,,21568322,CCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,RVX 208,7034,,,178103613,Antagonist,Antagonist,,f,f,,pIC50,0,6.550000191,0,IC50,0,280,0,=,Measured using a TR-FRET assay to evaluate binding to BD2 of BRD3.,,,24391744,OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,GW841819X,7514,,,187051816,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28.39999962,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD3.,,,21568322,O=C(NC1N=C(c2ccccc2)c2c(n3c1nnc3C)cccc2)OCc1ccccc1
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,I-BET151,7518,,,187051820,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,21964340,COc1cc2c(cc1c1c(C)noc1C)ncc1c2n(c(=O)[nH]1)[C@@H](c1ccccn1)C
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pKd,0,6.03000021,0,Kd,0,930,0,=,,,,24533473,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,molibresib,7033,,,178103612,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,42.20000076,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD3.,,,21568322,CCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,MS363,8876,,,252827533,Inhibitor,Inhibition,,f,f,,pKi,0,6.619999886,0,Ki,0,240,0,=,Affinity at bromodomain 1 of BRD3.,,,24144283,NC1=C(Cl)C(=O)C(=C/C/1=NNc1ccc(cc1)S(=O)(=O)Nc1ccccn1)C
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,RVX 208,7034,,,178103613,Inhibitor,Inhibition,,f,f,,pIC50,0,4.059999943,0,IC50,0,87000,0,=,AlphaScreen data for bromodomain 1 of BRD3.,,,24248379,OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,RVX 208,7034,,,178103613,Inhibitor,Inhibition,,f,f,,pIC50,0,5.309999943,0,IC50,0,4900,0,=,AlphaScreen data assessing the bromodomain 2 domain of BRD3.,,,24248379,OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,RVX 208,7034,,,178103613,Antagonist,Antagonist,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,Measured using a TR-FRET assay to evaluate binding to BD2 of BRD4.,,,24391744,OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,CPI-0610,9120,,,315661205,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,IC50 vs. BRD4-BD1,,,26815195,NC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(c3c1onc3C)cccc2
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,CPI-203,7513,,,187051815,Inhibitor,Inhibition,,f,f,,pIC50,0,7.429999828,0,IC50,0,37,0,=,Measured using a bead-based fluorescent proximity assay.,,,22509028,NC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,fedratinib,5716,,,178102342,Inhibitor,Inhibition,,f,f,,pKd,0,6.789999962,0,Kd,0,164,0,=,,,,24584101,Cc1cnc(nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C)Nc1ccc(cc1)OCCN1CCCC1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,GW841819X,7514,,,187051816,Inhibitor,Inhibition,,f,f,,pIC50,0,7.809999943,0,IC50,0,15.5,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD4.,,,21568322,O=C(NC1N=C(c2ccccc2)c2c(n3c1nnc3C)cccc2)OCc1ccccc1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,I-BET151,7518,,,187051820,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,790,0,=,,,,21964340,COc1cc2c(cc1c1c(C)noc1C)ncc1c2n(c(=O)[nH]1)[C@@H](c1ccccn1)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,isoxazole azepine compound 3,7527,,,187051828,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,Assayed using recombinant BRD4-BD1.,,,24900758,NC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(c3c1onc3C)sc(c2C)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,(+)-JQ1,7511,,,187051813,Inhibitor,Inhibition,,f,f,,pKd,0,7.300000191,0,Kd,0,50,0,=,Displacement binding constant to recombinant BRD4-BD1 protein.,,,20871596,O=C(OC(C)(C)C)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pKd,0,5.739999771,0,Kd,0,1830,0,=,,,,24533473,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,mivebresib,9117,,,315661202,Inhibitor,Inhibition,,f,f,,pKi,8.850000381,0,8.460000038,Ki,3.5,0,1.399999976,=,Inhibition of binding to the BD1 (8.46) or BD2 (8.85) bromodomains of human BRD4 using a TR-FRET assay.,,,0,CCS(=O)(=O)Nc1ccc(c(c1)c1cn(C)c(=O)c2c1cc[nH]2)Oc1ccc(cc1F)F
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,molibresib,7033,,,178103612,Inhibitor,Inhibition,,f,f,,pEC50,0,6.150000095,0,EC50,0,700,0,=,Measured in a ApoA1 reporter gene assay.,,,21568322,CCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,molibresib,7033,,,178103612,Inhibitor,Inhibition,,f,f,,pIC50,0,7.440000057,0,IC50,0,36.09999847,0,=,Displacement of a tetra-acetylated histone H4 peptide from the tandem BET bromodomains of BRD4.,,,21568322,CCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,MS417,7512,,,187051814,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,Inhibition of MS417 binding to recombinant BRD4-BD1 using FITC-labeled MS417 as the assay probe.,,,22645123,COC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,MS436,7509,,,187051811,Inhibitor,Inhibition,,f,f,,pKi,7.519999981,0,7.300000191,Ki,50,0,30,=,Range of inhibition of binding across both Brd1 and Brd2 bromodomains of BRD4.,,,24144283,Nc1cc(O)c(cc1/N=N/c1ccc(cc1)S(=O)(=O)Nc1ccccn1)C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,N-methyl-2-pyrrolidone,9520,,,336446906,Inhibitor,Inhibition,,f,f,,pIC50,0,2.220000029,0,IC50,0,6000000,0,=,,,,24813887,O=C1CCCN1C
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,PFI-1,7523,,,187051824,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,220,0,=,Assayed using recombinant  BRD4-BD1.,,,23095041,COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C(=O)N2)C
bromodomain containing 7,2726,BRD7,Q9NPI1,,,,,,Human,LP99,8572,,,252166773,Inhibitor,Inhibition,,f,f,,pKd,0,6,0,Kd,0,1000,0,~,Based on binding of BRD7 being 10-fold lower than for BRD9,,,25864491,Clc1ccc(cc1)[C@@H]1[C@H](CCC(=O)N1c1ccc2c(c1)n(C)c(=O)cc2C)NS(=O)(=O)CC(C)C
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,I-BRD9,8397,,,252166608,Inhibitor,Binding,,f,t,,pIC50,0,7.099999905,0,IC50,0,79.40000153,0,=,"Binding affinity for endogenous BRD9 from HuT-78 cell lysates, measured in a
chemoproteomic competition binding assay followed by Western blot analysis.",,,25856009,CCn1cc(c2cccc(c2)C(F)(F)F)c2c(c1=O)cc(s2)C(=N)NC1CCS(=O)(=O)CC1
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,LP99,8572,,,252166773,Inhibitor,Inhibition,,f,t,,pKd,0,7,0,Kd,0,99,0,=,Isothermal titration calorimetry (ITC) assay,,,25864491,Clc1ccc(cc1)[C@@H]1[C@H](CCC(=O)N1c1ccc2c(c1)n(C)c(=O)cc2C)NS(=O)(=O)CC(C)C
bromodomain PHD finger transcription factor,2723,BPTF,Q12830,,,,,,Human,MS363,8876,,,252827533,Inhibitor,Inhibition,,f,f,,pKi,0,5.789999962,0,Ki,0,1620,0,=,,,,24144283,NC1=C(Cl)C(=O)C(=C/C/1=NNc1ccc(cc1)S(=O)(=O)Nc1ccccn1)C
bromodomain testis associated,2729,Brdt,Q91Y44,,,,,,Mouse,(+)-JQ1,7511,,,187051813,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,Inhibition of H4Kac4 binding to mBRDT-BD1,,,22901802,O=C(OC(C)(C)C)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C
bromodomain testis associated,2729,BRDT,Q58F21,,,,,,Human,(+)-JQ1,7511,,,187051813,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,Inhibition of H4Kac4 binding to hBRDT-BD1,,,22901802,O=C(OC(C)(C)C)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,evobrutinib,9752,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,Binned value derived from a time-dependent BTK enzyme assay.,,,0,C=CC(=O)N1CCC(CC1)CNc1ncnc(c1c1ccc(cc1)Oc1ccccc1)N
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,fenebrutinib,9299,,,318164818,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OCc1c(ccnc1N1CCn2c(C1=O)cc1c2CC(C1)(C)C)c1cc(Nc2ccc(cn2)N2CCN(C[C@@H]2C)C2COC2)c(=O)n(c1)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,GDC-0834,9263,,,315661338,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,25701252,CN1CCN(C(=O)[C@H]1c1ccc(cc1)Nc1nc(cn(c1=O)C)c1cccc(c1C)NC(=O)c1cc2c(s1)CCCC2)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,17154430,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,LFM-A13,9262,,,315661337,Inhibitor,Inhibition,,f,f,,pIC50,0,4.760000229,0,IC50,0,17200,0,=,IN a cell-free BTK assay using BTK immunoprecipitated from B18.2 cells.,,,10092645,C/C(=C(/C(=O)Nc1cc(Br)ccc1Br)C#N)/O
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,ONO-4059,9265,,,315661340,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,0,C=CC(=O)N1CCC[C@@H](C1)n1c(=O)n(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,RN486,8249,,,249565929,Inhibitor,Inhibition,,f,t,,pKd,0,9.510000229,0,Kd,0,0.310000002,0,=,,,,22228807,OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1cc(Nc2ccc(cn2)N2CCN(CC2)C)c(=O)n(c1)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,spebrutinib,7837,,,223366168,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,<,,,,0,COCCOc1ccc(cc1)Nc1ncc(c(n1)Nc1cccc(c1)NC(=O)C=C)F
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,[des-Arg<sup>10</sup>]kallidin,644,KNG1,Human,135652109,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,8856107,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,[des-Arg<sup>10</sup>]kallidin,644,KNG1,Human,135652109,Agonist,Full agonist,,t,,,pKi,8.9,0,8.7,,0,0,0,,,,,10422787,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[des-Arg<sup>10</sup>]kallidin,644,KNG1,Human,135652109,Agonist,Full agonist,,t,,,pKi,10,0,9.6,-,0,0,0,=,,,,9111052,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,[des-Arg<sup>11</sup>]T-kinin,645,,,135652110,Agonist,Full agonist,,f,,,pKi,7.5,0,7.2,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[des-Arg<sup>11</sup>]T-kinin,645,,,135652110,Agonist,Full agonist,,f,,,pKi,5.9,0,5.7,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,[des-Arg<sup>9</sup>]bradykinin,646,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651731,Agonist,Full agonist,,t,,,pKi,0,9.2,0,,0,0,0,,,,,8856107,OCC(C(=O)N1CCCC1C(=O)NC(C(=O)O)Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[des-Arg<sup>9</sup>]bradykinin,646,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651731,Agonist,Full agonist,,t,,,pKi,5.8,0,5.7,,0,0,0,,,,,10422787,OCC(C(=O)N1CCCC1C(=O)NC(C(=O)O)Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[des-Phe<sup>9</sup>,des-Arg<sup>10</sup>]kallidin",647,,,135652114,Agonist,Full agonist,,f,,,pKi,6.2,0,6.1,,0,0,0,,,,,9111052,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[des-Pro<sup>8</sup>,des-Phe<sup>9</sup>,des-Arg<sup>10</sup>]kallidin",648,,,135652115,Agonist,Full agonist,,f,,,pKi,5.9,0,5.8,,0,0,0,,,,,9111052,
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,kallidin,650,KNG1,Human,135651794,Agonist,Full agonist,,f,,,pKi,6.6,0,6.5,-,0,0,0,=,,,,10422787,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,kallidin,650,KNG1,Human,135651794,Agonist,Full agonist,,f,,,pKi,0,6.3,0,-,0,0,0,=,,,,8856107,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,kallidin,650,KNG1,Human,135651794,Agonist,Full agonist,,t,,,pKi,8.9,0,7,,0,0,0,,,,,9111052,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,Lys-kallidin,637,,,135652274,Agonist,Full agonist,,f,,,pKi,6.9,0,6.7,,0,0,0,,,,,9111052,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,Met-Lys-bradykinin,638,,,135652286,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,8063797,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)NC(=O)[C@H](CCSC)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[Sar,<small>D</small>-Phe<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",643,,,135652451,Agonist,Full agonist,,f,f,,pKi,0,5.699999809,0,Ki,0,1990,0,=,,,,10422787,CNCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,"[Sar,<small>D</small>-Phe<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",643,,,135652451,Agonist,Full agonist,,f,,,pKi,7.4,0,7.1,,0,0,0,,,,,10422787,CNCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,<small>D</small>-Lys<sup>0</sup>-[des-Arg<sup>10</sup>]kallidin,636,,,135652468,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9111052,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[<small>D</small>-Lys<sup>1</sup>,des-Arg<sup>10</sup>]kallidin",640,,,135652469,Agonist,Full agonist,,f,,,pKi,7.6,0,7.4,,0,0,0,,,,,9111052,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,"[Leu<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",641,,,135652267,Agonist,Partial agonist,,f,,,pEC50,0,7.3,0,,0,0,0,,,,,9276157,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,[des-Arg<sup>10</sup>]icatibant,663,,,135652108,Antagonist,Antagonist,,f,,,pKi,7.6,0,7.4,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[des-Arg<sup>10</sup>]icatibant,663,,,135652108,Antagonist,Antagonist,,f,,,pKi,8.4,0,6.6,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,[des-Arg<sup>10</sup>]icatibant,663,,,135652108,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,8856107,
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,icatibant,667,,,135652196,Antagonist,Antagonist,,f,,,pKi,6.4,0,6.1,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,icatibant,667,,,135652196,Antagonist,Antagonist,,f,,,pKi,7,0,6.4,,0,0,0,,,,,10422787,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,JMV1431,656,,,135652220,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10882364,OC[C@@H](C(=O)N[C@@H]1CSc2c(N(C1=O)CC(=O)O)cccc2)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)[C@@H]1CC(CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,"[Leu<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",641,,,135652267,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.4,,0,0,0,,,,,10422787,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,"[Leu<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",641,,,135652267,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,8856107,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[Leu<sup>8</sup>,des-Arg<sup>9</sup>]bradykinin",641,,,135652267,Antagonist,Antagonist,,f,,,pKi,7.2,0,5.8,,0,0,0,,,,,9111052,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[Leu<sup>9</sup>,des-Arg<sup>10</sup>]kallidin",642,,,135652268,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,-,0,0,0,=,,,,8063797,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,"[Leu<sup>9</sup>,des-Arg<sup>10</sup>]kallidin",642,,,135652268,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8856107,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,"[Leu<sup>9</sup>,des-Arg<sup>10</sup>]kallidin",642,,,135652268,Antagonist,Antagonist,,f,,,pKi,9.3,0,9.1,-,0,0,0,=,,,,9111052,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,NPC 17731,657,,,135652337,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8995263,CCCO[C@@H]1CN[C@H](C1)C(=O)N([C@@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H]1NCC(C1)O)CO)C(=O)O)C(=O)C1N[C@@H]2[C@H](C1)CCCC2
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,NPC 18565,658,,,135652338,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,8995263,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,NVP-SAA164,659,,,135650752,Antagonist,Antagonist,,f,,,pKi,8.1,0,7.9,,0,0,0,,,,,15685199,CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,PS020990,660,,,135650862,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,10596850,Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,R-715,661,,,135652430,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0.629999995,0,=,,,,9276157,
B<sub>1</sub> receptor,41,Bdkrb1,Q61125,,,,,,Mouse,R-715,661,,,135652430,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9276157,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,R-715,661,,,135652430,Antagonist,Antagonist,,f,f,,pA2,0,8.5,0,-,0,0,0,=,,,,8901831,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,R-914,3906,,,178100739,Antagonist,Antagonist,,f,f,,pA2,0,8.600000381,0,-,0,0,0,=,,,,10082494,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,SSR240612,662,,,135651088,Antagonist,Antagonist,,f,,,pKi,9.2,0,9.1,,0,0,0,,,,,14747609,COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,[des-Arg<sup>9</sup>]bradykinin,646,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651731,Agonist,Full agonist,,t,,,pIC50,0,5.1,0,-,0,0,0,=,,,,8302267,OCC(C(=O)N1CCCC1C(=O)NC(C(=O)O)Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCN=C(N)N)N
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,[des-Arg<sup>9</sup>]bradykinin,646,KNG1|Kng1|Kng2,Human|Mouse|Rat,135651731,Agonist,Full agonist,,t,,,pIC50,0,5.2,0,-,0,0,0,=,,,,8302267,OCC(C(=O)N1CCCC1C(=O)NC(C(=O)O)Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCN=C(N)N)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,FR190997,668,,,135650287,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9224807,CNC(=O)c1ccc(cc1)/C=C/C(=O)NCC(=O)N(c1ccc(c(c1Cl)COc1cccc2c1nc(C)cc2OCc1ccccn1)Cl)C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,FR191413,669,,,135650288,Agonist,Full agonist,,f,,,pIC50,0,9.2,0,,0,0,0,,,,,15139763,COc1nc2c(n1Cc1ccccn1)cccc2OCc1c(Cl)ccc(c1Cl)N(C(=O)CNC(=O)/C=C/c1ccc(nc1)NC(=O)C)C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,"[Hyp<sup>3</sup>,Tyr(Me)<sup>8</sup>]BK",3841,,,178100683,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
B<sub>2</sub> receptor,42,Bdkrb2,P25023,,,,,,Rat,JMV1116,670,,,135652219,Agonist,Full agonist,,f,,,pKi,10.2,0,10,,0,0,0,,,,,10514288,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,JMV1116,670,,,135652219,Agonist,Full agonist,,f,,,pKi,9.2,0,9.1,,0,0,0,,,,,10514288,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,kallidin,650,KNG1,Human,135651794,Agonist,Full agonist,,t,,,pIC50,0,9.3,0,,0,0,0,,,,,8302267,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,kallidin,650,KNG1,Human,135651794,Agonist,Full agonist,,f,,,pIC50,0,9.3,0,-,0,0,0,=,,,,8302267,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>2</sub> receptor,42,Bdkrb2,P25023,,,,,,Rat,labradimil,672,,,135652255,Agonist,Full agonist,,f,,,pKi,8,0,7.7,,0,0,0,,,,,10514288,COc1ccc(cc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N)O)CO)CN[C@H](C(=O)O)CCCN=C(N)N
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,Met-Lys-bradykinin,638,,,135652286,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,8302267,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)NC(=O)[C@H](CCSC)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,Met-Lys-bradykinin,638,,,135652286,Agonist,Full agonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,8302267,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)NC(=O)[C@H](CCSC)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,"[Phe<sup>8</sup>,<i>&psi;</i>(CH<sub>2</sub>-NH)Arg<sup>9</sup>]BK",3846,,,178100686,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,[des-Arg<sup>10</sup>]kallidin,644,KNG1,Human,135652109,Agonist,Partial agonist,,f,,,pIC50,0,4.6,0,,0,0,0,,,,,8302267,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,FR167344,673,,,135650285,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,9203620,O=C(/C=C/c1ccc(cc1)C(=O)N(C)C)NCC(=O)N(c1ccc(c(c1Cl)COc1cccn2c1nc(c2Br)C)Cl)C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,FR173657,674,,,135650286,Antagonist,Antagonist,,f,f,,pA2,0,8.199999809,0,-,0,0,0,=,,,,9095082,CC(=O)Nc1ccc(cn1)/C=C/C(=O)NCC(=O)N(c1ccc(c(c1Cl)COc1cccc2c1nc(C)cc2)Cl)C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,FR173657,674,,,135650286,Antagonist,Antagonist,,f,f,,pIC50,0,8.100000381,0,IC50,0,7.949999809,0,=,,,,9203620,CC(=O)Nc1ccc(cn1)/C=C/C(=O)NCC(=O)N(c1ccc(c(c1Cl)COc1cccc2c1nc(C)cc2)Cl)C
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,icatibant,667,,,135652196,Antagonist,Antagonist,,f,t,,pIC50,9.399999619,0,8,-,0,0,0,=,,,,8302267,
B<sub>2</sub> receptor,42,Bdkrb2,P25023,,,,,,Rat,icatibant,667,,,135652196,Antagonist,Antagonist,,f,,,pKi,10.3,0,10,,0,0,0,,,,,10694205,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,icatibant,667,,,135652196,Antagonist,Antagonist,,f,t,,pKi,0,10.18999958,0,Ki,0,0.064000003,0,=,,,,10514288,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,icatibant,667,,,135652196,Antagonist,Antagonist,,f,t,,pA2,0,8.399999619,0,-,0,0,0,=,,,,8735629,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,icatibant,667,,,135652196,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,8302267,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,JMV1431,656,,,135652220,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,10882364,OC[C@@H](C(=O)N[C@@H]1CSc2c(N(C1=O)CC(=O)O)cccc2)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)[C@@H]1CC(CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,NPC 17731,657,,,135652337,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8995263,CCCO[C@@H]1CN[C@H](C1)C(=O)N([C@@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H]1NCC(C1)O)CO)C(=O)O)C(=O)C1N[C@@H]2[C@H](C1)CCCC2
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,NPC 18565,658,,,135652338,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8995263,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,NPC-349,675,,,135652339,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N[C@@H](C(=O)N([C@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)CNC(=O)[C@H]1NC[C@@H](C1)O)C(=O)O)C(=O)[C@H](Cc1cccs1)N)Cc1ccccc1)NC(=O)[C@H](Cc1cccs1)N
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,NPC-349,675,,,135652339,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N[C@@H](C(=O)N([C@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)CNC(=O)[C@H]1NC[C@@H](C1)O)C(=O)O)C(=O)[C@H](Cc1cccs1)N)Cc1ccccc1)NC(=O)[C@H](Cc1cccs1)N
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,NPC-567,676,,,135652340,Antagonist,Antagonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)O
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,NPC-567,676,,,135652340,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,8302267,OC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)O
B<sup>0</sup>AT1,939,Slc6a19,Q2A865,,,,,,Rat,nimesulide,7401,,,178103973,Inhibitor,Inhibition,,f,f,,pIC50,0,4.639999866,0,IC50,0,23000,0,=,,,,24704252,[O-][N+](=O)c1ccc(c(c1)Oc1ccccc1)NS(=O)(=O)C
B<sup>0</sup>AT2,940,SLC6A15,Q9H2J7,,,,,,Human,loratadine,7216,,,178103791,Inhibitor,Inhibition,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,25318072,CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1
butyrophilin subfamily 3 member A1,2948,BTN3A1,O00481,,,,,,Human,POM2-C-HMBP,9616,,,340590246,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,27271567,OC/C(=C/CCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)/C
butyrylcholinesterase,2471,BCHE,P06276,,,,,,Human,physostigmine,6598,,,178103211,Inhibitor,Inhibition,,f,,,pIC50,7.8,0,7.6,-,0,0,0,=,,,,16570913,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN([C@@H]1N2C)C
butyrylcholinesterase,2471,BCHE,P06276,,,,,,Human,pyridostigmine,8994,,,310264772,Inhibitor,Inhibition,,f,f,,pIC50,0,6.050000191,0,IC50,0,900,0,=,Inhibition of human plasma BCHE activity by a modified Ellman assay.,,,20627738,C[n+]1cccc(c1)OC(=O)N(C)C
butyrylcholinesterase,2471,BCHE,P06276,,,,,,Human,rivastigmine,6602,,,178103215,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,37,0,=,,,,16570913,CCN(C(=O)Oc1cccc(c1)[C@@H](N(C)C)C)C
C3a receptor,31,C3AR1,Q16581,,,,,,Human,E7,3915,,,178100747,Agonist,Full agonist,,f,,,pEC50,0,8.7,0,EC50,0,2,0,=,,,,9476119,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,FLPLAR,5761,,,178102386,Agonist,Full agonist,,f,,,pEC50,0,6.4,0,EC50,0,420,0,=,,,,20527893,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,SQ007-5,8379,,,252166591,Agonist,Partial agonist,,f,f,,pEC50,0,6.650000095,0,-,0,0,0,=,,,,22500977,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,FLTChaAR,5777,,,178102402,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,IC50,0,238,0,=,,,,20527893,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,SB290157,3529,,,178100508,Antagonist,Antagonist,,f,,,pIC50,0,7.6,0,IC50,0,28,0,=,,,,11342658,O=C(N[C@H](C(=O)O)CCCN=C(N)N)COCC(c1ccccc1)c1ccccc1
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,<i>N</i>-methyl-Phe-Lys-Pro-<small>D</small>-Cha-Cha-<small>D</small>-Arg-CO<sub>2</sub>H,572,,,178100214,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,-,0,0,0,=,,,,1732540,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,ribosomal protein S19,3728,RPS19,Human,178100599,Agonist,Full agonist,,t,,,-,0,0,0,,0,0,0,,,,,11107061,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,NDT9513727,9746,,,0,Agonist,Inverse agonist,,f,f,,pIC50,0,7.940000057,0,IC50,0,11.60000038,0,=,,,,18753409,CCCCn1c(CN(Cc2ccc3c(c2)OCO3)Cc2ccc3c(c2)OCO3)c(nc1c1ccccc1)c1ccccc1
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,DF2593A,9451,,,329968391,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,-,0,0,0,=,,,,25385614,C[C@H](c1ccc(cc1)OS(=O)(=O)C(F)(F)F)NC(=O)CCCN1CCCCC1
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,<i>N</i>-methyl-Phe-Lys-Pro-<small>D</small>-Cha-Trp-<small>D</small>-Arg-CO<sub>2</sub>H,576,,,178100216,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,-,0,0,0,=,,,,7930622,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,JPE1375,5763,,,178102388,Antagonist,Antagonist,,f,,,pIC50,0,7,0,IC50,0,111,0,=,,,,16876401,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,"L-156,602",577,,,178100217,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,7768675,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,NDT9520492,578,,,178100218,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,16230349,C[C@H](N1CCc2c([C@@H]1c1cccc3c1cccc3)cccc2)C(=O)N(C1Cc2c(C1)cccc2)Cc1ccccc1F
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,PMX205,5762,,,178102387,Antagonist,Antagonist,,f,,,pIC50,0,7.51,0,IC50,0,31,0,=,,,,15044616,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,PMX53,579,,,178100219,Antagonist,Antagonist,,f,,,pIC50,7.7,0,7.1,IC50,90,0,21,=,,,,11403208,NC(=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@H]2N(C(=O)[C@H](CCCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)C)CCC2)Cc1c[nH]c2c1cccc2)N
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,RPR121154,580,,,178100220,Antagonist,Antagonist,,f,,,pIC50,0,6.1,0,-,0,0,0,=,,,,0,CN=C(Nc1ccc(c(c1)c1ccccc1)OCCc1ccccc1)N
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,P32 [PMID: 27108698],9384,,,328083486,Agonist,Biased agonist,Exhibits selective partial agonism for recruitment of &beta;-arrestin 2 <i>via</i> C5aR2 in a BRET C5aR2-&beta;-arrestin 2 recruitment assay,f,f,,pKi,0,3.650000095,0,Ki,0,223000,0,=,Binding assay,,,27108698,
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,P59 [PMID: 27108698],9385,,,328083487,Agonist,Biased agonist,Exhibits selective partial agonism for recruitment of &beta;-arrestin 2 <i>via</i> C5aR2 in a BRET C5aR2-&beta;-arrestin 2 recruitment assay,f,f,,pKi,0,4.190000057,0,Ki,0,64000,0,=,Binding assay,,,27108698,
CaCC,708,ANO1,Q5XXA6,,,,,,Human,DCDPC,4173,,,178100993,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Clc1cccc(c1)Nc1cc(Cl)ccc1C(=O)O
CaCC,708,ANO1,Q5XXA6,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
CaCC,708,ANO1,Q5XXA6,,,,,,Human,flufenamic acid,2447,,,135650269,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
CaCC,708,ANO1,Q5XXA6,,,,,,Human,fluoxetine,203,,,135650270,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
CaCC,708,ANO1,Q5XXA6,,,,,,Human,"Ins(3,4,5,6)P<sub>4</sub>",4224,,,178101041,Channel blocker,None,,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@@H]([C@H]([C@@H]1O)OP(=O)(O)O)OP(=O)(O)O
CaCC,708,ANO1,Q5XXA6,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
CaCC,708,ANO1,Q5XXA6,,,,,,Human,niflumic acid,2439,,,135650716,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
CaCC,708,ANO1,Q5XXA6,,,,,,Human,NPPB,4270,,,178101087,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
CaCC,708,ANO1,Q5XXA6,,,,,,Human,SITS,4314,,,178101131,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,S=C=Nc1ccc(c(c1)/C=C/c1ccc(cc1S(=O)(=O)O)NC(=O)C)S(=O)(=O)O
CaCC,708,ANO1,Q5XXA6,,,,,,Human,crofelemer,7453,,,187051756,Inhibitor,Inhibition,,f,t,,pIC50,0,5.190000057,0,IC50,0,6500,0,=,,,,19808995,
calcium/calmodulin-dependent protein kinase II alpha subunit,1555,Camk2a,P11798,,,,,,Mouse,KN-93,6002,,,178102624,Inhibitor,Inhibition,,f,t,,pIC50,6.429999828,0,5.800000191,IC50,1600,0,370,=,"Assayed using purified mouse CaMKii&alpha; subunit (Komiya <i>et al</>, 2011).",,,21292482,OCCN(S(=O)(=O)c1ccc(cc1)OC)c1ccccc1CN(C/C=C/c1ccc(cc1)Cl)C
calcium/calmodulin-dependent protein kinase II alpha subunit,1555,Camk2a,P11275,,,,,,Rat,KN-93,6002,,,178102624,Inhibitor,Inhibition,,f,t,,pIC50,0,5.079999924,0,IC50,0,8400,0,=,"Assay performed using a truncated, recombinant rat CAMKIIalpha subunit, expressed in and purified from Sf9 cells.",,,11806708,OCCN(S(=O)(=O)c1ccc(cc1)OC)c1ccccc1CN(C/C=C/c1ccc(cc1)Cl)C
calcium/calmodulin-dependent protein kinase II beta subunit,1556,CAMK2B,Q13554,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,10,0,IC50,0,0.100000001,0,<,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
calcium/calmodulin-dependent protein kinase II delta subunit,1558,CAMK2D,Q13557,,,,,,Human,MELK-TI,9366,,,328083468,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,810,0,=,Measured in a MIllipore kinase screening panel assay,,,25589925,COc1cc(ccc1C(=O)Nc1ccc2c(c1)CCNCC2)c1cn[nH]c1
calcium/calmodulin dependent protein kinase kinase 1,1956,CAMKK1,Q8N5S9,,,,,,Human,STO609,5274,,,178101957,Inhibitor,Inhibition,,f,t,,pIC50,0,6.849999905,0,IC50,0,140,0,=,,,,11867640,OC(=O)c1ccc2c3c1cccc3c(=O)n1c2nc2c1cccc2
calcium/calmodulin dependent protein kinase kinase 2,1957,CAMKK2,Q96RR4,,,,,,Human,STO609,5274,,,178101957,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,11867640,OC(=O)c1ccc2c3c1cccc3c(=O)n1c2nc2c1cccc2
Calmodulin-dependent kinase II,1554,,,,,,,,Human,K-252a,336,,,135652695,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,1659814,COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
Calmodulin-dependent kinase II,1554,,,,,,,,Human,KN62,4235,,,178101052,Inhibitor,Inhibition,,f,t,,pIC50,0,6.050000191,0,IC50,0,900,0,=,,,,2155222,O=C([C@@H](N(S(=O)(=O)c1cccc2c1ccnc2)C)Cc1ccc(cc1)OS(=O)(=O)c1cccc2c1ccnc2)N1CCN(CC1)c1ccccc1
calpain 1,2336,,,,,,,,Pig,mercaptoacrylate inhibitor of calpain 1,8570,,,252166771,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,0,OC(=O)/C(=C/c1c[nH]c2c1cc(Br)cc2)/S
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,diclofenamide,6807,,,178103413,Inhibitor,Inhibition,,f,f,,pKi,7.130000114,0,5.920000076,Ki,1200,0,74,=,,,,17125255,Clc1cc(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,dorzolamide,6810,,,178103416,Inhibitor,Inhibition,,f,f,,pKi,0,4.300000191,0,Ki,0,50000,0,=,,,,15686894,CCN[C@H]1C[C@H](C)S(=O)(=O)c2c1cc(s2)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,ethoxzolamide,6814,,,178103420,Inhibitor,Inhibition,,f,f,,pKi,7.599999905,0,5.309999943,Ki,4900,0,25,=,,,,15686931,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,gallic acid,5549,,,178102191,Inhibitor,Inhibition,,f,f,,pKi,0,5.5,0,Ki,0,3200,0,=,,,,20185318,OC(=O)c1cc(O)c(c(c1)O)O
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,indisulam,7046,,,178103625,Inhibitor,Inhibition,,f,f,,pKi,0,7.510000229,0,Ki,0,31,0,=,,,,23965175,Clc1c[nH]c2c1cccc2NS(=O)(=O)c1ccc(cc1)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,methazolamide,6828,,,178103434,Inhibitor,Inhibition,,f,f,,pKi,7.480000019,0,7.300000191,Ki,50,0,33,=,,,,16039848,CC(=O)N=c1sc(nn1C)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,methocarbamol,6829,,,178103435,Inhibitor,Inhibition,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,17125255,COc1ccccc1OCC(COC(=O)N)O
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,diclofenamide,6807,,,178103413,Inhibitor,Inhibition,,f,t,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,15686894,Clc1cc(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,dorzolamide,6810,,,178103416,Inhibitor,Inhibition,,f,f,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,,,,15686894,CCN[C@H]1C[C@H](C)S(=O)(=O)c2c1cc(s2)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,ethoxzolamide,6814,,,178103420,Inhibitor,Inhibition,,f,f,,pKi,0,7.659999847,0,Ki,0,22,0,=,,,,15686894,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,indisulam,7046,,,178103625,Inhibitor,Inhibition,,f,f,,pKi,0,8.470000267,0,Ki,0,3.400000095,0,=,,,,23965175,Clc1c[nH]c2c1cccc2NS(=O)(=O)c1ccc(cc1)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,methazolamide,6828,,,178103434,Inhibitor,Inhibition,,f,f,,pKi,0,8.470000267,0,Ki,0,3.400000095,0,=,,,,15686894,CC(=O)N=c1sc(nn1C)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,dorzolamide,6810,,,178103416,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,15686931,CCN[C@H]1C[C@H](C)S(=O)(=O)c2c1cc(s2)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,ethoxzolamide,6814,,,178103420,Inhibitor,Inhibition,,f,t,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,16039848,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N
carbonic anhydrase 14,2598,CA14,Q9ULX7,,,,,,Human,methazolamide,6828,,,178103434,Inhibitor,Inhibition,,f,f,,pKi,0,7.570000172,0,Ki,0,27,0,=,,,,16039848,CC(=O)N=c1sc(nn1C)S(=O)(=O)N
carbonic anhydrase 4,2599,CA4,P22748,,,,,,Human,diclofenamide,6807,,,178103413,Inhibitor,Inhibition,,f,f,,pKi,0,4.820000172,0,Ki,0,15000,0,=,,,,17125255,Clc1cc(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N
carbonic anhydrase 4,2599,CA4,P22748,,,,,,Human,methazolamide,6828,,,178103434,Inhibitor,Inhibition,,f,f,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,16039848,CC(=O)N=c1sc(nn1C)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,dorzolamide,6810,,,178103416,Inhibitor,Inhibition,,f,f,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,,,,23965175,CCN[C@H]1C[C@H](C)S(=O)(=O)c2c1cc(s2)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,ethoxzolamide,6814,,,178103420,Inhibitor,Inhibition,,f,f,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,23965175,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,indisulam,7046,,,178103625,Inhibitor,Inhibition,,f,f,,pKi,0,6.909999847,0,Ki,0,122,0,=,,,,23965175,Clc1c[nH]c2c1cccc2NS(=O)(=O)c1ccc(cc1)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,methazolamide,6828,,,178103434,Inhibitor,Inhibition,,f,t,,pKi,0,8.680000305,0,Ki,0,2.099999905,0,=,,,,23965175,CC(=O)N=c1sc(nn1C)S(=O)(=O)N
carboxylesterase 1,2592,CES1,P23141,,,,,,Human,GR148672X,6701,,,178103312,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,IC50,0,4,0,,,,,0,Cc1cccc(c1)N/N=C(C(=O)C(F)(F)F)/C(=O)c1cccs1
Carboxypeptidase A1 (pancreatic),1587,,,,,,,,Bovine,<i>S</i>-BMPA,8676,,,252166876,Inhibitor,Inhibition,,f,f,,pKi,0,8.109999657,0,Ki,0,7.800000191,0,=,,,,0,SC[C@H](C(=O)O)Cc1ccccc1
Carboxypeptidase B2 (plasma),1594,CPB2,Q96IY4,,,,,,Human,"SQ-24,798",8656,,,252166856,Inhibitor,Inhibition,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,17990866,SCC(C(=O)O)CCCN=C(N)N
"Carboxypeptidase N, polypeptide 1",1597,CPN1,P15169,,,,,,Human,"SQ-24,798",8656,,,252166856,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,17990866,SCC(C(=O)O)CCCN=C(N)N
casein kinase 1 alpha 1,1995,CSNK1A1,P48729,,,,,,Human,D4476,5940,,,178102563,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,22944772,NC(=O)c1ccc(cc1)c1nc(c([nH]1)c1ccccn1)c1ccc2c(c1)OCCO2
casein kinase 1 alpha 1,1995,CSNK1A1,P48729,,,,,,Human,IC261,5985,,,178102608,Inhibitor,Inhibition,,f,f,,pIC50,0,4.800000191,0,IC50,0,16000,0,=,,,,10749871,COc1cc(OC)cc(c1C=C1C(=O)Nc2c1cccc2)OC
casein kinase 1 delta,1997,CSNK1D,P48730,,,,,,Human,D4476,5940,,,178102563,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,17850214,NC(=O)c1ccc(cc1)c1nc(c([nH]1)c1ccccn1)c1ccc2c(c1)OCCO2
casein kinase 1 delta,1997,CSNK1D,P48730,,,,,,Human,IC261,5985,,,178102608,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1000,0,=,,,,10749871,COc1cc(OC)cc(c1C=C1C(=O)Nc2c1cccc2)OC
casein kinase 1 delta,1997,CSNK1D,P48730,,,,,,Human,PF-4800567,8050,,,249565730,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,711,0,=,,,,19458106,Clc1cccc(c1)OCc1nn(c2c1c(N)ncn2)C1CCOCC1
casein kinase 1 delta,1997,CSNK1D,P48730,,,,,,Human,PF-670462,9371,,,328083473,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,In a biochemical kinase assay.,,,17502429,Nc1nccc(n1)c1n(cnc1c1ccc(cc1)F)C1CCCCC1
casein kinase 1 epsilon,1998,CSNK1E,P49674,,,,,,Human,IC261,5985,,,178102608,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1000,0,=,,,,10749871,COc1cc(OC)cc(c1C=C1C(=O)Nc2c1cccc2)OC
casein kinase 1 epsilon,1998,CSNK1E,P49674,,,,,,Human,PF-4800567,8050,,,249565730,Inhibitor,Inhibition,,f,t,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,19458106,Clc1cccc(c1)OCc1nn(c2c1c(N)ncn2)C1CCOCC1
casein kinase 1 epsilon,1998,CSNK1E,P49674,,,,,,Human,PF-670462,9371,,,328083473,Inhibitor,Inhibition,,f,f,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,In a biochemical kinase assay.,,,17502429,Nc1nccc(n1)c1n(cnc1c1ccc(cc1)F)C1CCCCC1
Casein kinase 2,1548,,,,,,,,Rat,CX-5011,9373,,,328083475,Inhibitor,Inhibition,,f,f,,pIC50,0,9.010000229,0,IC50,0,0.970000029,0,=,Native rat CK2 isolated from liver.,,,21870818,C#Cc1cccc(c1)Nc1nc2cc(ccc2c2c1ncnc2)C(=O)[O-]
Casein kinase 2,1548,,,,,,,,Human,CX-5011,9373,,,328083475,Inhibitor,Inhibition,,f,t,,pIC50,0,8.640000343,0,IC50,0,2.299999952,0,=,Recombinant holoenzyme with wild-type alpha subunits.,,,21870818,C#Cc1cccc(c1)Nc1nc2cc(ccc2c2c1ncnc2)C(=O)[O-]
Casein kinase 2,1548,,,,,,,,Human,CX-5279,9374,,,328083476,Inhibitor,Inhibition,,f,t,,pIC50,0,9.039999962,0,IC50,0,0.910000026,0,=,Recombinant human CK2 holoenzyme containiny wild-type alpha subunits.,,,21870818,[O-]C(=O)c1ccc2c(c1)nc(c1c2cnc(n1)NC1CC1)Nc1cccc(c1)C(F)(F)F
Casein kinase 2,1548,,,,,,,,Rat,CX-5279,9374,,,328083476,Inhibitor,Inhibition,,f,f,,pIC50,0,8.56000042,0,IC50,0,2.730000019,0,=,Native CK2 isolated from rat liver,,,21870818,[O-]C(=O)c1ccc2c(c1)nc(c1c2cnc(n1)NC1CC1)Nc1cccc(c1)C(F)(F)F
Casein kinase 2,1548,,,,,,,,Rat,DMAT,9323,,,318164842,Inhibitor,Inhibition,,f,t,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,0,CN(c1[nH]c2c(n1)c(Br)c(c(c2Br)Br)Br)C
Casein kinase 2,1548,,,,,,,,Human,DRB,5178,,,178101868,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,3456346,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1cc(Cl)c(c2)Cl
"casein kinase 2, alpha 1 polypeptide subunit",1549,CSNK2A1,P68400,,,,,,Human,CX-4945,8126,,,249565806,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,21174434,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O
"casein kinase 2, alpha prime polypeptide subunit",1550,CSNK2A2,P19784,,,,,,Human,CX-4945,8126,,,249565806,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,21174434,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O
Caspase 1,1617,CASP1,P29466,,,,,,Human,M826,8654,,,252166854,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,15686936,CCCCCCN(CC(=O)C(NC(=O)C(n1cc(nc(c1=O)NCc1nonc1C)C(C)(C)C)CC)CC(=O)O)C
Caspase 1,1617,CASP1,P29466,,,,,,Human,pralnacasan,6467,,,178103081,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,16375749,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2N1C(=O)[C@H](CCC2=O)NC(=O)c1nccc2c1cccc2
Caspase 14,1627,CASP14,P31944,,,,,,Human,grassystatin A,8674,,,252166874,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,=,,,,19715320,COC(=O)[C@@H]1CCCN1C(=O)[C@H](N(C(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)C[C@@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)OC(=O)[C@@H](N(C)C)C(C)C)CC(C)C)CC(=O)N)CC(C)C)O)C)C)Cc1ccccc1
Caspase 3,1619,CASP3,P42574,,,,,,Human,PAC1,5238,,,178101922,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,16936720,C=CCc1cccc(c1O)/C=NNC(=O)CN1CCN(CC1)Cc1ccccc1
Caspase 3,1619,CASP3,P42574,,,,,,Human,PETCM,5242,,,178101926,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,12522243,OC(C(Cl)(Cl)Cl)Cc1ccncc1
Caspase 3,1619,CASP3,P42574,,,,,,Human,M826,8654,,,252166854,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,15686936,CCCCCCN(CC(=O)C(NC(=O)C(n1cc(nc(c1=O)NCc1nonc1C)C(C)(C)C)CC)CC(=O)O)C
Caspase 4,1620,CASP4,P49662,,,,,,Human,M826,8654,,,252166854,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,15686936,CCCCCCN(CC(=O)C(NC(=O)C(n1cc(nc(c1=O)NCc1nonc1C)C(C)(C)C)CC)CC(=O)O)C
Caspase 5,1621,CASP5,P51878,,,,,,Human,M826,8654,,,252166854,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,15686936,CCCCCCN(CC(=O)C(NC(=O)C(n1cc(nc(c1=O)NCc1nonc1C)C(C)(C)C)CC)CC(=O)O)C
Caspase 7,1623,CASP7,P55210,,,,,,Human,isatin sulfonamide 34 [PMID: 11384246],6515,,,178103129,Inhibitor,Inhibition,,f,,,pKi,0,8.2,0,Ki,0,6,0,,,,,11384246,O=C1C(=O)N(c2c1cc(cc2)S(=O)(=O)N1CCC[C@H]1COc1ccccc1)Cc1ccccc1
Caspase 7,1623,CASP7,P55210,,,,,,Human,M826,8654,,,252166854,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,15686936,CCCCCCN(CC(=O)C(NC(=O)C(n1cc(nc(c1=O)NCc1nonc1C)C(C)(C)C)CC)CC(=O)O)C
Caspase 8,1624,CASP8,Q14790,,,,,,Human,emricasan,6508,,,178103122,Inhibitor,Inhibition,,f,,,pKi,0,8.3,0,Ki,0,5,0,,,,,16250635,OC(=O)C[C@@H](C(=O)COc1c(F)c(F)cc(c1F)F)NC(=O)[C@@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C
Caspase 9,1625,CASP9,P55211,,,,,,Human,isatin sulfonamide 34 [PMID: 11384246],6515,,,178103129,Inhibitor,Inhibition,,f,f,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,11384246,O=C1C(=O)N(c2c1cc(cc2)S(=O)(=O)N1CCC[C@H]1COc1ccccc1)Cc1ccccc1
CaS receptor,54,CASR,P41180,,,,,,Human,etelcalcetide,8375,,,252166587,Agonist,Agonist,,f,f,,pEC50,0,4.599999905,0,EC50,0,25000,0,=,Measuring ligand induced IP<sub>1</sub> accumulation.,,,23674604,
CaS receptor,54,CASR,P41180,,,,,,Human,evocalcet,9042,,,315661127,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)Cc1ccc(cc1)N1CC[C@@H](C1)N[C@@H](c1cccc2c1cccc2)C
CaS receptor,54,Casr,P48442,,,,,,Rat,neomycin,709,,,135652707,Agonist,Full agonist,,f,,,pKd,0,4,0,,0,0,0,,,,,7816802,OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@@H](CN)[C@H]([C@@H]([C@H]1N)O)O)O)O[C@@H]1[C@@H](O)[C@H](N)C[C@@H]([C@H]1O[C@H]1O[C@H](CN)[C@H]([C@@H]([C@H]1N)O)O)N
CaS receptor,54,CASR,P41180,,,,,,Human,spermine,710,,,135651562,Agonist,Full agonist,,t,,,pKd,0,3.5,0,,0,0,0,,,,,9357776,NCCCNCCCCNCCCN
CaS receptor,54,Casr,P48442,,,,,,Rat,Mg<sup>2+</sup>,708,,,135652741,Agonist,Partial agonist,,t,,,pKd,0,2.4,0,,0,0,0,,,,,7816802,
CaS receptor,54,CASR,P41180,,,,,,Human,encaleret,9474,,,329968414,Allosteric modulator,Negative,,f,f,,pIC50,0,7.900000095,0,-,0,0,0,=,Inhibition of 5 mM Ca<sup>2+</sup>-mediated luciferase reporter activity,,,24900301,O[C@H](CNC(Cc1ccc(c(c1)F)Cl)(C)C)CO[C@@H](c1ccccc1c1ccc(c(c1)C)C(=O)O)C
CaS receptor,54,CASR,P41180,,,,,,Human,NPS 2143,716,,,135650739,Allosteric modulator,Negative,,f,f,,pIC50,7.400000095,0,7.099999905,-,0,0,0,=,,,,15686947,N#Cc1c(cccc1Cl)OC[C@@H](CNC(Cc1ccc2c(c1)cccc2)(C)C)O
CaS receptor,54,CASR,P41180,,,,,,Human,NPS 2143,716,,,135650739,Allosteric modulator,Negative,,f,f,,pKB,6.699999809,0,6.199999809,-,0,0,0,=,Ca<sup>2+</sup><sub>i</sub> release,,,22210744,N#Cc1c(cccc1Cl)OC[C@@H](CNC(Cc1ccc2c(c1)cccc2)(C)C)O
CaS receptor,54,CASR,P41180,,,,,,Human,ronacaleret,9473,,,329968413,Allosteric modulator,Negative,,f,f,,pIC50,6.800000191,0,6.5,-,0,0,0,=,,,,19442519,O[C@@H](COc1cc(CCC(=O)O)cc(c1F)F)CNC(CC1Cc2c(C1)cccc2)(C)C
CaS receptor,54,CASR,P41180,,,,,,Human,SB-423562,9476,,,329968416,Allosteric modulator,Negative,,f,f,,pIC50,0,7.099999905,0,-,0,0,0,=,,,,19786130,N#Cc1ccc(cc1OC[C@@H](CNC(CC1Cc2c(C1)cccc2)(C)C)O)CCC(=O)O
CaS receptor,54,CASR,P41180,,,,,,Human,L-tryptophan,717,,,135651515,Allosteric modulator,Positive,,t,,,pKd,4.4,0,2.6,,0,0,0,,,,,10781086,OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,FPL64176,2518,,,135650283,Activator,None,,f,f,,pEC50,0,7.800000191,0,EC50,0,16,0,~,,,,0,COC(=O)c1c(C)[nH]c(c1C(=O)c1ccccc1Cc1ccccc1)C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,(-)-(S)-BayK8644,4065,,,178100888,Activator,None,,f,f,,pEC50,0,7.760000229,0,EC50,0,17.29999924,0,~,,,,0,COC(=O)C1=C(C)NC(=C([C@H]1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,diltiazem,2298,,,135650185,Channel blocker,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
Ca<sub>v</sub>1.1,528,Cacna1s,Q02485,,,,,,Rat,(+)-isradipine,2513,,,135650434,Gating inhibitor,Antagonist,,f,,,pIC50,8.2,0,6.7,,0,0,0,,,,,2458429,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.1,528,Cacna1s,Q02485,,,,,,Rat,nifedipine,2514,,,53801065,Gating inhibitor,Antagonist,,f,f,0.1-100,pIC50,0,6.300000191,0,-,0,0,0,=,,,,2451745,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,nimodipine,2523,,,53801057,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,~,,,,0,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
Ca<sub>v</sub>1.1,528,Cacna1s,Q02485,,,,,,Rat,nitrendipine,2334,,,135650723,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,2458429,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,FPL64176,2518,,,135650283,Activator,None,,f,f,15,-,0,0,0,-,0,0,0,=,,,,12842134,COC(=O)c1c(C)[nH]c(c1C(=O)c1ccccc1Cc1ccccc1)C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,(-)-(S)-BayK8644,4065,,,178100888,Activator,None,,f,f,,pEC50,0,7.760000229,0,EC50,0,17.29999924,0,~,,,,0,COC(=O)C1=C(C)NC(=C([C@H]1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,diltiazem,2298,,,135650185,Channel blocker,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,(-)-(<i>R</i>)-efonidipine,2519,,,135650419,Channel blocker,Antagonist,,f,,,pIC50,3.5,0,2,,0,0,0,,,,,15545287,CC1=C(C(=O)OCCN(c2ccccc2)Cc2ccccc2)[C@H](C(=C(N1)C)P1(=O)OCC(CO1)(C)C)c1cccc(c1)[N+](=O)[O-]
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Antagonist,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,10991994,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Channel blocker,Antagonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,12435810,
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,(-)-devapamil,2517,,,53801062,Gating inhibitor,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,8913371,COc1cccc(c1)CCN(CCC[C@@](c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,nifedipine,2514,,,53801065,Gating inhibitor,Antagonist,There was a 100-fold difference for nifedipine on smooth (pIC50 8.5) versus cardiac (pIC50 6.5) cells <i>in vitro</i> (Perez-Vizcaino <i>et al.</i> 1993).,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,11045961,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,nimodipine,2523,,,53801057,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6.800000191,0,-,0,0,0,=,,,,11487617,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,nitrendipine,2334,,,135650723,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,11487617,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.2,529,Cacna1c,Q01815,,,,,,Mouse,isradipine,4488,,,178101216,Gating inhibitor,None,,f,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,15146240,COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,nisoldipine,2524,,,135650722,Gating inhibitor,None,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,15454078,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OCC(C)C)C
Ca<sub>v</sub>1.2,529,Cacna1c,Q01815,,,,,,Mouse,nisoldipine,2524,,,135650722,Gating inhibitor,None,,f,,,pIC50,8,0,7,,0,0,0,,,,,10973973,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OCC(C)C)C
Ca<sub>v</sub>1.2,529,,,,,,,,Dog,nitrendipine,2334,,,135650723,Gating inhibitor,None,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,6093100,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,FPL64176,2518,,,135650283,Activator,None,,f,f,,pEC50,0,7.800000191,0,EC50,0,16,0,~,,,,0,COC(=O)c1c(C)[nH]c(c1C(=O)c1ccccc1Cc1ccccc1)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,(-)-(S)-BayK8644,4065,,,178100888,Activator,None,,f,f,,pEC50,0,7.760000229,0,EC50,0,17.29999924,0,~,,,,0,COC(=O)C1=C(C)NC(=C([C@H]1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,nifedipine,2514,,,53801065,Gating inhibitor,Antagonist,,f,f,,pIC50,0,7.699999809,0,IC50,0,20.10000038,0,=,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,,,19029287,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.3,530,Cacna1d,P27732,,,,,,Rat,nimodipine,2523,,,53801057,Gating inhibitor,Antagonist,,f,f,,pIC50,6.599999905,0,5.699999809,-,0,0,0,=,,,,11487617,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,nitrendipine,2334,,,135650723,Gating inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,3.589999914,0,=,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,,,19029287,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,isradipine,4488,,,178101216,Gating inhibitor,None,,f,,0.03-0.3,-,0,0,0,-,0,0,0,=,,,,11285265,COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,isradipine,4488,,,178101216,Gating inhibitor,None,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.50999999,0,=,Recombinant Ca<sub>v</sub>1.3 calcium channel complexes expressed in tsA201-cells,,,19029287,COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.3,530,Cacna1d,Q99246,,,,,,Mouse,nisoldipine,2524,,,135650722,Gating inhibitor,None,,f,,,pIC50,7,0,6.4,,0,0,0,,,,,12900400,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OCC(C)C)C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,(-)-(S)-BayK8644,4065,,,178100888,Activator,None,,f,f,,pEC50,0,7.760000229,0,EC50,0,17.29999924,0,~,,,,0,COC(=O)C1=C(C)NC(=C([C@H]1c1ccccc1C(F)(F)F)[N+](=O)[O-])C
Ca<sub>v</sub>1.4,531,Cacna1f,Q9JIS7,,,,,,Mouse,diltiazem,2298,,,135650185,Channel blocker,None,,f,f,,pIC50,0,4,0,-,0,0,0,=,,,,14744918,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,nifedipine,2514,,,53801065,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,14973233,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,nimodipine,2523,,,53801057,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,~,,,,0,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,nitrendipine,2334,,,135650723,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,~,,,,0,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
Ca<sub>v</sub>1.4,531,CACNA1F,O60840,,,,,,Human,isradipine,4488,,,178101216,Gating inhibitor,None,,f,f,1,-,0,0,0,-,0,0,0,=,,,,12853422,COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.4,531,Cacna1f,Q9JIS7,,,,,,Mouse,isradipine,4488,,,178101216,Gating inhibitor,None,,f,,,pIC50,0,6.7,0,-,0,0,0,=,,,,14744918,COC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.4,531,Cacna1f,Q9JIS7,,,,,,Mouse,L-(cis)-diltiazem,2349,,,135650511,Gating inhibitor,None,,f,,,pIC50,0,4.1,0,,0,0,0,,,,,14744918,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin CVIA,2531,,,135652364,Channel blocker,Antagonist,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin CVIB,2532,,,135652365,Channel blocker,Antagonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin CVIC,2533,,,135652366,Channel blocker,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin CVID,2534,,,135652367,Channel blocker,Antagonist,,f,,,pIC50,0,4.2,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin GVIA,2535,,,135652368,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,10938268,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CS)CCCNC(=N)N)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)N)CCCCN)CO)O)CO)CO)CS)CO)O)CO)Cc1ccc(cc1)O)CC(=O)N)CS)CS)CCCNC(=N)N)CO)CS)CC(=O)N)O)Cc1ccc(cc1)O
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin MVIIA,2536,,,135652369,Channel blocker,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10938268,NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,DW13.3,2527,,,135652139,Channel blocker,None,,f,,,pEC50,0,8.4,0,,0,0,0,,,,,9687583,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,None,,f,,100-1000,-,0,0,0,,0,0,0,,,,,8661496,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-conotoxin MVIIC,2537,,,135652370,Channel blocker,None,,f,f,25,pIC50,9.199999809,0,8.199999809,IC50,7,0,0.600000024,=,,,,10938268,
Ca<sub>v</sub>2.1,532,,,,,,,,Bovine,&omega;-conotoxin MVIID,2538,,,53801054,Channel blocker,None,,f,,,pIC50,0,9,0,,0,0,0,,,,,0,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-phonetoxin-IIA,2540,,,135652372,Channel blocker,None,,f,,,pKd,0,9.2,0,,0,0,0,,,,,9683727,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-PnTx3-3,2541,,,135652373,Channel blocker,None,,f,,0.06,-,0,0,0,,0,0,0,,,,,10884557,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,PnTx-3-6,2542,,,135652403,Channel blocker,None,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,15933156,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,kurtoxin,2521,,,135652245,Gating inhibitor,Antagonist,,f,,,pEC50,0,7.8,0,,0,0,0,,,,,11896142,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-grammotoxin SIA,2539,,,135652371,Gating inhibitor,Antagonist,,f,f,,pIC50,7.099999905,0,6.699999809,-,0,0,0,=,,,,9415720,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,mibefradil,2522,,,53801058,Gating inhibitor,None,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,10665814,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-agatoxin IIIA,2528,,,135652361,Gating inhibitor,None,,f,,,pKd,0,9.3,0,,0,0,0,,,,,8182443,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-agatoxin IVA,2529,,,135652362,Gating inhibitor,None,"P current component: Kd =~2nM, Q component Kd= >100nM",f,f,,pIC50,8.699999809,0,7,IC50,100,0,2,=,,,,10321243,
Ca<sub>v</sub>2.1,532,Cacna1a,P54282,,,,,,Rat,&omega;-agatoxin IVB,2530,,,135652363,Gating inhibitor,None,,f,f,,pKd,0,8.5,0,Kd,0,3,0,=,,,,8232218,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,DW13.3,2527,,,135652139,Channel blocker,Antagonist,,f,f,,pIC50,8.600000381,0,7.699999809,-,0,0,0,=,,,,9687583,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin CVIA,2531,,,135652364,Channel blocker,Antagonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin CVIB,2532,,,135652365,Channel blocker,Antagonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin CVIC,2533,,,135652366,Channel blocker,Antagonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,10938268,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin CVID,2534,,,135652367,Channel blocker,Antagonist,,f,f,,pIC50,0,10.19999981,0,-,0,0,0,=,,,,10938268,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin GVIA,2535,,,135652368,Channel blocker,Antagonist,,f,f,,pIC50,0,10.39999962,0,IC50,0,0.037999999,0,=,,,,10938268,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CS)CCCNC(=N)N)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)N)CCCCN)CO)O)CO)CO)CS)CO)O)CO)Cc1ccc(cc1)O)CC(=O)N)CS)CS)CCCNC(=N)N)CO)CS)CC(=O)N)O)Cc1ccc(cc1)O
Ca<sub>v</sub>2.2,533,CACNA1B,Q00975,,,,,,Human,&omega;-conotoxin MVIIA,2536,,,135652369,Channel blocker,Antagonist,,f,,,pIC50,0,1,0,,0,0,0,,,,,11756491,NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin MVIIA,2536,,,135652369,Channel blocker,Antagonist,,f,f,,pIC50,10.30000019,0,7.699999809,-,0,0,0,=,,,,10938268,NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-conotoxin MVIIC,2537,,,135652370,Channel blocker,Antagonist,,f,f,,pIC50,8.5,0,6.099999905,IC50,794,0,3.160000086,=,,,,1352986,
Ca<sub>v</sub>2.2,533,CACNA1B,Q00975,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Channel blocker,Antagonist,,f,,,pIC50,0,5.9,0,,0,0,0,,,,,12435810,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,kurtoxin,2521,,,135652245,Gating inhibitor,Antagonist,,f,,,pEC50,0,6.3,0,,0,0,0,,,,,11896142,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,&omega;-grammotoxin SIA,2539,,,135652371,Gating inhibitor,Antagonist,,f,,0.5,-,0,0,0,,0,0,0,,,,,9415720,
Ca<sub>v</sub>2.2,533,Cacna1b,Q02294,,,,,,Rat,NP118809,7765,,,223366098,Gating inhibitor,None,,f,f,,pIC50,0,7,0,IC50,0,110,0,=,,,,19815411,O=C(N1CCN(CC1)C(c1ccccc1)c1ccccc1)CC(c1ccccc1)c1ccccc1
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,DW13.3,2527,,,135652139,Channel blocker,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,9687583,
Ca<sub>v</sub>2.3,534,CACNA1E,Q15878,,,,,,Human,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,0,4.599999905,0,IC50,0,27400,0,=,,,,8071363,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,&omega;-phonetoxin-IIA,2540,,,135652372,Channel blocker,Antagonist,,f,,,pKd,0,7.2,0,,0,0,0,,,,,11827974,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,&omega;-PnTx3-3,2541,,,135652373,Channel blocker,Antagonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,10884557,
Ca<sub>v</sub>2.3,534,CACNA1E,Q15878,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Channel blocker,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,12435810,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,PnTx-3-6,2542,,,135652403,Channel blocker,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,15933156,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,Ni<sup>2+</sup>,2476,,,135652744,Gating inhibitor,Antagonist,,f,,,pIC50,4.7,0,3.6,,0,0,0,,,,,8661496,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,SNX482,4315,,,178101132,Gating inhibitor,Antagonist,,f,,,pIC50,8.2,0,7.1,-,0,0,0,=,,,,10627594,
Ca<sub>v</sub>2.3,534,CACNA1E,Q15878,,,,,,Human,SNX482,4315,,,178101132,Gating inhibitor,Antagonist,,f,f,,pIC50,8,0,7.5,IC50,30,0,15,=,,,,9799496,
Ca<sub>v</sub>2.3,534,Cacna1e,Q07652,,,,,,Rat,mibefradil,2522,,,53801058,Gating inhibitor,None,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,,,,10665814,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>3.1,535,Cacna1g,O54898,,,,,,Rat,(-)-(<i>R</i>)-efonidipine,2519,,,135650419,Channel blocker,Antagonist,,f,,,pIC50,7,0,5,,0,0,0,,,,,15545287,CC1=C(C(=O)OCCN(c2ccccc2)Cc2ccccc2)[C@H](C(=C(N1)C)P1(=O)OCC(CO1)(C)C)c1cccc(c1)[N+](=O)[O-]
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Antagonist,,f,f,,pIC50,6.599999905,0,6,IC50,1000,0,270,=,,,,10991994,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>3.1,535,Cacna1g,O54898,,,,,,Rat,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,3.799999952,0,3.599999905,IC50,250000,0,167000,=,,,,10585925,
Ca<sub>v</sub>3.1,535,Cacna1g,O54898,,,,,,Rat,pimozide,90,,,135650825,Channel blocker,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,11784784,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,ML218,7720,,,223366053,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,22368764,O=C(c1cc(Cl)cc(c1)Cl)NC[C@@H]1[C@@H]2[C@H]1CN(C2)CCC(C)(C)C
Ca<sub>v</sub>3.1,535,Cacna1g,O54898,,,,,,Rat,kurtoxin,2521,,,135652245,Gating inhibitor,Antagonist,,f,f,,pIC50,7.800000191,0,7.300000191,IC50,50.09999847,0,15.80000019,=,,,,11896142,
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Antagonist,,f,f,,pIC50,7.199999809,0,5.900000095,IC50,1100,0,69,=,,,,10991994,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,5.199999809,0,4.900000095,IC50,12000,0,5700,=,,,,10585925,
Ca<sub>v</sub>3.2,536,Cacna1h,Q9EQ60,,,,,,Rat,pimozide,90,,,135650825,Channel blocker,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,11784784,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,ML218,7720,,,223366053,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,22368764,O=C(c1cc(Cl)cc(c1)Cl)NC[C@@H]1[C@@H]2[C@H]1CN(C2)CCC(C)(C)C
Ca<sub>v</sub>3.2,536,Cacna1h,Q9EQ60,,,,,,Rat,kurtoxin,2521,,,135652245,Gating inhibitor,Antagonist,,f,f,,pIC50,7.599999905,0,7.300000191,IC50,50.09999847,0,25.10000038,=,,,,11896142,
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Antagonist,,f,f,,pIC50,0,5.800000191,0,IC50,0,1500,0,=,,,,10991994,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
Ca<sub>v</sub>3.3,537,Cacna1i,Q9Z0Y8,,,,,,Rat,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,4.099999905,0,3.700000048,IC50,216000,0,87000,=,,,,10585925,
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,pimozide,90,,,135650825,Channel blocker,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,11784784,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,ML218,7720,,,223366053,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,22368764,O=C(c1cc(Cl)cc(c1)Cl)NC[C@@H]1[C@@H]2[C@H]1CN(C2)CCC(C)(C)C
Catechol-O-methyltransferase,2472,COMT,P21964,,,,,,Human,entacapone,6647,,,178103260,Inhibitor,Inhibition,membrane-bound enzyme,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,membrane-bound enzyme,,,7703232,CCN(C(=O)/C(=C/c1cc(O)c(c(c1)[N+](=O)[O-])O)/C#N)CC
Catechol-O-methyltransferase,2472,COMT,P21964,,,,,,Human,entacapone,6647,,,178103260,Inhibitor,Inhibition,soluble enzyme,f,t,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,soluble enzyme,,,7703232,CCN(C(=O)/C(=C/c1cc(O)c(c(c1)[N+](=O)[O-])O)/C#N)CC
Catechol-O-methyltransferase,2472,COMT,P21964,,,,,,Human,opicapone,8988,,,310264766,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,24847974,OC1=C/C(=c/2o[nH]c(n2)c2c(C)c(Cl)c([n+](c2Cl)[O-])C)/C=C(C1=O)[N+](=O)[O-]
Catechol-O-methyltransferase,2472,Comt,P22734,,,,,,Rat,opicapone,8988,,,310264766,Inhibitor,Inhibition,,f,f,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,24847974,OC1=C/C(=c/2o[nH]c(n2)c2c(C)c(Cl)c([n+](c2Cl)[O-])C)/C=C(C1=O)[N+](=O)[O-]
Catechol-O-methyltransferase,2472,Comt,O88587,,,,,,Mouse,opicapone,8988,,,310264766,Inhibitor,Inhibition,,f,f,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,24847974,OC1=C/C(=c/2o[nH]c(n2)c2c(C)c(Cl)c([n+](c2Cl)[O-])C)/C=C(C1=O)[N+](=O)[O-]
Cathepsin A,1581,CTSA,P10619,,,,,,Human,example 166  [WO2014154727],7892,,,223366215,Inhibitor,Inhibition,,f,t,,pIC50,0,7.039999962,0,IC50,0,92,0,=,,,,0,OC(=O)CC(c1ncc(s1)C)c1cc(Cl)cc(c1)c1cccc(c1)CC(=O)N
cathepsin B,2343,CTSB,P07858,,,,,,Human,LHVS,9298,,,318164817,Inhibitor,Inhibition,,f,f,,pIC50,0,5.869999886,0,IC50,0,1360,0,=,,,,17535802,CC(C[C@H](C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1)NC(=O)N1CCOCC1)C
cathepsin D,2345,CTSD,P07339,,,,,,Human,grassystatin A,8674,,,252166874,Inhibitor,Inhibition,,f,f,,pIC50,0,7.579999924,0,IC50,0,26.5,0,=,,,,19715320,COC(=O)[C@@H]1CCCN1C(=O)[C@H](N(C(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)C[C@@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)OC(=O)[C@@H](N(C)C)C(C)C)CC(C)C)CC(=O)N)CC(C)C)O)C)C)Cc1ccccc1
cathepsin E,2346,CTSE,P14091,,,,,,Human,grassystatin A,8674,,,252166874,Inhibitor,Inhibition,,f,t,,pIC50,0,9.050000191,0,IC50,0,0.885999978,0,=,,,,19715320,COC(=O)[C@@H]1CCCN1C(=O)[C@H](N(C(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)C[C@@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)OC(=O)[C@@H](N(C)C)C(C)C)CC(C)C)CC(=O)N)CC(C)C)O)C)C)Cc1ccccc1
cathepsin K,2350,CTSK,P43235,,,,,,Human,L873724,7860,,,223366190,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,19453281,CC(C[C@@H](C(=O)NCC#N)N[C@H](C(F)(F)F)c1ccc(cc1)c1ccc(cc1)S(=O)(=O)C)C
cathepsin K,2350,CTSK,P43235,,,,,,Human,odanacatib,6478,,,178103092,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,18226527,N#CC1(CC1)NC(=O)[C@H](CC(F)(C)C)N[C@H](C(F)(F)F)c1ccc(cc1)c1ccc(cc1)S(=O)(=O)C
cathepsin K,2350,CTSK,P43235,,,,,,Human,relacatib,7862,,,223366192,Inhibitor,Inhibition,,f,t,,pKi,0,9.390000343,0,Ki,0,0.409999996,0,=,,,,20218623,CC(C[C@@H](C(=O)N[C@H]1CC[C@H](N(CC1=O)S(=O)(=O)c1ccccn1)C)NC(=O)c1cc2c(o1)cccc2)C
cathepsin L,2351,CTSL,P07711,,,,,,Human,KGP94,6533,,,178103147,Inhibitor,Inhibition,,f,t,,pIC50,0,6.900000095,0,IC50,0,131.3999939,0,=,,,,20933415,NC(=S)N/N=C(/c1cccc(c1)Br)c1cccc(c1)O
cathepsin L,2351,CTSL,P07711,,,,,,Human,LHVS,9298,,,318164817,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,17535802,CC(C[C@H](C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1)NC(=O)N1CCOCC1)C
cathepsin S,2353,CTSS,P25774,,,,,,Human,LHVS,9298,,,318164817,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,17535802,CC(C[C@H](C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1)NC(=O)N1CCOCC1)C
cathepsin S,2353,CTSS,P25774,,,,,,Human,odanacatib,6478,,,178103092,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,18226527,N#CC1(CC1)NC(=O)[C@H](CC(F)(C)C)N[C@H](C(F)(F)F)c1ccc(cc1)c1ccc(cc1)S(=O)(=O)C
cathepsin Z,2354,CTSZ,Q9UBR2,,,,,,Human,odanacatib,6478,,,178103092,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,18226527,N#CC1(CC1)NC(=O)[C@H](CC(F)(C)C)N[C@H](C(F)(F)F)c1ccc(cc1)c1ccc(cc1)S(=O)(=O)C
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,PGF<sub>1&alpha;</sub>,5412,,,178102065,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O)O
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,progesterone,2377,,,135651551,Activator,Full agonist,,t,f,,pEC50,8.109999657,0,8,EC50,10,0,7.699999809,=,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry,  2-3  &micro;M shows the saturating efficacy.",,,21412339,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Inhibition,,f,f,,pIC50,4.5,0,4.400000095,IC50,40000,0,30000,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry",,,21412338,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
CatSper1,388,Catsper1,Q91ZR5,,,,,,Mouse,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Inhibition,,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,=,Whole cell patch clamp,,,16467839,
CatSper1,388,Catsper1,Q91ZR5,,,,,,Mouse,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.6,0,IC50,0,2500,0,>,Patch clamp electrophysiology,,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry",,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper1,388,Catsper1,Q91ZR5,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,=,Whole cell patch clamp,,,16467839,
CatSper1,388,CATSPER1,Q8NEC5,,,,,,Human,HC-056456,4212,,,178101029,Channel blocker,None,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,19718436,[O-][n+]1onc(c1C(=O)c1cccs1)C(=O)c1cccs1
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,PGF<sub>1&alpha;</sub>,5412,,,178102065,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O)O
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,progesterone,2377,,,135651551,Activator,Full agonist,,t,f,,pEC50,0,8.109999657,0,EC50,0,7.699999809,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry; 2-3  &micro;M shows the saturating efficacy.",,,21412339,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
CatSper2,389,Catsper2,A2ARP9,,,,,,Mouse,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,=,Whole cell patch clamp.,,,21642646,
CatSper2,389,Catsper2,A2ARP9,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,=,Whole cell patch clamp.,,,21642646,
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Inhibition,,f,f,,pIC50,4.5,0,4.400000095,IC50,40000,0,30000,=,Patch clamp electrophysiology and kinetic rapid mixing fluometry.,,,21412338,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
CatSper2,389,CATSPER2,Q96P56,,,,,,Human,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,Patch clamp electrophysiology and kinetic rapid mixing fluometry.,,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper2,389,Catsper2,A2ARP9,,,,,,Mouse,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,4.6,0,IC50,0,25000,0,>,Patch clamp electrophysiology.,,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,PGF<sub>1&alpha;</sub>,5412,,,178102065,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O)O
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,progesterone,2377,,,135651551,Activator,Full agonist,,t,f,,pEC50,0,8.109999657,0,EC50,0,7.699999809,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry, 2-3&micro;M shows the saturating efficacy.",,,21412339,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
CatSper3,390,Catsper3,Q80W99,,,,,,Mouse,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CatSper3,390,Catsper3,Q80W99,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Inhibition,,f,f,,pIC50,4.5,0,4.400000095,IC50,40000,0,30000,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",,,21412338,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
CatSper3,390,CATSPER3,Q86XQ3,,,,,,Human,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper3,390,Catsper3,Q80W99,,,,,,Mouse,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.6,0,IC50,0,2500,0,>,Patch clamp electrophysiology.,,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,PGF<sub>1&alpha;</sub>,5412,,,178102065,Activator,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,Patch clamp electrophysiology.,,,21412339,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O)O
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,progesterone,2377,,,135651551,Activator,Full agonist,,t,f,,pEC50,0,8.109999657,0,EC50,0,7.699999809,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry, 2-3&micro;M shows the saturating efficacy.",,,21412339,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
CatSper4,391,Catsper4,Q8BVN3,,,,,,Mouse,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,Antagonist,,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CatSper4,391,Catsper4,Q8BVN3,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,=,Whole cell patch clamp electrophysiology.,,,16467839,
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,Inhibition,,f,f,,pIC50,4.5,0,4.400000095,IC50,40000,0,30000,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",,,21412338,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
CatSper4,391,Catsper4,Q8BVN3,,,,,,Mouse,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.6,0,IC50,0,2500,0,>,Patch clamp electrophysiology.,,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CatSper4,391,CATSPER4,Q7RTX7,,,,,,Human,NNC55-0396,4269,,,178101086,Channel blocker,Inhibition,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",,,21412339,CN(CC[C@]1(CCc2c([C@@H]1C(C)C)ccc(c2)F)OC(=O)C1CC1)CCCc1nc2c([nH]1)cccc2
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,<i>R</i>-(+)-methanandamide,2506,,,53801074,Agonist,Agonist,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,8893848,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)N[C@@H](CO)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,nabilone,9071,,,315661156,Agonist,Agonist,,f,f,,pKi,0,8.399999619,0,Ki,0,3.980000019,0,=,,,,21885167,CCCCCCC(c1cc(O)c2c(c1)OC(C1C2CC(=O)CC1)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,CP55940,730,,,135650130,Agonist,Full agonist,,f,f,,pKi,9.199999809,0,8.300000191,-,0,0,0,=,,,,7565624,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,HU-210,731,,,135650355,Agonist,Full agonist,,f,f,,pKi,10.19999981,0,9.100000381,-,0,0,0,=,,,,7565624,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,JWH-018,9706,,,348353665,Agonist,Full agonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,10525107,CCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,O-1812,732,,,135650753,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,11181068,OC[C@H](NC(=O)CCC/C=CC/C=CC/C=CC/C=CC(CCCCC#N)(C)C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,Sch.336,9799,,,0,Agonist,Inverse agonist,,f,f,,pEC50,0,6.699999809,0,EC50,0,200,0,=,,,,16258021,COc1ccc(c(c1)S(=O)(=O)c1ccc(cc1)OC)S(=O)(=O)c1ccc(cc1)[C@@H](NS(=O)(=O)C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,Sch.336,9799,,,0,Agonist,Inverse agonist,,f,f,,pKi,0,6.039999962,0,Ki,0,905,0,=,,,,15664857,COc1ccc(c(c1)S(=O)(=O)c1ccc(cc1)OC)S(=O)(=O)c1ccc(cc1)[C@@H](NS(=O)(=O)C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Agonist,Partial agonist,,f,t,,pKi,7.400000095,0,7.300000191,-,0,0,0,=,,,,7565624,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,GAT100,9237,,,315661312,Allosteric modulator,Negative,,f,f,,pEC50,0,6.389999866,0,EC50,0,409.7999878,0,=,"Measuring GAT100's inhibition of [<sup>3</sup>H]SR141716A binding, in radioligand binding assays",,,27046127,N#CSc1ccc2c(c1)c(CC)c([nH]2)C(=O)NCCc1ccc(cc1)N1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,GAT100,9237,,,315661312,Allosteric modulator,Negative,,f,f,,pEC50,0,7.71999979,0,EC50,0,19.20000076,0,=,"Although GAT100 antagonized CP55940-induced stimulation of [<sup>35</sup>S]GTP&gamma;S binding to human CB<sub>1</sub> CHO cell membranes, it enhanced the binding of [<sup>3</sup>H]CP55940 to these membranes. The EC<sub>50</sub> and E<sub>max</sub> values of GAT100 for this enhancement, with the 95% confidence limits shown in brackets, were 19.6 nM (10.4 & 36.9 nM) and 116.5% (108.3 & 124.6%), respectively. GAT100 (500 nM) was also found to enhance saturation binding of [<sup>3</sup>H]CP55940 to human CB<sub>1</sub> HEK293 cell membranes.",,,26529344,N#CSc1ccc2c(c1)c(CC)c([nH]2)C(=O)NCCc1ccc(cc1)N1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,pepcan-12,9188,,,315661267,Allosteric modulator,Negative,,f,f,,pKB,8.329999924,0,8.090000153,-,0,0,0,=,,,,22952224,
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,Org27569,7851,,,223366181,Allosteric modulator,Positive,,f,t,,pEC50,0,6.849999905,0,EC50,0,140,0,=,Measured as increased binding of radiolabelled orthosteric agonist CP55940,,,22571451,CCc1c([nH]c2c1cc(Cl)cc2)C(=O)NCCc1ccc(cc1)N1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,ibipinabant,9234,,,315661309,Antagonist,Antagonist,,f,t,,pKi,0,8.109999657,0,Ki,0,7.800000191,0,=,Displacement of CP-55940 binding from recombinant human cannabinoid receptor 1 expressed in CHO cells,,,14736243,CN=C(N1N=C([C@H](C1)c1ccccc1)c1ccc(cc1)Cl)NS(=O)(=O)c1ccc(cc1)Cl
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,LY320135,742,,,135650548,Antagonist,Antagonist,,f,f,,pKi,0,6.900000095,0,Ki,0,126,0,=,,,,9435190,COc1ccc2c(c1)oc(c2C(=O)c1ccc(cc1)C#N)c1ccc(cc1)OC
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,rimonabant,743,,,135650901,Antagonist,Antagonist,,f,f,,pKi,8.699999809,0,7.900000095,Ki,12.60000038,0,1.99000001,=,,,,7565624,Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,otenabant,9232,,,315661307,Antagonist,Inverse agonist,,f,t,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,Displacement of [3H]SR141716A from human CB1 receptor expressed in HEK293 cells,,,19102698,CCNC1(CCN(CC1)c1ncnc2c1nc(n2c1ccc(cc1)Cl)c1ccccc1Cl)C(=O)N
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,otenabant,9232,,,315661307,Antagonist,Inverse agonist,,f,f,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,Displacement of [3H]SR141716A from CB1 receptor in rat brain,,,19102698,CCNC1(CCN(CC1)c1ncnc2c1nc(n2c1ccc(cc1)Cl)c1ccccc1Cl)C(=O)N
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,nabilone,9071,,,315661156,Agonist,Agonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.309999943,0,=,,,,21885167,CCCCCCC(c1cc(O)c2c(c1)OC(C1C2CC(=O)CC1)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,CP55940,730,,,135650130,Agonist,Full agonist,,f,f,,pKi,9.199999809,0,8.600000381,-,0,0,0,=,,,,7565624,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,HU-210,731,,,135650355,Agonist,Full agonist,,f,f,,pKi,9.800000191,0,9.300000191,-,0,0,0,=,,,,7565624,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,HU-308,746,,,135650356,Agonist,Full agonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25.10000038,0,=,,,,10588688,CCCCCCC(c1cc(OC)c(c(c1)OC)[C@H]1C=C(CO)[C@@H]2C[C@H]1C2(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,JWH-018,9706,,,348353665,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,10525107,CCCCCn1cc(c2c1cccc2)C(=O)c1cccc2c1cccc2
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,JWH-133,747,,,135650450,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,10658595,CCCC(c1ccc2c(c1)OC([C@H]1[C@H]2CC(=CC1)C)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,"L-759,633",748,,,135650489,Agonist,Full agonist,,f,f,,pKi,8.199999809,0,7.699999809,Ki,19.89999962,0,6.309999943,=,,,,10188977,CCCCCCC(c1cc(OC)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,"L-759,656",749,,,135650490,Agonist,Full agonist,,f,f,,pKi,7.900000095,0,7.699999809,Ki,19.89999962,0,12.60000038,=,,,,10188977,CCCCCCC(c1cc(OC)c2c(c1)OC([C@H]1[C@H]2CC(=C)CC1)(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,Sch.336,9799,,,0,Agonist,Inverse agonist,,f,t,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,15664857,COc1ccc(c(c1)S(=O)(=O)c1ccc(cc1)OC)S(=O)(=O)c1ccc(cc1)[C@@H](NS(=O)(=O)C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,Sch.336,9799,,,0,Agonist,Inverse agonist,,f,t,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,"Measuring competitin binding with [<sup>3</sup>H]CP55,940 for binding to human CB<sub>2</sub> on Sf9 cell membranes.",,,16258021,COc1ccc(c(c1)S(=O)(=O)c1ccc(cc1)OC)S(=O)(=O)c1ccc(cc1)[C@@H](NS(=O)(=O)C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Agonist,Partial agonist,,f,f,,pKi,7.5,0,7.099999905,-,0,0,0,=,,,,7565624,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,ibipinabant,9234,,,315661309,Antagonist,Antagonist,,f,f,,pKi,0,5.099999905,0,Ki,0,7943,0,=,"Displacement of specific CP-55,940 binding in CHO cells stably transfected with human CB2
receptor",,,14736243,CN=C(N1N=C([C@H](C1)c1ccccc1)c1ccc(cc1)Cl)NS(=O)(=O)c1ccc(cc1)Cl
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,SR144528,751,,,135651075,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,8.300000191,Ki,5.010000229,0,0.629999995,=,,,,10188977,Cc1ccc(cc1)Cn1nc(cc1c1ccc(c(c1)C)Cl)C(=O)N[C@H]1[C@@]2(C)CC[C@@H](C1(C)C)C2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,gastrin-17,3559,GAST,Human,135651758,Agonist,Full agonist,,f,,,pIC50,0,6.1,0,-,0,0,0,=,,,,1975695,
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,Glaxo-11p,866,,,135650305,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,8558528,O=C(NC1C(=O)N(c2ccccc2)c2c(N(C1=O)CC(=O)N(c1ccc(cc1)N(C)C)C(C)C)cccc2)Nc1ccccc1
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,GW-5823,865,,,135650337,Agonist,Full agonist,,f,f,,pIC50,0,7.599999905,0,IC50,0,25.10000038,0,=,,,,9276016,COc1ccc(cc1)N(C(=O)CN1C(=O)C(Cc2[nH]nc3c2cccc3)C(=O)N(c2c1cccc2)c1ccccc1)C(C)C
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,JMV180,3888,,,178100724,Agonist,Full agonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5.440000057,0,=,,,,7654246,CCCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)OCCc1ccccc1)CC(=O)O)CCCC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)OC(C)(C)C)Cc1ccc(cc1)OS(=O)(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,PD136450,867,,,135650796,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,7516969,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)/C=C/C(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,pentagastrin,870,,,135652381,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,-,0,0,0,=,,,,1975695,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CCNC(=O)OCC(C)C
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,rebamipide,871,,,135650890,Agonist,Full agonist,,f,,,pIC50,0,4.4,0,,0,0,0,,,,,15556137,Clc1ccc(cc1)C(=O)NC(C(=O)O)Cc1cc(=O)[nH]c2c1cccc2
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,SR146131,868,,,135651076,Agonist,Full agonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,10215648,COc1cc(Cl)c(cc1c1nc(sc1CCC1CCCCC1)NC(=O)c1cc2c(n1CC(=O)O)c(C)cc(c2)C)OC
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,devazepide,878,,,135650466,Antagonist,Antagonist,,f,f,,pIC50,0,9.720000267,0,IC50,0,0.189999998,0,=,,,,1975695,O=C(c1cc2c([nH]1)cccc2)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,dexloxiglumide,889,,,135650173,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,17684117,CCCCCN(C(=O)[C@H](NC(=O)c1ccc(c(c1)Cl)Cl)CCC(=O)O)CCCOC
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,IQM-97423,876,,,135650413,Antagonist,Antagonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,15331911,O=C(NC(C)(C)C)N[C@H](C(=O)N[C@@H]1CCCN2[C@H]1CC(=O)N(C2=O)Cc1ccccc1)Cc1c[nH]c2c1cccc2
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,JNJ-17156516,877,,,135650445,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,17684117,COc1ccc(cc1)n1nc(cc1c1ccc(c(c1)Cl)Cl)C[C@@H](c1cccc(c1)C)C(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,L-365260,879,,,135650467,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,1975695,Cc1cccc(c1)NC(=O)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,L-736380,880,,,135650485,Antagonist,Antagonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,8632408,O=C(N[C@@H]1N=C(C2CCCCC2)c2c(N(C1=O)C)cccc2)Nc1cccc(c1)N(c1n[nH]nn1)C
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,L-740093,881,,,135650486,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,7969084,Cc1cccc(c1)NC(=O)N[C@@H]1N=C(N2CC3CCC(C2)CC3)c2c(N(C1=O)C)cccc2
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,lintitript,890,,,135650524,Antagonist,Antagonist,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,,,,10988332,OC(=O)Cn1c(cc2c1cccc2)C(=O)Nc1scc(n1)c1ccccc1Cl
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,lintitript,890,,,135650524,Antagonist,Antagonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,7681406,OC(=O)Cn1c(cc2c1cccc2)C(=O)Nc1scc(n1)c1ccccc1Cl
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,lorglumide,891,,,135650531,Antagonist,Antagonist,,f,f,,pIC50,8.199999809,0,6.699999809,IC50,199,0,6.309999943,=,,,,1975695,CCCCCN(C(=O)C(NC(=O)c1ccc(c(c1)Cl)Cl)CCC(=O)O)CCCCC
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,loxiglumide,892,,,135650534,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,3663268,CCCCCN(C(=O)C(NC(=O)c1ccc(c(c1)Cl)Cl)CCC(=O)O)CCCOC
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,PD-135158,882,,,135650794,Antagonist,Antagonist,,f,,,pIC50,0,5.9,0,,0,0,0,,,,,1975695,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](CC1CNc2c1cccc2)(NC(=O)OC1C[C@H]2C([C@]1(C)CC2)(C)C)C)CCC(=O)O
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,PD-140548,904,,,135650797,Antagonist,Antagonist,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,8605955,OC(=O)C[C@H](NC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1ccccc1
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,pranazepide,874,,,135650262,Antagonist,Antagonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,7509389,O=C(c1cc2c([nH]1)cccc2)N[C@H]1N=C(c2ccccc2F)c2c3N(C1=O)CCc3ccc2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,proglumide,893,,,135650854,Antagonist,Antagonist,,f,,,pIC50,0,2.2,0,,0,0,0,,,,,3440035,CCCN(C(=O)C(NC(=O)c1ccccc1)CCC(=O)O)CCC
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,SC-50998,883,,,135651019,Antagonist,Antagonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,0,OC(=O)C1CN(C(=O)C1NC(=O)c1c[nH]c2c1cccc2)c1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,desulfated gastrin-14,3558,GAST,Human,178100524,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,desulfated gastrin-17,8408,GAST,Human,252166618,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,desulfated gastrin-34,8409,GAST,Human,252166619,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,desulfated gastrin-71,8410,GAST,Human,252166620,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,gastrin-14,8411,GAST,Human,252166621,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,gastrin-34,3562,GAST,Human,178100525,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,gastrin-71,3566,GAST,Human,178100529,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,desulfated cholecystokinin-8,3725,,,178100598,Agonist,Full agonist,,t,f,,pIC50,8.699999809,0,8.300000191,-,0,0,0,=,,,,7681836,CSCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)C(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NN)CC(=O)O
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,gastrin-17,3559,GAST,Human,135651758,Agonist,Full agonist,,t,f,,pIC50,0,8.300000191,0,-,0,0,0,=,,,,1975695,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,JMV310,898,,,135652222,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,1698251,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,PBC-264,3948,,,178100775,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,IC50,0,0.86,0,=,,,,8720482,CCCC[C@H](NC(=O)[C@H](Cc1ccc(cc1)OS(=O)(=O)O)NC(=O)CC)NCC(=O)C(=O)N[C@H](C(=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCC)NC)CC(=O)O)Cc1ccccc1)Cc1c[nH]c2c1cccc2
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,pentagastrin,870,,,135652381,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,-,0,0,0,=,,,,1975695,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CCNC(=O)OCC(C)C
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,RB-400,900,,,135652432,Agonist,Full agonist,,f,f,,pKi,0,9.100000381,0,Ki,0,0.790000021,0,=,,,,14698161,CCCC[C@H](N(C(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CC(=O)O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,devazepide,878,,,135650466,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,7681836,O=C(c1cc2c([nH]1)cccc2)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,GV150013,3503,,,178100490,Antagonist,Antagonist,,f,f,,pIC50,0,9.409999847,0,IC50,0,0.389999986,0,=,,,,11020274,O=C(N[C@H]1C(=O)N(c2ccccc2)c2c(N(C1=O)CC13CC4CC(C3)CC(C1)C4)cccc2)Nc1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,GW-5823,865,,,135650337,Antagonist,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,9276016,COc1ccc(cc1)N(C(=O)CN1C(=O)C(Cc2[nH]nc3c2cccc3)C(=O)N(c2c1cccc2)c1ccccc1)C(C)C
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,itriglumide,909,,,135650437,Antagonist,Antagonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,10204685,OC(=O)C[C@H](c1cccc2c1cccc2)CC(=O)Nc1c(C)cc(cc1C(=O)N1CCC2(CC1)CCCC2)C
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,JNJ-26070109,6665,,,178103277,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,-,0,0,0,=,,,,21493750,Brc1ccc(c(c1)NS(=O)(=O)c1cccc2c1nccn2)C(=O)N[C@@H](c1ccc(cc1F)F)C
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,L-365260,879,,,135650467,Antagonist,Antagonist,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.980000019,0,=,,,,7681836,Cc1cccc(c1)NC(=O)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,L-740093,881,,,135650486,Antagonist,Antagonist,,f,f,,pIC50,0,9.199999809,0,IC50,0,0.629999995,0,=,,,,11738246,Cc1cccc(c1)NC(=O)N[C@@H]1N=C(N2CC3CCC(C2)CC3)c2c(N(C1=O)C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,lorglumide,891,,,135650531,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,8914862,CCCCCN(C(=O)C(NC(=O)c1ccc(c(c1)Cl)Cl)CCC(=O)O)CCCCC
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,LY262691,3509,,,178100495,Antagonist,Antagonist,,f,f,,pIC50,0,7.5,0,IC50,0,31,0,=,,,,21228869,Brc1ccc(cc1)NC(=O)N1NC(=O)[C@H]([C@@H]1c1ccccc1)c1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,LY-288513,902,,,135650545,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,8914862,Brc1ccc(cc1)NC(=O)N1NC(=O)[C@@H]([C@H]1c1ccccc1)c1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,PD-135158,882,,,135650794,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,,0,0,0,,,,,8914862,O=C(N[C@H](c1ccccc1)CNC(=O)[C@@](CC1CNc2c1cccc2)(NC(=O)OC1C[C@H]2C([C@]1(C)CC2)(C)C)C)CCC(=O)O
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,PD-135666,903,,,135650795,Antagonist,Antagonist,,f,,,pIC50,0,9.8,0,,0,0,0,,,,,8605955,OC(=O)C[C@@H](NC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1ccccc1
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,PD-140548,904,,,135650797,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,7684452,OC(=O)C[C@H](NC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1ccccc1
CCK<sub>2</sub> receptor,77,Cckbr,P56481,,,,,,Mouse,PD-149164,905,,,135650798,Antagonist,Antagonist,,f,,,pIC50,0,10.1,0,,0,0,0,,,,,8931944,OC(=O)CC(NC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1ccc(cc1)F
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,RP-69758,906,,,135650931,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,7813588,O=C(Nc1cccc(c1)CC(=O)O)NCC(=O)N(c1ccccc1)CC(=O)N(c1ccccc1)C
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,RP73870,3523,,,178100503,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,9.800000191,0,=,,,,10385255,COc1cccc(c1)N(C(=O)CNC(=O)Nc1cccc(c1)CCS(=O)(=O)O)CC(=O)N(c1ccccc1)C
CCR1,58,CCR1,P32246,,,,,,Human,Flu-CCL3,760,,,135652155,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,11170631,
CCR1,58,CCR1,P32246,,,,,,Human,"CP-481,715",3497,,,178100485,Antagonist,Antagonist,,f,f,,pKd,0,8,0,Kd,0,9.199999809,0,=,,,,12909630,O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C
CCR2,59,CCR2,P41597,,,,,,Human,HIV-Tat,773,,,135652187,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR2,59,CCR2,P41597,,,,,,Human,HIV-Tat,773,,,135652187,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,9789057,
CCR2,59,CCR2,P41597,,,,,,Human,GSK Compound 34,3502,,,178100489,Antagonist,Antagonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25.10000038,0,=,,,,0,OCC(CNc1cccc(c1)C1=C(C(=O)NC1=O)c1cn(c2c1cc(F)cc2)C)O
CCR2,59,CCR2,P41597,,,,,,Human,INCB3284,9045,,,315661130,Antagonist,Antagonist,,f,t,,pIC50,0,8.430000305,0,IC50,0,3.700000048,0,=,,,,24900329,COc1ccc(cn1)C1(O)CCC(CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F
CCR2,59,Ccr2,P51683,,,,,,Mouse,INCB3344,777,,,135650389,Antagonist,Antagonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,16210643,CCO[C@H]1CN(C[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)[C@@H]1CC[C@](CC1)(O)c1ccc2c(c1)OCO2
CCR2,59,CCR2,P41597,,,,,,Human,INCB8761,9032,,,315661117,Antagonist,Antagonist,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,,,,24900280,O=C(N1CC[C@@H](C1)NC1CCC(CC1)(O)c1ccc(cn1)c1ncccn1)CNC(=O)c1cccc(c1)C(F)(F)F
CCR2,59,CCR2,P41597,,,,,,Human,MC148R,778,,,135652282,Antagonist,Antagonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,9600978,
CCR2,59,,,,,,,,Monkey,MK-0812,9048,,,315661133,Antagonist,Antagonist,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,Measuring inhibition of [<sup>125</sup>]I-MCP-1 binding by MK-0812 on isolated monocytes.,,,19913021,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2c(C1)cc(cn2)C(F)(F)F
CCR2,59,CCR2,P41597,,,,,,Human,RS-102895,779,,,135650935,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10770925,O=C1Nc2ccccc2C2(O1)CCN(CC2)CCc1ccc(cc1)C(F)(F)F
CCR2,59,CCR2,P41597,,,,,,Human,RS-136270,780,,,135650940,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,10770925,Clc1cccc(c1)Cn1cccc1C(=O)O
CCR2,59,CCR2,P41597,,,,,,Human,RS-504393,781,,,135650944,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,12954060,O=C1Nc2ccc(cc2C2(O1)CCN(CC2)CCc1nc(oc1C)c1ccccc1)C
CCR2,59,CCR2,P41597,,,,,,Human,SB-282241,782,,,135651004,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12954060,O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2
CCR2,59,CCR2,P41597,,,,,,Human,plozalizumab,8921,,,310264702,Antibody,Binding,,f,t,,pEC50,0,9.720000267,0,EC50,0,0.189999998,0,=,Calculated from ng/ml based on a mol weight of ~150kDa.,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,HIV-Tat,773,,,135652187,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,HIV-Tat,773,,,135652187,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,9789057,
CCR3,60,CCR3,P51677,,,,,,Human,CXCL10,835,CXCL10,Human,135651705,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,CXCL11,836,CXCL11,Human,135651708,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,CXCL9,837,CXCL9,Human,135651727,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,GW766994,9680,,,348353639,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,22931505,O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl
CCR3,60,CCR3,P51677,,,,,,Human,Met-Ck&beta;7,788,,,135652285,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,10640766,
CCR3,60,CCR3,P51677,,,,,,Human,RO116-4875/608,789,,,135650912,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,12070060,COc1cc(NC(=O)N[C@H](C(C)C)CN2CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC
CCR3,60,CCR3,P51677,,,,,,Human,RO116-9132/238,790,,,135650913,Antagonist,Antagonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,12070060,COc1cc(NC(=O)N[C@H](C(C)C)C[N+]2(C)CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC
CCR3,60,CCR3,P51677,,,,,,Human,RO320-2947/001,791,,,135650915,Antagonist,Antagonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,12070060,COc1cc(NC(=O)N[C@H](C(O)C)CN2CCC(CC2)Cc2ccc(cc2)Cl)cc(c1OC)OC
CCR3,60,CCR3,P51677,,,,,,Human,RO330-0802/001,792,,,135650916,Antagonist,Antagonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,12070060,COc1cc(ccc1OC)c1cnc(nc1)SCC(=O)NCC[C@H]1NC[C@@H](C1)Cc1ccc(c(c1)Cl)Cl
CCR3,60,CCR3,P51677,,,,,,Human,SB328437,3530,,,178100509,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,Ki,0,3.980000019,0,=,,,,0,COC(=O)[C@@H](NC(=O)c1ccc2c(c1)cccc2)Cc1ccc(cc1)N(=O)=O
CCR4,61,CCR4,P51679,,,,,,Human,plerixafor,844,,,135649932,Antagonist,Antagonist,,f,t,,pIC50,0,6.190000057,0,IC50,0,651,0,=,,,,16815309,C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1
CCR4,61,CCR4,P51679,,,,,,Human,mogamulizumab,6477,,,178103091,Antibody,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,21154168,
CCR5,62,CCR5,P51681,,,,,,Human,Flu-CCL3,760,,,135652155,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11170631,
CCR5,62,CCR5,P51681,,,,,,Human,R5-HIV-1 gp120,3910,,,178100743,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,E913,3500,,,178100487,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,1.99000001,0,=,,,,11454872,CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2
CCR5,62,CCR5,P51681,,,,,,Human,maraviroc,806,,,135650567,Antagonist,Antagonist,,f,t,,pIC50,0,8.100000381,0,IC50,0,7.940000057,0,=,,,,16298345,O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C
CCR5,62,Ccr5,O08556,,,,,,Rat,MRK-1,3651,,,178100547,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,12604693,CCn1nc(cc1C1CCN(CC1)C[C@H]1C[C@@H](C[C@@H]1c1cccc(c1)F)N([C@@H](C(=O)O)C(C)C)C)Cc1ccccc1
CD159a,2849,KLRC1,P26715,,,,,,Human,monalizumab,8323,,,252166535,Antibody,Binding,,f,t,,pKd,0,10.56999969,0,Kd,0,0.027000001,0,~,,,,0,
CD19,2764,CD19,P15391,,,,,,Human,inebilizumab,7992,,,249565673,Antibody,Binding,,f,t,,pKd,10.30000019,0,9.300000191,Kd,0.5,0,0.050000001,=,,,,0,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,ibritumomab tiuxetan,6777,,,178103383,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,obinutuzumab,6941,,,178103523,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,23537278,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,ocrelizumab,7580,,,223365915,Antibody,Binding,,f,t,,pKd,0,9.079999924,0,Kd,0,0.839999974,0,=,,,,0,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,ofatumumab,6778,,,178103384,Antibody,Binding,,f,t,,pKd,0,9.920000076,0,Kd,0,0.120999999,0,=,Binding affinity for clone 2F2 ((HuMax-CD20).,,,0,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,rituximab,6780,,,178103386,Antibody,Binding,,f,t,,pKd,0,8.510000229,0,Kd,0,3.099999905,0,=,,,,15102696,
CD22,2786,CD22,P20273,,,,,,Human,inotuzumab ozogamicin,8266,,,252166478,Antibody,Binding,,f,t,,pKd,0,9.699999809,0,Kd,0,0.200000003,0,=,,,,14615373,
CD22,2786,CD22,P20273,,,,,,Human,moxetumomab pasudotox,7675,,,223366010,Antibody,Binding,,f,t,,pKd,0,8.220000267,0,Kd,0,6,0,=,,,,22355053,
CD28,2863,CD28,P10747,,,,,,Human,lulizumab pegol,8460,,,252166670,Antibody,Binding,,f,t,,pKd,9.43999958,0,9.289999962,Kd,0.50999999,0,0.360000014,=,"Note that this Kd value was determined using the 'naked' binding component, in the absence of PEGylation.",,,24081989,
CD33,2601,CD33,P20138,,,,,,Human,gemtuzumab ozogamicin,6775,,,178103381,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,10720144,
CD33,2601,CD33,P20138,,,,,,Human,lintuzumab,7983,,,249565664,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,~,,,,1458463,
CD38,2766,CD38,P28907,,,,,,Human,daratumumab,7395,,,178103967,Antibody,Antagonist,,f,t,,pKd,0,8.220000267,0,Kd,0,6.059999943,0,=,,,,0,
CD38,2766,CD38,P28907,,,,,,Human,isatuximab,8719,,,252827377,Antibody,Binding,,f,t,,pKd,10,0,8.520000458,Kd,3,0,0.100000001,=,,,,0,
CD3e,2742,CD3E,P07766,,,,,,Human,muromonab-CD3,6889,,,178103471,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,3105134,
CD3e,2742,CD3E,P07766,,,,,,Human,otelixizumab,8458,,,252166668,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,8436176,
CD6,2917,CD6,P30203,,,,,,Human,itolizumab,9421,,,328083521,Antibody,Binding,,f,t,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,18707547,
CD66e (CEACAM5),2836,CEACAM5,P06731,,,,,,Human,labetuzumab,8251,,,249565931,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
CD66e (CEACAM5),2836,CEACAM5,P06731,,,,,,Human,labetuzumab govitecan,8252,,,249565932,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
CD74,2840,CD74,P04233,,,,,,Human,milatuzumab,8267,,,252166479,Antibody,Binding,,f,t,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,,,,16033844,
CD79B,2852,CD79B,P40259,,,,,,Human,polatuzumab vedotin,8404,,,252166614,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
CDC42 binding protein kinase alpha,1507,CDC42BPA,Q5VT25,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,8.539999962,0,IC50,0,2.869999886,0,=,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
CDC like kinase 1,1990,CLK1,P49759,,,,,,Human,KH-CB19,8055,,,249565735,Inhibitor,Inhibition,,f,t,,pIC50,0,7.710000038,0,IC50,0,19.70000076,0,=,,,,21276940,CCOC(=O)c1c(/C(=CN)/C#N)c2c(n1C)c(Cl)c(cc2)Cl
CDC like kinase 1,1990,Clk1,P22518,,,,,,Mouse,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,f,,pIC50,0,10.81999969,0,IC50,0,0.015,0,=,,,,21615147,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
CDC like kinase 1,1990,CLK1,P49759,,,,,,Human,ML315,8162,,,249565842,Inhibitor,Inhibition,,f,t,,pIC50,0,7.170000076,0,IC50,0,68,0,=,,,,23642479,Clc1cc(CNc2ncncc2c2ccc3c(c2)OCO3)cc(c1)Cl
CDC like kinase 2,1991,CLK2,P49760,,,,,,Human,ML315,8162,,,249565842,Inhibitor,Inhibition,,f,f,,pIC50,0,6.639999866,0,IC50,0,231,0,=,,,,23642479,Clc1cc(CNc2ncncc2c2ccc3c(c2)OCO3)cc(c1)Cl
CDC like kinase 3,1992,CLK3,P49761,,,,,,Human,KH-CB19,8055,,,249565735,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,530,0,=,,,,21276940,CCOC(=O)c1c(/C(=CN)/C#N)c2c(n1C)c(Cl)c(cc2)Cl
CDC like kinase 3,1992,Clk3,O35492,,,,,,Mouse,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,21615147,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
CDC like kinase 4,1993,CLK4,Q9HAZ1,,,,,,Human,ML315,8162,,,249565842,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,68,0,=,,,,23642479,Clc1cc(CNc2ncncc2c2ccc3c(c2)OCO3)cc(c1)Cl
"CECR2, histone acetyl-lysine reader",2733,CECR2,Q9BXF3,,,,,,Human,NVS-1,8951,,,310264732,Inhibitor,Inhibition,,f,t,,pIC50,7.329999924,0,7.099999905,IC50,80,0,47,=,Measured using AlphaScreen or ITC assays.,,,0,CCCS(=O)(=O)c1nc(NC2CC2)cc(n1)c1ccc2c(c1)ccn2C1CC(C)(C)NC(C1)(C)C
ceramide kinase,2473,CERK,Q8TCT0,,,,,,Human,NVP 231,6668,,,178103280,Inhibitor,Inhibition,,f,,,pIC50,0,7.9,0,-,0,0,0,=,,,,18612076,O=C(c1ccccc1)Nc1sc2c(n1)ccc(c2)NC(=O)C12CC3CC(C2)CC(C1)C3
CFTR,707,CFTR,P13569,,,,,,Human,felodipine,4190,,,178101007,Activator,Potentiation,,f,,,pKi,0,8.4,0,Ki,0,4,0,=,,,,17452495,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1Cl)Cl)C(=O)OC)C
CFTR,707,CFTR,P13569,,,,,,Human,genistein,2826,,,135650300,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
CFTR,707,CFTR,P13569,,,,,,Human,ivacaftor,4342,,,178101159,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1c[nH]c2c(c1=O)cccc2)Nc1cc(O)c(cc1C(C)(C)C)C(C)(C)C
CFTR,707,CFTR,P13569,,,,,,Human,nimodipine,2523,,,53801057,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
CFTR,707,CFTR,P13569,,,,,,Human,NS004,4271,,,178101088,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(c(c1)n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F)O
CFTR,707,CFTR,P13569,,,,,,Human,phenylglycine-01,4284,,,178101101,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(C(N(C(=O)Cc1c[nH]c2c1cccc2)C)c1ccccc1)Nc1ccc(cc1)C(C)C
CFTR,707,CFTR,P13569,,,,,,Human,GaTx1,4198,,,178101015,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CFTR,707,CFTR,P13569,,,,,,Human,glibenclamide,2414,,,135650306,Channel blocker,None,,f,,,pKi,0,4.66,0,Ki,0,21800,0,=,,,,1281220,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
CFTR,707,CFTR,P13569,,,,,,Human,GlyH-101,4202,,,178101019,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,extracellular,0,O=C(CNc1ccc2c(c1)cccc2)NNC=C1C=C(Br)C(=C(C1=O)Br)O
CFTR,707,CFTR,P13569,,,,,,Human,crofelemer,7453,,,187051756,Inhibitor,Inhibition,,f,t,,pIC50,0,5.150000095,0,IC50,0,7000,0,=,,,,19808995,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,"[Cys(Et)2,7]&alpha;-CGRP (human)",693,,,135652077,Agonist,Full agonist,,f,,,pKi,0,10.5,0,-,0,0,0,=,,,,15794944,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,"[Cys(ACM)<sup>2,7</sup>]CGRP",698,,,135652076,Agonist,Partial agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,11693189,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,olcegepant,702,,,135649990,Antagonist,Antagonist,,f,f,,pKi,11,0,10.69999981,Ki,0.02,0,0.01,=,,,,11847213,NCCCC[C@@H](C(=O)N1CCN(CC1)c1ccncc1)NC(=O)[C@H](NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)Cc1cc(Br)c(c(c1)Br)O
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,erenumab,9250,,,315661325,Antibody,Antagonist,,f,t,,pKi,0,10.69999981,0,Ki,0,0.02,0,=,Displacement binding of  [(125)I]-CGRP at the human CGRP receptor,,,26559125,
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,isogranulatimide,5991,,,178102613,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,18321713,O=c1[nH]c(=O)c2c1c1c3ccccc3[nH]c1n1c2cnc1
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,MK-8776,7943,,,249565626,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21094607,Cn1ncc(c1)c1cnn2c1nc(C1CCCNC1)c(c2N)Br
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,PF-477736,8043,,,249565723,Inhibitor,Inhibition,,f,t,,pIC50,0,9.31000042,0,IC50,0,0.49000001,0,=,,,,18723486,Cn1ncc(c1)c1nc2c3c1c[nH][nH]c(=O)c3cc(c2)NC(=O)[C@@H](C1CCCCC1)N
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,prexasertib,9549,,,336446935,Inhibitor,Inhibition,,f,f,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,Biochemical assay using purified enzyme.,,,26141948,NCCCOc1cccc(c1c1[nH]nc(c1)Nc1cnc(cn1)C#N)OC
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,rabusertib,7960,,,249565643,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,24114124,O=C(Nc1cc(Br)c(cc1OC[C@@H]1CNCCO1)C)Nc1cnc(cn1)C
checkpoint kinase 1,1987,CHEK1,O14757,,,,,,Human,SB 218078,6037,,,178102659,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,10676638,O=c1[nH]c(=O)c2c1c1c3c4c2c2ccccc2n4C2OC(n3c3c1cccc3)CC2
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,isogranulatimide,5991,,,178102613,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,18077363,O=c1[nH]c(=O)c2c1c1c3ccccc3[nH]c1n1c2cnc1
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,PF-477736,8043,,,249565723,Inhibitor,Inhibition,,f,f,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,18723486,Cn1ncc(c1)c1nc2c3c1c[nH][nH]c(=O)c3cc(c2)NC(=O)[C@@H](C1CCCCC1)N
checkpoint kinase 2,1988,CHEK2,O96017,,,,,,Human,prexasertib,9549,,,336446935,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,Enzyme assay,,,26141948,NCCCOc1cccc(c1c1[nH]nc(c1)Nc1cnc(cn1)C#N)OC
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,resolvin E1,3333,,,178100364,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC[C@H](/C=C/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O)O
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,resolvin E1,3333,,,178100364,Agonist,Full agonist,,t,,,pKd,0,7.95,0,Kd,0,11.3,0,=,,,,15753205,CC[C@H](/C=C/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O)O
Choline transporter-like 1,1204,SLC44A1,Q8WWI5,,,,,,Human,hemicholinium-3,4494,,,178101222,Inhibitor,Inhibition,,f,,,pKi,4.5,0,3.5,Ki,310000,0,31000,,,,,0,OC1(OCC[N+](C1)(C)C)c1ccc(cc1)c1ccc(cc1)C1(O)OCC[N+](C1)(C)C
CHT,914,SLC5A7,Q9GZV3,,,,,,Human,hemicholinium-3,4494,,,178101222,Inhibitor,Inhibition,,f,f,,pKi,8,0,7,Ki,100,0,10,=,,,,12675135,OC1(OCC[N+](C1)(C)C)c1ccc(cc1)c1ccc(cc1)C1(O)OCC[N+](C1)(C)C
chymase 1,2340,CMA1,P23946,,,,,,Human,JNJ-10311795,6563,,,178103177,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,4.5,0,,,,,17361995,OP(=O)(C(c1cccc2c1cccc2)C(=O)c1cc2ccccc2cc1C(=O)N(C1CCN(CC1)C(=O)c1ccc2c(c1)cccc2)C)O
chymase 1,2340,CMA1,P23946,,,,,,Human,NK3201,6503,,,178103117,Inhibitor,Inhibition,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,,,,,14960660,O=CNc1cnc(n(c1=O)CC(=O)NC(C(=O)C(=O)CCCOc1ccccn1)Cc1ccccc1)c1ccccc1
Ciliary neutrophic factor receptor,2313,LIFR|IL6ST|CNTFR,P40189|P26992|P42702,,,,,,Human,CRCF1/CLCF1 heterodimer,6150,CLCF1|CRLF1,Human,178102771,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
claudin 18,2903,CLDN18,P56856|P56856-2,,,,,,Human,IMAB362,9209,,,315661285,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,19047087,
ClC-1,698,CLCN1,P35523,,,,,,Human,fenofibric acid,2662,,,135650256,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(cc1)C(=O)c1ccc(cc1)OC(C(=O)O)(C)C
ClC-1,698,CLCN1,P35523,,,,,,Human,<i>S</i>-(-)CPB,4097,,,178100920,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCC(C(=O)O)Oc1ccc(cc1)Cl
ClC-1,698,CLCN1,P35523,,,,,,Human,<i>S</i>-(-)CPP,4098,,,178100921,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CC(C(=O)O)Oc1ccc(cc1)Cl
ClC-1,698,CLCN1,P35523,,,,,,Human,niflumic acid,2439,,,135650716,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
ClC-2,699,CLCN2,P51788,,,,,,Human,lubiprostone,4242,,,178101059,Activator,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC([C@@]1(O)CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)(F)F
ClC-2,699,CLCN2,P51788,,,,,,Human,omeprazole,4279,,,178101096,Activator,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc2c(c1)nc([nH]2)S(=O)Cc1ncc(c(c1C)OC)C
ClC-2,699,CLCN2,P51788,,,,,,Human,diphenylamine-2-carboxylic acid,4182,,,178101001,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1ccccc1Nc1ccccc1
ClC-2,699,CLCN2,P51788,,,,,,Human,GaTx2,4199,,,178101016,Channel blocker,None,,f,,,pKd,0,10.8,0,Kd,0,0.015,0,=,,,,0,
ClC-2,699,CLCN2,P51788,,,,,,Human,NPPB,4270,,,178101087,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
ClC-3,702,CLCN3,P51790,,,,,,Human,phloretin,4285,,,178101102,Channel blocker,None,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,,,,,0,Oc1ccc(cc1)CCC(=O)c1c(O)cc(cc1O)O
ClC-6,705,CLCN6,P51797,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,pIC50,0,3,0,IC50,0,1000000,0,,,,,0,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
ClC-7,706,CLCN7,P51798,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,pIC50,0,4.4,0,IC50,0,40000,0,,,,,20830208,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
ClC-7,706,CLCN7,P51798,,,,,,Human,NPPB,4270,,,178101087,Channel blocker,None,,f,,,pIC50,0,3.8,0,IC50,0,156000,0,,,,,20830208,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
ClC-7,706,CLCN7,P51798,,,,,,Human,NS5818,4275,,,178101092,Channel blocker,None,,f,,,pIC50,0,4.3,0,IC50,0,52000,0,,,,,20830208,O=C(Nc1cc(Cl)cc(c1)Cl)Nc1ccc(c(c1)c1[nH]nnn1)c1ccc(cc1)C(=O)N(C)C
ClC-Ka,700,CLCNKA,P51800,,,,,,Human,niflumic acid,2439,,,135650716,Activator,None,,f,,,pEC50,5,0,3,EC50,1000000,0,10000,=,,,,0,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
ClC-Ka,700,CLCNKA,P51800,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
ClC-Ka,700,CLCNKA,P51800,,,,,,Human,niflumic acid,2439,,,135650716,Channel blocker,None,,f,,,pIC50,0,0,0,IC50,0,1000000,0,<,,,,0,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
ClC-Kb,701,CLCNKB,P51801,,,,,,Human,niflumic acid,2439,,,135650716,Activator,None,,f,,,pEC50,5,0,3,EC50,1000000,0,10000,,,,,0,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
ClC-Kb,701,CLCNKB,P51801,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
CNGA1,394,CNGA1,P29973,,,,,,Human,cyclic GMP,2347,,,135651454,Activator,Agonist,,t,f,,pKi,4.21999979,0,4.070000172,Ki,85000,0,60000,=,,,,12467592,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
CNGA1,394,CNGA1,P29973,,,,,,Human,dequalinium,2313,,,135650170,Channel blocker,Antagonist,,f,f,,pIC50,0,6.699999809,0,-,0,0,0,=,,,,12508052,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N
CNGA1,394,Cnga1,Q62927,,,,,,Rat,H-8,2348,,,135650343,Channel blocker,Antagonist,,f,,,pIC50,0,3.5,0,,0,0,0,,,,,9324234,CNCCNS(=O)(=O)c1cccc2c1ccnc2
CNGA1,394,CNGA1,P29973,,,,,,Human,L-(cis)-diltiazem,2349,,,135650511,Channel blocker,Antagonist,high affinity binding requires presence of CNGB subunits,f,f,,pKi,0,4,0,Ki,0,100000,0,=,,,,7682292,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C
CNGA2,395,Cnga2,Q00195,,,,,,Rat,cyclic AMP,2352,,,135651452,Activator,Agonist,,t,,,pEC50,4.34,0,4.21,EC50,61600,0,45700,=,,,,10377344,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
CNGA2,395,Cnga2,Q00195,,,,,,Rat,cyclic GMP,2347,,,135651454,Activator,Agonist,,t,,,pEC50,5.76,0,5.6,EC50,2500,0,1740,=,,,,7522482,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
CNGA2,395,CNGA2,Q16280,,,,,,Human,dequalinium,2313,,,135650170,Channel blocker,Antagonist,,f,f,,pIC50,0,5.599999905,0,-,0,0,0,=,,,,14981138,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N
CNGA2,395,Cnga2,Q00195,,,,,,Rat,L-(cis)-diltiazem,2349,,,135650511,Channel blocker,Antagonist,,f,,,pKi,0,2.12,0,,0,0,0,,,,,1697649,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C
CNGA2,395,Cnga2,Q00195,,,,,,Rat,pseudechetoxin,2354,,,135652416,Channel blocker,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9892706,
CNGA2,395,Cnga2,Q00195,,,,,,Rat,PIP<sub>3</sub>,2353,,,135651543,Gating inhibitor,Antagonist,,f,,10,-,0,0,0,-,0,0,0,=,,,,17032767,CC(=O)OC(OC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](OP(=O)(O)O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
CNGA3,396,Cnga3,,,,,,,Rat,cyclic AMP,2352,,,135651452,Activator,Agonist,,t,,,pKd,0,3.6,0,,0,0,0,,,,,11387380,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
CNGA3,396,CNGA3,Q16281,,,,,,Human,cyclic AMP,2352,,,135651452,Activator,Agonist,,t,,,pKd,0,2.88,0,,0,0,0,,,,,8814292,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
CNGA3,396,CNGA3,Q16281,,,,,,Human,cyclic GMP,2347,,,135651454,Activator,Agonist,,t,f,,pKd,5.599999905,0,4.730000019,-,0,0,0,=,,,,8814292,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
CNGA3,396,Cnga3,,,,,,,Rat,cyclic GMP,2347,,,135651454,Activator,Agonist,,t,f,,pKd,0,5.510000229,0,-,0,0,0,=,,,,11387380,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
CNGA3,396,CNGA3,Q16281,,,,,,Human,L-(cis)-diltiazem,2349,,,135650511,Inhibitor,None,high affinity binding requires presence of CNGB subunits,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C
CNGB3,399,Cngb3,Q9JJZ9,,,,,,Mouse,L-(cis)-diltiazem,2349,,,135650511,Channel blocker,Antagonist,Channel blocker when CNGB3 coexpressed with CNGA3,f,f,,pIC50,0,5.5,0,-,0,0,0,=,,,,10662822,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKi,0,7.639999866,0,Ki,0,23,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,MS049,9529,,,336446915,Inhibitor,Inhibition,,f,t,,pIC50,0,7.46999979,0,IC50,0,34,0,=,,,,27584694,CNCCN1CCC(CC1)OCc1ccccc1
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,MS049,9529,,,336446915,Inhibitor,Inhibition,,f,t,,pKd,0,7,0,Kd,0,100,0,=,Isothermal titration calorimetry (ITC) in the presence of SAH,,,27584694,CNCCN1CCC(CC1)OCc1ccccc1
coactivator associated arginine methyltransferase 1,1255,CARM1,Q86X55,,,,,,Human,SGC2085,9259,,,315661334,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,27390919,Cc1cc(cc(c1)C)Oc1ccc(cc1C)CNC(=O)[C@@H](N)C
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,dabigatran,6380,,,178102998,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,4.5,0,=,Binding affinity to human thrombin.,,,11960487,OC(=O)CCN(C(=O)c1ccc2c(c1)nc(n2C)CNc1ccc(cc1)C(=N)N)c1ccccn1
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,desirudin,6458,,,178103073,Inhibitor,Inhibition,,f,t,,pKi,0,12.69999981,0,Ki,0,0.0002,0,=,,,,1894196,
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,Dup-714,8760,,,252827418,Inhibitor,Inhibition,,f,t,,pKi,0,10.39000034,0,Ki,0,0.041000001,0,=,Affinity for thrombin active site.,,,0,CC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](B(O)O)CCCN=C(N)N)Cc1ccccc1
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,lepirudin,6469,,,178103083,Inhibitor,Inhibition,,f,t,,pKi,0,13,0,Ki,0,1E-04,0,=,,,,16363236,
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,melagatran,6382,,,178103000,Inhibitor,Inhibition,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,9459334,OC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)C1CCCCC1
coagulation factor IX,2364,F9,P00740,,,,,,Human,emicizumab,9744,,,0,Antibody,Binding,,f,f,,pKd,0,5.800000191,0,Kd,0,1580,0,=,Determined by surface plasmon resonance analysis.,,,28451690,
coagulation factor V,2606,F5,P12259,,,,,,Human,drotrecogin alfa,6788,,,178103394,Antagonist,Inhibition,Antithrombotic effect thought to occur via inhibition of factors Va and VIIIa,f,t,,-,0,0,0,-,0,0,0,=,,,,11463021,
coagulation factor VIII,2607,F8,P00451,,,,,,Human,drotrecogin alfa,6788,,,178103394,Antagonist,Inhibition,Antithrombotic effect thought to occur via inhibition of factors Va and VIIIa,f,t,,-,0,0,0,-,0,0,0,=,,,,11463021,
coagulation factor X,2359,F10,P00742,,,,,,Human,emicizumab,9744,,,0,Antibody,Binding,,f,f,,pKd,0,5.730000019,0,Kd,0,1850,0,=,Determined by surface plasmon resonance analysis.,,,28451690,
coagulation factor X,2359,F10,P00742,,,,,,Human,edoxaban,7575,,,223365911,Inhibitor,Inhibition,,f,t,,pKi,0,9.25,0,Ki,0,0.560000002,0,=,,,,20503967,CN1CCc2c(C1)sc(n2)C(=O)N[C@@H]1C[C@H](CC[C@@H]1NC(=O)C(=O)Nc1ccc(cn1)Cl)C(=O)N(C)C
coagulation factor X,2359,F10,P00742,,,,,,Human,eribaxaban,7408,,,178103980,Inhibitor,Inhibition,,f,t,,pIC50,0,9.239999771,0,IC50,0,0.569999993,0,=,,,,19231206,CO[C@@H]1C[C@@H](N(C1)C(=O)Nc1ccc(cc1)Cl)C(=O)Nc1ccc(cc1F)n1ccccc1=O
coagulation factor X,2359,F10,P00742,,,,,,Human,rivaroxaban,6388,,,178103004,Inhibitor,Inhibition,,f,t,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,20139357,O=C1O[C@H](CN1c1ccc(cc1)N1CCOCC1=O)CNC(=O)c1ccc(s1)Cl
coagulation factor XII,2361,F12,P00748,,,,,,Human,"methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate",6553,,,178103167,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,10.4,0,=,,,,0,COC(=O)c1[nH]nc(n1)NC(=O)c1ccc(cc1)C(C)(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,IL-34,8975,IL34,Human,310264755,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,18467591,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,LY3022855,9109,,,315661194,Antibody,Binding,,f,t,,pEC50,0,10.05000019,0,EC50,0,0.090000004,0,=,Measured in an ELISA binding assay.,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,crenolanib,7882,,,223366211,Inhibitor,Inhibition,,f,f,,pKd,0,7.519999981,0,Kd,0,30,0,=,,,,22745105,NC1CCN(CC1)c1cccc2c1nc(cc2)n1cnc2c1ccc(c2)OCC1(C)COC1
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.520000458,0,7.440000057,IC50,36,0,3,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,GTP-14564,5982,,,178102605,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,12815052,c1ccc(cc1)c1n[nH]c2c1oc1c2cccc1
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,GW-2580,5685,,,178102312,Inhibitor,Inhibition,,f,t,,pKd,0,8.659999847,0,Kd,0,2.200000048,0,=,,,,22037378,COc1cc(ccc1OCc1ccc(cc1)OC)Cc1cnc(nc1N)N
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,GW-2580,5685,,,178102312,Inhibitor,Inhibition,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,16249345,COc1cc(ccc1OCc1ccc(cc1)OC)Cc1cnc(nc1N)N
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,t,,pIC50,0,9.159999847,0,IC50,0,0.689999998,0,=,,,,19887542,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,t,,pKd,0,8.489999771,0,Kd,0,3.200000048,0,=,,,,22037378,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,JNJ-40346527,8942,,,310264723,Inhibitor,Inhibition,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,,,,26233509,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(nc1C1=CCC(CC1)(C)C)C1CC(C)(C)OC(C1)(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,Ki-20227,5690,,,178102317,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,17121910,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,Ki-20227,5690,,,178102317,Inhibitor,Inhibition,,f,t,,pKd,0,9.079999924,0,Kd,0,0.829999983,0,=,,,,22037378,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,OSI-930,9383,,,328083485,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,16424037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,f,,pIC50,0,6.840000153,0,IC50,0,146,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,f,,pKd,0,7.920000076,0,Kd,0,12,0,=,,,,19754199,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,G-CSF,4934,CSF3,Human,178101632,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,GM-CSF,4942,CSF2,Human,178101640,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,M-CSF,4905,CSF1,Human,178101604,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
complement C1r,2334,C1R,P00736,,,,,,Human,nafamostat,4262,,,178101079,Inhibitor,Inhibition,,f,t,,pIC50,0,4.920000076,0,IC50,0,12000,0,=,,,,9544206,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
complement factor D,2842,CFD,P00746,,,,,,Human,lampalizumab,8294,,,252166506,Antibody,Binding,,f,t,,pKi,0,10.69999981,0,Ki,0,0.02,0,=,,,,25232192,
complement factor D,2842,CFD,P00746,,,,,,Human,example 373 [WO2012093101],8296,,,252166508,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,24900375,N#CCOc1ccc2c(c1)c(NC(=O)N1[C@@H]3C[C@@H]3C[C@H]1C(=O)NCc1cccc(c1F)Cl)cn2C(=O)N
conserved helix-loop-helix ubiquitous kinase,1989,CHUK,O15111,,,,,,Human,PHA-408,9398,,,328083500,Inhibitor,Inhibition,,f,f,,pIC50,0,4.849999905,0,IC50,0,14100,0,=,,,,19168710,CN1CCN(CC1)c1ncc(c(c1)C(=O)Nc1ccc2c(c1)c1c(CC2)c(nn1c1ccc(cc1)F)C(=O)N)Cl
Constitutive androstane receptor,607,Nr1i3,Q3V008,,,,,,Mouse,meclizine,2757,,,135650575,Agonist,Agonist,,f,,,pEC50,0,7.6,0,,0,0,0,,,,,15272053,Clc1ccc(cc1)C(c1ccccc1)N1CCN(CC1)Cc1cccc(c1)C
Constitutive androstane receptor,607,NR1I3,Q14994,,,,,,Human,meclizine,2757,,,135650575,Antagonist,Antagonist,,f,,,pIC50,0,7.16,0,,0,0,0,,,,,15272053,Clc1ccc(cc1)C(c1ccccc1)N1CCN(CC1)Cc1cccc(c1)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,indomethacin,1909,,,135650390,Activator,Inhibition,,f,f,,pIC50,0,6.590000153,0,IC50,0,260,0,=,,,,29031075,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,diclofenac,2714,,,135650177,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,16252917,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
COX-1 ,1375,PTGS1,P23219,,,,,,Human,fenoprofen,4820,,,178101522,Inhibitor,Inhibition,,f,t,,pIC50,0,6.840000153,0,IC50,0,145,0,=,,,,0,OC(=O)C(c1cccc(c1)Oc1ccccc1)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,flurbiprofen,4194,,,178101011,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,10377455,OC(=O)C(c1ccc(c(c1)F)c1ccccc1)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,FR122047,5191,,,178101879,Inhibitor,Inhibition,,f,f,,pIC50,0,7.5,0,IC50,0,31.60000038,0,=,,,,10720634,COc1ccc(cc1)c1sc(nc1c1ccc(cc1)OC)C(=O)N1CCN(CC1)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,ibuprofen,2713,,,135650365,Inhibitor,Inhibition,,f,t,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,9544212,CC(Cc1ccc(cc1)C(C(=O)O)C)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,(<i>R</i>)-ARN2508,9000,,,310264778,Inhibitor,Inhibition,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@H](C(=O)O)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,(<i>S</i>)-ARN2508,8999,,,310264777,Inhibitor,Inhibition,,f,t,,pIC50,0,9.539999962,0,IC50,0,0.289999992,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@@H](C(=O)O)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,ketoprofen,4795,,,178101497,Inhibitor,Inhibition,,f,t,,pIC50,0,6.480000019,0,IC50,0,330,0,=,Inhibition of COX1 in human whole blood.,,,18667313,OC(=O)C(c1cccc(c1)C(=O)c1ccccc1)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,ketorolac,6661,,,178103273,Inhibitor,Inhibition,,f,,,pIC50,0,9.72,0,IC50,0,0.19,0,=,,,,10377455,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1
COX-1 ,1375,PTGS1,P23219,,,,,,Human,ketorolac,6661,,,178103273,Inhibitor,Inhibition,,f,t,,pIC50,0,4.5,0,IC50,0,31500,0,=,Instantaneous inhibition of human COX1 by compound (no pre-incubation).,,,22091869,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1
COX-1 ,1375,PTGS1,P23219,,,,,,Human,meclofenamic acid,7219,,,178103793,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,11844663,OC(=O)c1ccccc1Nc1c(Cl)ccc(c1Cl)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,mefenamic acid,2593,,,53801036,Inhibitor,Inhibition,,f,t,,pIC50,0,4.599999905,0,IC50,0,25000,0,=,,,,23454516,OC(=O)c1ccccc1Nc1cccc(c1C)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,meloxicam,7220,,,178103794,Inhibitor,Inhibition,,f,f,,pIC50,0,4.440000057,0,IC50,0,36600,0,=,,,,9083488,Cc1cnc(s1)N=C(C1=C(O)c2ccccc2S(=O)(=O)N1C)O
COX-1 ,1375,PTGS1,P23219,,,,,,Human,naproxcinod,9551,,,336446937,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,19392579,COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)OCCCCO[N+](=O)[O-])C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,naproxen,5230,,,178101914,Inhibitor,Inhibition,,f,t,,pIC50,0,5.489999771,0,IC50,0,3200,0,=,,,,9057869,COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)O)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,nimesulide,7401,,,178103973,Inhibitor,Inhibition,,f,t,,pIC50,0,4.760000229,0,IC50,0,17400,0,=,,,,15993594,[O-][N+](=O)c1ccc(c(c1)Oc1ccccc1)NS(=O)(=O)C
COX-1 ,1375,PTGS1,P23219,,,,,,Human,oxaprozin,7252,,,178103826,Inhibitor,Inhibition,,f,t,,pIC50,0,5.659999847,0,IC50,0,2200,0,=,,,,9650852,OC(=O)CCc1nc(c(o1)c1ccccc1)c1ccccc1
COX-1 ,1375,PTGS1,P23219,,,,,,Human,paracetamol,5239,,,178101923,Inhibitor,Inhibition,,f,t,,pKi,0,3.940000057,0,Ki,0,113600,0,=,,,,17884974,CC(=O)Nc1ccc(cc1)O
COX-1 ,1375,PTGS1,P23219,,,,,,Human,peptide 30 [PMID: 27019010],9253,,,315661328,Inhibitor,Inhibition,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,,,,27019010,NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)CC(C)C)Cc1ccccc1
COX-1 ,1375,PTGS1,P23219,,,,,,Human,phenylbutazone,7270,,,178103844,Inhibitor,Inhibition,,f,t,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,0,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1
COX-1 ,1375,PTGS1,P23219,,,,,,Human,piroxicam,7273,,,178103847,Inhibitor,Inhibition,,f,t,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,,,,9083488,OC(=Nc1ccccn1)C1=C(O)c2ccccc2S(=O)(=O)N1C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,diclofenac,2714,,,135650177,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,17341061,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
COX-2 ,1376,PTGS2,P35354,,,,,,Human,esflurbiprofen,9420,,,328083520,Inhibitor,Inhibition,,f,f,,pIC50,0,6.039999962,0,IC50,0,910,0,=,Inhibition of COX-2 in human blood.,,,8809636,OC(=O)[C@H](c1ccc(c(c1)F)c1ccccc1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,etodolac,7185,,,178103760,Inhibitor,Inhibition,,f,t,,pIC50,0,4.28000021,0,IC50,0,53000,0,=,Measured as LPS-induced PGE<sub>2</sub> production in COX-1-inhibited human monocytes.,,,11804398,CCC1(OCCc2c1[nH]c1c2cccc1CC)CC(=O)O
COX-2 ,1376,PTGS2,P35354,,,,,,Human,etoricoxib,2896,,,178100245,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1100,0,=,,,,11160644,Clc1cnc(c(c1)c1ccc(cc1)S(=O)(=O)C)c1ccc(nc1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,flurbiprofen,4194,,,178101011,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,10091674,OC(=O)C(c1ccc(c(c1)F)c1ccccc1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,ibuprofen,2713,,,135650365,Inhibitor,Inhibition,,f,t,,pIC50,0,5.869999886,0,IC50,0,1350,0,=,,,,22091869,CC(Cc1ccc(cc1)C(C(=O)O)C)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,indomethacin,1909,,,135650390,Inhibitor,Inhibition,,f,f,,pIC50,0,5.579999924,0,IC50,0,2630,0,=,,,,29031075,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,(<i>R</i>)-ARN2508,9000,,,310264778,Inhibitor,Inhibition,,f,f,,pIC50,0,4.639999866,0,IC50,0,22800,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@H](C(=O)O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,(<i>S</i>)-ARN2508,8999,,,310264777,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@@H](C(=O)O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,ketoprofen,4795,,,178101497,Inhibitor,Inhibition,,f,t,,pIC50,0,6.159999847,0,IC50,0,690,0,=,Inhibition of COX2 in human whole blood.,,,18667313,OC(=O)C(c1cccc(c1)C(=O)c1ccccc1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,ketorolac,6661,,,178103273,Inhibitor,Inhibition,,f,t,,pIC50,0,6.920000076,0,IC50,0,120,0,=,Inhibition of human COX2 measured after pre-incubation of enzyme with compound.,,,22091869,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1
COX-2 ,1376,PTGS2,P35354,,,,,,Human,ketorolac,6661,,,178103273,Inhibitor,Inhibition,,f,t,,pIC50,0,4.21999979,0,IC50,0,60500,0,=,Instantaneous inhibition of human COX2 by compound (no pre-incubation).,,,22091869,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1
COX-2 ,1376,PTGS2,P35354,,,,,,Human,lumiracoxib,2897,,,178100246,Inhibitor,Inhibition,,f,t,,pKi,0,6.489999771,0,Ki,0,320,0,=,,,,17434872,OC(=O)Cc1cc(C)ccc1Nc1c(F)cccc1Cl
COX-2 ,1376,PTGS2,P35354,,,,,,Human,meclofenamic acid,7219,,,178103793,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,11844663,OC(=O)c1ccccc1Nc1c(Cl)ccc(c1Cl)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,mefenamic acid,2593,,,53801036,Inhibitor,Inhibition,,f,t,,pIC50,0,5.539999962,0,IC50,0,2900,0,=,,,,23454516,OC(=O)c1ccccc1Nc1cccc(c1C)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,meloxicam,7220,,,178103794,Inhibitor,Inhibition,,f,t,,pIC50,0,6.309999943,0,IC50,0,490,0,=,,,,9083488,Cc1cnc(s1)N=C(C1=C(O)c2ccccc2S(=O)(=O)N1C)O
COX-2 ,1376,PTGS2,P35354,,,,,,Human,naproxcinod,9551,,,336446937,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,19392579,COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)OCCCCO[N+](=O)[O-])C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,naproxen,5230,,,178101914,Inhibitor,Inhibition,,f,t,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,,,,9057869,COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,nimesulide,7401,,,178103973,Inhibitor,Inhibition,,f,t,,pIC50,0,6.21999979,0,IC50,0,600,0,=,,,,15993594,[O-][N+](=O)c1ccc(c(c1)Oc1ccccc1)NS(=O)(=O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,NS-398,8976,,,310264756,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,Measuring inhibition of PGE<sub>2</sub> production in human IL-1-stimulated synovial cells,,,10821716,[O-][N+](=O)c1ccc(c(c1)OC1CCCCC1)NS(=O)(=O)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,oxaprozin,7252,,,178103826,Inhibitor,Inhibition,,f,t,,pIC50,0,4.440000057,0,IC50,0,36000,0,=,,,,9650852,OC(=O)CCc1nc(c(o1)c1ccccc1)c1ccccc1
COX-2 ,1376,PTGS2,P35354,,,,,,Human,paracetamol,5239,,,178101923,Inhibitor,Inhibition,,f,t,,pKi,0,4.590000153,0,Ki,0,25800,0,=,,,,17884974,CC(=O)Nc1ccc(cc1)O
COX-2 ,1376,PTGS2,P35354,,,,,,Human,peptide 30 [PMID: 27019010],9253,,,315661328,Inhibitor,Inhibition,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,27019010,NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)CC(C)C)Cc1ccccc1
COX-2 ,1376,PTGS2,P35354,,,,,,Human,phenylbutazone,7270,,,178103844,Inhibitor,Inhibition,,f,t,,pIC50,0,3.549999952,0,IC50,0,284000,0,=,,,,7562922,CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1
COX-2 ,1376,PTGS2,P35354,,,,,,Human,piroxicam,7273,,,178103847,Inhibitor,Inhibition,,f,t,,pIC50,0,3.660000086,0,IC50,0,218000,0,=,,,,7562922,OC(=Nc1ccccn1)C1=C(O)c2ccccc2S(=O)(=O)N1C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,resveratrol,8741,,,252827399,Inhibitor,Inhibition,,f,f,,pIC50,0,6.119999886,0,IC50,0,750,0,=,,,,20527891,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O
COX-2 ,1376,PTGS2,P35354,,,,,,Human,rofecoxib,2893,,,178100242,Inhibitor,Inhibition,,f,t,,pIC50,6.5,0,6.099999905,-,0,0,0,=,,,,10377455,O=C1OCC(=C1c1ccccc1)c1ccc(cc1)S(=O)(=O)C
CREB binding protein,2734,CREBBP,Q92793,,,,,,Human,I-CBP112,8236,,,249565916,Inhibitor,Inhibition,,f,t,,pKd,0,6.849999905,0,Kd,0,142,0,=,Isothermal titration calorimetry (ITC) assay.,,,0,CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]1CCCN(C1)C)c1ccc(c(c1)OC)OC
CREB binding protein,2734,CREBBP,Q92793,,,,,,Human,ischemin,7506,,,187051808,Inhibitor,Inhibition,,f,f,,pKd,0,4.71999979,0,Kd,0,19000,0,=,Binding to CBP's bromodomain (amino acid residues 1081-1197),,,21513889,NC1=CC(=O)C(=C/C/1=NNc1cc(c(cc1C)C)S(=O)(=O)O)C
CREB binding protein,2734,CREBBP,Q92793,,,,,,Human,SGC-CBP30,7529,,,187051830,Inhibitor,Inhibition,,f,t,,pIC50,0,7.159999847,0,IC50,0,69,0,=,,,,24497428,COc1ccc(cc1Cl)CCc1nc2c(n1C[C@@H](N1CCOCC1)C)ccc(c2)c1c(C)noc1C
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,corticotrophin-releasing hormone,912,CRH|Crh|Crh,Human|Mouse|Rat,135651696,Agonist,Full agonist,,t,,,pKd,9,0,7.1,,0,0,0,,,,,7692441,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,corticotropin-releasing factor,913,CRH,Sheep,135652064,Agonist,Full agonist,,f,,,pKd,8.9,0,7.2,-,0,0,0,=,,,,9326293,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,sauvagine,918,,,135652453,Agonist,Full agonist,,f,,,pKd,9.2,0,6.7,,0,0,0,,,,,9326293,
CRF<sub>1</sub> receptor,212,Crhr1,P35353,,,,,,Rat,"CP 154,526",3495,,,178100483,Antagonist,Antagonist,,f,f,,pIC50,10.40999985,0,9.289999962,IC50,0.50999999,0,0.039000001,=,,,,8874139,CCCCN(c1nc(C)nc2c1c(C)cn2c1c(C)cc(cc1C)C)CC
CRF<sub>1</sub> receptor,212,Crhr1,P35353,,,,,,Rat,CP376395,3496,,,178100484,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5.010000229,0,=,,,,18288792,CCC(Nc1cc(C)nc(c1C)Oc1c(C)cc(cc1C)C)CC
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,CRA1000,3498,,,53801053,Antagonist,Antagonist,,f,f,,pIC50,7.099999905,0,6.400000095,IC50,398,0,79.40000153,=,,,,10357258,CCN(c1ccc(cc1SC)C(C)C)c1nc(cc(n1)C)N1CCC(=CC1)c1cccc(c1)F
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,DMP696,3499,,,178100486,Antagonist,Antagonist,,f,f,,pKi,9,0,8.300000191,Ki,5.010000229,0,1,=,,,,10669572,COCC(Nc1nc(C)nc2n1nc(c2c1ccc(cc1Cl)Cl)C)COC
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,NBI27914,3512,,,53801052,Antagonist,Antagonist,,f,f,,pKi,9,0,8.300000191,Ki,5,0,1,=,,,,8893829,CCCN(c1nc(C)nc(c1Cl)Nc1c(Cl)cc(cc1Cl)Cl)CC1CC1
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,R121919,3520,,,53801047,Antagonist,Antagonist,,f,f,,pKi,9,0,8.300000191,Ki,5,0,1,=,,,,10867111,CCCN(c1cc(C)nc2n1nc(c2c1cnc(cc1C)N(C)C)C)CCC
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,SSR125543A,3533,,,178100512,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,Ki,0,0,0,=,,,,11907190,C#CCN([C@H](c1ccc(c(c1)F)C)CC1CC1)c1sc(c(n1)c1cc(C)c(cc1Cl)OC)C
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,corticotrophin-releasing hormone,912,CRH|Crh|Crh,Human|Mouse|Rat,135651696,Agonist,Full agonist,,t,,,pKd,7.4,0,6.5,,0,0,0,,,,,11123370,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,corticotrophin-releasing hormone,912,CRH|Crh|Crh,Human|Mouse|Rat,135651696,Agonist,Full agonist,,t,,,pKi,0,7.8,0,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,corticotrophin-releasing hormone,912,CRH|Crh|Crh,Human|Mouse|Rat,135651696,Agonist,Full agonist,,t,,,pKd,0,7.9,0,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,corticotropin-releasing factor,913,CRH,Sheep,135652064,Agonist,Full agonist,,f,,,pKd,6.9,0,5.9,,0,0,0,,,,,15450949,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,sauvagine,918,,,135652453,Agonist,Full agonist,,f,,,pKd,9.3,0,7.6,,0,0,0,,,,,15450949,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,sauvagine,918,,,135652453,Agonist,Full agonist,,f,,,pKd,8.7,0,8.4,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,sauvagine,918,,,135652453,Agonist,Full agonist,,f,,,pKd,8.8,0,8,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,K31440,3890,,,178100726,Antagonist,Antagonist,,f,f,,pKi,8.800000191,0,8.699999809,Ki,1.99000001,0,1.580000043,=,,,,11835994,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,K41498,3891,,,178100727,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0.629999995,0,=,,,,12110614,
"c-ros oncogene 1, receptor tyrosine kinase",1840,ROS1,P08922,,,,,,Human,lorlantinib,7476,,,187051779,Inhibitor,Inhibition,,f,t,,pKi,0,11.30000019,0,Ki,0,0.005,0,=,,,,0,N#Cc1n(C)nc2c1c1cnc(c(c1)O[C@H](C)c1c(C(=O)N(C2)C)ccc(c1)F)N
cryptochrome circadian regulator 1,2876,CRY1,Q16526,,,,,,Human,KL044,8609,,,252166810,None,Binding,,f,t,,pEC50,0,7.199999809,0,EC50,0,63,0,=,,,,26174033,N#Cc1cccc(c1NC(=O)Cn1c2ccccc2c2c1cccc2)Cl
CS1 (CD319),2850,SLAMF7,Q9NQ25,,,,,,Human,elotuzumab,8361,,,252166573,Antibody,Binding,,f,t,,pKd,0,8.050000191,0,Kd,0,8.859999657,0,=,,,,0,
C-terminal Src kinase,1994,CSK,P41240,,,,,,Human,NG-25,8074,,,249565754,Inhibitor,Inhibition,,f,f,,pIC50,0,7.25,0,IC50,0,56.40000153,0,=,,,,25075558,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)Oc1ccnc2c1cc[nH]2)C
C-terminal Src kinase,1994,CSK,P41240,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,520,0,=,,,,12534346,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
CT receptor,43,CALCR,P30988,,,,,,Human,pramlintide,7482,,,187051785,Agonist,Agonist,,f,f,,pEC50,0,8.260000229,0,EC50,0,5.494999886,0,=,Measuring ligand-induced cAMP in COS and KEK293 cells.,,,24169554,
CT receptor,43,CALCR,P30988,,,,,,Human,CT-(8-32) (salmon),690,,,135652065,Antagonist,Antagonist,,f,f,,pKd,0,9,0,-,0,0,0,=,,,,10856900,
CT receptor,43,CALCR,P30988,,,,,,Human,CT-(8-32) (salmon),690,,,135652065,Antagonist,Antagonist,,f,,,pKi,0,8.17,0,,0,0,0,,,,,15692146,
C-type lectin domain family 4 member E,2929,CLEC4E,Q9ULY5,,,,,,Human,GlcC14C18,9483,,,329968423,Agonist,Agonist,,f,f,,pEC50,0,10,0,EC50,0,0.100000001,0,~,Measuring activation of an NF-&kappa;B reporter in HEK293 cells expressing human mincle.,,,28223515,CCCCCCCCCCCCCCCC(C(=O)OCC1O[C@@H](O)C(C[C@@H]1O)O)CCCCCCCCCCCCC
Cx23,714,GJE1,A6NN92,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx23,714,GJE1,A6NN92,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx25,715,GJB7,Q6PEY0,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx25,715,GJB7,Q6PEY0,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx26,716,GJB2,P29033,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx26,716,GJB2,P29033,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx30,717,GJB6,O95452,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx30,717,GJB6,O95452,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx30.2,718,GJC3,Q8NFK1,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx30.2,718,GJC3,Q8NFK1,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx30.3,719,GJB4,Q9NTQ9,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx30.3,719,GJB4,Q9NTQ9,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx31,720,GJB3,O75712,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx31,720,GJB3,O75712,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx31.1,721,GJB5,O95377,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx31.1,721,GJB5,O95377,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx31.9,722,GJD3,Q8N144,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx31.9,722,GJD3,Q8N144,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx32,723,GJB1,P08034,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx32,723,GJB1,P08034,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx36,724,GJD2,Q9UKL4,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx36,724,GJD2,Q9UKL4,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx37,725,GJA4,P35212,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx37,725,GJA4,P35212,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx40,726,GJA5,P36382,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx40,726,GJA5,P36382,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx40.1,727,GJD4,Q96KN9,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx40.1,727,GJD4,Q96KN9,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx43,728,GJA1,P17302,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx43,728,GJA1,P17302,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx45,729,GJC1,P36383,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx45,729,GJC1,P36383,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx46,730,GJA3,Q9Y6H8,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx46,730,GJA3,Q9Y6H8,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx47,731,GJC2,Q5T442,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx47,731,GJC2,Q5T442,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx50,732,GJA8,P48165,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx50,732,GJA8,P48165,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx59,733,GJA9,P57773,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx59,733,GJA9,P57773,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
Cx62,734,GJA10,Q969M2,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Cx62,734,GJA10,Q969M2,,,,,,Human,octanol,4278,,,178101095,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCCO
CXCR1,68,CXCR1,P25024,,,,,,Human,CXCL8,821,CXCL8,Human,135651725,Agonist,Agonist,,f,f,,pKd,0,8.100000381,0,Kd,0,8,0,=,,,,22262769,
CXCR1,68,CXCR1,P25024,,,,,,Human,cytokine domain of tyrosyl tRNA synthetase,3729,YARS,Human,178100600,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
CXCR1,68,CXCR1,P25024,,,,,,Human,HIV-1 matrix protein p17,8495,,,252166703,Agonist,Agonist,,f,t,,pKd,0,5.739999771,0,Kd,0,1800,0,=,,,,22262769,
CXCR1,68,CXCR1,P25024,,,,,,Human,CXCL1,819,CXCL1,Human,135651702,Agonist,Full agonist,,t,,,pKi,0,6.4,0,-,0,0,0,=,,,,1379593,
CXCR1,68,CXCR1,P25024,,,,,,Human,CXCL6,820,CXCL6,Human,135651723,Agonist,Full agonist,,t,,,pKi,0,7,0,-,0,0,0,=,,,,9692902,
CXCR1,68,CXCR1,P25024,,,,,,Human,CXCL8,821,CXCL8,Human,135651725,Agonist,Full agonist,,t,,,pKi,9.5,0,8.8,-,0,0,0,=,,,,1379593,
CXCR1,68,CXCR1,P25024,,,,,,Human,mini-TyrRS,823,,,135652289,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,10102815,
CXCR1,68,CXCR1,P25024,,,,,,Human,reparixin,8498,,,252166706,Allosteric modulator,Negative,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,15282370,CC(Cc1ccc(cc1)[C@H](C(=O)NS(=O)(=O)C)C)C
CXCR1,68,CXCR1,P25024,,,,,,Human,navarixin,8497,,,252166705,Antagonist,Antagonist,,f,f,,pIC50,0,8.409999847,0,IC50,0,3.900000095,0,=,,,,24218476,CC[C@H](c1ccc(o1)C)NC1=C(C(=O)C1=O)Nc1cccc(c1O)C(=O)N(C)C
CXCR2,69,CXCR2,P25025,,,,,,Human,HIV-1 matrix protein p17,8495,,,252166703,Agonist,Agonist,,f,f,,pKd,0,6.889999866,0,Kd,0,130,0,=,,,,22262769,
CXCR2,69,Cxcr2,P35343,,,,,,Mouse,CXCL1,826,Cxcl1,Rat,135651703,Agonist,Full agonist,,f,,,pKi,0,7.2,0,-,0,0,0,=,,,,7961909,
CXCR2,69,Cxcr2,P35343,,,,,,Mouse,CXCL1,819,CXCL1,Human,135651702,Agonist,Full agonist,,f,,,pKi,0,8.1,0,-,0,0,0,=,,,,7961909,
CXCR2,69,Cxcr2,P35343,,,,,,Mouse,CXCL1,826,Cxcl1,Rat,135651703,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7961909,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL1,819,CXCL1,Human,135651702,Agonist,Full agonist,,t,,,pKi,9.7,0,8.4,-,0,0,0,=,,,,1379593,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL2,827,CXCL2,Human,135651714,Agonist,Full agonist,,t,,,pIC50,9.1,0,7,-,0,0,0,=,,,,8702798,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL3,828,CXCL3,Human,135651718,Agonist,Full agonist,,t,,,pIC50,9.2,0,7.8,-,0,0,0,=,,,,8702798,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL5,829,CXCL5,Human,135651721,Agonist,Full agonist,,t,,,pIC50,9,0,6.9,-,0,0,0,=,,,,8702798,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL6,820,CXCL6,Human,135651723,Agonist,Full agonist,,t,,,pKd,0,7,0,-,0,0,0,=,,,,9692902,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL7,830,PPBP,Human,135651724,Agonist,Full agonist,,t,,,pIC50,9.3,0,6.3,-,0,0,0,=,,,,8702798,
CXCR2,69,Cxcr2,P35343,,,,,,Mouse,CXCL8,821,CXCL8,Human,135651725,Agonist,Full agonist,,f,,,pKi,0,6.4,0,-,0,0,0,=,,,,7961909,
CXCR2,69,CXCR2,P25025,,,,,,Human,CXCL8,821,CXCL8,Human,135651725,Agonist,Full agonist,,t,,,pKi,9.5,0,8.8,-,0,0,0,=,,,,1379593,
CXCR2,69,CXCR2,P25025,,,,,,Human,reparixin,8498,,,252166706,Allosteric modulator,Negative,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,15282370,CC(Cc1ccc(cc1)[C@H](C(=O)NS(=O)(=O)C)C)C
CXCR2,69,CXCR2,P25025,,,,,,Human,danirixin,8500,,,252166708,Antagonist,Antagonist,,f,f,,pIC50,0,7.900000095,0,IC50,0,12.5,0,=,,,,26092545,O=C(Nc1cccc(c1C)F)Nc1ccc(c(c1O)S(=O)(=O)[C@H]1CCCNC1)Cl
CXCR2,69,CXCR2,P25025,,,,,,Human,elubirixin,8499,,,252166707,Antagonist,Antagonist,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,24218476,O=C(Nc1cccc(c1Cl)F)Nc1ccc(c(c1O)S(=O)(=O)N1CCNCC1)Cl
CXCR2,69,CXCR2,P25025,,,,,,Human,navarixin,8497,,,252166705,Antagonist,Antagonist,,f,t,,pIC50,0,10.31000042,0,IC50,0,0.048999999,0,=,,,,24218476,CC[C@H](c1ccc(o1)C)NC1=C(C(=O)C1=O)Nc1cccc(c1O)C(=O)N(C)C
CXCR2,69,CXCR2,P25025,,,,,,Human,NSC 157449,834,,,135651056,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,9553055,O=C(Nc1ccc(cc1O)[N+](=O)[O-])Nc1ccccc1
CXCR2,69,CXCR2,P25025,,,,,,Human,SB 225002,833,,,135650994,Antagonist,Antagonist,,f,f,,pIC50,0,7.699999809,0,IC50,0,19.89999962,0,=,,,,9553055,O=C(Nc1ccccc1Br)Nc1ccc(cc1O)[N+](=O)[O-]
CXCR3,70,CXCR3,P49682,,,,,,Human,CXCL10,835,CXCL10,Human,135651705,Agonist,Full agonist,,t,,,pKi,9.8,0,7.8,-,0,0,0,=,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CXCL11,836,CXCL11,Human,135651708,Agonist,Full agonist,,t,,,pKi,10.5,0,10.4,-,0,0,0,=,,,,15761110,
CXCR3,70,CXCR3,P49682,,,,,,Human,CXCL12&alpha;,4358,CXCL12,Human,135651881,Agonist,Full agonist,,t,,,pKi,0,6.4,0,-,0,0,0,=,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,CXCL9,837,CXCL9,Human,135651727,Agonist,Full agonist,,t,,,pKi,8.3,0,7.3,-,0,0,0,=,,,,9660793,
CXCR3,70,CXCR3,P49682,,,,,,Human,dioscin,840,,,135650191,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,15789559,OC[C@H]1O[C@@H](O[C@H]2CC[C@]3(C(=CC[C@@H]4[C@@H]3CC[C@]3([C@H]4C[C@H]4[C@@H]3[C@H](C)[C@]3(O4)CC[C@H](CO3)C)C)C2)C)[C@@H]([C@H]([C@@H]1O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
CXCR3,70,CXCR3,P49682,,,,,,Human,duramycin,841,,,135652137,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15789559,
CXCR3,70,CXCR3,P49682,,,,,,Human,hypoglaucin A,842,,,135652692,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,15789559,OC[C@H]1O[C@@H](O[C@H]2CC[C@]3(C(=CC[C@@H]4[C@@H]3CC[C@]3([C@H]4C[C@H]4[C@@H]3[C@H](C)[C@]3(O4)CC[C@@H](CO3)C)C)C2)C)[C@@H]([C@H]([C@@H]1O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O)O[C@H]1C[C@H](C)[C@H]([C@H]([C@H]1O)O)O
CXCR3,70,CXCR3,P49682,,,,,,Human,kallstroemin D,843,,,135652696,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,15789559,CC1CCC2(OC1)OC1C(C2C)C2(C(C1)C1CC=C3C(C1CC2)(C)CCC(C3)OC1OC(COC2OC(C)C(C(C2OC2(CC(O)C(C(O2)C)O)OC2OC(C)C(C(C2O)O)O)O)O)C(C(C1O)O)O)C
CXCR3,70,CXCR3,P49682,,,,,,Human,NBI-74330,839,,,135650695,Antagonist,Antagonist,,f,,,pKi,8.8,0,8.3,,0,0,0,,,,,15761110,CCOc1ccc(cc1)n1c(nc2c(c1=O)cccn2)C(N(C(=O)Cc1ccc(c(c1)C(F)(F)F)F)Cc1cccnc1)C
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&delta;,8531,CXCL12,Human,252166733,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,16626895,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&epsilon;,8532,CXCL12,Human,252166734,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,16626895,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&gamma;,8530,CXCL12,Human,252166732,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,16626895,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&phi;,8533,CXCL12,Human,252166735,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,16626895,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12<sub>H25R</sub> (monomer),8534,,,252166736,Agonist,Agonist,,f,f,,pKd,0,7.820000172,0,Kd,0,15,0,=,,,,21990345,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12-(1-17),846,,,135652069,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9712844,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12-(1-9),847,,,135652070,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,9712844,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12-(1-9) dimer,848,,,135652071,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9712844,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&alpha;,4358,CXCL12,Human,135651881,Agonist,Full agonist,,t,,,pKd,8.2,0,7.7,-,0,0,0,=,,,,9551924,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12&beta;,845,CXCL12,Human,135651882,Agonist,Full agonist,,t,,,pKd,0,7.86,0,Kd,0,13.7,0,=,,,,9551924,
CXCR4,71,CXCR4,P61073,,,,,,Human,CXCL12<sub>2</sub> (dimer),8535,,,252166737,Agonist,Partial agonist,,f,f,,pKd,0,6,0,Kd,0,1000,0,>,,,,21990345,
CXCR4,71,CXCR4,P61073,,,,,,Human,CX549,9701,,,348353660,Antagonist,Antagonist,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,~,,,,27938478,OC(=O)[C@H](CCC(=O)N1CCC(CC1)Nc1nc(NCc2nnn(c2)CCCNCCCNC2CCCCC2)nc2c1cccc2)N
CXCR4,71,CXCR4,P61073,,,,,,Human,HIV-Tat,773,,,135652187,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
CXCR4,71,CXCR4,P61073,,,,,,Human,isothiourea-1a,2900,,,135650432,Antagonist,Antagonist,,f,f,,pIC50,0,7.320000172,0,-,0,0,0,=,,,,19053768,C1CCC(CC1)N/C(=N/C1CCCCC1)/SCc1csc2=NCCn12
CXCR4,71,CXCR4,P61073,,,,,,Human,isothiourea-1a,2900,,,135650432,Antagonist,Antagonist,,f,f,,pEC50,0,7.960000038,0,-,0,0,0,=,,,,19053768,C1CCC(CC1)N/C(=N/C1CCCCC1)/SCc1csc2=NCCn12
CXCR4,71,Cxcr4,O08565,,,,,,Rat,isothiourea-1a,2900,,,135650432,Antagonist,Antagonist,,f,f,,pIC50,0,7.260000229,0,-,0,0,0,=,,,,19053768,C1CCC(CC1)N/C(=N/C1CCCCC1)/SCc1csc2=NCCn12
CXCR4,71,CXCR4,P61073,,,,,,Human,isothiourea-1t,2899,,,135650433,Antagonist,Antagonist,,f,f,,pEC50,0,9,0,-,0,0,0,=,,,,19053768,CC1(C)N=c2n(C1)c(cs2)CS/C(=NC1CCCCC1)/NC1CCCCC1
CXCR4,71,CXCR4,P61073,,,,,,Human,isothiourea-1t,2899,,,135650433,Antagonist,Antagonist,,f,f,,pIC50,0,8.100000381,0,-,0,0,0,=,,,,19053768,CC1(C)N=c2n(C1)c(cs2)CS/C(=NC1CCCCC1)/NC1CCCCC1
CXCR4,71,Cxcr4,O08565,,,,,,Rat,isothiourea-1t,2899,,,135650433,Antagonist,Antagonist,,f,f,,pIC50,0,7.960000038,0,-,0,0,0,=,,,,19053768,CC1(C)N=c2n(C1)c(cs2)CS/C(=NC1CCCCC1)/NC1CCCCC1
CXCR4,71,CXCR4,P61073,,,,,,Human,plerixafor,844,,,135649932,Antagonist,Antagonist,,f,t,,pKi,0,7,0,-,0,0,0,=,,,,11923301,C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1
CXCR4,71,CXCR4,P61073,,,,,,Human,"SDF-1, 1-9[P2G] dimer",851,,,135652455,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9712844,
CXCR4,71,CXCR4,P61073,,,,,,Human,SDF1 P2G,8536,,,252166738,Antagonist,Antagonist,,f,f,,pKd,0,8.050000191,0,Kd,0,9,0,=,,,,9384579,
CXCR5,72,CXCR5,P32302,,,,,,Human,CXCL13,3645,CXCL13,Human,135651710,Agonist,Full agonist,,t,f,,pKd,0,7.300000191,0,Kd,0,50.5,0,=,,,,22913878,
CXCR6,73,CXCR6,O00574,,,,,,Human,CXCL16,855,CXCL16,Human,135651711,Agonist,Full agonist,,t,,,pKd,0,9,0,Kd,0,1,0,=,,,,11290797,
CX<sub>3</sub>CR1,74,CX3CR1,P49238,,,,,,Human,CX<sub>3</sub>CL1,856,CX3CL1,Human,135651730,Agonist,Full agonist,,t,,,pIC50,0,8.9,0,-,0,0,0,=,,,,14607932,
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,dinaciclib,7379,,,178103951,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,24007471,OCC[C@@H]1CCCCN1c1cc(NCc2ccc[n+](c2)[O-])n2c(n1)c(CC)cn2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,GSK-3 inhibitor IX,5974,,,178102597,Inhibitor,Inhibition,,f,f,,pIC50,0,6.489999771,0,IC50,0,320,0,=,CDK1/cyclin B complex,,,14761195,ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
cyclin dependent kinase 1,1961,,,,,,,,spiny starfish,kenpaullone,6000,,,178102622,Inhibitor,Inhibition,,f,t,,pIC50,0,6.400000095,0,IC50,0,400,0,=,CDK1/cyclin B complex,,,10363974,O=C1Nc2ccccc2c2c(C1)c1cc(Br)ccc1[nH]2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,R547,5707,,,178102334,Inhibitor,Inhibition,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,Assayed using CDK1/cyclin B complex.,,,17121911,COc1ccc(c(c1C(=O)c1cnc(nc1N)NC1CCN(CC1)S(=O)(=O)C)F)F
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,in association with cyclin B1,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,riviciclib,7934,,,249565617,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,CDK1/cyclin B complex,,,17363486,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,roniciclib,7874,,,223366203,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,CDK1/cyclin B complex,,,23671017,C[C@H]([C@H](Oc1nc(ncc1C(F)(F)F)Nc1ccc(cc1)S(=O)(=N)C1CC1)C)O
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pKd,0,7.920000076,0,Kd,0,11.89999962,0,=,CDK19/cyclin C.,,,26502155,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,ponatinib,5890,,,178102513,Inhibitor,Inhibition,,f,f,,pKd,0,7.920000076,0,Kd,0,11.89999962,0,=,CDK19/cyclin C.,,,26502155,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C
cyclin dependent kinase 19,1972,CDK19,Q9BWU1,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pKd,0,6.989999771,0,Kd,0,103,0,=,CDK19/cyclin C.,,,26502155,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,dinaciclib,7379,,,178103951,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,24007471,OCC[C@@H]1CCCCN1c1cc(NCc2ccc[n+](c2)[O-])n2c(n1)c(CC)cn2
cyclin dependent kinase 2,1973,,,,,,,,spiny starfish,kenpaullone,6000,,,178102622,Inhibitor,Inhibition,,f,t,,pIC50,0,6.170000076,0,IC50,0,680,0,=,CDK2/cyclin A complex,,,10363974,O=C1Nc2ccccc2c2c(C1)c1cc(Br)ccc1[nH]2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,milciclib,7938,,,249565621,Inhibitor,Inhibition,,f,t,,pIC50,0,7.349999905,0,IC50,0,45,0,=,CDK2/cyclin A complex,,,19603809,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,MK-8776,7943,,,249565626,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,CDK2/cyclin A complex in assay,,,21094607,Cn1ncc(c1)c1cnn2c1nc(C1CCCNC1)c(c2N)Br
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,purvalanol A,6030,,,178102652,Inhibitor,Inhibition,,f,t,,pIC50,0,7.460000038,0,IC50,0,35,0,=,CDK2/cyclin E complex used in assay,,,9677190,OCC(C(C)C)Nc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,purvalanol B,7806,,,223366137,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,CDK2/cyclin A complex used in assay,,,9677190,OC[C@@H](C(C)C)Nc1nc(Nc2ccc(c(c2)Cl)C(=O)O)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,R547,5707,,,178102334,Inhibitor,Inhibition,,f,t,,pKd,0,9.279999733,0,Kd,0,0.529999971,0,=,,,,22037378,COc1ccc(c(c1C(=O)c1cnc(nc1N)NC1CCN(CC1)S(=O)(=O)C)F)F
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,R547,5707,,,178102334,Inhibitor,Inhibition,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,Assayed using CDK2/cyclin E complex.,,,17121911,COc1ccc(c(c1C(=O)c1cnc(nc1N)NC1CCN(CC1)S(=O)(=O)C)F)F
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,in association with cyclin E,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,roniciclib,7874,,,223366203,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,CDK2/cyclin E complex,,,23671017,C[C@H]([C@H](Oc1nc(ncc1C(F)(F)F)Nc1ccc(cc1)S(=O)(=N)C1CC1)C)O
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,seliciclib,6035,,,178102657,Inhibitor,Inhibition,,f,t,,pKi,0,6.599999905,0,Ki,0,250,0,=,CDK2/cyclin A complex used in assay,,,23252711,CC[C@@H](Nc1nc(NCc2ccccc2)c2c(n1)n(cn2)C(C)C)CO
cyclin dependent kinase 3,1975,CDK3,Q00526,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,in association with cyclin E,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,fascaplysin,5969,,,178102592,Inhibitor,Inhibition,,f,t,,pIC50,0,6.460000038,0,IC50,0,350,0,=,CDK4/cyclin D1 complex,,,10973815,O=C1c2c3[nH]c4c(c3cc[n+]2c2c1cccc2)cccc4
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,milciclib,7938,,,249565621,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,CDK4/cyclin D1 complex,,,19603809,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,palbociclib,7380,,,178103952,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,15542782,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,purvalanol A,6030,,,178102652,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,850,0,=,CDK4/cyclin D1 complex used in assay,,,9677190,OCC(C(C)C)Nc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,purvalanol B,7806,,,223366137,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,CDK4/cyclin D1 complex used in assay,,,9677190,OC[C@@H](C(C)C)Nc1nc(Nc2ccc(c(c2)Cl)C(=O)O)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,R547,5707,,,178102334,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,Assayed using CDK4/cyclin D1 complex.,,,17121911,COc1ccc(c(c1C(=O)c1cnc(nc1N)NC1CCN(CC1)S(=O)(=O)C)F)F
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,in association with cyclin D1,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,ribociclib,7383,,,178103955,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,0,CN(C(=O)c1cc2c(n1C1CCCC1)nc(nc2)Nc1ccc(cn1)N1CCNCC1)C
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,riviciclib,7934,,,249565617,Inhibitor,Inhibition,,f,t,,pIC50,0,7.199999809,0,IC50,0,63,0,=,CDK4/cyclin D1 complex,,,17363486,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,Ro-0505124,8203,,,249565883,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,0,CN1CCN(CC1)c1ccc(cc1)Nc1nc(c(s1)C(=O)c1ccc2c(c1)OCCO2)N
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,dinaciclib,7379,,,178103951,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,24007471,OCC[C@@H]1CCCCN1c1cc(NCc2ccc[n+](c2)[O-])n2c(n1)c(CC)cn2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,GSK-3 inhibitor IX,5974,,,178102597,Inhibitor,Inhibition,,f,f,,pIC50,0,7.079999924,0,IC50,0,83,0,=,CDK5/p25 complex,,,14761195,ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
cyclin dependent kinase 5,1977,,,,,,,,Bovine,kenpaullone,6000,,,178102622,Inhibitor,Inhibition,,f,t,,pIC50,0,6.070000172,0,IC50,0,850,0,=,CDK5/p25 complex,,,10363974,O=C1Nc2ccccc2c2c(C1)c1cc(Br)ccc1[nH]2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,purvalanol A,6030,,,178102652,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,75,0,=,CDK5/p35 complex used in assay,,,9677190,OCC(C(C)C)Nc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,purvalanol B,7806,,,223366137,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,CDK5/p35 complex used in assay,,,9677190,OC[C@@H](C(C)C)Nc1nc(Nc2ccc(c(c2)Cl)C(=O)O)c2c(n1)n(cn2)C(C)C
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,in association with regulatory subunit 1 (p35)cirs,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,palbociclib,7380,,,178103952,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,15542782,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,7.260000229,0,IC50,0,55,0,=,in association with cyclin D3,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,milciclib,7938,,,249565621,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,CDK7/cyclin H complex,,,19603809,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,in association with cyclin H,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pKd,0,8.159999847,0,Kd,0,6.840000153,0,=,CDK8/cyclin C.,,,26502155,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,ponatinib,5890,,,178102513,Inhibitor,Inhibition,,f,f,,pKd,0,8.170000076,0,Kd,0,6.769999981,0,=,CDK8/cyclin C.,,,26502155,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C
cyclin dependent kinase 8,1980,CDK8,P49336,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pKd,0,7,0,Kd,0,99.59999847,0,=,CDK8/cyclin C.,,,26502155,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,dinaciclib,7379,,,178103951,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24007471,OCC[C@@H]1CCCCN1c1cc(NCc2ccc[n+](c2)[O-])n2c(n1)c(CC)cn2
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,NVP-2,8053,,,249565733,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,0,COC[C@H](N[C@@H]1CC[C@H](CC1)Nc1ncc(c(c1)c1cccc(n1)NCC1(C#N)CCOCC1)Cl)C
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,in association with cyclin T1,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,riviciclib,7934,,,249565617,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,CDK9/cyclin T1 complex,,,17363486,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,seliciclib,6035,,,178102657,Inhibitor,Inhibition,,f,t,,pKi,0,6.099999905,0,Ki,0,790,0,=,CDK9/cyclin T complex used in assay,,,23252711,CC[C@@H](Nc1nc(NCc2ccccc2)c2c(n1)n(cn2)C(C)C)CO
cyclin G associated kinase,2027,GAK,O14976,,,,,,Human,SB203580,5269,,,178101952,Inhibitor,Inhibition,,f,f,,pIC50,0,6.869999886,0,IC50,0,135,0,=,,,,0,Fc1ccc(cc1)c1nc([nH]c1c1ccncc1)c1ccc(cc1)S(=O)C
CYP11A1,1358,CYP11A1,P05108,,,,,,Human,mitotane,6957,,,178103539,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,23254310,ClC(C(c1ccccc1Cl)c1ccc(cc1)Cl)Cl
CYP11B1,1359,CYP11B1,P15538,,,,,,Human,fadrozole,8311,,,252166523,Inhibitor,Inhibition,,f,f,,pKi,0,8.659999847,0,Ki,0,2.200000048,0,=,,,,19622340,N#Cc1ccc(cc1)C1CCCc2n1cnc2
CYP11B1,1359,CYP11B1,P15538,,,,,,Human,metyrapone,5224,,,178101909,Inhibitor,Inhibition,,f,t,,pIC50,0,7.840000153,0,IC50,0,14.60000038,0,=,,,,21129965,O=C(C(c1cccnc1)(C)C)c1cccnc1
CYP11B1,1359,CYP11B1,P15538,,,,,,Human,mitotane,6957,,,178103539,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,ClC(C(c1ccccc1Cl)c1ccc(cc1)Cl)Cl
CYP11B1,1359,CYP11B1,P15538,,,,,,Human,osilodrostat,8310,,,252166522,Inhibitor,Inhibition,,f,f,,pIC50,0,8.539999962,0,IC50,0,2.900000095,0,=,,,,24899257,N#Cc1ccc(c(c1)F)[C@H]1CCc2n1cnc2
CYP11B2,1360,CYP11B2,P19099,,,,,,Human,fadrozole,8311,,,252166523,Inhibitor,Inhibition,,f,f,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,19622340,N#Cc1ccc(cc1)C1CCCc2n1cnc2
CYP11B2,1360,CYP11B2,P19099,,,,,,Human,osilodrostat,8310,,,252166522,Inhibitor,Inhibition,,f,f,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,24899257,N#Cc1ccc(c(c1)F)[C@H]1CCc2n1cnc2
CYP17A1,1361,CYP17A1,P05093,,,,,,Human,galeterone,8638,,,252166838,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,15828836,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC=C2n2cnc3c2cccc3)C)C1)C
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,exemestane,7073,,,178103652,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50.09999847,0,=,Inhibition of aromatase (CYP19A1) extracted to homogeneity from human placenta.,,,2951074,O=C1C=C[C@]2(C(=C1)C(=C)C[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2=O)C)C
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,fadrozole,8311,,,252166523,Inhibitor,Inhibition,,f,t,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,1825337,N#Cc1ccc(cc1)C1CCCc2n1cnc2
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,letrozole,5209,,,178101895,Inhibitor,Inhibition,,f,t,,pKi,0,10.69999981,0,Ki,0,0.02,0,=,,,,22386564,N#Cc1ccc(cc1)C(n1cncn1)c1ccc(cc1)C#N
CYP24A1,1365,CYP24A1,Q07973,,,,,,Human,MK-24,8858,,,252827515,Inhibitor,Inhibition,,f,f,,pIC50,0,8.130000114,0,IC50,0,7.400000095,0,=,,,,15615534,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3(C2CC=C3[C@@H](CCS(=O)(=N)c2ccccc2)C)C)/C1
CYP27A1,1369,CYP27A1,Q02318,,,,,,Human,MK-24,8858,,,252827515,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15615534,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3(C2CC=C3[C@@H](CCS(=O)(=N)c2ccccc2)C)C)/C1
CYP27B1,1370,CYP27B1,O15528,,,,,,Human,MK-24,8858,,,252827515,Inhibitor,Inhibition,,f,f,,pIC50,0,6.260000229,0,IC50,0,554,0,=,,,,15615534,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3(C2CC=C3[C@@H](CCS(=O)(=N)c2ccccc2)C)C)/C1
CYP2C8,1325,CYP2C8,P10632,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Inhibition,,f,f,,pKi,0,5.139999866,0,Ki,0,7266,0,=,,,,16248836,NNCCc1ccccc1
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,nefazodone,7247,,,178103821,Inhibitor,Inhibition,,f,f,,pKi,0,6,0,Ki,0,1000,0,=,,,,22409598,CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,ritonavir,8804,,,252827462,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,100,0,<,,,,18285471,O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1
CYP3A5,1338,CYP3A5,P20815,,,,,,Human,ritonavir,8804,,,252827462,Inhibitor,Inhibition,,f,f,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,16248836,O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,Ca<sup>2+</sup> mobilisation assay in COS-7 or HEK-293 cells,t,,,pEC50,7.7,0,7.4,EC50,43,0,20,=,,,,10462554,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,pigment dispersion in <i>X. laevis</i> melanophores,t,,,pEC50,0,7.68,0,EC50,0,21,0,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,K<sub>i1</sub> and K<sub>i2</sub> against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,t,,,pKi,8.1,0,7,-,0,0,0,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 cells,t,,,pIC50,6.46,0,6.44,IC50,360,0,346,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,Ca<sup>2+</sup> mobilisation assay in COS-7 or HEK-293 cells,t,,,pEC50,9.22,0,7.34,EC50,46,0,0.6,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,pigment dispersion in <i>X. laevis</i> melanophores,t,,,pEC50,0,9.4,0,EC50,0,0.4,0,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in HEK-293 cells,t,,,pIC50,0,8.05,0,IC50,0,9,0,=,,,,10462554,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,Ca<sup>2+</sup> activated chloride conductance in <i>X. laevis</i> oocytes,t,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,Ca<sup>2+</sup> mobilisation assay in U937 cells,t,,,pEC50,0,8.47,0,EC50,0,3.4,0,=,,,,14518564,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,Ca<sup>2+</sup> mobilisation assay in COS-7 or HEK-293 cells,t,,,pEC50,7.24,0,6.62,EC50,240,0,58,=,,,,10462554,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,t,,,pEC50,0,6.41,0,EC50,0,391,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 cells,t,,,pIC50,6.97,0,6.56,IC50,274,0,107,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,pigment dispersion in <i>X. laevis</i> melanophores,t,,,pEC50,0,6.67,0,EC50,0,212,0,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,K<sub>i</sub> against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,t,,,pKi,7.8,0,7.05,-,0,0,0,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,N-methyl LTC<sub>4</sub>,6194,,,178102815,Agonist,Partial agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,f,,,pEC50,0,5.7,0,EC50,0,2000,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)NC
CysLT<sub>1</sub> receptor,269,,,,,,,,Guinea pig,ICI198615,3358,,,178100384,Antagonist,Antagonist,,f,f,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,0,COc1cc(ccc1Cn1ncc2c1cc(cc2)NC(=O)OC1CCCC1)C(=O)NS(=O)(=O)c1ccccc1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,iralukast,5861,,,178102485,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,f,,,pKi,0,7.8,0,-,0,0,0,=,,,,9504401,CCCc1c(OCCCC/C=CC=C[C@@H]([C@@H](c2cccc(c2)C(F)(F)F)O)Sc2ccc3c(c2)oc(cc3=O)C(=O)O)ccc(c1O)C(=O)C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,montelukast,3340,,,178100370,Antagonist,Antagonist,against [<sup>3</sup>H]LTD4 in COS-7 or HEK-293 cells,f,t,,pIC50,8.640000343,0,8.31000042,IC50,4.900000095,0,2.299999952,=,,,,10391245,OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,montelukast,3340,,,178100370,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,f,t,,pKi,0,8.550000191,0,-,0,0,0,=,,,,11996896,OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,montelukast,3340,,,178100370,Antagonist,Antagonist,against 33nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,t,,pIC50,0,8.640000343,0,IC50,0,2.299999952,0,=,,,,10462554,OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pobilukast,3334,,,178100365,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,f,,,pKi,0,7.1,0,-,0,0,0,=,,,,9547367,OC(=O)CCS[C@H](c1ccccc1CCCCCCCCc1ccccc1)[C@H](C(=O)O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pobilukast,3334,,,178100365,Antagonist,Antagonist,against 33nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,,,pIC50,0,8.26,0,IC50,0,5.5,0,=,,,,10462554,OC(=O)CCS[C@H](c1ccccc1CCCCCCCCc1ccccc1)[C@H](C(=O)O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pobilukast,3334,,,178100365,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in HEK-293,f,,,pIC50,0,7.52,0,IC50,0,30,0,=,,,,10462554,OC(=O)CCS[C@H](c1ccccc1CCCCCCCCc1ccccc1)[C@H](C(=O)O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pranlukast,3634,,,178100541,Antagonist,Antagonist,against 33nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,t,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,10462554,O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pranlukast,3634,,,178100541,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,f,t,,pKi,8.800000191,0,7.099999905,-,0,0,0,=,,,,11996896,O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,pranlukast,3634,,,178100541,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 or HEK-293 cells,f,t,,pIC50,8.369999886,0,8.140000343,IC50,7.199999809,0,4.300000191,=,,,,10391245,O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,SR2640,3329,,,178100361,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)OCc1ccc2c(n1)cccc2
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,Ca<sup>2+</sup> mobilization assay in HUVEC,t,,,pEC50,0,7.24,0,EC50,0,57,0,=,,,,21753081,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,Ca<sup>2+</sup> mobilisation assay in HEK-293 cells,t,,,pEC50,8.64,0,8.05,EC50,8.9,0,2.3,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,&beta;-arrestin assay in C2C12 myofibroblasts,t,,,pEC50,0,7.27,0,EC50,0,54,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 or HEK-293 cells,t,f,,pIC50,8.479999542,0,8.399999619,IC50,4,0,3.299999952,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Full agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,t,f,,pEC50,7.239999771,0,7.03000021,EC50,94,0,58,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,Ca<sup>2+</sup> mobolisation assay in HEK-293 cells,t,,,pEC50,8.6,0,8.03,EC50,9.3,0,2.5,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,K<sub>i1</sub> and K<sub>i2</sub> against [<sup>3</sup>H]LTC<sub>4</sub> in human lung parenchyma,t,,,pKi,8.1,0,7.3,-,0,0,0,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in HEK-293 cells,t,,,pIC50,0,8.15,0,IC50,0,7,0,=,,,,11093801,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,Ca<sup>2+</sup> mobilization assay in HUVEC,t,,,pEC50,0,7.44,0,EC50,0,36,0,=,,,,21753081,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,against [<sup>3</sup>H]LTC<sub>4</sub> in COS-1 cells,t,,,pIC50,0,7.23,0,IC50,0,59,0,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,&beta;-arrestin assay in C2C12,t,,,pEC50,0,7.46,0,EC50,0,35,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Full agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,t,,,pEC50,6.98,0,6.84,EC50,144,0,104,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,N-methyl LTC<sub>4</sub>,6194,,,178102815,Agonist,Full agonist,&beta;-arrestin assay in C2C12 myofibroblasts,f,,,pEC50,0,8.06,0,EC50,0,8.7,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)NC
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,N-methyl LTC<sub>4</sub>,6194,,,178102815,Agonist,Full agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,f,,,pEC50,0,6.91,0,EC50,0,122,0,=,,,,21078884,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)NC
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 or HEK-293 cells,t,,,pIC50,6.16,0,6.15,IC50,700,0,693,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,K<sub>i</sub> against [<sup>3</sup>H]LTC<sub>4</sub> in human lung parenchyma,t,,,pKi,0,6.5,0,-,0,0,0,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,Ca<sup>2+</sup> mobilization assay in HEK-293 cells,t,,,pEC50,7.11,0,6.53,EC50,293,0,77,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,against [<sup>3</sup>H]LTC<sub>4</sub> in COS-1 cells,t,,,pIC50,0,5.72,0,IC50,0,1890,0,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,LTE<sub>4</sub>,3352,,,135651514,Agonist,Partial agonist,aequorin-based Ca<sup>2+</sup> assay in HEK-293 cells,t,,,pEC50,5.92,0,5.64,EC50,2300,0,1208,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,HAMI3379,6197,,,178102818,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in CHO cells,f,,,pIC50,0,7.42,0,IC50,0,38,0,=,,,,20423349,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOC1CCCCC1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,HAMI3379,6197,,,178102818,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> -LTC<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,8.42,0,8.36,IC50,4.4,0,3.8,=,,,,20423349,OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOC1CCCCC1)C(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,iralukast,5861,,,178102485,Antagonist,Antagonist,against LTC<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in HUVEC,f,,,pA2,0,6.8,0,-,0,0,0,=,,,,0,CCCc1c(OCCCC/C=CC=C[C@@H]([C@@H](c2cccc(c2)C(F)(F)F)O)Sc2ccc3c(c2)oc(cc3=O)C(=O)O)ccc(c1O)C(=O)C
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,pobilukast,3334,,,178100365,Antagonist,Antagonist,against LTC<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in HUVEC,f,,,pA2,0,6.2,0,-,0,0,0,=,,,,0,OC(=O)CCS[C@H](c1ccccc1CCCCCCCCc1ccccc1)[C@H](C(=O)O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,pranlukast,3634,,,178100541,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 cells,f,,,pIC50,0,5.44,0,IC50,0,3620,0,=,,,,10851239,O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,pranlukast,3634,,,178100541,Antagonist,Antagonist,against LTC<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HUVEC,f,,,pA2,0,7.1,0,-,0,0,0,=,,,,0,O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1
Cystathionine &gamma;-lyase,1444,CTH,P32929,,,,,,Human,propargylglycine,5247,,,178101931,Inhibitor,Inhibition,,f,f,,pIC50,0,4.400000095,0,IC50,0,40000,0,=,,,,23488457,C#CCNCC(=O)O
Cystine/glutamate transporter,902,SLC7A11,Q9UPY5,,,,,,Human,quisqualate,1372,,,135650876,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,=,,,,20303751,OC(=O)[C@H](Cn1oc(=O)[nH]c1=O)N
cytotoxic T-lymphocyte-associated protein 4 (CD152),2743,CTLA4,P16410,,,,,,Human,ipilimumab,6888,,,178103470,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,0,
DAT,927,SLC6A3,Q01959,,,,,,Human,desvenlafaxine,7158,,,178103733,Inhibitor,Inhibition,,f,f,,pKi,0,6.070000172,0,Ki,0,854,0,>,,,,24900709,CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C
DAT,927,SLC6A3,Q01959,,,,,,Human,dexamfetamine,2147,,,135650979,Inhibitor,Inhibition,,f,t,,pKi,0,6.960000038,0,Ki,0,109,0,=,,,,23602445,C[C@@H](Cc1ccccc1)N
DAT,927,SLC6A3,Q01959,,,,,,Human,dexmethylphenidate,7554,,,223365890,Inhibitor,Inhibition,,f,t,,pKi,0,7.599999905,0,Ki,0,25,0,=,Displacement of [<sup>3</sup>H]WIN-35428 from human DAT stably expressed in mouse N2A cells,,,21129986,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1
DAT,927,SLC6A3,Q01959,,,,,,Human,GBR12935,4639,,,178101357,Inhibitor,Inhibition,,f,f,,pKi,0,7.599999905,0,Ki,0,25.10000038,0,=,,,,0,c1ccc(cc1)CCCN1CCN(CC1)CCOC(c1ccccc1)c1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,levomilnacipran,7435,,,178104007,Inhibitor,Inhibition,,f,f,,pIC50,0,5.489999771,0,IC50,0,3200,0,=,,,,18468895,NC[C@@H]1C[C@]1(c1ccccc1)C(=O)N(CC)CC
DAT,927,SLC6A3,Q01959,,,,,,Human,mazindol,4797,,,178101499,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,0,Clc1ccc(cc1)C1(O)c2ccccc2C2=NCCN12
DAT,927,SLC6A3,Q01959,,,,,,Human,methylphenidate,7236,,,178103810,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,17228864,COC(=O)C(c1ccccc1)C1CCCCN1
DAT,927,Slc6a3,P23977,,,,,,Rat,modafinil,7555,,,223365891,Inhibitor,Inhibition,,f,f,,pKi,0,5.420000076,0,Ki,0,3800,0,=,Inhibition of high affinity uptake by the dopamine transporter from rat synaptosomal nerve endings using [<sup>3</sup>H]dopamine as radioligand,,,15537337,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,nomifensine,4792,,,178101494,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CN1CC(c2ccccc2)c2c(C1)c(N)ccc2
DAT,927,SLC6A3,Q01959,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Inhibition,,f,f,,pKi,0,5.079999924,0,Ki,0,8400,0,=,,,,9537821,NNCCc1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,sibutramine,2586,,,135651043,Inhibitor,Inhibition,,f,t,,pKi,0,6.300000191,0,Ki,0,502,0,=,,,,0,CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
death associated protein kinase 1,2002,DAPK1,P53355,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
death associated protein kinase 3,2004,DAPK3,O43293,,,,,,Human,CX-4945,8126,,,249565806,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,21174434,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O
death associated protein kinase 3,2004,DAPK3,O43293,,,,,,Human,DAPK inhibitor 13,9422,,,328083522,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,253,0,=,,,,20206532,O=C1OC(=N/C/1=C/c1cccnc1)c1ccc(c(c1)C)Br
death receptor 4,1879,TNFRSF10A,O00220,,,,,,Human,SC-67655,8889,,,310264670,Agonist,Agonist,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,0,
"delta 4-desaturase, sphingolipid 1",2484,DEGS1,O15121,,,,,,Human,RBM2-1B,8879,,,252827536,Inhibitor,Inhibition,,f,f,,pIC50,0,4.739999771,0,IC50,0,18100,0,=,Measured in a A549 cellular assay as the formation of CerC6NBD from dihydro CerC6NBD.,,,22537678,CCCCCCCCCCCCCS/C=C/[C@@H](NC(=O)CCCCCCC)CO
&delta; receptor,317,OPRD1,P41143,,,,,,Human,hydromorphone,7082,,,178103661,Agonist,Agonist,,f,f,,pKi,0,7.420000076,0,Ki,0,38,0,=,,,,19282177,O=C1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,nalbuphine,1663,,,135650680,Agonist,Agonist,,f,t,,pKi,0,6.239999771,0,Ki,0,580,0,=,,,,19282177,O[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CCC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,pethidine,7221,,,178103795,Agonist,Agonist,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,11585443,CCOC(=O)C1(CCN(CC1)C)c1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,5.539999962,0,Ki,0,2854,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,DADLE,1607,,,135650156,Agonist,Full agonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0.629999995,0,=,,,,9686407,Oc1ccc(cc1)C[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)Cc1ccccc1)C)N
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,DADLE,1607,,,135650156,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,8114680,Oc1ccc(cc1)C[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)Cc1ccccc1)C)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[D-Ala<sup>2</sup>]deltorphin II,4060,,,178100884,Agonist,Full agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,2544892,
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,deltorphin II,1615,,,135650166,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,8114680,OC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)Cc1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,deltorphin II,1615,,,135650166,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9686407,OC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)Cc1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dihydromorphine,1616,,,135650183,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9686407,O[C@H]1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,diprenorphine,1617,,,135650194,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,DPDPE,1608,,,135652122,Agonist,Full agonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,9686407,O=C1CNC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)N)C(C)(C)SSC([C@@H](NC(=O)[C@@H](N1)Cc1ccccc1)C(=O)O)(C)C
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,DPDPE,1608,,,135652122,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8114680,O=C1CNC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)N)C(C)(C)SSC([C@@H](NC(=O)[C@@H](N1)Cc1ccccc1)C(=O)O)(C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,DSLET,1609,,,135652126,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9686407,OC[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(C)C)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)N
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,DSLET,1609,,,135652126,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,8114680,OC[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(C)C)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,DSTBULET,3873,,,178100709,Agonist,Full agonist,,f,,,pKi,0,8.6,0,Ki,0,2.81,0,=,,,,2831220,CC(C[C@@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)COC(C)(C)C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dynorphin-(1-11),1618,,,135652140,Agonist,Full agonist,,f,,,pKi,0,8,0,-,0,0,0,=,,,,9686407,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dynorphin A,1620,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651739,Agonist,Full agonist,,t,,,pKi,0,7.4,0,,0,0,0,,,,,9686407,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dynorphin A-(1-13),1619,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651738,Agonist,Full agonist,,t,,,pKi,0,7.8,0,,0,0,0,,,,,9686407,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dynorphin B,1622,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651741,Agonist,Full agonist,,t,,,pKi,0,7.8,0,,0,0,0,,,,,9686407,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,endomorphin-1,1623,,Human,135652148,Agonist,Full agonist,,t,,,pKi,0,6.1,0,,0,0,0,,,,,9849897,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)N
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,ethyketazocine,1610,,,135650225,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,8393575,CC[C@@]12CCN([C@H]([C@H]1C)C(=O)c1c2cc(O)cc1)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,ethylketocyclazocine,1602,,,135650226,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,9686407,CCC1CN(CC2CC2)C2C(C1c1cc(O)ccc1C2=O)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,etonitazene,1624,,,135650245,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9686407,CCOc1ccc(cc1)Cc1nc2c(n1CCN(CC)CC)ccc(c2)[N+](=O)[O-]
&delta; receptor,317,OPRD1,P41143,,,,,,Human,etorphine,1625,,,135650246,Agonist,Full agonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,9686407,CCCC(C1CC23C=CC1(OC)C1C43CCN(C2Cc2c4c(O1)c(O)cc2)C)(O)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,fentanyl,1626,,,135650258,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,9686407,CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[Leu]enkephalin,1613,PENK|Penk|Penk,Human|Mouse|Rat,135651802,Agonist,Full agonist,,t,,,pKi,0,8.7,0,,0,0,0,,,,,9686407,O=C(CNC(=O)C(Cc1ccc(cc1)O)N)NCC(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1ccccc1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,[Leu]enkephalin,1613,PENK|Penk|Penk,Human|Mouse|Rat,135651802,Agonist,Full agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,8114680,O=C(CNC(=O)C(Cc1ccc(cc1)O)N)NCC(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1ccccc1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,[Met]enkephalin,1614,PENK|Penk|Penk,Human|Mouse|Rat,135651808,Agonist,Full agonist,,t,,,pIC50,0,7.4,0,,0,0,0,,,,,8393575,CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,(-)-methadone,1605,,,135650582,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9686407,CCC(=O)C(c1ccccc1)(c1ccccc1)C[C@H](N(C)C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,morphine,1627,,,135650624,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,normorphine,1630,,,135650735,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2NCC3)ccc1O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,(-)-pentazocine,1606,,,135650806,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9686407,CC(=CCN1CC[C@@]2([C@H]([C@H]1Cc1c2cc(cc1)O)C)C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,SNC80,1611,,,135651062,Agonist,Full agonist,,f,f,,pKi,0,7.199999809,0,-,0,0,0,=,,,,9178661,C=CCN1C[C@H](C)N(C[C@H]1C)[C@@H](c1cccc(c1)OC)c1ccc(cc1)C(=O)N(CC)CC
&delta; receptor,317,OPRD1,P41143,,,,,,Human,(-)-cyclazocine,1604,,,135650145,Agonist,Partial agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9686407,Oc1ccc2c(c1)[C@]1(C)CCN([C@@H](C2)C1C)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,dynorphin A-(1-8),1621,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651740,Agonist,Partial agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,nalmefene,1628,,,135650681,Agonist,Partial agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9686407,C=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,nalorphine,1629,,,135650682,Agonist,Partial agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9686407,C=CCN1CC[C@@]23[C@@H]4[C@H]1Cc1c3c(O[C@H]2[C@H](C=C4)O)c(cc1)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,CTAP,1635,,,135652066,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,9686407,NC(=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC([C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1c[nH]c2c1cccc2)N
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,eluxadoline,7691,,,223366025,Antagonist,Antagonist,,f,f,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,22695132,COc1ccc(cc1C(=O)O)CN([C@H](c1ncc([nH]1)c1ccccc1)C)C(=O)[C@H](Cc1c(C)cc(cc1C)C(=O)N)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,LY2456302,9194,,,315661273,Antagonist,Antagonist,,f,f,,pKi,0,6.809999943,0,Ki,0,155,0,=,,,,24071566,Cc1cc(C)cc(c1)[C@@H]1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,methylnaltrexone,7563,,,223365899,Antagonist,Antagonist,,f,f,,pKi,0,6.050000191,0,Ki,0,900,0,=,,,,19282177,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2[N+](CC3)(C)CC2CC2)ccc1O)O
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,8114680,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,8393575,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,t,,pKi,0,7.199999809,0,-,0,0,0,=,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,naltrexone,1639,,,135650687,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8114680,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,naltrexone,1639,,,135650687,Antagonist,Antagonist,,f,t,,pKi,0,8,0,-,0,0,0,=,,,,9686407,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,naltriben,1640,,,135650688,Antagonist,Antagonist,,f,f,,pKi,0,10,0,Ki,0,0.100000001,0,=,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,naltriben,1640,,,135650688,Antagonist,Antagonist,,f,,,pKi,0,10.9,0,,0,0,0,,,,,8114680,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,f,,pKi,0,9.699999809,0,-,0,0,0,=,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,,,pKi,0,10.7,0,,0,0,0,,,,,8114680,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,8393575,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,quadazocine,1633,,,135650868,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,9686407,O=C(CCC1(C)[C@H]2Cc3c([C@]1(C)CCN2C)cc(cc3)O)CCC1CCCC1
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,"ICI 174,864",1636,,,135650369,Antagonist,Inverse agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10516632,C=CCN([C@H](C(=O)NC(C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccccc1)(C)C)Cc1ccc(cc1)O)CC=C
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,naltriben,1640,,,135650688,Antagonist,Inverse agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,10516632,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
Diacylglycerol lipase &alpha;,1396,DAGLA,Q9Y4D2,,,,,,Human,orlistat,5277,,,178101960,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,IC50,0,60,0,=,,,,14610053,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Diacylglycerol lipase &alpha;,1396,DAGLA,Q9Y4D2,,,,,,Human,RHC80267,5255,,,178101939,Inhibitor,Inhibition,,f,f,,pIC50,0,4.190000057,0,IC50,0,65000,0,=,,,,22738638,O=C(ON=C1CCCCC1)NCCCCCCNC(=O)ON=C1CCCCC1
Diacylglycerol lipase &beta;,1397,DAGLB,Q8NCG7,,,,,,Human,orlistat,5277,,,178101960,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,100,0,=,,,,14610053,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Diacylglycerol lipase &beta;,1397,DAGLB,Q8NCG7,,,,,,Human,RHC80267,5255,,,178101939,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(ON=C1CCCCC1)NCCCCCCNC(=O)ON=C1CCCCC1
diacylglycerol O-acyltransferase 1,2821,DGAT1,O75907,,,,,,Human,PF-04620110,7829,,,223366160,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,24900321,OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)N1CCOc2c(C1=O)c(N)ncn2
dihydrofolate reductase,2603,DHFR,P00374,,,,,,Human,methotrexate,4815,,,178101517,Inhibitor,Inhibition,,f,t,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,,,,7877140,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(Cc1cnc2c(n1)c(N)nc(n2)N)C
dihydrofolate reductase,2603,DHFR,P00374,,,,,,Human,pemetrexed,6837,,,178103443,Inhibitor,Inhibition,,f,t,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,16078850,OC(=O)CC[C@H](C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)nc([nH]2)N
dihydrofolate reductase,2603,DHFR,P00374,,,,,,Human,pralatrexate,6840,,,178103446,Inhibitor,Inhibition,,f,t,,pKi,0,7.349999905,0,Ki,0,45,0,=,,,,19221750,C#CCC(c1ccc(cc1)C(=O)N[C@H](C(=O)O)CCC(=O)O)Cc1cnc2c(n1)c(N)nc(n2)N
dihydroorotate dehydrogenase (quinone),2604,DHODH,Q02127,,,,,,Human,leflunomide,6825,,,178103431,Inhibitor,Inhibition,,f,t,,pKi,0,4.889999866,0,Ki,0,13000,0,=,,,,9719606,O=C(c1cnoc1C)Nc1ccc(cc1)C(F)(F)F
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,linagliptin,6318,,,178102936,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,18052023,CC#CCn1c(nc2c1c(=O)n(Cc1nc(C)c3c(n1)cccc3)c(=O)n2C)N1CCC[C@H](C1)N
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,omarigliptin,8402,,,252166612,Inhibitor,Inhibition,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,24660890,Fc1ccc(c(c1)[C@H]1OC[C@@H](C[C@@H]1N)N1Cc2c(C1)cn(n2)S(=O)(=O)C)F
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,saxagliptin,6316,,,178102934,Inhibitor,Inhibition,,f,t,,pKi,0,9.199999809,0,Ki,0,0.600000024,0,=,,,,19149538,N#C[C@@H]1C[C@H]2[C@@H](N1C(=O)[C@H](C13CC4CC(C1)CC(C3)(C4)O)N)C2
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,sitagliptin,6286,,,178102906,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8.600000381,0,=,,,,20927248,N[C@H](Cc1cc(F)c(cc1F)F)CC(=O)N1CCn2c(C1)nnc2C(F)(F)F
diphosphomevalonate decarboxylase,642,MVD,P53602,,,,,,Human,diphosphoglycolyl proline,3206,,,135650193,Inhibitor,Competitive,,f,,,pKi,0,8.64,0,Ki,0,2.3,0,=,"recombinant enzyme expressed in E coli, purified, in vitro spectrophotometric assay",,,18823933,OC(=O)C1CCCN1C(C(P(=O)(O)O)(P(=O)(O)O)O)O
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,P'-geranyl 2-fluoromevalonate 5-diphosphate,3207,,,135650812,Inhibitor,Competitive,,f,,,pIC50,0,5.34,0,IC50,0,4600,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,17888661,C/C(=CCOP(=O)(OP(=O)(OCCC(C(C(=O)O)F)(O)C)O)O)/CCC=C(C)C
diphosphomevalonate decarboxylase,642,MVD,P53602,,,,,,Human,P'-geranyl 2-fluoromevalonate 5-diphosphate,3207,,,135650812,Inhibitor,Competitive,,f,,,pKi,0,5.38,0,Ki,0,4150,0,=,"expression of rat enzyme in E coli, purification, in vitro spectrophotometric assay",,,18823933,C/C(=CCOP(=O)(OP(=O)(OCCC(C(C(=O)O)F)(O)C)O)O)/CCC=C(C)C
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,"P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate",3208,,,135649699,Inhibitor,Competitive,,f,,,pIC50,0,5.59,0,IC50,0,2600,0,=,"enzyme expressed in E coli, purified, in vitro assay, spectrophotometric assay",,,16524256,C/C(=CCOP(=O)(OP(=O)(OCCC(CC(CC(=O)O)(O)C)O)O)O)/CCC=C(C)C
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,"P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate",3210,,,135650813,Inhibitor,Competitive,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,"enzyme expressed in E coli, purified, in vitro assay, spectrophotometric assay",,,16524256,OC(CC(CC(=O)O)(O)C)CCCOP(=O)(OP(=O)(OC/C=C(/CCC=C(C)C)C)O)O
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,"P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate",5621,,,178102255,Inhibitor,Competitive,,f,,,pKi,0,5.19,0,Ki,0,6500,0,=,"enzyme expressed in E coli, purified, in vitro assay, spectrophotometric assay",,,16524256,OC(CC(CC(=O)O)(O)C)CCCCOP(=O)(OP(=O)(OC/C=C(/CCC=C(C)C)C)O)O
diphosphomevalonate decarboxylase,642,Mvd,Q62967,,,,,,Rat,geranyl diphosphate,3051,,,135651490,Inhibitor,Feedback inhibition,,t,,,pIC50,5.3,0,4.19,IC50,65000,0,5000,=,"expression of rat enzyme in E coli, purification, <i>in vitro</i> spectrophotometric assay",,,16626865,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CCC=C(C)C
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,DDR-IN-1,9354,,,328083456,Inhibitor,Inhibition,,f,t,,pIC50,0,6.980000019,0,IC50,0,105,0,=,In a Lanthascreen enzyme assay,,,23899692,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)C(=O)Nc1ccc(c(c1)Oc1ccc2c(c1)CC(=O)N2)C
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,imatinib,5687,,,178102314,Inhibitor,Inhibition,,f,f,,pIC50,0,6.46999979,0,IC50,0,337,0,=,,,,23899692,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C
discoidin domain receptor tyrosine kinase 1,1843,DDR1,Q08345,,,,,,Human,nilotinib,5697,,,178102324,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,23899692,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F
discoidin domain receptor tyrosine kinase 2,1844,DDR2,Q16832,,,,,,Human,DDR-IN-1,9354,,,328083456,Inhibitor,Inhibition,,f,f,,pIC50,0,6.380000114,0,IC50,0,413,0,=,In a Lanthascreen enzyme assay,,,23899692,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)C(=O)Nc1ccc(c(c1)Oc1ccc2c(c1)CC(=O)N2)C
discoidin domain receptor tyrosine kinase 2,1844,DDR2,Q16832,,,,,,Human,imatinib,5687,,,178102314,Inhibitor,Inhibition,,f,f,,pIC50,0,6.170000076,0,IC50,0,675,0,=,,,,23899692,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C
discoidin domain receptor tyrosine kinase 2,1844,DDR2,Q16832,,,,,,Human,nilotinib,5697,,,178102324,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,23899692,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F
discoidin domain receptor tyrosine kinase 2,1844,DDR2,Q16832,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,10,0,,,,,23279183,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
DM1 protein kinase,1505,DMPK,Q09013,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,7.46999979,0,IC50,0,34.06000137,0,=,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
DNA-dependent protein kinase catalytic subunit,2800,Prkdc,P97313,,,,,,Mouse,DNA-PK inhibitor III,5960,,,178102583,Inhibitor,Inhibition,,f,t,,pIC50,0,6.920000076,0,IC50,0,120,0,=,Inhibition of PRKDC in C57BL6 mouse endothelial cells,,,22835870,CC(=O)c1ccc(cc1O)N1CCOCC1
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,DNA-PK inhibitor V,5961,,,178102584,Inhibitor,Inhibition,,f,t,,pIC50,0,6.570000172,0,IC50,0,270,0,=,,,,17562705,Oc1cc(ccc1C(=O)c1ccccc1)N1CCOCC1
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,KU-0060648,8011,,,249565691,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,23855836,CCN1CCN(CC1)CC(=O)Nc1ccc(c2c1c1ccccc1s2)c1cccc2c1oc(cc2=O)N1CCOCC1
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,M-3814,9766,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,0,COc1ccc(nn1)[C@H](c1cc(c(cc1Cl)F)c1ncnc2c1ccc(c2)N1CCOCC1)O
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,NU-7026,5959,,,178102582,Inhibitor,Inhibition,,f,t,,pIC50,0,6.639999866,0,IC50,0,230,0,=,,,,12941339,O=c1cc(oc2c1ccc1c2cccc1)N1CCOCC1
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,NU-7441,8010,,,249565690,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,ELISA measuring the ability of DNA-PK (extracted from HeLa cells) to phosphorylate Ser<sup>15</sup> of a p53 peptide,,,15546735,O=c1cc(oc2c1cccc2c1cccc2c1sc1c2cccc1)N1CCOCC1
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16647110,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
DNA methyltransferase 1,2605,DNMT1,P26358,,,,,,Human,SGI-1027,8891,,,310264672,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,850,0,=,Value derived from a nanoscale HTS assay.,,,24387159,Cc1cc(Nc2ccc(cc2)NC(=O)c2ccc(cc2)Nc2ccnc3c2cccc3)nc(n1)N
DNA topoisomerase I,2636,,,,,,,,Bovine,irinotecan,6823,,,178103429,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,Effect of irinotecan on topoisomerase I-mediated DNA cleavage,,,9655905,CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4ccc(cc4c(c3Cn1c2=O)CC)OC(=O)N1CCC(CC1)N1CCCCC1
DNA topoisomerase I,2636,TOP1,P11387,,,,,,Human,(S)-DRF-1042,8261,,,249565941,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OCCO[C@H]1c2cc3ccccc3nc2c2n1c(=O)c1c(c2)C[C@@](C(=O)O1)(O)CC
DNA topoisomerase II alpha,2637,TOP2A,P11388,,,,,,Human,doxorubicin,7069,,,178103648,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,<i>In vitro</i> inhibition of DNA relaxation and decatenation activities in a topoisomerase extract from human placenta.,,,11430001,OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@@H]([C@@H](O2)C)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC
DNA topoisomerase II alpha,2637,TOP2A,P11388,,,,,,Human,etoposide,6815,,,178103421,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50.40000153,0,=,Note: enzyme subunit is not specified in the referenced article,,,0,COc1cc(cc(c1O)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2[C@@H](c2c1cc1OCOc1c2)O[C@@H]1O[C@@H]2CO[C@H](O[C@H]2[C@@H]([C@H]1O)O)C
DNA topoisomerase II alpha,2637,TOP2A,P11388,,,,,,Human,mitoxantrone,7242,,,178103816,Inhibitor,Inhibition,,f,f,,pIC50,0,5.28000021,0,IC50,0,5300,0,=,Inhibition of topoisomerase II&alpha;-mediated decatenation activity.,,,18258442,OCCNCCNc1ccc(c2c1C(=O)c1c(C2=O)c(O)ccc1O)NCCNCCO
Dopamine beta-hydroxylase (dopamine beta-monooxygenase),2486,DBH,P09172,,,,,,Human,nepicastat,6630,,,178103243,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,-,0,0,0,=,,,,9283721,NCc1c[nH]c(=S)n1[C@H]1CCc2c(C1)cc(cc2F)F
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,EPZ004777,7377,,,178103949,Inhibitor,Inhibition,,f,f,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,21741596,O=C(Nc1ccc(cc1)C(C)(C)C)NCCCN(C(C)C)C[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc2c1ncnc2N
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,pinometostat,7019,,,178103598,Inhibitor,Inhibition,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,,,,23801631,O[C@@H]1[C@@H](CN([C@@H]2C[C@@H](C2)CCc2nc3c([nH]2)ccc(c3)C(C)(C)C)C(C)C)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
DOT1 like histone lysine methyltransferase,2650,DOT1L,Q8TEK3,,,,,,Human,SGC0946,7020,,,178103599,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,23250418,O=C(Nc1ccc(cc1)C(C)(C)C)NCCCN(C(C)C)C[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)Br
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,&Delta;<sup>12</sup>-PGJ<sub>2</sub>,1876,,,135651467,Agonist,Full agonist,,f,,,pKd,0,7,0,,0,0,0,,,,,9579725,CCCCC[C@@H](C/C=C/1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,f,,pKi,6.599999905,0,6,-,0,0,0,=,,,,9579725,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,"L-644,698",1879,,,135650477,Agonist,Full agonist,,f,f,,pKi,9.300000191,0,9,-,0,0,0,=,,,,10448933,CCCCCC(CCN1C(CCCc2ccc(cc2)C(=O)O)SCC1=O)O
DP<sub>1</sub> receptor,338,Ptgdr,Q9R261,,,,,,Rat,"L-644,698",1879,,,135650477,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10448933,CCCCCC(CCN1C(CCCc2ccc(cc2)C(=O)O)SCC1=O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,"L-888,291",1880,,,135650503,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,15755909,OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,9.2,0,7.8,,0,0,0,,,,,10448933,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>1</sub> receptor,338,Ptgdr,Q9R261,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,7.6,0,,0,0,0,,,,,10448933,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>1</sub> receptor,338,Ptgdr,P70263,,,,,,Mouse,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,7.7,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,7.3,0,,0,0,0,,,,,9579725,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,7,0,6.5,,0,0,0,,,,,7642548,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,6.4,0,6.1,,0,0,0,,,,,9579725,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,PGJ<sub>2</sub>,1885,,,135651542,Agonist,Full agonist,,t,,,pKi,0,9,0,,0,0,0,,,,,9579725,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,SQ-27986,1887,,,135651067,Agonist,Full agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,10772998,OC(=O)CCC/C=CC[C@@H]1[C@@H]2CC[C@H]([C@H]1/C=C/[C@H](C1CCCCC1)O)O2
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,RS 93520,1886,,,135650948,Agonist,Partial agonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,,,,10772998,OC(=O)CC/C=C/1C[C@H]2[C@H]1CC[C@@H]([C@H]2C#C[C@H](C1CCCCC1)O)O
DP<sub>1</sub> receptor,338,,,,,,,,Unknown,laropiprant,3356,,,178100382,Antagonist,Antagonist,,f,f,,pKi,0,10.10000038,0,-,0,0,0,=,,,,17300164,OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,ONO-AE3-237,8537,,,252166739,Antagonist,Antagonist,,f,f,,pKi,0,7.699999809,0,-,0,0,0,=,,,,15388164,OC(=O)Cc1cccc2c1cc(n2C(=O)c1ccc(cc1)OC[C@@H]1CN(C)c2c(O1)ccc(c2)C)C
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,S-5751,1898,,,135650972,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,11454901,OC(=O)CCC/C=CC[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,&Delta;<sup>12</sup>-PGJ<sub>2</sub>,1876,,,135651467,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12466225,CCCCC[C@@H](C/C=C/1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,&Delta;<sup>12</sup>-PGJ<sub>2</sub>,1876,,,135651467,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12721327,CCCCC[C@@H](C/C=C/1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,indomethacin,1909,,,135650390,Agonist,Full agonist,,f,,,pKi,7.7,0,6.1,,0,0,0,,,,,12466225,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,indomethacin,1909,,,135650390,Agonist,Full agonist,,f,,,pKi,6,0,5.7,,0,0,0,,,,,12721327,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"L-888,291",1880,,,135650503,Agonist,Full agonist,,f,,,pKi,0,7.32,0,Ki,0,48,0,=,,,,15755909,OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,"L-888,607",1907,,,135650504,Agonist,Full agonist,,f,,,pKi,0,9.1,0,Ki,0,0.8,0,=,,,,15755909,OC(=O)C[C@@H]1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,7.5,0,7.4,,0,0,0,,,,,12721327,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q6XKD3,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,,0,0,0,,,,,12975488,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,8.6,0,7.6,,0,0,0,,,,,12466225,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,PGD<sub>3</sub>,1908,,,135650811,Agonist,Full agonist,,t,,,pKi,0,7.4,0,,0,0,0,,,,,12721327,CCC=CC[C@@H](C=C[C@H]1C(=O)C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,5.3,0,,0,0,0,,,,,12466225,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,5.5,0,,0,0,0,,,,,12721327,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,6.2,0,,0,0,0,,,,,12721327,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,6.4,0,,0,0,0,,,,,12466225,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,PGJ<sub>2</sub>,1885,,,135651542,Agonist,Full agonist,,t,,,pKi,0,7.3,0,,0,0,0,,,,,12721327,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,PGJ<sub>2</sub>,1885,,,135651542,Agonist,Full agonist,,t,,,pKi,0,8.2,0,-,0,0,0,=,,,,12466225,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=CCCCC(=O)O)C=CC1=O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,fevipiprant,8995,,,310264773,Antagonist,Antagonist,,f,t,,pKd,0,8.989999771,0,Kd,0,1.019999981,0,=,,,,26916831,OC(=O)Cc1c(C)n(c2c1cccn2)Cc1ccc(cc1C(F)(F)F)S(=O)(=O)C
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,QAV680,8996,,,310264774,Antagonist,Antagonist,,f,t,,pKd,0,7.820000172,0,Kd,0,15.10000038,0,=,,,,0,OC(=O)Cc1c(C)n(c2c1cccn2)Cc1ccc(cc1)S(=O)(=O)C
DP<sub>2</sub> receptor,339,Ptgdr2,Q6XKD3,,,,,,Rat,ramatroban,1911,,,135650884,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,12975488,OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
DP<sub>2</sub> receptor,339,Ptgdr2,Q9Z2J6,,,,,,Mouse,ramatroban,1911,,,135650884,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,16030019,OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,ramatroban,1911,,,135650884,Antagonist,Antagonist,,f,f,,pKi,0,7.400000095,0,-,0,0,0,=,,,,16256979,OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,SKF-83959,8443,,,252166653,Agonist,Biased agonist,,f,f,,pEC50,0,9.699999809,0,EC50,0,0.200000003,0,=,Biased towards G-protein signalling in a cellular assay expressing only D<sub>1</sub> receptor.,,,25660762,CN1CCc2c(C(C1)c1cccc(c1)C)cc(c(c2Cl)O)O
D<sub>1</sub> receptor,214,Drd1,P18901,,,,,,Rat,dihydrexidine,9267,,,315661342,Agonist,Full agonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,2572425,Oc1cc2CC[C@H]3[C@H](c2cc1O)c1ccccc1CN3
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,dopamine,940,,,135651480,Agonist,Full agonist,,t,t,,pKi,5.599999905,0,4.300000191,-,0,0,0,=,,,,1826762,NCCc1ccc(c(c1)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,fenoldopam,939,,,135651054,Agonist,Full agonist,,f,t,,pKi,7.900000095,0,6.5,-,0,0,0,=,,,,7525564,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,noradrenaline,484,,,135651526,Agonist,Full agonist,,t,,,pKi,0,4.3,0,,0,0,0,,,,,1826762,NCC(c1ccc(c(c1)O)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,N-propylnorapomorphine,934,,,135650737,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1826762,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,6.5,0,5.9,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,rotigotine,941,,,135650929,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,1826762,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1
D<sub>1</sub> receptor,214,Drd1,P18901,,,,,,Rat,SKF-75670,936,,,135651049,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,1973652,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)O)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,SKF-76783,937,,,135651050,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,1826762,
D<sub>1</sub> receptor,214,Drd1,P18901,,,,,,Rat,SKF-81297,938,,,135651051,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,Ki,0,1.99000001,0,=,,,,1973652,Oc1c(O)cc2c(c1Cl)CCNCC2c1ccccc1
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,(+)-SKF-82526,933,,,135651053,Agonist,Full agonist,,f,f,,pKi,0,7.550000191,0,Ki,0,28,0,=,,,,1826762,Oc1ccc(cc1)[C@@H]1CNCCc2c1cc(O)c(c2Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,SKF-38393,935,,,135651048,Agonist,Partial agonist,,f,f,,pKi,6.800000191,0,6.199999809,Ki,631,0,158,=,,,,1826762,Oc1cc2CCNCC(c2cc1O)c1ccccc1
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,(-)-SKF-82526,985,,,135651052,Agonist,Partial agonist,,f,f,,pKi,0,5.739999771,0,Ki,0,1818,0,=,,,,1826762,Oc1ccc(cc1)[C@H]1CNCCc2c1cc(O)c(c2Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,ecopipam,3304,,,178100341,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,Ki,0,5,0,=,,,,7862709,CN1CCc2c([C@@H]3[C@@H]1CCc1c3cccc1)cc(c(c2)Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,flupentixol,948,,,135650273,Antagonist,Antagonist,,f,t,,pKi,8.399999619,0,7,-,0,0,0,=,"Note that this assay uses the <i>cis</i> form of the compound, whereas the approved drug is a racemic mixture of <i>cis</i> and <i>trans</i> molecules.",,,1826762,OCCN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,1826762,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,f,,pKi,8.199999809,0,7.599999905,-,0,0,0,=,,,,1826762,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,1826762,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,6.989999771,0,Ki,0,103,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,periciazine,9216,,,315661292,Antagonist,Antagonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,7918347,N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,prochlorperazine,7279,,,178103853,Antagonist,Antagonist,,f,f,,pKi,0,7.110000134,0,Ki,0,78,0,=,,,,0,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,SCH-23390,943,,,135651025,Antagonist,Antagonist,,f,,,pKi,9.5,0,7.4,-,0,0,0,=,,,,1826762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,SKF-83566,944,,,135651055,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,-,0,0,0,=,,,,1826762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Br)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,1826762,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,HS665,9189,,,315661268,Agonist,Agonist,,f,f,,pKi,0,6.349999905,0,Ki,0,450,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,LP-12,8434,,,252166644,Agonist,Agonist,,f,f,,pKi,0,6.650000095,0,Ki,0,224,0,=,,,,17649988,O=C(NC1CCCc2c1cccc2)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,LP-211,8436,,,252166646,Agonist,Agonist,,f,f,,pKi,0,6.849999905,0,Ki,0,142,0,=,,,,18800769,N#Cc1ccc(cc1)CNC(=O)CCCCCN1CCN(CC1)c1ccccc1c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,LP-44,8435,,,252166645,Agonist,Agonist,,f,f,,pKi,0,8.140000343,0,Ki,0,7.300000191,0,=,,,,17649988,CSc1ccccc1N1CCN(CC1)CCCCCC(=O)NC1CCCc2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,ropinirole,7295,,,178103868,Agonist,Agonist,,f,t,,pKi,0,8.140000343,0,Ki,0,7.199999809,0,=,,,,9057850,CCCN(CCC)CCc1cccc2c1CC(=N2)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,rotigotine,941,,,135650929,Agonist,Agonist,,f,t,,pKi,0,10.22000027,0,Ki,0,0.059999999,0,=,,,,12086487,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,MLS1547,8369,,,252166581,Agonist,Biased agonist,,f,f,,pKi,0,8.229999542,0,Ki,0,5.900000095,0,=,Biased agonist for G-protein coupling to G<sub>i</sub>.,,,24755247,Clc1cc(CN2CCN(CC2)c2ccccn2)c(c2c1cccn2)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,dopamine,940,,,135651480,Agonist,Full agonist,,t,t,,pKi,7.199999809,0,4.699999809,-,0,0,0,=,,,,8301582,NCCc1ccc(c(c1)O)O
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,dopamine,940,,,135651480,Agonist,Full agonist,,t,,,pKi,6.4,0,5.3,,0,0,0,,,,,1975644,NCCc1ccc(c(c1)O)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(-)-N-porphynorapomorphine,969,,,135650738,Agonist,Full agonist,,f,,,pKi,8.9,0,7.5,,0,0,0,,,,,8301582,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,PD 128907,952,,,135650793,Agonist,Full agonist,,f,,,pKi,6.4,0,5.4,,0,0,0,,,,,7756621,CCCN1CCO[C@@H]2[C@@H]1COc1c2cc(cc1)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,7.6,0,7.5,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,pramipexole,953,,,135650847,Agonist,Full agonist,,f,t,,pKi,7.400000095,0,5.099999905,-,0,0,0,=,,,,7756621,CCCN[C@H]1CCc2c(C1)sc(n2)N
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,quinelorane,954,,,135650871,Agonist,Full agonist,,f,,,pKi,5.7,0,5.5,,0,0,0,,,,,1354163,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,0,5.199999809,0,-,0,0,0,=,,,,1975644,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,7.699999809,0,4.900000095,-,0,0,0,=,,,,7576010,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,9.5,0,9.2,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,piribedil,49,,,135650833,Agonist,Partial agonist,,f,,,pKi,6.9,0,6.8,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,SB269652,7694,,,223366027,Allosteric modulator,Negative,,f,f,,pKB,0,6.380000114,0,KB,0,416,0,=,Allosteric reduction of dopamine binding in a radioligand binding assay,,,25108820,N#Cc1ccc2c(c1)CN(CC2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1cc2c([nH]1)cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,domperidone,965,,,135650206,Antagonist,Antagonist,,f,t,,pKi,8.399999619,0,7.900000095,Ki,12.60000038,0,3.980000019,=,,,,8301582,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,domperidone,965,,,135650206,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,1975644,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,eticlopride,966,,,135650243,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,7907989,CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,flupentixol,948,,,135650273,Antagonist,Antagonist,,f,t,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,8301582,OCCN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Antagonist,,f,t,,pKi,0,8.840000153,0,Ki,0,1.440000057,0,=,,,,17826096,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,1975644,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,7.400000095,-,0,0,0,=,,,,8301582,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,iloperidone,87,,,135650377,Antagonist,Antagonist,,f,f,,pIC50,0,6.960000038,0,IC50,0,110,0,=,Measuring displacement of [<sup>3</sup>H]spiperone from rat striatum.,,,7707315,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,<i>trans</i>-flupenthixol,968,,,135651274,Antagonist,Antagonist,,f,f,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,8301582,OCCN1CCN(CC1)CC/C=C/1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,"L-741,626",177,,,135650487,Antagonist,Antagonist,,f,,,pKi,8.5,0,7.9,-,0,0,0,=,,,,8642550,Clc1ccc(cc1)C1(O)CCN(CC1)Cc1c[nH]c2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,loxapine,205,,,135650533,Antagonist,Antagonist,,f,t,,pKi,8.300000191,0,7.920000076,Ki,12,0,5,=,,,,12629531,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,lumateperone,9099,,,315661184,Antagonist,Antagonist,,f,f,,pKi,0,7.489999771,0,Ki,0,32,0,=,,,,25120104,Fc1ccc(cc1)C(=O)CCCN1CCC2C(C1)c1cccc3c1N2CCN3C
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,lurasidone,7461,,,187051764,Antagonist,Antagonist,,f,f,,pKi,0,8.770000458,0,Ki,0,1.679999948,0,=,,,,20404009,O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,8.659999847,0,Ki,0,2.200000048,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
D<sub>2</sub> receptor,215,Drd2,P61168,,,,,,Mouse,metoclopramide,241,,,135650598,Antagonist,Antagonist,,f,t,,pKi,0,7.539999962,0,Ki,0,28.79999924,0,=,,,,9808703,CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,ML321,8368,,,252166580,Antagonist,Antagonist,,f,t,,pKi,0,7,0,Ki,0,100,0,=,,,,24666157,O=C(c1ccc2c(c1)N(C)C(=O)c1c([S@@]2=O)cccc1)NCCc1cccs1
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,nafadotride,44,,,135650679,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,10617689,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,nafadotride,44,,,135650679,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,8531087,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,t,,pKi,0,8.680000305,0,Ki,0,2.099999905,0,=,,,,9430133,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,perospirone,7556,,,223365892,Antagonist,Antagonist,,f,t,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,1060115,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Antagonist,,f,t,,pKi,9.590000153,0,8.850000381,Ki,1.399999976,0,0.25999999,=,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,pimozide,90,,,135650825,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,7,-,0,0,0,=,,,,8301582,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,1975644,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,pipotiazine,7557,,,223365893,Antagonist,Antagonist,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,1586393,OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,prochlorperazine,7279,,,178103853,Antagonist,Antagonist,,f,t,,pKi,0,8.43999958,0,Ki,0,3.609999895,0,=,,,,0,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,promazine,7281,,,178103855,Antagonist,Antagonist,,f,t,,pKi,0,6.519999981,0,Ki,0,300,0,=,,,,16135699,CN(CCCN1c2ccccc2Sc2c1cccc2)C
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,quetiapine,50,,,135650869,Antagonist,Antagonist,,f,t,,pKi,0,7.199999809,0,Ki,0,69,0,=,,,,9430133,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,raclopride,94,,,135650880,Antagonist,Antagonist,,f,,,pKi,9.3,0,7.7,-,0,0,0,=,,,,1975644,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,raclopride,94,,,135650880,Antagonist,Antagonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,7473180,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,t,,pKi,0,9.359999657,0,Ki,0,0.439999998,0,=,,,,9430133,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,roxindole,52,,,135650930,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(+)-S-14297,955,,,135650956,Antagonist,Antagonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,7473180,CCCN(C1CCc2c(C1)cc1c(c2)CCO1)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(+)-SCH-23390,956,,,135651024,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,8301582,CN1CCc2c([C@@H](C1)c1ccccc1)cc(c(c2)Cl)O
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,t,,pKi,8.920000076,0,8.039999962,Ki,9.100000381,0,1.200000048,=,,,,12629531,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,9.4,0,8.4,,0,0,0,,,,,7907989,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(-)-stepholidine,8370,,,252166582,Antagonist,Antagonist,,f,f,,pKi,0,7.940000057,0,Ki,0,11.60000038,0,=,,,,25231919,COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,HS665,9189,,,315661268,Agonist,Agonist,,f,f,,pKi,0,6.550000191,0,Ki,0,282,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,PF-592379,7683,,,223366018,Agonist,Agonist,,f,f,,pIC50,0,6.670000076,0,IC50,0,215,0,=,,,,22470105,CCCN1C[C@H](OC[C@@H]1C)c1ccc(nc1)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,ropinirole,7295,,,178103868,Agonist,Agonist,,f,t,,pKi,0,7.71999979,0,Ki,0,19,0,=,,,,9057850,CCCN(CCC)CCc1cccc2c1CC(=N2)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,rotigotine,941,,,135650929,Agonist,Agonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,12086487,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,dopamine,940,,,135651480,Agonist,Full agonist,,t,t,,pKi,7.300000191,0,6.400000095,-,0,0,0,=,,,,8301582,NCCc1ccc(c(c1)O)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(-)-N-porphynorapomorphine,969,,,135650738,Agonist,Full agonist,,f,,,pKi,8.7,0,8.4,,0,0,0,,,,,8301582,CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,PD 128907,952,,,135650793,Agonist,Full agonist,,f,f,,pKi,7.699999809,0,7.599999905,Ki,25.10000038,0,19.89999962,=,,,,7756621,CCCN1CCO[C@@H]2[C@@H]1COc1c2cc(cc1)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,pramipexole,953,,,135650847,Agonist,Full agonist,,f,t,,pKi,8.699999809,0,8.399999619,-,0,0,0,=,,,,7756621,CCCN[C@H]1CCc2c(C1)sc(n2)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,quinelorane,954,,,135650871,Agonist,Full agonist,,f,,,pKi,7.4,0,7.2,,0,0,0,,,,,1354163,CCCN1CCC[C@H]2[C@H]1Cc1cnc(nc1C2)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,f,,pKi,8,0,6.400000095,Ki,398,0,10,=,,,,7756621,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,7.800000191,0,7.300000191,-,0,0,0,=,,,,7576010,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,f,,pKi,0,8.300000191,0,Ki,0,5.010000229,0,=,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,piribedil,49,,,135650833,Agonist,Partial agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,SB269652,7694,,,223366027,Allosteric modulator,Negative,,f,f,,pKi,0,9,0,Ki,0,1,0,~,,,,25583363,N#Cc1ccc2c(c1)CN(CC2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1cc2c([nH]1)cccc2
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,domperidone,965,,,135650206,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,1975644,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,domperidone,965,,,135650206,Antagonist,Antagonist,,f,t,,pKi,7.599999905,0,7.099999905,-,0,0,0,=,,,,8301582,Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,eticlopride,966,,,135650243,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7907989,CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,flupentixol,948,,,135650273,Antagonist,Antagonist,,f,f,,pKi,0,8.960000038,0,Ki,0,1.100000024,0,=,,,,8301582,OCCN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,1975644,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,t,,pKi,8.600000381,0,7.5,-,0,0,0,=,,,,8301582,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,<i>trans</i>-flupenthixol,968,,,135651274,Antagonist,Antagonist,,f,f,,pKi,0,6.519999981,0,Ki,0,300,0,=,,,,8301582,OCCN1CCN(CC1)CC/C=C/1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,loxapine,205,,,135650533,Antagonist,Antagonist,,f,t,,pKi,0,7.679999828,0,Ki,0,21,0,=,,,,0,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,mesoridazine,7227,,,178103801,Antagonist,Antagonist,,f,f,,pKi,0,7.639999866,0,Ki,0,23,0,=,,,,15357957,CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,nafadotride,44,,,135650679,Antagonist,Antagonist,,f,f,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,8531087,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,nemonapride,983,,,135650707,Antagonist,Antagonist,,f,,,pKi,9.3,0,9.2,,0,0,0,,,,,7907989,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,NGB 2904,6674,,,178103286,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,17627675,O=C(c1ccc2c(c1)Cc1c2cccc1)NCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,perospirone,7556,,,223365892,Antagonist,Antagonist,,f,t,,pKi,0,9.550000191,0,Ki,0,0.280000001,0,=,,,,1354163,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,PG01037,6675,,,178103287,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,-,0,0,0,=,,,,17672446,O=C(c1ccc(cc1)c1ccccn1)NC/C=C/CN1CCN(CC1)c1cccc(c1Cl)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,8.6,0,7,,0,0,0,,,,,8301582,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1975644,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,prochlorperazine,7279,,,178103853,Antagonist,Antagonist,,f,t,,pKi,0,8.350000381,0,Ki,0,4.449999809,0,=,,,,0,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,promazine,7281,,,178103855,Antagonist,Antagonist,,f,t,,pKi,0,6.800000191,0,Ki,0,159,0,=,,,,16135699,CN(CCCN1c2ccccc2Sc2c1cccc2)C
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,raclopride,94,,,135650880,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,1975644,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,raclopride,94,,,135650880,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,7473180,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,7473180,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(+)-S-14297,955,,,135650956,Antagonist,Antagonist,,f,f,,pKi,7.889999866,0,6.900000095,Ki,126,0,13,=,,,,7473180,CCCN(C1CCc2c(C1)cc1c(c2)CCO1)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,S33084,129,,,135650970,Antagonist,Antagonist,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,10869410,N#Cc1ccc2c(c1)[C@H]1CN(C[C@@H]1CO2)CCCCNC(=O)c1ccc(cc1)c1ccccc1
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,SB 277011-A,143,,,135651003,Antagonist,Antagonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,10945872,N#Cc1ccc2c(c1)CCN(C2)CC[C@@H]1CC[C@H](CC1)NC(=O)c1ccnc2c1cccc2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,8,Ki,10,0,1.600000024,=,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,1975644,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,PF-592379,7683,,,223366018,Agonist,Agonist,,f,f,,pIC50,0,5.380000114,0,IC50,0,4165,0,=,,,,22470105,CCCN1C[C@H](OC[C@@H]1C)c1ccc(nc1)N
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,rotigotine,941,,,135650929,Agonist,Agonist,,f,f,,pKi,0,7.260000229,0,Ki,0,55,0,=,,,,8863800,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,dopamine,940,,,135651480,Agonist,Full agonist,,t,,,pKi,0,7.4,0,,0,0,0,,,,,10617689,NCCc1ccc(c(c1)O)O
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,dopamine,940,,,135651480,Agonist,Full agonist,,t,t,,pKi,0,7.599999905,0,-,0,0,0,=,,,,1840645,NCCc1ccc(c(c1)O)O
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,fenoldopam,939,,,135651054,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,1840645,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,quinpirole,2,,,135650874,Agonist,Full agonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,12388666,CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,CP-226269,973,,,135650125,Agonist,Partial agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,15448188,Fc1ccc2c(c1)cc([nH]2)CN1CCN(CC1)c1ccccn1
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,FAUC213,974,,,135650253,Agonist,Partial agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,15448188,Clc1ccc(cc1)N1CCN(CC1)Cc1cc2n(n1)cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,"PD168,077",975,,,135650802,Agonist,Partial agonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,15448188,N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,pergolide,48,,,135650809,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,roxindole,52,,,135650930,Agonist,Partial agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12388666,Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,CP-293019,977,,,135650126,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,15448188,Fc1ccc(cc1)OC[C@@H]1CC[C@@H]2N(C1)CCN(C2)c1ncc(cn1)F
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,eticlopride,966,,,135650243,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,7475902,CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(c1OC)Cl
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,FAUC213,974,,,135650253,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,15448188,Clc1ccc(cc1)N1CCN(CC1)Cc1cc2n(n1)cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,8.699999809,-,0,0,0,=,,,,8102973,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,L741742,3302,,,178100339,Antagonist,Antagonist,,f,f,,pKi,0,8.5,0,Ki,0,3.160000086,0,=,,,,8642551,Clc1ccc(cc1)c1onc(c1C)C1CCN(CC1)CCc1ccccc1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,L745870,3303,,,178100340,Antagonist,Antagonist,,f,f,,pKi,0,9.409999847,0,Ki,0,0.389999986,0,=,,,,8642550,Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,"L-750,667",978,,,135650488,Antagonist,Antagonist,,f,,,pKi,0,10,0,,0,0,0,,,,,10617689,Ic1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,loxapine,205,,,135650533,Antagonist,Antagonist,,f,t,,pKi,0,8.109999657,0,Ki,0,7.800000191,0,=,,,,9015795,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,ML398,8440,,,252166650,Antagonist,Antagonist,,f,t,,pKi,0,7.440000057,0,Ki,0,36,0,=,,,,25221667,Clc1ccc(cc1)CN1CCO[C@@H](C1)CCc1ccccc1
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,nafadotride,44,,,135650679,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,10617689,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2c(c1OC)cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,nemonapride,983,,,135650707,Antagonist,Antagonist,,f,,,pKd,0,10,0,,0,0,0,,,,,8248849,COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,NGD 94-1,979,,,135650712,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,15448188,c1ccc(cc1)c1ncc([nH]1)CN1CCN(CC1)c1ncccn1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,perospirone,7556,,,223365892,Antagonist,Antagonist,,f,t,,pKi,0,10.05000019,0,Ki,0,0.090000004,0,=,,,,9577836,O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,piribedil,49,,,135650833,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12388666,c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,prochlorperazine,7279,,,178103853,Antagonist,Antagonist,,f,f,,pKi,0,6.090000153,0,Ki,0,810,0,=,,,,0,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,raclopride,94,,,135650880,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,-,0,0,0,=,,,,10617689,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,RBI257,981,,,135650888,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,15448188,CC(Oc1cccnc1N(C1CCN(CC1)Cc1ccc(cc1)I)C)C
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,Ro 10-4548,982,,,135650910,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,15448188,COc1cc(ccc1O)N1CCN(CC1)CC(COc1ccccc1NC(=O)C)O
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,t,,pKi,9.069999695,0,7.800000191,Ki,16,0,0.850000024,=,,,,16135699,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,sonepiprazole,980,,,135650842,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,15448188,NS(=O)(=O)c1ccc(cc1)N1CCN(CC1)CC[C@@H]1OCCc2c1cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,sonepiprazole,980,,,135650842,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,Ki,0,1.4,0,=,,,,9098699,NS(=O)(=O)c1ccc(cc1)N1CCN(CC1)CC[C@@H]1OCCc2c1cccc2
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,7475902,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,dopamine,940,,,135651480,Agonist,Full agonist,,t,t,,pKi,0,6.599999905,0,-,0,0,0,=,,,,1826762,NCCc1ccc(c(c1)O)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,noradrenaline,484,,,135651526,Agonist,Full agonist,,t,,,pKi,0,4.9,0,,0,0,0,,,,,1826762,NCC(c1ccc(c(c1)O)O)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,N-propylnorapomorphine,934,,,135650737,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,1826762,CCCN1CCc2c3C1Cc1ccc(c(c1c3ccc2)O)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,pergolide,48,,,135650809,Agonist,Full agonist,,f,,,pKi,7.5,0,6,,0,0,0,,,,,12388666,CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,rotigotine,941,,,135650929,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,1826762,CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,SKF-76783,937,,,135651050,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,1826762,
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,(-)-SKF-82526,985,,,135651052,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,1826762,Oc1ccc(cc1)[C@H]1CNCCc2c1cc(O)c(c2Cl)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,(+)-SKF-82526,933,,,135651053,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,1826762,Oc1ccc(cc1)[C@@H]1CNCCc2c1cc(O)c(c2Cl)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,lisuride,43,,,135650525,Agonist,Partial agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,SKF-38393,935,,,135651048,Agonist,Partial agonist,,f,f,,pKi,0,7,0,-,0,0,0,=,,,,1826762,Oc1cc2CCNCC(c2cc1O)c1ccccc1
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,ecopipam,3304,,,178100341,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,-,0,0,0,=,,,,1826762,CN1CCc2c([C@@H]3[C@@H]1CCc1c3cccc1)cc(c(c2)Cl)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,flupentixol,948,,,135650273,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,1826762,OCCN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,1826762,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,1826762,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,ketanserin,88,,,135650453,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,1826762,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,SCH-23390,943,,,135651025,Antagonist,Antagonist,,f,,,pKi,9.5,0,7.5,-,0,0,0,=,,,,1826762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,SKF-83566,944,,,135651055,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,-,0,0,0,=,,,,1826762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Br)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,spiperone,99,,,135651064,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,1826762,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,harmine,9352,,,328083454,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,19796173,COc1ccc2c(c1)[nH]c1c2ccnc1C
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,KH-CB19,8055,,,249565735,Inhibitor,Inhibition,,f,f,,pIC50,0,7.260000229,0,IC50,0,55.20000076,0,=,,,,21276940,CCOC(=O)c1c(/C(=CN)/C#N)c2c(n1C)c(Cl)c(cc2)Cl
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,Dyrk1a,Q63470,,,,,,Rat,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,f,,pIC50,0,10.39999962,0,IC50,0,0.039999999,0,=,,,,21615147,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
dual specificity tyrosine phosphorylation regulated kinase 1A,2009,DYRK1A,Q13627,,,,,,Human,ML315,8162,,,249565842,Inhibitor,Inhibition,,f,f,,pIC50,0,6.550000191,0,IC50,0,282,0,=,,,,23642479,Clc1cc(CNc2ncncc2c2ccc3c(c2)OCO3)cc(c1)Cl
dual specificity tyrosine phosphorylation regulated kinase 1B,2010,DYRK1B,Q9Y463,,,,,,Human,harmine,9352,,,328083454,Inhibitor,Inhibition,,f,f,,pIC50,0,6.78000021,0,IC50,0,166,0,=,,,,19796173,COc1ccc2c(c1)[nH]c1c2ccnc1C
dual specificity tyrosine phosphorylation regulated kinase 2,2011,DYRK2,Q92630,,,,,,Human,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,t,,pIC50,0,9.460000038,0,IC50,0,0.349999994,0,=,,,,21615147,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
dual specificity tyrosine phosphorylation regulated kinase 4,2013,DYRK4,Q9NR20,,,,,,Human,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,520,0,=,,,,22998443,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,curcumin,7000,,,178103579,Inhibitor,Inhibition,,f,f,,pIC50,0,4.599999905,0,IC50,0,25000,0,=,,,,15383533,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(c(c2)OC)O)ccc1O
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,epigallocatechin-3-gallate,7002,,,178103581,Inhibitor,Inhibition,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,=,,,,19147572,Oc1cc(O)c2c(c1)O[C@@H]([C@@H](C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,garcinol,7001,,,178103580,Inhibitor,Inhibition,,f,f,,pIC50,0,5.150000095,0,IC50,0,7000,0,=,,,,15155757,CC(=CC[C@]12C(=O)C(=C(c3ccc(c(c3)O)O)O)C(=O)[C@@](C1=O)(C[C@@H](C(=C)C)CC=C(C)C)C[C@H](C2(C)C)CC=C(C)C)C
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,H3-CoA-20,7035,,,178103614,Inhibitor,Inhibition,,f,f,,pIC50,0,3.700000048,0,IC50,0,200000,0,=,,,,10882143,
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,I-CBP112,8236,,,249565916,Inhibitor,Inhibition,,f,f,,pKd,0,6.199999809,0,Kd,0,625,0,=,Isothermal titration calorimetry (ITC) assay.,,,0,CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]1CCCN(C1)C)c1ccc(c(c1)OC)OC
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,Lys-CoA,7036,,,178103615,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,10882143,
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,plumbagin,7003,,,178103582,Inhibitor,Inhibition,,f,f,,pIC50,0,4.599999905,0,IC50,0,25000,0,=,,,,19570987,CC1=CC(=O)c2c(C1=O)cccc2O
E1A binding protein p300,2735,EP300,Q09472,,,,,,Human,SGC-CBP30,7529,,,187051830,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,24497428,COc1ccc(cc1Cl)CCc1nc2c(n1C[C@@H](N1CCOCC1)C)ccc(c2)c1c(C)noc1C
Ecto-5'-Nucleotidase,1232,NT5E,P21589,,,,,,Human,oleclumab,9596,,,340590226,Antibody,Binding,,f,t,,pKd,0,11.38000011,0,Kd,0,0.0042,0,=,,,,26854859,
Ecto-5'-Nucleotidase,1232,Nt5e,P21588,,,,,,Rat,PSB-0963,9023,,,315661108,Inhibitor,Inhibition,,f,f,,pKi,0,6.820000172,0,Ki,0,150,0,=,,,,20146483,O=C1c2ccccc2C(=O)c2c1c(N)c(cc2Nc1ccc2c(c1)cc1c(c2)cccc1)S(=O)(=O)[O-]
"ectodysplasin 1, anhidrotic receptor",2325,EDAR,Q9UNE0,,,,,,Human,ectodysplasin A1,6144,EDA,Human,178102765,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,11039935,
ectodysplasin A2 isoform receptor,1896,EDA2R,Q9HAV5,,,,,,Human,ectodysplasin A2,6143,EDA,Human,178102764,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,11039935,
ectonucleoside triphosphate diphosphohydrolase 1,2888,ENTPD1,P49961,,,,,,Human,PSB-0963,9023,,,315661108,Inhibitor,Inhibition,,f,f,,pKi,0,5.590000153,0,Ki,0,2590,0,=,,,,20146483,O=C1c2ccccc2C(=O)c2c1c(N)c(cc2Nc1ccc2c(c1)cc1c(c2)cccc1)S(=O)(=O)[O-]
ectonucleoside triphosphate diphosphohydrolase 2,2889,ENTPD2,Q9Y5L3,,,,,,Human,PSB-6426,9033,,,315661118,Inhibitor,Inhibition,,f,t,,pKi,0,5.090000153,0,Ki,0,8200,0,=,,,,18630897,CCOP(=O)(Cc1ccc(cc1)NC(=O)CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc(=O)[nH]c1=O)OCC
egl-9 family hypoxia inducible factor 1,2833,EGLN1,Q9GZT9,,,,,,Human,IOX1,8230,,,249565910,Inhibitor,Inhibition,,f,f,,pIC50,0,4.480000019,0,IC50,0,33000,0,=,,,,24504543,OC(=O)c1ccc(c2c1cccn2)O
egl-9 family hypoxia inducible factor 1,2833,EGLN1,Q9GZT9,,,,,,Human,IOX2,8229,,,249565909,Inhibitor,Inhibition,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,23683440,OC(=O)CNC(=O)c1c(O)c2ccccc2n(c1=O)Cc1ccccc1
egl-9 family hypoxia inducible factor 3,2834,EGLN3,Q9H6Z9,,,,,,Human,molidustat,8456,,,252166666,Inhibitor,Inhibition,,f,t,,pIC50,0,6.309999943,0,IC50,0,490,0,=,,,,0,O=c1n([nH]cc1n1ccnn1)c1ncnc(c1)N1CCOCC1
"elastase, neutrophil expressed",2358,ELANE,P08246,,,,,,Human,sivelestat,6441,,,178103057,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,44,0,=,,,,21741848,OC(=O)CNC(=O)c1ccccc1NS(=O)(=O)c1ccc(cc1)OC(=O)C(C)(C)C
ENaC&alpha;&beta;&gamma;,742,SCNN1B|SCNN1G|SCNN1A,P37088|P51168|P51170,,,,,,Human,S3969,4305,,,178101122,Activator,None,,f,f,,pEC50,0,5.900000095,0,EC50,0,1200,0,=,,,,18326490,OCCNC(=O)C(Sc1c[nH]c2c1c(C)ccc2)CC(C)C
ENaC&alpha;&beta;&gamma;,742,SCNN1B|SCNN1G|SCNN1A,P37088|P51168|P51170,,,,,,Human,P552-02,4280,,,178101097,Channel blocker,None,,f,f,,pIC50,0,8.100000381,0,IC50,0,7.599999905,0,=,,,,0,OCC(COc1ccc(cc1)CCCCN=C(NC(=O)c1nc(Cl)c(nc1N)N)N)O
Endothelial NOS,1249,NOS3,P29474,,,,,,Human,L-NNA,8759,,,252827417,Inhibitor,Inhibition,,f,f,,pKi,0,7.519999981,0,Ki,0,30,0,=,,,,9667974,[O-][N+](=O)NC(=NCCC[C@@H](C(=O)O)N)N
Endothelin-converting enzyme 1,1615,ECE1,P42892,,,,,,Human,daglutril,6506,,,178103120,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCOC(=O)[C@@H](CC1(CCCC1)C(=O)N[C@H]1CCc2c(N(C1=O)CC(=O)O)cccc2)CCc1ccccc1
Endothelin-converting enzyme 1,1615,ECE1,P42892,,,,,,Human,KC-12615,6507,,,178103121,Inhibitor,Inhibition,,f,,,pIC50,0,5.8,0,IC50,0,1500,0,,,,,22480515,OC(=O)CN1C(=O)[C@H](CCc2c1cccc2)NC(=O)C1(CCCC1)C[C@H](C(=O)O)CCc1ccccc1
Endothelin-converting enzyme 1,1615,ECE1,P42892,,,,,,Human,PD159790,8617,,,252166818,Inhibitor,Inhibition,,f,t,,pKi,0,5.639999866,0,Ki,0,2300,0,=,,,,0,CCN1CCCC(C1)Nc1nc(nc2c1cc(I)cc2)C(F)(F)F
Endothelin-converting enzyme 1,1615,Ece1,P42893,,,,,,Rat,SM19712,5272,,,178101955,Inhibitor,Inhibition,,f,f,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,11043447,N#Cc1c(C)nn(c1NC(=O)NS(=O)(=O)c1ccc(cc1)Cl)c1ccccc1.[Na+]
Endothelin-converting enzyme 2,1616,ECE2,O60344,,,,,,Human,S136492,8620,,,252166821,Inhibitor,Inhibition,,f,t,,pIC50,0,5.329999924,0,IC50,0,4630,0,=,,,,18507370,O=C1C=CC=C/C/1=CC=c1/ccc2c([nH]1)cccc2
enhancer of zeste 1 polycomb repressive complex 2 subunit,2835,EZH1,Q92800,,,,,,Human,GSK343,8240,,,249565920,Inhibitor,Inhibition,,f,f,,pIC50,0,6.619999886,0,IC50,0,240,0,=,,,,24900432,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2c1cnn2C(C)C)c1ccnc(c1)N1CCN(CC1)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,CPI-1205,9115,,,315661200,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,Cell-free biochemical assay,,,27739677,COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n(c2c1cccc2)[C@@H](C1CCN(CC1)CC(F)(F)F)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,EI1,7013,,,178103592,Inhibitor,Inhibition,,f,t,,pIC50,0,8.029999733,0,IC50,0,9.399999619,0,=,,,,23236167,CCC(n1ccc2c1cc(C#N)cc2C(=O)NCc1c(C)cc([nH]c1=O)C)CC
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,EPZ005687,8387,,,252166598,Inhibitor,Inhibition,,f,t,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,23023262,O=C(c1cc(cc2c1cnn2C1CCCC1)c1ccc(cc1)CN1CCOCC1)NCc1c(C)cc([nH]c1=O)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,EPZ011989,9273,,,315661348,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,<,,,,26005520,COCCN(C1CCC(CC1)N(c1cc(C#CCN2CCOCC2)cc(c1C)C(=O)NCc1c(C)cc([nH]c1=O)C)CC)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,GSK126,7012,,,178103591,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,9.899999619,0,=,"Measured using expressed and purified five-member PRC2 protein complex (human Flag?EZH2,EED, SUZ12, AEBP2, RbAp48).",,,23051747,CC[C@@H](n1cc(c2c1cc(cc2C(=O)NCc1c(C)cc([nH]c1=O)C)c1ccc(nc1)N1CCNCC1)C)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,GSK343,8240,,,249565920,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24900432,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2c1cnn2C(C)C)c1ccnc(c1)N1CCN(CC1)C
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,JQEZ5,9332,,,318164851,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,<i>In vitro</i> biochemical assay,,,27135738,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(nc2c1cnn2C(C)C)c1ccc(nc1)N1CCN(CC1)C
EPH receptor A2,1822,EPHA2,P29317,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
EPH receptor A3,1823,Epha3,P29319,,,,,,Mouse,fibatuzumab,8925,,,310264706,Antibody,Binding,,f,f,,pKd,0,9,0,Kd,0,1,0,<,,,,0,
EPH receptor A3,1823,EPHA3,P29320,,,,,,Human,fibatuzumab,8925,,,310264706,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,panitumumab,6883,,,178103465,Agonist,Binding,,f,t,,pKd,0,10.30000019,0,Kd,0,0.050000001,0,=,,,,14967460,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,MM-151,9125,,,315661210,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,25911688,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,necitumumab,8090,,,249565770,Antibody,Binding,,f,t,,pKd,0,9.489999771,0,Kd,0,0.319999993,0,=,Binding affinity of whole IMC-11F8 IgG using BIAcore sensor technology.,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,8.619999886,0,IC50,0,2.400000095,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,dacomitinib,7422,,,178103994,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,22621397,COc1cc2ncnc(c2cc1NC(=O)/C=C/CN1CCCCC1)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,15598814,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,EGFR/ErbB-2/ErbB-4 inhibitor,5965,,,178102588,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,16480284,CC#CC(=O)Nc1ncc2c(c1)c(ncn2)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,EGFR/ErbB-2 inhibitor,5964,,,178102587,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,11378364,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)OCc1ccccc1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,EGFR inhibitor,5963,,,178102586,Inhibitor,Inhibition,,f,t,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,18077363,O=C(C1CC1)Nc1cccc(c1)Nc1ncnc(c1)Nc1cccc(c1)C(F)(F)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,erlotinib,4920,,,178101619,Inhibitor,Inhibition,,f,t,,pKd,0,9.170000076,0,Kd,0,0.670000017,0,=,,,,22037378,COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,erlotinib,4920,,,178101619,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,14684309,COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,falnidamol,7646,,,223365981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,15199094,CN1CCC(CC1)Nc1ncc2c(n1)c(ncn2)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,gefitinib,4941,,,178101639,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5.5,0,=,,,,17416531,COc1cc2ncnc(c2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,gefitinib,4941,,,178101639,Inhibitor,Inhibition,,f,t,,pKd,0,9,0,Kd,0,1,0,=,,,,22037378,COc1cc2ncnc(c2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.279999733,0,IC50,0,5.300000191,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,icotinib,7641,,,223365976,Inhibitor,Inhibition,,f,t,,pIC50,0,7.349999905,0,IC50,0,45,0,=,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells.,,,22959248,C#Cc1cccc(c1)Nc1ncnc2c1cc1OCCOCCOCCOc1c2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,JAK3 inhibitor II,5993,,,178102615,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,18094329,COc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1)Br)O
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,lapatinib,5692,,,178102319,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10.19999981,0,=,,,,12467226,Fc1cccc(c1)COc1ccc(cc1Cl)Nc1ncnc2c1cc(cc2)c1ccc(o1)CNCCS(=O)(=O)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,lifirafenib,8958,,,310264739,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,Inhibition of wild type EGFR kinase domain (aa669-1210),,,26208524,O=C1CCc2c(N1)nccc2Oc1ccc2c(c1)[C@@H]1[C@H](O2)[C@H]1c1nc2c([nH]1)cc(cc2)C(F)(F)F
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,naquotinib,9248,,,315661323,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C=CC(=O)N1CC[C@H](C1)Oc1nc(Nc2ccc(cc2)N2CCC(CC2)N2CCN(CC2)C)c(nc1CC)C(=O)N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,nazartinib,9204,,,315661280,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,Biochemical assay using EGFR L858R/T790M with a 90 minute preincubation with the inhibitor.,,,0,CN(C/C=C/C(=O)N1CCCC[C@H](C1)n1c(NC(=O)c2ccnc(c2)C)nc2c1c(Cl)ccc2)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,neratinib,5686,,,178102313,Inhibitor,Inhibition,,f,f,,pIC50,0,7.039999962,0,IC50,0,92,0,=,Inhibition of autophosphorylation of the cytoplasmic domain of the RTK in a cell free system.,,,15173008,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/CN(C)C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,olmutinib,9196,,,315661275,Inhibitor,Inhibition,,f,f,,pIC50,7,0,6,IC50,1000,0,100,=,Biochemical assay,,,0,C=CC(=O)Nc1cccc(c1)Oc1nc(Nc2ccc(cc2)N2CCN(CC2)C)nc2c1scc2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,orantinib,7816,,,223366147,Inhibitor,Inhibition,,f,f,,pIC50,0,4,0,IC50,0,100000,0,>,,,,19110422,OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cccc2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,osimertinib,7719,,,223366052,Inhibitor,Inhibition,,f,f,,pIC50,0,6.309999943,0,IC50,0,494,0,=,,,,27071706,C=CC(=O)Nc1cc(Nc2nccc(n2)c2cn(c3c2cccc3)C)c(cc1N(CCN(C)C)C)OC
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PD 158780,6015,,,178102637,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,Inhibition of EGFR autophosphorylation,,,9191958,CNc1ncc2c(c1)c(ncn2)Nc1cccc(c1)Br
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,f,,pKi,0,7.059999943,0,Ki,0,87.5,0,=,,,,9400019,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PD 174265,6017,,,178102639,Inhibitor,Inhibition,,f,t,,pIC50,0,9.350000381,0,IC50,0,0.449999988,0,=,,,,9751783,CCC(=O)Nc1ccc2c(c1)c(ncn2)Nc1cccc(c1)Br
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,pelitinib,7644,,,223365979,Inhibitor,Inhibition,,f,f,,pIC50,9.220000267,0,7.840000153,IC50,14.5,0,0.600000024,=,,,,17416531,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/CN(C)C)Nc1ccc(c(c1)Cl)F)C#N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PF-06747775,9765,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.510000229,0,IC50,0,307,0,=,,,,28287730,C=CC(=O)N[C@@H]1CN(C[C@H]1F)c1nc(Nc2cn(nc2OC)C)c2c(n1)n(C)cn2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PF-670462,9371,,,328083473,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,In a biochemical kinase assay.,,,17502429,Nc1nccc(n1)c1n(cnc1c1ccc(cc1)F)C1CCCCC1
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PKI166,7642,,,223365977,Inhibitor,Inhibition,,f,f,,pIC50,0,8.430000305,0,IC50,0,3.700000048,0,=,,,,22018877,Oc1ccc(cc1)c1[nH]c2c(c1)c(ncn2)N[C@@H](c1ccccc1)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,poziotinib,7903,,,249565586,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,21306821,C=CC(=O)N1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1F)Cl)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,8557675,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,f,,pIC50,0,6.590000153,0,IC50,0,260,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,rociletinib,7966,,,249565649,Inhibitor,Inhibition,,f,f,,pKi,0,6.519999981,0,Ki,0,303.2999878,0,=,,,,24065731,C=CC(=O)Nc1cccc(c1)Nc1nc(ncc1C(F)(F)F)Nc1ccc(cc1OC)N1CCN(CC1)C(=O)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,sapitinib,7717,,,223366050,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24900741,CNC(=O)CN1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1cccc(c1F)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,pyrotinib,9662,,,348353621,Inhibitor,Irreversible inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,28115222,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/[C@H]1CCCN1C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,EGF,4916,EGF,Human,178101615,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,epigen,4917,EPGN,Human,178101616,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,epiregulin,4918,EREG,Human,178101617,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,HB-EGF,4948,HBEGF,Human,178101646,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
epoxide hydrolase 2,2970,EPHX2,P34913,,,,,,Human,GSK2256294,9718,,,348353677,Inhibitor,Inhibition,,f,f,,pIC50,0,6.960000038,0,IC50,0,110,0,=,In a biochemical enzyme assay.,,,0,CNc1nc(N[C@H]2CCC[C@H](C2)C(=O)NCc2ccc(cc2C(F)(F)F)C#N)nc(n1)C
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,enprostil,1918,,,135650232,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9537820,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,enprostil,1918,,,135650232,Agonist,Full agonist,,f,,,pKi,7.8,0,7.1,,0,0,0,,,,,10634944,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9313928,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,8,0,5.6,,0,0,0,,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9537820,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9313928,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,ONO-DI-004,1914,,,135650772,Agonist,Full agonist,,f,f,,pKi,0,6.800000191,0,-,0,0,0,=,,,,10746663,CCCC[C@@H](C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CC(=O)C1CCC(CC1)C(=O)O)O)C
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,5.2,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,4.7,0,,0,0,0,,,,,11999132,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,7,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,f,,pKi,0,7.400000095,0,-,0,0,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,t,,pKi,0,6.800000191,0,-,0,0,0,=,,,,11999132,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,7.7,0,-,0,0,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,7.7,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,8,0,7.3,,0,0,0,,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,6.4,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,6.3,0,6.2,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,5.9,0,-,0,0,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,PGI<sub>2</sub>,1915,,,135651541,Agonist,Full agonist,,t,t,,pKi,0,4.800000191,0,-,0,0,0,=,,,,11999132,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,iloprost,1895,,,135650378,Agonist,Partial agonist,,f,,,pKi,0,7.9,0,-,0,0,0,=,,,,9537820,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,GW848687X,3360,,,178100386,Antagonist,Antagonist,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,17084082,Clc1ccc(c(c1)C1=C(CCC1)c1cccc(n1)C(=O)O)OCc1ccc(cc1F)F
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,MF266-1,6068,,,178102689,Antagonist,Antagonist,,f,,,pKi,0,8.44,0,Ki,0,3.6,0,=,,,,18287210,Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,ONO-8711,1920,,,135650765,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,10537280,OC(=O)CCC/C=C[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,ONO-8711,1920,,,135650765,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,-,0,0,0,=,,,,10537280,OC(=O)CCC/C=C[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,ONO-8713,1921,,,135650766,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,10509919,CC(CN(S(=O)(=O)c1ccco1)c1ccc(cc1OCc1ccc(cc1)/C=C/C(=O)O)C(F)(F)F)C
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,ONO-8713,1921,,,135650766,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,10840160,CC(CN(S(=O)(=O)c1ccco1)c1ccc(cc1OCc1ccc(cc1)/C=C/C(=O)O)C(F)(F)F)C
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,SC-19220,1922,,,135651018,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,9537820,CC(=O)NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,SC-19220,1922,,,135651018,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,11999132,CC(=O)NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,SC-51089,1923,,,135651020,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,10634944,O=C(NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2)CCc1ccncc1
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,SC-51322,1924,,,135651021,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,10634944,O=C(NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2)CCSCc1ccco1
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,MRE-269,5852,,,178102476,Agonist,Agonist,,f,f,,pKi,0,5.239999771,0,Ki,0,5800,0,=,,,,17545310,OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,evatanepag,1929,,,135650129,Agonist,Full agonist,,f,f,,pIC50,0,7.300000191,0,IC50,0,50.09999847,0,=,,,,19250823,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)C(C)(C)C
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,evatanepag,1929,,,135650129,Agonist,Full agonist,,f,,,pEC50,0,9.5,0,EC50,0,0.3,0,=,,,,19250823,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)C(C)(C)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9313928,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,5.9,0,-,0,0,0,=,,,,9537820,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,isocarbacyclin,1934,,,135650430,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1CC(=C2)CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,6,0,5.3,,0,0,0,,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9537820,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,misoprostol (free acid form),1935,,,135650610,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)(O)C
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,misoprostol (methyl ester),1936,,,135650611,Agonist,Full agonist,,f,,,pKi,0,5,0,,0,0,0,,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)(O)C
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,ONO-AE1-259,1932,,,135650767,Agonist,Full agonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,10746663,C=CCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)C[C@H]([C@@H]1C/C=CCCCC(=O)O)Cl)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,ONO-AE1-329,1933,,,135650768,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,10746663,COCc1ccccc1CC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1SCCCSCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,ONO-AE-248,1931,,,135650769,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,10746663,CCCCC[C@@H](/C=C/[C@H]1[C@H](OC)CC(=O)[C@@H]1C/C=CCCCC(=O)O)OC
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,5.3,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,5,0,,0,0,0,,,,,10462542,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,f,f,,pKi,0,8.039999962,0,Ki,0,9.100000381,0,=,,,,8163486,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,f,,pKi,0,8,0,-,0,0,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,f,,pKi,0,8,0,-,0,0,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,8.2,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,7.9,0,7.4,-,0,0,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,t,,pKi,8.300000191,0,7.5,Ki,31.60000038,0,5.010000229,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,6,0,5.2,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,5.6,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,rivenprost,1930,,,135650764,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,11917107,COCc1cccc(c1)C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCSCCCC(=O)OC)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,PF-04418948,5817,,,178102442,Antagonist,Antagonist,,f,,,pKB,0,8.32,0,-,0,0,0,=,,,,22747912,COc1ccc2c(c1)ccc(c2)OCC1(CN(C1)C(=O)c1ccc(cc1)F)C(=O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PF-04418948,5817,,,178102442,Antagonist,Antagonist,PF-04418948 has weaker affinity at the EP2-receptor in guinea-pigs,f,f,,pKB,0,8.300000191,0,-,0,0,0,=,,,,21595651,COc1ccc2c(c1)ccc(c2)OCC1(CN(C1)C(=O)c1ccc(cc1)F)C(=O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,PF-04852946,8538,,,252166740,Antagonist,Antagonist,,f,f,,pKB,8.529999733,0,8.449999809,KB,3.549999952,0,2.950000048,=,,,,23786281,COc1ccc(cc1)C(=O)N1CCC(C1)(COc1ccc(cc1)c1ccc(cc1)C#N)C(=O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,GR 63799,1937,,,135650320,Agonist,Agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,7.14,0,Ki,0,73,0,=,,,,9537820,O[C@H](CO[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)Oc1ccc(cc1)NC(=O)c1ccccc1)COc1ccccc1
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,GR 63799,1937,,,135650320,Agonist,Agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,8.32,0,Ki,0,4.8,0,=,,,,10634944,O[C@H](CO[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)Oc1ccc(cc1)NC(=O)c1ccccc1)COc1ccccc1
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,enprostil,1918,,,135650232,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,7.13,0,Ki,0,74,0,=,,,,9537820,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,enprostil,1918,,,135650232,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,7.92,0,Ki,0,12,0,=,,,,10634944,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,enprostil,1918,,,135650232,Agonist,Full agonist,,f,,,pEC50,0,8.43,0,EC50,0,3.7,0,=,,,,9694973,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,fluprostenol,1940,,,135650277,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,6.15,0,Ki,0,708,0,=,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,I-BOP,1938,,,135650364,Agonist,Full agonist,,f,,,pKi,0,7,0,Ki,0,100,0,=,,,,9313928,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,iloprost,1895,,,135650378,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pEC50,0,9.2,0,EC50,0,0.63,0,=,,,,9537820,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,7.66,0,Ki,0,22,0,=,,,,9313928,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,iloprost,1895,,,135650378,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,7.33,0,Ki,0,47,0,=,,,,9537820,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,7.25,0,Ki,0,56,0,=,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,EP<sub>3</sub>-I isoform,f,,,pKi,0,6.68,0,Ki,0,208,0,=,,,,22480736,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,isocarbacyclin,1934,,,135650430,Agonist,Full agonist,,f,,,pKi,0,7.51,0,Ki,0,31,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1CC(=C2)CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,f,,pKi,0,9.850000381,0,Ki,0,0.140000001,0,=,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,f,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,,,,9313928,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,MB-28767,1913,,,135650568,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pEC50,0,9.26,0,EC50,0,0.55,0,=,,,,9537820,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,misoprostol (free acid form),1935,,,135650610,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,8.1,0,Ki,0,7.9,0,=,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)(O)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,misoprostol (methyl ester),1936,,,135650611,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,t,,pKi,0,6.5,0,Ki,0,319,0,=,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)(O)C
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,ONO-8713,1921,,,135650766,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,8.49,0,Ki,0,3.2,0,=,,,,9537820,CC(CN(S(=O)(=O)c1ccco1)c1ccc(cc1OCc1ccc(cc1)/C=C/C(=O)O)C(F)(F)F)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE1-329,1933,,,135650768,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,f,,pKi,0,5.920000076,0,Ki,0,1200,0,=,,,,10746663,COCc1ccccc1CC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1SCCCSCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE-248,1931,,,135650769,Agonist,Full agonist,EP3&alpha; isoform,f,f,,pKi,8.119999886,0,7.820000172,Ki,15,0,7.5,=,,,,10746663,CCCCC[C@@H](/C=C/[C@H]1[C@H](OC)CC(=O)[C@@H]1C/C=CCCCC(=O)O)OC
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,ONO-AE-248,1931,,,135650769,Agonist,Full agonist,,f,f,,pEC50,6.699999809,0,5.639999866,EC50,2300,0,200,=,,,,22342278,CCCCC[C@@H](/C=C/[C@H]1[C@H](OC)CC(=O)[C@@H]1C/C=CCCCC(=O)O)OC
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,5.9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pEC50,0,7.89,0,EC50,0,13,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,6.55,0,Ki,0,280,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,9,0,Ki,0,1,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pEC50,0,9.35,0,EC50,0,0.45,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,9,0,Ki,0,1,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,f,,pKi,0,9.069999695,0,Ki,0,0.850000024,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,9,0,-,0,0,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>-I isoform,t,,,pKd,9.1,0,8.22,Kd,6,0,0.8,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>-III isoform,t,f,,pKi,0,9.479999542,0,Ki,0,0.330000013,0,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>-II & -III isoforms,t,,,pKd,0,8.68,0,Kd,0,2.1,0,=,,,,18632791,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKd,0,8.85,0,Kd,0,1.4,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>&gamma; isoform,t,,,pKd,0,8.96,0,Kd,0,1.1,0,=,,,,18632791,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pKd,9.1,0,8.3,Kd,5,0,0.8,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>&beta; isoform,t,,,pKd,8.41,0,7.82,Kd,15,0,3.9,=,,,,8076679,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pEC50,0,9.39,0,EC50,0,0.41,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,7.12,0,Ki,0,75,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,EP<sub>3</sub>-III isoform,t,,,pKi,0,7.42,0,Ki,0,38,0,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pKi,0,6.67,0,Ki,0,213,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,t,,,pEC50,0,8.38,0,EC50,0,4.2,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>3</sub> receptor,342,,,,,,,,Guinea pig,SC46275,3331,,,178100362,Agonist,Full agonist,,f,f,,pEC50,0,10.39999962,0,EC50,0,0.039999999,0,=,,,,8140121,COC(=O)CC/C=CCC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/C[C@](/C=C/C1=CCCC1)(O)C)O
EP<sub>3</sub> receptor,342,,,,,,,,Dog,SC46275,3331,,,178100362,Agonist,Full agonist,,f,,,pIC50,0,11,0,IC50,0,0.01,0,=,,,,7562572,COC(=O)CC/C=CCC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/C[C@](/C=C/C1=CCCC1)(O)C)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,SC46275,3331,,,178100362,Agonist,Full agonist,,f,f,,pEC50,0,8.739999771,0,EC50,0,1.799999952,0,=,,,,16737803,COC(=O)CC/C=CCC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/C[C@](/C=C/C1=CCCC1)(O)C)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,STA<sub>2</sub>,1939,,,135651090,Agonist,Full agonist,,f,,,pKi,0,7.64,0,Ki,0,23,0,=,,,,9313928,CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=CCCCC(=O)O)S2)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,GR 63799,1937,,,135650320,Agonist,Partial agonist,,f,,,pKi,0,8.72,0,Ki,0,1.9,0,=,,,,9313928,O[C@H](CO[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)Oc1ccc(cc1)NC(=O)c1ccccc1)COc1ccccc1
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AP-324,5821,,,178102446,Agonist,Partial agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,7.96,0,Ki,0,11,0,=,,,,9863659,O=C(NC(c1ccccc1)c1ccccc1)CCc1cccc2c1cccc2OCC(=O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,rivenprost,1930,,,135650764,Agonist,Partial agonist,,f,,,pKi,0,7.25,0,Ki,0,56,0,=,,,,11917107,COCc1cccc(c1)C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCSCCCC(=O)OC)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,DG-041,5822,,,178102447,Antagonist,Antagonist,,f,f,,pKi,0,8.409999847,0,Ki,0,3.900000095,0,=,,,,19486006,Clc1ccc(c(c1)Cl)Cn1cc(c2c1c(/C=C/C(=O)NS(=O)(=O)c1sc(c(c1)Cl)Cl)cc(c2)F)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,DG-041,5822,,,178102447,Antagonist,Antagonist,EP<sub>3</sub>-I isoform,f,,,pKi,0,10.1,0,Ki,0,0.08,0,=,,,,18632791,Clc1ccc(c(c1)Cl)Cn1cc(c2c1c(/C=C/C(=O)NS(=O)(=O)c1sc(c(c1)Cl)Cl)cc(c2)F)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,DG-041,5822,,,178102447,Antagonist,Antagonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,9.52,0,Ki,0,0.3,0,=,,,,18632791,Clc1ccc(c(c1)Cl)Cn1cc(c2c1c(/C=C/C(=O)NS(=O)(=O)c1sc(c(c1)Cl)Cl)cc(c2)F)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,DG-041,5822,,,178102447,Antagonist,Antagonist,EP<sub>3</sub>-II isoform,f,,,pKi,0,9.92,0,Ki,0,0.12,0,=,,,,18632791,Clc1ccc(c(c1)Cl)Cn1cc(c2c1c(/C=C/C(=O)NS(=O)(=O)c1sc(c(c1)Cl)Cl)cc(c2)F)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,"L-798,106",1941,,,135650500,Antagonist,Antagonist,EP<sub>3</sub>-III isoform,f,f,,pKi,9.680000305,0,7.769999981,Ki,17,0,0.209999993,=,,,,11504634,COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c1ccccc1Cc1ccc2c(c1)cccc2)Br
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,L-826266,5844,,,178102469,Antagonist,Antagonist,EP<sub>3</sub>-III isoform (pK<sub>i</sub>=8.04 in the presence of HSA),f,f,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,11504634,COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c1cc(Cl)ccc1Cc1ccc2c(c1)cccc2)Br
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,L-826266,5844,,,178102469,Antagonist,Antagonist,,f,f,,pKi,9.100000381,0,7.960000038,Ki,11,0,0.800000012,=,,,,18287210,COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c1cc(Cl)ccc1Cc1ccc2c(c1)cccc2)Br
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,L-826266,5844,,,178102469,Antagonist,Antagonist,,f,f,,pKB,0,8.350000381,0,KB,0,4.5,0,=,,,,18287210,COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c1cc(Cl)ccc1Cc1ccc2c(c1)cccc2)Br
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-8711,1920,,,135650765,Antagonist,Antagonist,,f,f,,pKi,0,7.170000076,0,Ki,0,67,0,=,,,,10840160,OC(=O)CCC/C=C[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-8713,1921,,,135650766,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,10840160,CC(CN(S(=O)(=O)c1ccco1)c1ccc(cc1OCc1ccc(cc1)/C=C/C(=O)O)C(F)(F)F)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE2-227,5824,,,178102449,Antagonist,Antagonist,,f,,,pKi,0,7.68,0,Ki,0,21,0,=,,,,11782353,O=C(C(c1cccc2c1cccc2)C)Nc1ccccc1Cc1ccccc1C(=O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE2-227,5824,,,178102449,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,IC50,0,160,0,=,,,,11782353,O=C(C(c1cccc2c1cccc2)C)Nc1ccccc1Cc1ccccc1C(=O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE3-208,1942,,,135650770,Antagonist,Antagonist,,f,,,pKi,0,7.52,0,Ki,0,30,0,=,,,,11927615,N#Cc1ccc(c(c1)NC(=O)C(c1ccc(c2c1cccc2)F)C)CCCC(=O)O
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE3-240,1943,,,135650771,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,-,0,0,0,=,,,,12538661,CC(CC(c1cccc2c1cccc2)C(=O)Nc1cc(ccc1Cc1ccccc1C(=O)O)Cn1cccn1)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE3-240,1943,,,135650771,Antagonist,Antagonist,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.5,0,=,,,,12538661,CC(CC(c1cccc2c1cccc2)C(=O)Nc1cc(ccc1Cc1ccccc1C(=O)O)Cn1cccn1)C
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,ONO-AE5-599,5823,,,178102448,Antagonist,Antagonist,,f,,,pIC50,0,9.72,0,IC50,0,0.19,0,=,,,,17512019,CC(C[C@H](c1cc(C)cc(c1)C)NC(=C)c1cc(ccc1CCC(=O)O)COc1ccccc1C)C
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,SC-51322,1924,,,135651021,Antagonist,Antagonist,EP<sub>3</sub>-III isoform,f,,,pKi,0,6.15,0,Ki,0,700,0,=,,,,10634944,O=C(NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2)CCSCc1ccco1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,CP734432,4039,,,178100863,Agonist,Agonist,,f,,,pEC50,0,9,0,EC50,0,1,0,=,,,,19445930,O[C@@H](Cc1cccc(c1)C(F)(F)F)CC[C@H]1CCC(=O)N1CCCc1ccc(s1)C(=O)[O-]
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,L902688,3357,,,178100383,Agonist,Agonist,,f,f,,pKi,0,9.420000076,0,Ki,0,0.379999995,0,=,,,,0,O=C1CC[C@@H](N1CCCCCCc1nnn[nH]1)/C=C/[C@H](C(c1ccccc1)(F)F)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,L902688,3357,,,178100383,Agonist,Agonist,,f,f,,pEC50,10.30000019,0,8.050000191,EC50,9,0,0.050000001,=,,,,19584306,O=C1CC[C@@H](N1CCCCCCc1nnn[nH]1)/C=C/[C@H](C(c1ccccc1)(F)F)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,MRE-269,5852,,,178102476,Agonist,Agonist,,f,f,,pKi,0,5.309999943,0,Ki,0,4900,0,=,,,,17545310,OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,ONO-AE1-437,8541,,,252166742,Agonist,Agonist,,f,f,,pKi,0,9.149999619,0,Ki,0,0.709999979,0,=,,,,12954235,COCc1cccc(c1)C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCSCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,CP734432,4039,,,178100863,Agonist,Full agonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19445930,O[C@@H](Cc1cccc(c1)C(F)(F)F)CC[C@H]1CCC(=O)N1CCCc1ccc(s1)C(=O)[O-]
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,enprostil,1918,,,135650232,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10952683,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pEC50,0,6.4,0,EC50,0,400,0,=,,,,22480736,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,6.68,0,4.64,Ki,23000,0,210,=,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9313928,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pEC50,0,7.75,0,EC50,0,17.7,0,=,,,,19584306,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,8,0,7.5,,0,0,0,,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,f,,pKi,0,6.300000191,0,Ki,0,500,0,=,,,,9313928,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9537820,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,misoprostol (free acid form),1935,,,135650610,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)(O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,misoprostol (methyl ester),1936,,,135650611,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,10634944,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)(O)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,ONO-AE1-329,1933,,,135650768,Agonist,Full agonist,,f,f,,pEC50,7.800000191,0,7.659999847,EC50,22,0,16,=,,,,21323896,COCc1ccccc1CC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1SCCCSCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,ONO-AE1-329,1933,,,135650768,Agonist,Full agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,10746663,COCc1ccccc1CC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1SCCCSCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pEC50,0,8.77,0,EC50,0,1.7,0,=,,,,19584306,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,9,0,8.7,Ki,2,0,1,=,,,,10462542,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,5.9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pEC50,0,9.51,0,EC50,0,0.31,0,=,,,,19584306,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,9.2,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,8.7,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,f,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,10952683,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,8.7,0,8.52,Ki,3,0,2,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,f,,pKi,9.100000381,0,8.100000381,Ki,7.940000057,0,0.79400003,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKd,0,8.6,0,Kd,0,2.5,0,=,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pEC50,0,6.05,0,EC50,0,900,0,=,,,,19584306,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,6.2,0,-,0,0,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pEC50,0,6.05,0,EC50,0,900,0,=,,,,19584306,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,9.49,0,9.1,Ki,0.8,0,0.32,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,PGI<sub>2</sub>,1915,,,135651541,Agonist,Full agonist,,t,,,pKi,0,5.1,0,,0,0,0,,,,,10952683,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,rivenprost,1930,,,135650764,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11917107,COCc1cccc(c1)C[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCSCCCC(=O)OC)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,EP<sub>4</sub>A,1952,,,135650237,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,11408598,CCCCc1nn(c(=O)n1Cc1ccc(cc1)c1ccccc1S(=O)(=O)NC(=O)c1ccc(s1)C)c1ccccc1C(F)(F)F
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,EP<sub>4</sub>A,1952,,,135650237,Antagonist,Antagonist,,f,,,pKi,8.5,0,7.6,-,0,0,0,=,,,,11408598,CCCCc1nn(c(=O)n1Cc1ccc(cc1)c1ccccc1S(=O)(=O)NC(=O)c1ccc(s1)C)c1ccccc1C(F)(F)F
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,ER819762,4040,,,178100864,Antagonist,Antagonist,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,20423341,CCN1C(=O)N2C(=C[C@@H](c3c(C2)cc(OC)cc3OC)C)C21CCN(CC2)Cc1cc(C)cc(c1)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,ER819762,4040,,,178100864,Antagonist,Antagonist,,f,,,pKi,0,9.25,0,Ki,0,0.56,0,=,,,,20163116,CCN1C(=O)N2C(=C[C@@H](c3c(C2)cc(OC)cc3OC)C)C21CCN(CC2)Cc1cc(C)cc(c1)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,evatanepag,1929,,,135650129,Antagonist,Antagonist,,f,f,,pKi,0,8.600000381,0,Ki,0,2.50999999,0,=,,,,18155068,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)C(C)(C)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,grapiprant,5858,,,178102482,Antagonist,Antagonist,,f,t,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,17495127,CCc1nc2c(n1c1ccc(cc1)CCNC(=O)NS(=O)(=O)c1ccc(cc1)C)cc(nc2C)C
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,GW 627368,1953,,,135650338,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,7,Ki,100,0,79.40000153,=,,,,16604093,CCOc1c2C(=O)N(Cc2c(c2c1cccc2)OCC)c1ccc(cc1)CC(=O)NS(=O)(=O)c1ccccc1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,MF 498,5856,,,178102480,Antagonist,Antagonist,,f,,,pKi,0,9.15,0,Ki,0,0.7,0,=,,,,18287210,CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,MK-2894,4041,,,178100865,Antagonist,Antagonist,,f,f,,pKi,0,9.25,0,Ki,0,0.560000002,0,=,,,,10634944,OC(=O)c1ccc(cc1)C1(CC1)NC(=O)c1c(C)sc(c1Cc1ccc(cc1)C(F)(F)F)C
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,ONO-AE2-227,5824,,,178102449,Antagonist,Antagonist,,f,,,pKi,0,8.57,0,Ki,0,2.7,0,=,,,,11782353,O=C(C(c1cccc2c1cccc2)C)Nc1ccccc1Cc1ccccc1C(=O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,ONO-AE3-208,1942,,,135650770,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,11927615,N#Cc1ccc(c(c1)NC(=O)C(c1ccc(c2c1cccc2)F)C)CCCC(=O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,ONO-AE3-208,1942,,,135650770,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,-,0,0,0,=,,,,0,N#Cc1ccc(c(c1)NC(=O)C(c1ccc(c2c1cccc2)F)C)CCCC(=O)O
EP<sub>4</sub> receptor,343,Ptger4,P32240,,,,,,Mouse,ONO-AE3-240,1943,,,135650771,Antagonist,Antagonist,,f,,,pKi,0,7.24,0,Ki,0,58,0,=,,,,12538661,CC(CC(c1cccc2c1cccc2)C(=O)Nc1cc(ccc1Cc1ccccc1C(=O)O)Cn1cccn1)C
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,dilazep,4717,,,178101428,Inhibitor,Inhibition,,f,,,pKi,0,9,0,Ki,0,1,0,,,,,0,COc1cc(cc(c1OC)OC)C(=O)OCCCN1CCCN(CC1)CCCOC(=O)c1cc(OC)c(c(c1)OC)OC
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,dipyridamole,4807,,,178101509,Inhibitor,Inhibition,,f,t,,pKi,0,8.800000191,0,Ki,0,1.5,0,=,,,,14634039,OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,draflazine,4590,,,178101311,Inhibitor,Inhibition,,f,f,,pKi,0,9.600000381,0,Ki,0,0.280000001,0,=,,,,10763851,O=C(Nc1c(Cl)cc(cc1Cl)N)CN1CCN(CC1C(=O)N)CCCCC(c1ccc(cc1)F)c1ccc(cc1)F
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,KF24345,4734,,,178101445,Inhibitor,Inhibition,,f,,,pKi,0,9.4,0,Ki,0,0.4,0,,,,,14634039,CCOc1cc2c(cc1OCC)nc(nc2N1CCC(CC1)n1c(=O)c2cc(C)ccc2n(c1=O)C)N1CCOCC1
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,NBTGR ,4513,,,178101239,Inhibitor,Inhibition,,f,,,pKi,0,9.3,0,Ki,0,0.5,0,,,,,0,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N)n(c2=O)SCc1ccccc1[N+](=O)[O-]
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,nitrobenzylmercaptopurine ribonucleoside,4512,,,178101238,Inhibitor,Inhibition,,f,,,pKi,0,9.7,0,Ki,0,0.2,0,,,,,0,OC[C@H]1O[C@@]([C@@H]([C@@H]1O)O)(SCc1ccccc1[N+](=O)[O-])n1cnc2c1ncnc2O
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,istiratumab,8931,,,310264712,Antibody,Binding,,f,t,,pKd,0,9.520000458,0,Kd,0,0.300000012,0,=,,,,22248472,
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,margetuximab,8686,,,252166886,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,pertuzumab,5046,,,178101741,Antibody,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,Preferred value for inhibition of  heregulin &beta;1 binding to MCF7 cells.,,,0,
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,CP-724714,7883,,,223366212,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,18500794,COCC(=O)NC/C=C/c1ccc2c(c1)c(ncn2)Nc1ccc(c(c1)C)Oc1ccc(nc1)C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,15.69999981,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,dacomitinib,7422,,,178103994,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,22621397,COc1cc2ncnc(c2cc1NC(=O)/C=C/CN1CCCCC1)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,EGFR/ErbB-2/ErbB-4 inhibitor,5965,,,178102588,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,16480284,CC#CC(=O)Nc1ncc2c(c1)c(ncn2)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,EGFR/ErbB-2 inhibitor,5964,,,178102587,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,11378364,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)OCc1ccccc1
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,falnidamol,7646,,,223365981,Inhibitor,Inhibition,,f,f,,pIC50,0,5.46999979,0,IC50,0,3400,0,=,,,,15199094,CN1CCC(CC1)Nc1ncc2c(n1)c(ncn2)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.18999958,0,IC50,0,6.400000095,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,lapatinib,5692,,,178102319,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,9.800000191,0,=,,,,12467226,Fc1cccc(c1)COc1ccc(cc1Cl)Nc1ncnc2c1cc(cc2)c1ccc(o1)CNCCS(=O)(=O)C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,lapatinib,5692,,,178102319,Inhibitor,Inhibition,,f,t,,pKd,0,8.149999619,0,Kd,0,7,0,=,,,,22037378,Fc1cccc(c1)COc1ccc(cc1Cl)Nc1ncnc2c1cc(cc2)c1ccc(o1)CNCCS(=O)(=O)C
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,mubritinib,6011,,,178102633,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Measuring tyrosine phosphorylation of HER2 in human bladder cancer cell lineT24.,,,16771730,FC(c1ccc(cc1)/C=C/c1occ(n1)COc1ccc(cc1)CCCCn1nncc1)(F)F
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,neratinib,5686,,,178102313,Inhibitor,Inhibition,,f,t,,pIC50,0,7.230000019,0,IC50,0,59,0,=,Inhibition of autophosphorylation of the cytoplasmic domain of the RTK in a cell free system.,,,15173008,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/CN(C)C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,neratinib,5686,,,178102313,Inhibitor,Inhibition,,f,t,,pKd,0,8.220000267,0,Kd,0,6,0,=,,,,22037378,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/CN(C)C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,poziotinib,7903,,,249565586,Inhibitor,Inhibition,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.300000191,0,=,,,,21306821,C=CC(=O)N1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1F)Cl)Cl
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,sapitinib,7717,,,223366050,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,24900741,CNC(=O)CN1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1cccc(c1F)Cl
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,pyrotinib,9662,,,348353621,Inhibitor,Irreversible inhibition,,f,f,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,28115222,CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/[C@H]1CCCN1C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,elgemtumab,8715,,,252827373,Antibody,Binding,,f,t,,pKd,11.39999962,0,10.59000015,Kd,0.026000001,0,0.004,=,,,,0,
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,istiratumab,8931,,,310264712,Antibody,Binding,,f,t,,pKd,0,7.809999943,0,Kd,0,15.60999966,0,=,,,,22248472,
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,MM-141,8930,,,310264711,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,24282274,
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,seribantumab,8297,,,252166509,Antibody,Binding,,f,t,,pKd,0,9.109999657,0,Kd,0,0.768999994,0,=,,,,19567914,
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,sapitinib,7717,,,223366050,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24900741,CNC(=O)CN1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1cccc(c1F)Cl
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,neuregulin-1,5027,NRG1,Human,178101724,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,neuregulin-2,5029,NRG2,Human,178101725,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,dacomitinib,7422,,,178103994,Inhibitor,Inhibition,,f,f,,pIC50,0,7.130000114,0,IC50,0,74,0,=,,,,22621397,COc1cc2ncnc(c2cc1NC(=O)/C=C/CN1CCCCC1)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,EGFR/ErbB-2/ErbB-4 inhibitor,5965,,,178102588,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,16480284,CC#CC(=O)Nc1ncc2c(c1)c(ncn2)Nc1ccc(c(c1)Cl)F
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,poziotinib,7903,,,249565586,Inhibitor,Inhibition,,f,t,,pIC50,0,7.630000114,0,IC50,0,23.5,0,=,,,,21306821,C=CC(=O)N1CCC(CC1)Oc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1F)Cl)Cl
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,epiregulin,4918,EREG,Human,178101617,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,HB-EGF,4948,HBEGF,Human,178101646,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,neuregulin-1,5027,NRG1,Human,178101724,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,neuregulin-2,5029,NRG2,Human,178101725,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,neuregulin-3,5030,NRG3,Human,178101726,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,neuregulin-4,5031,NRG4,Human,178101727,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,diarylpropionitrile,2825,,,53801030,Agonist,Agonist,,f,f,,pEC50,0,7.179999828,0,EC50,0,66,0,=,,,,19596275,N#CC(c1ccc(cc1)O)Cc1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,diethylstilbestrol,2801,,,135651472,Agonist,Agonist,,f,t,,pKi,0,10.39999962,0,-,0,0,0,=,,,,9048584,CC/C(=C(c1ccc(cc1)O)/CC)/c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,estriol,2821,,,135651483,Agonist,Agonist,,t,t,,pKi,0,8.670000076,0,-,0,0,0,=,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1C[C@H]([C@@H]2O)O)C
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,estrone,2818,,,135651484,Agonist,Agonist,,t,t,,pKi,0,8.5,0,-,0,0,0,=,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2=O)C
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,ethinylestradiol,7071,,,178103650,Agonist,Agonist,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16722623,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O
Estrogen receptor-&alpha;,620,Esr1,P19785,,,,,,Mouse,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,6.119999886,0,IC50,0,750,0,=,,,,18097065,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&alpha;,620,Esr1,P06211,,,,,,Rat,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,6.210000038,0,IC50,0,620,0,=,,,,18097065,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,5.920000076,0,IC50,0,1216,0,=,,,,18097065,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,propylpyrazoletriol,2819,,,135650845,Agonist,Agonist,,f,f,,pKi,0,9.640000343,0,-,0,0,0,=,,,,11150164,CCCc1c(nn(c1c1ccc(cc1)O)c1ccc(cc1)O)c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,raloxifene,2820,,,135650883,Agonist,Agonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,11150164,Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,"R,R-THC",2822,,,135650105,Agonist,Agonist,,f,,,pKi,0,8.38,0,,0,0,0,,,,,9927308,CC[C@@H]1Cc2cc(O)ccc2C2=C1c1ccc(cc1C[C@H]2CC)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,lasofoxifene,7542,,,187051843,Agonist,Partial agonist,,f,f,,pIC50,0,8.510000229,0,IC50,0,3.099999905,0,=,,,,15658851,Oc1ccc2c(c1)CC[C@@H]([C@@H]2c1ccc(cc1)OCCN1CCCC1)c1ccccc1
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,fulvestrant,1015,,,135650370,Antagonist,Antagonist,,f,t,,pKi,0,8.979999542,0,Ki,0,1.039999962,0,=,,,,12672240,O=S(CCCC(C(F)(F)F)(F)F)CCCCCCCCC[C@@H]1Cc2cc(O)ccc2[C@@H]2[C@@H]1[C@@H]1CC[C@@H]([C@]1(CC2)C)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,GSK5182,8908,,,310264689,Antagonist,Antagonist,,f,f,,pIC50,0,6.489999771,0,IC50,0,320,0,=,,,,16307879,OCCC/C(=C(c1ccc(cc1)O)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,hexestrol,2823,,,135650348,Antagonist,Antagonist,,f,,,pKi,0,10.3,0,,0,0,0,,,,,9048584,CCC(C(c1ccc(cc1)O)CC)c1ccc(cc1)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,methyl-piperidino-pyrazole,3459,,,178100456,Antagonist,Antagonist,,f,,,pKi,0,8.57,0,Ki,0,2.7,0,=,,,,11861516,O=C1C=CC(=c2[nH]n(c(c2C)c2ccc(cc2)OCCN2CCCCC2)c2ccc(cc2)O)C=C1
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,raloxifene,2820,,,135650883,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,-,0,0,0,=,,,,9048584,Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,diarylpropionitrile,2825,,,53801030,Agonist,Agonist,,f,f,,pKi,0,8.600000381,0,-,0,0,0,=,,,,11150164,N#CC(c1ccc(cc1)O)Cc1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,diarylpropionitrile,2825,,,53801030,Agonist,Agonist,,f,t,,pEC50,0,9.069999695,0,EC50,0,0.850000024,0,=,,,,19596275,N#CC(c1ccc(cc1)O)Cc1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,diethylstilbestrol,2801,,,135651472,Agonist,Agonist,,f,,,pKi,0,9.8,0,-,0,0,0,=,,,,9048584,CC/C(=C(c1ccc(cc1)O)/CC)/c1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,estriol,2821,,,135651483,Agonist,Agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1C[C@H]([C@@H]2O)O)C
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,estrone,2818,,,135651484,Agonist,Agonist,,t,,,pKi,0,7.93,0,,0,0,0,,,,,9048584,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2=O)C
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,ethinylestradiol,7071,,,178103650,Agonist,Agonist,,f,f,,pIC50,0,8.090000153,0,IC50,0,8.100000381,0,=,,,,16722623,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,FERb 033,8898,,,310264679,Agonist,Agonist,,f,t,,pKi,0,8.149999619,0,Ki,0,7.099999905,0,=,,,,19128016,O/N=C/c1ccc(c(c1O)Cl)c1ccc(c(c1)F)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,FERb 033,8898,,,310264679,Agonist,Agonist,,f,f,,pEC50,0,8.319999695,0,EC50,0,4.800000191,0,=,,,,19128016,O/N=C/c1ccc(c(c1O)Cl)c1ccc(c(c1)F)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,genistein,2826,,,135650300,Agonist,Agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9048584,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,liquiritigenin,8899,,,310264680,Agonist,Agonist,,f,f,,pEC50,0,7.440000057,0,EC50,0,36.5,0,=,Measuring activation of the ERE tk-Luc reporter by ER&bets; in transfected U2OS cells.,,,18177995,Oc1ccc(cc1)C1CC(=O)c2c(O1)cc(cc2)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15456246,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&beta;,621,Esr2,O08537,,,,,,Mouse,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,8.430000305,0,IC50,0,3.700000048,0,=,,,,18097065,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&beta;,621,Esr2,Q62986,,,,,,Rat,prinaberel,6700,,,178103311,Agonist,Agonist,,f,f,,pIC50,0,8.510000229,0,IC50,0,3.099999905,0,=,,,,18097065,C=Cc1cc(O)cc2c1oc(n2)c1ccc(c(c1)F)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,lasofoxifene,7542,,,187051843,Agonist,Partial agonist,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,15658851,Oc1ccc2c(c1)CC[C@@H]([C@@H]2c1ccc(cc1)OCCN1CCCC1)c1ccccc1
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,fulvestrant,1015,,,135650370,Antagonist,Antagonist,,f,t,,pKi,0,8.859999657,0,Ki,0,1.389999986,0,=,,,,12672240,O=S(CCCC(C(F)(F)F)(F)F)CCCCCCCCC[C@@H]1Cc2cc(O)ccc2[C@@H]2[C@@H]1[C@@H]1CC[C@@H]([C@]1(CC2)C)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,HPTE,2827,,,135650353,Antagonist,Antagonist,,f,,,pKi,0,7.64,0,,0,0,0,,,,,10188995,ClC(C(c1ccc(cc1)O)c1ccc(cc1)O)(Cl)Cl
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,PHTPP,3461,,,178100457,Antagonist,Antagonist,,f,f,,pKi,0,6.900000095,0,Ki,0,139,0,=,,,,17228884,Oc1ccc(cc1)c1c(nn2c1nc(cc2C(F)(F)F)C(F)(F)F)c1ccccc1
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,raloxifene,2820,,,135650883,Antagonist,Antagonist,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,11459665,Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,"R,R-THC",2822,,,135650105,Antagonist,Antagonist,,f,f,,pKi,0,8.43999958,0,Ki,0,3.599999905,0,=,,,,9927308,CC[C@@H]1Cc2cc(O)ccc2C2=C1c1ccc(cc1C[C@H]2CC)O
Estrogen-related receptor-&alpha;,622,ESRRA,P11474,,,,,,Human,daidzein,2828,,,135649858,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)ccc(c2)O
Estrogen-related receptor-&alpha;,622,ESRRA,P11474,,,,,,Human,genistein,2826,,,135650300,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&alpha;,622,Esrra,O08580,,,,,,Mouse,diethylstilbestrol,2801,,,135651472,Antagonist,Antagonist,,f,f,,pIC50,5.300000191,0,4.800000191,-,0,0,0,=,,,,11297507,CC/C(=C(c1ccc(cc1)O)/CC)/c1ccc(cc1)O
Estrogen-related receptor-&beta;,623,ESRRB,O95718,,,,,,Human,daidzein,2828,,,135649858,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)ccc(c2)O
Estrogen-related receptor-&beta;,623,ESRRB,O95718,,,,,,Human,DY131,2834,,,135650213,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,15713377,CCN(c1ccc(cc1)/C=N/NC(=O)c1ccc(cc1)O)CC
Estrogen-related receptor-&beta;,623,ESRRB,O95718,,,,,,Human,genistein,2826,,,135650300,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&beta;,623,ESRRB,O95718,,,,,,Human,diethylstilbestrol,2801,,,135651472,Antagonist,Antagonist,,f,f,,pIC50,5.300000191,0,4.800000191,-,0,0,0,=,,,,11297507,CC/C(=C(c1ccc(cc1)O)/CC)/c1ccc(cc1)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,daidzein,2828,,,135649858,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)ccc(c2)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,DY131,2834,,,135650213,Agonist,Agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,15713377,CCN(c1ccc(cc1)/C=N/NC(=O)c1ccc(cc1)O)CC
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,genistein,2826,,,135650300,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14638870,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,GSK4716,2835,,,135650324,Agonist,Agonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,15857113,Oc1ccc(cc1)C(=O)N/N=C/c1ccc(cc1)C(C)C
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,GSK5182,8908,,,310264689,Agonist,Inverse agonist,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,16307879,OCCC/C(=C(c1ccc(cc1)O)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen-related receptor-&gamma;,624,ESRRG,P62508,,,,,,Human,diethylstilbestrol,2801,,,135651472,Antagonist,Antagonist,,f,,,pIC50,5.3,0,4.8,,0,0,0,,,,,11297507,CC/C(=C(c1ccc(cc1)O)/CC)/c1ccc(cc1)O
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,endothelin-1,989,EDN1|Edn1|Edn1,Human|Mouse|Rat,135651742,Agonist,Full agonist,,t,,,pIC50,8.5,0,7.8,,0,0,0,,,,,7647976,
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,endothelin-2,990,EDN2,Human,135651743,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,,0,0,0,,,,,7647976,NCCCC[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC1=O)CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CO)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)[C@H](CC)C)CC(=O)O)CC(C)C)Cc1[nH]cnc1)CO)Cc1c[nH]c2c1cccc2
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,sarafotoxin S6b,995,,,135652448,Agonist,Full agonist,,f,,,pIC50,8.1,0,7.5,,0,0,0,,,,,7647976,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CCSC)[C@H](O)C)CC(=O)O)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CO)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)C(C)C)CC(=O)O)CCC(=O)N)Cc1c[nH]cn1)Cc1ccccc1
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,darusentan,3508,,,178100494,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,8667356,COC([C@@H](C(=O)O)Oc1nc(OC)cc(n1)OC)(c1ccccc1)c1ccccc1
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,macitentan,7352,,,178103924,Antagonist,Antagonist,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,22862294,CCCNS(=O)(=O)Nc1ncnc(c1c1ccc(cc1)Br)OCCOc1ncc(cn1)Br
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,PD-156707,999,,,135650799,Antagonist,Antagonist,,f,f,,pA2,9.199999809,0,8.100000381,-,0,0,0,=,,,,10066864,COc1ccc(cc1)C(=O)/C(=C(/c1ccc2c(c1)OCO2)C(=O)[O-])/Cc1cc(OC)c(c(c1)OC)OC.[Na+]
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,PD-156707,999,,,135650799,Antagonist,Antagonist,,f,f,,pKd,9.800000191,0,9,Kd,0.920000017,0,0.150000006,=,,,,9023329,COc1ccc(cc1)C(=O)/C(=C(/c1ccc2c(c1)OCO2)C(=O)[O-])/Cc1cc(OC)c(c(c1)OC)OC.[Na+]
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,PD164333,3519,,,53801049,Antagonist,Antagonist,,f,f,,pKd,0,9,0,Kd,0,0.99000001,0,=,,,,9489609,COc1ccc(cc1)C(=O)/C(=C(/c1ccc2c(c1)OCO2)C(=O)O)/Cc1cc(OCCCC(=O)NCCc2ccc(c(c2)I)O)c(c(c1)OC)OC
ET<sub>A</sub> receptor,219,Ednra,P26684,,,,,,Rat,SB209670,3528,,,178100507,Antagonist,Antagonist,,f,,,pKB,0,9.4,0,KB,0,0.4,0,=,,,,8201588,CCCOc1ccc2c(c1)[C@H]([C@@H]([C@H]2c1ccc2c(c1)OCO2)C(=O)O)c1ccc(cc1OCC(=O)O)OC
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,SB234551,1000,,,135650996,Antagonist,Antagonist,,f,,,pIC50,9,0,8.7,IC50,0,0,0,=,,,,9694916,CCCCn1ncc(c1c1ccc(cc1OCc1ccccc1C(=O)O)OC)/C=C(/C(=O)O)Cc1cc2OCOc2cc1OC
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,sitaxsentan,3950,,,178100777,Antagonist,Antagonist,,f,t,,pA2,0,8,0,-,0,0,0,=,,,,9171878,O=C(c1sccc1S(=O)(=O)Nc1onc(c1Cl)C)Cc1cc2OCOc2cc1C
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,sparsentan,8448,,,252166658,Antagonist,Antagonist,,f,t,,pKi,0,8.029999733,0,Ki,0,9.300000191,0,=,,,,16220969,CCCCC1=NC2(C(=O)N1Cc1ccc(c(c1)COCC)c1ccccc1S(=O)(=O)Nc1noc(c1C)C)CCCC2
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,FR139317,998,,,135650284,Antagonist,Inverse agonist,,f,f,,pIC50,7.900000095,0,7.300000191,IC50,50,0,12.60000038,=,,,,7647976,CC(C[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)O)Cc1ccccn1)Cc1cn(c2c1cccc2)C)NC(=O)N1CCCCCC1)C
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,endothelin-3,1004,EDN3|Edn3|Edn3,Human|Mouse|Rat,135651744,Agonist,Full agonist,,t,,,pKd,11.5,0,9.8,,0,0,0,,,,,7524189,
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,endothelin-3,1004,EDN3|Edn3|Edn3,Human|Mouse|Rat,135651744,Agonist,Full agonist,,t,,,pKd,10.6,0,9.9,,0,0,0,,,,,8904635,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,IRL 1620,3886,,,178100722,Agonist,Full agonist,,f,f,,pKi,0,8.699999809,0,Ki,0,2.25999999,0,=,,,,1320877,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C)Cc1ccc(cc1)O)Cc1ccccc1)C)Cc1nc[nH]c1)CC(C)C)CC(=O)O)C
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,sarafotoxin S6c,1008,,,135652449,Agonist,Full agonist,,f,f,,pKd,9.800000191,0,8.800000191,Kd,1.600000024,0,0.159999996,=,,,,8904635,
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,sarafotoxin S6c,1008,,,135652449,Agonist,Full agonist,,f,,,pKd,10.8,0,10.2,,0,0,0,,,,,8904635,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,IRL 2500,3887,,,178100723,Antagonist,Antagonist,,f,f,,pKd,0,7.199999809,0,Kd,0,63.09999847,0,=,,,,8904635,Cc1cc(C)cc(c1)C(=O)N([C@@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)c1ccccc1)C
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,K-8794,9651,,,340590281,Antagonist,Antagonist,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,28805809,COc1ccccc1Oc1c(OCCC(=O)Nc2c(C)cccc2C)nc(nc1NS(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ncccn1
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,macitentan,7352,,,178103924,Antagonist,Antagonist,,f,f,,pIC50,0,6.409999847,0,IC50,0,391,0,=,,,,22862294,CCCNS(=O)(=O)Nc1ncnc(c1c1ccc(cc1)Br)OCCOc1ncc(cn1)Br
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,RES7011,3911,,,178100744,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,8183252,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,Ro 46-8443,1011,,,135650919,Antagonist,Antagonist,,f,f,,pIC50,0,7.199999809,0,IC50,0,69,0,=,,,,8612786,OC[C@H](COc1nc(nc(c1Oc1ccccc1OC)NS(=O)(=O)c1ccc(cc1)C(C)(C)C)c1ccc(cc1)OC)O
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,SB209670,3528,,,178100507,Antagonist,Antagonist,,f,,,pKB,0,9.4,0,KB,0,0.4,0,=,,,,8201588,CCCOc1ccc2c(c1)[C@H]([C@@H]([C@H]2c1ccc2c(c1)OCO2)C(=O)O)c1ccc(cc1OCC(=O)O)OC
eukaryotic translation initiation factor 2 alpha kinase 2,2016,EIF2AK2,P19525,,,,,,Human,indirubin derivative E804,5988,,,178102610,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,<,,,,21632247,OCC(CCONc1c2ccccc2[nH]c1C1=c2ccccc2=NC1=O)O
eukaryotic translation initiation factor 2 alpha kinase 2,2016,EIF2AK2,P19525,,,,,,Human,PKR inhibitor,6026,,,178102648,Inhibitor,Inhibition,,f,t,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,12890478,O=C1Nc2c(/C/1=C/c1cnc[nH]1)c1scnc1cc2
eukaryotic translation initiation factor 2 alpha kinase 3,2017,EIF2AK3,Q9NZJ5,,,,,,Human,GSK2606414,6740,,,178103351,Inhibitor,Inhibition,,f,t,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,22827572,Fc1cc(CC(=O)N2CCc3c2ccc(c3)c2cn(c3c2c(N)ncn3)C)cc(c1)C(F)(F)F
eukaryotic translation initiation factor 2 alpha kinase 3,2017,EIF2AK3,Q9NZJ5,,,,,,Human,GSK2656157,9544,,,336446930,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,Biochemical activity,,,24900593,O=C(N1CCc2c1ccc(c2F)c1cn(c2c1c(N)ncn2)C)Cc1cccc(n1)C
Excitatory amino acid transporter 1,868,SLC1A3,P43003,,,,,,Human,DL-TBOA,4631,,,178101349,Inhibitor,Inhibition,,f,,,pKB,0,5,0,KB,0,9000,0,,,,,9463476,N[C@@H]([C@@H](C(=O)O)OCc1ccccc1)C(=O)O
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,dihydrokainate,4571,,,178101292,Inhibitor,Inhibition,,f,,,pKB,0,5,0,KB,0,9000,0,,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(C)C
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,DL-TBOA,4631,,,178101349,Inhibitor,Inhibition,,f,,,pKB,0,6.9,0,KB,0,120,0,,,,,9463476,N[C@@H]([C@@H](C(=O)O)OCc1ccccc1)C(=O)O
Excitatory amino acid transporter 3,870,SLC1A1,P43005,,,,,,Human,DL-TBOA,4631,,,178101349,Inhibitor,Inhibition,,f,f,,pIC50,0,5.099999905,0,IC50,0,8000,0,=,,,,11078189,N[C@@H]([C@@H](C(=O)O)OCc1ccccc1)C(=O)O
Excitatory amino acid transporter 3,870,SLC1A1,P43005,,,,,,Human,L-&beta;-BA,4625,,,178101343,Inhibitor,Inhibition,[<sup>3</sup>H]D-aspartate uptake assay,f,f,,pKi,0,6.099999905,0,Ki,0,800,0,=,,,,16183084,N[C@@H]([C@@H](C(=O)O)Cc1ccccc1)C(=O)O
Excitatory amino acid transporter 3,870,SLC1A1,P43005,,,,,,Human,NBI-59159,4626,,,178101344,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,90,0,=,,,,17017964,O=C(C[C@@H](C(=O)O)N)Nc1ccc2c(c1)Cc1c2cccc1
Excitatory amino acid transporter 4,871,SLC1A6,P48664,,,,,,Human,DL-TBOA,4631,,,178101349,Inhibitor,Inhibition,,f,,,pKi,0,5.4,0,Ki,0,4400,0,,,,,11677257,N[C@@H]([C@@H](C(=O)O)OCc1ccccc1)C(=O)O
Excitatory amino acid transporter 5,872,SLC1A7,O00341,,,,,,Human,DL-TBOA,4631,,,178101349,Inhibitor,Inhibition,,f,,,pKi,0,5.5,0,Ki,0,3200,0,,,,,11677257,N[C@@H]([C@@H](C(=O)O)OCc1ccccc1)C(=O)O
Eythropoietin receptor,1718,EPOR,P19235,,,,,,Human,erythropoietin,4921,EPO,Human,178101620,Agonist,Agonist,,t,f,,pIC50,0,11.14999962,0,IC50,0,0.007,0,=,Assay performed using recombinant human EPO,,,16982323,
Eythropoietin receptor,1718,EPOR,P19235,,,,,,Human,peginesatide,7447,,,178104019,Agonist,Agonist,,f,t,,pIC50,0,10.43000031,0,IC50,0,0.037,0,=,,,,16982323,
Farnesoid X receptor,603,,,,,,,,None,deoxycholic acid,610,,,135651468,Agonist,Agonist,,t,,,pEC50,0,4,0,-,0,0,0,=,,,,7898771,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,fexaramine,2744,,,135650259,Agonist,Agonist,,f,f,,pEC50,0,6.599999905,0,-,0,0,0,=,,,,12718892,COC(=O)/C=C/c1cccc(c1)N(C(=O)C1CCCCC1)Cc1ccc(cc1)c1ccc(cc1)N(C)C
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,GW4064,2743,,,135650334,Agonist,Agonist,,f,f,,pEC50,0,7.800000191,0,-,0,0,0,=,,,,10956205,Clc1cc(ccc1/C=C/c1cccc(c1)C(=O)O)OCc1c(onc1c1c(Cl)cccc1Cl)C(C)C
Farnesoid X receptor,603,,,,,,,,None,lithocholic acid,611,,,135651505,Agonist,Agonist,,t,,,pEC50,0,5.3,0,,0,0,0,,,,,10334993,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,obeticholic acid,3435,,,178100437,Agonist,Agonist,,f,t,,pEC50,0,7,0,EC50,0,99,0,=,,,,12166927,CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@@H]([C@@]3(C)CC[C@@H]2[C@@]2([C@H]1C[C@H](O)CC2)C)[C@@H](CCC(=O)O)C
Farnesoid X receptor,603,Nr1h4,Q3V1T8,,,,,,Mouse,guggulsterone,2745,,,135652690,Antagonist,Antagonist,,f,f,,pEC50,0,5,0,-,0,0,0,=,,,,11988537,C/C=C1/C(=O)C[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,guggulsterone,2745,,,135652690,Antagonist,Antagonist,,f,f,,pIC50,6,0,5.699999809,IC50,2000,0,1000,=,,,,12089353,C/C=C1/C(=O)C[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Farnesoid X receptor-&beta;,604,Nr1h5,,,,,,,Mouse,desmosterol,2748,,,135651470,Agonist,Agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,12529392,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCC=C(C)C)C)C)C1)C
Farnesoid X receptor-&beta;,604,Nr1h5,,,,,,,Mouse,lanosterol,2746,,,135651499,Agonist,Agonist,,t,,,pEC50,0,6,0,-,0,0,0,=,,,,12529392,CC(=CCC[C@H]([C@H]1CC[C@@]2([C@]1(C)CCC1=C2CC[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)C)C)C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,diphosphoric acid,3151,,,135650821,Inhibitor,Inhibition,,f,,,pKi,0,7.39,0,Ki,0,40.5,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(OP(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,diphosphoric acid,3151,,,135650821,Inhibitor,Inhibition,,f,,,pKi,0,4.53,0,Ki,0,29.8,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(OP(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,geranyl biphosphonate,3175,,,135650303,Inhibitor,Inhibition,,f,,,pIC50,0,4.7,0,IC50,0,20000,0,=,Inhibition of human recombinant FDPS expressed in BL21 gold bacteria,,,18308574,C/C(=CCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,ibandronic acid,3059,,,135649664,Inhibitor,Inhibition,,f,t,,pKi,0,6.710000038,0,Ki,0,195,0,=,,,,18327899,CCCCCN(CCC(P(=O)(O)O)(P(=O)(O)O)O)C
farnesyl diphosphate synthase,644,Fdps,P05369,,,,,,Rat,ibandronic acid,3059,,,135649664,Inhibitor,Inhibition,,f,f,,pIC50,0,5.130000114,0,-,0,7400,0,=,in vitro using kidney cell lines,,,18325729,CCCCCN(CCC(P(=O)(O)O)(P(=O)(O)O)O)C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,isopentenyl diphosphate,3048,,,135651495,Inhibitor,Inhibition,,t,,,pKi,0,6.15,0,-,0,700,0,=,value not verified,,,4021811,CC(=C)CCOP(=O)(OP(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,minodronic acid,3164,,,135649663,Inhibitor,Inhibition,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,Inhibition of human FPPS after 10 mins using [14C]IPP as substrate by liquid scintillation counting,,,20394422,OP(=O)(C(P(=O)(O)O)(Cc1cnc2n1cccc2)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10575,3184,,,135650696,Inhibitor,Inhibition,,f,,,pKi,0,8.41,0,Ki,0,3.9,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,C[n+]1cccc(c1)CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10575,3184,,,135650696,Inhibitor,Inhibition,,f,,,pKi,0,6.75,0,Ki,0,177,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,C[n+]1cccc(c1)CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10575,3184,,,135650696,Inhibitor,Inhibition,,f,,,pIC50,0,7.71,0,IC50,0,19.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,C[n+]1cccc(c1)CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10575,3184,,,135650696,Inhibitor,Inhibition,,f,,,pIC50,0,5.77,0,IC50,0,1706,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,C[n+]1cccc(c1)CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10790,3165,,,135650697,Inhibitor,Inhibition,,f,,,pKi,0,4.21,0,Ki,0,61,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OC(=O)C(P(=O)(O)O)(Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE10790,3165,,,135650697,Inhibitor,Inhibition,,f,,,pKi,0,7.01,0,Ki,0,97.5,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OC(=O)C(P(=O)(O)O)(Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE11808,3160,,,135650698,Inhibitor,Inhibition,,f,,,pKi,0,8.64,0,Ki,0,2.3,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)CNc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE11808,3160,,,135650698,Inhibitor,Inhibition,,f,,,pIC50,0,7.82,0,IC50,0,15,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)CNc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE11808,3160,,,135650698,Inhibitor,Inhibition,,f,,,pIC50,0,6.72,0,IC50,0,190.1,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)CNc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE11808,3160,,,135650698,Inhibitor,Inhibition,,f,,,pKi,0,7.43,0,Ki,0,36.9,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)CNc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE21650,3167,,,135650699,Inhibitor,Inhibition,,f,,,pKi,0,7.19,0,Ki,0,64.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Nc1ccccc1CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE21650,3167,,,135650699,Inhibitor,Inhibition,,f,,,pIC50,0,7.67,0,IC50,0,21.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Nc1ccccc1CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE21650,3167,,,135650699,Inhibitor,Inhibition,,f,,,pIC50,0,6.43,0,IC50,0,370.7,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Nc1ccccc1CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE21650,3167,,,135650699,Inhibitor,Inhibition,,f,,,pKi,0,8.47,0,Ki,0,3.4,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Nc1ccccc1CC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58018,3168,,,135650700,Inhibitor,Inhibition,,f,,,pKi,0,9.13,0,Ki,0,0.74,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1ccccn1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58018,3168,,,135650700,Inhibitor,Inhibition,,f,,,pKi,0,7.23,0,Ki,0,59.3,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1ccccn1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58018,3168,,,135650700,Inhibitor,Inhibition,,f,,,pIC50,0,6.46,0,IC50,0,349.1,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1ccccn1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58018,3168,,,135650700,Inhibitor,Inhibition,,f,,,pIC50,0,8.04,0,IC50,0,9.2,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1ccccn1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58027,3154,,,135650701,Inhibitor,Inhibition,,f,,,pKi,0,8.8,0,Ki,0,1.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(CC1CCCCN1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58027,3154,,,135650701,Inhibitor,Inhibition,,f,,,pIC50,0,6.23,0,IC50,0,591.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(CC1CCCCN1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58027,3154,,,135650701,Inhibitor,Inhibition,,f,,,pIC50,0,7.86,0,IC50,0,13.7,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(CC1CCCCN1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58027,3154,,,135650701,Inhibitor,Inhibition,,f,,,pKi,0,6.86,0,Ki,0,136.7,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(CC1CCCCN1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58043,3179,,,135650702,Inhibitor,Inhibition,,f,,,pKi,0,8.13,0,Ki,0,7.4,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58043,3179,,,135650702,Inhibitor,Inhibition,,f,,,pIC50,0,6.76,0,IC50,0,173.4,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58043,3179,,,135650702,Inhibitor,Inhibition,,f,,,pKi,0,7.46,0,Ki,0,34.76,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58043,3179,,,135650702,Inhibitor,Inhibition,,f,,,pIC50,0,7.49,0,IC50,0,32.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1cccnc1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58062,3166,,,135650703,Inhibitor,Inhibition,,f,,,pIC50,0,6.27,0,IC50,0,540.8,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,CC1CCCN=C1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58062,3166,,,135650703,Inhibitor,Inhibition,,f,,,pIC50,0,7.99,0,IC50,0,10.3,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,CC1CCCN=C1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58062,3166,,,135650703,Inhibitor,Inhibition,,f,,,pKi,0,7.08,0,Ki,0,83.6,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,CC1CCCN=C1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE58062,3166,,,135650703,Inhibitor,Inhibition,,f,,,pKi,0,9,0,Ki,0,1,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,CC1CCCN=C1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE97220,3171,,,135650704,Inhibitor,Inhibition,,f,,,pIC50,0,8.21,0,IC50,0,6.2,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Cc1cccnc1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE97220,3171,,,135650704,Inhibitor,Inhibition,,f,,,pKi,0,7.92,0,Ki,0,12.1,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Cc1cccnc1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE97220,3171,,,135650704,Inhibitor,Inhibition,,f,,,pKi,0,8.96,0,Ki,0,1.09,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Cc1cccnc1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,NE97220,3171,,,135650704,Inhibitor,Inhibition,,f,,,pIC50,0,7.12,0,IC50,0,75.2,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,Cc1cccnc1NC(P(=O)(O)O)P(=O)(O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,pamidronic acid,7259,,,178103833,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,200,0,=,Inhibition of recombinant human FDPS expressed in <i>E. coli</i>.,,,18327899,NCCC(P(=O)(O)O)(P(=O)(O)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,piridronic acid,3183,,,135650705,Inhibitor,Inhibition,,f,,,pIC50,0,6.59,0,IC50,0,258.8,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,piridronic acid,3183,,,135650705,Inhibitor,Inhibition,,f,,,pKi,0,8.35,0,Ki,0,4.45,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,piridronic acid,3183,,,135650705,Inhibitor,Inhibition,,f,,,pIC50,0,7.52,0,IC50,0,30.4,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,piridronic acid,3183,,,135650705,Inhibitor,Inhibition,,f,,,pKi,0,7.41,0,Ki,0,38.95,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)Cc1ccccn1)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pIC50,0,8.409999847,0,IC50,0,3.900000095,0,=,,,,10620343,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pKi,0,7.090000153,0,Ki,0,82.19999695,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,,,pIC50,0,8.24,0,IC50,0,5.7,0,=,"in vitro assay, inhibition of recombinant human enzyme expressed in E.coli",,,11160603,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pKi,0,9.43999958,0,Ki,0,0.360000014,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,<i>In vitro</i> inhibition of recombinant human FDPS expressed in <i>E.coli</i>.,,,11160603,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,risedronate,3176,,,135650902,Inhibitor,Inhibition,,f,t,,pIC50,0,6.340000153,0,IC50,0,452.8999939,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
"farnesyltransferase, CAAX box, beta",2826,FNTB,P49356,,,,,,Human,FTI 276,6531,,,178103145,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,7592920,CSCC[C@@H](C(=O)O)NC(=O)c1ccc(cc1c1ccccc1)NC[C@H](CS)N
"farnesyltransferase, CAAX box, beta",2826,FNTB,P49356,,,,,,Human,"L-739,750",8030,,,249565710,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,8090782,CC[C@@H]([C@H](NC[C@H](CS)N)CO[C@H](C(=O)N[C@H](C(=O)O)CCS(=O)(=O)C)Cc1ccccc1)C
"farnesyltransferase, CAAX box, beta",2826,FNTB,P49356,,,,,,Human,LB42908,8028,,,249565708,Inhibitor,Inhibition,,f,t,,pIC50,9.050000191,0,8.619999886,IC50,2.400000095,0,0.899999976,=,Measured as inhibition of FTase transfer of [3H]-farnesylpyrophosphate (FPP) to HRAS (0.9nM) or NRAS (2.4nM),,,11714612,CN1CCN(CC1)C(=O)c1cn(cc1c1cccc2c1cccc2)Cc1cncn1CC1=CC2C(C=C1)OCO2
Fas,1875,FAS,P25445,,,,,,Human,Fas ligand,5078,FASLG,Human,178101771,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,example 13 [WO2009109743],9077,,,315661162,Inhibitor,Inhibition,,f,f,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,0,O=C(N1CC(C1)Oc1ccc(cn1)c1ccccc1)Nc1cccnn1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,(<i>R</i>)-ARN2508,9000,,,310264778,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,9.899999619,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@H](C(=O)O)C
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,(<i>S</i>)-ARN2508,8999,,,310264777,Inhibitor,Inhibition,,f,t,,pIC50,0,8.029999733,0,IC50,0,9.399999619,0,=,,,,26774927,CCCCCCNC(=O)Oc1cccc(c1)c1ccc(cc1F)[C@@H](C(=O)O)C
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,JNJ1661010,5206,,,178101892,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,15.80000019,0,=,,,,18693015,O=C(N1CCN(CC1)c1snc(n1)c1ccccc1)Nc1ccccc1
Fatty acid amide hydrolase,1400,Faah,P97612,,,,,,Rat,JNJ40355003,9050,,,315661135,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,24900385,Clc1ccc(cc1)Oc1cccc(c1)CN1CCN(CC1)C(=O)Nc1cccnc1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,JNJ40355003,9050,,,315661135,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,24900385,Clc1ccc(cc1)Oc1cccc(c1)CN1CCN(CC1)C(=O)Nc1cccnc1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,JNJ-42165279,9012,,,310264790,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,0,O=C(N1CCN(CC1)Cc1ccc2c(c1)OC(O2)(F)F)Nc1cnccc1Cl
Fatty acid amide hydrolase,1400,Faah,P97612,,,,,,Rat,JNJ-42165279,9012,,,310264790,Inhibitor,Inhibition,,f,f,,pIC50,0,6.489999771,0,IC50,0,320,0,=,,,,0,O=C(N1CCN(CC1)Cc1ccc2c(c1)OC(O2)(F)F)Nc1cnccc1Cl
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,JZL195,8606,,,252166807,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,<i>in vitro assay</i>,,,19918051,O=C(N1CCN(CC1)Cc1cccc(c1)Oc1ccccc1)Oc1ccc(cc1)[N+](=O)[O-]
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,OL135,5235,,,178101919,Inhibitor,Inhibition,,f,,,pIC50,0,7.4,0,IC50,0,39.8,0,=,,,,17015445,O=C(c1ncc(o1)c1ccccn1)CCCCCCc1ccccc1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,PF-04457845,6694,,,178103305,Inhibitor,Inhibition,,f,f,,pIC50,9,0,8,IC50,10,0,1,=,Inhibition of human FAAH <i>in vitro</i>.,,,21666860,O=C(N1CCC(=Cc2cccc(c2)Oc2ccc(cn2)C(F)(F)F)CC1)Nc1cccnn1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,PF3845,5243,,,178101927,Inhibitor,Inhibition,,f,,,pIC50,0,6.6,0,IC50,0,251,0,=,,,,19389627,O=C(N1CCC(CC1)Cc1cccc(c1)Oc1ccc(cn1)C(F)(F)F)Nc1cccnc1
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,PF750,5244,,,178101928,Inhibitor,Inhibition,,f,,,pIC50,7.8,0,6.3,IC50,501,0,15.8,=,,,,17949010,O=C(N1CCC(CC1)Cc1cnc2c(c1)cccc2)Nc1ccccc1
Fatty acid amide hydrolase-2,1401,FAAH2,Q6GMR7,,,,,,Human,JNJ1661010,5206,,,178101892,Inhibitor,Inhibition,,f,f,,pIC50,0,5.239999771,0,IC50,0,5700,0,=,20 min preincubation,,,19095868,O=C(N1CCN(CC1)c1snc(n1)c1ccccc1)Nc1ccccc1
Fatty acid amide hydrolase-2,1401,FAAH2,Q6GMR7,,,,,,Human,LY2077855,8989,,,310264767,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,19095868,Fc1ccc(cc1)Cc1nnnn1C(=O)N(C)C
Fatty acid amide hydrolase-2,1401,FAAH2,Q6GMR7,,,,,,Human,OL135,5235,,,178101919,Inhibitor,Inhibition,,f,f,,pIC50,8.399999619,0,7.900000095,IC50,12.60000038,0,4,=,,,,17015445,O=C(c1ncc(o1)c1ccccn1)CCCCCCc1ccccc1
fatty acid binding protein 1,2531,Fabp1,P02692,,,,,,Rat,fenofibrate,7186,,,178103761,Inhibitor,Inhibition,,f,f,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,18533710,CC(OC(=O)C(Oc1ccc(cc1)C(=O)c1ccc(cc1)Cl)(C)C)C
fatty acid binding protein 1,2531,Fabp1,P02692,,,,,,Rat,fenofibric acid,2662,,,135650256,Inhibitor,Inhibition,,f,f,,pKi,0,6.480000019,0,Ki,0,334,0,=,,,,18533710,Clc1ccc(cc1)C(=O)c1ccc(cc1)OC(C(=O)O)(C)C
fatty acid binding protein 1,2531,Fabp1,P12710,,,,,,Mouse,HTS01037,6736,,,178103347,Inhibitor,Inhibition,,f,f,,pKi,0,5.090000153,0,Ki,0,8170,0,=,,,,19754198,COC(=O)c1sc(cc1NC(=O)/C=C/C(=O)O)c1cccs1
fatty acid binding protein 4,2534,FABP4,P15090,,,,,,Human,HM50316,8788,,,252827446,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,<,,,,21481589,Clc1ccc(cc1)n1nc(cc1c1cccs1)c1ccccc1c1cccc(c1)OC(C(=O)O)(C)C
fatty acid binding protein 4,2534,Fabp4,P04117,,,,,,Mouse,HTS01037,6736,,,178103347,Inhibitor,Inhibition,,f,f,,pKi,0,6.170000076,0,Ki,0,670,0,=,,,,19754198,COC(=O)c1sc(cc1NC(=O)/C=C/C(=O)O)c1cccs1
fatty acid synthase,2608,FASN,P49327,,,,,,Human,GSK2194069,8605,,,252166806,Inhibitor,Inhibition,,f,t,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,,,,25086508,O=C(N1CC[C@H](C1)Cc1n[nH]c(=O)n1c1ccc(cc1)c1ccc2c(c1)cco2)C1CC1
Fc fragment of IgE receptor Ia,2933,FCER1A,P12319,,,,,,Human,IgE heavy chain,9557,,,336446943,Agonist,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,0,
Fc fragment of IgE receptor II,2935,FCER2,P06734,,,,,,Human,IgE heavy chain,9557,,,336446943,Agonist,Binding,,f,t,,pKd,0,7,0,Kd,0,100,0,=,,,,0,
Fc fragment of IgG receptor and transporter,2985,FCGRT,P55899,,,,,,Human,efgartigimod alfa,9777,,,0,Antibody,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Fc fragment of IgG receptor and transporter,2985,FCGRT,P55899,,,,,,Human,rozanolixizumab,9801,,,0,Antibody,Binding,,f,f,,pKd,8.699999809,0,8.220000267,Kd,6,0,2,~,"In a cell- based <i>in vitro</i> assay using neutral buffer. Note this affinity range is for the 01519.g57 Fab or PEGylated Fab fragment, not the intact IgG4P antibody.",,,0,
Ferroportin,1194,SLC40A1,Q9NP59,,,,,,Human,LY2928057,8416,,,252166626,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
FER tyrosine kinase,2022,FER,P16591,,,,,,Human,Ro3280,9403,,,328083505,Inhibitor,Inhibition,,f,f,,pKd,0,7.28000021,0,Kd,0,53,0,=,Ambit selectivity screen at 1&mu;M Ro3280.,,,22172702,COc1cc(ccc1Nc1ncc2c(n1)N(CC(C(=O)N2C)(F)F)C1CCCC1)C(=O)NC1CCN(CC1)C
"FES proto-oncogene, tyrosine kinase",2023,FES,P07332,,,,,,Human,lorlantinib,7476,,,187051779,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,24819116,N#Cc1n(C)nc2c1c1cnc(c(c1)O[C@H](C)c1c(C(=O)N(C2)C)ccc(c1)F)N
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,fasiglifam,6484,,,178103098,Agonist,Agonist,,f,f,,pEC50,0,7.099999905,0,-,0,0,0,=,,,,21752941,OC(=O)C[C@@H]1COc2c1ccc(c2)OCc1cccc(c1)c1c(C)cc(cc1C)OCCCS(=O)(=O)C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,docosahexaenoic acid,1051,,,135651477,Agonist,Full agonist,,t,,,pEC50,6,0,5.4,-,0,0,0,=,,,,12496284,CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,linoleic acid,1052,,,135651503,Agonist,Full agonist,,f,f,,pEC50,5.699999809,0,4.400000095,EC50,39800,0,1990,=,,,,12496284,CCCCC/C=CC/C=CCCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,medica 16,1053,,,135650576,Agonist,Full agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,12565875,OC(=O)CC(CCCCCCCCCCC(CC(=O)O)(C)C)(C)C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,myristic acid,2806,,,178100239,Agonist,Full agonist,,t,f,,pEC50,5.099999905,0,4.5,-,0,0,0,=,,,,12496284,CCCCCCCCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,oleic acid,1054,,,135651531,Agonist,Full agonist,,t,f,,pEC50,5.699999809,0,3.900000095,-,0,0,0,=,,,,12496284,CCCCCCCC/C=CCCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,palmitic acid,1055,,,135651535,Agonist,Full agonist,,f,,,pEC50,5.3,0,3.8,-,0,0,0,=,,,,12496284,CCCCCCCCCCCCCCCC(=O)O
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,rosiglitazone,1056,,,135650927,Agonist,Full agonist,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,12565875,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,GW9508,1050,,,135650341,Agonist,Partial agonist,,f,f,,pEC50,0,7.300000191,0,-,0,0,0,=,,,,16702987,OC(=O)CCc1ccc(cc1)NCc1cccc(c1)Oc1ccccc1
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,GW1100,1057,,,135650329,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,16702987,CCOc1ncc(cn1)Cc1cn(c2ccc(cc2)C(=O)OCC)c(nc1=O)SCc1ccc(cc1)F
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,isobutyric acid,1060,,,135651494,Agonist,Full agonist,,f,,,pEC50,3.8,0,3.2,,0,0,0,,,,,12711604,CC(C(=O)O)C
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,<i>trans</i>-2-methylcrotonic acid,6499,,,178103113,Agonist,Full agonist,,t,f,,pEC50,0,3.799999952,0,-,0,0,0,=,,,,21220428,C/C(=CC)/C(=O)O
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,pentanoic acid,1061,,,135651537,Agonist,Full agonist,,f,,,pEC50,3,0,2.8,-,0,0,0,=,,,,12496283,CCCCC(=O)O
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,propanoic acid,1062,,,135651552,Agonist,Full agonist,,t,f,,pEC50,4.900000095,0,3,-,0,0,0,=,,,,12496283,CCC(=O)O
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,(S)-4-CMTB,3420,,,178100426,Agonist,Full agonist,,f,f,,pEC50,0,6.400000095,0,-,0,0,0,=,,,,18818303,CC([C@H](C(=O)Nc1ncc(s1)F)c1ccc(cc1)Cl)C
FFA2 receptor,226,FFAR2,O15552,,,,,,Human,GLPG0974,8417,,,252166627,Antagonist,Antagonist,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,Inhibition of sodium acetate-induced calcium flux <i>via</i> the FFA2 receptor.,,,25380412,OC(=O)CCCN(C(=O)[C@@]1(C)CCN1C(=O)c1csc2c1cccc2)Cc1cccc(c1)Cl
FFA3 receptor,227,,,,,,,,Unknown,(S)-4-CMTB,3420,,,178100426,Agonist,Agonist,,f,,,pKi,0,6.4,0,-,0,0,0,=,,,,18818303,CC([C@H](C(=O)Nc1ncc(s1)F)c1ccc(cc1)Cl)C
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,isobutyric acid,1060,,,135651494,Agonist,Full agonist,,f,,,pEC50,4.8,0,4.3,,0,0,0,,,,,12496283,CC(C(=O)O)C
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,pentanoic acid,1061,,,135651537,Agonist,Full agonist,,f,,,pEC50,5.4,0,3.8,-,0,0,0,=,,,,12496283,CCCCC(=O)O
FFA3 receptor,227,FFAR3,O14843,,,,,,Human,propanoic acid,1062,,,135651552,Agonist,Full agonist,,t,f,,pEC50,5.699999809,0,3.900000095,-,0,0,0,=,,,,12496283,CCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,linoleic acid,1052,,,135651503,Agonist,Full agonist,,t,,,pEC50,0,5.89,0,EC50,0,0,0,=,,,,16702987,CCCCC/C=CC/C=CCCCCCCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,myristic acid,2806,,,178100239,Agonist,Full agonist,,t,f,,pEC50,0,5.199999809,0,-,0,0,0,=,,,,22282525,CCCCCCCCCCCCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,NCG21,5587,,,178102222,Agonist,Full agonist,,f,,,pEC50,0,5.92,0,EC50,0,1200,0,=,,,,19007110,OC(=O)CCCc1ccc(cc1)OCCN(c1ccccn1)c1ccccc1
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,oleic acid,1054,,,135651531,Agonist,Full agonist,,t,f,,pEC50,0,4.699999809,0,-,0,0,0,=,,,,22282525,CCCCCCCC/C=CCCCCCCCC(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,grifolic acid,5588,,,178102223,Agonist,Partial agonist,,f,,,pA2,0,4.95,0,-,0,0,0,=,,,,19471906,C/C(=CCc1c(O)cc(c(c1O)C(=O)O)C)/CC/C=C(/CCC=C(C)C)C
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,grifolic acid methyl ether,5589,,,178102224,Agonist,Partial agonist,,f,,,pA2,0,5.01,0,-,0,0,0,=,,,,20685848,COc1cc(C)c(c(c1C/C=C(/CC/C=C(/CCC=C(C)C)C)C)O)C(=O)O
FFA4 receptor,127,FFAR4,Q5NUL3,,,,,,Human,GW9508,1050,,,135650341,Agonist,Partial agonist,,f,f,,pEC50,0,5.460000038,0,EC50,0,0,0,=,,,,16702987,OC(=O)CCc1ccc(cc1)NCc1cccc(c1)Oc1ccccc1
"FGR proto-oncogene, Src family tyrosine kinase",2024,FGR,P09769,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,<,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"FGR proto-oncogene, Src family tyrosine kinase",2024,FGR,P09769,,,,,,Human,P505-15,8070,,,249565750,Inhibitor,Inhibition,,f,f,,pIC50,0,7.090000153,0,IC50,0,81,0,=,,,,22040680,N[C@H]1CCCC[C@H]1Nc1ncc(c(n1)Nc1cccc(c1)n1nccn1)C(=O)N
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,DEBIO1347,9787,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.039999962,0,IC50,0,9.199999809,0,=,,,,25169980,Cc1nc2c([nH]1)cc(cc2)n1ncc(c1N)C(=O)c1cc2c([nH]1)cccc2
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,derazantinib,9785,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,27627808,COCCNCCc1cccc(c1)Nc1ncc2c(n1)c1ccccc1[C@@H](C2)c1ccccc1F
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.100000381,0,7.960000038,IC50,11,0,8,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,erdafitinib,9039,,,315661124,Inhibitor,Inhibition,,f,f,,pIC50,0,8.93999958,0,IC50,0,1.139999986,0,=,,,,0,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C
fibroblast growth factor receptor 1,1808,,,,,,,,None,example 126 [WO2014007951],9767,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,,,,0,CCN1C(=O)N(Cc2c1c1cc([nH]c1nc2)CN1CCOCC1)c1c(F)c(OC)cc(c1F)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,LY2874455,8104,,,249565784,Inhibitor,Inhibition,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,21900693,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.190000057,0,IC50,0,65,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.159999847,0,IC50,0,69,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,orantinib,7816,,,223366147,Inhibitor,Inhibition,,f,f,,pIC50,0,5.739999771,0,IC50,0,1810,0,=,,,,19110422,OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cccc2
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,f,,pIC50,0,7.130000114,0,IC50,0,74,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,f,,pKi,0,7.409999847,0,Ki,0,39.29999924,0,=,,,,9400019,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,PRN1371,9788,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,28665128,C=CC(=O)N1CCN(CC1)CCCn1c2nc(NC)ncc2cc(c1=O)c1c(Cl)c(OC)cc(c1Cl)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,PRN1371,9788,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,In a kinase selectivity profiling assay.,,,28665128,C=CC(=O)N1CCN(CC1)CCCn1c2nc(NC)ncc2cc(c1=O)c1c(Cl)c(OC)cc(c1Cl)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,rogaratinib,9789,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,7.909999847,0,Ki,0,12.19999981,0,=,At a high ATP level.,,,0,COCc1c(CN2CCNC(=O)C2)n2c(c1c1cc3c(s1)c(OC)cc(c3)C)c(N)ncn2
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,580,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,example 126 [WO2014007951],9767,,,0,Activator,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,,,,0,CCN1C(=O)N(Cc2c1c1cc([nH]c1nc2)CN1CCOCC1)c1c(F)c(OC)cc(c1F)OC
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,palifermin,6954,,,178103536,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,DEBIO1347,9787,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.599999905,0,=,,,,25169980,Cc1nc2c([nH]1)cc(cc2)n1ncc(c1N)C(=O)c1cc2c([nH]1)cccc2
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,derazantinib,9785,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,27627808,COCCNCCc1cccc(c1)Nc1ncc2c(n1)c1ccccc1[C@@H](C2)c1ccccc1F
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,erdafitinib,9039,,,315661124,Inhibitor,Inhibition,,f,f,,pIC50,0,8.640000343,0,IC50,0,2.289999962,0,=,,,,0,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,LY2874455,8104,,,249565784,Inhibitor,Inhibition,,f,t,,pIC50,0,8.590000153,0,IC50,0,2.599999905,0,=,,,,21900693,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.429999828,0,IC50,0,37,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,PRN1371,9788,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,28665128,C=CC(=O)N1CCN(CC1)CCCn1c2nc(NC)ncc2cc(c1=O)c1c(Cl)c(OC)cc(c1Cl)OC
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,DEBIO1347,9787,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,25169980,Cc1nc2c([nH]1)cc(cc2)n1ncc(c1N)C(=O)c1cc2c([nH]1)cccc2
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,derazantinib,9785,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,27627808,COCCNCCc1cccc(c1)Nc1ncc2c(n1)c1ccccc1[C@@H](C2)c1ccccc1F
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.520000458,0,8.050000191,IC50,9,0,3,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,erdafitinib,9039,,,315661124,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3.019999981,0,=,,,,0,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,example 126 [WO2014007951],9767,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,,,,0,CCN1C(=O)N(Cc2c1c1cc([nH]c1nc2)CN1CCOCC1)c1c(F)c(OC)cc(c1F)OC
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,LY2874455,8104,,,249565784,Inhibitor,Inhibition,,f,t,,pIC50,0,8.18999958,0,IC50,0,6.400000095,0,=,,,,21900693,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,6.96999979,0,IC50,0,108,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,PRN1371,9788,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,28665128,C=CC(=O)N1CCN(CC1)CCCn1c2nc(NC)ncc2cc(c1=O)c1c(Cl)c(OC)cc(c1Cl)OC
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,rogaratinib,9789,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.610000134,0,IC50,0,24.79999924,0,=,,,,0,COCc1c(CN2CCNC(=O)C2)n2c(c1c1cc3c(s1)c(OC)cc(c3)C)c(N)ncn2
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,DEBIO1347,9787,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,6.539999962,0,Ki,0,290,0,=,,,,25169980,Cc1nc2c([nH]1)cc(cc2)n1ncc(c1N)C(=O)c1cc2c([nH]1)cccc2
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,erdafitinib,9039,,,315661124,Inhibitor,Inhibition,,f,f,,pIC50,0,8.25,0,IC50,0,5.619999886,0,=,,,,0,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,FGF401,9768,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,In a biochemical enzyme assay.,,,0,COCCNc1cc(ncc1C#N)NC(=O)N1CCCc2c1nc(C=O)c(c2)CN1CCN(CC1=O)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,LY2874455,8104,,,249565784,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,21900693,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,6.210000038,0,IC50,0,610,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,PRN1371,9788,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.710000038,0,IC50,0,19.29999924,0,=,,,,28665128,C=CC(=O)N1CCN(CC1)CCCn1c2nc(NC)ncc2cc(c1=O)c1c(Cl)c(OC)cc(c1Cl)OC
FK506 binding protein 1A,2609,Fkbp1a,Q62658,,,,,,Rat,pimecrolimus,6783,,,178103389,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Indirect measurement of primary target inhibition via rotamase inhibition,,,9808344,CC[C@@H]1/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@@H](C[C@@H]2OC)C)C(=O)C(=O)N2[C@H](C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]1CC[C@@H]([C@@H](C1)OC)Cl)/C)CCCC2
FK506 binding protein 1A,2609,FKBP1A,P62942,,,,,,Human,sirolimus,6031,,,178102653,Inhibitor,Inhibition,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,Measuring ability to inhibit the proteins rotamase activity,,,9857082,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.520000458,0,8,IC50,10,0,3,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,foretinib,5679,,,178102306,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,23098265,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,fruquintinib,9428,,,328083528,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,Evaluated in a [<sup>32</sup>]p-ATP incorporation assay,,,25482937,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,motesanib,5660,,,178102288,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,23098265,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.510000229,0,IC50,0,31,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,OSI-930,9383,,,328083485,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,16424037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,880,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,semaxanib,5056,,,178101750,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,10882357,O=C1Nc2c(/C/1=C/c1[nH]c(cc1C)C)cccc2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,crenolanib,7882,,,223366211,Inhibitor,Inhibition,,f,t,,pKd,0,9.130000114,0,Kd,0,0.74000001,0,=,,,,22745105,NC1CCN(CC1)c1cccc2c1nc(cc2)n1cnc2c1ccc(c2)OCC1(C)COC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,t,,pIC50,9,0,8.520000458,IC50,3,0,1,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,t,,pKd,0,9.18999958,0,Kd,0,0.639999986,0,=,,,,22037378,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,Flt-3 inhibitor,5970,,,178102593,Inhibitor,Inhibition,,f,t,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,16580199,COc1cc(ccc1OC)C(=O)Nc1sc2c(c1C(=O)N)CCCC2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,Flt-3 inhibitor II,5971,,,178102594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,16722630,Oc1ccc2c(c1)cc([nH]2)C(=O)c1cc2c([nH]1)ccc(c2)O
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,Flt-3 inhibitor III,5972,,,178102595,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,16854049,c1ccc(cc1)c1cnc(s1)Nc1ccc(cc1)OCCN1CCCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,G749,8108,,,249565788,Inhibitor,Inhibition,,f,t,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,24532805,CN1CCC(CC1)Nc1nc(Nc2ccc(cc2)Oc2ccccc2)c2c(n1)c(Br)c[nH]c2=O
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,GTP-14564,5982,,,178102605,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,12815052,c1ccc(cc1)c1n[nH]c2c1oc1c2cccc1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,19887542,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,JNJ-40346527,8942,,,310264723,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,26233509,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(nc1C1=CCC(CC1)(C)C)C1CC(C)(C)OC(C1)(C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,KW-2449,5691,,,178102318,Inhibitor,Inhibition,,f,t,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,,,,19541823,O=C(c1ccc(cc1)/C=C/c1[nH]nc2c1cccc2)N1CCNCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,KW-2449,5691,,,178102318,Inhibitor,Inhibition,,f,t,,pKd,0,7.820000172,0,Kd,0,15,0,=,,,,22037378,O=C(c1ccc(cc1)/C=C/c1[nH]nc2c1cccc2)N1CCNCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,lestaurtinib,5672,,,178102300,Inhibitor,Inhibition,,f,t,,pKd,0,8.069999695,0,Kd,0,8.5,0,=,,,,22037378,OC[C@@]1(O)C[C@H]2O[C@]1(C)n1c3c4n2c2ccccc2c4c2c(c3c3c1cccc3)CNC2=O
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,t,,pKd,0,9.199999809,0,Kd,0,0.629999995,0,=,,,,22037378,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,MELK-TI,9366,,,328083468,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,Measured in a MIllipore kinase screening panel assay,,,25589925,COc1cc(ccc1C(=O)Nc1ccc2c(c1)CCNCC2)c1cn[nH]c1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,midostaurin,5702,,,178102329,Inhibitor,Inhibition,,f,t,,pKd,0,7.960000038,0,Kd,0,11,0,=,,,,22037378,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O)N(C(=O)c1ccccc1)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,midostaurin,5702,,,178102329,Inhibitor,Inhibition,,f,t,,pIC50,0,6.28000021,0,IC50,0,528,0,=,,,,12124173,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O)N(C(=O)c1ccccc1)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,NMS-P937,7918,,,249565601,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,510,0,=,,,,21470862,OCCn1nc(c2c1c1nc(ncc1CC2)Nc1cc(ccc1OC(F)(F)F)N1CCN(CC1)C)C(=O)N
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,pacritinib,7793,,,223366124,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,21604762,C1/C=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,PF-562271,9381,,,328083483,Inhibitor,Inhibition,,f,f,,pIC50,0,7.010000229,0,IC50,0,97,0,=,,,,18339875,O=C1Nc2c(C1)cc(cc2)Nc1ncc(c(n1)NCc1cccnc1N(S(=O)(=O)C)C)C(F)(F)F
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,t,,pKd,8.890000343,0,8.800000191,Kd,1.600000024,0,1.299999952,=,,,,22037378,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,t,,pIC50,0,8.380000114,0,IC50,0,4.199999809,0,=,,,,19654408,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,SGI-1776,8784,,,252827442,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,22924342,CN1CCC(CC1)CNc1ccc2n(n1)c(cn2)c1cccc(c1)OC(F)(F)F
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,t,,pIC50,0,7.239999771,0,IC50,0,58,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,Fms-related tyrosine kinase 3 ligand,4932,FLT3LG,Human,178101630,None,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.520000458,0,8.100000381,IC50,8,0,3,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,foretinib,5679,,,178102306,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,23098265,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,fruquintinib,9428,,,328083528,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,Evaluated in a [<sup>32</sup>]p-ATP incorporation assay,,,25482937,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,lenvatinib,7426,,,178103998,Inhibitor,Inhibition,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,,,,23098265,COc1cc2nccc(c2cc1C(=O)N)Oc1ccc(c(c1)Cl)NC(=O)NC1CC1
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,78,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,motesanib,5660,,,178102288,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,23098265,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,t,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
fms related tyrosine kinase 4,1814,Flt4,P35917,,,,,,Mouse,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Ile-Phe-Leu,1021,,,135652156,Agonist,Full agonist,,f,,,pEC50,0,9.5,0,-,0,0,0,=,,,,23160941,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Ile-Phe-Leu,1021,,,135652156,Agonist,Full agonist,,f,,,pEC50,0,10.5,0,-,0,0,0,=,,,,2825171,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Ile-Val-Ile-Leu,5842,,,178102467,Agonist,Full agonist,,f,,,pEC50,0,8.7,0,-,0,0,0,=,,,,16025565,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Ile-Val-Thr-Leu-Phe,5841,,,178102466,Agonist,Full agonist,,f,,,pEC50,0,8.6,0,-,0,0,0,=,,,,16025565,
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Ile-Val-Thr-Leu-Phe,5841,,,178102466,Agonist,Full agonist,,f,,,pEC50,0,10.7,0,-,0,0,0,=,,,,23160941,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Leu-Phe,1022,,,135652157,Agonist,Full agonist,,f,,,pEC50,10.2,0,10.1,-,0,0,0,=,,,,1262785,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CC(C)C)NC=O
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Leu-Phe,1022,,,135652157,Agonist,Full agonist,,f,,,pEC50,0,4.7,0,-,0,0,0,=,,,,10477558,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CC(C)C)NC=O
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Leu-Phe-Glu,5840,,,178102465,Agonist,Full agonist,,f,,,pEC50,0,8.2,0,-,0,0,0,=,,,,23160941,
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Leu-Phe-Ile-Ile-Lys-FITC,5843,,,178102468,Agonist,Full agonist,,f,,,pKd,0,8.6,0,-,0,0,0,=,,,,23160941,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Met-Trp-Leu-Leu,5837,,,178102462,Agonist,Full agonist,,f,,,pEC50,0,9,0,-,0,0,0,=,,,,7559498,
FPR1,222,Fpr1,P33766,,,,,,Mouse,fMet-Met-Tyr-Ala-Leu-Phe,1023,,,135652158,Agonist,Full agonist,,f,,,pEC50,0,10,0,-,0,0,0,=,,,,23160941,
FPR1,222,FPR1,P21462,,,,,,Human,fMet-Met-Tyr-Ala-Leu-Phe,1023,,,135652158,Agonist,Full agonist,,f,,,pEC50,0,8,0,-,0,0,0,=,,,,16025565,
FPR1,222,FPR1,P21462,,,,,,Human,gG-2p20,5839,,,178102464,Agonist,Full agonist,,f,,,pEC50,6.3,0,6.2,-,0,0,0,=,,,,15699157,
FPR1,222,FPR1,P21462,,,,,,Human,Met-Met-Trp-Leu-Leu,5836,,,178102461,Agonist,Full agonist,,f,,,pEC50,0,9,0,-,0,0,0,=,,,,7559498,
FPR1,222,Fpr1,P33766,,,,,,Mouse,"pyrazolone, 1",5831,,,178102456,Agonist,Full agonist,,f,,,pEC50,0,8.7,0,-,0,0,0,=,,,,23160941,O=C(Nc1c(C(C)C)n(n(c1=O)c1ccccc1)C)Nc1ccc(cc1)Cl
FPR1,222,Fpr1,P33766,,,,,,Mouse,spinorphin,1026,,,135652476,Agonist,Partial agonist,,f,,,pEC50,0,3.9,0,-,0,0,0,=,,,,11714831,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)C(C)C)C(C)C)N)C
FPR1,222,FPR1,P21462,,,,,,Human,cyclosporin A,1024,,,135652074,Antagonist,Antagonist,,f,,,pEC50,6.3,0,6.2,-,0,0,0,=,,,,9310346,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
FPR1,222,FPR1,P21462,,,,,,Human,cyclosporin H,1025,,,135652075,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,6.099999905,Ki,794,0,79.40000153,=,,,,17082621,
FPR1,222,FPR1,P21462,,,,,,Human,deoxycholic acid,610,,,135651468,Antagonist,Antagonist,,f,,,pKi,0,4,0,-,0,0,0,=,,,,11853704,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
FPR1,222,FPR1,P21462,,,,,,Human,diamide 7,5830,,,178102455,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,21486695,Cc1ccc(s1)C(C(=O)Nc1c(C)cccc1C)NC(=O)c1ccccc1O
FPR1,222,FPR1,P21462,,,,,,Human,group E 1682-2106 [PMID:16118363],5827,,,178102452,Antagonist,Antagonist,,f,,,pIC50,0,5.3,0,-,0,0,0,=,,,,16118363,CC(C(N1C(=S)S/C(=C2/c3ccccc3N(C2=O)C)/C1=O)C(=O)O)C
FPR1,222,FPR1,P21462,,,,,,Human,i-Boc-Met-Leu-Phe,1028,,,135652195,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,8573582,
FPR1,222,FPR1,P21462,,,,,,Human,methionine benzimidazole 6,5829,,,178102454,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,-,0,0,0,=,,,,21486695,CSCCC(c1nc2c([nH]1)cccc2)NC(=O)c1oc2c(c1C)cc(cc2)OCC
FPR1,222,FPR1,P21462,,,,,,Human,spinorphin,1026,,,135652476,Antagonist,Antagonist,,t,,,pIC50,0,4.3,0,-,0,0,0,=,,,,11714831,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)C(C)C)C(C)C)N)C
FPR2/ALX,223,FPR2,P25090,,,,,,Human,Hp(2-20),1046,,,135652192,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,11602630,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,PrP<sub>106-126</sub>,6244,,,178102864,Agonist,Agonist,,t,,,pEC50,0,4.6,0,-,0,0,0,=,,,,23549262,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,CRAMP,6266,Camp,Mouse,178102886,Agonist,Full agonist,,t,,,pEC50,7,0,6.7,-,0,0,0,=,,,,15879124,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,F2L,3935,HEBP1,Human,178100763,Agonist,Full agonist,,f,,,pEC50,0,6.4,0,EC50,0,400,0,=,,,,17237393,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,fMet-Ile-Val-Thr-Leu-Phe,5841,,,178102466,Agonist,Full agonist,,f,,,pEC50,0,6.7,0,-,0,0,0,=,,,,16025565,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,fMet-Ile-Val-Thr-Leu-Phe,5841,,,178102466,Agonist,Full agonist,,f,,,pEC50,0,5.55,0,-,0,0,0,=,,,,23160941,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,fMet-Leu-Phe,1022,,,135652157,Agonist,Full agonist,,f,,,pKd,0,6.37,0,-,0,0,0,=,,,,8349692,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CC(C)C)NC=O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,fMet-Met-Tyr-Ala-Leu-Phe,1023,,,135652158,Agonist,Full agonist,,f,,,pEC50,0,7.82,0,-,0,0,0,=,,,,16025565,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,fMet-Met-Tyr-Ala-Leu-Phe,1023,,,135652158,Agonist,Full agonist,,f,,,pEC50,0,5.32,0,-,0,0,0,=,,,,23160941,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,F peptide,6247,,,178102867,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,10438703,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,humanin,1047,MT-RNR2,Human,135651789,Agonist,Full agonist,,t,,,pEC50,0,8.46,0,-,0,0,0,=,,,,15465011,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)N)C)CCCNC(=N)N)CO)CS)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CO)CCC(=O)O)CC(=O)O)CC(C)C
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,humanin,1047,MT-RNR2,Human,135651789,Agonist,Full agonist,,f,,,pEC50,7,0,6,-,0,0,0,=,,,,15153530,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)N)C)CCCNC(=N)N)CO)CS)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CO)CCC(=O)O)CC(=O)O)CC(C)C
FPR2/ALX,223,FPR2,P25090,,,,,,Human,LL-37,5527,CAMP,Human,178102170,Agonist,Full agonist,,t,,,pEC50,0,6,0,-,0,0,0,=,,,,11015447,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,LXA<sub>4</sub>,1034,,,135651504,Agonist,Full agonist,,t,,,pEC50,0,12,0,EC50,0,0.0011,0,~,,,,20080636,CCCCC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,MHC binding peptide,6250,,,178102870,Agonist,Full agonist,,f,,,pIC50,0,10,0,-,0,0,0,=,,,,10748237,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,MMK-1,6240,,,178102861,Agonist,Full agonist,,f,,,pEC50,0,8.7,0,-,0,0,0,=,,,,9853614,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,N36,6246,,,178102866,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,10964542,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,PSM&alpha;3,6267,,,178102887,Agonist,Full agonist,,f,,,pEC50,0,8.67,0,-,0,0,0,=,,,,20542250,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,"pyrazolone, 1",5831,,,178102456,Agonist,Full agonist,,f,,,pEC50,0,6.92,0,-,0,0,0,=,,,,23160941,O=C(Nc1c(C(C)C)n(n(c1=O)c1ccccc1)C)Nc1ccc(cc1)Cl
FPR2/ALX,223,FPR2,P25090,,,,,,Human,"pyrazolone, 1",5831,,,178102456,Agonist,Full agonist,,f,,,pEC50,0,7.4,0,-,0,0,0,=,,,,16697190,O=C(Nc1c(C(C)C)n(n(c1=O)c1ccccc1)C)Nc1ccc(cc1)Cl
FPR2/ALX,223,FPR2,P25090,,,,,,Human,quin-C1,6265,,,178102885,Agonist,Full agonist,,f,,,pEC50,0,5.72,0,-,0,0,0,=,,,,15308762,CCCCOc1ccc(cc1)C(=O)NN1C(Nc2c(C1=O)cccc2)c1ccc(cc1)OC
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,quin-C1,6265,,,178102885,Agonist,Full agonist,,f,,,pEC50,0,6.2,0,-,0,0,0,=,,,,23160941,CCCCOc1ccc(cc1)C(=O)NN1C(Nc2c(C1=O)cccc2)c1ccc(cc1)OC
FPR2/ALX,223,FPR2,P25090,,,,,,Human,resolvin D1,3934,,,178100762,Agonist,Full agonist,,t,,,pEC50,0,11.9,0,EC50,0,0.0012,0,~,,,,20080636,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@@H]([C@H](C/C=CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,RvD1-ME,5555,,,178102196,Agonist,Full agonist,,f,f,,pEC50,0,11.43000031,0,EC50,0,0.0037,0,=,,,,22449948,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](C/C=CCCC(=O)OC)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,sCK&beta;8-1,6251,,,178102871,Agonist,Full agonist,,f,,,pEC50,9.13,0,8.85,-,0,0,0,=,,,,14662730,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,serum amyloid A,6242,SAA1,Human,178102863,Agonist,Full agonist,,t,,,pEC50,0,6.6,0,EC50,0,250,0,=,,,,9892621,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,SHAAGtide,6275,,,178102895,Agonist,Full agonist,,f,,,pEC50,0,7.72,0,-,0,0,0,=,,,,14662730,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,LXA<sub>4</sub>,1034,,,135651504,Agonist,Partial agonist,,t,,,pKd,9.3,0,8.77,-,0,0,0,=,,,,8006586,CCCCC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)O)O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,PBP10,1043,,,135652379,Allosteric modulator,Positive,,f,,,pIC50,0,7,0,,0,0,0,,,,,16025565,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,FPRL1-inhibitor protein,6264,,,178102884,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,17114475,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,isopropylureido-FLFLF,1041,,,135652216,Antagonist,Antagonist,,f,,,pEC50,6,0,4.3,,0,0,0,,,,,8573582,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,quin-C7,1039,,,135650870,Antagonist,Antagonist,,f,,,pEC50,0,5.18,0,,0,0,0,,,,,17652444,CCCCOc1ccc(cc1)C(=O)NN1C(Nc2c(C1=O)cccc2)c1ccc(cc1)O
FPR3,224,FPR3,P25089,,,,,,Human,F2L,3935,HEBP1,Human,178100763,Agonist,Full agonist,,t,,,pEC50,8.2,0,8,-,0,0,0,=,,,,15623572,
FPR3,224,FPR3,P25089,,,,,,Human,F2L-[<sup>125</sup>I]Tyr,1045,,,135652153,Agonist,Full agonist,,f,,,pKd,0,8,0,-,0,0,0,=,,,,15623572,
FPR3,224,FPR3,P25089,,,,,,Human,fMet-Met-Tyr-Ala-Leu-Phe,1023,,,135652158,Agonist,Full agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,,,,16025565,
FPR3,224,FPR3,P25089,,,,,,Human,Hp(2-20),1046,,,135652192,Agonist,Full agonist,,f,,,pEC50,0,5,0,,0,0,0,,,,,11602630,
FPR3,224,FPR3,P25089,,,,,,Human,humanin,1047,MT-RNR2,Human,135651789,Agonist,Full agonist,,t,,,pEC50,0,8.95,0,,0,0,0,,,,,15465011,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)N)C)CCCNC(=N)N)CO)CS)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CO)CCC(=O)O)CC(=O)O)CC(C)C
FPR3,224,Fpr3,O08790,,,,,,Mouse,LXA<sub>4</sub>,1034,,,135651504,Agonist,Full agonist,,f,,,pKd,0,8.82,0,-,0,0,0,=,,,,9151906,CCCCC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,latanoprostene bunod,9635,,,340590265,Agonist,Agonist,,f,f,,pKi,0,8.600000381,0,Ki,0,2.50999999,0,~,Value based on agonist activity of latanoprost.,,,10634944,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)OCCCCO[N+](=O)[O-])O
FP receptor,344,PTGFR,P43088,,,,,,Human,enprostil,1918,,,135650232,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10634944,COC(=O)CCC=C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,fluprostenol,1940,,,135650277,Agonist,Full agonist,,f,f,,pKi,0,8.600000381,0,-,0,0,0,=,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,fluprostenol,1940,,,135650277,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,I-BOP,1938,,,135650364,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2
FP receptor,344,PTGFR,P43088,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
FP receptor,344,PTGFR,P43088,,,,,,Human,"L-888,607",1907,,,135650504,Agonist,Full agonist,,f,,,pKi,0,5,0,,0,0,0,,,,,15755909,OC(=O)C[C@@H]1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F
FP receptor,344,PTGFR,P43088,,,,,,Human,latanoprost (free acid form),1960,,,135650508,Agonist,Full agonist,,f,t,,pKi,0,8.600000381,0,-,0,0,0,=,,,,10634944,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,latanoprost (isopropyl ester),1961,,,135650509,Agonist,Full agonist,,f,t,,pKi,0,6.300000191,0,-,0,0,0,=,,,,10634944,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)OC(C)C)O
FP receptor,344,PTGFR,P43088,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9313928,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
FP receptor,344,PTGFR,P43088,,,,,,Human,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,7.7,0,,0,0,0,,,,,12519077,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,PGD<sub>2</sub>,1881,,,135651538,Agonist,Full agonist,,t,,,pKi,0,7.3,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,7,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,6.9,0,6.4,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,8.5,0,7.9,,0,0,0,,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,8.5,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
FSH receptor,253,FSHR,P23945,,,,,,Human,FSH,1157,CGA|FSHB,Human,135651747,Agonist,Agonist,,t,t,,-,0,0,0,-,0,0,0,=,,,,0,
FSH receptor,253,FSHR,P23945,,,,,,Human,FSH deglycosylated &alpha;/&beta;,1158,,,135652159,Antagonist,Antagonist,,f,f,,pKd,0,10,0,-,0,0,0,=,,,,8188681,
"furin, paired basic amino acid cleaving enzyme",2366,FURIN,P09958,,,,,,Human,furin inhibitor peptide,8668,,,252166868,Inhibitor,Inhibition,,f,t,,pKi,0,7.639999866,0,Ki,0,23,0,=,,,,17537721,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N
"furin, paired basic amino acid cleaving enzyme",2366,FURIN,P09958,,,,,,Human,MI-1148,8601,,,252166802,Inhibitor,Inhibition,,f,t,,pKi,0,11.26000023,0,Ki,0,0.0055,0,=,,,,25974265,CC([C@@H](C(=O)N[C@H](C(=O)NCc1ccc(cc1)C(=N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)Cc1ccc(cc1)CN=C(N)N)CCCN=C(N)N)(C)C
"furin, paired basic amino acid cleaving enzyme",2366,FURIN,P09958,,,,,,Human,peptide 18 [PMID: 24350995],8658,,,252166858,Inhibitor,Inhibition,,f,f,,pKi,0,8.369999886,0,Ki,0,4.300000191,0,=,,,,24350995,NCCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N
"furin, paired basic amino acid cleaving enzyme",2366,FURIN,P09958,,,,,,Human,phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide,6564,,,178103178,Inhibitor,Inhibition,,f,f,,pKi,0,9.100000381,0,Ki,0,0.810000002,0,=,,,,20038105,NC(=NCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)Cc1ccccc1)CCCN=C(N)N)N
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,8.680000305,0,IC50,0,2.099999905,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,8557675,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
"FYN proto-oncogene, Src family tyrosine kinase",2026,FYN,P06241,,,,,,Human,PP2,9404,,,328083506,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,8557675,Clc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
fyn related Src family tyrosine kinase,2025,FRK,P42685,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
FZD<sub>4</sub>,232,Fzd4,Q61088,,,,,,Mouse,norrin,2947,Ndp,Mouse,135651823,Agonist,Full agonist,,t,,,pKd,0,8.4,0,,0,0,0,,,,,15035989,
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,flumazenil,4192,,,178101009,Allosteric modulator,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,Affinity measured using &alpha;1&beta;3&gamma;2 receptors.,benzodiazepine site,,9767648,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,L838417,4241,,,178101058,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Fc1ccc(c(c1)c1nnc2n1nc(OCc1ncnn1C)c(c2)C(C)(C)C)F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,indiplon,4221,,,178101038,Allosteric modulator,Full agonist,high affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CC(=O)N(c1cccc(c1)c1ccnc2n1ncc2C(=O)c1cccs1)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,ocinaplon,4277,,,178101094,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1cnn2c1nccc2c1ccncc1)c1ccccn1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,DMCM,4179,,,178100998,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COC(=O)c1ncc2c(c1CC)c1cc(OC)c(cc1[nH]2)OC
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,MRK016,4257,,,178101074,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cc1onc(c1)c1nncc2n1nc(c2C(C)(C)C)OCc1ncnn1C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,Ro19-4603,4297,,,178101114,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1Cc2c(ncn2c2c(C1=O)scc2)C(=O)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,RO4938581,4299,,,178101116,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Brc1ccc2c(c1)c1ncnn1Cc1n2cnc1C(F)F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,diazepam,3364,,,178100389,Allosteric modulator,Positive,,f,t,,pKi,0,7.789999962,0,Ki,0,16.29999924,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;1&gamma;2.,benzodiazepine site,,2551039,Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,flunitrazepam,4193,,,178101010,Allosteric modulator,Positive,,f,t,,pKi,0,8.279999733,0,Ki,0,5.199999809,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;3&gamma;2.,benzodiazepine site,,8632757,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,flumazenil,4192,,,178101009,Allosteric modulator,Antagonist,,f,t,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,Affinity measured using &alpha;2&beta;3&gamma;2 receptors.,benzodiazepine site,,9767648,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,DMCM,4179,,,178100998,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COC(=O)c1ncc2c(c1CC)c1cc(OC)c(cc1[nH]2)OC
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,MRK016,4257,,,178101074,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cc1onc(c1)c1nncc2n1nc(c2C(C)(C)C)OCc1ncnn1C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,Ro19-4603,4297,,,178101114,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1Cc2c(ncn2c2c(C1=O)scc2)C(=O)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,RO4938581,4299,,,178101116,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Brc1ccc2c(c1)c1ncnn1Cc1n2cnc1C(F)F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,L838417,4241,,,178101058,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Fc1ccc(c(c1)c1nnc2n1nc(OCc1ncnn1C)c(c2)C(C)(C)C)F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,ocinaplon,4277,,,178101094,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1cnn2c1nccc2c1ccncc1)c1ccccn1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,diazepam,3364,,,178100389,Allosteric modulator,Positive,,f,t,,pKi,0,7.769999981,0,Ki,0,16.89999962,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;2&beta;1&gamma;2.,benzodiazepine site,,2551039,Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,flunitrazepam,4193,,,178101010,Allosteric modulator,Positive,,f,t,,pKi,0,8.279999733,0,Ki,0,5.199999809,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;2&beta;1&gamma;2.,benzodiazepine site,,8632757,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,PF-06372865,9798,,,0,Allosteric modulator,Positive,,f,f,,pKi,0,8.609999657,0,Ki,0,2.470000029,0,<,Determined in a radioligand competition binding assay using [<sup>3</sup>H]flumazenil and recombinant human GABA<sub>A</sub> receptor with the &alpha;2/&beta;2/&gamma;3 configuration.,,,0,COc1cc(ccc1c1cc(ccc1F)c1cnnc2c1ncn2CC)S(=O)(=O)CC
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,flumazenil,4192,,,178101009,Allosteric modulator,Antagonist,,f,t,,pKi,0,8.979999542,0,Ki,0,1.049999952,0,=,Affinity measured using &alpha;3&beta;3&gamma;2 receptors.,benzodiazepine site,,9767648,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,DMCM,4179,,,178100998,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COC(=O)c1ncc2c(c1CC)c1cc(OC)c(cc1[nH]2)OC
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,MRK016,4257,,,178101074,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cc1onc(c1)c1nncc2n1nc(c2C(C)(C)C)OCc1ncnn1C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,Ro19-4603,4297,,,178101114,Allosteric modulator,Inverse agonist,higher affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1Cc2c(ncn2c2c(C1=O)scc2)C(=O)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,RO4938581,4299,,,178101116,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Brc1ccc2c(c1)c1ncnn1Cc1n2cnc1C(F)F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,L838417,4241,,,178101058,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Fc1ccc(c(c1)c1nnc2n1nc(OCc1ncnn1C)c(c2)C(C)(C)C)F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,ocinaplon,4277,,,178101094,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1cnn2c1nccc2c1ccncc1)c1ccccn1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,diazepam,3364,,,178100389,Allosteric modulator,Positive,,f,t,,pKi,0,7.769999981,0,Ki,0,17,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;3&beta;1&gamma;2.,benzodiazepine site,,2551039,Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,flunitrazepam,4193,,,178101010,Allosteric modulator,Positive,,f,t,,pKi,0,7.800000191,0,Ki,0,15.69999981,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;3&beta;1&gamma;2.,benzodiazepine site,,8632757,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Full agonist,relatively high efficacy,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,low efficacy,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;4 subunit,407,Gabra4,P28471,,,,,,Rat,flumazenil,4192,,,178101009,Allosteric modulator,Positive,,f,f,,pKi,0,7.03000021,0,Ki,0,94,0,=,Antagonism of complexes containing &alpha;4&beta;2&gamma;2 subunits heterologously expressed <i>in vitro</i>.,,,7799410,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,flumazenil,4192,,,178101009,Allosteric modulator,Antagonist,,f,t,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,Affinity measured using &alpha;5&beta;3&gamma;2 receptors.,benzodiazepine site,,9767648,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,DMCM,4179,,,178100998,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,COC(=O)c1ncc2c(c1CC)c1cc(OC)c(cc1[nH]2)OC
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,L655708,4238,,,178101055,Allosteric modulator,Inverse agonist,high affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1C1CCCN1C(=O)c1c2ccc(c1)OC
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,MRK016,4257,,,178101074,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cc1onc(c1)c1nncc2n1nc(c2C(C)(C)C)OCc1ncnn1C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,Ro19-4603,4297,,,178101114,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1Cc2c(ncn2c2c(C1=O)scc2)C(=O)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,RO4938581,4299,,,178101116,Allosteric modulator,Inverse agonist,higher affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Brc1ccc2c(c1)c1ncnn1Cc1n2cnc1C(F)F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,RY024,4301,,,178101118,Allosteric modulator,Inverse agonist,high affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,C#Cc1ccc2c(c1)C(=O)N(C)Cc1n2cnc1C(=O)OC(C)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,L838417,4241,,,178101058,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Fc1ccc(c(c1)c1nnc2n1nc(OCc1ncnn1C)c(c2)C(C)(C)C)F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,ocinaplon,4277,,,178101094,Allosteric modulator,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=C(c1cnn2c1nccc2c1ccncc1)c1ccccn1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,flunitrazepam,4193,,,178101010,Allosteric modulator,Positive,,f,t,,pKi,0,8.260000229,0,Ki,0,5.5,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;5&beta;1&gamma;2.,benzodiazepine site,,8632757,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,isonipecotic acid,4227,,,178101044,Agonist,Full agonist,relatively high efficacy,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,muscimol,4259,,,178101076,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Agonist,Full agonist,low efficacy,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,Ro15-4513,4296,,,178101113,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,flumazenil,4192,,,178101009,Allosteric modulator,Partial agonist,low affinity,f,f,,pKi,0,6.829999924,0,Ki,0,148,0,=,Affinity measured using &alpha;6&beta;3&gamma;2 receptors.,benzodiazepine site,,9767648,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,gabazine,4197,,,178101014,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &beta;1 subunit,410,GABRB1,P18505,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &beta;2 subunit,411,GABRB2,P47870,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &beta;3 subunit,412,GABRB3,P28472,,,,,,Human,etazolate,7336,,,178103908,Allosteric modulator,Binding,,f,f,,pIC50,0,5.460000038,0,IC50,0,3500,0,=,inhibition of [35S]TBPS binding,,,8773466,CCOC(=O)c1cnc2c(c1NN=C(C)C)cnn2CC
GABA<sub>A</sub> receptor &beta;3 subunit,412,GABRB3,P28472,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &delta; subunit,416,GABRD,O14764,,,,,,Human,gaboxadol,4322,,,178101139,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &delta; subunit,416,GABRD,O14764,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &epsilon; subunit,417,GABRE,P78334,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &gamma;1 subunit,413,GABRG1,Q8N1C3,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &gamma;2 subunit,414,GABRG2,P18507,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &gamma;3 subunit,415,GABRG3,Q99928,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &pi; subunit,419,GABRP,O00591,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,(&plusmn;)-<i>cis</i>-2-CAMP,4067,,,178100890,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCC1CC1C(=O)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,muscimol,4259,,,178101076,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,gaboxadol,4322,,,178101139,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,<i>cis</i>-3-ACPBPA,4096,,,178100919,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@@H](C1)N)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,isonipecotic acid,4227,,,178101044,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,<i>trans</i>-3-ACPBPA,4099,,,178100922,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@H](C1)N)O
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,(&plusmn;)-<i>cis</i>-2-CAMP,4067,,,178100890,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCC1CC1C(=O)O
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,muscimol,4259,,,178101076,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,gaboxadol,4322,,,178101139,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,<i>cis</i>-3-ACPBPA,4096,,,178100919,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@@H](C1)N)O
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,isonipecotic acid,4227,,,178101044,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,<i>trans</i>-3-ACPBPA,4099,,,178100922,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@H](C1)N)O
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,(&plusmn;)-<i>cis</i>-2-CAMP,4067,,,178100890,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCC1CC1C(=O)O
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,isoguvacine,4226,,,178101043,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1=CCNCC1
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,muscimol,4259,,,178101076,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,gaboxadol,4322,,,178101139,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,O=c1[nH]oc2c1CCNC2
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,<i>cis</i>-3-ACPBPA,4096,,,178100919,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@@H](C1)N)O
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,isonipecotic acid,4227,,,178101044,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OC(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,<i>trans</i>-3-ACPBPA,4099,,,178100922,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,CCCCP(=O)([C@@H]1CC[C@H](C1)N)O
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,piperidine-4-sulphonic acid,4287,,,178101104,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,OS(=O)(=O)C1CCNCC1
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>A</sub> receptor &theta; subunit,418,GABRQ,Q9UN88,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
GABA<sub>B1</sub>,240,GABBR1,Q9UBS5,,,,,,Human,lesogaberan,7705,,,223366038,Agonist,Agonist,,f,t,,pEC50,0,8.100000381,0,EC50,0,8,0,=,,,,0,NC[C@H](CP(=O)O)F
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,GABA,1067,,,135651489,Agonist,Full agonist,,t,,,pIC50,4.6,0,4.5,,0,0,0,,,,,9069281,NCCCC(=O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,saclofen,1078,,,135650976,Antagonist,Antagonist,,f,,,pIC50,3.5,0,3.4,,0,0,0,,,,,9069281,NCC(c1ccc(cc1)Cl)CS(=O)(=O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,SCH 50911,1075,,,135651028,Antagonist,Antagonist,,f,,,pIC50,0,6.4,0,-,0,0,0,=,,,,7562513,OC(=O)C[C@@H]1OCC(NC1)(C)C
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,GABA,1067,,,135651489,Agonist,Full agonist,,t,,,pIC50,0,8.3,0,-,0,0,0,=,,,,0,NCCCC(=O)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,GABA,1067,,,135651489,Agonist,Full agonist,,t,,,pKi,6.7,0,4.1,,0,0,0,,,,,11082110,NCCCC(=O)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,phaclofen,1091,,,135650815,Antagonist,Antagonist,,f,,,pKi,0,3.9,0,,0,0,0,,,,,11082110,NCC(c1ccc(cc1)Cl)CP(=O)(O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,phaclofen,1091,,,135650815,Antagonist,Antagonist,,f,,,pIC50,0,4.1,0,,0,0,0,,,,,12037141,NCC(c1ccc(cc1)Cl)CP(=O)(O)O
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,saclofen,1078,,,135650976,Antagonist,Antagonist,,f,,,pKi,4.3,0,3.7,,0,0,0,,,,,11082110,NCC(c1ccc(cc1)Cl)CS(=O)(=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,saclofen,1078,,,135650976,Antagonist,Antagonist,,f,,,pIC50,0,5.4,0,,0,0,0,,,,,12037141,NCC(c1ccc(cc1)Cl)CS(=O)(=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,SCH 50911,1075,,,135651028,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,7562513,OC(=O)C[C@@H]1OCC(NC1)(C)C
GABA<sub>B</sub> receptor,242,GABBR1|GABBR2|KCTD16|KCTD8|KCTD12,Q9UBS5|O75899|Q6ZWB6|Q96CX2|Q68DU8,,,,,,Human,SCH 50911,1075,,,135651028,Antagonist,Antagonist,,f,,,pKi,6,0,5.5,-,0,0,0,=,,,,11082110,OC(=O)C[C@@H]1OCC(NC1)(C)C
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(10-29) (pig),6094,,,178102715,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,8750821,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,galanin(10-29) (rat/mouse),6093,,,178102714,Agonist,Agonist,,f,,,pKi,0,5.78,0,Ki,0,1670,0,>,,,,9832122,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(1-11),6084,,,178102705,Agonist,Agonist,,f,,,pIC50,0,8.96,0,IC50,0,1.1,0,=,,,,11481429,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(1-13)amide,6085,,,178102706,Agonist,Agonist,,f,,,pKd,0,6.9,0,Kd,0,125,0,=,,,,8738882,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pKi,8.52,0,7.94,Ki,11.5,0,3,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pIC50,0,8.77,0,IC50,0,1.68,0,=,,,,9685625,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,9.3,0,8.3,Ki,5,0,0.5,=,,,,9808667,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pIC50,9.22,0,9,IC50,1.01,0,0.6,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,9.02,0,8.05,Ki,9,0,0.95,=,,,,9305929,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pIC50,0,9.57,0,IC50,0,0.27,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,8.99,0,8.66,Ki,2.2,0,1.02,=,,,,9271210,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(1-19) (human),6088,,,178102709,Agonist,Agonist,,f,,,pIC50,0,9.47,0,IC50,0,0.34,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(1-19) (human),6088,,,178102709,Agonist,Agonist,,f,,,pIC50,0,9.82,0,IC50,0,0.15,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pIC50,0,6.06,0,IC50,0,879,0,=,,,,11481429,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pKi,0,5.3,0,Ki,0,5000,0,>,,,,15944002,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-30) (human),6090,,,178102711,Agonist,Agonist,,f,,,pKi,0,7.28,0,Ki,0,52,0,=,,,,11983932,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,6,0,5,Ki,10000,0,1000,>,,,,9880084,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,9685625,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9305929,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9405385,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,0,5.78,0,Ki,0,1650,0,>,,,,9832122,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pKi,0,8.17,0,Ki,0,6.76,0,=,,,,9880084,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pKi,0,7.61,0,Ki,0,24.55,0,=,,,,9722565,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,6.39,0,6,Ki,1000,0,407.4,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,0,6.2,0,Ki,0,630.96,0,=,,,,9880084,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin-like peptide,3596,Galp,Rat,135651752,Agonist,Agonist,,f,,,pIC50,0,7.35,0,IC50,0,45,0,=,,,,20880399,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin-like peptide,6120,GALP,Pig,178102741,Agonist,Agonist,,f,,,pIC50,0,8.37,0,IC50,0,4.3,0,=,,,,10601261,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin-like peptide,3594,GALP,Human,135651754,Agonist,Agonist,,f,,,pIC50,0,7.11,0,IC50,0,77,0,=,,,,15944009,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin-like peptide,6120,GALP,Pig,178102741,Agonist,Agonist,,f,,,pEC50,0,7.52,0,EC50,0,30,0,=,,,,10601261,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2,6105,,,178102726,Agonist,Agonist,,f,,,pKi,0,8.46,0,Ki,0,3.5,0,=,,,,19053761,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-C<sub>10</sub>,6112,,,178102733,Agonist,Agonist,,f,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-C<sub>12</sub>,6113,,,178102734,Agonist,Agonist,,f,,,pKi,0,8.85,0,Ki,0,1.4,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-C<sub>14</sub>,6114,,,178102735,Agonist,Agonist,,f,,,pKi,0,8.59,0,Ki,0,2.6,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-C<sub>18</sub>,6115,,,178102736,Agonist,Agonist,,f,,,pKi,0,8.4,0,Ki,0,4,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-C<sub>8</sub>,6111,,,178102732,Agonist,Agonist,,f,,,pKi,0,9.15,0,Ki,0,0.7,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-dPEG<sub>24</sub>,6106,,,178102727,Agonist,Agonist,,f,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,23259957,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B2-MPEG<sub>4</sub>,6116,,,178102737,Agonist,Agonist,,f,,,pKi,0,9.3,0,Ki,0,0.5,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-B5,6107,,,178102728,Agonist,Agonist,,f,,,pKi,0,6.41,0,Ki,0,387,0,=,,,,19053761,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Gal-(K)4,6110,,,178102731,Agonist,Agonist,,f,,,pKi,0,9.4,0,Ki,0,0.4,0,=,,,,19199479,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galmic,6119,,,178102740,Agonist,Agonist,,f,,,pKi,0,4.47,0,Ki,0,34200,0,=,,,,15944006,NCCCC[C@@H](C(=O)OC)NC(=O)[C@]1(C)NC(=O)c2nc(oc2C)[C@@](C)(NC(=O)c2nc([C@](NC(=O)c3nc1oc3C)(C)C(=O)NCC1CCCCC1)oc2C)C(=O)NC1c2ccccc2c2c1cccc2
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galnon,6118,,,178102739,Agonist,Agonist,,f,,,pKi,0,4.93,0,Ki,0,11700,0,=,,,,15944006,NCCCC[C@@H](C(=O)Nc1ccc2c(c1)oc(=O)cc2C)NC(=O)[C@@H](NC(=O)OCC1c2ccccc2c2c1cccc2)CC1CCCCC1
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,GALP(1-32) (human),6121,,,178102742,Agonist,Agonist,,f,,,pIC50,0,6.89,0,IC50,0,129,0,=,,,,15944009,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,GALP(3-32) (human),6122,,,178102743,Agonist,Agonist,,f,,,pIC50,0,7.48,0,IC50,0,33,0,=,,,,15944009,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galparan,6096,,,178102717,Agonist,Agonist,,f,,,pKd,0,8.19,0,Kd,0,6.4,0,=,,,,8738882,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,J18 (galanin analogue),6075,,,178102696,Agonist,Agonist,,f,,,pKi,0,6.86,0,Ki,0,138,0,=,,,,23600864,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,J20 (galanin analogue),6076,,,178102697,Agonist,Agonist,,f,,,pKi,0,7.6,0,Ki,0,25,0,=,,,,23600864,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M1145,6101,,,178102722,Agonist,Agonist,,f,f,,pKi,0,6.230000019,0,Ki,0,587,0,=,,,,19467704,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M1151,6102,,,178102723,Agonist,Agonist,,f,,,pKi,0,7.01,0,Ki,0,98.6,0,=,,,,21333705,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M1152,6103,,,178102724,Agonist,Agonist,,f,,,pKi,0,5.63,0,Ki,0,2370,0,=,,,,21333705,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M1153,6104,,,178102725,Agonist,Agonist,,f,,,pKi,0,5.72,0,Ki,0,1890,0,=,,,,21333705,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M1160,6074,,,178102695,Agonist,Agonist,,f,,,pKi,0,4.81,0,Ki,0,15500,0,=,,,,23192661,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M242,6099,,,178102720,Agonist,Agonist,,f,,,pKi,0,9.6,0,Ki,0,0.25,0,=,,,,11600206,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M617,6100,,,178102721,Agonist,Agonist,,f,,,pKi,0,9.64,0,Ki,0,0.23,0,=,,,,0,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,"[N-Me,des-Sar]Gal-B2",6109,,,178102730,Agonist,Agonist,,f,,,pKi,0,6.44,0,Ki,0,364.5,0,=,,,,20121116,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,"[Sar<sup>1</sup>, D-Ala<sup>12</sup>]galanin(1-16)",6082,,,178102703,Agonist,Agonist,,f,,,pIC50,0,9.4,0,IC50,0,0.4,0,=,,,,11491429,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,f,,,pKi,9.85,0,9.22,Ki,0.6,0,0.14,=,,,,9722565,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,10.6,0,9.64,Ki,0.23,0,0.025,=,,,,9808667,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,f,,,pIC50,10.22,0,10.15,IC50,0.07,0,0.06,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pIC50,10.01,0,8.85,IC50,1.4,0,0.097,=,,,,10601261,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,10,0,9.09,Ki,0.82,0,0.1,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pKi,10.51,0,9.1,Ki,0.8,0,0.031,=,,,,9808667,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKd,0,9.1,0,Kd,0,0.8,0,=,,,,7524088,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pIC50,9.89,0,9.57,IC50,0.27,0,0.13,=,,,,11481429,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pIC50,0,9.89,0,IC50,0,0.13,0,=,,,,9685625,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pKi,10.1,0,9,Ki,1,0,0.08,=,,,,9722565,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pKi,10.33,0,9.34,Ki,0.46,0,0.047,=,,,,9271210,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pKi,10.1,0,8.76,Ki,1.75,0,0.08,=,,,,9880084,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKd,0,9.13,0,Kd,0,0.74,0,=,,,,8738882,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pIC50,10.22,0,10.15,IC50,0.07,0,0.06,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pEC50,0,9.8,0,EC50,0,0.16,0,=,,,,10601261,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pIC50,9.85,0,9.8,IC50,0.16,0,0.14,=,,,,9168941,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pIC50,0,7.52,0,IC50,0,30.4,0,=,,,,9685625,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pKi,8.15,0,7.08,Ki,82.5,0,7.14,=,,,,8750821,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pKi,0,7.58,0,Ki,0,26.3,0,=,,,,9880084,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pKi,7.07,0,5.96,Ki,1100,0,85,=,,,,9281594,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pIC50,0,8.14,0,IC50,0,7.2,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pKi,7.97,0,7.07,Ki,84.6,0,10.8,=,,,,9271210,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,"dithiipin-1,1,4,4-tetroxide analogue 7",6124,,,178102745,Antagonist,Antagonist,,f,,,pIC50,0,6.72,0,IC50,0,190,0,=,,,,10896115,Cc1ccc(cc1)C1=CS(=O)(=O)CCCS1(=O)=O
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,GalR3ant,6127,,,178102748,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,15944007,COc1ccc(cn1)N1C(=O)/C(=N/c2ccc(c(c2)Cl)Cl)/c2c1cccc2
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,10.57,0,9.4,Ki,0.4,0,0.027,=,,,,9808667,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,8.65,0,8.2,Ki,6.3,0,2.24,=,,,,9271210,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pIC50,8.84,0,8.82,IC50,1.5,0,1.46,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pIC50,0,9,0,IC50,0,1,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,9.19,0,8,Ki,10,0,0.65,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,9.74,0,9.59,Ki,0.26,0,0.18,=,,,,9880084,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,9.22,0,9.17,Ki,0.68,0,0.6,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,10.92,0,8.32,Ki,4.8,0,0.012,=,,,,9808667,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pIC50,0,10.4,0,IC50,0,0.04,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,9.52,0,9.34,Ki,0.46,0,0.3,=,,,,9305929,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pIC50,0,11,0,IC50,0,0.01,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,9.96,0,8.62,Ki,2.4,0,0.11,=,,,,9808667,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,10.4,0,9.37,Ki,0.43,0,0.04,=,,,,9271210,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pIC50,0,9.05,0,IC50,0,0.9,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,8.4,0,7.95,Ki,11.3,0,4,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pIC50,0,9.3,0,IC50,0,0.5,0,=,,,,9168941,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,M871,3900,,,178100734,Antagonist,Antagonist,,f,,,pKi,0,6.38,0,Ki,0,420,0,=,,,,0,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,Sch 202596,6128,,,178102749,Antagonist,Antagonist,,f,,,pKi,0,5.77,0,Ki,0,1700,0,=,,,,0,COC(=O)C1=C[C@@H](O)[C@H]([C@@H]([C@@H]1Oc1c(Cl)c(C)c(c2c1C(=O)[C@@]1(O2)C(=CC(=O)C=C1C(=O)OC)OC)Cl)O)O
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,"(D-Thr<sup>6</sup>, D-Trp<sup>8,9</sup>)galanin(1-15)ol",6133,,,178102754,Agonist,Agonist,,f,,,pKi,0,5.9,0,Ki,0,1250,0,>,,,,9281594,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(10-29) (pig),6094,,,178102715,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(10-29) (pig),6094,,,178102715,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(10-29) (rat/mouse),6093,,,178102714,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,galanin(10-29) (rat/mouse),6093,,,178102714,Agonist,Agonist,,f,,,pKi,0,5.73,0,Ki,0,1860,0,>,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-10),6140,,,178102761,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-11),6084,,,178102705,Agonist,Agonist,,f,,,pIC50,0,8.78,0,IC50,0,1.65,0,=,,,,11481429,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-12),6141,,,178102762,Agonist,Agonist,,f,,,pKi,0,8.19,0,Ki,0,6.4,0,=,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pIC50,0,8.13,0,IC50,0,7.4,0,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pEC50,0,9.14,0,EC50,0,0.72,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pIC50,0,8.61,0,IC50,0,2.47,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pEC50,0,7.19,0,EC50,0,65,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pKi,0,8.46,0,Ki,0,3.5,0,=,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-15),6086,,,178102707,Agonist,Agonist,,f,,,pKi,0,9.15,0,Ki,0,0.7,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pEC50,9.38,0,7.26,EC50,54.95,0,0.42,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pIC50,8.52,0,7.88,IC50,13.2,0,3,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pIC50,0,8.66,0,IC50,0,2.17,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,8.74,0,7.89,Ki,13,0,1.8,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pEC50,0,7.03,0,EC50,0,94,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,0,7.93,0,Ki,0,11.8,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,8.8,0,7.89,Ki,13,0,1.6,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(1-19) (rat/mouse),6139,,,178102760,Agonist,Agonist,,f,,,pKi,0,8.33,0,Ki,0,4.7,0,=,,,,9405385,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(1-20)  (human),6137,,,178102758,Agonist,Agonist,,f,,,pKi,0,9.11,0,Ki,0,0.78,0,=,,,,9480833,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pKi,0,7.78,0,Ki,0,16.6,0,=,,,,19467704,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pIC50,0,8.75,0,IC50,0,1.76,0,=,,,,11481429,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pKi,0,7.06,0,Ki,0,88,0,=,,,,15944007,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,,,,9108306,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,0,5.66,0,Ki,0,2200,0,>,,,,9832122,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,6,0,5.51,Ki,3125,0,1000,=,,,,9405385,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(3-30) (human),6138,,,178102759,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(5-29) (pig),5359,,,178102021,Agonist,Agonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,7683428,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(5-29) (rat/mouse),6134,,,178102755,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pEC50,0,7.46,0,EC50,0,34.67,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pKi,0,8.6,0,Ki,0,2.51,0,=,,,,9480833,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(9-25) (rat/mouse),6136,,,178102757,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(9-29) (rat/mouse),6135,,,178102756,Agonist,Agonist,,f,,,pKi,0,6.15,0,Ki,0,700,0,>,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,8.15,0,7.56,Ki,27.54,0,7,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pEC50,0,6.47,0,EC50,0,338.84,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pEC50,0,6.82,0,EC50,0,150,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,0,6.7,0,Ki,0,199.53,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin-like peptide,3594,GALP,Human,135651754,Agonist,Agonist,,f,,,pIC50,7.73,0,7.55,IC50,28,0,18.7,=,,,,15944009,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin-like peptide,6120,GALP,Pig,178102741,Agonist,Agonist,,f,,,pIC50,0,9.62,0,IC50,0,0.24,0,=,,,,10601261,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin-like peptide,6120,GALP,Pig,178102741,Agonist,Agonist,,f,,,pEC50,0,8.62,0,EC50,0,2.4,0,=,,,,10601261,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2,6105,,,178102726,Agonist,Agonist,,f,,,pKi,0,7.29,0,Ki,0,51.5,0,=,,,,19053761,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-C<sub>10</sub>,6112,,,178102733,Agonist,Agonist,,f,,,pKi,0,7.84,0,Ki,0,14.4,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-C<sub>12</sub>,6113,,,178102734,Agonist,Agonist,,f,,,pKi,0,7.79,0,Ki,0,16.1,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-C<sub>14</sub>,6114,,,178102735,Agonist,Agonist,,f,,,pKi,0,7.74,0,Ki,0,18.2,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-C<sub>18</sub>,6115,,,178102736,Agonist,Agonist,,f,,,pKi,0,7.82,0,Ki,0,15,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-C<sub>8</sub>,6111,,,178102732,Agonist,Agonist,,f,,,pKi,0,7.83,0,Ki,0,14.9,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-dPEG<sub>24</sub>,6106,,,178102727,Agonist,Agonist,,f,,,pKi,0,7.87,0,Ki,0,13.5,0,=,,,,23259957,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B2-MPEG<sub>4</sub>,6116,,,178102737,Agonist,Agonist,,f,,,pKi,0,7.69,0,Ki,0,20.5,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-B5,6107,,,178102728,Agonist,Agonist,,f,,,pKi,0,7.32,0,Ki,0,48,0,=,,,,19053761,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-(K)4,6110,,,178102731,Agonist,Agonist,,f,,,pKi,0,7.62,0,Ki,0,24,0,=,,,,19199479,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galmic,6119,,,178102740,Agonist,Agonist,,f,,,pKd,0,5,0,Kd,0,10000,0,>,,,,15240875,NCCCC[C@@H](C(=O)OC)NC(=O)[C@]1(C)NC(=O)c2nc(oc2C)[C@@](C)(NC(=O)c2nc([C@](NC(=O)c3nc1oc3C)(C)C(=O)NCC1CCCCC1)oc2C)C(=O)NC1c2ccccc2c2c1cccc2
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galnon,6118,,,178102739,Agonist,Agonist,,f,,,pKi,0,4.47,0,Ki,0,34100,0,=,,,,15240875,NCCCC[C@@H](C(=O)Nc1ccc2c(c1)oc(=O)cc2C)NC(=O)[C@@H](NC(=O)OCC1c2ccccc2c2c1cccc2)CC1CCCCC1
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,GALP(1-32) (human),6121,,,178102742,Agonist,Agonist,,f,,,pIC50,0,7.16,0,IC50,0,69,0,=,,,,15944009,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,GALP(3-32) (human),6122,,,178102743,Agonist,Agonist,,f,,,pIC50,0,7.82,0,IC50,0,15,0,=,,,,15944009,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,Gal-R2-dPEG<sub>24</sub>,6108,,,178102729,Agonist,Agonist,,f,,,pKi,0,7.22,0,Ki,0,60.4,0,=,,,,23259957,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,GMAP(1-41),6131,GAL,Pig,178102752,Agonist,Agonist,,f,,,pKi,0,6.08,0,Ki,0,840,0,>,,,,9281594,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,GMAP(44-59),6132,GAL,Pig,178102753,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9405385,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,J18 (galanin analogue),6075,,,178102696,Agonist,Agonist,,f,,,pKi,0,7.7,0,Ki,0,20,0,=,,,,23600864,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,J20 (galanin analogue),6076,,,178102697,Agonist,Agonist,,f,,,pKi,0,8.31,0,Ki,0,4.9,0,=,,,,23600864,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M1151,6102,,,178102723,Agonist,Agonist,,f,,,pKi,0,7.54,0,Ki,0,28.9,0,=,,,,21333705,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M1152,6103,,,178102724,Agonist,Agonist,,f,,,pKi,0,7.44,0,Ki,0,36.4,0,=,,,,21333705,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M1153,6104,,,178102725,Agonist,Agonist,,f,,,pKi,0,8.3,0,Ki,0,4.98,0,=,,,,21333705,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M1160,6074,,,178102695,Agonist,Agonist,,f,,,pKi,0,7.48,0,Ki,0,33.3,0,=,,,,23192661,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M242,6099,,,178102720,Agonist,Agonist,,f,,,pKi,0,8.23,0,Ki,0,5.84,0,=,,,,11600206,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M617,6100,,,178102721,Agonist,Agonist,,f,,,pKi,0,8.24,0,Ki,0,5.71,0,=,,,,0,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,"[N-Me,des-Sar]Gal-B2",6109,,,178102730,Agonist,Agonist,,f,,,pKi,0,7.69,0,Ki,0,20.2,0,=,,,,20121116,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,"[Sar<sup>1</sup>, D-Ala<sup>12</sup>]galanin(1-16)",6082,,,178102703,Agonist,Agonist,,f,,,pIC50,0,8.76,0,IC50,0,1.74,0,=,,,,11481429,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,[D-Trp<sup>2</sup>]galanin-(1-29),3866,,,178100704,Agonist,Full agonist,,f,f,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pKi,9.07,0,8.63,Ki,2.34,0,0.86,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pKi,0,8.41,0,Ki,0,3.9,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pIC50,0,9.47,0,IC50,0,0.34,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pEC50,0,8.09,0,EC50,0,8.12,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pIC50,9.12,0,7.93,IC50,11.75,0,0.76,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,f,,,pIC50,9,0,8.6,IC50,2.5,0,1,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pIC50,0,9.46,0,IC50,0,0.35,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pEC50,0,8.28,0,EC50,0,5.2,0,=,,,,10601261,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pIC50,9.43,0,9.34,IC50,0.46,0,0.37,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pKi,8.81,0,8.53,Ki,2.98,0,1.54,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,9.3,0,8.98,Ki,1.05,0,0.5,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pKi,9.25,0,8.25,Ki,5.6,0,0.56,=,,,,9722565,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pEC50,9.15,0,7.91,EC50,12.3,0,0.71,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,0,9.02,0,Ki,0,0.95,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pEC50,0,7.74,0,EC50,0,18,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,f,,,pKi,0,8.6,0,Ki,0,2.51,0,=,,,,9722565,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pIC50,9.32,0,8.72,IC50,1.9,0,0.48,=,,,,10601261,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pIC50,0,9.29,0,IC50,0,0.51,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pEC50,8.93,0,7.62,EC50,23.99,0,1.17,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pIC50,8.74,0,8.73,IC50,1.87,0,1.8,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Full agonist,,f,,,pKi,0,8.54,0,Ki,0,2.88,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pKi,8.72,0,7.25,Ki,56,0,1.9,=,,,,9281594,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,f,,pKi,0,9.039999962,0,Ki,0,0.910000026,0,=,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pIC50,0,8.54,0,IC50,0,2.9,0,=,,,,9108306,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Full agonist,,f,,,pKi,0,8.17,0,Ki,0,6.8,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(2-30) (human),6090,,,178102711,Agonist,Full agonist,,f,,,pKi,8.74,0,8,Ki,10,0,1.8,=,,,,11983932,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,galanin(7-29) (pig),6083,,,178102704,Agonist,Full agonist,,f,,,pKi,0,8.31,0,Ki,0,4.9,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M1145,6101,,,178102722,Agonist,Full agonist,,f,,,pKi,0,8.18,0,Ki,0,6.55,0,=,,,,19467704,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,CYM2503,8547,,,252166748,Allosteric modulator,Positive,,f,t,,pEC50,0,9.159999847,0,EC50,0,0.689999998,0,=,Potentiation of galanin-induced IP1 accumulation <i>in vitro</i>.,,,20660766,O=C(N[C@H](C(=O)N[C@H](C(=O)Nc1ccc2c(c1)[nH]c(=O)cc2C)CCCNC(=O)OC(C)(C)C)CC1CCCCC1)OCC1C2C=CC=CC2c2c1cccc2
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,"dithiipin-1,1,4,4-tetroxide analogue 7",6124,,,178102745,Antagonist,Antagonist,,f,,,pIC50,0,4.52,0,IC50,0,30000,0,>,,,,10896115,Cc1ccc(cc1)C1=CS(=O)(=O)CCCS1(=O)=O
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,GalR3ant,6127,,,178102748,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,15944002,COc1ccc(cn1)N1C(=O)/C(=N/c2ccc(c(c2)Cl)Cl)/c2c1cccc2
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pIC50,0,8.4,0,IC50,0,4.02,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,9,0,7.8,Ki,15.7,0,1,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pEC50,0,6.52,0,EC50,0,300,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,,,,,,,,Honeybee,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,0,8.97,0,Ki,0,1.07,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,0,8.85,0,Ki,0,1.4,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pEC50,9.19,0,8.04,EC50,9.12,0,0.65,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pIC50,8.32,0,7.55,IC50,28,0,4.8,=,,,,9427506,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pEC50,8.37,0,7.85,EC50,14.13,0,4.23,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,8.84,0,8.66,Ki,2.18,0,1.45,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M32,3897,,,178100731,Antagonist,Antagonist,,f,f,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,9.22,0,9.1,Ki,0.79,0,0.6,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,0,8.31,0,Ki,0,4.9,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pEC50,9.14,0,7.86,EC50,13.8,0,0.72,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,8.74,0,8.71,Ki,1.95,0,1.8,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pEC50,0,7.54,0,EC50,0,29,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,9.22,0,8.09,Ki,8.2,0,0.6,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pIC50,9.37,0,8.55,IC50,2.8,0,0.43,=,,,,9427506,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,9.15,0,7.74,Ki,18,0,0.7,=,,,,9305929,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pEC50,0,7.55,0,EC50,0,28,0,=,,,,9305929,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pEC50,0,7.79,0,EC50,0,16.21,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,8.82,0,8.39,Ki,4.07,0,1.5,=,,,,9880084,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pIC50,8.72,0,8.57,IC50,2.7,0,1.9,=,,,,9427506,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,0,8.55,0,Ki,0,2.8,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,M871,3900,,,178100734,Antagonist,Antagonist,,f,f,,pKi,0,7.880000114,0,Ki,0,13.10000038,0,=,,,,0,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,SNAP 37889,6126,,,178102747,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,16287967,O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1ccccc1)cccc2
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,SNAP 398299,6125,,,178102746,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,16287967,O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,"(D-Thr<sup>6</sup>, D-Trp<sup>8,9</sup>)galanin(1-15)ol",6133,,,178102754,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9405385,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(10-29) (pig),6094,,,178102715,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9405385,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,7.3,0,7.05,Ki,89.13,0,49.6,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(1-16) (rat/mouse/pig),6087,,,178102708,Agonist,Agonist,,f,,,pKi,0,6.5,0,Ki,0,316.23,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(1-19) (rat/mouse),6139,,,178102760,Agonist,Agonist,,f,,,pKi,0,8.2,0,Ki,0,6.25,0,=,,,,9405385,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pKi,0,6.7,0,Ki,0,199,0,=,,,,19467704,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(2-11),5357,,,178102019,Agonist,Agonist,,f,,,pKi,0,6.57,0,Ki,0,271,0,=,,,,15944007,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(2-29) (pig),6130,,,178102751,Agonist,Agonist,,f,,,pKi,0,7.22,0,Ki,0,60.26,0,=,,,,9880084,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(2-29) (rat/mouse),3876,,,178100712,Agonist,Agonist,,f,,,pKi,0,7.9,0,Ki,0,12.6,0,=,,,,9405385,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(3-29) (pig),6091,,,178102712,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(3-29) (rat/mouse),6092,,,178102713,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9405385,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pKi,0,7.52,0,Ki,0,30.2,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(7-29) (pig),6083,,,178102704,Agonist,Agonist,,f,,,pKi,0,7.45,0,Ki,0,35.48,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin(D-Trp<sup>2</sup>) (pig),6095,,,178102716,Agonist,Agonist,,f,,,pKi,0,6,0,Ki,0,1000,0,>,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin-like peptide,3596,Galp,Rat,135651752,Agonist,Agonist,,f,,,pIC50,0,8.82,0,IC50,0,1.53,0,=,,,,20880399,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin-like peptide,3594,GALP,Human,135651754,Agonist,Agonist,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,15944009,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,J18 (galanin analogue),6075,,,178102696,Agonist,Agonist,,f,,,pKi,0,6.95,0,Ki,0,112,0,=,,,,23600864,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,J20 (galanin analogue),6076,,,178102697,Agonist,Agonist,,f,,,pKi,0,7.89,0,Ki,0,13,0,=,,,,23600864,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1145,6101,,,178102722,Agonist,Agonist,,f,,,pKi,0,6.3,0,Ki,0,497,0,=,,,,19467704,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1151,6102,,,178102723,Agonist,Agonist,,f,,,pKi,0,6.06,0,Ki,0,874,0,=,,,,21333705,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1152,6103,,,178102724,Agonist,Agonist,,f,,,pKi,0,6.18,0,Ki,0,656,0,=,,,,21333705,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1153,6104,,,178102725,Agonist,Agonist,,f,,,pKi,0,6.64,0,Ki,0,230,0,=,,,,21333705,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1160,6074,,,178102695,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,23192661,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M1160,6074,,,178102695,Agonist,Agonist,,f,,,pKd,0,5,0,Kd,0,10000,0,>,,,,23192661,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M617,6100,,,178102721,Agonist,Agonist,,f,,,pKi,0,7.31,0,Ki,0,49,0,=,,,,0,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,f,,,pKi,0,7.28,0,Ki,0,52.48,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,0,8.01,0,Ki,0,9.77,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,f,,,pKi,8.35,0,7.91,Ki,12.3,0,4.49,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pIC50,0,7.12,0,IC50,0,75,0,=,,,,9832121,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Full agonist,,t,,,pIC50,0,6.96,0,IC50,0,108.4,0,=,,,,20880399,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin,3592,GAL,Human,135651751,Agonist,Full agonist,,t,,,pKi,0,7.16,0,Ki,0,69.18,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pKi,0,8.14,0,Ki,0,7.24,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,galanin,6129,GAL,Pig,178102750,Agonist,Full agonist,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,9832121,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,galanin,3593,Gal|Gal,Mouse|Rat,135651750,Agonist,Partial agonist,,t,,,pKi,8.83,0,8.13,Ki,7.4,0,1.47,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,GalR3ant,6127,,,178102748,Antagonist,Antagonist,,f,,,pKi,7.82,0,7.7,Ki,20,0,15,=,,,,15944002,COc1ccc(cn1)N1C(=O)/C(=N/c2ccc(c(c2)Cl)Cl)/c2c1cccc2
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,Ki,0,39.81,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,M15,3896,,,178100730,Antagonist,Antagonist,,f,,,pKi,7.98,0,7.07,Ki,85,0,10.5,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,0,8.91,0,Ki,0,1.23,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M32,3897,,,178100731,Antagonist,Antagonist,,f,,,pKi,0,8.22,0,Ki,0,6.03,0,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,8.68,0,8.12,Ki,7.5,0,2.09,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M35,3898,,,178100732,Antagonist,Antagonist,,f,,,pKi,7.84,0,7.8,Ki,16,0,14.45,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,7.27,0,7.1,Ki,79.43,0,54,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M40,3899,,,178100733,Antagonist,Antagonist,,f,,,pKi,7.28,0,6.54,Ki,288.4,0,52,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,M871,3900,,,178100734,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,0,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,SNAP 37889,6126,,,178102747,Antagonist,Antagonist,,f,f,,pKi,7.769999981,0,7.760000229,Ki,17.44000053,0,17,=,,,,16287967,O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1ccccc1)cccc2
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,SNAP 398299,6125,,,178102746,Antagonist,Antagonist,,f,f,,pKi,0,8.270000458,0,Ki,0,5.329999924,0,=,,,,16287967,O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2
GAT1,929,Slc6a1,P31648,,,,,,Mouse,LU32-176B,4756,,,178101466,Inhibitor,Inhibition,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,15550575,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCNC1CCCc2c1c(O)no2
GAT1,929,SLC6A1,P30531,,,,,,Human,NNC-711,4669,,,178101384,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,7851497,OC(=O)C1=CCCN(C1)CCO/N=C(c1ccccc1)/c1ccccc1
GAT1,929,SLC6A1,P30531,,,,,,Human,(R)-EF-1520,6512,,,178103126,Inhibitor,Inhibition,,f,f,,pIC50,5.400000095,0,5.099999905,IC50,8900,0,4000,=,,,,0,CN([C@@H]1CCCc2c1c(O)no2)CCC=C(c1sccc1C)c1sccc1C
GAT1,929,SLC6A1,P30531,,,,,,Human,(R/S) EF-1500,4583,,,178101304,Inhibitor,Inhibition,,f,,,pIC50,5.7,0,4.9,IC50,13000,0,2000,=,,,,0,Cc1ccsc1C(=CCCNC1CCCc2c1c(O)no2)c1sccc1C
GAT1,929,SLC6A1,P30531,,,,,,Human,(S)-EF-1520,6513,,,178103127,Inhibitor,Inhibition,,f,f,,pIC50,3.900000095,0,3.599999905,IC50,250000,0,120000,=,,,,0,CN([C@H]1CCCc2c1c(O)no2)CCC=C(c1sccc1C)c1sccc1C
GAT1,929,SLC6A1,P30531,,,,,,Human,SKF89976A,4705,,,178101417,Inhibitor,Inhibition,,f,f,,pIC50,0,6.900000095,0,IC50,0,130,0,=,,,,0,OC(=O)C1CCCN(C1)CC/C=C(c1ccccc1)/c1ccccc1
GAT2,930,Slc6a13,P31646,,,,,,Rat,SNAP-5114,4677,,,178101391,Inhibitor,Inhibition,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,7874447,COc1ccc(cc1)C(c1ccc(cc1)OC)(c1ccc(cc1)OC)OCCN1CCC[C@@H](C1)C(=O)O
GAT3,931,,,,,,,,None,SNAP-5114,4677,,,178101391,Inhibitor,Inhibition,,f,,,pIC50,0,5.18,0,IC50,0,6600,0,=,,,,0,COc1ccc(cc1)C(c1ccc(cc1)OC)(c1ccc(cc1)OC)OCCN1CCC[C@@H](C1)C(=O)O
GDNF family receptor alpha like,2977,GFRAL,Q6UXV0,,,,,,Human,growth differentiation factor 15,9735,GDF15,Human,0,Agonist,Agonist,,t,f,,pKd,0,7.599999905,0,Kd,0,25,0,=,Native GDF15 binding to the extracellular domain of GFRAL <i>in vitro</i>.,,,28846098,
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,geranylgeranyl diphosphate,3052,,,135651491,Inhibitor,Feedback inhibition,,t,,,pKi,0,4.6,0,-,0,25000,0,=,"recombinant human protein expressed in E coli, in vitro assay",,,16698791,C/C(=CCC/C(=C/COP(=O)(OP(=O)(O)O)O)/C)/CC/C=C(/CCC=C(C)C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,digeranyl bisphosphonate,3187,,,135650180,Inhibitor,Inhibition,,f,,,pIC50,0,6.7,0,IC50,0,200,0,=,"recombinant human protein expressed in BL21 gold bacteria, purified, in vitro assay",,,17208200,C/C(=CCC(P(=O)(O)O)(P(=O)(O)O)C/C=C(/CCC=C(C)C)C)/CCC=C(C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,digeranyl bisphosphonate,3187,,,135650180,Inhibitor,Inhibition,,f,,,pIC50,0,6,0,-,0,0,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,C/C(=CCC(P(=O)(O)O)(P(=O)(O)O)C/C=C(/CCC=C(C)C)C)/CCC=C(C)C
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,minodronic acid,3164,,,135649663,Inhibitor,Inhibition,,f,,,pIC50,0,4,0,-,0,0,0,=,Inhibition of human recombinant geranylgeranyl diphosphate synthase,,,18800762,OP(=O)(C(P(=O)(O)O)(Cc1cnc2n1cccc2)O)O
geranylgeranyl diphosphate synthase,643,GGPS1,O95749,,,,,,Human,minodronic acid,3164,,,135649663,Inhibitor,Inhibition,,f,,,pIC50,0,6.17,0,IC50,0,670,0,=,Inhibition of GGPPS after 10 mins using [14C]IPP as substrate by liquid scintillation counting,,,20394422,OP(=O)(C(P(=O)(O)O)(Cc1cnc2n1cccc2)O)O
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,"L-692,429",5868,,,178102492,Agonist,Agonist,"Calcium release, IP<sub>3</sub> accumulation.",f,,,pEC50,7.59,0,7.33,EC50,47,0,26,=,,,,15905359,O=C(CC(N)(C)C)N[C@@H]1CCc2c(N(C1=O)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)cccc2
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,"L-692,429",5868,,,178102492,Agonist,Agonist,GH release,f,,,pEC50,0,7.22,0,EC50,0,60,0,=,,,,8503009,O=C(CC(N)(C)C)N[C@@H]1CCc2c(N(C1=O)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)cccc2
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,macimorelin,9745,,,0,Agonist,Agonist,,f,t,,pIC50,0,7.809999943,0,IC50,0,15.60000038,0,=,"In a radioligand displacement assay using <sup>125</sup>I-labeled ghrelin as the probe, and human pituitary gland samples.",,,12240910,O=CN[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](NC(=O)C(N)(C)C)Cc1c[nH]c2c1cccc2
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,[des-octanoyl]ghrelin,1098,GHRL,Human,135651737,Agonist,Full agonist,,f,,,pKi,0,7.9,0,-,0,0,0,=,,,,11314756,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,examorelin,1100,,,135652183,Agonist,Full agonist,,f,,,pKd,0,7.89,0,Kd,0,13,0,=,,,,11061542,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ghrelin,1099,GHRL,Human,135651762,Agonist,Full agonist,,f,f,,pEC50,0,8.149999619,0,EC50,0,7.099999905,0,=,Measuring ghrelin-induced GHSR activation detected by &beta;-arrestin recruitment in cells stably expressing hGHSR.,,,0,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ghrelin,1099,GHRL,Human,135651762,Agonist,Full agonist,calcium release,t,,,pEC50,7.49,0,7.21,EC50,61,0,32,=,,,,15905359,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ghrelin,1099,GHRL,Human,135651762,Agonist,Full agonist,,t,,,pKd,9.44,0,8.64,Kd,2.3,0,0.36,=,,,,12907757,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ghrelin,1099,GHRL,Human,135651762,Agonist,Full agonist,IP<sub>3</sub> accumulation,t,,,pEC50,0,9.47,0,EC50,0,0.34,0,=,,,,12907757,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ghrelin,1099,GHRL,Human,135651762,Agonist,Full agonist,,t,,,pKi,8.1,0,7.8,,0,0,0,,,,,11314756,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,GHRP-6,1093,,,135652165,Agonist,Full agonist,IP<sub>3</sub> accumulation,f,,,pEC50,0,9.08,0,EC50,0,0.83,0,=,,,,15905359,NCCCCC(C(=O)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(Cc1cnc[nH]1)N)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,GHRP-6,1093,,,135652165,Agonist,Full agonist,,f,,,pKd,8.8,0,6.6,Kd,250,0,1.6,=,,,,9092793,NCCCCC(C(=O)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(Cc1cnc[nH]1)N)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,GHRP-6,1093,,,135652165,Agonist,Full agonist,Calcium release,f,,,pEC50,0,8.34,0,EC50,0,4.6,0,=,,,,15905359,NCCCCC(C(=O)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(Cc1cnc[nH]1)N)C
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,GHRP-6,1093,,,135652165,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9092793,NCCCCC(C(=O)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(Cc1cnc[nH]1)N)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ibutamoren,5867,,,178102491,Agonist,Full agonist,"Calcium release, IP<sub>3</sub> accumulation.",f,,,pEC50,9.72,0,8.62,EC50,2.4,0,0.19,=,,,,15905359,O=C([C@H](NC(=O)C(N)(C)C)COCc1ccccc1)N1CCC2(CC1)CN(c1c2cccc1)S(=O)(=O)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,ibutamoren,5867,,,178102491,Agonist,Full agonist,,f,,,pKi,0,9.34,0,Ki,0,0.46,0,=,,,,10427162,O=C([C@H](NC(=O)C(N)(C)C)COCc1ccccc1)N1CCC2(CC1)CN(c1c2cccc1)S(=O)(=O)C
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,pralmorelin,1092,,,135652164,Agonist,Full agonist,,f,,,pKi,0,9.3,0,-,0,0,0,=,,,,9092793,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)[C@H](N)C)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,"SM-130,686",5866,,,178102490,Agonist,Partial agonist,,f,,,pIC50,0,8.92,0,IC50,0,1.2,0,=,,,,11741481,CCN(CCN1c2cc(cc(c2[C@](C1=O)(O)c1ccccc1Cl)C(F)(F)F)C(=O)N)CC
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,"SM-130,686",5866,,,178102490,Agonist,Partial agonist,IP<sub>3</sub> accumulation,f,,,pEC50,0,9.51,0,EC50,0,0.31,0,=,,,,18923064,CCN(CCN1c2cc(cc(c2[C@](C1=O)(O)c1ccccc1Cl)C(F)(F)F)C(=O)N)CC
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,"L-692,429",5868,,,178102492,Allosteric modulator,Positive,,f,,,pEC50,0,7,0,EC50,0,100,0,=,,,,15905359,O=C(CC(N)(C)C)N[C@@H]1CCc2c(N(C1=O)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)cccc2
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,"[D-Arg<sup>1</sup>,D-Phe<sup>5</sup>,D-Trp<sup>7,9</sup>,Leu<sup>11</sup>]substance P",1102,,,135652082,Antagonist,Antagonist,,f,,,pKd,0,7.35,0,Kd,0,45,0,=,,,,12907757,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,GSK1614343,5870,,,178102494,Antagonist,Antagonist,,f,,,pIC50,0,8.4,0,IC50,0,4,0,=,,,,20593439,O=C([C@@H](c1cccnc1)N1CCN2[C@@H](C1)CCC2)NNc1cc(cc(c1)C(F)(F)F)C(F)(F)F
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,GSK1614343,5870,,,178102494,Antagonist,Antagonist,,f,,,pKB,0,8,0,-,0,0,0,=,,,,21034740,O=C([C@@H](c1cccnc1)N1CCN2[C@@H](C1)CCC2)NNc1cc(cc(c1)C(F)(F)F)C(F)(F)F
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,JMV3008,5872,,,178102496,Antagonist,Antagonist,,f,,,pIC50,0,8.25,0,IC50,0,5.6,0,=,,,,17927165,COc1ccc(c(c1)OC)n1c(nnc1n1cc(c2c1cccc2)CC)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,liver enriched antimicrobial peptide 2,9734,LEAP2,Human,0,Antagonist,Antagonist,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,IC<sub>50</sub> for LEAP2 antagonism of GHSR activation in the presence of ghrelin.,,,0,
ghrelin receptor,246,Ghsr,Q99P50,,,,,,Mouse,PF-05190457,9060,,,315661145,Antagonist,Antagonist,,f,f,,pKi,0,8.109999657,0,Ki,0,7.699999809,0,=,Measured <i>in vitro</i> in recombinant receptor over-expressing cells,,,26784385,Cc1ncnc(c1)c1ccc2c(c1)CC[C@H]2N1CC2(C1)CCN(CC2)C(=O)Cc1nc2n(c1)cc(s2)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,PF-05190457,9060,,,315661145,Antagonist,Antagonist,,f,t,,pKi,0,8.850000381,0,Ki,0,1.419999957,0,=,Measured <i>in vitro</i> in recombinant receptor over-expressing cells.,,,26784385,Cc1ncnc(c1)c1ccc2c(c1)CC[C@H]2N1CC2(C1)CCN(CC2)C(=O)Cc1nc2n(c1)cc(s2)C
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,PF-05190457,9060,,,315661145,Antagonist,Antagonist,,f,f,,pKi,0,8.489999771,0,Ki,0,3.200000048,0,=,Measured <i>in vitro</i> in recombinant receptor over-expressing cells,,,26784385,Cc1ncnc(c1)c1ccc2c(c1)CC[C@H]2N1CC2(C1)CCN(CC2)C(=O)Cc1nc2n(c1)cc(s2)C
GHRH receptor,247,GHRHR,Q02643,,,,,,Human,JI-38,6523,,,178103137,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,24373935,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JI-38,6523,,,178103137,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,20133784,
GHRH receptor,247,GHRHR,Q02643,,,,,,Human,JMR-132,9114,,,315661199,Agonist,Agonist,,f,f,,pIC50,0,9.850000381,0,IC50,0,0.140000001,0,=,Measuring displacement of [<sup>12</sup>5I]JV-1-42 in a radioligand binding assay.,,,17261802,
GHRH receptor,247,GHRHR,Q02643,,,,,,Human,sermorelin,6998,,,178103577,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,GHRH-(1-29)-NH<sub>2</sub> (human),1103,,,135652161,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,1534126,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,GHRH-(1-29)-NH<sub>2</sub> (rat),1104,,,135652162,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,-,0,0,0,=,,,,1534126,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,GHRH-(1-29)-OH (human),1105,,,135652163,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,1534126,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-10,1106,,,135652228,Antagonist,Antagonist,,f,,,pKi,0,10.3,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-36,1107,,,135652229,Antagonist,Antagonist,,f,f,,pKi,10.40999985,0,10.10000038,Ki,0.079000004,0,0.039000001,=,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-37,1108,,,135652230,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-38,1109,,,135652231,Antagonist,Antagonist,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079000004,0,=,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-39,1110,,,135652232,Antagonist,Antagonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-40,1111,,,135652233,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-41,1112,,,135652234,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-42,1113,,,135652235,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-43,1114,,,135652236,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9892695,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-62,1115,,,135652237,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,14755056,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,JV-1-63,1116,,,135652238,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,14755056,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-4-169,1117,,,135652311,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,7991622,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-4-181,1118,,,135652312,Antagonist,Antagonist,,f,,,pKi,0,10.3,0,,0,0,0,,,,,7991622,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-4-243,1119,,,135652313,Antagonist,Antagonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,7991622,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-4-71,1120,,,135652314,Antagonist,Antagonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,7991622,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-5-156,1121,,,135652315,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,9145431,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-5-192,1122,,,135652316,Antagonist,Antagonist,,f,,,pIC50,0,10.2,0,,0,0,0,,,,,9145431,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-5-78,1123,,,135652317,Antagonist,Antagonist,,f,,,pIC50,0,10.2,0,,0,0,0,,,,,9145431,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,MZ-6-55,1124,,,135652318,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,9892695,
GIP receptor,248,GIPR,P48546,,,,,,Human,gastric inhibitory polypeptide,3542,GIP,Human,135651767,Agonist,Agonist,,f,f,,pKi,0,9.119999886,0,Ki,0,0.75,0,=,,,,26572091,
GIP receptor,248,GIPR,P48546,,,,,,Human,human GIP(1-30)NH2,8973,,,310264753,Agonist,Agonist,,f,f,,pKi,0,9.050000191,0,Ki,0,0.889999986,0,=,Value derived from ligand binding In a competitive binding assay.,,,26572091,
GIP receptor,248,Gipr,P43219,,,,,,Rat,gastric inhibitory polypeptide,1126,Gip,Rat,135651766,Agonist,Full agonist,,t,,,pKd,0,8.6,0,,0,0,0,,,,,8795084,
GIP receptor,248,Gipr,P43219,,,,,,Rat,gastric inhibitory polypeptide,3542,GIP,Human,135651767,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,-,0,0,0,=,,,,9226399,
GIP receptor,248,GIPR,P48546,,,,,,Human,gastric inhibitory polypeptide,3542,GIP,Human,135651767,Agonist,Full agonist,,t,,,pKd,0,8.7,0,-,0,0,0,=,,,,7589426,
GIP receptor,248,Gipr,P43219,,,,,,Rat,GIP-(6-30)-amide,1129,,,135652167,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,9226399,
GIP receptor,248,Gipr,P43219,,,,,,Rat,GIP-(10-30),1128,,,135652166,Agonist,Partial agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,9226399,
GIP receptor,248,Gipr,P43219,,,,,,Rat,GIP-(7-30),1130,,,135652168,Agonist,Partial agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,9226399,
GIP receptor,248,GIPR,P48546,,,,,,Human,human GIP(3-30)NH2,8971,,,310264751,Antagonist,Antagonist,,f,f,,pKi,0,8.640000343,0,Ki,0,2.299999952,0,=,,,,26572091,
GIP receptor,248,GIPR,P48546,,,,,,Human,human GIP(3-42)NH2,8970,,,310264750,Antagonist,Antagonist,,f,f,,pIC50,7.039999962,0,6.139999866,IC50,731,0,92,=,Measuring <i>in vitro</i> inhibition of native GIP-induced cAMP accumulation at [GIP] of 10 pM and 1 nM.,,,16608883,
GIP receptor,248,GIPR,P48546,,,,,,Human,human GIP(5-30)NH2,8972,,,310264752,Antagonist,Antagonist,,f,f,,pKi,0,8.229999542,0,Ki,0,5.900000095,0,=,,,,26572091,
GIP receptor,248,GIPR,P48546,,,,,,Human,MK-0893,9135,,,315661220,Antagonist,Antagonist,,f,f,,pIC50,0,5.989999771,0,IC50,0,1020,0,=,,,,22708876,COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl
GIP receptor,248,Gipr,Q0P543,,,,,,Mouse,[Pro<sup>3</sup>]GIP,3847,,,178100687,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,12627321,
GIP receptor,248,GIPR,P48546,,,,,,Human,human GIP(3-42)NH2,8970,,,310264750,Antagonist,Binding,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,Binding affinity for the human receptor expressed in COS7 cells.,,,16608883,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,exendin-4,1135,,,135652150,Agonist,Agonist,,f,t,,pIC50,0,9.180000305,0,IC50,0,0.660000026,0,=,Displacement of GLP-1 from hGLP-1 receptor expressed in CHOK1 cells by exendin-4,,,18412318,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,lixisenatide,7387,,,178103959,Agonist,Agonist,,f,t,,pKi,0,8.880000114,0,Ki,0,1.330000043,0,=,CHO-K1 cells overexpressing the human GLP-1 receptor.,,,20570597,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCCN)CCCCN)CCCCN)CCCCN)CCCCN)CO)C)CO)CO)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1[nH]cnc1)N)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CC(C)C)CO)CCCCN)CCC(=O)N)CCSC)CCC(=O)O)CCC(=O)O)CCC(=O)O)C)CCCNC(=N)N)CC(C)C)Cc1ccccc1)CCC(=O)O)CC(C)C
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,Peptide 5 [PMID: 28562585],9588,,,340590219,Agonist,Agonist,,f,f,,pEC50,0,10.80000019,0,-,0,0,0,=,,,,28562585,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,Peptide 5 [PMID: 28562585],9588,,,340590219,Agonist,Agonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,28562585,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,semaglutide,9724,,,0,Agonist,Agonist,,f,t,,pEC50,0,11.21000004,0,EC50,0,0.0062,0,=,<i>In vitro</i> potency assessed in BHK cells expressing the human GLP-1R and a luciferase reporter system.,,,26308095,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)C(NC(=O)[C@H](Cc1[nH]cnc1)N)(C)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C)CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)CCC(=O)O)Cc1ccccc1)C
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,semaglutide,9724,,,0,Agonist,Agonist,,f,t,,pIC50,0,9.420000076,0,IC50,0,0.379999995,0,=,Membrane radioligand displacement assay (<sup>125</sup>I-GLP-1 as tracer) performed in the absence of human serum albumin.,,,26308095,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)C(NC(=O)[C@H](Cc1[nH]cnc1)N)(C)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C)CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)CCC(=O)O)Cc1ccccc1)C
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,exendin-3,3730,,,178100601,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,1704369,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,exendin-4,1135,,,135652150,Agonist,Full agonist,,f,t,,pKi,9,0,8.699999809,Ki,1.99000001,0,1,=,,,,15528268,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,glucagon,1136,GCG|Gcg|Gcg,Human|Mouse|Rat,135651778,Agonist,Full agonist,,t,,,pKi,7,0,6.9,,0,0,0,,,,,15528268,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(=O)N)CCSC)CC(C)C)Cc1c[nH]c2c1cccc2)CCC(=O)N)C(C)C)Cc1ccccc1)CC(=O)O)CCC(=O)N)C)CCCN=C(N)N)CCCN=C(N)N)CO)CC(=O)O)CC(C)C)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)CO)CCC(=O)N)Cc1ccccc1)CO)CC(=O)O)Cc1ccc(cc1)O)CO
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,glucagon-like peptide 1-(7-36) amide,1132,GCG|Gcg|Gcg,Human|Mouse|Rat,135651769,Agonist,Full agonist,,t,,,pKi,0,9.2,0,-,0,0,0,=,,,,15528268,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,glucagon-like peptide 1-(7-37),3544,GCG|Gcg|Gcg,Human|Mouse|Rat,135651770,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,8404634,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,liraglutide,1133,,,135652269,Agonist,Full agonist,,f,t,,pEC50,0,10.19999981,0,-,0,0,0,=,,,,10794683,CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,exendin-(9-39),1138,,,135652151,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,15528268,
GLP-1 receptor,249,Glp1r,P32301,,,,,,Rat,GLP-1-(9-36),6524,,,178103138,Antagonist,Antagonist,,f,f,,pIC50,0,6.909999847,0,IC50,0,122.4000015,0,=,,,,9261127,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,glucagon-like peptide 2,1140,GCG,Human,135651771,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9990065,
GLP-2 receptor,250,GLP2R,O95838,,,,,,Human,glucagon-like peptide 2,1140,GCG,Human,135651771,Agonist,Full agonist,,t,,,pIC50,0,8.5,0,-,0,0,0,=,,,,11738243,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,glucagon-like peptide 2,1141,Gcg,Rat,135651772,Agonist,Full agonist,,t,,,pKi,0,10.2,0,,0,0,0,,,,,9990065,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,GLP-2-(1-29) (rat),1139,,,135652170,Agonist,Partial agonist,,t,,,pKi,0,9.5,0,,0,0,0,,,,,9990065,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,glucagon-like peptide 2-(2-33),1142,Gcg,Rat,135651774,Agonist,Partial agonist,,t,,,pKi,0,6.1,0,,0,0,0,,,,,9990065,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,glucagon-like peptide 2-(3-33),1144,Gcg,Rat,135651775,Agonist,Partial agonist,,t,,,pKi,0,6.6,0,,0,0,0,,,,,9990065,
GLP-2 receptor,250,GLP2R,O95838,,,,,,Human,glucagon-like peptide 2-(3-33),1143,GCG,Human,135651777,Agonist,Partial agonist,,t,,,pIC50,0,7.4,0,,0,0,0,,,,,11738243,
GluA1,444,GRIA1,P42261,,,,,,Human,(<i>S</i>)-5-fluorowillardiine,4070,,,178100893,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](Cn1cc(F)c(=O)[nH]c1=O)N
GluA1,444,GRIA1,P42261,,,,,,Human,CX516,4165,,,178100985,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)nccn2)N1CCCCC1
GluA1,444,GRIA1,P42261,,,,,,Human,CX546,4166,,,178100986,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)OCCO2)N1CCCCC1
GluA1,444,GRIA1,P42261,,,,,,Human,cyclothiazide,4167,,,178100987,Allosteric modulator,Positive,,f,f,,pEC50,0,4.71999979,0,EC50,0,19000,0,=,,,,11406188,Clc1cc2NC(NS(=O)(=O)c2cc1S(=O)(=O)N)C1CC2CC1C=C2
GluA1,444,GRIA1,P42261,,,,,,Human,IDRA-21,4219,,,178101036,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC1Nc2ccc(cc2S(=O)(=O)N1)Cl
GluA1,444,GRIA1,P42261,,,,,,Human,LY392098,4248,,,178101065,Allosteric modulator,Positive,,f,f,,pEC50,0,5.75,0,EC50,0,1770,0,=,,,,11406188,CC(c1ccc(cc1)c1ccccc1F)CNS(=O)(=O)C(C)C
GluA1,444,GRIA1,P42261,,,,,,Human,LY404187,4249,,,178101066,Allosteric modulator,Positive,,f,f,,pEC50,0,5.25,0,EC50,0,5650,0,=,,,,11406188,N#Cc1ccc(cc1)c1ccc(cc1)C(CNS(=O)(=O)C(C)C)C
GluA1,444,GRIA1,P42261,,,,,,Human,LY503430,4251,,,178101068,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)c1ccc(cc1)c1ccc(cc1)[C@](CNS(=O)(=O)C(C)C)(F)C
GluA1,444,GRIA1,P42261,,,,,,Human,piracetam,4288,,,178101105,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)CN1CCCC1=O
GluA1,444,GRIA1,P42261,,,,,,Human,S18986,4304,,,178101121,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=S1(=O)N[C@H]2CCCN2c2c1cccc2
GluA1,444,GRIA1,P42261,,,,,,Human,GYKI53655,4209,,,178101026,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)N1N=C(c2ccc(cc2)N)c2c(CC1C)cc1c(c2)OCO1
GluA1,444,GRIA1,P42261,,,,,,Human,GYKI53784,4210,,,178101027,Antagonist,Antagonist,"active isomer, non-competitive",f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1ccc(cc1)C1=NN=C(Cc2c1cc1OCOc1c2)C
GluA1,444,GRIA1,P42261,,,,,,Human,NBQX,4264,,,178101081,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2c2c1c(ccc2)S(=O)(=O)N
GluA1,444,GRIA1,P42261,,,,,,Human,joro toxin,4229,,,178101046,Channel blocker,None,selective for channels lacking GluA2,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NCCCNCCCCNCCC(=O)NCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N
GluA2,445,GRIA2,P42262,,,,,,Human,(<i>S</i>)-5-fluorowillardiine,4070,,,178100893,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](Cn1cc(F)c(=O)[nH]c1=O)N
GluA2,445,GRIA2,P42262,,,,,,Human,CX516,4165,,,178100985,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)nccn2)N1CCCCC1
GluA2,445,GRIA2,P42262,,,,,,Human,CX546,4166,,,178100986,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)OCCO2)N1CCCCC1
GluA2,445,GRIA2,P42262,,,,,,Human,cyclothiazide,4167,,,178100987,Allosteric modulator,Positive,,f,f,,pEC50,0,5.650000095,0,EC50,0,2240,0,=,,,,11406188,Clc1cc2NC(NS(=O)(=O)c2cc1S(=O)(=O)N)C1CC2CC1C=C2
GluA2,445,GRIA2,P42262,,,,,,Human,IDRA-21,4219,,,178101036,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC1Nc2ccc(cc2S(=O)(=O)N1)Cl
GluA2,445,GRIA2,P42262,,,,,,Human,LY392098,4248,,,178101065,Allosteric modulator,Positive,,f,f,,pEC50,0,6.659999847,0,EC50,0,220,0,=,,,,11406188,CC(c1ccc(cc1)c1ccccc1F)CNS(=O)(=O)C(C)C
GluA2,445,GRIA2,P42262,,,,,,Human,LY404187,4249,,,178101066,Allosteric modulator,Positive,,f,f,,pEC50,0,6.820000172,0,EC50,0,150,0,=,,,,11406188,N#Cc1ccc(cc1)c1ccc(cc1)C(CNS(=O)(=O)C(C)C)C
GluA2,445,GRIA2,P42262,,,,,,Human,LY503430,4251,,,178101068,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)c1ccc(cc1)c1ccc(cc1)[C@](CNS(=O)(=O)C(C)C)(F)C
GluA2,445,GRIA2,P42262,,,,,,Human,piracetam,4288,,,178101105,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)CN1CCCC1=O
GluA2,445,GRIA2,P42262,,,,,,Human,S18986,4304,,,178101121,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=S1(=O)N[C@H]2CCCN2c2c1cccc2
GluA2,445,GRIA2,P42262,,,,,,Human,GYKI53655,4209,,,178101026,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)N1N=C(c2ccc(cc2)N)c2c(CC1C)cc1c(c2)OCO1
GluA2,445,GRIA2,P42262,,,,,,Human,GYKI53784,4210,,,178101027,Antagonist,Antagonist,"active isomer, non-competitive",f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1ccc(cc1)C1=NN=C(Cc2c1cc1OCOc1c2)C
GluA2,445,GRIA2,P42262,,,,,,Human,NBQX,4264,,,178101081,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2c2c1c(ccc2)S(=O)(=O)N
GluA3,446,GRIA3,P42263,,,,,,Human,(<i>S</i>)-5-fluorowillardiine,4070,,,178100893,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](Cn1cc(F)c(=O)[nH]c1=O)N
GluA3,446,GRIA3,P42263,,,,,,Human,CX516,4165,,,178100985,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)nccn2)N1CCCCC1
GluA3,446,GRIA3,P42263,,,,,,Human,CX546,4166,,,178100986,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)OCCO2)N1CCCCC1
GluA3,446,GRIA3,P42263,,,,,,Human,cyclothiazide,4167,,,178100987,Allosteric modulator,Positive,,f,f,,pEC50,0,4.860000134,0,EC50,0,13700,0,=,,,,11406188,Clc1cc2NC(NS(=O)(=O)c2cc1S(=O)(=O)N)C1CC2CC1C=C2
GluA3,446,GRIA3,P42263,,,,,,Human,IDRA-21,4219,,,178101036,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC1Nc2ccc(cc2S(=O)(=O)N1)Cl
GluA3,446,GRIA3,P42263,,,,,,Human,LY392098,4248,,,178101065,Allosteric modulator,Positive,,f,f,,pEC50,0,5.71999979,0,EC50,0,1890,0,=,,,,11406188,CC(c1ccc(cc1)c1ccccc1F)CNS(=O)(=O)C(C)C
GluA3,446,GRIA3,P42263,,,,,,Human,LY404187,4249,,,178101066,Allosteric modulator,Positive,,f,f,,pEC50,0,5.78000021,0,EC50,0,1660,0,=,,,,11406188,N#Cc1ccc(cc1)c1ccc(cc1)C(CNS(=O)(=O)C(C)C)C
GluA3,446,GRIA3,P42263,,,,,,Human,LY503430,4251,,,178101068,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)c1ccc(cc1)c1ccc(cc1)[C@](CNS(=O)(=O)C(C)C)(F)C
GluA3,446,GRIA3,P42263,,,,,,Human,piracetam,4288,,,178101105,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)CN1CCCC1=O
GluA3,446,GRIA3,P42263,,,,,,Human,S18986,4304,,,178101121,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=S1(=O)N[C@H]2CCCN2c2c1cccc2
GluA3,446,GRIA3,P42263,,,,,,Human,GYKI53655,4209,,,178101026,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)N1N=C(c2ccc(cc2)N)c2c(CC1C)cc1c(c2)OCO1
GluA3,446,GRIA3,P42263,,,,,,Human,GYKI53784,4210,,,178101027,Antagonist,Antagonist,"active isomer, non-competitive",f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1ccc(cc1)C1=NN=C(Cc2c1cc1OCOc1c2)C
GluA3,446,GRIA3,P42263,,,,,,Human,NBQX,4264,,,178101081,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2c2c1c(ccc2)S(=O)(=O)N
GluA3,446,GRIA3,P42263,,,,,,Human,joro toxin,4229,,,178101046,Channel blocker,None,selective for channels lacking GluA2,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NCCCNCCCCNCCC(=O)NCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N
GluA4,447,GRIA4,P48058,,,,,,Human,(<i>S</i>)-5-fluorowillardiine,4070,,,178100893,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](Cn1cc(F)c(=O)[nH]c1=O)N
GluA4,447,GRIA4,P48058,,,,,,Human,CX516,4165,,,178100985,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)nccn2)N1CCCCC1
GluA4,447,GRIA4,P48058,,,,,,Human,CX546,4166,,,178100986,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccc2c(c1)OCCO2)N1CCCCC1
GluA4,447,GRIA4,P48058,,,,,,Human,cyclothiazide,4167,,,178100987,Allosteric modulator,Positive,,f,f,,pEC50,0,5.409999847,0,EC50,0,3910,0,=,,,,11406188,Clc1cc2NC(NS(=O)(=O)c2cc1S(=O)(=O)N)C1CC2CC1C=C2
GluA4,447,GRIA4,P48058,,,,,,Human,IDRA-21,4219,,,178101036,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC1Nc2ccc(cc2S(=O)(=O)N1)Cl
GluA4,447,GRIA4,P48058,,,,,,Human,LY392098,4248,,,178101065,Allosteric modulator,Positive,,f,f,,pEC50,0,6.699999809,0,EC50,0,200,0,=,,,,11406188,CC(c1ccc(cc1)c1ccccc1F)CNS(=O)(=O)C(C)C
GluA4,447,GRIA4,P48058,,,,,,Human,LY404187,4249,,,178101066,Allosteric modulator,Positive,,f,f,,pEC50,0,6.679999828,0,EC50,0,210,0,=,,,,11406188,N#Cc1ccc(cc1)c1ccc(cc1)C(CNS(=O)(=O)C(C)C)C
GluA4,447,GRIA4,P48058,,,,,,Human,LY503430,4251,,,178101068,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)c1ccc(cc1)c1ccc(cc1)[C@](CNS(=O)(=O)C(C)C)(F)C
GluA4,447,GRIA4,P48058,,,,,,Human,piracetam,4288,,,178101105,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)CN1CCCC1=O
GluA4,447,GRIA4,P48058,,,,,,Human,S18986,4304,,,178101121,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=S1(=O)N[C@H]2CCCN2c2c1cccc2
GluA4,447,GRIA4,P48058,,,,,,Human,GYKI53655,4209,,,178101026,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC(=O)N1N=C(c2ccc(cc2)N)c2c(CC1C)cc1c(c2)OCO1
GluA4,447,GRIA4,P48058,,,,,,Human,GYKI53784,4210,,,178101027,Antagonist,Antagonist,"active isomer, non-competitive",f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1ccc(cc1)C1=NN=C(Cc2c1cc1OCOc1c2)C
GluA4,447,GRIA4,P48058,,,,,,Human,NBQX,4264,,,178101081,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2c2c1c(ccc2)S(=O)(=O)N
GluA4,447,GRIA4,P48058,,,,,,Human,joro toxin,4229,,,178101046,Channel blocker,None,selective for channels lacking GluA2,f,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,NCCCNCCCCNCCC(=O)NCCCCCNC(=O)[C@@H](NC(=O)Cc1ccc(cc1O)O)CC(=O)N
glucagon receptor,251,GCGR,P47871,,,,,,Human,NNC1702,9760,,,0,Agonist,Agonist,,f,f,,pIC50,0,7.269999981,0,IC50,0,53.5,0,=,,,,29300013,
glucagon receptor,251,GCGR,P47871,,,,,,Human,glucagon,1136,GCG|Gcg|Gcg,Human|Mouse|Rat,135651778,Agonist,Full agonist,,t,t,,pEC50,0,9,0,-,0,0,0,=,,,,4305077,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(=O)N)CCSC)CC(C)C)Cc1c[nH]c2c1cccc2)CCC(=O)N)C(C)C)Cc1ccccc1)CC(=O)O)CCC(=O)N)C)CCCN=C(N)N)CCCN=C(N)N)CO)CC(=O)O)CC(C)C)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)CO)CCC(=O)N)Cc1ccccc1)CO)CC(=O)O)Cc1ccc(cc1)O)CO
glucagon receptor,251,Gcgr,P30082,,,,,,Rat,glucagon-(1-21),1146,,,135652171,Agonist,Full agonist,,f,,,pEC50,0,6,0,,0,0,0,,,,,210180,
glucagon receptor,251,Gcgr,P30082,,,,,,Rat,glucagon-(1-6),1147,,,135652172,Agonist,Partial agonist,,f,,,pEC50,0,4,0,,0,0,0,,,,,216670,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)[C@H](O)C)CCC(=O)N)NC(=O)[C@H](Cc1[nH]cnc1)N
glucagon receptor,251,GCGR,P47871,,,,,,Human,MK-0893,9135,,,315661220,Allosteric modulator,Negative,,f,t,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,,,,22708876,COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl
glucagon receptor,251,GCGR,P47871,,,,,,Human,NNC0640,9574,,,336446960,Allosteric modulator,Negative,,f,f,,pIC50,0,7.159999847,0,IC50,0,69.19999695,0,=,,,,28514451,O=C(N(c1ccc(cc1)C1CCCCC1)Cc1ccc(cc1)C(=O)Nc1n[nH]nn1)Nc1cccc(c1)S(=O)(=O)C
glucagon receptor,251,Gcgr,P30082,,,,,,Rat,des-His<sup>1</sup>-[Glu<sup>9</sup>]glucagon-NH<sub>2</sub>,1150,,,135652112,Antagonist,Antagonist,,f,f,,pA2,0,7.199999809,0,-,0,0,0,=,,,,3035568,
glucagon receptor,251,Gcgr,P30082,,,,,,Rat,des-His<sup>1</sup>-[Leu<sup>4</sup>-Glu<sup>9</sup>]glucagon-NH<sub>2</sub>,1151,,,135652113,Antagonist,Antagonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,11532074,
glucagon receptor,251,GCGR,P47871,,,,,,Human,hGCGR antagonist,1148,,,135650674,Antagonist,Antagonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,15713396,CCC(C(=O)Nc1sc2c(c1C#N)CCC(C2)C(CC)(C)C)CC
glucagon receptor,251,GCGR,P47871,,,,,,Human,hGCGR antagonist,1148,,,135650674,Antagonist,Antagonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,15561959,CCC(C(=O)Nc1sc2c(c1C#N)CCC(C2)C(CC)(C)C)CC
glucagon receptor,251,GCGR,P47871,,,,,,Human,"L-168,049",3505,,,178100492,Antagonist,Antagonist,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.700000048,0,=,,,,10085108,CCCOc1ccc(cc1c1cc([nH]c1c1ccncc1)c1ccc(cc1)Cl)Br
glucagon receptor,251,GCGR,P47871,,,,,,Human,NNC 92-1687,3515,,,53801051,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,9100,0,=,,,,9857085,O=C(c1ccc(c(c1)O)O)CSc1nc2c([nH]1)cccc2
glucagon receptor,251,Gcgr,Q61606,,,,,,Mouse,crotedumab,9614,,,340590244,Antibody,Antagonist,,f,f,,pKd,10.52000046,0,10.05000019,Kd,0.089900002,0,0.0305,=,,,,26020795,
glucagon receptor,251,GCGR,P47871,,,,,,Human,crotedumab,9614,,,340590244,Antibody,Antagonist,,f,t,,pKd,9.960000038,0,9.789999962,Kd,0.162,0,0.108999997,=,,,,26020795,
glucagon receptor,251,Gcgr,P30082,,,,,,Rat,crotedumab,9614,,,340590244,Antibody,Antagonist,,f,f,,pKd,0,10.81999969,0,Kd,0,0.015,0,=,,,,26020795,
glucagon receptor,251,,,,,,,,Monkey,crotedumab,9614,,,340590244,Antibody,Antagonist,,f,f,,pKd,10.52000046,0,9.409999847,Kd,0.386000007,0,0.030300001,=,,,,26020795,
Glucocorticoid receptor,625,Nr3c1,P06537,,,,,,Mouse,corticosterone,2869,,,135651462,Agonist,Agonist,,t,t,,pIC50,0,7.199999809,0,-,0,0,0,=,,,,8282004,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,cortisol,2868,,,53801089,Agonist,Agonist,,t,t,,pIC50,8,0,7.300000191,-,0,0,0,=,,,,8282004,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,deoxycorticosterone,2871,,,135651469,Agonist,Agonist,,t,,,pIC50,0,7.2,0,-,0,0,0,=,,,,8282004,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,desoximetasone,7067,,,178103646,Agonist,Agonist,,f,t,,pKi,0,8.930000305,0,Ki,0,1.169999957,0,=,,,,0,OCC(=O)[C@H]1[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,dexamethasone,2768,,,135651471,Agonist,Agonist,,f,t,,pIC50,9,0,8.100000381,-,0,0,0,=,,,,8282004,OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,diflorasone diacetate,7068,,,178103647,Agonist,Agonist,,f,t,,pKi,0,8.539999962,0,Ki,0,2.910000086,0,=,,,,0,CC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F)C(=O)COC(=O)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,difluprednate,7474,,,187051777,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,21182429,CCCC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F)C(=O)COC(=O)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,flunisolide,7076,,,178103655,Agonist,Agonist,,f,t,,pKi,0,8.619999886,0,Ki,0,2.420000076,0,=,,,,0,OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1C[C@@H](C1=CC(=O)C=C[C@]21C)F)(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluocinolone acetonide,7077,,,178103656,Agonist,Agonist,,f,t,,pIC50,0,8.5,0,IC50,0,3.130000114,0,=,,,,0,OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1C[C@@H](C1=CC(=O)C=C[C@]21C)F)F)(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluocinonide,7078,,,178103657,Agonist,Agonist,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.260000229,0,=,,,,0,CC(=O)OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1C[C@@H](C1=CC(=O)C=C[C@]21C)F)F)(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluorometholone,7079,,,178103658,Agonist,Agonist,,f,t,,pKi,0,8.800000191,0,Ki,0,1.580000043,0,=,,,,0,O=C1C=C[C@]2(C(=C1)[C@@H](C)C[C@@H]1[C@]2(F)[C@@H](O)C[C@]2([C@H]1CC[C@]2(O)C(=O)C)C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluticasone,6699,,,178103310,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,FCSC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluticasone propionate,7080,,,178103659,Agonist,Agonist,,f,f,,pEC50,0,8.050000191,0,EC50,0,9,0,=,,,,28937774,FCSC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fluticasone propionate,7080,,,178103659,Agonist,Agonist,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,Inhibition of [<sup>3</sup>H]dexamethasone binding to recombinant human glucocorticoid receptor  ecpressed in Tni cells.,,,10633034,FCSC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,GSK866,9653,,,340590283,Agonist,Agonist,,f,t,,pIC50,0,8.5,0,IC50,0,3.160000086,0,=,,,,18952422,CCN(C(=O)c1c(Cl)cccc1Cl)C[C@](C(F)(F)F)(CNC(=O)c1cnn(c1N)c1ccc(cc1)F)O
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,mapracorat,9654,,,340590284,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,19422381,Fc1cc2CCOc2c(c1)C(C[C@](C(F)(F)F)(CNc1cccc2c1ccc(n2)C)O)(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,methylprednisolone,7088,,,178103666,Agonist,Agonist,,f,t,,pKi,0,8.300000191,0,Ki,0,5.03000021,0,=,,,,0,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,mometasone,9029,,,315661114,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,ClCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,prednisone,7096,,,178103674,Agonist,Agonist,,f,t,,pKi,0,6.28000021,0,Ki,0,521,0,=,,,,0,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Glucocorticoid receptor,625,,,,,,,,Unknown,RU26988,3446,,,178100446,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2C=CC2=CC(=O)C=C[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,RU28362,3445,,,178100445,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2C=C(C2=CC(=O)C=C[C@]12C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,prednisolone,2866,,,135650850,Agonist,Full agonist,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,Binding to human GR <i>in vitro</i>.,,,29424542,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,prednisolone,2866,,,135650850,Agonist,Full agonist,,f,t,,pIC50,0,7.800000191,0,-,0,0,0,=,,,,10747884,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,dagrocorat,9650,,,340590280,Agonist,Partial agonist,,f,f,,pIC50,0,8.880000114,0,IC50,0,1.309999943,0,=,Measured in a glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay.,,,0,O=C(c1ccc2c(c1)CC[C@H]1[C@]2(CC[C@](C1)(O)C(F)(F)F)Cc1ccccc1)Nc1cccnc1C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,fosdagrocorat,9649,,,340590279,Agonist,Partial agonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,79,0,=,Measured in a glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay.,,,0,O=C(c1ccc2c(c1)CC[C@H]1[C@]2(CC[C@](C1)(OP(=O)(O)O)C(F)(F)F)Cc1ccccc1)Nc1cccnc1C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,mifepristone,2805,,,135650608,Antagonist,Antagonist,,f,t,,pKd,0,9.399999619,0,-,0,0,0,=,,,,8282004,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,onapristone,2882,,,135650760,Antagonist,Antagonist,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,12781198,OCCC[C@@]1(O)CC[C@@H]2[C@@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Glucose-6-phosphate transporter,1168,Slc37a4,,,,,,,Rat,S-4048,8845,,,252827502,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,0,"O=C(/C=C(
1cnc2c1cccn2)/c1ccccc1)O[C@@H]1C[C@@](OC[C@@H]2C[C@@H]2c2ccc(cc2)Cl)(C[C@H]([C@H]1O)O)C(=O)O"
"glucosidase alpha, acid",2611,GAA,P10253,,,,,,Human,miglitol,4842,,,178101544,Inhibitor,Inhibition,,f,t,,pIC50,0,6.460000038,0,IC50,0,350,0,=,,,,18595718,OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
GluK1,450,GRIK1,P39086,,,,,,Human,(<i>S</i>)-5-iodowillardiine,4071,,,178100894,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](Cn1cc(I)c(=O)[nH]c1=O)N
GluK1,450,GRIK1,P39086,,,,,,Human,LY339434,4246,,,178101063,Agonist,Agonist,,f,t,,pKi,7.889999866,0,7.820000172,Ki,15,0,13,=,,,,9849663,OC(=O)C(CC(C(=O)O)N)C/C=C/c1ccc2c(c1)cccc2
GluK1,450,GRIK1,P39086,,,,,,Human,domoic acid,4181,,,178101000,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)O)/C(=CC=C[C@H](C(=O)O)C)/C
GluK1,450,Grik1,P22756,,,,,,Rat,dysiherbaine,4185,,,178101004,Agonist,Full agonist,,f,f,,pKi,0,9.130000114,0,Ki,0,0.74000001,0,=,,,,11160654,CN[C@@H]1[C@H](O)CO[C@H]2[C@@H]1O[C@@](C2)(C[C@@H](C(=O)O)N)C(=O)O
GluK1,450,GRIK1,P39086,,,,,,Human,(<i>S</i>)-4-AHCP,4069,,,178100892,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H](CC1=CCCCc2c1c(O)no2)N
GluK1,450,GRIK1,P39086,,,,,,Human,kainate,4231,,,178101048,Agonist,Full agonist,,f,f,,pKi,0,6.75,0,Ki,0,177,0,=,,,,9849663,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK1,450,GRIK1,P39086,,,,,,Human,LY382884,4247,,,178101064,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1NC[C@H]2[C@@H](C1)C[C@H](CC2)Cc1ccc(cc1)C(=O)O
GluK1,450,GRIK1,P39086,,,,,,Human,LY466195,4250,,,178101067,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C1NCC2C(C1)CC(CC2)CN1CC(CC1C(=O)O)(F)F
GluK1,450,GRIK1,P39086,,,,,,Human,MSVIII-19,4258,,,178101075,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@H](C[C@]1(O[C@H]2[C@@H](C1)OCCC2)C(=O)[O-])[NH3+]
GluK1,450,GRIK1,P39086,,,,,,Human,NS3763,4274,,,178101091,Antagonist,Antagonist,non-competitive,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1ccccc1)Nc1cc(NC(=O)c2ccccc2)c(cc1C(=O)O)C(=O)O
GluK2,451,Grik2,P42260,,,,,,Rat,kainate,4231,,,178101048,Agonist,Agonist,,f,f,,pKi,8.430000305,0,7.840000153,Ki,14.30000019,0,3.700000048,=,Measured using kainic acid in rat forebrain homogenate.,,,8996224,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK2,451,GRIK2,Q13002,,,,,,Human,LY339434,4246,,,178101063,Agonist,Agonist,,f,f,,pKi,4.920000076,0,4.809999943,Ki,15406,0,12040,=,,,,9849663,OC(=O)C(CC(C(=O)O)N)C/C=C/c1ccc2c(c1)cccc2
GluK2,451,GRIK2,Q13002,,,,,,Human,domoic acid,4181,,,178101000,Agonist,Full agonist,,f,f,,pKi,0,7.739999771,0,Ki,0,18.29999924,0,=,Measuring displacement of [<sup>3</sup>H]Kainate binding by domoate.,,,8809152,OC(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)O)/C(=CC=C[C@H](C(=O)O)C)/C
GluK2,451,Grik2,P42260,,,,,,Rat,dysiherbaine,4185,,,178101004,Agonist,Full agonist,,f,f,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,,,,11160654,CN[C@@H]1[C@H](O)CO[C@H]2[C@@H]1O[C@@](C2)(C[C@@H](C(=O)O)N)C(=O)O
GluK2,451,GRIK2,Q13002,,,,,,Human,kainate,4231,,,178101048,Agonist,Full agonist,,f,f,,pKi,7.489999771,0,7.28000021,Ki,53,0,32,=,Measured using kainic acid.,,,8809152,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK3,452,Grik3,P42264,,,,,,Rat,domoic acid,4181,,,178101000,Agonist,Agonist,,f,f,,pKi,0,8.420000076,0,Ki,0,3.839999914,0,=,,,,18578478,OC(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)O)/C(=CC=C[C@H](C(=O)O)C)/C
GluK3,452,GRIK3,Q13003,,,,,,Human,dysiherbaine,4185,,,178101004,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN[C@@H]1[C@H](O)CO[C@H]2[C@@H]1O[C@@](C2)(C[C@@H](C(=O)O)N)C(=O)O
GluK3,452,Grik3,P42264,,,,,,Rat,kainate,4231,,,178101048,Agonist,Full agonist,low potency,f,f,,pKi,0,7.480000019,0,Ki,0,32.79999924,0,=,,,,18578478,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK4,453,GRIK4,Q16099,,,,,,Human,domoic acid,4181,,,178101000,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)O)/C(=CC=C[C@H](C(=O)O)C)/C
GluK4,453,GRIK4,Q16099,,,,,,Human,dysiherbaine,4185,,,178101004,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN[C@@H]1[C@H](O)CO[C@H]2[C@@H]1O[C@@](C2)(C[C@@H](C(=O)O)N)C(=O)O
GluK4,453,GRIK4,Q16099,,,,,,Human,kainate,4231,,,178101048,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK5,454,GRIK5,Q16478,,,,,,Human,domoic acid,4181,,,178101000,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)O)/C(=CC=C[C@H](C(=O)O)C)/C
GluK5,454,GRIK5,Q16478,,,,,,Human,dysiherbaine,4185,,,178101004,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN[C@@H]1[C@H](O)CO[C@H]2[C@@H]1O[C@@](C2)(C[C@@H](C(=O)O)N)C(=O)O
GluK5,454,GRIK5,Q16478,,,,,,Human,kainate,4231,,,178101048,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluN1,455,GRIN1,Q05586,,,,,,Human,D-aspartic acid,6511,,,178103125,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@H](C(=O)O)N
GluN1,455,GRIN1,Q05586,,,,,,Human,D-serine,4171,,,178100991,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,OC[C@H](C(=O)O)N
GluN1,455,GRIN1,Q05586,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,L-aspartic acid,3309,,,135651597,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@@H](C(=O)O)N
GluN1,455,GRIN1,Q05586,,,,,,Human,(<i>RS</i>)-(tetrazol-5-yl)glycine,4068,,,178100891,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C(c1nnn[nH]1)N
GluN1,455,GRIN1,Q05586,,,,,,Human,NMDA,4268,,,178101085,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CN[C@@H](C(=O)O)CC(=O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,(+)-HA966,4066,,,178100889,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C1[C@H](N)CCN1O
GluN1,455,GRIN1,Q05586,,,,,,Human,homoquinolinic acid,4216,,,178101033,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)Cc1cccnc1C(=O)O
GluN1,455,Grin1,P35439,,,,,,Rat,GV196771A,4208,,,178101025,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,8.100000381,Ki,8,0,4,=,Measuring the high affinity binding site for the compound at two different splice variants expressed in HEK293 cells.,glycine site,,10780999,Clc1cc(Cl)c2c(c1)[nH]c(c2/C=C/1CCN(C1=O)c1ccccc1)C(=O)[O-]
GluN1,455,Grin1,P35439,,,,,,Rat,L689560,4239,,,178101056,Antagonist,Antagonist,,f,f,,pIC50,0,8.130000114,0,IC50,0,7.400000095,0,=,Measuring displacement of [<sup>3</sup>H]glycine from rat brain membranes,glycine site,,1534584,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN1,455,Grin1,P35439,,,,,,Rat,L701324,4240,,,178101057,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,"Measuring inhibition of [<sup>3</sup>H]L-689,560 binding to the strychnine-insensitive glycine site on rat brain membranes.",glycine site,,8182696,Clc1ccc2c(c1)[nH]c(c(c2=O)c1cccc(c1)Oc1ccccc1)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,D-aspartic acid,6511,,,178103125,Agonist,Agonist,GluN2D > GluN2C = GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@H](C(=O)O)N
GluN2A,456,GRIN2A,Q12879,,,,,,Human,D-serine,4171,,,178100991,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,OC[C@H](C(=O)O)N
GluN2A,456,GRIN2A,Q12879,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,L-aspartic acid,3309,,,135651597,Agonist,Agonist,GluN2D = GluN2B > GluN2C = GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@@H](C(=O)O)N
GluN2A,456,GRIN2A,Q12879,,,,,,Human,homoquinolinic acid,4216,,,178101033,Agonist,Full agonist,GluN2B &ge; GluN2A &ge; GluN2D > GluN2C; partial agonist at GluN2A and GluN2C,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)Cc1cccnc1C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,(<i>RS</i>)-(tetrazol-5-yl)glycine,4068,,,178100891,Agonist,Full agonist,GluN2D > GluN2C = GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C(c1nnn[nH]1)N
GluN2A,456,GRIN2A,Q12879,,,,,,Human,NMDA,4268,,,178101085,Agonist,Full agonist,GluN2D > GluN2C > GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CN[C@@H](C(=O)O)CC(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,(+)-HA966,4066,,,178100889,Agonist,Partial agonist,GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C1[C@H](N)CCN1O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,d-AP5,4168,,,178100988,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H](CCCP(=O)(O)[O-])N
GluN2A,456,GRIN2A,Q12879,,,,,,Human,d-CCPene,4170,,,178100990,Antagonist,Antagonist,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)C/C=C/P(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,GV196771A,4208,,,178101025,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2/C=C/1CCN(C1=O)c1ccccc1)C(=O)[O-]
GluN2A,456,GRIN2A,Q12879,,,,,,Human,L689560,4239,,,178101056,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2A,456,GRIN2A,Q12879,,,,,,Human,L701324,4240,,,178101057,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1ccc2c(c1)[nH]c(c(c2=O)c1cccc(c1)Oc1ccccc1)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,LY233053,4243,,,178101060,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H]1NCC[C@@H](C1)Cc1nnn[nH]1
GluN2A,456,GRIN2A,Q12879,,,,,,Human,NVP-AAM077,4276,,,178101093,Antagonist,Antagonist,"GluN2A > GluN2B (human), but weakly selective for rat GluN2A versus GluN2B",f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,11909726,Brc1ccc(cc1)[C@@H](N[C@@H](P(=O)(O)O)c1cccc2c1[nH]c(=O)c(=O)[nH]2)C
GluN2A,456,GRIN2A,Q12879,,,,,,Human,selfotel,4155,,,178100976,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@H]1NCC[C@H](C1)CP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,dizocilpine,2403,,,135650617,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[C@]12N[C@@H](c3c2cccc3)Cc2c1cccc2
GluN2A,456,GRIN2A,Q12879,,,,,,Human,ketamine,4233,,,178101050,Channel blocker,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CNC1(CCCCC1=O)c1ccccc1Cl
GluN2A,456,GRIN2A,Q12879,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluN2A,456,GRIN2A,Q12879,,,,,,Human,N<sup>1</sup>-dansyl-spermine,4260,,,178101077,Channel blocker,None,GluN2A = GluN2B >> GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCNCCCCNCCCNS(=O)(=O)c1cccc2c1cccc2N(C)C
GluN2A,456,GRIN2A,Q12879,,,,,,Human,phencyclidine,4282,,,178101099,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C1CCC(CC1)(N1CCCCC1)c1ccccc1
GluN2B,457,GRIN2B,Q13224,,,,,,Human,D-aspartic acid,6511,,,178103125,Agonist,Agonist,GluN2D > GluN2C = GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@H](C(=O)O)N
GluN2B,457,GRIN2B,Q13224,,,,,,Human,D-serine,4171,,,178100991,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,OC[C@H](C(=O)O)N
GluN2B,457,GRIN2B,Q13224,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,L-aspartic acid,3309,,,135651597,Agonist,Agonist,GluN2D = GluN2B > GluN2C = GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@@H](C(=O)O)N
GluN2B,457,GRIN2B,Q13224,,,,,,Human,homoquinolinic acid,4216,,,178101033,Agonist,Full agonist,GluN2B &ge; GluN2A &ge; GluN2D > GluN2C; partial agonist at GluN2A and GluN2C,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)Cc1cccnc1C(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,(<i>RS</i>)-(tetrazol-5-yl)glycine,4068,,,178100891,Agonist,Full agonist,GluN2D > GluN2C = GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C(c1nnn[nH]1)N
GluN2B,457,GRIN2B,Q13224,,,,,,Human,NMDA,4268,,,178101085,Agonist,Full agonist,GluN2D > GluN2C > GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CN[C@@H](C(=O)O)CC(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,(+)-HA966,4066,,,178100889,Agonist,Partial agonist,GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C1[C@H](N)CCN1O
GluN2B,457,Grin2b,Q00960,,,,,,Rat,DQP-1105,7843,,,223366173,Allosteric modulator,Negative,,f,f,,pIC50,0,6.949999809,0,IC50,0,113,0,=,Measured using recombinant GluN1-1a NMDA subunits co-expressed with GluN2C subunits.,,,21807990,OC(=O)CCC(=O)N1N=C(CC1c1ccc(cc1)Br)C1C(=O)N=c2c(=C1c1ccccc1)cc(cc2)C
GluN2B,457,GRIN2B,Q13224,,,,,,Human,d-AP5,4168,,,178100988,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H](CCCP(=O)(O)[O-])N
GluN2B,457,GRIN2B,Q13224,,,,,,Human,d-CCPene,4170,,,178100990,Antagonist,Antagonist,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)C/C=C/P(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,GV196771A,4208,,,178101025,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2/C=C/1CCN(C1=O)c1ccccc1)C(=O)[O-]
GluN2B,457,GRIN2B,Q13224,,,,,,Human,L689560,4239,,,178101056,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2B,457,GRIN2B,Q13224,,,,,,Human,L701324,4240,,,178101057,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1ccc2c(c1)[nH]c(c(c2=O)c1cccc(c1)Oc1ccccc1)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,LY233053,4243,,,178101060,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H]1NCC[C@@H](C1)Cc1nnn[nH]1
GluN2B,457,GRIN2B,Q13224,,,,,,Human,NVP-AAM077,4276,,,178101093,Antagonist,Antagonist,"GluN2A > GluN2B (human), but weakly selective for rat GluN2A versus GluN2B",f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,11909726,Brc1ccc(cc1)[C@@H](N[C@@H](P(=O)(O)O)c1cccc2c1[nH]c(=O)c(=O)[nH]2)C
GluN2B,457,GRIN2B,Q13224,,,,,,Human,selfotel,4155,,,178100976,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@H]1NCC[C@H](C1)CP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,dizocilpine,2403,,,135650617,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[C@]12N[C@@H](c3c2cccc3)Cc2c1cccc2
GluN2B,457,GRIN2B,Q13224,,,,,,Human,ketamine,4233,,,178101050,Channel blocker,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CNC1(CCCCC1=O)c1ccccc1Cl
GluN2B,457,GRIN2B,Q13224,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluN2B,457,GRIN2B,Q13224,,,,,,Human,N<sup>1</sup>-dansyl-spermine,4260,,,178101077,Channel blocker,None,GluN2A = GluN2B >> GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCNCCCCNCCCNS(=O)(=O)c1cccc2c1cccc2N(C)C
GluN2B,457,GRIN2B,Q13224,,,,,,Human,phencyclidine,4282,,,178101099,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C1CCC(CC1)(N1CCCCC1)c1ccccc1
GluN2C,458,GRIN2C,Q14957,,,,,,Human,D-aspartic acid,6511,,,178103125,Agonist,Agonist,GluN2D > GluN2C = GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@H](C(=O)O)N
GluN2C,458,GRIN2C,Q14957,,,,,,Human,D-serine,4171,,,178100991,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,OC[C@H](C(=O)O)N
GluN2C,458,GRIN2C,Q14957,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,L-aspartic acid,3309,,,135651597,Agonist,Agonist,GluN2D = GluN2B > GluN2C = GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@@H](C(=O)O)N
GluN2C,458,GRIN2C,Q14957,,,,,,Human,homoquinolinic acid,4216,,,178101033,Agonist,Full agonist,GluN2B &ge; GluN2A &ge; GluN2D > GluN2C; partial agonist at GluN2A and GluN2C,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)Cc1cccnc1C(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,(<i>RS</i>)-(tetrazol-5-yl)glycine,4068,,,178100891,Agonist,Full agonist,GluN2D > GluN2C = GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C(c1nnn[nH]1)N
GluN2C,458,GRIN2C,Q14957,,,,,,Human,NMDA,4268,,,178101085,Agonist,Full agonist,GluN2D > GluN2C > GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CN[C@@H](C(=O)O)CC(=O)O
GluN2C,458,Grin2c,Q00961,,,,,,Rat,DQP-1105,7843,,,223366173,Allosteric modulator,Negative,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,Measured using recombinant GluN1-1a NMDA subunits co-expressed with GluN2C subunits.,,,21807990,OC(=O)CCC(=O)N1N=C(CC1c1ccc(cc1)Br)C1C(=O)N=c2c(=C1c1ccccc1)cc(cc2)C
GluN2C,458,GRIN2C,Q14957,,,,,,Human,d-AP5,4168,,,178100988,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H](CCCP(=O)(O)[O-])N
GluN2C,458,GRIN2C,Q14957,,,,,,Human,d-CCPene,4170,,,178100990,Antagonist,Antagonist,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)C/C=C/P(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,GV196771A,4208,,,178101025,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2/C=C/1CCN(C1=O)c1ccccc1)C(=O)[O-]
GluN2C,458,GRIN2C,Q14957,,,,,,Human,L689560,4239,,,178101056,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2C,458,GRIN2C,Q14957,,,,,,Human,L701324,4240,,,178101057,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1ccc2c(c1)[nH]c(c(c2=O)c1cccc(c1)Oc1ccccc1)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,LY233053,4243,,,178101060,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H]1NCC[C@@H](C1)Cc1nnn[nH]1
GluN2C,458,GRIN2C,Q14957,,,,,,Human,selfotel,4155,,,178100976,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@H]1NCC[C@H](C1)CP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,dextromethorphan,6953,,,178103535,Channel blocker,None,,f,f,,pIC50,0,6.329999924,0,IC50,0,466,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C
GluN2C,458,GRIN2C,Q14957,,,,,,Human,dextrorphan,9052,,,315661137,Channel blocker,None,,f,f,,pIC50,0,6.940000057,0,IC50,0,114,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,Oc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C
GluN2C,458,GRIN2C,Q14957,,,,,,Human,dizocilpine,2403,,,135650617,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[C@]12N[C@@H](c3c2cccc3)Cc2c1cccc2
GluN2C,458,GRIN2C,Q14957,,,,,,Human,ketamine,4233,,,178101050,Channel blocker,None,,f,t,,pIC50,0,6.179999828,0,IC50,0,660,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,CNC1(CCCCC1=O)c1ccccc1Cl
GluN2C,458,GRIN2C,Q14957,,,,,,Human,levorphanol,7595,,,223365930,Channel blocker,None,,f,f,,pIC50,0,6.21999979,0,IC50,0,601,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,Oc1ccc2c(c1)[C@]13CCCC[C@H]3[C@@H](C2)N(CC1)C
GluN2C,458,GRIN2C,Q14957,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluN2C,458,GRIN2C,Q14957,,,,,,Human,N<sup>1</sup>-dansyl-spermine,4260,,,178101077,Channel blocker,None,GluN2A = GluN2B >> GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCNCCCCNCCCNS(=O)(=O)c1cccc2c1cccc2N(C)C
GluN2C,458,GRIN2C,Q14957,,,,,,Human,phencyclidine,4282,,,178101099,Channel blocker,None,,f,f,,pIC50,0,7.110000134,0,IC50,0,77,0,=,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",,,17303642,C1CCC(CC1)(N1CCCCC1)c1ccccc1
GluN2D,459,GRIN2D,O15399,,,,,,Human,D-aspartic acid,6511,,,178103125,Agonist,Agonist,GluN2D > GluN2C = GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@H](C(=O)O)N
GluN2D,459,GRIN2D,O15399,,,,,,Human,D-serine,4171,,,178100991,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,OC[C@H](C(=O)O)N
GluN2D,459,GRIN2D,O15399,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,GluN2D > GluN2C > GluN2B > GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,L-aspartic acid,3309,,,135651597,Agonist,Agonist,GluN2D = GluN2B > GluN2C = GluN2A,t,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C[C@@H](C(=O)O)N
GluN2D,459,GRIN2D,O15399,,,,,,Human,homoquinolinic acid,4216,,,178101033,Agonist,Full agonist,GluN2B &ge; GluN2A &ge; GluN2D > GluN2C; partial agonist at GluN2A and GluN2C,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)Cc1cccnc1C(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,(<i>RS</i>)-(tetrazol-5-yl)glycine,4068,,,178100891,Agonist,Full agonist,GluN2D > GluN2C = GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C(c1nnn[nH]1)N
GluN2D,459,GRIN2D,O15399,,,,,,Human,NMDA,4268,,,178101085,Agonist,Full agonist,GluN2D > GluN2C > GluN2B > GluN2A,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CN[C@@H](C(=O)O)CC(=O)O
GluN2D,459,Grin2d,Q62645,,,,,,Rat,DQP-1105,7843,,,223366173,Allosteric modulator,Negative,,f,t,,pIC50,0,5.570000172,0,IC50,0,2700,0,=,Measured using recombinant GluN1-1a NMDA subunits co-expressed with GluN2D subunits.,,,21807990,OC(=O)CCC(=O)N1N=C(CC1c1ccc(cc1)Br)C1C(=O)N=c2c(=C1c1ccccc1)cc(cc2)C
GluN2D,459,Grin2d,Q62645,,,,,,Rat,QNZ 46,7845,,,223366175,Allosteric modulator,Negative,,f,t,,pIC50,5.489999771,0,5.409999847,IC50,3900,0,3200,=,Measured using co-expression of recombinant rGluN1 and rGluN2D. IC50 variable between expression cell lines.,,,21389220,COC1=CC2C(=NC(=[N+](C2=O)c2ccc(cc2)C(=O)O)/C=C/c2cccc(c2)[N+](=O)[O-])C=C1
GluN2D,459,GRIN2D,O15399,,,,,,Human,d-AP5,4168,,,178100988,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H](CCCP(=O)(O)[O-])N
GluN2D,459,GRIN2D,O15399,,,,,,Human,d-CCPene,4170,,,178100990,Antagonist,Antagonist,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)C/C=C/P(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,GV196771A,4208,,,178101025,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2/C=C/1CCN(C1=O)c1ccccc1)C(=O)[O-]
GluN2D,459,GRIN2D,O15399,,,,,,Human,L689560,4239,,,178101056,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2D,459,GRIN2D,O15399,,,,,,Human,L701324,4240,,,178101057,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1ccc2c(c1)[nH]c(c(c2=O)c1cccc(c1)Oc1ccccc1)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,LY233053,4243,,,178101060,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@@H]1NCC[C@@H](C1)Cc1nnn[nH]1
GluN2D,459,GRIN2D,O15399,,,,,,Human,selfotel,4155,,,178100976,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)[C@H]1NCC[C@H](C1)CP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,dizocilpine,2403,,,135650617,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[C@]12N[C@@H](c3c2cccc3)Cc2c1cccc2
GluN2D,459,GRIN2D,O15399,,,,,,Human,ketamine,4233,,,178101050,Channel blocker,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CNC1(CCCCC1=O)c1ccccc1Cl
GluN2D,459,GRIN2D,O15399,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,GluN2A = GluN2B > GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GluN2D,459,GRIN2D,O15399,,,,,,Human,N<sup>1</sup>-dansyl-spermine,4260,,,178101077,Channel blocker,None,GluN2A = GluN2B >> GluN2C = GluN2D,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCNCCCCNCCCNS(=O)(=O)c1cccc2c1cccc2N(C)C
GluN2D,459,GRIN2D,O15399,,,,,,Human,phencyclidine,4282,,,178101099,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C1CCC(CC1)(N1CCCCC1)c1ccccc1
Glutamic acid decarboxylase 1,1272,GAD1,Q99259,,,,,,Human,s-allylglycine,5267,,,178101950,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N[C@H](C(=O)O)CC=C
Glutamic acid decarboxylase 2,1273,GAD2,Q05329,,,,,,Human,s-allylglycine,5267,,,178101950,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N[C@H](C(=O)O)CC=C
glutaminyl-peptide cyclotransferase,2411,QPCT,Q16769,,,,,,Human,PBD150,8356,,,252166568,Inhibitor,Inhibition,,f,f,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,16420052,COc1cc(ccc1OC)NC(=S)NCCCn1cncc1
glutathione-disulfide reductase,2613,GSR,P00390,,,,,,Human,oxiglutatione,6835,,,178103441,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,Human,glycine,727,,,135651492,Agonist,Agonist,,t,,,pEC50,4.6,0,4.3,,0,0,0,,,,,8404844,NCC(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,Human,ivermectin,2373,,,135650439,Agonist,Irreversible agonist,,f,,,pEC50,0,6.4,0,,0,0,0,,,,,11278873,CO[C@H]1C[C@H](OC2C(C)/C=C/C=C/3COC4C3(O)[C@@H](C=C([C@H]4O)C)C(=O)O[C@H]3CC(C/C=C/2C)O[C@]2(C3)CCC(C(O2)C(CC)C)C)O[C@H](C1O[C@H]1C[C@H](OC)C([C@@H](O1)C)O)C
Glycine Receptor (All subtypes),428,,,,,,,,Rat,GABA,1067,,,135651489,Agonist,Partial agonist,,f,,,pEC50,1.2,0,0,,0,0,0,,,,,11559772,NCCCC(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,Human,ethanol,2299,,,135651485,Allosteric modulator,Potentiation,Potentiation of weakly activated GlyRs only,f,,10000-200000,-,0,0,0,,0,0,0,,,,,8700149,CCO
Glycine Receptor (All subtypes),428,,,,,,,,Rat,RU5135,2378,,,135650951,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,4007055,O[C@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C(=O)C[C@]2([C@H]1CC(=N2)N)C)C
Glycine Receptor (All subtypes),428,,,,,,,,Human,cyanotriphenylborate,2368,,,135652748,Channel blocker,None,,f,f,<1,pIC50,0,5.900000095,0,-,0,0,0,=,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
Glycine Receptor (All subtypes),428,,,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,,,pIC50,5.3,0,4.6,,0,0,0,,,,,1385113,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
Glycine Receptor (All subtypes),428,,,,,,,,None,cyanotriphenylborate,2368,,,135652748,Subunit-specific,Inhibition,1 > 2,f,f,<1,-,0,0,0,-,0,0,0,=,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
Glycine Receptor (All subtypes),428,,,,,,,,None,dehydroepiandrosterone,2370,,,135651466,Subunit-specific,Inhibition," 1, 2  > 1, 2 ,4",f,,<1,-,0,0,0,,0,0,0,,,,,11522328,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CCC2=O)C)C1)C
Glycine Receptor (All subtypes),428,,,,,,,,None,ginkgolide A,1861,,,135652684,Subunit-specific,Inhibition,2 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,16805834,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,ginkgolide B,1862,,,135652686,Subunit-specific,Inhibition," 1, 2 > 1, 2 ",f,,<0.01,-,0,0,0,,0,0,0,,,,,18221374,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,ginkgolide C,1863,,,135652687,Subunit-specific,Inhibition,"1, 2 > 1, 2 ",f,,<1,-,0,0,0,,0,0,0,,,,,16805834,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)[C@@H]([C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C)O
Glycine Receptor (All subtypes),428,,,,,,,,None,ginkgolide J,1864,,,135652688,Subunit-specific,Inhibition,1 > 1,f,,<1,-,0,0,0,,0,0,0,,,,,18221374,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2)[C@H](OC3=O)[C@@H]([C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C)O
Glycine Receptor (All subtypes),428,,,,,,,,None,HU-210,731,,,135650355,Subunit-specific,Inhibition,"&alpha;3>&alpha;2, no inhibition of &alpha;1",f,,<0.01,pIC50,7.3,0,7.05,,0,0,0,,,,,18755158,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,HU-308,746,,,135650356,Subunit-specific,Inhibition,&alpha;3>&alpha;2>&alpha;1,f,f,<1,pIC50,7,0,6,-,0,0,0,=,,,,18755158,CCCCCCC(c1cc(OC)c(c(c1)OC)[C@H]1C=C(CO)[C@@H]2C[C@H]1C2(C)C)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,NBBCC,2374,,,135650693,Subunit-specific,Inhibition,2  > 2 ,f,,<1,-,0,0,0,,0,0,0,,,,,15722459,CCCCOC(=O)c1ncc2c(c1)c1ccccc1[nH]2
Glycine Receptor (All subtypes),428,,,,,,,,None,picrotoxinin,2291,,,135652708,Subunit-specific,Inhibition,"2, 3 > 1 >> 1, 2 ,3",f,,<1,-,0,0,0,,0,0,0,,,,,1385113,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
Glycine Receptor (All subtypes),428,,,,,,,,None,progesterone,2377,,,135651551,Subunit-specific,Inhibition,"2 > 1, 1 ",f,,<1,-,0,0,0,,0,0,0,,,,,11522328,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,HU-210,731,,,135650355,Subunit-specific,Potentiation,"
&alpha;1 only, no potentiation of &alpha;3 or &alpha;3",f,,<1,pEC50,0,6.57,0,,0,0,0,,,,,18755158,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,NV-31,2375,,,135650750,Subunit-specific,Potentiation," 1 only, no effect on 2, 3",f,,<0.01,-,0,0,0,,0,0,0,,,,,18329806,CC(C1(O)CCS(=O)CC1)(C)C
Glycine Receptor (All subtypes),428,,,,,,,,None,pregnenolone,2376,,,135651548,Subunit-specific,Potentiation,"1 only, no effect on 2, 1 ",f,,<1,-,0,0,0,,0,0,0,,,,,11522328,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2C(=O)C)C)C1)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,Cu<sup>2+</sup>,4164,,,178100984,Allosteric modulator,Inhibition,endogenous; not affected by &beta; subunit co-expression,t,f,,pIC50,5.400000095,0,4.800000191,IC50,15000,0,4000,=,,,,0,
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Allosteric modulator,Inhibition,endogenous,t,f,,-,0,0,0,-,0,0,0,=,,,Extracellular,0,
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Allosteric modulator,Potentiation,~1500% potentiation,f,f,,pEC50,0,5.5,0,EC50,0,3000,0,~,,,,0,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,HU-210,731,,,135650355,Allosteric modulator,Potentiation,,f,f,,pEC50,0,6.599999905,0,EC50,0,270,0,=,,,,0,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,ginkgolide X,4201,,,178101018,Antagonist,Antagonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,760,0,=,,,,0,CC1=C2C=C3O[C@H]4[C@@]5([C@@]3(C[C@@H]2OC1=O)[C@@H](O)C[C@H]5C(C)(C)C)[C@H](C(=O)O4)O
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,HU-308,746,,,135650356,Antagonist,Antagonist,weak inhibition,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCCC(c1cc(OC)c(c(c1)OC)[C@H]1C=C(CO)[C@@H]2C[C@H]1C2(C)C)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,nifedipine,2514,,,53801065,Antagonist,Antagonist,,f,f,,pIC50,0,5.5,0,IC50,0,3300,0,=,,,,0,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,PMBA,4289,,,178101106,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1cccc(c1)c1ccccc1CP(=O)(O)O)N
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Antagonist,Antagonist,,f,f,,pKi,0,5.699999809,0,Ki,0,1900,0,=,,,,0,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,cyanotriphenylborate,2368,,,135652748,Channel blocker,None,,f,f,,pIC50,0,5.900000095,0,IC50,0,1300,0,=,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,,f,f,,pIC50,6.199999809,0,5.099999905,IC50,8000,0,600,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,picrotin,4286,,,178101103,Channel blocker,None,,f,f,,pIC50,0,5.300000191,0,IC50,0,5200,0,=,,,,0,O=C1O[C@@H]2[C@H]([C@H]1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,pIC50,0,5.199999809,0,IC50,0,6300,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,f,,pIC50,0,5.300000191,0,IC50,0,5100,0,=,,,,0,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,Cu<sup>2+</sup>,4164,,,178100984,Allosteric modulator,Inhibition,endogenous,t,f,,pIC50,0,4.800000191,0,IC50,0,17000,0,=,,,,0,
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Allosteric modulator,Potentiation,~230% potentiation,f,f,,pEC50,0,6,0,EC50,0,1000,0,~,,,,0,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,ginkgolide X,4201,,,178101018,Antagonist,Antagonist,,f,f,,pIC50,0,5.599999905,0,IC50,0,2800,0,=,,,,0,CC1=C2C=C3O[C@H]4[C@@]5([C@@]3(C[C@@H]2OC1=O)[C@@H](O)C[C@H]5C(C)(C)C)[C@H](C(=O)O4)O
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,HU-210,731,,,135650355,Antagonist,Antagonist,,f,f,,pIC50,0,7,0,IC50,0,90,0,=,,,,0,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,HU-308,746,,,135650356,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1100,0,=,,,,0,CCCCCCC(c1cc(OC)c(c(c1)OC)[C@H]1C=C(CO)[C@@H]2C[C@H]1C2(C)C)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,PMBA,4289,,,178101106,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1cccc(c1)c1ccccc1CP(=O)(O)O)N
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Antagonist,Antagonist,,f,f,,pKi,0,5.300000191,0,Ki,0,5500,0,=,,,,0,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,cyanotriphenylborate,2368,,,135652748,Channel blocker,None,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,<,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,,f,f,,pIC50,5.400000095,0,4.900000095,IC50,11400,0,3700,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,picrotin,4286,,,178101103,Channel blocker,None,,f,f,,pIC50,0,4.900000095,0,IC50,0,13100,0,=,,,,0,O=C1O[C@@H]2[C@H]([C@H]1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,,f,f,,pIC50,0,5.599999905,0,IC50,0,2300,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,f,,pIC50,0,6.400000095,0,IC50,0,410,0,=,,,,0,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,Cu<sup>2+</sup>,4164,,,178100984,Allosteric modulator,Inhibition,endogenous,t,f,,pIC50,0,5,0,IC50,0,9000,0,=,,,,0,
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Allosteric modulator,Potentiation,~1500% potentiation,f,f,,pEC50,0,5.300000191,0,EC50,0,5000,0,~,,,,0,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,HU-210,731,,,135650355,Antagonist,Antagonist,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,0,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,HU-308,746,,,135650356,Antagonist,Antagonist,,f,f,,pIC50,0,7,0,IC50,0,97,0,=,,,,0,CCCCCCC(c1cc(OC)c(c(c1)OC)[C@H]1C=C(CO)[C@@H]2C[C@H]1C2(C)C)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,nifedipine,2514,,,53801065,Antagonist,Antagonist,,f,f,,pIC50,0,4.5,0,IC50,0,29200,0,=,,,,0,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,,f,f,,pIC50,0,5.699999809,0,IC50,0,1800,0,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,picrotin,4286,,,178101103,Channel blocker,None,,f,f,,pIC50,0,5.199999809,0,IC50,0,6000,0,=,,,,0,O=C1O[C@@H]2[C@H]([C@H]1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,block is weaker when &beta; subunit is co-expressed,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,,f,f,,pIC50,0,6.400000095,0,IC50,0,430,0,=,,,,0,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,ginkgolide X,4201,,,178101018,Antagonist,Antagonist,when co-expressed with the &alpha;2 subunit,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,<,,,,0,CC1=C2C=C3O[C@H]4[C@@]5([C@@]3(C[C@@H]2OC1=O)[C@@H](O)C[C@H]5C(C)(C)C)[C@H](C(=O)O4)O
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,ginkgolide X,4201,,,178101018,Antagonist,Antagonist,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,<,,,,0,CC1=C2C=C3O[C@H]4[C@@]5([C@@]3(C[C@@H]2OC1=O)[C@@H](O)C[C@H]5C(C)(C)C)[C@H](C(=O)O4)O
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,nifedipine,2514,,,53801065,Antagonist,Antagonist,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,5.900000095,0,IC50,0,1200,0,=,,,,0,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,nifedipine,2514,,,53801065,Antagonist,Antagonist,when co-expressed with the &alpha;3 subunit,f,f,,pIC50,0,4.900000095,0,IC50,0,11400,0,=,,,,0,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Antagonist,Antagonist,when co-expressed with the &alpha;1 subunit,f,f,,pKi,0,5.599999905,0,Ki,0,2700,0,=,,,,0,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Antagonist,Antagonist,when co-expressed with the &alpha;2 subunit,f,f,,pKi,0,5,0,Ki,0,10100,0,=,,,,0,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
glycine receptor &beta; subunit,427,Glrb,P20781,,,,,,Rat,cyanotriphenylborate,2368,,,135652748,Channel blocker,None,when co-expressed with the human &alpha;2 subunit,f,f,,pIC50,0,5.099999905,0,IC50,0,7500,0,=,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
glycine receptor &beta; subunit,427,Glrb,P20781,,,,,,Rat,cyanotriphenylborate,2368,,,135652748,Channel blocker,None,when co-expressed with the human &alpha;1 subunit,f,f,,pIC50,0,5.599999905,0,IC50,0,2800,0,=,,,,8090751,N#C[B-](c1ccccc1)(c1ccccc1)c1ccccc1
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,when co-expressed with the &alpha;2 subunit,f,f,,pIC50,6.900000095,0,6.099999905,IC50,800,0,140,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,when co-expressed with the &alpha;3 subunit,f,f,,pIC50,0,6.300000191,0,IC50,0,550,0,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,ginkgolide B,1862,,,135652686,Channel blocker,None,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,6.699999809,0,5.599999905,IC50,2500,0,180,=,,,,0,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotin,4286,,,178101103,Channel blocker,None,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,4.599999905,0,IC50,0,27000,0,=,,,,0,O=C1O[C@@H]2[C@H]([C@H]1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotin,4286,,,178101103,Channel blocker,None,when co-expressed with the &alpha;3 subunit,f,f,,pIC50,0,4.599999905,0,IC50,0,24000,0,=,,,,0,O=C1O[C@@H]2[C@H]([C@H]1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,3.700000048,0,IC50,0,219000,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotoxin,4051,,,178100875,Channel blocker,None,when co-expressed with the &alpha;2 subunit,f,f,,pIC50,0,4.5,0,IC50,0,29700,0,=,,,,0,CC(=C)[C@@H]1C2OC(=O)C1[C@]1([C@]3([C@@H]2OC(=O)[C@]23C(C1)O2)C)O.O=C1OC2[C@H](C1[C@]1(O)C[C@@H]3[C@]4([C@@]1([C@@H]2OC4=O)C)O3)C(O)(C)C
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,when co-expressed with the &alpha;1 subunit,f,f,,pIC50,0,4.599999905,0,IC50,0,27000,0,=,,,,0,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,picrotoxinin,2291,,,135652708,Channel blocker,None,when co-expressed with the &alpha;3 subunit,f,f,,pIC50,0,5.099999905,0,IC50,0,8900,0,=,,,,0,CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1([C@]3([C@@H]2OC(=O)[C@]23[C@@H](C1)O2)C)O
glycogen synthase kinase 3 alpha,2029,,,,,,,,Pig,GSK-3 inhibitor IX,5974,,,178102597,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,GSK3&alpha;/&beta; complex from pig brain,,,14761195,ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
glycogen synthase kinase 3 alpha,2029,,,,,,,,Pig,GSK-3 inhibitor X,5975,,,178102598,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,"Measured using GSK3 as a complex of &alpha; and  &beta; isozymes, isolated from pig brain",,,14761195,CC(=O)ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,SB 216763,8015,,,249565695,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,11033082,Clc1ccc(c(c1)Cl)C1=C(C(=O)NC1=O)c1cn(c2c1cccc2)C
glycogen synthase kinase 3 alpha,2029,GSK3A,P49840,,,,,,Human,SB-415286,8019,,,249565699,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,11033082,O=C1NC(=O)C(=C1Nc1ccc(c(c1)Cl)O)c1ccccc1[N+](=O)[O-]
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,GSK-3&beta; inhibitor 3 [PMID: 25845281],9811,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,<i>In vitro</i> GSK-3&beta; inhibitory activity,,,25845281,COc1nc(sc1C(=O)N)c1ccnc(c1)NC(=O)C1CC1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,GSK-3beta inhibitor I,5977,,,178102600,Inhibitor,Inhibition,,f,t,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,,,,23099099,O=c1sn(c(=O)n1Cc1ccccc1)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,GSK-3beta inhibitor II,5978,,,178102601,Inhibitor,Inhibition,,f,t,,pIC50,0,6.409999847,0,IC50,0,390,0,=,,,,12031334,Ic1cccc(c1)CSc1nnc(o1)c1ccncc1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,GSK-3beta inhibitor VIII,5979,,,178102602,Inhibitor,Inhibition,,f,t,,pKi,0,7.420000076,0,Ki,0,38,0,=,,,,12928438,COc1ccc(cc1)CNC(=O)Nc1ncc(s1)[N+](=O)[O-]
glycogen synthase kinase 3 beta,2030,,,,,,,,Rabbit,GSK-3beta inhibitor XI,5981,,,178102604,Inhibitor,Inhibition,,f,t,,pKi,0,7.599999905,0,Ki,0,25,0,=,,,,15158785,OCCCn1cc(c2c1nccc2)C1=C(C(=O)NC1=O)c1cnccn1
glycogen synthase kinase 3 beta,2030,,,,,,,,Pig,GSK-3 inhibitor IX,5974,,,178102597,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,GSK3&alpha;/&beta; complex from pig brain,,,14761195,ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
glycogen synthase kinase 3 beta,2030,,,,,,,,Pig,GSK-3 inhibitor X,5975,,,178102598,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,"Measured using GSK3 as a complex of &alpha; and  &beta; isozymes, isolated from pig brain",,,14761195,CC(=O)ONC1=c2ccccc2=N/C/1=C/1C(=O)Nc2c1ccc(c2)Br
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,GSK-3 inhibitor XIII,5976,,,178102599,Inhibitor,Inhibition,,f,t,,pKi,0,7.659999847,0,Ki,0,22,0,=,,,,19447622,Cc1[nH]nc(c1)Nc1nc(nc2c1cccc2)c1ccccc1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,IM-12,8017,,,249565697,Inhibitor,Inhibition,,f,t,,pIC50,0,7.28000021,0,IC50,0,53,0,=,,,,20708937,Fc1ccc(cc1)CCNC1=C(C(=O)N(C1=O)C)c1c(C)[nH]c2c1cccc2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,indirubin-3'-monoxime,5989,,,178102611,Inhibitor,Inhibition,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,11013232,ONc1c([nH]c2c1cccc2)C1=c2ccccc2=NC1=O
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,isogranulatimide,5991,,,178102613,Inhibitor,Inhibition,,f,t,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,18077363,O=c1[nH]c(=O)c2c1c1c3ccccc3[nH]c1n1c2cnc1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,kenpaullone,6000,,,178102622,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,11013232,O=C1Nc2ccccc2c2c(C1)c1cc(Br)ccc1[nH]2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,Li<sup>+</sup>,5212,,,178101897,Inhibitor,Inhibition,Competive with Mg2+,f,f,,pIC50,0,2.599999905,0,IC50,0,2500000,0,=,,,,11162580,
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,LY2090314,7958,,,249565641,Inhibitor,Inhibition,,f,t,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,Inhibition of GSK-3&beta;-mediated phosphoryaltion of phosph0-CREB,,,15267232,Fc1cc2CN(CCn3c2c(c1)c(c3)C1=C(C(=O)NC1=O)c1cnc2n1cccc2)C(=O)N1CCCCC1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,SB 216763,8015,,,249565695,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,~,,,,11033082,Clc1ccc(c(c1)Cl)C1=C(C(=O)NC1=O)c1cn(c2c1cccc2)C
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,SB-415286,8019,,,249565699,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,~,,,,11033082,O=C1NC(=O)C(=C1Nc1ccc(c(c1)Cl)O)c1ccccc1[N+](=O)[O-]
GlyT1,935,SLC6A9,P48067,,,,,,Human,GSK931145,4598,,,178101318,Inhibitor,Inhibition,,f,,,pIC50,0,7.6,0,IC50,0,26,0,,,,,0,O=C(c1c(C)cccc1C)N[C@H](C1(CCCC1)N(C)C)c1ccccc1
GlyT1,935,SLC6A9,P48067,,,,,,Human,LY2365109,4712,,,178101423,Inhibitor,Inhibition,,f,,,pIC50,0,7.8,0,IC50,0,16,0,,,,,0,CN(CC(=O)O)CCOc1ccc(cc1C(C)(C)C)c1ccc2c(c1)OCO2
GlyT1,935,SLC6A9,P48067,,,,,,Human,N-methyl-SSR504734,4604,,,178101324,Inhibitor,Inhibition,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,,,,,0,CN1CCCC[C@H]1[C@H](c1ccccc1)NC(=O)c1cccc(c1Cl)C(F)(F)F
GlyT1,935,SLC6A9,P48067,,,,,,Human,PF-03463275,9057,,,315661142,Inhibitor,Inhibition,,f,t,,pKi,0,7.940000057,0,Ki,0,11.60000038,0,=,,,,19410451,CN1C[C@@H]2[C@H](C1)C2CN(C(=O)c1ncn(c1)C)Cc1ccc(c(c1)Cl)F
GlyT1,935,SLC6A9,P48067,,,,,,Human,(R)-NFPS,4618,,,178101336,Inhibitor,Inhibition,,f,,,pIC50,9.1,0,8.5,IC50,3,0,0.8,,,,,0,CN(CC(=O)O)CC[C@H](c1ccc(cc1)F)Oc1ccc(cc1)c1ccccc1
GlyT1,935,SLC6A9,P48067,,,,,,Human,SSR-103800,4778,,,178101480,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,18621075,
GlyT2,936,SLC6A5,Q9Y345,,,,,,Human,Org 25543,4667,,,178101382,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,11495577,COc1cc(cc(c1OCc1ccccc1)OC)C(=O)NCC1(CCCC1)N(C)C
"GM-CSF receptor, &alpha; subunit",1707,CSF2RA,P15509,,,,,,Human,GM-CSF,4942,CSF2,Human,178101640,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
"GM-CSF receptor, &alpha; subunit",1707,CSF2RA,P15509,,,,,,Human,mavrilimumab,7785,,,223366117,Antibody,Binding,,f,t,,pIC50,0,9.859999657,0,IC50,0,0.138999999,0,=,,,,0,
GnRH<sub>1</sub> receptor,256,Gnrhr,Q01776,,,,,,Mouse,"[des-Gly<sup>10</sup>,<small>D</small>-Ala<sup>6</sup>]GnRH <i>N</i>-ethylamide",1174,,,135652111,Agonist,Full agonist,,f,,,pIC50,0,9.9,0,,0,0,0,,,,,1328228,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,deslorelin,9343,,,328083446,Agonist,Full agonist,,f,f,,pKi,10,0,9.100000381,Ki,0.800000012,0,0.100000001,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,deslorelin,9343,,,328083446,Agonist,Full agonist,,f,f,,pKd,10,0,9.399999619,Kd,0.400000006,0,0.100000001,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[D-Lys<sup>6</sup>]GnRH-II,5581,,,178102216,Agonist,Full agonist,,f,,,pIC50,0,7.59,0,IC50,0,26,0,=,,,,19638591,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,fertirelin,9341,,,328083444,Agonist,Full agonist,,f,f,,pKd,9.100000381,0,9.050000191,Kd,0.899999976,0,0.800000012,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,fertirelin,9341,,,328083444,Agonist,Full agonist,,f,f,,pKi,9.149999619,0,9,Ki,1,0,0.699999988,=,,,,26398856,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[Gln<sup>8</sup>]GnRH,1169,,,135652169,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,17452338,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pKd,8.539999962,0,7.659999847,Kd,22,0,2.900000095,=,,,,26398856,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,Gnrhr,Q01776,,,,,,Mouse,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,,,pIC50,0,8.3,0,,0,0,0,,,,,1328228,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,Gnrhr,Q01776,,,,,,Mouse,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pEC50,7.920000076,0,7.769999981,EC50,17,0,12,=,,,,26774084,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,,,pIC50,0,7.7,0,,0,0,0,,,,,8013367,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pKi,8.399999619,0,7.889999866,Ki,13,0,4,=,,,,26398856,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,,,pKi,0,6.8,0,-,0,0,0,=,,,,11726197,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pEC50,0,10,0,EC50,0,0.100000001,0,=,,,,26774084,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,,,pKi,8.4,0,7.3,-,0,0,0,=,,,,11726197,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pIC50,0,8.600000381,0,-,0,0,0,=,,,,17452338,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH II,1164,GNRH2,Human,135651780,Agonist,Full agonist,,t,f,,pIC50,7.900000095,0,7.099999905,-,0,0,0,=,,,,17452338,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,GnRH III,3878,,,178100714,Agonist,Full agonist,,f,,,pKd,0,8.2,0,Kd,0,6.3,0,=,,,,17254668,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,goserelin,3879,,,178100715,Agonist,Full agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)CCCN=C(N)N)CC(C)C)COC(C)(C)C)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"[His<sup>5</sup>,<small>D</small>-Tyr<sup>6</sup>]GnRH",1170,,,135652186,Agonist,Full agonist,,f,,,pKi,8.4,0,7.8,,0,0,0,,,,,17095587,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,histerelin,9344,,,328083447,Agonist,Full agonist,,f,f,,pKi,9.699999809,0,8.720000267,Ki,1.899999976,0,0.200000003,=,,,,26398856,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,histerelin,9344,,,328083447,Agonist,Full agonist,,f,f,,pKd,10.39999962,0,9,Kd,1,0,0.039999999,=,,,,26398856,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,histrelin,3884,,,178100720,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ncn(c1)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,leuprolide,1175,,,135652260,Agonist,Full agonist,,f,t,,pKi,9.100000381,0,8.5,Ki,3.160000086,0,0.790000021,=,,,,17095587,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,leuprolide,1175,,,135652260,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,-,0,0,0,=,,,,8013367,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CC(C)C)CCCN=C(N)N
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,nafarelin,3902,,,178100736,Agonist,Full agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[Ser<sup>8</sup>]GnRH,1171,,,135652461,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,17452338,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,FD-1,1182,,,135650254,Allosteric modulator,Negative,,f,,,pIC50,0,5.3,0,,0,0,0,,,,,18344315,COc1nc(OC)c(c(n1)OC)NC(=O)c1ccc(o1)Oc1cc2c(cc1C)C(C)(C)C(CC2(C)C)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,cyclorelix,1191,,,135652073,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9300077,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,D-23487,1180,,,135652078,Antagonist,Antagonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9300077,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,D-24710,1181,,,135652079,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9300077,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,degarelix,5585,,,178102220,Antagonist,Antagonist,,f,t,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,,,,21188095,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)Cc1ccc(cc1)NC(=O)N)Cc1ccc(cc1)NC(=O)[C@@H]1CC(=O)NC(=O)N1)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,elagolix,8362,,,252166574,Antagonist,Antagonist,,f,t,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,19006286,COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,FD-1,1182,,,135650254,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,18344315,COc1nc(OC)c(c(n1)OC)NC(=O)c1ccc(o1)Oc1cc2c(cc1C)C(C)(C)C(CC2(C)C)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,ganirelix,3877,,,178100713,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCNC(=NCCCC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCCC1C(=O)N[C@@H](C(=O)N)C)CCCCN=C(NCC)NCC)CC(C)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C(Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1)CO)Cc1ccc(cc1)O)NCC
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,IN-3,5584,,,178102219,Antagonist,Antagonist,,f,,,pIC50,0,9.22,0,IC50,0,0.6,0,=,,,,11551758,Cc1cc(C)cc(c1)c1[nH]c2c(c1[C@@H](CNCCc1ccncc1)C)cc(cc2)C(C(=O)N1CC2CCC1CC2)(C)C
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,IN-3,5584,,,178102219,Antagonist,Antagonist,,f,,,pIC50,0,8.77,0,IC50,0,1.7,0,=,,,,11551758,Cc1cc(C)cc(c1)c1[nH]c2c(c1[C@@H](CNCCc1ccncc1)C)cc(cc2)C(C(=O)N1CC2CCC1CC2)(C)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,iturelix,3854,,,178100693,Antagonist,Antagonist,,f,,,pIC50,0,8.98,0,IC50,0,1.05,0,=,,,,11861490,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)CCCCNC(=O)c1cccnc1)CCCCNC(=O)c1cccnc1)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,iturelix,3854,,,178100693,Antagonist,Antagonist,,f,,,pKi,0,9.46,0,Ki,0,0.35,0,=,,,,1850267,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)CCCCNC(=O)c1cccnc1)CCCCNC(=O)c1cccnc1)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,NBI-42902,1178,,,135650694,Antagonist,Antagonist,,f,,,pKi,9.3,0,9,,0,0,0,,,,,17095587,COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)N)c(=O)n(c1C)Cc1c(F)cccc1F
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,NBI-42902,1178,,,135650694,Antagonist,Antagonist,,f,,,pKi,9.5,0,9.1,,0,0,0,,,,,17095587,COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)N)c(=O)n(c1C)Cc1c(F)cccc1F
GnRH<sub>2</sub> receptor,257,,,,,,,,Monkey,GnRH I,1162,GNRH1|Gnrh1|Gnrh1,Human|Mouse|Rat,135651779,Agonist,Full agonist,,t,f,,pIC50,0,7.369999886,0,IC50,0,42.59999847,0,=,,,,11493674,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1
GnRH<sub>2</sub> receptor,257,,,,,,,,Monkey,GnRH II,1164,GNRH2,Human,135651780,Agonist,Full agonist,,t,f,,pIC50,0,8.970000267,0,IC50,0,1.070000052,0,=,,,,11493674,
GPBA receptor,37,Gpbar1,Q80SS6,,,,,,Mouse,S-EMCA,7048,,,178103627,Agonist,Agonist,,f,f,,pEC50,0,6.090000153,0,-,0,0,0,=,,,,20014870,CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@@H]([C@@]3(C)[C@H](C[C@@H]2[C@@]2([C@H]1C[C@H](O)CC2)C)O)[C@@H](C[C@@H](C(=O)O)C)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,deoxycholic acid,610,,,135651468,Agonist,Full agonist,,t,,,pEC50,0,6.2,0,-,0,0,0,=,,,,12419312,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,lithocholic acid,611,,,135651505,Agonist,Full agonist,,t,,,pEC50,0,7.5,0,,0,0,0,,,,,12419312,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
GPBA receptor,37,GPBAR1,Q8TDU6,,,,,,Human,oleanolic acid,3306,,,178100342,Agonist,Full agonist,,f,,,pEC50,0,5.65,0,EC50,0,2250,0,=,,,,17825251,O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2CC=C2[C@@]1(C)CC[C@@]1([C@H]2CC(C)(C)CC1)C(=O)O)C)C
GPER,221,GPER1,Q99527,,,,,,Human,fulvestrant,1015,,,135650370,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,15539556,O=S(CCCC(C(F)(F)F)(F)F)CCCCCCCCC[C@@H]1Cc2cc(O)ccc2[C@@H]2[C@@H]1[C@@H]1CC[C@@H]([C@]1(CC2)C)O
GPER,221,GPER1,Q99527,,,,,,Human,G1,1014,,,135650294,Agonist,Full agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,16520733,CC(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@@H](N2)c1cc2OCOc2cc1Br
GPER,221,GPER1,Q99527,,,,,,Human,raloxifene,2820,,,135650883,Agonist,Full agonist,,f,f,,pKi,0,7,0,-,0,0,0,=,,,,24379833,Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O
GPER,221,GPER1,Q99527,,,,,,Human,G15,3320,,,178100354,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,199,0,=,,,,19430488,Brc1cc2OCOc2cc1[C@@H]1Nc2ccccc2[C@H]2[C@@H]1CC=C2
GPER,221,GPER1,Q99527,,,,,,Human,G36,6480,,,178103094,Antagonist,Antagonist,,f,f,,pIC50,6.949999809,0,6.78000021,IC50,165,0,112,=,,,,21782022,CC(c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@@H](N2)c1cc2OCOc2cc1Br)C
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,glycine,727,,,135651492,Agonist,Full agonist,,t,,,pEC50,0,3.6,0,,0,0,0,,,,,15576628,NCC(=O)O
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-alanine,720,,,135651498,Agonist,Full agonist,,t,,,pEC50,0,3.8,0,,0,0,0,,,,,15576628,C[C@@H](C(=O)O)N
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-arginine,721,,,135651500,Agonist,Full agonist,,t,,,pEC50,0,4.4,0,,0,0,0,,,,,15576628,OC(=O)[C@H](CCCN=C(N)N)N
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-citrulline,722,,,135650512,Agonist,Full agonist,,t,,,pEC50,0,3.6,0,,0,0,0,,,,,15576628,NC(=O)NCCC[C@@H](C(=O)O)N
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-glutamine,723,,,135651502,Agonist,Full agonist,,t,,,pEC50,0,3.2,0,,0,0,0,,,,,15576628,NC(=O)CC[C@@H](C(=O)O)N
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-lysine,724,,,135651507,Agonist,Full agonist,,t,,,pEC50,0,3.8,0,,0,0,0,,,,,15576628,NCCCC[C@@H](C(=O)O)N
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-ornithine,725,,,135651508,Agonist,Full agonist,,t,,,pEC50,0,4,0,,0,0,0,,,,,15576628,N[C@H](C(=O)O)CCCN
GPRC6 receptor,55,GPRC6A,Q5T6X5,,,,,,Human,L-serine,726,,,135651510,Agonist,Full agonist,,t,,,pEC50,0,3.2,0,,0,0,0,,,,,15576628,OC[C@@H](C(=O)O)N
GPRC6 receptor,55,Gprc6a,Q8K4Z6,,,,,,Mouse,NPS 2143,716,,,135650739,Allosteric modulator,Negative,,f,f,,pIC50,0,5,0,IC50,0,10000,0,~,This is an inferred IC50 based on 10&micro;M of the compound inhibiting maximum L-ornithine-induced activation of GPCR6 by approximately 50% (see Fig 1B in reference).,,,19836834,N#Cc1c(cccc1Cl)OC[C@@H](CNC(Cc1ccc2c(c1)cccc2)(C)C)O
G protein subunit alpha q,2914,,,,,,,,Hamster,FR900359,9336,,,318164855,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,0,CCC(=O)N[C@@H]([C@@H](C(C)C)O)C(=O)O[C@@H]([C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@H](C)NC(=O)C(=C)N(C)C(=O)[C@H](OC(=O)[C@H]([C@H](OC(=O)[C@@H](N(C1=O)C)[C@H](OC)C)C(C)C)NC(=O)C)Cc1ccccc1)C(C)C
Granulocyte colony-stimulating factor receptor,1719,CSF3R,Q99062,,,,,,Human,G-CSF,4934,CSF3,Human,178101632,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Granulocyte colony-stimulating factor receptor,1719,CSF3R,Q99062,,,,,,Human,pegfilgrastim,6969,,,178103549,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
Granulocyte macrophage colony-stimulating factor receptor,2309,CSF2RB|CSF2RA,P32927|P15509,,,,,,Human,G-CSF,4934,CSF3,Human,178101632,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Granulocyte macrophage colony-stimulating factor receptor,2309,CSF2RB|CSF2RA,P32927|P15509,,,,,,Human,GM-CSF,4942,CSF2,Human,178101640,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth/differentiation factor receptors,2587,BMPR1A|BMPR1B|ACVR1B|ACVR2A|ACVR2B|TGFBR1|ACVR1C|BMPR2,O00238|P27037|P36894|P36896|P36897|Q13705|Q13873|Q8NER5,,,,,,Human,growth/differentiation factor-1,4936,GDF1,Human,178101634,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth/differentiation factor receptors,2587,BMPR1A|BMPR1B|ACVR1B|ACVR2A|ACVR2B|TGFBR1|ACVR1C|BMPR2,O00238|P27037|P36894|P36896|P36897|Q13705|Q13873|Q8NER5,,,,,,Human,growth/differentiation factor-10,4937,GDF10,Human,178101635,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth/differentiation factor receptors,2587,BMPR1A|BMPR1B|ACVR1B|ACVR2A|ACVR2B|TGFBR1|ACVR1C|BMPR2,O00238|P27037|P36894|P36896|P36897|Q13705|Q13873|Q8NER5,,,,,,Human,growth/differentiation factor-3,4938,GDF3,Human,178101636,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth/differentiation factor receptors,2587,BMPR1A|BMPR1B|ACVR1B|ACVR2A|ACVR2B|TGFBR1|ACVR1C|BMPR2,O00238|P27037|P36894|P36896|P36897|Q13705|Q13873|Q8NER5,,,,,,Human,growth/differentiation factor-7,4877,GDF7,Human,178101577,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Growth/differentiation factor receptors,2587,BMPR1A|BMPR1B|ACVR1B|ACVR2A|ACVR2B|TGFBR1|ACVR1C|BMPR2,O00238|P27037|P36894|P36896|P36897|Q13705|Q13873|Q8NER5,,,,,,Human,growth/differentiation factor-9,4939,GDF9,Human,178101637,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth hormone receptor,1720,GHR,P10912,,,,,,Human,growth hormone 1,4943,GH1,Human,178101641,Agonist,Agonist,,t,t,,-,0,0,0,-,0,0,0,=,,,,0,
Growth hormone receptor,1720,GHR,P10912,,,,,,Human,growth hormone 2,4944,GH2,Human,178101642,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Growth hormone receptor,1720,GHR,P10912,,,,,,Human,pegvisomant,7485,,,187051788,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,10770982,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,<i>Dendroaspis</i> natriuretic peptide,9070,,,315661155,Agonist,Agonist,,f,f,,pKd,0,9.699999809,0,Kd,0,0.200000003,0,=,Binding affinity for the iodinated peptide.,,,16778132,
Guanylyl cyclase-A,1747,Npr1,P18910,,,,,,Rat,PL-3994,9067,,,315661152,Agonist,Agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,23154072,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,PL-3994,9067,,,315661152,Agonist,Agonist,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,23154072,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,sANP,5053,,,178101748,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8700153,
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,HS142-1,4952,,,178101650,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,1674870,
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,isosorbide dinitrate,7051,,,178103630,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O[N+](=O)[O-]
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,isosorbide mononitrate,7052,,,178103631,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,latanoprostene bunod,9635,,,340590265,Activator,Activation,,f,f,,pEC50,0,5.039999962,0,EC50,0,9200,0,=,Activation of NO-mediated cGMP formation in HEK293 cells.,,,21396362,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)OCCCCO[N+](=O)[O-])O
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,Gucy1a3|Gucy1b3,P19686|P20595,,,,,,Rat,latanoprostene bunod,9635,,,340590265,Activator,Activation,,f,f,,pEC50,0,5.800000191,0,EC50,0,1600,0,=,Activation of NO-mediated cGMP formation in PC12 cells.,,,21396362,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)OCCCCO[N+](=O)[O-])O
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,nitroglycerin,7053,,,178103632,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)OC(CO[N+](=O)[O-])CO[N+](=O)[O-]
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,NO,2509,,,178100228,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,riociguat,5257,,,178101941,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,11242081,COC(=O)N(c1c(N)nc(nc1N)c1nn(c2c1cccn2)Cc1ccccc1F)C
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,,,,,,,,Bovine,NS 2028,6554,,,178103168,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,-,0,0,0,=,,,,9489619,Brc1ccc2c(c1)n1c(CO2)noc1=O
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,ODQ,5234,,,178101918,Inhibitor,Inhibition,,f,f,,pIC50,0,7.5,0,IC50,0,31.60000038,0,=,,,,7544433,O=c1onc2n1c1ccccc1nc2
"Guanylyl cyclase, &alpha;<sub>2</sub>&beta;<sub>1</sub>",2897,GUCY1B1|GUCY1A2,P33402|Q02153,,,,,,Human,riociguat,5257,,,178101941,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,11242081,COC(=O)N(c1c(N)nc(nc1N)c1nn(c2c1cccn2)Cc1ccccc1F)C
"Guanylyl cyclase, &alpha;<sub>2</sub>&beta;<sub>1</sub>",2897,GUCY1B1|GUCY1A2,P33402|Q02153,,,,,,Human,ODQ,5234,,,178101918,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=c1onc2n1c1ccccc1nc2
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,HS142-1,4952,,,178101650,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,1674870,
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,peptide P19 [PMID: 15652659],9163,,,315661246,Antagonist,Antagonist,,f,f,,pKd,0,7.809999943,0,-,0,0,0,=,,,,15652659,
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,"[Ser<sup>11</sup>](N-CNP,C-ANP)pBNP<sup>2-15</sup>",4853,,,178101554,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,15652659,
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,C-type natriuretic peptide,4896,NPPC,Human,178101596,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,1309330,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,<i>E. coli</i> heat-stable enterotoxin (ST<sub>a</sub>),4854,,,178101555,Agonist,Agonist,,f,f,,pKi,0,8.800000191,0,Ki,0,1.570000052,0,=,Competitive-inhibition of [<sup>125</sup>I]-STa binding to T84 colorectal carcinoma cells,,,20863829,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,linaclotide,5017,,,178101714,Agonist,Agonist,,f,t,,pKi,0,8.909999847,0,Ki,0,1.24000001,0,=,Competitive-inhibition of [<sup>125</sup>I]-STa binding to T84 colorectal carcinoma cells,,,17694454,
Guanylyl cyclase-C,1750,Gucy2c,P23897,,,,,,Rat,linaclotide,5017,,,178101714,Agonist,Agonist,,f,f,,pKi,0,8.380000114,0,Ki,0,4.199999809,0,=,Competitive-inhibition of [<sup>125</sup>I]-STa binding to rat intestinal mucosa,,,20863829,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,plecanatide,9069,,,315661154,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,23625291,OC(=O)CC[C@@H]1NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(C)C)CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@H](O)C)C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CC(=O)N)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)N)CC(=O)O)CCC(=O)O
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,indusatumab vedotin,8718,,,252827376,Antibody,Binding,,f,t,,pKd,0,9.869999886,0,Kd,0,0.136000007,0,=,Binding of the unconjugated parent antibody to human GUCY2C.,,,0,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,guanylin,4945,GUCA2A,Human,178101643,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Guanylyl cyclase-E,2031,GUCY2D,Q02846,,,,,,Human,Guanylyl cyclase-activating protein 1,9164,GUCA1A|Guca1a|Guca1a,Human|Mouse|Rat,315661247,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Guanylyl cyclase-E,2031,GUCY2D,Q02846,,,,,,Human,Guanylyl cyclase-activating protein 2,9165,GUCA1B|Guca1b|Guca1b,Human|Mouse|Rat,315661248,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Guanylyl cyclase-F,2899,GUCY2F,P51841,,,,,,Human,Guanylyl cyclase-activating protein 1,9164,GUCA1A|Guca1a|Guca1a,Human|Mouse|Rat,315661247,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Guanylyl cyclase-F,2899,GUCY2F,P51841,,,,,,Human,Guanylyl cyclase-activating protein 2,9165,GUCA1B|Guca1b|Guca1b,Human|Mouse|Rat,315661248,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,nicotinic acid,1588,,,135651525,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,12522134,OC(=O)c1cccnc1
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,&gamma;-hydroxybutyric acid,4711,,,178101422,Agonist,Full agonist,,f,,,pEC50,0,1.82,0,EC50,0,15300000,0,=,,,,19047060,OCCCC(=O)O
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,L-lactic acid,2932,,,135651506,Agonist,Full agonist,,t,,,pEC50,2.89,0,1.3,-,0,0,0,=,,,,18952058,OC(=O)[C@@H](O)C
HCA<sub>1</sub> receptor,311,Hcar1,Q8C131,,,,,,Mouse,L-lactic acid,2932,,,135651506,Agonist,Full agonist,,t,,,pEC50,2.82,0,2.17,-,0,0,0,=,,,,19047060,OC(=O)[C@@H](O)C
HCA<sub>1</sub> receptor,311,HCAR1,Q9BXC0,,,,,,Human,D-lactic acid,2934,,,135651476,Agonist,Partial agonist,,f,,,pEC50,0,2.52,0,-,0,0,0,=,,,,18952058,OC(=O)[C@H](O)C
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,GSK256073,8470,,,252166680,Agonist,Agonist,,f,f,,pEC50,0,7.5,0,-,0,0,0,=,,,,25773497,CCCCCn1c(=O)[nH]c(=O)c2c1nc([nH]2)Cl
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,SCH 900271,8469,,,252166679,Agonist,Agonist,,f,f,,pEC50,0,8.699999809,0,-,0,0,0,=,,,,24900372,O=c1cc(CCCC2(C)CC2)c2c(o1)[nH]c(=O)[nH]c2=O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,MK 1903,5785,,,178102410,Agonist,Full agonist,,f,f,,pEC50,0,7.559999943,0,EC50,0,27.5,0,=,,,,22435740,OC(=O)c1n[nH]c2c1CC1C2C1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,MK 6892,5788,,,178102413,Agonist,Full agonist,,f,f,,pEC50,0,7.800000191,0,EC50,0,16,0,=,,,,20184326,Oc1ccc(nc1)c1noc(n1)CC(C(=O)NC1=C(CCCC1)C(=O)O)(C)C
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,MK 6892,5788,,,178102413,Agonist,Full agonist,,f,,,pKi,0,8.4,0,Ki,0,4,0,=,,,,20184326,Oc1ccc(nc1)c1noc(n1)CC(C(=O)NC1=C(CCCC1)C(=O)O)(C)C
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,monomethyl fumarate,5786,,,178102411,Agonist,Full agonist,,f,f,,pEC50,0,5.03000021,0,EC50,0,9400,0,=,,,,18722346,COC(=O)/C=C/C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,monomethyl fumarate,5786,,,178102411,Agonist,Full agonist,,f,,,pKi,0,6.74,0,Ki,0,180,0,=,,,,21167710,COC(=O)/C=C/C(=O)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,nicotinic acid,1588,,,135651525,Agonist,Full agonist,,f,f,,pEC50,7.199999809,0,6,EC50,1000,0,63.09999847,=,,,,12522134,OC(=O)c1cccnc1
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,para-coumaric acid,5787,,,178102412,Agonist,Full agonist,,f,,,pEC50,0,3.51,0,EC50,0,310000,0,=,,,,19136666,OC(=O)/C=C/c1ccc(cc1)O
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,MK 0354,5784,,,178102409,Agonist,Partial agonist,,f,,,pEC50,0,5.78,0,EC50,0,1650,0,=,,,,18665582,n1[nH]nc(n1)c1n[nH]c2c1CCC2
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,D-kynurenine,5799,,,178102424,Agonist,Full agonist,,f,,,pEC50,0,5.58,0,EC50,0,2610,0,=,,,,19237584,OC(=O)[C@@H](CC(=O)c1ccccc1N)N
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,D-phenylalanine,5797,,,178102422,Agonist,Full agonist,,f,,,pEC50,0,5.04,0,EC50,0,9020,0,=,,,,19237584,N[C@@H](C(=O)O)Cc1ccccc1
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,D-tryptophan,5798,,,178102423,Agonist,Full agonist,,f,,,pEC50,0,5.01,0,EC50,0,9720,0,=,,,,19237584,OC(=O)[C@@H](Cc1c[nH]c2c1cccc2)N
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,IBC 293,1597,,,135649667,Agonist,Full agonist,,f,f,,pEC50,0,6.400000095,0,EC50,0,398,0,=,,,,16480258,OC(=O)c1ccc2c(c1)nnn2C(C)C
HCA<sub>3</sub> receptor,313,HCAR3,P49019,,,,,,Human,nicotinic acid,1588,,,135651525,Agonist,Full agonist,,f,,,pEC50,6.52,0,4,-,0,0,0,=,,,,12522134,OC(=O)c1cccnc1
"HCK proto-oncogene, Src family tyrosine kinase",2032,HCK,P08631,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"HCK proto-oncogene, Src family tyrosine kinase",2032,HCK,P08631,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"HCK proto-oncogene, Src family tyrosine kinase",2032,HCK,P08631,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
HCN1,400,Hcn1,O88704,,,,,,Mouse,cyclic AMP,2352,,,135651452,Activator,Agonist,,t,f,,pKd,0,7.199999809,0,-,0,0,0,=,,,,11331358,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
HCN1,400,HCN1,O60741,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pIC50,0,3.700000048,0,IC50,0,201,0,=,,,,16043489,
HCN1,400,HCN1,O60741,,,,,,Human,ivabradine,2357,,,135650438,Channel blocker,Antagonist,,f,f,,pIC50,0,5.699999809,0,IC50,0,2250,0,=,,,,16387796,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN1,400,Hcn1,O88704,,,,,,Mouse,ivabradine,2357,,,135650438,Channel blocker,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,16484306,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN1,400,Hcn1,O88704,,,,,,Mouse,MEL57A,6260,,,178102880,Channel blocker,None,,f,,,pEC50,0,6.49,0,EC50,0,320,0,=,,,,22091830,COc1cc(ccc1OC)[C@H](CN(C/C=CCN1C=Cc2c(CC1=O)cc(c(c2)OC)OC)C/C=CCN1C=Cc2c(CC1=O)cc(c(c2)OC)OC)C
HCN1,400,Hcn1,O88704,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,,,pIC50,0,3.3,0,-,0,0,0,=,,,,18579800,
HCN1,400,Hcn1,O88704,,,,,,Mouse,propofol,5464,,,178102114,Channel blocker,None,,f,,,pIC50,0,5.2,0,-,0,0,0,=,,,,16033909,CC(c1cccc(c1O)C(C)C)C
HCN2,401,Hcn2,O88703,,,,,,Mouse,cyclic AMP,2352,,,135651452,Activator,Agonist,,t,,,pKi,0,6.3,0,,0,0,0,,,,,9634236,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
HCN2,401,Hcn2,O88703,,,,,,Mouse,cyclic GMP,2347,,,135651454,Activator,Agonist,,t,,,pKi,0,5.2,0,,0,0,0,,,,,9634236,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
HCN2,401,Hcn2,O88703,,,,,,Mouse,cyclic CMP,6261,,,178102881,Activator,None,,f,,,pEC50,0,4.52,0,EC50,0,30000,0,=,,,,22715094,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1ccc(nc1=O)N
HCN2,401,Hcn2,O88703,,,,,,Mouse,PIP<sub>2</sub>,2387,,,135651544,Activator,None,,f,,,pEC50,0,4.96,0,EC50,0,10900,0,=,,,,17074978,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
HCN2,401,HCN2,Q9UL51,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pIC50,0,3.700000048,0,IC50,0,206,0,=,,,,16043489,
HCN2,401,Hcn2,O88703,,,,,,Mouse,ivabradine,2357,,,135650438,Channel blocker,Antagonist,,f,f,,pIC50,0,5.599999905,0,IC50,0,2290,0,=,,,,16387796,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN2,401,Hcn2,O88703,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,,,pIC50,0,3.2,0,-,0,0,0,=,,,,18579800,
HCN3,402,HCN3,Q9P1Z3,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pIC50,0,3.799999952,0,IC50,0,157000,0,=,,,,16043489,
HCN3,402,HCN3,Q9P1Z3,,,,,,Human,ivabradine,2357,,,135650438,Channel blocker,Antagonist,,f,f,,pIC50,0,5.699999809,0,IC50,0,2250,0,=,,,,16387796,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pIC50,0,3.799999952,0,IC50,0,175,0,=,,,,16043489,
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,ivabradine,2357,,,135650438,Channel blocker,Antagonist,,f,f,,pIC50,0,5.699999809,0,IC50,0,2250,0,=,,,,16387796,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,EC18,6262,,,178102882,Channel blocker,None,,f,,,pEC50,0,5.4,0,EC50,0,3980,0,=,,,,22091830,COc1ccc(cc1OC)CCN(C1CCCC(C1)N1CCc2c(CC1=O)cc(c(c2)OC)OC)C
heat shock protein 90 alpha family class A member 1,2905,HSP90AA1,P07900,,,,,,Human,retaspimycin hydrochloride,9827,,,0,Inhibitor,Inhibition,,f,f,,pEC50,0,6.920000076,0,EC50,0,119,0,=,,,,16854066,C=CCNc1c(O)cc2c(c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(C)/[C@@H]([C@H](/C=CC=C(C(=O)N2)/C)OC)OC(=O)N)O.Cl
heat shock protein 90 alpha family class A member 1,2905,HSP90AA1,P07900,,,,,,Human,SNX0723,9260,,,315661335,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,24332488,NC(=O)c1c(N[C@@H]2COCC2)cc(cc1F)n1cc(c2c1CC(C)(C)CC2=O)C
heat shock protein 90 alpha family class B member 1,2907,HSP90AB1,P08238,,,,,,Human,geldanamycin,9829,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.550000191,0,IC50,0,282,0,=,,,,24984936,CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(C2=O)NC(=O)/C(=C/C=C[C@@H]([C@H](/C(=C/[C@@H]([C@H]1O)C)/C)OC(=O)N)OC)/C
heat shock protein 90 alpha family class B member 1,2907,HSP90AB1,P08238,,,,,,Human,luminespib,9261,,,315661336,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,0,CCNC(=O)c1noc(c1c1ccc(cc1)CN1CCOCC1)c1cc(C(C)C)c(cc1O)O
heat shock protein 90 beta family member 1,2904,HSP90B1,P14625,,,,,,Human,semapimod,9211,,,315661287,Inhibitor,Inhibition,,f,t,,pIC50,6.699999809,0,6.400000095,IC50,400,0,200,=,,,,27194788,O=C(Nc1cc(cc(c1)/C(=NN=C(N)N)/C)/C(=N/N=C(N)N)/C)CCCCCCCCC(=O)Nc1cc(cc(c1)/C(=NN=C(N)N)/C)/C(=N/N=C(N)N)/C
Hepatitis C virus genome polyprotein,2952,,Q6GYR8,,,,,,Hepatitis C virus,simeprevir,7367,,,178103939,Inhibitor,Inhibition,,f,t,,pKi,0,9.43999958,0,Ki,0,0.360000014,0,=,,,,18678486,COc1ccc2c(c1C)nc(cc2O[C@@H]1C[C@@H]2[C@@H](C1)C(=O)N(C)CCCC/C=C[C@H]1[C@](NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C
Hepatocyte nuclear factor-4-&alpha;,608,HNF4A,P41235,,,,,,Human,linoleic acid,1052,,,135651503,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,19440305,CCCCC/C=CC/C=CCCCCCCCC(=O)O
herpes virus entry mediator,1887,TNFRSF14,Q92956,,,,,,Human,LIGHT,5070,TNFSF14,Human,178101763,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
herpes virus entry mediator,1887,TNFRSF14,Q92956,,,,,,Human,lymphotoxin-&alpha;,5064,LTA,Human,178101757,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Histidine decarboxylase,1274,HDC,P19113,,,,,,Human,FMH,5189,,,178101877,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,7452304,NC(C(=O)O)(CF)Cc1cnc[nH]1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,8.350000381,0,IC50,0,4.5,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,8.770000458,0,IC50,0,1.700000048,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,9.260000229,0,Ki,0,0.550000012,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pEC50,0,6.739999771,0,EC50,0,181,0,=,,,,17868033,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pKi,0,7.659999847,0,Ki,0,22,0,=,,,,20139990,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,7.550000191,0,EC50,0,28,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.449999809,0,IC50,0,356,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,mocetinostat,7008,,,178103587,Inhibitor,Inhibition,,f,f,,pKi,0,8.050000191,0,Ki,0,9,0,=,,,,20139990,O=C(c1ccc(cc1)CNc1nccc(n1)c1cccnc1)Nc1ccccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,nexturastat A,7504,,,187051806,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3002,0,=,,,,23009203,CCCCN(C(=O)Nc1ccccc1)Cc1ccc(cc1)C(=O)NO
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,pracinostat,8365,,,252166577,Inhibitor,Inhibition,,f,f,,pIC50,0,7.309999943,0,IC50,0,49,0,=,,,,20197387,CCCCc1nc2c(n1CCN(CC)CC)ccc(c2)/C=C/C(=O)NO
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,9.960000038,0,IC50,0,0.109999999,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,resminostat,7502,,,187051804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,42.5,0,=,,,,20201941,ONC(=O)/C=C/c1ccn(c1)S(=O)(=O)c1ccc(cc1)CN(C)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,RGFP109,7501,,,187051803,Inhibitor,Inhibition,,f,f,,pKi,0,7.489999771,0,Ki,0,32,0,=,,,,20098685,O=C(Nc1ccccc1N)CCCCCNC(=O)c1ccc(cc1)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,ricolinostat,7010,,,178103589,Inhibitor,Inhibition,,f,f,,pIC50,0,7.239999771,0,IC50,0,58,0,=,,,,22262760,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,t,,pKi,0,11.81999969,0,Ki,0,0.0015,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.579999924,0,IC50,0,26.10000038,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.190000057,0,IC50,0,643,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,pracinostat,8365,,,252166577,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,20197387,CCCCc1nc2c(n1CCN(CC)CC)ccc(c2)/C=C/C(=O)NO
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,9.340000153,0,IC50,0,0.460000008,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 11,2615,HDAC11,Q96DB2,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,8.270000458,0,IC50,0,5.400000095,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 11,2615,HDAC11,Q96DB2,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.230000019,0,IC50,0,584,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 11,2615,HDAC11,Q96DB2,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,9.430000305,0,IC50,0,0.370000005,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.900000095,0,IC50,0,12.60000038,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pEC50,0,5.940000057,0,EC50,0,1155,0,=,,,,17868033,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pKi,0,7.190000057,0,Ki,0,65,0,=,,,,20139990,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,7.25,0,EC50,0,56,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,5.809999943,0,IC50,0,1542,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,mocetinostat,7008,,,178103587,Inhibitor,Inhibition,,f,f,,pKi,0,7.46999979,0,Ki,0,34,0,=,,,,20139990,O=C(c1ccc(cc1)CNc1nccc(n1)c1cccnc1)Nc1ccccc1N
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,9.479999542,0,IC50,0,0.330000013,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,ricolinostat,7010,,,178103589,Inhibitor,Inhibition,,f,f,,pIC50,0,7.320000172,0,IC50,0,48,0,=,,,,22262760,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,10.42000008,0,Ki,0,0.037999999,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,santacruzamate A,7916,,,249565599,Inhibitor,Inhibition,,f,t,,pIC50,0,9.920000076,0,IC50,0,0.119000003,0,=,,,,24164245,CCOC(=O)NCCCC(=O)NCCc1ccccc1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,8.659999847,0,Ki,0,2.200000048,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,8.039999962,0,IC50,0,9.100000381,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,8.380000114,0,Ki,0,4.199999809,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,droxinostat,8464,,,252166674,Inhibitor,Inhibition,,f,f,,pIC50,0,4.769999981,0,IC50,0,16900,0,=,,,,20053768,ONC(=O)CCCOc1ccc(cc1C)Cl
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pKi,0,6.440000057,0,Ki,0,360,0,=,,,,20139990,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pEC50,0,5.639999866,0,EC50,0,2311,0,=,,,,17868033,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,7.679999828,0,EC50,0,21,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,710,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,mocetinostat,7008,,,178103587,Inhibitor,Inhibition,,f,f,,pKi,0,6.579999924,0,Ki,0,265,0,=,,,,20139990,O=C(c1ccc(cc1)CNc1nccc(n1)c1cccnc1)Nc1ccccc1N
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,8.399999619,0,EC50,0,4,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,pracinostat,8365,,,252166577,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,20197387,CCCCc1nc2c(n1CCN(CC)CC)ccc(c2)/C=C/C(=O)NO
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,8.31000042,0,IC50,0,4.860000134,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,resminostat,7502,,,187051804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50.09999847,0,=,,,,20201941,ONC(=O)/C=C/c1ccn(c1)S(=O)(=O)c1ccc(cc1)CN(C)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,RGFP109,7501,,,187051803,Inhibitor,Inhibition,,f,f,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,20098685,O=C(Nc1ccccc1N)CCCCCNC(=O)c1ccc(cc1)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,RGFP966,7500,,,187051802,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,,,,23297220,O=C(Nc1ccc(cc1N)F)/C=C/c1cnn(c1)C/C=C/c1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,ricolinostat,7010,,,178103589,Inhibitor,Inhibition,,f,f,,pIC50,0,7.289999962,0,IC50,0,51,0,=,,,,22262760,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,9.819999695,0,Ki,0,0.150000006,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,8.390000343,0,Ki,0,4.099999905,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.880000114,0,IC50,0,13.19999981,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,5.650000095,0,Ki,0,2250,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,5.980000019,0,Ki,0,1050,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,7.28000021,0,EC50,0,52,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,5.510000229,0,IC50,0,3072,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,7.920000076,0,EC50,0,12,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,9.18999958,0,IC50,0,0.639999986,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,7.690000057,0,Ki,0,20.5,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,santacruzamate A,7916,,,249565599,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,24164245,CCOC(=O)NCCCC(=O)NCCc1ccccc1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,5.119999886,0,Ki,0,7500,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.940000057,0,IC50,0,11.39999962,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,6.380000114,0,Ki,0,420,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,6.21999979,0,Ki,0,600,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1093,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,pracinostat,8365,,,252166577,Inhibitor,Inhibition,,f,f,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,20197387,CCCCc1nc2c(n1CCN(CC)CC)ccc(c2)/C=C/C(=O)NO
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,8.430000305,0,IC50,0,3.690000057,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,6.260000229,0,Ki,0,550,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,6,0,Ki,0,1000,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,8.289999962,0,IC50,0,5.099999905,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,8.020000458,0,Ki,0,9.5,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,droxinostat,8464,,,252166674,Inhibitor,Inhibition,,f,t,,pIC50,0,5.610000134,0,IC50,0,2470,0,=,,,,20053768,ONC(=O)CCCOc1ccc(cc1C)Cl
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,7.570000172,0,EC50,0,27,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,8.380000114,0,Ki,0,4.199999809,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,nexturastat A,7504,,,187051806,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5.019999981,0,=,,,,23009203,CCCCN(C(=O)Nc1ccccc1)Cc1ccc(cc1)C(=O)NO
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,NQN-1,7058,,,178103637,Inhibitor,Inhibition,,f,f,,pKi,0,5.889999866,0,Ki,0,1300,0,=,,,,22047054,O=C(c1ccccc1)NC1=CC(=O)c2c(C1=O)cccc2
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,7.210000038,0,EC50,0,61,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,76.80000305,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,resminostat,7502,,,187051804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.139999866,0,IC50,0,71.80000305,0,=,,,,20201941,ONC(=O)/C=C/c1ccn(c1)S(=O)(=O)c1ccc(cc1)CN(C)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,ricolinostat,7010,,,178103589,Inhibitor,Inhibition,,f,f,,pIC50,0,8.329999924,0,IC50,0,4.699999809,0,=,,,,22262760,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,8.020000458,0,Ki,0,9.5,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,santacruzamate A,7916,,,249565599,Inhibitor,Inhibition,,f,f,,pIC50,0,6.360000134,0,IC50,0,434,0,=,,,,24164245,CCOC(=O)NCCCC(=O)NCCc1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,6.429999828,0,IC50,0,373,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,5.019999981,0,Ki,0,9500,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pEC50,0,6.789999962,0,EC50,0,163,0,=,,,,17868033,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,6.619999886,0,Ki,0,240,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.010000229,0,IC50,0,986,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,7.849999905,0,EC50,0,14,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,119,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,5.900000095,0,Ki,0,1250,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,5.650000095,0,Ki,0,2250,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,79.80000305,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,6.46999979,0,Ki,0,340,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,droxinostat,8464,,,252166674,Inhibitor,Inhibition,,f,t,,pIC50,0,5.840000153,0,IC50,0,1460,0,=,,,,20053768,ONC(=O)CCCOc1ccc(cc1C)Cl
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,7.409999847,0,Ki,0,39,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.440000057,0,IC50,0,363,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,6.610000134,0,EC50,0,248,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,8.369999886,0,IC50,0,4.260000229,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,resminostat,7502,,,187051804,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,877,0,=,,,,20201941,ONC(=O)/C=C/c1ccn(c1)S(=O)(=O)c1ccc(cc1)CN(C)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,ricolinostat,7010,,,178103589,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,22262760,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,9.819999695,0,Ki,0,0.150000006,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,6.980000019,0,Ki,0,105,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,CUDC-101,8894,,,310264675,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,67.19999695,0,=,,,,20143778,ONC(=O)CCCCCCOc1cc2c(ncnc2cc1OC)Nc1cccc(c1)C#C
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,dacinostat,7497,,,187051799,Inhibitor,Inhibition,,f,f,,pKi,0,5.050000191,0,Ki,0,9000,0,=,,,,20139990,OCCN(Cc1ccc(cc1)/C=C/C(=O)NO)CCc1c[nH]c2c1cccc2
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,entinostat,7007,,,178103586,Inhibitor,Inhibition,,f,f,,pEC50,0,6.300000191,0,EC50,0,505,0,=,,,,17868033,O=C(OCc1cccnc1)NCc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,givinostat,7490,,,187051793,Inhibitor,Inhibition,,f,f,,pKi,0,6.409999847,0,Ki,0,390,0,=,,,,20139990,CCN(Cc1ccc2c(c1)ccc(c2)COC(=O)Nc1ccc(cc1)C(=O)NO)CC
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,KA1010,9663,,,348353622,Inhibitor,Inhibition,,f,f,,pIC50,0,6.25,0,IC50,0,558,0,=,,,,27222932,ONC(=O)CCCCCCN(c1ccccn1)c1ccccn1
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,panobinostat,7489,,,187051792,Inhibitor,Inhibition,,f,f,,pEC50,0,8.520000458,0,EC50,0,3,0,=,,,,17868033,ONC(=O)/C=C/c1ccc(cc1)CNCCc1c(C)[nH]c2c1cccc2
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,quisinostat,7503,,,187051805,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32.09999847,0,=,,,,19861438,ONC(=O)c1cnc(nc1)N1CCC(CC1)CNCc1cn(c2c1cccc2)C
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,romidepsin,7006,,,178103585,Inhibitor,Inhibition,,f,f,,pKi,0,5.960000038,0,Ki,0,1100,0,=,,,,20139990,C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,scriptaid,7505,,,187051807,Inhibitor,Inhibition,,f,f,,pKi,0,5.099999905,0,Ki,0,8000,0,=,,,,20139990,ONC(=O)CCCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
histone H3 associated protein kinase,2028,HASPIN,Q8TF76,,,,,,Human,SGI-1776,8784,,,252827442,Inhibitor,Inhibition,,f,f,,pIC50,0,7.46999979,0,IC50,0,34,0,=,,,,22924342,CN1CCC(CC1)CNc1ccc2n(n1)c(cn2)c1cccc(c1)OC(F)(F)F
homeodomain interacting protein kinase 1,2033,HIPK1,Q86Z02,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,5.579999924,0,IC50,0,2639,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
homeodomain interacting protein kinase 3,2035,HIPK3,Q9H422,,,,,,Human,CX-4945,8126,,,249565806,Inhibitor,Inhibition,,f,f,,pIC50,0,7.349999905,0,IC50,0,45,0,=,,,,21174434,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O
H-PGDS,1381,HPGDS,O60760,,,,,,Human,HQL-79,6662,,,178103274,Inhibitor,Inhibition,,f,,,pIC50,5.5,0,5.3,-,0,0,0,=,,,,16547010,c1ccc(cc1)C(c1ccccc1)OC1CCN(CC1)CCCc1nnn[nH]1
HRAS,2822,HRAS,P01112,,,,,,Human,lonafarnib,8024,,,249565704,Inhibitor,Inhibition,,f,f,,pIC50,0,8.720000267,0,IC50,0,1.899999976,0,=,Measuring inhibition of farnesylation of HRAS by human farnesyltransferase,,,9810004,Clc1cc(Br)c2c(c1)CCc1c([C@@H]2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,ST-1006,8983,,,310264763,Agonist,Agonist,,f,f,,pKi,0,6,0,Ki,0,1000,0,>,,,,26084539,CN1CCN(CC1)c1cc(NCc2c(Cl)cccc2Cl)nc(n1)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,dimethylhistaprodifen,1203,,,135650187,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12626648,CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,5.9,0,4.7,,0,0,0,,,,,7925364,NCCc1cnc[nH]1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,histaprodifen,4026,,,178100852,Agonist,Full agonist,,f,,,pKi,0,5.7,0,-,0,0,0,=,,,,15947036,NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,methylhistaprodifen,1205,,,135650593,Agonist,Full agonist,,f,f,,pKi,0,6.400000095,0,Ki,0,398,0,=,,,,12626648,CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,oxo-arpromidine,1199,,,135651299,Agonist,Full agonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,16394198,NC(=NCCCc1[nH]cnc1)NC(=O)CC(c1ccccn1)c1ccc(cc1)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,cyclizine,7151,,,178103726,Antagonist,Antagonist,,f,t,,pKi,0,8.350000381,0,Ki,0,4.440000057,0,=,,,,0,CN1CCN(CC1)C(c1ccccc1)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,cyproheptadine,277,,,135650152,Antagonist,Antagonist,,f,t,,pKi,0,10.19999981,0,-,0,0,0,=,,,,7925364,CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,desloratadine,7157,,,178103732,Antagonist,Antagonist,,f,t,,pKi,0,9.010000229,0,Ki,0,0.970000029,0,=,,,,15482930,Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,diphenhydramine,1224,,,135650192,Antagonist,Antagonist,,f,t,,pKi,0,7.900000095,0,-,0,0,0,=,,,,12065734,CN(CCOC(c1ccccc1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,10379421,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,doxepin,1225,,,135650208,Antagonist,Antagonist,,f,,,pKi,10,0,9.5,,0,0,0,,,,,12065734,CN(CC/C=C1/c2ccccc2OCc2c1cccc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,epinastine,7176,,,178103751,Antagonist,Antagonist,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,Antagonism of 5 nM [<sup>3</sup>H]mepyramine binding in an intact cell assay using U373 MG astrocytoma cells.,,,18446005,N=C1NCC2N1c1ccccc1Cc1c2cccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,fexofenadine,4819,,,178101521,Antagonist,Antagonist,,f,t,,pKi,0,7.570000172,0,Ki,0,27,0,=,,,,19660947,OC(=O)C(c1ccc(cc1)C(CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O)O)(C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,fluphenazine,204,,,135650275,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,fluspirilene,85,,,135650278,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,haloperidol,86,,,135650345,Antagonist,Antagonist,,f,,,pKi,6.1,0,5.7,,0,0,0,,,,,8935801,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,hydroxyzine,7199,,,178103774,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,1.99000001,0,=,,,,11809864,OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(+)-<i>cis</i>-H<sub>2</sub>-PAT,1208,,,135650373,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12065734,CN([C@H]1Cc2ccccc2[C@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,impromidine,1226,,,135650388,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,16394198,NC(=NCCCc1cnc[nH]1)NCCSCc1nc[nH]c1C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,INCB-38579,8982,,,310264762,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,CN1CCN(CC1)C1=CC(=NC(N1)N)c1ccc2c(c1)CN(CC2)C(=O)CCC1CCCC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(-)-<i>trans</i>-H<sub>2</sub>-PAT,1212,,,135650435,Antagonist,Antagonist,,f,,,pKi,8.8,0,8.6,,0,0,0,,,,,12065734,CN([C@H]1Cc2ccccc2[C@@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(+)-<i>trans</i>-H<sub>2</sub>-PAT,1209,,,135650436,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.4,,0,0,0,,,,,12065734,CN([C@@H]1Cc2ccccc2[C@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,JNJ-39758979,8984,,,310264764,Antagonist,Antagonist,,f,f,,pKi,0,6,0,Ki,0,1000,0,>,,,,26084539,N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,ketotifen,7206,,,178103781,Antagonist,Antagonist,,f,t,,pKi,0,8.600000381,0,Ki,0,2.5,0,=,,,,21470866,CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,loratadine,7216,,,178103791,Antagonist,Antagonist,,f,t,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,15771458,CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,loxapine,205,,,135650533,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12629531,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,MK-0249,7346,,,178103918,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,Cc1nc2cccc(c2c(=O)n1c1ccc(cc1)OCCCN1CCCC1)C(F)(F)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,molindone,207,,,135650621,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,12629531,CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,olanzapine,47,,,135650756,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.7,,0,0,0,,,,,8935801,CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,perphenazine,209,,,135650810,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,12629531,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,pimozide,90,,,135650825,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,12629531,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,pipamperone,92,,,135650830,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8935801,O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,pitolisant,8924,,,310264705,Antagonist,Antagonist,,f,f,,pKi,0,5.78000021,0,-,0,0,0,=,,,,26084539,Clc1ccc(cc1)CCCOCCCN1CCCCC1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(&plusmn;)-<i>cis</i>-H<sub>2</sub>-PAT,1206,,,135650837,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.8,,0,0,0,,,,,12065734,CN([C@@H]1Cc2ccccc2[C@@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(&plusmn;)-<i>cis</i>-H<sub>2</sub>-PAT,1206,,,135650837,Antagonist,Antagonist,,f,,,pKi,8.2,0,8.1,,0,0,0,,,,,12065734,CN([C@@H]1Cc2ccccc2[C@@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(&plusmn;)-<i>trans</i>-H<sub>2</sub>-PAT,1207,,,135650838,Antagonist,Antagonist,,f,,,pKi,8.6,0,8.4,,0,0,0,,,,,12065734,CN([C@@H]1Cc2ccccc2[C@H](C1)c1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,promethazine,7282,,,178103856,Antagonist,Antagonist,,f,t,,pKi,0,9.619999886,0,Ki,0,0.239999995,0,=,,,,16782354,CN(C(CN1c2ccccc2Sc2c1cccc2)C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,quetiapine,50,,,135650869,Antagonist,Antagonist,,f,,,pKi,8.7,0,8,,0,0,0,,,,,8935801,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,risperidone,96,,,135650903,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.6,,0,0,0,,,,,8935801,Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,sertindole,98,,,135651037,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,8935801,Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(<i>R</i>)-cetirizine,1214,,,135650416,Antagonist,Inverse agonist,,f,t,,pKi,0,8.5,0,-,0,0,0,=,,,,15206929,OC(=O)COCCN1CCN(CC1)[C@@H](c1ccc(cc1)Cl)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,(<i>S</i>)-cetirizine,1215,,,135650427,Antagonist,Inverse agonist,,f,f,,pKi,0,6.699999809,0,-,0,0,0,=,,,,15206929,OC(=O)COCCN1CCN(CC1)[C@H](c1ccc(cc1)Cl)c1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,pyrilamine,1227,,,135650867,Antagonist,Inverse agonist,,f,t,,pKi,9,0,8.699999809,-,0,0,0,=,,,,12065734,COc1ccc(cc1)CN(c1ccccn1)CCN(C)C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,ST-1006,8983,,,310264763,Agonist,Agonist,,f,f,,pKi,0,6,0,Ki,0,1000,0,>,,,,26084539,CN1CCN(CC1)c1cc(NCc2c(Cl)cccc2Cl)nc(n1)N
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,0,3.8,0,,0,0,0,,,,,9384502,NCCc1cnc[nH]1
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,impromidine,1226,,,135650388,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,16394198,NC(=NCCCc1cnc[nH]1)NCCSCc1nc[nH]c1C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,oxo-arpromidine,1199,,,135651299,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,16394198,NC(=NCCCc1[nH]cnc1)NC(=O)CC(c1ccccn1)c1ccc(cc1)F
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,famotidine,7074,,,178103653,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,NC(=Nc1scc(n1)CSCC/C(=N/S(=O)(=O)N)/N)N
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,INCB-38579,8982,,,310264762,Antagonist,Antagonist,,f,f,,pKi,0,5.300000191,0,Ki,0,10000,0,>,,,,26084539,CN1CCN(CC1)C1=CC(=NC(N1)N)c1ccc2c(c1)CN(CC2)C(=O)CCC1CCCC1
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,iodoaminopotentidine,1232,,,135650404,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9384502,N#CNC(=NCCCOc1cccc(c1)CN1CCCCC1)NCCNC(=O)c1ccc(c(c1)I)N
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,JNJ-39758979,8984,,,310264764,Antagonist,Antagonist,,f,f,,pKi,0,6,0,Ki,0,1000,0,>,,,,26084539,N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,metiamide,1233,,,135650597,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9384502,CNC(=S)NCCSCc1nc[nH]c1C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,MK-0249,7346,,,178103918,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,Cc1nc2cccc(c2c(=O)n1c1ccc(cc1)OCCCN1CCCC1)C(F)(F)F
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,pitolisant,8924,,,310264705,Antagonist,Antagonist,,f,f,,pKi,0,4.960000038,0,-,0,0,0,=,,,,26084539,Clc1ccc(cc1)CCCOCCCN1CCCCC1
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,ranitidine,1234,,,135650887,Antagonist,Antagonist,,f,f,,pKi,0,6.199999809,0,Ki,0,631,0,=,,,,9384502,CN/C(=C[N+](=O)[O-])/NCCSCc1ccc(o1)CN(C)C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,ranitidine,1234,,,135650887,Antagonist,Antagonist,,f,t,,pKi,0,7.099999905,0,Ki,0,79.40000153,0,=,,,,7921611,CN/C(=C[N+](=O)[O-])/NCCSCc1ccc(o1)CN(C)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,ST-1006,8983,,,310264763,Agonist,Agonist,,f,f,,pKi,0,6.289999962,0,-,0,0,0,=,,,,26084539,CN1CCN(CC1)c1cc(NCc2c(Cl)cccc2Cl)nc(n1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,dimaprit,1248,,,135650186,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,11179434,CN(CCCSC(=N)N)C
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,7.9,0,7.2,,0,0,0,,,,,10869375,NCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,7.8,0,7.1,,0,0,0,,,,,12706455,NCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,8.3,0,7.8,,0,0,0,,,,,10869375,NCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,imbutamine,1249,,,135650379,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,14640553,NCCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,9.7,0,8.8,,0,0,0,,,,,10869375,NC(=N)SCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,9.7,0,8.8,,0,0,0,,,,,12706455,NC(=N)SCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,9.7,0,9,,0,0,0,,,,,10869375,NC(=N)SCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,immepip,1251,,,135650385,Agonist,Full agonist,,f,,,pKi,8.9,0,8.8,,0,0,0,,,,,10869375,N1CCC(CC1)Cc1[nH]cnc1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,immepip,1251,,,135650385,Agonist,Full agonist,,f,,,pKi,9.7,0,8.8,,0,0,0,,,,,10869375,N1CCC(CC1)Cc1[nH]cnc1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,immepip,1251,,,135650385,Agonist,Full agonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,12706455,N1CCC(CC1)Cc1[nH]cnc1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,immethridine,4024,,,178100850,Agonist,Full agonist,,f,,,pKi,0,9.1,0,-,0,0,0,=,,,,15115383,n1ccc(cc1)Cc1c[nH]cn1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,impentamine,1252,,,135650386,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,14640553,NCCCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,<i>N</i>-&alpha;-methylhistamine,1239,,,135650394,Agonist,Full agonist,,f,,,pKi,0,9,0,-,0,0,0,=,,,,12706455,CNCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,<i>N</i>-methylhistamine,1242,,,135650397,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,10869375,Cn1cc(nc1)CCN
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,<i>N</i>-methylhistamine,1242,,,135650397,Agonist,Full agonist,,f,,,pKi,9.3,0,8.6,,0,0,0,,,,,10869375,Cn1cc(nc1)CCN
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,<i>N</i>-[<sup>3</sup>H]&alpha;-methylhistamine,1240,,,135650398,Agonist,Full agonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,12706455,CNCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,<i>N</i>-[<sup>3</sup>H]methylhistamine,1241,,,135650399,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,10869375,Cn1cc(nc1)CCN
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,<i>N</i>-[<sup>3</sup>H]methylhistamine,1241,,,135650399,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,11179434,Cn1cc(nc1)CCN
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,iodoproxyfan,1253,,,135650406,Agonist,Full agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,12393057,Ic1ccc(cc1)COCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,iodoproxyfan,1253,,,135650406,Agonist,Full agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,12393057,Ic1ccc(cc1)COCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,8.7,0,8,,0,0,0,,,,,10869375,C[C@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,9.2,0,8.4,,0,0,0,,,,,10869375,C[C@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12706455,C[C@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,(<i>S</i>)-&alpha;-methylhistamine,1238,,,135650426,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12393057,C[C@@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,(<i>S</i>)-&alpha;-methylhistamine,1238,,,135650426,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12393057,C[C@@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,methimepip,1254,,,135650583,Agonist,Full agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,15771452,CN1CCC(CC1)Cc1[nH]cnc1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,proxyfan,1255,,,135650860,Agonist,Full agonist,,f,,,pKi,8.5,0,8,,0,0,0,,,,,11162480,C(CCc1cnc[nH]1)OCc1ccccc1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,proxyfan,1255,,,135650860,Agonist,Full agonist,,f,,,pKi,8.5,0,8.2,,0,0,0,,,,,15341517,C(CCc1cnc[nH]1)OCc1ccccc1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,proxyfan,1255,,,135650860,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12393057,C(CCc1cnc[nH]1)OCc1ccccc1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,MK-0249,7346,,,178103918,Agonist,Inverse agonist,,f,f,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,,,,18598020,Cc1nc2cccc(c2c(=O)n1c1ccc(cc1)OCCCN1CCCC1)C(F)(F)F
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,GR 175737,1243,,,135650315,Agonist,Partial agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,12393057,Clc1ccc(cc1)Cc1noc(n1)CCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,GR 175737,1243,,,135650315,Agonist,Partial agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12393057,Clc1ccc(cc1)Cc1noc(n1)CCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,impromidine,1226,,,135650388,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,11179434,NC(=NCCCc1cnc[nH]1)NCCSCc1nc[nH]c1C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,FUB 349,1259,,,135650291,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,11090094,c1ccc(cc1)CCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,FUB 349,1259,,,135650291,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11090094,c1ccc(cc1)CCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,FUB 349,1259,,,135650291,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.6,,0,0,0,,,,,15341517,c1ccc(cc1)CCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,FUB 465,1260,,,135650292,Antagonist,Antagonist,,f,,,pKi,6.9,0,6.4,,0,0,0,,,,,11162480,CCOCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,GSK334429,9103,,,315661188,Antagonist,Antagonist,,f,t,,pKi,9.890000343,0,9.489999771,Ki,0.319999993,0,0.129999995,=,,,,21062081,CC(N1CCCN(CC1)C(=O)C1CCN(CC1)c1ccc(nc1)C(F)(F)F)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,GT2394,1261,,,135650325,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12393057,O=C(N[C@@H]1C[C@H]1c1cnc[nH]1)OCC1CCCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,GT2394,1261,,,135650325,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12393057,O=C(N[C@@H]1C[C@H]1c1cnc[nH]1)OCC1CCCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,impentamine,1252,,,135650386,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11714875,NCCCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,impentamine,1252,,,135650386,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11714875,NCCCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,INCB-38579,8982,,,310264762,Antagonist,Antagonist,,f,f,,pKi,0,6.389999866,0,-,0,0,0,=,,,,26084539,CN1CCN(CC1)C1=CC(=NC(N1)N)c1ccc2c(c1)CN(CC2)C(=O)CCC1CCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,iodophenpropit,1266,,,135650405,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.8,,0,0,0,,,,,11714875,N[C@H](SCCCc1cnc[nH]1)NCCc1ccc(cc1)I
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,iodophenpropit,1266,,,135650405,Antagonist,Antagonist,,f,f,,pKi,8.699999809,0,8.199999809,Ki,6.309999943,0,1.99000001,=,,,,11714875,N[C@H](SCCCc1cnc[nH]1)NCCc1ccc(cc1)I
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,JB 98064,1262,,,135650443,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12393057,Clc1ccc(cc1)CN(C(=N)N)CCCCCCCN1CCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,JB 98064,1262,,,135650443,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,12393057,Clc1ccc(cc1)CN(C(=N)N)CCCCCCCN1CCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,JNJ-39758979,8984,,,310264764,Antagonist,Antagonist,,f,f,,pKi,0,6,0,Ki,0,1000,0,=,,,,26084539,N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,JNJ-5207852,1256,,,135649651,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12930154,C1CCN(CC1)CCCOc1ccc(cc1)CN1CCCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,MK-0249,7346,,,178103918,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,26084539,Cc1nc2cccc(c2c(=O)n1c1ccc(cc1)OCCCN1CCCC1)C(F)(F)F
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,PF-03654746,9058,,,315661143,Antagonist,Antagonist,,f,f,,pKi,0,8.640000343,0,Ki,0,2.299999952,0,=,,,,21928839,CCNC(=O)C1CC(C1)(F)c1ccc(c(c1)F)CN1CCCC1
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,PF-03654746,9058,,,315661143,Antagonist,Antagonist,,f,f,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,21928839,CCNC(=O)C1CC(C1)(F)c1ccc(c(c1)F)CN1CCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,pitolisant,8924,,,310264705,Antagonist,Antagonist,,f,t,,pKi,8.569999695,0,8.06000042,Ki,0,2.700000048,0,=,Measured in a [<sup>125</sup>I]iodoproxyfan binding assay in cells exogenously expressing the human H<sub>3</sub> receptor.,,,26084539,Clc1ccc(cc1)CCCOCCCN1CCCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,proxyfan,1255,,,135650860,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,11090094,C(CCc1cnc[nH]1)OCc1ccccc1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,proxyfan,1255,,,135650860,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11090094,C(CCc1cnc[nH]1)OCc1ccccc1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,ST-1006,8983,,,310264763,Agonist,Agonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,26084539,CN1CCN(CC1)c1cc(NCc2c(Cl)cccc2Cl)nc(n1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,dimaprit,1248,,,135650186,Agonist,Full agonist,,f,,,pKi,6.5,0,4.9,,0,0,0,,,,,11179434,CN(CCCSC(=N)N)C
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,8.3,0,7.8,,0,0,0,,,,,11179434,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,0,7.2,0,,0,0,0,,,,,11561071,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,histamine,1204,,,135651493,Agonist,Full agonist,,t,,,pKi,0,7.4,0,,0,0,0,,,,,11561071,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,HTMT,1273,,,135650354,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,11179436,CC(NCCc1cnc[nH]1)CCCCC(=O)Nc1ccc(cc1)C(F)(F)F
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11561071,NC(=N)SCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,8.9,0,8.2,,0,0,0,,,,,11179434,NC(=N)SCCc1cnc[nH]1
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,imetit,1250,,,135650381,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11561071,NC(=N)SCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,immepip,1251,,,135650385,Agonist,Full agonist,,f,,,pKi,8,0,7.6,,0,0,0,,,,,11179434,N1CCC(CC1)Cc1[nH]cnc1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,improgan,1276,,,135650387,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,11179436,CN=C(NC#N)NCCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,<i>N</i>-&alpha;-methylhistamine,1239,,,135650394,Agonist,Full agonist,,f,,,pKi,7.2,0,6.8,,0,0,0,,,,,11181941,CNCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,<i>N</i>-ethylhistamine,1271,,,135650396,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,16432504,NCCc1ncn(c1)CC
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,<i>N</i>-methylhistamine,1242,,,135650397,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,11561071,Cn1cc(nc1)CCN
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,<i>N</i>-methylhistamine,1242,,,135650397,Agonist,Full agonist,,f,,,pKi,7.6,0,7.3,,0,0,0,,,,,11179434,Cn1cc(nc1)CCN
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,<i>N</i>-methylhistamine,1242,,,135650397,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,11561071,Cn1cc(nc1)CCN
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,<i>N</i>-[<sup>3</sup>H]methylhistamine,1241,,,135650399,Agonist,Full agonist,,f,,,pKd,0,7.8,0,,0,0,0,,,,,11179434,Cn1cc(nc1)CCN
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,"<i>N,N</i>-dimethylhistamine",1270,,,135650400,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,16432504,CN(CCc1[nH]cnc1)C
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,11561071,C[C@H](Cc1cnc[nH]1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,6.9,0,6.5,,0,0,0,,,,,11179434,C[C@H](Cc1cnc[nH]1)N
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,(<i>R</i>)-&alpha;-methylhistamine,1236,,,135650415,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,11561071,C[C@H](Cc1cnc[nH]1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,(<i>S</i>)-&alpha;-methylhistamine,1238,,,135650426,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,11181941,C[C@@H](Cc1cnc[nH]1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,methimepip,1254,,,135650583,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,15771452,CN1CCC(CC1)Cc1[nH]cnc1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,impromidine,1226,,,135650388,Agonist,Partial agonist,,f,,,pKi,7.9,0,7.6,,0,0,0,,,,,11179434,NC(=NCCCc1cnc[nH]1)NCCSCc1nc[nH]c1C
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,INCB-38579,8982,,,310264762,Antagonist,Antagonist,,f,f,,pKi,0,8.300000191,0,-,0,0,0,=,,,,26084539,CN1CCN(CC1)C1=CC(=NC(N1)N)c1ccc2c(c1)CN(CC2)C(=O)CCC1CCCC1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,iodophenpropit,1266,,,135650405,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,11179436,N[C@H](SCCCc1cnc[nH]1)NCCc1ccc(cc1)I
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,JNJ-10191584,1277,,,135649827,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,15454206,CN1CCN(CC1)C(=O)c1nc2c([nH]1)cc(cc2)Cl
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,JNJ-39758979,8984,,,310264764,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,Ki,0,12.5,0,=,,,,26084539,N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,JNJ 7777120,1278,,,135650446,Antagonist,Antagonist,,f,f,,pKi,8.300000191,0,7.800000191,Ki,15.80000019,0,5.010000229,=,,,,15947036,CN1CCN(CC1)C(=O)c1cc2c([nH]1)ccc(c2)Cl
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,MK-0249,7346,,,178103918,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,26084539,Cc1nc2cccc(c2c(=O)n1c1ccc(cc1)OCCCN1CCCC1)C(F)(F)F
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,pitolisant,8924,,,310264705,Antagonist,Antagonist,,f,f,,pKi,0,4,0,Ki,0,100000,0,>,,,,26084539,Clc1ccc(cc1)CCCOCCCN1CCCCC1
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,DFGYVAE,3023,,,135651956,Inhibitor,Competitive,,f,,,pIC50,0,6.8,0,IC50,0,160,0,=,Inhibition of HMG-CoA reductase,,,20494585,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccccc1)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,DFGYVAE,3023,,,135651956,Inhibitor,Competitive,,f,,,pKi,0,7.29,0,Ki,0,51,0,=,In vitro inhibition of HMG-CoA reductase,,,20494585,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccccc1)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,t,,pIC50,0,7.550000191,0,IC50,0,28,0,=,Inhibition of HMG-CoA reductase,,,11349148,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,t,,pKi,0,6.559999943,0,Ki,0,256,0,=,In vitro inhibition of HMG-CoA reductase,,,16128575,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,in vitro inhibition of HMG-CoA reductase,,,19502059,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,,,pIC50,0,8.42,0,IC50,0,3.78,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,t,,pKi,0,7.550000191,0,Ki,0,28,0,=,,,,12773150,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,In vitro inhibition of HMG-CoA reductase,,,1656041,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,fluvastatin,2951,,,135650279,Inhibitor,Competitive,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,In vitro inhibition of HMG-CoA reductase,,,8246237,OC(=O)C[C@@H](C[C@@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,in vitro inhibition of  HMG-CoA reductase,,,2153213,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,7.96,0,IC50,0,11,0,=,in vitro inhibition of  HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,in vitro inhibition of  HMG-CoA reductase,,,1656041,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,6.8,0,IC50,0,160,0,=,in vitro inhition of  HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,t,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,Inhibition of HMG-CoA reductase,,,6933445,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,Q01237,,,,,,Mouse,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,7.57,0,IC50,0,27,0,=,In vitro inhibition of HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,in vitro inhibition of  HMG-CoA reductase,,,2153213,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,6.3,0,IC50,0,530,0,=,in vitro inhition of  HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,7.55,0,IC50,0,27,0,=,in vitro inhition of  HMG-CoA reductase,,,1992138,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,,,pIC50,0,8.52,0,IC50,0,3,0,=,in vitro inhition of  HMG-CoA reductase,,,8246234,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,lovastatin,2739,,,135652701,Inhibitor,Competitive,,f,t,,pIC50,0,7.690000057,0,IC50,0,20,0,=,in vitro inhition of  HMG-CoA reductase,,,1597859,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,,,,3989819,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,7.52,0,IC50,0,30,0,=,in vitro inhibition of  HMG-CoA reductase,,,1992137,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,5.94,0,IC50,0,1150,0,=,in vitro inhibition of HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,7.4,0,IC50,0,40,0,=,in vitro inhibition of HMG-CoA reductase,,,19502059,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,in vitro inhibition of  HMG-CoA reductase,,,3989819,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pKi,0,9,0,Ki,0,1,0,=,<i>in vitro</i> inhibition of  HMG-CoA reductase,,,3981532,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pKi,0,8.85,0,Ki,0,1.4,0,=,,,,3656359,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,7,0,IC50,0,110,0,=,in vitro inhibition of HMG-CoA reductase,,,0,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,15686906,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,7.6,0,IC50,0,25,0,=,in vitro inhibition of  HMG-CoA reductase,,,1992138,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,mevastatin,3031,,,135650602,Inhibitor,Competitive,,f,,,pIC50,0,8,0,IC50,0,10,0,=,in vitro inhibition of  HMG-CoA reductase,,,3973903,CC[C@@H](C(=O)O[C@H]1CCC=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,t,,pKi,0,6.989999771,0,Ki,0,103,0,=,In vitro inhibition of HMG-CoA reductase,,,16128575,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,,,pIC50,0,8.16,0,IC50,0,6.93,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,,,pIC50,0,7.89,0,IC50,0,13,0,=,In vitro inhibition of HMG-CoA reductase,,,18072721,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,In vitro inhibition of HMG-CoA reductase,,,8246234,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,,,pEC50,0,8.38,0,IC50,0,4.2,0,=,In vitro inhibition of HMG-CoA reductase,,,11392538,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,In vitro inhibition of HMG-CoA reductase,,,1597859,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,pravastatin,2953,,,135650848,Inhibitor,Competitive,,f,t,,pIC50,0,5.860000134,0,IC50,0,1370,0,=,In vitro inhibition of HMG-CoA reductase,,,11392538,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,rosuvastatin,2954,,,135650928,Inhibitor,Competitive,,f,t,,pIC50,0,8.510000229,0,IC50,0,3.099999905,0,=,Inhibition of HMG-CoA reductase,,,17574412,O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,rosuvastatin,2954,,,135650928,Inhibitor,Competitive,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,11349148,O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,rosuvastatin,2954,,,135650928,Inhibitor,Competitive,,f,t,,pKi,0,8.640000343,0,Ki,0,2.299999952,0,=,,,,16128575,O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,rosuvastatin,2954,,,135650928,Inhibitor,Competitive,,f,,,pIC50,0,9.8,0,IC50,0,0.16,0,=,Inhibition of  cholesterol systhesis,,,11256847,O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,rosuvastatin,2954,,,135650928,Inhibitor,Competitive,,f,t,,pIC50,0,8.270000458,0,IC50,0,5.400000095,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,t,,pIC50,0,7.920000076,0,IC50,0,12.10000038,0,=,In vitro inhibition of HMG-CoA reductase,,,1433193,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,11349148,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,,,pIC50,0,9.05,0,IC50,0,0.9,0,=,Inhibition of HMG-CoA reductase,,,3634830,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,,,pIC50,0,8.56,0,IC50,0,2.74,0,=,in vitro inhibition of cholesterol synthesis,,,11256847,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,,,pIC50,0,8.89,0,IC50,0,1.3,0,=,In vitro inhibition of cellular cholesterol synthesis,,,17574412,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,,,pIC50,0,6.82,0,IC50,0,150,0,=,In vitro inhibition of cellular cholesterol synthesis,,,17574412,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,simvastatin,2955,,,135651045,Inhibitor,Competitive,,f,,,pIC50,0,7.31,0,IC50,0,49,0,=,In vitro inhibition of HMG-CoA reductase,,,17574412,CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,dalvastatin,3036,,,178100252,Inhibitor,Inhibition,,f,t,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,Rat liver HMG-CoA reductase inhibition assay.,,,8434028,O[C@@H]1CC(=O)O[C@H](C1)/C=C/C1=C(CC(CC1(C)C)(C)C)c1ccc(c(c1)C)F
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,FPYVAE peptide [PMID: 20494585],3024,,,135651957,Inhibitor,Inhibition,,f,,,pIC50,0,5.83,0,IC50,0,1470,0,=,In vitro inhibition of HMG-CoA reductase,,,20494585,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)N)Cc1ccc(cc1)O)C
hydroxymethylglutaryl-CoA reductase,639,HMGCR,P04035,,,,,,Human,GLPDGG peptide [PMID: 20494585],2980,,,135649778,Inhibitor,Inhibition,,f,,,pIC50,0,4.65,0,IC50,0,22310,0,=,Inhibition of HMG-CoA reductase,,,20494585,NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)CC(=O)O)CC(C)C
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,o-hydroxyatorvastatin,6705,,,178103316,Inhibitor,Inhibition,,f,,,pKd,0,7.56,0,Kd,0,27.4,0,=,,,,18540668,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1O
hydroxymethylglutaryl-CoA reductase,639,Hmgcr,P51639,,,,,,Rat,pitavastatin,3035,,,178100251,Inhibitor,Inhibition,,f,f,,pKi,0,5.050000191,0,Ki,0,8900,0,=,Note this assay used the pitavastatin calcium salt.,,,19879766,O[C@H](C[C@@H](/C=C/c1c(nc2c(c1c1ccc(cc1)F)cccc2)C1CC1)O)CC(=O)O
hydroxymethylglutaryl-CoA synthase 1,638,HMGCS1,Q01581,,,,,,Human,(S)-3-hydroxy-3-methylglutaryl-CoA,3040,,,135651558,Inhibitor,Feedback inhibition,,f,f,,pKi,5.900000095,0,5.5,Ki,3100,0,1100,=,,,,19706283,O=C(NCCSC(=O)C[C@](CC(=O)O)(O)C)CCNC(=O)[C@@H](C(COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1OP(=O)(O)O)O)n1cnc2c1ncnc2N)O)O)(C)C)O
hydroxymethylglutaryl-CoA synthase 1,638,Hmgcs1,P17425,,,,,,Rat,"L-659,699",5886,,,178102510,Inhibitor,Unknown,,f,,,pIC50,0,7,0,IC50,0,100,0,=,,,,2890166,OC[C@H]1C(=O)O[C@@H]1CCCC[C@H](C/C(=C/C(=C/C(=O)O)/C)/C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,JNJ-38431055,5727,,,178102353,Agonist,Agonist,,f,,,pEC50,0,7.3,0,-,0,0,0,=,,,,22264481,COc1c(ncnc1Nc1ccc(nc1C)S(=O)(=O)C)OC1CCN(CC1)C(=O)OC(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,lysophosphatidylethanolamine,5652,,,178102280,Agonist,Agonist,,f,,,pEC50,0,5.2,0,-,0,0,0,=,,,,15607732,[O-]P(=O)(OCCN)OC[C@@H](COC(=O)C)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,lysophosphatidylinositol,4028,,,178100854,Agonist,Agonist,,f,,,pEC50,0,5.2,0,-,0,0,0,=,,,,15607732,O[C@@H](COC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)O)O)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,N-oleoyldopamine,5552,,,178102194,Agonist,Agonist,,f,,,pEC50,0,5.5,0,-,0,0,0,=,,,,19901198,CCCCCCCC/C=CCCCCCCCC(=O)NCCc1ccc(c(c1)O)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,N-oleoylethanolamide,2661,,,135651533,Agonist,Agonist,,t,f,,pEC50,6.300000191,0,5.400000095,-,0,0,0,=,,,,16517404,CCCCCCCC/C=CCCCCCCCC(=O)NCCO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,oleoyl-lysophosphatidylcholine,3623,,,178100540,Agonist,Agonist,,f,,,pEC50,0,5.8,0,-,0,0,0,=,,,,15607732,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@H](COP(=O)(OCC[N+](C)(C)C)[O-])O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,olvanil,2488,,,135650758,Agonist,Agonist,,f,,,pEC50,0,5.1,0,-,0,0,0,=,,,,19901198,CCCCCCCC/C=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,PSN375963,3318,,,178100352,Agonist,Agonist,,f,f,,pEC50,0,5.099999905,0,-,0,0,0,=,,,,16517404,CCCCC1CCC(CC1)c1onc(n1)c1ccncc1
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,PSN632408,3319,,,178100353,Agonist,Agonist,,f,f,,pEC50,0,5.300000191,0,-,0,0,0,=,,,,16517404,O=C(N1CCC(CC1)OCc1onc(n1)c1ccncc1)OC(C)(C)C
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,(R)-N-oleoyltyrosinol,5720,,,178102346,Agonist,Agonist,,f,,,pEC50,0,6.3,0,-,0,0,0,=,,,,19901198,CCCCCCCC/C=C/CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)O)CO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,(S)-N-oleoyltyrosinol,5721,,,178102347,Agonist,Agonist,,f,,,pEC50,0,6.2,0,-,0,0,0,=,,,,19901198,CCCCCCCC/C=CCCCCCCCC(=O)N[C@@H](Cc1ccc(cc1)O)CO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,N-palmitoylethanolamine,3622,,,178100539,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCCCCCCCCCCCC(=O)NCCO
<i>GPR119</i>,126,GPR119,Q8TDV5,,,,,,Human,SEA,3621,,,178100538,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCCCCCCCCCCCCCC(=O)NCCO
<i>GPR12</i>,86,GPR12,P47775,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Full agonist,,t,,,pEC50,6.97,0,5.51,EC50,3100,0,1200,=,,,,12220620,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
<i>GPR12</i>,86,GPR12,P47775,,,,,,Human,sphingosylphosphorylcholine,4032,,,135651564,Agonist,Full agonist,,f,,,pEC50,7.49,0,7.18,EC50,66,0,32,=,,,,12574419,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(OCC[N+](C)(C)C)[O-])N)O
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,JNJ-63533054,8766,,,252827424,Agonist,Agonist,,f,t,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,26349500,O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,LP-360924,8773,,,252827431,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,19525486,COCCCNc1nc(Nc2nc(c(s2)C(=O)N2CCN(CC2)c2ncccn2)c2ccccc2)nc(n1)OC
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-phenylalanine,3313,,,178100347,Agonist,Agonist,,t,t,,pKi,0,3.059999943,0,Ki,0,872000,0,=,Inhibition equilibrium constant from a radioligand membrane binding assay.,,,26349500,N[C@H](C(=O)O)Cc1ccccc1
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-phenylalanine,3313,,,178100347,Agonist,Agonist,,t,t,,pEC50,0,3.49000001,0,EC50,0,320000,0,=,,,,24826842,N[C@H](C(=O)O)Cc1ccccc1
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-phenylalanine,3313,,,178100347,Agonist,Agonist,,t,t,,pIC50,0,4.510000229,0,IC50,0,31000,0,=,Measured using a GTP&gamma;S assay in transfected COS7 cells.,,,26349500,N[C@H](C(=O)O)Cc1ccccc1
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-tryptophan,717,,,135651515,Agonist,Agonist,,t,t,,pEC50,0,3.660000086,0,EC50,0,220000,0,=,,,,24826842,OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-tryptophan,717,,,135651515,Agonist,Agonist,,t,t,,pIC50,0,4.590000153,0,IC50,0,26000,0,=,Measured using a GTP&gamma;S assay in transfected COS7 cells.,,,26349500,OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,L-tryptophan,717,,,135651515,Agonist,Agonist,,t,t,,pKi,0,3.130000114,0,Ki,0,738000,0,=,Inhibition equilibrium constant from a radioligand membrane binding assay.,,,26349500,OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,LP-471756,8774,,,252827432,Antagonist,Antagonist,,f,f,,pIC50,0,6.190000057,0,IC50,0,640,0,=,,,,19525486,Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1
<i>GPR139</i>,130,GPR139,Q6DWJ6,,,,,,Human,NCRW0005-F05,8775,,,252827433,Antagonist,Antagonist,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,26027661,COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F
<i>GPR143</i>,203,GPR143,P51810,,,,,,Human,levodopa,3639,,,178100545,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,18828673,OC(=O)[C@H](Cc1ccc(c(c1)O)O)N
<i>GPR174</i>,145,GPR174,Q9BXC1,,,,,,Human,lysophosphatidylserine,4064,,,178100887,Agonist,Full agonist,,t,,,pEC50,0,7.1,0,EC50,0,81,0,=,,,,22983457,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OC[C@@H](C(=O)O)N)O)O
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,LTC<sub>4</sub>,3354,,,135651512,Agonist,Agonist,,t,,,pEC50,9.48,0,7.83,EC50,14.8,0,0.33,=,[<sup>35</sup>S]GTP&gamma;S binding to 1321N1 cell membranes expressing hGPR17.,,,16990797,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,LTC<sub>4</sub>,3354,,,135651512,Agonist,Agonist,,t,,,pEC50,0,9.13,0,EC50,0,0.74,0,=,,,,18974869,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,LTD<sub>4</sub>,3353,,,135651513,Agonist,Agonist,,t,,,pEC50,8.36,0,8.14,EC50,7.2,0,4.4,=,[<sup>35</sup>S]GTP&gamma;S binding to COS-7 cell membranes expressing hGPR17.,,,16990797,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,LTD<sub>4</sub>,3353,,,135651513,Agonist,Agonist,,t,,,pEC50,0,9.2,0,EC50,0,0.63,0,=,,,,18974869,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,LTE<sub>4</sub>,3352,,,135651514,Agonist,Agonist,,t,,,pEC50,0,9.51,0,EC50,0,0.31,0,=,,,,18974869,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,montelukast,3340,,,178100370,Antagonist,Antagonist,,f,,,pIC50,0,7.21,0,IC50,0,61,0,=,,,,18974869,OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,N-arachidonoylglycine,3635,,,178100542,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,16844083,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCC(=O)O
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,O-1602,5525,,,178102168,Agonist,Agonist,,f,,,pEC50,0,7.19,0,EC50,0,65.3,0,=,,,,21595653,CC1=C[C@H]([C@@H](CC1)C(=C)C)c1c(C)cc(cc1O)O
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Agonist,Full agonist,,t,,,pEC50,0,6.02,0,EC50,0,960,0,=,,,,21595653,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
<i>GPR18</i>,89,GPR18,Q14330,,,,,,Human,N-arachidonoylglycine,3635,,,178100542,Agonist,Full agonist,,t,,,pEC50,7.7,0,7.35,EC50,44.5,0,20,=,,,,21595653,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCC(=O)O
<i>GPR32</i>,99,GPR32,O75388,,,,,,Human,LXA<sub>4</sub>,1034,,,135651504,Agonist,Full agonist,,t,f,,pEC50,0,9.699999809,0,EC50,0,0.200000003,0,=,,,,20080636,CCCCC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)O)O
<i>GPR32</i>,99,GPR32,O75388,,,,,,Human,resolvin D1,3934,,,178100762,Agonist,Full agonist,,t,f,,pEC50,0,11.06000042,0,EC50,0,0.0088,0,=,,,,20080636,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@@H]([C@H](C/C=CCCC(=O)O)O)O)O
<i>GPR32</i>,99,GPR32,O75388,,,,,,Human,RvD1-ME,5555,,,178102196,Agonist,Full agonist,,f,f,,pEC50,0,11.34000015,0,EC50,0,0.0046,0,=,,,,22449948,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@H]([C@H](C/C=CCCC(=O)OC)O)O)O
<i>GPR34</i>,101,Gpr34,Q9R1K6,,,,,,Mouse,lysophosphatidylserine,4064,,,178100887,Agonist,Agonist,,t,,,pEC50,0,7.31,0,EC50,0,49,0,=,,,,16460680,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OC[C@@H](C(=O)O)N)O)O
<i>GPR34</i>,101,GPR34,Q9UPC5,,,,,,Human,lysophosphatidylserine,4064,,,178100887,Agonist,Full agonist,,t,,,pEC50,6.89,0,6.57,EC50,270,0,129,=,,,,16460680,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OC[C@@H](C(=O)O)N)O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,CXCL17,6479,CXCL17,Human,178103093,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,As assessed by ability to induce GRR35-dependent calcium flux.,,,25411203,
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,furosemide,4839,,,178101541,Agonist,Agonist,,f,,,pEC50,5.63,0,5.21,-,0,0,0,=,,,,22236570,OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N
<i>GPR35</i>,102,Gpr35,Q9ES90,,,,,,Mouse,kynurenic acid,2918,,,135651497,Agonist,Agonist,,t,,,pEC50,0,4.96,0,,0,0,0,,,,,16754668,OC(=O)c1cc(=O)c2c([nH]1)cccc2
<i>GPR35</i>,102,Gpr35,Q33BM1,,,,,,Rat,kynurenic acid,2918,,,135651497,Agonist,Agonist,,t,,,pEC50,0,5.15,0,,0,0,0,,,,,16754668,OC(=O)c1cc(=O)c2c([nH]1)cccc2
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,kynurenic acid,2918,,,135651497,Agonist,Agonist,,t,,,pEC50,4.41,0,3.9,-,0,0,0,=,,,,16754668,OC(=O)c1cc(=O)c2c([nH]1)cccc2
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,lodoxamide,9743,,,0,Agonist,Agonist,,f,f,,pEC50,0,9,0,EC50,0,1,0,=,In an AP-TGF-&alpha; shedding assay using GPR35 expressing HEK293 cells.,,,29068046,N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl
<i>GPR35</i>,102,Gpr35,Q33BM1,,,,,,Rat,pamoic acid,2920,,,135650787,Agonist,Agonist,,f,,,pEC50,5,0,3,,0,0,0,,,,,20919992,OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,pamoic acid,2920,,,135650787,Agonist,Agonist,,f,,,pEC50,0,7.29,0,,0,0,0,,,,,20919992,OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O
<i>GPR37</i>,103,GPR37,O15354,,,,,,Human,neuropeptide head activator,2496,,,135652325,Agonist,Agonist,,f,,,pEC50,8.48,0,7.96,EC50,11,0,3.3,=,,,,16443751,
<i>GPR37</i>,103,GPR37,O15354,,,,,,Human,prosaptide,6067,PSAP,Human,178102688,Agonist,Agonist,,t,,,pEC50,0,8.15,0,EC50,0,7,0,=,,,,23690594,
<i>GPR37L1</i>,104,GPR37L1,O60883,,,,,,Human,prosaptide,6067,PSAP,Human,178102688,Agonist,Agonist,,t,,,pEC50,0,8.3,0,EC50,0,5,0,=,,,,23690594,
<i>GPR3</i>,83,GPR3,P46089,,,,,,Human,diphenyleneiodonium chloride,7802,,,223366133,Agonist,Full agonist,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,24633425,c1ccc2c(c1)[I+]c1c2cccc1.[Cl-]
<i>GPR3</i>,83,GPR3,P46089,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Full agonist,,t,,,pEC50,7.7,0,7.1,,0,0,0,,,,,12220620,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
<i>GPR52</i>,108,GPR52,Q9Y2T5,,,,,,Human,"derivative 17 [Nakahata <i>et al</i>., 2018]",9804,,,0,Agonist,Agonist,,f,f,,pEC50,0,7.679999828,0,EC50,0,21,0,=,,,,0,OCCNC(=O)c1c(C)nn(c1CO)c1cccc2c1sc(c2)Cc1cccc(c1)C(F)(F)F
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,CP55940,730,,,135650130,Agonist,Agonist,,f,,,pEC50,0,8.3,0,EC50,0,5,0,=,,,,17876302,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Agonist,Agonist,,f,,,pEC50,0,8.1,0,EC50,0,8,0,=,,,,17876302,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,GSK494581A,5562,,,178102200,Agonist,Agonist,,f,,,pEC50,0,8.19,0,EC50,0,6.5,0,=,,,,21233197,COC(c1ccc(c(c1)F)N1CCN(CC1)C(=O)c1cc(ccc1c1ccc(cc1)F)S(=O)(=O)C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,GSK575594A,5561,,,178102199,Agonist,Agonist,,f,,,pEC50,0,8.17,0,EC50,0,6.8,0,=,,,,21233197,Fc1ccc(cc1)c1ccc(cc1C(=O)N1CCN(CC1)c1ccc(cc1F)N)S(=O)(=O)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,HU-210,731,,,135650355,Agonist,Agonist,,f,,,pEC50,0,7.59,0,EC50,0,26,0,=,,,,17876302,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,JWH015,5558,,,178102197,Agonist,Agonist,,f,,,pEC50,0,8.4,0,EC50,0,4,0,=,,,,17876302,CCCn1c(C)c(c2c1cccc2)C(=O)c1cccc2c1cccc2
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,lysophosphatidylinositol,4028,,,178100854,Agonist,Agonist,,t,,,pEC50,7.31,0,5.5,EC50,1000,0,49,=,,,,17765871,O[C@@H](COC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)O)O)O
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,N-oleoylethanolamide,2661,,,135651533,Agonist,Agonist,,f,,,pEC50,6.5,0,6.25,EC50,565,0,315,=,,,,17876302,CCCCCCCC/C=CCCCCCCCC(=O)NCCO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,N-palmitoylethanolamine,3622,,,178100539,Agonist,Agonist,,t,f,,pEC50,0,8.399999619,0,EC50,0,4,0,=,,,,17876302,CCCCCCCCCCCCCCCC(=O)NCCO
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,O-1602,5525,,,178102168,Agonist,Agonist,,f,,,pEC50,8.85,0,7.89,EC50,13,0,1.4,=,,,,10381763,CC1=C[C@H]([C@@H](CC1)C(=C)C)c1c(C)cc(cc1O)O
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,O-arachidonoyl ethanolamine,5554,,,178102195,Agonist,Agonist,,f,,,pEC50,0,7.92,0,EC50,0,12,0,=,,,,17876302,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)OCCN
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,"CP55,244",5568,,,178102205,Agonist,Inverse agonist,,f,,,pIC50,0,8.3,0,-,0,0,0,=,,,,21233197,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)C[C@H]2[C@H]1C[C@@H](CO)CC2)(C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,rimonabant,743,,,135650901,Antagonist,Antagonist,,f,,,pEC50,6.55,0,5.26,EC50,5500,0,280,=,,,,20136841,Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,"CP55,667",5570,,,178102206,Antagonist,Inverse agonist,,f,,,pIC50,0,6.8,0,-,0,0,0,=,,,,21233197,CCCCCCC(c1ccc(c(c1)O)C1CC(O)CCC1CCCO)(C)C
<i>GPR63</i>,112,GPR63,Q9BZJ6,,,,,,Human,dihydrosphingosine 1-phosphate,2921,,,135650184,Agonist,Full agonist,,t,,,pEC50,0,6.17,0,EC50,0,680,0,=,,,,12618218,CCCCCCCCCCCCCCC[C@H]([C@H](COP(=O)(O)O)N)O
<i>GPR63</i>,112,GPR63,Q9BZJ6,,,,,,Human,dioleoylphosphatidic acid,5512,,,178102157,Agonist,Full agonist,,t,,,pEC50,0,6.3,0,EC50,0,500,0,=,,,,12618218,CCCCCCCC/C=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O)O
<i>GPR63</i>,112,GPR63,Q9BZJ6,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Full agonist,,t,,,pEC50,6.18,0,6.1,EC50,800,0,660,=,,,,12618218,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
<i>GPR68</i>,114,GPR68,Q15743,,,,,,Human,lorazepam,5884,,,178102508,Allosteric modulator,Positive,lorazepam characterised as a non-selective GPR68 positive allosteric modulator for the agonist proton in cAMP production,f,f,,-,0,0,0,-,0,0,0,=,,,,26550826,Clc1ccc2c(c1)C(=NC(C(=O)N2)O)c1ccccc1Cl
<i>GPR6</i>,85,Gpr6,Q6YNI2,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Full agonist,,t,,,pEC50,7.66,0,7.25,EC50,56,0,22,=,,,,12220620,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
<i>GPR83</i>,119,Gpr83,P30731,,,,,,Mouse,PEN,9140,Pcsk1n,Rat,315661225,Agonist,Agonist,,f,f,,pKd,0,8.100000381,0,Kd,0,8,0,=,N-terminally tyrosinated radioidodinated rPEN binding to mouse GPR83 in hypothalamic membrane preparations.,,,27117253,
<i>GPR83</i>,119,Gpr83,P30731,,,,,,Mouse,PEN,9139,Pcsk1n,Mouse,315661224,Agonist,Agonist,,f,f,,pEC50,0,6.960000038,0,EC50,0,110,0,=,Low affinity binding site of mouse GPR83,,,27117253,
<i>GPR83</i>,119,Gpr83,P30731,,,,,,Mouse,PEN,9139,Pcsk1n,Mouse,315661224,Agonist,Agonist,,f,f,,pEC50,0,10.73999977,0,EC50,0,0.017999999,0,=,High affinity binding site of mouse GPR83,,,27117253,
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,lauric acid,5534,,,178102176,Agonist,Agonist,,f,,,pEC50,0,5.05,0,EC50,0,9000,0,=,,,,16966319,CCCCCCCCCCCC(=O)O
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,decanoic acid,5532,,,178102174,Agonist,Full agonist,,f,,,pEC50,5.4,0,5,-,0,0,0,=,,,,16966319,CCCCCCCCCC(=O)O
<i>GPR87</i>,122,GPR87,Q9BY21,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pEC50,0,7.44,0,-,0,0,0,=,,,,17905198,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
<i>GPR87</i>,122,GPR87,Q9BY21,,,,,,Human,dioctanoylglycerol pyrophosphate,2916,,,135650190,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,17905198,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)COP(=O)(OP(=O)(O)O)O
<i>GPR87</i>,122,GPR87,Q9BY21,,,,,,Human,Ki16425,2907,,,135650457,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,17905198,OC(=O)CCSCc1ccc(cc1)c1onc(c1NC(=O)OC(c1ccc(cc1Cl)C)C)C
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.31000042,0,IC50,0,4.900000095,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
<i>LGR4</i>,147,LGR4,Q9BXB1,,,,,,Human,R-spondin-1,3697,RSPO1,Human,178100586,Agonist,Full agonist,,t,f,,pEC50,0,10.69999981,0,EC50,0,0.02,0,=,,,,21693646,
<i>LGR4</i>,147,LGR4,Q9BXB1,,,,,,Human,R-spondin-2,3698,RSPO2,Human,178100587,Agonist,Full agonist,,t,f,,pEC50,0,12.52000046,0,EC50,0,0.0003,0,=,,,,21693646,
<i>LGR4</i>,147,LGR4,Q9BXB1,,,,,,Human,R-spondin-3,3699,RSPO3,Human,178100588,Agonist,Full agonist,,f,f,,pKd,0,8.659999847,0,Kd,0,2.200000048,0,=,,,,21909076,
<i>LGR4</i>,147,LGR4,Q9BXB1,,,,,,Human,R-spondin-3,3699,RSPO3,Human,178100588,Agonist,Full agonist,,t,f,,pEC50,0,10.69999981,0,EC50,0,0.02,0,=,,,,21693646,
<i>LGR4</i>,147,LGR4,Q9BXB1,,,,,,Human,R-spondin-4,3700,RSPO4,Human,178100589,Agonist,Full agonist,,t,f,,pEC50,0,10.05000019,0,EC50,0,0.090000004,0,=,,,,21693646,
<i>LGR5</i>,148,LGR5,O75473,,,,,,Human,R-spondin-1,3697,RSPO1,Human,178100586,Agonist,Full agonist,,t,f,,pEC50,0,11.10000038,0,EC50,0,0.008,0,=,,,,21693646,
<i>LGR5</i>,148,LGR5,O75473,,,,,,Human,R-spondin-2,3698,RSPO2,Human,178100587,Agonist,Full agonist,,t,f,,pEC50,0,12,0,EC50,0,0.001,0,=,,,,21693646,
<i>LGR5</i>,148,LGR5,O75473,,,,,,Human,R-spondin-3,3699,RSPO3,Human,178100588,Agonist,Full agonist,,t,f,,pEC50,0,11,0,EC50,0,0.01,0,=,,,,21693646,
<i>LGR5</i>,148,LGR5,O75473,,,,,,Human,R-spondin-4,3700,RSPO4,Human,178100589,Agonist,Full agonist,,t,f,,pEC50,0,9.399999619,0,EC50,0,0.400000006,0,=,,,,21693646,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-3,3699,RSPO3,Human,178100588,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,21727895,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-1,5539,Rspo1,Mouse,178102181,Agonist,Full agonist,,f,f,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,22615920,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-1,3697,RSPO1,Human,178100586,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,21727895,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-2,5540,Rspo2,Mouse,178102182,Agonist,Full agonist,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,22615920,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-2,3698,RSPO2,Human,178100587,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,21727895,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-3,5541,Rspo3,Mouse,178102183,Agonist,Full agonist,,f,f,,pIC50,0,8.770000458,0,IC50,0,1.700000048,0,=,,,,22615920,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-4,3700,RSPO4,Human,178100589,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,21727895,
<i>LGR6</i>,149,LGR6,Q9HBX8,,,,,,Human,R-spondin-4,4383,Rspo4,Mouse,178101191,Agonist,Full agonist,,f,,,pIC50,0,8.15,0,IC50,0,7,0,=,,,,22615920,
<i>MAS1</i>,150,Mas1,P12526,,,,,,Rat,MBP7,7038,,,178103617,Agonist,Full agonist,,f,f,,pEC50,0,4.440000057,0,EC50,0,36410,0,=,,,,16336942,
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,neuropeptide FF,1479,NPFF|Npff|Npff,Human|Mouse|Rat,135651833,Agonist,Full agonist,,f,f,,pEC50,0,6.400000095,0,EC50,0,400,0,=,,,,11551509,
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,[D-Ala<sup>7</sup>]-angiotensin(1-7),6081,,,178102702,Antagonist,Antagonist,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,12829792,
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,[D-Ala<sup>7</sup>]-angiotensin(1-7),6081,,,178102702,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,Ki,0,4.96,0,=,,,,21670420,
immunoglobulin heavy constant epsilon,2741,IGHE,P01854,,,,,,Human,ligelizumab,8997,,,310264775,Antibody,Binding,,f,t,,pKd,11.82999992,0,9.859999657,Kd,0.138999999,0,0.00147,=,<i>In vitro</i> binding affinity,,,25200415,
immunoglobulin heavy constant epsilon,2741,IGHE,P01854,,,,,,Human,omalizumab,6890,,,178103472,Antibody,Binding,,f,t,,pKd,0,7.590000153,0,Kd,0,26,0,=,F(ab) apparent binding affinity of e25 measured by surface plasmon resonance,,,0,
immunoglobulin heavy constant epsilon,2741,IGHE,P01854,,,,,,Human,omalizumab,6890,,,178103472,Antibody,Binding,,f,t,,pKd,0,8.159999847,0,Kd,0,6.980000019,0,=,<i>In vitro</i> binding affinity,,,25200415,
immunoglobulin heavy constant epsilon,2741,IGHE,P01854,,,,,,Human,quilizumab,8998,,,310264776,Antibody,Binding,,f,t,,pKd,0,8.819999695,0,Kd,0,1.5,0,=,,,,0,
IMPase 1,1463,IMPA1,P29218,,,,,,Human,Li<sup>+</sup>,5212,,,178101897,Inhibitor,Inhibition,,f,t,,pKi,0,3.5,0,-,0,0,0,=,,,,1377913,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,(R)-ZINC-3573,9566,,,336446952,Agonist,Agonist,,f,t,,pEC50,0,6.119999886,0,EC50,0,760,0,=,,,,28288109,CN([C@@H]1CCN(C1)c1cc(nc2n1ncc2)c1ccccc1)C
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Agonist,,f,f,,pEC50,0,5.380000114,0,EC50,0,4170,0,=,In a calcium mobilisation assay.,,,23396314,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,f,f,,pEC50,7.599999905,0,6.900000095,EC50,48.5,0,25,=,,,,12915402,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,PAMP-12 (human),4056,,,178100880,Agonist,Full agonist,,f,,,pEC50,7.68,0,7.24,EC50,57.2,0,20.8,=,,,,15823563,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,PAMP-20,4057,ADM,Human,178100881,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,15823563,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,QWF,9568,,,336446954,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,27734033,
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,epacadostat,8221,,,249565901,Inhibitor,Inhibition,,f,t,,pIC50,0,7.170000076,0,IC50,0,67,0,=,,,,19507862,O=N/C(=c1/[nH]onc1NCCNS(=O)(=O)N)/Nc1ccc(c(c1)Br)F
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,necrostatin-1,9750,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,4.940000057,0,Ki,0,11600,0,=,Using a purified recombinant human IDO enzyme for <i>in vitro>/i> assays.,,,15711557,S=C1NC(C(=O)N1C)Cc1c[nH]c2c1cccc2
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,NLG919,9019,,,315661104,Inhibitor,Inhibition,,f,f,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,0,OC(C1CCCCC1)CC1c2ccccc2c2n1cnc2
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,PF-06840003,9565,,,336446951,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,Measuring inhibition of IDO1-induced kynurenine production <i>in vitro</i>.,,,0,Fc1cc2c(C3CC(=O)NC3=O)c[nH]c2cc1
Inducible NOS,1250,NOS2,P35228,,,,,,Human,L-NNA,8759,,,252827417,Inhibitor,Inhibition,,f,f,,pKi,0,6.170000076,0,Ki,0,670,0,=,,,,9667974,[O-][N+](=O)NC(=NCCC[C@@H](C(=O)O)N)N
Inducible NOS,1250,NOS2,P35228,,,,,,Human,NIL,5231,,,178101915,Inhibitor,Inhibition,,f,,,pIC50,0,5.5,0,IC50,0,3160,0,,,,,7525961,CC(=N)NCCCC[C@H](C(=O)O)N
Inducible NOS,1250,NOS2,P35228,,,,,,Human,PIBTU,5246,,,178101930,Inhibitor,Inhibition,,f,,,pIC50,0,7.3,0,IC50,0,50.1,0,,,,,7523409,NC(=N)SCCc1cccc(c1)CCSC(=N)N
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,IKK-2 inhibitor IV,5986,,,178102609,Inhibitor,Inhibition,,f,t,,pIC50,0,7.75,0,IC50,0,17.89999962,0,=,FRET measurement using recombinant human IKK2 (residues 1-756),,,15316093,NC(=O)Nc1sc(cc1C(=O)N)c1ccc(cc1)F
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,MLN-120B,5694,,,178102321,Inhibitor,Inhibition,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,16525037,COc1c(Cl)cc2c(c1NC(=O)c1cccnc1C)[nH]c1c2ccnc1
inhibitor of nuclear factor kappa B kinase subunit beta,2039,IKBKB,O14920,,,,,,Human,PHA-408,9398,,,328083500,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,19168710,CN1CCN(CC1)c1ncc(c(c1)C(=O)Nc1ccc2c(c1)c1c(CC2)c(nn1c1ccc(cc1)F)C(=O)N)Cl
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,MPI-0485520,9580,,,336446966,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,Using a Kinase Hotspot&reg; assay.,,,0,N#Cc1cc(ccc1N1CCCC1)c1ccnc(n1)Nc1ccc2c(c1)CC(=O)N2
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,MRT67307,8062,,,249565742,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,21138416,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1cccc(c1)CN1CCOCC1
inhibitor of nuclear factor kappa B kinase subunit epsilon,2040,IKBKE,Q14164,,,,,,Human,SR8185,9578,,,336446964,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,In an enzyme assay.,,,24150799,N#Cc1cc(ccc1N1CCCC1)c1ccnc(n1)Nc1cccc(c1)NC(=O)N1CCCC1
<i>N</i>-Acylethanolamine acid amidase,1402,Naaa,Q5KTC7,,,,,,Rat,<i>S</i>-OOPP,6493,,,178103107,Inhibitor,Inhibition,,f,,,pIC50,0,6.4,0,-,0,0,0,=,,,,19926854,O=C(N[C@H]1COC1=O)CCc1ccccc1
inosine monophosphate dehydrogenase 1,2624,IMPDH1,P20839,,,,,,Human,mycophenolate mofetil,6831,,,178103437,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1c(C/C=C(/CCC(=O)OCCN2CCOCC2)C)c(O)c2c(c1C)COC2=O
inosine monophosphate dehydrogenase 1,2624,IMPDH1,P20839,,,,,,Human,mycophenolic acid,6832,,,178103438,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,Reference does not distinguish which enzyme isoform is assayed,,,1967654,COc1c(C/C=C(/CCC(=O)O)C)c(O)c2c(c1C)COC2=O
inosine monophosphate dehydrogenase 1,2624,IMPDH1,P20839,,,,,,Human,ribavirin,6842,,,178103448,Inhibitor,Inhibition,,f,t,,pIC50,6,0,5.599999905,IC50,2500,0,1000,=,"<i>In vitro</i> inhibition of IMPDH (isoform not specified, human and mouse assayed)",,,22555152,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(n1)C(=O)N
inosine monophosphate dehydrogenase 2,2625,IMPDH2,P12268,,,,,,Human,mycophenolate mofetil,6831,,,178103437,Inhibitor,Inhibition,See <b>Inhibitor Comment</b> below,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1c(C/C=C(/CCC(=O)OCCN2CCOCC2)C)c(O)c2c(c1C)COC2=O
inosine monophosphate dehydrogenase 2,2625,IMPDH2,P12268,,,,,,Human,mycophenolic acid,6832,,,178103438,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,Reference does not distinguish which enzyme isoform is assayed,,,1967654,COc1c(C/C=C(/CCC(=O)O)C)c(O)c2c(c1C)COC2=O
inosine monophosphate dehydrogenase 2,2625,IMPDH2,P12268,,,,,,Human,ribavirin,6842,,,178103448,Inhibitor,Inhibition,,f,t,,pIC50,6,0,5.599999905,IC50,2500,0,1000,=,"<i>In vitro</i> inhibition of IMPDH (isoform not specified, human and mouse assayed)",,,22555152,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(n1)C(=O)N
INPP5D,1455,INPP5D,Q92835,,,,,,Human,rosiptor,9249,,,315661324,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,23121445,NC[C@@H]1[C@H](CC[C@]2([C@H]1CCC2=C)C)[C@@]1(C)CC[C@@H](C[C@@H]1CO)O
insulin degrading enzyme,2371,IDE,P14735,,,,,,Human,NTE-1,8596,,,252166797,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,26085101,COC(=O)NC[C@H](c1ccc(cc1)OCCCCCc1ccc(cc1)NC(=O)[C@@H](N1CCC[C@@H](C1=O)N)C1CCCCC1)Cc1cnc2c(c1)cccc2
insulin degrading enzyme,2371,IDE,P14735,,,,,,Human,NTE-2,8597,,,252166798,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,26085101,COC(=O)NC[C@H](c1cc(CCCCCc2ccc(cc2)NC(=O)[C@@H](N2CCC[C@@H](C2=O)N)C2CCCCC2)ccc1F)Cc1cnc2c(c1)cccc2
insulin degrading enzyme,2371,IDE,P14735,,,,,,Human,quinoline 2,8599,,,252166800,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,26085101,O=C(OC(C)(C)C)NC[C@H](c1cc(F)ccc1F)Cc1cnc2c(c1)cccc2
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,insulin-like growth factor 1,4971,IGF1,Human,178101669,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,insulin-like growth factor 2,4972,IGF2,Human,178101670,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,emactuzumab,8944,,,310264725,Antibody,Binding,,f,t,,pKd,0,9.539999962,0,Kd,0,0.289999992,0,=,Affinity data measured by surface plasmon resonance.,,,0,
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,MM-141,8930,,,310264711,Antibody,Binding,,f,t,,pKd,0,9,0,Kd,0,1,0,<,,,,24282274,
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,GSK1511931,8644,,,252166844,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,19081716,COc1cc(ccc1Nc1nc(Nc2cccc3c2cccn3)c2c(n1)[nH]cc2)N1CCN(CC1)C(C)C
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,GSK-1838705A,5683,,,178102310,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19825801,CNC(=O)c1c(cccc1F)Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2c1cc[nH]2
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,GSK-1838705A,5683,,,178102310,Inhibitor,Inhibition,,f,t,,pKd,0,8.149999619,0,Kd,0,7,0,=,,,,22037378,CNC(=O)c1c(cccc1F)Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2c1cc[nH]2
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,linsitinib,7423,,,178103995,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,21425998,Nc1nccn2c1c(nc2[C@@H]1C[C@](C1)(C)O)c1ccc2c(c1)nc(cc2)c1ccccc1
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,NVP-AEW541,8067,,,249565747,Inhibitor,Inhibition,,f,t,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,15050915,Nc1ncnc2c1c(cn2C1CC(C1)CN1CCC1)c1cccc(c1)OCc1ccccc1
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,NVP-TAE 226,9382,,,328083484,Inhibitor,Inhibition,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,~,<i>In vitro</i> kinase assay with recombinant kinase domains and peptide substrates.,,,17431114,CNC(=O)c1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCOCC1
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,picropodophyllin,7873,,,223366202,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,~,,,,14729630,COc1cc(cc(c1OC)OC)[C@H]1[C@@H]2C(=O)OC[C@@H]2[C@H](c2c1cc1OCOc1c2)O
Insulin-like growth factor I receptor,1801,IGF1R,P08069,,,,,,Human,PQ401,5048,,,178101743,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1000,0,<,,,,16648580,COc1ccc(cc1NC(=O)Nc1cc(C)nc2c1cccc2)Cl
Insulin receptor,1800,INSR,P06213,,,,,,Human,insulin,5012,INS,Human,178101709,Agonist,Agonist,,t,t,,-,0,0,0,-,0,0,0,=,,,,0,
Insulin receptor,1800,INSR,P06213,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,15598814,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
Insulin receptor,1800,INSR,P06213,,,,,,Human,GSK-1838705A,5683,,,178102310,Inhibitor,Inhibition,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.600000024,0,=,,,,19825801,CNC(=O)c1c(cccc1F)Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2c1cc[nH]2
Insulin receptor,1800,INSR,P06213,,,,,,Human,linsitinib,7423,,,178103995,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,,,,21425998,Nc1nccn2c1c(nc2[C@@H]1C[C@](C1)(C)O)c1ccc2c(c1)nc(cc2)c1ccccc1
Insulin receptor,1800,INSR,P06213,,,,,,Human,NVP-TAE 226,9382,,,328083484,Inhibitor,Inhibition,,f,f,,pIC50,7.590000153,0,7.210000038,IC50,61,0,26,=,<i>In vitro</i> kinase assay with recombinant kinase domains and peptide substrates.,,,17431114,CNC(=O)c1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCOCC1
Insulin receptor-related receptor,1802,INSRR,P14616,,,,,,Human,linsitinib,7423,,,178103995,Inhibitor,Inhibition,,f,f,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,21425998,Nc1nccn2c1c(nc2[C@@H]1C[C@](C1)(C)O)c1ccc2c(c1)nc(cc2)c1ccccc1
integrin &alpha;1&beta;1,2577,ITGA1|ITGB1,P05556|P56199,,,,,,Human,obtustatin,6581,,,178103195,Inhibitor,Inhibition,,f,,,pIC50,0,9.1,0,-,0,0,0,=,,,,12727812,
"integrin, alpha 3 subunit (antigen CD49C, alpha 3 subunit of VLA-3 receptor)",2442,ITGA3,P26006,,,,,,Human,peptide ligand 2 [PMID: 19055415],8849,,,252827506,None,Binding,,f,f,,pIC50,0,7.239999771,0,IC50,0,57,0,=,,,,19055415,O[C@@H]1C[C@@H]2N(C1)C(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC2=O)CC(=O)N)C(=O)N)N)Cc1ccc(c(c1)[N+](=O)[O-])O
integrin &alpha;4&beta;1,2580,ITGA4|ITGB1,P05556|P13612,,,,,,Human,natalizumab,6591,,,178103204,Antibody,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,15293871,
integrin &alpha;4&beta;7,2770,ITGA4|ITGB7,P13612|P26010,,,,,,Human,etrolizumab,8407,,,252166617,Inhibitor,Binding,,f,t,,pIC50,0,10.11999989,0,IC50,0,0.075000003,0,=,Inhibition of &beta;7-MAdCAM-1-mediated cell adhesion.,,,0,
"integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",2443,ITGA4,P13612,,,,,,Human,natalizumab,6591,,,178103204,Antibody,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,15293871,
integrin &alpha;IIb&beta;3,2579,ITGA2B|ITGB3,P05106|P17301,,,,,,Human,eptifibatide,6585,,,178103198,Inhibitor,Inhibition,,f,t,,pIC50,6.849999905,0,6.239999771,IC50,570,0,140,=,inhibition of human platelet aggregation. The IC50 varies according to the anti-coagulant used during blood collection.,,,10999999,OC(=O)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)Cc1c[nH]c3c1cccc3)CCC2)C(=O)N
integrin &alpha;IIb&beta;3,2579,ITGA2B|ITGB3,P05106|P17301,,,,,,Human,G4120,6588,,,178103201,Inhibitor,Inhibition,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,7955174,
integrin &alpha;IIb&beta;3,2579,ITGA2B|ITGB3,P05106|P17301,,,,,,Human,GR 144053,6587,,,178103200,Inhibitor,Inhibition,,f,f,,pIC50,0,7.429999828,0,IC50,0,37,0,=,Inhibition of ADP (10 &micro;M)-induced aggregation in human gel-filtered platelets.,,,7966149,OC(=O)CN1CCC(CC1)N1CCN(CC1)c1ccc(cc1)C(=N)N
"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",2451,ITGAL,P20701,,,,,,Human,lifitegrast,7533,,,187051834,Antagonist,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,24900456,OC(=O)[C@@H](NC(=O)c1c(Cl)cc2c(c1Cl)CCN(C2)C(=O)c1ccc2c(c1)occ2)Cc1cccc(c1)S(=O)(=O)C
"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",2451,ITGAL,P20701,,,,,,Human,efalizumab,6593,,,178103206,Antibody,Binding,,f,t,,pKd,0,11.39999962,0,Kd,0,0.004,0,=,Binding of humanized MHM24 to human CD11a on Jurkat cells.,,,0,
"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",2451,ITGAL,P20701,,,,,,Human,rovelizumab,9598,,,340590228,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,9784282,
integrin &alpha;V&beta;3,2583,ITGAV|ITGB3,P05106|P06756,,,,,,Human,etaracizumab,6596,,,178103209,Antibody,Binding,,f,t,,pKd,0,6.340000153,0,Kd,0,458,0,=,,,,0,
integrin &alpha;V&beta;3,2583,ITGAV|ITGB3,P05106|P06756,,,,,,Human,echistatin,6594,,,178103207,Inhibitor,Inhibition,,f,,,pIC50,0,11.7,0,-,0,0,0,=,,,,15634795,
integrin &alpha;V&beta;3,2583,ITGAV|ITGB3,P05106|P06756,,,,,,Human,P11,6595,,,178103208,Inhibitor,Inhibition,,f,,,pIC50,0,11.6,0,-,0,0,0,=,,,,15634795,
"integrin, alpha V subunit",2453,ITGAV,P06756,,,,,,Human,MK-0429,9689,,,348353648,Antagonist,Antagonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,Binding to the &alpha;v&beta;3 integrin using a scintillation-proximity assay (SPAV3).,,,14561098,COc1ccc(cn1)[C@@H](N1CCN(C1=O)CCCc1ccc2c(n1)NCCC2)CC(=O)O
"integrin, beta 2 subunit (complement component 3 receptor 3 and 4 subunit)",2456,ITGB2,P05107,,,,,,Human,rovelizumab,9598,,,340590228,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,9784282,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;10,4956,IFNA10,Human,178101654,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;1/13,4955,IFNA1|IFNA13,Human,178101653,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;14,4957,IFNA14,Human,178101655,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;16,4958,IFNA16,Human,178101656,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;17,4959,IFNA17,Human,178101657,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;2,4960,IFNA2,Human,178101658,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;21,4961,IFNA21,Human,178101659,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;4,4962,IFNA4,Human,178101660,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;5,4963,IFNA5,Human,178101661,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;6,4964,IFNA6,Human,178101662,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;7,4965,IFNA7,Human,178101663,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&alpha;8,4966,IFNA8,Human,178101664,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&beta;,4967,IFNB1,Human,178101665,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&kappa;,4969,IFNK,Human,178101667,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,IFN-&omega;,4970,IFNW1,Human,178101668,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&alpha;/&beta; receptor,1898,IFNAR1|IFNAR2,P17181|P48551,,,,,,Human,peginterferon alfa-2b,7462,,,187051765,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,10607680,
interferon &alpha;/&beta;  receptor 1,1723,IFNAR1,P17181,,,,,,Human,IFN-&beta;,4967,IFNB1,Human,178101665,Agonist,Agonist,,t,f,,pKd,0,7.800000191,0,Kd,0,15.80000019,0,=,"Measured using a surface plasmon resonance (SPR) assay, and recombinant hIFNAR1-extracellular domain (ECD) expressed in insect cells.",,,29311663,
interferon &alpha;/&beta;  receptor 1,1723,IFNAR1,P17181,,,,,,Human,peginterferon alfa-2b,7462,,,187051765,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,10607680,
Interferon-&gamma; receptor,1899,IFNGR1|IFNGR2,P15260|P38484,,,,,,Human,IFN-&gamma;,4968,IFNG,Human,178101666,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interferon-&lambda; receptor 1,1904,IL10RB|IFNLR1,Q08334|Q8IU57,,,,,,Human,IFN-&lambda;1,4993,IFNL1,Human,178101690,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interferon-&lambda; receptor 1,1904,IL10RB|IFNLR1,Q08334|Q8IU57,,,,,,Human,IFN-&lambda;2,4991,IFNL2,Human,178101688,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interferon-&lambda; receptor 1,1904,IL10RB|IFNLR1,Q08334|Q8IU57,,,,,,Human,IFN-&lambda;3,4992,IFNL3,Human,178101689,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-10 receptor,1900,IL10RA|IL10RB,Q08334|Q13651,,,,,,Human,IL-10,4975,IL10,Human,178101673,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin 10 receptor, &alpha; subunit",1727,IL10RA,Q13651,,,,,,Human,IL-10,4975,IL10,Human,178101673,Agonist,Agonist,,f,f,,pEC50,10.30000019,0,9.699999809,EC50,0.200000003,0,0.050000001,=,,,,19161426,
Interleukin-11 receptor,2311,IL11RA|IL6ST,P40189|Q14626,,,,,,Human,IL-11,4976,IL11,Human,178101674,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-11 receptor,2311,IL11RA|IL6ST,P40189|Q14626,,,,,,Human,oprelvekin,6971,,,178103550,Agonist,Full agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,18020592,
Interleukin-12 receptor,2292,IL12RB2|IL12RB1,P42701|Q99665,,,,,,Human,IL-12,4977,IL12A|IL12B,Human,178101675,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-15 receptor,2302,IL2RG|IL15RA|IL2RB,P31785|P14784|Q13261,,,,,,Human,IL-15,4981,IL15,Human,178101678,Agonist,Agonist,,t,f,,pIC50,0,11.42000008,0,IC50,0,0.0038,0,=,"Binding of rhIL-15 <i>in vitro</i>, using cells expressing the intact hIL-15R&alpha;-hIL-15R&beta;-h&gamma; complex.",,,19710453,
Interleukin-15 receptor subunit &alpha;,1702,IL15RA,Q13261,,,,,,Human,IL-15,4981,IL15,Human,178101678,Agonist,Agonist,,f,f,,pKd,0,11.42000008,0,Kd,0,0.0038,0,=,Binding of recombinant hIL-15 to IL-15R&alpha; subunit using Surface Plasmon Resonance (SPR),,,0,
Interleukin-17C receptor,2296,IL17RA|IL17RE,Q8NFR9|Q96F46,,,,,,Human,IL-17C,5875,IL17C,Human,178102499,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-17 receptor,2294,IL17RA|IL17RC,Q8NAC3|Q96F46,,,,,,Human,IL-17A,4982,IL17A,Human,178101679,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-17 receptor,2294,IL17RA|IL17RC,Q8NAC3|Q96F46,,,,,,Human,IL-17A/IL-17F,5874,IL17A|IL17F,Human,178102498,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-17 receptor,2294,IL17RA|IL17RC,Q8NAC3|Q96F46,,,,,,Human,IL-17F,5873,IL17F,Human,178102497,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-18 receptor,1908,IL18R1|IL18RAP,Q13478|O95256,,,,,,Human,IL-18,4983,IL18,Human,178101680,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-18 receptor,1908,IL18R1|IL18RAP,Q13478|O95256,,,,,,Human,IL-37,6149,IL37,Human,178102770,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
interleukin 1 receptor associated kinase 1,2042,IRAK1,P51617,,,,,,Human,IRAK-1/4 inhibitor,5990,,,178102612,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,16563752,O=C(c1cccc(c1)[N+](=O)[O-])Nc1nc2c(n1CCN1CCOCC1)cccc2
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,IRAK-1/4 inhibitor,5990,,,178102612,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,16563752,O=C(c1cccc(c1)[N+](=O)[O-])Nc1nc2c(n1CCN1CCOCC1)cccc2
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,IRAK4 inhibitor 4b [PMID: 18474425],8080,,,249565760,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,18474425,COc1cc(ccc1NC(=O)c1cccc(n1)c1ccn[nH]1)N1CCOCC1
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,IRAK4 inhibitor rac-45 [PMID: 18501603],8081,,,249565761,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,18501603,Clc1ccc2n(c1)c(cn2)c1cccc(n1)NC1CNCC1
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,ND-2110,8082,,,249565762,Inhibitor,Inhibition,,f,t,,pKi,0,8.119999886,0,Ki,0,7.5,0,=,,,,25479567,NC(=O)C[C@H]1CCc2c1c1c(ncnc1s2)O[C@@H]1CC[C@H](CC1)N1CCOCC1
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,ND-2158,8083,,,249565763,Inhibitor,Inhibition,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,25479567,NC(=O)[C@H](C[C@H]1CCc2c1c1c(ncnc1s2)O[C@@H]1CC[C@H](CC1)N1CCOCC1)O
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,PF-06426779,9666,,,348353625,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,0,COc1cc2c(OC[C@H]3NC(=O)[C@H]([C@H]3C)F)nccc2cc1C(=O)N
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,PF-06650833,9667,,,348353626,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,28498658,CC[C@H]1[C@@H](COc2nccc3c2cc(OC)c(c3)C(=O)N)NC(=O)[C@H]1F
Interleukin-1 receptor-like 2,1736,IL1RL2,Q9HB29,,,,,,Human,MAB92,9665,,,348353624,Antibody,Antagonist,,f,t,,pKd,0,10.61999989,0,Kd,0,0.024,0,=,,,,28726542,
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,IL-1&alpha;,4973,IL1A,Human,178101671,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,IL-1&beta;,4974,IL1B,Human,178101672,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,IL-1 receptor antagonist,5878,IL1RN,Human,178102502,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin-1 receptor, type I",1905,IL1R1|IL1RAP,Q9NPH3|P14778,,,,,,Human,isunakinra,9704,,,348353663,Inhibitor,Inhibition,,f,t,,pKd,0,10.52000046,0,Kd,0,0.029999999,0,=,,,,28727604,
Interleukin-20 receptor,1901,IL20RB|IL20RA,Q6UXL0|Q9UHF4,,,,,,Human,IL-19,4984,IL19,Human,178101681,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-20 receptor,1901,IL20RB|IL20RA,Q6UXL0|Q9UHF4,,,,,,Human,IL-20,4986,IL20,Human,178101683,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-20 receptor,1901,IL20RB|IL20RA,Q6UXL0|Q9UHF4,,,,,,Human,IL-24,4990,IL24,Human,178101687,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-21 receptor,2304,IL2RG|IL21R,P31785|Q9HBE5,,,,,,Human,IL-21,4987,IL21,Human,178101684,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-22&alpha;1/10&beta; heteromer,1903,IL22RA1|IL10RB,Q08334|Q8N6P7,,,,,,Human,IL-22,4988,IL22,Human,178101685,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-22&alpha;1/20&beta; heteromer,1902,IL22RA1|IL20RB,Q6UXL0|Q8N6P7,,,,,,Human,IL-20,4986,IL20,Human,178101683,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-22&alpha;1/20&beta; heteromer,1902,IL22RA1|IL20RB,Q6UXL0|Q8N6P7,,,,,,Human,IL-24,4990,IL24,Human,178101687,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-23 receptor,2293,IL23R|IL12RB1,P42701|Q5VWK5,,,,,,Human,IL-23,4978,IL12B|IL23A,Human,178101676,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-25 receptor,2295,IL17RA|IL17RB,Q96F46|Q9NRM6,,,,,,Human,IL-17B,5877,IL17B,Human,178102501,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-25 receptor,2295,IL17RA|IL17RB,Q96F46|Q9NRM6,,,,,,Human,IL-25,5876,IL25,Human,178102500,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-27 receptor,2316,IL6ST|IL27RA,P40189|Q6UWB1,,,,,,Human,IL-27,6151,IL27|EBI3,Human,178102772,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-2 receptor,2297,IL2RG|IL2RA|IL2RB,P31785|P01589|P14784,,,,,,Human,IL-2,4985,IL2,Human,178101682,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-2 receptor,2297,IL2RG|IL2RA|IL2RB,P31785|P01589|P14784,,,,,,Human,IL-1 receptor antagonist,5878,IL1RN,Human,178102502,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-2 receptor,2297,IL2RG|IL2RA|IL2RB,P31785|P01589|P14784,,,,,,Human,Ro26-4550,5052,,,178101747,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NN=CN1CCC[C@@H](C1)CC(=O)N[C@H](C(=O)OC)Cc1ccc(cc1)C#Cc1ccccc1
Interleukin-2 receptor subunit &alpha;,1695,IL2RA,P01589,,,,,,Human,daclizumab,6880,,,178103462,Antibody,Binding,,f,t,,pKd,0,8,0,Kd,0,10,0,<,,,,0,
Interleukin-31 receptor,2312,OSMR|IL31RA,Q8NI17|Q99650,,,,,,Human,IL-31,4995,IL31,Human,178101692,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin-31 receptor, &alpha; subunit",1710,IL31RA,Q8NI17,,,,,,Human,nemolizumab,8720,,,252827378,Antibody,Binding,,f,t,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,0,
Interleukin-33 receptor,1906,IL1RL1|IL1RAP,Q9NPH3|Q01638,,,,,,Human,IL-33,5880,IL33,Human,178102504,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-36 receptor,1907,IL1RL2|IL1RAP,Q9NPH3|Q9HB29,,,,,,Human,IL-36&alpha;,5881,IL36A,Human,178102505,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-36 receptor,1907,IL1RL2|IL1RAP,Q9NPH3|Q9HB29,,,,,,Human,IL-36&beta;,5882,IL36B,Human,178102506,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-36 receptor,1907,IL1RL2|IL1RAP,Q9NPH3|Q9HB29,,,,,,Human,IL-36&gamma;,5883,IL36G,Human,178102507,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-36 receptor,1907,IL1RL2|IL1RAP,Q9NPH3|Q9HB29,,,,,,Human,IL-36 receptor antagonist,5879,IL36RN,Human,178102503,Antagonist,Antagonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-3 receptor,2307,CSF2RB|IL3RA,P32927|P26951,,,,,,Human,IL-3,4994,IL3,Human,178101691,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin 3 receptor, &alpha; subunit",1705,IL3RA,P26951,,,,,,Human,IL-3,4994,IL3,Human,178101691,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interleukin-4 receptor subunit &alpha;,1697,IL4R,P24394,,,,,,Human,dupilumab,7574,,,223365910,Antibody,Binding,,f,t,,pIC50,0,11.06000042,0,IC50,0,0.0088,0,=,Value derived from an ELISA-based solution competition assay.,,,0,
Interleukin-4 receptor type I,2298,IL2RG|IL4R,P31785|P24394,,,,,,Human,IL-4,4996,IL4,Human,178101693,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-4 receptor type II,2299,IL13RA1|IL4R,P24394|P78552,,,,,,Human,IL-13,4980,IL13,Human,178101677,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-4 receptor type II,2299,IL13RA1|IL4R,P24394|P78552,,,,,,Human,IL-4,4996,IL4,Human,178101693,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-5 receptor,2308,CSF2RB|IL5RA,P32927|Q01344,,,,,,Human,IL-5,4997,IL5,Human,178101694,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"Interleukin 5 receptor, &alpha; subunit",1706,IL5RA,Q01344,,,,,,Human,IL-5,4997,IL5,Human,178101694,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,0,
Interleukin-6 receptor,2310,IL6R|IL6ST,P40189|P08887,,,,,,Human,IL-6,4998,IL6,Human,178101695,Agonist,Agonist,"Murine NIH/3T3 fibroblasts with human IL6R  exhibited a single class of binding sites for 125I-labeled recombinant human interleukin-6 (125I-rhIL-6) (Kd = 440 pM, 20,000 receptors per cell).",t,t,,pKd,0,9.359999657,0,Kd,0,0.439999998,0,=,,,,1995637,
Interleukin-6 receptor,2310,IL6R|IL6ST,P40189|P08887,,,,,,Human,satralizumab,9093,,,315661178,Antibody,Binding,,f,t,,pKd,0,8.850000381,0,Kd,0,1.399999976,0,=,,,,0,
"Interleukin-6 receptor, &alpha; subunit",1708,IL6R,P08887,,,,,,Human,IL-6,4998,IL6,Human,178101695,Agonist,Agonist,"IL6R) expressed stably in murine NIH/3T3 fibroblasts.exhibited a single class of binding sites for 125I-labeled recombinant human interleukin-6 (125I-rhIL-6) (Kd = 440 pM, 20,000 receptors per cell).",t,t,,pKd,0,9.359999657,0,Kd,0,0.439999998,0,=,,,,1995637,
"Interleukin-6 receptor, &alpha; subunit",1708,IL6R,P08887,,,,,,Human,sarilumab,7999,,,249565679,Antibody,Binding,,f,t,,pKd,11.05000019,0,10.64000034,Kd,0.023,0,0.009,=,Dissociation equilibrium constant calculated using two different assay methods (kinetic <i>vs.</i> equilibrium/solution),,,0,
Interleukin-7 receptor,2300,IL2RG|IL7R,P31785|P16871,,,,,,Human,IL-7,4999,IL7,Human,178101696,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Interleukin-7 receptor subunit &alpha;,1698,IL7R,P16871,,,,,,Human,OSE-127,9604,,,340590234,Antibody,Antagonist,,f,t,,pEC50,0,11.39999962,0,EC50,0,0.004,0,=,In an ELISA binding assay.,,,0,
Interleukin-9 receptor,2301,IL2RG|IL9R,P31785|Q01113,,,,,,Human,IL-9,5000,IL9,Human,178101697,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
<i>P2RY10</i>,165,P2RY10,O00398,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pEC50,0,6.9,0,-,0,0,0,=,,,,18466763,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
<i>P2RY10</i>,165,P2RY10,O00398,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,,,pEC50,0,7.3,0,-,0,0,0,=,,,,18466763,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
<i>P2RY10</i>,165,P2RY10,O00398,,,,,,Human,dioctanoylglycerol pyrophosphate,2916,,,135650190,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,18466763,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)COP(=O)(OP(=O)(O)O)O
<i>P2RY10</i>,165,P2RY10,O00398,,,,,,Human,JTE-013,2917,,,135650448,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,18466763,O=C(Nc1cc(Cl)nc(c1)Cl)NNc1cc(C(C)C)c2c(n1)n(C)nc2C
IP receptor,345,PTGIR,P43119,,,,,,Human,esuberaprost,8314,,,252166526,Agonist,Agonist,,f,t,,pKd,0,7.889999866,0,Kd,0,13,0,=,,,,2665758,CC#CC[C@@H]([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1c1cccc(c1O2)CCCC(=O)O)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,PGI<sub>2</sub>,1915,,,135651541,Agonist,Agonist,,t,f,,pKi,0,7.800000191,0,Ki,0,15.85000038,0,=,,,,372237,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O
IP receptor,345,Ptgir,P43253,,,,,,Rat,selexipag,7552,,,223365888,Agonist,Agonist,,f,f,,pKi,0,5.679999828,0,Ki,0,2100,0,=,,,,17545310,O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
IP receptor,345,PTGIR,P43119,,,,,,Human,selexipag,7552,,,223365888,Agonist,Agonist,,f,f,,pKi,0,6.590000153,0,Ki,0,260,0,=,,,,17545310,O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
IP receptor,345,PTGIR,P43119,,,,,,Human,EP 157,5853,,,178102477,Agonist,Full agonist,,f,,,pIC50,5.69,0,4.95,IC50,11200,0,2030,=,,,,3026540,OC(=O)CCC/C=CC[C@@H]1[C@@H]2CC[C@H]([C@H]1/C=N/OC(c1ccccc1)c1ccccc1)C=C2
IP receptor,345,PTGIR,P43119,,,,,,Human,FK-788,5855,,,178102479,Agonist,Full agonist,,f,,,pKi,0,8.05,0,-,0,0,0,=,,,,15914004,OC(=O)COc1cccc2c1CC[C@](C2)(O)COC(=O)N(c1ccccc1)c1ccccc1
IP receptor,345,PTGIR,P43119,,,,,,Human,FR181157,5854,,,178102478,Agonist,Full agonist,,f,,,pKi,0,7.27,0,-,0,0,0,=,,,,16837197,OC(=O)COc1cccc(c1)CC1CCCC=C1c1nc(c(o1)c1ccccc1)c1ccccc1
IP receptor,345,PTGIR,P43119,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,t,,pKi,8,0,7.5,-,0,0,0,=,,,,16604093,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
IP receptor,345,Ptgir,P43252,,,,,,Mouse,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9313928,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
IP receptor,345,Ptgir,P43252,,,,,,Mouse,isocarbacyclin,1934,,,135650430,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1CC(=C2)CCCCC(=O)O)O
IP receptor,345,Ptgir,P43253,,,,,,Rat,MRE-269,5852,,,178102476,Agonist,Full agonist,,f,f,,pKi,0,6.659999847,0,Ki,0,220,0,=,,,,17545310,OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
IP receptor,345,PTGIR,P43119,,,,,,Human,MRE-269,5852,,,178102476,Agonist,Full agonist,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,17545310,OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C
IP receptor,345,Ptgir,P43252,,,,,,Mouse,ONO-1301,1964,,,135650762,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9313928,OC(=O)COc1cccc2c1CCC=C2CCO/N=C(/c1cccnc1)c1ccccc1
IP receptor,345,Ptgir,P43252,,,,,,Mouse,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,,,pKi,0,7.5,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
IP receptor,345,PTGIR,P43119,,,,,,Human,PGE<sub>1</sub>,1882,,,135650814,Agonist,Full agonist,,t,f,,pKi,6.820000172,0,6.5,Ki,318,0,150,=,,,,11454473,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
IP receptor,345,PTGIR,P43119,,,,,,Human,RO1138452,1969,,,135650911,Antagonist,Antagonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,16331286,CC(Oc1ccc(cc1)Cc1ccc(cc1)NC1=NCCN1)C
IP receptor,345,PTGIR,P43119,,,,,,Human,RO1138452,1969,,,135650911,Antagonist,Antagonist,,f,f,,pA2,9,0,8.199999809,-,0,0,0,=,,,,16331286,CC(Oc1ccc(cc1)Cc1ccc(cc1)NC1=NCCN1)C
IP receptor,345,PTGIR,P43119,,,,,,Human,RO3244794,4042,,,178100866,Antagonist,Antagonist,,f,f,,pA2,0,8.5,0,-,0,0,0,=,,,,16331286,Fc1ccc(cc1)CC(C(=O)O)NC(=O)OCc1cc2c(o1)ccc(c2)c1ccc(cc1)F
IP receptor,345,PTGIR,P43119,,,,,,Human,RO3244794,4042,,,178100866,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,-,0,0,0,=,,,,16331286,Fc1ccc(cc1)CC(C(=O)O)NC(=O)OCc1cc2c(o1)ccc(c2)c1ccc(cc1)F
IP receptor,345,PTGIR,P43119,,,,,,Human,RO3244794,4042,,,178100866,Antagonist,Antagonist,,f,,,pKB,9.53,0,9.1,-,0,0,0,=,,,,19880449,Fc1ccc(cc1)CC(C(=O)O)NC(=O)OCc1cc2c(o1)ccc(c2)c1ccc(cc1)F
IP<sub>3</sub> kinase A,1447,ITPKA,P23677,,,,,,Human,GNF362,9548,,,336446934,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,26121493,N#Cc1ccc(cc1)c1n[nH]cc1CN1CCN([C@@H](C1)C)c1ccc(cn1)C(F)(F)F
IP<sub>3</sub> kinase B,1448,ITPKB,P27987,,,,,,Human,GNF362,9548,,,336446934,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,26121493,N#Cc1ccc(cc1)c1n[nH]cc1CN1CCN([C@@H](C1)C)c1ccc(cn1)C(F)(F)F
IP<sub>3</sub> kinase C,1449,ITPKC,Q96DU7,,,,,,Human,GNF362,9548,,,336446934,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,26121493,N#Cc1ccc(cc1)c1n[nH]cc1CN1CCN([C@@H](C1)C)c1ccc(cn1)C(F)(F)F
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,"inositol 2,4,5-trisphosphate",4223,,,178101040,Activator,None,pharmacological; also activated by other InsP<sub>3</sub> analogues,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@H]1[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@@H]([C@@H]([C@@H]1O)OP(=O)([O-])[O-])O
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,IP<sub>3</sub>,4222,,,178101039,Activator,None,endogenous; nM - &mu;M range,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)O
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,decavanadate,2459,,,135652750,Antagonist,Antagonist,&mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,[O-][V](=O)(O[V]1(=O)O[V]2(=O)O[V](=O)(O[V]3(=O)O[V](=O)(O1)O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O2)O[V](=O)([O-])[O-])[O-]
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Antagonist,Antagonist,&mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
IP<sub>3</sub>R2,744,ITPR2,Q14571,,,,,,Human,"inositol 2,4,5-trisphosphate",4223,,,178101040,Activator,None,pharmacological; also activated by other InsP<sub>3</sub> analogues,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@H]1[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@@H]([C@@H]([C@@H]1O)OP(=O)([O-])[O-])O
IP<sub>3</sub>R2,744,ITPR2,Q14571,,,,,,Human,IP<sub>3</sub>,4222,,,178101039,Activator,None,endogenous; nM - &mu;M range,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)O
IP<sub>3</sub>R2,744,ITPR2,Q14571,,,,,,Human,decavanadate,2459,,,135652750,Antagonist,Antagonist,&mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,[O-][V](=O)(O[V]1(=O)O[V]2(=O)O[V](=O)(O[V]3(=O)O[V](=O)(O1)O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O2)O[V](=O)([O-])[O-])[O-]
IP<sub>3</sub>R3,745,ITPR3,Q14573,,,,,,Human,IP<sub>3</sub>,4222,,,178101039,Activator,None,endogenous; nM - &mu;M range,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)O
IP<sub>3</sub>R3,745,ITPR3,Q14573,,,,,,Human,decavanadate,2459,,,135652750,Antagonist,Antagonist,&mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,[O-][V](=O)(O[V]1(=O)O[V]2(=O)O[V](=O)(O[V]3(=O)O[V](=O)(O1)O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O2)O[V](=O)([O-])[O-])[O-]
"isocitrate dehydrogenase (NADP(+)) 1, cytosolic",2884,IDH1,O75874,,,,,,Human,ivosidenib,9217,,,315661293,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,N#Cc1ccnc(c1)N1C(=O)CC[C@H]1C(=O)N([C@@H](c1ccccc1Cl)C(=O)NC1CC(C1)(F)F)c1cncc(c1)F
"isocitrate dehydrogenase (NADP(+)) 2, mitochondrial",2885,IDH2,P48735,,,,,,Human,enasidenib,8960,,,310264741,Inhibitor,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)c1cccc(n1)C(F)(F)F)(O)C
isopentenyl-diphosphate &Delta;-isomerase 1,646,IDI1,Q13907,,,,,,Human,NE21650,3167,,,135650699,Inhibitor,Inhibition,,f,,,pIC50,0,4.2,0,IC50,0,70000,0,~,in vitro inhibition assay,,,11785983,Nc1ccccc1CC(P(=O)(O)O)(P(=O)(O)O)O
<i>TAAR3</i>,168,Taar3,Q5QD16,,,,,,Mouse,isoamylamine,5506,,,178102152,Agonist,Full agonist,,t,,,pEC50,0,5,0,EC50,0,10000,0,=,,,,16878137,NCCC(C)C
<i>TAAR4P </i>,169,Taar4,Q5QD15,,,,,,Mouse,naphazoline,5509,,,178102155,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,20559446,C1CN=C(N1)Cc1cccc2c1cccc2
<i>TAAR4P </i>,169,Taar4,Q923Y7,,,,,,Rat,naphazoline,5509,,,178102155,Agonist,Partial agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,20559446,C1CN=C(N1)Cc1cccc2c1cccc2
<i>TAAR5</i>,170,Taar5,Q5QD14,,,,,,Mouse,dimethylethylamine,5523,,,178102166,Agonist,Full agonist,,f,,,pEC50,0,6.15,0,EC50,0,700,0,=,,,,17088868,CCN(C)C
<i>TAS2R31</i>,674,TAS2R31,P59538,,,,,,Human,GIV3727,9112,,,315661197,Antagonist,Antagonist,,f,f,,pIC50,5.190000057,0,5.099999905,IC50,7900,0,6400,=,,,,20537538,CC1CCC(C1(C)C)CCCC(=O)O
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,decernotinib,8309,,,252166521,Inhibitor,Inhibition,,f,f,,pIC50,0,7.880000114,0,IC50,0,13.19999981,0,=,,,,24417533,CC[C@](C(=O)NCC(F)(F)F)(Nc1ccnc(n1)c1c[nH]c2c1cccn2)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,delgocitinib,9619,,,340590249,Inhibitor,Inhibition,,f,f,,pKi,0,8.680000305,0,Ki,0,2.099999905,0,=,"In an assay using the kinase domain of the recombinant human enzyme, a biotinylated peptide substrate, and [<sup>33</sup>P]ATP.",,,25387665,N#CCC(=O)N1C[C@@H]([C@]21CCN(C2)c1ncnc2c1cc[nH]2)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,fedratinib,5716,,,178102342,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,21106455,Cc1cnc(nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C)Nc1ccc(cc1)OCCN1CCCC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,filgotinib,7913,,,249565596,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,10,0,=,,,,24006460,O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,itacitinib,8364,,,252166576,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,<,,,,0,N#CCC1(CN(C1)C1CCN(CC1)C(=O)c1ccnc(c1F)C(F)(F)F)n1ncc(c1)c1ncnc2c1cc[nH]2
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,JAK3 inhibitor II,5993,,,178102615,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,18094329,COc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1)Br)O
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,JAK3 inhibitor IV,5994,,,178102616,Inhibitor,Inhibition,,f,f,,pIC50,0,4.400000095,0,IC50,0,39810,0,=,,,,10741557,CC(N(Cc1ccccc1)CCC(=O)c1ccc2c(c1)cccc2)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,momelotinib,7791,,,223366122,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,19295546,N#CCNC(=O)c1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,NS-018,7839,,,223366170,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,22829185,Fc1ccc(cc1)[C@@H](Nc1nc(Nc2cnccn2)cc(c1)c1cnn(c1)C)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,oclacitinib,9696,,,348353655,Inhibitor,Inhibition,,f,f,,pIC50,0,8.020000458,0,IC50,0,9.529999733,0,=,,,,0,CNS(=O)(=O)C[C@@H]1CC[C@H](CC1)N(c1[nH]cnc2c1ccn2)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,pacritinib,7793,,,223366124,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1280,0,=,,,,21604762,C1/C=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,PF-06651600,9559,,,336446945,Inhibitor,Inhibition,,f,f,,pIC50,0,5.789999962,0,IC50,0,1640,0,=,At 1 mM ATP.,,,28139931,C=CC(=O)N1C[C@@H](CC[C@@H]1C)Nc1ncnc2c1cc[nH]2
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,ruxolitinib,5688,,,178102315,Inhibitor,Inhibition,,f,t,,pIC50,10.05000019,0,8.479999542,IC50,3.299999952,0,0.090000004,=,,,,20130243,N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.230000019,0,IC50,0,59,0,=,In a TR-FRET assay.,,,25156366,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,In a <sup>33</sup>P-ATP assay.,,,25156366,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,solcitinib,9697,,,348353656,Inhibitor,Inhibition,,f,t,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,,,,0,O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,decernotinib,8309,,,252166521,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,24417533,CC[C@](C(=O)NCC(F)(F)F)(Nc1ccnc(n1)c1c[nH]c2c1cccn2)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,delgocitinib,9619,,,340590249,Inhibitor,Inhibition,,f,f,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,"In an assay using the kinase domain of the recombinant human enzyme, a biotinylated peptide substrate, and [<sup>33</sup>P]ATP.",,,25387665,N#CCC(=O)N1C[C@@H]([C@]21CCN(C2)c1ncnc2c1cc[nH]2)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,fedratinib,5716,,,178102342,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21106455,Cc1cnc(nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C)Nc1ccc(cc1)OCCN1CCCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,filgotinib,7913,,,249565596,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,28,0,=,,,,24006460,O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,gandotinib,7909,,,249565592,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23584399,Clc1ccc(c(c1)F)Cc1c(C)nc2n1nc(Nc1n[nH]c(c1)C)cc2CN1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,HG-10-102-01,9392,,,328083494,Inhibitor,Inhibition,,f,f,,pKi,0,5.489999771,0,Ki,0,3200,0,>,,,,22591441,COc1cc(ccc1Nc1ncc(c(n1)NC)Cl)C(=O)N1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,itacitinib,8364,,,252166576,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,>,,,,0,N#CCC1(CN(C1)C1CCN(CC1)C(=O)c1ccnc(c1F)C(F)(F)F)n1ncc(c1)c1ncnc2c1cc[nH]2
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,JAK3 inhibitor II,5993,,,178102615,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,18094329,COc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1)Br)O
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,JAK inhibitor I,5992,,,178102614,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,11934592,Fc1ccc2c(c1)c1c(=O)[nH]ccc1c1c2[nH]c(n1)C(C)(C)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,momelotinib,7791,,,223366122,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,19295546,N#CCNC(=O)c1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,NS-018,7839,,,223366170,Inhibitor,Inhibition,,f,t,,pIC50,0,9.140000343,0,IC50,0,0.720000029,0,=,,,,22829185,Fc1ccc(cc1)[C@@H](Nc1nc(Nc2cnccn2)cc(c1)c1cnn(c1)C)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,oclacitinib,9696,,,348353655,Inhibitor,Inhibition,,f,f,,pIC50,0,7.760000229,0,IC50,0,17.5,0,=,,,,0,CNS(=O)(=O)C[C@@H]1CC[C@H](CC1)N(c1[nH]cnc2c1ccn2)C
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,pacritinib,7793,,,223366124,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,21604762,C1/C=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,ruxolitinib,5688,,,178102315,Inhibitor,Inhibition,,f,t,,pIC50,9.619999886,0,8.550000191,IC50,2.799999952,0,0.239999995,=,,,,20130243,N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.050000191,0,IC50,0,882,0,=,In a TR-FRET assay.,,,25156366,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,solcitinib,9697,,,348353656,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,67,0,=,,,,0,O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,decernotinib,8309,,,252166521,Inhibitor,Inhibition,,f,t,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,24417533,CC[C@](C(=O)NCC(F)(F)F)(Nc1ccnc(n1)c1c[nH]c2c1cccn2)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,delgocitinib,9619,,,340590249,Inhibitor,Inhibition,,f,f,,pIC50,0,8.260000229,0,IC50,0,5.5,0,=,"In an assay using the kinase domain of the recombinant human enzyme, a biotinylated peptide substrate, and [<sup>33</sup>P]ATP.",,,25387665,N#CCC(=O)N1C[C@@H]([C@]21CCN(C2)c1ncnc2c1cc[nH]2)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,fedratinib,5716,,,178102342,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,21106455,Cc1cnc(nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C)Nc1ccc(cc1)OCCN1CCCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,filgotinib,7913,,,249565596,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,810,0,=,,,,24006460,O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,gandotinib,7909,,,249565592,Inhibitor,Inhibition,,f,f,,pIC50,0,7.320000172,0,IC50,0,48,0,=,,,,23584399,Clc1ccc(c(c1)F)Cc1c(C)nc2n1nc(Nc1n[nH]c(c1)C)cc2CN1CCOCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,JAK3 inhibitor II,5993,,,178102615,Inhibitor,Inhibition,,f,f,,pIC50,0,5.739999771,0,IC50,0,1800,0,=,,,,18094329,COc1cc2c(ncnc2cc1OC)Nc1ccc(c(c1)Br)O
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,JAK3 inhibitor IV,5994,,,178102616,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,79,0,=,,,,10741557,CC(N(Cc1ccccc1)CCC(=O)c1ccc2c(c1)cccc2)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,JAK inhibitor I,5992,,,178102614,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,11934592,Fc1ccc2c(c1)c1c(=O)[nH]ccc1c1c2[nH]c(n1)C(C)(C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,momelotinib,7791,,,223366122,Inhibitor,Inhibition,,f,f,,pIC50,0,6.809999943,0,IC50,0,155,0,=,,,,19295546,N#CCNC(=O)c1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,NS-018,7839,,,223366170,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,,,,22829185,Fc1ccc(cc1)[C@@H](Nc1nc(Nc2cnccn2)cc(c1)c1cnn(c1)C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,oclacitinib,9696,,,348353655,Inhibitor,Inhibition,,f,f,,pIC50,0,7.019999981,0,IC50,0,95.09999847,0,=,,,,0,CNS(=O)(=O)C[C@@H]1CC[C@H](CC1)N(c1[nH]cnc2c1ccn2)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,pacritinib,7793,,,223366124,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,520,0,=,,,,21604762,C1/C=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,peficitinib,8315,,,252166527,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,25704750,NC(=O)c1cnc2c(c1NC1[C@@H]3CC4C[C@H]1CC(C3)(C4)O)cc[nH]2
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,PF-06651600,9559,,,336446945,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,At 4 &mu;M ATP (Km).,,,0,C=CC(=O)N1C[C@@H](CC[C@@H]1C)Nc1ncnc2c1cc[nH]2
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,ruxolitinib,5688,,,178102315,Inhibitor,Inhibition,,f,f,,pIC50,0,8.489999771,0,IC50,0,3.220000029,0,=,,,,23061660,N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,5.840000153,0,IC50,0,1437,0,=,In a TR-FRET assay.,,,25156366,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,solcitinib,9697,,,348353656,Inhibitor,Inhibition,,f,f,,pIC50,0,6.389999866,0,IC50,0,408,0,=,,,,0,O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
kallikrein 1,2865,KLK1,P06870,,,,,,Human,example 131 [WO2009133348],8489,,,252166697,Inhibitor,Inhibition,,f,f,,pIC50,0,9.270000458,0,IC50,0,0.540000021,0,=,,,,0,CCN1CCC[C@@H]1C(=O)N[C@H](C(=O)NCc1ccc(nc1)N)Cc1ccc(c(c1)F)F
kallikrein B1,2379,KLKB1,P03952,,,,,,Human,lanadelumab,9094,,,315661179,Antibody,Binding,,f,t,,pIC50,0,10.05000019,0,IC50,0,0.090000004,0,=,,,,0,
kallikrein related peptidase 2,2372,KLK2,P20151,,,,,,Human,hK2p01 derivative KLK2 inhibitor,8672,,,252166872,Inhibitor,Inhibition,,f,t,,pKi,0,5.849999905,0,Ki,0,1410,0,=,,,,16527822,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)C)C)Cc1c[nH]c2c1cccc2)Cc1c[nH]c2c1cccc2)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N)Cc1ccccc1
kallikrein related peptidase 2,2372,KLK2,P20151,,,,,,Human,peptide KLK2b(c1),8484,,,252166692,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,17436344,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,difelikefalin,9044,,,315661129,Agonist,Agonist,,f,t,,pEC50,0,9.800000191,0,EC50,0,0.159999996,0,=,,,,0,NCCCC[C@H](C(=O)N1CCC(CC1)(N)C(=O)O)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1ccccc1)CC(C)C
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,difelikefalin,9044,,,315661129,Agonist,Agonist,,f,f,,pEC50,0,10.31999969,0,EC50,0,0.048,0,=,,,,0,NCCCC[C@H](C(=O)N1CCC(CC1)(N)C(=O)O)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1ccccc1)CC(C)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,hydrocodone,7081,,,178103660,Agonist,Agonist,,f,f,,pKi,0,6.590000153,0,Ki,0,260,0,=,,,,22439881,COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4CCC1=O)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,hydromorphone,7082,,,178103661,Agonist,Agonist,,f,f,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,,,,19282177,O=C1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,MP1104,9759,,,0,Agonist,Agonist,,f,f,,pKi,0,9.479999542,0,Ki,0,0.330000013,0,=,,,,29307491,Ic1cccc(c1)C(=O)N[C@@H]1C=CC2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,pethidine,7221,,,178103795,Agonist,Agonist,,f,f,,pIC50,0,5.630000114,0,IC50,0,2370,0,=,,,,11585443,CCOC(=O)C1(CCN(CC1)C)c1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 1.1 [PMID: 24187130],9191,,,315661270,Agonist,Agonist,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,24187130,Cc1ccc(cc1C(F)(F)F)CSc1nnc(n1Cc1ccco1)c1ccccn1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 2.1 [PMID: 24187130],9192,,,315661271,Agonist,Agonist,,f,f,,pKi,0,9.460000038,0,Ki,0,0.349999994,0,=,,,,24187130,O=C([C@H]1CC=C[C@@H]2[C@H]1C(=O)N(CC2)c1ccccc1F)Nc1ccc(c(c1)C(F)(F)F)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,6.880000114,0,Ki,0,131,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,SR16835,8867,,,252827524,Agonist,Agonist,,f,f,,pKi,0,6.170000076,0,Ki,0,681.2999878,0,=,Radioligand binding assay,,,19773529,O=C1Cc2c(N1C1CCN(CC1)C1CCC3c4c1cccc4CCC3)cccc2
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 1.1 [PMID: 24187130],9191,,,315661270,Agonist,Biased agonist,,f,f,,pEC50,0,7.510000229,0,EC50,0,31,0,=,Measuring [<sup>35</sup>S]GTP&gamma;S binding,,,24187130,Cc1ccc(cc1C(F)(F)F)CSc1nnc(n1Cc1ccco1)c1ccccn1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 1.1 [PMID: 24187130],9191,,,315661270,Agonist,Biased agonist,,f,f,,pEC50,0,5.380000114,0,EC50,0,4129,0,=,Measuring &beta;arrestin2 recruitment,,,24187130,Cc1ccc(cc1C(F)(F)F)CSc1nnc(n1Cc1ccco1)c1ccccn1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 2.1 [PMID: 24187130],9192,,,315661271,Agonist,Biased agonist,,f,f,,pEC50,0,7.070000172,0,EC50,0,84.69999695,0,=,Measuring [<sup>35</sup>S]GTP&gamma;S binding,,,24187130,O=C([C@H]1CC=C[C@@H]2[C@H]1C(=O)N(CC2)c1ccccc1F)Nc1ccc(c(c1)C(F)(F)F)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,probe 2.1 [PMID: 24187130],9192,,,315661271,Agonist,Biased agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,Measuring &beta;arrestin2 recruitment,,,24187130,O=C([C@H]1CC=C[C@@H]2[C@H]1C(=O)N(CC2)c1ccccc1F)Nc1ccc(c(c1)C(F)(F)F)C
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,"[D-Ala<sup>2</sup>,F<sub>5</sub>,Phe<sup>4</sup>]dynorphin-(1-13)-NH<sub>2</sub>",1657,,,135652080,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,"[D-Ala<sup>2</sup>,F<sub>5</sub>,Phe<sup>4</sup>]dynorphin-(1-17)-NH<sub>2</sub>",1658,,,135652081,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dynorphin-(1-11),1618,,,135652140,Agonist,Full agonist,,f,,,pKi,0,9.7,0,-,0,0,0,=,,,,9686407,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,dynorphin-(1-17)-NH<sub>2</sub>,1661,,,135652141,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,dynorphin A,1620,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651739,Agonist,Full agonist,,t,,,pIC50,0,9.4,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,dynorphin A,1620,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651739,Agonist,Full agonist,,t,,,pKi,10.3,0,10,,0,0,0,,,,,8240268,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dynorphin A,1620,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651739,Agonist,Full agonist,,t,,,pKi,10.8,0,8.3,,0,0,0,,,,,9686407,
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,dynorphin A-(1-13),1619,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651738,Agonist,Full agonist,,t,,,pKi,0,9.9,0,-,0,0,0,=,,,,8234341,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dynorphin A-(1-13),1619,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651738,Agonist,Full agonist,,t,,,pKi,10.7,0,9.3,,0,0,0,,,,,9686407,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dynorphin A-(1-8),1621,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651740,Agonist,Full agonist,,t,,,pKi,9.9,0,8,,0,0,0,,,,,9686407,
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,dynorphin A-(1-8),1621,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651740,Agonist,Full agonist,,t,,,pIC50,0,9.7,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,dynorphin B,1622,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651741,Agonist,Full agonist,,t,,,pKi,0,9.5,0,-,0,0,0,=,,,,8234341,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,dynorphin B,1622,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651741,Agonist,Full agonist,,t,,,pIC50,0,10,0,,0,0,0,,,,,8393575,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,E2078,1648,,,135652142,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,8234341,CCNC(=O)[C@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC)CC(C)C)CCCN=C(N)N)C)CCCN=C(N)N)CC(C)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,E2078,1648,,,135652142,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9918595,CCNC(=O)[C@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC)CC(C)C)CCCN=C(N)N)C)CCCN=C(N)N)CC(C)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,enadoline,1646,,,135650230,Agonist,Full agonist,,f,f,,pKd,9.199999809,0,8.600000381,-,0,0,0,=,,,,8863844,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1cccc2c1cco2
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,enadoline,1646,,,135650230,Agonist,Full agonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,14613319,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1cccc2c1cco2
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,ethyketazocine,1610,,,135650225,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,9262330,CC[C@@]12CCN([C@H]([C@H]1C)C(=O)c1c2cc(O)cc1)CC1CC1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,ethyketazocine,1610,,,135650225,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8393575,CC[C@@]12CCN([C@H]([C@H]1C)C(=O)c1c2cc(O)cc1)CC1CC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,ethyketazocine,1610,,,135650225,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,8234341,CC[C@@]12CCN([C@H]([C@H]1C)C(=O)c1c2cc(O)cc1)CC1CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,ethylketocyclazocine,1602,,,135650226,Agonist,Full agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9686407,CCC1CN(CC2CC2)C2C(C1c1cc(O)ccc1C2=O)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,etorphine,1625,,,135650246,Agonist,Full agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,9686407,CCCC(C1CC23C=CC1(OC)C1C43CCN(C2Cc2c4c(O1)c(O)cc2)C)(O)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,GR 89696,1649,,,135650321,Agonist,Full agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,11786275,COC(=O)N1CCN(C(C1)CN1CCCC1)C(=O)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,HS665,9189,,,315661268,Agonist,Full agonist,,f,t,,pKi,0,9.31000042,0,Ki,0,0.49000001,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,HS665,9189,,,315661268,Agonist,Full agonist,,f,t,,pEC50,0,8.43999958,0,EC50,0,3.619999886,0,=,Measuring stimulation of [<sup>35</sup>S]GTP&gamma;S binding.,,,23134120,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,ICI 204448,1650,,,135650371,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,8393575,OC(=O)COc1cccc(c1)C(N(C(=O)Cc1ccc(c(c1)Cl)Cl)C)CN1CCCC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,ICI 204448,1650,,,135650371,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,8240267,OC(=O)COc1cccc(c1)C(N(C(=O)Cc1ccc(c(c1)Cl)Cl)C)CN1CCCC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,[Leu]enkephalin,1613,PENK|Penk|Penk,Human|Mouse|Rat,135651802,Agonist,Full agonist,,t,,,pKi,0,6,0,,0,0,0,,,,,8234341,O=C(CNC(=O)C(Cc1ccc(cc1)O)N)NCC(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1ccccc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,[Met]enkephalin,1614,PENK|Penk|Penk,Human|Mouse|Rat,135651808,Agonist,Full agonist,,t,,,pKi,0,6,0,,0,0,0,,,,,8234341,CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,[Met<sup>5</sup>]dynorphin-(1-17),1659,,,135652287,Agonist,Full agonist,,f,,,pIC50,0,9.2,0,,0,0,0,,,,,8393575,
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,nalbuphine,1663,,,135650680,Agonist,Full agonist,,f,t,,pKi,7.5,0,7.400000095,-,0,0,0,=,,,,9262330,O[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CCC2)ccc1O)O
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,nalbuphine,1663,,,135650680,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,8393575,O[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CCC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,nalfurafine,1651,,,135651282,Agonist,Full agonist,,f,,,pKd,0,10.1,0,,0,0,0,,,,,15383632,CN([C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)C(=O)/C=C/c1ccoc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,normorphine,1630,,,135650735,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2NCC3)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,salvinorin A,1666,,,135652714,Agonist,Full agonist,,f,f,,pKi,8.699999809,0,7.800000191,-,0,0,0,=,,,,12192085,COC(=O)[C@@H]1C[C@H](OC(=O)C)C(=O)[C@H]2[C@@]1(C)CC[C@@H]1[C@]2(C)C[C@H](OC1=O)c1cocc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,spiradoline,1653,,,135651291,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8240267,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,spiradoline,1653,,,135651291,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8393575,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,(-)-cyclazocine,1604,,,135650145,Agonist,Partial agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9686407,Oc1ccc2c(c1)[C@]1(C)CCN([C@@H](C2)C1C)CC1CC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,DAMGO,1647,,,135650158,Agonist,Partial agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8234341,OCCNC(=O)[C@@H](N(C(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)C)Cc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,DAMGO,1647,,,135650158,Agonist,Partial agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9686407,OCCNC(=O)[C@@H](N(C(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)C)Cc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dihydromorphine,1616,,,135650183,Agonist,Partial agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9686407,O[C@H]1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,dynorphin B,1622,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651741,Agonist,Partial agonist,,t,,,pKi,9.9,0,8.1,,0,0,0,,,,,9686407,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,etonitazene,1624,,,135650245,Agonist,Partial agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9686407,CCOc1ccc(cc1)Cc1nc2c(n1CCN(CC)CC)ccc(c2)[N+](=O)[O-]
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,fentanyl,1626,,,135650258,Agonist,Partial agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9686407,CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,(-)-methadone,1605,,,135650582,Agonist,Partial agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9686407,CCC(=O)C(c1ccccc1)(c1ccccc1)C[C@H](N(C)C)C
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,morphine,1627,,,135650624,Agonist,Partial agonist,,f,,,pKi,7,0,6.7,,0,0,0,,,,,8240267,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,morphine,1627,,,135650624,Agonist,Partial agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,nalorphine,1629,,,135650682,Agonist,Partial agonist,,f,,,pKi,9.1,0,7.9,,0,0,0,,,,,9686407,C=CCN1CC[C@@]23[C@@H]4[C@H]1Cc1c3c(O[C@H]2[C@H](C=C4)O)c(cc1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,naloxone benzoylhydrazone,1664,,,135650686,Agonist,Partial agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2/C(=N/NC(=O)c2ccccc2)/CC4)c(cc1)O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,(-)-pentazocine,1606,,,135650806,Agonist,Partial agonist,,f,,,pKi,8.6,0,7.8,-,0,0,0,=,,,,9686407,CC(=CCN1CC[C@@]2([C@H]([C@H]1Cc1c2cc(cc1)O)C)C)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,diprenorphine,1617,,,135650194,Antagonist,Antagonist,,f,,,pKi,9.7,0,9.6,,0,0,0,,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,JDTic,7362,,,178103934,Antagonist,Antagonist,,f,t,,pKi,9.399999619,0,9,Ki,1,0,0.398000002,=,,,,25635572,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,JDTic,7362,,,178103934,Antagonist,Antagonist,,f,t,,pKi,0,11.22000027,0,Ki,0,0.006,0,=,"Measuring antagonism of U50,488-induced [<sup>35</sup>S]GTP&gamma;S binding",,,11495579,Oc1ccc2c(c1)CN[C@H](C2)C(=O)N[C@@H](C(C)C)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,LY2456302,9194,,,315661273,Antagonist,Antagonist,,f,t,,pKi,0,9.090000153,0,Ki,0,0.806999981,0,=,,,,24071566,Cc1cc(C)cc(c1)[C@@H]1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,LY2456302,9194,,,315661273,Antagonist,Antagonist,,f,t,,pKB,0,9.090000153,0,KB,0,0.813000023,0,=,Measuring inhibition of agonist-induced [<sup>35</sup>S]GTP&gamma;S binding <i>in vitro</i>.,,,24071566,Cc1cc(C)cc(c1)[C@@H]1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,methylnaltrexone,7563,,,223365899,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,6.300000191,0,=,,,,19282177,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2[N+](CC3)(C)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,nalmefene,1628,,,135650681,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,-,0,0,0,=,,,,9686407,C=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,t,,pKi,8.600000381,0,7.599999905,-,0,0,0,=,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,,,pKi,8,0,7.7,-,0,0,0,=,,,,8240267,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,8393575,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,(+)-naloxone,1668,,,135650685,Antagonist,Antagonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,8234341,C=CCN1CC[C@@]23[C@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,naltrexone,1639,,,135650687,Antagonist,Antagonist,,f,t,,pKi,9.399999619,0,8.399999619,-,0,0,0,=,,,,9686407,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,naltrexone,1639,,,135650687,Antagonist,Antagonist,,f,,,pIC50,0,9.2,0,,0,0,0,,,,,8393575,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,naltriben,1640,,,135650688,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,8393575,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8240268,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,f,,pKi,11,0,8.899999619,-,0,0,0,=,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,,,pKi,10.7,0,9.6,,0,0,0,,,,,8240267,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,,0,0,0,,,,,8393575,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,quadazocine,1633,,,135650868,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,9686407,O=C(CCC1(C)[C@H]2Cc3c([C@]1(C)CCN2C)cc(cc3)O)CCC1CCCC1
K-Cl cotransporter 1,971,SLC12A4,Q9UP95,,,,,,Human,DIOA,4589,,,178101310,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC1(Cc2c(C1=O)c(Cl)c(c(c2)OCC(=O)O)Cl)C1CCCC1
K-Cl cotransporter 2,972,SLC12A5,Q9H2X9,,,,,,Human,DIOA,4589,,,178101310,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC1(Cc2c(C1=O)c(Cl)c(c(c2)OCC(=O)O)Cl)C1CCCC1
K-Cl cotransporter 3,973,SLC12A6,Q9UHW9,,,,,,Human,DIOA,4589,,,178101310,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC1(Cc2c(C1=O)c(Cl)c(c(c2)OCC(=O)O)Cl)C1CCCC1
K-Cl cotransporter 4,974,SLC12A7,Q9Y666,,,,,,Human,DIOA,4589,,,178101310,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC1(Cc2c(C1=O)c(Cl)c(c(c2)OCC(=O)O)Cl)C1CCCC1
kelch like ECH-associated protein 1,2757,KEAP1,Q14145,,,,,,Human,Nrf2 peptide [PMID: 23647822],8772,,,252827430,Inhibitor,Binding,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,23647822,
kelch like ECH-associated protein 1,2757,KEAP1,Q14145,,,,,,Human,CPUY192018,9710,,,348353669,None,Binding,,f,f,,pIC50,0,7.840000153,0,IC50,0,14.39999962,0,=,Measured using a fluorescence polarisation assay.,,,26258437,COc1ccc(cc1)S(=O)(=O)N(c1ccc(c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)OC)CC(=O)O)CC(=O)O
kelch like ECH-associated protein 1,2757,KEAP1,Q14145,,,,,,Human,CPUY192018,9710,,,348353669,None,Binding,,f,f,,pKd,0,7.400000095,0,Kd,0,39.79999924,0,=,Measuerd using a isothermal titration calorimetry (ITC) assay.,,,27215610,COc1ccc(cc1)S(=O)(=O)N(c1ccc(c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)OC)CC(=O)O)CC(=O)O
Kidney-specific Na-K-Cl symporter,968,SLC12A1,Q13621,,,,,,Human,furosemide,4839,,,178101541,Inhibitor,Inhibition,,f,t,,pIC50,0,5.150000095,0,-,0,0,0,=,,,,11882915,OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N
Kidney-specific Na-K-Cl symporter,968,SLC12A1,Q13621,,,,,,Human,piretanide,4742,,,178101453,Inhibitor,Inhibition,,f,f,,pIC50,0,5.96999979,0,-,0,0,0,=,,,,11882915,OC(=O)c1cc(N2CCCC2)c(c(c1)S(=O)(=O)N)Oc1ccccc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,ramucirumab,7390,,,178103962,Antibody,Antagonist,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,12917408,
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,ramucirumab,7390,,,178103962,Antibody,Antagonist,,f,t,,pKd,0,10.30000019,0,Kd,0,0.050000001,0,=,,,,12917408,
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,CP-547632,7881,,,223366210,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,14612527,O=C(Nc1snc(c1C(=O)N)OCc1c(F)cc(cc1F)Br)NCCCCN1CCCC1
kinase insert domain receptor,1813,Kdr,P35918,,,,,,Mouse,DMBI,5958,,,178102581,Inhibitor,Inhibition,,f,t,,pIC50,0,6.099999905,0,IC50,0,794,0,=,,,,10956210,O=C1Nc2c(/C/1=Cc1ccc(cc1)N(C)C)cccc2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,0,0,0,IC50,65,0,13,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,erdafitinib,9039,,,315661124,Inhibitor,Inhibition,,f,f,,pIC50,0,7.440000057,0,IC50,0,36.29999924,0,=,,,,0,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,famitinib,7886,,,249565577,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,21028894,CCN(CCN1CCc2c(C1=O)c(C)c([nH]2)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,foretinib,5679,,,178102306,Inhibitor,Inhibition,,f,t,,pIC50,9.100000381,0,8.170000076,IC50,6.800000191,0,0.800000012,=,,,,23098265,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,fruquintinib,9428,,,328083528,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,Evaluated in a Z-lyte assay.,,,25482937,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,fruquintinib,9428,,,328083528,Inhibitor,Inhibition,,f,t,,pIC50,0,7.460000038,0,IC50,0,35,0,=,Evaluated in a [<sup>32</sup>]p-ATP incorporation assay,,,25482937,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,glesatinib,9133,,,315661218,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,18434145,S=C(NC(=O)Cc1ccccc1)Nc1ccc(c(c1)F)Oc1ccnc2c1sc(c2)c1ncn(c1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,golvatinib,7956,,,249565639,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,Measured as inhibition of VEGFR-2 autophosphorylation in HUVEC cells.,,,19832844,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1nccc(c1)Oc1ccc(c(c1)F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,Ki-20227,5690,,,178102317,Inhibitor,Inhibition,,f,f,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,17121910,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,lenvatinib,7426,,,178103998,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23098265,COc1cc2nccc(c2cc1C(=O)N)Oc1ccc(c(c1)Cl)NC(=O)NC1CC1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,LY2874455,8104,,,249565784,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,<i>In vitro</i> biochemical assay result,,,21900693,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,MLKL compound 1,9513,,,336446900,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,15990302,O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,motesanib,5660,,,178102288,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,23098265,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,motesanib,5660,,,178102288,Inhibitor,Inhibition,,f,t,,pKd,0,8.590000153,0,Kd,0,2.599999905,0,=,,,,22037378,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,orantinib,7816,,,223366147,Inhibitor,Inhibition,,f,t,,pIC50,0,6.170000076,0,IC50,0,680,0,=,,,,19110422,OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cccc2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,OSI-930,9383,,,328083485,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,16424037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,t,,pKd,0,7.849999905,0,Kd,0,14,0,=,,,,22037378,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.360000134,0,IC50,0,440,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,PLX-4720,5703,,,178102330,Inhibitor,Inhibition,,f,t,,pKi,0,8.050000191,0,Ki,0,9,0,=,,,,12538485,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(Cl)cn2)F
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,regorafenib,5891,,,178102514,Inhibitor,Inhibition,,f,,,pIC50,0,7.9,0,IC50,0,13,0,,,,,21170960,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,semaxanib,5056,,,178101750,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,10882357,O=C1Nc2c(/C/1=C/c1[nH]c(cc1C)C)cccc2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,t,,pKd,0,7.230000019,0,Kd,0,59,0,=,,,,22037378,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,t,,pIC50,0,7.050000191,0,IC50,0,90,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
kisspeptin receptor,266,Kiss1r,Q91V45,,,,,,Mouse,[dY]<sup>1</sup>KP-10,4015,,,178100841,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,IC50,0,3.6,0,=,,,,19934405,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-10,1283,KISS1,Human,135651795,Agonist,Full agonist,,t,,,pKi,10.4,0,8.6,-,0,0,0,=,,,,11385580,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CC(C)C)Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)CC(=O)N)CC(=O)N
kisspeptin receptor,266,Kiss1r,Q924U1,,,,,,Rat,kisspeptin-10,1283,KISS1,Human,135651795,Agonist,Full agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,11457843,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CC(C)C)Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)CC(=O)N)CC(=O)N
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-13,1284,KISS1,Human,135651797,Agonist,Full agonist,,t,,,pKi,0,8.4,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,Kiss1r,Q924U1,,,,,,Rat,kisspeptin-13,1284,KISS1,Human,135651797,Agonist,Full agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-14,1285,KISS1,Human,135651798,Agonist,Full agonist,,t,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,Kiss1r,Q924U1,,,,,,Rat,kisspeptin-14,1285,KISS1,Human,135651798,Agonist,Full agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-15,1286,,,135652242,Agonist,Full agonist,,f,,,pKi,0,10,0,-,0,0,0,=,,,,11385580,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-28,1287,,,135652243,Agonist,Full agonist,,f,,,pEC50,0,8.8,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,Kiss1r,Q924U1,,,,,,Rat,kisspeptin-54,1288,KISS1,Human,135651801,Agonist,Full agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,11457843,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-54,1288,KISS1,Human,135651801,Agonist,Full agonist,,t,,,pKi,9.5,0,8.8,-,0,0,0,=,,,,11385580,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,kisspeptin-9,1289,,,135652244,Agonist,Full agonist,,f,,,pKi,0,7,0,-,0,0,0,=,,,,11385580,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,peptide 234,4012,,,178100838,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,19321788,
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,stem cell factor,5055,KITLG,Human,178101749,Agonist,Agonist,,t,f,,pKd,9.819999695,0,9.619999886,Kd,0.239999995,0,0.150000006,=,"Binding affinity of KIT receptors on cell membranes from OCIM1, MO7e and HEL cells, using 125I-SCF as radioligand.",,,7536489,
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,CP-673451,8069,,,249565749,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,252,0,=,,,,15705896,COCCOc1ccc2c(c1)ncn2c1ccc2c(n1)c(ccc2)N1CCC(CC1)N
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,crenolanib,7882,,,223366211,Inhibitor,Inhibition,,f,f,,pKd,0,7.110000134,0,Kd,0,78,0,=,,,,22745105,NC1CCN(CC1)c1cccc2c1nc(cc2)n1cnc2c1ccc(c2)OCC1(C)COC1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,DCC-2618,9175,,,315661258,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Cn1ncc(c1)c1nccc(c1)Oc1cc(F)c(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccccc1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.699999809,0,8.520000458,IC50,3,0,2,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,famitinib,7886,,,249565577,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,21028894,CCN(CCN1CCc2c(C1=O)c(C)c([nH]2)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,GTP-14564,5982,,,178102605,Inhibitor,Inhibition,,f,t,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,12815052,c1ccc(cc1)c1n[nH]c2c1oc1c2cccc1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,19887542,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,JNJ-40346527,8942,,,310264723,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,26233509,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(nc1C1=CCC(CC1)(C)C)C1CC(C)(C)OC(C1)(C)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,KBP-7018,9691,,,348353650,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,0,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc2c(c1)CCN2C(=O)CN1CCOCC1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,Ki-20227,5690,,,178102317,Inhibitor,Inhibition,,f,f,,pIC50,0,6.349999905,0,IC50,0,451,0,=,,,,17121910,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,6.28000021,0,IC50,0,527,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,masitinib,5656,,,178102284,Inhibitor,Inhibition,,f,t,,pKd,0,8.090000153,0,Kd,0,8.100000381,0,=,,,,22037378,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1scc(n1)c1cccnc1)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,masitinib,5656,,,178102284,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,19789626,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1scc(n1)c1cccnc1)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,OSI-930,9383,,,328083485,Inhibitor,Inhibition,,f,f,,pIC50,7.599999905,0,6.400000095,IC50,400,0,25,=,"The IC50 varied dependent on whether KIT was activated or unactivated, with the lower value measured for the activated enzyme.",,,16424037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,<,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,f,,pKd,0,8.319999695,0,Kd,0,4.800000191,0,=,,,,19754199,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,semaxanib,5056,,,178101750,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,10882357,O=C1Nc2c(/C/1=C/c1[nH]c(cc1C)C)cccc2
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,t,,pIC50,0,7.170000076,0,IC50,0,68,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
KRAS,2824,KRAS,P01116,,,,,,Human,lonafarnib,8024,,,249565704,Inhibitor,Inhibition,,f,f,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,Measuring inhibition of farnesylation of KRAS4B by human farnesyltransferase,,,9810004,Clc1cc(Br)c2c(c1)CCc1c([C@@H]2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,docosahexaenoic acid,1051,,,135651477,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,10880510,CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)O
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,halothane,2401,,,135650346,Activator,None,studied at 1-5 mM,f,t,,-,0,0,0,-,0,0,0,=,,,,10880510,ClC(C(F)(F)F)Br
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,linoleic acid,1052,,,135651503,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,10880510,CCCCC/C=CC/C=CCCCCCCCC(=O)O
K<sub>2P</sub>10.1,521,KCNK10,P57789,,,,,,Human,lysophosphatidylcholine,2508,,,53801071,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,10880510,O[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])COC(=O)C
K<sub>2P</sub>10.1,521,Kcnk10,Q9JIS4,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,12122143,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>12.1,522,KCNK12,Q9HB15,,,,,,Human,halothane,2401,,,135650346,Inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,25148687,ClC(C(F)(F)F)Br
K<sub>2P</sub>13.1,523,KCNK13,Q9HB14,,,,,,Human,halothane,2401,,,135650346,Inhibitor,None,studied at ~5 mM,f,f,,-,0,0,0,-,0,0,0,=,,,,25148687,ClC(C(F)(F)F)Br
K<sub>2P</sub>16.1,525,KCNK16,Q96T55,,,,,,Human,isoflurane,2505,,,53801075,Activator,None,,f,,700-900,-,0,0,0,,0,0,0,,,,,11263999,FC(OC(C(F)(F)F)Cl)F
K<sub>2P</sub>16.1,525,KCNK16,Q96T55,,,,,,Human,NO,2509,,,178100228,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,,11263999,
K<sub>2P</sub>16.1,525,KCNK16,Q96T55,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,100,-,0,0,0,,0,0,0,,,,,11263999,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>17.1,526,KCNK17,Q96T54,,,,,,Human,NO,2509,,,178100228,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,,15513946,
K<sub>2P</sub>18.1,527,,,,,,,,None,quinidine,2342,,,135650872,Channel blocker,None,,f,,100-200,-,0,0,0,,0,0,0,,,,,0,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>18.1,527,,,,,,,,None,quinine,2510,,,135652709,Channel blocker,None,,f,,100-200,-,0,0,0,,0,0,0,,,,,0,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,halothane,2401,,,135650346,Activator,None,studied at 1-5 mM,f,f,,-,0,0,0,-,0,0,0,=,,,,10321245,ClC(C(F)(F)F)Br
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,isoflurane,2505,,,53801075,Activator,None,studied at 1-5 mM,f,f,,-,0,0,0,-,0,0,0,=,,,,10321245,FC(OC(C(F)(F)F)Cl)F
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,riluzole,2326,,,135650900,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>2P</sub>2.1,514,KCNK2,O95069,,,,,,Human,norfluoxetine,208,,,135650734,Inhibitor,None,,f,f,,pIC50,0,5.050000191,0,IC50,0,9000,0,=,,,,15685212,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,halothane,2401,,,135650346,Activator,None,studied at 1-10 mM,f,f,,-,0,0,0,-,0,0,0,=,,,,0,ClC(C(F)(F)F)Br
K<sub>2P</sub>3.1,515,Kcnk3,O54912,,,,,,Rat,halothane,2401,,,135650346,Activator,Positive,studied at 1-10 mM,f,f,1000,pEC50,0,3,0,EC50,0,1000000,0,=,,,,11850453,ClC(C(F)(F)F)Br
K<sub>2P</sub>3.1,515,Kcnk3,O54912,,,,,,Rat,isoflurane,2505,,,53801075,Activator,Positive,,f,,,pEC50,0,2.7,0,,0,0,0,,,,,11850453,FC(OC(C(F)(F)F)Cl)F
K<sub>2P</sub>3.1,515,KCNK3,O14649,,,,,,Human,<i>R</i>-(+)-methanandamide,2506,,,53801074,Channel blocker,None,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,~,,,,11226154,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)N[C@@H](CO)C
K<sub>2P</sub>4.1,516,KCNK4,Q9NYG8,,,,,,Human,riluzole,2326,,,135650900,Activator,None,studied at 1-100 &micro;M,f,f,,-,0,0,0,-,0,0,0,=,,,,10779373,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>2P</sub>4.1,516,KCNK4,Q9NYG8,,,,,,Human,riluzole,2326,,,135650900,Activator,Positive,,f,f,3-100,-,0,0,0,-,0,0,0,=,,,,10779373,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>2P</sub>5.1,517,KCNK5,O95279,,,,,,Human,halothane,2401,,,135650346,Activator,None,,f,,100-1000,pIC50,0,3.7,0,,0,0,0,,,,,10839924,ClC(C(F)(F)F)Br
K<sub>2P</sub>5.1,517,KCNK5,O95279,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,14985088,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>6.1,518,Kcnk6,,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,None,,f,,<100,pIC50,0,0,0,,0,0,0,,,,,10887187,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>2P</sub>9.1,520,KCNK9,Q9NPC2,,,,,,Human,halothane,2401,,,135650346,Activator,None,studied at 1-5 mM,f,t,,-,0,0,0,-,0,0,0,=,,,,11886861,ClC(C(F)(F)F)Br
K<sub>2P</sub>9.1,520,,,,,,,,None,ruthenium red,2432,,,135652746,Channel blocker,None,,f,,,pIC50,0,6.16,0,,0,0,0,,,,,0,
K<sub>2P</sub>9.1,520,KCNK9,Q9NPC2,,,,,,Human,<i>R</i>-(+)-methanandamide,2506,,,53801074,Inhibitor,None,studied at 1-10 &micro;M,f,f,,-,0,0,0,-,0,0,0,=,,,,10747866,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)N[C@@H](CO)C
K<sub>2P</sub>9.1,520,KCNK9,Q9NPC2,,,,,,Human,ruthenium red,2432,,,135652746,Inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,NS1643,2308,,,135650743,Activator,Agonist,,f,,,pEC50,5.68,0,5.24,,0,0,0,,,,,8938721,O=C(Nc1cc(ccc1O)C(F)(F)F)Nc1cc(ccc1O)C(F)(F)F
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,flindokalner,2307,,,135650001,Activator,None,,f,,,pEC50,0,6.5,0,,0,0,0,,,,,11283675,COc1ccc(cc1[C@]1(F)C(=O)Nc2c1ccc(c2)C(F)(F)F)Cl
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,NS004,4271,,,178101088,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(c(c1)n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F)O
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,NS1619,4272,,,178101089,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F)C(F)(F)F
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,slotoxin,2310,,,135652466,Channel blocker,Antagonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,11576530,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)Cc1ccc(cc1)O)CS)CCCCN)CS)CCCCN)CCCCN)CCSC)CS)CCCCN)CCCNC(=N)N)CC(=O)O)C(C)C)Cc1ccccc1)C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)N)Cc1ccccc1)CC(=O)O)CC(=O)O)CS)CO)CCCCN)CCC(=O)O)CS)C)CS
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,iberiotoxin,4218,,,178101035,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCCC1NC(=O)C(CSSCC(NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC(=O)O)CC(C)C)Cc1ccccc1)C(C)C)CC(=O)O)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC1CSSCC(NC(=O)C(NC1=O)CCCNC(=N)N)C(=O)NC(C(=O)NC(C(=O)O)CCC(=O)N)Cc1ccc(cc1)O)CCCCN)CCCCN)CCSC)NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C1CSSCC(NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C2CCC(=O)N2)Cc2ccccc2)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCC(=O)O)CCCCN)CO)C(C)C)CO
K<sub>Ca</sub>1.1,380,Kcnma1,Q08460,,,,,,Mouse,paxilline,2309,,,135650789,Inhibitor,None,,f,f,,pKi,0,8.720000267,0,Ki,0,1.899999976,0,=,,,,8938726,O=C1C=C2C(OC1C(O)(C)C)CCC1(C2(O)CCC2C1(C)c1[nH]c3c(c1C2)cccc3)C
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,EBIO,2314,,,135650218,Activator,Agonist,,f,f,2000,-,0,0,0,-,0,0,0,=,,,,11134030,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,GW542573X,9313,,,318164832,Activator,Agonist,,f,f,,pEC50,0,5.090000153,0,EC50,0,8200,0,=,,,,19515965,COc1ccccc1NC(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,NS309,2317,,,135650745,Activator,Agonist,,f,f,0.03-0.1,-,0,0,0,-,0,0,0,=,,,,15471565,ONC1=c2ccc(c(c2=NC1=O)Cl)Cl
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,riluzole,2326,,,135650900,Activator,Agonist,,f,f,,pEC50,0,4.679999828,0,EC50,0,21000,0,=,,,,18955585,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,SKA-20,9312,,,318164831,Activator,Agonist,,f,f,,pEC50,0,6.369999886,0,EC50,0,430,0,=,,,,18955585,Nc1nc2c(s1)c1cc3ccccc3cc1cc2
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,SKA-31,2335,,,135651046,Activator,Agonist,,f,f,,pEC50,0,5.539999962,0,EC50,0,2900,0,=,,,,18955585,Nc1nc2c(s1)ccc1c2cccc1
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,dequalinium,2313,,,135650170,Channel blocker,Antagonist,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,10683185,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,Lei-Dab7,2315,,,135652258,Channel blocker,Antagonist,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,,,,11527975,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,leiurotoxin I,2316,,,135652259,Channel blocker,Antagonist,,f,f,,pIC50,7.099999905,0,6.519999981,IC50,300,0,80,=,,,,10696100,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,NS8593,2318,,,135650747,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,16926279,c1ccc2c(c1)[C@@H](CCC2)Nc1nc2c([nH]1)cccc2
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,CyPPA,2323,,,135650151,Activator,Agonist,,f,f,,pEC50,0,4.900000095,0,-,0,0,0,=,,,,17486140,Cc1cc(NC2CCCCC2)nc(n1)n1nc(cc1C)C
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,DC-EBIO,2324,,,135650163,Activator,Agonist,,f,f,,pEC50,0,4.599999905,0,-,0,0,0,=,,,,16239218,CCn1c(=O)[nH]c2c1cc(Cl)c(c2)Cl
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,EBIO,2314,,,135650218,Activator,Agonist,,f,f,,pEC50,0,3.299999952,0,-,0,0,0,=,,,,16239218,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,EBIO,2314,,,135650218,Activator,Agonist,,f,f,2000,pEC50,0,3,0,-,0,0,0,=,,,,11134030,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>2.2,382,Kcnn2,P58390,,,,,,Mouse,NS13001,9316,,,318164835,Activator,Agonist,,f,f,,pEC50,0,5.739999771,0,EC50,0,1800,0,=,,,,23102227,Clc1ccc(cc1)Nc1nc(nc2c1ncn2C)n1nc(cc1C)C
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,NS309,2317,,,135650745,Activator,Agonist,,f,f,0.03-0.1,pEC50,0,6.199999809,0,-,0,0,0,=,,,,15471565,ONC1=c2ccc(c(c2=NC1=O)Cl)Cl
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,riluzole,2326,,,135650900,Activator,Agonist,,f,f,,pEC50,0,4.889999866,0,EC50,0,12800,0,=,,,,18955585,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,SKA-31,2335,,,135651046,Activator,Agonist,,f,f,,pEC50,0,5.699999809,0,EC50,0,2000,0,=,,,,18955585,Nc1nc2c(s1)ccc1c2cccc1
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,dequalinium,2313,,,135650170,Channel blocker,Antagonist,,f,f,,pIC50,6.800000191,0,6.5,-,0,0,0,=,,,,10696100,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,Lei-Dab7,2315,,,135652258,Channel blocker,Antagonist,,f,f,,pIC50,0,8.300000191,0,-,0,0,0,=,,,,11527975,
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,leiurotoxin I,2316,,,135652259,Channel blocker,Antagonist,,f,f,,pIC50,9.699999809,0,9.5,-,0,0,0,=,,,,11527975,
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,leiurotoxin I,2316,,,135652259,Channel blocker,Antagonist,,f,f,,pIC50,0,9.5,0,-,0,0,0,=,,,,10696100,
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,P05,2325,,,135652375,Channel blocker,Antagonist,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,11527975,
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,NS8593,2318,,,135650747,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6.199999809,0,-,0,0,0,=,,,,16926279,c1ccc2c(c1)[C@@H](CCC2)Nc1nc2c([nH]1)cccc2
K<sub>Ca</sub>2.2,382,Kcnn2,P58390,,,,,,Mouse,RA-2,9317,,,318164836,Gating inhibitor,Antagonist,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,25468883,O=C(c1ccc(c(c1)F)O)OCc1cccc(c1)COC(=O)c1ccc(c(c1)F)O
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,CyPPA,2323,,,135650151,Activator,Agonist,,f,f,,pEC50,0,5.300000191,0,-,0,0,0,=,,,,17486140,Cc1cc(NC2CCCCC2)nc(n1)n1nc(cc1C)C
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,DC-EBIO,2324,,,135650163,Activator,Agonist,,f,f,,pEC50,0,4.900000095,0,-,0,0,0,=,,,,17584055,CCn1c(=O)[nH]c2c1cc(Cl)c(c2)Cl
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,EBIO,2314,,,135650218,Activator,Agonist,,f,f,50,-,0,0,0,-,0,0,0,=,,,,11378158,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,EBIO,2314,,,135650218,Activator,Agonist,,f,f,,pEC50,0,3.799999952,0,-,0,0,0,=,,,,14978258,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>2.3,383,Kcnn3,P58391,,,,,,Mouse,NS13001,9316,,,318164835,Activator,Agonist,,f,f,,pEC50,0,6.849999905,0,EC50,0,140,0,=,,,,23102227,Clc1ccc(cc1)Nc1nc(nc2c1ncn2C)n1nc(cc1C)C
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,NS309,2317,,,135650745,Activator,Agonist,,f,f,0.03,-,0,0,0,-,0,0,0,=,,,,15471565,ONC1=c2ccc(c(c2=NC1=O)Cl)Cl
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,riluzole,2326,,,135650900,Activator,Agonist,,f,f,,pEC50,0,4.900000095,0,EC50,0,12500,0,=,,,,18955585,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,riluzole,2326,,,135650900,Activator,Agonist,,f,f,310,-,0,0,0,-,0,0,0,=,,,,11378158,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,SKA-31,2335,,,135651046,Activator,Agonist,,f,f,,pEC50,0,5.519999981,0,EC50,0,3000,0,=,,,,18955585,Nc1nc2c(s1)ccc1c2cccc1
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,Lei-Dab7,2315,,,135652258,Channel blocker,Agonist,,f,f,,pKd,0,8.420000076,0,Kd,0,3.799999952,0,=,,,,11527975,
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,P05,2325,,,135652375,Channel blocker,Agonist,,f,f,,pIC50,0,7.599999905,0,-,0,0,0,=,,,,11527975,
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,dequalinium,2313,,,135650170,Channel blocker,Antagonist,,f,f,,pIC50,0,4.5,0,-,0,0,0,=,,,,11369031,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,leiurotoxin I,2316,,,135652259,Channel blocker,Antagonist,,f,f,,pIC50,9,0,8.699999809,-,0,0,0,=,,,,11527975,
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,leiurotoxin I,2316,,,135652259,Channel blocker,Antagonist,,f,f,,pIC50,0,8.100000381,0,-,0,0,0,=,,,,11533126,
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,NS8593,2318,,,135650747,Gating inhibitor,Antagonist,,f,f,,pIC50,0,6.099999905,0,-,0,0,0,=,,,,16926279,c1ccc2c(c1)[C@@H](CCC2)Nc1nc2c([nH]1)cccc2
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,RA-2,9317,,,318164836,Gating inhibitor,Antagonist,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,25468883,O=C(c1ccc(c(c1)F)O)OCc1cccc(c1)COC(=O)c1ccc(c(c1)F)O
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,NS11757,2944,,,135650742,Gating inhibitor,None,,f,f,,pKd,0,8.100000381,0,-,0,0,0,=,,,,18998663,Clc1cc2CCCC(c2cc1Cl)Nc1nc2c([nH]1)cccc2
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,DC-EBIO,2324,,,135650163,Activator,Agonist,,f,,,pEC50,0,6.1,0,,0,0,0,,,,,11160649,CCn1c(=O)[nH]c2c1cc(Cl)c(c2)Cl
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,EBIO,2314,,,135650218,Activator,Agonist,,f,f,,pEC50,4.5,0,4.099999905,-,0,0,0,=,,,,11134030,CCn1c(=O)[nH]c2c1cccc2
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,NS309,2317,,,135650745,Activator,Agonist,,f,f,,pEC50,0,8,0,-,0,0,0,=,,,,15471565,ONC1=c2ccc(c(c2=NC1=O)Cl)Cl
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,SKA-121,8492,,,252166700,Activator,Agonist,,f,f,,pEC50,0,6.960000038,0,EC50,0,109,0,=,,,,24958817,Nc1nc2c(o1)c1ccccc1c(c2)C
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,riluzole,2326,,,135650900,Activator,None,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,,,,18955585,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,SKA-31,2335,,,135651046,Activator,None,,f,f,,pEC50,0,6.599999905,0,-,0,0,0,=,,,,18955585,Nc1nc2c(s1)ccc1c2cccc1
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,maurotoxin,2332,,,135652279,Channel blocker,Inhibition,,f,,,pIC50,0,9,0,,0,0,0,,,,,12527813,
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,nitrendipine,2334,,,135650723,Channel blocker,Inhibition,,f,f,,pKd,0,6.099999905,0,-,0,0,0,=,,,,10884437,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,nitrendipine,2334,,,135650723,Channel blocker,Inhibition,,f,f,,pIC50,0,7.599999905,0,-,0,0,0,=,,,,9730970,CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC)C
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,NS6180,9318,,,318164837,Channel blocker,Inhibition,,f,f,,pIC50,0,9,0,-,0,0,0,=,,,,22891655,O=C1CSc2c(N1Cc1cccc(c1)C(F)(F)F)cccc2
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,senicapoc,2331,,,135650366,Channel blocker,Inhibition,,f,,,pIC50,0,7.96,0,,0,0,0,,,,,12433690,Fc1ccc(cc1)C(c1ccc(cc1)F)(c1ccccc1)C(=O)N
K<sub>Ca</sub>5.1,387,KCNU1,A8MYU2,,,,,,Human,NS004,4271,,,178101088,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(c(c1)n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F)O
K<sub>Ca</sub>5.1,387,KCNU1,A8MYU2,,,,,,Human,NS1619,4272,,,178101089,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F)C(F)(F)F
K<sub>Ca</sub>5.1,387,Kcnu1,O54982,,,,,,Mouse,quinidine,2342,,,135650872,Channel blocker,None,,f,f,20,-,0,0,0,-,0,0,0,=,,,,19934650,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>Ca</sub>5.1,387,KCNU1,A8MYU2,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,f,<100,-,0,0,0,-,0,0,0,=,,,,26381170,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,K<sup>+</sup>,2381,,,135652739,Activator,Activation,,t,f,1000-100000,pEC50,0,2.299999952,0,-,0,0,0,=,,,Extracellular,8663367,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pIC50,0,2.900000095,0,-,0,0,0,=,,,,8997197,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,f,1000-3000,pKi,0,2.200000048,0,Ki,0,6000000,0,=,,,Extracellular,21030597,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,f,200-5000,pKi,0,2.299999952,0,Ki,0,5000000,0,=,,,Cytoplasmic,21030597,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,t,f,,pIC50,0,6.800000191,0,-,0,0,0,=,,,Intracellular,8663367,
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,f,10-50,-,0,0,0,-,0,0,0,=,,,,15980413,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,30-300,pKd,4,0,1.299999952,-,0,0,0,=,,,,8799888,
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Antagonist,,t,f,,pKd,0,4.800000191,0,Kd,0,17100,0,=,,,Intracellular,7748552,
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,putrescine,2388,,,135651553,Channel blocker,Antagonist,,t,f,,pKd,0,5.099999905,0,-,0,0,0,=,,,,7748552,NCCCCN
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,Rb<sup>+</sup>,2389,,,135652745,Channel blocker,Antagonist,,f,,1000-10000,-,0,0,0,,0,0,0,,,,,8799888,
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,spermidine,2390,,,135651561,Channel blocker,Antagonist,,t,f,,pKd,0,8.100000381,0,-,0,0,0,=,,,,7748552,NCCCNCCCCN
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,spermine,710,,,135651562,Channel blocker,Antagonist,,t,f,,pKd,0,9.100000381,0,-,0,0,0,=,,,,7748552,NCCCNCCCCNCCCN
K<sub>ir</sub>2.1,430,Kcnj2,P35561,,,,,,Mouse,oleoyl-CoA,2386,,,135651532,Gating inhibitor,Antagonist,,t,,0.018-10,-,0,0,0,,0,0,0,,,,,15980413,CCCCCCCC/C=CCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1OP(=O)(O)O)O)n1cnc2c1ncnc2N)O)O)(C)C)O
K<sub>ir</sub>2.2,431,Kcnj12,P52187,,,,,,Mouse,Cs<sup>+</sup>,2356,,,135652734,Gating inhibitor,Antagonist,,f,f,5-50,-,0,0,0,-,0,0,0,=,,,,8083233,
K<sub>ir</sub>2.2,431,KCNJ12,Q14500,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Inhibitor,None,,t,f,,pIC50,0,4.960000038,0,IC50,0,11000,0,=,,,Intracellular,8735700,
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,3-300,pKi,4.519999981,0,1.309999943,-,0,0,0,=,,,,8051145,
K<sub>ir</sub>2.3,432,Kcnj4,P52189,,,,,,Mouse,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,5-500,pIC50,0,4.960000038,0,-,0,0,0,=,,,,8013643,
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Antagonist,,t,f,,pKd,0,5,0,Kd,0,10000,0,=,,,Intracellular,7969496,
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,putrescine,2388,,,135651553,Channel blocker,Antagonist,,t,f,50-1000,-,0,0,0,-,0,0,0,=,,,,7969496,NCCCCN
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,SCH-23390,943,,,135651025,Channel blocker,Antagonist,,f,,100,-,0,0,0,,0,0,0,,,,,12065762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,spermidine,2390,,,135651561,Channel blocker,Antagonist,,t,f,25-1000,-,0,0,0,-,0,0,0,=,,,,7969496,NCCCNCCCCN
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,spermine,710,,,135651562,Channel blocker,Antagonist,,t,f,50-1000,-,0,0,0,-,0,0,0,=,,,,7969496,NCCCNCCCCNCCCN
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,t,,,pKi,7.4,0,6.7,-,0,0,0,=,,,Extracellular,7576658,
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,t,,,pKi,6.77,0,6.76,-,0,0,0,=,,,Intracellular,10200419,
K<sub>ir</sub>2.3,432,Kcnj4,P52189,,,,,,Mouse,rose bengal (photoactivated),2393,,,135650926,Gating inhibitor,Antagonist,,f,,0.1,-,0,0,0,,0,0,0,,,,,8524851,Clc1c(Cl)c(Cl)c(c(c1Cl)C(=O)O)c1c2cc(I)c(=O)c(c2oc2c1cc(I)c(c2I)O)I
K<sub>ir</sub>2.4,433,Kcnj14,O70596,,,,,,Rat,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,,,pKi,0,2.09,0,,0,0,0,,,,,9592090,
K<sub>ir</sub>2.4,433,KCNJ14,Q9UNX9,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pKd,4.079999924,0,3,-,0,0,0,=,,,,10942728,
K<sub>ir</sub>2.4,433,KCNJ14,Q9UNX9,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,t,,,pKi,0,7.14,0,-,0,0,0,=,,,Extracellular,10942728,
K<sub>ir</sub>2.4,433,KCNJ14,Q9UNX9,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Inhibitor,None,,t,f,,-,0,0,0,-,0,0,0,=,,,Intracellular,0,
K<sub>ir</sub>3.1,434,Kcnj3,P63250,,,,,,Mouse,ethanol,2299,,,135651485,Activator,Agonist,,f,f,10000,-,0,0,0,-,0,0,0,=,,,,10570485,CCO
K<sub>ir</sub>3.1,434,KCNJ3,P48549,,,,,,Human,Na<sup>+</sup>,2340,,,135652743,Activator,Agonist,,t,,,pEC50,1.6,0,1.4,,0,0,0,,,,,10085101,
K<sub>ir</sub>3.1,434,,,,,,,,Unknown,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,f,50,pKd,0,6.300000191,0,Kd,0,501,0,=,,,,9486652,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<sub>ir</sub>3.1,434,KCNJ3,P48549,,,,,,Human,ML297,7768,,,223366101,Activator,None,,f,f,10,pEC50,0,6.699999809,0,EC50,0,190,0,=,,,,23730969,O=C(Nc1cc(nn1c1ccccc1)C)Nc1ccc(c(c1)F)F
K<sub>ir</sub>3.2,435,,,,,,,,None,ethanol,2299,,,135651485,Activator,Agonist,,f,f,10000-200000,-,0,0,0,-,0,0,0,=,,,,10570485,CCO
K<sub>ir</sub>3.2,435,KCNJ6,P48051,,,,,,Human,Na<sup>+</sup>,2340,,,135652743,Activator,Agonist,,t,,,pEC50,0,1.6,0,,0,0,0,,,,,10085101,
K<sub>ir</sub>3.2,435,,,,,,,,Unknown,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,f,50,pKd,0,6.300000191,0,Kd,0,501,0,=,,,,9486652,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,desipramine,2399,,,135650171,Channel blocker,Antagonist,Data obtained using K<sub>ir</sub>3.1/3.2 heteromer,f,f,,pIC50,0,4.400000095,0,-,0,0,0,=,,,,15150531,CNCCCN1c2ccccc2CCc2c1cccc2
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,imipramine,357,,,135650384,Channel blocker,Antagonist,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,15150531,CN(CCCN1c2ccccc2CCc2c1cccc2)C
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,maprotiline,2402,,,135650566,Channel blocker,Antagonist,,f,,,pIC50,0,4,0,,0,0,0,,,,,15150531,CNCCCC12CCC(c3c1cccc3)c1c2cccc1
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,nortriptyline,2404,,,135650736,Channel blocker,Antagonist,,f,,,pIC50,0,3.9,0,,0,0,0,,,,,15150531,CNCCC=C1c2ccccc2CCc2c1cccc2
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,QX-314,2405,,,135650877,Channel blocker,Antagonist,,f,,,pIC50,0,3.7,0,-,0,0,0,=,,,,8630252,CC[N+](CC(=O)Nc1c(C)cccc1C)(CC)CC
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,dizocilpine,2403,,,135650617,Gating inhibitor,Antagonist,,f,,,pIC50,0,3.7,0,,0,0,0,,,,,8630252,C[C@]12N[C@@H](c3c2cccc3)Cc2c1cccc2
K<sub>ir</sub>3.2,435,,,,,,,,None,F3,2400,,,135650249,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.1,0,,0,0,0,,,,,11465552,FC1(Cl)CCC1(F)F
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,fluoxetine,203,,,135650270,Gating inhibitor,Antagonist,,f,f,,pIC50,4.800000191,0,4.099999905,-,0,0,0,=,,,,12684268,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,haloperidol,86,,,135650345,Gating inhibitor,Antagonist,,f,,,pEC50,0,4.1,0,,0,0,0,,,,,10780978,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
K<sub>ir</sub>3.2,435,,,,,,,,None,halothane,2401,,,135650346,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.2,0,,0,0,0,,,,,11455015,ClC(C(F)(F)F)Br
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,pimozide,90,,,135650825,Gating inhibitor,Antagonist,Data obtained using K<sub>ir</sub>3.1/3.2 heteromer,f,f,,pEC50,0,5.5,0,-,0,0,0,=,,,,10780978,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
K<sub>ir</sub>3.2,435,KCNJ6,P48051,,,,,,Human,SCH-23390,943,,,135651025,Gating inhibitor,Antagonist,,f,f,,pIC50,5.099999905,0,4.099999905,-,0,0,0,=,,,,12065762,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
K<sub>ir</sub>3.3,436,KCNJ9,Q92806,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,8688080,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,fingolimod,2407,,,135650261,Activator,Agonist,,f,,0.01-0.1,-,0,0,0,,0,0,0,,,,,15707407,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N
K<sub>ir</sub>3.4,437,KCNJ5,P48544,,,,,,Human,Na<sup>+</sup>,2340,,,135652743,Activator,Agonist,,t,,,pEC50,0,1.4,0,,0,0,0,,,,,8923264,
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,ethanol,2299,,,135651485,Activator,None,,f,,10000-200000,-,0,0,0,,0,0,0,,,,,10570485,CCO
K<sub>ir</sub>3.4,437,KCNJ5,P48544,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,8688080,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,,,pEC50,0,4,0,,0,0,0,,,,,7877685,
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,desipramine,2399,,,135650171,Channel blocker,Antagonist,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,15150531,CNCCCN1c2ccccc2CCc2c1cccc2
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,imipramine,357,,,135650384,Channel blocker,Antagonist,,f,,,pEC50,0,4.5,0,,0,0,0,,,,,15150531,CN(CCCN1c2ccccc2CCc2c1cccc2)C
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,maprotiline,2402,,,135650566,Channel blocker,Antagonist,,f,,,pIC50,0,3.5,0,,0,0,0,,,,,15150531,CNCCCC12CCC(c3c1cccc3)c1c2cccc1
K<sub>ir</sub>3.4,437,KCNJ5,P48544,,,,,,Human,NIP-142,2408,,,135650721,Channel blocker,Antagonist,,f,,1-100,-,0,0,0,,0,0,0,,,,,15879679,COc1ccc(cc1)CC(=O)Nc1cc2c(cc1[N+](=O)[O-])OC([C@@H]([C@H]2NC1CC1)O)(C)C
K<sub>ir</sub>3.4,437,Kcnj5,P48545,,,,,,Mouse,nortriptyline,2404,,,135650736,Channel blocker,Antagonist,,f,,,pIC50,0,3.4,0,,0,0,0,,,,,15150531,CNCCC=C1c2ccccc2CCc2c1cccc2
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,phorbol 12-myristate 13-acetate,2341,,,135650820,Gating inhibitor,None,,f,,0.03,-,0,0,0,,0,0,0,,,,,14732702,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
K<sub>ir</sub>4.1,438,Kcnj10,P49655,,,,,,Rat,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,30-300,-,0,0,0,-,0,0,0,=,,,,7608203,
K<sub>ir</sub>4.1,438,KCNJ10,P78508,,,,,,Human,nortriptyline,2404,,,135650736,Channel blocker,Antagonist,,f,f,,pKd,4.800000191,0,4.400000095,-,0,0,0,=,,,,17071817,CNCCC=C1c2ccccc2CCc2c1cccc2
K<sub>ir</sub>4.1,438,Kcnj10,P49655,,,,,,Rat,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,t,f,,pEC50,6.099999905,0,6,-,0,0,0,=,,,Intracellular,11306656,
K<sub>ir</sub>4.2,439,Kcnj15,O88932,,,,,,Mouse,K<sup>+</sup>,2381,,,135652739,Activator,Activation,,t,f,100000,-,0,0,0,-,0,0,0,=,,,Extracellular,9882736,
K<sub>ir</sub>4.2,439,Kcnj15,O88932,,,,,,Mouse,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,K<sub>ir</sub>4.2 expressed in <i>Xenopus oocytes</i>,f,f,10-100,-,0,0,0,-,0,0,0,=,,,,9882736,
K<sub>ir</sub>4.2,439,Kcnj15,Q91ZF1,,,,,,Rat,H<sup>+</sup>,2346,,,135652738,Gating inhibitor,Antagonist,,f,f,,pEC50,7.099999905,0,6.699999809,-,0,0,0,=,,,Intracellular,11306656,
K<sub>ir</sub>5.1,440,Kcnj16,P52191,,,,,,Rat,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,7874445,
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,diazoxide,2409,,,135650176,Activator,Agonist,,f,f,200,-,0,0,0,-,0,0,0,=,,,,9130167,Clc1ccc2c(c1)S(=O)(=O)N=C(N2)C
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,guanosine 5'-diphosphate,2410,,,135650298,Activator,Agonist,,t,,100,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]c(N)nc2=O
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,guanosine-5'-triphosphate,1742,,,135650326,Activator,Agonist,,t,,0.1-100,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]c(N)nc2=O
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,nicorandil,2411,,,135650715,Activator,Agonist,,f,f,300,-,0,0,0,-,0,0,0,=,,,,9130167,[O-][N+](=O)OCCNC(=O)c1cccnc1
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,pinacidil,2412,,,135650826,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,9130167,CC(C(C)(C)C)N=C(Nc1ccncc1)NC#N
K<sub>ir</sub>6.1,441,KCNJ8,Q15842,,,,,,Human,cromakalim,2413,,,135650138,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N#Cc1ccc2c(c1)C(N1CCCC1=O)C(C(O2)(C)C)O
K<sub>ir</sub>6.1,441,KCNJ8,Q15842,,,,,,Human,minoxidil,4254,,,178101071,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1cc(nc([n+]1[O-])N)N1CCCCC1
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,guanosine-5'-triphosphate,1742,,,135650326,Gating inhibitor,Antagonist,,f,,3,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]c(N)nc2=O
K<sub>ir</sub>6.1,441,KCNJ8,Q15842,,,,,,Human,glibenclamide,2414,,,135650306,Inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,cromakalim,2413,,,135650138,Activator,Agonist,,f,f,30,-,0,0,0,-,0,0,0,=,,,,8630239,N#Cc1ccc2c(c1)C(N1CCCC1=O)C(C(O2)(C)C)O
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,diazoxide,2409,,,135650176,Activator,Agonist,,f,f,,pEC50,0,4.199999809,0,EC50,0,63000,0,=,,,,7502040,Clc1ccc2c(c1)S(=O)(=O)N=C(N2)C
K<sub>ir</sub>6.2,442,Kcnj11,P70673,,,,,,Rat,diazoxide,2409,,,135650176,Activator,Agonist,,f,f,200,-,0,0,0,-,0,0,0,=,,,,8798681,Clc1ccc2c(c1)S(=O)(=O)N=C(N2)C
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,pinacidil,2412,,,135650826,Activator,Agonist,,f,,30-100,-,0,0,0,,0,0,0,,,,,8630239,CC(C(C)(C)C)N=C(Nc1ccncc1)NC#N
K<sub>ir</sub>6.2,442,Kcnj11,P70673,,,,,,Rat,pinacidil,2412,,,135650826,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,8798681,CC(C(C)(C)C)N=C(Nc1ccncc1)NC#N
K<sub>ir</sub>6.2,442,KCNJ11,Q14654,,,,,,Human,minoxidil,4254,,,178101071,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1cc(nc([n+]1[O-])N)N1CCCCC1
K<sub>ir</sub>6.2,442,KCNJ11,Q14654,,,,,,Human,nicorandil,2411,,,135650715,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-][N+](=O)OCCNC(=O)c1cccnc1
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,glibenclamide,2414,,,135650306,Channel blocker,Antagonist,,f,,1,pIC50,0,5.7,0,,0,0,0,,,,,7502040,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
K<sub>ir</sub>6.2,442,Kcnj11,P70673,,,,,,Rat,glibenclamide,2414,,,135650306,Channel blocker,Antagonist,,f,,1,-,0,0,0,,0,0,0,,,,,8798681,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
K<sub>ir</sub>6.2,442,KCNJ11,Q14654,,,,,,Human,glibenclamide,2414,,,135650306,Inhibitor,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
K<sub>ir</sub>7.1,443,KCNJ13,O60928,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Antagonist,,f,f,,pKi,0,1.600000024,0,-,0,0,0,=,,,,9620703,
K<sub>ir</sub>7.1,443,KCNJ13,O60928,,,,,,Human,fampridine,2416,,,135649796,Channel blocker,Antagonist,,f,,1000-10000,-,0,0,0,,0,0,0,,,,,9620703,Nc1ccncc1
K<sub>Na</sub>1.1,385,KCNT1,Q5JUK3,,,,,,Human,loxapine,205,,,135650533,Activator,Agonist,,f,f,,pEC50,0,5.360000134,0,EC50,0,4400,0,=,,,,22171093,CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,Na<sup>+</sup>,2340,,,135652743,Activator,Agonist,,t,,15000,-,0,0,0,,0,0,0,,,,,12628167,
K<sub>Na</sub>1.1,385,KCNT1,Q5JUK3,,,,,,Human,niclosamide,8494,,,252166702,Activator,Agonist,,f,f,,pEC50,0,5.539999962,0,EC50,0,2900,0,=,,,,22171093,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,phorbol 12-myristate 13-acetate,2341,,,135650820,Activator,Agonist,,f,,,pEC50,7.3,0,7,,0,0,0,,,,,16687497,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
K<sub>Na</sub>1.1,385,KCNT1,Q5JUK3,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,Antagonist,,f,f,100-300,-,0,0,0,-,0,0,0,=,,,,24591078,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,None,,f,f,,pIC50,0,4,0,-,0,0,0,=,,,,16876206,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,flufenamic acid,2447,,,135650269,Activator,Agonist,,f,f,,pEC50,0,8.850000381,0,EC50,0,1.399999976,0,=,,,,20176855,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
K<sub>Na</sub>1.2,386,Kcnt2,Q6UVM4,,,,,,Rat,Na<sup>+</sup>,2340,,,135652743,Activator,Agonist,,t,,1000-100000,-,0,0,0,,0,0,0,,,,,14684870,
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,niflumic acid,2439,,,135650716,Activator,Agonist,,f,f,,pEC50,0,8.680000305,0,EC50,0,2.099999905,0,=,,,,20176855,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
K<sub>Na</sub>1.2,386,Kcnt2,Q6UVM4,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,Inhibition,,f,f,1000,-,0,0,0,-,0,0,0,=,,,,14684870,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,phorbol 12-myristate 13-acetate,2341,,,135650820,Gating inhibitor,Inhibition,,f,,,pIC50,0,7.92,0,,0,0,0,,,,,16687497,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,dofetilide,2604,,,135650201,Channel blocker,None,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,16949586,CN(CCc1ccc(cc1)NS(=O)(=O)C)CCOc1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,E4031,2605,,,135650215,Channel blocker,None,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,12522086,Cc1cccc(n1)CCN1CCC(CC1)C(=O)c1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,haloperidol,86,,,135650345,Channel blocker,None,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,12522086,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,imipramine,357,,,135650384,Channel blocker,None,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,15365094,CN(CCCN1c2ccccc2CCc2c1cccc2)C
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,LY97241,2606,,,135650562,Channel blocker,None,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,12522086,CCCCCCCN(CCCCc1ccc(cc1)[N+](=O)[O-])CC
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,MK-499,2607,,,53801034,Channel blocker,None,,f,,,pIC50,0,6,0,,0,0,0,,,,,16949586,N#Cc1ccc2c(c1)CC[C@H](C2)N1CCC2(CC1)C[C@@H](O)c1c(O2)ccc(c1)NS(=O)(=O)C
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,,pIC50,0,5.8,0,,0,0,0,,,,,11943152,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,ICA-105574,7656,,,223365991,Gating inhibitor,Inhibition,,f,f,,pIC50,0,5.900000095,0,-,0,0,0,=,,,,23319419,O=C(c1cccc(c1)[N+](=O)[O-])Nc1ccc(cc1)Oc1ccccc1
K<SUB>v</SUB>10.2,571,KCNH5,Q8NCM2,,,,,,Human,LY97241,2606,,,135650562,Channel blocker,Pore blocker,,f,f,,pIC50,0,5.800000191,0,-,0,0,0,=,,,,9400421,CCCCCCCN(CCCCc1ccc(cc1)[N+](=O)[O-])CC
K<SUB>v</SUB>10.2,571,KCNH5,Q8NCM2,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,Pore blocker,,f,f,,pIC50,0,3.799999952,0,-,0,0,0,=,,,,15102940,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>1.1,538,KCNA1,Q09470,,,,,,Human,margatoxin,2547,,,135652277,Channel blocker,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4.199999809,0,=,,,,24878374,
K<SUB>v</SUB>1.1,538,Kcna1,P10499,,,,,,Rat,margatoxin,2547,,,135652277,Channel blocker,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5.460000038,0,=,,,,9346893,
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,dendrotoxin-I,2544,,,135652103,Channel blocker,None,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,7517498,
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,diltiazem,2298,,,135650185,Channel blocker,None,,f,f,,pIC50,0,3.799999952,0,-,0,0,0,=,,,,7517498,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,flecainide,2560,,,135650266,Channel blocker,None,,f,f,,pKd,0,3.700000048,0,-,0,0,0,=,,,,7517498,O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1
K<SUB>v</SUB>1.1,538,Kcna1,P10499,,,,,,Rat,hongotoxin-1,2545,,,135652189,Channel blocker,None,,f,,,pIC50,0,10.5,0,,0,0,0,,,,,9446567,
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,kaliotoxin,2546,,,135652239,Channel blocker,None,,f,f,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,7517498,
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,mast cell degranulating peptide,2548,,,135652278,Channel blocker,None,,f,f,,pIC50,0,6.300000191,0,IC50,0,490,0,=,,,,7517498,NCCCCC1NC(=O)C(CCCNC(=N)N)NC(=O)C2CSSCC(NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(CC)C)C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CC(=O)N)CCCCN)NC(=O)C(NC(=O)C(C(CC)C)N)CCCCN)CC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1N=CN=C1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)N2)C(CC)C)CC2N=CN=C2)CCC1)CCCCN)C(CC)C)C(C)C
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,nifedipine,2514,,,53801065,Channel blocker,None,,f,f,,pIC50,0,4,0,-,0,0,0,=,,,,7517498,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,resiniferatoxin,2491,,,53801085,Channel blocker,None,,f,f,,pIC50,0,5.099999905,0,-,0,0,0,=,,,,7517498,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
K<SUB>v</SUB>1.1,538,Kcna1,P10499,,,,,,Rat,ShK Toxin,2549,,,135652463,Channel blocker,None,,f,f,,pIC50,0,10.80000019,0,-,0,0,0,=,,,,7517498,
K<SUB>v</SUB>1.1,538,Kcna1,P10499,,,,,,Rat,dendrotoxin-k,7738,,,223366071,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,8612784,
K<SUB>v</SUB>1.1,538,KCNA1,Q09470,,,,,,Human,HelaTx1,7737,,,223366070,Channel blocker,Pore blocker,,f,f,,pEC50,0,5,0,EC50,0,9900,0,=,,,,22305749,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,ginsenoside Rg3,7658,,,223365993,Activator,Activation,,f,f,,pEC50,0,6.400000095,0,-,0,0,0,=,,,,21586280,OC[C@H]1O[C@@H](O[C@H]2CC[C@]3([C@H](C2(C)C)CC[C@@]2([C@@H]3C[C@@H](O)[C@H]3[C@@]2(C)CC[C@@H]3[C@](CCC=C(C)C)(O)C)C)C)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,ICA-105574,7656,,,223365991,Activator,Activation,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,19805508,O=C(c1cccc(c1)[N+](=O)[O-])Nc1ccc(cc1)Oc1ccccc1
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,KB-130015,7659,,,223365994,Activator,Activation,,f,f,,pEC50,0,4.900000095,0,-,0,0,0,=,,,,20097192,OC(=O)COc1c(I)cc(cc1I)Cc1c(C)oc2c1cccc2
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,NS1643,2308,,,135650743,Activator,Activation,,f,f,,pEC50,0,5,0,-,0,0,0,=,,,,16284303,O=C(Nc1cc(ccc1O)C(F)(F)F)Nc1cc(ccc1O)C(F)(F)F
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,NS3623,7660,,,223365995,Activator,Activation,,f,f,,pEC50,0,4.099999905,0,-,0,0,0,=,,,,16825484,O=C(Nc1ccc(cc1c1nn[nH]n1)Br)Nc1cccc(c1)C(F)(F)F
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,rottlerin,2611,,,135652702,Activator,Activation,,f,f,,pEC50,0,6.5,0,-,0,0,0,=,,,,16928897,O=C(c1c(O)c(Cc2c(O)c(C)c(c(c2O)C(=O)C)O)c(c2c1OC(C)(C)C=C2)O)/C=C/c1ccccc1
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,PD-118057,7676,,,223366011,Activator,None,,f,f,10,-,0,0,0,-,0,0,0,=,,,,15976038,OC(=O)c1ccccc1Nc1ccc(cc1)CCc1ccc(c(c1)Cl)Cl
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,PD-307243,7677,,,223366012,Activator,None,,f,f,2,-,0,0,0,-,0,0,0,=,,,,18042732,OC(=O)c1cccnc1Nc1ccc2c(c1)CN(C2)c1ccc(c(c1)Cl)Cl
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,RPR260243,7657,,,223365992,Activator,None,,f,f,3,-,0,0,0,-,0,0,0,=,,,,15548764,COc1ccc2c(c1)c(ccn2)C(=O)CC[C@@H]1CCN(C[C@@H]1C(=O)O)CC#Cc1cc(F)cc(c1F)F
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,disopyramide,7167,,,178103742,Channel blocker,Inhibition,,f,f,,pIC50,0,4.039999962,0,IC50,0,91201,0,=,,,,12873512,CC(N(C(C)C)CCC(c1ccccn1)(c1ccccc1)C(=N)O)C
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,dofetilide,2604,,,135650201,Channel blocker,Inhibition,,f,t,,pKi,0,8.18999958,0,Ki,0,6.400000095,0,=,,,,17536794,CN(CCc1ccc(cc1)NS(=O)(=O)C)CCOc1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,E4031,2605,,,135650215,Channel blocker,None,,f,f,,pIC50,0,8.100000381,0,IC50,0,7.699999809,0,=,,,,9449325,Cc1cccc(n1)CCN1CCC(CC1)C(=O)c1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>11.1,572,Kcnh2,O08962,,,,,,Rat,E4031,2605,,,135650215,Channel blocker,None,,f,f,,pKd,0,7,0,-,0,0,0,=,,,,9390998,Cc1cccc(n1)CCN1CCC(CC1)C(=O)c1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>11.1,572,Kcnh2,O08962,,,,,,Rat,ErgTx-1,2612,,,135652149,Channel blocker,None,,f,f,,pKd,0,8.199999809,0,-,0,0,0,=,,,,16497878,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,ErgTx-1,2612,,,135652149,Channel blocker,None,,f,f,,pKd,0,8.300000191,0,-,0,0,0,=,,,,16497878,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,&gamma;-KTx1.7,7689,,,223366024,Channel blocker,None,,f,f,,pKd,0,7.900000095,0,-,0,0,0,=,,,,18338253,
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,ibutilide,7200,,,178103775,Channel blocker,None,,f,t,,pIC50,8,0,7.599999905,IC50,25.10000038,0,10,=,,,,12873512,CCCCCCCN(CCCC(c1ccc(cc1)NS(=O)(=O)C)O)CC
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,nemiralisib,9425,,,328083525,Inhibitor,Inhibition,,f,f,,pIC50,0,5.5,0,IC50,0,3162,0,=,,,,26301626,CC(N1CCN(CC1)Cc1cnc(o1)c1cc(cc2c1cn[nH]2)c1cccc2c1cc[nH]2)C
K<SUB>v</SUB>11.2,573,KCNH6,Q9H252,,,,,,Human,NS1643,2308,,,135650743,Activator,None,,f,,,pEC50,0,4.9,0,,0,0,0,,,,,17610913,O=C(Nc1cc(ccc1O)C(F)(F)F)Nc1cc(ccc1O)C(F)(F)F
K<SUB>v</SUB>11.2,573,Kcnh6,O54853,,,,,,Rat,E4031,2605,,,135650215,Channel blocker,None,,f,,,pKd,0,6.9,0,,0,0,0,,,,,9390998,Cc1cccc(n1)CCN1CCC(CC1)C(=O)c1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>11.2,573,KCNH6,Q9H252,,,,,,Human,ErgTx-1,2612,,,135652149,Gating inhibitor,Inhibition,,f,f,,pKd,0,6.699999809,0,-,0,0,0,=,,,,6497878,
K<SUB>v</SUB>11.2,573,Kcnh6,O54853,,,,,,Rat,ErgTx-1,2612,,,135652149,Gating inhibitor,None,,f,,,pKd,0,8.5,0,,0,0,0,,,,,9390998,
K<SUB>v</SUB>11.2,573,KCNH6,Q9H252,,,,,,Human,&gamma;-KTx1.7,7689,,,223366024,Gating inhibitor,None,,f,f,,pKd,0,8.800000191,0,-,0,0,0,=,,,,18338253,
K<SUB>v</SUB>11.3,574,Kcnh7,O54852,,,,,,Rat,NS1643,2308,,,135650743,Activator,None,10 &micro;M NS1643 produced a -15 to -20mV shift in V0.5 of channel activation,f,f,10,-,0,0,0,-,0,0,0,=,,,,23226420,O=C(Nc1cc(ccc1O)C(F)(F)F)Nc1cc(ccc1O)C(F)(F)F
K<SUB>v</SUB>11.3,574,Kcnh7,O54852,,,,,,Rat,E4031,2605,,,135650215,Channel blocker,None,,f,,,pKd,0,6.7,0,,0,0,0,,,,,9390998,Cc1cccc(n1)CCN1CCC(CC1)C(=O)c1ccc(cc1)NS(=O)(=O)C
K<SUB>v</SUB>11.3,574,Kcnh7,O54852,,,,,,Rat,ErgTx-1,2612,,,135652149,Channel blocker,Pore blocker,,f,f,,pKd,0,8.399999619,0,-,0,0,0,=,,,,17097705,
K<SUB>v</SUB>1.2,539,KCNA2,P16389,,,,,,Human,margatoxin,2547,,,135652277,Channel blocker,Inhibition,,f,f,,pIC50,0,11.19999981,0,IC50,0,0.0064,0,=,,,,24878374,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,dendrotoxin-I,2544,,,135652103,Channel blocker,None,,f,,,pKd,0,7.8,0,,0,0,0,,,,,7517498,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,hongotoxin-1,2545,,,135652189,Channel blocker,None,,f,,,pKd,13,0,12.6,-,0,0,0,=,,,,9446567,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,mast cell degranulating peptide,2548,,,135652278,Channel blocker,None,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,,,,7517498,NCCCCC1NC(=O)C(CCCNC(=N)N)NC(=O)C2CSSCC(NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(CC)C)C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CC(=O)N)CCCCN)NC(=O)C(NC(=O)C(C(CC)C)N)CCCCN)CC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1N=CN=C1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)N2)C(CC)C)CC2N=CN=C2)CCC1)CCCCN)C(CC)C)C(C)C
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,noxiustoxin,2552,,,135652335,Channel blocker,None,,f,f,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,7517498,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,pandinotoxin-K &alpha;,2553,,,135652378,Channel blocker,None,,f,f,,pIC50,0,10.5,0,-,0,0,0,=,,,,11527374,
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,diltiazem,2298,,,135650185,Channel blocker,Pore blocker,,f,f,,pKd,0,3.700000048,0,Kd,0,187000,0,=,,,,7517498,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,fampridine,2416,,,135649796,Channel blocker,Pore blocker,,f,f,,pKd,0,3.200000048,0,Kd,0,590000,0,=,,,,7517498,Nc1ccncc1
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,flecainide,2560,,,135650266,Channel blocker,Pore blocker,,f,f,,pKd,0,3.700000048,0,Kd,0,217000,0,=,,,,7517498,O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,nifedipine,2514,,,53801065,Channel blocker,Pore blocker,,f,f,,pKd,0,4.699999809,0,Kd,0,18000,0,=,,,,7517498,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
K<SUB>v</SUB>1.2,539,Kcna2,P63142,,,,,,Rat,resiniferatoxin,2491,,,53801085,Channel blocker,Pore blocker,,f,f,,pKd,0,4.5,0,Kd,0,31000,0,=,,,,7517498,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
K<SUB>v</SUB>12.2,576,KCNH3,Q9ULD8,,,,,,Human,Cs<sup>+</sup>,2356,,,135652734,Channel blocker,Pore blocker,,f,f,,pKd,0,1.200000048,0,-,0,0,0,=,,,,12193184,
K<SUB>v</SUB>12.2,576,Kcnh3,Q9WVJ0,,,,,,Mouse,CX4,7663,,,223365998,Gating inhibitor,Inhibition,,f,f,,pIC50,0,5,0,-,0,0,0,=,10 &micro;M CX4 depolarizes voltage dependence of activation by ~+40 mV,,,20676103,S=C(Nc1c(C)cccc1Cl)NC(c1ccccc1)Cc1ccccc1
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,correolide,2555,,,135652678,Channel blocker,None,,f,f,,pIC50,0,7.099999905,0,IC50,0,86,0,=,,,,10213593,COC(=O)[C@@]12O[C@@H]1C(=C)C[C@@]1([C@@]2(C)[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@]2([C@H]1CC[C@@]1([C@@H]2[C@H](OC(=O)C)[C@H](OC(=O)C)[C@@]2([C@H]1C=CC(=O)OC2)C(OC(=O)C)C)C)C)O
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,HsTX1[R14A],9582,,,340590213,Channel blocker,None,,f,t,,pIC50,0,10.56999969,0,IC50,0,0.027000001,0,=,,,,28389388,
K<SUB>v</SUB>1.3,540,Kcna3,P15384,,,,,,Rat,kaliotoxin,2546,,,135652239,Channel blocker,None,,f,,,pIC50,0,9.2,0,,0,0,0,,,,,7517498,
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,margatoxin,2547,,,135652277,Channel blocker,None,,f,f,,pIC50,10.30000019,0,10,IC50,0.100000001,0,0.050000001,=,,,,10961988,
K<SUB>v</SUB>1.3,540,,,,,,,,None,maurotoxin,2332,,,135652279,Channel blocker,None,,f,f,,pIC50,0,6.800000191,0,-,0,0,0,=,,,,9792177,
K<SUB>v</SUB>1.3,540,Kcna3,P16390,,,,,,Mouse,noxiustoxin,2552,,,135652335,Channel blocker,None,,f,f,,pKd,0,9,0,Kd,0,1,0,=,,,,7517498,
K<SUB>v</SUB>1.3,540,Kcna3,P16390,,,,,,Mouse,OSK1-K16-D20,2556,,,135652374,Channel blocker,None,,f,,,pIC50,0,11.5,0,,0,0,0,,,,,15588251,
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,psora-4,9583,,,340590214,Channel blocker,None,,f,f,,pIC50,0,6.139999866,0,IC50,0,724,0,=,Inhibition of human Kv1.3 expressed in CGE22 cells measured by patch clamp assay.,,,20971642,O=c1ccc2c(o1)cc1c(c2OCCCCc2ccccc2)cco1
K<SUB>v</SUB>1.3,540,Kcna3,P15384,,,,,,Rat,ShK(L5),2557,,,135652462,Channel blocker,None,,f,,,pIC50,10.9,0,10.2,,0,0,0,,,,,15665253,
K<SUB>v</SUB>1.3,540,Kcna3,P15384,,,,,,Rat,ShK Toxin,2549,,,135652463,Channel blocker,None,,f,f,,pIC50,12,0,9.899999619,-,0,0,0,=,,,,9830012,
K<SUB>v</SUB>1.3,540,KCNA3,P22001,,,,,,Human,correolide,2555,,,135652678,Channel blocker,Pore blocker,,f,f,,pKd,0,8,0,-,0,0,0,=,,,,10213593,COC(=O)[C@@]12O[C@@H]1C(=C)C[C@@]1([C@@]2(C)[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@]2([C@H]1CC[C@@]1([C@@H]2[C@H](OC(=O)C)[C@H](OC(=O)C)[C@@]2([C@H]1C=CC(=O)OC2)C(OC(=O)C)C)C)C)O
K<SUB>v</SUB>1.4,541,Kcna4,Q61423,,,,,,Mouse,CP-339818,2558,,,135650128,Channel blocker,None,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,8967992,CCCCCN=c1ccn(c2c1cccc2)Cc1ccccc1
K<SUB>v</SUB>1.4,541,Kcna4,P15385,,,,,,Rat,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,1.899999976,0,IC50,0,12500000,0,=,,,,2555158,Nc1ccncc1
K<SUB>v</SUB>1.4,541,Kcna4,P15385,,,,,,Rat,nicardipine,2559,,,135650714,Channel blocker,None,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,12788813,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C
K<SUB>v</SUB>1.4,541,Kcna4,P15385,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,None,,f,,,pIC50,0,3.7,0,,0,0,0,,,,,7589202,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>1.5,542,,,,,,,,None,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,4.300000191,0,-,0,0,0,=,,,,8508531,Nc1ccncc1
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,flecainide,2560,,,135650266,Channel blocker,None,,f,,,pKd,0,4,0,,0,0,0,,,,,7517498,O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,nifedipine,2514,,,53801065,Channel blocker,None,,f,,,pKd,0,4.1,0,,0,0,0,,,,,7517498,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,propafenone,2561,,,135650856,Channel blocker,None,,f,f,,pIC50,0,4.400000095,0,-,0,0,0,=,,,,9846634,CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,,pKd,0,5.2,0,,0,0,0,,,,,1538710,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,resiniferatoxin,2491,,,53801085,Channel blocker,None,,f,,,pKd,0,4.6,0,,0,0,0,,,,,7517498,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,S9947,2562,,,135650974,Channel blocker,None,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,12382079,O=C(NCc1ccccc1c1ccccc1C(=O)NCCc1ccccn1)OCc1ccccc1
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,diltiazem,2298,,,135650185,Channel blocker,Pore blocker,,f,f,,pKd,0,3.900000095,0,Kd,0,115000,0,=,,,,7517498,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,fampridine,2416,,,135649796,Channel blocker,Pore blocker,,f,f,,pKd,0,3.599999905,0,Kd,0,270000,0,=,,,,7517498,Nc1ccncc1
K<SUB>v</SUB>1.5,542,KCNA5,P22460,,,,,,Human,dronedarone,7465,,,187051768,Inhibitor,Inhibition,,f,f,,pIC50,0,5.630000114,0,IC50,0,2370,0,=,Whole cell patch clamp experiment using HEK293 cells expressing human Kv1.5.,,,24824064,CCCCc1oc2c(c1C(=O)c1ccc(cc1)OCCCN(CCCC)CCCC)cc(cc2)NS(=O)(=O)C
K<SUB>v</SUB>1.6,543,Kcna6,P17659,,,,,,Rat,hongotoxin-1,2545,,,135652189,Channel blocker,None,,f,,,pKd,0,11,0,,0,0,0,,,,,9446567,
K<SUB>v</SUB>1.6,543,KCNA6,P17658,,,,,,Human,mast cell degranulating peptide,2548,,,135652278,Channel blocker,None,,f,,,pIC50,0,8,0,,0,0,0,,,,,2347305,NCCCCC1NC(=O)C(CCCNC(=N)N)NC(=O)C2CSSCC(NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(CC)C)C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CC(=O)N)CCCCN)NC(=O)C(NC(=O)C(C(CC)C)N)CCCCN)CC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1N=CN=C1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)N2)C(CC)C)CC2N=CN=C2)CCC1)CCCCN)C(CC)C)C(C)C
K<SUB>v</SUB>1.6,543,Kcna6,P17659,,,,,,Rat,ShK Toxin,2549,,,135652463,Channel blocker,None,,f,,,pIC50,0,9.8,0,,0,0,0,,,,,9830012,
K<SUB>v</SUB>1.6,543,Kcna6,P17659,,,,,,Rat,conopeptide Y-PI1,7742,,,223366075,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.800000191,0,IC50,0,170,0,=,,,,18505731,
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,CP-339818,2558,,,135650128,Channel blocker,None,,f,,,pIC50,0,5,0,,0,0,0,,,,,9488722,CCCCCN=c1ccn(c2c1cccc2)Cc1ccccc1
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,cromakalim,2413,,,135650138,Channel blocker,None,,f,,,pIC50,0,3.3,0,,0,0,0,,,,,9488722,N#Cc1ccc2c(c1)C(N1CCCC1=O)C(C(O2)(C)C)O
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,diltiazem,2298,,,135650185,Channel blocker,None,,f,,,pIC50,0,4.2,0,,0,0,0,,,,,9488722,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,3.599999905,0,IC50,0,245000,0,=,,,,9488722,Nc1ccncc1
K<SUB>v</SUB>1.7,544,KCNA7,Q96RP8,,,,,,Human,flecainide,2560,,,135650266,Channel blocker,None,,f,,,pKd,0,5.1,0,,0,0,0,,,,,11896454,O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,margatoxin,2547,,,135652277,Channel blocker,None,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,9488722,
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,nifedipine,2514,,,53801065,Channel blocker,None,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,9488722,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,noxiustoxin,2552,,,135652335,Channel blocker,None,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,9488722,
K<SUB>v</SUB>1.7,544,KCNA7,Q96RP8,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,,pKd,0,4.8,0,,0,0,0,,,,,11896454,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,resiniferatoxin,2491,,,53801085,Channel blocker,None,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,9488722,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,ShK Toxin,2549,,,135652463,Channel blocker,None,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,9488722,
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,conkunitzin-S1 toxin,7758,,,223366091,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.400000095,0,IC50,0,439,0,=,,,,22438204,
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,Pore blocker,,f,f,,pKd,0,3.799999952,0,-,0,0,0,=,,,,16801386,Nc1ccncc1
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,fampridine,2416,,,135649796,Channel blocker,None,,f,t,,pIC50,0,2.799999952,0,IC50,0,1580000,0,=,,,,10836990,Nc1ccncc1
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,ketoconazole,2568,,,135650454,Channel blocker,None,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10836990,Clc1ccc(c(c1)Cl)C1(OCC(O1)COc1ccc(cc1)N1CCN(CC1)C(=O)C)Cn1cncc1
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,pimozide,90,,,135650825,Channel blocker,None,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,10836990,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
K<SUB>v</SUB>2.1,546,KCNB1,Q14721,,,,,,Human,linoleic acid,1052,,,135651503,Activator,None,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,11546665,CCCCC/C=CC/C=CCCCCCCCC(=O)O
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,DABCO-C<sub>16</sub>,2572,,,135650155,Channel blocker,None,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16317109,CCCCCCCCCCCCCCCC[N+]12CCN(CC1)CC2
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,halothane,2401,,,135650346,Channel blocker,None,,f,,,pEC50,0,3.5,0,,0,0,0,,,,,8638845,ClC(C(F)(F)F)Br
K<SUB>v</SUB>2.1,546,KCNB1,Q14721,,,,,,Human,linoleic acid,1052,,,135651503,Channel blocker,None,,f,,,pIC50,0,5.1,0,,0,0,0,,,,,11546665,CCCCC/C=CC/C=CCCCCCCCC(=O)O
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,fampridine,2416,,,135649796,Channel blocker,Pore blocker,,f,f,,pIC50,0,3.299999952,0,IC50,0,500000,0,=,,,,8301258,Nc1ccncc1
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,Na<sup>+</sup>,2340,,,135652743,Channel blocker,Pore blocker,,f,f,,pIC50,0,1.600000024,0,-,0,0,0,=,,,,8189205,
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,SsmTx-1,7764,,,223366097,Channel blocker,Pore blocker,,f,f,,pIC50,0,7.400000095,0,IC50,0,41.70000076,0,=,,,,24464516,
K<SUB>v</SUB>2.1,546,KCNB1,Q14721,,,,,,Human,GxTx-1E,7760,,,223366093,Gating inhibitor,None,,f,f,,pIC50,0,2,0,-,0,0,0,=,,,,16567526,
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,HaTx1,7762,,,223366095,Gating inhibitor,None,,f,f,,pKd,0,7.380000114,0,Kd,0,42,0,=,,,,7576642,
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,jingzhaotoxin-III,2574,,,135652217,Gating inhibitor,None,,f,f,,pIC50,0,6.400000095,0,IC50,0,380,0,=,,,,17481690,
K<SUB>v</SUB>2.1,546,Kcnb1,Q03717,,,,,,Mouse,jingzhaotoxin-XI,2575,,,135652218,Gating inhibitor,None,,f,,,pKd,0,6.1,0,,0,0,0,,,,,17176080,
K<SUB>v</SUB>2.1,546,KCNB1,Q14721,,,,,,Human,RY796,7759,,,223366092,Gating inhibitor,None,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,21948463,O=C(C(C)C)Nc1ccc(c(c1)C(=O)N[C@@H](c1ccccc1)C)N(C)C
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,ScTx1,2576,,,135652454,Gating inhibitor,None,,f,f,,pIC50,0,7.900000095,0,IC50,0,12.69999981,0,=,,,,12065754,
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,SGTx1,7761,,,223366094,Gating inhibitor,None,,f,f,,pKd,0,5.699999809,0,Kd,0,2000,0,=,,,,14744131,
K<SUB>v</SUB>2.2,547,KCNB2,Q92953,,,,,,Human,fampridine,2416,,,135649796,Channel blocker,None,,f,t,,pIC50,0,2.799999952,0,IC50,0,1500000,0,=,,,,9612272,Nc1ccncc1
K<SUB>v</SUB>2.2,547,KCNB2,Q92953,,,,,,Human,quinine,2510,,,135652709,Channel blocker,None,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,9612272,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>2.2,547,KCNB2,Q92953,,,,,,Human,GxTx-1E,7760,,,223366093,Gating inhibitor,None,,f,f,,pKd,0,8.600000381,0,Kd,0,2.599999905,0,=,,,,16567526,
K<SUB>v</SUB>2.2,547,KCNB2,Q92953,,,,,,Human,RY796,7759,,,223366092,Gating inhibitor,None,,f,f,,pIC50,0,7.099999905,0,IC50,0,90,0,=,,,,21948463,O=C(C(C)C)Nc1ccc(c(c1)C(=O)N[C@@H](c1ccccc1)C)N(C)C
K<SUB>v</SUB>2.2,547,Kcnb2,Q63099,,,,,,Rat,ScTx1,2576,,,135652454,Gating inhibitor,None,,f,f,,pIC50,0,7.699999809,0,IC50,0,21.39999962,0,=,,,,12065754,
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,cromakalim,2413,,,135650138,Channel blocker,None,,f,,,pIC50,0,3.6,0,,0,0,0,,,,,7517498,N#Cc1ccc2c(c1)C(N1CCCC1=O)C(C(O2)(C)C)O
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,diltiazem,2298,,,135650185,Channel blocker,None,,f,,,pIC50,0,4,0,,0,0,0,,,,,7517498,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,4.5,0,IC50,0,29000,0,=,,,,7517498,Nc1ccncc1
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,flecainide,2560,,,135650266,Channel blocker,None,,f,,,pIC50,0,4,0,,0,0,0,,,,,7517498,O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,nifedipine,2514,,,53801065,Channel blocker,None,,f,,,pIC50,0,3.9,0,,0,0,0,,,,,7517498,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,resiniferatoxin,2491,,,53801085,Channel blocker,None,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,7517498,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
K<SUB>v</SUB>3.1,548,Kcnc1,P25122,,,,,,Rat,fluoxetine,203,,,135650270,Gating inhibitor,None,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,11543764,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
K<SUB>v</SUB>3.1,548,Kcnc1,P25122,,,,,,Rat,norfluoxetine,208,,,135650734,Gating inhibitor,None,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,11543764,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
K<SUB>v</SUB>3.2,549,Kcnc2,P22462,,,,,,Rat,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,4.599999905,0,IC50,0,24000,0,=,,,,11790809,Nc1ccncc1
K<SUB>v</SUB>3.2,549,KCNC2,Q96PR1,,,,,,Human,ShK Toxin,2549,,,135652463,Channel blocker,None,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,15709110,
K<SUB>v</SUB>3.3,550,Kcnc3,Q01956,,,,,,Rat,fampridine,2416,,,135649796,Channel blocker,None,,f,,,pIC50,0,2.9,0,,0,0,0,,,,,1381835,Nc1ccncc1
K<SUB>v</SUB>3.4,551,Kcnc4,Q63734,,,,,,Rat,DABCO,2577,,,135650154,Channel blocker,None,,f,,,pIC50,0,3.2,0,,0,0,0,,,,,16317109,C1CN2CCN1CC2
K<SUB>v</SUB>3.4,551,Kcnc4,Q63734,,,,,,Rat,DABCO-C<sub>16</sub>,2572,,,135650155,Channel blocker,None,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,16317109,CCCCCCCCCCCCCCCC[N+]12CCN(CC1)CC2
K<SUB>v</SUB>3.4,551,Kcnc4,Q63734,,,,,,Rat,sea anemone toxin BDS-I,2578,,,135652456,Channel blocker,None,,f,f,,pIC50,0,7.300000191,0,IC50,0,47,0,=,,,,9506974,
K<SUB>v</SUB>4.1,552,KCND1,Q9NSA2,,,,,,Human,fampridine,2416,,,135649796,Channel blocker,None,,f,t,,pIC50,0,2,0,-,0,0,0,=,,,,10729221,Nc1ccncc1
K<SUB>v</SUB>4.1,552,Kcnd1,Q03719,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,None,,f,,,pIC50,0,2,0,,0,0,0,,,,,11805342,Nc1ccncc1
K<SUB>v</SUB>4.1,552,Kcnd1,Q03719,,,,,,Mouse,HmTx1,2580,,,135652182,Channel blocker,None,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,12065754,
K<SUB>v</SUB>4.2,553,Kcnd2,Q9Z0V2,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,None,,f,f,,pIC50,0,2.299999952,0,-,0,0,0,=,,,,16317109,Nc1ccncc1
K<SUB>v</SUB>4.2,553,Kcnd2,Q63881,,,,,,Rat,heteropodatoxin-2,2581,,,135652181,Channel blocker,None,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,15208026,
K<SUB>v</SUB>4.2,553,Kcnd2,Q9Z0V2,,,,,,Mouse,phrixotoxin 1,2582,,,53801042,Channel blocker,None,,f,f,,pIC50,8.300000191,0,7.099999905,-,0,0,0,=,,,,15096626,
K<SUB>v</SUB>4.2,553,Kcnd2,Q9Z0V2,,,,,,Mouse,phrixotoxin 2,2583,,,135652400,Channel blocker,None,,f,f,,pIC50,8.300000191,0,7.099999905,-,0,0,0,=,,,,15096626,
K<SUB>v</SUB>4.2,553,Kcnd2,Q63881,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,None,,f,f,,pIC50,0,4.900000095,0,-,0,0,0,=,,,,12721103,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
K<SUB>v</SUB>4.2,553,Kcnd2,Q63881,,,,,,Rat,sBmTX 3,2584,,,53801041,Channel blocker,None,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,16987219,
K<SUB>v</SUB>4.3,554,Kcnd3,Q9Z0V1,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,None,,f,,,pIC50,0,2.4,0,,0,0,0,,,,,17016508,Nc1ccncc1
K<SUB>v</SUB>4.3,554,Kcnd3,Q62897,,,,,,Rat,nicotine,2585,,,53801040,Channel blocker,None,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,10973847,CN1CCC[C@H]1c1cccnc1
K<SUB>v</SUB>4.3,554,Kcnd3,Q62897,,,,,,Rat,phrixotoxin 1,2582,,,53801042,Channel blocker,None,,f,,,pIC50,8.7,0,7.1,,0,0,0,,,,,10973847,
K<SUB>v</SUB>4.3,554,Kcnd3,Q62897,,,,,,Rat,phrixotoxin 2,2583,,,135652400,Channel blocker,None,,f,,,pIC50,8.7,0,7.1,,0,0,0,,,,,10973847,
K<SUB>v</SUB>4.3,554,Kcnd3,Q9Z0V1,,,,,,Mouse,phrixotoxin 2,2583,,,135652400,Channel blocker,None,,f,,,pIC50,0,7,0,,0,0,0,,,,,17016508,
K<SUB>v</SUB>4.3,554,Kcnd3,Q62897,,,,,,Rat,sibutramine,2586,,,135651043,Channel blocker,None,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,17312186,CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
K<SUB>v</SUB>4.3,554,Kcnd3,Q62897,,,,,,Rat,riluzole,2326,,,135650900,Gating inhibitor,None,,f,,,pIC50,0,3.9,0,,0,0,0,,,,,16815868,Nc1nc2c(s1)cc(cc2)OC(F)(F)F
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,ML277,7666,,,223366001,Activator,Activation,,f,f,,pEC50,0,6.599999905,0,EC50,0,260,0,=,,,,22910039,COc1ccc(cc1)c1csc(n1)NC(=O)[C@H]1CCCCN1S(=O)(=O)c1ccc(cc1)C
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,mefenamic acid,2593,,,53801036,Activator,None,,f,,100,-,0,0,0,,0,0,0,,,,,11207363,OC(=O)c1ccccc1Nc1cccc(c1C)C
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,R-L3,2595,,,135650906,Activator,None,,f,,1,pEC50,0,6,0,,0,0,0,,,,,9658209,O=C1[C@H](N=C(c2c(N1C)cccc2)c1ccccc1F)Cc1c[nH]c2c1cccc2
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,niflumic acid,2439,,,135650716,Activator,Positive,,f,,100,-,0,0,0,,0,0,0,,,,,7969055,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,HMR-1556,2590,,,135650352,Channel blocker,Antagonist,,f,f,,pIC50,0,7.099999905,0,-,0,0,0,=,,,,16909339,CCS(=O)(=O)N([C@H]1c2cc(OCCCC(F)(F)F)ccc2OC([C@@H]1O)(C)C)C
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,IKs124,2591,,,135650376,Channel blocker,None,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,15579540,CCCCN(S(=O)(=O)CC)C1CC(C)(C)Oc2c1cc(C#N)cc2
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,L735821,2592,,,135650484,Channel blocker,None,,f,f,,pIC50,7.5,0,6.800000191,-,0,0,0,=,,,,12815162,O=C(N[C@@H]1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2)/C=C/c1ccc(cc1Cl)Cl
K<SUB>v</SUB>7.1,560,Kcnq1,P97414,,,,,,Mouse,linopirdine,2599,,,135650523,Inhibitor,None,,f,f,,pIC50,0,4.400000095,0,IC50,0,42000,0,=,,,,12690036,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,flindokalner,2307,,,135650001,Activator,None,,f,,,pEC50,0,5,0,,0,0,0,,,,,11378159,COc1ccc(cc1[C@]1(F)C(=O)Nc2c1ccc(c2)C(F)(F)F)Cl
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,flupirtine,2598,,,135650276,Activator,None,,f,,,pEC50,0,5,0,,0,0,0,,,,,14736843,CCOC(=O)Nc1ccc(nc1N)NCc1ccc(cc1)F
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,ICA-27243,7667,,,223366002,Activator,None,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,19733209,Clc1ccc(cn1)NC(=O)c1ccc(c(c1)F)F
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,None,,t,,,pEC50,0,3.7,0,,0,0,0,,,,,16251430,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,QO-58,7669,,,223366004,Activator,None,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,23013484,Clc1nc(Cl)c(cc1c1cc(=O)n2c([nH]1)c(c1ccccc1)c(n2)C(F)(F)F)F
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,retigabine,2601,,,135650896,Activator,None,,f,t,,pEC50,0,5.599999905,0,EC50,0,2500,0,=,,,,11466425,CCOC(=O)Nc1ccc(cc1N)NCc1ccc(cc1)F
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide,2600,,,135650748,Activator,None,,f,,,pEC50,0,5.5,0,,0,0,0,,,,,12852750,O=C(N[C@H](c1cccc(c1)N1CCOCC1)C)/C=C/c1ccccc1
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,L735821,2592,,,135650484,Channel blocker,None,,f,,,pIC50,0,5.8,0,,0,0,0,,,,,9827540,O=C(N[C@@H]1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2)/C=C/c1ccc(cc1Cl)Cl
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,linopirdine,2599,,,135650523,Channel blocker,None,,f,f,,pIC50,0,5.300000191,0,IC50,0,4800,0,=,,,,9836639,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2
K<SUB>v</SUB>7.3,562,KCNQ3,O43525,,,,,,Human,retigabine,2601,,,135650896,Activator,None,,f,t,,pEC50,0,6.199999809,0,EC50,0,631,0,=,,,,11466425,CCOC(=O)Nc1ccc(cc1N)NCc1ccc(cc1)F
K<SUB>v</SUB>7.3,562,Kcnq3,O88944,,,,,,Rat,linopirdine,2599,,,135650523,Inhibitor,None,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,9836639,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,ML213,7665,,,223366000,Activator,Activation,,f,f,,pEC50,0,6.300000191,0,EC50,0,510,0,=,,,,22125664,O=C(C1CC2CC1CC2)Nc1c(C)cc(cc1C)C
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,NC00075159,7664,,,223365999,Activator,Activation,,f,f,,pEC50,0,5,0,-,0,0,0,=,,,,21782781,CC(N1C(=S)S/C(=Cc2ccc(cc2)N(C)C)/C1=O)C(=O)O
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,flindokalner,2307,,,135650001,Activator,None,,f,,,pEC50,0,5,0,,0,0,0,,,,,11245603,COc1ccc(cc1[C@]1(F)C(=O)Nc2c1ccc(c2)C(F)(F)F)Cl
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,None,,t,,,pEC50,0,3.7,0,,0,0,0,,,,,16251430,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,retigabine,2601,,,135650896,Activator,None,,f,t,,pEC50,0,5.199999809,0,EC50,0,6310,0,=,,,,11466425,CCOC(=O)Nc1ccc(cc1N)NCc1ccc(cc1)F
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide,2600,,,135650748,Activator,None,,f,f,,pIC50,0,5,0,IC50,0,10400,0,=,,,,16904708,O=C(N[C@H](c1cccc(c1)N1CCOCC1)C)/C=C/c1ccccc1
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,linopirdine,2599,,,135650523,Channel blocker,None,,f,f,,pIC50,0,4.900000095,0,IC50,0,14000,0,=,,,,11245603,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,flindokalner,2307,,,135650001,Activator,None,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,11890900,COc1ccc(cc1[C@]1(F)C(=O)Nc2c1ccc(c2)C(F)(F)F)Cl
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,retigabine,2601,,,135650896,Activator,None,,f,t,,pEC50,0,5,0,EC50,0,10000,0,=,,,,11890900,CCOC(=O)Nc1ccc(cc1N)NCc1ccc(cc1)F
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide,2600,,,135650748,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,,16904708,O=C(N[C@H](c1cccc(c1)N1CCOCC1)C)/C=C/c1ccccc1
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,linopirdine,2599,,,135650523,Channel blocker,None,,f,f,,pKd,0,4.800000191,0,Kd,0,16000,0,=,,,,10787416,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2
Kynurenine 3-monooxygenase,2886,KMO,O15229,,,,,,Human,GSK180,9007,,,310264785,Inhibitor,Inhibition,,f,t,,pIC50,0,8.199999809,0,-,0,0,0,=,Biochemical assay using human KMO expressed as a GST-fusion protein in a baculovirus expression system.,,,26752518,OC(=O)CCn1c(=O)oc2c1cc(Cl)c(c2)Cl
lanosterol synthase,2434,LSS,P48449,,,,,,Human,Ro 48-8071,6710,,,178103321,Inhibitor,Inhibition,,f,,,pIC50,0,8.24,0,IC50,0,5.7,0,=,,,,22533316,C=CCN(CCCCCCOc1ccc(c(c1)F)C(=O)c1ccc(cc1)Br)C
L-Aromatic amino-acid decarboxylase ,1271,DDC,P20711,,,,,,Human,L-&alpha;-methyldopa,5217,,,178101902,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@](Cc1ccc(c(c1)O)O)(N)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,<,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.199999809,0,IC50,0,6.300000191,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,f,,pIC50,0,7.059999943,0,IC50,0,88,0,=,,,,19887542,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,Lck inhibitor,6003,,,178102625,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,11012022,Nc1ncnc2c1c(cn2C1CCCC1)c1ccc(cc1)Oc1ccccc1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,860,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,8557675,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,PP2,9404,,,328083506,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,8557675,Clc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,saracatinib,7731,,,223366064,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,<,,,,17064066,CN1CCN(CC1)CCOc1cc(OC2CCOCC2)c2c(c1)ncnc2Nc1c(Cl)ccc2c1OCO2
Leptin receptor,1712,Lepr,P48356,,,,,,Mouse,leptin,5015,LEP,Human,178101712,Agonist,Agonist,,t,f,,pKd,0,10.18999958,0,Kd,0,0.0647,0,=,"Binding to extracellular domain of WT murine leptin receptor expressed as Fc-fusion protein, measured using surface plasmon resonance.",,,24743494,
leucine rich repeat and Ig domain containing 1,2882,LINGO1,Q96FE5,,,,,,Human,opicinumab,8923,,,310264704,Antibody,Binding,,f,t,,pEC50,0,9.960000038,0,EC50,0,0.109999999,0,<,Binding to LINGO1 by Fab of the antibody.,,,0,
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,GNE-7915,8073,,,249565753,Inhibitor,Binding,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,24354345,CCNc1nc(ncc1C(F)(F)F)Nc1cc(F)c(cc1OC)C(=O)N1CCOCC1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,GNE-0877,9393,,,328083495,Inhibitor,Inhibition,,f,t,,pKi,0,9.149999619,0,Ki,0,0.699999988,0,=,In a biochemical assay,,,24354345,N#CC(n1nc(c(c1)Nc1ncc(c(n1)NC)C(F)(F)F)C)(C)C
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,GNE-7915,8073,,,249565753,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,Inhibition of autophosphorylation in a cellular assay.,,,24354345,CCNc1nc(ncc1C(F)(F)F)Nc1cc(F)c(cc1OC)C(=O)N1CCOCC1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,GNE-9605,7919,,,249565602,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,24354345,CNc1nc(ncc1C(F)(F)F)Nc1cnn(c1Cl)[C@H]1CCN(C[C@@H]1F)C1COC1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,HG-10-102-01,9392,,,328083494,Inhibitor,Inhibition,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,22591441,COc1cc(ccc1Nc1ncc(c(n1)NC)Cl)C(=O)N1CCOCC1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,JAK3 inhibitor VI,5995,,,178102617,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,0,CS(=O)(=O)O.O=C1Nc2c(/C/1=C/c1ccc[nH]1)cc(cc2)c1cccnc1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,LRRK2-IN-1,9396,,,328083498,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,With 0.1 mM ATP in the assay.,,,21378983,COc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)C(=O)N1CCC(CC1)N1CCN(CC1)C
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,LRRK2-IN-1,9396,,,328083498,Inhibitor,Inhibition,,f,t,,pKi,0,8.220000267,0,Ki,0,6,0,=,Biochemical assay dissociation constant.,,,23721803,COc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)C(=O)N1CCC(CC1)N1CCN(CC1)C
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,PF-06447475,8054,,,249565734,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,Biochemical assay using Invitrogen's Lantha Screen technology.,,,25353650,N#Cc1cccc(c1)c1c[nH]c2c1c(ncn2)N1CCOCC1
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,PF-06454589,8295,,,252166507,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,25353650,Cn1ncc(c1)c1c[nH]c2c1c(ncn2)N1CCOCC1
Leucyl-cysteinyl aminopeptidase,1570,LNPEP,Q9UIQ6,,,,,,Human,inhibitor 19 [PMID: 21476495],8621,,,252166822,Inhibitor,Inhibition,,f,t,,pKi,0,8.739999771,0,Ki,0,1.799999952,0,=,,,,21476495,O=C1C[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CC/C=C/CC[C@H](N1)C(=O)NCc1ccccc1CC(=O)O
Leukemia inhibitory factor receptor,2314,LIFR|IL6ST,P40189|P42702,,,,,,Human,LIF,5016,LIF,Human,178101713,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Leukemia inhibitory factor receptor,2314,LIFR|IL6ST,P40189|P42702,,,,,,Human,oncostatin M,5035,OSM,Human,178101731,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Leukotriene A<sub>4</sub> hydrolase,1395,LTA4H,P09960,,,,,,Human,DG-051,6548,,,178103162,Inhibitor,Inhibition,,f,,,pIC50,0,7.3,0,IC50,0,47,0,,,,,19950900,OC(=O)CCCN1CCC[C@H]1COc1ccc(cc1)Oc1ccc(cc1)Cl
Leukotriene A<sub>4</sub> hydrolase,1395,LTA4H,P09960,,,,,,Human,SC-22716,9102,,,315661187,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,10691697,C1CCN(C1)CCOc1ccc(cc1)c1ccccc1
Leukotriene C4 synthase,1391,LTC4S,Q16873,,,,,,Human,example 36 [WO2016177845],9555,,,336446941,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,0,COc1cc(cnc1C(=O)C1CC1C(=O)O)N(c1ccc2c3c1cccc3CC2)CC1CC1
LH receptor,254,LHCGR,P22888,,,,,,Human,hCG,1160,CGA|CGB3,Human,135651787,Agonist,Full agonist,,t,f,,pKd,11.80000019,0,9.899999619,-,0,0,0,=,,,,12727981,
LH receptor,254,LHCGR,P22888,,,,,,Human,LH,1159,CGA|LHB,Human,135651804,Agonist,Full agonist,,t,t,,pIC50,10.89999962,0,9.899999619,-,0,0,0,=,,,,12727981,
LIM domain kinase 1,2054,LIMK1,P53667,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,8.760000229,0,IC50,0,1.74000001,0,=,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
"lipase G, endothelial type",2591,LIPG,Q9Y5X9,,,,,,Human,GSK-264220A,6697,,,178103308,Inhibitor,Irreversible inhibition,,f,,,pIC50,0,8.9,0,IC50,0,130,0,,,,,19058966,O=C(Nc1ccccc1)Nc1cc(oc1C)S(=O)(=O)N1CCCCC1
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,desmosterol,2748,,,135651470,Agonist,Agonist,,f,f,,pKi,0,5.539999962,0,Ki,0,2900,0,=,,,,16857673,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCC=C(C)C)C)C)C1)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,GW3965,2754,,,135650333,Agonist,Agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,11985463,OC(=O)Cc1cccc(c1)OCCCN(CC(c1ccccc1)c1ccccc1)Cc1cccc(c1Cl)C(F)(F)F
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,L-783483,2688,,,135650496,Agonist,Agonist,,f,,,pKd,0,7.9,0,,0,0,0,,,,,12072387,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1onc2C(F)(F)F
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,paxilline,2309,,,135650789,Agonist,Agonist,,f,,,pEC50,0,5.4,0,,0,0,0,,,,,12893846,O=C1C=C2C(OC1C(O)(C)C)CCC1(C2(O)CCC2C1(C)c1[nH]c3c(c1C2)cccc3)C
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,GSK2033,8690,,,252166890,Antagonist,Antagonist,,f,f,,pIC50,0,7,0,-,0,0,0,=,,,,20345102,Cc1cc(C)c(c(c1)C)S(=O)(=O)N(Cc1ccc(o1)C(F)(F)F)Cc1ccc(cc1)c1cccc(c1)S(=O)(=O)C
Liver X receptor-&alpha;,602,Nr1h3,Q9Z0Y9,,,,,,Mouse,SR9238,8692,,,252166892,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.670000076,0,IC50,0,214,0,=,,,,23237488,CCOC(=O)c1ccc(o1)CN(S(=O)(=O)c1c(C)cc(cc1C)C)Cc1ccc(cc1)c1cccc(c1)S(=O)(=O)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,desmosterol,2748,,,135651470,Agonist,Agonist,,f,f,,pKi,0,5.849999905,0,Ki,0,1400,0,=,,,,16857673,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCC=C(C)C)C)C)C1)C
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,GW3965,2754,,,135650333,Agonist,Agonist,,f,,,pEC50,0,7.52,0,,0,0,0,,,,,11985463,OC(=O)Cc1cccc(c1)OCCCN(CC(c1ccccc1)c1ccccc1)Cc1cccc(c1Cl)C(F)(F)F
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,L-783483,2688,,,135650496,Agonist,Agonist,,f,,,pKd,0,8.2,0,,0,0,0,,,,,12072387,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1onc2C(F)(F)F
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,rovazolac,9625,,,340590255,Agonist,Agonist,,f,f,,pEC50,0,6,0,EC50,0,1000,0,<,Binned data point measured in a luciferase  transactivation assay in HEK293 cells expressing the hLXR&beta; ligand binding domain (aa 153-461),,,0,CCOC(=O)Cn1nc(cc1c1ccc(cc1)c1cccc(c1)S(=O)(=O)C)C(F)(F)F
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,GSK9772,8693,,,252166893,Allosteric modulator,Negative,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,18800767,CCCCN(c1ccc(cc1)C(C(F)(F)F)(C(F)(F)F)O)Cc1cc(Cl)c(c(c1)Cl)O
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,GSK2033,8690,,,252166890,Antagonist,Antagonist,,f,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,20345102,Cc1cc(C)c(c(c1)C)S(=O)(=O)N(Cc1ccc(o1)C(F)(F)F)Cc1ccc(cc1)c1cccc(c1)S(=O)(=O)C
Liver X receptor-&beta;,601,Nr1h2,Q60644,,,,,,Mouse,SR9238,8692,,,252166892,Antagonist,Inverse agonist,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,23237488,CCOC(=O)c1ccc(o1)CN(S(=O)(=O)c1c(C)cc(cc1C)C)Cc1ccc(cc1)c1cccc(c1)S(=O)(=O)C
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,LPA,2906,,,135651509,Agonist,Full agonist,,t,f,,pEC50,8.300000191,0,7.900000095,EC50,11.69999981,0,5,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,NAEPA,6982,,,178103561,Agonist,Partial agonist,,f,f,,pEC50,0,6.710000038,0,EC50,0,197,0,=,,,,18781939,CCCCCCCC/C=C/CCCCCCCC(=O)NCCOP(=O)(O)O
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,oleoyl-thiophosphate,6983,,,178103562,Agonist,Partial agonist,,f,f,,pEC50,0,6.710000038,0,EC50,0,193,0,=,,,,20729877,CCCCCCCC/C=CCCCCCCCC(=O)OP(=O)(SC(=O)CCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCC/C=CCCCCCCCC
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,oleoyl-thiophosphate,6983,,,178103562,Agonist,Partial agonist,,f,f,,pEC50,0,6.710000038,0,EC50,0,193,0,=,,,,16033271,CCCCCCCC/C=CCCCCCCCC(=O)OP(=O)(SC(=O)CCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCC/C=CCCCCCCCC
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,dioctanoylglycerol pyrophosphate,2916,,,135650190,Antagonist,Antagonist,,f,f,,pKi,5.179999828,0,5.150000095,Ki,7000,0,6600,=,,,,18781939,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)COP(=O)(OP(=O)(O)O)O
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,Ki16425,2907,,,135650457,Antagonist,Antagonist,,f,f,,pIC50,6.900000095,0,6.599999905,IC50,250,0,130,=,,,,14500756,OC(=O)CCSCc1ccc(cc1)c1onc(c1NC(=O)OC(c1ccc(cc1Cl)C)C)C
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,ONO-3080573,8588,,,252166789,Antagonist,Antagonist,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,FLIPR intracellular calcium mobilisation assay,,,26091040,COc1cc(cc(c1C)OC)[C@H]([C@@H](OC1Cc2c(C1)cccc2)COc1ccc(cc1)C1(CC1)C(=O)O)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,ONO-7300243,9499,,,329968438,Antagonist,Antagonist,,f,t,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,27774128,COc1cc(cc(c1C)OC)C(=O)N(Cc1ccc(cc1)CC(=O)O)CCCc1ccccc1
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,ONO-9780307,8589,,,252166790,Antagonist,Antagonist,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,FLIPR intracellular calcium mobilisation assay,,,26091040,COC(=O)c1cn(cc1CC(=O)O)C[C@@H]([C@@H](c1cc(OC)c(c(c1)OC)C)O)CC1Cc2c(C1)cccc2
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,ONO-9910539,8590,,,252166791,Antagonist,Antagonist,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,FLIPR intracellular calcium mobilisation assay,,,26091040,COC(=O)c1cn(cc1CCC(=O)O)C[C@@H]([C@@H](c1cc(OC)c(c(c1)OC)C(=O)C)O)CC1Cc2c(C1)cccc2
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,farnesyl diphosphate,2910,,,135651487,Agonist,Agonist,,t,f,,pIC50,0,5.679999828,0,-,0,0,0,=,,,,19366702,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,GRI977143,6580,,,178103194,Agonist,Agonist,,f,,,pEC50,0,4.48,0,EC50,0,33000,0,=,,,,22968304,O=Cc1ccccc1SCCCn1c(=O)c2cccc3c2c(c1=O)ccc3
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pEC50,8.16,0,6.71,,0,0,0,,,,,10727522,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,decyl dihydrogen phosphate,4030,,,178100856,Agonist,Full agonist,,f,,,pEC50,0,5.4,0,EC50,0,3700,0,=,,,,12695531,CCCCCCCCCCOP(=O)(O)O
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,dodecylphosphate,4031,,,178100857,Agonist,Full agonist,,f,,,pEC50,0,6.2,0,EC50,0,700,0,=,,,,12695531,CCCCCCCCCCCCOP(=O)([O-])[O-]
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,LPA,2906,,,135651509,Agonist,Full agonist,,t,f,,pEC50,8.170000076,0,8,EC50,10,0,6.800000191,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,NAEPA,6982,,,178103561,Agonist,Full agonist,,f,f,,pEC50,0,7.519999981,0,EC50,0,30,0,=,,,,18781939,CCCCCCCC/C=C/CCCCCCCC(=O)NCCOP(=O)(O)O
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,dodecyl-thiophosphate,6990,,,178103569,Agonist,Partial agonist,,f,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,16033271,CCCCCCCCCCCCOP(=S)(O)O
LPA<sub>2</sub> receptor,273,Lpar2,Q9JL06,,,,,,Mouse,oleoyl-thiophosphate,6983,,,178103562,Agonist,Partial agonist,,f,f,,pEC50,0,6.610000134,0,EC50,0,244,0,=,,,,16033271,CCCCCCCC/C=CCCCCCCCC(=O)OP(=O)(SC(=O)CCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCC/C=CCCCCCCCC
LPA<sub>2</sub> receptor,273,,,,,,,,None,farnesyl monophosphate,2911,,,135651488,Antagonist,Antagonist,,t,,,pIC50,0,6.8,0,,0,0,0,,,,,19366702,C/C(=C/CC/C(=CCOP(=O)(O)O)/C)/CCC=C(C)C
LPA<sub>2</sub> receptor,273,LPAR2,Q9HBW0,,,,,,Human,Ki16425,2907,,,135650457,Antagonist,Antagonist,,f,,,pKi,0,5.25,0,,0,0,0,,,,,14500756,OC(=O)CCSCc1ccc(cc1)c1onc(c1NC(=O)OC(c1ccc(cc1Cl)C)C)C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,dioctanoylglycerol pyrophosphate,2916,,,135650190,Agonist,Agonist,,f,f,,pIC50,0,6.96999979,0,IC50,0,106,0,=,,,,11562440,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)COP(=O)(OP(=O)(O)O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,Ki16425,2907,,,135650457,Agonist,Agonist,,f,f,,pKi,0,6.440000057,0,Ki,0,360,0,=,,,,14500756,OC(=O)CCSCc1ccc(cc1)c1onc(c1NC(=O)OC(c1ccc(cc1Cl)C)C)C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pKd,0,6.69,0,,0,0,0,,,,,10488122,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,LPA,2906,,,135651509,Agonist,Agonist,,t,f,,pEC50,0,6.599999905,0,EC50,0,253,0,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,NAEPA,6982,,,178103561,Agonist,Agonist,,f,f,,pEC50,0,5.300000191,0,EC50,0,5000,0,>,,,,18781939,CCCCCCCC/C=C/CCCCCCCC(=O)NCCOP(=O)(O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,OMPT,2912,,,135650759,Agonist,Agonist,,f,,,pEC50,0,7.17,0,-,0,0,0,=,,,,12554733,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](COP(=S)(O)O)OC
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,oleoyl-thiophosphate,6983,,,178103562,Agonist,Partial agonist,,f,f,,pEC50,0,6.260000229,0,EC50,0,546,0,=,,,,16033271,CCCCCCCC/C=CCCCCCCCC(=O)OP(=O)(SC(=O)CCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCC/C=CCCCCCCCC
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,dioctanoylglycerol pyrophosphate,2916,,,135650190,Antagonist,Antagonist,,f,,,pKi,7,0,5.5,Ki,0,3330,0,=,,,,14500756,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)COP(=O)(OP(=O)(O)O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,dodecylphosphate,4031,,,178100857,Antagonist,Antagonist,,f,,,pKi,0,7.05,0,-,0,0,0,=,,,,12695531,CCCCCCCCCCCCOP(=O)([O-])[O-]
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,dodecyl-thiophosphate,6990,,,178103569,Antagonist,Antagonist,,f,f,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,16033271,CCCCCCCCCCCCOP(=S)(O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,farnesyl diphosphate,2910,,,135651487,Antagonist,Antagonist,,t,,,pKd,0,6.81,0,,0,0,0,,,,,17092771,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,farnesyl diphosphate,2910,,,135651487,Antagonist,Antagonist,,t,f,,pIC50,0,6.809999943,0,-,0,0,0,=,,,,19366702,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,farnesyl monophosphate,2911,,,135651488,Antagonist,Antagonist,,t,,,pIC50,0,6.3,0,,0,0,0,,,,,19366702,C/C(=C/CC/C(=CCOP(=O)(O)O)/C)/CCC=C(C)C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,farnesyl monophosphate,2911,,,135651488,Antagonist,Antagonist,,t,,,pKd,0,7.32,0,,0,0,0,,,,,17092771,C/C(=C/CC/C(=CCOP(=O)(O)O)/C)/CCC=C(C)C
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,Ki16425,2907,,,135650457,Antagonist,Antagonist,,f,f,,pKi,0,6.440000057,0,-,0,0,0,=,,,,14500756,OC(=O)CCSCc1ccc(cc1)c1onc(c1NC(=O)OC(c1ccc(cc1Cl)C)C)C
LPA<sub>4</sub> receptor,94,Lpar4,Q8BLG2,,,,,,Mouse,LPA,2906,,,135651509,Agonist,Agonist,,t,f,,pKd,0,7.349999905,0,Kd,0,45,0,=,,,,12724320,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>4</sub> receptor,94,LPAR4,Q99677,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pKd,0,7.35,0,,0,0,0,,,,,12724320,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>4</sub> receptor,94,LPAR4,Q99677,,,,,,Human,farnesyl diphosphate,2910,,,135651487,Antagonist,Antagonist,,t,,,pIC50,0,5.7,0,,0,0,0,,,,,19366702,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
LPA<sub>4</sub> receptor,94,LPAR4,Q99677,,,,,,Human,farnesyl monophosphate,2911,,,135651488,Antagonist,Antagonist,,f,,,pIC50,0,5.84,0,,0,0,0,,,,,19366702,C/C(=C/CC/C(=CCOP(=O)(O)O)/C)/CCC=C(C)C
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,farnesyl monophosphate,2911,,,135651488,Agonist,Agonist,,t,,,pEC50,0,7.31,0,,0,0,0,,,,,19366702,C/C(=C/CC/C(=CCOP(=O)(O)O)/C)/CCC=C(C)C
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,f,,pEC50,7.900000095,0,4.300000191,-,0,0,0,=,,,,18499677,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,LPA,2906,,,135651509,Agonist,Full agonist,,t,f,,pKd,0,8.18999958,0,Kd,0,6.400000095,0,=,,,,16651401,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,farnesyl diphosphate,2910,,,135651487,Agonist,Partial agonist,,t,f,,pEC50,6.539999962,0,5.840000153,EC50,1460,0,290,=,,,,19366702,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,N-arachidonoylglycine,3635,,,178100542,Agonist,Partial agonist,,t,f,,pEC50,0,4.300000191,0,EC50,0,50000,0,>,,,,19366702,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCC(=O)O
LPA<sub>5</sub> receptor,124,Lpar5,,,,,,,Rat,octyl thiophosphatidic acid,6995,,,178103574,Agonist,Partial agonist,,f,f,,pEC50,0,5.679999828,0,EC50,0,2100,0,=,,,,19366702,CCCCCCCCOC[C@@H](COP(=S)(O)O)OCCCCCCCC
LPA<sub>6</sub> receptor,163,LPAR6,P43657,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pEC50,0,6,0,,0,0,0,,,,,19386608,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
LPA<sub>6</sub> receptor,163,Lpar6,Q8BMC0,,,,,,Mouse,LPA,2906,,,135651509,Agonist,Partial agonist,,t,f,,pEC50,0,6,0,EC50,0,1000,0,=,,,,19386608,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
L-Phenylalanine hydroxylase ,1240,PAH,P00439,,,,,,Human,sapropterin,5276,,,178101959,Activator,Activation,,f,t,,pKi,0,5.400000095,0,Ki,0,4000,0,=,Binding affinity for human PAH.,,,15537351,C[C@@H]([C@@H]([C@H]1CNc2c(N1)c(=O)[nH]c(n2)N)O)O
L-Phenylalanine hydroxylase ,1240,PAH,P00439,,,,,,Human,fenclonine,5240,,,178101924,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,NC(C(=O)O)Cc1ccc(cc1)Cl
L-Tryptophan hydroxylase 1,1241,TPH1,P17752,,,,,,Human,fenclonine,5240,,,178101924,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,NC(C(=O)O)Cc1ccc(cc1)Cl
L-Tryptophan hydroxylase 1,1241,TPH1,P17752,,,,,,Human,fenfluramine,4613,,,178101333,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCNC(Cc1cccc(c1)C(F)(F)F)C
L-Tryptophan hydroxylase 2,1242,TPH2,Q8IWU9,,,,,,Human,fenclonine,5240,,,178101924,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,NC(C(=O)O)Cc1ccc(cc1)Cl
L-Tryptophan hydroxylase 2,1242,TPH2,Q8IWU9,,,,,,Human,fenfluramine,4613,,,178101333,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CCNC(Cc1cccc(c1)C(F)(F)F)C
L-type amino acid transporter 1,896,SLC7A5,Q01650,,,,,,Human,KYT-0353,9347,,,328083449,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,19900191,OC(=O)[C@H](Cc1cc(Cl)c(c(c1)Cl)OCc1cc(N)cc2c1oc(n2)c1ccccc1)N
L-Tyrosine hydroxylase ,1243,TH,P07101,,,,,,Human,methyltyrosine,5094,,,178101787,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1)CC(C(=O)O)(N)C
lymphocyte antigen 96,2890,LY96,Q9Y6Y9,,,,,,Human,neoceptin-3,9137,,,315661222,Agonist,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,26831104,O=C([C@@H](NC(=O)c1ccc(c(c1)CCc1ccc(cc1)O)N)CCc1ccccc1)OC(C)(C)C
lymphocyte antigen 96,2890,LY96,Q9Y6Y9,,,,,,Human,L6H21,9027,,,315661112,Inhibitor,Inhibition,,f,t,,pKd,0,4.480000019,0,Kd,0,33000,0,=,,,,26076332,COc1ccc(cc1)C(=O)/C=C/c1cccc(c1OC)OC
lymphotoxin &beta; receptor,1872,LTBR,P36941,,,,,,Human,LIGHT,5070,TNFSF14,Human,178101763,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
lymphotoxin &beta; receptor,1872,,,,,,,,None,lymphotoxin &beta;<sub>2</sub>&alpha;<sub>1</sub> heterotrimer,6142,LTA|LTB,Human,178102763,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,NG-25,8074,,,249565754,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,12.89999962,0,=,,,,25075558,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)Oc1ccnc2c1cc[nH]2)C
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,epigallocatechin-3-gallate,7002,,,178103581,Inhibitor,Inhibition,,f,f,,pIC50,0,4.21999979,0,IC50,0,60000,0,=,,,,19147572,Oc1cc(O)c2c(c1)O[C@@H]([C@@H](C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,garcinol,7001,,,178103580,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5000,0,=,,,,15155757,CC(=CC[C@]12C(=O)C(=C(c3ccc(c(c3)O)O)O)C(=O)[C@@](C1=O)(C[C@@H](C(=C)C)CC=C(C)C)C[C@H](C2(C)C)CC=C(C)C)C
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,H3-CoA-20,7035,,,178103614,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,10882143,
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,LTK-14,8385,,,252166597,Inhibitor,Inhibition,,f,f,,pIC50,5.300000191,0,5.150000095,IC50,7000,0,5000,=,,,,17584612,COc1ccc(cc1O)C(=O)C1=C2OC(C)(C)[C@H](C[C@]32C[C@H](C([C@@](C1=O)(C3=O)CC=C(C)C)(C)C)CC=C(C)C)CC=C(C)C
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,Lys-CoA,7036,,,178103615,Inhibitor,Inhibition,,f,f,,pIC50,0,3.700000048,0,IC50,0,200000,0,=,,,,10882143,
lysine acetyltransferase 2B,2737,,,,,,,,Unknown,MB-3,8393,,,252166604,Inhibitor,Inhibition,,f,f,,pIC50,0,4,0,IC50,0,100000,0,=,,,,15274229,CCC[C@@H]1OC(=O)C(=O)[C@H]1C(=O)O
lysine acetyltransferase 2B,2737,KAT2B,Q92831,,,,,,Human,plumbagin,7003,,,178103582,Inhibitor,Inhibition,,f,f,,pIC50,0,4.300000191,0,IC50,0,50000,0,>,,,,19570987,CC1=CC(=O)c2c(C1=O)cccc2O
lysine acetyltransferase 5,2664,KAT5,Q92993,,,,,,Human,MG149,7488,,,187051791,Inhibitor,Inhibition,,f,f,,pIC50,0,4.130000114,0,IC50,0,74000,0,=,,,,22100137,CCCCCCCc1ccc(cc1)CCc1cccc(c1C(=O)O)O
lysine acetyltransferase 8,2668,KAT8,Q9H7Z6,,,,,,Human,MG149,7488,,,187051791,Inhibitor,Inhibition,,f,f,,pIC50,0,4.329999924,0,IC50,0,47000,0,=,,,,22100137,CCCCCCCc1ccc(cc1)CCc1cccc(c1C(=O)O)O
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,ORY-1001,8390,,,252166601,Activator,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,<,,,,26111032,NC1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,GSK2879552,9116,,,315661201,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,,,,0,OC(=O)c1ccc(cc1)CN1CCC(CC1)CN[C@@H]1C[C@H]1c1ccccc1
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,GSK-LSD1,8241,,,249565921,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,0,N1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,NCL-1,7024,,,178103603,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,21227703,O=C([C@H](NC(=O)c1ccccc1)CCOc1cccc(c1)[C@@H]1C[C@H]1N)NCc1ccccc1
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,OG-L002,7023,,,178103602,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,<i>In vitro</i> KDM1A demethylation assay using purified human KDM1A protein and dimethylated H3K4 peptide as substrate.,,,23386436,N[C@H]1C[C@@H]1c1ccc(cc1)c1cccc(c1)O
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,RN-1,8980,,,310264760,Inhibitor,Inhibition,,f,t,,pIC50,7,0,6.150000095,IC50,700,0,100,=,<In vitro</i> values.,,,22754608,CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1c1ccc(cc1)OCc1ccccc1
lysine demethylase 2A,2671,KDM2A,Q9Y2K7,,,,,,Human,daminozide,7025,,,178103604,Inhibitor,Inhibition,,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,=,,,,22724510,CN(NC(=O)CCC(=O)O)C
lysine demethylase 2A,2671,KDM2A,Q9Y2K7,,,,,,Human,IOX2,8229,,,249565909,Inhibitor,Inhibition,,f,f,,pIC50,0,7.28000021,0,IC50,0,52,0,=,,,,23683440,OC(=O)CNC(=O)c1c(O)c2ccccc2n(c1=O)Cc1ccccc1
lysine demethylase 3A,2673,KDM3A,Q9Y4C1,,,,,,Human,IOX1,8230,,,249565910,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,24504543,OC(=O)c1ccc(c2c1cccn2)O
lysine demethylase 4A,2675,KDM4A,O75164,,,,,,Human,ML324,9584,,,340590215,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,<,,,,24260783,CN(CCCNC(=O)c1ccc(cc1)c1cc(O)c2c(c1)cccn2)C
lysine demethylase 4C,2677,KDM4C,Q9H3R0,,,,,,Human,IOX1,8230,,,249565910,Inhibitor,Inhibition,,f,f,,pIC50,0,6.21999979,0,IC50,0,600,0,=,,,,24504543,OC(=O)c1ccc(c2c1cccn2)O
lysine demethylase 4E,2679,KDM4E,B2RXH2,,,,,,Human,ML324,9584,,,340590215,Inhibitor,Inhibition,,f,f,,pIC50,0,6.039999962,0,IC50,0,920,0,=,,,,24260783,CN(CCCNC(=O)c1ccc(cc1)c1cc(O)c2c(c1)cccn2)C
lysine demethylase 5A,2680,KDM5A,P29375,,,,,,Human,GSK-J1,7027,,,178103606,Inhibitor,Inhibition,,f,f,,pIC50,0,5.170000076,0,IC50,0,6800,0,=,,,,25279926,OC(=O)CCNc1nc(nc(c1)N1CCc2ccccc2CC1)c1ccccn1
lysine demethylase 5A,2680,KDM5A,P29375,,,,,,Human,PBIT,7026,,,178103605,Inhibitor,Inhibition,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,,,,23408432,Cc1ccc(cc1)n1sc2c(c1=O)cccc2
lysine demethylase 5B,2681,KDM5B,Q9UGL1,,,,,,Human,GSK-J1,7027,,,178103606,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,25279926,OC(=O)CCNc1nc(nc(c1)N1CCc2ccccc2CC1)c1ccccn1
lysine demethylase 5B,2681,KDM5B,Q9UGL1,,,,,,Human,GSK-J4,8979,,,310264759,Inhibitor,Inhibition,,f,f,,pIC50,0,5.010000229,0,IC50,0,9700,0,=,,,,25279926,CCOC(=O)CCNc1cc(nc(n1)c1ccccn1)N1CCc2c(CC1)cccc2
lysine demethylase 5B,2681,KDM5B,Q9UGL1,,,,,,Human,PBIT,7026,,,178103605,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,23408432,Cc1ccc(cc1)n1sc2c(c1=O)cccc2
lysine demethylase 5C,2682,KDM5C,P41229,,,,,,Human,GSK-J1,7027,,,178103606,Inhibitor,Inhibition,,f,f,,pIC50,0,6.260000229,0,IC50,0,550,0,=,,,,25279926,OC(=O)CCNc1nc(nc(c1)N1CCc2ccccc2CC1)c1ccccn1
lysine demethylase 5C,2682,KDM5C,P41229,,,,,,Human,GSK-J4,8979,,,310264759,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15000,0,=,,,,25279926,CCOC(=O)CCNc1cc(nc(n1)c1ccccn1)N1CCc2c(CC1)cccc2
lysine demethylase 5C,2682,KDM5C,P41229,,,,,,Human,IOX2,8229,,,249565909,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,159,0,=,,,,23683440,OC(=O)CNC(=O)c1c(O)c2ccccc2n(c1=O)Cc1ccccc1
lysine demethylase 5C,2682,KDM5C,P41229,,,,,,Human,PBIT,7026,,,178103605,Inhibitor,Inhibition,,f,f,,pIC50,0,5.309999943,0,IC50,0,4900,0,=,,,,23408432,Cc1ccc(cc1)n1sc2c(c1=O)cccc2
lysine demethylase 6A,2684,KDM6A,O15550,,,,,,Human,GSK-J1,7027,,,178103606,Inhibitor,Inhibition,,f,f,,pIC50,0,7.28000021,0,IC50,0,53,0,=,,,,25279926,OC(=O)CCNc1nc(nc(c1)N1CCc2ccccc2CC1)c1ccccn1
lysine demethylase 6A,2684,KDM6A,O15550,,,,,,Human,GSK-J4,8979,,,310264759,Inhibitor,Inhibition,,f,f,,pIC50,0,5.179999828,0,IC50,0,6600,0,=,,,,25279926,CCOC(=O)CCNc1cc(nc(n1)c1ccccn1)N1CCc2c(CC1)cccc2
lysine demethylase 6B,2685,KDM6B,O15054,,,,,,Human,GSK-J1,7027,,,178103606,Inhibitor,Inhibition,,f,f,,pIC50,7.550000191,0,7.21999979,IC50,60,0,28,=,,,,22842901,OC(=O)CCNc1nc(nc(c1)N1CCc2ccccc2CC1)c1ccccn1
lysine demethylase 6B,2685,KDM6B,O15054,,,,,,Human,GSK-J4,8979,,,310264759,Inhibitor,Inhibition,,f,f,,pIC50,0,5.070000172,0,IC50,0,8600,0,=,,,,25279926,CCOC(=O)CCNc1cc(nc(n1)c1ccccn1)N1CCc2c(CC1)cccc2
lysine demethylase 6B,2685,KDM6B,O15054,,,,,,Human,IOX1,8230,,,249565910,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,24504543,OC(=O)c1ccc(c2c1cccn2)O
lysine demethylase 7A,2686,KDM7A,Q6ZMT4,,,,,,Human,daminozide,7025,,,178103604,Inhibitor,Inhibition,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,22724510,CN(NC(=O)CCC(=O)O)C
lysine methyltransferase 5A,2704,KMT5A,Q9NQR1,,,,,,Human,nahuoic acid A,7022,,,178103601,Inhibitor,Inhibition,,f,f,,pKi,0,5.699999809,0,Ki,0,2000,0,=,,,,23272941,O[C@H](C[C@H]([C@@H]([C@H](C(C)C)O)C)O)C/C=C(/[C@@H]1C(=C[C@]2([C@@H]([C@H]1/C=C(/C(=O)O)C)[C@@H](C)[C@@H](C[C@H]2O)O)C)C)C
lysyl oxidase like 2,2853,LOXL2,Q9Y4K0,,,,,,Human,simtuzumab,8412,,,252166622,Inhibitor,Inhibition,,f,t,,pKi,0,7.170000076,0,Ki,0,67,0,=,,,,0,
macrophage stimulating 1 receptor,1816,MST1R,Q04912,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
macrophage stimulating 1 receptor,1816,MST1R,Q04912,,,,,,Human,macrophage stimulating protein 1,5023,MST1,Human,178101720,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
MALT1 paracaspase,2983,MALT1,Q9UDY8,,,,,,Human,pecazine,9782,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,510,0,=,In an enzyme activity assay.,,,23946259,CN1CCCC(C1)CN1c2ccccc2Sc2c1cccc2
maltase-glucoamylase,2627,MGAM,O43451,,,,,,Human,miglitol,4842,,,178101544,Inhibitor,Inhibition,,f,t,,pKi,0,6,0,Ki,0,1000,0,=,Inhibition of human recombinant N-terminal subunit of maltase-glucoamylase after 60 mins by glucose oxidase assay,,,20970346,OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
maltase-glucoamylase,2627,Mgam,,,,,,,Mouse,miglitol,4842,,,178101544,Inhibitor,Inhibition,Inhibition across MGAM catalytic subunits,f,f,,pKi,6.679999828,0,6,Ki,1000,0,211,=,,,,21669536,OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
MAP kinase interacting serine/threonine kinase 1,2104,MKNK1,Q9BUB5,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
MAP kinase interacting serine/threonine kinase 1,2104,MKNK1,Q9BUB5,,,,,,Human,MNK1 inhibitor,6010,,,178102632,Inhibitor,Inhibition,,f,t,,pIC50,0,6.059999943,0,IC50,0,870,0,=,,,,20722422,Fc1ccc(cc1)Nc1[nH]nc2c1c(N)ncn2
MAP kinase interacting serine/threonine kinase 2,2105,MKNK2,Q9HBH9,,,,,,Human,MELK-TI,9366,,,328083468,Inhibitor,Inhibition,,f,f,,pIC50,0,6.119999886,0,IC50,0,760,0,=,Measured in a MIllipore kinase screening assay,,,25589925,COc1cc(ccc1C(=O)Nc1ccc2c(c1)CCNCC2)c1cn[nH]c1
MAP kinase interacting serine/threonine kinase 2,2105,MKNK2,Q9HBH9,,,,,,Human,MNK1 inhibitor,6010,,,178102632,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,20722422,Fc1ccc(cc1)Nc1[nH]nc2c1c(N)ncn2
MATE2,1217,Slc47a2,Q3V050,,,,,,Mouse,pyrimethamine,4800,,,178101502,Inhibitor,Inhibition,,f,,,pKi,0,6.3,0,Ki,0,460,0,=,,,,20065018,CCc1nc(N)nc(c1c1ccc(cc1)Cl)N
maternal embryonic leucine zipper kinase,2102,MELK,Q14680,,,,,,Human,MELK-TI,9366,,,328083468,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,Measured in a MIllipore kinase screening assay,,,25589925,COc1cc(ccc1C(=O)Nc1ccc2c(c1)CCNCC2)c1cn[nH]c1
maternal embryonic leucine zipper kinase,2102,MELK,Q14680,,,,,,Human,OTSSP167,8046,,,249565726,Inhibitor,Inhibition,,f,f,,pIC50,0,9.390000343,0,IC50,0,0.409999996,0,=,,,,23283305,CN(CC1CCC(CC1)Nc1c(cnc2c1[nH]c(=C1C=C(Cl)C(=O)C(=C1)Cl)cc2)C(=O)C)C
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,GTP&gamma;S,4207,,,178101024,Activator,None,,f,,,-,0,0,0,-,0,0,0,=,,,cytosolic,0,OC1C(COP(=O)(OP(=O)(OP(=S)(O)O)O)O)OC(C1O)n1cnc2c1[nH]c(N)nc2=O
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,pIC50,0,4.4,0,IC50,0,40000,0,,,,,20830208,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,diphenylamine-2-carboxylic acid,4182,,,178101001,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1ccccc1
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,extracellular,0,
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,NPPB,4270,,,178101087,Channel blocker,None,,f,,,pIC50,0,3.8,0,IC50,0,156000,0,,,,,20830208,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,SITS,4314,,,178101131,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,S=C=Nc1ccc(c(c1)/C=C/c1ccc(cc1S(=O)(=O)O)NC(=O)C)S(=O)(=O)O
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,MCH (salmon),1301,,,135652447,Agonist,Full agonist,,f,,,pKi,9.6,0,9.4,,0,0,0,,,,,10421367,
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,MCH (salmon),1301,,,135652447,Agonist,Full agonist,,f,,,pKi,9.5,0,9.3,,0,0,0,,,,,11561073,
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,MCH<sub>6-17</sub>,1293,,,135652283,Agonist,Full agonist,,f,,,pKi,9.7,0,9.4,,0,0,0,,,,,11561073,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,MCH<sub>6-17</sub>,1293,,,135652283,Agonist,Full agonist,,f,,,pKi,9.8,0,9.2,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,melanin-concentrating hormone,1298,PMCH|Pmch|Pmch,Human|Mouse|Rat,135651807,Agonist,Full agonist,,t,,,pKi,10.5,0,9.7,,0,0,0,,,,,10421367,CSCCC1NC(=O)C(CSSCC(NC(=O)C2CCCN2C(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)C(C)C)CCCNC(=N)N)C(C)C)Cc1ccc(cc1)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)C)CCC(=O)O)Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(CC(=O)O)N)CCSC)CCCNC(=N)N
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,melanin-concentrating hormone,1298,PMCH|Pmch|Pmch,Human|Mouse|Rat,135651807,Agonist,Full agonist,,t,,,pKi,10,0,9.8,,0,0,0,,,,,11561073,CSCCC1NC(=O)C(CSSCC(NC(=O)C2CCCN2C(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)C(C)C)CCCNC(=N)N)C(C)C)Cc1ccc(cc1)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)C)CCC(=O)O)Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(CC(=O)O)N)CCSC)CCCNC(=N)N
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,p-guanidinobenzoyl-MCH-(7-17),1300,,,135652387,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,19619599,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"[Phe<sup>13</sup>,Tyr<sup>19</sup>]MCH",1297,,,135652394,Agonist,Full agonist,,f,,,pIC50,10,0,8.2,,0,0,0,,,,,11159839,
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,"[Phe<sup>13</sup>,Tyr<sup>19</sup>]MCH",1297,,,135652394,Agonist,Full agonist,,f,,,pKi,9.5,0,9.2,,0,0,0,,,,,11561073,
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,S36057,1294,,,135652441,Agonist,Full agonist,,f,,,pKi,10.3,0,10.1,,0,0,0,,,,,11561073,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S36057,1294,,,135652441,Agonist,Full agonist,,f,,,pKi,10.4,0,10.1,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,Mchr1,P97639,,,,,,Rat,S36077,1295,,,135652442,Agonist,Full agonist,,f,,,pKi,7.2,0,6.6,,0,0,0,,,,,11561073,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S36077,1295,,,135652442,Agonist,Full agonist,,f,,,pKi,7.4,0,6.7,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,MQ1,8587,,,252166788,Allosteric modulator,Negative,,f,t,,pIC50,8.960000038,0,8.659999847,IC50,2.200000048,0,1.100000024,=,,,,22490048,O=C(c1ccc(cc1)OCC1CC1)Nc1ccc2c(c1C)ncc(c2)[C@H](N1CCCC1)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,GW803430,4033,,,178100858,Antagonist,Antagonist,,f,,,pIC50,0,9.3,0,-,0,0,0,=,,,,16870432,COc1cc(ccc1OCCN1CCCC1)n1cnc2c(c1=O)sc(c2)c1ccc(cc1)Cl
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,pyrrolidine MCHR1 antagonist 1,7756,,,223366089,Antagonist,Antagonist,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,21414780,COc1ccc(cc1)[C@H]1CN(C[C@@H]1CC(=O)Nc1cccc(c1)Cl)CCC1(O)CCOCC1
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S36539,1308,,,135652443,Antagonist,Antagonist,,f,,,pKi,8,0,7.3,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S36540,1309,,,135652444,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.2,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S36541,1310,,,135652445,Antagonist,Antagonist,,f,,,pKi,8.3,0,7.9,,0,0,0,,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,S38151,1311,,,135652446,Antagonist,Antagonist,,f,,,pKd,10,0,9.3,,0,0,0,,,,,19619599,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,SB-568849,1312,,,135651010,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,16839763,CCNCCOc1ccc(cc1OC)N(C(=O)c1ccc(cc1)c1ccc(cc1)C(F)(F)F)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,SNAP-7941,1313,,,135651061,Antagonist,Antagonist,,f,,,pA2,0,9.2,0,-,0,0,0,=,,,,12118247,COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,SNAP-7941,1313,,,135651061,Antagonist,Antagonist,,f,,,pKd,0,9.7,0,-,0,0,0,=,,,,12118247,COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,MCH (salmon),1301,,,135652447,Agonist,Full agonist,,f,,,pIC50,7.1,0,6.2,,0,0,0,,,,,11459838,
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,melanin-concentrating hormone,1298,PMCH|Pmch|Pmch,Human|Mouse|Rat,135651807,Agonist,Full agonist,,t,,,pIC50,9.2,0,8.2,,0,0,0,,,,,11404457,CSCCC1NC(=O)C(CSSCC(NC(=O)C2CCCN2C(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)C(C)C)CCCNC(=N)N)C(C)C)Cc1ccc(cc1)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)C)CCC(=O)O)Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(CC(=O)O)N)CCSC)CCCNC(=N)N
MCH<sub>2</sub> receptor,281,MCHR2,Q969V1,,,,,,Human,"[Phe<sup>13</sup>,Tyr<sup>19</sup>]MCH",1297,,,135652394,Agonist,Full agonist,,f,,,pIC50,9.2,0,8.4,,0,0,0,,,,,11459838,
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,setmelanotide,9272,,,315661347,Agonist,Agonist,,f,f,,pKi,0,8.409999847,0,Ki,0,3.900000095,0,=,,,,19646498,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,MS05,1322,,,135652303,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,10764951,
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,MT-II,1323,,,135652308,Agonist,Full agonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,12007532,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,HS014,1321,,,135652193,Agonist,Partial agonist,,f,,,pKd,0,7,0,,0,0,0,,,,,10657491,
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,SHU9119,1325,,,135652464,Agonist,Partial agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,10657491,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,HS024,1328,,,135652194,Antagonist,Antagonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,9832440,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,corticotrophin-releasing hormone,912,CRH|Crh|Crh,Human|Mouse|Rat,135651696,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,corticotropin zinc hydroxide,6967,,,178103547,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,cosyntropin,6965,,,178103545,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,setmelanotide,9272,,,315661347,Agonist,Agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,19646498,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,[D-Trp<sup>8</sup>]&gamma;-MSH,1334,,,135652134,Agonist,Full agonist,,f,f,,pIC50,0,8.199999809,0,IC50,0,6.309999943,0,=,,,,11150170,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,&gamma;-MSH,1333,POMC|Pomc|Pomc,Human|Mouse|Rat,135651755,Agonist,Full agonist,,t,,,pKd,0,8.5,0,,0,0,0,,,,,10358030,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,MT-II,1323,,,135652308,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,10493100,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,HS014,1321,,,135652193,Antagonist,Antagonist,,f,,,pKd,0,7.3,0,,0,0,0,,,,,10657491,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,HS024,1328,,,135652194,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,,0,0,0,,,,,9832440,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,PG-106,6546,,,178103160,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,IC50,0,210,0,=,,,,17482720,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,PG-901,1341,,,135652384,Antagonist,Antagonist,,f,,,pIC50,0,9.7,0,-,0,0,0,=,,,,12431055,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,SHU9119,1325,,,135652464,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.9,-,0,0,0,=,,,,12007532,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C
MC<sub>3</sub> receptor,284,Mc3r,P32244,,,,,,Rat,SHU9119,1325,,,135652464,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,Ki,0,0.879,0,=,,,,10493100,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C
MC<sub>4</sub> receptor,285,Mc4r,P70596,,,,,,Rat,setmelanotide,9272,,,315661347,Agonist,Agonist,,f,f,,pKi,0,8.569999695,0,Ki,0,2.700000048,0,=,,,,19646498,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,setmelanotide,9272,,,315661347,Agonist,Agonist,,f,f,,pKi,0,8.680000305,0,Ki,0,2.099999905,0,=,,,,19646498,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,MT-II,1323,,,135652308,Agonist,Full agonist,,f,,,pKi,8.8,0,8.2,,0,0,0,,,,,2535874,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,RY764,1337,,,135650955,Agonist,Full agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,15982875,O=C([C@@H]1C[C@@H]2CC[C@H]1N(C2)C)N[C@@H](C(=O)N1CCC(CC1)(C1CCCCC1)C(=O)NC(C)(C)C)Cc1ccc(cc1)F
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,HS014,1321,,,135652193,Antagonist,Antagonist,,f,f,,pKd,0,8.5,0,Kd,0,3.160000086,0,=,,,,10051117,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,HS014,1321,,,135652193,Antagonist,Antagonist,,f,f,,pKi,0,8.5,0,Ki,0,3.200000048,0,=,,,,9630346,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,HS024,1328,,,135652194,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,9832440,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,MBP10,1339,,,135652281,Antagonist,Antagonist,,f,f,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,11606131,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,MCL0129,1340,,,135650570,Antagonist,Antagonist,,f,,,pKd,0,10.1,0,,0,0,0,,,,,12538838,COc1ccc2c(c1CCCCN1CCN(CC1)C[C@H](c1ccc(cc1)F)N1CCN(CC1)C(C)C)cccc2
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,PG-901,1341,,,135652384,Antagonist,Antagonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,12431055,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,SHU9119,1325,,,135652464,Antagonist,Antagonist,,f,,,pKi,9.6,0,9.4,,0,0,0,,,,,10657491,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,setmelanotide,9272,,,315661347,Agonist,Agonist,,f,f,,pKi,0,6.369999886,0,Ki,0,430,0,=,,,,19646498,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,MT-II,1323,,,135652308,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,12007532,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,PG-901,1341,,,135652384,Agonist,Full agonist,,f,,,pIC50,0,10.5,0,,0,0,0,,,,,12431055,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,SHU9119,1325,,,135652464,Agonist,Partial agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,10657491,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,HS024,1328,,,135652194,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,9832440,
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,dactolisib,7950,,,249565633,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Measured as inhibition of downstream mTOR activated p70S6K,,,18606717,N#CC(c1ccc(cc1)n1c(=O)n(c2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2)C)(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,eCF309,9571,,,336446957,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,In a biochemical assys using recombinant wild type enzyme.,,,0,CCOC(Cn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)OCC
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,eCF309,9571,,,336446957,Inhibitor,Inhibition,,f,t,,pEC50,0,8.050000191,0,EC50,0,9,0,=,In a cell viability assay.,,,0,CCOC(Cn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)OCC
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,everolimus,5889,,,178102512,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,9723437,OCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,gedatolisib,7940,,,249565623,Inhibitor,Inhibition,,f,t,,pIC50,0,8.800000191,0,IC50,0,1.600000024,0,=,,,,20166697,O=C(Nc1ccc(cc1)c1nc(nc(n1)N1CCOCC1)N1CCOCC1)Nc1ccc(cc1)C(=O)N1CCC(CC1)N(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,INK-128,7933,,,249565616,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22367541,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,INK-128,7933,,,249565616,Inhibitor,Inhibition,,f,t,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,22367541,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,KU-0063794,9360,,,328083462,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,Inhibition of immunoprecipitated mTORC1 (S6K1 as substrate) and mTORC2 (Akt as substrate).,,,19402821,COc1ccc(cc1CO)c1ccc2c(n1)nc(nc2N1CCOCC1)N1C[C@H](C)O[C@@H](C1)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,LY3023414,8918,,,310264699,Inhibitor,Inhibition,,f,t,,pIC50,0,6.78000021,0,IC50,0,165,0,=,,,,0,CO[C@H](Cn1c(=O)n(c2c1c1cc(ccc1nc2)c1cncc(c1)C(O)(C)C)C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,omipalisib,8974,,,310264754,Inhibitor,Inhibition,,f,f,,pKi,6.739999771,0,6.519999981,Ki,300,0,180,=,,,,24900173,COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2c(c1)c(ccn2)c1ccnnc1
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,PF-04691502,7936,,,249565619,Inhibitor,Inhibition,,f,t,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,24900269,OCCO[C@@H]1CC[C@H](CC1)n1c(=O)c(cc2c1nc(N)nc2C)c1ccc(nc1)OC
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,PP-242,5704,,,178102331,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,18849971,Oc1ccc2c(c1)cc([nH]2)c1nn(c2c1c(N)ncn2)C(C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,RapaLink-1,9212,,,315661288,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,27279227,CO[C@@H]1C[C@H](CC[C@@H]1OCCOCc1nnn(c1)CCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)C[C@H]([C@@H]1CC(=O)[C@H](C)/C=C(C)/[C@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(/[C@@H](C[C@H]2O[C@](C(=O)C(=O)N3[C@@H](C(=O)O1)CCCC3)(O)[C@H](C)CC2)OC)C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,ridaforolimus,7884,,,223366213,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,"Measured as dose-dependent inhibition of phosphorylation of ribosomal protein S6, a signaling protein downstream of mTOR",,,21482695,CO[C@@H]1C[C@@H](CC[C@H]1OP(=O)(C)C)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,serabelisib,8969,,,310264749,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,<,,,,0,Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,STK16-IN-1,9692,,,348353651,Inhibitor,Inhibition,,f,f,,pIC50,0,5.25,0,IC50,0,5560,0,=,In an <i>in vitro</i> enzymatic assay.,,,27082499,Fc1ccc(cc1C)n1c(=O)ccc2c1c1cc[nH]c1nc2
melanoma cell adhesion molecule,2988,MCAM,P43121,,,,,,Human,PRX-003,9805,,,0,Antibody,Binding,,f,t,,pKd,0,8.06000042,0,Kd,0,8.699999809,0,=,,,,0,
"MER proto-oncogene, tyrosine kinase",1837,MERTK,Q12866,,,,,,Human,G749,8108,,,249565788,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,24532805,CN1CCC(CC1)Nc1nc(Nc2ccc(cc2)Oc2ccccc2)c2c(n1)c(Br)c[nH]c2=O
"MER proto-oncogene, tyrosine kinase",1837,MERTK,Q12866,,,,,,Human,LDC1267,8247,,,249565927,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24553136,CCOc1cn(nc1C(=O)Nc1ccc(c(c1)F)Oc1ccnc2c1cc(OC)c(c2)OC)c1ccc(cc1C)F
"MER proto-oncogene, tyrosine kinase",1837,MERTK,Q12866,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
"MER proto-oncogene, tyrosine kinase",1837,MERTK,Q12866,,,,,,Human,growth arrest specific protein 6,4935,GAS6,Human,178101633,None,None,,t,,,-,0,0,0,,0,0,0,,,,,8939948,
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,emibetuzumab,7748,,,223366081,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,binding constant for hMET extracellular domain measured using proprietary BIACore&reg; technology,,,0,
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,onartuzumab,8966,,,310264746,Antibody,Binding,,f,t,,pIC50,0,8.369999886,0,IC50,0,4.300000191,0,=,,,,0,
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,crizotinib,4903,,,178101602,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,21812414,Nc1ncc(cc1O[C@@H](c1c(Cl)ccc(c1Cl)F)C)c1cnn(c1)C1CCNCC1
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,crizotinib,4903,,,178101602,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.779999971,0,=,,,,21708465,Nc1ncc(cc1O[C@@H](c1c(Cl)ccc(c1Cl)F)C)c1cnn(c1)C1CCNCC1
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,ensartinib,8959,,,310264740,Inhibitor,Inhibition,,f,f,,pIC50,0,9.130000114,0,IC50,0,0.74000001,0,=,Result from DiscoveRx KINOMEscan&reg; selectivity screen.,,,21613408,CN1CCN(CC1)C(=O)c1ccc(cc1)NC(=O)c1nnc(c(c1)O[C@@H](c1c(Cl)ccc(c1Cl)F)C)N
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,foretinib,5679,,,178102306,Inhibitor,Inhibition,,f,t,,pIC50,9.399999619,0,9.300000191,IC50,0.5,0,0.400000006,=,,,,23098265,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,foretinib,5679,,,178102306,Inhibitor,Inhibition,,f,t,,pKd,0,8.850000381,0,Kd,0,1.399999976,0,=,,,,22037378,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,glesatinib,9133,,,315661218,Inhibitor,Inhibition,,f,f,,pIC50,0,7.539999962,0,IC50,0,29,0,=,,,,18434145,S=C(NC(=O)Cc1ccccc1)Nc1ccc(c(c1)F)Oc1ccnc2c1sc(c2)c1ncn(c1)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,golvatinib,7956,,,249565639,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,Measured as inhibition of c-MET phosphorylation in MKN45 cells,,,19832844,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1nccc(c1)Oc1ccc(c(c1)F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,t,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,PHA-665752,5700,,,178102327,Inhibitor,Inhibition,,f,t,,pKd,0,9.569999695,0,Kd,0,0.270000011,0,=,,,,22037378,O=C1Nc2c(/C/1=C/c1[nH]c(c(c1C)C(=O)N1CCC[C@@H]1CN1CCCC1)C)cc(cc2)S(=O)(=O)Cc1c(Cl)cccc1Cl
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,PHA-665752,5700,,,178102327,Inhibitor,Inhibition,,f,t,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,14612533,O=C1Nc2c(/C/1=C/c1[nH]c(c(c1C)C(=O)N1CCC[C@@H]1CN1CCCC1)C)cc(cc2)S(=O)(=O)Cc1c(Cl)cccc1Cl
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,SGX-523,5709,,,178102335,Inhibitor,Inhibition,,f,t,,pKd,0,9.720000267,0,Kd,0,0.189999998,0,=,,,,22037378,Cn1ncc(c1)c1ccc2n(n1)c(nn2)Sc1ccc2c(c1)cccn2
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,SGX-523,5709,,,178102335,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,19934279,Cn1ncc(c1)c1ccc2n(n1)c(nn2)Sc1ccc2c(c1)cccn2
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,GE-137,8585,,,252166786,None,Binding,,f,t,,pKd,0,8.520000458,0,Kd,0,3,0,=,<i>In vitro</i> fluorescence polarization assay.,,,26168295,OC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CCC(=O)O)Cc1ccccc1)CCCNC(=N)N)Cc1c[nH]c2c1cccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N)CCCCNC(=O)CCCCCN1c2ccc(cc2C(/C/1=C/C=C/C=C/C1=[N+](CCCCS(=O)(=O)O)c2c(C1(C)CCCCS(=O)(=O)O)cc(cc2)S(=O)(=O)[O-])(C)C)S(=O)(=O)O)[C@H](O)C)CCC(=O)O)[C@H](O)C)CCC(=O)O)Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)C)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,hepatocyte growth factor,4949,HGF,Human,178101647,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
mevalonate kinase,640,MVK,Q03426,,,,,,Human,dimethylallyl diphosphate,3049,,,135651475,Inhibitor,Competitive,,t,,,pKi,0,4.7,0,Ki,0,20000,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,CC(=CCOP(=O)(OP(=O)([O-])[O-])[O-])C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,dolichol phosphate,3214,,,135650204,Inhibitor,Competitive,,f,f,,pKi,0,4.079999924,0,Ki,0,83000,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,CC(CC/C=C(/CCC=C(C)C)C)CCOP(=O)(O)O
mevalonate kinase,640,MVK,Q03426,,,,,,Human,farnesol,3215,,,135651486,Inhibitor,Competitive,,f,,,pKi,0,4.14,0,Ki,0,72000,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,OCC=C(CCC=C(CCC=C(C)C)C)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,geranyl diphosphate,3051,,,135651490,Inhibitor,Feedback inhibition,,t,,,pKi,0,6.94,0,Ki,0,116,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CCC=C(C)C
mevalonate kinase,640,Mvk,P17256,,,,,,Rat,geranyl diphosphate,3051,,,135651490,Inhibitor,Feedback inhibition,,t,,,pIC50,0,5.3,0,IC50,0,5000,0,=,"in vitro assay, enzyme expressed in E coli, purified",,,16524256,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CCC=C(C)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,geranylgeranyl diphosphate,3052,,,135651491,Inhibitor,Feedback inhibition,,t,,,pKi,0,7.23,0,Ki,0,59,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,C/C(=CCC/C(=C/COP(=O)(OP(=O)(O)O)O)/C)/CC/C=C(/CCC=C(C)C)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,isopentenyl diphosphate,3048,,,135651495,Inhibitor,Feedback inhibition,,t,,,pKi,0,4.8,0,Ki,0,16000,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,CC(=C)CCOP(=O)(OP(=O)(O)O)O
mevalonate kinase,640,Mvk,P17256,,,,,,Rat,(RS)-5-diphosphomevalonate,3055,,,135650946,Inhibitor,Feedback inhibition,,f,,,pIC50,0,3.74,0,IC50,0,180000,0,=,"in vitro assay, enzyme expressed in E coli, purified",,,16524256,OC(=O)CC(CCOP(=O)(OP(=O)(O)O)O)(O)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,farnesyl thiodiphosphate,3216,,,135650252,Inhibitor,Inhibition,,f,,,pKi,0,7.54,0,Ki,0,29,0,=,Spectrophotometric in vitro assay,,,14679225,CC(=CCOP(=O)(OP(=O)(S)[O-])[O-])CCC=C(CCC=C(C)C)C
mevalonate kinase,640,Mvk,P17256,,,,,,Rat,farnesyl thiodiphosphate,3216,,,135650252,Inhibitor,Inhibition,,f,,,pKi,0,6.33,0,Ki,0,473,0,=,Spectrophotometric in vitro assay,,,14679225,CC(=CCOP(=O)(OP(=O)(S)[O-])[O-])CCC=C(CCC=C(C)C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5,0,4.800000191,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,ibotenic acid,1371,,,135652693,Agonist,Full agonist,,f,,,pKi,6.4,0,5.9,,0,0,0,,,,,7690672,OC(=O)C(c1o[nH]c(=O)c1)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,11080213,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,6.5,0,6.4,,0,0,0,,,,,12695537,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,quisqualate,1372,,,135650876,Agonist,Full agonist,,f,,,pKi,8,0,7.5,,0,0,0,,,,,12695537,OC(=O)[C@H](Cn1oc(=O)[nH]c1=O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,(<i>S</i>)-3HPG,1366,,,135650424,Agonist,Partial agonist,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,11080213,OC(=O)[C@H](c1cccc(c1)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,CPCCOEt,1382,,,135650133,Allosteric modulator,Negative,,f,,,pEC50,0,5.3,0,EC50,0,5000,0,=,,,,11961143,CCOC(=O)C12CC2/C(=NO)/c2c(O1)cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,CPCCOEt,1382,,,135650133,Allosteric modulator,Negative,,f,,,pKi,0,5.3,0,,0,0,0,,,,,12695537,CCOC(=O)C12CC2/C(=NO)/c2c(O1)cccc2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,CPCCOEt,1382,,,135650133,Allosteric modulator,Negative,,f,f,,pIC50,5.800000191,0,5.199999809,IC50,6300,0,1500,=,,,,10051528,CCOC(=O)C12CC2/C(=NO)/c2c(O1)cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,DM-PPP,1383,,,135650197,Allosteric modulator,Negative,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,12470711,CCCOC(=O)c1[nH]c(c(c1C)C(=O)O[C@H](C(C)(C)C)C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,EM-TBPC,3363,,,178100388,Allosteric modulator,Negative,,f,f,,pKi,0,7.769999981,0,Ki,0,17,0,=,,,,12509432,CCn1c(C)nc(c(c1=O)C#N)N1CCc2c(CC1)cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,EM-TBPC,3363,,,178100388,Allosteric modulator,Negative,,f,f,,pIC50,0,6.900000095,0,IC50,0,128,0,=,,,,12509432,CCn1c(C)nc(c(c1=O)C#N)N1CCc2c(CC1)cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,FITM,8767,,,252827425,Allosteric modulator,Negative,,f,f,,pKi,0,8.270000458,0,Ki,0,5.400000095,0,=,Measured using rat brain homogenate in a competition binding assay displacing [<sup>18</sup>F}-FITM.,,,22316010,CC(Nc1ncnc(c1)c1csc(n1)N(C(=O)c1ccc(cc1)F)C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,FPTQ,6353,,,178102971,Allosteric modulator,Negative,,f,,,pKi,0,7.9,0,Ki,0,12.6,0,=,,,,21172734,Cc1c(nnn1c1cccnc1F)c1ccc2c(c1)cccn2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,FTIDC,6363,,,178102981,Allosteric modulator,Negative,,f,,,pIC50,0,8.32,0,IC50,0,4.8,0,=,,,,17360958,CC(N(C(=O)N1CCC(=CC1)c1nnn(c1C)c1cccnc1F)C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,FTIDC,6363,,,178102981,Allosteric modulator,Negative,,f,,,pIC50,0,8.24,0,IC50,0,5.8,0,=,,,,17360958,CC(N(C(=O)N1CCC(=CC1)c1nnn(c1C)c1cccnc1F)C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,<i>cis</i>-10 [PMID: 15771457],6474,,,178103088,Allosteric modulator,Negative,,f,,,pIC50,0,7.03,0,IC50,0,94,0,=,,,,15771457,CO[C@@H]1CC[C@@H](CC1)C(=O)c1ccc2c(c1)cc(c(n2)OC)CC
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,JNJ16259685,1385,,,135650879,Allosteric modulator,Negative,,f,f,,pIC50,0,8.899999619,0,IC50,0,1.210000038,0,=,,,,15555631,COC1CCC(CC1)C(=O)c1ccc2c(c1)cc1c(n2)OCCC1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,JNJ-16567083,7442,,,178104014,Allosteric modulator,Negative,,f,f,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,16078827,CO[C@@H]1CC[C@@H](CC1)C(=O)c1ccc2c(c1)cc(c(n2)C)CC
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,LY456066,3347,,,178100377,Allosteric modulator,Negative,,f,,,pKi,0,6.84,0,Ki,0,143,0,=,,,,19559036,OCCSc1nc(NC2Cc3c(C2)cccc3)c2c(n1)CCCC2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,LY456066,3347,,,178100377,Allosteric modulator,Negative,,f,,,pIC50,0,7.55,0,IC50,0,28,0,=,,,,19559036,OCCSc1nc(NC2Cc3c(C2)cccc3)c2c(n1)CCCC2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,LY456236,3346,,,178100376,Allosteric modulator,Negative,,f,f,,pIC50,0,6.900000095,0,IC50,0,140,0,=,,,,0,COc1ccc(cc1)Nc1ncnc2c1cc(OC)cc2
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,MK-5435,6335,,,178102953,Allosteric modulator,Negative,,f,,,pIC50,0,8.37,0,IC50,0,4.3,0,=,,,,20524178,Fc1ccc(c(c1)F)n1nnc(c1C)c1ccc2c(c1)CN(C2=O)C(C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,NPS2390,1384,,,135650740,Allosteric modulator,Negative,,f,,,pKi,0,8.9,0,,0,0,0,,,,,12695537,O=C(c1cnc2c(n1)cccc2)NC12CC3CC(C2)CC(C1)C3
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,R214127,6336,,,178102954,Allosteric modulator,Negative,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,12695537,O=C(c1ccc2c(c1)cc1c(n2)OCCC1)Cc1ccccc1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,R214127,6336,,,178102954,Allosteric modulator,Negative,,f,,,pIC50,0,7.98,0,IC50,0,10.4,0,=,,,,12695537,O=C(c1ccc2c(c1)cc1c(n2)OCCC1)Cc1ccccc1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,PHCCC,1416,,,135650816,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccccc1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,Ro01-6128,1386,,,135650908,Allosteric modulator,Positive,,f,f,,pKi,7.699999809,0,7.5,Ki,31.60000038,0,19.89999962,=,,,,11606768,CCOC(=O)NC(=O)C(c1ccccc1)c1ccccc1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,Ro0711401,6204,,,178102825,Allosteric modulator,Positive,,f,,,pEC50,0,7.25,0,EC50,0,56,0,=,,,,19233648,O=C(C1c2ccccc2Oc2c1cccc2)Nc1occ(n1)C(F)(F)F
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,Ro67-4853,1387,,,135650923,Allosteric modulator,Positive,,f,f,,pKi,0,5.099999905,0,Ki,0,7940,0,=,,,,11606768,CCCCOC(=O)NC(=O)C1c2ccccc2Oc2c1cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,Ro67-7476,1388,,,135650924,Allosteric modulator,Positive,,f,f,,pKi,7.900000095,0,7.5,Ki,31.60000038,0,12.60000038,=,,,,11606768,Cc1ccc(cc1)S(=O)(=O)N1CCCC1c1ccc(cc1)F
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,DCG-IV,1377,,,135650164,Antagonist,Antagonist,,f,,,pKi,0,4.1,0,,0,0,0,,,,,11080213,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,(<i>S</i>)-4C3HPG,1374,,,135650425,Antagonist,Antagonist,,f,,,pKi,6,0,5.8,,0,0,0,,,,,12695537,N[C@@H](c1ccc(c(c1)O)C(=O)O)C(=O)O
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9680254,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,LY367385,1379,,,135650555,Antagonist,Antagonist,,f,,,pIC50,0,5.1,0,IC50,0,8800,0,=,,,,0,OC(=O)c1ccc(c(c1)C)[C@@H](C(=O)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,LY367385,1379,,,135650555,Antagonist,Antagonist,,f,f,,pKi,0,5.900000095,0,Ki,0,1260,0,=,,,,12695537,OC(=O)c1ccc(c(c1)C)[C@@H](C(=O)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,,0,0,0,,,,,12695537,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,(S)-4CPG,1418,,,135650971,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,12695537,N[C@@H](c1ccc(cc1)C(=O)O)C(=O)O
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,(S)-(+)-CBPG,3421,,,178100427,Antagonist,Antagonist,,f,f,,pIC50,0,4.199999809,0,IC50,0,67000,0,=,,,,10428410,OC(=O)[C@H](C12CC(C1)(C2)C(=O)O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,(S)-TBPG,3419,,,178100425,Antagonist,Antagonist,,f,f,,pIC50,0,4.199999809,0,IC50,0,68900,0,=,,,,11249114,OC(=O)[C@H](C12CC(C1)(C2)c1n[nH]nn1)N
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5.400000095,0,4.699999809,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,DCG-IV,1377,,,135650164,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9504391,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,DCG-IV,1377,,,135650164,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10530814,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,10530814,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pKi,7.9,0,7.8,,0,0,0,,,,,9504391,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,(<i>S</i>)-4C3HPG,1374,,,135650425,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,9504391,N[C@@H](c1ccc(c(c1)O)C(=O)O)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,7,0,6.8,,0,0,0,,,,,9504391,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10530814,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,0,4.9,0,,0,0,0,,,,,10530814,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,5.9,0,5.4,,0,0,0,,,,,8022410,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,LY379268,1394,,,135650556,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,10090786,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CO2)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,MGS0028,1395,,,135650604,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11123999,O=C1C[C@@]([C@H]2[C@@H]1[C@]2(F)C(=O)O)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,MNI-135,6219,,,178102840,Allosteric modulator,Negative,,f,,,pIC50,7.71,0,7.52,IC50,30.2,0,19.6,=,,,,17416742,N#Cc1cccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)I
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,MNI-135,6219,,,178102840,Allosteric modulator,Negative,,f,,,pIC50,7.98,0,6.93,IC50,118,0,10.5,=,,,,17416742,N#Cc1cccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)I
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,MNI-136,6220,,,178102841,Allosteric modulator,Negative,,f,,,pIC50,7.71,0,7.67,IC50,21.3,0,19.7,=,,,,17416742,O=C1CCC(=Nc2c(N1)ccc(c2)Br)c1cccc(c1)c1ccncc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,MNI-136,6220,,,178102841,Allosteric modulator,Negative,,f,,,pIC50,8.06,0,7.33,IC50,46.6,0,8.8,=,,,,17416742,O=C1CCC(=Nc2c(N1)ccc(c2)Br)c1cccc(c1)c1ccncc1
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,MNI-137,6221,,,178102842,Allosteric modulator,Negative,,f,,,pIC50,8.1,0,7.7,IC50,20.3,0,8.3,=,,,,17416742,N#Cc1nccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)Br
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,MNI-137,6221,,,178102842,Allosteric modulator,Negative,,f,,,pIC50,7.9,0,7.14,IC50,72.7,0,12.6,=,,,,17416742,N#Cc1nccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)Br
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pKi,0,8.27,0,Ki,0,5.4,0,=,,,,22091727,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pIC50,0,7.85,0,IC50,0,14,0,=,,,,20971004,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pKi,8.21,0,6.44,Ki,364,0,6.2,=,,,,22091727,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pIC50,8.7,0,6.53,IC50,296,0,2,=,,,,20971004,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,RO4988546,6324,,,178102942,Allosteric modulator,Negative,,f,,,pKi,0,8.64,0,Ki,0,2.3,0,=,,,,21470207,FC(c1cc(nc2n1ncc2C#Cc1cncc(c1)S(=O)(=O)O)c1ccc(cc1)C(F)(F)F)(F)F
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,RO4988546,6324,,,178102942,Allosteric modulator,Negative,,f,,,pIC50,0,8.26,0,IC50,0,5.5,0,=,,,,21470207,FC(c1cc(nc2n1ncc2C#Cc1cncc(c1)S(=O)(=O)O)c1ccc(cc1)C(F)(F)F)(F)F
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,RO5488608,6325,,,178102943,Allosteric modulator,Negative,,f,,,pKi,8.72,0,7.94,Ki,11.4,0,1.9,=,,,,21470207,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cccc(c1)S(=O)(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,Ro64-5229,3955,,,178100782,Allosteric modulator,Negative,,f,,,pIC50,0,7,0,IC50,0,110,0,=,,,,10465539,Clc1cccc(c1/C(=C/n1cncn1)/OC1CCCCCC1)Cl
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,cyPPTS,6257,,,178102877,Allosteric modulator,Positive,,f,,,pEC50,0,7.6,0,EC50,0,24,0,=,,,,15717213,FC(CS(=O)(=O)N(c1cccc(c1)OC1CCCC1)Cc1cccnc1)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,GSK1331258,6252,,,178102872,Allosteric modulator,Positive,,f,,,pEC50,0,7.1,0,EC50,0,80,0,=,,,,20005096,Clc1cc(cnc1N1CCN(CC1)Cc1nc2c(n1C)cccc2)C(F)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,GSK1331268,6253,,,178102873,Allosteric modulator,Positive,,f,,,pEC50,0,6.9,0,EC50,0,125,0,=,,,,20005096,Clc1cnc(nc1)N1CCN(CC1)Cc1nc2c(n1C)cccc2
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,JNJ-40068782,6330,,,178102948,Allosteric modulator,Positive,,f,,,pEC50,0,7.28,0,EC50,0,52,0,=,,,,23766542,N#Cc1c(ccn(c1=O)CC1CC1)N1CCC(CC1)c1ccccc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-40068782,6330,,,178102948,Allosteric modulator,Positive,,f,,,pEC50,7.82,0,6.84,EC50,143,0,15,=,,,,23766542,N#Cc1c(ccn(c1=O)CC1CC1)N1CCC(CC1)c1ccccc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-40411813,8946,,,310264727,Allosteric modulator,Positive,,f,t,,pEC50,0,6.829999924,0,EC50,0,147,0,=,Measured in a [<sup>35</sup>S]GTP&gamma;S binding assay with human metabotropic glutamate type 2 receptor expressed in CHO cells.,,,25692015,CCCCn1ccc(c(c1=O)Cl)N1CCC(CC1)c1ccccc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-42153605,6317,,,178102935,Allosteric modulator,Positive,,f,,,pEC50,0,7.77,0,EC50,0,17,0,=,,,,23072213,FC(c1c(ccn2c1nnc2CC1CC1)N1CCC(CC1)c1ccccc1)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-42153605,6317,,,178102935,Allosteric modulator,Positive,,f,,,pKi,0,7.82,0,Ki,0,15,0,=,,,,23072213,FC(c1c(ccn2c1nnc2CC1CC1)N1CCC(CC1)c1ccccc1)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-46281222,8947,,,310264728,Allosteric modulator,Positive,,f,t,,pKi,0,8.329999924,0,Ki,0,4.679999828,0,=,Homologous displacement assay.,,,26589404,FC(c1c(ccn2c1nnc2CC1CC1)CN1CCC(CC1)c1ccccc1)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,JNJ-46281222,8947,,,310264728,Allosteric modulator,Positive,,f,t,,pKd,0,8.770000458,0,Kd,0,1.700000048,0,=,"Saturation binding experiment using tritiated compound, and membranes from CHO-K1 cells stably expressing the human mGlu<sub>2</sub> receptor.",,,26589404,FC(c1c(ccn2c1nnc2CC1CC1)CN1CCC(CC1)c1ccccc1)(F)F
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,PTBE,1403,,,135650863,Allosteric modulator,Positive,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,15317469,CCCc1c(OCCCCOc2ccc(cc2)c2n[nH]nn2)ccc(c1O)C(=O)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,eGlu,1400,,,135650224,Antagonist,Antagonist,,f,,,pKi,4.6,0,4.4,,0,0,0,,,,,9504391,CC[C@@](C(=O)O)(CCC(=O)O)N
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,10530814,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,9,0,7.7,,0,0,0,,,,,9504391,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,9504391,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,,0,0,0,,,,,10530814,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,MGS0039,1397,,,135650605,Antagonist,Antagonist,,f,,,pKi,8.7,0,8.6,,0,0,0,,,,,14975669,OC(=O)[C@]1(N)[C@H](OCc2ccc(c(c2)Cl)Cl)C[C@@H]2[C@H]1[C@@]2(F)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,PCCG-4,3335,,,178100366,Antagonist,Antagonist,,f,f,,pIC50,0,5.099999905,0,IC50,0,8000,0,=,,,,8667369,OC(=O)[C@H]([C@H]1[C@H]([C@@H]1C(=O)O)c1ccccc1)N
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5.400000095,0,5.300000191,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,DCG-IV,1377,,,135650164,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10530814,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,DCG-IV,1377,,,135650164,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,10884552,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,10530814,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10884552,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10884552,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,10530814,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,0,7.4,0,,0,0,0,,,,,10530814,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,0,6.4,0,,0,0,0,,,,,10884552,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,LY379268,1394,,,135650556,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,10090786,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CO2)(N)C(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,NAAG,1405,,,135651520,Agonist,Full agonist,,t,,,pKi,0,4.7,0,-,0,0,0,=,,,,10884552,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)C)CC(=O)O
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,LY2389575,9694,,,348353653,Allosteric modulator,Negative,,f,t,,pIC50,0,6.71999979,0,IC50,0,190,0,=,"Assessed in AV-12 cells expressing the human mGlu3, activated by glutamate as agonist.",,,22607673,Clc1ccc(c(c1)Cl)CN[C@H]1CCN(C1)c1ncc(cn1)Br
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,ML337,8765,,,252827423,Allosteric modulator,Negative,,f,t,,pIC50,0,6.230000019,0,IC50,0,593,0,=,,,,23718281,COc1ccc(cc1)C#Cc1ccc(c(c1)F)C(=O)N1CCC[C@H](C1)O
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,MNI-135,6219,,,178102840,Allosteric modulator,Negative,,f,,,pEC50,0,7.5,0,EC50,0,30.2,0,=,,,,17416742,N#Cc1cccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)I
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,MNI-136,6220,,,178102841,Allosteric modulator,Negative,,f,,,pIC50,0,7.7,0,IC50,0,21.3,0,=,,,,17416742,O=C1CCC(=Nc2c(N1)ccc(c2)Br)c1cccc(c1)c1ccncc1
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,MNI-137,6221,,,178102842,Allosteric modulator,Negative,,f,,,pIC50,0,7.7,0,IC50,0,20.3,0,=,,,,17416742,N#Cc1nccc(c1)C1=Nc2ccc(cc2NC(=O)CC1)Br
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pIC50,0,6.6,0,IC50,0,270,0,=,,,,22091727,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,Ro4491533,6226,,,178102847,Allosteric modulator,Negative,,f,,,pIC50,0,8,0,IC50,0,10,0,<,,,,20971004,O=C1CC(=Nc2c(N1)cc(c(c2)C)C(F)(F)F)c1cccc(c1)c1cc(C)nc(c1)C
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,eGlu,1400,,,135650224,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,10884552,CC[C@@](C(=O)O)(CCC(=O)O)N
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,10884552,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,10530814,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,,0,0,0,,,,,10530814,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,MGS0039,1397,,,135650605,Antagonist,Antagonist,,f,,,pKi,8.4,0,8.3,,0,0,0,,,,,14975669,OC(=O)[C@]1(N)[C@H](OCc2ccc(c(c2)Cl)Cl)C[C@@H]2[C@H]1[C@@]2(F)C(=O)O
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,L-AP4,1410,,,135650507,Agonist,Agonist,,f,,,pEC50,0,6.5,0,EC50,0,320,0,=,,,,9473604,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5.5,0,4.699999809,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,L-serine-O-phosphate,1411,,,135651511,Agonist,Agonist,,f,,,pEC50,0,5.9,0,EC50,0,1420,0,=,,,,9473604,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,LSP1-2111,6739,,,178103350,Agonist,Agonist,,f,,,pEC50,0,5.66,0,EC50,0,2200,0,=,,,,19525404,COc1cc(cc(c1O)[N+](=O)[O-])C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,LSP4-2022,6706,,,178103317,Agonist,Agonist,,f,,,pEC50,0,6.96,0,EC50,0,110,0,=,,,,22223752,OC(=O)COc1ccc(cc1)C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,FP0429,1409,,,135650282,Agonist,Full agonist,,f,,,pEC50,7.4,0,7.3,-,0,0,0,=,,,,17167031,OC(=O)/C=C/C(=O)N1C[C@](C[C@H]1C(=O)O)(N)C(=O)O
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,"(<i>R,S</i>)-4-PPG",1406,,,135650421,Agonist,Full agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,10336568,OC(=O)C(c1ccc(cc1)P(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,"(<i>S</i>)-3,4-DCPG",1407,,,135650423,Agonist,Full agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,11166323,N[C@@H](c1ccc(c(c1)C(=O)O)C(=O)O)C(=O)O
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,L-AP4,1410,,,135650507,Agonist,Full agonist,,f,,,pIC50,6.4,0,6,,0,0,0,,,,,8463825,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pIC50,5,0,4.3,,0,0,0,,,,,1330184,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,5.5,0,4.9,,0,0,0,,,,,9144638,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,L-serine-O-phosphate,1411,,,135651511,Agonist,Full agonist,,t,,,pIC50,6.2,0,5.4,-,0,0,0,=,,,,8463825,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,foliglurax,9622,,,340590252,Allosteric modulator,Positive,,f,f,,pEC50,0,7.119999886,0,EC50,0,76,0,=,Calcium assay using human mGluR4.,,,0,ON=c1cc(oc2c1cc(CCCN1CCOCC1)cc2)c1ncc2c(c1)scc2
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,Lu AF21934,6237,,,178102858,Allosteric modulator,Positive,,f,,,pEC50,0,6.3,0,EC50,0,500,0,=,,,,22491024,NOC[C@@H]1CCCC[C@@H]1C(=O)Nc1ccc(c(c1)Cl)Cl
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,MPEP,1426,,,135650628,Allosteric modulator,Positive,obtained in the presence of L-AP4,f,f,,pEC50,6.599999905,0,6.300000191,EC50,550,0,260,=,,,,12684257,Cc1cccc(n1)C#Cc1ccccc1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,PHCCC,1416,,,135650816,Allosteric modulator,Positive,obtained in the presence of L-AP4,f,f,,pEC50,0,4.5,0,-,0,0,0,=,,,,14573382,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccccc1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,SIB-1893,1432,,,135651042,Allosteric modulator,Positive,obtained in the presence of L-AP4,f,f,,pEC50,6.800000191,0,6.300000191,EC50,470,0,150,=,,,,12684257,Cc1cccc(n1)/C=C/c1ccccc1
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,CPPG,1413,,,135650134,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,10187777,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(C1CC1)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,8532170,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,MAP4,1414,,,135650565,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,-,0,0,0,=,,,,10187777,OC(=O)[C@](CCP(=O)(O)O)(N)C
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,MPPG,1415,,,135650629,Antagonist,Antagonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,10187777,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(N)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5.5,0,5,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,ibotenic acid,1371,,,135652693,Agonist,Full agonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,11080213,OC(=O)C(c1o[nH]c(=O)c1)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pIC50,0,5.8,0,,0,0,0,,,,,11080213,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pIC50,0,6.1,0,,0,0,0,,,,,11080213,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,quisqualate,1372,,,135650876,Agonist,Full agonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,11080213,OC(=O)[C@H](Cn1oc(=O)[nH]c1=O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,(<i>S</i>)-3HPG,1366,,,135650424,Agonist,Partial agonist,,f,,,pIC50,0,5,0,,0,0,0,,,,,11080213,OC(=O)[C@H](c1cccc(c1)O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,(S)-(+)-CBPG,3421,,,178100427,Agonist,Partial agonist,,f,f,,pEC50,0,4.300000191,0,EC50,0,47000,0,=,,,,10428410,OC(=O)[C@H](C12CC(C1)(C2)C(=O)O)N
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CTEP,6409,,,178103025,Allosteric modulator,Negative,,f,f,,pKi,7.789999962,0,7.699999809,Ki,20,0,16.39999962,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,Grm5,Q3UVX5,,,,,,Mouse,CTEP,6409,,,178103025,Allosteric modulator,Negative,,f,,,pKi,0,8.02,0,Ki,0,9.5,0,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CTEP,6409,,,178103025,Allosteric modulator,Negative,,f,,,pIC50,8.19,0,7.94,IC50,11.4,0,6.4,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,CTEP,6409,,,178103025,Allosteric modulator,Negative,,f,,,pKi,0,7.9,0,Ki,0,12.6,0,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,dipraglurant,6452,,,178103068,Allosteric modulator,Negative,,f,,,pIC50,0,7.7,0,IC50,0,20,0,=,,,,23434029,Fc1ccc2n(c1)cc(n2)CCC#Cc1ccccn1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,fenobam,1434,,,135650255,Allosteric modulator,Negative,,f,,,pIC50,0,7.2,0,-,0,0,0,=,,,,16040814,O=C(NC1=NC(=O)CN1C)Nc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,GRN-529,6428,,,178103044,Allosteric modulator,Negative,,f,,,pKi,0,8.27,0,Ki,0,5.4,0,=,,,,22551786,FC(Oc1ccc(cc1C#Cc1ccccn1)C(=O)N1Cc2c(C1)cccn2)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,GRN-529,6428,,,178103044,Allosteric modulator,Negative,,f,,,pIC50,0,8.6,0,IC50,0,2.6,0,=,,,,22551786,FC(Oc1ccc(cc1C#Cc1ccccn1)C(=O)N1Cc2c(C1)cccn2)F
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,GSK2210875,6435,,,178103051,Allosteric modulator,Negative,,f,,,pIC50,0,7.4,0,IC50,0,40,0,=,,,,21051228,O=C(O[C@@H](c1sc2n(c1C)ncn2)C)Nc1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,M-5MPEP,6396,,,178103012,Allosteric modulator,Negative,,f,,,pKi,0,6.52,0,Ki,0,300,0,=,,,,16155210,COc1cccc(c1)C#Cc1ccc(cn1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,methoxymethyl-MTEP,3345,,,178100375,Allosteric modulator,Negative,,f,f,,pIC50,0,7.5,0,IC50,0,30,0,=,,,,12438526,COCc1cncc(c1)C#Cc1csc(n1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,MPEP,1426,,,135650628,Allosteric modulator,Negative,,f,,,pIC50,7.7,0,7.4,-,0,0,0,=,,,,11814808,Cc1cccc(n1)C#Cc1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,MTEB,1428,,,135650670,Allosteric modulator,Negative,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,14697765,N#Cc1cccc(c1)C#Cc1csc(n1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,MTEP,3336,,,178100367,Allosteric modulator,Negative,,f,,,pKi,0,7.8,0,Ki,0,16,0,=,,,,12473093,Cc1scc(n1)C#Cc1cccnc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,PTeB,1430,,,135650864,Allosteric modulator,Negative,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,15341479,O=C([C@H](Oc1ccc(cc1)C)C)Nc1ccc(cc1)C(=O)c1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,SIB-1757,1431,,,135651041,Allosteric modulator,Negative,,f,,,pIC50,6.4,0,6,-,0,0,0,=,,,,11814808,Cc1ccc(c(n1)/N=N/c1ccccc1)O
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,SIB-1893,1432,,,135651042,Allosteric modulator,Negative,,f,,,pIC50,6.5,0,5.9,-,0,0,0,=,,,,11814808,Cc1cccc(n1)/C=C/c1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,SP203,6434,,,178103050,Allosteric modulator,Negative,,f,,,pIC50,0,10.44,0,IC50,0,0.036,0,=,,,,17571866,FCc1scc(n1)C#Cc1cc(F)cc(c1)C#N
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CPPHA,1423,,,135650135,Allosteric modulator,Positive,,f,,,pIC50,0,6.3,0,-,0,0,0,=,,,,14747613,Clc1ccc(c(c1)CN1C(=O)c2c(C1=O)cccc2)NC(=O)c1ccccc1O
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,CPPZ,6416,,,178103032,Allosteric modulator,Positive,,f,,,pEC50,0,6.3,0,EC50,0,500,0,=,,,,21335002,Fc1ccc(c(c1)Cl)N1CCN(CC1)C(=O)COCc1ccncc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,CPPZ,6416,,,178103032,Allosteric modulator,Positive,,f,,,pKi,0,5.51,0,Ki,0,3100,0,=,,,,21335002,Fc1ccc(c(c1)Cl)N1CCN(CC1)C(=O)COCc1ccncc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,LSN2463359,6394,,,178103010,Allosteric modulator,Positive,,f,,,pKi,0,6.42,0,Ki,0,377,0,=,,,,22884720,CC(NC(=O)c1ccc(cn1)C#Cc1ccncc1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,LSN2463359,6394,,,178103010,Allosteric modulator,Positive,,f,,,pEC50,0,7.48,0,EC50,0,33,0,=,,,,22884720,CC(NC(=O)c1ccc(cn1)C#Cc1ccncc1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,LSN2463359,6394,,,178103010,Allosteric modulator,Positive,,f,,,pEC50,0,7.62,0,EC50,0,24,0,=,,,,22884720,CC(NC(=O)c1ccc(cn1)C#Cc1ccncc1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,LSN2814617,6395,,,178103011,Allosteric modulator,Positive,,f,,,pKi,0,5.87,0,Ki,0,1340,0,=,,,,22884720,Fc1ccc(cc1)c1noc(n1)[C@H]1CCn2c(C1)nnc2C(C)(C)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,LSN2814617,6395,,,178103011,Allosteric modulator,Positive,,f,,,pEC50,0,7.28,0,EC50,0,52,0,=,,,,22884720,Fc1ccc(cc1)c1noc(n1)[C@H]1CCn2c(C1)nnc2C(C)(C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,LSN2814617,6395,,,178103011,Allosteric modulator,Positive,,f,,,pEC50,0,7.03,0,EC50,0,93,0,=,,,,22884720,Fc1ccc(cc1)c1noc(n1)[C@H]1CCn2c(C1)nnc2C(C)(C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,NCFP,6471,,,178103085,Allosteric modulator,Positive,EC<sub>50</sub> with high mGlu5 expression,f,,,pEC50,0,6.67,0,EC50,0,214,0,=,,,,23348500,Clc1ccc(c(c1)CN1C(=O)c2c(C1=O)c(F)ccc2)NC(=O)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,NCFP,6471,,,178103085,Allosteric modulator,Positive,EC<sub>50</sub>  from assay using rat astrocytes,f,,,pEC50,0,6.01,0,EC50,0,969,0,=,,,,23348500,Clc1ccc(c(c1)CN1C(=O)c2c(C1=O)c(F)ccc2)NC(=O)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,NCFP,6471,,,178103085,Allosteric modulator,Positive,EC<sub>50</sub> with low mGlu5 expression,f,,,pEC50,0,6.43,0,EC50,0,370,0,=,,,,23348500,Clc1ccc(c(c1)CN1C(=O)c2c(C1=O)c(F)ccc2)NC(=O)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,DCG-IV,1377,,,135650164,Antagonist,Antagonist,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,11080213,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,(<i>S</i>)-4C3HPG,1374,,,135650425,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,11080213,N[C@@H](c1ccc(c(c1)O)C(=O)O)C(=O)O
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pIC50,0,5.1,0,,0,0,0,,,,,9680254,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pIC50,0,3.7,0,,0,0,0,,,,,11080213,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,methoxy-MPEP,3344,,,178100374,Antagonist,Antagonist,,f,t,,pIC50,0,8.43999958,0,IC50,0,3.599999905,0,=,[<sup>3</sup>H]-M-MPEP displacement assay.,,,11814808,COc1cccc(c1)C#Cc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,(S)-4CPG,1418,,,135650971,Antagonist,Antagonist,,f,,,pIC50,0,4.6,0,,0,0,0,,,,,11080213,N[C@@H](c1ccc(cc1)C(=O)O)C(=O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,homo-AMPA,3359,,,178100385,Agonist,Agonist,,f,f,,pEC50,0,4.099999905,0,EC50,0,82000,0,=,,,,8759641,OC(=O)C(CCc1c(C)o[nH]c1=O)N
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,0,4.800000191,0,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,LSP1-2111,6739,,,178103350,Agonist,Agonist,,f,,,pEC50,0,5.77,0,EC50,0,1700,0,=,,,,19525404,COc1cc(cc(c1O)[N+](=O)[O-])C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,LSP4-2022,6706,,,178103317,Agonist,Agonist,,f,,,pEC50,0,5.36,0,EC50,0,4400,0,=,,,,22223752,OC(=O)COc1ccc(cc1)C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,10090786,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,"(<i>R,S</i>)-4-PPG",1406,,,135650421,Agonist,Full agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,10336568,OC(=O)C(c1ccc(cc1)P(=O)(O)O)N
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,"(<i>S</i>)-3,4-DCPG",1407,,,135650423,Agonist,Full agonist,,f,f,,pEC50,0,5.400000095,0,EC50,0,3980,0,=,,,,11166323,N[C@@H](c1ccc(c(c1)C(=O)O)C(=O)O)C(=O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,L-AP4,1410,,,135650507,Agonist,Full agonist,,f,,,pEC50,7.3,0,6.7,,0,0,0,,,,,11166323,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,f,,pEC50,0,6.199999809,0,-,0,0,0,=,,,,9144651,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,f,,pEC50,0,5.199999809,0,-,0,0,0,=,,,,9833633,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pEC50,0,5.2,0,,0,0,0,,,,,9144651,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pEC50,0,4.4,0,,0,0,0,,,,,9833633,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,L-serine-O-phosphate,1411,,,135651511,Agonist,Full agonist,,t,,,pEC50,0,6.4,0,-,0,0,0,=,,,,9144651,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,LY379268,1394,,,135650556,Agonist,Full agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,10090786,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CO2)(N)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,PHCCC,1416,,,135650816,Allosteric modulator,Positive,,f,,,pEC50,0,4.8,0,EC50,0,15000,0,=,,,,18593581,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccccc1
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,DCG-IV,1377,,,135650164,Antagonist,Antagonist,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,9833633,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>6</sub> receptor,294,Grm6,P35349,,,,,,Rat,MAP4,1414,,,135650565,Antagonist,Antagonist,,f,,,pIC50,0,3.5,0,-,0,0,0,=,,,,12769621,OC(=O)[C@](CCP(=O)(O)O)(N)C
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,MPPG,1415,,,135650629,Antagonist,Antagonist,,f,,,pIC50,0,3.3,0,,0,0,0,,,,,0,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-AP4,1410,,,135650507,Agonist,Agonist,,f,,,pEC50,0,3.8,0,EC50,0,175000,0,=,,,,9473604,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,0,3,0,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-serine-O-phosphate,1411,,,135651511,Agonist,Agonist,,f,,,pEC50,0,4.5,0,EC50,0,31000,0,=,,,,9473604,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>7</sub> receptor,295,Grm7,P35400,,,,,,Rat,LSP1-2111,6739,,,178103350,Agonist,Agonist,,f,,,pEC50,0,4.28,0,EC50,0,53000,0,=,,,,19525404,COc1cc(cc(c1O)[N+](=O)[O-])C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,LSP4-2022,6706,,,178103317,Agonist,Agonist,,f,f,,pEC50,0,4.940000057,0,EC50,0,11600,0,=,,,,22223752,OC(=O)COc1ccc(cc1)C(P(=O)(CC[C@@H](C(=O)O)N)O)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,"(<i>R,S</i>)-4-PPG",1406,,,135650421,Agonist,Full agonist,,f,,,pIC50,0,3.7,0,,0,0,0,,,,,10336568,OC(=O)C(c1ccc(cc1)P(=O)(O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-AP4,1410,,,135650507,Agonist,Full agonist,,f,,,pKi,0,3.7,0,,0,0,0,,,,,11138847,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,11138847,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pKi,0,3.1,0,,0,0,0,,,,,11138847,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,L-serine-O-phosphate,1411,,,135651511,Agonist,Full agonist,,t,,,pKi,0,4.4,0,,0,0,0,,,,,11138847,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,PPG,1438,,,135650844,Agonist,Full agonist,,f,,,pKi,0,3.7,0,,0,0,0,,,,,11138847,NCCO/C=C/C(C(=O)O)NCC1=C(CNC(C1=O)C)COP(=O)(O)O
mGlu<sub>7</sub> receptor,295,Grm7,P35400,,,,,,Rat,MDIP,6218,,,178102839,Allosteric modulator,Negative,,f,,,pIC50,0,7.6,0,IC50,0,26,0,=,,,,17609420,Cn1c(cc2c(c1=O)c(no2)c1ccccc1)c1ccccc1
mGlu<sub>7</sub> receptor,295,Grm7,P35400,,,,,,Rat,MMPIP,3341,,,178100371,Allosteric modulator,Negative,,f,,,pIC50,7.6,0,6.1,IC50,717,0,25,=,,,,17609420,COc1ccc(cc1)c1cc2onc(c2c(=O)n1C)c1ccncc1
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,DCG-IV,1377,,,135650164,Antagonist,Antagonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,11138847,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,11138847,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,MAP4,1414,,,135650565,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,,0,0,0,,,,,11138847,OC(=O)[C@](CCP(=O)(O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,MCCG,1439,,,135650569,Antagonist,Antagonist,,f,,,pKi,0,3.2,0,,0,0,0,,,,,11138847,OC(=O)[C@H]1C[C@@H]1[C@@](C(=O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,(+)-MCPG,1373,,,135650572,Antagonist,Antagonist,,f,,,pKi,0,3.2,0,,0,0,0,,,,,11138847,OC(=O)c1ccc(cc1)[C@@](C(=O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,MPPG,1415,,,135650629,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,,0,0,0,,,,,11138847,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(N)C
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,MSOPPE,1440,,,135650669,Antagonist,Antagonist,,f,,,pKi,0,3.6,0,,0,0,0,,,,,11138847,OC(=O)C(COP(=O)(Oc1ccccc1)O)(N)C
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Agonist,,t,f,,pEC50,5.599999905,0,4.900000095,-,0,0,0,=,,,,10443583,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,D-AP4,1443,,,135650159,Agonist,Full agonist,,f,,,pEC50,0,5.5,0,,0,0,0,,,,,9473604,OC(=O)[C@@H](CCP(=O)(O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,eglumegad,1393,,,135650554,Agonist,Full agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,10216218,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,"(<i>R,S</i>)-4-PPG",1406,,,135650421,Agonist,Full agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10336568,OC(=O)C(c1ccc(cc1)P(=O)(O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,"(<i>S</i>)-3,4-DCPG",1407,,,135650423,Agonist,Full agonist,,f,,,pEC50,0,7.5,0,-,0,0,0,=,,,,11166323,N[C@@H](c1ccc(c(c1)C(=O)O)C(=O)O)C(=O)O
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,L-AP4,1410,,,135650507,Agonist,Full agonist,,f,,,pEC50,0,6.2,0,,0,0,0,,,,,9016353,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,L-AP4,1410,,,135650507,Agonist,Full agonist,,f,,,pIC50,7.2,0,7,-,0,0,0,=,,,,10216218,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pIC50,6.3,0,6.1,,0,0,0,,,,,10216218,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,L-CCG-I,1368,,,135650510,Agonist,Full agonist,,f,,,pEC50,0,6.2,0,,0,0,0,,,,,9016353,N[C@@H]([C@H]1C[C@@H]1C(=O)O)C(=O)O
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,L-glutamic acid,1369,,,135651501,Agonist,Full agonist,,t,,,pIC50,5.7,0,5,,0,0,0,,,,,9473604,OC(=O)CC[C@@H](C(=O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,L-serine-O-phosphate,1411,,,135651511,Agonist,Full agonist,,t,,,pIC50,7.2,0,6.2,-,0,0,0,=,,,,9473604,OC(=O)[C@H](COP(=O)(O)O)N
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,CPPG,1413,,,135650134,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10719229,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(C1CC1)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,DCG-IV,1377,,,135650164,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,10216218,N[C@@H](C1[C@H]([C@@H]1C(=O)O)C(=O)O)C(=O)O
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,LY341495,1378,,,135650552,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,9680254,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>8</sub> receptor,296,Grm8,P70579,,,,,,Rat,MAP4,1414,,,135650565,Antagonist,Antagonist,,f,,,pIC50,7.6,0,5.1,,0,0,0,,,,,9016353,OC(=O)[C@](CCP(=O)(O)O)(N)C
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,MPPG,1415,,,135650629,Antagonist,Antagonist,,f,,,pIC50,0,4.33,0,IC50,0,46500,0,=,,,,9473604,OC(=O)C(c1ccc(cc1)P(=O)(O)O)(N)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,cortisol,2868,,,53801089,Agonist,Agonist,,t,,,pIC50,9.95,0,9.8,-,0,0,0,=,,,,8282004,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,deoxycorticosterone,2871,,,135651469,Agonist,Agonist,,t,t,,pIC50,0,11,0,-,0,0,0,=,,,,8282004,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,dexamethasone,2768,,,135651471,Agonist,Agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8282004,OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,fludrocortisone,2873,,,135650268,Agonist,Agonist,,f,t,,pIC50,0,9.920000076,0,-,0,0,0,=,,,,8282004,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)CC[C@]12C)F
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,fluticasone propionate,7080,,,178103659,Agonist,Agonist,,f,f,,pEC50,0,6.829999924,0,EC50,0,149,0,=,,,,28937774,FCSC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,prednisolone,2866,,,135650850,Agonist,Agonist,,f,t,,pKi,0,7.429999828,0,Ki,0,37,0,=,,,,11520196,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,prednisolone,2866,,,135650850,Agonist,Agonist,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,29424542,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,progesterone,2377,,,135651551,Agonist,Agonist,,t,,,pIC50,0,11,0,,0,0,0,,,,,8282004,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,drospirenone,2874,,,135650211,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,1493716,O=C1CC[C@]2(C(=C1)[C@@H]1C[C@@H]1[C@@H]1[C@@H]2CC[C@]2([C@H]1[C@@H]1C[C@@H]1[C@]12CCC(=O)O1)C)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,eplerenone,2876,,,135650235,Antagonist,Antagonist,,f,t,,pKi,0,6.909999847,0,Ki,0,124,0,=,,,,18038968,COC(=O)[C@@H]1CC2=CC(=O)CC[C@@]2([C@@]23[C@@H]1[C@@H]1CC[C@]4([C@@]1(C)C[C@H]3O2)CCC(=O)O4)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,finerenone,8678,,,252166878,Antagonist,Antagonist,,f,f,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,22791416,CCOc1ncc(c2c1[C@@H](C(=C(N2)C)C(=O)N)c1ccc(cc1OC)C#N)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,nimodipine,2523,,,53801057,Antagonist,Antagonist,inhibition of aldosterone-induced luciferase activity in a reporter system driven by the mineralocorticoid receptor ligand binding domain,f,t,,pIC50,0,6.800000191,0,IC50,0,160,0,=,,,,18250364,COCCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(C)C)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,onapristone,2882,,,135650760,Antagonist,Antagonist,,f,f,,pIC50,0,6.329999924,0,IC50,0,470,0,=,,,,12781198,OCCC[C@@]1(O)CC[C@@H]2[C@@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,PF-03882845,9061,,,315661146,Antagonist,Antagonist,,f,t,,pIC50,0,8.039999962,0,IC50,0,9.199999809,0,=,,,,24738581,N#Cc1ccc(cc1Cl)N1N=C2[C@@H]([C@@H]1C1CCCC1)CCc1c2ccc(c1)C(=O)O
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,RU28318,3451,,,178100449,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CCC[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]2[C@@H]1[C@@H]1CC[C@@]([C@]1(CC2)C)(O)CCC(=O)O)C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,spironolactone,2875,,,135651065,Antagonist,Antagonist,,f,t,,pKi,0,8.630000114,0,Ki,0,2.319999933,0,=,,,,18038968,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]2[C@@H]1[C@@H]1CC[C@]3([C@]1(CC2)C)CCC(=O)O3)C
misshapen like kinase 1,2103,MINK1,Q8N4C8,,,,,,Human,PF-03715455,8179,,,249565859,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,21888439,OCCSc1ccccc1c1nnc2n1cc(cc2)Sc1ccccc1CNC(=O)Nc1cc(nn1c1ccc(c(c1)Cl)O)C(C)(C)C
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,ERK inhibitor III,5968,,,178102591,Inhibitor,Binding,,f,t,,pKd,0,4.889999866,0,Kd,0,13000,0,=,"Measuring binding of the compound to human ERK2 in a fluorescence spectroscopy experiment, where fluorescence quenching is indicative of a binding interaction",,,17000106,[O-][N+](=O)N/C(=N/N=Cc1ccc(o1)c1cccc(c1)[N+](=O)[O-])/N
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,ERK inhibitor II,5966,,,178102589,Inhibitor,Inhibition,,f,t,,pKi,0,6.849999905,0,Ki,0,140,0,=,,,,16139248,Nc1[nH]nc2c1cc(nn2)c1c(nn2c1cccc2)c1ccccc1
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,ravoxertinib,9229,,,315661304,Inhibitor,Inhibition,,f,t,,pIC50,8.510000229,0,7.809999943,IC50,15.5,0,3.099999905,=,,,,0,OC[C@@H](n1ccc(cc1=O)c1ccnc(n1)Nc1ccnn1C)c1ccc(c(c1)F)Cl
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,SCH772984,8056,,,249565736,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23614898,O=C(N1CCN(CC1)c1ccc(cc1)c1ncccn1)CN1CC[C@H](C1)C(=O)Nc1ccc2c(c1)c(n[nH]2)c1ccncc1
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,SCH772984,8056,,,249565736,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,23614898,O=C(N1CCN(CC1)c1ccc(cc1)c1ncccn1)CN1CC[C@H](C1)C(=O)Nc1ccc2c(c1)c(n[nH]2)c1ccncc1
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,GNE-3511,9355,,,328083457,Inhibitor,Inhibition,,f,f,,pIC50,0,6.440000057,0,IC50,0,364,0,=,,,,25341110,N#Cc1ccnc(c1)Nc1cc(cc(n1)N1CCC(C1)(F)F)C1CCN(CC1)C1COC1
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,JNK-IN-8,8058,,,249565738,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22284361,CN(C/C=C/C(=O)Nc1cccc(c1)C(=O)Nc1ccc(c(c1)C)Nc1nccc(n1)c1cccnc1)C
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,JNK inhibitor 9l,9377,,,328083479,Inhibitor,Inhibition,,f,f,,pIC50,0,6.829999924,0,IC50,0,148,0,=,,,,19947601,Fc1cc(cc(c1)c1ccnc(n1)Nc1ccc(cc1)n1cnc(n1)N1CCOCC1)N1CCOCC1
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,JNK inhibitor IX,5996,,,178102618,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,0,199.5299988,0,=,,,,0,N#Cc1c(sc2c1CCCC2)NC(=O)c1cccc2c1cccc2
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,JNK inhibitor V,5997,,,178102619,Inhibitor,Inhibition,,f,t,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,0,N#C/C(=c/1sc2c([nH]1)cccc2)/c1ccnc(n1)NCCc1cccnc1
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,JNK inhibitor VIII,5998,,,178102620,Inhibitor,Inhibition,,f,f,,pKi,0,7.28000021,0,Ki,0,52,0,=,,,,16759099,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(c1C#N)N
mitogen-activated protein kinase 10,1498,MAPK10,P53779,,,,,,Human,SP600125,5273,,,178101956,Inhibitor,Inhibition,,f,,,pIC50,0,7.05,0,IC50,0,90,0,=,,,,11717429,O=c1c2ccccc2c2c3c1cccc3[nH]n2
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,doramapimod,5668,,,178102296,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,Inhibition of p38&beta;2.,,,22014550,O=C(Nc1cc(nn1c1ccc(cc1)C)C(C)(C)C)Nc1ccc(c2c1cccc2)OCCN1CCOCC1
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,neflamapimod,5719,,,178102345,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,18183025,Fc1ccc(c(c1)F)Sc1ccc2n(n1)cnc(=O)c2c1c(Cl)cccc1Cl
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,PH-797804,7818,,,223366149,Inhibitor,Inhibition,,f,t,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,21620699,CNC(=O)c1ccc(c(c1)n1c(C)cc(c(c1=O)Br)OCc1ccc(cc1F)F)C
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,SB203580,5269,,,178101952,Inhibitor,Inhibition,,f,,,pKi,0,7,0,-,0,0,0,=,,,,9653550,Fc1ccc(cc1)c1nc([nH]c1c1ccncc1)c1ccc(cc1)S(=O)C
mitogen-activated protein kinase 12,1501,MAPK12,P53778,,,,,,Human,doramapimod,5668,,,178102296,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,22014550,O=C(Nc1cc(nn1c1ccc(cc1)C)C(C)(C)C)Nc1ccc(c2c1cccc2)OCCN1CCOCC1
mitogen-activated protein kinase 13,1502,MAPK13,O15264,,,,,,Human,doramapimod,5668,,,178102296,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,22014550,O=C(Nc1cc(nn1c1ccc(cc1)C)C(C)(C)C)Nc1ccc(c2c1cccc2)OCCN1CCOCC1
mitogen-activated protein kinase 13,1502,MAPK13,O15264,,,,,,Human,PF-03715455,8179,,,249565859,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,21888439,OCCSc1ccccc1c1nnc2n1cc(cc2)Sc1ccccc1CNC(=O)Nc1cc(nn1c1ccc(c(c1)Cl)O)C(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,PF-03715455,8179,,,249565859,Inhibitor,Binding,,f,t,,pKd,0,12,0,Kd,0,0.001,0,=,,,,21888439,OCCSc1ccccc1c1nnc2n1cc(cc2)Sc1ccccc1CNC(=O)Nc1cc(nn1c1ccc(c(c1)Cl)O)C(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,dilmapimod,7815,,,223366146,Inhibitor,Inhibition,,f,t,,pIC50,0,5,0,IC50,0,10000,0,<,,,,0,OCC(Nc1nc(c2ccc(cc2C)F)c2c(n1)n(c(=O)cc2)c1c(F)cccc1F)CO
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,doramapimod,5668,,,178102296,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,22014550,O=C(Nc1cc(nn1c1ccc(cc1)C)C(C)(C)C)Nc1ccc(c2c1cccc2)OCCN1CCOCC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,doramapimod,5668,,,178102296,Inhibitor,Inhibition,,f,t,,pKd,0,9.350000381,0,Kd,0,0.449999988,0,=,,,,22037378,O=C(Nc1cc(nn1c1ccc(cc1)C)C(C)(C)C)Nc1ccc(c2c1cccc2)OCCN1CCOCC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,losmapimod,7835,,,223366166,Inhibitor,Inhibition,,f,t,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,19772287,O=C(c1ccc(nc1)c1cc(cc(c1C)F)C(=O)NC1CC1)NCC(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,neflamapimod,5719,,,178102345,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,18183025,Fc1ccc(c(c1)F)Sc1ccc2n(n1)cnc(=O)c2c1c(Cl)cccc1Cl
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,PF-03715455,8179,,,249565859,Inhibitor,Inhibition,,f,t,,pIC50,0,9.06000042,0,IC50,0,0.879999995,0,=,,,,21888439,OCCSc1ccccc1c1nnc2n1cc(cc2)Sc1ccccc1CNC(=O)Nc1cc(nn1c1ccc(c(c1)Cl)O)C(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,PF-670462,9371,,,328083473,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,In a biochemical kinase assay.,,,17502429,Nc1nccc(n1)c1n(cnc1c1ccc(cc1)F)C1CCCCC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,PH-797804,7818,,,223366149,Inhibitor,Inhibition,,f,t,,pKi,0,8.539999962,0,Ki,0,2.900000095,0,=,,,,0,CNC(=O)c1ccc(c(c1)n1c(C)cc(c(c1=O)Br)OCc1ccc(cc1F)F)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pIC50,0,6.190000057,0,IC50,0,640,0,=,,,,12534346,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,ralimetinib,7959,,,249565642,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,18039577,Fc1ccc(cc1)c1nc([nH]c1c1ccc2c(n1)n(CC(C)(C)C)c(n2)N)C(C)(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,SB202190,4307,,,178101124,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,16509574,Oc1ccc(cc1)c1nc(c([nH]1)c1ccc(cc1)F)c1ccncc1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,SB203580,5269,,,178101952,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,9653550,Fc1ccc(cc1)c1nc([nH]c1c1ccncc1)c1ccc(cc1)S(=O)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,SB220025,6038,,,178102660,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,11597418,Nc1nccc(n1)c1n(cnc1c1ccc(cc1)F)C1CCNCC1
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,SKF-86002,6040,,,178102662,Inhibitor,Inhibition,,f,t,,pIC50,0,6.960000038,0,IC50,0,110,0,=,Measured using a classic homogeneous time-resolved fluorescence (HTRF) kinase assay,,,19928858,Fc1ccc(cc1)c1nc2n(c1c1ccncc1)CCS2
mitogen-activated protein kinase 3,1494,MAPK3,P27361,,,,,,Human,ERK inhibitor II,5966,,,178102589,Inhibitor,Inhibition,,f,t,,pKi,0,6.389999866,0,Ki,0,410,0,=,,,,16139248,Nc1[nH]nc2c1cc(nn2)c1c(nn2c1cccc2)c1ccccc1
mitogen-activated protein kinase 3,1494,MAPK3,P27361,,,,,,Human,ravoxertinib,9229,,,315661304,Inhibitor,Inhibition,,f,t,,pIC50,8.479999542,0,8.210000038,IC50,6.099999905,0,3.299999952,=,,,,0,OC[C@@H](n1ccc(cc1=O)c1ccnc(n1)Nc1ccnn1C)c1ccc(c(c1)F)Cl
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,GNE-3511,9355,,,328083457,Inhibitor,Inhibition,,f,f,,pIC50,0,6.889999866,0,IC50,0,129,0,=,,,,25341110,N#Cc1ccnc(c1)Nc1cc(cc(n1)N1CCC(C1)(F)F)C1CCN(CC1)C1COC1
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,JNK-IN-8,8058,,,249565738,Inhibitor,Inhibition,,f,t,,pIC50,0,8.329999924,0,IC50,0,4.699999809,0,=,,,,22284361,CN(C/C=C/C(=O)Nc1cccc(c1)C(=O)Nc1ccc(c(c1)C)Nc1nccc(n1)c1cccnc1)C
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,JNK inhibitor 9l,9377,,,328083479,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,99,0,=,,,,19947601,Fc1cc(cc(c1)c1ccnc(n1)Nc1ccc(cc1)n1cnc(n1)N1CCOCC1)N1CCOCC1
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,JNK inhibitor VIII,5998,,,178102620,Inhibitor,Inhibition,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,16759099,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(c1C#N)N
mitogen-activated protein kinase 8,1496,MAPK8,P45983,,,,,,Human,SP600125,5273,,,178101956,Inhibitor,Inhibition,,f,,,pIC50,0,7.4,0,IC50,0,40,0,=,,,,11717429,O=c1c2ccccc2c2c3c1cccc3[nH]n2
mitogen-activated protein kinase 9,1497,MAPK9,P45984,,,,,,Human,JNK-IN-8,8058,,,249565738,Inhibitor,Inhibition,,f,t,,pIC50,0,7.730000019,0,IC50,0,18.70000076,0,=,,,,22284361,CN(C/C=C/C(=O)Nc1cccc(c1)C(=O)Nc1ccc(c(c1)C)Nc1nccc(n1)c1cccnc1)C
mitogen-activated protein kinase 9,1497,MAPK9,P45984,,,,,,Human,JNK inhibitor IX,5996,,,178102618,Inhibitor,Inhibition,,f,t,,pIC50,0,6.5,0,IC50,0,316.230011,0,=,,,,17194588,N#Cc1c(sc2c1CCCC2)NC(=O)c1cccc2c1cccc2
mitogen-activated protein kinase 9,1497,MAPK9,P45984,,,,,,Human,JNK inhibitor VIII,5998,,,178102620,Inhibitor,Inhibition,,f,t,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,16759099,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(c1C#N)N
mitogen-activated protein kinase 9,1497,MAPK9,P45984,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
mitogen-activated protein kinase 9,1497,MAPK9,P45984,,,,,,Human,SP600125,5273,,,178101956,Inhibitor,Inhibition,,f,,,pIC50,0,7.4,0,IC50,0,40,0,=,,,,11717429,O=c1c2ccccc2c2c3c1cccc3[nH]n2
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,MK2a inhibitor,6009,,,178102631,Inhibitor,Inhibition,,f,t,,pKi,0,6.480000019,0,Ki,0,330,0,=,,,,17964780,O=C(Nc1ccc(cc1)O)CCCc1ccc(cc1)c1ccccc1F
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,PF-3644022,8045,,,249565725,Inhibitor,Inhibition,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,20237073,C[C@@H]1CNc2c(C(=O)N1)sc1c2c2ccc(nc2cc1)c1ccc(nc1)C
mitogen-activated protein kinase-activated protein kinase 2,2094,MAPKAPK2,P49137,,,,,,Human,PF-3644022,8045,,,249565725,Inhibitor,Inhibition,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,,,,20237073,C[C@@H]1CNc2c(C(=O)N1)sc1c2c2ccc(nc2cc1)c1ccc(nc1)C
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,refametinib,7942,,,249565625,Allosteric modulator,Negative,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,19706763,OC[C@H](CC1(CC1)S(=O)(=O)Nc1c(OC)cc(c(c1Nc1ccc(cc1F)I)F)F)O
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,selumetinib,5665,,,178102293,Allosteric modulator,Negative,,f,t,,pIC50,7.920000076,0,7.849999905,IC50,14.10000038,0,12,=,,,,17332304,OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1Cl)Br)F
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,E6201,7836,,,223366167,Inhibitor,Inhibition,,f,t,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,,,,19684251,CCNc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C[C@H]([C@@H](OC(=O)c2c(c1)O)C)C
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,MEK inhibitor I,6006,,,178102628,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,15006386,N#C/C(=C(Sc1ccccc1N)/N)/c1cccc(c1)C(c1ccncc1)O
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,MEK inhibitor II,6007,,,178102629,Inhibitor,Inhibition,,f,f,,pIC50,0,6.420000076,0,IC50,0,380,0,=,,,,18077363,O=C1CCC(=O)N1C1=C(Cl)C(=O)c2c(C1=O)cccc2
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,PD 0325901,7935,,,249565618,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,23474388,OC[C@H](CONC(=O)c1ccc(c(c1Nc1ccc(cc1F)I)F)F)O
mitogen-activated protein kinase kinase 2,2063,MAP2K2,P36507,,,,,,Human,refametinib,7942,,,249565625,Allosteric modulator,Negative,,f,t,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,19706763,OC[C@H](CC1(CC1)S(=O)(=O)Nc1c(OC)cc(c(c1Nc1ccc(cc1F)I)F)F)O
mitogen-activated protein kinase kinase 2,2063,MAP2K2,P36507,,,,,,Human,MEK1/2 inhibitor,6008,,,178102630,Inhibitor,Inhibition,,f,t,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,18077363,N#C/C(=C(Sc1ccc(cc1)N)/N)/c1ccccc1C(F)(F)F
mitogen-activated protein kinase kinase 3,2064,MAP2K3,P46734,,,,,,Human,MEK inhibitor I,6006,,,178102628,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15006386,N#C/C(=C(Sc1ccccc1N)/N)/c1cccc(c1)C(c1ccncc1)O
mitogen-activated protein kinase kinase 4,2065,MAP2K4,P45985,,,,,,Human,MEK inhibitor I,6006,,,178102628,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15006386,N#C/C(=C(Sc1ccccc1N)/N)/c1cccc(c1)C(c1ccncc1)O
mitogen-activated protein kinase kinase 4,2065,MAP2K4,P45985,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,12166950,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
mitogen-activated protein kinase kinase 6,2067,MAP2K6,P52564,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,12166950,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
mitogen-activated protein kinase kinase kinase 1,2069,MAP3K1,Q13233,,,,,,Human,E6201,7836,,,223366167,Inhibitor,Inhibition,,f,t,,pIC50,0,7.510000229,0,IC50,0,31,0,=,,,,19684251,CCNc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C[C@H]([C@@H](OC(=O)c2c(c1)O)C)C
mitogen-activated protein kinase kinase kinase 13,2073,MAP3K13,O43283,,,,,,Human,GNE-3511,9355,,,328083457,Inhibitor,Inhibition,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,<,,,,25341110,N#Cc1ccnc(c1)Nc1cc(cc(n1)N1CCC(C1)(F)F)C1CCN(CC1)C1COC1
mitogen-activated protein kinase kinase kinase 5,2080,MAP3K5,Q99683,,,,,,Human,MSC2032964A,8076,,,249565756,Inhibitor,Inhibition,,f,t,,pIC50,0,7.03000021,0,IC50,0,93,0,=,,,,21064192,O=C(c1cccnc1)Nc1nn2c(n1)cc(cc2NC1CC1)C(F)(F)F
mitogen-activated protein kinase kinase kinase 5,2080,MAP3K5,Q99683,,,,,,Human,selonsertib,9040,,,315661125,Inhibitor,Inhibition,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,"Determined is aTR-FRET immunoassay, measuring phosphorylation of a biotinylated peptide substrate by ASK1 kinase.",,,0,O=C(c1cc(c(cc1F)C)n1cnc(c1)C1CC1)Nc1cccc(n1)c1nncn1C(C)C
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,NG-25,8074,,,249565754,Inhibitor,Inhibition,,f,f,,pIC50,0,6.829999924,0,IC50,0,149,0,=,,,,25075558,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)Oc1ccnc2c1cc[nH]2)C
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,RGB-286638,7744,,,223366077,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,23807770,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1
mitogen-activated protein kinase kinase kinase 8,2083,MAP3K8,P41279,,,,,,Human,MEK inhibitor II,6007,,,178102629,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,18077363,O=C1CCC(=O)N1C1=C(Cl)C(=O)c2c(C1=O)cccc2
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,GNE-3511,9355,,,328083457,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,67.80000305,0,=,,,,25341110,N#Cc1ccnc(c1)Nc1cc(cc(n1)N1CCC(C1)(F)F)C1CCN(CC1)C1COC1
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,P505-15,8070,,,249565750,Inhibitor,Inhibition,,f,f,,pIC50,0,7.059999943,0,IC50,0,88,0,=,,,,22040680,N[C@H]1CCCC[C@H]1Nc1ncc(c(n1)Nc1cccc(c1)n1nccn1)C(=O)N
mitogen-activated protein kinase kinase kinase kinase 2,2086,MAP4K2,Q12851,,,,,,Human,NG-25,8074,,,249565754,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,21.70000076,0,=,,,,25075558,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)Oc1ccnc2c1cc[nH]2)C
mixed lineage kinase domain like pseudokinase,2106,MLKL,Q8NB16,,,,,,Human,MLKL compound 1,9513,,,336446900,Inhibitor,Inhibition,,f,f,,pIC50,7,0,6.300000191,IC50,500,0,100,=,Inhibition of TSQ-induced necroptosis in cellular assays.,,,25288762,O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
mixed lineage kinase domain like pseudokinase,2106,MLKL,Q8NB16,,,,,,Human,MLKL compound 1,9513,,,336446900,None,Binding,,f,f,,pKd,0,5.03000021,0,Kd,0,9300,0,=,Surface plasmon resonance (SPR) assay.,,,25288762,O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
MMP1,1628,MMP1,P03956,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP12,1636,MMP12,P39900,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP12,1636,MMP12,P39900,,,,,,Human,RXP470.1,7812,,,223366143,Inhibitor,Inhibition,,f,t,,pKi,0,8.619999886,0,Ki,0,2.400000095,0,=,,,,23343195,OC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N)CCC(=O)O)NC(=O)[C@@H](CP(=O)(c1ccc(cc1)Br)O)Cc1onc(c1)c1ccc(cc1)c1cccc(c1)Cl
MMP13,1637,MMP13,P45452,,,,,,Human,PF-152,9014,,,310264792,Inhibitor,Inhibition,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,0,OC[C@@H]1CO[C@H](CO1)Cn1nnc(n1)c1nc(C)nc(c1)C(=O)NCc1ccc(c(c1)OC)F
MMP13,1637,MMP13,P45452,,,,,,Human,prinomastat,6505,,,178103119,Inhibitor,Inhibition,,f,f,,pIC50,0,10.39999962,0,IC50,0,0.037999999,0,=,,,,16789888,ONC(=O)[C@@H]1N(CCSC1(C)C)S(=O)(=O)c1ccc(cc1)Oc1ccncc1
MMP13,1637,MMP13,P45452,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,9.350000381,0,Ki,0,0.449999988,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
MMP14,1638,MMP14,P50281,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP15,1639,MMP15,P51511,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP15,1639,MMP15,P51511,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
MMP16,1640,MMP16,P51512,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP16,1640,MMP16,P51512,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,7.460000038,0,Ki,0,35,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
MMP17,1641,MMP17,Q9ULZ9,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,17623656,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP2,1629,MMP2,P08253,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP2,1629,MMP2,P08253,,,,,,Human,SB-3CT,9509,,,329968448,Inhibitor,Inhibition,,f,t,,pKi,0,7.860000134,0,Ki,0,13.89999962,0,=,,,,0,O=S(=O)(c1ccc(cc1)Oc1ccccc1)CC1SC1
MMP26,1648,MMP26,Q9NRE1,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP7,1631,MMP7,P09237,,,,,,Human,doxycycline,6464,,,178103078,Inhibitor,Inhibition,,f,t,,pKd,0,4.139999866,0,Kd,0,73000,0,=,,,,15665254,CN([C@@H]1C(=O)C(=C([C@@]2([C@H]1[C@@H](O)[C@@H]1[C@@H](C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C
MMP7,1631,MMP7,P09237,,,,,,Human,RS 39066,8567,,,252166768,Inhibitor,Inhibition,,f,t,,pIC50,0,9.640000343,0,IC50,0,0.230000004,0,=,,,,0,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)Nc1ccc(cc1)C(=O)OC)CC(C)C)CC(C)C
MMP7,1631,MMP7,P09237,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
MMP8,1632,MMP8,P22894,,,,,,Human,doxycycline,6464,,,178103078,Inhibitor,Inhibition,,f,f,,pIC50,0,4.599999905,0,IC50,0,26000,0,=,,,,7781360,CN([C@@H]1C(=O)C(=C([C@@]2([C@H]1[C@@H](O)[C@@H]1[C@@H](C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C
MMP8,1632,MMP8,P22894,,,,,,Human,ONO-4817,6544,,,178103158,Inhibitor,Inhibition,,f,,,pKi,0,9,0,Ki,0,1.1,0,,,,,10858013,CCOCOC[C@@H](NC(=O)c1ccc(cc1)Oc1ccccc1)C[C@@H](C(=O)NO)C
MMP8,1632,MMP8,P22894,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
MMP9,1633,MMP9,P14780,,,,,,Human,ilomastat,7409,,,178103981,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,14684295,ONC(=O)C[C@H](C(=O)N[C@H](C(=O)NC)Cc1c[nH]c2c1cccc2)CC(C)C
MMP9,1633,MMP9,P14780,,,,,,Human,SB-3CT,9509,,,329968448,Inhibitor,Inhibition,,f,f,,pKi,0,6.21999979,0,Ki,0,600,0,=,,,,0,O=S(=O)(c1ccc(cc1)Oc1ccccc1)CC1SC1
MMP9,1633,MMP9,P14780,,,,,,Human,SL422,8629,,,252166829,Inhibitor,Inhibition,,f,f,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,11472217,CNC(=O)CNC(=O)[C@@H]1Cc2ccc(cc2)OCCC[C@@H]([C@H](C(=O)N1)CC(C)C)C(=O)NO
Monoacylglycerol lipase,1399,MGLL,Q99685,,,,,,Human,JJKK 048,9481,,,329968421,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,-,0,0,0,=,,,,23521796,O=C(n1cncn1)N1CCC(CC1)C(c1ccc2c(c1)OCO2)c1ccc2c(c1)OCO2
Monoacylglycerol lipase,1399,MGLL,Q99685,,,,,,Human,JZL184,5207,,,178101893,Inhibitor,Inhibition,,f,,,pIC50,0,8.1,0,,0,7.94,0,,,,,19029917,O=C(N1CCC(CC1)C(c1ccc2c(c1)OCO2)(c1ccc2c(c1)OCO2)O)Oc1ccc(cc1)[N+](=O)[O-]
Monoacylglycerol lipase,1399,MGLL,Q99685,,,,,,Human,JZL195,8606,,,252166807,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,<i>in vitro assay</i>,,,19918051,O=C(N1CCN(CC1)Cc1cccc(c1)Oc1ccccc1)Oc1ccc(cc1)[N+](=O)[O-]
Monoacylglycerol lipase,1399,MGLL,Q99685,,,,,,Human,KML29,9482,,,329968422,Inhibitor,Inhibition,,f,f,,pIC50,0,8.5,0,-,0,0,0,=,,,,22542104,O=C(N1CCC(CC1)C(c1ccc2c(c1)OCO2)(c1ccc2c(c1)OCO2)O)OC(C(F)(F)F)C(F)(F)F
Monoacylglycerol lipase,1399,MGLL,Q99685,,,,,,Human,JZL184,5207,,,178101893,Inhibitor,Irreversible inhibition,,f,,,pIC50,0,8.4,0,IC50,0,3.9,0,,,,,22542104,O=C(N1CCC(CC1)C(c1ccc2c(c1)OCO2)(c1ccc2c(c1)OCO2)O)Oc1ccc(cc1)[N+](=O)[O-]
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,moclobemide,7428,,,178104000,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,21680183,O=C(c1ccc(cc1)Cl)NCCN1CCOCC1
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,pirlindole,6638,,,178103251,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,9564636,Cc1ccc2c(c1)c1CCCC3c1n2CCN3
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,selegiline,6639,,,178103252,Inhibitor,Inhibition,,f,f,,pKi,0,4.170000076,0,Ki,0,67250,0,=,,,,21377879,C[C@@H](N(CC#C)C)Cc1ccccc1
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Irreversible inhibition,,f,t,,pKi,0,7.329999924,0,Ki,0,47,0,=,,,,18426226,NNCCc1ccccc1
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,lazabemide,6640,,,178103253,Inhibitor,Inhibition,,f,f,,pKi,0,7.079999924,0,Ki,0,84,0,=,,,,2122653,NCCNC(=O)c1ccc(cn1)Cl
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,moclobemide,7428,,,178104000,Inhibitor,Inhibition,,f,f,,pKi,0,5.96999979,0,Ki,0,1080,0,=,,,,21680183,O=C(c1ccc(cc1)Cl)NCCN1CCOCC1
Monoamine oxidase B,2490,Maob,P19643,,,,,,Rat,pargyline,7262,,,178103836,Inhibitor,Inhibition,,f,f,,pIC50,0,5.739999771,0,IC50,0,1800,0,=,,,,6817759,CN(Cc1ccccc1)CC#C
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,rasagiline,6641,,,178103254,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,11159700,C#CCN[C@@H]1CCc2c1cccc2
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,safinamide,8291,,,252166503,Inhibitor,Inhibition,,f,t,,pKi,0,6.349999905,0,Ki,0,450,0,=,,,,15027868,NC(=O)[C@@H](NCc1ccc(cc1)OCc1cccc(c1)F)C
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,safinamide,8291,,,252166503,Inhibitor,Inhibition,,f,t,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,,,,24139167,NC(=O)[C@@H](NCc1ccc(cc1)OCc1cccc(c1)F)C
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,selegiline,6639,,,178103252,Inhibitor,Inhibition,,f,t,,pKi,6,0,5.699999809,Ki,1960,0,970,=,,,,15974574,C[C@@H](N(CC#C)C)Cc1ccccc1
Monoamine oxidase B,2490,Maob,P19643,,,,,,Rat,mofegiline,9754,,,0,Inhibitor,Irreversible inhibition,,f,f,,pIC50,0,8.43999958,0,IC50,0,3.599999905,0,=,,,,2597310,NC/C(=C/F)/CCc1ccc(cc1)F
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Irreversible inhibition,,f,t,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,18426226,NNCCc1ccccc1
motilin receptor,297,MLNR,O43193,,,,,,Human,EM-523,1445,,,135652681,Agonist,Full agonist,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,15764739,CCN([C@H]1C[C@@H](C)O[C@H]([C@@H]1O)O[C@@H]1[C@@H](C)[C@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@@H](C)C(=O)O[C@@H]([C@@]([C@@H]([C@H](C2=C(C[C@]1(C)O2)C)C)O)(C)O)CC)C
motilin receptor,297,MLNR,O43193,,,,,,Human,erythromycin-A,1456,,,135652682,Agonist,Full agonist,,f,,,pIC50,6.5,0,5.5,-,0,0,0,=,,,,10381885,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@H]([C@]1(C)O)O)C)C)(C)O
motilin receptor,297,MLNR,O43193,,,,,,Human,KOS1326,1446,,,135652697,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,15764739,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)C[C@](C2)(C)OC)[C@H](C)[C@H]([C@@]2(OC(=C(C)C2)[C@@H]([C@H]([C@]1(C)O)O)C)C)O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C
motilin receptor,297,MLNR,O43193,,,,,,Human,[Leu<sup>13</sup>]motilin (human),1453,,,135652261,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,10381885,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CCC(=O)N)CCCCN)CC(=O)N)CCCNC(=N)N)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1ccccc1)Cc1ccc(cc1)O)CCC(=O)O)CC(C)C)CCC(=O)N)CCCNC(=N)N)CC(C)C)CCC(=O)N)CCC(=O)O
motilin receptor,297,MLNR,O43193,,,,,,Human,ME36,1447,,,135652703,Agonist,Full agonist,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,15764739,CCN(C1CC(C)OC(C1O)OC1C(C)C(OC2OC(C)C(C(C2)(C)OC)O)C(C)C(=O)OC(CC)C(C(C(C(=O)C(CC1(C)O)C)C)O)(C)O)C
motilin receptor,297,MLNR,O43193,,,,,,Human,ME4,1448,,,135652704,Agonist,Full agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,15764739,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@H]([C@@]2(OC(=C(C)C2)[C@@H]([C@H]([C@]1(C)O)O)C)C)O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C
motilin receptor,297,MLNR,O43193,,,,,,Human,ME67,1449,,,135652705,Agonist,Full agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,15764739,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@H]([C@]2(OC(=C(C)C2)[C@@H]([C@H]([C@@H]1C)O)C)C)O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C
motilin receptor,297,,,,,,,,Rabbit,mitemcinal,3511,,,178100497,Agonist,Full agonist,,f,f,,pIC50,8.199999809,0,8.100000381,-,0,0,0,=,,,,10081621,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@H]([C@]2(OC(=C(C)C2)[C@@H](C(=O)[C@]1(C)OC)C)C)O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C(C)C)C
motilin receptor,297,,,,,,,,Rabbit,mitemcinal,3511,,,178100497,Agonist,Full agonist,,f,f,,pEC50,7.800000191,0,7.5,-,0,0,0,=,,,,17183187,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@H]([C@]2(OC(=C(C)C2)[C@@H](C(=O)[C@]1(C)OC)C)C)O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C(C)C)C
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin,1457,MLN,Dog,135652293,Agonist,Full agonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin,1459,MLN,Rabbit,135652294,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin,1458,MLN|MLN,Human|Pig,135651809,Agonist,Full agonist,,t,,,pKi,8.7,0,8.4,-,0,0,0,=,,,,15677347,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CCC(=O)N)CCCCN)CC(=O)N)CCCNC(=N)N)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1ccccc1)Cc1ccc(cc1)O)CCC(=O)O)CC(C)C)CCC(=O)N)CCCNC(=N)N)CCSC)CCC(=O)N)CCC(=O)O
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin-(1-11) (human),1460,,,135652295,Agonist,Full agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin-(1-12) (human),1461,,,135652296,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin-(1-13) (human),1462,,,135652297,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin-(1-19) (human),1463,,,135652298,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,motilin-(2-22) (human),1464,,,135652299,Agonist,Full agonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,"[nLeu<sup>13</sup>,Glu<sup>14</sup>]motilin (human)",1455,,,135652328,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,"[Phe<sup>3</sup>,Leu<sup>13</sup>]motilin (human)",1454,,,135652397,Agonist,Full agonist,,f,,,pIC50,0,8.9,0,,0,0,0,,,,,10381885,
motilin receptor,297,MLNR,O43193,,,,,,Human,roxithromycin,1465,,,135652712,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,10381885,COCCOCO/N=C/1[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@H](C)[C@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C(=O)O[C@@H]([C@@]([C@@H]([C@H]1C)O)(C)O)CC)C
motilin receptor,297,MLNR,O43193,,,,,,Human,"[<small>D</small>-Bpa<sup>5</sup>,Ile<sup>13</sup>]motilin (human)",1450,,,135652467,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,15677347,
motilin receptor,297,MLNR,O43193,,,,,,Human,"[<small>L</small>-Bpa<sup>5</sup>,Ile<sup>13</sup>]motilin (human)",1451,,,135652470,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,15677347,
motilin receptor,297,,,,,,,,Rabbit,GM-109,1466,,,135652173,Antagonist,Antagonist,,f,f,,pA2,7.5,0,7.199999809,-,0,0,0,=,,,,10081621,O=C1NCCCC[C@H](NC(=O)[C@H](Cc2ccccc2)N)C(=O)N[C@H](C(=O)NCC1)Cc1ccc(c(c1)C(C)(C)C)O
motilin receptor,297,,,,,,,,Rabbit,GM-109,1466,,,135652173,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,-,0,0,0,=,,,,11806718,O=C1NCCCC[C@H](NC(=O)[C@H](Cc2ccccc2)N)C(=O)N[C@H](C(=O)NCC1)Cc1ccc(c(c1)C(C)(C)C)O
motilin receptor,297,MLNR,O43193,,,,,,Human,MA-2029,4036,,,178100861,Antagonist,Antagonist,,f,,,pA2,0,9.2,0,-,0,0,0,=,,,,18164286,CCNC(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@H](Cc1ccc(cc1)F)NC)C)C(C)C)Cc1ccc(c(c1)C(C)(C)C)O.Cl
motilin receptor,297,MLNR,O43193,,,,,,Human,OHM-11526,1467,,,135652360,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,9277420,
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,methacholine,7438,,,178104010,Agonist,Agonist,,f,f,,pEC50,0,6.400000095,0,EC50,0,400,0,=,,,,9622546,CC(C[N+](C)(C)C)OC(=O)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,furtrethonium,299,,,135650293,Agonist,Full agonist,,f,,,pKi,0,4.1,0,,0,0,0,,,,,9224827,C[N+](Cc1ccco1)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,methylfurmethide,300,,,135650592,Agonist,Full agonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,9224827,Cc1ccc(o1)C[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,NNC 11-1314,291,,,135650726,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,NNC 11-1585,292,,,135650727,Agonist,Full agonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccc(cc1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,NNC 11-1607,293,,,135650728,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1cccc(c1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,oxotremorine-M,303,,,135650783,Agonist,Full agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,oxotremorine-M,303,,,135650783,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,2537406,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,pentylthio-TZTP,304,,,135650807,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9224827,CCCCCSc1nsnc1C1=CCCN(C1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,LY593093,5441,,,178102092,Agonist,Partial agonist,,f,f,,pKi,0,6.210000038,0,-,0,0,0,=,,,,21558436,O[C@@H]1Cc2c([C@H]1NC(=O)c1ccc(cc1)c1ccccc1)cc(cc2)N=C(N(Cc1ccc(cc1)F)C)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,2537406,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,5.2,0,4.8,,0,0,0,,,,,7620715,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,milameline,301,,,135650609,Agonist,Partial agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,10323594,CO/N=C/C1=CCCN(C1)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,oxotremorine,302,,,135650782,Agonist,Partial agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,2537406,O=C1CCCN1CC#CCN1CCCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,oxotremorine,302,,,135650782,Agonist,Partial agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CCN1CCCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,f,,pKi,0,5.099999905,0,-,0,0,0,=,,,,9224827,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,2537406,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,(&plusmn;)YM796,285,,,135650840,Agonist,Partial agonist,,f,,,pKi,4.7,0,4.1,,0,0,0,,,,,1310135,CN1CCC2(CC1)CC(=C)C(O2)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,sabcomeline,306,,,135650975,Agonist,Partial agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,10323594,CO/N=C(/[C@H]1CN2CCC1CC2)C#N
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,G&ouml; 7874,335,,,135650308,Allosteric modulator,Negative,,f,,,pKd,0,5.8,0,,0,0,0,,,,,10860942,COc1ccc2c(c1)c1c3c(=O)[nH]c(=O)c3c3c(c1n2CC(CN(C)C)O)n(C)c1c3cccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Negative,,f,,,pKd,0,4.4,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,muscarinic toxin 7,314,,,135652307,Allosteric modulator,Negative,,f,f,,pKi,11.10000038,0,11,-,0,0,0,=,,,,10799315,
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Negative,,f,,,pKd,0,4.1,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Negative,,f,,,pKd,0,4.9,0,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Neutral,,f,,,pKd,5,0,4.9,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,<i>N</i>-desmethylclozapine,333,,,135650395,Allosteric modulator,Positive,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,16959945,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,<i>N</i>-desmethylclozapine,333,,,135650395,Allosteric modulator,Positive,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,14595031,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,K-252a,336,,,135652695,Allosteric modulator,Positive,,f,,,pKd,0,5.1,0,,0,0,0,,,,,10860942,COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,KT 5720,337,,,135652698,Allosteric modulator,Positive,,f,f,,pKd,0,6.400000095,0,Kd,0,398,0,=,,,,10860942,CCCCCCOC(=O)[C@@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,KT 5823,338,,,135652699,Allosteric modulator,Positive,,f,,,pKd,0,5.7,0,,0,0,0,,,,,10860942,COC(=O)[C@@]1(OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CN(C1=O)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,ML169,5437,,,178102089,Allosteric modulator,Positive,,f,f,,pEC50,0,5.900000095,0,EC50,0,1380,0,=,,,,23173069,Brc1ccc(c(c1)Cn1cc(c2c1cccc2)S(=O)(=O)CC(=O)Nc1noc(c1)C)F
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,PF-06767832,9228,,,315661303,Allosteric modulator,Positive,,f,t,,pEC50,0,7.21999979,0,EC50,0,60,0,=,FLIPR calcium mobilisation assay,,,27275946,O[C@H]1COCC[C@@H]1NC(=O)c1ncc(c(c1)Cc1ccc(cc1)c1cscn1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,staurosporine,346,,,135652717,Allosteric modulator,Positive,,f,,,pKd,0,5.9,0,,0,0,0,,,,,10860942,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,Cy3B-telenzepine,8598,,,252166799,Antagonist,Antagonist,,f,f,,pKd,0,10.5,0,-,0,0,0,=,,,,20133736,O=C(Cc1ccc2c(c1)C(C)(C)C1=C3C=C4C(OC3CCN21)CC[N+]1=C4C(C)(C)c2c1ccc(c2)S([O-])([O-])[O-])NCCCCCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2[nH]c(=O)c2c1c(C)sc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,darifenacin,321,,,135650160,Antagonist,Antagonist,,f,f,,pKi,8.300000191,0,7.5,-,0,0,0,=,,,,11303071,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,dicyclomine,355,,,135650178,Antagonist,Antagonist,,f,t,,pKi,0,9.079999924,0,Ki,0,0.829999983,0,=,,,,0,CCN(CCOC(=O)C1(CCCCC1)C1CCCCC1)CC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,8100134,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,ethopropazine,7181,,,178103756,Antagonist,Antagonist,,f,f,,pKi,0,8.510000229,0,Ki,0,3.099999905,0,=,Displacement of [<sup<3</sup>H]QNB binding in rat forebrain brain homogenate.,,,2904117,CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,glycopyrrolate,7459,,,187051762,Antagonist,Antagonist,,f,t,,pIC50,0,9.899999619,0,IC50,0,0.126000002,0,=,Assay uses glycopyrronium bromide,,,21036043,O=C(C(c1ccccc1)(C1CCCC1)O)OC1CC[N+](C1)(C)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,guanylpirenzepine,3276,,,178100317,Antagonist,Antagonist,,f,,,pKi,7.6,0,7.3,-,0,0,0,=,,,,8813552,NC(=N)N1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,hexahydrodifenidol,322,,,135650347,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,2704370,OC(c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.4,,0,0,0,,,,,1325587,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8759038,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,hexocyclium,323,,,135650349,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)CC(c1ccccc1)(C1CCCCC1)O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,himbacine,324,,,135650350,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,6.699999809,-,0,0,0,=,,,,7925952,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.1,,0,0,0,,,,,12049493,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,ipratropium,325,,,135650410,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,11303071,OCC(c1ccccc1)C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,f,,pKi,7.300000191,0,6.599999905,-,0,0,0,=,,,,8759038,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,2704370,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,ML381,8591,,,252166792,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,24692176,CN(C(=O)c1noc(c1)COc1cccc(c1)C(=O)C)[C@H](c1ccccn1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,muscarinic toxin 1,311,,,135652304,Antagonist,Antagonist,,f,,,pKi,7.6,0,7.3,,0,0,0,,,,,12512959,
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,muscarinic toxin 2,312,,,135652305,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12512959,
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,muscarinic toxin 3,313,,,135652306,Antagonist,Antagonist,,f,f,,pKi,0,7.099999905,0,-,0,0,0,=,,,,7925952,
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,N-methyl scopolamine,316,,,135650725,Antagonist,Antagonist,,f,t,,pKi,0,9.899999619,0,-,0,0,0,=,,,,16439611,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,f,,pKd,0,6.199999809,0,-,0,0,0,=,,,,8759038,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,,,pKi,6.3,0,5.9,,0,0,0,,,,,1325587,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,16220976,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,t,,pKi,0,8.600000381,0,Ki,0,2.400000095,0,=,,,,22243489,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,t,,pKi,8.300000191,0,7.800000191,-,0,0,0,=,,,,12049493,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.8,,0,0,0,,,,,1325587,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,propantheline,329,,,135650857,Antagonist,Antagonist,,f,t,,pKi,0,9.699999809,0,-,0,0,0,=,,,,12049493,O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,scopolamine,330,,,135651031,Antagonist,Antagonist,,f,t,,pKi,0,9,0,-,0,0,0,=,,,,12049493,OC[C@H](c1ccccc1)C(=O)O[C@@H]1C[C@H]2N([C@@H](C1)[C@H]1[C@@H]2O1)C
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,silahexocyclium,331,,,135651044,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)C[Si](c1ccccc1)(C1CCCCC1)O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pIC50,0,7.199999809,0,IC50,0,63.5,0,=,,,,21524581,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,16220976,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,0,7.599999905,0,-,0,0,0,=,,,,12122494,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,methacholine,7438,,,178104010,Agonist,Agonist,,f,f,,pKi,0,7.230000019,0,Ki,0,59,0,=,,,,9622546,CC(C[N+](C)(C)C)OC(=O)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,furtrethonium,299,,,135650293,Agonist,Full agonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,9224827,C[N+](Cc1ccco1)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,iperoxo,6937,,,178103519,Agonist,Full agonist,,f,f,,pEC50,0,9.800000191,0,-,0,0,0,=,,,,23062057,C[N+](CC#CCOC1=NOCC1)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,methylfurmethide,300,,,135650592,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,9224827,Cc1ccc(o1)C[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,NNC 11-1314,291,,,135650726,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,NNC 11-1585,292,,,135650727,Agonist,Full agonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccc(cc1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,NNC 11-1607,293,,,135650728,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1cccc(c1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,oxotremorine,302,,,135650782,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9454790,O=C1CCCN1CC#CCN1CCCC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,oxotremorine,302,,,135650782,Agonist,Full agonist,,f,,,pKi,6.6,0,5,,0,0,0,,,,,9224827,O=C1CCCN1CC#CCN1CCCC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,oxotremorine-M,303,,,135650783,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,pentylthio-TZTP,304,,,135650807,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9224827,CCCCCSc1nsnc1C1=CCCN(C1)C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,6,0,4.7,,0,0,0,,,,,7680092,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,9224827,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,C<sub>7</sub>/3-phth,7634,,,223365969,Allosteric modulator,Negative,,f,f,,pKd,0,7.099999905,0,-,0,0,0,=,,,,9890565,O=C1N(CCC[N+](CCCCCCC[N+](CCCN2C(=O)c3c(C2=O)cccc3)(C)C)(C)C)C(=O)c2c1cccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,gallamine,356,,,135650296,Allosteric modulator,Negative,,f,f,,pKi,7.599999905,0,5.800000191,-,0,0,0,=,,,,9454790,CC[N+](CCOc1c(OCC[N+](CC)(CC)CC)cccc1OCC[N+](CC)(CC)CC)(CC)CC
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,gallamine,356,,,135650296,Allosteric modulator,Negative,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9454790,CC[N+](CCOc1c(OCC[N+](CC)(CC)CC)cccc1OCC[N+](CC)(CC)CC)(CC)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,gallamine,356,,,135650296,Allosteric modulator,Negative,,f,f,,pKd,6.300000191,0,5.900000095,-,0,0,0,=,,,,7651370,CC[N+](CCOc1c(OCC[N+](CC)(CC)CC)cccc1OCC[N+](CC)(CC)CC)(CC)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,G&ouml; 7874,335,,,135650308,Allosteric modulator,Negative,,f,,,pKd,0,5,0,,0,0,0,,,,,10860942,COc1ccc2c(c1)c1c3c(=O)[nH]c(=O)c3c3c(c1n2CC(CN(C)C)O)n(C)c1c3cccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Negative,,f,,,pKd,0,4.8,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Negative,,f,,,pKd,0,4.6,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,dimethyl-W84,365,,,135650189,Allosteric modulator,Positive,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12815174,Cc1cccc2c1C(=O)N(C2=O)CCC[N+](CCCCCC[N+](CCCN1C(=O)c2c(C1=O)c(C)ccc2)(C)C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,Duo3,7635,,,223365970,Allosteric modulator,Positive,,f,f,,pEC50,0,7.050000191,0,-,0,0,0,=,,,,16157694,Clc1cccc(c1CO/N=C/c1cc[n+](cc1)CCC[n+]1ccc(cc1)/C=N/OCc1c(Cl)cccc1Cl)Cl
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Positive,,f,,,pKd,0,4.8,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,KT 5823,338,,,135652699,Allosteric modulator,Positive,,f,,,pKd,0,5.7,0,,0,0,0,,,,,10860942,COC(=O)[C@@]1(OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CN(C1=O)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,LY2033298,3262,,,178100305,Allosteric modulator,Positive,,f,f,,pKd,0,4.400000095,0,-,0,0,0,=,,,,21989256,COc1nc2sc(c(c2c(c1Cl)C)N)C(=O)NC1CC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,LY2119620,6938,,,178103520,Allosteric modulator,Positive,,f,f,,pKd,0,5.699999809,0,-,0,0,0,=,,,,24256733,CN1CCN(CC1)C(=O)COc1nc2sc(c(c2c(c1Cl)C)N)C(=O)NC1CC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Positive,,f,,,pKd,0,4.6,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,staurosporine,346,,,135652717,Allosteric modulator,Positive,,f,,,pKd,0,5.1,0,,0,0,0,,,,,10860942,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Positive,,f,,,pKd,5,0,4.9,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,Cy3B-telenzepine,8598,,,252166799,Antagonist,Antagonist,,f,f,,pKi,0,10.39999962,0,-,0,0,0,=,,,,23357106,O=C(Cc1ccc2c(c1)C(C)(C)C1=C3C=C4C(OC3CCN21)CC[N+]1=C4C(C)(C)c2c1ccc(c2)S([O-])([O-])[O-])NCCCCCCCCCCN1CCN(CC1)CC(=O)n1c2ccccc2[nH]c(=O)c2c1c(C)sc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,dexetimide,354,,,135650172,Antagonist,Antagonist,,f,t,,pKi,0,8.899999619,0,-,0,0,0,=,,,,9454790,O=C1CC[C@](C(=O)N1)(C1CCN(CC1)Cc1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,dexetimide,354,,,135650172,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9454790,O=C1CC[C@](C(=O)N1)(C1CCN(CC1)Cc1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,dicyclomine,355,,,135650178,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,2704370,CCN(CCOC(=O)C1(CCCCC1)C1CCCCC1)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,6.960000038,0,Ki,0,109,0,=,,,,8100134,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,ethopropazine,7181,,,178103756,Antagonist,Antagonist,,f,f,,pKi,0,8.140000343,0,Ki,0,7.199999809,0,=,Displacement of [<sup<3</sup>H]QNB binding in rat hindbrain brain homogenate.,,,2904117,CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,guanylpirenzepine,3276,,,178100317,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,-,0,0,0,=,,,,8813552,NC(=N)N1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,hexahydrodifenidol,322,,,135650347,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,2704370,OC(c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.6,,0,0,0,,,,,8759038,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.7,,0,0,0,,,,,1325587,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,hexocyclium,323,,,135650349,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)CC(c1ccccc1)(C1CCCCC1)O
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,himbacine,324,,,135650350,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,7.900000095,-,0,0,0,=,,,,7925952,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,himbacine,324,,,135650350,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9454790,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,imipramine,357,,,135650384,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9454790,CN(CCCN1c2ccccc2CCc2c1cccc2)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.1,,0,0,0,,,,,12049493,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,ipratropium,325,,,135650410,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,11303071,OCC(c1ccccc1)C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,levetimide,358,,,135650514,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,9454790,O=C1CC[C@@](C(=O)N1)(C1CCN(CC1)Cc1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,levetimide,358,,,135650514,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,9454790,O=C1CC[C@@](C(=O)N1)(C1CCN(CC1)Cc1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9454790,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,7.300000191,-,0,0,0,=,,,,8759038,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,ML381,8591,,,252166792,Antagonist,Antagonist,,f,f,,pKi,0,4.519999981,0,Ki,0,30000,0,>,,,,24692176,CN(C(=O)c1noc(c1)COc1cccc(c1)C(=O)C)[C@H](c1ccccn1)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,muscarinic toxin 3,313,,,135652306,Antagonist,Antagonist,,f,f,,pA2,0,6.300000191,0,-,0,0,0,<,,,,9862767,
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,muscarinic toxin 3,313,,,135652306,Antagonist,Antagonist,,f,,,pKi,0,6,0,-,0,0,0,>,,,,7925952,
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,muscarinic toxin 7,314,,,135652307,Antagonist,Antagonist,,f,f,,pKi,0,5,0,-,0,0,0,>,,,,10799315,
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,,,pKi,7.3,0,4.6,,0,0,0,,,,,2846274,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,f,,pKi,7.199999809,0,6.699999809,-,0,0,0,=,,,,2704370,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,f,,pKi,8.100000381,0,7.699999809,-,0,0,0,=,,,,12122494,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,f,,pKi,6.699999809,0,6,-,0,0,0,=,,,,12049493,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,,,pKi,7.4,0,5.3,,0,0,0,,,,,2846274,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,propantheline,329,,,135650857,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,-,0,0,0,=,,,,12049493,O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,SCH 57790,350,,,135651029,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,10069520,COc1ccc(cc1)S(=O)c1ccc(cc1)C(N1CCN(CC1)C1CCCCC1)C#N
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,scopolamine,330,,,135651031,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,12049493,OC[C@H](c1ccccc1)C(=O)O[C@@H]1C[C@H]2N([C@@H](C1)[C@H]1[C@@H]2O1)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,silahexocyclium,331,,,135651044,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)C[Si](c1ccccc1)(C1CCCCC1)O
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,6.900000095,-,0,0,0,=,,,,12122494,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,t,,pIC50,0,6.239999771,0,IC50,0,573,0,=,,,,21524581,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,glycopyrrolate,7459,,,187051762,Antagonist,Full agonist,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.500999987,0,=,Assay uses glycopyrronium bromide,,,21036043,O=C(C(c1ccccc1)(C1CCCC1)O)OC1CC[N+](C1)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,darifenacin,321,,,135650160,Antagonist,Inverse agonist,,f,f,,pKi,7.599999905,0,7,-,0,0,0,=,,,,11303071,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Inverse agonist,,f,f,,pKi,0,7.929999828,0,Ki,0,11.75,0,=,,,,22243489,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,methacholine,7438,,,178104010,Agonist,Agonist,,f,f,,pEC50,0,6.920000076,0,EC50,0,120,0,=,,,,9622546,CC(C[N+](C)(C)C)OC(=O)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,furtrethonium,299,,,135650293,Agonist,Full agonist,,f,,,pKi,0,4.1,0,,0,0,0,,,,,9224827,C[N+](Cc1ccco1)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,methylfurmethide,300,,,135650592,Agonist,Full agonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,9224827,Cc1ccc(o1)C[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,NNC 11-1314,291,,,135650726,Agonist,Full agonist,,f,,,pKi,7.7,0,7.1,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,NNC 11-1585,292,,,135650727,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccc(cc1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,NNC 11-1607,293,,,135650728,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1cccc(c1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,oxotremorine,302,,,135650782,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CCN1CCCC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,oxotremorine-M,303,,,135650783,Agonist,Full agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,pentylthio-TZTP,304,,,135650807,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9224827,CCCCCSc1nsnc1C1=CCCN(C1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,5.3,0,5,,0,0,0,,,,,7620715,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,milameline,301,,,135650609,Agonist,Partial agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,10323594,CO/N=C/C1=CCCN(C1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,t,,pKi,0,5.099999905,0,-,0,0,0,=,,,,9224827,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,sabcomeline,306,,,135650975,Agonist,Partial agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,10323594,CO/N=C(/[C@H]1CN2CCC1CC2)C#N
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,G&ouml; 7874,335,,,135650308,Allosteric modulator,Negative,,f,,,pKd,0,5.1,0,,0,0,0,,,,,10860942,COc1ccc2c(c1)c1c3c(=O)[nH]c(=O)c3c3c(c1n2CC(CN(C)C)O)n(C)c1c3cccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Negative,,f,,,pKd,0,3.8,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Negative,,f,,,pKd,5.7,0,4.2,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Positive,,f,,,pKd,0,3.8,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Positive,,f,f,,pKd,0,3.299999952,0,Kd,0,501187,0,=,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,darifenacin,321,,,135650160,Antagonist,Antagonist,,f,t,,pKi,9.100000381,0,8.600000381,-,0,0,0,=,,,,11303071,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,dicyclomine,355,,,135650178,Antagonist,Antagonist,,f,t,,pKi,0,9.029999733,0,Ki,0,0.930000007,0,=,,,,0,CCN(CCOC(=O)C1(CCCCC1)C1CCCCC1)CC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,7.420000076,0,Ki,0,38,0,=,,,,8100134,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,glycopyrrolate,7459,,,187051762,Antagonist,Antagonist,,f,t,,pIC50,0,9.600000381,0,IC50,0,0.250999987,0,=,Assay uses glycopyrronium bromide,,,21036043,O=C(C(c1ccccc1)(C1CCCC1)O)OC1CC[N+](C1)(C)C
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,guanylpirenzepine,3276,,,178100317,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,-,0,0,0,=,,,,8813552,NC(=N)N1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,hexahydrodifenidol,322,,,135650347,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,2704370,OC(c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,8,0,7.7,,0,0,0,,,,,8759038,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,hexocyclium,323,,,135650349,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)CC(c1ccccc1)(C1CCCCC1)O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,himbacine,324,,,135650350,Antagonist,Antagonist,,f,f,,pKi,7.199999809,0,6.900000095,-,0,0,0,=,,,,7925952,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.3,,0,0,0,,,,,12049493,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,1325587,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,ipratropium,325,,,135650410,Antagonist,Antagonist,,f,t,,pKi,9.800000191,0,9.300000191,-,0,0,0,=,,,,11303071,OCC(c1ccccc1)C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,f,,pKi,6.900000095,0,6.099999905,-,0,0,0,=,,,,8759038,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,ML381,8591,,,252166792,Antagonist,Antagonist,,f,f,,pKi,0,4.519999981,0,Ki,0,30000,0,>,,,,24692176,CN(C(=O)c1noc(c1)COc1cccc(c1)C(=O)C)[C@H](c1ccccn1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,muscarinic toxin 3,313,,,135652306,Antagonist,Antagonist,,f,,,pKi,0,6,0,-,0,0,0,>,,,,7925952,
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,muscarinic toxin 7,314,,,135652307,Antagonist,Antagonist,,f,f,,pKi,0,5,0,-,0,0,0,>,,,,10799315,
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,N-methyl scopolamine,316,,,135650725,Antagonist,Antagonist,,f,t,,pKi,0,10.39999962,0,-,0,0,0,=,,,,16847442,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,1325587,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,f,,pKi,0,6.099999905,0,-,0,0,0,=,,,,2704370,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,t,,pKi,8.899999619,0,8.800000191,-,0,0,0,=,,,,22243489,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,f,,pKi,6.800000191,0,6.5,-,0,0,0,=,,,,12049493,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,1325587,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,propantheline,329,,,135650857,Antagonist,Antagonist,,f,t,,pKi,0,10,0,-,0,0,0,=,,,,12049493,O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,scopolamine,330,,,135651031,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,12049493,OC[C@H](c1ccccc1)C(=O)O[C@@H]1C[C@H]2N([C@@H](C1)[C@H]1[C@@H]2O1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,silahexocyclium,331,,,135651044,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)C[Si](c1ccccc1)(C1CCCCC1)O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,t,,pIC50,0,6.880000114,0,IC50,0,130.8000031,0,=,,,,21524581,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,8,0,7.699999809,-,0,0,0,=,,,,12122494,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,methacholine,7438,,,178104010,Agonist,Agonist,,f,f,,pKi,0,5.800000191,0,Ki,0,1600,0,=,,,,9622546,CC(C[N+](C)(C)C)OC(=O)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,furtrethonium,299,,,135650293,Agonist,Full agonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,9224827,C[N+](Cc1ccco1)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,methylfurmethide,300,,,135650592,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,9224827,Cc1ccc(o1)C[N+](C)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,NNC 11-1314,291,,,135650726,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,NNC 11-1585,292,,,135650727,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccc(cc1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,NNC 11-1607,293,,,135650728,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1cccc(c1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,oxotremorine,302,,,135650782,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CCN1CCCC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,oxotremorine-M,303,,,135650783,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9224827,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,pentylthio-TZTP,304,,,135650807,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9224827,CCCCCSc1nsnc1C1=CCCN(C1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,6.7,0,5.6,,0,0,0,,,,,7680092,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,milameline,301,,,135650609,Agonist,Partial agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,10323594,CO/N=C/C1=CCCN(C1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,f,,pKi,0,5.199999809,0,-,0,0,0,=,,,,9224827,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,sabcomeline,306,,,135650975,Agonist,Partial agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10323594,CO/N=C(/[C@H]1CN2CCC1CC2)C#N
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Negative,,f,,,pKd,0,4.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,muscarinic toxin 3,313,,,135652306,Allosteric modulator,Negative,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,7925952,
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,G&ouml; 7874,335,,,135650308,Allosteric modulator,Neutral,,f,,,pKd,0,5.7,0,,0,0,0,,,,,10860942,COc1ccc2c(c1)c1c3c(=O)[nH]c(=O)c3c3c(c1n2CC(CN(C)C)O)n(C)c1c3cccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Neutral,,f,,,pKd,0,4.5,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,KT 5720,337,,,135652698,Allosteric modulator,Neutral,,f,,,pKd,0,6.4,0,,0,0,0,,,,,10860942,CCCCCCOC(=O)[C@@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Neutral,,f,,,pKd,0,4.4,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,staurosporine,346,,,135652717,Allosteric modulator,Neutral,,f,,,pKd,0,5.3,0,,0,0,0,,,,,10860942,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,LY2033298,3262,,,178100305,Allosteric modulator,Positive,,f,,,-,0,0,0,-,0,0,0,=,,,,18678919,COc1nc2sc(c(c2c(c1Cl)C)N)C(=O)NC1CC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,LY2119620,6938,,,178103520,Allosteric modulator,Positive,,f,f,,pKd,0,5.699999809,0,-,0,0,0,=,,,,24807965,CN1CCN(CC1)C(=O)COc1nc2sc(c(c2c(c1Cl)C)N)C(=O)NC1CC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Positive,,f,,,pKd,5,0,4.8,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,darifenacin,321,,,135650160,Antagonist,Antagonist,,f,f,,pKi,8.100000381,0,7.300000191,-,0,0,0,=,,,,11303071,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,7.210000038,0,Ki,0,61,0,=,,,,8100134,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,glycopyrrolate,7459,,,187051762,Antagonist,Antagonist,,f,t,,pIC50,0,9.800000191,0,IC50,0,0.158000007,0,=,Assay uses glycopyrronium bromide,,,21036043,O=C(C(c1ccccc1)(C1CCCC1)O)OC1CC[N+](C1)(C)C
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,guanylpirenzepine,3276,,,178100317,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,-,0,0,0,=,,,,8813552,NC(=N)N1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,hexahydrodifenidol,322,,,135650347,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,2704370,OC(c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,1325587,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,7.7,0,6.5,,0,0,0,,,,,8759038,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,hexocyclium,323,,,135650349,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)CC(c1ccccc1)(C1CCCCC1)O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,himbacine,324,,,135650350,Antagonist,Antagonist,,f,f,,pKi,8.199999809,0,7.900000095,-,0,0,0,=,,,,7925952,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.1,,0,0,0,,,,,12049493,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,ipratropium,325,,,135650410,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11303071,OCC(c1ccccc1)C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,f,,pKi,7.5,0,6.599999905,-,0,0,0,=,,,,8759038,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,ML381,8591,,,252166792,Antagonist,Antagonist,,f,f,,pKi,0,4.519999981,0,Ki,0,30000,0,<,,,,24692176,CN(C(=O)c1noc(c1)COc1cccc(c1)C(=O)C)[C@H](c1ccccn1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,muscarinic toxin 1,311,,,135652304,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12512959,
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,muscarinic toxin 2,312,,,135652305,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,12512959,
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,muscarinic toxin 7,314,,,135652307,Antagonist,Antagonist,,f,f,,pKi,0,5,0,-,0,0,0,>,,,,10799315,
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,1325587,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,f,,pKd,0,7,0,-,0,0,0,=,,,,8759038,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,20590605,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,1325587,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,f,,pKi,7.599999905,0,7,-,0,0,0,=,,,,12049493,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,propantheline,329,,,135650857,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,12049493,O=C(C1c2ccccc2Oc2c1cccc2)OCC[N+](C(C)C)(C(C)C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,scopolamine,330,,,135651031,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12049493,OC[C@H](c1ccccc1)C(=O)O[C@@H]1C[C@H]2N([C@@H](C1)[C@H]1[C@@H]2O1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,silahexocyclium,331,,,135651044,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)C[Si](c1ccccc1)(C1CCCCC1)O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,0,6.800000191,0,-,0,0,0,=,,,,20590605,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,NNC 11-1314,291,,,135650726,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccccc1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,NNC 11-1585,292,,,135650727,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1ccc(cc1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,NNC 11-1607,293,,,135650728,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,11504829,C1CN2CCC1C(C2)c1nsnc1OCC#Cc1cccc(c1)C#CCOc1nsnc1C1CN2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,McN-A-343,290,,,135650571,Agonist,Partial agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,7620715,O=C(Nc1cccc(c1)Cl)OCC#CC[N+](C)(C)C.[Cl-]
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,milameline,301,,,135650609,Agonist,Partial agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,10323594,CO/N=C/C1=CCCN(C1)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,pilocarpine,305,,,135650824,Agonist,Partial agonist,,f,f,,pKi,0,5,0,-,0,0,0,=,,,,16002459,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,sabcomeline,306,,,135650975,Agonist,Partial agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10323594,CO/N=C(/[C@H]1CN2CCC1CC2)C#N
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Negative,,f,,,pKd,0,3.7,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,ML375,7631,,,223365966,Allosteric modulator,Negative,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,24164599,Clc1ccc(cc1)[C@]12N(CCN1C(=O)c1c2cccc1)C(=O)c1ccc(c(c1)F)F
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,N-chloromethyl-brucine,344,,,135652706,Allosteric modulator,Negative,,f,,,pKd,0,4.4,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)CCl
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,strychnine,347,,,135652718,Allosteric modulator,Negative,,f,,,pKd,0,3.6,0,,0,0,0,,,,,7651370,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,<i>N</i>-benzyl brucine,332,,,135652694,Allosteric modulator,Neutral,,f,,,pKd,0,3.7,0,,0,0,0,,,,,9495826,COc1cc2c(cc1OC)N1[C@@H]3[C@@]42CC[N+]2([C@H]4C[C@@H]4[C@H]3[C@H](CC1=O)OCC=C4C2)Cc1ccccc1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,ML380,8687,,,252166887,Allosteric modulator,Positive,,f,f,,pEC50,0,6.71999979,0,EC50,0,190,0,=,,,,25147929,CCN(C(=O)C1CCN(CC1)S(=O)(=O)c1ccc2c(c1)cn[nH]2)Cc1ccccc1C(F)(F)F
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,darifenacin,321,,,135650160,Antagonist,Antagonist,,f,f,,pKi,8.600000381,0,7.900000095,-,0,0,0,=,,,,11303071,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,dosulepin,7549,,,223365885,Antagonist,Antagonist,,f,f,,pKi,0,7.039999962,0,Ki,0,92,0,=,,,,8100134,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,glycopyrrolate,7459,,,187051762,Antagonist,Antagonist,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,21036043,O=C(C(c1ccccc1)(C1CCCC1)O)OC1CC[N+](C1)(C)C
M<sub>5</sub> receptor,17,,,,,,,,Unknown,guanylpirenzepine,3276,,,178100317,Antagonist,Antagonist,,f,f,,pKd,0,6.800000191,0,Kd,0,175,0,=,,,,7808421,NC(=N)N1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,hexahydrodifenidol,322,,,135650347,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,2704370,OC(c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>5</sub> receptor,17,Chrm5,P08911,,,,,,Rat,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,1325587,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,hexahydrosiladifenidol,310,,,135652751,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.8,,0,0,0,,,,,8759038,O[Si](c1ccccc1)(C1CCCCC1)CCCN1CCCCC1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,hexocyclium,323,,,135650349,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)CC(c1ccccc1)(C1CCCCC1)O
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,himbacine,324,,,135650350,Antagonist,Antagonist,,f,f,,pKi,6.5,0,5.400000095,-,0,0,0,=,,,,7925952,C[C@@H]1OC(=O)[C@@H]2[C@H]1[C@H](/C=C/[C@H]1CCC[C@@H](N1C)C)[C@H]1CCCC[C@@H]1C2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,<i>p</i>-F-HHSiD,308,,,135650408,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8759038,Fc1ccc(cc1)[Si](C1CCCCC1)(CCCN1CCCCC1)O
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,ipratropium,325,,,135650410,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,11303071,OCC(c1ccccc1)C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,lithocholylcholine,326,,,135650527,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,12235229,OC(C[N+](C)(C)C)CCCC(C1CCC2C1(C)CCC1C2CCC2C1(C)CCC(C2)O)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,methoctramine,327,,,135650585,Antagonist,Antagonist,,f,f,,pKi,7.199999809,0,6.300000191,-,0,0,0,=,,,,8759038,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,ML381,8591,,,252166792,Antagonist,Antagonist,,f,f,,pKi,0,6.300000191,0,-,0,0,0,=,,,,24692176,CN(C(=O)c1noc(c1)COc1cccc(c1)C(=O)C)[C@H](c1ccccn1)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,muscarinic toxin 3,313,,,135652306,Antagonist,Antagonist,,f,f,,pKi,0,6,0,-,0,0,0,>,,,,7925952,
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,muscarinic toxin 7,314,,,135652307,Antagonist,Antagonist,,f,f,,pKi,0,5,0,-,0,0,0,>,,,,10799315,
M<sub>5</sub> receptor,17,Chrm5,P08911,,,,,,Rat,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,1325587,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,otenzepad,309,,,135649900,Antagonist,Antagonist,,f,f,,pKi,0,5.599999905,0,-,0,0,0,=,,,,2704370,CCN(CC1CCCCN1CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CC
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,oxybutynin,359,,,135650784,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,20590605,CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC
M<sub>5</sub> receptor,17,Chrm5,P08911,,,,,,Rat,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,1325587,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,pirenzepine,328,,,135650832,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,6.800000191,-,0,0,0,=,,,,7925952,CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,silahexocyclium,331,,,135651044,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,2704370,C[N+]1(C)CCN(CC1)C[Si](c1ccccc1)(C1CCCCC1)O
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,solifenacin,7483,,,187051786,Antagonist,Antagonist,,f,f,,pKi,0,7.199999809,0,-,0,0,0,=,,,,20590605,O=C(N1CCc2c([C@@H]1c1ccccc1)cccc2)O[C@H]1CN2CCC1CC2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,difluoroagomelatine,7776,,,223366109,Agonist,Full agonist,,f,f,,pKi,0,10.5,0,Ki,0,0.029999999,0,=,,,,22301214,COc1ccc2c(c1)c(CCNC(=O)C(F)F)ccc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,EFPPEA,7774,,,223366107,Agonist,Full agonist,,f,f,,pKi,0,10.19999981,0,Ki,0,0.061999999,0,=,,,,21568291,CCc1nn2c(c1CCNC(=O)C)c1CCOc1cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,GR 196429,1349,,,135650316,Agonist,Full agonist,,f,,,pKi,9.9,0,9.4,,0,0,0,,,,,10696085,CC(=O)NCCN1CCc2c1c1CCOc1cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,IIK7,1350,,,135650375,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,10737738,CCCC(=O)NCCc1c2c3ccccc3Cn2c2c1cc(OC)cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,LY 156735,1351,,,135650542,Agonist,Full agonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,15302228,COc1cc2c(cc1Cl)[nH]cc2[C@H](CNC(=O)C)C
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,melatonin,224,,,135651518,Agonist,Full agonist,,t,t,,pKi,9.699999809,0,9.100000381,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,ramelteon,1356,,,135651228,Agonist,Full agonist,,f,t,,pKi,0,10.89999962,0,-,0,0,0,=,,,,15695169,CCC(=O)NCC[C@@H]1CCc2c1c1CCOc1cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S24773,1354,,,135650967,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)cc(c2)c1cccc(c1)N
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,GR 128107,1348,,,135650313,Agonist,Partial agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9089668,COc1ccc2c(c1)c(c[nH]2)C1CCCN(C1)C(=O)C
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S24014,1353,,,135650966,Agonist,Partial agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12764576,COc1cccc(c1)Cc1oc2c(c1CCNC(=O)C)cc(cc2)OC
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S26284,1355,,,135650969,Agonist,Partial agonist,,f,,,pKi,9.2,0,8.5,,0,0,0,,,,,12764576,CC(=O)NCCc1cccc2c1cc(OCCCCOc1ccc3c(c1)c(CCNC(=O)C)ccc3)cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,K185,1359,,,135650451,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,10737738,CCCC(=O)NCCc1c2c3ccccc3CCCn2c2c1cc(OC)cc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,luzindole,1363,,,135650539,Antagonist,Antagonist,,f,f,,pKi,6.800000191,0,6.199999809,-,0,0,0,=,,,,10696085,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2c1cccc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S20928,1360,,,135650963,Antagonist,Antagonist,,f,,,pKi,6.9,0,6.4,,0,0,0,,,,,12764576,O=C(C1CCC1)NCCc1cccc2c1cccc2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S22153,1361,,,135650965,Antagonist,Antagonist,,f,,,pKi,8.1,0,7.8,,0,0,0,,,,,12764576,CCc1ccc2c(c1)c(CCNC(=O)C)cs2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,S26131,1362,,,135650968,Antagonist,Antagonist,,f,,,pKi,9.3,0,8.4,,0,0,0,,,,,12764576,CC(=O)NCCc1cccc2c1cc(OCCCOc1ccc3c(c1)c(CCNC(=O)C)ccc3)cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,EFPPEA,7774,,,223366107,Agonist,Full agonist,,f,f,,pKi,0,9.399999619,0,-,0,0,0,=,,,,21568291,CCc1nn2c(c1CCNC(=O)C)c1CCOc1cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,GR 196429,1349,,,135650316,Agonist,Full agonist,,f,,,pKi,9.8,0,9.7,,0,0,0,,,,,10696085,CC(=O)NCCN1CCc2c1c1CCOc1cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,IIK7,1350,,,135650375,Agonist,Full agonist,,f,f,,pKi,0,10.30000019,0,Ki,0,0.050000001,0,=,,,,10737738,CCCC(=O)NCCc1c2c3ccccc3Cn2c2c1cc(OC)cc2
MT<sub>2</sub> receptor,288,Mtnr1b,Q8CIQ6,,,,,,Mouse,IIK7,1350,,,135650375,Agonist,Full agonist,,f,f,,pKi,0,10.30000019,0,Ki,0,0.052000001,0,=,,,,24106342,CCCC(=O)NCCc1c2c3ccccc3Cn2c2c1cc(OC)cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,LY 156735,1351,,,135650542,Agonist,Full agonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,15302228,COc1cc2c(cc1Cl)[nH]cc2[C@H](CNC(=O)C)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,melatonin,224,,,135651518,Agonist,Full agonist,,t,t,,pKi,9.800000191,0,9.399999619,-,0,0,0,=,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,ramelteon,1356,,,135651228,Agonist,Full agonist,,f,t,,pKi,0,10,0,-,0,0,0,=,,,,15695169,CCC(=O)NCC[C@@H]1CCc2c1c1CCOc1cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,GR 128107,1348,,,135650313,Agonist,Partial agonist,,f,,,pKi,9.1,0,8.6,,0,0,0,,,,,9089668,COc1ccc2c(c1)c(c[nH]2)C1CCCN(C1)C(=O)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,isoamyl-agomelatine,7781,,,223366114,Agonist,Partial agonist,,f,f,,pKi,0,11,0,-,0,0,0,=,,,,22301214,COc1ccc2c(c1)c(CCNC(=O)C)cc(c2)CCC(C)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S22153,1361,,,135650965,Agonist,Partial agonist,,f,,,pKi,8.2,0,8.1,,0,0,0,,,,,12764576,CCc1ccc2c(c1)c(CCNC(=O)C)cs2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S24014,1353,,,135650966,Agonist,Partial agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,12764576,COc1cccc(c1)Cc1oc2c(c1CCNC(=O)C)cc(cc2)OC
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S24773,1354,,,135650967,Agonist,Partial agonist,,f,,,pKi,9.6,0,9.3,,0,0,0,,,,,12764576,COc1ccc2c(c1)c(CCNC(=O)C)cc(c2)c1cccc(c1)N
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S26284,1355,,,135650969,Agonist,Partial agonist,,f,,,pKi,7.2,0,6.8,,0,0,0,,,,,12764576,CC(=O)NCCc1cccc2c1cc(OCCCCOc1ccc3c(c1)c(CCNC(=O)C)ccc3)cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,DH97,3366,,,178100390,Antagonist,Antagonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,9840420,CCCCC(=O)NCCc1c(Cc2ccccc2)[nH]c2c1cccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,(hydroxymethylphenyl)agomelatine,7922,,,249565605,Antagonist,Antagonist,,f,f,,pKi,0,9.399999619,0,Ki,0,0.360000014,0,=,,,,18778943,COc1ccc2c(c1)c(CCNC(=O)C)cc(c2)c1cccc(c1)CO
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,K185,1359,,,135650451,Antagonist,Antagonist,,f,f,,pKi,0,9.289999962,0,Ki,0,0.50999999,0,=,,,,10737738,CCCC(=O)NCCc1c2c3ccccc3CCCn2c2c1cc(OC)cc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,luzindole,1363,,,135650539,Antagonist,Antagonist,,f,f,,pKi,8.100000381,0,7.599999905,-,0,0,0,=,,,,10696085,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2c1cccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S20928,1360,,,135650963,Antagonist,Antagonist,,f,,,pKi,7.2,0,7.1,,0,0,0,,,,,12764576,O=C(C1CCC1)NCCc1cccc2c1cccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,S26131,1362,,,135650968,Antagonist,Antagonist,,f,,,pKi,7,0,6.8,,0,0,0,,,,,12764576,CC(=O)NCCc1cccc2c1cc(OCCCOc1ccc3c(c1)c(CCNC(=O)C)ccc3)cc2
Multidrug and toxin extrusion,1216,SLC47A1,Q96FL8,,,,,,Human,pyrimethamine,4800,,,178101502,Inhibitor,Inhibition,,f,f,,pKi,0,7.099999905,0,Ki,0,77,0,=,,,,20065018,CCc1nc(N)nc(c1c1ccc(cc1)Cl)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,eluxadoline,7691,,,223366025,Agonist,Agonist,,f,f,,pKi,0,8.770000458,0,Ki,0,1.700000048,0,=,,,,22695132,COc1ccc(cc1C(=O)O)CN([C@H](c1ncc([nH]1)c1ccccc1)C)C(=O)[C@H](Cc1c(C)cc(cc1C)C(=O)N)N
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,eluxadoline,7691,,,223366025,Agonist,Agonist,,f,f,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,22695132,COc1ccc(cc1C(=O)O)CN([C@H](c1ncc([nH]1)c1ccccc1)C)C(=O)[C@H](Cc1c(C)cc(cc1C)C(=O)N)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,HS665,9189,,,315661268,Agonist,Agonist,,f,f,,pKi,0,6.269999981,0,Ki,0,542,0,=,,,,23134120,Oc1cccc(c1)CCN(CC1CCC1)CCc1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,hydrocodone,7081,,,178103660,Agonist,Agonist,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,22439881,COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4CCC1=O)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,hydromorphone,7082,,,178103661,Agonist,Agonist,,f,t,,pKi,0,9.550000191,0,Ki,0,0.280000001,0,=,,,,19282177,O=C1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,levorphanol,7595,,,223365930,Agonist,Agonist,,f,t,,pIC50,0,9.890000343,0,IC50,0,0.129999995,0,=,,,,12502358,Oc1ccc2c(c1)[C@]13CCCC[C@H]3[C@@H](C2)N(CC1)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,loperamide,7215,,,178103790,Agonist,Agonist,,f,t,,pKi,0,9.279999733,0,Ki,0,0.529999971,0,=,,,,15454210,Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,methadone,5458,,,178102108,Agonist,Agonist,,f,t,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,Binding affinity against &mu;-opioid receptor (human) using [<sup>3</sup>H]DAMGO radioligand.,,,11585443,CCC(=O)C(c1ccccc1)(c1ccccc1)CC(N(C)C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,nalbuphine,1663,,,135650680,Agonist,Agonist,,f,t,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,19282177,O[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CCC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,pethidine,7221,,,178103795,Agonist,Agonist,,f,t,,pIC50,0,6.5,0,IC50,0,315,0,=,,,,11585443,CCOC(=O)C1(CCN(CC1)C)c1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,7.190000057,0,Ki,0,65,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,SR16835,8867,,,252827524,Agonist,Agonist,,f,f,,pKi,0,7.099999905,0,Ki,0,79.90000153,0,=,Radioligand binding assay,,,19773529,O=C1Cc2c(N1C1CCN(CC1)C1CCC3c4c1cccc4CCC3)cccc2
&mu; receptor,319,OPRM1,P35372,,,,,,Human,PZM21,9286,,,318164805,Agonist,Biased agonist,,f,t,,pEC50,0,8.340000153,0,EC50,0,4.599999905,0,=,In a G<sub>i/o</sub> activation assay.,,,27533032,C[C@@H](Cc1cscc1)NC(=O)NC[C@@H](N(C)C)Cc1ccc(cc1)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,PZM21,9286,,,318164805,Agonist,Biased agonist,,f,t,,pKi,0,8.960000038,0,Ki,0,1.100000024,0,=,,,,27533032,C[C@@H](Cc1cscc1)NC(=O)NC[C@@H](N(C)C)Cc1ccc(cc1)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,DADLE,1607,,,135650156,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9686407,Oc1ccc(cc1)C[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)Cc1ccccc1)C)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,DAMGO,1647,,,135650158,Agonist,Full agonist,,f,f,,pKi,0,9.300000191,0,-,0,0,0,=,,,,9686407,OCCNC(=O)[C@@H](N(C(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)C)Cc1ccccc1
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,DAMGO,1647,,,135650158,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,8114680,OCCNC(=O)[C@@H](N(C(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)C)Cc1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dihydromorphine,1616,,,135650183,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9686407,O[C@H]1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,DSLET,1609,,,135652126,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9686407,OC[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(C)C)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dynorphin-(1-11),1618,,,135652140,Agonist,Full agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,9686407,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dynorphin A,1620,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651739,Agonist,Full agonist,,t,,,pKi,0,8.1,0,,0,0,0,,,,,9686407,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dynorphin A-(1-13),1619,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651738,Agonist,Full agonist,,t,,,pKi,0,8.3,0,,0,0,0,,,,,9686407,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dynorphin A-(1-8),1621,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651740,Agonist,Full agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,dynorphin B,1622,PDYN|Pdyn|Pdyn,Human|Mouse|Rat,135651741,Agonist,Full agonist,,t,,,pKi,0,8.5,0,,0,0,0,,,,,9686407,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,endomorphin-1,1623,,Human,135652148,Agonist,Full agonist,,t,f,,pKi,0,8.300000191,0,Ki,0,5.010000229,0,=,,,,9849897,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)N
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,endomorphin-2,3668,,Human,178100562,Agonist,Full agonist,,t,f,,pKi,0,8.5,0,Ki,0,3.24000001,0,=,,,,9087409,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1ccccc1)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,ethylketocyclazocine,1602,,,135650226,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9686407,CCC1CN(CC2CC2)C2C(C1c1cc(O)ccc1C2=O)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,etonitazene,1624,,,135650245,Agonist,Full agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,9686407,CCOc1ccc(cc1)Cc1nc2c(n1CCN(CC)CC)ccc(c2)[N+](=O)[O-]
&mu; receptor,319,OPRM1,P35372,,,,,,Human,etorphine,1625,,,135650246,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9686407,CCCC(C1CC23C=CC1(OC)C1C43CCN(C2Cc2c4c(O1)c(O)cc2)C)(O)C
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,fentanyl,1626,,,135650258,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,8114680,CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,fentanyl,1626,,,135650258,Agonist,Full agonist,,f,t,,pKi,0,9.199999809,0,-,0,0,0,=,,,,9686407,CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,[Met]enkephalin,1614,PENK|Penk|Penk,Human|Mouse|Rat,135651808,Agonist,Full agonist,,t,,,pKi,0,9.2,0,,0,0,0,,,,,8114680,CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,(-)-methadone,1605,,,135650582,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9686407,CCC(=O)C(c1ccccc1)(c1ccccc1)C[C@H](N(C)C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,morphine,1627,,,135650624,Agonist,Full agonist,,f,t,,pKi,0,9,0,-,0,0,0,=,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,normorphine,1630,,,135650735,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9686407,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2NCC3)ccc1O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,PL017,1671,,,135650836,Agonist,Full agonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,9686407,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N([C@H](C(=O)N1CCC[C@@H]1C(=O)N)Cc1ccccc1)C)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,(-)-cyclazocine,1604,,,135650145,Agonist,Partial agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9686407,Oc1ccc2c(c1)[C@]1(C)CCN([C@@H](C2)C1C)CC1CC1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,[Leu]enkephalin,1613,PENK|Penk|Penk,Human|Mouse|Rat,135651802,Agonist,Partial agonist,,t,,,pKi,0,8.1,0,,0,0,0,,,,,9686407,O=C(CNC(=O)C(Cc1ccc(cc1)O)N)NCC(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1ccccc1
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,morphine,1627,,,135650624,Agonist,Partial agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,8114680,O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,(-)-pentazocine,1606,,,135650806,Agonist,Partial agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9686407,CC(=CCN1CC[C@@]2([C@H]([C@H]1Cc1c2cc(cc1)O)C)C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,CTAP,1635,,,135652066,Antagonist,Antagonist,,f,f,,pKi,0,8.600000381,0,-,0,0,0,=,,,,9686407,NC(=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC([C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1c[nH]c2c1cccc2)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,CTOP,1674,,,135652067,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,8114680,NCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC([C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@@H](Cc1ccccc1)N)Cc1ccc(cc1)O)Cc1c[nH]c2c1cccc2
&mu; receptor,319,OPRM1,P35372,,,,,,Human,diprenorphine,1617,,,135650194,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,diprenorphine,1617,,,135650194,Antagonist,Antagonist,,f,,,pKi,0,10.1,0,,0,0,0,,,,,8114680,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,GSK1521498,9287,,,318164806,Antagonist,Antagonist,,f,t,,pKi,0,9.380000114,0,Ki,0,0.416999996,0,=,,,,24973897,Fc1cc(cc(c1CNC1Cc2c(C1)cccc2)F)c1cccc(c1)c1ncn[nH]1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,levallorphan,7209,,,178103784,Antagonist,Antagonist,,f,t,,pKi,9.319999695,0,8.770000458,Ki,1.690000057,0,0.479999989,=,Competition binding assay- the calculated K<sub>i</sub> varies depending on the radioligand used.,,,21621410,C=CCN1CC[C@@]23[C@H]([C@H]1Cc1c3cc(cc1)O)CCCC2
&mu; receptor,319,OPRM1,P35372,,,,,,Human,LY2456302,9194,,,315661273,Antagonist,Antagonist,,f,f,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,24071566,Cc1cc(C)cc(c1)[C@@H]1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,methylnaltrexone,7563,,,223365899,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,Displacement of [<sup>3</sup>H]DAMGO from human &mu; opioid receptors expressed in CHO cells,,,19282177,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2[N+](CC3)(C)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,nalmefene,1628,,,135650681,Antagonist,Antagonist,,f,t,,pKi,0,9.5,0,-,0,0,0,=,,,,9686407,C=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,nalorphine,1629,,,135650682,Antagonist,Antagonist,,f,t,,pKi,0,8.899999619,0,-,0,0,0,=,,,,9686407,C=CCN1CC[C@@]23[C@@H]4[C@H]1Cc1c3c(O[C@H]2[C@H](C=C4)O)c(cc1)O
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,naloxonazine,1677,,,135650683,Antagonist,Antagonist,,f,,,pKi,0,10.3,0,,0,0,0,,,,,8114680,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2/C(=NN=C/2CC[C@@]3([C@@]56[C@H]2Oc2c6c(C[C@H]3N(CC5)CC=C)ccc2O)O)/CC4)c(cc1)O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,f,,pKi,0,8.899999619,0,-,0,0,0,=,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,naloxone,1638,,,135650684,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8114680,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naloxone benzoylhydrazone,1664,,,135650686,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2/C(=N/NC(=O)c2ccccc2)/CC4)c(cc1)O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naloxone benzoylhydrazone,1664,,,135650686,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9686407,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2/C(=N/NC(=O)c2ccccc2)/CC4)c(cc1)O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naltrexone,1639,,,135650687,Antagonist,Antagonist,,f,t,,pKi,9.699999809,0,9.149999619,Ki,0.709999979,0,0.199000001,=,,,,9686407,O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naltriben,1640,,,135650688,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,naltrindole,1641,,,135650689,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,nor-binaltorphimine,1642,,,135650730,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9686407,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)CC1CC1
&mu; receptor,319,OPRM1,P35372,,,,,,Human,quadazocine,1633,,,135650868,Antagonist,Antagonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9686407,O=C(CCC1(C)[C@H]2Cc3c([C@]1(C)CCN2C)cc(cc3)O)CCC1CCCC1
myosin light chain kinase,1552,,,,,,,,Chicken,MLCK inhibitor peptide 18,9351,,,328083453,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,10072688,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)CCCN=C(N)N)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)N)CCCCN)CCCCN)Cc1ccc(cc1)O
myosin light chain kinase,1552,MYLK,Q15746,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,7.809999943,0,IC50,0,15.63000011,0,=,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
myosin light chain kinase 2,1553,MYLK2,Q9H1R3,,,,,,Human,GSK2606414,6740,,,178103351,Inhibitor,Inhibition,,f,f,,pIC50,0,6.150000095,0,IC50,0,701,0,=,,,,22827572,Fc1cc(CC(=O)N2CCc3c2ccc(c3)c2cn(c3c2c(N)ncn3)C)cc(c1)C(F)(F)F
Na-Cl symporter,970,SLC12A3,P55017,,,,,,Human,cyclothiazide,4167,,,178100987,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cc2NC(NS(=O)(=O)c2cc1S(=O)(=O)N)C1CC2CC1C=C2
Na-Cl symporter,970,SLC12A3,P55017,,,,,,Human,hydrochlorothiazide,4836,,,178101538,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cc2NCNS(=O)(=O)c2cc1S(=O)(=O)N
Na-Cl symporter,970,SLC12A3,P55017,,,,,,Human,metolazone,4838,,,178101540,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(=O)(=O)N
Na<sub>vi</sub>2.1,750,NALCN,Q8IZF0,,,,,,Human,Co<sup>2+</sup>,4160,,,178100980,Channel blocker,None,,f,,,pIC50,0,3.6,0,IC50,0,260000,0,,,,,0,
Na<sub>vi</sub>2.1,750,NALCN,Q8IZF0,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,None,,f,,,pIC50,0,5.6,0,IC50,0,1400,0,,,,,0,
Na<sub>v</sub>1.1,578,Scn1a,P04774,,,,,,Rat,Hm1a,9553,,,336446939,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,27281198,
Na<sub>v</sub>1.1,578,Scn1a,P04774,,,,,,Rat,&mu;-conotoxin SmIIIA,7567,,,223365903,Channel blocker,Pore blocker,,f,f,,pKi,0,8.399999619,0,-,0,0,0,=,Two-microelectrode voltage clamp on rat Na<sub>v</sub>1.1 in <i>Xenopus</i> oocytes,,,21652775,
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,lacosamide,7472,,,187051775,Channel blocker,Antagonist,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,=,,,,24065921,COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,etidocaine,2621,,,135650244,Channel blocker,Pore blocker,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,8085162,CCCN(C(C(=O)Nc1c(C)cccc1C)CC)CC
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,lamotrigine,2622,,,135650506,Channel blocker,Pore blocker,,f,f,,pIC50,0,4.5,0,-,0,0,0,=,,,,12604088,Nc1nnc(c(n1)N)c1cccc(c1Cl)Cl
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,f,,pIC50,0,5,0,-,0,0,0,=,,,,8799190,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,&mu;-conotoxin SmIIIA,7567,,,223365903,Channel blocker,Pore blocker,,f,f,,pKd,0,8.899999619,0,-,0,0,0,=,,,,21652775,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,phenytoin,2624,,,53801032,Channel blocker,Pore blocker,,f,t,,pIC50,0,4.900000095,0,-,0,0,0,=,,,,1658608,O=C1NC(=O)NC1(c1ccccc1)c1ccccc1
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,phenytoin,2624,,,53801032,Channel blocker,Pore blocker,,f,f,,pIC50,0,4.699999809,0,-,0,0,0,=,,,,8799190,O=C1NC(=O)NC1(c1ccccc1)c1ccccc1
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.700000048,0,=,,,,15815630,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,&delta;-hexatoxin-Mg1a,7569,,,223365905,Gating inhibitor,Slows inactivation,Inhibitor of fast activation,f,f,,pEC50,0,4.5,0,EC50,0,0,0,=,,,,19592486,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,huwentoxin IV,7570,,,223365906,Gating inhibitor,Voltage-dependent inhibition,,f,f,,pKd,0,7.800000191,0,-,0,0,0,=,Automated patch clamp (QPatch) of transfected human embryonic kidney cells (HEK293),,,23760503,
Na<sub>v</sub>1.2,579,SCN2A,Q99250,,,,,,Human,protoxin II,7571,,,223365907,Gating inhibitor,Voltage-dependent inhibition,,f,f,,pKi,0,7.400000095,0,-,0,0,0,=,Whole cell voltage clamp of transfected human embryonic kidney cells (HEK293),,,18728100,
Na<sub>v</sub>1.3,580,Scn3a,P08104,,,,,,Rat,lacosamide,7472,,,187051775,Channel blocker,Antagonist,,f,f,,pIC50,0,3.400000095,0,IC50,0,415000,0,=,,,,18378801,COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,grayanotoxin III,2628,,,135652689,Activator,Agonist,,f,,300,-,0,0,0,,0,0,0,,,,,11562450,O[C@@H]1C[C@@]23C[C@@]([C@@H]([C@H]2O)CC[C@H]3[C@@]([C@H]2[C@@]1(O)C(C)(C)[C@H](C2)O)(C)O)(C)O
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,mexiletine,2629,,,135650603,Channel blocker,Antagonist,,f,t,,pIC50,0,3.400000095,0,-,0,0,0,=,,,,14608007,CC(COc1c(C)cccc1C)N
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,&mu;-conotoxin GIIIA,2630,,,135652309,Channel blocker,Antagonist,,f,,,pIC50,7.7,0,7.3,,0,0,0,,,,,10627583,
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,&mu;-conotoxin PIIIA,2631,,,135652310,Channel blocker,Antagonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,10627583,
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,f,,pIC50,0,2.700000048,0,-,0,0,0,=,,,,10533585,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,&mu;-conotoxin GIIIA,2630,,,135652309,Channel blocker,Pore blocker,,f,f,,pIC50,0,5.900000095,0,IC50,0,1200,0,=,,,,8058462,
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.399999619,0,IC50,0,4.099999905,0,=,,,,11159437,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,f,,pIC50,0,4.199999809,0,-,0,0,0,=,,,,2546048,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,t,,pKd,0,4.800000191,0,-,0,0,0,=,,,,8786356,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,&mu;-conotoxin SmIIIA,7567,,,223365903,Channel blocker,Pore blocker,,f,f,,pKi,0,5.5,0,-,0,0,0,=,Two-microelectrode of <i>Xenopus</i> oocytes expression rat Na<sub>v</sub>1.5.,,,21652775,
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,quinidine,2342,,,135650872,Channel blocker,Pore blocker,,f,f,,pIC50,5,0,4.400000095,-,0,0,0,=,,,,2546048,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,ropivacaine,7602,,,223365937,Channel blocker,Pore blocker,Open-channel block,f,f,,pIC50,0,3.49000001,0,IC50,0,322200,0,=,,,,25692452,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,ropivacaine,7602,,,223365937,Channel blocker,Pore blocker,Blockade of inactivated channel,f,f,,pIC50,0,4.559999943,0,IC50,0,27300,0,=,,,,25692452,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,pKd,0,7.400000095,0,-,0,0,0,=,,,,8967455,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,jingzhaotoxin-III,2574,,,135652217,Gating inhibitor,Voltage-dependent inhibition,,f,f,,pKi,0,6.5,0,-,0,0,0,=,Whole-cell voltage clamp of human embryonic kidney cells (HEK293) transfected with human Na<sub>v</sub>1.5.,,,21665957,
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,protoxin II,7571,,,223365907,Gating inhibitor,Voltage-dependent inhibition,,f,f,,pKi,0,6.5,0,-,0,0,0,=,Whole-cell voltage clamp of human Na<sub>v</sub>1.5 channels expressed in human embryonic kidney cells (HEK293).,,,12475222,
Na<sub>v</sub>1.5,582,SCN5A,Q14524,,,,,,Human,eleclazine,8413,,,252166623,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1N(CCOc2c1cc(cc2)c1ccc(cc1)OC(F)(F)F)Cc1ncccn1
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,lacosamide,7472,,,187051775,Channel blocker,Antagonist,,f,t,,pIC50,0,3.700000048,0,IC50,0,182000,0,=,,,,18378801,COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,pyrrolopyrimidine 48 [PMID: 22318156],5731,,,178102357,Channel blocker,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,110,0,=,Electrophysiology,,,22318156,c1ccc(cc1)Cn1ccc2c1ncnc2OC1CCN(CC1)c1ccccn1
Na<sub>v</sub>1.7,584,Scn9a,O08562,,,,,,Rat,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,f,,pIC50,0,3.299999952,0,-,0,0,0,=,,,,15148257,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,saxitoxin,2625,,,135652715,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.199999809,0,IC50,0,702,0,=,,,,23077250,NC(=O)OC[C@@H]1N=C(N)N2[C@@]3([C@H]1NC(=N3)N)C(O)(O)CC2
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,N-Me-aminopyrimidinone 9,5733,,,178102359,Gating inhibitor,Inhibition,,f,,,pIC50,0,7.1,0,IC50,0,80,0,=,Electrophysiology,,,22209205,CC(c1ccc(cc1)CSc1nc(N)cc(=O)n1C)(C)C
Na<sub>v</sub>1.8,585,Scn10a,Q62968,,,,,,Rat,lacosamide,7472,,,187051775,Channel blocker,Antagonist,,f,f,,pIC50,0,4.800000191,0,IC50,0,16000,0,=,,,,18378801,COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
Na<sub>v</sub>1.8,585,Scn10a,Q62968,,,,,,Rat,lidocaine,2623,,,135650521,Channel blocker,Pore blocker,,f,f,,pIC50,0,4,0,-,0,0,0,=,,,,1514825,CCN(CC(=O)Nc1c(C)cccc1C)CC
Na<sub>v</sub>1.8,585,SCN10A,Q9Y5Y9,,,,,,Human,PF-01247324,8521,,,252166723,Channel blocker,Pore blocker,,f,t,,pIC50,0,6.710000038,0,IC50,0,196,0,=,,,,25625641,CNC(=O)c1ccc(c(n1)N)c1cc(Cl)cc(c1Cl)Cl
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,osteocrin,5036,OSTN,Human,178101732,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,17951249,
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,PL-3994,9067,,,315661152,Agonist,Agonist,,f,f,,pKi,0,8.149999619,0,Ki,0,7,0,=,,,,23154072,
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,M372049,5020,,,178101717,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15337698,CC[C@@H]([C@H](N1CC[C@H](C1=O)NC(=O)Cc1ccc(cc1)NC(=O)c1cnc2c(n1)cccc2)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)CCCNC(=N)N)CC(=O)O)C
nerve growth factor receptor,1888,NGFR,P08138,,,,,,Human,neurotrophin-3,5033,NTF3,Human,178101729,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
nerve growth factor receptor,1888,NGFR,P08138,,,,,,Human,neurotrophin-4,5034,NTF4,Human,178101730,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
nerve growth factor receptor,1888,NGFR,P08138,,,,,,Human,NGF,5026,NGF,Human,178101723,None,None,,t,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,22227462,
NET,926,SLC6A2,P23975,,,,,,Human,desipramine,2399,,,135650171,Inhibitor,Inhibition,,f,t,,pKi,0,8.680000305,0,Ki,0,2.099999905,0,=,,,,20462211,CNCCCN1c2ccccc2CCc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,desvenlafaxine,7158,,,178103733,Inhibitor,Inhibition,,f,t,,pKi,0,6.190000057,0,Ki,0,650,0,>,,,,24900709,CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C
NET,926,SLC6A2,P23975,,,,,,Human,dexamfetamine,2147,,,135650979,Inhibitor,Inhibition,,f,t,,pKi,0,7,0,Ki,0,101,0,=,,,,23602445,C[C@@H](Cc1ccccc1)N
NET,926,Slc6a2,,,,,,,Rat,dexmethylphenidate,7554,,,223365890,Inhibitor,Inhibition,,f,f,,pKi,0,6.570000172,0,Ki,0,270,0,=,Displacement of [<sup>3</sup>H]nisoxetine from NET in Sprague-Dawley rat cortical tissue.,,,17489581,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1
NET,926,SLC6A2,P23975,,,,,,Human,dosulepin,7549,,,223365885,Inhibitor,Inhibition,,f,t,,pKi,0,7.340000153,0,Ki,0,46,0,=,,,,9537821,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
NET,926,SLC6A2,P23975,,,,,,Human,doxepin,1225,,,135650208,Inhibitor,Inhibition,,f,t,,pKi,0,7.539999962,0,Ki,0,29,0,=,,,,0,CN(CC/C=C1/c2ccccc2OCc2c1cccc2)C
NET,926,SLC6A2,P23975,,,,,,Human,duloxetine,202,,,135650212,Inhibitor,Inhibition,,f,t,,pKi,0,8.220000267,0,Ki,0,5.96999979,0,=,,,,23084899,CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,imipramine,357,,,135650384,Inhibitor,Inhibition,,f,t,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,0,CN(CCCN1c2ccccc2CCc2c1cccc2)C
NET,926,SLC6A2,P23975,,,,,,Human,<i>N</i>-desalkylquetiapine,7545,,,187051846,Inhibitor,Inhibition,,f,f,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,18059438,N1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,levomilnacipran,7435,,,178104007,Inhibitor,Inhibition,,f,t,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,18468895,NC[C@@H]1C[C@]1(c1ccccc1)C(=O)N(CC)CC
NET,926,SLC6A2,P23975,,,,,,Human,lofepramine,7551,,,223365887,Inhibitor,Inhibition,,f,t,,pKi,0,8.270000458,0,Ki,0,5.400000095,0,=,,,,9537821,CN(CC(=O)c1ccc(cc1)Cl)CCCN1c2ccccc2CCc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,maprotiline,2402,,,135650566,Inhibitor,Inhibition,,f,t,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,19836247,CNCCCC12CCC(c3c1cccc3)c1c2cccc1
NET,926,SLC6A2,P23975,,,,,,Human,mazindol,4797,,,178101499,Inhibitor,Inhibition,,f,f,,pKi,0,8.899999619,0,Ki,0,1.25999999,0,=,,,,0,Clc1ccc(cc1)C1(O)c2ccccc2C2=NCCN12
NET,926,SLC6A2,P23975,,,,,,Human,methylphenidate,7236,,,178103810,Inhibitor,Inhibition,,f,t,,pIC50,0,7.210000038,0,IC50,0,61,0,=,,,,0,COC(=O)C(c1ccccc1)C1CCCCN1
NET,926,Slc6a2,,,,,,,Rat,mianserin,135,,,135650606,Inhibitor,Inhibition,,f,f,,pKi,0,7.590000153,0,Ki,0,26,0,=,Inhibition of [<sup>3</sup>H]NE uptake into rat synaptosomes,,,6747993,CN1CCN2C(C1)c1ccccc1Cc1c2cccc1
NET,926,SLC6A2,P23975,,,,,,Human,milnacipran,7436,,,178104008,Inhibitor,Inhibition,,f,t,,pIC50,0,9.100000381,0,IC50,0,0.79400003,0,=,,,,23347683,NCC1CC1(c1ccccc1)C(=O)N(CC)CC
NET,926,SLC6A2,P23975,,,,,,Human,nefazodone,7247,,,178103821,Inhibitor,Inhibition,,f,t,,pKd,0,6.440000057,0,Kd,0,360,0,=,Dissociation constant of [3H]- nisoxatine <i>vs</i>. nefazodone.,,,9871604,CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl
NET,926,SLC6A2,P23975,,,,,,Human,nisoxetine,4637,,,178101355,Inhibitor,Inhibition,,f,f,,pKi,0,8.399999619,0,Ki,0,3.980000019,0,=,,,,0,CNCCC(c1ccccc1)Oc1ccccc1OC
NET,926,SLC6A2,P23975,,,,,,Human,nomifensine,4792,,,178101494,Inhibitor,Inhibition,,f,t,,pKi,0,8.100000381,0,Ki,0,7.940000057,0,=,,,,0,CN1CC(c2ccccc2)c2c(C1)c(N)ccc2
NET,926,SLC6A2,P23975,,,,,,Human,nortriptyline,2404,,,135650736,Inhibitor,Inhibition,,f,t,,pKi,0,8.199999809,0,Ki,0,6.300000191,0,=,,,,10715164,CNCCC=C1c2ccccc2CCc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,norzotepine,7537,,,187051838,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,20223878,CNCCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2
NET,926,SLC6A2,P23975,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Inhibition,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,9537821,NNCCc1ccccc1
NET,926,SLC6A2,P23975,,,,,,Human,protriptyline,7285,,,178103859,Inhibitor,Inhibition,,f,t,,pKi,0,8.170000076,0,Ki,0,6.800000191,0,=,,,,18983139,CNCCCC1c2ccccc2C=Cc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,protriptyline,7285,,,178103859,Inhibitor,Inhibition,,f,t,,pKd,0,8.850000381,0,Kd,0,1.409999967,0,=,,,,9537821,CNCCCC1c2ccccc2C=Cc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,protriptyline,7285,,,178103859,Inhibitor,Inhibition,,f,t,,pIC50,0,8.770000458,0,IC50,0,1.700000048,0,=,Inhibition of [<sup>3</sup>H]nisoxetine binding to CHO cells expressing hNET.,,,22420844,CNCCCC1c2ccccc2C=Cc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,quetiapine,50,,,135650869,Inhibitor,Inhibition,,f,f,,pKi,0,6.03000021,0,Ki,0,927,0,=,,,,18059438,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,reboxetine,4808,,,178101510,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,10812041,CCOc1ccccc1O[C@@H](c1ccccc1)[C@H]1OCCNC1
NET,926,SLC6A2,P23975,,,,,,Human,sibutramine,2586,,,135651043,Inhibitor,Inhibition,,f,t,,pKi,0,5.25,0,Ki,0,5619,0,=,,,,0,CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
Neuronal NOS,1251,NOS1,P29475,,,,,,Human,L-NNA,8759,,,252827417,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,9667974,[O-][N+](=O)NC(=NCCC[C@@H](C(=O)O)N)N
Neuronal NOS,1251,Nos1,P29476,,,,,,Rat,N<sup>&omega;</sup>propyl-L-arginine,6525,,,178103139,Inhibitor,Inhibition,,f,f,,pKi,0,7.199999809,0,-,0,0,0,=,,,,9397167,CCCNC(=N)NCCC[C@@H](C(=O)O)N
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,GNF-5837,8071,,,249565751,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,24900443,O=C(Nc1cc(ccc1F)C(F)(F)F)Nc1ccc(c(c1)Nc1ccc2c(c1)NC(=O)/C/2=Cc1ccc[nH]1)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,GW-2580,5685,,,178102312,Inhibitor,Inhibition,,f,f,,pKd,0,6.199999809,0,Kd,0,630,0,=,,,,22037378,COc1cc(ccc1OCc1ccc(cc1)OC)Cc1cnc(nc1N)N
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,JNJ-28312141,5689,,,178102316,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,19887542,N#Cc1c[nH]c(n1)C(=O)Nc1ccc(cc1C1=CCCCC1)C1CCN(CC1)C(=O)CN(C)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,larotrectinib,8909,,,310264690,Inhibitor,Inhibition,,f,f,,pIC50,0,8.010000229,0,IC50,0,9.699999809,0,=,Measured using a TrkA ELISA.,,,0,O[C@H]1CCN(C1)C(=O)Nc1cnn2c1nc(cc2)N1CCC[C@@H]1c1cc(F)ccc1F
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,milciclib,7938,,,249565621,Inhibitor,Inhibition,,f,t,,pIC50,0,7.28000021,0,IC50,0,53,0,=,,,,19603809,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C
neurotrophic receptor tyrosine kinase 1,1817,NTRK1,P04629,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.340000153,0,IC50,0,46,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,GNF-5837,8071,,,249565751,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,24900443,O=C(Nc1cc(ccc1F)C(F)(F)F)Nc1ccc(c(c1)Nc1ccc2c(c1)NC(=O)/C/2=Cc1ccc[nH]1)C
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,GW-2580,5685,,,178102312,Inhibitor,Inhibition,,f,f,,pKd,0,7.440000057,0,Kd,0,36,0,=,,,,22037378,COc1cc(ccc1OCc1ccc(cc1)OC)Cc1cnc(nc1N)N
neurotrophic receptor tyrosine kinase 2,1818,NTRK2,Q16620,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.210000038,0,IC50,0,61,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
neurotrophic receptor tyrosine kinase 3,1819,NTRK3,Q16288,,,,,,Human,GNF-5837,8071,,,249565751,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,24900443,O=C(Nc1cc(ccc1F)C(F)(F)F)Nc1ccc(c(c1)Nc1ccc2c(c1)NC(=O)/C/2=Cc1ccc[nH]1)C
neurotrophic receptor tyrosine kinase 3,1819,NTRK3,Q16288,,,,,,Human,GW-2580,5685,,,178102312,Inhibitor,Inhibition,,f,f,,pKd,0,6.920000076,0,Kd,0,120,0,=,,,,22037378,COc1cc(ccc1OCc1ccc(cc1)OC)Cc1cnc(nc1N)N
neurotrophic receptor tyrosine kinase 3,1819,NTRK3,Q16288,,,,,,Human,pexidartinib,8710,,,252827368,Inhibitor,Inhibition,,f,f,,pIC50,0,6.050000191,0,IC50,0,890,0,=,,,,26222558,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F
neurotrophic receptor tyrosine kinase 3,1819,NTRK3,Q16288,,,,,,Human,neurotrophin-3,5033,NTF3,Human,178101729,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,daglutril,6506,,,178103120,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCOC(=O)[C@@H](CC1(CCCC1)C(=O)N[C@H]1CCc2c(N(C1=O)CC(=O)O)cccc2)CCc1ccccc1
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,fasidotril,6501,,,178103115,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CC(=O)SC[C@H](C(=O)N[C@H](C(=O)OCc1ccccc1)C)Cc1ccc2c(c1)OCO2
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,fasidotrilat,6502,,,178103116,Inhibitor,Inhibition,,f,f,,pKi,0,8.300000191,0,Ki,0,5.599999905,0,=,,,,16789889,SC[C@H](C(=O)N[C@H](C(=O)O)C)Cc1ccc2c(c1)OCO2
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,KC-12615,6507,,,178103121,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4.199999809,0,=,,,,22480516,OC(=O)CN1C(=O)[C@H](CCc2c1cccc2)NC(=O)C1(CCCC1)C[C@H](C(=O)O)CCc1ccccc1
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,sacubitrilat,7858,,,223366188,Inhibitor,Inhibition,,f,f,,pIC50,0,8.140000343,0,IC50,0,7.300000191,0,=,,,,0,C[C@@H](C(=O)O)C[C@@H](Cc1ccc(cc1)c1ccccc1)NC(=O)CCC(=O)O
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,muscarine,3996,,,178100822,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1C[C@H](O[C@H]1C)C[N+](C)(C)C
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,nicotine,2585,,,53801040,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCC[C@H]1c1cccnc1
nicotinic acetylcholine receptor &alpha;10 subunit,470,Chrna10,Q9JLB5,,,,,,Rat,RgIA4,9472,,,329968412,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,,,,28223528,
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,RgIA4,9472,,,329968412,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,28223528,
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,pancuronium,4001,,,178100827,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]1(C)CCCCC1)C)CC[C@]1([C@H]3C[C@@H]([C@@H]1OC(=O)C)[N+]1(C)CCCCC1)C
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,gallamine,356,,,135650296,Channel blocker,None,(&alpha;1)<sub>2</sub>&beta;1&gamma;&delta; and (&alpha;1)<sub>2</sub>&beta;1&delta;&epsilon;,f,f,,pIC50,0,6,0,IC50,0,1000,0,~,,,,0,CC[N+](CCOc1c(OCC[N+](CC)(CC)CC)cccc1OCC[N+](CC)(CC)CC)(CC)CC
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,(&alpha;1)<sub>2</sub>&beta;1&delta;&epsilon;,f,f,,pIC50,0,5.820000172,0,IC50,0,1500,0,~,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,CP-601927,9056,,,315661141,Agonist,Partial agonist,,f,t,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,Measured against &alpha;2&beta;4 nAchRs- species not identified.,,,21566524,FC(c1ccc2c(c1)[C@H]1CNC[C@@H]2C1)(F)F
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,LY2087101,3992,,,178100818,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,16738207,Fc1ccc(cc1)Nc1nc(c(s1)C(=O)c1cscc1)C
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,&alpha;3&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,&alpha;3&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,&alpha;3&beta;4,f,t,,pIC50,0,6.409999847,0,IC50,0,390,0,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,&alpha;3&beta;2,f,t,,pIC50,0,5.119999886,0,IC50,0,7600,0,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,NS1738,4000,,,178100826,Channel blocker,None,&alpha;3&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,17625074,O=C(Nc1cc(Cl)ccc1O)Nc1cc(ccc1Cl)C(F)(F)F
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,rivanicline,3994,,,178100820,Agonist,Agonist,,f,f,,pKi,0,7.599999905,0,Ki,0,25,0,~,Binding affinity for the &alpha;4&beta;2 nicotinic acetylcholine receptor.,,,14698195,CNCC/C=C/c1cccnc1
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,rivanicline,3994,,,178100820,Agonist,Agonist,,f,f,,pKi,0,7.590000153,0,Ki,0,26,0,=,,,,8968366,CNCC/C=C/c1cccnc1
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,LY2087101,3992,,,178100818,Allosteric modulator,Positive,potentiates &alpha;4&beta;2 and &alpha;4&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,16738207,Fc1ccc(cc1)Nc1nc(c(s1)C(=O)c1cscc1)C
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,NS9283,3993,,,178100819,Allosteric modulator,Positive,&alpha;4&beta;2 and &alpha;4&beta;4,f,f,,-,0,0,0,-,0,0,0,=,,,,21763685,N#Cc1cccc(c1)c1onc(n1)c1cccnc1
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,&alpha;4&beta;2,f,f,,pIC50,5.170000076,0,4.539999962,IC50,29000,0,6800,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,&alpha;4&beta;4,f,f,,pIC50,0,4.039999962,0,IC50,0,91000,0,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,&alpha;4&beta;2,f,f,,pIC50,5.440000057,0,5.389999866,IC50,4100,0,3600,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,&alpha;4&beta;4,f,f,,pIC50,6.480000019,0,5.309999943,IC50,4900,0,330,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,NS1738,4000,,,178100826,Channel blocker,None,&alpha;4&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,17625074,O=C(Nc1cc(Cl)ccc1O)Nc1cc(ccc1Cl)C(F)(F)F
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,hexamethonium,3963,,,178100789,Channel blocker,None,&alpha;6/&alpha;3&beta;2&beta;3 chimera,f,f,,pIC50,0,4.039999962,0,IC50,0,91000,0,=,,,,0,C[N+](CCCCCC[N+](C)(C)C)(C)C
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,&alpha;6/&alpha;3&beta;2&beta;3 chimera,f,f,,pIC50,0,4.960000038,0,IC50,0,11000,0,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,PHA-543613,3998,,,178100824,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,16821801,O=C(c1ncc2c(c1)cco2)N[C@H]1CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,PHA-709829,3997,,,178100823,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,18490160,O=C(c1ncc2c(c1)cco2)N[C@@H]1C[C@H]2CCN(C1)C2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,PNU-282987,3988,,,178100814,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,15715459,O=C(c1ccc(cc1)Cl)N[C@H]1CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,PSAB-OFP,3968,,,178100794,Agonist,Full agonist,,f,f,,pEC50,0,5.699999809,0,EC50,0,2200,0,=,,,,12354563,c1ccc(cc1)c1cnc2c(c1)C[C@]1(O2)CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,encenicline,6926,,,178103508,Agonist,Partial agonist,,f,t,,pKi,0,8.369999886,0,Ki,0,4.300000191,0,=,,,,15293871,O=C(c1cc2c(s1)c(Cl)ccc2)N[C@H]1CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,ivermectin,2373,,,135650439,Allosteric modulator,Positive,,f,f,,pEC50,0,5.099999905,0,EC50,0,9000,0,=,,,,9463487,CO[C@H]1C[C@H](OC2C(C)/C=C/C=C/3COC4C3(O)[C@@H](C=C([C@H]4O)C)C(=O)O[C@H]3CC(C/C=C/2C)O[C@]2(C3)CCC(C(O2)C(CC)C)C)O[C@H](C1O[C@H]1C[C@H](OC)C([C@@H](O1)C)O)C
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,JNJ1930942,3966,,,178100792,Allosteric modulator,Positive,(&alpha;7)<sub>5</sub>:Type 1/2,f,f,,-,0,0,0,-,0,0,0,=,,,,21084390,OCc1sc(nc1c1ccncc1)Nc1ccc(c(c1)C(F)(F)F)F
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,LY2087101,3992,,,178100818,Allosteric modulator,Positive,(&alpha;7)<sub>5</sub>:Type 1,f,f,,-,0,0,0,-,0,0,0,=,,,,16738207,Fc1ccc(cc1)Nc1nc(c(s1)C(=O)c1cscc1)C
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,NS1738,4000,,,178100826,Allosteric modulator,Positive,(&alpha;7)<sub>5</sub>:Type 1; also blocks &alpha;3&beta;4 and &alpha;4&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,17625074,O=C(Nc1cc(Cl)ccc1O)Nc1cc(ccc1Cl)C(F)(F)F
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,PNU-120596,3991,,,178100817,Allosteric modulator,Positive,(&alpha;7)<sub>5</sub>:Type 2,f,f,,-,0,0,0,-,0,0,0,=,,,,15858066,COc1cc(OC)c(cc1NC(=O)Nc1noc(c1)C)Cl
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,methyllycaconitine,4005,,,178100831,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCN1C[C@@]2(CC[C@@H]([C@]34[C@H]1[C@](O)([C@H]([C@H]23)OC)[C@@]1([C@@H]2[C@H]4C[C@@H]([C@@H]2OC)[C@H](C1)OC)O)OC)COC(=O)c1ccccc1N1C(=O)C[C@@H](C1=O)C
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,mecamylamine,3990,,,178100816,Channel blocker,None,(&alpha;7)<sub>5</sub>,f,f,,pIC50,0,4.809999943,0,IC50,0,15600,0,=,,,,0,CNC1(C)C2CCC(C1(C)C)C2
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,muscarine,3996,,,178100822,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1C[C@H](O[C@H]1C)C[N+](C)(C)C
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,muscarine,3996,,,178100822,Antagonist,Antagonist,(&alpha;9)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1C[C@H](O[C@H]1C)C[N+](C)(C)C
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,nicotine,2585,,,53801040,Antagonist,Antagonist,(&alpha;9)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCC[C@H]1c1cccnc1
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,nicotine,2585,,,53801040,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CN1CCC[C@H]1c1cccnc1
nicotinic acetylcholine receptor &alpha;9 subunit,469,Chrna9,P43144,,,,,,Rat,RgIA4,9472,,,329968412,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,,,,28223528,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,RgIA4,9472,,,329968412,Antagonist,Antagonist,&alpha;9&alpha;10,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,28223528,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,strychnine,347,,,135652718,Antagonist,Antagonist,(&alpha;9)<sub>5</sub>,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
nicotinic acetylcholine receptor &delta; subunit,476,CHRND,Q07001,,,,,,Human,PhTX-11,8883,,,252827540,Antagonist,Antagonist,,f,f,,pIC50,6.340000153,0,6.239999771,IC50,580,0,460,=,,,,11934578,CCCC(=O)N[C@H](C(=O)NCCCCCCCCCCCN)Cc1ccc(cc1)O
NIMA related kinase 2,2117,NEK2,P51955,,,,,,Human,GSK579289A,8150,,,249565830,Inhibitor,Inhibition,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,19237286,CN1CCC(CC1)Oc1ccc2c(c1)n(cn2)c1cc(c(s1)C(=O)N)O[C@@H](c1ccccc1Cl)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,eledoisin,2086,,,135652147,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,-,0,0,0,=,,,,8702757,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)[C@H](CC)C)Cc1ccccc1)C)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)CO
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,hemokinin 1,2087,Tac4,Mouse,135651788,Agonist,Full agonist,,t,,,pKi,11.7,0,9.8,,0,0,0,,,,,11786503,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,kassinin,2088,,,135652240,Agonist,Full agonist,,f,,,pIC50,7.1,0,6.6,-,0,0,0,=,,,,8702757,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CCC(=O)N)CC(=O)O)CO)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C(CC(=O)O)N
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Full agonist,,t,,,pKi,9.3,0,6.2,,0,0,0,,,,,11786503,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,neurokinin B,2090,TAC3|Tac2|Tac3|TAC3,Human|Mouse|Pig|Rat,135651811,Agonist,Full agonist,,t,,,pKi,6.4,0,6.1,,0,0,0,,,,,9190866,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,neuropeptide-&gamma;,2092,,,135652324,Agonist,Full agonist,,t,f,,pIC50,7.650000095,0,7.550000191,IC50,28.20000076,0,22.20000076,=,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,neuropeptide K,2091,TAC1|Tac1,Human|Rat,135651815,Agonist,Full agonist,,t,,,pIC50,6.5,0,6.4,,0,0,0,,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,phyllomedusin,2093,,,135652401,Agonist,Full agonist,,f,,,pIC50,8.5,0,8.3,,0,0,0,,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,physalaemin,2094,,,135652402,Agonist,Full agonist,,f,,,pIC50,9.2,0,9.1,-,0,0,0,=,,,,8702757,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CCSC)CC(C)C)Cc1ccc(cc1)O)Cc1ccccc1)NC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(NC(=O)C1CCC(=O)N1)C)CC(=O)O)CC(=O)N
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,[Pro<sup>9</sup>]SP,3849,,,178100689,Agonist,Full agonist,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.799999952,0,=,,,,9243521,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"[Sar<sup>9</sup>,Met(O<sub>2</sub>)<sup>11</sup>]SP",3850,,,178100690,Agonist,Full agonist,,f,f,,pIC50,9.899999619,0,9.699999809,-,0,0,0,=,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,septide,2095,,,135652460,Agonist,Full agonist,,f,f,,pKi,9.300000191,0,7,-,0,0,0,=,,,,11786503,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N1)CC(C)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,CP 99994,2102,,,135650132,Antagonist,Antagonist,,f,f,,pKi,9.699999809,0,9.300000191,-,0,0,0,=,,,,9190866,COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,ezlopitant,5751,,,178102377,Antagonist,Antagonist,,f,,,pKi,0,9.7,0,Ki,0,0.2,0,=,,,,12372904,COc1ccc(cc1CN[C@H]1C2CCN([C@H]1C(c1ccccc1)c1ccccc1)CC2)C(C)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,FK 224,2103,,,135652683,Antagonist,Antagonist,,f,,,pIC50,8.3,0,7.5,,0,0,0,,,,,1378096,CCCCCc1ccccc1CCC(=O)NC1C(C)OC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)/C(=C/c2ccc(cc2)O)/N(C1=O)C)CC(C)C)Cc1ccccc1)C(O)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,FK-888,2114,,,135650263,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,Ki,0,0.8,0,=,,,,8630576,O[C@@H]1C[C@H](N(C1)C(=O)c1cn(c2c1cccc2)C)C(=O)N[C@H](C(=O)N(Cc1ccccc1)C)Cc1ccc2c(c1)cccc2
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,fosaprepitant,7623,,,223365958,Antagonist,Antagonist,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,10737756,Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1nc(=O)n([nH]1)P(=O)(O)O)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"L-703,606",2104,,,135650480,Antagonist,Antagonist,,f,,,pIC50,8.4,0,8.2,,0,0,0,,,,,8702757,Ic1ccccc1CN[C@@H]1C2CCN([C@@H]1C(c1ccccc1)c1ccccc1)CC2
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"L-732,138",9461,,,329968401,Antagonist,Antagonist,,f,t,,pIC50,0,8.640000343,0,IC50,0,2.299999952,0,=,"Antagonism of [<sup>125</sup>]-substance P binding, to NK<sub>1</sub> receptors expressed in CHO cells.",,,7509807,CC(=O)N[C@H](C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F)Cc1c[nH]c2c1cccc2
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,"L-732,138",9461,,,329968401,Antagonist,Antagonist,,f,f,,pIC50,0,6.340000153,0,IC50,0,460,0,~,,,,7509807,CC(=O)N[C@H](C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F)Cc1c[nH]c2c1cccc2
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,lanepitant,3510,,,178100496,Antagonist,Antagonist,,f,f,,pKi,10,0,9.800000191,Ki,0.150000006,0,0.100000001,=,,,,7473161,COc1ccccc1CN(C(=O)C)C[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)CN1CCC(CC1)N1CCCCC1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,lanepitant,3510,,,178100496,Antagonist,Antagonist,,f,f,,pIC50,0,9.819999695,0,IC50,0,0.150000006,0,=,,,,20533894,COc1ccccc1CN(C(=O)C)C[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)CN1CCC(CC1)N1CCCCC1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,netupitant,5742,,,178102368,Antagonist,Antagonist,,f,,,pKi,0,9.02,0,Ki,0,0.95,0,=,,,,16332435,CN1CCN(CC1)c1ncc(c(c1)c1ccccc1C)N(C(=O)C(c1cc(cc(c1)C(F)(F)F)C(F)(F)F)(C)C)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,nolpitantium,2107,,,135651073,Antagonist,Antagonist,,f,f,,pIC50,9,0,8.899999619,-,0,0,0,=,,,,8702757,CC(Oc1cccc(c1)CC(=O)N1CCC[C@](C1)(CC[N+]12CCC(CC1)(CC2)c1ccccc1)c1ccc(c(c1)Cl)Cl)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,,,pKi,6.6,0,6,,0,0,0,,,,,12206858,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,9042606,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,R116031,5754,,,178102379,Antagonist,Antagonist,,f,,,pKi,0,9.35,0,Ki,0,0.45,0,=,,,,12130734,O=C(Nc1c(C)cccc1C)CN1CCN(CC1)[C@H]1CCN([C@@H](C1)Cc1ccccc1)C(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,R-486,2105,,,135652429,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,12206858,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,rolapitant,5749,,,178102375,Antagonist,Antagonist,,f,,,pKi,0,9.18,0,Ki,0,0.66,0,=,,,,22497992,O=C1CC[C@@]2(N1)CC[C@@](NC2)(CO[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,RP67580,3522,,,178100502,Antagonist,Antagonist,,f,f,,pIC50,0,7.699999809,0,Ki,0,0,0,=,,,,1281470,COc1ccccc1CC(=N)N1C[C@H]2[C@@H](C1)C(CCC2=O)(c1ccccc1)c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.1,,0,0,0,,,,,9190866,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,SCH 206272,2106,,,135651023,Antagonist,Antagonist,,f,,,pKi,8.9,0,8.3,,0,0,0,,,,,12206858,CO/N=C(/[C@@H](c1ccc(c(c1)Cl)Cl)CCN1CCC(CC1)N1CCC[C@@H](C1=O)CC(=O)NC)CN(C(=O)c1cc(Cl)cc(c1)Cl)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,serlopitant,9280,,,318164799,Antagonist,Antagonist,,f,f,,pIC50,0,10.22000027,0,IC50,0,0.059999999,0,=,Inhibition of binding of <sup>125</sup>I-Substance P <i>in vitro</i>.,,,19354254,O=C1CCC(=C1)N1C[C@@H]2[C@@H](C1)[C@@H]([C@H](CC2)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)c1ccc(cc1)F
NK<sub>1</sub> receptor,360,,,,,,,,Rabbit,spantide I,2096,,,135652474,Antagonist,Antagonist,Measuring inhibition of contraction of the rabbit iris sphincter.,f,f,,pIC50,0,8.279999733,0,IC50,0,5.199999809,0,=,,,,1693780,
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,spantide I,2096,,,135652474,Antagonist,Antagonist,Inhibition of histamine release from peritoneal mast cells,f,,,pEC50,0,5.6,0,-,0,0,0,=,,,,1702895,
NK<sub>1</sub> receptor,360,,,,,,,,Guinea pig,spantide I,2096,,,135652474,Antagonist,Antagonist,,f,,,pA2,7.1,0,7,-,0,0,0,=,,,,1693780,
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,spantide I,2096,,,135652474,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,,,,6208451,
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,spantide II,2097,,,135652475,Antagonist,Antagonist,Inhibition of histamine release from peritoneal mast cells.,f,,,pEC50,0,5.5,0,-,0,0,0,=,,,,1702895,CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cccnc1)N)C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)c1cccnc1)N)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(c(c1)Cl)Cl)N)CC(=O)N)Cc1ccccc1)CC(C)C
NK<sub>1</sub> receptor,360,,,,,,,,Guinea pig,spantide II,2097,,,135652475,Antagonist,Antagonist,,f,,,pA2,8.1,0,7,-,0,0,0,=,,,,1693780,CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cccnc1)N)C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)c1cccnc1)N)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(c(c1)Cl)Cl)N)CC(=O)N)Cc1ccccc1)CC(C)C
NK<sub>1</sub> receptor,360,,,,,,,,Rabbit,spantide II,2097,,,135652475,Antagonist,Antagonist,Measuring inhibition of contraction of the rabbit iris sphincter.,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,1693780,CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cccnc1)N)C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)c1cccnc1)N)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(c(c1)Cl)Cl)N)CC(=O)N)Cc1ccccc1)CC(C)C
NK<sub>2</sub> receptor,361,,,,,,,,Guinea pig,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Agonist,,f,,,pEC50,0,8.89,0,EC50,0,1.3,0,=,,,,2426129,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>2</sub> receptor,361,,,,,,,,Guinea pig,neuropeptide &gamma;,3667,TAC1|Tac1|Tac1,Human|Mouse|Rat,178100561,Agonist,Agonist,,t,,,pEC50,0,9.5,0,EC50,0,0.316,0,=,,,,1311427,
NK<sub>2</sub> receptor,361,,,,,,,,Guinea pig,neuropeptide K,2091,TAC1|Tac1,Human|Rat,135651815,Agonist,Agonist,,t,,,pEC50,0,8.8,0,EC50,0,1.58,0,=,,,,1311427,
NK<sub>2</sub> receptor,361,Tacr2,P16610,,,,,,Rat,GR64349,3881,,,178100717,Agonist,Full agonist,,f,f,,pEC50,0,8.399999619,0,EC50,0,3.700000048,0,=,,,,1331460,
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,hemokinin 1,2087,Tac4,Mouse,135651788,Agonist,Full agonist,,t,,,pKi,0,6.3,0,,0,0,0,,,,,11786503,
NK<sub>2</sub> receptor,361,Tacr2,P16610,,,,,,Rat,"[Lys<sup>5</sup>,Me-Leu<sup>9</sup>,Nle<sup>10</sup>]NKA-(4-10)",3843,,,178100684,Agonist,Full agonist,,f,f,,pIC50,9.399999619,0,8.800000191,-,0,0,0,=,,,,9718274,
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Full agonist,,t,,,pKi,9.1,0,8,-,0,0,0,=,,,,11786503,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,neurokinin B,2090,TAC3|Tac2|Tac3|TAC3,Human|Mouse|Pig|Rat,135651811,Agonist,Full agonist,,t,,,pKi,7.7,0,5,,0,0,0,,,,,9190866,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,[Phe(Me)<sup>7</sup>]neurokinin B,2113,,,135652392,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9190866,
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,FK-888,2114,,,135650263,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,-,0,0,0,=,,,,11937780,O[C@@H]1C[C@H](N(C1)C(=O)c1cn(c2c1cccc2)C)C(=O)N[C@H](C(=O)N(Cc1ccccc1)C)Cc1ccc2c(c1)cccc2
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,GR100679,3880,,,178100716,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8210508,O=C(N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N(C)C)Cc1ccccc1)Cc1c[nH]c2c1cccc2)C)CNC(=O)C1CCCCC1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,GR 159897,2115,,,135650314,Antagonist,Antagonist,,f,f,,pKd,9.5,0,7.800000191,-,0,0,0,=,,,,7682062,COC1(CCN(CC1)CCc1c[nH]c2c1cc(F)cc2)C[S@@](=O)c1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,GR94800,3882,,,178100718,Antagonist,Antagonist,,f,f,,pKi,0,9.800000191,0,Ki,0,0,0,=,,,,8027981,CC[C@@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1ccccc1)C)C)Cc1ccccc1)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,ibodutant,2117,,,135650578,Antagonist,Antagonist,,f,,,pKi,10.3,0,9.8,,0,0,0,,,,,16979621,O=C([C@H](NC(=O)C1(CCCC1)NC(=O)c1cc2c(s1)cc(cc2)C)Cc1ccccc1)NCC1CCN(CC1)CC1CCOCC1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,MEN 10376,2116,,,135652284,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,-,0,0,0,=,,,,7682062,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)O
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,MEN10627,3901,,,178100735,Antagonist,Antagonist,,f,f,,pKi,0,9.199999809,0,Ki,0,0,0,=,,,,11063600,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]2CNC(=O)C[C@@H](NC1=O)C(=O)N[C@H](Cc1c[nH]c3c1cccc3)C(=O)N[C@H](C(=O)N2)Cc1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,nepadutant,2123,,,135652323,Antagonist,Antagonist,,f,f,,pKi,8.699999809,0,8.5,-,0,0,0,=,,,,16979621,OC[C@H]1O[C@@H](NC(=O)C[C@@H](C(=O)N[C@H]2CC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)Cc2c[nH]c3c2cccc3)Cc2ccccc2)C(=O)N[C@H](C(=O)O)CC(C)C)N)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.3,-,0,0,0,=,,,,9190866,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,R396,2118,,,135652428,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,-,0,0,0,=,,,,7682062,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCC(=O)N)CC(=O)O)NC(=O)C)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,f,,pKi,9.699999809,0,9.399999619,-,0,0,0,=,,,,9190866,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>2</sub> receptor,361,Tacr2,P16610,,,,,,Rat,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,,,pKi,9.4,0,9.2,Ki,0.6,0,0.42,=,,,,1313515,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>2</sub> receptor,361,,,,,,,,Guinea pig,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,,,pIC50,0,10.25,0,IC50,0,0.056,0,=,,,,1334836,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,SB 414240,5769,,,178102394,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,11356103,O=C(c1c(CN2CCC(CC2)N2CCCCC2)c(nc2c1cccc2)c1ccccc1)N[C@H](C(C)(C)C)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,SCH 206272,2106,,,135651023,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,12206858,CO/N=C(/[C@@H](c1ccc(c(c1)Cl)Cl)CCN1CCC(CC1)N1CCC[C@@H](C1=O)CC(=O)NC)CN(C(=O)c1cc(Cl)cc(c1)Cl)C
NK<sub>3</sub> receptor,362,,,,,,,,Guinea pig,senktide,2127,,,135652459,Agonist,Agonist,,f,,,pEC50,0,9.3,0,EC50,0,0.5,0,=,,,,2431898,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,eledoisin,2086,,,135652147,Agonist,Full agonist,,f,,,pIC50,6.6,0,6.2,IC50,589.4,0,264.2,=,,,,8702757,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)[C@H](CC)C)Cc1ccccc1)C)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)CO
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,hemokinin 1,2087,Tac4,Mouse,135651788,Agonist,Full agonist,,t,,,pKi,9.3,0,9.2,,0,0,0,,,,,11226387,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,hemokinin 1,2087,Tac4,Mouse,135651788,Agonist,Full agonist,,f,,,pKi,9.1,0,8.6,-,0,0,0,=,,,,11226387,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,kassinin,2088,,,135652240,Agonist,Full agonist,,f,,,pIC50,7,0,6.7,-,0,0,0,=,,,,8702757,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CCC(=O)N)CC(=O)O)CO)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C(CC(=O)O)N
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Full agonist,,t,,,pKi,0,6.1,0,,0,0,0,,,,,11226387,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Full agonist,,t,,,pKi,6.3,0,5.5,,0,0,0,,,,,9190866,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,neurokinin A,2089,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651810,Agonist,Full agonist,,t,,,pEC50,0,7.4,0,EC50,0,40,0,=,,,,1312036,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,neurokinin B,2090,TAC3|Tac2|Tac3|TAC3,Human|Mouse|Pig|Rat,135651811,Agonist,Full agonist,,t,,,pKi,9.2,0,7.7,,0,0,0,,,,,9190866,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,neurokinin B,2090,TAC3|Tac2|Tac3|TAC3,Human|Mouse|Pig|Rat,135651811,Agonist,Full agonist,,t,,,pKi,8.7,0,8.6,,0,0,0,,,,,11226387,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,neurokinin B,2090,TAC3|Tac2|Tac3|TAC3,Human|Mouse|Pig|Rat,135651811,Agonist,Full agonist,,t,,,pEC50,0,8.4,0,EC50,0,4,0,=,,,,1312036,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,[Phe(Me)<sup>7</sup>]neurokinin B,2113,,,135652392,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11226387,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,[Phe(Me)<sup>7</sup>]neurokinin B,2113,,,135652392,Agonist,Full agonist,,f,f,,pKi,9.600000381,0,8.699999809,-,0,0,0,=,,,,9190866,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,[Phe(Me)<sup>7</sup>]neurokinin B,2113,,,135652392,Agonist,Full agonist,,f,f,,pEC50,0,8.899999619,0,EC50,0,1.299999952,0,=,,,,2176308,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,[Pro<sup>7</sup>]neurokinin B,2126,,,135652414,Agonist,Full agonist,,f,,,pIC50,6.6,0,6.4,,0,0,0,,,,,8702757,
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,senktide,2127,,,135652459,Agonist,Full agonist,,f,,,pKi,8,0,7.6,,0,0,0,,,,,11226387,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,senktide,2127,,,135652459,Agonist,Full agonist,,f,f,,pKi,8.600000381,0,7.099999905,-,0,0,0,=,,,,8702757,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
NK<sub>3</sub> receptor,362,Tacr3,P16177,,,,,,Rat,senktide,2127,,,135652459,Agonist,Full agonist,,f,,,pEC50,8.8,0,7.9,EC50,12,0,1.5,=,,,,2426259,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
NK<sub>3</sub> receptor,362,Tacr3,P16177,,,,,,Rat,senktide,2127,,,135652459,Agonist,Full agonist,,f,,,pKd,9.1,0,7.9,Kd,12,0,0.9,=,,,,2426259,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,FK 224,2103,,,135652683,Antagonist,Antagonist,,f,,,pKi,8.4,0,8.2,,0,0,0,,,,,1378096,CCCCCc1ccccc1CCC(=O)NC1C(C)OC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)/C(=C/c2ccc(cc2)O)/N(C1=O)C)CC(C)C)Cc1ccccc1)C(O)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,GR138676,2128,,,135652174,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,7534879,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CC[C@H]2[C@@H]1C(=O)N(C2)[C@@H](C(=O)NC(COCc1ccccc1)COCc1ccccc1)CC(C)C)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N
NK<sub>3</sub> receptor,362,,,,,,,,Guinea pig,GSK 172981,5773,,,178102398,Antagonist,Antagonist,,f,,,pKi,0,8.11,0,Ki,0,7.8,0,=,,,,19879867,Fc1cccc(c1)c1nc2ccccc2c(c1N)C(=O)N[C@H](c1ccccc1)C1CC1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,GSK 172981,5773,,,178102398,Antagonist,Antagonist,,f,,,pKi,0,8,0,Ki,0,0,0,=,,,,19117759,Fc1cccc(c1)c1nc2ccccc2c(c1N)C(=O)N[C@H](c1ccccc1)C1CC1
NK<sub>3</sub> receptor,362,,,,,,,,Guinea pig,GSK 256471,5774,,,178102399,Antagonist,Antagonist,,f,,,pKi,0,8.08,0,Ki,0,8.4,0,=,,,,19879867,O=C(c1c(CN(S(=O)(=O)C)C)c(nc2c1cccc2)c1ccccc1)N[C@H](c1ccccc1)C1CC1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,GSK 256471,5774,,,178102399,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,0,0,=,,,,19117759,O=C(c1c(CN(S(=O)(=O)C)C)c(nc2c1cccc2)c1ccccc1)N[C@H](c1ccccc1)C1CC1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,"N',2-diphenylquinoline-4-carbohydrazide 8m",2130,,,135650673,Antagonist,Antagonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,16950617,COC(=O)N(c1ccccc1)NC(=O)c1c(CN2CCN(CC2)C(C)(C)C)c(nc2c1cccc2F)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,"N&#8242;,2-diphenylquinoline-4-carbohydrazide",2129,,,135650676,Antagonist,Antagonist,,f,,,pIC50,8.4,0,7.9,,0,0,0,,,,,16950620,COC(=O)N(c1ccccc1)NC(=O)c1c(OC)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,f,,pKi,9.699999809,0,8.399999619,-,0,0,0,=,,,,8702757,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,f,,pIC50,8,0,7.900000095,IC50,12,0,10,=,,,,7476898,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>3</sub> receptor,362,,,,,,,,Guinea pig,osanetant,2110,,,135650780,Antagonist,Antagonist,,f,,,pKi,0,9.96,0,Ki,0,0.11,0,=,,,,7830490,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,PD 154740,5766,,,178102391,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,Ki,0,40,0,=,,,,7476898,OCCCCCCCCN[C@@](C(=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)(Cc1ccccc1)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,PD 154740,5766,,,178102391,Antagonist,Antagonist,,f,,,pIC50,6.24,0,6.17,IC50,680,0,580,=,,,,7476898,OCCCCCCCCN[C@@](C(=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)(Cc1ccccc1)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,PD157672,2125,,,135650800,Antagonist,Antagonist,,f,f,,pIC50,7.900000095,0,7.800000191,IC50,16,0,12.10000038,=,,,,8702757,NC(=O)NCCCCCCCNC(=O)[C@@](Cc1ccccc1)(NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,PD157672,2125,,,135650800,Antagonist,Antagonist,,f,f,,pKi,8,0,7.800000191,-,0,0,0,=,,,,7476898,NC(=O)NCCCCCCCNC(=O)[C@@](Cc1ccccc1)(NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,PD 161182,5767,,,178102392,Antagonist,Antagonist,,f,,,pIC50,0,8.15,0,IC50,0,7,0,=,,,,8648606,NC(=O)NCCCCCCCNC(=O)[C@](Cc1cccc(c1F)F)(NC(=O)O[C@H](c1ccccc1)C(C)C)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,,,pKi,6.2,0,5.7,,0,0,0,,,,,9190866,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,saredutant,2111,,,135650980,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,IC50,0,350,0,=,,,,8117304,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SB 218795,5764,,,178102389,Antagonist,Antagonist,,f,,,pKi,7.97,0,7.8,Ki,16,0,10.6,=,,,,8691422,COC(=O)[C@@H](c1ccccc1)NC(=O)c1cc(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SB 222200,2131,,,135650991,Antagonist,Antagonist,,f,,,pIC50,0,7.7,0,IC50,0,18.4,0,=,,,,10992004,CC[C@@H](c1ccccc1)NC(=O)c1c(C)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SB 222200,2131,,,135650991,Antagonist,Antagonist,,f,,,pKi,8.4,0,6.6,-,0,0,0,=,,,,11226387,CC[C@@H](c1ccccc1)NC(=O)c1c(C)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SB 235375,5772,,,178102397,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,Ki,0,2.2,0,=,,,,11752131,CC[C@@H](c1ccccc1)NC(=O)c1c(OCC(=O)O)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SCH 206272,2106,,,135651023,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12206858,CO/N=C(/[C@@H](c1ccc(c(c1)Cl)Cl)CCN1CCC(CC1)N1CCC[C@@H](C1=O)CC(=O)NC)CN(C(=O)c1cc(Cl)cc(c1)Cl)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,SSR 146977,2133,,,135651086,Antagonist,Antagonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,12056557,CN(C(=O)NC1(CCN(CC1)CCC[C@@]1(CCCN(C1)C(=O)c1ccccc1)c1ccc(c(c1)Cl)Cl)c1ccccc1)C
NLRP1,1768,NLRP1,Q9C000,,,,,,Human,muramyl dipeptide,5024,,,178101721,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1O[C@@H](O)[C@@H]([C@H]([C@@H]1O)O[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N)CCC(=O)O)C)C)NC(=O)C
NLRP3,1770,NLRP3,Q96P20,,,,,,Human,MCC950,8228,,,249565908,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,<,,,,25686105,O=C(NS(=O)(=O)c1occ(c1)C(O)(C)C)Nc1c2CCCc2cc2c1CCC2
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin S-33,1468,NMS,Human,135651819,Agonist,Agonist,,t,f,,pIC50,0,10,0,-,0,0,0,=,,,,15635449,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-23,1469,Nmu,Rat,135651820,Agonist,Agonist,,f,,,pKi,0,10.1,0,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-25,1471,NMU,Pig,135652329,Agonist,Agonist,,f,,,pKi,0,9.6,0,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-25,1470,NMU,Human,135651821,Agonist,Agonist,,t,,,pKi,0,9.5,0,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-8,1472,NMU,Dog,135652331,Agonist,Agonist,,f,,,pKi,0,8.5,0,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-8,1473,NMU,Pig,135652330,Agonist,Agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,HAS-NMU,7925,,,249565608,Agonist,Full agonist,,f,f,,pEC50,9,0,8.5,-,0,0,0,=,,,,24222478,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin S-33,1468,NMS,Human,135651819,Agonist,Full agonist,,t,f,,pEC50,0,10.19999981,0,-,0,0,0,=,,,,15635449,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-23,1469,Nmu,Rat,135651820,Agonist,Full agonist,,f,,,pEC50,9.1,0,8.7,-,0,0,0,=,,,,10894543,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-25,1471,NMU,Pig,135652329,Agonist,Full agonist,,f,,,pEC50,8.9,0,8.3,-,0,0,0,=,,,,10894543,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-25,1470,NMU,Human,135651821,Agonist,Full agonist,,t,f,,pEC50,9.399999619,0,8.399999619,-,0,0,0,=,,,,10894543,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,neuromedin U-8,1473,NMU,Pig,135652330,Agonist,Full agonist,,f,,,pEC50,10,0,9,-,0,0,0,=,,,,10894543,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,NM4-C<sub>16</sub>,9009,,,310264787,Agonist,Full agonist,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,26204509,CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)CCCCCC(=O)NC(C(=O)NC(C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N1CCCC1C(=O)N[C@H](C(=O)NC(C(=O)N)CC(=O)N)CCCNC(=N)N)CCCNC(=N)N)Cc1ccccc1)CC(C)C)Cc1ccccc1)(C)C
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,PEG40-NMU,7928,,,249565611,Agonist,Full agonist,,f,f,,pEC50,8,0,7,-,0,0,0,=,,,,22771182,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin S-33,1468,NMS,Human,135651819,Agonist,Agonist,,t,f,,pIC50,0,9.199999809,0,-,0,0,0,=,,,,15635449,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-23,1469,Nmu,Rat,135651820,Agonist,Agonist,,f,,,pKi,0,9.7,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-25,1470,NMU,Human,135651821,Agonist,Agonist,,t,,,pKi,0,9.6,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-25,1471,NMU,Pig,135652329,Agonist,Agonist,,f,,,pKi,0,9.9,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-8,1473,NMU,Pig,135652330,Agonist,Agonist,,f,,,pKi,0,9.3,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-8,1472,NMU,Dog,135652331,Agonist,Agonist,,f,,,pKi,0,8.1,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,HAS-NMU,7925,,,249565608,Agonist,Full agonist,,f,f,,pEC50,9,0,8.5,-,0,0,0,=,,,,24222478,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin S-33,1468,NMS,Human,135651819,Agonist,Full agonist,,t,,,pEC50,0,10,0,-,0,0,0,=,,,,15635449,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-23,1469,Nmu,Rat,135651820,Agonist,Full agonist,,f,,,pEC50,9.3,0,8.5,-,0,0,0,=,,,,10894543,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-25,1471,NMU,Pig,135652329,Agonist,Full agonist,,f,,,pEC50,9,0,8.6,-,0,0,0,=,,,,10894543,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-25,1470,NMU,Human,135651821,Agonist,Full agonist,,t,f,,pEC50,9.399999619,0,8.399999619,-,0,0,0,=,,,,10894543,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,neuromedin U-8,1473,NMU,Pig,135652330,Agonist,Full agonist,,f,,,pEC50,9.5,0,8.5,-,0,0,0,=,,,,10894543,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,NM4-C<sub>16</sub>,9009,,,310264787,Agonist,Full agonist,,f,f,,pIC50,0,6.099999905,0,-,0,0,0,=,,,,26204509,CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)CCCCCC(=O)NC(C(=O)NC(C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N1CCCC1C(=O)N[C@H](C(=O)NC(C(=O)N)CC(=O)N)CCCNC(=N)N)CCCNC(=N)N)Cc1ccccc1)CC(C)C)Cc1ccccc1)(C)C
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,PEG40-NMU,7928,,,249565611,Agonist,Full agonist,,f,f,,pEC50,8,0,7,-,0,0,0,=,,,,22771182,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,R-PSOP,3524,,,178100504,Antagonist,Antagonist,,f,,,pKB,0,7.04,0,KB,0,92,0,=,,,,19369576,O=C(Nc1ccccc1)Nc1cnc2c(c1)C[C@]1(O2)CN2CC[C@H]1CC2
NOP receptor,320,OPRL1,P41146,,,,,,Human,nociceptin/orphanin FQ,1681,PNOC|Pnoc|Pnoc,Human|Mouse|Rat,135651822,Agonist,Agonist,,f,f,,pEC50,9.800000191,0,8.399999619,-,0,0,0,=,,,,9353393,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)N)CC(=O)N)C)CC(C)C)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCNC(=N)N
NOP receptor,320,OPRL1,P41146,,,,,,Human,[(pF)Phe<sup>4</sup>]N/OFQ-(1-13)-NH<sub>2</sub>,1686,,,135652383,Agonist,Agonist,,f,f,,pEC50,0,10.11999989,0,-,0,0,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,15743186,
NOP receptor,320,OPRL1,P41146,,,,,,Human,PWT2-N/OFQ,8865,,,252827522,Agonist,Agonist,,f,f,,pEC50,0,8.800000191,0,-,0,0,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,24903280,
NOP receptor,320,OPRL1,P41146,,,,,,Human,PWT2-N/OFQ,8865,,,252827522,Agonist,Agonist,,f,f,,pKi,0,10.30000019,0,-,0,0,0,=,,,,24903280,
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ro64-6198,1684,,,135650922,Agonist,Agonist,,f,f,,pEC50,0,7.409999847,0,-,0,0,0,=,Stimulation of GTP&gamma;<sup>35</sup>S binding,,,11006485,O=C1NCN(C21CCN(CC2)[C@H]1CC[C@H]2c3c1cccc3CCC2)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,(R)-Ro65-6570,8864,,,252827521,Agonist,Agonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,10476866,O=C1NCN(C21CCN(CC2)[C@@H]1Cc2c3c1cccc3ccc2)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,(R)-Ro65-6570,8864,,,252827521,Agonist,Agonist,,f,f,,pEC50,0,7.400000095,0,-,0,0,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,10476866,O=C1NCN(C21CCN(CC2)[C@@H]1Cc2c3c1cccc3ccc2)c1ccccc1
NOP receptor,320,Oprl1,P35377,,,,,,Mouse,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,8.93999958,0,Ki,0,1.149999976,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
NOP receptor,320,Oprl1,P35370,,,,,,Rat,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,9.380000114,0,Ki,0,0.419999987,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,Radioligand binding assay,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,SCH221510,8868,,,252827525,Agonist,Agonist,,f,f,,pEC50,0,7.920000076,0,EC50,0,12,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,18492950,Cc1ccccc1C(c1ccccc1C)N1C2CCC1CC(C2)(O)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,SCH486757,8869,,,252827526,Agonist,Agonist,,f,f,,pEC50,0,7.099999905,0,EC50,0,79,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,20006596,Clc1ccccc1C(c1ccccc1Cl)N1[C@@H]2CC[C@H]1CC(C2)(O)c1ncccn1
NOP receptor,320,OPRL1,P41146,,,,,,Human,SCH486757,8869,,,252827526,Agonist,Agonist,,f,f,,pKi,0,8.340000153,0,Ki,0,4.599999905,0,=,Radioligand binding assay,,,20006596,Clc1ccccc1C(c1ccccc1Cl)N1[C@@H]2CC[C@H]1CC(C2)(O)c1ncccn1
NOP receptor,320,OPRL1,P41146,,,,,,Human,SR16835,8867,,,252827524,Agonist,Agonist,,f,f,,pEC50,0,7.340000153,0,EC50,0,46.09999847,0,=,Stimulation of GTP-&gamma;<sup>35</sup>S binding,,,19773529,O=C1Cc2c(N1C1CCN(CC1)C1CCC3c4c1cccc4CCC3)cccc2
NOP receptor,320,OPRL1,P41146,,,,,,Human,SR16835,8867,,,252827524,Agonist,Agonist,,f,f,,pKi,0,7.940000057,0,Ki,0,11.39999962,0,=,Radioligand binding assay,,,19773529,O=C1Cc2c(N1C1CCN(CC1)C1CCC3c4c1cccc4CCC3)cccc2
NOP receptor,320,OPRL1,P41146,,,,,,Human,nociceptin/orphanin FQ,1681,PNOC|Pnoc|Pnoc,Human|Mouse|Rat,135651822,Agonist,Full agonist,,t,f,,pKi,10.39999962,0,9.699999809,-,0,0,0,=,,,,10369464,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)N)CC(=O)N)C)CC(C)C)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCNC(=N)N
NOP receptor,320,Oprl1,P35377,,,,,,Mouse,nociceptin/orphanin FQ,1681,PNOC|Pnoc|Pnoc,Human|Mouse|Rat,135651822,Agonist,Full agonist,,t,,,pKi,0,9.4,0,,0,0,0,,,,,9353393,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)N)CC(=O)N)C)CC(C)C)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCNC(=N)N
NOP receptor,320,OPRL1,P41146,,,,,,Human,N/OFQ-(1-13)-NH<sub>2</sub>,1682,,,135652333,Agonist,Full agonist,,f,f,,pKi,10.39999962,0,10.10000038,-,0,0,0,=,,,,12967935,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCN=C(N)N
NOP receptor,320,OPRL1,P41146,,,,,,Human,N/OFQ-NH<sub>2</sub>,1683,,,135652334,Agonist,Full agonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,12967935,
NOP receptor,320,OPRL1,P41146,,,,,,Human,[(pF)Phe<sup>4</sup>]N/OFQ-(1-13)-NH<sub>2</sub>,1686,,,135652383,Agonist,Full agonist,,f,f,,pKi,11.31999969,0,10.80000019,-,0,0,0,=,,,,12070757,
NOP receptor,320,OPRL1,P41146,,,,,,Human,Ro64-6198,1684,,,135650922,Agonist,Full agonist,,f,f,,pKi,0,9.409999847,0,-,0,0,0,=,,,,10758169,O=C1NCN(C21CCN(CC2)[C@H]1CC[C@H]2c3c1cccc3CCC2)c1ccccc1
NOP receptor,320,OPRL1,P41146,,,,,,Human,[F/G]N/OFQ-(1-13)-NH<sub>2</sub>,1690,,,135652154,Agonist,Partial agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12967935,
NOP receptor,320,OPRL1,P41146,,,,,,Human,J-113397,1691,,,135650442,Antagonist,Antagonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,10940356,OC[C@@H]1CN(CC[C@H]1n1c(=O)n(c2c1cccc2)CC)CC1CCCCCCC1
NOP receptor,320,OPRL1,P41146,,,,,,Human,J-113397,1691,,,135650442,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,0,0,=,,,,10602690,OC[C@@H]1CN(CC[C@H]1n1c(=O)n(c2c1cccc2)CC)CC1CCCCCCC1
NOP receptor,320,OPRL1,P41146,,,,,,Human,JTC-801,1692,,,135650447,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,11101358,CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C
NOP receptor,320,OPRL1,P41146,,,,,,Human,LY2940094,9462,,,329968402,Antagonist,Antagonist,,f,f,,pKi,0,10,0,Ki,0,0.100000001,0,=,,,,24678969,OCc1cccnc1n1nc(c(c1)CN1CCC2(CC1)OCC(c1c2sc(c1)Cl)(F)F)C
NOP receptor,320,OPRL1,P41146,,,,,,Human,[Nphe<sup>1</sup>]N/OFQ-(1-13)-NH<sub>2</sub>,1695,,,135652341,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12010780,
NOP receptor,320,OPRL1,P41146,,,,,,Human,peptide III-BTD,1696,,,135652382,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,10488086,CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1CCC2N(C1=O)[C@H](CS2)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N)Cc1ccc(cc1)Cl)CCCN=C(N)N)CC1CCCCC1)CCCN=C(N)N
NOP receptor,320,OPRL1,P41146,,,,,,Human,SB 612111,1693,,,135651011,Antagonist,Antagonist,,f,f,,pIC50,9.699999809,0,8.199999809,-,0,0,0,=,,,,14593080,O[C@H]1C[C@H](CCc2c1cccc2C)CN1CCC(CC1)c1c(Cl)cccc1Cl
NOP receptor,320,OPRL1,P41146,,,,,,Human,SB 612111,1693,,,135651011,Antagonist,Antagonist,,f,f,,pKi,9.5,0,9.199999809,-,0,0,0,=,,,,14593080,O[C@H]1C[C@H](CCc2c1cccc2C)CN1CCC(CC1)c1c(Cl)cccc1Cl
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,des-Br-neuropeptide B-23,1499,NPB,Human,135651732,Agonist,Full agonist,,t,,,pIC50,0,8.8,0,,0,0,0,,,,,12401809,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,des-Br-neuropeptide B-29,1500,NPB,Human,135651733,Agonist,Full agonist,,t,,,pIC50,0,9.5,0,,0,0,0,,,,,12401809,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,neuropeptide B-29,1502,NPB,Human,135651831,Agonist,Full agonist,,t,,,pIC50,0,9.5,0,-,0,0,0,=,,,,12118011,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,neuropeptide W-23,1495,NPW,Human,135651839,Agonist,Full agonist,,t,,,pIC50,0,10,0,,0,0,0,,,,,12130646,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,neuropeptide W-30,1496,NPW,Human,135651841,Agonist,Full agonist,,t,,,pIC50,0,10.6,0,,0,0,0,,,,,12130646,
NPBW2 receptor,304,NPBWR2,P48146,,,,,,Human,neuropeptide B-23,1501,NPB,Human,135651827,Agonist,Full agonist,,t,,,pIC50,0,8.4,0,,0,0,0,,,,,12401809,
NPBW2 receptor,304,NPBWR2,P48146,,,,,,Human,neuropeptide B-29,1502,NPB,Human,135651831,Agonist,Full agonist,,t,,,pIC50,0,9,0,,0,0,0,,,,,12401809,
NPBW2 receptor,304,NPBWR2,P48146,,,,,,Human,neuropeptide W-23,1495,NPW,Human,135651839,Agonist,Full agonist,,t,,,pIC50,0,9.6,0,,0,0,0,,,,,12401809,
NPBW2 receptor,304,NPBWR2,P48146,,,,,,Human,neuropeptide W-30,1496,NPW,Human,135651841,Agonist,Full agonist,,t,,,pIC50,0,9.4,0,,0,0,0,,,,,12401809,
NPC1 like intracellular cholesterol transporter 1,2629,NPC1L1,Q9UHC9,,,,,,Human,ezetimibe,6816,,,178103422,Antagonist,Inhibition,,f,t,,pKd,0,6.659999847,0,Kd,0,220,0,=,Measure of ezetimibe glucuronide binding to NPC1L1,,,15928087,Oc1ccc(cc1)[C@@H]1[C@@H](CC[C@@H](c2ccc(cc2)F)O)C(=O)N1c1ccc(cc1)F
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,EFWSLAAPQRF-NH<sub>2</sub>,1478,,,135652144,Agonist,Full agonist,,f,,,pKi,0,7.3,0,-,0,0,0,=,,,,12242085,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,neuropeptide FF,1479,NPFF|Npff|Npff,Human|Mouse|Rat,135651833,Agonist,Full agonist,,t,f,,pKi,9.899999619,0,8.5,-,0,0,0,=,,,,12242085,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,RFRP-3,4016,NPVF,Human,178100842,Agonist,Full agonist,,t,,,pKi,9.3,0,9.2,-,0,0,0,=,,,,12242085,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,pancreatic polypeptide,1480,ppy,European common frog,135652405,Agonist,Partial agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11024015,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,RF9,1486,,,135652436,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,-,0,0,0,=,,,,16407169,NC(=N)NCCC[C@@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)NC(=O)C12CC3CC(C2)CC(C1)C3
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,dNPA,1489,,,135652121,Agonist,Full agonist,,f,f,,pKi,0,10.56999969,0,Ki,0,0.027000001,0,=,,,,16129413,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,EFWSLAAPQRF-NH<sub>2</sub>,1478,,,135652144,Agonist,Full agonist,,f,,,pKi,0,9.6,0,-,0,0,0,=,,,,12242085,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,neuropeptide FF,1479,NPFF|Npff|Npff,Human|Mouse|Rat,135651833,Agonist,Full agonist,,t,f,,pKi,0,9.699999809,0,-,0,0,0,=,,,,12421602,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,pancreatic polypeptide,1480,ppy,European common frog,135652405,Agonist,Full agonist,,f,,,pKi,8.2,0,8.1,,0,0,0,,,,,11024015,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,RFRP-3,4016,NPVF,Human,178100842,Agonist,Full agonist,,f,,,pKi,0,7.8,0,-,0,0,0,=,,,,12242085,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,RF9,1486,,,135652436,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,16407169,NC(=N)NCCC[C@@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)NC(=O)C12CC3CC(C2)CC(C1)C3
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,[Cy5-Lys<sup>19</sup>]NPS,9166,,,315661249,Agonist,Full agonist,,f,f,,pEC50,0,5.820000172,0,EC50,0,1500,0,=,,,,26865629,
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,neuropeptide S,1490,NPS,Human,135651836,Agonist,Full agonist,,t,,,pEC50,0,8,0,-,0,0,0,=,,,,15312648,
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,neuropeptide S,1491,Nps,Mouse,135651834,Agonist,Full agonist,,t,,,pEC50,0,8.5,0,,0,0,0,,,,,15312648,
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,neuropeptide S,1492,Nps,Rat,135651835,Agonist,Full agonist,,t,,,pEC50,0,8.5,0,,0,0,0,,,,,15312648,
NPS receptor,302,Npsr1,Q8BZP8,,,,,,Mouse,PWT1-NPS,9167,,,315661250,Agonist,Full agonist,,f,f,,pEC50,0,8.989999771,0,-,0,0,0,=,In a calcium mobilisation assay,,,25692025,
NPS receptor,302,Npsr1,Q8BZP8,,,,,,Mouse,[D-Cys(<sup><i>t</sup></i>Bu)<sup>5</sup>]NPS,5810,,,178102435,Antagonist,Antagonist,,f,,,pA2,0,6.4,0,-,0,0,0,=,,,,18971372,
NPS receptor,302,Npsr1,P0C0L6,,,,,,Rat,[D-Cys(<sup><i>t</sup></i>Bu)<sup>5</sup>]NPS,5810,,,178102435,Antagonist,Antagonist,,f,,,pA2,0,6.6,0,-,0,0,0,=,,,,22342393,
NPS receptor,302,Npsr1,Q8BZP8,,,,,,Mouse,[D-Val<sup>5</sup>]NPS,5811,,,178102436,Antagonist,Antagonist,,f,,,pKB,0,6.5,0,-,0,0,0,=,,,,19473027,
NPS receptor,302,Npsr1,Q8BZP8,,,,,,Mouse,[<i><sup>t</sup></i>Bu-D-Gly<sup>5</sup>]NPS,5812,,,178102437,Antagonist,Antagonist,,f,,,pKB,0,7.1,0,-,0,0,0,=,,,,19473027,
NPS receptor,302,Npsr1,P0C0L6,,,,,,Rat,[<i><sup>t</sup></i>Bu-D-Gly<sup>5</sup>]NPS,5812,,,178102437,Antagonist,Antagonist,,f,,,pA2,0,7.2,0,-,0,0,0,=,,,,22342393,
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,NCGC 84,9168,,,315661251,Antagonist,Antagonist,,f,t,,pA2,0,8.979999542,0,-,0,0,0,=,Result from a cAMP accumulation assay.,,,23761908,Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,PI1,5814,,,178102439,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,-,0,0,0,=,,,,20615693,CCN(C(=O)CCC1(c2ccc(cc2)Cl)n2ccnc2c2c1c(OC)ccc2)CC
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,QA1,5815,,,178102440,Antagonist,Antagonist,,f,,,pIC50,0,8,0,-,0,0,0,=,,,,20510609,CCC(N(C(=O)C1CCCCC1)Cc1cc2ccccc2n(c1=O)C)(CCN1CCOCC1)C
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,RTI-118,7929,,,249565612,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,pK<sub>e</sub> value of 6.96 vs. hNPS receptor variant Ile<sup>107</sup>,,,18555684,O=C(N1CCN2C(C1)C(OC2=O)(c1ccccc1)c1ccccc1)NCCN1CCCCC1
NPS receptor,302,Npsr1,Q8BZP8,,,,,,Mouse,SHA 68,5813,,,178102438,Antagonist,Antagonist,,f,f,,pA2,0,8.100000381,0,-,0,0,0,=,,,,20172007,Fc1ccc(cc1)CNC(=O)N1CCN2C(C1)C(OC2=O)(c1ccccc1)c1ccccc1
NPS receptor,302,Npsr1,P0C0L6,,,,,,Rat,SHA 68,5813,,,178102438,Antagonist,Antagonist,,f,,,pA2,0,7.6,0,-,0,0,0,=,,,,22342393,Fc1ccc(cc1)CNC(=O)N1CCN2C(C1)C(OC2=O)(c1ccccc1)c1ccccc1
NRAS,2823,NRAS,P01111,,,,,,Human,lonafarnib,8024,,,249565704,Inhibitor,Inhibition,,f,f,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,Measuring inhibition of farnesylation of NRAS by human farnesyltransferase,,,9810004,Clc1cc(Br)c2c(c1)CCc1c([C@@H]2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,contulakin-G,1575,,,135652063,Agonist,Full agonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,10318778,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,contulakin-G,1575,,,135652063,Agonist,Full agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10318778,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,EISAI-1,1566,,,135652145,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12869647,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@H](C(=O)OCC)CC(C)C)Cc1c[nH]c2c1cccc2)NC(=O)[C@H](CCCN=C(N)N)NC
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,EISAI-2,1567,,,135652146,Agonist,Full agonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,12869647,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,JMV2004,1568,,,135652221,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,11723247,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,JMV431,1569,,,135652223,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,11723247,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,JMV449,1570,,,135652224,Agonist,Full agonist,,f,f,,pKi,0,10,0,Ki,0,0.100000001,0,=,,,,12869647,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)NC[C@H](CCCCN)N
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,JMV457,1571,,,135652225,Agonist,Full agonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,11723247,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,JMV458,1572,,,135652226,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,11723247,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)CCCN=C(N)N)CCCN=C(N)N)C
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,KH28,5306,,,178101988,Agonist,Full agonist,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,16095636,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,large neuromedin N,1576,NTS,Human,135652256,Agonist,Full agonist,,t,,,pIC50,0,7.4,0,-,0,0,0,=,,,,11811984,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,large neurotensin,1577,NTS,Human,135652257,Agonist,Full agonist,,t,,,pIC50,0,8.7,0,-,0,0,0,=,,,,11811984,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,neuromedin N,1578,Nts|Nts,Mouse|Rat,135651813,Agonist,Full agonist,,t,,,pKi,0,8.7,0,,0,0,0,,,,,12869647,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,neurotensin,1579,NTS|Nts|Nts|NTS,Bovine|Human|Mouse|Rat,135651816,Agonist,Full agonist,,t,,,pKi,9.7,0,8.3,,0,0,0,,,,,11723247,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,neurotensin,1579,NTS|Nts|Nts|NTS,Bovine|Human|Mouse|Rat,135651816,Agonist,Full agonist,,t,,,pKi,10,0,8.2,,0,0,0,,,,,12869647,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,meclinertant,1582,,,135651079,Antagonist,Antagonist,,f,f,,pIC50,8.199999809,0,7.5,IC50,31.60000038,0,6.309999943,=,,,,9023294,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,meclinertant,1582,,,135651079,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11723247,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,meclinertant,1582,,,135651079,Antagonist,Antagonist,,f,,,pKi,8.6,0,8,,0,0,0,,,,,7746272,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,SR142948A,1580,,,135651074,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,-,0,0,0,=,,,,9023294,COc1cccc(c1c1cc(nn1c1ccc(cc1C(C)C)C(=O)N(CCCN(C)C)C)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,SR48527,1581,,,135651078,Antagonist,Antagonist,,f,,,pKi,7.5,0,7.1,,0,0,0,,,,,7746272,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)N[C@@H](C1CCCCC1)C(=O)O)OC
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,contulakin-G,1575,,,135652063,Agonist,Full agonist,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,10318778,
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,[D-Trp<sup>11</sup>]neurotensin,1584,,,135652130,Agonist,Full agonist,,f,,,pIC50,7.6,0,7.5,,0,0,0,,,,,9480852,
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,JMV2004,1568,,,135652221,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,11723247,
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,JMV431,1569,,,135652223,Agonist,Full agonist,,f,,,pKd,0,7,0,,0,0,0,,,,,11723247,
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,JMV457,1571,,,135652225,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,11723247,
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,JMV458,1572,,,135652226,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,11723247,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)CCCN=C(N)N)CCCN=C(N)N)C
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,levocabastine,1586,,,135650515,Agonist,Full agonist,,f,,,pIC50,8.7,0,8.4,,0,0,0,,,,,9480852,N#C[C@@]1(CC[C@@H](CC1)N1CC[C@]([C@@H](C1)C)(C(=O)O)c1ccccc1)c1ccc(cc1)F
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,levocabastine,1586,,,135650515,Agonist,Full agonist,,f,f,,pKi,0,6.800000191,0,-,0,0,0,=,,,,11723247,N#C[C@@]1(CC[C@@H](CC1)N1CC[C@]([C@@H](C1)C)(C(=O)O)c1ccccc1)c1ccc(cc1)F
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,meclinertant,1582,,,135651079,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,11723247,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,meclinertant,1582,,,135651079,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,9480852,COc1cccc(c1c1cc(nn1c1ccnc2c1ccc(c2)Cl)C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3)OC
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,neuromedin N,1578,Nts|Nts,Mouse|Rat,135651813,Agonist,Full agonist,,t,,,pIC50,0,8.3,0,,0,0,0,,,,,8647296,
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,neuromedin N,1578,Nts|Nts,Mouse|Rat,135651813,Agonist,Full agonist,,t,,,pIC50,8.8,0,8.6,-,0,0,0,=,,,,9480852,
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,neurotensin,1579,NTS|Nts|Nts|NTS,Bovine|Human|Mouse|Rat,135651816,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,,0,0,0,,,,,10318778,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N
NTS<sub>2</sub> receptor,310,NTSR2,O95665,,,,,,Human,neurotensin,1579,NTS|Nts|Nts|NTS,Bovine|Human|Mouse|Rat,135651816,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,11723247,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,neurotensin,1579,NTS|Nts|Nts|NTS,Bovine|Human|Mouse|Rat,135651816,Agonist,Full agonist,,t,,,pIC50,8.7,0,8.5,,0,0,0,,,,,9480852,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,levocabastine,1586,,,135650515,Agonist,Partial agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,8647296,N#C[C@@]1(CC[C@@H](CC1)N1CC[C@]([C@@H](C1)C)(C(=O)O)c1ccccc1)c1ccc(cc1)F
NUAK family kinase 1,2129,NUAK1,O60285,,,,,,Human,HTH-01-015,8977,,,310264757,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,24171924,Cc1nc(Nc2cnn(c2)C2CCNCC2)nc2c1n(C)c(=O)c1c(n2C)cc2c(c1)cccc2
nucleobindin 1,2871,NUCB1,Q02818,,,,,,Human,KML110,8702,,,252166902,Antagonist,Antagonist,,f,f,,pIC50,0,5.019999981,0,IC50,0,9600,0,=,,,,26091042,CN1CCN(CC1)C(=O)C1=C(c2ccccc2)c2c(C1C)ccc(c2)[N+](=O)[O-]
nucleobindin 1,2871,NUCB1,Q02818,,,,,,Human,MJN228,8515,,,252166718,Antagonist,Antagonist,,f,t,,pIC50,0,5.480000019,0,IC50,0,3300,0,=,,,,26091042,CN1CCN(CC1)C(=O)c1[nH]c2c(c1c1ccccc1)cc(cc2)[N+](=O)[O-]
nucleotide binding oligomerization domain containing 1,1762,NOD1,Q9Y239,,,,,,Human,meso-DAP,5021,,,178101718,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,N[C@H](C(=O)O)CCC[C@H](C(=O)O)N
nucleotide binding oligomerization domain containing 1,1762,NOD1,Q9Y239,,,,,,Human,ML130,8887,,,310264668,Inhibitor,Inhibition,,f,t,,pIC50,0,6.25,0,IC50,0,560,0,=,,,,22003428,Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2c1cccc2
nucleotide binding oligomerization domain containing 2,1763,NOD2,Q9HC29,,,,,,Human,muramyl dipeptide,5024,,,178101721,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1O[C@@H](O)[C@@H]([C@H]([C@@H]1O)O[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N)CCC(=O)O)C)C)NC(=O)C
nucleotide binding oligomerization domain containing 2,1763,NOD2,Q9HC29,,,,,,Human,ML130,8887,,,310264668,Inhibitor,Inhibition,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,>,,,,22003428,Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2c1cccc2
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,naringin,4738,,,178101449,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,17301733,OC[C@H]1O[C@@H](Oc2cc(O)c3c(c2)O[C@@H](CC3=O)c2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,rifampicin,2765,,,135652711,Inhibitor,Inhibition,,f,f,,pKi,0,4.289999962,0,Ki,0,51000,0,=,,,,12085361,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C)c(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,rifamycin SV,4570,,,178101291,Inhibitor,Inhibition,,f,f,,pKi,0,4.960000038,0,Ki,0,11000,0,=,,,,12085361,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,,f,f,,pKi,0,7.289999962,0,Ki,0,51,0,=,,,,14530907,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,estrone-3-sulphate,4749,,,178101459,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,"Measured using estropipate, which is estrone-3-sulfate stabilized with piperazine.",,,20448812,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,gemfibrozil,3439,,,178100439,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,17470528,Cc1ccc(c(c1)OCCCC(C(=O)O)(C)C)C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,glycyrrhizin,4688,,,178101402,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)[C@H](O[C@@H]([C@H]1O)C(=O)O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,indocyanine green,4844,,,178101545,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CC1(C)c2c3ccccc3ccc2[N+](=C1C=CC=CC=CC=C1N(CCCCS(=O)(=O)[O-])c2c(C1(C)C)c1ccccc1cc2)CCCCS(=O)(=O)[O-].[Na+]
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,rifampicin,2765,,,135652711,Inhibitor,Inhibition,,f,f,,pKi,0,5.960000038,0,Ki,0,1100,0,=,Inhibition of atorvastatin transport by OATP1B1.,,,22541068,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C)c(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,rifamycin SV,4570,,,178101291,Inhibitor,Inhibition,,f,f,,pKi,0,5.699999809,0,Ki,0,2000,0,=,,,,12085361,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,pravastatin,2953,,,135650848,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC[C@@H](C(=O)O[C@H]1C[C@H](O)C=C2[C@H]1[C@@H](CC[C@H](C[C@H](CC(=O)O)O)O)[C@H](C=C2)C)C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,,,,17496208,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,gemfibrozil,3439,,,178100439,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,Cc1ccc(c(c1)OCCCC(C(=O)O)(C)C)C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,glycyrrhizin,4688,,,178101402,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)[C@H](O[C@@H]([C@H]1O)C(=O)O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,rifampicin,2765,,,135652711,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,17496208,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C)c(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,rifamycin SV,4570,,,178101291,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,sildenafil,4743,,,178101454,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,,,,17496208,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,DPDPE,1608,,,135652122,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CNC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)N)C(C)(C)SSC([C@@H](NC(=O)[C@@H](N1)Cc1ccccc1)C(=O)O)(C)C
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,probenecid,4357,,,178101174,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCN(S(=O)(=O)c1ccc(cc1)C(=O)O)CCC
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,erlotinib,4920,,,178101619,Inhibitor,Inhibition,,f,f,,pKi,0,6.28000021,0,Ki,0,530,0,=,,,,22541068,COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,gemfibrozil,3439,,,178100439,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,Cc1ccc(c(c1)OCCCC(C(=O)O)(C)C)C
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,glibenclamide,2414,,,135650306,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,COc1ccc(cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)Cl
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,rifamycin SV,4570,,,178101291,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,sildenafil,4743,,,178101454,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Inhibition only observed at sildenafil concentrations above those achieved in therapeutic use.,,,17496208,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
Oncostatin-M receptor,2315,OSMR|IL6ST,P40189|Q99650,,,,,,Human,oncostatin M,5035,OSM,Human,178101731,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Organic anion transporter 1,1025,SLC22A6,Q4U2R8,,,,,,Human,probenecid,4357,,,178101174,Inhibitor,Inhibition,Inhibition of urate transport by human SCL22A6.,f,t,,pIC50,0,4.900000095,0,IC50,0,12500,0,=,,,,12472777,CCCN(S(=O)(=O)c1ccc(cc1)C(=O)O)CCC
Organic cation transporter 2,1020,SLC22A2,O15244,,,,,,Human,decynium 22,8482,,,252166690,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,100,0,=,Measuring inhibition of tetraethylammonium (TEA) uptake <i>via</i> OCT2 expressed in <i>Xenopus</i> oocytes.,,,9260930,CC[n+]1c(ccc2c1cccc2)/C=c/1ccc2c(n1CC)cccc2
Organic cation transporter 3,1021,SLC22A3,O75751,,,,,,Human,disprocynium24,8826,,,252827483,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,10196521,CC([n+]1ccc(c2c1cccc2)/C=c1/ccc2c(n1C(C)C)cccc2)C
Ornithine decarboxylase,1276,ODC1,P11926,,,,,,Human,eflornithine,5176,,,178101866,Inhibitor,Inhibition,,f,t,,pKd,0,4.889999866,0,Kd,0,13000,0,=,,,,12859253,NCCCC(C(=O)O)(C(F)F)N
OT receptor,369,OXTR,P30559,,,,,,Human,dAVP,2181,,,135652083,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,15084136,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
OT receptor,369,OXTR,P30559,,,,,,Human,d[Cha<sup>4</sup>]AVP,2187,,,135652086,Agonist,Full agonist,,f,,,pKi,7.7,0,7.1,,0,0,0,,,,,12446593,
OT receptor,369,Oxtr,P70536,,,,,,Rat,"d[Cha<sup>4</sup>,Dab<sup>8</sup>]VP",2186,,,135652087,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,17300166,
OT receptor,369,Oxtr,P70536,,,,,,Rat,d[Cha<sup>4</sup>]LVP,2188,,,135652088,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,17300166,
OT receptor,369,OXTR,P30559,,,,,,Human,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,7.6,0,6.7,,0,0,0,,,,,7774575,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
OT receptor,369,OXTR,P30559,,,,,,Human,d[Leu<sup>4</sup>]AVP,2190,,,135652116,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,15084136,
OT receptor,369,Oxtr,P70536,,,,,,Rat,"d[Leu<sup>4</sup>,Dap<sup>8</sup>]VP",2189,,,135652117,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,17300166,
OT receptor,369,Oxtr,P70536,,,,,,Rat,d[Leu<sup>4</sup>]LVP,2191,,,135652118,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,17300166,
OT receptor,369,OXTR,P30559,,,,,,Human,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,t,,pKi,9.600000381,0,8.199999809,-,0,0,0,=,,,,10519430,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
OT receptor,369,Oxtr,P70536,,,,,,Rat,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,,,pKi,0,8.7,0,,0,0,0,,,,,12660315,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
OT receptor,369,OXTR,P30559,,,,,,Human,[Phe<sup>3</sup>]OT,2178,,,135652398,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7774575,CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C
OT receptor,369,OXTR,P30559,,,,,,Human,d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP,2223,,,135652096,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,7475979,COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N
OT receptor,369,OXTR,P30559,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2219,,,135652098,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,11337500,
OT receptor,369,OXTR,P30559,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3<sup>125</sup>I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2218,,,135652099,Antagonist,Antagonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,11337500,
OT receptor,369,OXTR,P30559,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr(3<sup>125</sup>I)-NH<sub>2</sub><sup>9</sup>]OVT",2220,,,135652100,Antagonist,Antagonist,,f,,,pKd,10,0,9.7,,0,0,0,,,,,7774575,
OT receptor,369,OXTR,P30559,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT",2221,,,135652101,Antagonist,Antagonist,,f,,,pKi,10,0,9.2,,0,0,0,,,,,15880385,
OT receptor,369,OXTR,P30559,,,,,,Human,"desGlyNH<sub>2</sub>-d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Orn<sup>8</sup>]OT",3870,,,178100707,Antagonist,Antagonist,,f,f,,pKi,0,8.5,0,Ki,0,0,0,=,,,,0,
OT receptor,369,OXTR,P30559,,,,,,Human,L023103,2194,,,135650461,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,16302826,CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C
OT receptor,369,Oxtr,P70536,,,,,,Rat,L023103,2194,,,135650461,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,16302826,CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-365,209",2241,,,135652251,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,7475979,CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-366,509",2242,,,135650468,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,7475979,OC(=O)CC1(O)CC2C(C1(CC2)CS(=O)(=O)N1CCC2(CC1)C=Cc1c2cccc1)(C)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-366,682",2243,,,135652252,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7475979,C=C[C@@H]([C@@H](C(=O)N1CCCC[C@]1(C=O)C(=O)N1CCCCC1)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1cnc[nH]1)N)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-366,875",2244,,,135652253,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,7475979,
OT receptor,369,OXTR,P30559,,,,,,Human,"L-366,948",2245,,,135652254,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,7475979,CC[C@@H]([C@@H](C(=O)[C@@]1(C=O)CCCN1C(=O)[C@@H](CC1=NC(N=C1)(C(=O)N1CCCCC1)C(=O)N1CCCCC1)N)NC(=O)[C@H](Cc1ccc2c(c1)cccc2)N)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-367,773",2246,,,135650469,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,7475979,O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-367,938",2247,,,135650470,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,7475979,
OT receptor,369,OXTR,P30559,,,,,,Human,"L-368,228",2248,,,135650471,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7475979,
OT receptor,369,OXTR,P30559,,,,,,Human,"L-368,899",2249,,,135650472,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,7475979,O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C
OT receptor,369,OXTR,P30559,,,,,,Human,"L-368,930",2250,,,135650473,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,7475979,
OT receptor,369,OXTR,P30559,,,,,,Human,"L-369,020",2251,,,135650474,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,7475979,
OT receptor,369,OXTR,P30559,,,,,,Human,"L-371,257",2252,,,135650475,Antagonist,Antagonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,16158071,COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C
OT receptor,369,OXTR,P30559,,,,,,Human,L-372662,2253,,,135650476,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,-,0,0,0,=,,,,9622556,COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-]
OT receptor,369,OXTR,P30559,,,,,,Human,LS-192629,2192,,,135650535,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.6,,0,0,0,,,,,12660315,CO/N=C/1CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C
OT receptor,369,Oxtr,P70536,,,,,,Rat,LS-192629,2192,,,135650535,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12660315,CO/N=C/1CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C
OT receptor,369,OXTR,P30559,,,,,,Human,"[Mpa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,<small>D</small>-Tic<sup>7</sup>,Aib<sup>9</sup>]OT",2255,,,135652300,Antagonist,Antagonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,17316912,
OT receptor,369,OXTR,P30559,,,,,,Human,"[Mpa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,<small>D</small>-Tic<sup>7</sup>]OT",2256,,,135652301,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,17316912,
OT receptor,369,OXTR,P30559,,,,,,Human,"[Mpa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,<small>D</small>-Tic<sup>7</sup>,<small>D</small>-Tic<sup>9</sup>]OT",2254,,,135652302,Antagonist,Antagonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,17316912,
OT receptor,369,OXTR,P30559,,,,,,Human,nelivaptan,2202,,,135651087,Antagonist,Antagonist,,f,,,pKi,8.8,0,6.8,,0,0,0,,,,,11861823,COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl
OT receptor,369,OXTR,P30559,,,,,,Human,OPC-21268,2196,,,135650773,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,7475979,CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2
OT receptor,369,OXTR,P30559,,,,,,Human,relcovaptan,2200,,,135651080,Antagonist,Antagonist,,f,,,pKi,7,0,6.5,,0,0,0,,,,,10519430,COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl
OT receptor,369,OXTR,P30559,,,,,,Human,retosiban,8403,,,252166613,Antagonist,Antagonist,,f,t,,pKi,0,9.18999958,0,Ki,0,0.649999976,0,=,,,,17395790,CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C
OT receptor,369,OXTR,P30559,,,,,,Human,Ro5028442,8529,,,252166731,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,9891,0,=,,,,25654260,CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C
OT receptor,369,OXTR,P30559,,,,,,Human,SSR126768A,2201,,,135651085,Antagonist,Antagonist,,f,f,,pKi,9.050000191,0,8.819999695,Ki,1.5,0,0.899999976,=,,,,14722330,CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1
OX40,1873,TNFRSF4,P43489,,,,,,Human,MOXR0916,9245,,,315661320,Antibody,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
OX40,1873,TNFRSF4,P43489,,,,,,Human,OX-40 ligand,5076,TNFSF4,Human,178101769,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,Gue1654,6173,,,178102794,Allosteric modulator,Negative,,f,,,pIC50,0,6,0,IC50,0,1000,0,~,,,,22634634,CSc1nc2c(s1)c1sc(nc1cc2)NC(=O)C(c1ccccc1)c1ccccc1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,orexin-A,1697,HCRT|Hcrt|Hcrt,Human|Mouse|Rat,135651845,Agonist,Full agonist,,t,f,,pEC50,10.19999981,0,6.5,-,0,0,0,=,,,,9491897,
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,orexin-B,1699,HCRT,Human,135651847,Agonist,Full agonist,,t,f,,pEC50,9.199999809,0,5.800000191,-,0,0,0,=,,,,9491897,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCN=C(N)N)CO)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CC(C)C)CCC(=O)N)C)CO)CC(=O)N)Cc1nc[nH]c1)C)C)[C@H](CC)C)CC(C)C)[C@H](O)C)N
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,filorexant,4460,,,135650616,Antagonist,Antagonist,,f,f,,pKi,0,8.600000381,0,Ki,0,2.50999999,0,=,,,,22019562,Cc1ccc(c(c1)C(=O)N1C[C@@H](CC[C@H]1C)COc1ccc(cn1)F)c1ncccn1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,JNJ-10397049,1701,,,135649646,Antagonist,Antagonist,,f,,,pKi,5.8,0,5.3,,0,0,0,,,,,15261275,O=C(Nc1ccc(cc1Br)Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,JNJ-42847922,9308,,,318164827,Antagonist,Antagonist,,f,f,,pKi,0,6.099999905,0,Ki,0,794,0,=,<i>In vitro</i> radioligand binding assay,,,26177655,Cc1cc(C)nc(n1)N1CC2C(C1)CN(C2)C(=O)c1c(F)cccc1n1nccn1
OX<sub>1</sub> receptor,321,Hcrtr1,P56718,,,,,,Rat,JNJ-42847922,9308,,,318164827,Antagonist,Antagonist,,f,f,,pKi,0,6.199999809,0,Ki,0,630,0,=,<i>In vitro</i> radioligand binding assay,,,26177655,Cc1cc(C)nc(n1)N1CC2C(C1)CN(C2)C(=O)c1c(F)cccc1n1nccn1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,lemborexant,9302,,,318164821,Antagonist,Antagonist,,f,t,,pKi,0,8.220000267,0,Ki,0,6,0,=,In a radioligand binding assay,,,25953512,O=C([C@@H]1C[C@@]1(COc1cnc(nc1C)C)c1cccc(c1)F)Nc1ccc(cn1)F
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,LSN2424100,9121,,,315661206,Antagonist,Antagonist,,f,f,,pKi,0,6.409999847,0,Ki,0,393,0,=,,,,24478625,Fc1ccc(cc1)S(=O)(=O)N(c1ccccc1c1ccccc1)Cc1[nH]ccn1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,MK-1064,9306,,,318164825,Antagonist,Antagonist,,f,f,,pKi,0,5.800000191,0,Ki,0,1584,0,=,,,,24376006,COc1nc(CNC(=O)c2cc(cnc2c2ccccn2)c2cncc(c2)Cl)ccc1OC
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,MK-3697,9307,,,318164826,Antagonist,Antagonist,,f,f,,pKi,0,5.440000057,0,Ki,0,3600,0,=,,,,25248679,COc1nc(CNC(=O)c2cc(ncc2c2nccs2)c2cncc(c2)C)ccc1OC
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,SB-334867,1703,,,135651005,Antagonist,Antagonist,,f,f,,pKi,7.5,0,7.400000095,-,0,0,0,=,,,,11459658,O=C(Nc1ccnc2c1nccc2)Nc1ccc2c(c1)oc(n2)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,SB-408124,1704,,,135651007,Antagonist,Antagonist,,f,f,,pKi,7.599999905,0,7.199999809,Ki,57,0,27,=,,,,14691055,O=C(Nc1cc(C)nc2c1cc(F)cc2F)Nc1ccc(cc1)N(C)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,SB-410220,1705,,,135651008,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,14691055,O=C(Nc1ccnc2c1c(F)ccc2F)Nc1ccc(cc1)N(C)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,SB-649868,4461,,,135651012,Antagonist,Antagonist,,f,f,,pKi,0,9.100000381,0,Ki,0,0.79400003,0,=,,,,21831639,Fc1ccc(cc1)c1sc(nc1C(=O)N1CCCC[C@H]1CNC(=O)c1cccc2c1cco2)C
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,SB-674042,9136,,,315661221,Antagonist,Antagonist,,f,t,,pKi,9.100000381,0,8.699999809,Ki,1.99000001,0,0.790000021,=,,,,14691055,Cc1sc(c(n1)C(=O)N1CCC[C@H]1Cc1nnc(o1)c1ccccc1)c1ccccc1F
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,orexin-A,1697,HCRT|Hcrt|Hcrt,Human|Mouse|Rat,135651845,Agonist,Full agonist,,t,f,,pEC50,10,0,6.5,-,0,0,0,=,,,,9491897,
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,orexin-B,1699,HCRT,Human,135651847,Agonist,Full agonist,,t,f,,pEC50,10,0,6.5,-,0,0,0,=,,,,9491897,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCN=C(N)N)CO)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CC(C)C)CCC(=O)N)C)CO)CC(=O)N)Cc1nc[nH]c1)C)C)[C@H](CC)C)CC(C)C)[C@H](O)C)N
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,EMPA,4037,,,135650708,Antagonist,Antagonist,,f,f,,pKi,0,9,0,-,0,0,0,=,,,,19751316,COc1ccc(cn1)N(S(=O)(=O)c1ccccc1C)CC(=O)N(Cc1cccnc1)CC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,filorexant,4460,,,135650616,Antagonist,Antagonist,,f,f,,pKi,0,9.5,0,Ki,0,0.319999993,0,=,,,,22019562,Cc1ccc(c(c1)C(=O)N1C[C@@H](CC[C@H]1C)COc1ccc(cn1)F)c1ncccn1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,JNJ-10397049,1701,,,135649646,Antagonist,Antagonist,,f,f,,pKi,8.600000381,0,8,-,0,0,0,=,,,,15261275,O=C(Nc1ccc(cc1Br)Br)N[C@H]1COC(O[C@H]1c1ccccc1)(C)C
OX<sub>2</sub> receptor,322,Hcrtr2,P56719,,,,,,Rat,JNJ-42847922,9308,,,318164827,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,Ki,0,7.900000095,0,=,<i>In vitro</i> radioligand binding assay,,,26177655,Cc1cc(C)nc(n1)N1CC2C(C1)CN(C2)C(=O)c1c(F)cccc1n1nccn1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,JNJ-42847922,9308,,,318164827,Antagonist,Antagonist,,f,t,,pKi,0,8,0,Ki,0,10,0,=,<i>In vitro</i> radioligand binding assay,,,26177655,Cc1cc(C)nc(n1)N1CC2C(C1)CN(C2)C(=O)c1c(F)cccc1n1nccn1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,lemborexant,9302,,,318164821,Antagonist,Antagonist,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,<i>In vitro</i> radioligand binding assay,,,25953512,O=C([C@@H]1C[C@@]1(COc1cnc(nc1C)C)c1cccc(c1)F)Nc1ccc(cn1)F
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,LSN2424100,9121,,,315661206,Antagonist,Antagonist,,f,t,,pKi,0,8.350000381,0,Ki,0,4.5,0,=,,,,24478625,Fc1ccc(cc1)S(=O)(=O)N(c1ccccc1c1ccccc1)Cc1[nH]ccn1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,MK-1064,9306,,,318164825,Antagonist,Antagonist,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,24376006,COc1nc(CNC(=O)c2cc(cnc2c2ccccn2)c2cncc(c2)Cl)ccc1OC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,MK-3697,9307,,,318164826,Antagonist,Antagonist,,f,t,,pKi,0,8.960000038,0,Ki,0,1.100000024,0,=,,,,25248679,COc1nc(CNC(=O)c2cc(ncc2c2nccs2)c2cncc(c2)C)ccc1OC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,SB-334867,1703,,,135651005,Antagonist,Antagonist,,f,f,,pKi,6.300000191,0,5.199999809,-,0,0,0,=,,,,11459658,O=C(Nc1ccnc2c1nccc2)Nc1ccc2c(c1)oc(n2)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,SB-408124,1704,,,135651007,Antagonist,Antagonist,,f,f,,pKi,6,0,5.699999809,-,0,0,0,=,,,,14691055,O=C(Nc1cc(C)nc2c1cc(F)cc2F)Nc1ccc(cc1)N(C)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,SB-649868,4461,,,135651012,Antagonist,Antagonist,,f,f,,pKi,0,8.899999619,0,Ki,0,1.25,0,=,,,,21831639,Fc1ccc(cc1)c1sc(nc1C(=O)N1CCCC[C@H]1CNC(=O)c1cccc2c1cco2)C
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,SB-674042,9136,,,315661221,Antagonist,Antagonist,,f,f,,pKi,0,6.889999866,0,Ki,0,129,0,=,,,,23891187,Cc1sc(c(n1)C(=O)N1CCC[C@H]1Cc1nnc(o1)c1ccccc1)c1ccccc1F
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,FRAX486,8938,,,310264719,Inhibitor,Inhibition,,f,f,,pIC50,0,8.079999924,0,IC50,0,8.25,0,=,,,,23509247,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)Cl)Nc1ccc(c(c1)F)N1CCNCC1
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,FRAX597,8939,,,310264720,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,23960073,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)c1cncs1)Nc1ccc(cc1)N1CCN(CC1)C
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,Il-94,8132,,,249565812,Inhibitor,Inhibition,,f,t,,pKi,0,7.429999828,0,Ki,0,36.79999924,0,=,,,,24900689,COCCN(c1nccc(n1)Nc1n[nH]c(c1)C1CC1)Cc1cc(F)cc2c1cn[nH]2
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,IPA-3,8940,,,310264721,Inhibitor,Inhibition,,f,t,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,,,,18420139,Oc1ccc2c(c1SSc1c(O)ccc3c1cccc3)cccc2
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pKi,0,7.440000057,0,Ki,0,36,0,=,,,,24432870,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
p21 (RAC1) activated kinase 1,2133,PAK1,Q13153,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,FRAX486,8938,,,310264719,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,39.5,0,=,,,,23509247,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)Cl)Nc1ccc(c(c1)F)N1CCNCC1
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,FRAX597,8939,,,310264720,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,23960073,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)c1cncs1)Nc1ccc(cc1)N1CCN(CC1)C
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,Il-94,8132,,,249565812,Inhibitor,Inhibition,,f,f,,pIC50,0,7.190000057,0,IC50,0,64.09999847,0,=,,,,24900689,COCCN(c1nccc(n1)Nc1n[nH]c(c1)C1CC1)Cc1cc(F)cc2c1cn[nH]2
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,26191365,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,PQA-18,9454,,,329968394,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,Using immunoprecipitated PAK2 and histone H4 substrate from Jurkat cells.,,,26827943,CC(=CCOc1cc(nc2c1cccc2OCC=C(C)C)C(=O)OCC=C(C)C)C
p21 (RAC1) activated kinase 2,2134,PAK2,Q13177,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
p21 (RAC1) activated kinase 3,2135,PAK3,O75914,,,,,,Human,FRAX486,8938,,,310264719,Inhibitor,Inhibition,,f,f,,pIC50,0,7.260000229,0,IC50,0,55.29999924,0,=,,,,23509247,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)Cl)Nc1ccc(c(c1)F)N1CCNCC1
p21 (RAC1) activated kinase 3,2135,PAK3,O75914,,,,,,Human,FRAX597,8939,,,310264720,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,23960073,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)c1cncs1)Nc1ccc(cc1)N1CCN(CC1)C
p21 (RAC1) activated kinase 3,2135,PAK3,O75914,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,99,0,=,,,,26191365,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
p21 (RAC1) activated kinase 4,2136,PAK4,O96013,,,,,,Human,FRAX486,8938,,,310264719,Inhibitor,Inhibition,,f,f,,pIC50,0,6.110000134,0,IC50,0,779,0,=,,,,23509247,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)Cl)Nc1ccc(c(c1)F)N1CCNCC1
p21 (RAC1) activated kinase 4,2136,PAK4,O96013,,,,,,Human,FRAX597,8939,,,310264720,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,23960073,CCn1c2nc(ncc2cc(c1=O)c1ccc(cc1Cl)c1cncs1)Nc1ccc(cc1)N1CCN(CC1)C
p21 (RAC1) activated kinase 4,2136,PAK4,O96013,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,Data from binding assays.,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
p21 (RAC1) activated kinase 4,2136,PAK4,O96013,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,24432870,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
p21 (RAC1) activated kinase 5,2138,PAK5,Q9P286,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,7.28000021,0,IC50,0,52,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
p21 (RAC1) activated kinase 5,2138,PAK5,Q9P286,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,171,0,=,,,,26191365,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
p21 (RAC1) activated kinase 6,2137,PAK6,Q9NQU5,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Data from binding assays.,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
p21 (RAC1) activated kinase 6,2137,PAK6,Q9NQU5,,,,,,Human,PF-3758309,8937,,,310264718,Inhibitor,Inhibition,,f,f,,pIC50,0,6.739999771,0,IC50,0,181,0,=,,,,26191365,CN(C[C@H](c1ccccc1)NC(=O)N1Cc2c(C1(C)C)[nH]nc2Nc1nc(C)nc2c1scc2)C
P2X1,478,P2RX1,P51575,,,,,,Human,L-&beta;&gamma;-meATP,4236,,,178101053,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H](COP(=O)(OP(=O)(CP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2X1,478,P2RX1,P51575,,,,,,Human,MRS 2219,6496,,,178103110,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,9632352,Cc1ncc2c(c1O)COP(=O)(OC2)O
P2X1,478,P2RX1,P51575,,,,,,Human,Ip<sub>5</sub>I,4225,,,178101042,Antagonist,Antagonist,,f,f,,pIC50,0,8.5,0,IC50,0,3.200000048,0,~,,,,0,OC1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OP(=O)([O-])[O-])[O-])[O-])[O-])OC[C@H]2O[C@H](C(C2O)O)n2cnc3c2ncnc3O)O[C@H](C1O)n1cnc2c1ncnc2O
P2X1,478,P2RX1,P51575,,,,,,Human,NF023,4266,,,178101083,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,~,,,,0,[Na]OS(=O)(=O)c1cc(cc2c1c(ccc2S(=O)(=O)O[Na])NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O[Na])S(=O)(=O)O[Na])S(=O)(=O)O[Na])S(=O)(=O)O[Na]
P2X1,478,P2RX1,P51575,,,,,,Human,NF449,4267,,,178101084,Antagonist,Antagonist,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,~,,,,15072843,[Na]OS(=O)(=O)c1cc(ccc1NC(=O)c1cc(NC(=O)Nc2cc(cc(c2)C(=O)Nc2ccc(cc2S(=O)(=O)O[Na])S(=O)(=O)O[Na])C(=O)Nc2ccc(cc2S(=O)(=O)O[Na])S(=O)(=O)O[Na])cc(c1)C(=O)Nc1ccc(cc1S(=O)(=O)O[Na])S(=O)(=O)O[Na])S(=O)(=O)O[Na]
P2X2,479,P2RX2,Q9UBL9,,,,,,Human,NF770,9545,,,336446931,Antagonist,Antagonist,,f,f,,pIC50,8,0,7,-,0,0,0,=,,,,23253448,COc1cc(cc2c1cc(NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1cc3c(OC)cc(cc3cc1S(=O)(=O)O)S(=O)(=O)O)C)c(c2)S(=O)(=O)O)S(=O)(=O)O
P2X2,479,P2RX2,Q9UBL9,,,,,,Human,NF778,9546,,,336446932,Antagonist,Antagonist,,f,f,,pIC50,8,0,7,-,0,0,0,=,,,,23253448,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1c(cc2c(c1S(=O)(=O)O)cc(cc2)S(=O)(=O)O)S(=O)(=O)O)NC1=CC(C=CC1)C(=O)NC1=C(C)C=CC(C1)C(=O)Nc1c(cc2c(c1S(=O)(=O)O)cc(cc2)S(=O)(=O)O)S(=O)(=O)O
P2X2,479,P2RX2,Q9UBL9,,,,,,Human,PSB-10211,9539,,,336446925,Antagonist,Antagonist,,f,f,,pIC50,0,7,0,-,0,0,0,~,,,,23253448,Clc1nc(Nc2cccc(c2)Nc2cc(c(c3c2C(=O)c2ccccc2C3=O)N)S(=O)(=O)O)nc(n1)Cl
P2X3,480,P2RX3,P56373,,,,,,Human,spinorphin,1026,,,135652476,Allosteric modulator,Negative,,f,f,,pIC50,0,11,0,-,0,0,0,=,,,,0,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)C(C)C)C(C)C)N)C
P2X3,480,P2RX3,P56373,,,,,,Human,RO3,4298,,,178101115,Antagonist,Antagonist,,f,f,,pIC50,0,7.5,0,IC50,0,31,0,~,,,,16465177,COc1cc(Cc2cnc(nc2N)N)c(cc1OC)C(C)C
P2X4,481,P2rx4,P51577,,,,,,Rat,ivermectin,2373,,,135650439,Allosteric modulator,Positive,,f,f,,pEC50,0,6.599999905,0,EC50,0,250,0,~,,,,10460235,CO[C@H]1C[C@H](OC2C(C)/C=C/C=C/3COC4C3(O)[C@@H](C=C([C@H]4O)C)C(=O)O[C@H]3CC(C/C=C/2C)O[C@]2(C3)CCC(C(O2)C(CC)C)C)O[C@H](C1O[C@H]1C[C@H](OC)C([C@@H](O1)C)O)C
P2X4,481,P2RX4,Q99571,,,,,,Human,paroxetine,4790,,,178101492,Antagonist,Antagonist,,f,f,,pIC50,6,0,5,-,0,0,0,=,,,,23253448,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2c(c1)OCO2
P2X4,481,P2RX4,Q99571,,,,,,Human,PSB-12062,9542,,,336446928,Antagonist,Antagonist,,f,f,,pIC50,6,0,5,-,0,0,0,=,,,,23253448,Cc1ccc(cc1)S(=O)(=O)N1c2ccccc2Oc2c1cccc2
P2X7,484,P2RX7,Q99572,,,,,,Human,GW791343,9022,,,315661107,Allosteric modulator,Negative,,f,f,,-,0,0,0,-,0,0,0,=,,,,18071294,O=C(Nc1cc(ccc1C)CN1CCNCC1)CNc1ccc(c(c1)F)F
P2X7,484,P2RX7,Q99572,,,,,,Human,KN62,4235,,,178101052,Allosteric modulator,Negative,,f,,,-,0,0,0,-,0,0,0,=,,,,15210579,O=C([C@@H](N(S(=O)(=O)c1cccc2c1ccnc2)C)Cc1ccc(cc1)OS(=O)(=O)c1cccc2c1ccnc2)N1CCN(CC1)c1ccccc1
P2X7,484,P2rx7,Q64663,,,,,,Rat,GW791343,9022,,,315661107,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,18071294,O=C(Nc1cc(ccc1C)CN1CCNCC1)CNc1ccc(c(c1)F)F
P2X7,484,P2RX7,Q99572,,,,,,Human,ivermectin,2373,,,135650439,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,22506590,CO[C@H]1C[C@H](OC2C(C)/C=C/C=C/3COC4C3(O)[C@@H](C=C([C@H]4O)C)C(=O)O[C@H]3CC(C/C=C/2C)O[C@]2(C3)CCC(C(O2)C(CC)C)C)O[C@H](C1O[C@H]1C[C@H](OC)C([C@@H](O1)C)O)C
P2X7,484,P2RX7,Q99572,,,,,,Human,decavanadate,2459,,,135652750,Antagonist,Antagonist,pA<sub>2</sub> = 7.4,f,f,,pA2,0,7.400000095,0,-,0,0,0,=,,,,16487507,[O-][V](=O)(O[V]1(=O)O[V]2(=O)O[V](=O)(O[V]3(=O)O[V](=O)(O1)O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O2)O[V](=O)([O-])[O-])[O-]
P2X7,484,P2RX7,Q99572,,,,,,Human,JNJ-47965567,7538,,,187051839,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,Measuring antagonism of BzATP induced calcium flux.,,,23889535,O=C(c1cccnc1Sc1ccccc1)NCC1(CCOCC1)N1CCN(CC1)c1ccccc1
P2X7,484,P2RX7,Q99572,,,,,,Human,JNJ-47965567,7538,,,187051839,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,Ki,0,12.60000038,0,=,,,,23889535,O=C(c1cccnc1Sc1ccccc1)NCC1(CCOCC1)N1CCN(CC1)c1ccccc1
P2X7,484,P2RX7,Q99572,,,,,,Human,PF-04905428,9062,,,315661147,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,21565499,COC[C@@H](Cn1c(=O)cnn(c1=O)c1ccc(c(c1)C(=O)NCC1(O)CCCCCC1)Cl)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,dATP,1760,,,135651464,Agonist,Full agonist,,f,,,pEC50,5,0,4.8,,0,0,0,,,,,10578132,O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NAADP,2450,,,53801022,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,17707504,O[C@@H]1[C@H](O)[C@H](O[C@H]1[n+]1cccc(c1)C(=O)O)COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)n1cnc2c1ncnc2N)O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NAD,2451,,,135651521,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,16926152,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)O)[O-])O[C@H]([C@@H]1O)[n+]1cccc(c1)C(=O)N
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NF546,4046,,,178100870,Agonist,Full agonist,,f,,,pEC50,0,6.27,0,-,0,0,0,=,,,,19815812,[Na]OP(=O)(Cc1cc(ccc1NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(cc1CP(=O)(O[Na])O)CP(=O)(O[Na])O)C)CP(=O)(O[Na])O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NF157,1761,,,135650710,Antagonist,Antagonist,,f,f,,pKi,0,7.349999905,0,-,0,0,0,=,,,,16250663,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NF340,1762,,,135650711,Antagonist,Antagonist,,f,,,pEC50,7.7,0,7.35,-,0,0,0,=,,,,18404494,[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,NF340,1762,,,135650711,Antagonist,Antagonist,,f,f,,pIC50,7.099999905,0,6.400000095,-,0,0,0,=,,,,19815812,[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,f,,pIC50,0,5,0,-,0,0,0,=,,,,10578132,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,INS49266,1769,,,135650402,Antagonist,Antagonist,,f,,,pIC50,0,6.28,0,,0,0,0,,,,,18232657,O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,pCMPS,1773,,,135650790,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,15199474,Cl[Hg]c1ccc(cc1)S(=O)(=O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,PSB-0739,5904,,,178102527,Antagonist,Antagonist,,f,,,pA2,0,9.8,0,-,0,0,0,=,,,,19690189,[Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na]
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,PSB-0739,5904,,,178102527,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,Ki,0,24.9,0,=,,,,19463000,[Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na]
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,R-138727,1771,,,135650878,Antagonist,Antagonist,,f,,,pIC50,5.7,0,4.7,,0,0,0,,,,,16268477,OC(=O)/C=C1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,regrelor,1770,,,135650403,Antagonist,Antagonist,,f,,,pIC50,0,7.95,0,,0,0,0,,,,,18232657,CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,MRS2211,1777,,,135650655,Antagonist,Antagonist,,f,f,,pIC50,0,5.96999979,0,-,0,0,0,=,,,,15913566,OCc1c(COP(=O)(O)O)c(/N=N/c2cc(ccc2Cl)N(=O)=O)nc(c1O)C
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,MRS2603,1778,,,135650662,Antagonist,Antagonist,,f,f,,pIC50,0,6.179999828,0,-,0,0,0,=,,,,15913566,O=CC1=C(COP(=O)(O)O)/C(=N/Nc2ccc(c(c2)[N+](=O)[O-])Cl)/N=C(C1=O)C
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,PPADS,1725,,,135650843,Antagonist,Antagonist,,f,,,pIC50,0,4.9,0,,0,0,0,,,,,12815166,O=Cc1c(COP(=O)(O)O)c(/N=N/c2ccc(cc2S(=O)(=O)O)S(=O)(=O)O)nc(c1O)C
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,12815166,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,MRS2690,3337,,,178100368,Agonist,Agonist,,f,f,,pEC50,7.309999943,0,6.639999866,EC50,229,0,49,=,,,,17407275,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=S)O[Na])O[Na])[C@@H]([C@H]([C@@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,MRS2802,5909,,,178102532,Agonist,Agonist,,f,,,pEC50,0,7.2,0,EC50,0,63,0,=,,,,19902968,O[C@H]1[C@@H](COP(=O)(C(P(=O)(O)O)(F)F)O)O[C@H]([C@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,MRS2905,5908,,,178102531,Agonist,Agonist,,f,f,,pEC50,0,9,0,EC50,0,0.920000017,0,=,,,,21484092,O[C@H]1[C@@H](COP(=O)(CCP(=O)(O)O)O)O[C@H]([C@H]1O)n1ccc(=O)[nH]c1=S
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,MRS4183,9471,,,329968411,Agonist,Agonist,,f,f,,pEC50,0,9.020000458,0,EC50,0,0.959999979,0,=,Measuring inhibition of forskolin-stimulated cAMP formation in CHO cells expressing the human P2Y<sub>14</sub> receptor,,,26303895,O=C(COc1ccc(cc1)C1=[N+]2C(=Cc3n([B-]2(F)F)c(cc3)c2cccs2)C=C1)NCCCCCNC(=O)[C@H]1O[C@H](OP(=O)(OP(=O)(OCC2OC(C(C2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,MRS4174,9470,,,329968410,Antagonist,Antagonist,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079999998,0,=,,,,25299434,O=C(c1ccc(c(c1)C(=O)O)c1c2ccc(c(c2oc2c1ccc(=[NH2+])c2S(=O)(=O)[O-])S(=O)(=O)O)N)NCCCCCCn1nnc(c1)CCCCN1CCC(CC1)c1ccc(cc1)c1cc(cc2c1ccc(c2)c1ccc(cc1)C(F)(F)F)C(=O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,PPTN,5802,,,178102427,Antagonist,Antagonist,,f,f,,pKi,0,10.10000038,0,KB,0,0.433999985,0,=,,,,23592514,OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2365,3338,,,178100369,Agonist,Agonist,,f,f,,pEC50,0,9.399999619,0,-,0,0,0,=,,,,15345752,CSc1nc(N)c2c(n1)n(cn2)C1[C@H](O)[C@@H]([C@]2([C@@H]1C2)COP(=O)(OP(=O)(O[Na])O[Na])O[Na])O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,dATP&alpha;S,1715,,,135651465,Agonist,Partial agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,9154346,O[C@H]1C[C@@H](O[C@@H]1COP(=S)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,GlaxoSmithKline compound 5h [PMID:20542694],5807,,,178102432,Antagonist,Antagonist,,f,,,pKi,0,6.85,0,Ki,0,140,0,=,,,,20542694,CCCCCc1ccc(cc1)NC(=O)Nc1cccc2c1oc(c2)c1ccccc1C(C)C
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,GlaxoSmithKline compound 6i [PMID:18926700],5806,,,178102431,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,Ki,0,70,0,=,,,,18926700,CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2c(N1C(=O)c1cc(Cl)cc(c1)Cl)cccc2
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2179,1720,,,135650654,Antagonist,Antagonist,,f,f,,pKi,7.099999905,0,7,-,0,0,0,=,,,,12391289,CNc1ncnc2c1ncn2[C@H]1C[C@@H]([C@H](O1)COP(=O)(O)[O-])OP(=O)(O)[O-]
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2279,1721,,,135650656,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,12391289,CNc1nc(Cl)nc2c1ncn2C[C@H]1C[C@@H]([C@H](C1)COP(=O)(O)O)OP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2298,1722,,,135650657,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15476670,CNc1nc(Cl)nc2c1ncn2CC(COP(=O)(O)O)COP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2496,1723,,,135650658,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,15476670,CNc1nc(Cl)nc2c1ncn2CC(CP(=O)(O)O)CP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2500,1724,,,135650659,Antagonist,Antagonist,,f,f,,pKi,9.100000381,0,8.800000191,-,0,0,0,=,,,,15476670,CNc1nc(I)nc2c1ncn2[C@H]1C[C@@H]([C@]2([C@@H]1C2)COP(=O)(O)O)OP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,MRS2950,5809,,,178102434,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,IC50,0,140,0,=,,,,22831801,O=C(Nc1ccc(c(c1)Cl)Cl)Nc1ccc(cc1)S(=C)(=C)Nc1onc(c1C)C
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,Pfizer compound 11 [PMID:18445527],5804,,,178102429,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,Ki,0,50,0,=,,,,18445527,O=C(Nc1ccccc1Oc1cc(nn1c1ccccc1Cl)C)Nc1ccc(cc1)OC(F)(F)F
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,Pfizer compound 67 [PMID:18445527],5805,,,178102430,Antagonist,Antagonist,,f,,,pKi,0,8,0,Ki,0,10,0,=,,,,18445527,CCc1ccccc1n1nc(cc1Oc1ccccc1NC(=O)Nc1ccc(cc1)C1CCCCC1)C
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,PPADS,1725,,,135650843,Antagonist,Antagonist,,f,f,,pKi,0,5.199999809,0,-,0,0,0,=,,,,12391289,O=Cc1c(COP(=O)(O)O)c(/N=N/c2ccc(cc2S(=O)(=O)O)S(=O)(=O)O)nc(c1O)C
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,denufosol,1737,,,135651590,Agonist,Full agonist,,f,f,,pEC50,0,6.699999809,0,-,0,0,0,=,,,,11206448,Nc1ccn(c(=O)n1)[C@@H]1O[C@@H]([C@H](C1)O)COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O)O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,diquafosol,1736,,,135651591,Agonist,Full agonist,,f,f,,pEC50,0,7,0,-,0,0,0,=,,,,11206448,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,MRS2698,1733,,,135650664,Agonist,Full agonist,,f,f,,pEC50,0,8.100000381,0,-,0,0,0,=,,,,17302398,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1N)n1ccc(=O)[nH]c1=S
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,MRS2768,4043,,,178100867,Agonist,Full agonist,EC<sub>50</sub> value determined using an IP<sub>3</sub> functional assay,f,f,,pEC50,0,5.699999809,0,EC50,0,1890,0,=,,,,18514530,C[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(Oc2ccccc2)O)O)O)O)O[C@H]([C@@H]1C)n1ccc(=O)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,PSB1114,5902,,,178102525,Agonist,Full agonist,EC<sub>50</sub> value determined using an IP<sub>3</sub> functional assay,f,f,,pEC50,0,6.900000095,0,EC50,0,134,0,=,,,,17125260,O[C@@H]1[C@@H](COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O)O[C@H]([C@@H]1O)n1ccc(=S)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,PSB-416,9468,,,329968408,Antagonist,Antagonist,,f,f,,pIC50,0,4.659999847,0,IC50,0,21700,0,=,,,,19419204,COc1ccc(cc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,-,0,0,0,=,,,,10401562,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,denufosol,1737,,,135651590,Agonist,Full agonist,,f,f,,pEC50,0,6.099999905,0,-,0,0,0,=,,,,12183642,Nc1ccn(c(=O)n1)[C@@H]1O[C@@H]([C@H](C1)O)COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O)O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,diquafosol,1736,,,135651591,Agonist,Full agonist,,f,f,,pEC50,0,6.400000095,0,-,0,0,0,=,,,,16475938,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,MRS2927,6199,,,178102820,Agonist,Full agonist,,f,f,,pEC50,0,7.210000038,0,EC50,0,62,0,=,,,,21528910,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)C2C=CC(=O)NC2=O)O)O)O)O)[C@@H]([C@H]([C@@H]1O)F)O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,MRS4062,4044,,,178100868,Agonist,Full agonist,,f,f,,pEC50,0,7.599999905,0,EC50,0,23,0,=,,,,21528910,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cc/c(=N/OCCCc2ccccc2)/[nH]c1=O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,(N)methanocarba-UTP,1740,,,135650724,Agonist,Full agonist,,f,f,,pEC50,0,7.099999905,0,-,0,0,0,=,,,,11754592,OC1C(n2ccc(=O)[nH]c2=O)C2C(C1O)(C2)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,N<sup>4</sup>-phenylethoxycytidine-5'-triphosphate,6200,,,178102821,Agonist,Full agonist,,f,,,pEC50,0,7.14,0,EC50,0,73,0,=,,,,21528910,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cc/c(=N/OCCc2ccccc2)/[nH]c1=O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,CTP,1741,,,135651463,Agonist,Partial agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(nc1=O)N
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,guanosine-5'-triphosphate,1742,,,135650326,Agonist,Partial agonist,,f,,,pEC50,0,5.2,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]c(N)nc2=O
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,guanosine-5'-triphosphate,1742,,,135650326,Agonist,Partial agonist,,f,,,pEC50,0,5.6,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]c(N)nc2=O
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,ITP,1743,,,135651496,Agonist,Partial agonist,,f,,,pEC50,5.8,0,5.7,,0,0,0,,,,,9647463,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]cnc2=O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,ITP,1743,,,135651496,Agonist,Partial agonist,,f,,,pEC50,0,5.1,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1[nH]cnc2=O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,PPADS,1725,,,135650843,Antagonist,Antagonist,,f,f,,pEC50,5,0,2,-,0,0,0,=,,,,18600475,O=Cc1c(COP(=O)(O)O)c(/N=N/c2ccc(cc2S(=O)(=O)O)S(=O)(=O)O)nc(c1O)C
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,f,,pIC50,0,4.699999809,0,-,0,0,0,=,,,,9647463,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS2957,5903,,,178102526,Agonist,Agonist,,f,f,,pEC50,0,7.900000095,0,EC50,0,12,0,=,,,,20446735,CO/N=c1/ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O)COP(=O)(OP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,Rp-5-OMe-UDP&alpha;B,5910,,,178102533,Agonist,Agonist,,f,f,,pEC50,0,8.100000381,0,EC50,0,8,0,=,,,,22901672,COC1CN(C(=O)NC1=O)C1O[C@@H]([C@@H]([C@@H]1O)O)CO[P@@](=O)(OP(=O)(O)O)[BH3-]
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,INS48823,1746,,,135650401,Agonist,Full agonist,,f,,,pEC50,0,6.9,0,,0,0,0,,,,,16475938,O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS2693,1747,,,135650663,Agonist,Full agonist,,f,f,,pEC50,0,7.820000172,0,EC50,0,15,0,=,,,,16942026,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1c(I)cc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS2782,1748,,,135650665,Agonist,Full agonist,,f,,,pEC50,0,6.18,0,,0,0,0,,,,,18514530,O[C@@H]1[C@@H](COP(=O)(CP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS2567,1752,,,135650660,Antagonist,Antagonist,,f,f,,pIC50,0,6.900000095,0,-,0,0,0,=,,,,15081875,S=C=Nc1ccc(cc1)CCc1ccc(cc1)N=C=S
P2Y<sub>6</sub> receptor,326,P2ry6,Q63371,,,,,,Rat,MRS2567,1752,,,135650660,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15081875,S=C=Nc1ccc(cc1)CCc1ccc(cc1)N=C=S
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS2578,1753,,,135650661,Antagonist,Antagonist,,f,f,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,15081875,S=C=Nc1cccc(c1)NC(=S)NCCCCNC(=S)Nc1cccc(c1)N=C=S
P2Y<sub>6</sub> receptor,326,P2ry6,Q63371,,,,,,Rat,MRS2578,1753,,,135650661,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15081875,S=C=Nc1cccc(c1)NC(=S)NCCCCNC(=S)Nc1cccc(c1)N=C=S
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,MRS4162,9469,,,329968409,Antagonist,Antagonist,,f,f,,pEC50,0,7.639999866,0,EC50,0,23,0,=,,,,24712832,O=C(COc1ccc(cc1)CCCONc1ccn(c(=O)n1)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O)NCCc1nnn(c1)CCCNC(=O)CCCCCNC(=O)COc1ccc(cc1)/C=C/c1ccc2n1[B-](F)(F)[N+]1=C(C=CC1=C2)c1cccs1
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,PPADS,1725,,,135650843,Antagonist,Antagonist,,f,f,,pKB,0,4,0,KB,0,100000,0,=,,,,26519900,O=Cc1c(COP(=O)(O)O)c(/N=N/c2ccc(cc2S(=O)(=O)O)S(=O)(=O)O)nc(c1O)C
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,f,,pIC50,0,4.5,0,IC50,0,31000,0,=,,,,16475938,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,reactive blue-2,1739,,,135650889,Antagonist,Antagonist,,f,f,,pKB,0,6,0,KB,0,1000,0,=,,,,26519900,OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,maxadilan,2264,,,135652280,Agonist,Agonist,,f,f,,pEC50,0,10.30000019,0,EC50,0,0.054000001,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,maxadilan,2264,,,135652280,Agonist,Agonist,,f,f,,pEC50,0,6.199999809,0,EC50,0,568,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,9.1,0,EC50,0,0.8,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,7.4,0,EC50,0,37,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,8.5,0,EC50,0,3.3,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,9,0,EC50,0,1,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,8.5,0,Ki,0,3,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,7.6,0,IC50,0,25,0,=,inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,10.6,0,EC50,0,0.026,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,10.1,0,EC50,0,0.08,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,10,0,EC50,0,0.1,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,8.5,0,Ki,0,3.1,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,8.8,0,Ki,0,1.5,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,6.9,0,Ki,0,129,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,8.5,0,Ki,0,2.9,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,8.7,0,EC50,0,2,0,=,stimulation of cyclic AMP formation in NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,9.2,0,EC50,0,0.6,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,9.5,0,EC50,0,0.34,0,=,stimulation of adenylate cyclase in COS cells transiently expressing recombinant receptor,,,8995389,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,7.5,0,EC50,0,29,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,10,0,EC50,0,0.1,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,8.8,0,Ki,0,1.7,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,9,0,Ki,0,1.1,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,8.3,0,EC50,0,5.1,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,10.3,0,EC50,0,0.049,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,10,0,EC50,0,0.1,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,8.8,0,Ki,0,1.5,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,8.4,0,Ki,0,4,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,9.2,0,EC50,0,0.7,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,6.9,0,Ki,0,121,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Agonist,,f,,,pEC50,0,7.1,0,EC50,0,71.3,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,,,pIC50,0,5,0,IC50,0,10000,0,>,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9145428,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,=,Inhibition of [125I]-Ac-His1-PACAP-27 binding in membranes from CHO cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,M65,3305,,,135652276,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,IC50,0,277.4,0,=,inhibition of calcium influx stimulated by 30nM PACAP-27 in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,M65,3305,,,135652276,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,IC50,0,149.6,0,=,inhibition of cyclic AMP formation stimulated by 0.1nM PACAP-27 in CHO cells stably expressing recombinant receptor,,,16930633,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,MK-0893,9135,,,315661220,Antagonist,Antagonist,,f,f,,pIC50,0,5.039999962,0,IC50,0,9200,0,=,,,,22708876,COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,N-stearyl-[Nle<sup>17</sup>] neurotensin-(6-11)/VIP-(7-28),2266,,,135652357,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,IC50,0,65,0,=,inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-(6-38),2267,,,135652376,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,Ki,0,8,0,=,inhibition of PACAP-27 stimulated  adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-(6-38),2267,,,135652376,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,Ki,0,30,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PACAP-(6-38),2267,,,135652376,Antagonist,Antagonist,,f,,,pKi,0,8,0,Ki,0,10,0,=,inhibition of PACAP-27 stimulated  adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9437716,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,9437714,
PAF receptor,334,,,,,,,,Unknown,methylcarbamyl PAF,3427,,,135651517,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCCCCCCCCCCCCOC[C@@H](OC(=O)NC)COP(=O)(OCC[N+](C)(C)C)[O-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,enantio PAF C-16,1834,,,135650231,Agonist,Full agonist,,f,,,pIC50,0,5,0,,0,0,0,,,,,7594622,CCCCCCCCCCCCCCCCOCC(OC(=O)C)COP(=O)(OCC[N+](C)(C)C)[O-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,PAF,1831,,,135651534,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,-,0,0,0,=,,,,7594622,CCCCCCCCCCCCCCCCOC[C@@H](OC(=O)C)COP(=O)(OCC[N+](C)(C)C)[O-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,PAF,1831,,,135651534,Agonist,Full agonist,,t,,,pKi,7.9,0,7.5,,0,0,0,,,,,1657923,CCCCCCCCCCCCCCCCOC[C@@H](OC(=O)C)COP(=O)(OCC[N+](C)(C)C)[O-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,CV-3988,6079,,,178102700,Antagonist,Antagonist,,f,,,pIC50,0,6.8,0,IC50,0,160,0,=,,,,2986648,CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)(OCC[n+]1ccsc1)[O-])OC
PAF receptor,334,PTAFR,P25105,,,,,,Human,CV-6209,1852,,,135650142,Antagonist,Antagonist,,f,f,,pIC50,8.300000191,0,8.100000381,-,0,0,0,=,,,,1657923,CCCCCCCCCCCCCCCCCCNC(=O)OCC(COC(=O)N(C(=O)C)Cc1cccc[n+]1CC)OC
PAF receptor,334,PTAFR,P25105,,,,,,Human,foropafant,1856,,,135651077,Antagonist,Antagonist,,f,f,,pKi,0,10.30000019,0,-,0,0,0,=,,,,8395255,CN(CCN(c1scc(n1)c1c(cc(cc1C(C)C)C(C)C)C(C)C)Cc1cccnc1)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,ginkgolide A,1861,,,135652684,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,12190325,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,ginkgolide B,1862,,,135652686,Antagonist,Antagonist,,f,f,,pKi,6.199999809,0,6.099999905,-,0,0,0,=,,,,12570381,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)C[C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,ginkgolide C,1863,,,135652687,Antagonist,Antagonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,12190325,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2O)[C@H](OC3=O)[C@@H]([C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C)O
PAF receptor,334,Ptafr,Q62035,,,,,,Mouse,ginkgolide J,1864,,,135652688,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,12190325,O=C1O[C@@H]2[C@@]([C@@H]1C)(O)[C@@]13C4(C2)[C@H](OC3=O)[C@@H]([C@H](C24[C@H](O1)OC(=O)C2O)C(C)(C)C)O
PAF receptor,334,PTAFR,P25105,,,,,,Human,israpafant,1857,,,135651337,Antagonist,Antagonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,1657923,CC(Cc1ccc(cc1)CCc1sc2c(c1)C(=NC(c1n2c(C)nn1)C)c1ccccc1Cl)C
PAF receptor,334,PTAFR,P25105,,,,,,Human,L659989,3426,,,178100430,Antagonist,Antagonist,,f,f,,pKi,0,7.800000191,0,Ki,0,14.30000019,0,=,,,,2841449,CCCOc1c(OC)cc(cc1S(=O)(=O)C)[C@@H]1CC[C@H](O1)c1cc(OC)c(c(c1)OC)OC
PAF receptor,334,PTAFR,P25105,,,,,,Human,PCA 4248,6080,,,178102701,Antagonist,Antagonist,Inhibition of PAF-induced platelet aggregation.,f,,,pIC50,0,5.44,0,IC50,0,3600,0,=,,,,2170626,COC(=O)C1=C(C)NC(=C(C1C)C(=O)OCCSc1ccccc1)C
PAF receptor,334,PTAFR,P25105,,,,,,Human,PCA 4248,6080,,,178102701,Antagonist,Antagonist,Displacement of [<sup>3</sup>H]PAF binding to polymorphonuclear cells.,f,,,pA2,0,7.4,0,-,0,0,0,=,,,,2170626,COC(=O)C1=C(C)NC(=C(C1C)C(=O)OCCSc1ccccc1)C
PAF receptor,334,PTAFR,P25105,,,,,,Human,RP-52770,1839,,,135649816,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,2831350,Clc1cccc(c1)NC(=O)c1ccn2c1CSC2c1cccnc1
PAF receptor,334,PTAFR,P25105,,,,,,Human,SCH 37370,1853,,,135651026,Antagonist,Antagonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,10465415,Clc1ccc2c(c1)CCc1c(C2=C2CCN(CC2)C(=O)C)nccc1
PAF receptor,334,PTAFR,P25105,,,,,,Human,SCH 40338,1854,,,135651027,Antagonist,Antagonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,10465415,Clc1ccc2c(c1)CCc1c(C2N2CCN(CC2)C(=O)C)nccc1
PAF receptor,334,PTAFR,P25105,,,,,,Human,SDZ 64-412,1855,,,135651034,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,3183958,COc1cc(CCc2ccc(cc2)c2cc3ccccc3c3=NCCn23)cc(c1OC)OC
pancreatic lipase,2590,PNLIP,P16233,,,,,,Human,orlistat,5277,,,178101960,Inhibitor,Inhibition,,f,t,,pIC50,0,8.899999619,0,IC50,0,1.299999952,0,=,,,,0,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
PAR1,347,F2R,P25116,,,,,,Human,F16357,9255,,,315661330,Agonist,Agonist,,f,f,,pIC50,0,5.190000057,0,IC50,0,6400,0,=,,,,0,Fc1ccc(cc1)CN1CCN(CC1)C(=O)/C=C/c1ccccc1Cl
PAR1,347,F2R,P25116,,,,,,Human,RWJ-56110,3525,,,178100505,Antagonist,Antagonist,,f,f,,pIC50,0,6.360000134,0,IC50,0,440,0,=,,,,10535908,NCC[C@@H](C(=O)NCc1ccccc1)NC(=O)[C@H](Cc1ccc(c(c1)F)F)NC(=O)Nc1ccc2c(c1)n(Cc1c(Cl)cccc1Cl)cc2CN1CCCC1
PAR2,348,F2RL1,P55085,,,,,,Human,GB110,6657,,,178103269,Agonist,Agonist,,f,,,pEC50,0,6.55,0,EC50,0,280,0,=,,,,20873792,NCC1CCN(CC1)C(=O)c1cccc(c1)CNC(=O)[C@H](C(CC)C)NC(=O)[C@@H](NC(=O)c1ccno1)CC1CCCCC1
PAR2,348,F2RL1,P55085,,,,,,Human,SLIGKV-NH<sub>2</sub>,3740,,,178100604,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,18179608,
PAR2,348,F2RL1,P55085,,,,,,Human,SLIGRL-NH<sub>2</sub>,3741,,,178100605,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,18179608,
PAR2,348,F2RL1,P55085,,,,,,Human,GB88,6658,,,178103270,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,,,,21806599,CC[C@H]([C@@H](C(=O)N1CCC2(CC1)C=Cc1c2cccc1)NC(=O)[C@@H](NC(=O)c1ccno1)CC1CCCCC1)C
PAR2,348,F2RL1,P55085,,,,,,Human,P2pal18s,6659,,,178103271,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,21536878,
PAR4,350,F2RL3,Q96RI0,,,,,,Human,GYPGKF-NH2,3883,,,178100719,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
PAR4,350,F2RL3,Q96RI0,,,,,,Human,GYPGQV-NH<sub>2</sub>,3739,,,178100603,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
PAR4,350,F2RL3,Q96RI0,,,,,,Human,ML354,9459,,,329968399,Antagonist,Antagonist,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,=,Antagonism measured in a novel PAC-1 fluorescent &alpha;IIb&beta;3 activation assay.,,,25176330,OCc1c(c2ccccc2)c2c(n1C)ccc(c2)[N+](=O)[O-]
PAS domain containing serine/threonine kinase,2139,PASK,Q96RG2,,,,,,Human,PP-242,5704,,,178102331,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition at 1&mu;M compound.,,,18849971,Oc1ccc2c(c1)cc([nH]2)c1nn(c2c1c(N)ncn2)C(C)C
PDZ binding kinase,2140,PBK,Q96KB5,,,,,,Human,OTS964,7813,,,223366144,Inhibitor,Inhibition,,f,t,,pIC50,0,7.550000191,0,IC50,0,28,0,=,,,,25338756,CN(C[C@@H](c1ccc(cc1)c1c(O)cc(c2c1c1ccsc1c(=O)[nH]2)C)C)C
peptidase D,2389,,,,,,,,Pig,phosphoenolpyruvic acid,4692,,,178101405,Inhibitor,Inhibition,,f,f,,pKi,9.619999886,0,9.520000458,Ki,0.300000012,0,0.239999995,=,Biphasic inhibition of purified enzyme from pig kidney.,,,0,OC(=O)C(=C)OP(=O)(O)O
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,Lys[Z(NO<sub>2</sub>)]-Pro,4498,,,178101226,Inhibitor,Inhibition,,f,f,,pKi,5.300000191,0,5,Ki,10000,0,5000,=,,,,11284702,O=C(Oc1ccc(cc1)[N+](=O)[O-])NCCCCC(C(=O)N1CCC[C@H]1C(=O)O)N
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,Lys[Z(NO<sub>2</sub>)]-Val,9486,,,329968426,Inhibitor,Inhibition,,f,f,,pKi,0,5.699999809,0,Ki,0,2000,0,=,Competition assays in Caco-2 cells expressing PEPT1.,,,14706812,
Peptide transporter 2,985,SLC15A2,Q16348,,,,,,Human,Lys[Z(NO<sub>2</sub>)]-Lys[Z(NO<sub>2</sub>)],4499,,,178101227,Inhibitor,Inhibition,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,16868651,O=C(OCc1ccc(cc1)[N+](=O)[O-])NCCCCC(C(=O)[O-])NC(=O)C(CCCCNC(=O)Oc1ccc(cc1)[N+](=O)[O-])[NH3+]
Peptide transporter 2,985,SLC15A2,Q16348,,,,,,Human,Lys[Z(NO<sub>2</sub>)]-Pro,4498,,,178101226,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(Oc1ccc(cc1)[N+](=O)[O-])NCCCCC(C(=O)N1CCC[C@H]1C(=O)O)N
peptidyl arginine deiminase 1,2894,PADI1,Q9ULC6,,,,,,Human,<i>o</i>-F-amidine,8625,,,315661097,Inhibitor,Irreversible inhibition,,f,t,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,,,,21882827,FCC(=N)NCCCC(C(=O)N)NC(=O)c1ccccc1C(=O)O
peptidyl arginine deiminase 3,2878,,,,,,,,None,streptonigrin,8683,,,252166883,Inhibitor,Inhibition,,f,f,,pIC50,0,6.369999886,0,IC50,0,430,0,=,,,,0,COC1=C(OC)C=C/C(=c2/c(N)c([nH]c(c2C)C(=O)O)c2ccc3c(n2)C(=O)C(=C(C3=O)OC)N)/C1=O
peptidyl arginine deiminase 4,2877,,,,,,,,None,streptonigrin,8683,,,252166883,Inhibitor,Inhibition,,f,t,,pIC50,0,5.599999905,0,IC50,0,2500,0,=,,,,20740228,COC1=C(OC)C=C/C(=c2/c(N)c([nH]c(c2C)C(=O)O)c2ccc3c(n2)C(=O)C(=C(C3=O)OC)N)/C1=O
peptidyl arginine deiminase 4,2877,PADI4,Q9UM07,,,,,,Human,<i>o</i>-F-amidine,8625,,,315661097,Inhibitor,Irreversible inhibition,,f,t,,pIC50,0,5.71999979,0,IC50,0,1900,0,=,,,,21882827,FCC(=N)NCCCC(C(=O)N)NC(=O)c1ccccc1C(=O)O
peptidylprolyl isomerase A,2751,PPIA,P62937,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,Inhibition of the phosphatase activity of calcineurin in Jurkat cells.,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,1373887,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,CP-775146,6691,,,178103303,Agonist,Agonist,,f,,,pEC50,0,7.3,0,-,0,0,0,=,,,,18971326,O=C(N1CCC[C@H](C1)c1cccc(c1)OC(C(=O)O)(C)C)Cc1ccc(cc1)C(C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,DRF 2519,2671,,,135650210,Agonist,Agonist,,f,,,pEC50,0,5,0,,0,0,0,,,,,15140637,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN1COc2c(C1=O)cccc2
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,edaglitazone,8907,,,310264688,Agonist,Agonist,,f,f,,pEC50,0,5.980000019,0,EC50,0,1053,0,=,Measuring agonist-induced cofactor recruitment.,,,22489042,O=C1NC(=O)C(S1)Cc1ccc(c2c1scc2)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,,,,,,,,Unknown,eicosatetranoic acid,2669,,,135651482,Agonist,Agonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,8384714,CCCCCC#CCC#CCC#CCC#CCCCC(=O)O
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,farglitazar,2672,,,135650251,Agonist,Agonist,,f,,,pEC50,0,6.35,0,,0,0,0,,,,,15452359,OC(=O)[C@@H](Nc1ccccc1C(=O)c1ccccc1)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,fenofibrate,7186,,,178103761,Agonist,Agonist,,f,t,,pEC50,0,4.519999981,0,EC50,0,30000,0,=,In a cell based hPPAR-GAL4 transactivation assay.,,,15293980,CC(OC(=O)C(Oc1ccc(cc1)C(=O)c1ccc(cc1)Cl)(C)C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,gemfibrozil,3439,,,178100439,Agonist,Agonist,,f,t,,pEC50,0,4.230000019,0,EC50,0,59000,0,=,,,,21889235,Cc1ccc(c(c1)OCCCC(C(=O)O)(C)C)C
Peroxisome proliferator-activated receptor-&alpha;,593,,,,,,,,Unknown,GW2331,2680,,,135650331,Agonist,Agonist,,f,,,pKd,0,6.8,0,,0,0,0,,,,,1324435,CCCCCCCN(C(=O)Nc1ccc(cc1F)F)CCc1ccc(cc1)O[C@](C(=O)O)(CC)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,GW409544,2656,,,135650335,Agonist,Agonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,15293980,C/C(=C/C(=O)c1ccccc1)/N[C@H](C(=O)O)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,GW7647,2674,,,135650339,Agonist,Agonist,,f,f,,pEC50,0,8.199999809,0,-,0,0,0,=,,,,10389847,O=C(N(CCc1ccc(cc1)SC(C(=O)O)(C)C)CCCCC1CCCCC1)NC1CCCCC1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,GW9578,2673,,,135650342,Agonist,Agonist,,f,,,pEC50,0,7.3,0,,0,0,0,,,,,10389847,CCCCCCCN(C(=O)Nc1ccc(cc1F)F)CCc1ccc(cc1)SC(C(=O)O)(C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,imiglitazar,2675,,,135650383,Agonist,Agonist,,f,,,pEC50,0,7.17,0,,0,0,0,,,,,11095972,OC(=O)CC/C(=NOCc1ccc(cc1)OCc1nc(oc1C)c1ccccc1)/c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,,,,,,,,Unknown,LTB<sub>4</sub>,2487,,,53801088,Agonist,Agonist,,t,,,pIC50,0,7,0,-,0,0,0,=,,,,8900274,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,LY-465608,2659,,,135650557,Agonist,Agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,11405642,Cc1oc(nc1CCOc1ccc(cc1)OC(C(=O)O)(C)C)c1ccc(cc1)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,LY-510929,2657,,,135650558,Agonist,Agonist,,f,,,pIC50,0,7.55,0,,0,0,0,,,,,15115385,OC(=O)[C@@](Oc1ccccc1)(Cc1ccc(cc1)OCCc1nc(oc1C)c1cccs1)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,LY-518674,2658,,,135650559,Agonist,Agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,14613314,Cc1ccc(cc1)Cn1[nH]c(nc1=O)CCCc1ccc(cc1)OC(C(=O)O)(C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,MK-0767,2677,,,135650612,Agonist,Agonist,,f,,,pKd,7.64,0,6.8,,0,0,0,,,,,15120604,COc1ccc(cc1C(=O)NCc1ccc(cc1)C(F)(F)F)CC1SC(=O)NC1=O
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,N-oleoylethanolamide,2661,,,135651533,Agonist,Agonist,,f,,,pIC50,0,6.92,0,,0,0,0,,,,,12955147,CCCCCCCC/C=CCCCCCCCC(=O)NCCO
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,NS-220,2678,,,135650744,Agonist,Agonist,,f,,,pEC50,0,6.73,0,,0,0,0,,,,,14982965,Cc1ccc(cc1)c1oc(c(n1)CCCC[C@@H]1CO[C@](OC1)(C)C(=O)O)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,pirinixic acid,2666,,,135650834,Agonist,Agonist,,f,f,,pEC50,0,5.300000191,0,-,0,0,0,=,,,,10691680,OC(=O)CSc1nc(cc(n1)Cl)Nc1cccc(c1C)C
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,pristanic acid,2676,,,135651550,Agonist,Agonist,,t,,,pEC50,0,4.4,0,,0,0,0,,,,,11060349,C[C@@H](CCC[C@@H](C(=O)O)C)CCC[C@@H](CCCC(C)C)C
Peroxisome proliferator-activated receptor-&alpha;,593,,,,,,,,None,pterostilbene,2681,,,135650865,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,COc1cc(/C=C/c2ccc(cc2)O)cc(c1)OC
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,ragaglitazar,2664,,,135650882,Agonist,Agonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,12672231,CCO[C@H](C(=O)O)Cc1ccc(cc1)OCCN1c2ccccc2Oc2c1cccc2
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,reglitazar,2670,,,135650893,Agonist,Agonist,,f,,,pEC50,0,5.72,0,,0,0,0,,,,,9932726,O=C1ONC(=O)C1Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,GW6471,3440,,,178100440,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,IC50,0,240,0,=,,,,11845213,CCC(=O)NC[C@H](Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1)N/C(=CC(=O)c1ccc(cc1)C(F)(F)F)/C
Peroxisome proliferator-activated receptor-&alpha;,593,Ppara,P23204,,,,,,Mouse,MK-886,2655,,,135650618,Antagonist,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,11139388,Clc1ccc(cc1)Cn1c2ccc(cc2c(c1CC(C(=O)O)(C)C)SC(C)(C)C)C(C)C
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,GW0742X,2686,,,135650328,Agonist,Full agonist,,f,,,pIC50,0,9,0,-,0,0,0,=,,,,15939051,OC(=O)COc1ccc(cc1C)SCc1sc(nc1C)c1ccc(c(c1)F)C(F)(F)F
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,GW2433,2716,,,135650332,Agonist,Full agonist,,f,f,,pEC50,0,6.599999905,0,-,0,0,0,=,,,,10691680,O=C(N(CCc1c(F)cccc1Cl)CCCc1ccc(cc1)OC(C(=O)O)(C)C)Nc1cccc(c1Cl)Cl
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,GW501516,2687,,,135650336,Agonist,Full agonist,,f,f,,pEC50,0,9,0,-,0,0,0,=,,,,11309497,OC(=O)COc1ccc(cc1C)SCc1sc(nc1C)c1ccc(cc1)C(F)(F)F
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,GW9578,2673,,,135650342,Agonist,Full agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,11354382,CCCCCCCN(C(=O)Nc1ccc(cc1F)F)CCc1ccc(cc1)SC(C(=O)O)(C)C
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,L-165041,2691,,,135650464,Agonist,Full agonist,,f,f,,pKi,0,8.199999809,0,-,0,0,0,=,,,,10691680,CCCc1c(OCCCOc2ccc(cc2)OCC(=O)O)ccc(c1O)C(=O)C
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,L-783483,2688,,,135650496,Agonist,Full agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,10037770,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1onc2C(F)(F)F
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,L-796449,2689,,,135650497,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,15293980,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1occ2c1ccccc1
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,GSK0660,3441,,,178100441,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,IC50,0,300,0,=,,,,17975020,COC(=O)c1sccc1S(=O)(=O)Nc1ccc(cc1OC)Nc1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,edaglitazone,8907,,,310264688,Agonist,Agonist,,f,t,,pEC50,0,7.449999809,0,EC50,0,35.59999847,0,=,Measuring agonist-induced cofactor recruitment.,,,22489042,O=C1NC(=O)C(S1)Cc1ccc(c2c1scc2)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,rosiglitazone,1056,,,135650927,Agonist,Agonist,,f,t,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,11720854,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,COOH,2715,,,53801056,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,14600074,CCCc1cc(ccc1OCCc1cc2c([nH]1)ccc(c2)CC(=O)O)Oc1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,DRF 2519,2671,,,135650210,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,15140637,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN1COc2c(C1=O)cccc2
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW1929,2703,,,135650330,Agonist,Full agonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,10389847,OC(=O)[C@@H](Nc1ccccc1C(=O)c1ccccc1)Cc1ccc(cc1)OCCN(c1ccccn1)C
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,GW2331,2680,,,135650331,Agonist,Full agonist,,f,,,pKd,0,6.52,0,,0,0,0,,,,,9113987,CCCCCCCN(C(=O)Nc1ccc(cc1F)F)CCc1ccc(cc1)O[C@](C(=O)O)(CC)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW409544,2656,,,135650335,Agonist,Full agonist,,f,,,pEC50,0,9.55,0,,0,0,0,,,,,15293980,C/C(=C/C(=O)c1ccccc1)/N[C@H](C(=O)O)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW7845,2704,,,135650340,Agonist,Full agonist,,f,,,pKi,0,8.43,0,,0,0,0,,,,,9836620,COC(=O)c1ccccc1N[C@H](C(=O)O)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW9578,2673,,,135650342,Agonist,Full agonist,,f,,,pEC50,0,6,0,,0,0,0,,,,,11354382,CCCCCCCN(C(=O)Nc1ccc(cc1F)F)CCc1ccc(cc1)SC(C(=O)O)(C)C
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,ibuprofen,2713,,,135650365,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,11755111,CC(Cc1ccc(cc1)C(C(=O)O)C)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,L-165461,2690,,,135650465,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,10037770,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1onc2CC
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,L-783483,2688,,,135650496,Agonist,Full agonist,,f,,,pKi,0,7.85,0,,0,0,0,,,,,10037770,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1onc2C(F)(F)F
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,L-796449,2689,,,135650497,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,10037770,CCCc1c(OCCCSc2ccc(cc2Cl)CC(=O)O)ccc2c1occ2c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,LG100754,2814,,,135650518,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,11463859,CCCOc1cc2c(cc1/C(=CC=CC(=CC(=O)O)C)/C)C(C)(C)CCC2(C)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,linoleic acid,1052,,,135651503,Agonist,Full agonist,,t,,,pKd,0,5.3,0,,0,0,0,,,,,11301062,CCCCC/C=CC/C=CCCCCCCCC(=O)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,LY-465608,2659,,,135650557,Agonist,Full agonist,,f,,,pIC50,0,6.26,0,,0,0,0,,,,,11405642,Cc1oc(nc1CCOc1ccc(cc1)OC(C(=O)O)(C)C)c1ccc(cc1)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,LY-510929,2657,,,135650558,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,3071214,OC(=O)[C@@](Oc1ccccc1)(Cc1ccc(cc1)OCCc1nc(oc1C)c1cccs1)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,mesalazine,2700,,,135649824,Agonist,Full agonist,,f,t,,pIC50,0,1.820000052,0,-,0,0,0,=,,,,15824083,Nc1ccc(c(c1)C(=O)O)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,MK-0767,2677,,,135650612,Agonist,Full agonist,,f,,,pEC50,0,7,0,,0,0,0,,,,,15120604,COc1ccc(cc1C(=O)NCc1ccc(cc1)C(F)(F)F)CC1SC(=O)NC1=O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,MK-0767,2677,,,135650612,Agonist,Full agonist,,f,,,pKd,0,6.49,0,,0,0,0,,,,,9836514,COc1ccc(cc1C(=O)NCc1ccc(cc1)C(F)(F)F)CC1SC(=O)NC1=O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,netoglitazone,2707,,,135650709,Agonist,Full agonist,,f,,,pKd,0,6.3,0,,0,0,0,,,,,9830009,O=C1NC(=O)C(S1)Cc1ccc2c(c1)ccc(c2)OCc1ccccc1F
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,pioglitazone,2694,,,135650829,Agonist,Full agonist,,f,t,,pIC50,0,6.199999809,0,-,0,0,0,=,,,,9836620,CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,ragaglitazar,2664,,,135650882,Agonist,Full agonist,,f,,,pIC50,0,7.03,0,,0,0,0,,,,,12672231,CCO[C@H](C(=O)O)Cc1ccc(cc1)OCCN1c2ccccc2Oc2c1cccc2
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,reglitazar,2670,,,135650893,Agonist,Full agonist,,f,,,pEC50,0,7.1,0,,0,0,0,,,,,9932726,O=C1ONC(=O)C1Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,rosiglitazone,1056,,,135650927,Agonist,Full agonist,,f,t,,pKd,0,7.400000095,0,-,0,0,0,=,,,,9836620,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,SB-219993,2698,,,53801072,Agonist,Full agonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,9454824,OC(=O)[C@@H](Cc1ccc(cc1)OCCN(c1nc2c(o1)cccc2)C)OCC(F)(F)F
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,SB-219994,2697,,,135650989,Agonist,Full agonist,,f,,,pIC50,0,8.68,0,,0,0,0,,,,,9454824,OC(=O)[C@H](Cc1ccc(cc1)OCCN(c1nc2c(o1)cccc2)C)OCC(F)(F)F
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,diclofenac,2714,,,135650177,Agonist,Partial agonist,,f,,,-,0,0,0,,0,0,0,,,,,14646253,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,farglitazar,2672,,,135650251,Agonist,Partial agonist,,f,,,pKd,0,7.47,0,,0,0,0,,,,,9836620,OC(=O)[C@@H](Nc1ccccc1C(=O)c1ccccc1)Cc1ccc(cc1)OCCc1nc(oc1C)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,FMOC-L-Leucine,2705,,,135650280,Agonist,Partial agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,11684010,CC(CC(C(=O)O)NC(=O)OCC1c2ccccc2c2c1cccc2)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW0072,2695,,,135651255,Agonist,Partial agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,10339548,CCCCCCC[C@@H]1S[C@H](C(=O)N1CCCCc1ccc(cc1)C(=O)O)CC(=O)N(Cc1ccccc1)Cc1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,indomethacin,1909,,,135650390,Agonist,Partial agonist,,f,,,pKd,0,7.38,0,,0,0,0,,,,,11301062,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,L-764406,2696,,,135650491,Agonist,Partial agonist,,f,,,pIC50,0,7.15,0,,0,0,0,,,,,10075686,Clc1nc2ccccc2nc1CS(=O)(=O)c1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,MRL20,6742,,,178103353,Agonist,Partial agonist,<i>In vitro</i> hPPAR&gamma; binding,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,,,,15603954,COc1ccc(cc1)C(=O)n1c(C)c(c2c1ccc(c2)OC(F)(F)F)Cc1ccccc1O[C@H](C(=O)O)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,MRL24,6743,,,178103354,Agonist,Partial agonist,<i>In vitro</i> hPPAR&gamma; binding,f,,,pIC50,0,9,0,IC50,0,1,0,=,,,,15603954,COc1ccc(cc1)C(=O)n1c(C)c(c2c1ccc(c2)OC(F)(F)F)Cc1cccc(c1)O[C@H](C(=O)O)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,nTzDpa,2699,,,135650749,Agonist,Partial agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,12554792,Clc1ccc2c(c1)c(Sc1ccccc1)c(n2Cc1ccc(cc1)Cl)C(=O)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,PAT5A,2709,,,135650788,Agonist,Partial agonist,,f,,,pKd,0,6.35,0,,0,0,0,,,,,12730351,O=C1NC(=O)/C(=C/c2ccc(cc2)OCC2CCCN2c2ccccn2)/S1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,diclofenac,2714,,,135650177,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,-,0,0,0,=,,,,11752200,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,resveratrol,8741,,,252827399,Antagonist,Antagonist,,f,f,,pKd,0,5.849999905,0,Kd,0,1400,0,=,,,,24796862,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,GW9662,3442,,,178100442,Antagonist,Irreversible inhibition,,f,,,pIC50,0,8.1,0,-,0,0,0,=,,,,12022867,Clc1ccc(cc1C(=O)Nc1ccccc1)[N+](=O)[O-]
PHD finger protein 8,2698,PHF8,Q9UPP1,,,,,,Human,daminozide,7025,,,178103604,Inhibitor,Inhibition,,f,f,,pIC50,0,6.260000229,0,IC50,0,550,0,=,,,,22724510,CN(NC(=O)CCC(=O)O)C
Phenylethanolamine N-methyltransferase,2496,PNMT,P11086,,,,,,Human,LY134046,6631,,,178103244,Inhibitor,Inhibition,,f,,,pKi,0,7.6,0,-,0,0,0,=,,,,6268095,Clc1ccc2c(c1Cl)CNCCC2
phosphatase and tensin homolog,2497,PTEN,P60484,,,,,,Human,P6949,8877,,,252827534,Inhibitor,Inhibition,,f,f,,pIC50,0,5.050000191,0,IC50,0,8870,0,=,,,,22705189,OC(=O)CCc1cccc(c1)[Sb](=O)(O)O
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,PIK-III,9379,,,328083481,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,,,,25327288,Nc1ncc(c(n1)CC1CC1)c1ccnc(n1)Nc1ccncc1
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,SAR405,9353,,,328083455,Inhibitor,Inhibition,,f,t,,pKd,0,8.819999695,0,Kd,0,1.519999981,0,=,,,,25326666,Clc1cncc(c1)CN1c2nc(cc(=O)n2CC[C@H]1C(F)(F)F)N1CCOC[C@H]1C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PIK-108,8968,,,310264748,Allosteric modulator,Negative,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,22524426,Cc1cc([C@@H](Nc2ccccc2)C)c2c(c1)c(=O)cc(o2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,dactolisib,7950,,,249565633,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,18606717,N#CC(c1ccc(cc1)n1c(=O)n(c2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2)C)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,dezapelisib,9728,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,>,,,,0,Fc1cccc(c1)c1c(nc2n(c1=O)c(C)cs2)[C@@H](Nc1ncnc2c1nc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,duvelisib,7795,,,223366126,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1602,0,=,,,,24211136,Clc1cccc2c1c(=O)n(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,eCF309,9571,,,336446957,Inhibitor,Inhibition,,f,f,,pIC50,0,6.010000229,0,IC50,0,981,0,=,In a biochemical assay.,,,0,CCOC(Cn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)OCC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,GDC-0077,9636,,,340590266,Inhibitor,Inhibition,,f,t,,pKi,0,10.47000027,0,Ki,0,0.034000002,0,=,,,,0,NC(=O)[C@@H](Nc1ccc2c(c1)OCCn1c2nc(c1)N1C(=O)OC[C@H]1C(F)F)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,gedatolisib,7940,,,249565623,Inhibitor,Inhibition,,f,t,,pIC50,0,9.399999619,0,IC50,0,0.400000006,0,=,,,,20166697,O=C(Nc1ccc(cc1)c1nc(nc(n1)N1CCOCC1)N1CCOCC1)Nc1ccc(cc1)C(=O)N1CCC(CC1)N(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,GSK1059615,9826,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,24900173,O=C1NC(=O)/C(=C/c2ccc3c(c2)c(ccn3)c2ccncc2)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,HS-173,8243,,,249565923,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,21388141,CCOC(=O)c1cnc2n1cc(cc2)c1cncc(c1)NS(=O)(=O)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,idelalisib,6741,,,178103352,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,820,0,=,,,,20959606,CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1[nH]cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,INK-128,7933,,,249565616,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,219,0,=,,,,22367541,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,IPI549,9563,,,336446949,Inhibitor,Inhibition,,f,f,,pKd,0,7.769999981,0,Kd,0,17,0,=,,,,27660692,Cn1ncc(c1)C#Cc1cccc2c1c(=O)n(c(c2)[C@@H](NC(=O)c1c(N)nn2c1nccc2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,KU-0060648,8011,,,249565691,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,23855836,CCN1CCN(CC1)CC(=O)Nc1ccc(c2c1c1ccccc1s2)c1cccc2c1oc(cc2=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,leniolisib,9424,,,328083524,Inhibitor,Inhibition,,f,f,,pIC50,0,6.579999924,0,IC50,0,262,0,=,<i>In vitro</i> enzyme assay,,,0,CCC(=O)N1CC[C@@H](C1)Nc1ncnc2c1CN(CC2)c1cnc(c(c1)C(F)(F)F)OC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,t,,pIC50,0,6.699999809,0,IC50,300,0,200,=,,,,19297156,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,LY3023414,8918,,,310264699,Inhibitor,Inhibition,,f,t,,pIC50,0,8.210000038,0,IC50,0,6.099999905,0,=,,,,0,CO[C@H](Cn1c(=O)n(c2c1c1cc(ccc1nc2)c1cncc(c1)C(O)(C)C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,nemiralisib,9425,,,328083525,Inhibitor,Inhibition,,f,f,,pIC50,0,5.300000191,0,IC50,0,5011,0,=,In a homogeneous time-resolved fluorescence (HTRF) assay,,,26301626,CC(N1CCN(CC1)Cc1cnc(o1)c1cc(cc2c1cn[nH]2)c1cccc2c1cc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,omipalisib,8974,,,310264754,Inhibitor,Inhibition,,f,t,,pKi,0,7.71999979,0,Ki,0,19,0,=,,,,24900173,COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2c(c1)c(ccn2)c1ccnnc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PF-04691502,7936,,,249565619,Inhibitor,Inhibition,,f,t,,pKi,0,9.239999771,0,Ki,0,0.569999993,0,=,,,,24900269,OCCO[C@@H]1CC[C@H](CC1)n1c(=O)c(cc2c1nc(N)nc2C)c1ccc(nc1)OC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PI 3-Kg inhibitor,6023,,,178102645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)nccn3)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PI 3-Kg inhibitor II,6024,,,178102646,Inhibitor,Inhibition,,f,f,,pIC50,0,5.349999905,0,IC50,0,4500,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(O3)(F)F)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,f,,pKi,0,8.590000153,0,Ki,0,2.559999943,0,=,,,,0,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,18754654,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,t,,pIC50,0,8.239999771,0,IC50,0,5.800000191,0,=,,,,16647110,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,17601739,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,pilaralisib,7963,,,249565646,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,,,,0,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2c(c1)nsn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,7.28000021,0,IC50,0,52,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,quinostatin,8978,,,310264758,Inhibitor,Inhibition,,f,f,,pIC50,0,4.820000172,0,IC50,0,15000,0,=,Inhibition of lipid-kinase activity <i>in vitro</i>.,,,17462572,CCc1ccc(cc1)C(=O)c1cnc2c(c1N1CCC(CC1)C(=O)N)cc1c(c2)OCCO1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,quinostatin,8978,,,310264758,Inhibitor,Inhibition,,f,f,,pKd,0,6.21999979,0,Kd,0,600,0,=,<i>In vitro</i> binding affinity to recombinant complex of PI3K alpha regulatory and catalytic subunits.,,,17462572,CCc1ccc(cc1)C(=O)c1cnc2c(c1N1CCC(CC1)C(=O)N)cc1c(c2)OCCO1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,seletalisib,9800,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,5.440000057,0,IC50,0,3638,0,=,,,,28442583,[O-][n+]1cccc(c1)c1nc2c(cc1[C@H](C(F)(F)F)Nc1ncnc3c1nccc3)cccc2Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,serabelisib,8969,,,310264749,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,<,,,,0,Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PIK-108,8968,,,310264748,Allosteric modulator,Negative,,f,f,,pIC50,0,7.550000191,0,IC50,0,28,0,=,,,,22524426,Cc1cc([C@@H](Nc2ccccc2)C)c2c(c1)c(=O)cc(o2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,7.269999981,0,IC50,0,54,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,dezapelisib,9728,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,>,,,,0,Fc1cccc(c1)c1c(nc2n(c1=O)c(C)cs2)[C@@H](Nc1ncnc2c1nc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,duvelisib,7795,,,223366126,Inhibitor,Inhibition,,f,f,,pIC50,0,7.070000172,0,IC50,0,85,0,=,,,,24211136,Clc1cccc2c1c(=O)n(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,GDC-0077,9636,,,340590266,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,99.69999695,0,=,,,,0,NC(=O)[C@@H](Nc1ccc2c(c1)OCCn1c2nc(c1)N1C(=O)OC[C@H]1C(F)F)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,idelalisib,6741,,,178103352,Inhibitor,Inhibition,,f,f,,pIC50,0,6.25,0,IC50,0,565,0,=,,,,20959606,CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1[nH]cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,IPI549,9563,,,336446949,Inhibitor,Inhibition,,f,f,,pKd,0,7.090000153,0,Kd,0,82,0,=,,,,27660692,Cn1ncc(c1)C#Cc1cccc2c1c(=O)n(c(c2)[C@@H](NC(=O)c1c(N)nn2c1nccc2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,KU-0060648,8011,,,249565691,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,23855836,CCN1CCN(CC1)CC(=O)Nc1ccc(c2c1c1ccccc1s2)c1cccc2c1oc(cc2=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,t,,pIC50,0,6.570000172,0,IC50,0,270,0,=,,,,23855836,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pKd,0,6.570000172,0,Kd,0,270,0,=,,,,24533473,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,LY3023414,8918,,,310264699,Inhibitor,Inhibition,,f,f,,pIC50,0,7.110000134,0,IC50,0,78,0,=,,,,0,CO[C@H](Cn1c(=O)n(c2c1c1cc(ccc1nc2)c1cncc(c1)C(O)(C)C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,nemiralisib,9425,,,328083525,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1584,0,=,In a homogeneous time-resolved fluorescence (HTRF) assay,,,26301626,CC(N1CCN(CC1)Cc1cnc(o1)c1cc(cc2c1cn[nH]2)c1cccc2c1cc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,omipalisib,8974,,,310264754,Inhibitor,Inhibition,,f,f,,pKi,0,6.889999866,0,Ki,0,130,0,=,,,,24900173,COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2c(c1)c(ccn2)c1ccnnc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PI-3065,8242,,,249565922,Inhibitor,Inhibition,,f,f,,pIC50,0,5.96999979,0,IC50,0,1078,0,=,,,,24919154,Fc1ccc2c(c1c1nc3cc(sc3c(n1)N1CCOCC1)CN1CCN(CC1)CC1CC1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PI 3-Kg inhibitor,6023,,,178102645,Inhibitor,Inhibition,,f,f,,pIC50,0,6.570000172,0,IC50,0,270,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)nccn3)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,f,,pKi,0,7.150000095,0,Ki,0,70.19999695,0,=,,,,0,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,t,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,18754654,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,,,,16647110,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,850,0,=,,,,17601739,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,pilaralisib,7963,,,249565646,Inhibitor,Inhibition,,f,f,,pIC50,0,6.420000076,0,IC50,0,383,0,=,,,,0,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2c(c1)nsn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,f,,pIC50,0,5.849999905,0,IC50,0,1400,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,seletalisib,9800,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,5.670000076,0,IC50,0,2129,0,=,,,,28442583,[O-][n+]1cccc(c1)c1nc2c(cc1[C@H](C(F)(F)F)Nc1ncnc3c1nccc3)cccc2Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,serabelisib,8969,,,310264749,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,<,,,,0,Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PIK-108,8968,,,310264748,Allosteric modulator,Negative,,f,f,,pIC50,0,6.179999828,0,IC50,0,658,0,=,,,,22524426,Cc1cc([C@@H](Nc2ccccc2)C)c2c(c1)c(=O)cc(o2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,dactolisib,7950,,,249565633,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,18606717,N#CC(c1ccc(cc1)n1c(=O)n(c2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2)C)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,dezapelisib,9728,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,<,The same value was obtained using an enzyme activity assay and a scintillation proximity assay.,,,0,Fc1cccc(c1)c1c(nc2n(c1=O)c(C)cs2)[C@@H](Nc1ncnc2c1nc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,duvelisib,7795,,,223366126,Inhibitor,Inhibition,,f,t,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,24211136,Clc1cccc2c1c(=O)n(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,eCF309,9571,,,336446957,Inhibitor,Inhibition,,f,f,,pIC50,0,5.739999771,0,IC50,0,1840,0,=,In a biochemical assay.,,,0,CCOC(Cn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)OCC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,GDC-0077,9636,,,340590266,Inhibitor,Inhibition,,f,f,,pKi,0,7.909999847,0,Ki,0,12.19999981,0,=,,,,0,NC(=O)[C@@H](Nc1ccc2c(c1)OCCn1c2nc(c1)N1C(=O)OC[C@H]1C(F)F)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,IC-87114,9376,,,328083478,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,~,,,,15975507,Nc1ncnc2c1ncn2Cc1nc2cccc(c2c(=O)n1c1ccccc1C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,IC-87114,9376,,,328083478,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,=,,,,12594293,Nc1ncnc2c1ncn2Cc1nc2cccc(c2c(=O)n1c1ccccc1C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,idelalisib,6741,,,178103352,Inhibitor,Inhibition,<i>in vitro</i> activity against recombinant enzyme,f,t,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,20959606,CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1[nH]cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,INK-128,7933,,,249565616,Inhibitor,Inhibition,,f,f,,pIC50,0,6.639999866,0,IC50,0,230,0,=,,,,22367541,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,IPI549,9563,,,336446949,Inhibitor,Inhibition,,f,f,,pKd,0,7.639999866,0,Kd,0,23,0,=,,,,27660692,Cn1ncc(c1)C#Cc1cccc2c1c(=O)n(c(c2)[C@@H](NC(=O)c1c(N)nn2c1nccc2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,KU-0060648,8011,,,249565691,Inhibitor,Inhibition,,f,t,,pIC50,0,10,0,IC50,0,0.100000001,0,<,,,,23855836,CCN1CCN(CC1)CC(=O)Nc1ccc(c2c1c1ccccc1s2)c1cccc2c1oc(cc2=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,leniolisib,9424,,,328083524,Inhibitor,Inhibition,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,<i>In vitro</i> enzyme assay,,,0,CCC(=O)N1CC[C@@H](C1)Nc1ncnc2c1CN(CC2)c1cnc(c(c1)C(F)(F)F)OC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,t,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,23855836,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pKd,0,6.150000095,0,Kd,0,710,0,=,,,,24533473,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,LY3023414,8918,,,310264699,Inhibitor,Inhibition,,f,f,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,0,CO[C@H](Cn1c(=O)n(c2c1c1cc(ccc1nc2)c1cncc(c1)C(O)(C)C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,nemiralisib,9425,,,328083525,Inhibitor,Inhibition,,f,t,,pIC50,0,9.899999619,0,IC50,0,0.126000002,0,=,In a homogeneous time-resolved fluorescence (HTRF) assay in the presence of 2mM ATP.,,,26301626,CC(N1CCN(CC1)Cc1cnc(o1)c1cc(cc2c1cn[nH]2)c1cccc2c1cc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,omipalisib,8974,,,310264754,Inhibitor,Inhibition,,f,f,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,24900173,COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2c(c1)c(ccn2)c1ccnnc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PI-3065,8242,,,249565922,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,24919154,Fc1ccc2c(c1c1nc3cc(sc3c(n1)N1CCOCC1)CN1CCN(CC1)CC1CC1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PI 3-Kg inhibitor,6023,,,178102645,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)nccn3)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,f,,pKi,0,8.81000042,0,Ki,0,1.539999962,0,=,,,,0,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,18754654,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,6.289999962,0,IC50,0,510,0,=,,,,16647110,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,pilaralisib,7963,,,249565646,Inhibitor,Inhibition,,f,f,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,0,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2c(c1)nsn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,RP5264,8916,,,310264697,Inhibitor,Inhibition,,f,t,,pIC50,0,7.860000134,0,IC50,0,13.82999992,0,=,,,,0,CC(Oc1ccc(cc1F)c1nn(c2c1c(N)ncn2)[C@H](c1oc2ccc(cc2c(=O)c1c1cccc(c1)F)F)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,seletalisib,9800,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,,,,28442583,[O-][n+]1cccc(c1)c1nc2c(cc1[C@H](C(F)(F)F)Nc1ncnc3c1nccc3)cccc2Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,serabelisib,8969,,,310264749,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,<,,,,0,Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,STK16-IN-1,9692,,,348353651,Inhibitor,Inhibition,,f,f,,pIC50,0,6.070000172,0,IC50,0,856,0,=,In an <i>in vitro</i> enzymatic assay.,,,27082499,Fc1ccc(cc1C)n1c(=O)ccc2c1c1cc[nH]c1nc2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,CUDC-907,8952,,,310264733,Inhibitor,Inhibition,,f,f,,pIC50,0,6.510000229,0,IC50,0,311,0,=,,,,22693356,ONC(=O)c1cnc(nc1)N(Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,CZC 24832,6653,,,178103265,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,22544264,Nc1nn2c(n1)c(F)cc(c2)c1cncc(c1)S(=O)(=O)NC(C)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,CZC 24832,6653,,,178103265,Inhibitor,Inhibition,,f,t,,pKd,0,7.699999809,0,-,0,0,0,=,,,,22544264,Nc1nn2c(n1)c(F)cc(c2)c1cncc(c1)S(=O)(=O)NC(C)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,dactolisib,7950,,,249565633,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,18606717,N#CC(c1ccc(cc1)n1c(=O)n(c2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2)C)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,dezapelisib,9728,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.300000191,0,IC50,0,500,0,>,,,,0,Fc1cccc(c1)c1c(nc2n(c1=O)c(C)cs2)[C@@H](Nc1ncnc2c1nc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,duvelisib,7795,,,223366126,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,24211136,Clc1cccc2c1c(=O)n(c(c2)[C@@H](Nc1ncnc2c1[nH]cn2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,eCF309,9571,,,336446957,Inhibitor,Inhibition,,f,f,,pIC50,0,5.869999886,0,IC50,0,1340,0,=,In a biochemical assay.,,,0,CCOC(Cn1nc(c2c1ncnc2N)c1ccc2c(c1)nc(o2)N)OCC
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,GDC-0077,9636,,,340590266,Inhibitor,Inhibition,,f,f,,pKi,0,7.739999771,0,Ki,0,18.20000076,0,=,,,,0,NC(=O)[C@@H](Nc1ccc2c(c1)OCCn1c2nc(c1)N1C(=O)OC[C@H]1C(F)F)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,idelalisib,6741,,,178103352,Inhibitor,Inhibition,,f,f,,pIC50,0,7.050000191,0,IC50,0,89,0,=,,,,20959606,CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1[nH]cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,INK-128,7933,,,249565616,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,221,0,=,,,,22367541,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,IPI549,9563,,,336446949,Inhibitor,Inhibition,,f,t,,pKd,0,9.539999962,0,Kd,0,0.289999992,0,=,,,,27660692,Cn1ncc(c1)C#Cc1cccc2c1c(=O)n(c(c2)[C@@H](NC(=O)c1c(N)nn2c1nccc2)C)c1ccccc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,KU-0060648,8011,,,249565691,Inhibitor,Inhibition,,f,f,,pIC50,0,6.230000019,0,IC50,0,590,0,=,,,,23855836,CCN1CCN(CC1)CC(=O)Nc1ccc(c2c1c1ccccc1s2)c1cccc2c1oc(cc2=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,LY 294002,6004,,,178102626,Inhibitor,Inhibition,,f,f,,pIC50,5.920000076,0,5.519999981,IC50,3002,0,1200,=,,,,19297156,O=c1cc(oc2c1cccc2c1ccccc1)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,LY3023414,8918,,,310264699,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,23.79999924,0,=,,,,0,CO[C@H](Cn1c(=O)n(c2c1c1cc(ccc1nc2)c1cncc(c1)C(O)(C)C)C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,nemiralisib,9425,,,328083525,Inhibitor,Inhibition,,f,f,,pIC50,0,5.199999809,0,IC50,0,6310,0,=,In a homogeneous time-resolved fluorescence (HTRF) assay,,,26301626,CC(N1CCN(CC1)Cc1cnc(o1)c1cc(cc2c1cn[nH]2)c1cccc2c1cc[nH]2)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,omipalisib,8974,,,310264754,Inhibitor,Inhibition,,f,f,,pKi,0,7.619999886,0,Ki,0,24,0,=,,,,24900173,COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2c(c1)c(ccn2)c1ccnnc1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,19584227,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PI 3-Kg inhibitor,6023,,,178102645,Inhibitor,Inhibition,,f,t,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)nccn3)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PI 3-Kg inhibitor II,6024,,,178102646,Inhibitor,Inhibition,,f,t,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,16127437,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(O3)(F)F)/S1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,f,,pKi,0,7.380000114,0,Ki,0,41.79999924,0,=,,,,0,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,pictilisib,5682,,,178102309,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,75,0,=,,,,18754654,CS(=O)(=O)N1CCN(CC1)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,7.119999886,0,IC50,0,76,0,=,,,,16647110,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PIK-75,8012,,,249565692,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,17601739,Brc1ccc2n(c1)c(/C=N/N(S(=O)(=O)c1cc(ccc1C)[N+](=O)[O-])C)cn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,pilaralisib,7963,,,249565646,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,0,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2c(c1)nsn2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,f,,pIC50,0,5.960000038,0,IC50,0,1100,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,quinostatin,8978,,,310264758,Inhibitor,Inhibition,,f,f,,pIC50,0,4.519999981,0,IC50,0,30000,0,=,Inhibition of lipid-kinase activity <i>in vitro</i>.,,,17462572,CCc1ccc(cc1)C(=O)c1cnc2c(c1N1CCC(CC1)C(=O)N)cc1c(c2)OCCO1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,seletalisib,9800,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.550000191,0,IC50,0,282,0,=,,,,28442583,[O-][n+]1cccc(c1)c1nc2c(cc1[C@H](C(F)(F)F)Nc1ncnc3c1nccc3)cccc2Cl
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,serabelisib,8969,,,310264749,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,<,,,,0,Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,STK16-IN-1,9692,,,348353651,Inhibitor,Inhibition,,f,f,,pIC50,0,6.059999943,0,IC50,0,867,0,=,In an <i>in vitro</i> enzymatic assay.,,,27082499,Fc1ccc(cc1C)n1c(=O)ccc2c1c1cc[nH]c1nc2
phosphatidylinositol 4-kinase alpha,2148,PI4KA,P42356,,,,,,Human,phenylarsine oxide,9201,,,315661277,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,11923287,O=[As]c1ccccc1
phosphatidylinositol 4-kinase beta,2149,PI4KB,Q9UBF8,,,,,,Human,PIK-93,6062,,,178102683,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,16647110,OCCNS(=O)(=O)c1cc(ccc1Cl)c1sc(nc1C)NC(=O)C
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,2151,PIK3C2B,O00750,,,,,,Human,PI-103,5701,,,178102328,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,17601739,Oc1cccc(c1)c1nc(N2CCOCC2)c2c(n1)c1cccnc1o2
phosphatidylinositol-4-phosphate 5-kinase type 1 alpha,2164,PIP5K1A,Q99755,,,,,,Human,ISA-2011B,8444,,,252166654,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,25071204,Clc1ccc2c(c1)c(c[nH]2)[C@H]1N2C(=O)CN(C(=O)[C@@H]2Cc2c1cc1OCOc1c2)C
phosphodiesterase 10A,1310,PDE10A,Q9Y233,,,,,,Human,mardepodect,9617,,,340590247,Inhibitor,Inhibition,,f,t,,pIC50,0,9.430000305,0,IC50,0,0.370000005,0,=,,,,19630403,Cn1nc(c(c1)c1ccncc1)c1ccc(cc1)OCc1ccc2c(n1)cccc2
phosphodiesterase 1A,1294,PDE1A,P54750,,,,,,Human,crisaborole,9151,,,315661236,Inhibitor,Inhibition,,f,f,,pIC50,0,5.210000038,0,IC50,0,6100,0,=,,,,19303290,N#Cc1ccc(cc1)Oc1ccc2c(c1)COB2O
phosphodiesterase 1A,1294,PDE1A,P54750,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,IC50,0,63.1,0,,,,,8961086,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphodiesterase 1B,1295,PDE1B,Q01064,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,IC50,0,63.1,0,,,,,8961086,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphodiesterase 1C,1296,PDE1C,Q14123,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,IC50,0,63.1,0,,,,,8961086,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphodiesterase 2A,1297,PDE2A,O00408,,,,,,Human,cyclic GMP,2347,,,135651454,Activator,Activation,,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
phosphodiesterase 2A,1297,PDE2A,O00408,,,,,,Human,EHNA,5179,,,178101869,Inhibitor,Inhibition,,f,,,pIC50,0,5.3,0,IC50,0,5010,0,,,,,8730511,CCCCCC[C@H](n1cnc2c1ncnc2[NH3+])[C@H](O)C.[Cl-]
phosphodiesterase 2A,1297,PDE2A,O00408,,,,,,Human,milrinone,5225,,,178101910,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,>,,,,10644042,N#Cc1cc(c2ccncc2)c([nH]c1=O)C
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,cyclic GMP,2347,,,135651454,Inhibitor,Inhibition,,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,enoximone,9063,,,315661148,Inhibitor,Inhibition,,f,t,,pIC50,0,5.420000076,0,IC50,0,3800,0,=,Measuring inhibition of human platelet  PDE,,,3027339,CSc1ccc(cc1)C(=O)c1[nH]c(=O)[nH]c1C
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,ibudilast,7399,,,178103971,Inhibitor,Inhibition,,f,f,,pIC50,0,3.519999981,0,IC50,0,299000,0,=,,,,21530250,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,inamrinone,7202,,,178103777,Inhibitor,Inhibition,,f,t,,pIC50,0,4.800000191,0,IC50,0,16000,0,=,"Inhibition of PDE3 purified from human platelets, and therefore assumed to be the PDE3A subtype.",,,2536438,Oc1ncc(cc1N)c1ccncc1
phosphodiesterase 3A,1298,PDE3A,Q14432,,,,,,Human,milrinone,5225,,,178101910,Inhibitor,Inhibition,,f,t,,pIC50,6.360000134,0,6.349999905,IC50,450,0,440,=,,,,10644042,N#Cc1cc(c2ccncc2)c([nH]c1=O)C
phosphodiesterase 3B,1299,PDE3B,Q13370,,,,,,Human,cyclic GMP,2347,,,135651454,Inhibitor,Inhibition,,t,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O
phosphodiesterase 3B,1299,PDE3B,Q13370,,,,,,Human,inamrinone,7202,,,178103777,Inhibitor,Inhibition,,f,t,,pIC50,0,4.510000229,0,IC50,0,31200,0,=,,,,10644042,Oc1ncc(cc1N)c1ccncc1
phosphodiesterase 3B,1299,PDE3B,Q13370,,,,,,Human,milrinone,5225,,,178101910,Inhibitor,Inhibition,,f,,,pIC50,0,6,0,IC50,0,1000,0,,,,,10644042,N#Cc1cc(c2ccncc2)c([nH]c1=O)C
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,ibudilast,7399,,,178103971,Inhibitor,Inhibition,,f,t,,pIC50,0,7.269999981,0,IC50,0,54,0,=,,,,18686943,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,Ro20-1724,5258,,,178101942,Inhibitor,Inhibition,,f,f,,pIC50,0,6.5,0,IC50,0,316,0,=,,,,9177268,CCCCOc1cc(ccc1OC)CC1CNC(=O)N1
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,rolipram,5260,,,178101944,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,9177268,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,RS-25344,6557,,,178103171,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,-,0,0,0,=,,,,9720765,O=N(=O)c1cccc(c1)n1c(=O)n(Cc2ccncc2)c(=O)c2c1nccc2
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,crisaborole,9151,,,315661236,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,19303290,N#Cc1ccc(cc1)Oc1ccc2c(c1)COB2O
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,ibudilast,7399,,,178103971,Inhibitor,Inhibition,,f,t,,pIC50,0,7.190000057,0,IC50,0,65,0,=,,,,18686943,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,Ro20-1724,5258,,,178101942,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,398,0,=,,,,9177268,CCCCOc1cc(ccc1OC)CC1CNC(=O)N1
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,roflumilast,6962,,,178103543,Inhibitor,Inhibition,,f,t,,pIC50,0,9.399999619,0,-,0,0,0,=,,,,19195882,FC(Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl)F
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,rolipram,5260,,,178101944,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,9177268,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1
phosphodiesterase 4B,1301,PDE4B,Q07343,,,,,,Human,RS-25344,6557,,,178103171,Inhibitor,Inhibition,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,9720765,O=N(=O)c1cccc(c1)n1c(=O)n(Cc2ccncc2)c(=O)c2c1nccc2
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,ibudilast,7399,,,178103971,Inhibitor,Inhibition,,f,t,,pIC50,0,6.619999886,0,IC50,0,239,0,=,,,,18686943,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,Ro20-1724,5258,,,178101942,Inhibitor,Inhibition,,f,f,,pIC50,0,5.400000095,0,IC50,0,3980,0,=,,,,9177268,CCCCOc1cc(ccc1OC)CC1CNC(=O)N1
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,rolipram,5260,,,178101944,Inhibitor,Inhibition,,f,f,,pIC50,0,6.5,0,IC50,0,316,0,=,,,,9177268,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1
phosphodiesterase 4C,1302,PDE4C,Q08493,,,,,,Human,RS-25344,6557,,,178103171,Inhibitor,Inhibition,,f,,,pIC50,0,8.1,0,-,0,0,0,=,,,,9720765,O=N(=O)c1cccc(c1)n1c(=O)n(Cc2ccncc2)c(=O)c2c1nccc2
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,OPA-15406,9776,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,<,Measuring inhibition of substrate hydrolysis by the PDE4D3 isoform.,,,0,CCOc1ccccc1C(=O)NCc1coc(n1)c1ccc(c(c1)OC(C)C)OC(F)F
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,Ro20-1724,5258,,,178101942,Inhibitor,Inhibition,,f,f,,pIC50,0,6.199999809,0,IC50,0,631,0,=,,,,9177268,CCCCOc1cc(ccc1OC)CC1CNC(=O)N1
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,rolipram,5260,,,178101944,Inhibitor,Inhibition,,f,f,,pIC50,0,7.199999809,0,IC50,0,63.09999847,0,=,,,,9177268,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1
phosphodiesterase 4D,1303,PDE4D,Q08499,,,,,,Human,RS-25344,6557,,,178103171,Inhibitor,Inhibition,,f,,,pIC50,0,8.4,0,-,0,0,0,=,,,,9720765,O=N(=O)c1cccc(c1)n1c(=O)n(Cc2ccncc2)c(=O)c2c1nccc2
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,gisadenafil,6558,,,178103172,Inhibitor,Inhibition,,f,f,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,22100260,COCCn1nc2c(c1CC)[nH]c(nc2=O)c1cc(cnc1OCC)S(=O)(=O)N1CCN(CC1)CC
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,ibudilast,7399,,,178103971,Inhibitor,Inhibition,,f,f,,pIC50,0,3.99000001,0,IC50,0,103000,0,=,,,,21530250,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,milrinone,5225,,,178101910,Inhibitor,Inhibition,,f,f,,pIC50,0,7.309999943,0,IC50,0,49.09999847,0,=,,,,0,N#Cc1cc(c2ccncc2)c([nH]c1=O)C
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,nitrosoprodenafil,9552,,,336446938,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,21145686,CCCc1nn(c2c1nc(nc2Oc1ncc(s1)N(N=O)C)c1cc(ccc1OCC)S(=O)(=O)C1CC(C)NC(C1)C)C
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,PF-00489791,8377,,,252166589,Inhibitor,Inhibition,,f,t,,pIC50,0,9.149999619,0,IC50,0,0.709999979,0,=,,,,0,CCOCCn1nc(c2c1c(Nc1nccc(c1)C)nc(n2)N(CC)C)C(=O)NS(=O)(=O)C
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,f,,pIC50,0,7.199999809,0,IC50,0,63.09999847,0,=,,,,8961086,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,sildenafil,4743,,,178101454,Inhibitor,Inhibition,,f,t,,pIC50,9,0,8.409999847,IC50,3.900000095,0,1,=,,,,10385692,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
phosphodiesterase 6C,1314,PDE6C,P51160,,,,,,Human,sildenafil,4743,,,178101454,Inhibitor,Inhibition,,f,f,,pIC50,0,7.409999847,0,IC50,0,39.20000076,0,=,,,,23137303,CCCc1nn(c2c1[nH]c(nc2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C
phosphodiesterase 7A,1305,PDE7A,Q13946,,,,,,Human,crisaborole,9151,,,315661236,Inhibitor,Inhibition,,f,f,,pIC50,0,6.139999866,0,IC50,0,730,0,=,,,,19303290,N#Cc1ccc(cc1)Oc1ccc2c(c1)COB2O
phosphodiesterase 7B,1306,PDE7B,Q9NP56,,,,,,Human,dipyridamole,4807,,,178101509,Inhibitor,Inhibition,,f,,,pIC50,6,0,5.7,IC50,1990,0,1000,=,,,,10872825,OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
phosphodiesterase 7B,1306,PDE7B,Q9NP56,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,,,pIC50,0,5.8,0,IC50,0,1580,0,=,,,,10814504,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphodiesterase 8A,1307,PDE8A,O60658,,,,,,Human,dipyridamole,4807,,,178101509,Inhibitor,Inhibition,,f,,,pIC50,0,5.1,0,IC50,0,7940,0,,,,,9618252,OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
phosphodiesterase 8A,1307,PDE8A,O60658,,,,,,Human,PF-04957325,9659,,,348353618,Inhibitor,Inhibition,,f,t,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,24687066,Nc1nc(nc2c1nnn2C[C@@H]1OCCN(C1)Cc1nccs1)C(F)(F)F
phosphodiesterase 8B,1308,PDE8B,O95263,,,,,,Human,dipyridamole,4807,,,178101509,Inhibitor,Inhibition,,f,,,pIC50,0,4.3,0,IC50,0,50100,0,,,,,9784418,OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
phosphodiesterase 9A,1309,PDE9A,O76083,,,,,,Human,SCH51866,5270,,,178101953,Inhibitor,Inhibition,,f,,,pIC50,0,5.8,0,IC50,0,1580,0,,,,,9624146,Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
phosphomevalonate kinase,641,Pmvk,Q5RK24,,,,,,Rat,isoferulic acid,7980,,,252166475,Inhibitor,Competitive,,f,f,,pKi,0,2.410000086,0,Ki,0,3850000,0,=,"extracted from rat liver, in vitro assay",,,226078,COc1ccc(cc1O)/C=C/C(=O)O
phosphomevalonate kinase,641,PMVK,Q15126,,,,,,Human,(R)-5-diphosphomevalonate,3047,,,135651554,Inhibitor,Competitive,,t,,,pKi,0,4.75,0,Ki,0,18000,0,=,,,,17902708,OC(=O)C[C@@](CCOP(=O)(OP(=O)(O)O)O)(O)C
"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase",2612,Gart,Q64737,,,,,,Mouse,pemetrexed,6837,,,178103443,Inhibitor,Inhibition,,f,f,,pKi,0,5.03000021,0,Ki,0,9300,0,=,,,,9762351,OC(=O)CC[C@H](C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)nc([nH]2)N
phosphorylase kinase catalytic subunit gamma 2,2147,PHKG2,P15735,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,10,0,IC50,0,0.100000001,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,CX-4945,8126,,,249565806,Inhibitor,Inhibition,,f,f,,pIC50,0,6.670000076,0,IC50,0,216,0,=,,,,21870818,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,CX-5011,9373,,,328083475,Inhibitor,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2510,0,=,,,,21870818,C#Cc1cccc(c1)Nc1nc2cc(ccc2c2c1ncnc2)C(=O)[O-]
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,CX-5279,9374,,,328083476,Inhibitor,Inhibition,,f,f,,pIC50,0,5.070000172,0,IC50,0,8520,0,=,,,,21870818,[O-]C(=O)c1ccc2c(c1)nc(c1c2cnc(n1)NC1CC1)Nc1cccc(c1)C(F)(F)F
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,CX-6258,9368,,,328083470,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24900437,CN1CCCN(CC1)C(=O)c1cccc(c1)c1ccc(o1)/C=C1/C(=O)Nc2c1cc(Cl)cc2
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,leucettine L41,8167,,,249565847,Inhibitor,Inhibition,,f,f,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,21615147,O=C1NC(=N/C/1=Cc1ccc2c(c1)OCO2)Nc1ccccc1
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,LGB321,9367,,,328083469,Inhibitor,Inhibition,,f,f,,pKi,0,12,0,Ki,0,0.001,0,=,Assayed at 400&mu;M ATP,,,24474669,C[C@H]1CN(C[C@H]([C@@H]1O)N)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,PIM447,9790,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,11.22000027,0,Ki,0,0.006,0,=,,,,26505898,C[C@@H]1C[C@H](N)C[C@@H](C1)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,18077363,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,SGI-1776,8784,,,252827442,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,22924342,CN1CCC(CC1)CNc1ccc2n(n1)c(cn2)c1cccc(c1)OC(F)(F)F
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,CX-6258,9368,,,328083470,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,24900437,CN1CCCN(CC1)C(=O)c1cccc(c1)c1ccc(o1)/C=C1/C(=O)Nc2c1cc(Cl)cc2
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,LGB321,9367,,,328083469,Inhibitor,Inhibition,,f,f,,pKi,0,11.68000031,0,Ki,0,0.0021,0,=,Assayed at 4&mu;M ATP,,,24474669,C[C@H]1CN(C[C@H]([C@@H]1O)N)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,PIM447,9790,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,10.73999977,0,Ki,0,0.017999999,0,=,,,,26505898,C[C@@H]1C[C@H](N)C[C@@H](C1)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,>,,,,18077363,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
"Pim-2 proto-oncogene, serine/threonine kinase",2159,PIM2,Q9P1W9,,,,,,Human,SGI-1776,8784,,,252827442,Inhibitor,Inhibition,,f,f,,pIC50,0,6.440000057,0,IC50,0,363,0,=,,,,22924342,CN1CCC(CC1)CNc1ccc2n(n1)c(cn2)c1cccc(c1)OC(F)(F)F
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,CX-6258,9368,,,328083470,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,24900437,CN1CCCN(CC1)C(=O)c1cccc(c1)c1ccc(o1)/C=C1/C(=O)Nc2c1cc(Cl)cc2
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,LGB321,9367,,,328083469,Inhibitor,Inhibition,,f,f,,pKi,0,12.10000038,0,Ki,0,0.0008,0,=,Assayed at 40&mu;M ATP,,,24474669,C[C@H]1CN(C[C@H]([C@@H]1O)N)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,PIM447,9790,,,0,Inhibitor,Inhibition,,f,f,,pKi,0,11.05000019,0,Ki,0,0.009,0,=,,,,26505898,C[C@@H]1C[C@H](N)C[C@@H](C1)c1ccncc1NC(=O)c1ccc(c(n1)c1c(F)cccc1F)F
"Pim-3 proto-oncogene, serine/threonine kinase",2160,PIM3,Q86V86,,,,,,Human,SGI-1776,8784,,,252827442,Inhibitor,Inhibition,,f,f,,pIC50,0,7.159999847,0,IC50,0,69,0,=,,,,22924342,CN1CCC(CC1)CNc1ccc2n(n1)c(cn2)c1cccc(c1)OC(F)(F)F
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,IS1,8517,,,252166719,Agonist,Agonist,,f,f,,pEC50,0,5.599999905,0,-,0,0,0,=,,,,25831128,O=C(/C(=C/c1ccco1)/NC(=O)c1ccccc1)NCc1cccnc1
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,IS20,8518,,,252166720,Agonist,Agonist,,f,f,,pEC50,0,7.360000134,0,EC50,0,44,0,=,,,,25831128,COc1ccc(cc1)/C=C(/C(=O)NCc1cccnc1)NC(=O)c1ccccc1
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,MIT1,1865,,,135652290,Agonist,Full agonist,,f,f,,pIC50,0,8.399999619,0,-,0,0,0,=,,,,12054613,
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,prokineticin-1,1866,PROK1,Human,135651858,Agonist,Full agonist,,t,f,,pIC50,7.599999905,0,6.599999905,-,0,0,0,=,,,,12054613,
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,prokineticin-2,1867,PROK2,Human,135651862,Agonist,Full agonist,,t,f,,pIC50,8.399999619,0,8.199999809,-,0,0,0,=,,,,12054613,
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,prokineticin-2&beta;,1868,PROK2,Human,135652412,Agonist,Full agonist,,t,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,15772293,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,MIT1,1865,,,135652290,Agonist,Full agonist,,f,f,,pIC50,0,9.199999809,0,-,0,0,0,=,,,,12054613,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,prokineticin-1,1866,PROK1,Human,135651858,Agonist,Full agonist,,t,f,,pIC50,7.300000191,0,7.099999905,-,0,0,0,=,,,,12054613,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,prokineticin-2,1867,PROK2,Human,135651862,Agonist,Full agonist,,t,f,,pIC50,8.199999809,0,8.100000381,-,0,0,0,=,,,,12054613,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,prokineticin-2&beta;,1868,PROK2,Human,135652412,Agonist,Full agonist,,t,f,,pIC50,0,6,0,IC50,0,1000,0,>,,,,15772293,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,PKR-A,6066,,,178102687,Antagonist,Antagonist,,f,f,,pIC50,7.360000134,0,7.28000021,IC50,52.70000076,0,43.5,=,,,,22431614,CC(CN(C(=O)C1OCCN(C1)Cc1ccccc1)Cc1ccc2c(c1)OCCCO2)C
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,decynium 22,8482,,,252166690,Inhibitor,Inhibition,,f,f,,pKi,0,7,0,Ki,0,100,0,=,,,,16099839,CC[n+]1c(ccc2c1cccc2)/C=c/1ccc2c(n1CC)cccc2
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,desipramine,2399,,,135650171,Inhibitor,Inhibition,,f,f,,pKi,0,4.489999771,0,Ki,0,32600,0,=,,,,16099839,CNCCCN1c2ccccc2CCc2c1cccc2
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,dipyridamole,4807,,,178101509,Inhibitor,Inhibition,,f,f,,pKi,0,5.900000095,0,-,0,0,0,=,,,,24021350,OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,fluoxetine,203,,,135650270,Inhibitor,Inhibition,,f,f,,pKi,0,4.639999866,0,Ki,0,22700,0,=,,,,16099839,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,quinidine,2342,,,135650872,Inhibitor,Inhibition,,f,f,,pKi,0,4.599999905,0,Ki,0,25300,0,=,,,,16099839,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,quinine,2510,,,135652709,Inhibitor,Inhibition,,f,f,,pKi,0,4.570000172,0,Ki,0,26900,0,=,,,,16099839,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](c1ccnc2c1cc(OC)cc2)O
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,rhodamine123,4607,,,178101327,Inhibitor,Inhibition,,f,f,,pKi,0,5.989999771,0,Ki,0,1020,0,=,,,,16099839,COC(=O)c1ccccc1c1c2ccc(=[NH2+])cc2oc2c1ccc(c2)N
"plasminogen activator, tissue type",2392,PLAT,P00750,,,,,,Human,Dup-714,8760,,,252827418,Inhibitor,Inhibition,,f,f,,pKi,0,8.239999771,0,Ki,0,5.699999809,0,=,,,,0,CC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](B(O)O)CCCN=C(N)N)Cc1ccccc1
Plasmodium falciparum dihydroorotate dehydrogenase,2949,DHODH,Q08210,,,,,,Plasmodium falciparum 3D7,DSM265,9644,,,340590274,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,26180101,Cc1cc(Nc2ccc(cc2)S(F)(F)(F)(F)F)n2c(n1)nc(n2)C(F)(F)C
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,rilapladib,7376,,,178103948,Inhibitor,Competitive,,f,t,,pIC50,0,9.640000343,0,IC50,0,0.230000004,0,=,,,,19667981,COCCN1CCC(CC1)N(C(=O)Cn1c(SCc2cccc(c2F)F)cc(=O)c2c1cccc2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,darapladib,6696,,,178103307,Inhibitor,Inhibition,,f,t,,pIC50,0,9.960000038,0,IC50,0,0.109999999,0,=,,,,12643913,CCN(CCN(C(=O)Cn1c(SCc2ccc(cc2)F)nc(=O)c2c1CCC2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F)CC
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,darapladib,6696,,,178103307,Inhibitor,Inhibition,,f,f,,pIC50,0,10.31000042,0,IC50,0,0.048999999,0,=,"In a biochemical assay, measuring fluorescence intensity and using Thio-Paf.",,,27933945,CCN(CCN(C(=O)Cn1c(SCc2ccc(cc2)F)nc(=O)c2c1CCC2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F)CC
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,darapladib,6696,,,178103307,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,"In an assay using whole human plasma and recombinant hPLA2-G7, that approximates the physiological environment of the enzyme.",,,27933945,CCN(CCN(C(=O)Cn1c(SCc2ccc(cc2)F)nc(=O)c2c1CCC2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F)CC
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,(<i>S</i>)-23 [PMID: 27933945],9796,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.489999771,0,IC50,0,32,0,=,Recombinant hLp-PLA2 in a whole human plasma Thio-PAF assay.,,,27933945,N#Cc1cc(OCCN2C[C@@H](CC2=O)C2(C)CCS(=O)(=O)CC2)ccc1F
PLA<sub>2</sub>-G7,1432,PLA2G7,Q13093,,,,,,Human,(<i>S</i>)-23 [PMID: 27933945],9796,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,Recombinant hLp-PLA2 Thio-PAF biochemical assay.,,,27933945,N#Cc1cc(OCCN2C[C@@H](CC2=O)C2(C)CCS(=O)(=O)CC2)ccc1F
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,olaratumab,9172,,,315661255,Antibody,Binding,,f,t,,pKd,0,10.39999962,0,Kd,0,0.039999999,0,=,BIAcore assay,,,0,
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,olaratumab,9172,,,315661255,Antibody,Binding,,f,t,,pIC50,0,9.239999771,0,IC50,0,0.579999983,0,=,Cellular assay,,,0,
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,CP-673451,8069,,,249565749,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,15705896,COCCOc1ccc2c(c1)ncn2c1ccc2c(n1)c(ccc2)N1CCC(CC1)N
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,crenolanib,7882,,,223366211,Inhibitor,Inhibition,,f,t,,pKd,0,8.680000305,0,Kd,0,2.099999905,0,=,,,,22745105,NC1CCN(CC1)c1cccc2c1nc(cc2)n1cnc2c1ccc(c2)OCC1(C)COC1
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,,,,15598814,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.25,0,IC50,0,56,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,masitinib,5656,,,178102284,Inhibitor,Inhibition,,f,f,,pIC50,0,6.269999981,0,IC50,0,540,0,=,,,,19789626,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1scc(n1)c1cccnc1)C
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
platelet derived growth factor receptor alpha,1803,Pdgfra,P26618,,,,,,Mouse,PDGF receptor tyrosine kinase inhibitor II,6018,,,178102640,Inhibitor,Inhibition,,f,t,,pIC50,0,5.960000038,0,IC50,0,1100,0,=,Inhibition of PDGFR in intact Swiss 3T3 fibroblasts,,,11855980,CCCC(=O)Oc1ccc2c(c1)cc([nH]2)C(=O)c1cc2c([nH]1)cccc2
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
platelet derived growth factor receptor alpha,1803,PDGFRA,P16234,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,f,,pKd,0,7.960000038,0,Kd,0,11,0,=,,,,19754199,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,CP-673451,8069,,,249565749,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,15705896,COCCOc1ccc2c(c1)ncn2c1ccc2c(n1)c(ccc2)N1CCC(CC1)N
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,crenolanib,7882,,,223366211,Inhibitor,Inhibition,,f,t,,pKd,0,8.489999771,0,Kd,0,3.200000048,0,=,,,,22745105,NC1CCN(CC1)c1cccc2c1nc(cc2)n1cnc2c1ccc(c2)OCC1(C)COC1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,DEBIO1347,9787,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.25,0,IC50,0,560,0,=,,,,25169980,Cc1nc2c([nH]1)cc(cc2)n1ncc(c1N)C(=O)c1cc2c([nH]1)cccc2
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,dovitinib,5962,,,178102585,Inhibitor,Inhibition,,f,f,,pIC50,8.300000191,0,7.570000172,IC50,27,0,5,=,,,,19113866,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,famitinib,7886,,,249565577,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,21028894,CCN(CCN1CCc2c(C1=O)c(C)c([nH]2)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,Flt-3 inhibitor II,5971,,,178102594,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,171,0,=,,,,16722630,Oc1ccc2c(c1)cc([nH]2)C(=O)c1cc2c([nH]1)ccc(c2)O
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,GTP-14564,5982,,,178102605,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,12815052,c1ccc(cc1)c1n[nH]c2c1oc1c2cccc1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,KBP-7018,9691,,,348353650,Inhibitor,Inhibition,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,0,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc2c(c1)CCN2C(=O)CN1CCOCC1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,Ki-20227,5690,,,178102317,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,217,0,=,,,,17121910,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,7.179999828,0,IC50,0,66,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,masitinib,5656,,,178102284,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,,,,19789626,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1scc(n1)c1cccnc1)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,MK-2461,7962,,,249565645,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,20145145,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,nintedanib,5936,,,178102559,Inhibitor,Inhibition,,f,f,,pIC50,0,7.190000057,0,IC50,0,65,0,=,,,,18559524,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,orantinib,7816,,,223366147,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,19110422,OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cccc2
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,pazopanib,5698,,,178102325,Inhibitor,Inhibition,,f,f,,pIC50,0,7.079999924,0,IC50,0,84,0,=,,,,18620382,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,f,,pKi,0,7.010000229,0,Ki,0,98.30000305,0,=,,,,9400019,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,PDGF receptor tyrosine kinase inhibitor III,6019,,,178102641,Inhibitor,Inhibition,,f,t,,pIC50,0,7.099999905,0,IC50,0,80,0,=,,,,14584942,COc1cc2c(cc1OC)ncnc2N1CCN(CC1)C(=O)Nc1ccc(cc1)Oc1ccccc1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,PDGF receptor tyrosine kinase inhibitor IV,6020,,,178102642,Inhibitor,Inhibition,,f,t,,pIC50,0,8.380000114,0,IC50,0,4.199999809,0,=,,,,16366598,COc1cc2c(cc1OC)Cc1c2[nH]nc1Nc1cccc(c1)F
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,PDGF RTK inhibitor,6021,,,178102643,Inhibitor,Inhibition,,f,t,,pIC50,0,7.920000076,0,IC50,0,12,0,=,Inhibition of PDGFR autophosphorylation in human G292 cells,,,16570914,COc1cc2nccc(c2cc1OC)Oc1ccc(cc1)NC(=S)NC(=O)c1ccccc1C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,f,,pKd,0,8.109999657,0,Kd,0,7.699999809,0,=,,,,19754199,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,semaxanib,5056,,,178101750,Inhibitor,Inhibition,,f,f,,pIC50,0,6.170000076,0,IC50,0,680,0,=,,,,10882357,O=C1Nc2c(/C/1=C/c1[nH]c(cc1C)C)cccc2
platelet derived growth factor receptor beta,1804,Pdgfrb,P05622,,,,,,Mouse,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,7.239999771,0,IC50,0,57,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
PLD1,1433,PLD1,Q13393,,,,,,Human,FIPI,8781,,,252827439,Inhibitor,Inhibition,,f,f,,pIC50,0,8.020000458,0,IC50,0,9.5,0,=,,,,19136975,Fc1ccc2c(c1)cc([nH]2)C(=O)NCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
PLD2,1434,PLD2,O14939,,,,,,Human,oleic acid,1054,,,135651531,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,12374567,CCCCCCCC/C=CCCCCCCCC(=O)O
PLD2,1434,PLD2,O14939,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,Activation,,t,,,-,0,0,0,-,0,0,0,=,,,,9582313,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
PLD2,1434,PLD2,O14939,,,,,,Human,FIPI,8781,,,252827439,Inhibitor,Inhibition,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,19136975,Fc1ccc2c(c1)cc([nH]2)C(=O)NCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,GSK-461364A,5684,,,178102311,Inhibitor,Inhibition,,f,t,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,19690138,CN1CCN(CC1)Cc1ccc2c(c1)n(cn2)c1cc(c(s1)C(=O)N)O[C@@H](c1ccccc1C(F)(F)F)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,GSK579289A,8150,,,249565830,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19237286,CN1CCC(CC1)Oc1ccc2c(c1)n(cn2)c1cc(c(s1)C(=O)N)O[C@@H](c1ccccc1Cl)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,GW853606,8645,,,252166845,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,19097784,NC(=O)c1sc(cc1OCc1ccccc1Br)n1cnc2c1cc(cc2)C(F)(F)F
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,MLN0905,9402,,,328083504,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,22070629,CN(CCCc1cnc(c(c1)Nc1ncc2c(n1)c1ccc(cc1NC(=S)C2)C(F)(F)F)C)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,NMS-P937,7918,,,249565601,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,21470862,OCCn1nc(c2c1c1nc(ncc1CC2)Nc1cc(ccc1OC(F)(F)F)N1CCN(CC1)C)C(=O)N
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,Ro3280,9403,,,328083505,Inhibitor,Inhibition,,f,t,,pKd,0,10.05000019,0,Kd,0,0.090000004,0,=,Ambit selectivity screen at 1&mu;M Ro3280.,,,22172702,COc1cc(ccc1Nc1ncc2c(n1)N(CC(C(=O)N2C)(F)F)C1CCCC1)C(=O)NC1CCN(CC1)C
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,Ro3280,9403,,,328083505,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,In a biochemical enzymatic assay.,,,22172702,COc1cc(ccc1Nc1ncc2c(n1)N(CC(C(=O)N2C)(F)F)C1CCCC1)C(=O)NC1CCN(CC1)C
polo like kinase 2,2169,PLK2,Q9NYY3,,,,,,Human,NMS-P937,7918,,,249565601,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,21470862,OCCn1nc(c2c1c1nc(ncc1CC2)Nc1cc(ccc1OC(F)(F)F)N1CCN(CC1)C)C(=O)N
polo like kinase 3,2170,PLK3,Q9H4B4,,,,,,Human,NMS-P937,7918,,,249565601,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,>,,,,21470862,OCCn1nc(c2c1c1nc(ncc1CC2)Nc1cc(ccc1OC(F)(F)F)N1CCN(CC1)C)C(=O)N
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,niraparib,8275,,,252166487,Inhibitor,Binding,,f,t,,pIC50,0,8.420000076,0,IC50,0,3.799999952,0,=,,,,19873981,NC(=O)c1cccc2c1nn(c2)c1ccc(cc1)[C@@H]1CCCNC1
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,ME0328,8468,,,252166678,Inhibitor,Inhibition,,f,f,,pIC50,0,5.199999809,0,IC50,0,6300,0,=,,,,24188023,O=C(N[C@H](c1ccccc1)C)CCc1nc(=O)c2c([nH]1)cccc2
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,olaparib,7519,,,187051821,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,"Assayed using PARP-1 isolated from HeLa cells, in a scintillation proximity ELISA.",,,18800822,O=C(N1CCN(CC1)C(=O)c1cc(ccc1F)Cc1n[nH]c(=O)c2c1cccc2)C1CC1
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,rucaparib,7736,,,223366069,Inhibitor,Inhibition,,f,t,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,17363489,CNCc1ccc(cc1)c1[nH]c2c3c1CCNC(=O)c3cc(c2)F
poly(ADP-ribose) polymerase 2,2772,PARP2,Q9UGN5,,,,,,Human,niraparib,8275,,,252166487,Inhibitor,Binding,,f,t,,pIC50,0,8.680000305,0,IC50,0,2.099999905,0,=,,,,19873981,NC(=O)c1cccc2c1nn(c2)c1ccc(cc1)[C@@H]1CCCNC1
poly(ADP-ribose) polymerase 2,2772,PARP2,Q9UGN5,,,,,,Human,olaparib,7519,,,187051821,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,"Assayed using PARP-2 isolated from HeLa cells, in a scintillation proximity ELISA.",,,18800822,O=C(N1CCN(CC1)C(=O)c1cc(ccc1F)Cc1n[nH]c(=O)c2c1cccc2)C1CC1
poly (ADP-ribose) polymerase 3,2864,PARP3,Q9Y6F1,,,,,,Human,ME0328,8468,,,252166678,Inhibitor,Inhibition,,f,t,,pIC50,0,6.050000191,0,IC50,0,900,0,=,,,,24188023,O=C(N[C@H](c1ccccc1)C)CCc1nc(=O)c2c([nH]1)cccc2
polybromo 1,2738,PBRM1,Q86U86,,,,,,Human,PFI-3,7915,,,249565598,Inhibitor,Binding,,f,t,,pKd,0,7.320000172,0,Kd,0,48,0,=,,,,0,O=C(c1ccccc1O)/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,dexamethasone,2768,,,135651471,Agonist,Agonist,,f,,,pEC50,0,6.1,0,,0,0,0,,,,,9489701,OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,hyperforin,2764,,,135652691,Agonist,Agonist,,f,f,,pEC50,0,7.599999905,0,-,0,0,0,=,,,,10852961,CC(=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(C(=O)[C@]1(C(=O)C(C)C)C(=C(C2=O)CC=C(C)C)O)CC=C(C)C)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,lithocholic acid,611,,,135651505,Agonist,Agonist,,t,,,pEC50,0,5.05,0,,0,0,0,,,,,11248085,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,mifepristone,2805,,,135650608,Agonist,Agonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,~,,,,9727070,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,nifedipine,2514,,,53801065,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,9770465,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,paclitaxel,2770,,,135652721,Agonist,Agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,11329060,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)c1ccccc1)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,phenobarbital,2804,,,135650817,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,9727070,CCC1(C(=O)NC(=O)NC1=O)c1ccccc1
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,pregnenolone-16&alpha;-carbonitrile,2762,,,135650852,Agonist,Agonist,,f,,,pEC50,0,6.5,0,,0,0,0,,,,,9489701,N#C[C@@H]1C[C@@H]2[C@]([C@H]1C(=O)C)(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,rifampicin,2765,,,135652711,Agonist,Agonist,,f,f,,pEC50,6,0,5.5,-,0,0,0,=,,,,9784494,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C)c(c(c2c(c3C)O)O)NC(=O)/C(=CC=C[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,S20,2773,,,135650964,Agonist,Agonist,,f,,,pEC50,0,5.7,0,,0,0,0,,,,,15872116,CC(NC(=O)C1(C)CC1C(c1ccccc1)NC(=O)OCc1ccccc1)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,(+)-S20,2772,,,135650962,Agonist,Agonist,,f,,,pEC50,0,6.4,0,,0,0,0,,,,,15872116,CC(NC(=O)[C@@]1(C)C[C@@H]1[C@H](c1ccccc1)NC(=O)OCc1ccccc1)C
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,schisandrin A,2769,,,135652716,Agonist,Agonist,,f,,,pEC50,0,5.7,0,,0,0,0,,,,,16267138,COc1c2c(C[C@H](C)[C@@H](Cc3c2c(OC)c(c(c3)OC)OC)C)cc(c1OC)OC
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,schisandrin A,2769,,,135652716,Agonist,Agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,16267138,COc1c2c(C[C@H](C)[C@@H](Cc3c2c(OC)c(c(c3)OC)OC)C)cc(c1OC)OC
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,SR12813,2763,,,135651072,Agonist,Agonist,,f,,,pEC50,0,6.7,0,,0,0,0,,,,,10628745,CCOP(=O)(C(=Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C)P(=O)(OCC)OCC)OCC
Pregnane X receptor,606,NR1I2,O75469,,,,,,Human,lovastatin,2739,,,135652701,Agonist,Full agonist,,f,,,pEC50,6,0,5.3,EC50,5000,0,1000,=,,,,9727070,CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
presenilin 1,2402,PSEN1,P49768,,,,,,Human,ELND006,7337,,,178103909,Inhibitor,Inhibition,,f,t,,pIC50,0,9.470000267,0,IC50,0,0.340000004,0,=,A-beta release assay,,,23713656,Fc1cc2c3[nH]ncc3[C@H](N(c2cc1F)S(=O)(=O)c1ccc(cc1)C(F)(F)F)C1CC1
presenilin 1,2402,PSEN1,P49768,,,,,,Human,RO4929097,7338,,,178103910,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,19773430,O=C1Nc2ccccc2c2c([C@@H]1NC(=O)C(C(=O)NCC(C(F)(F)F)(F)F)(C)C)cccc2
presenilin 1,2402,PSEN1,P49768,,,,,,Human,SCH-900229,8848,,,252827505,Inhibitor,Inhibition,,f,t,,pIC50,9,0,8.890000343,IC50,1.299999952,0,1,=,Data range indicates inhibition of A&beta;42 or A&beta;40 production.,,,0,Clc1ccc(cc1)S(=O)(=O)[C@@]12CCO[C@H]([C@@H]1COc1c2c(F)ccc1F)CCS(=O)(=O)C
presenilin 1,2402,PSEN1,P49768,,,,,,Human,semagacestat,6978,,,178103557,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,19694467,O=C([C@@H](NC(=O)[C@H](C(C)C)O)C)N[C@@H]1C(=O)N(C)CCc2c1cccc2
Progesterone receptor,627,PGR,P06401,,,,,,Human,dydrogesterone,2878,,,135650214,Agonist,Agonist,Binding to PRs on MCF-7 cells,f,t,,pKi,0,6.900000095,0,Ki,0,126,0,=,,,,14670641,O=C1CC[C@@]2(C(=C1)C=C[C@@H]1[C@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,fluticasone propionate,7080,,,178103659,Agonist,Agonist,,f,f,,pEC50,0,7.679999828,0,EC50,0,21,0,=,,,,28937774,FCSC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Progesterone receptor,627,PGR,P06401,,,,,,Human,levonorgestrel,2881,,,135650516,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,14670641,C#C[C@]1(O)CC[C@@H]2[C@]1(CC)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12
Progesterone receptor,627,PGR,P06401,,,,,,Human,medroxyprogesterone,2879,,,135650577,Agonist,Agonist,Affinity at human PR-A,f,t,,pKi,0,9.470000267,0,Ki,0,0.340000004,0,=,,,,9464360,O=C1CC[C@]2(C(=C1)[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(O)C(=O)C)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,norethisterone,2880,,,135650731,Agonist,Agonist,,f,t,,pEC50,0,8.659999847,0,EC50,0,2.200000048,0,=,,,,9464361,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12
Progesterone receptor,627,PGR,P06401,,,,,,Human,ORG2058,3453,,,178100451,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC[C@@H]1C[C@@H]2[C@]([C@H]1C(=O)CO)(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12
Progesterone receptor,627,PGR,P06401,,,,,,Human,progesterone,2377,,,135651551,Agonist,Agonist,,t,t,,pEC50,0,8.819999695,0,EC50,0,1.5,0,=,,,,9667968,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,progesterone,2377,,,135651551,Agonist,Agonist,Affinity at human PR-A,f,t,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,,,,9464360,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,promegestone,2877,,,135650855,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,14670641,CCC(=O)[C@@]1(C)CC[C@@H]2[C@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@H]21
Progesterone receptor,627,PGR,P06401,,,,,,Human,mifepristone,2805,,,135650608,Agonist,Mixed,,f,t,,pKi,0,8.960000038,0,Ki,0,1.100000024,0,=,,,,12781197,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Progesterone receptor,627,PGR,P06401,,,,,,Human,onapristone,2882,,,135650760,Antagonist,Antagonist,,f,,,pKi,0,7.74,0,Ki,0,18,0,=,,,,8627601,OCCC[C@@]1(O)CC[C@@H]2[C@@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Progesterone receptor,627,PGR,P06401,,,,,,Human,PF-03882845,9061,,,315661146,Antagonist,Antagonist,,f,f,,pIC50,0,6.380000114,0,IC50,0,416,0,=,,,,24738581,N#Cc1ccc(cc1Cl)N1N=C2[C@@H]([C@@H]1C1CCCC1)CCc1c2ccc(c1)C(=O)O
Progesterone receptor,627,PGR,P06401,,,,,,Human,mifepristone,2805,,,135650608,Antagonist,Mixed,,f,,,pKi,0,8.96,0,Ki,0,1.1,0,=,,,,12781197,CC#C[C@]1(O)CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21
programmed cell death 1 (CD279),2760,PDCD1,Q15116,,,,,,Human,nivolumab,7335,,,178103907,Antibody,Binding,,f,t,,pKd,0,9.140000343,0,Kd,0,0.730000019,0,=,,,,21154117,
programmed cell death 1 (CD279),2760,PDCD1,Q15116,,,,,,Human,pembrolizumab,7499,,,187051801,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,~,,,,0,
programmed cell death 1 (CD279),2760,PDCD1,Q15116,,,,,,Human,programmed cell death 1 ligand 1,9606,CD274,Human,340590236,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Prolactin receptor,1721,Prlr,Q08501,,,,,,Mouse,prolactin,5049,PRL,Human,178101744,Agonist,Agonist,,t,f,,pKd,0,8.050000191,0,Kd,0,9,0,=,,,,4362846,
prolyl endopeptidase,2395,PREP,P48147,,,,,,Human,S 17092,6565,,,178103179,Inhibitor,Inhibition,,f,,,pKi,0,8.8,0,Ki,0,1.5,0,,,,,20058865,O=C([C@@H]1C[C@H]1c1ccccc1)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CSCC1
proprotein convertase subtilisin/kexin type 1,2382,PCSK1,P29120,,,,,,Human,phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide,6564,,,178103178,Inhibitor,Inhibition,,f,f,,pKi,0,9.119999886,0,Ki,0,0.75,0,=,,,,20038105,NC(=NCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)Cc1ccccc1)CCCN=C(N)N)N
proprotein convertase subtilisin/kexin type 2,2383,PCSK2,P16519,,,,,,Human,peptide 18 [PMID: 24350995],8658,,,252166858,Inhibitor,Inhibition,,f,f,,pKi,0,9.619999886,0,Ki,0,0.239999995,0,=,,,,24350995,NCCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 4,2384,PCSK4,Q6UW60,,,,,,Human,furin inhibitor peptide,8668,,,252166868,Inhibitor,Inhibition,,f,f,,pKi,0,6.360000134,0,Ki,0,441,0,=,,,,17537721,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 5,2385,PCSK5,Q92824,,,,,,Human,furin inhibitor peptide,8668,,,252166868,Inhibitor,Inhibition,,f,f,,pKi,0,6.630000114,0,Ki,0,232,0,=,,,,17537721,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 5,2385,PCSK5,Q92824,,,,,,Human,phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide,6564,,,178103178,Inhibitor,Inhibition,,f,f,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,20038105,NC(=NCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)Cc1ccccc1)CCCN=C(N)N)N
proprotein convertase subtilisin/kexin type 6,2386,PCSK6,P29122,,,,,,Human,furin inhibitor peptide,8668,,,252166868,Inhibitor,Inhibition,,f,f,,pKi,0,6.789999962,0,Ki,0,162,0,=,,,,17537721,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 6,2386,PCSK6,P29122,,,,,,Human,multi-Leu (ML)-peptide,8648,,,252166848,Inhibitor,Inhibition,,f,t,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,23126600,
proprotein convertase subtilisin/kexin type 6,2386,PCSK6,P29122,,,,,,Human,peptide 18 [PMID: 24350995],8658,,,252166858,Inhibitor,Inhibition,,f,f,,pKi,0,8.510000229,0,Ki,0,3.099999905,0,=,,,,24350995,NCCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 6,2386,PCSK6,P29122,,,,,,Human,phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide,6564,,,178103178,Inhibitor,Inhibition,,f,f,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,20038105,NC(=NCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)Cc1ccccc1)CCCN=C(N)N)N
proprotein convertase subtilisin/kexin type 7,2387,PCSK7,Q16549,,,,,,Human,furin inhibitor peptide,8668,,,252166868,Inhibitor,Inhibition,,f,f,,pKi,0,6.820000172,0,Ki,0,152,0,=,,,,17537721,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 7,2387,PCSK7,Q16549,,,,,,Human,peptide 18 [PMID: 24350995],8658,,,252166858,Inhibitor,Inhibition,,f,f,,pKi,0,7.860000134,0,Ki,0,13.80000019,0,=,,,,24350995,NCCCC[C@@H](C(=O)NCc1ccc(cc1)C(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N
proprotein convertase subtilisin/kexin type 9,2388,PCSK9,Q8NBP7,,,,,,Human,evolocumab,7343,,,178103915,Inhibitor,Inhibition,,f,t,,pKd,0,9.720000267,0,Kd,0,0.189999998,0,=,"Dissociation equilibrium constant for wild-type hPCSK9, measured using proprietary BIACore&reg; technology.",,,0,
PROT,938,SLC6A7,Q99884,,,,,,Human,LP-403812,4576,,,178101297,Inhibitor,Inhibition,,f,,,pIC50,0,7,0,IC50,0,110,0,,,,,19159658,Cc1ccc(cc1)C(=O)Nc1sc2c(n1)n(nc2C(=O)N1CCC[C@H]1CN1CCCC1)C(C)(C)C
proteasome subunit beta 5,2406,PSMB5,P28074,,,,,,Human,ixazomib,8450,,,252166660,Inhibitor,Inhibition,,f,t,,pKi,0,9.029999733,0,Ki,0,0.930000007,0,=,,,,20160034,OB([C@@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)CC(C)C)O
proteasome subunit beta 5,2406,PSMB5,P28074,,,,,,Human,oprozomib,8739,,,252827397,Inhibitor,Inhibition,,f,t,,pIC50,8,0,7.489999771,IC50,32,0,10,=,,,,22978849,COC[C@@H](C(=O)N[C@H](C(=O)[C@]1(C)OC1)Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1cnc(s1)C)COC
proteasome subunit beta 8,2408,PSMB8,P28062,,,,,,Human,HT1042,8649,,,252166849,Inhibitor,Inhibition,,f,t,,pKi,0,6.380000114,0,Ki,0,420,0,=,,,,0,O=c1snc(o1)c1cccc(c1)[N+](=O)[O-]
proteasome subunit beta 8,2408,PSMB8,P28062,,,,,,Human,ONX-0914,9031,,,315661116,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,19525961,COc1ccc(cc1)C[C@@H](C(=O)N[C@H](C(=O)[C@@]1(C)CO1)Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN1CCOCC1)C
protein arginine methyltransferase 1 ,1252,PRMT1,Q99873,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
protein arginine methyltransferase 1 ,1252,PRMT1,Q99873,,,,,,Human,RM65,7029,,,178103608,Inhibitor,Inhibition,,f,f,,pIC50,0,4.260000229,0,IC50,0,55400,0,=,,,,17570663,O=C(C(SC1c2ccccc2Oc2c1cccc2)C)NCCNC(=O)C(SC1c2ccccc2Oc2c1cccc2)C
protein arginine methyltransferase 3,1254,PRMT3,O60678,,,,,,Human,SGC707,8552,,,252166753,Allosteric modulator,Negative,,f,t,,pKd,0,7.28000021,0,Kd,0,53,0,=,,,,25728001,O=C(Nc1ccc2c(c1)ccnc2)NCC(=O)N1CCCC1
protein arginine methyltransferase 3,1254,PRMT3,O60678,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKi,0,7.260000229,0,Ki,0,55,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
protein arginine methyltransferase 5 ,1256,PRMT5,O14744,,,,,,Human,DS-437,8395,,,252166606,Inhibitor,Inhibition,,f,t,,pIC50,0,5.230000019,0,IC50,0,5900,0,=,,,,25893041,CCNC(=O)NCCSC[C@H]1OC([C@@H]([C@H]1O)O)n1cnc2c1ncnc2N
protein arginine methyltransferase 5 ,1256,PRMT5,O14744,,,,,,Human,EPZ015666,8287,,,252166499,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,0,O[C@H](CN1CCc2c(C1)cccc2)CNC(=O)c1ncnc(c1)NC1COC1
protein arginine methyltransferase 5 ,1256,PRMT5,O14744,,,,,,Human,GSK591,8954,,,310264735,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,Measuring inhibition of methylation of histone H4 in an <i>in vitro</i> biochemical assay.,,,0,O[C@H](CN1CCc2c(C1)cccc2)CNC(=O)c1ccnc(c1)NC1CCC1
protein arginine methyltransferase 5 ,1256,PRMT5,O14744,,,,,,Human,LLY-283,9527,,,336446913,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,Inhibition of methylation of an H4R3 derived peptide substrate <i>in vitro</i>.,,,0,O[C@@H]([C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1ccc2c1ncnc2N)c1ccccc1
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,EPZ020411,9243,,,315661318,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,26101569,CNCCN(Cc1cn[nH]c1c1ccc(cc1)OC1CC(C1)OCCC1CCOCC1)C
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKd,0,8.220000267,0,Kd,0,6,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,MS049,9529,,,336446915,Inhibitor,Inhibition,,f,t,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,27584694,CNCCN1CCC(CC1)OCc1ccccc1
protein arginine methyltransferase 6,1257,PRMT6,Q96LA8,,,,,,Human,MS049,9529,,,336446915,Inhibitor,Inhibition,,f,t,,pKd,0,7.059999943,0,Kd,0,87,0,=,Isothermal titration calorimetry (ITC) in the presence of SAH,,,27584694,CNCCN1CCC(CC1)OCc1ccccc1
protein arginine methyltransferase 7 ,1258,PRMT7,Q9NVM4,,,,,,Human,DS-437,8395,,,252166606,Inhibitor,Inhibition,,f,t,,pIC50,0,5.21999979,0,IC50,0,6000,0,=,,,,25893041,CCNC(=O)NCCSC[C@H]1OC([C@@H]([C@H]1O)O)n1cnc2c1ncnc2N
protein arginine methyltransferase 8,1259,PRMT8,Q9NR22,,,,,,Human,MS023,8955,,,310264736,Inhibitor,Inhibition,,f,f,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,0,NCCN(Cc1c[nH]cc1c1ccc(cc1)OC(C)C)C
protein arginine methyltransferase 8,1259,PRMT8,Q9NR22,,,,,,Human,MS049,9529,,,336446915,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,27584694,CNCCN1CCC(CC1)OCc1ccccc1
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,N<sup>6</sup> benzyl-cAMP,5228,,,178101912,Activator,Activation,,f,,,-,0,0,0,-,0,0,0,=,,,,12819211,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2NCc1ccccc1
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,Rp-cAMPS,5262,,,178101946,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H]2O[P@@](=S)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
protein kinase AMP-activated non-catalytic subunit beta 1,1543,PRKAB1,Q9Y478,,,,,,Human,MT47-100,8821,,,252827478,Activator,Activation,,f,f,,pKi,0,5.429999828,0,Ki,0,3700,0,=,,,,26091167,Oc1ccccc1c1ccc(cc1)c1ccc2c(c1)c(O)c(c(n2)O)O
protein kinase AMP-activated non-catalytic subunit beta 2,1544,PRKAB2,O43741,,,,,,Human,MT47-100,8821,,,252827478,Allosteric modulator,Negative,,f,f,,pKi,0,4.610000134,0,Ki,0,24800,0,=,,,,26091167,Oc1ccccc1c1ccc(cc1)c1ccc2c(c1)c(O)c(c(n2)O)O
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,ingenol mebutate,7443,,,178104015,Activator,Activation,,f,f,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,,,,15126366,C/C=C(C(=O)O[C@H]1C(=C[C@]23[C@]1(O)[C@H](O)C(=C[C@H](C3=O)[C@H]1[C@@H](C[C@H]2C)C1(C)C)CO)C)/C
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,enzastaurin,5693,,,178102320,Inhibitor,Inhibition,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,,,,12749884,O=C1NC(=O)C(=C1c1cn(c2c1cccc2)C1CCN(CC1)Cc1ccccn1)c1cn(c2c1cccc2)C
protein kinase C alpha,1482,,,,,,,,Bovine,GF109203X,5193,,,178101881,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,1874734,CN(CCCn1cc(c2c1cccc2)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2)C
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,G&ouml; 6976,5973,,,178102596,Inhibitor,Inhibition,,f,t,,pIC50,0,8.640000343,0,IC50,0,2.299999952,0,=,,,,8486620,N#CCCn1c2ccccc2c2c1c1c(c3c2CNC3=O)c2c(n1C)cccc2
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,G&ouml; 6983,5192,,,178101880,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,8772178,COc1ccc2c(c1)c(cn2CCCN(C)C)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C alpha,1482,,,,,,,,Bovine,Ro-32-0432,6034,,,178102656,Inhibitor,Inhibition,,f,t,,pIC50,8.050000191,0,8.029999733,IC50,9.300000191,0,9,=,,,,8114006,CN(C[C@H]1CCn2c(C1)c(C1=C(C(=O)NC1=O)c1cn(c3c1cccc3)C)c1c2cccc1)C
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,f,,pIC50,0,6.440000057,0,IC50,0,360,0,=,,,,15380221,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
protein kinase C alpha,1482,PRKCA,P17252,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,8.680000305,0,IC50,0,2.099999905,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
"protein kinase, cAMP-dependent, catalytic, alpha subunit",1476,PRKACA,P17612,,,,,,Human,H-89,5983,,,178102606,Inhibitor,Inhibition,,f,t,,pKi,0,7.320000172,0,Ki,0,48,0,=,,,,2156866,Brc1ccc(cc1)/C=C/CNCCNS(=O)(=O)c1cccc2c1ccnc2
"protein kinase, cAMP-dependent, catalytic, beta subunit",1477,PRKACB,P22694,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,21435888,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,ingenol mebutate,7443,,,178104015,Activator,Activation,,f,f,,pKi,0,9.979999542,0,Ki,0,0.104999997,0,=,,,,15126366,C/C=C(C(=O)O[C@H]1C(=C[C@]23[C@]1(O)[C@H](O)C(=C[C@H](C3=O)[C@H]1[C@@H](C[C@H]2C)C1(C)C)CO)C)/C
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,enzastaurin,5693,,,178102320,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,12749884,O=C1NC(=O)C(=C1c1cn(c2c1cccc2)C1CCN(CC1)Cc1ccccn1)c1cn(c2c1cccc2)C
protein kinase C beta,1483,,,,,,,,Bovine,GF109203X,5193,,,178101881,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,1874734,CN(CCCn1cc(c2c1cccc2)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2)C
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,G&ouml; 6983,5192,,,178101880,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,8772178,COc1ccc2c(c1)c(cn2CCCN(C)C)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,PKCbeta inhibitor,6025,,,178102647,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15380221,O=C1NC(=O)C(=C1c1cn(c2c1cccc2)CCCn1cncc1)Nc1ccccc1
protein kinase C beta,1483,,,,,,,,Bovine,Ro-32-0432,6034,,,178102656,Inhibitor,Inhibition,,f,t,,pIC50,7.519999981,0,7.510000229,IC50,31,0,30,=,,,,8114006,CN(C[C@H]1CCn2c(C1)c(C1=C(C(=O)NC1=O)c1cn(c3c1cccc3)C)c1c2cccc1)C
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,t,,pIC50,0,8.229999542,0,IC50,0,5.900000095,0,=,,,,8709095,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
protein kinase C beta,1483,PRKCB,P05771,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,ingenol mebutate,7443,,,178104015,Activator,Activation,,f,t,,pKi,0,9.420000076,0,Ki,0,0.375999987,0,=,,,,15126366,C/C=C(C(=O)O[C@H]1C(=C[C@]23[C@]1(O)[C@H](O)C(=C[C@H](C3=O)[C@H]1[C@@H](C[C@H]2C)C1(C)C)CO)C)/C
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,enzastaurin,5693,,,178102320,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,12749884,O=C1NC(=O)C(=C1c1cn(c2c1cccc2)C1CCN(CC1)Cc1ccccn1)c1cn(c2c1cccc2)C
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,G&ouml; 6983,5192,,,178101880,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,8772178,COc1ccc2c(c1)c(cn2CCCN(C)C)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,f,,pIC50,0,6.599999905,0,IC50,0,250,0,=,,,,8709095,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
protein kinase C delta,1485,PRKCD,Q05655,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,8.890000343,0,IC50,0,1.299999952,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,ingenol mebutate,7443,,,178104015,Activator,Activation,,f,f,,pKi,0,9.770000458,0,Ki,0,0.171000004,0,=,,,,15126366,C/C=C(C(=O)O[C@H]1C(=C[C@]23[C@]1(O)[C@H](O)C(=C[C@H](C3=O)[C@H]1[C@@H](C[C@H]2C)C1(C)C)CO)C)/C
protein kinase C epsilon,1486,Prkce,P16054,,,,,,Mouse,Ro-32-0432,6034,,,178102656,Inhibitor,Inhibition,,f,t,,pIC50,0,6.96999979,0,IC50,0,108,0,=,,,,8114006,CN(C[C@H]1CCn2c(C1)c(C1=C(C(=O)NC1=O)c1cn(c3c1cccc3)C)c1c2cccc1)C
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,8.210000038,0,IC50,0,6.199999809,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C eta,1487,PRKCH,P24723,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,8.210000038,0,IC50,0,6.099999905,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,ingenol mebutate,7443,,,178104015,Activator,Activation,,f,f,,pKi,0,9.789999962,0,Ki,0,0.162,0,=,,,,15126366,C/C=C(C(=O)O[C@H]1C(=C[C@]23[C@]1(O)[C@H](O)C(=C[C@H](C3=O)[C@H]1[C@@H](C[C@H]2C)C1(C)C)CO)C)/C
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,enzastaurin,5693,,,178102320,Inhibitor,Inhibition,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,12749884,O=C1NC(=O)C(=C1c1cn(c2c1cccc2)C1CCN(CC1)Cc1ccccn1)c1cn(c2c1cccc2)C
protein kinase C gamma,1484,,,,,,,,Bovine,GF109203X,5193,,,178101881,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,1874734,CN(CCCn1cc(c2c1cccc2)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2)C
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,G&ouml; 6983,5192,,,178101880,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,8772178,COc1ccc2c(c1)c(cn2CCCN(C)C)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C gamma,1484,,,,,,,,Bovine,Ro-32-0432,6034,,,178102656,Inhibitor,Inhibition,,f,t,,pIC50,7.440000057,0,7.429999828,IC50,37,0,36.5,=,,,,8114006,CN(C[C@H]1CCn2c(C1)c(C1=C(C(=O)NC1=O)c1cn(c3c1cccc3)C)c1c2cccc1)C
protein kinase C gamma,1484,PRKCG,P05129,,,,,,Human,ruboxistaurin,5263,,,178101947,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,8709095,CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C
protein kinase C iota,1490,PRKCI,P41743,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,6.460000038,0,IC50,0,346,0,=,,,,17875639,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
protein kinase C theta,1488,PRKCQ,Q04759,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
protein kinase C theta,1488,PRKCQ,Q04759,,,,,,Human,PKC&theta; inhibitor 14,9452,,,329968392,Inhibitor,Inhibition,,f,t,,pIC50,0,9.600000381,0,IC50,0,0.25,0,=,In a biochemical assay.,,,27117263,O=C1NC(C)(C)N(c2c1ccc(c2)n1c(=O)[nH]c2c1cccn2)[C@@H](c1ccccc1)C
protein kinase C theta,1488,PRKCQ,Q04759,,,,,,Human,sotrastaurin,7946,,,249565629,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,19827831,CN1CCN(CC1)c1nc2ccccc2c(n1)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase C zeta,1491,PRKCZ,Q05513,,,,,,Human,G&ouml; 6983,5192,,,178101880,Inhibitor,Inhibition,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,8772178,COc1ccc2c(c1)c(cn2CCCN(C)C)C1=C(C(=O)NC1=O)c1c[nH]c2c1cccc2
protein kinase D1,1489,PRKD1,Q15139,,,,,,Human,CRT 0066101,8048,,,249565728,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,20442301,CC[C@H](CNc1ccnc(n1)c1cc(ccc1O)c1cnn(c1)C)N
protein kinase D1,1489,PRKD1,Q15139,,,,,,Human,G&ouml; 6976,5973,,,178102596,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,8772178,N#CCCn1c2ccccc2c2c1c1c(c3c2CNC3=O)c2c(n1C)cccc2
protein kinase D1,1489,PRKD1,Q15139,,,,,,Human,kb-NB142-70,9369,,,328083471,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28.29999924,0,=,,,,21617763,Oc1cc2c3SCCNC(=O)c3sc2cc1
protein kinase D2,2173,PRKD2,Q9BZL6,,,,,,Human,CRT 0066101,8048,,,249565728,Inhibitor,Inhibition,,f,t,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,20442301,CC[C@H](CNc1ccnc(n1)c1cc(ccc1O)c1cnn(c1)C)N
protein kinase D3,2174,PRKD3,O94806,,,,,,Human,CRT 0066101,8048,,,249565728,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,20442301,CC[C@H](CNc1ccnc(n1)c1cc(ccc1O)c1cnn(c1)C)N
Protein kinase G (PKG) 1,1492,PRKG1,Q13976,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
Protein kinase G (PKG) 1,1492,PRKG1,Q13976,,,,,,Human,ipatasertib,7887,,,249565578,Inhibitor,Inhibition,,f,f,,pIC50,0,7.159999847,0,IC50,0,69,0,=,,,,22934575,CC(NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2c1[C@H](C)C[C@H]2O)c1ccc(cc1)Cl)C
Protein kinase G (PKG) 1,1492,PRKG1,Q13976,,,,,,Human,Rp-8-CPT-cGMPS,5261,,,178101945,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,7851503,O[C@H]1C2OP(O)(S)OC[C@H]2OC1n1c(Sc2ccc(cc2)Cl)nc2c1nc(N)[nH]c2=O
"protein kinase, membrane associated tyrosine/threonine 1",2167,PKMYT1,Q99640,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,f,,pIC50,8.149999619,0,7.139999866,IC50,72,0,7,=,,,,11719452,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
protein kinase N1,1520,PKN1,Q16512,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,<,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
protein kinase N1,1520,PKN1,Q16512,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
"protein kinase, X-linked",2175,PRKX,P51817,,,,,,Human,GSK690693,5196,,,178101884,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,18800763,CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(O)(C)C)c1nonc1N
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.260000229,0,IC50,0,55,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,example 96 [WO2012092880],9763,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,<,In a time-resolved fluorescence (TRF) assay using recombinant GST-tagged FAK.,,,0,COc1cc(ccc1Nc1nc2NCCc2c(n1)Nc1ccccc1S(=O)(=O)NC(C)C)N1CCC(CC1)N1CCN(CC1)C
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,NVP-TAE 226,9382,,,328083484,Inhibitor,Inhibition,,f,f,,pIC50,0,8.260000229,0,IC50,0,5.5,0,=,,,,17219439,CNC(=O)c1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCOCC1
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,PF-562271,9381,,,328083483,Inhibitor,Inhibition,,f,f,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,18339875,O=C1Nc2c(C1)cc(cc2)Nc1ncc(c(n1)NCc1cccnc1N(S(=O)(=O)C)C)C(F)(F)F
protein tyrosine kinase 2 beta,2181,PTK2B,Q14289,,,,,,Human,example 96 [WO2012092880],9763,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,<,In a time-resolved fluorescence (TRF) assay using recombinant GST-tagged Pyk2.,,,0,COc1cc(ccc1Nc1nc2NCCc2c(n1)Nc1ccccc1S(=O)(=O)NC(C)C)N1CCC(CC1)N1CCN(CC1)C
protein tyrosine kinase 2 beta,2181,PTK2B,Q14289,,,,,,Human,NVP-TAE 226,9382,,,328083484,Inhibitor,Inhibition,,f,f,,pIC50,8.699999809,0,8.300000191,IC50,5,0,2,=,,,,17431114,CNC(=O)c1ccccc1Nc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCOCC1
protein tyrosine kinase 2 beta,2181,PTK2B,Q14289,,,,,,Human,PF-562271,9381,,,328083483,Inhibitor,Inhibition,,f,f,,pIC50,0,7.889999866,0,IC50,0,13,0,=,,,,18339875,O=C1Nc2c(C1)cc(cc2)Nc1ncc(c(n1)NCc1cccnc1N(S(=O)(=O)C)C)C(F)(F)F
"protein tyrosine phosphatase, non-receptor type 1",2976,PTPN1,P18031,,,,,,Human,HPN,9732,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,6.199999809,0,IC50,0,630,0,=,In a surface plasmon resonance (SPR) assay using immobilised recombinant enzyme PTP1B<sub>1?321</sub>.,,,23364683,CC(OCc1cc(O)c(c(c1Cc1cc(O)c(c(c1Br)Br)O)Br)O)C
Proton-coupled Amino acid Transporter 1,1161,SLC36A1,Q7Z2H8,,,,,,Human,indole-3-propionic acid,4709,,,178101420,Inhibitor,Inhibition,,f,,,pKi,0,2.3,0,Ki,0,4600000,0,,,,,16126914,OC(=O)CCc1c[nH]c2c1cccc2
Proton-coupled Amino acid Transporter 1,1161,SLC36A1,Q7Z2H8,,,,,,Human,L-tryptophan,717,,,135651515,Inhibitor,Inhibition,,f,,,pKi,0,2.3,0,Ki,0,4600000,0,,,,,16126914,OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,indomethacin,1909,,,135650390,Inhibitor,Inhibition,,f,,,pIC50,0,3.7,0,IC50,0,200000,0,=,,,,17129779,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PrRP-20,1871,PRLH,Human,135651863,Agonist,Full agonist,,t,f,,pKi,9.600000381,0,9,-,0,0,0,=,,,,11030716,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PrRP-20,1872,Prlh,Rat,135651864,Agonist,Full agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,11030716,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PrRP-(24-31) (human),1870,,,135652415,Agonist,Full agonist,,f,,,pKi,0,7.3,0,-,0,0,0,=,,,,12606605,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PrRP-31,1873,PRLH,Human,135651865,Agonist,Full agonist,,t,f,,pKi,9.199999809,0,9,-,0,0,0,=,,,,11030716,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PrRP-31,1874,Prlh,Rat,135651866,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,11030716,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,PTHrP,3738,PTHLH,Human,135651870,Agonist,Full agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,"NPY-(18-36) (human, pig)",1557,,,135652347,Agonist,Partial agonist,,f,,,pKi,0,5.1,0,-,0,0,0,=,,,,12606605,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Antagonist,Antagonist,,t,,,pKi,0,5.4,0,-,0,0,0,=,,,,15885496,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[His<sup>5</sup>,Arg<sup>19</sup>]PTH-(1-34) (human)",1793,,,135652184,Agonist,Full agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,[His<sup>5</sup>]PTH-(1-34) (human),1794,,,135652185,Agonist,Full agonist,,f,,,pIC50,0,5.1,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[His<sup>5</sup>]PTH-(1-34) (human),1794,,,135652185,Agonist,Full agonist,,f,,,pIC50,0,5.3,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[Ile<sup>5</sup>,Glu<sup>19</sup>]PTHrP-(1-34) (human)",1796,,,135652198,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[Ile<sup>5</sup>,Glu<sup>19</sup>,Val<sup>21</sup>]PTHrP-(1-34) (human)",1795,,,135652199,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,[Ile<sup>5</sup>]PTHrP-(1-34) (human),1803,,,135652200,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[Ile<sup>5</sup>]PTHrP-(1-36) (human),1804,,,135652202,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(1-36) (human)",1798,,,135652203,Agonist,Full agonist,,f,,,pIC50,7.8,0,7.4,,0,0,0,,,,,8702701,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(2-36) (human)",1799,,,135652204,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,10537121,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(3-36) (human)",1800,,,135652205,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,10537121,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(4-36) (human)",1801,,,135652206,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,10537121,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>,Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human)",1797,,,135652209,Agonist,Full agonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,9360953,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[Ile<sup>5</sup>,Val<sup>21</sup>]PTHrP-(1-34) (human)",1802,,,135652210,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,7896796,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[Nle<sup>8,18</sup>,Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (bovine)",1805,,,135652326,Agonist,Full agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,8662729,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,"[Nle<sup>8,18</sup>,Tyr<sup>34</sup>]PTH-(3-34)-NH<sub>2</sub> (bovine)",1806,,,135652327,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,8662729,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[Phe<sup>23</sup>]PTH-(1-34) (human),1807,,,135652395,Agonist,Full agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,PTH-(1-34) (rat),4449,,,135652418,Agonist,Full agonist,,f,,,pIC50,7.2,0,7.1,,0,0,0,,,,,10537121,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,PTHrP-(1-20)/TIP-(23-39) (human),1787,,,135652419,Agonist,Full agonist,,f,,,pIC50,8,0,7.5,,0,0,0,,,,,11159842,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,PTHrP-(1-21)/PTH-(22-34) (human),1788,,,135652421,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,PTHrP-(1-34) (human),1822,,,135652422,Agonist,Full agonist,,f,,,pIC50,8.1,0,7.8,-,0,0,0,=,,,,7896796,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,PTHrP-(1-36),1790,PTHLH,Human,135651871,Agonist,Full agonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[D-Trp<sup>12</sup>,Tyr<sup>34</sup>]PTH-(7-34) (bovine)",1819,,,135652132,Antagonist,Antagonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,11046116,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(5-36)",1821,,,135652207,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,10537121,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"PTHrP-(7-34) (human, rat, mouse)",1814,,,135652423,Antagonist,Antagonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,11046116,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,[His<sup>5</sup>]PTH-(1-34) (human),1794,,,135652185,Agonist,Full agonist,,f,,,pIC50,0,6.6,0,,0,0,0,,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,[Ile<sup>5</sup>]PTHrP-(1-36),1825,,,135652201,Agonist,Full agonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(1-36) (human)",1798,,,135652203,Agonist,Full agonist,,f,,,pIC50,8,0,7.1,,0,0,0,,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(2-36) (human)",1799,,,135652204,Agonist,Full agonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,10537121,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(3-36) (human)",1800,,,135652205,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,10537121,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(4-36) (human)",1801,,,135652206,Agonist,Full agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,10537121,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(5-36) (human)",1824,,,135652208,Agonist,Full agonist,,f,,,pIC50,0,7,0,-,0,0,0,=,,,,10537121,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>,Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human)",1797,,,135652209,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,9360953,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,[Phe<sup>23</sup>]PTH-(1-34) (human),1807,,,135652395,Agonist,Full agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,PTH-(1-34) (rat),4449,,,135652418,Agonist,Full agonist,,f,,,pIC50,9.5,0,7.2,,0,0,0,,,,,10537121,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,PTH-(1-34) (rat),4449,,,135652418,Agonist,Full agonist,,f,,,pIC50,0,6.8,0,-,0,0,0,=,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,PTHrP-(1-34) (human),1822,,,135652422,Agonist,Full agonist,,t,,,pIC50,0,6.1,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,PTHrP-(1-34) (human),1822,,,135652422,Agonist,Full agonist,,t,,,pIC50,0,5.3,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,PTHrP-(1-36),1790,PTHLH,Human,135651871,Agonist,Full agonist,,t,,,pIC50,0,5.7,0,,0,0,0,,,,,8702701,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,[D-Trp<sup>12</sup>]PTH-(7-34) (bovine),1820,,,135652131,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,[D-Trp<sup>12</sup>]PTH-(7-34) (bovine),1820,,,135652131,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[D-Trp<sup>12</sup>,Tyr<sup>34</sup>]PTH-(7-34) (bovine)",1819,,,135652132,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,11046116,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,"[His<sup>4</sup>, Tyr<sup>5</sup>, Trp<sup>6</sup>, His<sup>7</sup>]TIP39 (human)",5572,,,178102208,Antagonist,Antagonist,,f,,,pA2,0,7.61,0,-,0,0,0,=,,,,0,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Ile<sup>5</sup>,Trp<sup>23</sup>]PTHrP-(5-36)",1821,,,135652207,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,10537121,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,PTHrP-(1-21)/PTH-(22-34) (human),1788,,,135652421,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,-,0,0,0,=,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,PTHrP-(1-21)/PTH-(22-34) (human),1788,,,135652421,Antagonist,Antagonist,,f,,,pIC50,8,0,7,-,0,0,0,=,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"PTHrP-(7-34) (human, rat, mouse)",1814,,,135652423,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,11046116,
purine nucleoside phosphorylase,2841,PNP,P00491,,,,,,Human,forodesine,8272,,,252166484,Inhibitor,Inhibition,,f,t,,pKi,0,10.14000034,0,Ki,0,0.071999997,0,=,,,,9628722,OC[C@H]1N[C@H]([C@@H]([C@@H]1O)O)c1c[nH]c2c1[nH]cnc2=O
Px1,735,PANX1,Q96RD7,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,little block by flufenamic acid,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Px2,736,PANX2,Q96RD6,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,little block by flufenamic acid,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
Px3,737,PANX3,Q96QZ0,,,,,,Human,flufenamic acid,2447,,,135650269,Inhibitor,None,little block by flufenamic acid,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,LV-2172,9442,,,329968382,Agonist,Agonist,,f,f,,pEC50,0,6.789999962,0,EC50,0,164,0,=,,,,22800498,
QRFP receptor,333,Qrfpr,P83861,,,,,,Mouse,QRFP26,5896,Qrfp,Mouse,178102519,Agonist,Full agonist,,t,,,pEC50,0,8.22,0,EC50,0,6,0,=,,,,12714592,
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,QRFP26,5895,QRFP,Human,178102518,Agonist,Full agonist,,t,f,,pEC50,0,8.149999619,0,EC50,0,7,0,=,,,,12714592,
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,QRFP43,3665,QRFP,Human,135651879,Agonist,Full agonist,,t,,,pEC50,8.57,0,6.9,EC50,0,2.7,0,=,,,,16500002,
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,QRFP43,3713,Qrfp,Rat,135651878,Agonist,Full agonist,,f,,,pEC50,0,7.64,0,EC50,0,23,0,=,,,,16648250,
QRFP receptor,333,Qrfpr,P83861,,,,,,Mouse,QRFP43,3713,Qrfp,Rat,135651878,Agonist,Full agonist,This range compares the A and B isoforms of mouse Qrfpr.,f,,,pEC50,7.2,0,7.04,EC50,91,0,63,=,,,,16648250,
QRFP receptor,333,Qrfpr,P83861,,,,,,Mouse,QRFP43,3712,Qrfp,Mouse,135651877,Agonist,Full agonist,This range compares the A and B isoforms of mouse Qrfpr.,t,,,pEC50,7.15,0,6.71,EC50,194,0,70,=,,,,16648250,
QRFP receptor,333,Qrfpr,P83861,,,,,,Mouse,QRFP43,3665,QRFP,Human,135651879,Agonist,Full agonist,This range compares the A and B isoforms of mouse Qrfpr.,f,,,pEC50,7.38,0,7.14,EC50,73,0,42,=,,,,16648250,
QRFP receptor,333,Qrfpr,P83858,,,,,,Rat,QRFP43,3665,QRFP,Human,135651879,Agonist,Full agonist,,t,f,,pIC50,9.279999733,0,7.800000191,IC50,16,0,0.519999981,=,,,,16648250,
"RAB27A, member RAS oncogene family",2916,RAB27A,P51159,,,,,,Human,Nexinhib20,9419,,,328083519,Inhibitor,Inhibition,,f,t,,pIC50,0,5.590000153,0,IC50,0,2600,0,=,,,,27702998,O=C(C(C)(C)C)/C(=C/c1cccc(c1)[N+](=O)[O-])/n1cncn1
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,GW5074,8072,,,249565752,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,15255937,Ic1ccc2c(c1)/C(=C/c1cc(Br)c(c(c1)Br)O)/C(=O)N2
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,L779450,9129,,,315661214,Inhibitor,Inhibition,,f,f,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,18346893,Oc1cc(ccc1Cl)c1nc([nH]c1c1ccncc1)c1ccccc1
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,LY3009120,8943,,,310264724,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,26343583,CNc1ncc2c(n1)nc(c(c2)c1cc(NC(=O)NCCC(C)(C)C)c(cc1C)F)C
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,OSI-930,9383,,,328083485,Inhibitor,Inhibition,,f,f,,pIC50,0,7.389999866,0,IC50,0,41,0,=,,,,16424037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,PLX8394,9131,,,315661216,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,26466569,F[C@@H]1CCN(C1)S(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1cnc(nc1)C1CC1)F
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,SB590885,9389,,,328083491,Inhibitor,Inhibition,,f,f,,pIC50,0,8.760000229,0,IC50,0,1.720000029,0,=,In a cell-free assay,,,17145850,"O=NC1=c2cc/c(=c/3
c([nH]c3=c3cc[nH]cc3)c3ccc(cc3)OCCN(C)C)/cc2CC1"
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,15466206,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
Rap guanine nucleotide exchange factor 3,1292,RAPGEF3,O95398,,,,,,Human,ESI-09,7917,,,249565600,Inhibitor,Inhibition,,f,f,,pIC50,0,5.489999771,0,IC50,0,3200,0,=,Measuring EPAC1-mediated guanine nucleotide exchange factor (GEF) activity.,,,23066090,N#C/C(=NNc1cccc(c1)Cl)/C(=O)c1noc(c1)C(C)(C)C
Rap guanine nucleotide exchange factor 4,1293,RAPGEF4,Q8WZA2,,,,,,Human,ESI-09,7917,,,249565600,Inhibitor,Inhibition,,f,f,,pIC50,5.150000095,0,4.409999847,IC50,39000,0,7000,=,Measuring EPAC2-mediated guanine nucleotide exchange factor (GEF) activity.,,,23066090,N#C/C(=NNc1cccc(c1)Cl)/C(=O)c1noc(c1)C(C)(C)C
Rap guanine nucleotide exchange factor 4,1293,RAPGEF4,Q8WZA2,,,,,,Human,HJC 0350,6556,,,178103170,Inhibitor,Inhibition,,f,,,pIC50,0,6.5,0,-,0,0,0,=,,,,23286832,Cc1cc(C)c(c(c1)C)S(=O)(=O)n1cc(cc1C)C
RAR-related orphan receptor-&gamma;,600,RORC,P51449,,,,,,Human,GNE-3500,9660,,,348353619,Agonist,Inverse agonist,,f,t,,pEC50,0,7.920000076,0,EC50,0,12,0,=,Measuring inhibition of SRC1 coactivator peptide recruitment by the ligand binding domain of human ROR&gamma;.,,,26061388,C[C@H]1CC[C@@H](S(=O)(=O)N1Cc1ccc(cc1F)N1CCN(CC1)C(=O)C)c1ccccc1
RAR-related orphan receptor-&gamma;,600,RORC,P51449,,,,,,Human,GSK2981278,9661,,,348353620,Agonist,Inverse agonist,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,Measuring inhibition of human T cell cytokine production under Th17 skewing conditions.,,,26870941,OCc1cc(ccc1OCC1CCOCC1)S(=O)(=O)N(c1ccc(cc1)CC)CC(C)C
receptor activator of NF-kappa B,1881,TNFRSF11A,Q9Y6Q6,,,,,,Human,RANK ligand,5066,TNFSF11,Human,178101759,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,GSK2982772,9554,,,336446940,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,28151659,O=C(c1n[nH]c(n1)Cc1ccccc1)N[C@H]1COc2c(N(C1=O)C)cccc2
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,necrostatin-1,9750,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6.309999943,0,IC50,0,490,0,=,Measuring inhibition of cellular necrosis in TNF&alpha;-treated FADD-deficient Jurkat cells.,,,18408713,S=C1NC(C(=O)N1C)Cc1c[nH]c2c1cccc2
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,necrostatin-1s,9751,,,0,Inhibitor,Inhibition,,f,f,,pKd,0,7.429999828,0,Kd,0,37,0,=,Affinity constant measured at 37<sup>o</sup>C.,,,9736715,CN1C(=O)C(NC1=O)Cc1c[nH]c2c1cccc2Cl
receptor interacting serine/threonine kinase 1,2189,RIPK1,Q13546,,,,,,Human,RIPA-56,9643,,,340590273,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,Inhibition of RIPK1 activity <i>in vitro</i>.,,,27992216,CCC(C(=O)N(Cc1ccccc1)O)(C)C
receptor interacting serine/threonine kinase 2,2190,Ripk2,,,,,,,Rat,GSK583,9134,,,315661219,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,27109867,Fc1ccc2c(c1)c(n[nH]2)Nc1ccnc2c1cc(cc2)S(=O)(=O)C(C)(C)C
receptor interacting serine/threonine kinase 2,2190,RIPK2,O43353,,,,,,Human,GSK583,9134,,,315661219,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,27109867,Fc1ccc2c(c1)c(n[nH]2)Nc1ccnc2c1cc(cc2)S(=O)(=O)C(C)(C)C
receptor interacting serine/threonine kinase 2,2190,RIPK2,O43353,,,,,,Human,RIPK2 inhibitor 8,9688,,,348353647,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,29057049,CCOc1cc2ncc(n2cc1S(=O)(=O)C(C)(C)C)c1cc(N)nc(c1)F
receptor interacting serine/threonine kinase 2,2190,RIPK2,O43353,,,,,,Human,Src kinase inhibitor I,6042,,,178102664,Inhibitor,Inhibition,,f,f,,pIC50,0,7.590000153,0,IC50,0,26,0,=,,,,17850214,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)Oc1ccccc1
Reduced folate transporter 1,1014,SLC19A1,P41440,,,,,,Human,methotrexate,4815,,,178101517,Inhibitor,Inhibition,,f,f,,pKi,0,5.329999924,0,Ki,0,4700,0,=,Inhibition of [<sup>3</sup>H]methotrexate uptake by CCRF-CEM (human T lymphoblast) cells.,,,15615544,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(Cc1cnc2c(n1)c(N)nc(n2)N)C
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,RGS4 inhibitor 11b,8033,,,249565713,Inhibitor,Inhibition,,f,t,,pIC50,0,7.840000153,0,IC50,0,14.39999962,0,=,Inhibition of G&alpha;o binding,,,22368763,CCCCn1c(=O)sn(c1=O)CC
regulator of G-protein signaling 4,2811,RGS4,P49798,,,,,,Human,RGS4 inhibitor 13,8034,,,249565714,Inhibitor,Inhibition,,f,t,,pIC50,0,7.269999981,0,IC50,0,54.29999924,0,=,Inhibition of G&alpha;o binding,,,22368763,COCCn1c(=O)sn(c1=O)CC
regulator of G-protein signaling 8,2813,RGS8,P57771,,,,,,Human,RGS4 inhibitor 11b,8033,,,249565713,Inhibitor,Inhibition,,f,f,,pIC50,0,4.079999924,0,IC50,0,83500,0,=,Inhibition of G&alpha;o binding,,,22368763,CCCCn1c(=O)sn(c1=O)CC
regulator of G-protein signaling 8,2813,RGS8,P57771,,,,,,Human,RGS4 inhibitor 13,8034,,,249565714,Inhibitor,Inhibition,,f,f,,pIC50,0,4.440000057,0,IC50,0,36100,0,=,Inhibition of G&alpha;o binding,,,22368763,COCCn1c(=O)sn(c1=O)CC
repulsive guidance molecule BMP co-receptor a,2911,RGMA,Q96B86,,,,,,Human,elezanumab,9290,,,318164809,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
reticulon 4,2838,RTN4,Q9NQC3|Q9NQC3-3|Q9NQC3-2,,,,,,Human,ozanezumab,8254,,,249565934,Antibody,Binding,,f,t,,pKd,0,9.18999958,0,Kd,0,0.639999986,0,=,Binding dissociation constant for clone H28L16.,,,0,
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,Ro 40-6055,2647,,,135650917,Agonist,Agonist,,f,f,,pEC50,0,9.520000458,0,EC50,0,0.300000012,0,=,,,,19058965,O=C(c1ccc2c(c1)C(C)(C)CCC2(C)C)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,Ro 40-6055,2647,,,135650917,Agonist,Agonist,,f,f,,pKd,0,0,0,Kd,0,6,0,=,,,,1656191,O=C(c1ccc2c(c1)C(C)(C)CCC2(C)C)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,Ro 41-5253,2642,,,135650918,Antagonist,Antagonist,,f,f,,pIC50,7.21999979,0,6.340000153,-,0,0,0,=,,,,8264595,CCCCCCCOc1cc2c(cc1/C(=C/c1ccc(cc1)C(=O)O)/C)C(C)(C)CCS2(=O)=O
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,Ro 40-6055,2647,,,135650917,Agonist,Agonist,,f,f,,pEC50,0,8.069999695,0,EC50,0,8.600000381,0,=,,,,19058965,O=C(c1ccc2c(c1)C(C)(C)CCC2(C)C)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,palovarotene,8276,,,252166488,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1ccc(cc1)/C=C/c1cc2c(cc1Cn1cccn1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,Ro 40-6055,2647,,,135650917,Agonist,Agonist,,f,f,,pEC50,0,7.889999866,0,EC50,0,13,0,=,,,,19058965,O=C(c1ccc2c(c1)C(C)(C)CCC2(C)C)Nc1ccc(cc1)C(=O)O
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,MM 11253,4062,,,178100886,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,10723137,OC(=O)c1ccc2c(c1)ccc(c2)C1(SCCS1)c1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,Rxra,P28700,,,,,,Mouse,docosahexaenoic acid,1051,,,135651477,Agonist,Agonist,,t,,,-,0,0,0,,0,0,0,,,,,10529898,CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)O
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,fluorobexarotene,8904,,,310264685,Agonist,Agonist,,f,f,,pKi,0,7.920000076,0,Ki,0,12,0,=,,,,19791803,Cc1cc2c(cc1C(=C)c1ccc(c(c1)F)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,fluorobexarotene,8904,,,310264685,Agonist,Agonist,,f,f,,pEC50,0,7.369999886,0,EC50,0,43,0,=,,,,19791803,Cc1cc2c(cc1C(=C)c1ccc(c(c1)F)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,LG100268,2808,,,135650517,Agonist,Agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,10637371,Cc1cc2c(cc1C1(CC1)c1ccc(cn1)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,methoprene acid,2812,,,135650586,Agonist,Agonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,7597096,COC(CCCC(C/C=C/C(=C/C(=O)O)/C)C)(C)C
Retinoid X receptor-&alpha;,610,Rxra,P28700,,,,,,Mouse,phytanic acid,2813,,,135651546,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,11690641,CC(CCCC(CC(=O)O)C)CCCC(CCCC(C)C)C
Retinoid X receptor-&alpha;,610,,,,,,,,Unknown,SR11237,2809,,,135651069,Agonist,Agonist,,f,f,,pEC50,0,7.5,0,EC50,0,34,0,=,,,,1335166,OC(=O)c1ccc(cc1)C1(OCCO1)c1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,HX 531,8079,,,249565759,Antagonist,Antagonist,,f,f,,pIC50,0,6.050000191,0,IC50,0,900,0,=,Measuring inhibition of agonist-induced activation of RXR&alpha;.,,,17651969,OC(=O)c1ccc(cc1)C1=Nc2cc(ccc2N(c2c1cc1c(c2)C(C)(C)CCC1(C)C)C)[N+](=O)[O-]
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,LG100754,2814,,,135650518,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,-,0,0,0,=,,,,11463859,CCCOc1cc2c(cc1/C(=CC=CC(=CC(=O)O)C)/C)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,PA451,2815,,,135650786,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,12139443,CCCCCOc1cc2c(cc1N(c1ncc(cn1)C(=O)O)C)C(C)(C)CCC2(C)C
Retinoid X receptor-&alpha;,610,RXRA,P19793,,,,,,Human,PA452,8905,,,310264686,Antagonist,Antagonist,,f,f,,pA2,0,7.110000134,0,-,0,0,0,=,,,,24900278,CCCCCCOc1cc2c(cc1N(c1ncc(cn1)C(=O)O)C)C(C)(C)CCC2(C)C
Retinoid X receptor-&beta;,611,,,,,,,,None,LG100268,2808,,,135650517,Agonist,Agonist,,f,,,pIC50,8.5,0,8.1,,0,0,0,,,,,10637371,Cc1cc2c(cc1C1(CC1)c1ccc(cn1)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&beta;,611,RXRB,P28702,,,,,,Human,LG100754,2814,,,135650518,Antagonist,Antagonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,11463859,CCCOc1cc2c(cc1/C(=CC=CC(=CC(=O)O)C)/C)C(C)(C)CCC2(C)C
Retinoid X receptor-&gamma;,612,,,,,,,,None,LG100268,2808,,,135650517,Agonist,Agonist,,f,,,pIC50,8.52,0,8,,0,0,0,,,,,10637371,Cc1cc2c(cc1C1(CC1)c1ccc(cn1)C(=O)O)C(C)(C)CCC2(C)C
Retinoid X receptor-&gamma;,612,,,,,,,,None,LG100754,2814,,,135650518,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,Ki,0,12.19999981,0,=,,,,8837780,CCCOc1cc2c(cc1/C(=CC=CC(=CC(=O)O)C)/C)C(C)(C)CCC2(C)C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,KBP-7018,9691,,,348353650,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.599999905,0,=,,,,0,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)Nc1ccc2c(c1)CCN2C(=O)CN1CCOCC1
ret proto-oncogene,2185,RET,P07949,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,5.71999979,0,IC50,0,1900,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
ret proto-oncogene,2185,RET,P07949,,,,,,Human,lucitanib,7649,,,223365984,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,22304225,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
ret proto-oncogene,2185,RET,P07949,,,,,,Human,ponatinib,5890,,,178102513,Inhibitor,Inhibition,,f,f,,pIC50,0,8.199999809,0,IC50,0,7,0,=,,,,23811235,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,quizartinib,5658,,,178102286,Inhibitor,Inhibition,,f,f,,pKd,0,8,0,Kd,0,9.899999619,0,=,,,,19754199,O=C(Nc1noc(c1)C(C)(C)C)Nc1ccc(cc1)c1cn2c(n1)sc1c2ccc(c1)OCCN1CCOCC1
ret proto-oncogene,2185,RET,P07949,,,,,,Human,sorafenib,5711,,,178102337,Inhibitor,Inhibition,,f,f,,pIC50,0,7.900000095,0,IC50,0,14,0,=,,,,23279183,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,GSK4112,2903,,,135650323,Agonist,Agonist,,f,f,,pIC50,0,5.639999866,0,IC50,0,2300,0,=,,,,21043485,O=C(OC(C)(C)C)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,GSK4112,2903,,,135650323,Agonist,Agonist,,f,f,,pEC50,0,6.400000095,0,EC50,0,400,0,=,,,,20677822,O=C(OC(C)(C)C)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,heme,4349,,,178101166,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,18037887,C=CC1=C(C)C2=NC1=Cc1[n-]c(c(c1C)CCC(=O)O)C=C1N=C(C=c3[n-]c(=C2)c(C=C)c3C)C(=C1CCC(=O)O)C.[Fe+2]
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,SR9009,8901,,,310264682,Agonist,Agonist,,f,f,,pIC50,0,6.170000076,0,IC50,0,670,0,=,,,,22460951,CCOC(=O)N1CCC(C1)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,SR9011,8900,,,310264681,Agonist,Agonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,790,0,=,,,,22460951,CCCCCNC(=O)N1CCC(C1)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,SR8278,2904,,,135651083,Antagonist,Antagonist,,f,f,,pEC50,0,6.300000191,0,-,0,0,0,=,,,,21043485,CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(s1)SC
Rev-Erb-&alpha;,596,NR1D1,P20393,,,,,,Human,SR8278,2904,,,135651083,Antagonist,Antagonist,,f,f,,pIC50,0,6.5,0,-,0,0,0,=,,,,21043485,CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(s1)SC
Rev-Erb-&beta;,597,NR1D2,Q14995,,,,,,Human,heme,4349,,,178101166,Agonist,Agonist,,t,f,,pKd,0,6.449999809,0,Kd,0,353,0,=,,,,18037887,C=CC1=C(C)C2=NC1=Cc1[n-]c(c(c1C)CCC(=O)O)C=C1N=C(C=c3[n-]c(=C2)c(C=C)c3C)C(=C1CCC(=O)O)C.[Fe+2]
Rev-Erb-&beta;,597,NR1D2,Q14995,,,,,,Human,SR9009,8901,,,310264682,Agonist,Agonist,,f,f,,pIC50,0,6.099999905,0,IC50,0,800,0,=,,,,22460951,CCOC(=O)N1CCC(C1)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rev-Erb-&beta;,597,NR1D2,Q14995,,,,,,Human,SR9011,8900,,,310264681,Agonist,Agonist,,f,f,,pIC50,0,6.25,0,IC50,0,560,0,=,,,,22460951,CCCCCNC(=O)N1CCC(C1)CN(Cc1ccc(s1)[N+](=O)[O-])Cc1ccc(cc1)Cl
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,fasudil,5181,,,178101871,Inhibitor,Inhibition,,f,t,,pIC50,5.570000172,0,5.5,IC50,3160,0,2670,=,,,,21145740,O=S(=O)(c1cccc2c1ccnc2)N1CCNCCC1
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,fasudil,5181,,,178101871,Inhibitor,Inhibition,,f,t,,pKi,0,7,0,Ki,0,100,0,=,,,,21145740,O=S(=O)(c1cccc2c1ccnc2)N1CCNCCC1
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,GSK269962A,8037,,,249565717,Inhibitor,Inhibition,,f,t,,pIC50,0,8.800000191,0,IC50,0,1.600000024,0,=,<i>In vitro</i> inhibitory activity against recombinant ROCK1.,,,17018693,CCn1c(nc2c1cc(nc2)Oc1cccc(c1)NC(=O)c1ccc(cc1)OCCN1CCOCC1)c1nonc1N
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,GSK429286A,9356,,,328083458,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,17201405,O=C1NC(=C(C(C1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F)C
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,KD025,9558,,,336446944,Inhibitor,Inhibition,,f,t,,pIC50,0,4.619999886,0,IC50,0,24000,0,=,In a radiometric cell-free enzyme assay.,,,18832915,CC(NC(=O)COc1cccc(c1)c1nc(Nc2ccc3c(c2)cn[nH]3)c2c(n1)cccc2)C
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,SAR407899,8910,,,310264691,Inhibitor,Inhibition,,f,f,,pIC50,0,6.559999943,0,IC50,0,276,0,=,,,,19597037,O=c1[nH]ccc2c1ccc(c2)OC1CCNCC1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,fasudil,5181,,,178101871,Inhibitor,Inhibition,,f,f,,pKi,0,6.570000172,0,Ki,0,271,0,=,,,,19597037,O=S(=O)(c1cccc2c1ccnc2)N1CCNCCC1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,fasudil,5181,,,178101871,Inhibitor,Inhibition,,f,t,,pIC50,5.889999866,0,5.869999886,IC50,1349,0,1290,=,,,,21145740,O=S(=O)(c1cccc2c1ccnc2)N1CCNCCC1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,GSK269962A,8037,,,249565717,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,<i>In vitro</i> inhibitory activity against recombinant ROCK2.,,,17018693,CCn1c(nc2c1cc(nc2)Oc1cccc(c1)NC(=O)c1ccc(cc1)OCCN1CCOCC1)c1nonc1N
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,KD025,9558,,,336446944,Inhibitor,Inhibition,,f,t,,pIC50,0,6.980000019,0,IC50,0,105,0,=,In a radiometric cell-free enzyme assay.,,,18832915,CC(NC(=O)COc1cccc(c1)c1nc(Nc2ccc3c(c2)cn[nH]3)c2c(n1)cccc2)C
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,netarsudil,9322,,,318164841,Inhibitor,Inhibition,,f,f,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,27072905,NC[C@@H](C(=O)Nc1ccc2c(c1)ccnc2)c1ccc(cc1)COC(=O)c1ccc(cc1C)C
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,Rho kinase inhibitor IV,6033,,,178102655,Inhibitor,Inhibition,,f,t,,pIC50,0,7.929999828,0,IC50,0,11.80000019,0,=,,,,16213195,NCC(=O)N1CCCN([C@H](C1)C)S(=O)(=O)c1cccc2c1c(C)cnc2
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,RKI-1447,8152,,,249565832,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,<,,,,23275831,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,SAR407899,8910,,,310264691,Inhibitor,Inhibition,,f,f,,pIC50,0,6.989999771,0,IC50,0,102,0,=,,,,19597037,O=c1[nH]ccc2c1ccc(c2)OC1CCNCC1
Rho associated coiled-coil containing protein kinase 2,1504,Rock2,Q62868,,,,,,Rat,SAR407899,8910,,,310264691,Inhibitor,Inhibition,,f,f,,pKi,0,7.389999866,0,Ki,0,41,0,=,,,,19597037,O=c1[nH]ccc2c1ccc(c2)OC1CCNCC1
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,SAR407899,8910,,,310264691,Inhibitor,Inhibition,,f,f,,pKi,0,7.440000057,0,Ki,0,36,0,=,,,,19597037,O=c1[nH]ccc2c1ccc(c2)OC1CCNCC1
ribonucleotide reductase catalytic subunit M1,2630,RRM1,P23921,,,,,,Human,fludarabine,4802,,,178101504,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1000,0,=,Inhibition of ADP reduction by ribonucleotide reductase from HeLa cells,,,7048062,OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1cnc2c1nc(F)nc2N
ribonucleotide reductase catalytic subunit M1,2630,RRM1,P23921,,,,,,Human,gemcitabine,4793,,,178101495,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,2233693,OC[C@H]1O[C@H](C([C@@H]1O)(F)F)n1ccc(nc1=O)N
ribonucleotide reductase catalytic subunit M1,2630,RRM1,P23921,,,,,,Human,hydroxyurea,6822,,,178103428,Inhibitor,Inhibition,,f,t,,pIC50,0,3.829999924,0,IC50,0,148000,0,=,"Dissolved in 1% DMSO, <i>in vitro</i> assay using reconstituted RRM1/RRM2 holoenzyme",,,15670581,NC(=O)NO
ribonucleotide reductase regulatory subunit M2,2631,RRM2,P31350,,,,,,Human,fludarabine,4802,,,178101504,Inhibitor,Inhibition,,f,t,,pIC50,0,6,0,IC50,0,1000,0,=,Inhibition of ADP reduction by ribonucleotide reductase from HeLa cells,,,7048062,OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1cnc2c1nc(F)nc2N
ribonucleotide reductase regulatory subunit M2,2631,RRM2,P31350,,,,,,Human,gemcitabine,4793,,,178101495,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,2233693,OC[C@H]1O[C@H](C([C@@H]1O)(F)F)n1ccc(nc1=O)N
ribonucleotide reductase regulatory subunit M2,2631,RRM2,P31350,,,,,,Human,hydroxyurea,6822,,,178103428,Inhibitor,Inhibition,,f,t,,pIC50,0,3.829999924,0,IC50,0,148000,0,=,"Dissolved in 1% DMSO, <i>in vitro</i> assay using reconstituted RRM1/RRM2 holoenzyme",,,15670581,NC(=O)NO
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,6.679999828,0,IC50,0,210,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,GSK-1838705A,5683,,,178102310,Inhibitor,Inhibition,,f,f,,pIC50,0,5.800000191,0,IC50,0,1600,0,=,,,,19825801,CNC(=O)c1c(cccc1F)Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2c1cc[nH]2
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,GSK429286A,9356,,,328083458,Inhibitor,Inhibition,,f,f,,pIC50,0,6.110000134,0,IC50,0,780,0,=,,,,17201405,O=C1NC(=C(C(C1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F)C
ribosomal protein S6 kinase A1,1527,RPS6KA1,Q15418,,,,,,Human,prexasertib,9549,,,336446935,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,Enzyme assay,,,26141948,NCCCOc1cccc(c1c1[nH]nc(c1)Nc1cnc(cn1)C#N)OC
ribosomal protein S6 kinase A3,1528,RPS6KA3,P51812,,,,,,Human,FMK,9358,,,328083460,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,17259979,OCCCn1c(C(=O)CF)c(c2c1ncnc2N)c1ccc(cc1)C
ribosomal protein S6 kinase A5,1523,RPS6KA5,O75582,,,,,,Human,SB-747651A,8130,,,249565810,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,15955699,CCn1c(nc2c1c(CNC1CCNCC1)cnc2)c1nonc1N
ribosomal protein S6 kinase B1,1525,RPS6KB1,P23443,,,,,,Human,GNE-3511,9355,,,328083457,Inhibitor,Inhibition,,f,f,,pIC50,0,5.710000038,0,IC50,0,1940,0,=,,,,17201405,N#Cc1ccnc(c1)Nc1cc(cc(n1)N1CCC(C1)(F)F)C1CCN(CC1)C1COC1
ribosomal protein S6 kinase B1,1525,RPS6KB1,P23443,,,,,,Human,LY2584702,8248,,,249565928,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24440085,Cn1cc(nc1C1CCN(CC1)c1ncnc2c1cn[nH]2)c1ccc(c(c1)C(F)(F)F)F
ribosomal protein S6 kinase B1,1525,RPS6KB1,P23443,,,,,,Human,PF-4708671,8036,,,249565716,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,<i>In vitro</i> assay of full length RPS6KB1.,,,20704563,CCc1cncnc1N1CCN(CC1)Cc1nc2c([nH]1)cc(cc2)C(F)(F)F
RTP Type F,1855,PTPRF,P10586,,,,,,Human,illudalic acid,8770,,,252827428,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,Measured utilising purified recombinant LAR catalytic domain.,,,18579388,O=Cc1c(O)c2CC(Cc2c2c1CC(O)OC2=O)(C)C
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,europium-labelled relaxin,3874,,,178100710,Agonist,Agonist,,f,f,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,,,,22425984,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,europium-labelled relaxin,3874,,,178100710,Agonist,Full agonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,19343240,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,INSL3,1995,INSL3,Human,135651792,Agonist,Full agonist,,f,f,,pKi,0,5.699999809,0,-,0,0,0,=,,,,23303914,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,f,f,,pEC50,0,10.36999989,0,-,0,0,0,=,,,,18434306,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin,1994,RLN,Rhesus macaque,135652434,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,15649866,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin,1993,Rln1,Rat,135651880,Agonist,Full agonist,,f,,,pKd,0,7.3,0,,0,0,0,,,,,15649866,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin,1992,RLN,Pig,135652435,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,15649866,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,t,f,,pKi,10.19999981,0,9.239999771,-,0,0,0,=,,,,12506116,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin-1,1988,RLN1,Human,135651783,Agonist,Full agonist,,t,,,pEC50,0,8.8,0,,0,0,0,,,,,16411781,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,,,pKi,8,0,7.5,,0,0,0,,,,,12506116,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,ML290,8322,,,252166534,Allosteric modulator,Agonist,,f,f,,pEC50,0,7.03000021,0,EC50,0,94,0,=,,,,23764525,CC(Oc1ccccc1C(=O)Nc1ccccc1C(=O)Nc1cccc(c1)S(=O)(=O)C(F)(F)F)C
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,europium-labelled INSL3,3875,,,178100711,Agonist,Full agonist,,f,,,pKd,0,9,0,Kd,0,0.9,0,=,,,,18529069,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,INSL3,1995,INSL3,Human,135651792,Agonist,Full agonist,,f,f,,pKd,0,10.35000038,0,-,0,0,0,=,,,,18434306,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,INSL3,1995,INSL3,Human,135651792,Agonist,Full agonist,,t,f,,pKi,9.699999809,0,9.340000153,-,0,0,0,=,,,,15649866,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin,1994,RLN,Rhesus macaque,135652434,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,15649866,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,f,f,,pEC50,0,9.130000114,0,-,0,0,0,=,,,,18434306,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,t,f,,pKi,8.479999542,0,8.300000191,-,0,0,0,=,,,,15649866,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin,1992,RLN,Pig,135652435,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,15649866,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin-1,1988,RLN1,Human,135651783,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,16411781,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,,,pKi,0,7,0,,0,0,0,,,,,16411781,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,cyclic INSL3 B-chain analogue 6,8333,,,252166545,Antagonist,Antagonist,,f,f,,pKi,0,6.650000095,0,-,0,0,0,=,,,,17120268,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,(des 1-8) A-chain INSL3 analogue,3754,,,178100607,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15708846,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,INSL3 B-chain analogue,3885,,,178100721,Antagonist,Antagonist,,f,f,,pKi,0,5.099999905,0,Ki,0,7943,0,=,,,,16547350,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,INSL3 B chain dimer analogue 8,4372,,,178101186,Antagonist,Antagonist,,f,f,,pKi,0,8.5,0,-,0,0,0,=,,,,20560146,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,europium-labelled relaxin-3-B/INSL5 A chimera,4374,,,178101188,Agonist,Agonist,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,21384867,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,europium-labelled relaxin-3-B/INSL5 A chimera,4374,,,178101188,Agonist,Full agonist,,f,f,,pKd,0,9.300000191,0,-,0,0,0,=,,,,21384867,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,minimised relaxin-3 analogue 2,8336,,,252166548,Agonist,Full agonist,,f,f,,pKi,0,7.869999886,0,-,0,0,0,=,,,,22257012,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,minimised relaxin-3 analogue 2,8336,,,252166548,Agonist,Full agonist,,f,f,,pEC50,10.39999962,0,8.430000305,-,0,0,0,=,,,,22257012,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,R3/I5,1998,,,135652176,Agonist,Full agonist,,f,,,pIC50,0,9.3,0,,0,0,0,,,,,15465925,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,f,f,,pEC50,8.350000381,0,7.050000191,-,0,0,0,=,,,,20159943,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin,1989,RLN2,Human,135651784,Agonist,Full agonist,,f,f,,pKd,0,10,0,-,0,0,0,=,,,,20159943,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,,,pIC50,9.6,0,9.4,,0,0,0,,,,,15367576,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,f,,pKi,8.920000076,0,7.78000021,-,0,0,0,=,,,,22257012,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,f,f,,pEC50,9.930000305,0,8.260000229,-,0,0,0,=,,,,20159943,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin-3 (B chain),1997,RLN3,Human,135651786,Agonist,Full agonist,,t,,,pIC50,0,6.9,0,-,0,0,0,=,,,,14522968,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,relaxin-3 B chain dimer,8337,,,252166549,Agonist,Full agonist,,f,f,,pKi,0,6.610000134,0,-,0,0,0,=,,,,17351017,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,europium-labelled R3(B1-22R),8342,,,252166554,Antagonist,Antagonist,,f,f,,pKd,0,7.550000191,0,-,0,0,0,=,,,,25792111,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,INSL5,2000,INSL5,Human,135651793,Antagonist,Antagonist,,t,f,,pKi,0,7.010000229,0,Ki,0,0,0,=,,,,18582868,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,minimised relaxin-3 analogue 3,8326,,,252166538,Antagonist,Antagonist,,f,f,,pKi,0,7.599999905,0,-,0,0,0,=,,,,22257012,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,R3-B1-22R,4373,,,178101187,Antagonist,Antagonist,,f,f,,pKi,0,7.440000057,0,Ki,0,36.29999924,0,=,,,,21384867,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,R3(B&Delta;23-27)R/I5 chimeric peptide,3907,,,178100740,Antagonist,Antagonist,,f,f,,pEC50,9.020000458,0,8.869999886,-,0,0,0,=,,,,24641548,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,R3(B&Delta;23-27)R/I5 chimeric peptide,3907,,,178100740,Antagonist,Antagonist,,f,f,,pKi,0,8.489999771,0,-,0,0,0,=,,,,21384867,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,R3(B&Delta;23-27)R/I5 chimeric peptide,3907,,,178100740,Antagonist,Antagonist,,f,f,,pIC50,0,9.199999809,0,IC50,0,0.670000017,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,europium-labelled mouse INSL5,6522,,,178103136,Agonist,Agonist,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,21866895,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,europium-labelled relaxin-3-B/INSL5 A chimera,4374,,,178101188,Agonist,Agonist,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,21384867,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,europium-labelled mouse INSL5,6522,,,178103136,Agonist,Full agonist,,f,f,,pKd,0,8.600000381,0,-,0,0,0,=,,,,24188028,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,hINSL5: A8-21 (T9R),9324,,,318164843,Agonist,Full agonist,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,26824523,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,hINSL5: A8-21 (T9R),9324,,,318164843,Agonist,Full agonist,,f,f,,pKi,0,7.5,0,-,0,0,0,=,,,,0,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,INSL5,6519,Insl5,Mouse,178103133,Agonist,Full agonist,,t,f,,pIC50,0,9.289999962,0,-,0,0,0,=,,,,24188028,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5,2000,INSL5,Human,135651793,Agonist,Full agonist,,f,f,,pEC50,7.699999809,0,7,-,0,0,0,=,,,,27243554,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,INSL5,6519,Insl5,Mouse,178103133,Agonist,Full agonist,,t,f,,pKi,8.800000191,0,8.470000267,-,0,0,0,=,,,,24188028,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,INSL5,6519,Insl5,Mouse,178103133,Agonist,Full agonist,,f,f,,pEC50,8.899999619,0,7.800000191,-,0,0,0,=,,,,27243554,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5,2000,INSL5,Human,135651793,Agonist,Full agonist,,t,f,,pEC50,8.93999958,0,8.890000343,-,0,0,0,=,,,,15525639,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5,2000,INSL5,Human,135651793,Agonist,Full agonist,,t,f,,pKi,8.800000191,0,7.300000191,-,0,0,0,=,,,,15525639,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5,2000,INSL5,Human,135651793,Agonist,Full agonist,,t,f,,pIC50,8.920000076,0,8.300000191,-,0,0,0,=,,,,15525639,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5 amide (human),8350,,,252166562,Agonist,Full agonist,,f,f,,pIC50,0,7.480000019,0,-,0,0,0,=,,,,21866895,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,INSL5 amide (human),8350,,,252166562,Agonist,Full agonist,,f,f,,pKi,0,6.940000057,0,-,0,0,0,=,,,,21866895,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,INSL5 amide (mouse),8351,,,252166563,Agonist,Full agonist,,f,f,,pKi,0,7.070000172,0,-,0,0,0,=,,,,21866895,
RXFP4,354,Rxfp4,Q7TQP4,,,,,,Mouse,INSL5 amide (mouse),8351,,,252166563,Agonist,Full agonist,,f,f,,pIC50,0,6.849999905,0,-,0,0,0,=,,,,21866895,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,minimised relaxin-3 analogue 2,8336,,,252166548,Agonist,Full agonist,,f,f,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,22257012,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,minimised relaxin-3 analogue 2,8336,,,252166548,Agonist,Full agonist,,f,f,,pKi,0,7.099999905,0,-,0,0,0,=,,,,22257012,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,R3/I5,1998,,,135652176,Agonist,Full agonist,,f,f,,pEC50,0,8.93999958,0,-,0,0,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,R3/I5,1998,,,135652176,Agonist,Full agonist,,f,f,,pKi,0,8.880000114,0,-,0,0,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,,,pKi,0,9,0,,0,0,0,,,,,14522967,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,f,f,,pEC50,0,9.010000229,0,-,0,0,0,=,,,,18582868,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,f,,pKi,8.829999924,0,8.81000042,-,0,0,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3,1990,RLN3,Human,135651785,Agonist,Full agonist,,t,f,,pIC50,0,9.020000458,0,-,0,0,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,minimised INSL5 analogue 7,8334,,,252166546,Agonist,Partial agonist,,f,f,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,24188028,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,minimised INSL5 analogue 7,8334,,,252166546,Agonist,Partial agonist,,f,f,,pKi,0,6.28000021,0,-,0,0,0,=,,,,24188028,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3 (B chain),1997,RLN3,Human,135651786,Agonist,Partial agonist,,f,f,,pIC50,7.059999943,0,6.900000095,-,0,0,0,=,,,,15525639,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,relaxin-3 (B chain),1997,RLN3,Human,135651786,Agonist,Partial agonist,,f,f,,pEC50,0,7,0,-,0,0,0,=,,,,14522967,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,minimised relaxin-3 analogue 3,8326,,,252166538,Antagonist,Antagonist,,f,f,,pIC50,0,6.599999905,0,-,0,0,0,=,,,,22257012,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,R3(B&Delta;23-27)R/I5 chimeric peptide,3907,,,178100740,Antagonist,Antagonist,,f,f,,pIC50,8.640000343,0,8,IC50,0,0,0,=,,,,17606621,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,europium-labelled INSL5,4375,,,178101189,None,None,,f,,,pKd,0,8.3,0,Kd,0,5,0,=,,,,21384867,
RyR1,747,RYR1,P21817,,,,,,Human,ryanodine,4303,,,178101120,Activator,None,pharmacological; nM - &mu;M range,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C[C@H]1CC[C@]2([C@@]3([C@@H]1O)O[C@@]1([C@]4([C@@]3(O)[C@@]([C@@]2(C)C1)(O)[C@@H]([C@]4(O)C(C)C)OC(=O)c1[nH]ccc1)C)O)O
RyR1,747,RYR1,P21817,,,,,,Human,dantrolene,4172,,,178100992,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CN(C(=O)N1)/N=C/c1ccc(o1)c1ccc(cc1)[N+](=O)[O-]
RyR1,747,RYR1,P21817,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Antagonist,Antagonist,mM range,t,,,-,0,0,0,-,0,0,0,=,,,cytosolic,0,
RyR1,747,RYR1,P21817,,,,,,Human,procaine,4291,,,178101108,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CCN(CCOC(=O)c1ccc(cc1)N)CC
RyR1,747,RYR1,P21817,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
RyR1,747,RYR1,P21817,,,,,,Human,ryanodine,4303,,,178101120,Channel blocker,None,,f,,>100,-,0,0,0,-,0,0,0,=,,,,0,C[C@H]1CC[C@]2([C@@]3([C@@H]1O)O[C@@]1([C@]4([C@@]3(O)[C@@]([C@@]2(C)C1)(O)[C@@H]([C@]4(O)C(C)C)OC(=O)c1[nH]ccc1)C)O)O
RyR2,748,RYR2,Q92736,,,,,,Human,ryanodine,4303,,,178101120,Activator,None,pharmacological; nM - &mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@H]1CC[C@]2([C@@]3([C@@H]1O)O[C@@]1([C@]4([C@@]3(O)[C@@]([C@@]2(C)C1)(O)[C@@H]([C@]4(O)C(C)C)OC(=O)c1[nH]ccc1)C)O)O
RyR2,748,RYR2,Q92736,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Antagonist,Antagonist,mM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
RyR2,748,RYR2,Q92736,,,,,,Human,procaine,4291,,,178101108,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCN(CCOC(=O)c1ccc(cc1)N)CC
RyR2,748,RYR2,Q92736,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
RyR2,748,RYR2,Q92736,,,,,,Human,ryanodine,4303,,,178101120,Channel blocker,None,,f,,>100,-,0,0,0,,0,0,0,,,,,0,C[C@H]1CC[C@]2([C@@]3([C@@H]1O)O[C@@]1([C@]4([C@@]3(O)[C@@]([C@@]2(C)C1)(O)[C@@H]([C@]4(O)C(C)C)OC(=O)c1[nH]ccc1)C)O)O
RyR3,749,RYR3,Q15413,,,,,,Human,ryanodine,4303,,,178101120,Activator,None,pharmacological; nM - &mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@H]1CC[C@]2([C@@]3([C@@H]1O)O[C@@]1([C@]4([C@@]3(O)[C@@]([C@@]2(C)C1)(O)[C@@H]([C@]4(O)C(C)C)OC(=O)c1[nH]ccc1)C)O)O
RyR3,749,RYR3,Q15413,,,,,,Human,dantrolene,4172,,,178100992,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CN(C(=O)N1)/N=C/c1ccc(o1)c1ccc(cc1)[N+](=O)[O-]
RyR3,749,RYR3,Q15413,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Antagonist,Antagonist,mM range,t,,,-,0,0,0,,0,0,0,,,,cytosolic,0,
RyR3,749,RYR3,Q15413,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,CYM5181,2927,,,135650149,Agonist,Agonist,,f,f,,pEC50,0,8.470000267,0,-,0,0,0,=,,,,18708635,CCOc1cc(ccc1OCC)c1onc(n1)c1ccncc1
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,CYM5442,2928,,,135650150,Agonist,Agonist,,f,,,pEC50,0,8.91,0,,0,0,0,,,,,18708635,OCCNC1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)OCC)OCC
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,etrasimod,9331,,,318164850,Agonist,Agonist,,f,t,,pEC50,0,8.210000038,0,EC50,0,6.099999905,0,=,In a &beta;-arrestin recruitment assay.,,,25516790,OC(=O)C[C@H]1CCc2c1[nH]c1c2cc(cc1)OCc1ccc(c(c1)C(F)(F)F)C1CCCC1
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,fingolimod,2407,,,135650261,Agonist,Agonist,,f,t,,pIC50,0,6.079999924,0,IC50,0,840,0,=,,,,15615513,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,,,pEC50,9.5,0,8.2,,0,0,0,,,,,17898319,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pEC50,9.5,0,8.100000381,-,0,0,0,=,,,,17055593,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pEC50,0,9.520000458,0,EC50,0,0.300000012,0,=,,,,17114004,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,14747617,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,KRP 203-phosphate,2923,,,135650459,Agonist,Agonist,,f,f,,pEC50,0,9.069999695,0,-,0,0,0,=,,,,17898319,OCC(COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cccc(c1)Oc1ccccc1)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,LPA,2906,,,135651509,Agonist,Agonist,,t,,,pKd,0,5.6,0,,0,0,0,,,,,9705355,CCCCCCCC/C=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,t,,pEC50,0,9.390000343,0,EC50,0,0.409999996,0,=,In a GTP&gamma;S assay.,,,26990079,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,t,,pEC50,0,9.800000191,0,EC50,0,0.159999996,0,=,In a cAMP assay.,,,18708635,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,ponesimod,9320,,,318164839,Agonist,Agonist,,f,t,,pEC50,0,9.119999886,0,EC50,0,0.75999999,0,=,In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>1</sub>,,,20446681,CCCN=C1S/C(=Cc2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,SEW2871,2926,,,135651038,Agonist,Agonist,,f,f,,pEC50,7.900000095,0,7.539999962,EC50,28.79999924,0,12.60000038,=,,,,18708635,FC(c1sc(cc1c1ccccc1)c1onc(n1)c1cccc(c1)C(F)(F)F)(F)F
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,SEW2871,2926,,,135651038,Agonist,Agonist,,f,f,,pEC50,0,7.679999828,0,EC50,0,20.70000076,0,=,,,,14732717,FC(c1sc(cc1c1ccccc1)c1onc(n1)c1cccc(c1)C(F)(F)F)(F)F
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,SEW2871,2926,,,135651038,Agonist,Agonist,,f,f,,pKi,7.699999809,0,5.5,Ki,2890,0,18,=,,,,14732717,FC(c1sc(cc1c1ccccc1)c1onc(n1)c1cccc(c1)C(F)(F)F)(F)F
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,siponimod,9289,,,318164808,Agonist,Agonist,,f,t,,pEC50,0,9.399999619,0,EC50,0,0.400000006,0,=,In a GTP&gamma;S binding assay,,,24900670,CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,9.399999619,0,7.099999905,EC50,1,0,0.400000006,=,,,,11705398,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pKd,9.409999847,0,7.880000114,Kd,13.19999981,0,0.389999986,=,,,,10446161,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,0,8.850000381,0,EC50,0,1.399999976,0,=,,,,17114004,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,NIBR-0213,6997,,,178103576,Antagonist,Antagonist,,f,f,,pKd,0,9.430000305,0,Kd,0,0.370000005,0,=,,,,22999882,OC(=O)[C@@H](NC(=O)c1c(C)cc(cc1C)c1cccc(c1)N[C@@H](c1ccc(c(c1)C)Cl)C)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,NIBR-0213,6997,,,178103576,Antagonist,Antagonist,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,=,,,,22999882,OC(=O)[C@@H](NC(=O)c1c(C)cc(cc1C)c1cccc(c1)N[C@@H](c1ccc(c(c1)C)Cl)C)C
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,SPM-354,9493,,,329968433,Antagonist,Antagonist,,f,f,,pA2,0,7.849999905,0,-,0,0,0,=,In a &beta;-arrestin assay.,,,26494861,CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,Measured using an impedance-based assay system,f,f,,pEC50,0,7.460000038,0,EC50,0,35,0,=,,,,25762025,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,In a GTP&gamma;S assay.,,,26990079,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,8.539999962,0,8.050000191,-,0,0,0,=,,,,11705398,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pKd,7.690000057,0,7.570000172,Kd,27,0,20.39999962,=,,,,10446161,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>2</sub> receptor,276,S1pr2,P52592,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,0,8.699999809,0,EC50,0,2,0,=,,,,14732717,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>2</sub> receptor,276,S1PR2,O95136,,,,,,Human,JTE-013,2917,,,135650448,Antagonist,Antagonist,,f,f,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,12445827,O=C(Nc1cc(Cl)nc(c1)Cl)NNc1cc(C(C)C)c2c(n1)n(C)nc2C
S1P<sub>2</sub> receptor,276,S1pr2,P47752,,,,,,Rat,JTE-013,2917,,,135650448,Antagonist,Antagonist,,f,f,,pIC50,7.769999981,0,7.659999847,IC50,22,0,17,=,,,,12557151,O=C(Nc1cc(Cl)nc(c1)Cl)NNc1cc(C(C)C)c2c(n1)n(C)nc2C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pEC50,9.399999619,0,7.800000191,-,0,0,0,=,,,,11967257,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,14747617,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,f,,pEC50,0,5,0,EC50,0,10000,0,>,In a GTP&gamma;S assay.,,,26990079,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,ponesimod,9320,,,318164839,Agonist,Agonist,,f,f,,pIC50,0,5.679999828,0,IC50,0,2068,0,=,In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>2</sub>,,,20446681,CCCN=C1S/C(=Cc2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,(S)-FTY720-phosphate,6996,,,178103575,Agonist,Agonist,,f,f,,pEC50,0,8.510000229,0,EC50,0,3.099999905,0,=,,,,17114004,CCCCCCCCc1ccc(cc1)CC[C@@](COP(=O)(O)O)(CO)N
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,siponimod,9289,,,318164808,Agonist,Agonist,,f,f,,pEC50,0,5.300000191,0,EC50,0,5000,0,=,In a GTP&gamma;S binding assay,,,24900670,CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C
S1P<sub>3</sub> receptor,277,S1pr3,Q9Z0U9,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,0,8.640000343,0,EC50,0,2.299999952,0,=,,,,14732717,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,9.800000191,0,8.399999619,-,0,0,0,=,,,,11705398,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pKd,9.640000343,0,7.579999924,Kd,26.20000076,0,0.230000004,=,,,,10446161,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,CYM-5541,9494,,,329968434,Allosteric modulator,Positive,,f,f,,pA2,0,8.5,0,-,0,0,0,=,In a &beta;-arrestin assay.,,,26494861,O=C(N(C1CCCCC1)C1CCCCC1)c1noc(c1)C1CC1
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,SPM-354,9493,,,329968433,Antagonist,Antagonist,,f,f,,pA2,0,9.300000191,0,-,0,0,0,=,In a &beta;-arrestin assay.,,,26494861,CCC[C@@](COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cc(ccc1O)C(F)(F)F)N
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,dihydrosphingosine 1-phosphate,2921,,,135650184,Agonist,Agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,12270137,CCCCCCCCCCCCCCC[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,etrasimod,9331,,,318164850,Agonist,Agonist,,f,f,,pEC50,0,6.829999924,0,EC50,0,147,0,=,In a &beta;-arrestin recruitment assay.,,,12110609,OC(=O)C[C@H]1CCc2c1[nH]c1c2cc(cc1)OCc1ccc(c(c1)C(F)(F)F)C1CCCC1
S1P<sub>4</sub> receptor,278,S1pr4,Q9Z0L1,,,,,,Mouse,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,,,pEC50,0,7.15,0,,0,0,0,,,,,17898319,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pEC50,9.220000267,0,6.599999905,-,0,0,0,=,,,,17114004,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>4</sub> receptor,278,S1pr4,Q9Z0L1,,,,,,Mouse,KRP 203-phosphate,2923,,,135650459,Agonist,Agonist,,f,,,pEC50,0,8,0,,0,0,0,,,,,17898319,OCC(COP(=O)(O)O)(CCc1ccc(cc1Cl)Sc1cccc(c1)Oc1ccccc1)N
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,f,,pEC50,0,5.099999905,0,EC50,0,7865,0,>,In a &beta;-arrestin assay.,,,26990079,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,phytosphingosine 1-phosphate,2922,,,135650822,Agonist,Agonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,12270137,CCCCCCCCCCCCCC[C@H]([C@H]([C@H](COP(=O)(O)O)N)O)O
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,siponimod,9289,,,318164808,Agonist,Agonist,,f,f,,pEC50,0,6.119999886,0,EC50,0,750,0,=,In a GTP&gamma;S binding assay,,,24125884,CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,8.069999695,0,7.170000076,EC50,0,67,0,=,,,,12270137,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>4</sub> receptor,278,S1pr4,Q9Z0L1,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,0,7.119999886,0,EC50,0,75,0,=,,,,14732717,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,,,pIC50,7,0,6.1,,0,0,0,,,,,12270137,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,ponesimod,9320,,,318164839,Agonist,Partial agonist,,f,f,,pIC50,0,5.710000038,0,IC50,0,1956,0,=,In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>4</sub>,,,20446681,CCCN=C1S/C(=Cc2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,etrasimod,9331,,,318164850,Agonist,Agonist,,f,f,,pEC50,0,7.610000134,0,EC50,0,24.39999962,0,=,In a &beta;-arrestin recruitment assay.,,,25516790,OC(=O)C[C@H]1CCc2c1[nH]c1c2cc(cc1)OCc1ccc(c(c1)C(F)(F)F)C1CCCC1
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,fingolimod,2407,,,135650261,Agonist,Agonist,,f,t,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,15615513,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pEC50,9.520000458,0,8.199999809,-,0,0,0,=,,,,17114004,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,FTY720-phosphate,2924,,,135650290,Agonist,Agonist,,f,f,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,,,,14747617,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,t,,pEC50,0,7.960000038,0,EC50,0,11,0,=,In a GTP&gamma;S assay.,,,26990079,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,ozanimod,8709,,,252827367,Agonist,Agonist,,f,f,,pEC50,0,7.260000229,0,EC50,0,55.20000076,0,=,,,,0,OCCN[C@H]1CCc2c1cccc2c1noc(n1)c1ccc(c(c1)C#N)OC(C)C
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,siponimod,9289,,,318164808,Agonist,Agonist,,f,t,,pEC50,0,9.010000229,0,EC50,0,0.980000019,0,=,In a GTP&gamma;S binding assay,,,24125884,CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C
S1P<sub>5</sub> receptor,279,S1pr5,Q9JKM5,,,,,,Rat,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,,,pKd,0,8.7,0,,0,0,0,,,,,10799507,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,8.899999619,0,7.400000095,-,0,0,0,=,,,,11705398,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>5</sub> receptor,279,S1pr5,Q91X56,,,,,,Mouse,sphingosine 1-phosphate,911,,,135651563,Agonist,Agonist,,t,f,,pEC50,7.900000095,0,7.800000191,EC50,0,16,0,=,,,,11705398,CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)(O)O)N)O
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,ponesimod,9320,,,318164839,Agonist,Partial agonist,,f,t,,pIC50,0,6.849999905,0,IC50,0,142,0,=,In a radioligand binding assay using membranes from CHO cells expressing human S1P<sub>5</sub>,,,20446681,CCCN=C1S/C(=Cc2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C
S-Adenosylhomocysteine hydrolase,1233,,,,,,,,Hamster,DZNep,8392,,,252166603,Inhibitor,Inhibition,,f,f,,pKi,0,12.30000019,0,Ki,0,0.0005,0,=,Inhibition of a SAHH preparation isolated from hamster liver.,,,3457563,OCC1CC([C@@H]([C@@H]1O)O)n1cnc2c1ccnc2N
S-Adenosylmethionine decarboxylase ,1269,,,,,,,,None,sardomozide,5268,,,178101951,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,8340919,NC(=N/N=C/1CCc2c1cccc2C(=N)N)N
salt inducible kinase 1,2197,SIK1,P57059,,,,,,Human,dasatinib,5678,,,178102305,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,25351958,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
salt inducible kinase 1,2197,SIK1,P57059,,,,,,Human,HG-9-91-01,8049,,,249565729,Inhibitor,Inhibition,,f,t,,pIC50,0,9.039999962,0,IC50,0,0.920000017,0,=,,,,23033494,COc1cc(OC)ccc1N(C(=O)Nc1c(C)cccc1C)c1ncnc(c1)Nc1ccc(cc1)N1CCN(CC1)C
salt inducible kinase 2,2198,SIK2,Q9H0K1,,,,,,Human,dasatinib,5678,,,178102305,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,<,,,,25351958,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
salt inducible kinase 2,2198,SIK2,Q9H0K1,,,,,,Human,HG-9-91-01,8049,,,249565729,Inhibitor,Inhibition,,f,t,,pIC50,0,8.180000305,0,IC50,0,6.599999905,0,=,,,,23033494,COc1cc(OC)ccc1N(C(=O)Nc1c(C)cccc1C)c1ncnc(c1)Nc1ccc(cc1)N1CCN(CC1)C
secretin receptor,252,Sctr,P23811,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of [125I]Tyr25 secretin binding in membranes from CHO cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
secretin receptor,252,Sctr,P23811,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Full agonist,,f,,,pKi,9,0,8,-,0,0,0,=,,,,1646711,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
secretin receptor,252,Sctr,P23811,,,,,,Rat,secretin,2943,Sct,Rat,135651883,Agonist,Full agonist,,t,,,pKi,9,0,8,-,0,0,0,=,,,,10383421,
secretin receptor,252,SCTR,P47872,,,,,,Human,secretin,3643,SCT,Human,135651884,Agonist,Full agonist,,t,t,,pEC50,0,9.699999809,0,EC50,0,0.200000003,0,=,,,,7612008,
secretin receptor,252,Sctr,P23811,,,,,,Rat,secretin-(5-27) (pig),1156,,,135652458,Agonist,Full agonist,,f,,,pIC50,0,5,0,,0,0,0,,,,,1646711,
serine palmitoyltransferase long chain base subunit 1,2509,Sptlc1,O35704,,,,,,Mouse,myriocin,6664,,,178103276,Inhibitor,Inhibition,,f,f,,pKi,0,9.550000191,0,Ki,0,0.280000001,0,=,,,,7794249,CCCCCCC(=O)CCCCCC/C=C/C[C@H]([C@@H]([C@](C(=O)O)(CO)N)O)O
serine palmitoyltransferase long chain base subunit 2,2510,SPTLC2,O15270,,,,,,Human,myriocin,6664,,,178103276,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,7794249,CCCCCCC(=O)CCCCCC/C=C/C[C@H]([C@@H]([C@](C(=O)O)(CO)N)O)O
serine palmitoyltransferase long chain base subunit 3,2511,SPTLC3,Q9NUV7,,,,,,Human,myriocin,6664,,,178103276,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,7794249,CCCCCCC(=O)CCCCCC/C=C/C[C@H]([C@@H]([C@](C(=O)O)(CO)N)O)O
serine protease 1,2397,PRSS1,P07477,,,,,,Human,nafamostat,4262,,,178101079,Inhibitor,Inhibition,,f,t,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,9544206,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
serine protease 1,2397,,,,,,,,Bovine,RWJ-56423,9333,,,318164852,Inhibitor,Inhibition,,f,f,,pKi,0,8.090000153,0,Ki,0,8.090000153,0,=,,,,12930148,NC(=N)NCCC[C@@H](C(=O)c1nc2c(s1)cccc2)NC(=O)[C@@H]1C[C@H](CN1C(=O)C)O
serine/threonine kinase 16,2213,STK16,O75716,,,,,,Human,STK16-IN-1,9692,,,348353651,Inhibitor,Inhibition,,f,t,,pIC50,0,6.53000021,0,IC50,0,295,0,=,In an <i>in vitro</i> enzymatic inhibition assay.,,,27082499,Fc1ccc(cc1C)n1c(=O)ccc2c1c1cc[nH]c1nc2
serine/threonine kinase 3,2219,STK3,Q13188,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,9.390000343,0,IC50,0,0.409999996,0,=,,,,19397322,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
serine/threonine kinase 36,2223,STK36,Q9NRP7,,,,,,Human,Ro-0505124,8203,,,249565883,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,16476733,CN1CCN(CC1)c1ccc(cc1)Nc1nc(c(s1)C(=O)c1ccc2c(c1)OCCO2)N
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,dalteparin,6803,,,178103409,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,,,3744129,
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,danaparoid,6804,,,178103410,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,,,8137606,
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,enoxaparin,6811,,,178103417,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,,,7667822,OCC1OC(OC2C(OC(C(C2O)OS(=O)(=O)O)OC2C(COS(=O)(=O)O)OC(C(C2O)NC(=O)C)O)C(=O)O)C(C(C1OC1OC(C(=O)O)C(C(C1OS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,fondaparinux,6819,,,178103425,Activator,Activation,,f,t,,pKd,0,7.489999771,0,Kd,0,32,0,=,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,,,12383040,CO[C@H]1O[C@H](COS(=O)(=O)O)[C@H]([C@@H]([C@H]1NS(=O)(=O)O)O)O[C@@H]1O[C@@H](C(=O)O)[C@H]([C@@H]([C@H]1OS(=O)(=O)O)O)O[C@H]1O[C@H](COS(=O)(=O)O)[C@H]([C@@H]([C@H]1NS(=O)(=O)O)OS(=O)(=O)O)O[C@@H]1O[C@H](C(=O)O)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@H](COS(=O)(=O)O)[C@H]([C@@H]([C@H]1NS(=O)(=O)O)O)O
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,heparin,4214,,,178101031,Activator,Activation,,f,t,,pKd,0,7.849999905,0,Kd,0,14.19999981,0,=,Catalyses the inactivation of coagulation proteases by activatted antithrombin-III,,,23598032,CC(=O)N[C@H]1[C@@H](O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@@H]2[C@@H](O)O[C@@H]([C@@H]([C@H]2CS(=O)(=O)O)OS(=O)(=O)O)O[C@@H]2[C@@H](OC([C@@H]([C@H]2O)OS(=O)(=O)O)O)C(=O)O)C(=O)O)O[C@@H]([C@H]([C@@H]1O)O)COS(=O)(=O)O
SERT,928,SLC6A4,P31645,,,,,,Human,dapoxetine,7901,,,249565584,Inhibitor,Inhibition,,f,t,,pIC50,0,8.949999809,0,IC50,0,1.120000005,0,=,Inhibition of the reuptake of [<sup>3</sup>H]5-HT,,,0,CN([C@H](c1ccccc1)CCOc1cccc2c1cccc2)C
SERT,928,Slc6a4,P31652,,,,,,Rat,desipramine,2399,,,135650171,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,20945906,CNCCCN1c2ccccc2CCc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,desipramine,2399,,,135650171,Inhibitor,Inhibition,,f,t,,pKi,0,6.789999962,0,Ki,0,163,0,=,Assay using HEK-293 cells transfected with hSERT,,,9400006,CNCCCN1c2ccccc2CCc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,desvenlafaxine,7158,,,178103733,Inhibitor,Inhibition,,f,t,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,24900709,CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C
SERT,928,SLC6A4,P31645,,,,,,Human,dosulepin,7549,,,223365885,Inhibitor,Inhibition,,f,t,,pKi,0,8.069999695,0,Ki,0,8.600000381,0,=,,,,9537821,CN(CC/C=C/1c2ccccc2SCc2c1cccc2)C
SERT,928,SLC6A4,P31645,,,,,,Human,doxepin,1225,,,135650208,Inhibitor,Inhibition,,f,t,,pKi,0,7.170000076,0,Ki,0,68,0,=,,,,9537821,CN(CC/C=C1/c2ccccc2OCc2c1cccc2)C
SERT,928,SLC6A4,P31645,,,,,,Human,duloxetine,202,,,135650212,Inhibitor,Inhibition,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,18387300,CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,escitalopram,7177,,,178103752,Inhibitor,Inhibition,,f,f,,pKd,0,8.680000305,0,Kd,0,2.099999905,0,=,,,,27049939,N#Cc1ccc2c(c1)CO[C@@]2(CCCN(C)C)c1ccc(cc1)F
SERT,928,SLC6A4,P31645,,,,,,Human,escitalopram,7177,,,178103752,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,19720528,N#Cc1ccc2c(c1)CO[C@@]2(CCCN(C)C)c1ccc(cc1)F
SERT,928,SLC6A4,P31645,,,,,,Human,fluoxetine,203,,,135650270,Inhibitor,Inhibition,,f,t,,pKi,0,8.5,0,Ki,0,3,0,=,,,,9537821,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
SERT,928,Slc6a4,P31652,,,,,,Rat,fluvoxamine,7189,,,178103764,Inhibitor,Inhibition,,f,f,,pKi,0,8.18999958,0,Ki,0,6.5,0,=,Inhibition of [<sup>3</sup>]5-HT uptake into rat astrocyte cultures.,,,11311448,NCCO/N=C(/c1ccc(cc1)C(F)(F)F)CCCCOC
SERT,928,SLC6A4,P31645,,,,,,Human,fluvoxamine,7189,,,178103764,Inhibitor,Inhibition,,f,t,,pKd,0,8.659999847,0,Kd,0,2.200000048,0,=,,,,9537821,NCCO/N=C(/c1ccc(cc1)C(F)(F)F)CCCCOC
SERT,928,SLC6A4,P31645,,,,,,Human,imipramine,357,,,135650384,Inhibitor,Inhibition,,f,t,,pKi,0,7.690000057,0,Ki,0,20.29999924,0,=,Displacement of [<sup>3</sup>H]citalopram from hSERT.,,,8496700,CN(CCCN1c2ccccc2CCc2c1cccc2)C
SERT,928,SLC6A4,P31645,,,,,,Human,levomilnacipran,7435,,,178104007,Inhibitor,Inhibition,,f,t,,pIC50,0,6.489999771,0,IC50,0,320,0,=,,,,18468895,NC[C@@H]1C[C@]1(c1ccccc1)C(=O)N(CC)CC
SERT,928,SLC6A4,P31645,,,,,,Human,lofepramine,7551,,,223365887,Inhibitor,Inhibition,,f,t,,pKi,0,7.21999979,0,Ki,0,60,0,=,,,,9537821,CN(CC(=O)c1ccc(cc1)Cl)CCCN1c2ccccc2CCc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,lumateperone,9099,,,315661184,Inhibitor,Inhibition,,f,f,,pKi,0,7.210000038,0,Ki,0,62,0,=,,,,25120104,Fc1ccc(cc1)C(=O)CCCN1CCC2C(C1)c1cccc3c1N2CCN3C
SERT,928,SLC6A4,P31645,,,,,,Human,milnacipran,7436,,,178104008,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50.11999893,0,=,,,,23347683,NCC1CC1(c1ccccc1)C(=O)N(CC)CC
SERT,928,SLC6A4,P31645,,,,,,Human,nefazodone,7247,,,178103821,Inhibitor,Inhibition,,f,t,,pKd,0,6.699999809,0,Kd,0,200,0,=,,,,9871604,CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl
SERT,928,SLC6A4,P31645,,,,,,Human,nortriptyline,2404,,,135650736,Inhibitor,Inhibition,,f,t,,pKi,0,8.159999847,0,Ki,0,6.980000019,0,=,,,,0,CNCCC=C1c2ccccc2CCc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,norzotepine,7537,,,187051838,Inhibitor,Inhibition,,f,f,,pIC50,0,5.210000038,0,IC50,0,6191,0,=,,,,20223878,CNCCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2
SERT,928,SLC6A4,P31645,,,,,,Human,paroxetine,4790,,,178101492,Inhibitor,Inhibition,,f,f,,pKd,0,10.10000038,0,Kd,0,0.079999998,0,=,,,,27049939,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2c(c1)OCO2
SERT,928,SLC6A4,P31645,,,,,,Human,paroxetine,4790,,,178101492,Inhibitor,Inhibition,,f,t,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,9537821,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2c(c1)OCO2
SERT,928,SLC6A4,P31645,,,,,,Human,phenelzine,7266,,,178103840,Inhibitor,Inhibition,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,9537821,NNCCc1ccccc1
SERT,928,SLC6A4,P31645,,,,,,Human,protriptyline,7285,,,178103859,Inhibitor,Inhibition,,f,t,,pKd,0,7.710000038,0,Kd,0,19.60000038,0,=,,,,9537821,CNCCCC1c2ccccc2C=Cc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,sertraline,4798,,,178101500,Inhibitor,Inhibition,,f,t,,pKi,0,9.100000381,0,Ki,0,0.790000021,0,=,,,,0,CN[C@H]1CC[C@H](c2c1cccc2)c1ccc(c(c1)Cl)Cl
SERT,928,SLC6A4,P31645,,,,,,Human,sibutramine,2586,,,135651043,Inhibitor,Inhibition,,f,f,,pKi,0,5.960000038,0,Ki,0,1108,0,=,,,,0,CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
serum/glucocorticoid regulated kinase 1,1534,SGK1,O00141,,,,,,Human,EMD638683,9407,,,328083509,Inhibitor,Inhibition,,f,t,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,<i>In vitro</i> testing,,,21865856,CCc1c(ccc(c1C)O)C(=O)NNC(=O)C(c1cc(F)cc(c1)F)O
serum/glucocorticoid regulated kinase 1,1534,SGK1,O00141,,,,,,Human,GSK650394,8040,,,249565720,Inhibitor,Inhibition,,f,t,,pIC50,0,7.210000038,0,IC50,0,62,0,=,,,,18794135,OC(=O)c1ccc(cc1C1CCCC1)c1c[nH]c2c1cc(cn2)c1ccccc1
SET and MYND domain containing 2,2714,SMYD2,Q9NRG4,,,,,,Human,LLY-507,8239,,,249565919,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,<,,,,0,N#Cc1cc(cc(c1)c1ccccc1N1CCN(CC1)CCn1cc(c2c1cccc2)C)C(=O)NCCCN1CCCC1
SET domain containing lysine methyltransferase 7,2703,SETD7,Q8WTS6,,,,,,Human,(<i>R</i>)-PFI-2,8235,,,249565915,Inhibitor,Inhibition,,f,t,,pKi,0,9.479999542,0,Ki,0,0.330000013,0,=,,,,25136132,O=C([C@H](NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)Cc1cccc(c1)C(F)(F)F)N1CCCC1
"SGK2, serine/threonine kinase 2",1535,SGK2,Q9HBY8,,,,,,Human,GSK650394,8040,,,249565720,Inhibitor,Inhibition,,f,t,,pIC50,0,6.989999771,0,IC50,0,103,0,=,,,,18794135,OC(=O)c1ccc(cc1C1CCCC1)c1c[nH]c2c1cc(cn2)c1ccccc1
SGLT6,925,SLC5A11,Q8WWX8,,,,,,Human,phlorizin,4757,,,178101467,Inhibitor,Inhibition,,f,f,,pKi,0,4.099999905,0,Ki,0,76000,0,=,,,,12133831,OC[C@H]1O[C@@H](Oc2cc(O)cc(c2C(=O)CCc2ccc(cc2)O)O)[C@@H]([C@H]([C@@H]1O)O)O
&sigma;2,2553,TMEM97,Q5BJF2,,,,,,Human,PB-28,6681,,,178103293,Agonist,Agonist,,f,f,,pKi,0,8.300000191,0,-,0,0,0,=,,,,8568804,COc1cccc2c1CCCC2CCCN1CCN(CC1)C1CCCCC1
&sigma;2,2553,TMEM97,Q5BJF2,,,,,,Human,SM 21,6682,,,178103294,Antagonist,Antagonist,,f,f,,pIC50,0,7.199999809,0,-,0,0,0,=,,,,10096443,CCC(C(=O)OC1CC2CCC(C1)N2C)Oc1ccc(cc1)Cl
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,dextromethorphan,6953,,,178103535,Agonist,Agonist,,f,f,,pKi,0,6.28000021,0,Ki,0,521,0,=,"Sigma receptor cloned from Jurkat cells, identified as SIGMAR1.",,,10087012,COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,PRE-084,6678,,,178103290,Agonist,Agonist,,f,f,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,1658302,O=C(C1(CCCCC1)c1ccccc1)OCCN1CCOCC1
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,(RS)-PPCC,6676,,,178103288,Agonist,Agonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,17328523,COC(=O)C1(CC1CN1CCC(CC1)(O)c1ccccc1)c1ccc(cc1)C
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,(+)-SKF 10.047,6677,,,178103289,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,C=CCN1CC[C@]2([C@@H]([C@@H]1Cc1c2cc(cc1)O)C)C
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,NE-100,6679,,,178103291,Antagonist,Antagonist,,f,f,,pIC50,0,8.399999619,0,-,0,0,0,=,,,,7901723,CCCN(CCc1ccc(c(c1)OCCc1ccccc1)OC)CCC
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,(-)-pentazocine,1606,,,135650806,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=CCN1CC[C@@]2([C@H]([C@H]1Cc1c2cc(cc1)O)C)C)C
SIK family kinase 3,2199,SIK3,Q9Y2K2,,,,,,Human,dasatinib,5678,,,178102305,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,25351958,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
SIK family kinase 3,2199,SIK3,Q9Y2K2,,,,,,Human,HG-9-91-01,8049,,,249565729,Inhibitor,Inhibition,,f,t,,pIC50,0,8.020000458,0,IC50,0,9.600000381,0,=,,,,23033494,COc1cc(OC)ccc1N(C(=O)Nc1c(C)cccc1C)c1ncnc(c1)Nc1ccc(cc1)N1CCN(CC1)C
single Ig and TIR domain containing,2969,SIGIRR,Q6IA17,,,,,,Human,IL-37,6149,IL37,Human,178102770,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,Interaction determined using fluorescence lifetime imaging?F&ouml;rster resonance energy transfer (FLIM-FRET) and proximity ligation assay (PLA) studies in LPS-stimulated human PBMCs.,,,25729923,
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,SIRT1 activator 3,9514,,,336446901,Activator,Activation,,f,f,,pIC50,0,6,0,IC50,0,1000,0,<,In an enzymatic assay,,,17099246,COCCCn1c2nc3ccccc3nc2c(c1N)C(=O)NC1CCCC1
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,SRT1720,7703,,,223366036,Activator,Activation,,f,t,,pEC50,0,6.800000191,0,EC50,0,160,0,=,,,,18046409,O=C(c1cnc2c(n1)cccc2)Nc1ccccc1c1cn2c(n1)scc2CN1CCNCC1
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,SRT2104,9515,,,336446902,Activator,Activation,EC<sub>1.5</sub> is 430nM.,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(c1sc(nc1C)c1cccnc1)Nc1ccccc1c1cn2c(n1)scc2CN1CCOCC1
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,selisistat,8100,,,249565780,Inhibitor,Inhibition,,f,t,,pIC50,0,7.420000076,0,IC50,0,38,0,=,,,,16354677,NC(=O)C1CCCc2c1[nH]c1c2cc(cc1)Cl
sirtuin 1,2707,SIRT1,Q96EB6,,,,,,Human,splitomicin,8101,,,249565781,Inhibitor,Inhibition,,f,f,,pIC50,0,4.019999981,0,IC50,0,96200,0,=,,,,20041717,O=C1CCc2c(O1)ccc1c2cccc1
SMCT1,922,SLC5A8,Q8N695,,,,,,Human,fenoprofen,4820,,,178101522,Inhibitor,Inhibition,,f,f,,pIC50,0,4.570000172,0,IC50,0,27000,0,=,,,,16729224,OC(=O)C(c1cccc(c1)Oc1ccccc1)C
SMCT1,922,SLC5A8,Q8N695,,,,,,Human,ibuprofen,2713,,,135650365,Inhibitor,Inhibition,,f,f,,pIC50,0,4.199999809,0,IC50,0,63095,0,=,,,,16729224,CC(Cc1ccc(cc1)C(C(=O)O)C)C
SMCT1,922,SLC5A8,Q8N695,,,,,,Human,ketoprofen,4795,,,178101497,Inhibitor,Inhibition,,f,f,,pIC50,0,3.920000076,0,IC50,0,119000,0,=,,,,16729224,OC(=O)C(c1cccc(c1)C(=O)c1ccccc1)C
SMIT,924,SLC5A3,P53794,,,,,,Human,phlorizin,4757,,,178101467,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,12133831,OC[C@H]1O[C@@H](Oc2cc(O)cc(c2C(=O)CCc2ccc(cc2)O)O)[C@@H]([C@H]([C@@H]1O)O)O
SMO,239,SMO,Q99835,,,,,,Human,glasdegib,8201,,,249565881,Antagonist,Antagonist,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,24900436,N#Cc1ccc(cc1)NC(=O)N[C@@H]1CCN([C@H](C1)c1nc2c([nH]1)cccc2)C
SMO,239,SMO,Q99835,,,,,,Human,saridegib,8198,,,249565878,Antagonist,Antagonist,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,19522463,C[C@@H]1CN[C@@H]2[C@@H](C1)O[C@@]1([C@@H]2C)CC[C@@H]2C(=C(C1)C)C[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@H](C2)NS(=O)(=O)C
SMO,239,SMO,Q99835,,,,,,Human,sonidegib,8199,,,249565879,Antagonist,Antagonist,,f,t,,pKi,0,8.220000267,0,Ki,0,6,0,=,,,,23063522,C[C@@H]1O[C@H](C)CN(C1)c1ccc(cn1)NC(=O)c1cccc(c1C)c1ccc(cc1)OC(F)(F)F
Sodium/bile acid and sulphated solute cotransporter 1,959,SLC10A1,Q14973,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,,f,f,,pKi,0,5.119999886,0,Ki,0,7600,0,=,,,,23339484,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
Sodium/bile acid and sulphated solute cotransporter 1,959,SLC10A1,Q14973,,,,,,Human,cyclosporin A,1024,,,135652074,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,10565843,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C
Sodium/bile acid and sulphated solute cotransporter 1,959,SLC10A1,Q14973,,,,,,Human,irbesartan,589,,,135650414,Inhibitor,Inhibition,,f,f,,pKi,0,4.920000076,0,Ki,0,11900,0,=,,,,23339484,CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2
Sodium/bile acid and sulphated solute cotransporter 1,959,SLC10A1,Q14973,,,,,,Human,(-)-propranolol,63,,,135650859,Inhibitor,Inhibition,,f,f,,pIC50,0,8.210000038,0,IC50,0,6.099999905,0,=,,,,10565843,O[C@H](COc1cccc2c1cccc2)CNC(C)C
Sodium/bile acid and sulphated solute cotransporter 1,959,SLC10A1,Q14973,,,,,,Human,(+)-propranolol,7596,,,223365931,Inhibitor,Inhibition,,f,f,,pIC50,0,5.260000229,0,IC50,0,5500,0,=,,,,10565843,O[C@@H](COc1cccc2c1cccc2)CNC(C)C
Sodium/bile acid and sulphated solute cotransporter 2,960,SLC10A2,Q12908,,,,,,Human,SC-435,6530,,,178103144,Inhibitor,Inhibition,,f,,,pIC50,0,8.82,0,IC50,0,1.5,0,=,,,,12810816,CCCCC1(CCCC)CS(=O)(=O)c2c([C@H]([C@H]1O)c1ccc(cc1)OCCCC[N+]13CCN(CC1)CC3)cc(c(c2)OC)OC
Sodium-dependent vitamin C transporter 1,1041,SLC23A1,Q9UHI7,,,,,,Human,phloretin,4285,,,178101102,Inhibitor,Inhibition,,f,f,,pKi,0,4.190000057,0,Ki,0,65000,0,=,,,,10331392,Oc1ccc(cc1)CCC(=O)c1c(O)cc(cc1O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,dapagliflozin,4594,,,178101315,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,370,0,=,,,,21398124,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,empagliflozin,4754,,,178101464,Inhibitor,Inhibition,,f,f,,pIC50,0,5.099999905,0,IC50,0,7943,0,=,,,,21985634,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,ertugliflozin,8376,,,252166588,Inhibitor,Inhibition,,f,f,,pIC50,0,5.710000038,0,IC50,0,1960,0,=,,,,21449606,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@]12OC[C@@](O1)(CO)[C@H]([C@@H]([C@H]2O)O)O
Sodium/glucose cotransporter 1,915,Slc5a1,Q8C3K6,,,,,,Mouse,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,f,,pIC50,0,5.860000134,0,IC50,0,1380,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing mSGLT1.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,f,,pIC50,0,5.730000019,0,IC50,0,1876,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing hSGLT1.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,Slc5a1,P53790,,,,,,Rat,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,f,,pIC50,0,5.929999828,0,IC50,0,1166,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing rSGLT1.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,mizagliflozin,9547,,,336446933,Inhibitor,Inhibition,,f,f,,pKi,0,7.570000172,0,Ki,0,27,0,=,Monitoring the uptake of <sup>14</sup>C-labeled AMG,,,28410751,OC[C@H]1O[C@@H](Oc2n[nH]c(c2Cc2ccc(cc2C)OCCCNCC(C(=O)N)(C)C)C(C)C)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,remogliflozin,4588,,,178101309,Inhibitor,Inhibition,,f,f,,pKi,0,5.300000191,0,Ki,0,4520,0,=,,,,18583547,OC[C@H]1O[C@@H](Oc2n[nH]c(c2C(=O)Cc2ccc(cc2)OC(C)C)C(C)C)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,sergliflozin,4587,,,178101308,Inhibitor,Inhibition,,f,f,,pKi,0,5.099999905,0,Ki,0,7943,0,=,,,,17050778,CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(cc2)OC)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,sotagliflozin,8312,,,252166524,Inhibitor,Inhibition,,f,t,,pIC50,0,7.440000057,0,IC50,0,36,0,=,,,,22739142,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@@H]1O[C@H](SC)[C@H]([C@@H]([C@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,dapagliflozin,4594,,,178101315,Inhibitor,Inhibition,,f,t,,pIC50,0,9.300000191,0,IC50,0,0.49000001,0,=,,,,20637636,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,empagliflozin,4754,,,178101464,Inhibitor,Inhibition,,f,t,,pIC50,0,8.5,0,IC50,0,3.200000048,0,=,,,,21985634,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,ertugliflozin,8376,,,252166588,Inhibitor,Inhibition,,f,t,,pIC50,0,9.06000042,0,IC50,0,0.876999974,0,=,,,,21449606,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@]12OC[C@@](O1)(CO)[C@H]([C@@H]([C@H]2O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,t,,pIC50,0,8.130000114,0,IC50,0,7.380000114,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing hSGLT2.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,Slc5a2,Q923I7,,,,,,Mouse,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,f,,pIC50,0,8.25,0,IC50,0,5.639999866,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing mSGLT2.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,Slc5a2,P53792,,,,,,Rat,ipragliflozin,9394,,,328083496,Inhibitor,Inhibition,,f,f,,pIC50,0,8.199999809,0,IC50,0,6.369999886,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing rSGLT2.,,,22139434,OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2cc3c(s2)cccc3)F)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,remogliflozin,4588,,,178101309,Inhibitor,Inhibition,,f,t,,pKi,0,7.900000095,0,Ki,0,12.39999962,0,=,,,,18583547,OC[C@H]1O[C@@H](Oc2n[nH]c(c2C(=O)Cc2ccc(cc2)OC(C)C)C(C)C)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,sergliflozin,4587,,,178101308,Inhibitor,Inhibition,,f,t,,pKi,0,6.800000191,0,Ki,0,158,0,=,,,,17050778,CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(cc2)OC)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,sotagliflozin,8312,,,252166524,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,22739142,CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@@H]1O[C@H](SC)[C@H]([C@@H]([C@H]1O)O)O
Sodium phosphate 2,1136,SLC34A2,O95436,,,,,,Human,lifastuzumab vedotin,8405,,,252166615,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
sodium/potassium-transporting ATPase subunit &alpha;-1,833,ATP1A1,P05023,,,,,,Human,deslanoside,6806,,,178103412,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,OC[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]2[C@@H]3C[C@@H](O)[C@]3([C@]2(O)CC[C@@H]3C2=CC(=O)OC2)C)C)[C@@H]([C@H]([C@@H]1O)O)O
sodium/potassium-transporting ATPase subunit &alpha;-1,833,ATP1A1,P05023,,,,,,Human,digitoxin,6782,,,178103388,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1OCC(=C1)[C@H]1CC[C@]2([C@]1(C)CC[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O)O
sodium/potassium-transporting ATPase subunit &alpha;-1,833,,,,,,,,Dog,digitoxin,6782,,,178103388,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,8421289,O=C1OCC(=C1)[C@H]1CC[C@]2([C@]1(C)CC[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O)O
sodium/potassium-transporting ATPase subunit &alpha;-1,833,,,,,,,,Dog,digoxin,4726,,,178101437,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,12904068,O=C1OCC(=C1)[C@H]1CC[C@]2([C@]1(C)[C@H](O)C[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O)O
sodium/potassium-transporting ATPase subunit &alpha;-1,833,ATP1A1,P05023,,,,,,Human,digoxin,4726,,,178101437,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1OCC(=C1)[C@H]1CC[C@]2([C@]1(C)[C@H](O)C[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O)O
sphingomyelin phosphodiesterase 2,2515,,,,,,,,Bovine,inhibitor A [PMID: 12482429],8847,,,252827504,Inhibitor,Inhibition,,f,f,,pKi,0,5.800000191,0,Ki,0,1600,0,=,,,,12482429,CCCCCCCCCCCCCCCC(=O)N[C@H]([C@@H](c1ccccc1)O)CC(P(=O)(O)O)(F)F
sphingosine kinase 1,2204,SPHK1,Q9NYA1,,,,,,Human,PF-543,6623,,,178103236,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,22397330,OC[C@H]1CCCN1Cc1ccc(cc1)COc1cc(C)cc(c1)CS(=O)(=O)c1ccccc1
sphingosine kinase 1,2204,SPHK1,Q9NYA1,,,,,,Human,SK1-I,6622,,,178103235,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,18511810,CCCCCc1ccc(cc1)/C=C/[C@@H]([C@H](NC)CO)O
sphingosine kinase 1,2204,SPHK1,Q9NYA1,,,,,,Human,SKI II,6041,,,178102663,Inhibitor,Inhibition,,f,t,,pIC50,0,6.300000191,0,IC50,0,500,0,=,Measured using a GST-hSPHK1 fusion protein,,,14522923,Oc1ccc(cc1)Nc1scc(n1)c1ccc(cc1)Cl
sphingosine kinase 2,2205,SPHK2,Q9NRA0,,,,,,Human,ROMe,6625,,,178103238,Inhibitor,Inhibition,,f,t,,pIC50,0,4.570000172,0,IC50,0,27000,0,=,,,,21620961,CCCCCCCCc1ccc(cc1)CC[C@](COC)(CO)N
sPLA<sub>2</sub>-2A,1417,PLA2G2A,P14555,,,,,,Human,KH064,6703,,,178103314,Inhibitor,Inhibition,,f,,,pIC50,0,7.5,0,IC50,0,29,0,,,,,12616631,OC(=O)CC[C@@H](Cc1ccc(cc1)OCc1ccccc1)NC(=O)CCCCCCc1ccccc1
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,entospletinib,7889,,,249565580,Inhibitor,Inhibition,,f,t,,pIC50,0,8.109999657,0,IC50,0,7.699999809,0,=,,,,24779514,O1CCN(CC1)c1ccc(cc1)Nc1nc(cn2c1ncc2)c1ccc2c(c1)[nH]nc2
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,ER-27319,9611,,,340590241,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,=,Inhibition of Syk in human mast cells by immunoprecipitation assay,,,22257213,NCCCn1c2ccccc2c(=O)c2c1c(C)c(C)cc2
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,example 2 [US9290505],9764,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.869999886,0,IC50,0,13.5,0,=,,,,0,Nc1cncc(n1)c1cn2ccnc2c(n1)Nc1ccc(cc1)N1CCN(CC1)C1COC1
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,GSK143,9388,,,328083490,Inhibitor,Inhibition,,f,f,,pIC50,0,8.119999886,0,IC50,0,7.5,0,=,Enzyme inhibition assay using recombinant human protein,,,21903390,N[C@@H]1COCC[C@@H]1Nc1ncc(c(n1)Nc1ccc(cc1)C)C(=O)N
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,P505-15,8070,,,249565750,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,22040680,N[C@H]1CCCC[C@H]1Nc1ncc(c(n1)Nc1cccc(c1)n1nccn1)C(=O)N
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,CP-294838,3058,,,135650127,Inhibitor,Inhibition,,f,,,pIC50,0,6.89,0,-,0,130,0,=,"in vitro, soluable microsomal enzymes purified from rat and human liver microsomes",,,9473303,OC(=O)CC1OC(c2c(N(C1=O)CC(C)(C)C)ccc(c2)Cl)c1ccccc1Cl
squalene synthase ,645,FDFT1,P37268,,,,,,Human,E5700,3104,,,135650216,Inhibitor,Inhibition,,f,,,pIC50,0,8.82,0,IC50,0,1.5,0,=,Inhibition of human recombinant squalene synthase,,,17371809,CO[C@@H]1CN(C[C@@H]1O)c1ccc(c(n1)Cc1ccccc1)C#C[C@]1(O)CN2CCC1CC2
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,ibandronic acid,3059,,,135649664,Inhibitor,Inhibition,,f,,,pIC50,0,6.19,0,IC50,0,640,0,=,Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting,,,20299227,CCCCCN(CCC(P(=O)(O)O)(P(=O)(O)O)O)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,J-104118,3070,,,135650440,Inhibitor,Inhibition,,f,,,pIC50,0,9.28,0,IC50,0,0.52,0,=,Inhibitory activity against HepG2 Squalene Synthase (SQS),,,0,O=C(C[C@H](C(=O)O)CC(=O)O)N[C@H]([C@H](c1ccc(c(c1)F)c1ccccc1)Cc1ccc(c(c1)Cl)Cl)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,J-104118,3070,,,135650440,Inhibitor,Inhibition,,f,,,pIC50,0,9.14,0,IC50,0,0.73,0,=,Inhibitory activity against HepG2 Squalene Synthase (SQS),,,0,O=C(C[C@H](C(=O)O)CC(=O)O)N[C@H]([C@H](c1ccc(c(c1)F)c1ccccc1)Cc1ccc(c(c1)Cl)Cl)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,J-104123,3110,,,135650441,Inhibitor,Inhibition,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,Inhibitory activity against squalene synthase (SQS) obtained from HepG2 cells,,,0,C[C@@H](CC(=O)O)CC(=O)N[C@H]([C@@H](Cc1ccc(c(c1)Cl)Cl)/C=C/c1ccc2c(c1)cccc2)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,L-731120,3069,,,135650481,Inhibitor,Inhibition,,f,f,,pIC50,0,6.590000153,0,IC50,0,260,0,=,In vitro inhibitory activity against rat squalene synthase,,,0,OC(=O)CC(C(C(=O)O)CCCCC/C(=C/C(Cc1ccccc1)C)/C)(C(=O)O)O
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,L-731128,3068,,,135650482,Inhibitor,Inhibition,,f,,,pIC50,0,6.12,0,IC50,0,767,0,=,In vitro inhibitory activity against rat squalene synthase,,,0,CC(CC(C/C=C/c1ccccc1)C)CCCCCC(C(C(=O)O)(CC(=O)O)O)C(=O)O
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,L-735021,3117,,,135650483,Inhibitor,Inhibition,,f,,,pIC50,0,9.85,0,IC50,0,0.14,0,=,Tested for inhibition against squalene synthase enzyme in rat liver,,,7966163,CC(CCCc1ccccc1)/C=C/CCC(=O)O[C@@H]1[C@@H](O)C2(OC1(C(=O)O)C(O)(C(=O)O)C(O2)C(=O)O)CCCCC(Cc1ccccc1)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,NB-598,3103,,,135650692,Inhibitor,Inhibition,,f,,,pIC50,0,7.7,0,IC50,0,20,0,=,In vitro ability to inhibit cholesterol biosynthesis in HepG2 cells in culture from [14C]-acetate,,,7650673,CCN(Cc1cccc(c1)OCc1scc(c1)c1cscc1)C/C=C/C#CC(C)(C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,SQ-109,7997,,,249565677,Inhibitor,Inhibition,,f,f,,pKi,0,6.130000114,0,Ki,0,740,0,=,,,,22486710,C/C(=CCNCCNC1C2CC3CC1CC(C2)C3)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,SQ-34919,3101,,,135649829,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition rat liver microsomal squalene synthase,,,7629799,C/C(=CCCCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,SQ-34919,3101,,,135649829,Inhibitor,Inhibition,,f,,,pIC50,0,9,0,IC50,0,1,0,=,Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]-FPP as radioligand,,,8576905,C/C(=CCCCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,dasatinib,5678,,,178102305,Inhibitor,Inhibition,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,15930265,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,dorsomorphin,4907,,,178101606,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,<,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,ENMD-2076,7885,,,249565576,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,19320489,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,GSK-3 inhibitor XIII,5976,,,178102599,Inhibitor,Inhibition,,f,f,,pKi,0,7.090000153,0,Ki,0,81,0,=,,,,19447622,Cc1[nH]nc(c1)Nc1nc(nc2c1cccc2)c1ccccc1
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,NG-25,8074,,,249565754,Inhibitor,Inhibition,,f,f,,pIC50,0,6.949999809,0,IC50,0,113,0,=,,,,25075558,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)Oc1ccnc2c1cc[nH]2)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,t,,pKi,0,8.079999924,0,Ki,0,8.399999619,0,=,,,,9400019,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,PP121,8013,,,249565693,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,18849971,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,saracatinib,7731,,,223366064,Inhibitor,Inhibition,,f,t,,pIC50,0,8.569999695,0,IC50,0,2.700000048,0,=,,,,17064066,CN1CCN(CC1)CCOc1cc(OC2CCOCC2)c2c(c1)ncnc2Nc1c(Cl)ccc2c1OCO2
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,9.1,0,7.7,,0,0,0,,,,,9650799,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,9.6,0,9.1,,0,0,0,,,,,9650799,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"cyclo(7-12) Des-AA<sup>1,2,5</sup>-[Glu<sup>7</sup>,D-Trp<sup>8</sup>,IAmp<sup>9</sup>,m-I-Tyr<sup>11</sup>,hhLys<sup>12</sup>]SRIF",2025,,,135652072,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,15658865,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"Des-AA<sup>1,2,5,12,13</sup>-[D-Trp<sup>8</sup>]SRIF",2009,,,135652104,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,15658865,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"Des-AA<sup>1,5</sup>-[Tyr<sup>2</sup>,D-Trp<sup>8</sup>,IAmp<sup>9</sup>]SRIF",2011,,,135652105,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,15658865,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF,2012,,,135652106,Agonist,Full agonist,,f,,,pIC50,9.1,0,8.9,,0,0,0,,,,,15658864,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"Des-Ala<sup>1,2,5</sup>-[D-Trp<sup>8</sup>,IAmp<sup>9</sup>]SRIF",2010,,,135652107,Agonist,Full agonist,,f,f,,pIC50,0,7.5,0,-,0,0,0,=,,,,15658864,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,KE 108,2013,,,135652241,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,12450568,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,6.2,0,6.1,,0,0,0,,,,,9650799,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"L-797,591",2015,,,135650499,Agonist,Full agonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,9784130,NCCC(CC(CNC(=O)[C@@H](Cc1cccc2c1cccc2)NC(=O)N(CCc1ccccn1)CCc1ccccc1)(C)C)C
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,"L-817,818",2016,,,135650502,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,9784130,NCCCC[C@@H](C(=O)OC[C@@H](N)C)NC(=O)Cc1c([nH]c2c1ccc1c2cccc1)c1ccc2c(c1)cccc2
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,NC 4-28B,2017,,,135652320,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7988476,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,pasireotide,2018,,,135652473,Agonist,Full agonist,,f,t,,pIC50,0,8,0,-,0,0,0,=,,,,15477717,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>1</sub> receptor,355,Sstr1,P28646,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pIC50,0,8.4,0,,0,0,0,,,,,9166718,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,9.5,0,8.6,,0,0,0,,,,,9784130,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,9.4,0,8.6,,0,0,0,,,,,8769372,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,,,pKi,5.3,0,5,,0,0,0,,,,,12616335,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,5.9,0,5.7,,0,0,0,,,,,12616335,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,SRA880,2030,,,135651084,Antagonist,Antagonist,,f,f,,pKd,8.100000381,0,8,-,0,0,0,=,,,,15135911,COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-]
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,KE 108,2013,,,135652241,Agonist,Agonist,,f,,,pEC50,10.24,0,7.92,EC50,12.1,0,0.057,=,,,,19910453,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,"L-779,976",2050,,,135650495,Agonist,Agonist,,f,,,pEC50,0,10.05,0,EC50,0,0.09,0,=,,,,15855408,NC[C@@H]1CCC[C@H](C1)CNC(=O)[C@@H]([C@H](c1c[nH]c2c1cccc2)C)NC(=O)N1CCC(CC1)n1c(=O)[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,pasireotide,2018,,,135652473,Agonist,Agonist,,f,,,pEC50,9.07,0,7.76,EC50,17.5,0,0.86,=,,,,19910453,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Agonist,,f,,,pEC50,9.14,0,8.99,EC50,1.02,0,0.73,=,,,,15855408,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,9,0,8.4,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,9.3,0,8.8,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,DC 23-60,2043,,,135652085,Agonist,Full agonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,DC 23-60,2043,,,135652085,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,demotate 2,5636,,,178102265,Agonist,Full agonist,,f,,,pIC50,0,8.49,0,IC50,0,3.2,0,=,,,,16568203,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,EC 5-21,2044,,,135652143,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,EC 5-21,2044,,,135652143,Agonist,Full agonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Ga-DOTA-NOC,5639,,,178102267,Agonist,Full agonist,,f,,,pIC50,0,8.72,0,IC50,0,1.9,0,=,,,,17225119,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Ga-DOTA-TOC,5638,,,178102266,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,IC50,0,2.5,0,=,,,,10774879,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[Ga-DOTA,Tyr<sup>3</sup>,Thr<sup>8</sup>]octreotide",5632,,,178102261,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,IC50,0,0.2,0,=,,,,17225119,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Ga-KE88,5640,,,178102268,Agonist,Full agonist,,f,,,pIC50,0,8.39,0,IC50,0,4.1,0,=,,,,18381940,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,In-NODAGATOC,5642,,,178102270,Agonist,Full agonist,,f,,,pIC50,0,8.77,0,IC50,0,1.7,0,=,,,,12009943,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,KE 108,2013,,,135652241,Agonist,Full agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,12450568,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"L-054,522",2046,,,135650462,Agonist,Full agonist,,f,f,,pKi,0,11,0,-,0,0,0,=,,,,9724791,NCCCC[C@@H](C(=O)OC(C)(C)C)NC(=O)[C@@H]([C@H](c1c[nH]c2c1cccc2)C)NC(=O)N1CCC(CC1)n1c(=O)[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,8.8,0,8.4,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,8.5,0,7,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,"L-363,301",2047,,,135652248,Agonist,Full agonist,,f,,,pIC50,9.1,0,8.1,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"L-363,301",2047,,,135652248,Agonist,Full agonist,,f,,,pKi,8.5,0,8.3,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"L-363,377",2048,,,135652249,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9784130,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,"L-363,377",2048,,,135652249,Agonist,Full agonist,,f,,,pIC50,0,9.4,0,,0,0,0,,,,,8769370,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,"L-363,409",2049,,,135652250,Agonist,Full agonist,,f,,,pIC50,0,12,0,,0,0,0,,,,,8769370,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"L-779,976",2050,,,135650495,Agonist,Full agonist,,f,f,,pKi,0,10.30000019,0,-,0,0,0,=,,,,9784130,NC[C@@H]1CCC[C@H](C1)CNC(=O)[C@@H]([C@H](c1c[nH]c2c1cccc2)C)NC(=O)N1CCC(CC1)n1c(=O)[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,t,,pKi,9.600000381,0,8.699999809,-,0,0,0,=,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pKi,9.1,0,6.9,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"maltotriose-[<sup>125</sup>I][Tyr<sup>3</sup>,Thr<sup>8</sup>]octreotide",5631,,,178102260,Agonist,Full agonist,,f,,,pIC50,0,9.02,0,IC50,0,0.95,0,=,,,,11807604,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,NC 4-28B,2017,,,135652320,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,NC 4-28B,2017,,,135652320,Agonist,Full agonist,,f,,,pIC50,11.7,0,10,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,NC 8-12,2052,,,135652321,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,8769370,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,NC 8-12,2052,,,135652321,Agonist,Full agonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,7988476,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,NOC-ATE,2053,,,135652332,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,15709181,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,NODAGA-[Tyr<sup>3</sup>]-octreotide,5627,,,178102257,Agonist,Full agonist,,f,,,pIC50,0,8.49,0,IC50,0,3.2,0,=,,,,12009943,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,9.2,0,7.5,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,octreotide,2055,,,135652471,Agonist,Full agonist,,f,f,,pKi,9.899999619,0,8.699999809,-,0,0,0,=,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,pasireotide,2018,,,135652473,Agonist,Full agonist,,f,t,,pIC50,0,9,0,-,0,0,0,=,,,,15477717,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,9.9,0,7.1,,0,0,0,,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,seglitide,2051,,,135652292,Agonist,Full agonist,,f,f,,pKi,10.30000019,0,8.800000191,-,0,0,0,=,,,,8769372,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,SiFA-Asn(AcNH-&beta;-Glc)-PEG-Tyr<sup>3</sup>-octreotate,5634,,,178102263,Agonist,Full agonist,,f,,,pIC50,0,8.48,0,IC50,0,3.3,0,=,,,,21082773,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,SiFA-Asn(AcNH-&beta;-Glc)-Tyr<sup>3</sup>-octreotate,5633,,,178102262,Agonist,Full agonist,,f,,,pIC50,0,8.36,0,IC50,0,4.4,0,=,,,,21082773,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,9.6,0,8.8,,0,0,0,,,,,9600011,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,9600011,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,10.5,0,8.9,,0,0,0,,,,,9784130,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,10.2,0,8.4,,0,0,0,,,,,8769372,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,9600011,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pIC50,9.5,0,9,,0,0,0,,,,,9600011,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,KE 108,2013,,,135652241,Agonist,Partial agonist,,f,,,pEC50,0,7.63,0,EC50,0,23.6,0,=,,,,21493671,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,"L-779,976",2050,,,135650495,Agonist,Partial agonist,,f,,,pEC50,0,9.25,0,EC50,0,0.56,0,=,,,,15855408,NC[C@@H]1CCC[C@H](C1)CNC(=O)[C@@H]([C@H](c1c[nH]c2c1cccc2)C)NC(=O)N1CCC(CC1)n1c(=O)[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,pasireotide,2018,,,135652473,Agonist,Partial agonist,,f,,,pEC50,0,7.63,0,EC50,0,23.3,0,=,,,,21493671,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,DOTA-BASS,5645,,,178102273,Antagonist,Antagonist,,f,,,pIC50,0,8.82,0,IC50,0,1.5,0,=,,,,18543899,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,f,,pKd,8.899999619,0,8.100000381,-,0,0,0,=,,,,12616335,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Ga-NODAGA-LM3,5643,,,178102271,Antagonist,Antagonist,,f,,,pIC50,0,8.89,0,IC50,0,1.3,0,=,,,,21680701,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,KE 108,2013,,,135652241,Antagonist,Antagonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,,,,19910453,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,8.4,0,8.1,,0,0,0,,,,,12616335,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,pasireotide,2018,,,135652473,Antagonist,Antagonist,,f,,,pEC50,0,5,0,EC50,0,10000,0,>,,,,19910453,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,PRL-2915,2066,,,135652410,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9544214,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,PRL-2970,2067,,,135652411,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9544214,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,9.9,0,9.1,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,9.9,0,8.7,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF,2012,,,135652106,Agonist,Full agonist,,f,,,pIC50,8.5,0,8.4,,0,0,0,,,,,15658864,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,KE 108,2013,,,135652241,Agonist,Full agonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,12450568,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,"L-362,823",2072,,,135652246,Agonist,Full agonist,,f,,,pIC50,0,10.1,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,8.3,0,7.6,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"L-363,301",2047,,,135652248,Agonist,Full agonist,,f,,,pKi,7,0,6.3,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"L-796,778",2073,,,135650498,Agonist,Full agonist,,f,f,,pKi,0,7.599999905,0,-,0,0,0,=,,,,9784130,NCCCC[C@@H](C(=O)OC)NC(=O)[C@H](NC(=O)N[C@H](C(=O)Nc1ccc(cc1)[N+](=O)[O-])Cc1ccccc1)CCCC
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pKi,8,0,7.2,,0,0,0,,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,8100350,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,NC 4-28B,2017,,,135652320,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,NC 4-28B,2017,,,135652320,Agonist,Full agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,NC 8-12,2052,,,135652321,Agonist,Full agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,7988476,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,NOC-ATE,2053,,,135652332,Agonist,Full agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,15709181,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,8100350,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,8.6,0,7.4,,0,0,0,,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,pasireotide,2018,,,135652473,Agonist,Full agonist,,f,t,,pIC50,0,8.800000191,0,-,0,0,0,=,,,,15477717,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,7.9,0,6.6,,0,0,0,,,,,8769372,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,8100350,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,0,8.9,0,,0,0,0,,,,,9600011,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,10,0,8.7,,0,0,0,,,,,9784130,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pIC50,0,10.1,0,,0,0,0,,,,,8100350,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,9.9,0,8.1,,0,0,0,,,,,8769372,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pIC50,0,10.2,0,,0,0,0,,,,,8100350,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,0,9.1,0,,0,0,0,,,,,9600011,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.2,,0,0,0,,,,,10818261,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,6.8,0,6.2,,0,0,0,,,,,10818261,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,NVP ACQ090,2076,,,135650751,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,0,COc1ccc(cn1)CC(CN1C[C@@H]2CCCC[C@@H]2[C@@H](C1)C(=O)N1CCN(CC1)c1ccc(c(c1)F)F)C
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,PRL-2915,2066,,,135652410,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9544214,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,PRL-2970,2067,,,135652411,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9544214,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,sst<sub>3</sub>-ODN-8,2077,,,135652477,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,11095748,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,8.8,0,8.6,,0,0,0,,,,,9650799,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,9.6,0,8.5,,0,0,0,,,,,9650799,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF,2012,,,135652106,Agonist,Full agonist,,f,,,pIC50,8.9,0,8.7,,0,0,0,,,,,15658864,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,"H-c[Cys-Phe-LAgl(N<sup>&beta;</sup>Me,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH",2079,,,135652177,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,14667212,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,"H-c[Cys-Phe-LAgl(N<sup>&beta;</sup>Me,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH",2080,,,135652178,Agonist,Full agonist,,f,,,pIC50,8.6,0,8.1,,0,0,0,,,,,14667212,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,"H-c[DCys-Phe-LAgl(N<sup>&beta;</sup>Me,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH",2081,,,135652179,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,14667212,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,KE 108,2013,,,135652241,Agonist,Full agonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,12450568,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,7.3,0,6.8,,0,0,0,,,,,9650799,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,"L-803,087",2082,,,135650501,Agonist,Full agonist,,f,f,,pKi,0,9.199999809,0,-,0,0,0,=,,,,9784130,COC(=O)[C@@H](NC(=O)CCCc1c([nH]c2c1cc(F)cc2F)c1ccccc1)CCCN=C(N)N
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,NNC269100,3513,,,178100498,Agonist,Full agonist,,f,,,pKi,0,8.2,0,Ki,0,6,0,=,,,,9822540,O=C(NCCCc1cnc[nH]1)NCCCN(c1ccc(cn1)Br)Cc1ccc(c(c1)Cl)Cl
SST<sub>4</sub> receptor,358,Sstr4,P30937,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pIC50,0,8.2,0,,0,0,0,,,,,9166718,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,9.3,0,8.4,,0,0,0,,,,,9784130,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,9.2,0,8.1,,0,0,0,,,,,8769372,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,,,pKi,6,0,5.8,,0,0,0,,,,,12616335,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,6.5,0,6.2,,0,0,0,,,,,12616335,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,PRL-2915,2066,,,135652410,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10354394,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,9.7,0,8.4,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,cortistatin-14,2007,Cort|Cort,Mouse|Rat,135651697,Agonist,Full agonist,,t,,,pKi,9.4,0,8.7,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,10.2,0,8.5,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,CST-17,2008,CORT,Human,135651698,Agonist,Full agonist,,t,,,pKi,9.8,0,8.8,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF,2012,,,135652106,Agonist,Full agonist,,f,,,pIC50,8.4,0,8.2,,0,0,0,,,,,15658864,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,KE 108,2013,,,135652241,Agonist,Full agonist,,f,,,pIC50,0,9.2,0,,0,0,0,,,,,12450568,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9600011,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,9.2,0,7.2,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,"L-362,855",2014,,,135652247,Agonist,Full agonist,,f,,,pKi,8.7,0,7.7,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"L-363,301",2047,,,135652248,Agonist,Full agonist,,f,,,pKi,9.5,0,7.2,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,"L-363,301",2047,,,135652248,Agonist,Full agonist,,f,,,pKd,8.3,0,7,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"L-817,818",2016,,,135650502,Agonist,Full agonist,,f,f,,pKi,0,9.399999619,0,-,0,0,0,=,,,,9784130,NCCCC[C@@H](C(=O)OC[C@@H](N)C)NC(=O)Cc1c([nH]c2c1ccc1c2cccc1)c1ccc2c(c1)cccc2
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,lanreotide,2031,,,135652022,Agonist,Full agonist,,f,t,,pKi,9.300000191,0,7.400000095,-,0,0,0,=,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,NOC-ATE,2053,,,135652332,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,15709181,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,9.5,0,7.2,,0,0,0,,,,,8769372,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9600011,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,octreotide,2055,,,135652471,Agonist,Full agonist,,f,,,pKi,9.9,0,7.7,,0,0,0,,,,,10818261,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,pasireotide,2018,,,135652473,Agonist,Full agonist,,f,t,,pIC50,0,9.800000191,0,-,0,0,0,=,,,,15477717,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,10.2,0,6.6,,0,0,0,,,,,8769372,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,8.5,0,6.7,,0,0,0,,,,,10818261,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,seglitide,2051,,,135652292,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9600011,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,9.1,0,7.7,,0,0,0,,,,,10818261,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,9.9,0,8.4,,0,0,0,,,,,9784130,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,SRIF-14,2019,SST|Sst|Sst,Human|Mouse|Rat,135651886,Agonist,Full agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,9600011,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,9.9,0,9.8,,0,0,0,,,,,10818261,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,10.3,0,9.2,,0,0,0,,,,,8769372,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,SRIF-28,2020,SST|Sst|Sst,Human|Mouse|Rat,135651887,Agonist,Full agonist,,t,,,pKi,0,9,0,,0,0,0,,,,,9600011,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,,,pKi,8,0,6.4,,0,0,0,,,,,12616335,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[D-Tyr<sup>8</sup>]CYN 154806,2028,,,135652136,Antagonist,Antagonist,,f,,,pKi,7.5,0,6.6,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.2,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[L-Tyr<sup>8</sup>]CYN 154806,2029,,,135652271,Antagonist,Antagonist,,f,,,pKi,9.1,0,7.3,,0,0,0,,,,,12616335,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,PRL-2915,2066,,,135652410,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,10354394,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,PRL-2970,2067,,,135652411,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10354394,
STE20 like kinase,2200,SLK,Q9H2G2,,,,,,Human,danusertib,7937,,,249565620,Inhibitor,Inhibition,,f,f,,pIC50,0,6.210000038,0,IC50,0,621,0,=,,,,17125279,CO[C@@H](C(=O)N1Cc2c(C1)[nH]nc2NC(=O)c1ccc(cc1)N1CCN(CC1)C)c1ccccc1
STE20 like kinase,2200,SLK,Q9H2G2,,,,,,Human,RN486,8249,,,249565929,Inhibitor,Inhibition,,f,f,,pKd,0,7.369999886,0,Kd,0,43,0,=,,,,22228807,OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1cc(Nc2ccc(cn2)N2CCN(CC2)C)c(=O)n(c1)C
steroid 5 alpha-reductase 2,2633,SRD5A2,P31213,,,,,,Human,finasteride,6818,,,178103424,Inhibitor,Inhibition,,f,t,,pIC50,0,7.840000153,0,IC50,0,14.60000038,0,=,,,,3783591,O=C1C=C[C@]2([C@H](N1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)NC(C)(C)C)C)C
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,"<i>cis</i>-1,2-cyclopropanedicarboxylic acid",9632,,,340590262,Agonist,Full agonist,,f,f,,pEC50,0,4.309999943,0,EC50,0,49000,0,=,,,,28160606,OC(=O)[C@@H]1C[C@@H]1C(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,<i>cis</i>-epoxysuccinic acid,9631,,,340590261,Agonist,Full agonist,,f,f,,pEC50,0,5.570000172,0,EC50,0,2700,0,=,,,,28160606,OC(=O)[C@@H]1O[C@@H]1C(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,maleic acid,9630,,,340590260,Agonist,Full agonist,,f,f,,pEC50,0,4.03000021,0,EC50,0,94000,0,=,,,,26386312,OC(=O)/C=CC(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,maleic acid,9630,,,340590260,Agonist,Full agonist,,f,f,,pEC50,0,4.239999771,0,EC50,0,57000,0,=,,,,28160606,OC(=O)/C=CC(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,maleic acid,9630,,,340590260,Agonist,Full agonist,,f,f,,pEC50,0,3.869999886,0,EC50,0,134000,0,=,,,,15141213,OC(=O)/C=CC(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,methylmalonic acid,9633,,,340590263,Agonist,Full agonist,,f,f,,pEC50,0,3.549999952,0,EC50,0,284000,0,=,,,,15141213,CC(C(=O)O)C(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,methylmalonic acid,9633,,,340590263,Agonist,Full agonist,,f,f,,pEC50,0,3.769999981,0,EC50,0,169000,0,=,,,,28160606,CC(C(=O)O)C(=O)O
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,(S)-chlorosuccinic acid,9634,,,340590264,Agonist,Full agonist,,f,f,,pEC50,0,4.139999866,0,EC50,0,72000,0,=,,,,28160606,OC(=O)C[C@@H](C(=O)O)Cl
"SUMO peptidase family member, NEDD8 specific",2417,SENP8,Q96LD8,,,,,,Human,ST074946,6539,,,178103153,Inhibitor,Inhibition,,f,,,pIC50,0,7.8,0,IC50,0,17.3,0,=,,,,0,N#Cc1c(N)n(nc2c1=CC(C)(C)OC2)c1ccccc1
suppression of tumorigenicity 14,2418,ST14,Q9Y5Y6,,,,,,Human,"inhibitor 1 [Colombo <i>et al.</i>, 2012]",8624,,,252166825,Inhibitor,Inhibition,,f,t,,pKi,0,10.96000004,0,Ki,0,0.011,0,=,,,,0,NC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)c1nc2c(s1)cccc2)CCCN=C(N)N)C)NC(=O)[C@H](CCCN=C(N)N)N
"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",2740,SMARCA4,P51532,,,,,,Human,PFI-3,7915,,,249565598,Inhibitor,Binding,,f,t,,pKd,0,7.050000191,0,Kd,0,89,0,=,,,,0,O=C(c1ccccc1O)/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1
synaptic vesicle glycoprotein 2A,2634,Sv2a,Q02563,,,,,,Rat,levetiracetam,6826,,,178103432,Inhibitor,Inhibition,,f,t,,pKi,0,5.800000191,0,Ki,0,1580,0,=,,,,8605950,CC[C@H](N1CCCC1=O)C(=O)N
synaptic vesicle glycoprotein 2A,2634,Sv2a,Q02563,,,,,,Rat,levetiracetam,6826,,,178103432,Inhibitor,Inhibition,,f,t,,pIC50,0,6.099999905,0,IC50,0,794,0,=,"<i>In vitro</i> inhibitory activity against [<sup>3</sup>H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding site, in rat brain homogenate",,,14736235,CC[C@H](N1CCCC1=O)C(=O)N
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,MPI-0485520,9580,,,336446966,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,Using a Kinase Hotspot&reg; assay.,,,0,N#Cc1cc(ccc1N1CCCC1)c1ccnc(n1)Nc1ccc2c(c1)CC(=O)N2
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,MRT67307,8062,,,249565742,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,21138416,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1cccc(c1)CN1CCOCC1
TANK binding kinase 1,2237,TBK1,Q9UHD2,,,,,,Human,SR8185,9578,,,336446964,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,In an enzyme assay.,,,24150799,N#Cc1cc(ccc1N1CCCC1)c1ccnc(n1)Nc1cccc(c1)NC(=O)N1CCCC1
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,dexamfetamine,2147,,,135650979,Agonist,Full agonist,,f,,,pEC50,6.9,0,6,-,0,0,0,=,,,,18524885,C[C@@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,dexamfetamine,2147,,,135650979,Agonist,Full agonist,,f,,,pEC50,8.7,0,6.7,,0,0,0,,,,,17218486,C[C@@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,dexamfetamine,2147,,,135650979,Agonist,Full agonist,,f,,,pEC50,6.4,0,6.1,,0,0,0,,,,,17218486,C[C@@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,octopamine,2149,,,135651529,Agonist,Full agonist,,f,,,pEC50,5.8,0,4.8,-,0,0,0,=,,,,11459929,NCC(c1ccc(cc1)O)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,octopamine,2149,,,135651529,Agonist,Full agonist,,f,,,pEC50,0,5.9,0,,0,0,0,,,,,11723224,NCC(c1ccc(cc1)O)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,octopamine,2149,,,135651529,Agonist,Full agonist,,f,,,pEC50,5.8,0,5.4,-,0,0,0,=,,,,17212650,NCC(c1ccc(cc1)O)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,R(-)amphetamine,2146,,,135650886,Agonist,Full agonist,,f,,,pEC50,7.2,0,5.3,,0,0,0,,,,,17218486,C[C@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,R(-)amphetamine,2146,,,135650886,Agonist,Full agonist,,f,,,pEC50,0,6.6,0,,0,0,0,,,,,18524885,C[C@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,R(-)amphetamine,2146,,,135650886,Agonist,Full agonist,,f,,,pEC50,0,6.2,0,EC50,0,600,0,=,,,,22037049,C[C@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,RO5166017,5862,,,178102486,Agonist,Full agonist,,f,,,pKi,0,8.6,0,Ki,0,2.7,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,RO5166017,5862,,,178102486,Agonist,Full agonist,,f,,,pKi,0,7.5,0,Ki,0,31,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,RO5166017,5862,,,178102486,Agonist,Full agonist,,f,,,pEC50,0,7.9,0,EC50,0,14,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,RO5166017,5862,,,178102486,Agonist,Full agonist,,f,f,,pEC50,0,7.300000191,0,EC50,0,55,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,R(-)amphetamine,2146,,,135650886,Agonist,Partial agonist,,f,,,pEC50,6.7,0,6.5,,0,0,0,,,,,17218486,C[C@H](Cc1ccccc1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,RO5166017,5862,,,178102486,Agonist,Partial agonist,,f,,,pKi,0,8.7,0,Ki,0,1.9,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,RO5166017,5862,,,178102486,Agonist,Partial agonist,,f,,,pEC50,0,8.5,0,EC50,0,3.3,0,=,,,,21525407,CCN(c1ccccc1)C[C@H]1COC(=N1)N
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,EPPTB,5457,,,178102107,Antagonist,Inverse agonist,,f,,,pIC50,0,5.4,0,IC50,0,4500,0,=,,,,19892733,CCOc1cccc(c1)NC(=O)c1ccc(c(c1)C(F)(F)F)N1CCCC1
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,EPPTB,5457,,,178102107,Antagonist,Inverse agonist,,f,,,pKi,0,6,0,Ki,0,942,0,=,,,,19892733,CCOc1cccc(c1)NC(=O)c1ccc(c(c1)C(F)(F)F)N1CCCC1
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,EPPTB,5457,,,178102107,Antagonist,Inverse agonist,,f,,,pIC50,0,7.7,0,IC50,0,19,0,=,,,,19892733,CCOc1cccc(c1)NC(=O)c1ccc(c(c1)C(F)(F)F)N1CCCC1
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,EPPTB,5457,,,178102107,Antagonist,Inverse agonist,,f,,,pKi,0,9,0,Ki,0,0.9,0,=,,,,21237643,CCOc1cccc(c1)NC(=O)c1ccc(c(c1)C(F)(F)F)N1CCCC1
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,EPPTB,5457,,,178102107,Antagonist,Inverse agonist,,f,f,,pIC50,0,5.099999905,0,IC50,0,7487,0,=,,,,19892733,CCOc1cccc(c1)NC(=O)c1ccc(c(c1)C(F)(F)F)N1CCCC1
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
tec protein tyrosine kinase,2238,TEC,P42680,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,f,,pIC50,0,8.479999542,0,IC50,0,3.299999952,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
TEK receptor tyrosine kinase,1842,TEK,Q02763,,,,,,Human,linifanib,5657,,,178102285,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,16648571,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2
Testicular receptor 4,614,NR2C2,P49116,,,,,,Human,retinol,4053,,,178100877,Agonist,Full agonist,,t,f,,pEC50,0,4.710000038,0,EC50,0,19400,0,=,,,,21068381,OC/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)C)C
Thrombopoietin receptor,1722,MPL,P40238,,,,,,Human,eltrombopag,6961,,,178103542,Agonist,Agonist,,f,t,,pEC50,0,7.420000076,0,EC50,0,38,0,=,,,,18783949,OC(=O)c1cccc(c1)c1cccc(c1O)N/N=C1/C(=NN(C1=O)c1ccc(c(c1)C)C)C
Thrombopoietin receptor,1722,MPL,P40238,,,,,,Human,romiplostim,6974,,,178103553,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
thymidylate synthetase,2642,Tyms,P07607,,,,,,Mouse,ONX-0801,9590,,,340590221,Inhibitor,Inhibition,,f,f,,pKi,0,8.920000076,0,Ki,0,1.200000048,0,=,Thymidylate synthase isolated from mouse L1210 lymphocytic leukemia cells.,,,16357184,C#CCN([C@H]1CCc2c1cc1c(=O)nc([nH]c1c2)CO)c1ccc(cc1)C(=O)N[C@H](C(=O)O)CCC(=O)N[C@@H](C(=O)O)CCC(=O)O
thymidylate synthetase,2642,TYMS,P04818,,,,,,Human,pemetrexed,6837,,,178103443,Inhibitor,Inhibition,,f,f,,pKi,0,6.960000038,0,Ki,0,109,0,=,,,,9762351,OC(=O)CC[C@H](C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)nc([nH]2)N
thymidylate synthetase,2642,Tyms,P07607,,,,,,Mouse,plevitrexed,8278,,,252166490,Inhibitor,Inhibition,,f,f,,pKi,0,9.359999657,0,Ki,0,0.439999998,0,=,Measured using partially purified thymidylate synthase from mouse L1210 leukemia cells.,,,10508430,C#CCN(c1ccc(c(c1)F)C(=O)N[C@H](C(=O)O)CCc1n[nH]nn1)Cc1cc2c(=O)nc([nH]c2cc1C)C
thymidylate synthetase,2642,Tyms,P07607,,,,,,Mouse,raltitrexed,7403,,,178103975,Inhibitor,Inhibition,,f,f,,pKi,0,6.380000114,0,Ki,0,418,0,=,,,,1372358,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(s1)N(Cc1ccc2c(c1)c(=O)nc([nH]2)C)C
thymidylate synthetase,2642,TYMS,P04818,,,,,,Human,raltitrexed,7403,,,178103975,Inhibitor,Inhibition,,f,t,,pIC50,0,6.539999962,0,IC50,0,290,0,=,,,,22739090,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(s1)N(Cc1ccc2c(c1)c(=O)nc([nH]2)C)C
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,dextrothyroxine,6951,,,178103533,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,6777394,OC(=O)[C@@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,KB-141,2638,,,135650452,Agonist,Agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,12699376,OC(=O)Cc1cc(Cl)c(c(c1)Cl)Oc1ccc(c(c1)C(C)C)O
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,rT<sub>3</sub>,2636,,,135650897,Agonist,Agonist,,f,,,pIC50,0,0,0,-,0,0,0,=,,,,2158622,OC(=O)C(Cc1ccc(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,sobetirome,2639,,,135650297,Agonist,Agonist,,f,,,pKd,0,9.36,0,,0,0,0,,,,,2158622,OC(=O)COc1cc(C)c(c(c1)C)Cc1ccc(c(c1)C(C)C)O
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,NH-3,2633,,,135650713,Antagonist,Antagonist,,f,,,pKd,0,7.62,0,,0,0,0,,,,,12109914,OC(=O)COc1cc(C)c(c(c1)C)Cc1cc(C(C)C)c(c(c1)C#Cc1ccc(cc1)[N+](=O)[O-])O
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,dextrothyroxine,6951,,,178103533,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,6777394,OC(=O)[C@@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,KB-141,2638,,,135650452,Agonist,Agonist,,f,,,pIC50,0,8.96,0,,0,0,0,,,,,12888625,OC(=O)Cc1cc(Cl)c(c(c1)Cl)Oc1ccc(c(c1)C(C)C)O
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,rT<sub>3</sub>,2636,,,135650897,Agonist,Agonist,,f,,,pKd,0,7.34,0,,0,0,0,,,,,2158622,OC(=O)C(Cc1ccc(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,sobetirome,2639,,,135650297,Agonist,Agonist,,f,,,pKd,0,10.17,0,-,0,0,0,=,,,,269396,OC(=O)COc1cc(C)c(c(c1)C)Cc1ccc(c(c1)C(C)C)O
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,NH-3,2633,,,135650713,Antagonist,Antagonist,,f,,,pKd,0,7.03,0,,0,0,0,,,,,12109914,OC(=O)COc1cc(C)c(c(c1)C)Cc1cc(C(C)C)c(c(c1)C#Cc1ccc(cc1)[N+](=O)[O-])O
thyroid peroxidase,2526,TPO,P07202,,,,,,Human,methimazole,6649,,,178103262,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,748042,Cn1ccnc1S
thyroid peroxidase,2526,TPO,P07202,,,,,,Human,propylthiouracil,6650,,,178103263,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,748042,CCCc1cc(=O)[nH]c(=S)[nH]1
TLR2,1752,Tlr2,Q9QUN7,,,,,,Mouse,defoslimod,9024,,,315661109,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,17383632,CCCCCCCCCCC[C@H](CC(=O)N[C@H]1[C@H](O[C@@H]([C@H]([C@@H]1O)O)CO[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1NC(=O)C[C@@H](OC(=O)CCCCCCCCCCC)CCCCCCCCCCC)O)OP(=O)(O)O)OP(=O)(O)O)O
TLR2,1752,TLR2,O60603,,,,,,Human,peptidoglycan,5044,,,178101739,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,10364168,
TLR2,1752,Tlr2,Q9QUN7,,,,,,Mouse,OPN305,9408,,,328083510,Antibody,Binding,,f,f,,pKd,0,7.920000076,0,Kd,0,11.89999962,0,=,In a BIACORE surface plasmon resonance (SPR) assay.,,,0,
TLR2,1752,TLR2,O60603,,,,,,Human,OPN305,9408,,,328083510,Antibody,Binding,,f,t,,pKd,0,7.539999962,0,Kd,0,28.89999962,0,=,In a BIACORE surface plasmon resonance (SPR) assay.,,,0,
TLR3,1753,TLR3,O15455,,,,,,Human,poly(I:C),5047,,,178101742,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,11607032,OC1C(O)C(OC1n1cnc2c1[nH]cnc2=O)COP(=O)(O)O.Nc1ccn(c(=O)n1)C1OC(C(C1O)O)COP(=O)(O)O
TLR4,1754,Tlr4,Q9QUK6,,,,,,Mouse,defoslimod,9024,,,315661109,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,17383632,CCCCCCCCCCC[C@H](CC(=O)N[C@H]1[C@H](O[C@@H]([C@H]([C@@H]1O)O)CO[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1NC(=O)C[C@@H](OC(=O)CCCCCCCCCCC)CCCCCCCCCCC)O)OP(=O)(O)O)OP(=O)(O)O)O
TLR4,1754,TLR4,O00206,,,,,,Human,LPS,5019,,,178101716,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,9851930,
TLR4,1754,TLR4,O00206,,,,,,Human,neoceptin-3,9137,,,315661222,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,26831104,O=C([C@@H](NC(=O)c1ccc(c(c1)CCc1ccc(cc1)O)N)CCc1ccccc1)OC(C)(C)C
TLR4,1754,Tlr4,Q9QUK6,,,,,,Mouse,paclitaxel,2770,,,135652721,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,10644670,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)c1ccccc1)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
TLR4,1754,TLR4,O00206,,,,,,Human,resatorvid,9036,,,315661121,Antagonist,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,16373689,CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(cc1Cl)F
TLR5,1755,TLR5,O60602,,,,,,Human,flagellin,4931,,,178101629,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,Measuring TLR5 activation using a NF-kappaB luciferase reporter system in CHO cells.,,,11323673,
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,GSK2245035,9254,,,315661329,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,26861551,CCC[C@@H](Oc1nc(N)c2c(n1)n(CCCCCN1CCCCC1)c(=O)[nH]2)C
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,imiquimod,5003,,,178101700,Agonist,Agonist,,f,t,,pEC50,0,4.940000057,0,EC50,0,11400,0,=,,,,0,CC(Cn1cnc2c1c1ccccc1nc2N)C
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,loxoribine,5018,,,178101715,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,14579267,C=CCn1c(=O)n(c2c1c(=O)nc([nH]2)N)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,resiquimod,5051,,,178101746,Agonist,Agonist,,f,f,,pEC50,0,5.869999886,0,EC50,0,1340,0,=,,,,11812998,CCOCc1nc2c(n1CC(O)(C)C)c1ccccc1nc2N
TLR7,1757,TLR7,Q9NYK1,,,,,,Human,hydroxychloroquine,7198,,,178103773,Antagonist,Antagonist,,f,t,,pIC50,0,5.559999943,0,IC50,0,2780,0,=,Inhibition of hTLR7 R848-induced luciferase reporter gene activation.,,,24342772,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC
TLR8,1758,TLR8,Q9NR97,,,,,,Human,motolimod,9026,,,315661111,Agonist,Agonist,,f,f,,pEC50,0,7,0,EC50,0,100,0,~,,,,22128302,CCCN(C(=O)C1=Cc2ccc(cc2N=C(C1)N)c1ccc(cc1)C(=O)N1CCCC1)CCC
TLR8,1758,TLR8,Q9NR97,,,,,,Human,resiquimod,5051,,,178101746,Agonist,Agonist,,f,f,,pEC50,0,5.210000038,0,EC50,0,6130,0,=,,,,11812998,CCOCc1nc2c(n1CC(O)(C)C)c1ccccc1nc2N
TLR8,1758,TLR8,Q9NR97,,,,,,Human,CU-CPT8m,9795,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.170000076,0,IC50,0,67,0,=,,,,29155428,Cc1cccc(c1)c1ccnc2n1ncc2C(=O)N
TLR8,1758,TLR8,Q9NR97,,,,,,Human,CU-CPT8m,9795,,,0,Inhibitor,Inhibition,,f,f,,pKd,0,6.659999847,0,Kd,0,220,0,=,Dissociation constant measured using isothermal titration calorimetry (ITC) and the hTRL8 ectodomain.,,,29155428,Cc1cccc(c1)c1ccnc2n1ncc2C(=O)N
TLR9,1759,TLR9,Q9NR96,,,,,,Human,hydroxychloroquine,7198,,,178103773,Antagonist,Antagonist,,f,t,,pIC50,0,7.099999905,0,IC50,0,80,0,=,Inhibition of hTLR9 CpG2006-induced luciferase reporter gene activation.,,,24342772,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC
TNF receptor associated protein 1,2909,TRAP1,Q12931,,,,,,Human,luminespib,9261,,,315661336,Inhibitor,Inhibition,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,0,CCNC(=O)c1noc(c1c1ccc(cc1)CN1CCOCC1)c1cc(C(C)C)c(cc1O)O
toxicity and JNK inducer,1891,,,,,,,,None,lymphotoxin-&alpha;,5064,LTA,Human,178101757,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
TPC1,392,TPCN1,Q9ULQ1,,,,,,Human,"phosphatidyl (3,5) inositol bisphosphate",2794,,,178100233,Activator,Activation,,f,f,,pEC50,0,6.519999981,0,EC50,0,300,0,=,,,,24776928,CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(=O)(OC1[C@H](O)[C@H](OP(=O)(O)O)C([C@@H]([C@H]1O)OP(=O)(O)O)O)O
TPC2,393,TPCN2,Q8NHX9,,,,,,Human,"phosphatidyl (3,5) inositol bisphosphate",2794,,,178100233,Activator,Activation,,f,f,,pEC50,0,6.400000095,0,EC50,0,400,0,=,,,,23063126,CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(=O)(OC1[C@H](O)[C@H](OP(=O)(O)O)C([C@@H]([C@H]1O)OP(=O)(O)O)O)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,I-BOP,1938,,,135650364,Agonist,Agonist,,f,f,,pKd,9.319999695,0,8.93999958,Kd,1.159999967,0,0.479999989,=,,,,1830308,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,STA<sub>2</sub>,1939,,,135651090,Agonist,Agonist,,f,f,,pIC50,7.059999943,0,6.380000114,IC50,420,0,87,=,,,,8242228,CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=CCCCC(=O)O)S2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,EP 171,1971,,,135650233,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,2743082,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@@H](COc1ccc(cc1)F)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,fluprostenol,1940,,,135650277,Agonist,Full agonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,10634944,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,I-BOP,1938,,,135650364,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,iloprost,1895,,,135650378,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,10634944,CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C
TP receptor,346,TBXA2R,P21731,,,,,,Human,MB-28767,1913,,,135650568,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,10634944,OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O
TP receptor,346,TBXA2R,P21731,,,,,,Human,PGE<sub>2</sub>,1883,,,135651539,Agonist,Full agonist,,t,,,pKi,0,4.5,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,PGF<sub>2&alpha;</sub>,1884,,,135651540,Agonist,Full agonist,,t,,,pKi,0,5.1,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
TP receptor,346,Tbxa2r,P34978,,,,,,Rat,SQ 26655,6070,,,178102691,Agonist,Full agonist,,f,,,pEC50,0,9.05,0,EC50,0,0.9,0,=,,,,4067988,CCCCC[C@@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O2)O
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,STA<sub>2</sub>,1939,,,135651090,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9313928,CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=CCCCC(=O)O)S2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,daltroban,1986,,,135650157,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,1434130,OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,domitroban,1979,,,135650957,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9313928,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2
TP receptor,346,TBXA2R,P21731,,,,,,Human,domitroban,1979,,,135650957,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,1833018,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2
TP receptor,346,TBXA2R,P21731,,,,,,Human,ICI 192605,6072,,,178102693,Antagonist,Antagonist,,f,,,pIC50,0,7.19,0,IC50,0,65,0,=,,,,8859002,OC(=O)CC/C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl
TP receptor,346,TBXA2R,P21731,,,,,,Human,ifetroban,1987,,,135650374,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,8.050000191,Ki,9,0,4,=,,,,8437108,CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,I-SAP,3332,,,178100363,Antagonist,Antagonist,,f,,,pKd,0,9.33,0,Kd,0,0.47,0,=,,,,1386885,OC(=O)CCC/C=CC[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)I
TP receptor,346,TBXA2R,P21731,,,,,,Human,KW-3635,1977,,,135650460,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,1434130,[O-]C(=O)c1ccc2c(c1)/C(=C/Cn1cnc3c1cc(C)c(c3)C)/c1ccccc1CO2
TP receptor,346,TBXA2R,P21731,,,,,,Human,ONO-3708,1978,,,135650763,Antagonist,Antagonist,,f,f,,pKi,8.899999619,0,7.400000095,Ki,39.79999924,0,1.25999999,=,,,,3008368,OC(=O)CCC/C=CC[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C
TP receptor,346,TBXA2R,P21731,,,,,,Human,ONO-8711,1920,,,135650765,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,10537280,OC(=O)CCC/C=C[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2
TP receptor,346,TBXA2R,P21731,,,,,,Human,PBT-3,9755,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,5.920000076,0,IC50,0,1200,0,=,Antagonism of TPbeta (long) isoform expressed in COS7 cells.,,,14560042,CCCCC/C=CCC(C(C1CC1)[C@H](/C=CC/C=CCCCC(=O)OC)O)C1CC1
TP receptor,346,TBXA2R,P21731,,,,,,Human,PBT-3,9755,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,Antagonism of TPalpha (short) isoform expressed in COS7 cells.,,,14560042,CCCCC/C=CCC(C(C1CC1)[C@H](/C=CC/C=CCCCC(=O)OC)O)C1CC1
TP receptor,346,TBXA2R,P21731,,,,,,Human,ramatroban,1911,,,135650884,Antagonist,Antagonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,1387312,OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
TP receptor,346,TBXA2R,P21731,,,,,,Human,S-5751,1898,,,135650972,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11454901,OC(=O)CCC/C=CC[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,SQ-29548,1980,,,135651068,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9313928,O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=CCCCC(=O)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,SQ-29548,1980,,,135651068,Antagonist,Antagonist,,f,f,,pKi,9.100000381,0,8.100000381,-,0,0,0,=,,,,16604093,O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=CCCCC(=O)O)O2
TRAF2 and NCK interacting kinase,2244,TNIK,Q9UKE5,,,,,,Human,staurosporine,346,,,135652717,Inhibitor,Inhibition,,f,f,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,23232060,CN[C@@H]1C[C@H]2O[C@]([C@@H]1OC)(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,<i>H. polygyrus</i> TGF-&beta; mimic,9713,,,348353672,Agonist,Agonist,,f,f,,pKd,0,6.460000038,0,Kd,0,350,0,=,Measured using a SPR assay and immobilised ligand.,,,29170498,
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,galunisertib,7797,,,223366128,Inhibitor,Inhibition,,f,t,,pIC50,0,7.25,0,IC50,0,56,0,=,Inhibition of a 6~-HIS tagged cytoplasmic kinase domain representing TGF&beta;R1,,,0,Cc1cccc(n1)c1nn2c(c1c1ccnc3c1cc(cc3)C(=O)N)CCC2
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,LDN-214117,8481,,,252166689,Inhibitor,Inhibition,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,25101911,COc1cc(cc(c1OC)OC)c1cc(cnc1C)c1ccc(cc1)N1CCNCC1
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,LY2109761,8075,,,249565755,Inhibitor,Inhibition,,f,t,,pKi,0,7.420000076,0,Ki,0,38,0,=,,,,18413796,O1CCN(CC1)CCOc1ccc2c(c1)nccc2c1c2CCCn2nc1c1ccccn1
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,SB-431542,8216,,,249565896,Inhibitor,Inhibition,,f,t,,pIC50,0,7.03000021,0,IC50,0,94,0,=,Inhibition of TGFBR1-induced Smad3 phosphorylation <i>in vitro</i>.,,,11855979,NC(=O)c1ccc(cc1)c1[nH]c(c(n1)c1ccccn1)c1ccc2c(c1)OCO2
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,SD-208,8246,,,249565926,Inhibitor,Inhibition,,f,t,,pIC50,0,7.28000021,0,IC50,0,53,0,=,,,,17289388,Clc1ccc(c(c1)c1nc(Nc2ccncc2)c2c(n1)nccn2)F
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,<i>H. polygyrus</i> TGF-&beta; mimic,9713,,,348353672,Agonist,Agonist,,f,f,,pKd,0,5.53000021,0,Kd,0,2960,0,=,Measured using a SPR assay and immobilised ligand.,,,29170498,
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,LY2109761,8075,,,249565755,Inhibitor,Inhibition,,f,f,,pKi,0,6.519999981,0,Ki,0,300,0,=,,,,18413796,O1CCN(CC1)CCOc1ccc2c(c1)nccc2c1c2CCCn2nc1c1ccccn1
Translocator protein,2879,Tspo,P16257,,,,,,Rat,emapunil,8704,,,252166904,Agonist,Agonist,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,19217778,CCN(C(=O)Cn1c2nc(ncc2n(c1=O)C)c1ccccc1)Cc1ccccc1
Translocator protein,2879,TSPO,P30536,,,,,,Human,PK 11195,8703,,,252166903,None,Binding,,f,f,,pKi,0,8.149999619,0,Ki,0,7.110000134,0,=,,,,21741237,CCC(N(C(=O)c1cc2ccccc2c(n1)c1ccccc1Cl)C)C
transmembrane serine protease 11D,2420,TMPRSS11D,O60235,,,,,,Human,"inhibitor 1 [Colombo <i>et al.</i>, 2012]",8624,,,252166825,Inhibitor,Inhibition,,f,f,,pKi,0,8.079999924,0,Ki,0,8.399999619,0,=,,,,0,NC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)c1nc2c(s1)cccc2)CCCN=C(N)N)C)NC(=O)[C@H](CCCN=C(N)N)N
transmembrane serine protease 6,2422,TMPRSS6,Q8IU80,,,,,,Human,"inhibitor 1 [Colombo <i>et al.</i>, 2012]",8624,,,252166825,Inhibitor,Inhibition,,f,f,,pKi,0,8.479999542,0,Ki,0,3.299999952,0,=,,,,0,NC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)c1nc2c(s1)cccc2)CCCN=C(N)N)C)NC(=O)[C@H](CCCN=C(N)N)N
TRH<sub>1</sub> receptor,363,TRHR,P34981,,,,,,Human,MeTRH,2137,,,135650600,Agonist,Partial agonist,,f,,,pKi,0,8.5,0,-,0,0,0,=,,,,5001013,O=C(N1CCC[C@H]1C(=O)N)[C@@H](NC(=O)[C@@H]1CCC(=O)N1C)Cc1[nH]cnc1
TRH<sub>1</sub> receptor,363,Trhr,Q01717,,,,,,Rat,diazepam,3364,,,178100389,Antagonist,Antagonist,,f,,,pKi,0,5.15,0,Ki,0,7100,0,=,,,,2566295,Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1
TRH<sub>1</sub> receptor,363,Trhr,Q01717,,,,,,Rat,midazolam,3342,,,178100372,Antagonist,Antagonist,,f,f,,pKi,0,5.489999771,0,Ki,0,3200,0,=,,,,2566295,Clc1ccc2c(c1)C(=NCc1n2c(C)nc1)c1ccccc1F
TRH<sub>2</sub> receptor,754,Trhr2,,,,,,,Mouse,MeTRH,2137,,,135650600,Agonist,Partial agonist,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,23303050,O=C(N1CCC[C@H]1C(=O)N)[C@@H](NC(=O)[C@@H]1CCC(=O)N1C)Cc1[nH]cnc1
tripeptidyl peptidase 2,2423,TPP2,P29144,,,,,,Human,example 8 [WO1999033801A1],8581,,,252166782,Inhibitor,Inhibition,,f,f,,pKi,0,9.43999958,0,Ki,0,0.360000014,0,=,,,,0,CC[C@@H](C(=O)N1[C@H](Cc2c1cccc2F)C(=O)NCC(F)(F)F)N
tripeptidyl peptidase 2,2423,TPP2,P29144,,,,,,Human,peptide 4 [PMID: 18294843],8582,,,252166783,Inhibitor,Inhibition,,f,f,,pKi,0,7.699999809,0,Ki,0,20,0,=,,,,18294843,NC(=NCCC[C@@H](C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)C(C)C)C)N)N
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,crotylaldehyde,6288,,,178102908,Activator,Activation,,f,,,pEC50,0,4.6,0,-,0,0,0,=,Calcium imaging,,,18568077,C/C=C/C=O
TRPA1,485,TRPA1,O75762,,,,,,Human,Cu<sup>2+</sup>,4164,,,178100984,Activator,Activation,,f,,,pEC50,0,5.89,0,EC50,0,1300,0,=,Sodium imaging,,,19416844,
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,Cu<sup>2+</sup>,4164,,,178100984,Activator,Activation,,f,,,pEC50,0,6.22,0,EC50,0,600,0,=,,,,19416844,
TRPA1,485,TRPA1,O75762,,,,,,Human,dibenzoxazepine,6472,,,178103086,Activator,Activation,,f,,,pEC50,0,7.2,0,-,0,0,0,=,Calcium imaging,,,18501939,c1ccc2c(c1)Oc1ccccc1C=N2
TRPA1,485,TRPA1,O75762,,,,,,Human,dibutyl phthalate,6295,,,178102915,Activator,Activation,,f,,,pEC50,0,4.6,0,-,0,0,0,=,Calcium imaging,,,19135264,CCCCOC(=O)c1ccccc1C(=O)OCCCC
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,docosahexaenoic acid,1051,,,135651477,Activator,Activation,This compound has similar activity at human and mouse TRPA1,t,,,pEC50,0,4.4,0,-,0,0,0,=,Patch clamp,,,22723860,CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)O
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,flufenamic acid,2447,,,135650269,Activator,Activation,,f,,,pEC50,0,3.8,0,-,0,0,0,=,Two electrode voltage clamp,,,19888597,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,formalin,4196,,,178101013,Activator,Activation,covalent. This level of activity is also observed for rat TRPA1,f,f,,pEC50,0,3.400000095,0,EC50,0,398107,0,=,Calcium imaging,,,17686976,C=O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,H<sub>2</sub>O<sub>2</sub>,2448,,,135652736,Activator,Activation,,t,,,pEC50,0,3.6,0,-,0,0,0,=,Calcium imaging,,,18322093,
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,isoflurane,2505,,,53801075,Activator,Activation,,f,,,pEC50,0,3.7,0,-,0,0,0,=,Patch clamp,,,18574153,FC(OC(C(F)(F)F)Cl)F
TRPA1,485,TRPA1,O75762,,,,,,Human,isovelleral,6287,,,178102907,Activator,Activation,This compound is also an activator of mouse TRPA1.,f,,,pEC50,0,6.3,0,-,0,0,0,=,Calcium imaging,,,18550530,O=CC1=C[C@@H]2CC(C[C@@H]2[C@@]2([C@@]1(C=O)C2)C)(C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,methylglyoxal,6303,,,178102922,Activator,Activation,This compound has similar activity at mouse and rat TRPA1,t,,,pEC50,6,0,2.5,-,0,0,0,=,"Calcium imaging, patch clamp",,,22701540,O=CC(=O)C
TRPA1,485,TRPA1,O75762,,,,,,Human,methyl isocyanate,6290,,,178102910,Activator,Activation,This compound also activates mouse TRPA1,f,,,pEC50,0,4.6,0,-,0,0,0,=,Calcium imaging,,,19036859,CN=C=O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,methyl p-hydroxybenzoate,6273,,,178102893,Activator,Activation,,f,,,pEC50,0,2.4,0,-,0,0,0,=,Patch clamp,,,17351650,COC(=O)c1ccc(cc1)O
TRPA1,485,TRPA1,O75762,,,,,,Human,morphanthridine,6473,,,178103087,Activator,Activation,,f,,,pEC50,0,7.1,0,-,0,0,0,=,Patch clamp,,,18501939,c1ccc2c(c1)Cc1ccccc1C=N2
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,MTSEA,6272,,,178102892,Activator,Activation,,f,,,pEC50,0,2.8,0,EC50,0,1580000,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,17237762,CS(=S)(=O)OCCN
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,N-acetyl-4-benzoquinoneimine,6299,,,178102919,Activator,Activation,This compound has similar activity at human and mouse TRPA1,f,,,pEC50,0,5.6,0,-,0,0,0,=,Calcium imaging,,,20720158,O=C1C=CC(=NC(=O)C)C=C1
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,NaHS,6278,,,178102898,Activator,Activation,This compound has similar activity at the human TRPA1,t,,,pEC50,0,2.9,0,-,0,0,0,=,Calcium imaging,,,18031925,[Na]S
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,NH<sub>4</sub>Cl,6289,,,178102909,Activator,Activation,,f,,,pEC50,0,2,0,-,0,0,0,=,Patch clamp,,,19033673,
TRPA1,485,TRPA1,O75762,,,,,,Human,nicotine,2585,,,53801040,Activator,Activation,non-covalent,f,f,,pEC50,0,4.800000191,0,EC50,0,17000,0,=,Patch clamp,,,19749751,CN1CCC[C@H]1c1cccnc1
TRPA1,485,Trpa1,Q6RI86,,,,,,Rat,niflumic acid,2439,,,135650716,Activator,Activation,,f,,,pEC50,0,3.3,0,-,0,0,0,=,Two electrode voltage clamp,,,19888597,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
TRPA1,485,TRPA1,O75762,,,,,,Human,nitrooleic acid,6296,,,178102916,Activator,Activation,This compound has a similar activity at mouse TRPA1,f,,,pEC50,0,5.7,0,-,0,0,0,=,Calcium imaging,,,19171673,CCCCCCCC/C=C(/[N+](=O)[O-])CCCCCCCC(=O)O
TRPA1,485,TRPA1,O75762,,,,,,Human,NPPB,4270,,,178101087,Activator,Activation,,f,,,pEC50,0,6.49,0,-,0,0,0,=,FLIPR calcium influx assay,,,20226176,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
TRPA1,485,TRPA1,O75762,,,,,,Human,oleocanthal,6308,,,178102927,Activator,Activation,,f,,,pEC50,0,5.6,0,-,0,0,0,=,Patch clamp,,,21248124,O=CC[C@H](/C(=CC)/C=O)CC(=O)OCCc1ccc(cc1)O
TRPA1,485,TRPA1,O75762,,,,,,Human,omega-chloroacetophenone,6285,,,178102905,Activator,Activation,,f,,,pEC50,0,6.6,0,-,0,0,0,=,Calcium imaging,,,18501939,ClCC(=O)c1ccccc1
TRPA1,485,TRPA1,O75762,,,,,,Human,O<sub>3</sub>,6297,,,178102917,Activator,Activation,Ozone has similar activity at mouse TRPA1,f,,,pEC50,0,5.5,0,-,0,0,0,=,Calcium imaging,,,20008466,
TRPA1,485,TRPA1,O75762,,,,,,Human,PF-4840154,6309,,,178102928,Activator,Activation,This compound has similar activity at rat and mouse TRPA1,f,,,pEC50,0,7.6,0,-,0,0,0,=,Calcium imaging,,,21741838,CC(CNc1nc(ncc1C(=O)NCc1ccccc1)N1CCN(CC1)CC1CCCOC1)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,prostaglandin A2,6279,,,178102899,Activator,Activation,,t,,,pEC50,0,4.6,0,-,0,0,0,=,Calcium imaging,,,18687886,CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
TRPA1,485,TRPA1,O75762,,,,,,Human,salirasib,6281,,,178102901,Activator,Activation,,t,,,pEC50,0,5.3,0,-,0,0,0,=,FLIPR calcium-influx assay,,,18171730,C/C(=CCSc1ccccc1C(=O)O)/CC/C=C(/CCC=C(C)C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Activator,Agonist,non-covalent,f,f,,pEC50,0,4.900000095,0,EC50,0,12589,0,=,,,,14712238,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,eugenol,2425,,,135650247,Activator,Agonist,,f,,600,-,0,0,0,,0,0,0,,,,,15046718,C=CCc1ccc(c(c1)OC)O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,gingerol,2428,,,135650304,Activator,Agonist,,f,,600,-,0,0,0,,0,0,0,,,,,15046718,CCCCC[C@@H](CC(=O)CCc1ccc(c(c1)OC)O)O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,icilin,2429,,,135650372,Activator,Agonist,non-covalent,f,f,100,-,0,0,0,-,0,0,0,=,,,,12654248,O=C1NC(=CCN1c1ccccc1O)c1cccc(c1)[N+](=O)[O-]
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,methyl salicylate,2431,,,135650594,Activator,Agonist,,f,,600,-,0,0,0,,0,0,0,,,,,15046718,COC(=O)c1ccccc1O
TRPA1,485,TRPA1,O75762,,,,,,Human,(-)-menthol,2430,,,135651519,Activator,Partial agonist,"Menthol is also active at the mouse TRPA1, but becomes inhibitory at &gt;100&micro;M",f,f,,pEC50,4.5,0,4,EC50,95000,0,28400,=,"Calcium imaging, patch clamp",,,18815250,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,15843607,
TRPA1,485,TRPA1,O75762,,,,,,Human,HC030031,4211,,,178101028,Channel blocker,Inhibition,,f,,,pIC50,0,5.2,0,IC50,0,6200,0,=,Calcium imaging,,,17686976,O=C(Cn1cnc2c1c(=O)n(C)c(=O)n2C)Nc1ccc(cc1)C(C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,f,,pIC50,0,5.5,0,IC50,0,3550,0,=,,,,15843607,
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,gentamicin,2427,,,135650301,Gating inhibitor,Antagonist,,f,,,pIC50,0,5.2,0,,0,0,0,,,,,15843607,CNC(C1CCC(C(O1)OC1C(N)CC(C(C1O)OC1OCC(C(C1O)NC)(C)O)N)N)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,(-)-menthol,2430,,,135651519,Gating inhibitor,Antagonist,,f,,,pIC50,0,4.2,0,,0,0,0,,,,,16829128,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPA1,485,TRPA1,O75762,,,,,,Human,HC030031,4211,,,178101028,Gating inhibitor,Inhibition,,f,,,pIC50,0,5.2,0,-,0,0,0,=,Calcium imaging,,,17686976,O=C(Cn1cnc2c1c(=O)n(C)c(=O)n2C)Nc1ccc(cc1)C(C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,isopentenyl diphosphate,3048,,,135651495,Gating inhibitor,Inhibition,,t,,,pIC50,0,5.1,0,-,0,0,0,=,Calcium imaging,,,20880407,CC(=C)CCOP(=O)(OP(=O)(O)O)O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,resolvin D1,3934,,,178100762,Gating inhibitor,Inhibition,,t,,,pIC50,0,7.2,0,-,0,0,0,=,"Calcium imaging, patch clamp",,,22171045,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@@H]([C@H](C/C=CCCC(=O)O)O)O)O
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,resolvin D2,5417,,,178102070,Gating inhibitor,Inhibition,,t,,,pIC50,0,8.7,0,-,0,0,0,=,Patch-clamp,,,22171045,CC/C=CC[C@@H](C(/C=C/C=C/C=CC=C[C@@H](C/C=CCCC(=O)O)O)O)O
TRPC1,486,TRPC1,P48995,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,f,20,-,0,0,0,-,0,0,0,=,,,,8663995,
TRPC1,486,TRPC1,P48995,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,11301024,
TRPC1,486,TRPC1,P48995,,,,,,Human,GsMTx-4,4206,,,178101023,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC1,486,TRPC1,P48995,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPC2,487,Trpc2,Q9R244,,,,,,Mouse,DOG,2435,,,135651479,Activator,Agonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,14642279,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)CO
TRPC2,487,Trpc2,Q9R244,,,,,,Mouse,OAG,2436,,,135651528,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,14642279,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(OC(=O)C)CO
TRPC2,487,Trpc2,Q9R244,,,,,,Mouse,SAG,2437,,,135651559,Activator,Agonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,14642279,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCC/C=CC/C=CC/C=CC/C=CCCCCC)CO
TRPC3,488,TRPC3,Q13507,,,,,,Human,OAG,2436,,,135651528,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,9930701,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(OC(=O)C)CO
TRPC3,488,TRPC3,Q13507,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,f,,pEC50,0,7,0,EC50,0,100,0,=,,,,10970899,
TRPC3,488,TRPC3,Q13507,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,10970899,
TRPC3,488,TRPC3,Q13507,,,,,,Human,KB-R7943,4232,,,178101049,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CS(=O)(=O)O.NC(=N)SCCc1ccc(cc1)OCc1ccc(cc1)[N+](=O)[O-]
TRPC3,488,TRPC3,Q13507,,,,,,Human,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC3,488,TRPC3,Q13507,,,,,,Human,Pyr3,4293,,,178101110,Channel blocker,None,,f,f,,pIC50,0,6.150000095,0,IC50,0,700,0,=,,,,19289841,CCOC(=O)c1cnn(c1C(F)(F)F)c1ccc(cc1)NC(=O)C(=C(Cl)Cl)Cl
TRPC3,488,TRPC3,Q13507,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Activator,None,&mu;M range,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,(-)-englerin A,8372,,,252166584,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,25707820,OCC(=O)O[C@@H]1C[C@@]2(O[C@@]1(C)[C@@H]1CC[C@H]([C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1)C)C(C)C
TRPC4,489,Trpc4,Q9QUQ5,,,,,,Mouse,niflumic acid,2439,,,135650716,Channel blocker,Antagonist,,f,f,30,-,0,0,0,-,0,0,0,=,,,,12388058,OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
TRPC4,489,Trpc4,Q9QUQ5,,,,,,Mouse,ML204,4255,,,178101072,Channel blocker,Inhibition,,f,,,pIC50,0,5.54,0,IC50,0,2910,0,=,,,,21795696,Cc1cc(nc2c1cccc2)N1CCCCC1
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,mM range,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,ML204,4255,,,178101072,Channel blocker,None,,f,,,pIC50,0,5.5,0,IC50,0,2900,0,,,,,21795696,Cc1cc(nc2c1cccc2)N1CCCCC1
TRPC4,489,TRPC4,Q9UBN4,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,rosiglitazone,1056,,,135650927,Activator,Activation,,f,,,pEC50,0,4.51,0,-,0,0,0,=,,,,21406603,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,daidzein,2828,,,135649858,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Oc1ccc(cc1)c1coc2c(c1=O)ccc(c2)O
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Activator,None,,f,f,100,-,0,0,0,-,0,0,0,=,,,,0,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,genistein,2826,,,135650300,Activator,None,independent of tyrosine kinase inhibition,f,f,,-,0,0,0,-,0,0,0,=,,,,20233211,Oc1ccc(cc1)c1coc2c(c1=O)c(O)cc(c2)O
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Activator,None,&mu;M range,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,lysophosphatidylcholine,2508,,,53801071,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])COC(=O)C
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,Pb<sup>2+</sup>,2525,,,53801055,Activator,None,,f,f,5,-,0,0,0,-,0,0,0,=,,,,0,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,(-)-englerin A,8372,,,252166584,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,25707820,OCC(=O)O[C@@H]1C[C@@]2(O[C@@]1(C)[C@@H]1CC[C@H]([C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1)C)C(C)C
TRPC5,490,Trpc5,Q9QX29,,,,,,Mouse,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,5000,-,0,0,0,-,0,0,0,=,,,,12456670,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,KB-R7943,4232,,,178101049,Channel blocker,Inhibition,,f,f,,pIC50,0,5.860000134,0,IC50,0,1380,0,=,,,,17658472,CS(=O)(=O)O.NC(=N)SCCc1ccc(cc1)OCc1ccc(cc1)[N+](=O)[O-]
TRPC5,490,Trpc5,,,,,,,Rat,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Inhibition,Internal magnesium,f,,,pIC50,0,3.34,0,-,0,0,0,=,,,,15689561,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,progesterone,2377,,,135651551,Channel blocker,Inhibition,,f,,,pIC50,0,5.3,0,-,0,0,0,=,,,,21108630,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,flufenamic acid,2447,,,135650269,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,GsMTx-4,4206,,,178101023,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,ML204,4255,,,178101072,Channel blocker,None,,f,f,,pIC50,0,5,0,IC50,0,10000,0,~,,,,21795696,Cc1cc(nc2c1cccc2)N1CCCCC1
TRPC5,490,TRPC5,Q9UL62,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,OAG,2436,,,135651528,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,9930701,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(OC(=O)C)CO
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,SAG,2437,,,135651559,Activator,Agonist,,f,,10,-,0,0,0,,0,0,0,,,,,9930701,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCC/C=CC/C=CC/C=CC/C=CCCCCC)CO
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,SLG,2442,,,135651560,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,9930701,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CC/C=CCCCCC)CO
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,flufenamate,4191,,,178101008,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,hyp 9,4101,,,178100924,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,20008516,CCCCCC(=O)c1c(O)cc(c(c1O)C(=O)CCCCC)O
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,hyperforin,2764,,,135652691,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,17666455,CC(=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(C(=O)[C@]1(C(=O)C(C)C)C(=C(C2=O)CC=C(C)C)O)CC=C(C)C)C
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,lysophosphatidylcholine,2508,,,53801071,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])COC(=O)C
TRPC6,491,Trpc6,Q61143,,,,,,Mouse,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,f,,pIC50,0,5.699999809,0,IC50,0,1900,0,=,,,,11179201,
TRPC6,491,Trpc6,Q61143,,,,,,Mouse,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,,,pIC50,0,5.4,0,,0,0,0,,,,,11179201,
TRPC6,491,Trpc6,Q61143,,,,,,Mouse,SKF96365,2441,,,135651058,Channel blocker,Antagonist,,f,f,,pIC50,0,5.400000095,0,IC50,0,4200,0,=,,,,11179201,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,GsMTx-4,4206,,,178101023,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,Extracellular,0,
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,KB-R7943,4232,,,178101049,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CS(=O)(=O)O.NC(=N)SCCc1ccc(cc1)OCc1ccc(cc1)[N+](=O)[O-]
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,,pIC50,0,5.21999979,0,IC50,0,6000,0,~,,,,0,
TRPC6,491,TRPC6,Q9Y210,,,,,,Human,ML9,4256,,,178101073,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cccc2c1cccc2S(=O)(=O)N1CCNCCC1
TRPC7,492,Trpc7,Q9WVC5,,,,,,Mouse,DOG,2435,,,135651479,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,10488066,CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC)CO
TRPC7,492,Trpc7,Q9WVC5,,,,,,Mouse,OAG,2436,,,135651528,Activator,Agonist,,f,,100,-,0,0,0,,0,0,0,,,,,10488066,CCCCCCCC/C=C/CCCCCCCC(=O)OCC(OC(=O)C)CO
TRPC7,492,Trpc7,Q9WVC5,,,,,,Mouse,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,10488066,
TRPC7,492,Trpc7,Q9WVC5,,,,,,Mouse,SKF96365,2441,,,135651058,Channel blocker,Antagonist,,f,f,25,-,0,0,0,-,0,0,0,=,,,,10488066,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPM1,493,TRPM1,Q7Z4N2,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,21278253,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,OAADPR,6333,,,178102951,Activator,Activation,,f,,,pKd,0,4,0,Kd,0,100000,0,=,,,,16565078,CC(=O)O[C@H]1C(O)O[C@@H]([C@H]1O)COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N)O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,Activation,,t,f,,-,0,0,0,-,0,0,0,=,,,membrane,22847436,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,H<sub>2</sub>O<sub>2</sub>,2448,,,135652736,Activator,Agonist,,t,f,0.5-50,-,0,0,0,-,0,0,0,=,,,,15302683,
TRPM2,494,TRPM2,O94759,,,,,,Human,NAADP,2450,,,53801022,Activator,Agonist,,t,,,pEC50,0,3.1,0,,0,0,0,,,,,16585058,O[C@@H]1[C@H](O)[C@H](O[C@H]1[n+]1cccc(c1)C(=O)O)COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)n1cnc2c1ncnc2N)O)O
TRPM2,494,TRPM2,O94759,,,,,,Human,NAD,2451,,,135651521,Activator,Agonist,,t,,300-1000,-,0,0,0,,0,0,0,,,,,16601673,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)O)[O-])O[C@H]([C@@H]1O)[n+]1cccc(c1)C(=O)N
TRPM2,494,TRPM2,O94759,,,,,,Human,GEA 3162,4200,,,178101017,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Nc1on[n+](n1)c1ccc(c(c1)Cl)Cl
TRPM2,494,TRPM2,O94759,,,,,,Human,econazole,2446,,,135650220,Channel blocker,Antagonist,,f,f,330,-,0,0,0,-,0,0,0,=,,,,15549272,Clc1ccc(cc1)COC(c1ccc(cc1Cl)Cl)Cn1cncc1
TRPM2,494,TRPM2,O94759,,,,,,Human,flufenamic acid,2447,,,135650269,Channel blocker,Antagonist,,f,f,50-1000,-,0,0,0,-,0,0,0,=,,,,18204483,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPM2,494,TRPM2,O94759,,,,,,Human,miconazole,2449,,,53801024,Channel blocker,Antagonist,,f,f,10,-,0,0,0,-,0,0,0,=,,,,18204483,Clc1ccc(c(c1)Cl)COC(c1ccc(cc1Cl)Cl)Cn1cncc1
TRPM2,494,TRPM2,O94759,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Channel blocker,None,,t,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,NN-dimethyl-D-erythrosphingosine,2454,,,135650729,Activator,Agonist,,t,,20,-,0,0,0,,0,0,0,,,,,15550678,CCCCCCCCCCCCC/C=C/[C@@H]([C@H](N(C)C)CO)O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,sphinganine,2453,,,135651473,Activator,Agonist,,t,f,20,-,0,0,0,-,0,0,0,=,,,,15550678,CCCCCCCCCCCCCCC[C@H]([C@H](CO)N)O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,sphingosine,2452,,,53801018,Activator,Agonist,,t,f,,pEC50,0,4.900000095,0,EC50,0,12589,0,=,,,,15550678,CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)N)O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,epipregnanolone sulphate,4188,,,178101006,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,20735426,CC(=O)C1CCC2[C@]1(C)CCC1C2CC[C@H]2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,nifedipine,2514,,,53801065,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OC)C
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,pregnenolone sulphate,4290,,,178101107,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,,18978782,CC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)OS(=O)(=O)O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,12672827,
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,12672827,
TRPM3,495,Trpm3,,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Antagonist,,t,f,9000,-,0,0,0,-,0,0,0,=,,,,15824111,
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,mefenamic acid,2593,,,53801036,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,21198543,OC(=O)c1ccccc1Nc1cccc(c1C)C
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,Na<sup>+</sup>,2340,,,135652743,Channel blocker,None,TRPM3&alpha;2 only,t,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,pioglitazone,2694,,,135650829,Channel blocker,None,independent of PPAR-&gamma;,f,f,,-,0,0,0,-,0,0,0,=,,,,21406603,CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,rosiglitazone,1056,,,135650927,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,21406603,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,decavanadate,2459,,,135652750,Activator,Agonist,,f,f,,pEC50,0,5.699999809,0,EC50,0,1.899999976,0,=,,,,15331675,[O-][V](=O)(O[V]1(=O)O[V]2(=O)O[V](=O)(O[V]3(=O)O[V](=O)(O1)O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O2)O[V](=O)([O-])[O-])[O-]
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,,,pEC50,0,5.3,0,,0,0,0,,,,,16424899,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
TRPM4,496,Trpm4,Q7TN37,,,,,,Mouse,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,,,pEC50,0,5.2,0,,0,0,0,,,,,16186107,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
TRPM4,496,TRPM4,Q8TD43,,,,,,Human,spermine,710,,,135651562,Channel blocker,Antagonist,,f,f,,pIC50,0,4.199999809,0,IC50,0,61000,0,=,,,,14758478,NCCCNCCCCNCCCN
TRPM4,496,Trpm4,Q7TN37,,,,,,Mouse,spermine,710,,,135651562,Channel blocker,Antagonist,,f,,,pIC50,0,4.5,0,,0,0,0,,,,,15670874,NCCCNCCCCNCCCN
TRPM4,496,Trpm4,Q7TN37,,,,,,Mouse,flufenamic acid,2447,,,135650269,Gating inhibitor,Antagonist,,f,f,,pIC50,0,5.599999905,0,IC50,0,2800,0,=,,,,15670874,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPM5,497,TRPM5,Q9NZQ8,,,,,,Human,flufenamic acid,2447,,,135650269,Channel blocker,None,,f,f,,pIC50,0,4.619999886,0,IC50,0,24000,0,=,,,,0,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPM5,497,TRPM5,Q9NZQ8,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Channel blocker,None,,f,f,,pIC50,0,3.200000048,0,IC50,0,630000,0,=,,,Extracellular,0,
TRPM5,497,TRPM5,Q9NZQ8,,,,,,Human,spermine,710,,,135651562,Channel blocker,None,,f,f,,pIC50,0,4.429999828,0,IC50,0,37000,0,=,,,intracellular,0,NCCCNCCCCNCCCN
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Activator,None,,t,f,,-,0,0,0,-,0,0,0,=,,,intracellular,0,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,Potentiation,&mu;M range,t,f,,-,0,0,0,-,0,0,0,=,,,extracellular,0,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Antagonist,,t,,,pIC50,0,3.3,0,,0,0,0,,,,,14576148,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,0.1-10,-,0,0,0,,0,0,0,,,,,14576148,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,inward current mediated by monovalent cations is blocked,t,,,pIC50,6,0,5.5,IC50,3400,0,1100,,,,,0,
TRPM6,498,TRPM6,Q9BX84,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,0,
TRPM7,499,Trpm7,Q925B3,,,,,,Rat,PIP<sub>2</sub>,2387,,,135651544,Activator,Agonist,,t,,20,-,0,0,0,,0,0,0,,,,,11941371,CCCCCCCC/C=CCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=CCCCCCCCC)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O
TRPM7,499,TRPM7,Q96QT4,,,,,,Human,cyclic AMP,2352,,,135651452,Activator,None,elevated cAMP levels,t,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
TRPM7,499,TRPM7,Q96QT4,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,Extracellular,0,
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,La<sup>3+</sup>,2434,,,135652740,Channel blocker,Antagonist,,f,f,2000,-,0,0,0,-,0,0,0,=,,,,11161216,
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,Antagonist,Reversible inhibition,f,f,,pIC50,0,2.49000001,0,IC50,0,3200000,0,=,,,,11385574,
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,fingolimod,2407,,,135650261,Channel blocker,Inhibition,,f,,,pIC50,0,6.14,0,IC50,0,720,0,=,,,,23145923,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N
TRPM7,499,TRPM7,Q96QT4,,,,,,Human,nafamostat,4262,,,178101079,Channel blocker,Inhibition,"Reversible inhibition, voltage and divalent cation dependent",f,,,pIC50,0,3.21,0,IC50,0,617000,0,=,,,,21122141,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,NS8593,2318,,,135650747,Channel blocker,Inhibition,,f,,,pIC50,0,5.8,0,IC50,0,1600,0,=,,,,22242975,c1ccc2c(c1)[C@@H](CCC2)Nc1nc2c([nH]1)cccc2
TRPM7,499,Trpm7,Q925B3,,,,,,Rat,spermine,710,,,135651562,Channel blocker,Inhibition,"Reversible, voltage dependent inhibition in RBL2H3 rats",f,f,,pKi,0,5.639999866,0,Ki,0,2300,0,=,,,,12149283,NCCCNCCCCNCCCN
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,sphingosine,2452,,,53801018,Channel blocker,Inhibition,,f,,,pIC50,0,6.23,0,IC50,0,590,0,=,,,,23145923,CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)N)O
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,icilin,2429,,,135650372,Activator,Agonist,,f,f,,pEC50,6.900000095,0,6.699999809,EC50,199,0,125,=,,,,15190109,O=C1NC(=CCN1c1ccccc1O)c1cccc(c1)[N+](=O)[O-]
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,CPS125,6369,,,178102987,Activator,Full agonist,,f,,,pEC50,0,4.5,0,-,0,0,0,=,"Whole-cell voltage-clamp recordings or Ca<sup>2+<.sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8",,,20816009,C[C@@H]1CC[C@H]([C@@H](C1)C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1)C(C)C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,frescolat ML,2466,,,53800999,Activator,Full agonist,,f,,,pEC50,0,3.8,0,-,0,0,0,=,"Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8",,,14757700,C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)C(O)C)C(C)C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,icilin,2429,,,135650372,Activator,Full agonist,Icilin activation is Ca<sup>2+</sup>-dependent.,f,,,pEC50,0,6.4,0,-,0,0,0,=,"Whole-cell voltage-clamp recordings or Ca<sup>2+</sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8.",,,11882888,O=C1NC(=CCN1c1ccccc1O)c1cccc(c1)[N+](=O)[O-]
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,(-)-menthol,2430,,,135651519,Activator,None,inhibited by intracellular Ca<sup>2+</sup>,f,t,,pEC50,0,4.599999905,0,EC50,0,25100,0,=,,,,15306801,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,cooling agent 10,2463,,,53801004,Activator,Partial agonist,,f,,,pEC50,0,5.2,0,,0,0,0,,,,,14757700,OCC(COC1CC(C)CCC1C(C)C)O
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,eucalyptol,2464,,,53801002,Activator,Partial agonist,,f,,,pEC50,0,2.5,0,,0,0,0,,,,,11882888,CC12CCC(CC1)C(O2)(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,eucalyptol,2464,,,53801002,Activator,Partial agonist,,f,,,pEC50,0,2.1,0,,0,0,0,,,,,14757700,CC12CCC(CC1)C(O2)(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,frescolat MGA,2465,,,53801001,Activator,Partial agonist,,f,,,pEC50,0,5.3,0,,0,0,0,,,,,14757700,OCC1COC2(O1)CC(C)CCC2C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,frescolat ML,2466,,,53800999,Activator,Partial agonist,,f,,,pEC50,0,5.5,0,,0,0,0,,,,,14757700,C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)C(O)C)C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,geraniol,2467,,,135650302,Activator,Partial agonist,,f,,,pEC50,0,2.2,0,,0,0,0,,,,,14757700,OC/C=C(/CCC=C(C)C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,hydroxycitronellal,2468,,,53800997,Activator,Partial agonist,,f,,,pEC50,0,1.7,0,,0,0,0,,,,,14757700,O=CCC(CCCC(O)(C)C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,isopulegol,2462,,,135650123,Activator,Partial agonist,,f,,,pEC50,0,4.2,0,,0,0,0,,,,,14757700,C[C@@H]1CC[C@H]([C@@H](C1)O)C(=C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,linalool,2469,,,135650522,Activator,Partial agonist,,f,,,pEC50,0,2.2,0,,0,0,0,,,,,14757700,C=CC(CCC=C(C)C)(O)C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,(-)-menthol,2430,,,135651519,Activator,Partial agonist,,f,,,pEC50,4.2,0,4.1,,0,0,0,,,,,11882888,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,(-)-menthol,2430,,,135651519,Activator,Partial agonist,,f,,,pEC50,5.4,0,4,-,0,0,0,=,,,,15190109,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,(+)-menthol,2471,,,135650579,Activator,Partial agonist,,f,,,pEC50,0,4.8,0,,0,0,0,,,,,14757700,C[C@H]1CC[C@@H]([C@H](C1)O)C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,PMD38,2472,,,135650841,Activator,Partial agonist,,f,,,pEC50,0,4.5,0,,0,0,0,,,,,14757700,C[C@@H]1CC[C@H]([C@@H](C1)O)C(O)(C)C
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,example 104 [WO2012124825],9774,,,0,Antagonist,Antagonist,,f,f,,pIC50,0,9.050000191,0,IC50,0,0.899999976,0,=,Inhibition of menthol-induced intracellular calcium mobilisation using HEK293 cells stably expressing hTRPM8.,,,0,OC(=O)c1ccc(cc1)S(=O)(=O)N(c1ncc2c(c1C1CC1)cccc2)Cc1ccc(cc1)OC(F)(F)F
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,PBMC,6370,,,178102988,Channel blocker,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK) expressing TRPM8,,,21984952,NCCN(C(=O)O[C@@H](c1ccccc1)C)Cc1ccc(c(c1)OC)OCc1ccccc1
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,linoleic acid,1052,,,135651503,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CCCCCCCCC(=O)O
TRPM8,500,TRPM8,Q7Z2W7,,,,,,Human,NADA,4261,,,178101078,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCc1ccc(c(c1)O)O
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,M8-B,6376,,,178102994,Channel blocker,Pore blocker,"Inhibited activation by cold (IC<sub>50</sub> = 7.8nM); icilin (IC<sub>50</sub> = 26.9nM), or menthol (IC<sub>50</sub> = 64.3nM) in a concentration-dependent manner.",f,f,,pIC50,8.100000381,0,7.199999809,IC50,64.30000305,0,7.800000191,=,,,,22323721,NCCN(C(=O)c1cccs1)Cc1ccc(c(c1)OC)OCc1ccccc1
TRPML1,501,MCOLN1,Q9GZU1,,,,,,Human,MK6-83,9783,,,0,Activator,Activation,,f,f,,pEC50,0,6.960000038,0,EC50,0,110,0,=,,,,25119295,Cc1ccc(s1)S(=O)(=O)Nc1ccccc1N1CCCCC1
TRPML1,501,MCOLN1,Q9GZU1,,,,,,Human,"phosphatidyl (3,5) inositol bisphosphate",2794,,,178100233,Activator,Activation,Also activates other TRPMLs,t,f,,pEC50,0,7.320000172,0,EC50,0,48,0,=,,,,20802798,CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(=O)(OC1[C@H](O)[C@H](OP(=O)(O)O)C([C@@H]([C@H]1O)OP(=O)(O)O)O)O
TRPML3,503,MCOLN3,Q8TDD5,,,,,,Human,MK6-83,9783,,,0,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,Measurement of intracellular calcium levels (fura-2 ratios F340/F380),,,0,Cc1ccc(s1)S(=O)(=O)Nc1ccccc1N1CCCCC1
TRPML3,503,MCOLN3,Q8TDD5,,,,,,Human,SF-11,6404,,,178103020,Activator,Activation,,f,,,pEC50,0,6.59,0,EC50,0,260,0,=,,,,20189104,Cc1ccc(cc1)S(=O)(=O)n1nccc1c1c(C)onc1c1ccc(cc1)Cl
TRPML3,503,MCOLN3,Q8TDD5,,,,,,Human,SF-21,6405,,,178103021,Activator,Activation,,f,,,pEC50,0,6.35,0,EC50,0,450,0,=,,,,20189104,Clc1ccc(cc1)S(=O)(=O)NC1CCCCC1N1CCOCC1
TRPML3,503,MCOLN3,Q8TDD5,,,,,,Human,SN-1,6401,,,178103017,Activator,Activation,,f,,,pEC50,0,6.06,0,EC50,0,880,0,=,,,,20189104,CCOc1ccc(cc1c1nc(=O)c2c([nH]1)c(nn2C)C(C)(C)C)S(=O)(=O)NC(C)(C)C
TRPML3,503,MCOLN3,Q8TDD5,,,,,,Human,SN-2,6402,,,178103018,Activator,Activation,,f,,,pEC50,0,5.96,0,EC50,0,1100,0,=,,,,20189104,Cc1cc(C)c(c(c1)C)C1=NOC2C1C1CCC2C1
TRPML3,503,Mcoln3,Q8R4F0,,,,,,Mouse,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,18162548,
TRPP1,504,PKD2,Q13563,,,,,,Human,Ni<sup>2+</sup>,2476,,,135652744,Channel blocker,None,,f,,100,-,0,0,0,,0,0,0,,,,,16396967,
TRPP1,504,PKD2,Q13563,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,,100,-,0,0,0,,0,0,0,,,,,16396967,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,HCl,2479,,,53800991,Activator,Agonist,,f,,11000-15000,pEC50,0,1.89,0,,0,0,0,,,,,16891422,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,malic acid,2480,,,135651516,Activator,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,16891422,OC(=O)CC(C(=O)O)O
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,ethylisopropylamiloride,4186,,,178101005,Channel blocker,None,,f,f,,pIC50,0,5,0,IC50,0,10500,0,=,,,,0,CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,flufenamate,4191,,,178101008,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,flufenamic acid,2447,,,135650269,Channel blocker,None,,f,,500,-,0,0,0,,0,0,0,,,,,10517637,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,None,,f,f,100,-,0,0,0,-,0,0,0,=,,,,10517637,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,100,-,0,0,0,-,0,0,0,=,,,,10517637,
TRPP2,505,PKD2L1,Q9P0L9,,,,,,Human,phenamil,4281,,,178101098,Channel blocker,None,,f,f,,pIC50,0,6.900000095,0,IC50,0,140,0,=,,,,0,N/C(=NC(=O)c1nc(Cl)c(nc1N)N)/Nc1ccccc1
TRPV1,507,Trpv1,O35433,,,,,,Rat,DkTx,4178,,,178100997,Activator,Activation,,f,f,,pEC50,0,6.599999905,0,EC50,0,0.230000004,0,=,,,,20510930,
TRPV1,507,Trpv1,O35433,,,,,,Rat,LTB<sub>4</sub>,2487,,,53801088,Activator,Agonist,,t,f,,pEC50,0,4.900000095,0,EC50,0,12500,0,=,,,,10823958,CCCCC/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,olvanil,2488,,,135650758,Activator,Agonist,,f,f,,pEC50,0,7.699999809,0,EC50,0,19.89999962,0,=,,,,11301059,CCCCCCCC/C=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,Trpv1,O35433,,,,,,Rat,olvanil,2488,,,135650758,Activator,Agonist,,f,,,pEC50,0,8.1,0,,0,0,0,,,,,10864900,CCCCCCCC/C=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,olvanil,2488,,,135650758,Activator,Agonist,,f,,,pEC50,0,8.4,0,,0,0,0,,,,,15489017,CCCCCCCC/C=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,piperine,2489,,,53801087,Activator,Agonist,,f,,,pEC50,0,4.4,0,,0,0,0,,,,,15685214,O=C(N1CCCCC1)/C=C/C=C/c1ccc2c(c1)OCO2
TRPV1,507,Trpv1,O35433,,,,,,Rat,PPAHV,2490,,,53801086,Activator,Agonist,,f,,,pEC50,5.5,0,5,,0,0,0,,,,,11226139,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@@H]3C([C@]3(OC(=O)C)[C@@H]([C@H]([C@@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)O)C)OC(=O)Cc1ccccc1)(C)C
TRPV1,507,Trpv1,Q704Y3,,,,,,Mouse,resiniferatoxin,2491,,,53801085,Activator,Agonist,,f,,,pEC50,0,9.8,0,,0,0,0,,,,,15489017,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,resiniferatoxin,2491,,,53801085,Activator,Agonist,,f,f,,pEC50,0,8.399999619,0,EC50,0,3.980000019,0,=,,,,11301059,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
TRPV1,507,Trpv1,O35433,,,,,,Rat,resiniferatoxin,2491,,,53801085,Activator,Agonist,,f,,,pEC50,0,7.5,0,,0,0,0,,,,,9349813,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,diphenylboronic anhydride,2494,,,53801083,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O(B(c1ccccc1)c1ccccc1)B(c1ccccc1)c1ccccc1
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Activator,None,at 37&deg;C,t,f,,pEC50,0,5.400000095,0,EC50,0,3980,0,=,,,extracellular,0,
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,phenylacetylrinvanil,4283,,,178101100,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,15356216,CCCCCC[C@@H](C(=O)Cc1ccccc1)C/C=CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,JNJ17203212,4228,,,178101045,Channel blocker,Antagonist,,f,f,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,15771431,O=C(N1CCN(CC1)c1ncccc1C(F)(F)F)Nc1ccc(cn1)C(F)(F)F
TRPV1,507,Trpv1,O35433,,,,,,Rat,JYL1421,4230,,,178101047,Channel blocker,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,9.199999809,0,=,,,,12237342,S=C(NCc1ccc(cc1)C(C)(C)C)NCc1ccc(c(c1)F)NS(=O)(=O)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,11226139,
TRPV1,507,Trpv1,O35433,,,,,,Rat,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,11226139,
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,SB452533,4310,,,178101127,Channel blocker,Antagonist,,f,f,,pKB,0,7.699999809,0,-,0,0,0,=,,,,0,CCN(c1cccc(c1)C)CCNC(=O)Nc1ccccc1Br
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,SB705498,4311,,,178101128,Channel blocker,Antagonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,79.40000153,0,=,,,,17392405,O=C(Nc1ccccc1Br)N[C@@H]1CCN(C1)c1ccc(cn1)C(F)(F)F
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,NADA,4261,,,178101078,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCC/C=CC/C=CC/C=CC/C=CCCCC(=O)NCCc1ccc(c(c1)O)O
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,,,pIC50,7,0,6.7,IC50,220,0,90,,,,,0,
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,SB366791,4309,,,178101126,Channel blocker,None,,f,f,,pIC50,0,8.239999771,0,IC50,0,5.699999809,0,=,,,,14654105,COc1cccc(c1)NC(=O)/C=C/c1ccc(cc1)Cl
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,&Delta;<sup>9</sup>-tetrahydrocannabinol,2424,,,135651250,Activator,Activation,,f,f,,pEC50,0,4.849999905,0,EC50,0,14000,0,=,,,,18550765,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,lysophosphatidylcholine,2508,,,53801071,Activator,Activation,,f,,1,-,0,0,0,-,0,0,0,=,,,,21147993,O[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])COC(=O)C
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,lysophosphatidylinositol,4028,,,178100854,Activator,Activation,,f,,1,-,0,0,0,-,0,0,0,=,,,,19321128,O[C@@H](COC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)O)O)O
TRPV2,508,Trpv2,Q9WUD2,,,,,,Rat,probenecid,4357,,,178101174,Activator,Activation,,f,f,,pEC50,0,4.5,0,EC50,0,31900,0,=,,,,17850966,CCCN(S(=O)(=O)c1ccc(cc1)C(=O)O)CCC
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,diphenylboronic anhydride,2494,,,53801083,Activator,Agonist,,f,f,100,-,0,0,0,-,0,0,0,=,,,,15722340,O(B(c1ccccc1)c1ccccc1)B(c1ccccc1)c1ccccc1
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,insulin-like growth factor 1,2495,Igf1,Mouse,53801082,Activator,Agonist,,t,,0.002,-,0,0,0,,0,0,0,,,,,10559903,
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,neuropeptide head activator,2496,,,135652325,Activator,Agonist,,t,,0.002,-,0,0,0,,0,0,0,,,,,11707512,
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,10201375,
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,fampridine,2416,,,135649796,Channel blocker,Inhibition,,f,,5000,-,0,0,0,-,0,0,0,=,,,,17673572,Nc1ccncc1
TRPV2,508,TRPV2,Q9Y5S1,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPV2,508,TRPV2,Q9Y5S1,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,f,,pIC50,0,6.199999809,0,IC50,0,600,0,=,,,,0,
TRPV2,508,TRPV2,Q9Y5S1,,,,,,Human,SKF96365,2441,,,135651058,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CCCOC(c1ccc(cc1)OC)Cn1ccnc1
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,dihydrocarveol,6415,,,178103031,Activator,Activation,,f,,,pEC50,0,2.59,0,EC50,0,2570000,0,=,Two-electrode voltage-clamp,,,17420775,CC(=C)C1CCC(C(C1)O)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,farnesyl diphosphate,2910,,,135651487,Activator,Activation,Specifically activates TRPV3 among the tested TRP channels,f,,,pEC50,0,6.89,0,EC50,0,130,0,=,Calcium imaging and patch clamp electrophysiology,,,20395302,C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(CCC=C(C)C)/C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,incensole acetate,4220,,,178101037,Activator,Activation,,f,f,,pEC50,0,4.800000191,0,EC50,0,16000,0,=,Calcium imaging,,,18492727,CC(=O)OC1CCC(=CCCC(=CCC2(OC1(C)CC2)C(C)C)C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,(-)-menthol,2430,,,135651519,Activator,Activation,,f,f,,pEC50,0,1.700000048,0,EC50,0,19952624,0,=,Patch clamp electrophysiology and calcium imaging,,,16829128,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,diphenylboronic anhydride,2494,,,53801083,Activator,Full agonist,,f,f,,pEC50,4.199999809,0,4.099999905,EC50,79400,0,63095,=,Patch clamp electrophysiology,,,15722340,O(B(c1ccccc1)c1ccccc1)B(c1ccccc1)c1ccccc1
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,eugenol,2425,,,135650247,Activator,Full agonist,,f,f,3000,-,0,0,0,-,0,0,0,=,Patch clamp electrophysiology,,,16617338,C=CCc1ccc(c(c1)OC)O
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,diphenyltetrahydrofuran,2498,,,53801080,Channel blocker,Antagonist,,f,f,,pIC50,5.199999809,0,5,IC50,10,0,6,=,Patch clamp electrophysiology,,,15722340,c1ccc(cc1)C1(CCCO1)c1ccccc1
TRPV3,509,TRPV3,Q8NET8,,,,,,Human,isopentenyl diphosphate,3048,,,135651495,Channel blocker,Inhibition,,f,,,pIC50,0,6.62,0,IC50,0,239,0,=,Calcium imaging,,,21353389,CC(=C)CCOP(=O)(OP(=O)(O)O)O
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,f,1,-,0,0,0,-,0,0,0,=,Patch clamp electrophysiology,,,12016205,
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,GSK1016790A,4205,,,178101022,Activator,Activation,,f,,,pEC50,0,8,0,-,0,0,0,=,,,,18499744,OC[C@@H](C(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc2c(s1)cccc2)CC(C)C)NS(=O)(=O)c1ccc(cc1Cl)Cl
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,GSK1016790A,4205,,,178101022,Activator,Activation,,f,f,,pEC50,0,8.699999809,0,EC50,0,2.099999905,0,=,,,,18499743,OC[C@@H](C(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc2c(s1)cccc2)CC(C)C)NS(=O)(=O)c1ccc(cc1Cl)Cl
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,GSK1016790A,4205,,,178101022,Activator,Activation,,f,,,pEC50,0,7.7,0,-,0,0,0,=,,,,18499743,OC[C@@H](C(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc2c(s1)cccc2)CC(C)C)NS(=O)(=O)c1ccc(cc1Cl)Cl
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,RN1747,4295,,,178101112,Activator,Activation,,f,f,,pEC50,0,6.099999905,0,EC50,0,770,0,=,,,,19737537,Clc1ccc(c(c1)[N+](=O)[O-])S(=O)(=O)N1CCN(CC1)Cc1ccccc1
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,RN1747,4295,,,178101112,Activator,Activation,,f,,,pEC50,0,5.4,0,-,0,0,0,=,,,,19737537,Clc1ccc(c(c1)[N+](=O)[O-])S(=O)(=O)N1CCN(CC1)Cc1ccccc1
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,RN1747,4295,,,178101112,Activator,Activation,,f,,,pEC50,0,5.4,0,-,0,0,0,=,,,,19737537,Clc1ccc(c(c1)[N+](=O)[O-])S(=O)(=O)N1CCN(CC1)Cc1ccccc1
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,phorbol 12-myristate 13-acetate,2341,,,135650820,Activator,Agonist,,f,,,pEC50,0,5.5,0,-,0,0,0,=,,,,11827975,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,phorbol 12-myristate 13-acetate,2341,,,135650820,Activator,Agonist,,f,f,,pEC50,0,7.900000095,0,EC50,0,12.5,0,=,,,,12970074,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,,1,-,0,0,0,-,0,0,0,=,,,,11827975,
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,GSK2193874,6465,,,178103079,Channel blocker,Inhibition,,f,,,pEC50,0,8.7,0,-,0,0,0,=,,,,23136043,Brc1ccc2c(c1)nc(c(c2C(=O)NC1(CC1)c1ccccc1)CN1CCC(CC1)N1CCCCC1)c1cccc(c1)C(F)(F)F
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,GSK2193874,6465,,,178103079,Channel blocker,Inhibition,,f,,,pEC50,0,7.4,0,-,0,0,0,=,,,,23136043,Brc1ccc2c(c1)nc(c(c2C(=O)NC1(CC1)c1ccccc1)CN1CCC(CC1)N1CCCCC1)c1cccc(c1)C(F)(F)F
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,GSK2193874,6465,,,178103079,Channel blocker,Inhibition,,f,,,pEC50,0,8.3,0,-,0,0,0,=,,,,23136043,Brc1ccc2c(c1)nc(c(c2C(=O)NC1(CC1)c1ccccc1)CN1CCC(CC1)N1CCCCC1)c1cccc(c1)C(F)(F)F
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,HC067047,4213,,,178101030,Channel blocker,Inhibition,,f,,,pIC50,0,7.8,0,-,0,0,0,=,,,,20956320,O=C(c1cc(n(c1C)CCCN1CCOCC1)c1ccccc1)Nc1cccc(c1)C(F)(F)F
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,HC067047,4213,,,178101030,Channel blocker,Inhibition,,f,,,pIC50,0,6.9,0,-,0,0,0,=,,,,20956320,O=C(c1cc(n(c1C)CCCN1CCOCC1)c1ccccc1)Nc1cccc(c1)C(F)(F)F
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,HC067047,4213,,,178101030,Channel blocker,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,48,0,=,,,,20956320,O=C(c1cc(n(c1C)CCCN1CCOCC1)c1ccccc1)Nc1cccc(c1)C(F)(F)F
TRPV4,510,Trpv4,Q9EPK8,,,,,,Mouse,RN1734,4294,,,178101111,Channel blocker,Inhibition,,f,,,pIC50,0,5.2,0,-,0,0,0,=,,,,19737537,CC(NCCN(S(=O)(=O)c1ccc(cc1Cl)Cl)C(C)C)C
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,RN1734,4294,,,178101111,Channel blocker,Inhibition,,f,f,,pIC50,0,5.599999905,0,IC50,0,2300,0,=,,,,19737537,CC(NCCN(S(=O)(=O)c1ccc(cc1Cl)Cl)C(C)C)C
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,RN1734,4294,,,178101111,Channel blocker,Inhibition,,f,,,pIC50,0,5.5,0,-,0,0,0,=,,,,19737537,CC(NCCN(S(=O)(=O)c1ccc(cc1Cl)Cl)C(C)C)C
TRPV4,510,Trpv4,Q9ERZ8,,,,,,Rat,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,f,0.2,-,0,0,0,-,0,0,0,=,,,,12151520,
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,f,1,-,0,0,0,-,0,0,0,=,,,,15075247,
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,Gd<sup>3+</sup>,2426,,,135652735,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPV4,510,TRPV4,Q9HBA0,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPV5,511,,,,,,,,Rabbit,ruthenium red,2432,,,135652746,Channel blocker,Inhibition,,f,,,pIC50,0,6.95,0,IC50,0,111,0,=,,,,11588099,
TRPV5,511,TRPV5,Q9NQA5,,,,,,Human,econazole,2446,,,135650220,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(cc1)COC(c1ccc(cc1Cl)Cl)Cn1cncc1
TRPV5,511,TRPV5,Q9NQA5,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPV5,511,TRPV5,Q9NQA5,,,,,,Human,miconazole,2449,,,53801024,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1ccc(c(c1)Cl)COC(c1ccc(cc1Cl)Cl)Cn1cncc1
TRPV5,511,TRPV5,Q9NQA5,,,,,,Human,ruthenium red,2432,,,135652746,Channel blocker,None,,f,f,,pIC50,0,6.900000095,0,IC50,0,121,0,=,,,,0,
TRPV6,512,Trpv6,Q91WD2,,,,,,Mouse,ruthenium red,2432,,,135652746,Channel blocker,Antagonist,,f,f,,pIC50,0,5,0,IC50,0,9000,0,=,,,,11744752,
TRPV6,512,TRPV6,Q9H1D0,,,,,,Human,La<sup>3+</sup>,2434,,,135652740,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
TRPV6,512,TRPV6,Q9H1D0,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
tryptase alpha/beta 1,2424,TPSAB1,Q15661,,,,,,Human,gabexate,7863,,,223366193,Inhibitor,Inhibition,,f,t,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,11172730,CCOC(=O)c1ccc(cc1)OC(=O)CCCCCN=C(N)N
tryptase alpha/beta 1,2424,TPSAB1,Q15661,,,,,,Human,nafamostat,4262,,,178101079,Inhibitor,Inhibition,,f,t,,pIC50,0,10,0,IC50,0,0.095299996,0,=,,,,12939527,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
tryptase alpha/beta 1,2424,TPSAB1,Q15661,,,,,,Human,RWJ-56423,9333,,,318164852,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,12930148,NC(=N)NCCC[C@@H](C(=O)c1nc2c(s1)cccc2)NC(=O)[C@@H]1C[C@H](CN1C(=O)C)O
"tryptophan 2,3-dioxygenase",2887,TDO2,P48775,,,,,,Human,LM10,9016,,,315661101,Inhibitor,Inhibition,,f,t,,pIC50,0,6.210000038,0,IC50,0,620,0,=,"Concentration inhibiting TDO activity by 50% in a cellular assay, at 80&mu;M L-tryptophan.",,,22308364,Fc1ccc2c(c1)[nH]cc2/C=C/c1nnn[nH]1
"tryptophan 2,3-dioxygenase",2887,TDO2,P48775,,,,,,Human,LM10,9016,,,315661101,Inhibitor,Inhibition,,f,t,,pKi,0,5.25,0,Ki,0,5600,0,=,,,,22308364,Fc1ccc2c(c1)[nH]cc2/C=C/c1nnn[nH]1
"tryptophan 2,3-dioxygenase",2887,Tdo2,P48776,,,,,,Mouse,LM10,9016,,,315661101,Inhibitor,Inhibition,,f,f,,pIC50,0,5.710000038,0,IC50,0,1960,0,=,"Concentration inhibiting TDO activity by 50% in a cellular assay, at 80&mu;M L-tryptophan.",,,22308364,Fc1ccc2c(c1)[nH]cc2/C=C/c1nnn[nH]1
TTK protein kinase,2264,TTK,P33981,,,,,,Human,empesertib,9427,,,328083527,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,<,,,,26832791,COc1cc(ccc1Nc1nc2n(n1)cc(cc2)c1ccc(cc1)NC(=O)[C@@H](c1ccc(cc1)F)C)S(=O)(=O)C
TTK protein kinase,2264,TTK,P33981,,,,,,Human,GNE-7915,8073,,,249565753,Inhibitor,Inhibition,,f,f,,pKi,0,7.28000021,0,Ki,0,53,0,=,,,,24354345,CCNc1nc(ncc1C(F)(F)F)Nc1cc(F)c(cc1OC)C(=O)N1CCOCC1
TTK protein kinase,2264,TTK,P33981,,,,,,Human,MPI-0479605,9399,,,328083501,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,21980130,Cc1cc(ccc1Nc1nc(NC2CCCCC2)c2c(n1)nc[nH]2)N1CCOCC1
TTK protein kinase,2264,TTK,P33981,,,,,,Human,MPS1-IN-1,9271,,,315661346,Inhibitor,Inhibition,,f,t,,pIC50,0,6.440000057,0,IC50,0,367,0,=,,,,20383151,COc1cc(ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(n1)[nH]cc2)N1CCC(CC1)O
TTK protein kinase,2264,TTK,P33981,,,,,,Human,NMS-P715,9401,,,328083503,Inhibitor,Inhibition,,f,t,,pIC50,0,6.739999771,0,IC50,0,182,0,=,,,,21723120,CCc1cccc(c1NC(=O)c1nn(c2c1CCc1c2nc(nc1)Nc1ccc(cc1OC(F)(F)F)C(=O)NC1CCN(CC1)C)C)CC
TTK protein kinase,2264,TTK,P33981,,,,,,Human,Ro3280,9403,,,328083505,Inhibitor,Inhibition,,f,f,,pKd,0,7.289999962,0,Kd,0,51,0,=,Ambit selectivity screen at 1&mu;M Ro3280.,,,22172702,COc1cc(ccc1Nc1ncc2c(n1)N(CC(C(=O)N2C)(F)F)C1CCCC1)C(=O)NC1CCN(CC1)C
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,docetaxel,6809,,,178103415,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(=O)O[C@@]12CO[C@@H]1C[C@@H]([C@@]1([C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@@H]([C@H](c3ccccc3)NC(=O)OC(C)(C)C)O)C(=C(C2(C)C)[C@H](C1=O)O)C)C)O
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,eribulin,6813,,,178103419,Inhibitor,Inhibition,,f,t,,pIC50,0,8.229999542,0,IC50,0,5.900000095,0,=,,,,21324687,NC[C@H](C[C@H]1O[C@@H]2[C@@H]([C@H]1OC)CC(=O)C[C@H]1CC[C@H]3[C@H](O1)[C@@H]1O[C@]4(CC[C@@H]5O[C@@H](CC[C@@H]6O[C@H](C2)C(=C)[C@@H](C6)C)C(=C)C5)O[C@@H]2[C@H](O3)[C@H]1O[C@@H]2C4)O
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,ixabepilone,6824,,,178103430,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C1N[C@@H](C[C@@H]2O[C@]2(C)CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](C1)O)(C)C)C)O)C)/C(=C/c1csc(n1)C)/C
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,paclitaxel,2770,,,135652721,Inhibitor,Inhibition,Mitotic cell cycle arrest in A431 cells,f,t,,pEC50,0,8.050000191,0,EC50,0,9,0,=,,,,16377187,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)c1ccccc1)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
tumor associated calcium signal transducer 2,2837,TACSTD2,P09758,,,,,,Human,sacituzumab govitecan,8253,,,249565933,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
tumor necrosis factor receptor 1,1870,TNFRSF1A,P19438,,,,,,Human,lymphotoxin-&alpha;,5064,LTA,Human,178101757,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
tumor necrosis factor receptor 2,1871,TNFRSF1B,P20333,,,,,,Human,lymphotoxin-&alpha;,5064,LTA,Human,178101757,None,None,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
TXK tyrosine kinase,2268,TXK,P42681,,,,,,Human,PRN694,9285,,,318164804,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,25593320,C=CC(=O)N1CCC[C@@H]1Cn1c(NC(=O)c2ccc(s2)C(F)F)nc2c1ccc(c2)CN[C@H](C(C)(C)C)C
TYRO3 protein tyrosine kinase,1836,TYRO3,Q06418,,,,,,Human,LDC1267,8247,,,249565927,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,24553136,CCOc1cn(nc1C(=O)Nc1ccc(c(c1)F)Oc1ccnc2c1cc(OC)c(c2)OC)c1ccc(cc1C)F
TYRO3 protein tyrosine kinase,1836,TYRO3,Q06418,,,,,,Human,growth arrest specific protein 6,4935,GAS6,Human,178101633,None,None,,t,,,-,0,0,0,,0,0,0,,,,,8939948,
TYRO3 protein tyrosine kinase,1836,TYRO3,Q06418,,,,,,Human,protein S,5050,PROS1,Human,178101745,None,None,,t,,,-,0,0,0,,0,0,0,,,,,7867073,
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,delgocitinib,9619,,,340590249,Inhibitor,Inhibition,,f,f,,pKi,0,7.849999905,0,Ki,0,14,0,=,"In an assay using the kinase domain of the recombinant human enzyme, a biotinylated peptide substrate, and [<sup>33</sup>P]ATP.",,,25387665,N#CCC(=O)N1C[C@@H]([C@]21CCN(C2)c1ncnc2c1cc[nH]2)C
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,fedratinib,5716,,,178102342,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,21106455,Cc1cnc(nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C)Nc1ccc(cc1)OCCN1CCCC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,filgotinib,7913,,,249565596,Inhibitor,Inhibition,,f,f,,pIC50,0,6.940000057,0,IC50,0,116,0,=,,,,24006460,O=C(C1CC1)Nc1nc2n(n1)c(ccc2)c1ccc(cc1)CN1CCS(=O)(=O)CC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,JAK inhibitor I,5992,,,178102614,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,18077363,Fc1ccc2c(c1)c1c(=O)[nH]ccc1c1c2[nH]c(n1)C(C)(C)C
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,NS-018,7839,,,223366170,Inhibitor,Inhibition,,f,f,,pIC50,0,7.659999847,0,IC50,0,22,0,=,,,,22829185,Fc1ccc(cc1)[C@@H](Nc1nc(Nc2cnccn2)cc(c1)c1cnn(c1)C)C
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,oclacitinib,9696,,,348353655,Inhibitor,Inhibition,,f,f,,pIC50,0,7.119999886,0,IC50,0,75.09999847,0,=,,,,0,CNS(=O)(=O)C[C@@H]1CC[C@H](CC1)N(c1[nH]cnc2c1ccn2)C
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,ruxolitinib,5688,,,178102315,Inhibitor,Inhibition,,f,f,,pIC50,0,9.260000229,0,IC50,0,0.550000012,0,=,,,,23061660,N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,9.220000267,0,IC50,0,0.600000024,0,=,In a <sup>33</sup>P-ATP assay.,,,0,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,SAR-20347,9803,,,0,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,In a TR-FRET assay.,,,21193033,O=C(c1ccc(cc1)Nc1oc(nc1C(=O)N)c1c(F)cccc1Cl)N1CCOCC1
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,solcitinib,9697,,,348353656,Inhibitor,Inhibition,,f,f,,pIC50,0,6.659999847,0,IC50,0,219,0,=,,,,0,O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
ubiquitin C-terminal hydrolase L1,2426,UCHL1,P09936,,,,,,Human,LDN-91946,8661,,,252166861,Inhibitor,Inhibition,,f,t,,pKi,0,5.639999866,0,Ki,0,2300,0,=,,,,17449248,O=C(c1sc2c(c1N)cc(c(=O)[nH]2)C(=O)O)c1ccccc1
ubiquitin specific peptidase 1,2428,USP1,O94782,,,,,,Human,ML323,7898,,,223366218,Inhibitor,Inhibition,,f,t,,pIC50,0,7.119999886,0,IC50,0,76,0,=,,,,25229643,Cc1cnc(nc1NCc1ccc(cc1)n1nncc1)c1ccccc1C(C)C
ubiquitin specific peptidase 14,2429,USP14,P54578,,,,,,Human,IU1,8880,,,252827537,Inhibitor,Inhibition,,f,f,,pIC50,0,5.329999924,0,IC50,0,4700,0,=,Measuring inhibition of Ub?AMC hydrolysis by proteasome-bound USP14,,,20829789,Fc1ccc(cc1)n1c(C)cc(c1C)C(=O)CN1CCCC1
UDP-glucose ceramide glucosyltransferase,2528,UGCG,Q16739,,,,,,Human,miglustat,4841,,,178101543,Inhibitor,Inhibition,,f,t,,pKi,0,5.130000114,0,Ki,0,7400,0,=,,,,0,CCCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
UDP glucuronosyltransferase family 1 member A1,2990,UGT1A1,P22309,,,,,,Human,ritonavir,8804,,,252827462,Inhibitor,Inhibition,Both inhibitor and substrate,f,f,,pIC50,0,5.769999981,0,IC50,0,1700,0,=,,,,21030469,O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1
Urate anion exchanger 1,1031,SLC22A12,Q96S37,,,,,,Human,lesinurad,7673,,,223366008,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)CSc1nnc(n1c1ccc(c2c1cccc2)C1CC1)Br
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,FL104,3501,,,178100488,Agonist,Full agonist,,f,f,,pEC50,7.5,0,5.800000191,-,0,0,0,=,,,,17112638,CN(CCC(c1ccc(cc1)Cl)NC(=O)c1ccc(cc1)c1ccccc1)C
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,[Pen<sup>5</sup>]U-(4-11) (human),2160,,,135652380,Agonist,Full agonist,,f,f,,pKi,0,9.699999809,0,-,0,0,0,=,,,,12238917,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,JNJ-39319202,9437,,,329968377,Antagonist,Antagonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4,0,=,,,,19731961,CCN1CCN(CC1)c1cccc2c1CN(C2=O)[C@@H](c1ccc(c(c1)OC)OC)CCCNS(=O)(=O)c1cccs1
UT receptor,365,Uts2r,P49684,,,,,,Rat,[Orn<sup>5</sup>]URP,9438,,,329968378,Antagonist,Antagonist,,f,f,,pKi,0,7.170000076,0,Ki,0,67.69999695,0,=,,,,18082287,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,palosuran,3516,,,178100499,Antagonist,Antagonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,0,0,=,,,,15146030,O=C(Nc1cc(C)nc2c1cccc2)NCCN1CCC(CC1)(O)Cc1ccccc1
UT receptor,365,Uts2r,P49684,,,,,,Rat,SB-436811,2164,,,135651009,Antagonist,Antagonist,,f,f,,pKi,0,6.699999809,0,-,0,0,0,=,,,,15936190,CN(CCCOc1ccc(cc1)CN1CC[C@@H](C1)NC(=O)c1ccc(c(c1)Cl)Cl)C
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,SB-611812,3531,,,178100510,Antagonist,Antagonist,,f,f,,pKi,0,6.599999905,0,Ki,0,0,0,=,,,,16171813,CN(CCOc1cc(ccc1Cl)NS(=O)(=O)c1c(Cl)cc(cc1Cl)C(F)(F)F)C
UT receptor,365,Uts2r,P49684,,,,,,Rat,SB-706375,2165,,,135651016,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,15852036,COc1cc(c(cc1OC)Br)S(=O)(=O)Nc1ccc(c(c1)O[C@@H]1CCN(C1)C)C(F)(F)F
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,SB-706375,2165,,,135651016,Antagonist,Antagonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,15852036,COc1cc(c(cc1OC)Br)S(=O)(=O)Nc1ccc(c(c1)O[C@@H]1CCN(C1)C)C(F)(F)F
UT receptor,365,Uts2r,Q8VIH9,,,,,,Mouse,SB-706375,2165,,,135651016,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,15852036,COc1cc(c(cc1OC)Br)S(=O)(=O)Nc1ccc(c(c1)O[C@@H]1CCN(C1)C)C(F)(F)F
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,S6716,2163,,,135650973,Antagonist,Inverse agonist,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,,,,11960491,NC(=N)c1cccc(c1)Cn1c(cc2c1cccc2C)C(=O)NCc1cccc2c1cccc2
Vesicular monoamine transporter 1,1011,SLC18A1,P54219,,,,,,Human,ketanserin,88,,,135650453,Inhibitor,Inhibition,,f,,,pKi,0,5.8,0,Ki,0,1700,0,,,,,8643547,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
Vesicular monoamine transporter 1,1011,SLC18A1,P54219,,,,,,Human,reserpine,4823,,,178101525,Inhibitor,Inhibition,,f,,,pKi,0,7.45,0,Ki,0,34,0,,,,,8643547,COc1ccc2c(c1)[nH]c1c2CCN2[C@@H]1C[C@H]1[C@@H](C2)C[C@H]([C@@H]([C@H]1C(=O)OC)OC)OC(=O)c1cc(OC)c(c(c1)OC)OC
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,deutetrabenazine,8707,,,252827365,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CC(C[C@@H]1CN2CCc3c([C@H]2CC1=O)cc(c(c3)OC([2H])([2H])[2H])OC([2H])([2H])[2H])C
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,ketanserin,88,,,135650453,Inhibitor,Inhibition,,f,f,,pKi,0,6.300000191,0,Ki,0,540,0,=,,,,8643547,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,reserpine,4823,,,178101525,Inhibitor,Inhibition,,f,t,,pKi,0,7.900000095,0,Ki,0,12,0,=,,,,8643547,COc1ccc2c(c1)[nH]c1c2CCN2[C@@H]1C[C@H]1[C@@H](C2)C[C@H]([C@@H]([C@H]1C(=O)OC)OC)OC(=O)c1cc(OC)c(c(c1)OC)OC
Vitamin D receptor,605,VDR,P11473,,,,,,Human,doxercalciferol,2790,,,135651481,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@@H](C(C)C)C)C)C)/C1
Vitamin D receptor,605,Vdr,P13053,,,,,,Rat,eldecalcitol,2783,,,135650221,Agonist,Agonist,,f,,,pKd,0,8,0,,0,0,0,,,,,8396500,OCCCO[C@@H]1[C@H](O)C/C(=C/C=C/2CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(O)(C)C)C)C)/C(=C)[C@H]1O
Vitamin D receptor,605,Vdr,P13053,,,,,,Rat,elocalcitol,2785,,,135650914,Agonist,Agonist,,f,,,pIC50,0,8.21,0,,0,0,0,,,,,11956143,CCC(/C=C/C[C@@H](C1=CC[C@@H]2[C@]1(C)CCC/C/2=CC=C/1C[C@@H](O)C[C@@H](C1=C)F)C)(CC)O
Vitamin D receptor,605,,,,,,,,Chicken,falecalcitriol,2781,,,135650250,Agonist,Agonist,,f,f,,pKd,0,8.800000191,0,-,0,0,0,=,,,,11003160,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(C(F)(F)F)(C(F)(F)F)O)C)C)/C1
Vitamin D receptor,605,,,,,,,,Unknown,gemini,2782,,,135650299,Agonist,Agonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,15013848,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3(C2CC[C@@H]3C(CCCC(O)(C)C)CCCC(O)(C)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,inecalcitol,7747,,,223366080,Agonist,Agonist,,f,t,,pKd,0,9.279999733,0,Kd,0,0.529999971,0,=,,,,10825140,O[C@H]1C[C@H](O)CC(=C/C=C/2CCC[C@]3([C@@H]2CC[C@@H]3[C@@H](CC#CC(O)(C)C)C)C)C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,lexacalcitol,2775,,,135650456,Agonist,Agonist,,f,,,pKd,0,10.1,0,,0,0,0,,,,,8573413,CCC(CCCO[C@@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=CC=C/1C[C@@H](O)C[C@@H](C1=C)O)C)(CC)O
Vitamin D receptor,605,VDR,P11473,,,,,,Human,LG190178,2787,,,135650519,Agonist,Agonist,,f,,,pKi,0,6.82,0,,0,0,0,,,,,10322128,OCC(COc1ccc(cc1C)C(c1ccc(c(c1)C)OCC(C(C)(C)C)O)(CC)CC)O
Vitamin D receptor,605,VDR,P11473,,,,,,Human,lithocholic acid,611,,,135651505,Agonist,Agonist,,t,,,pKi,0,5.1,0,,0,0,0,,,,,12016314,O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C
Vitamin D receptor,605,Vdr,P13053,,,,,,Rat,maxacalcitol,2784,,,135651387,Agonist,Agonist,,f,,,pEC50,0,8.21,0,,0,0,0,,,,,8443002,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](OCCC(O)(C)C)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,paricalcitol,2791,,,135651536,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O[C@H]1C[C@H](O)CC(=C/C=C/2CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@@H](C(O)(C)C)C)C)C)C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,seocalcitol,2777,,,135650217,Agonist,Agonist,,f,f,,pKd,0,9.600000381,0,-,0,0,0,=,,,,8573413,CCC(/C=C/C=C/[C@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=CC=C/1C[C@@H](O)C[C@@H](C1=C)O)C)(CC)O
vitamin K epoxide reductase complex subunit 1,2645,VKORC1,Q9BQB6,,,,,,Human,dicumarol,6808,,,178103414,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,18610395,O=c1oc2ccccc2c(c1Cc1c(=O)oc2c(c1O)cccc2)O
vitamin K epoxide reductase complex subunit 1,2645,VKORC1,Q9BQB6,,,,,,Human,phenindione,6838,,,178103444,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,12978288,O=C1C(c2ccccc2)C(=O)c2c1cccc2
vitamin K epoxide reductase complex subunit 1,2645,VKORC1,Q9BQB6,,,,,,Human,phenprocoumon,6839,,,178103445,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,13037763,CCC(c1c(=O)oc2c(c1O)cccc2)c1ccccc1
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,GHRH,2270,GHRH,Human,135651763,Agonist,Agonist,,t,,,pKi,0,6.2,0,Ki,0,600,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,helodermin,2280,,,135652180,Agonist,Agonist,,f,,,pKi,0,7.3,0,Ki,0,46,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,helodermin,2280,,,135652180,Agonist,Agonist,,f,,,pIC50,0,8.1,0,IC50,0,8,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,helodermin,2280,,,135652180,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor,,,9437714,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,f,,pEC50,0,8.300000191,0,EC50,0,5,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,f,,pIC50,0,7.699999809,0,IC50,0,20,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,N-stearyl-[Nle<sup>17</sup>]VIP,2271,,,135652358,Agonist,Agonist,,f,,,pIC50,0,8.3,0,IC50,0,5,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,N-stearyl-[Nle<sup>17</sup>]VIP,2271,,,135652358,Agonist,Agonist,,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,9.9,0,EC50,0,0.13,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,7.8,0,IC50,0,15,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pKi,0,8.9,0,Ki,0,1.3,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,9,0,IC50,0,1,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,7.6,0,EC50,0,22.6,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,8.2,0,EC50,0,6,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,7.4,0,EC50,0,37.4,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,9.7,0,EC50,0,0.22,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pKi,0,8.2,0,Ki,0,6.8,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Agonist,,f,,,pEC50,0,8.1,0,EC50,0,8.04,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Agonist,,f,,,pEC50,0,5.5,0,EC50,0,3000,0,>,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PHI,2273,VIP,Pig,135652399,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,PHI,2273,VIP,Pig,135652399,Agonist,Agonist,,f,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PHM,2274,VIP,Human,135651852,Agonist,Agonist,,t,,,pKi,0,5.7,0,Ki,0,2000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,PHV,2275,Vip,Rat,135651854,Agonist,Agonist,,t,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PHV,2275,Vip,Rat,135651854,Agonist,Agonist,,f,,,pIC50,0,5.5,0,IC50,0,3000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1392,2276,,,135652439,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,9152366,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1392,2276,,,135652439,Agonist,Agonist,,f,,,pKi,0,5.5,0,Ki,0,3000,0,>,inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor,,,9152366,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,6.5,0,IC50,0,300,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,5.8,0,IC50,0,1500,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,5.8,0,IC50,0,1500,0,=,Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,6.5,0,IC50,0,300,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Partial agonist,,f,,,pIC50,0,6.7,0,IC50,0,200,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11068102,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Partial agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Partial agonist,,f,,,pIC50,0,6.1,0,IC50,0,800,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10570056,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Partial agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Partial agonist,,f,,,pIC50,0,7,0,IC50,0,100,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9145428,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Partial agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,10570056,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,N-stearyl-[Nle<sup>17</sup>] neurotensin-(6-11)/VIP-(7-28),2266,,,135652357,Antagonist,Antagonist,,f,,,pIC50,0,7.5,0,IC50,0,30,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,"inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor",,,9437716,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,f,,pIC50,0,8,0,IC50,0,9.899999619,0,=,inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9437716,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,10570056,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,helodermin,2280,,,135652180,Agonist,Agonist,,f,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,helodermin,2280,,,135652180,Agonist,Agonist,,f,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,>,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,>,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,"[Lys<sup>15</sup>,Arg<sup>16</sup>,Leu<sup>27</sup>]VIP-(1-7)/GRF-(8-27)-NH<sub>2</sub>",3842,,,135652275,Agonist,Agonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,N-stearyl-[Nle<sup>17</sup>]VIP,2271,,,135652358,Agonist,Agonist,,f,,,pIC50,0,9,0,IC50,0,1,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,N-stearyl-[Nle<sup>17</sup>]VIP,2271,,,135652358,Agonist,Agonist,,f,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,9.4,0,EC50,0,0.38,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,8.4,0,EC50,0,4,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pEC50,0,7.6,0,EC50,0,23.9,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,7.6,0,IC50,0,25,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-27,2257,ADCYAP1|Adcyap1|Adcyap1|ADCYAP1,Human|Mouse|Rat|Sheep,135651849,Agonist,Agonist,,t,,,pIC50,0,7.7,0,IC50,0,21,0,=,inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor,,,11978642,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,7.7,0,EC50,0,19.4,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PACAP-38,2258,ADCYAP1|Adcyap1|Adcyap1,Human|Mouse|Rat,135651850,Agonist,Agonist,,t,,,pEC50,0,9.3,0,EC50,0,0.53,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,PHI,2273,VIP,Pig,135652399,Agonist,Agonist,,f,,,pIC50,0,7.5,0,IC50,0,30,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PHI,2273,VIP,Pig,135652399,Agonist,Agonist,,f,,,pIC50,0,7.5,0,IC50,0,30,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PHV,2275,Vip,Rat,135651854,Agonist,Agonist,,f,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,PHV,2275,Vip,Rat,135651854,Agonist,Agonist,,t,,,pIC50,0,8.2,0,IC50,0,6,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,Ro 25-1392,2276,,,135652439,Agonist,Agonist,,f,f,,pEC50,0,8.5,0,EC50,0,3,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,9152366,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,Ro 25-1392,2276,,,135652439,Agonist,Agonist,,f,f,,pKi,0,8,0,Ki,0,9.600000381,0,=,inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor,,,9152366,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,f,,pIC50,9.520000458,0,7.820000172,IC50,15,0,0.300000012,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,f,,pEC50,0,8.300000191,0,EC50,0,5,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,10570056,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,Ro 25-1553,2259,,,135652440,Agonist,Agonist,,f,f,,pEC50,0,8.699999809,0,EC50,0,2,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,5.3,0,IC50,0,5000,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,secretin,1155,SCT,Pig,135652457,Agonist,Agonist,,f,,,pIC50,0,4.5,0,IC50,0,30000,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,maxadilan,2264,,,135652280,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Partial agonist,,f,,,pIC50,0,7.6,0,IC50,0,22.9,0,=,inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Partial agonist,,f,,,pEC50,0,8.3,0,EC50,0,4.9,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 99-465,2272,,,135652386,Agonist,Partial agonist,,f,,,pEC50,0,8.4,0,EC50,0,4.4,0,=,inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor,,,16930633,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,N-stearyl-[Nle<sup>17</sup>] neurotensin-(6-11)/VIP-(7-28),2266,,,135652357,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,IC50,0,50,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9437716,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,pIC50,0,5.5,0,IC50,0,3000,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9437716,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 97-269,2268,,,135652385,Antagonist,Antagonist,,f,,,pIC50,0,5.7,0,IC50,0,2000,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,10570056,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,PG 99-465,2272,,,135652386,Antagonist,Antagonist,,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,11068102,
VRAC,710,,,,,,,,Human,GTP&gamma;S,4207,,,178101024,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC1C(COP(=O)(OP(=O)(OP(=S)(O)O)O)O)OC(C1O)n1cnc2c1[nH]c(N)nc2=O
VRAC,710,,,,,,,,Human,DCPIB,4174,,,178100994,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC1(Cc2c(C1=O)c(Cl)c(c(c2)OCCCC(=O)O)Cl)C1CCCC1
VRAC,710,,,,,,,,Human,diBA-(5)-C4,4176,,,178100995,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCN1C(=O)C(=CC=CC=Cc2c(O)n(CCCC)c(=O)n(c2=O)CCCC)C(=O)N(C1=O)CCCC
VRAC,710,,,,,,,,Human,DIDS,4177,,,178100996,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,S=C=Nc1ccc(c(c1)S(=O)(=O)O)C=Cc1ccc(cc1S(=O)(=O)O)N=C=S
VRAC,710,,,,,,,,Human,gossypol,4204,,,178101021,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=Cc1c(O)c(O)c(c2c1c(O)c(c(c2)C)c1c(C)cc2c(c1O)c(C=O)c(c(c2C(C)C)O)O)C(C)C
VRAC,710,,,,,,,,Human,IAA-94,4217,,,178101034,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)COc1cc2CC(C(=O)c2c(c1Cl)Cl)(C)C1CCCC1
VRAC,710,,,,,,,,Human,mefloquine,4252,,,178101069,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H](c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)[C@H]1CCCCN1
VRAC,710,,,,,,,,Human,Mg<sup>2+</sup>,708,,,135652741,Channel blocker,None,,t,f,,-,0,0,0,-,0,0,0,=,,,intracellular,0,
VRAC,710,,,,,,,,Human,mibefradil,2522,,,53801058,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
VRAC,710,,,,,,,,Human,nafoxidine,4263,,,178101080,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,COc1ccc2c(c1)CCC(=C2c1ccc(cc1)OCCN1CCCC1)c1ccccc1
VRAC,710,,,,,,,,Human,nordihydroguiaretic acid,4265,,,178101082,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CC(C(Cc1ccc(c(c1)O)O)C)Cc1ccc(c(c1)O)O
VRAC,710,,,,,,,,Human,NPPB,4270,,,178101087,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+](=O)[O-]
VRAC,710,,,,,,,,Human,NS3728,4273,,,178101090,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(Nc1ccc(cc1c1[nH]nnn1)Br)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F
VRAC,710,,,,,,,,Human,quinidine,2342,,,135650872,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
VRAC,710,,,,,,,,Human,quinine,2510,,,135652709,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](c1ccnc2c1cc(OC)cc2)O
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,dAVP,2181,,,135652083,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12446593,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,DAVP,2170,,,135652084,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,7774575,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,d[Cha<sup>4</sup>]AVP,2187,,,135652086,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,12446593,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,"d[Cha<sup>4</sup>,Dab<sup>8</sup>]VP",2186,,,135652087,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,17300166,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,d[Cha<sup>4</sup>]LVP,2188,,,135652088,Agonist,Full agonist,,f,,,pKi,0,5,0,,0,0,0,,,,,17300166,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,7774575,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,7.7,0,7,,0,0,0,,,,,9884074,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,d[Leu<sup>4</sup>]AVP,2190,,,135652116,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,15084136,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,"d[Leu<sup>4</sup>,Dap<sup>8</sup>]VP",2189,,,135652117,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,17300166,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,d[Leu<sup>4</sup>]LVP,2191,,,135652118,Agonist,Full agonist,,f,,,pKi,0,5.4,0,,0,0,0,,,,,17300166,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,d[<small>D</small>-Phe<sup>2</sup>]AVP,2185,,,135652129,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,12446593,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,dVDAVP,2183,,,135652138,Agonist,Full agonist,,f,,,pKi,8,0,7.6,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,F180,2171,,,135652152,Agonist,Full agonist,,f,f,,pKd,8.300000191,0,7.900000095,-,0,0,0,=,,,,10866830,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,LVP,2172,AVP,Pig,135652273,Agonist,Full agonist,,f,,,pKi,0,8.6,0,-,0,0,0,=,,,,9322919,NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,OPC-51803,2173,,,135650776,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,10780976,CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,,,pKi,0,6.1,0,,0,0,0,,,,,7774575,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,,,pKi,8.3,0,6.9,,0,0,0,,,,,8106369,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,[Phe<sup>3</sup>]OT,2178,,,135652398,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,7774575,CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,conivaptan,2203,,,135651340,Antagonist,Antagonist,,f,t,,pKi,8.399999619,0,8.199999809,-,0,0,0,=,,,,9884074,Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub>]AVP",2215,,,135652089,Antagonist,Antagonist,,f,,,pKi,7.3,0,7.2,,0,0,0,,,,,8106369,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub><sup>9</sup>]AVP",2214,,,135652090,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2216,,,135652094,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,10866830,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,des-Gly<sup>9</sup>]AVP",2217,,,135652095,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9884074,CCOc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)C(C)C)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)CCCN=C(N)N
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Arg<sup>8</sup>]VP",3867,,,178100705,Antagonist,Antagonist,,f,f,,pKi,0,9,0,Ki,0,0,0,=,,,,0,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP,2223,,,135652096,Antagonist,Antagonist,,f,,,pKi,9.2,0,8.4,,0,0,0,,,,,9884074,COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>]OVT",2222,,,135652097,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2219,,,135652098,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,11337500,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3<sup>125</sup>I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2218,,,135652099,Antagonist,Antagonist,,f,,,pKd,0,9.3,0,,0,0,0,,,,,11337500,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr(3<sup>125</sup>I)-NH<sub>2</sub><sup>9</sup>]OVT",2220,,,135652100,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,11337500,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT",2221,,,135652101,Antagonist,Antagonist,,f,,,pKi,8.4,0,8.3,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"d[Pen<sup>1</sup>,Tyr(Me)<sup>2</sup>]AVP",2225,,,135652123,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9884074,COc1ccc(cc1)CC1NC(=O)CC(C)(C)SSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,d[<small>D</small>-Pal<sup>2</sup>]AVP,2184,,,135652128,Antagonist,Antagonist,,f,f,,pKi,8.369999886,0,7.46999979,Ki,34.20000076,0,4.28000021,=,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,L023103,2194,,,135650461,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,16302826,CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,LS-192629,2192,,,135650535,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,12660315,CO/N=C/1CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,mozavaptan,2197,,,135650774,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9864265,O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,mozavaptan,2197,,,135650774,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.8,,0,0,0,,,,,9884074,O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,nelivaptan,2202,,,135651087,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,11861823,COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,OH-LVA,2195,,,135652359,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,OPC-21268,2196,,,135650773,Antagonist,Antagonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9322919,CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Lys<sup>6</sup>,des-Gly<sup>9</sup>]AVP",2208,,,135652388,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.9,,0,0,0,,,,,8106369,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Tyr-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2209,,,135652389,Antagonist,Antagonist,,f,,,pKi,8.6,0,8.5,,0,0,0,,,,,8106369,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Me)<sup>2</sup>,Arg<sup>6</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2210,,,135652390,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr<sup>2</sup>,Val<sup>4</sup>,Arg<sup>6</sup>,Arg-NH<sub>2</sub><sup>9</sup>]AVP",2211,,,135652391,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,relcovaptan,2200,,,135651080,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,8.100000381,-,0,0,0,=,,,,8106369,COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,Ro5028442,8529,,,252166731,Antagonist,Antagonist,,f,t,,pKi,0,9,0,Ki,0,1,0,=,,,,25654260,CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,RWJ-351647,2198,,,135650953,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,16620295,Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,satavaptan,2199,,,135651071,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9884074,CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,SSR126768A,2201,,,135651085,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,14722330,CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,dAVP,2181,,,135652083,Agonist,Full agonist,,f,,,pKi,9.4,0,8.2,,0,0,0,,,,,9884074,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d[Cha<sup>4</sup>]AVP,2187,,,135652086,Agonist,Full agonist,,f,f,,pKi,9.699999809,0,9,-,0,0,0,=,,,,12446593,
V<sub>1B</sub> receptor,367,Avpr1b,P48974,,,,,,Rat,"d[Cha<sup>4</sup>,Dab<sup>8</sup>]VP",2186,,,135652087,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,17300166,
V<sub>1B</sub> receptor,367,Avpr1b,P48974,,,,,,Rat,d[Cha<sup>4</sup>]LVP,2188,,,135652088,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,17300166,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,8.2,0,7.7,,0,0,0,,,,,10780976,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d[Leu<sup>4</sup>]AVP,2190,,,135652116,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,15084136,
V<sub>1B</sub> receptor,367,Avpr1b,P48974,,,,,,Rat,"d[Leu<sup>4</sup>,Dap<sup>8</sup>]VP",2189,,,135652117,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,17300166,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d[Leu<sup>4</sup>]LVP,2191,,,135652118,Agonist,Full agonist,,f,f,,pKi,0,9.800000191,0,-,0,0,0,=,,,,17300166,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d[<small>D</small>-Pal<sup>2</sup>]AVP,2184,,,135652128,Agonist,Full agonist,,f,f,,pKi,7.860000134,0,7.300000191,Ki,50,0,13.80000019,=,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d[<small>D</small>-Phe<sup>2</sup>]AVP,2185,,,135652129,Agonist,Full agonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,12446593,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,dVDAVP,2183,,,135652138,Agonist,Full agonist,,f,,,pKi,9,0,7.6,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,LVP,2172,AVP,Pig,135652273,Agonist,Full agonist,,t,,,pKi,0,8.5,0,,0,0,0,,,,,9322919,NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,,,pKi,7,0,5.7,,0,0,0,,,,,9884074,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>1B</sub> receptor,367,Avpr1b,P48974,,,,,,Rat,desmopressin,2182,,,135652102,Agonist,Partial agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9264324,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub>]AVP",2215,,,135652089,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub><sup>9</sup>]AVP",2214,,,135652090,Antagonist,Antagonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,des-Gly<sup>9</sup>]AVP",2217,,,135652095,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9884074,CCOc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)C(C)C)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)CCCN=C(N)N
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP,2223,,,135652096,Antagonist,Antagonist,,f,,,pKi,7,0,6.4,,0,0,0,,,,,9884074,COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>]OVT",2222,,,135652097,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2219,,,135652098,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,11337500,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT",2221,,,135652101,Antagonist,Antagonist,,f,,,pKi,0,5,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"d[Pen<sup>1</sup>,Tyr(Me)<sup>2</sup>]AVP",2225,,,135652123,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9884074,COc1ccc(cc1)CC1NC(=O)CC(C)(C)SSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,mozavaptan,2197,,,135650774,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,9322919,O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,nelivaptan,2202,,,135651087,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,8.399999619,-,0,0,0,=,,,,11861823,COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,OH-LVA,2195,,,135652359,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Lys<sup>6</sup>,des-Gly<sup>9</sup>]AVP",2208,,,135652388,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Tyr-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2209,,,135652389,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Me)<sup>2</sup>,Arg<sup>6</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2210,,,135652390,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr<sup>2</sup>,Val<sup>4</sup>,Arg<sup>6</sup>,Arg-NH<sub>2</sub><sup>9</sup>]AVP",2211,,,135652391,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,relcovaptan,2200,,,135651080,Antagonist,Antagonist,,f,,,pKi,7.3,0,6.3,,0,0,0,,,,,9884074,COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,satavaptan,2199,,,135651071,Antagonist,Antagonist,,f,,,pKi,0,4.3,0,,0,0,0,,,,,11429400,CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,d[<small>D</small>-Pal<sup>2</sup>]AVP,2184,,,135652128,Agonist,Agonist,,f,f,,pKi,5.190000057,0,5.019999981,Ki,9600,0,6422,=,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,dAVP,2181,,,135652083,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12446593,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,DAVP,2170,,,135652084,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,DAVP,2170,,,135652084,Agonist,Full agonist,,f,,,pKi,7.6,0,7.3,,0,0,0,,,,,7774575,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,d[Cha<sup>4</sup>]AVP,2187,,,135652086,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12446593,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"d[Cha<sup>4</sup>,Dab<sup>8</sup>]VP",2186,,,135652087,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,17300166,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,d[Cha<sup>4</sup>]LVP,2188,,,135652088,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,17300166,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9792651,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,desmopressin,2182,,,135652102,Agonist,Full agonist,,f,,,pKi,8.6,0,7.2,Ki,63,0,2.5,=,,,,9884074,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,d[Leu<sup>4</sup>]AVP,2190,,,135652116,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,15084136,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"d[Leu<sup>4</sup>,Dap<sup>8</sup>]VP",2189,,,135652117,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,17300166,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,d[Leu<sup>4</sup>]LVP,2191,,,135652118,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,17300166,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,d[<small>D</small>-Phe<sup>2</sup>]AVP,2185,,,135652129,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12446593,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d[Val<sup>4</sup>,DArg<sup>8</sup>]VP",3869,,,178100706,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,dVDAVP,2183,,,135652138,Agonist,Full agonist,,f,,,pKi,9.1,0,8.6,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,LVP,2172,AVP,Pig,135652273,Agonist,Full agonist,,t,,,pKi,8.5,0,7,,0,0,0,,,,,9322919,NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,OPC-51803,2173,,,135650776,Agonist,Full agonist,,f,f,,pKi,0,7,0,-,0,0,0,=,,,,10780976,CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,oxytocin,2174,OXT|Oxt|Oxt,Human|Mouse|Rat,135651848,Agonist,Full agonist,,t,,,pKi,6.8,0,5.4,,0,0,0,,,,,9884074,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,[Phe<sup>3</sup>]OT,2178,,,135652398,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,7774575,CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,conivaptan,2203,,,135651340,Antagonist,Antagonist,,f,t,,pKi,0,9.43999958,0,Ki,0,0.360000014,0,=,,,,20471258,Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub>]AVP",2215,,,135652089,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Ala-NH<sub>2</sub><sup>9</sup>]AVP",2214,,,135652090,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.1,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>]AVP",2236,,,135652091,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,6.900000095,-,0,0,0,=,,,,11012895,CC[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)CS)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)CC1CCCCC1=S)Cc1ccccc1)C
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2235,,,135652092,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2235,,,135652092,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2237,,,135652093,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2237,,,135652093,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2216,,,135652094,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,10866830,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,des-Gly<sup>9</sup>]AVP",2217,,,135652095,Antagonist,Antagonist,,f,,,pKi,8.3,0,8,,0,0,0,,,,,9884074,CCOc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)C(C)C)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)CCCN=C(N)N
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP,2223,,,135652096,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.7,,0,0,0,,,,,9884074,COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>]OVT",2222,,,135652097,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Phe(3I,4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT",2219,,,135652098,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,11337500,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT",2221,,,135652101,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"d[Pen<sup>1</sup>,Tyr(Me)<sup>2</sup>]AVP",2225,,,135652123,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.4,,0,0,0,,,,,9884074,COc1ccc(cc1)CC1NC(=O)CC(C)(C)SSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,nelivaptan,2202,,,135651087,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,11861823,COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,OH-LVA,2195,,,135652359,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,OPC-21268,2196,,,135650773,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,9322919,CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Lys<sup>6</sup>,des-Gly<sup>9</sup>]AVP",2208,,,135652388,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Tyr-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2209,,,135652389,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr(Me)<sup>2</sup>,Arg<sup>6</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2210,,,135652390,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[Phaa<sup>1</sup>,<small>D</small>-Tyr<sup>2</sup>,Val<sup>4</sup>,Arg<sup>6</sup>,Arg-NH<sub>2</sub><sup>9</sup>]AVP",2211,,,135652391,Antagonist,Antagonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,relcovaptan,2200,,,135651080,Antagonist,Antagonist,,f,,,pKi,6.9,0,6.6,,0,0,0,,,,,9884074,COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,Ro5028442,8529,,,252166731,Antagonist,Antagonist,,f,f,,pKi,0,4.519999981,0,Ki,0,30000,0,>,,,,25654260,CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,RWJ-351647,2198,,,135650953,Antagonist,Antagonist,,f,,,pKi,0,9,0,,0,0,0,,,,,16620295,Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,satavaptan,2199,,,135651071,Antagonist,Antagonist,,f,f,,pKi,9.300000191,0,8.399999619,-,0,0,0,=,,,,9884074,CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,satavaptan,2199,,,135651071,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,9792651,CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,SKF-105494,2229,,,135652465,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,11012895,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,lixivaptan,2238,,,135650528,Antagonist,Inverse agonist,,f,f,,pKi,9.199999809,0,8.899999619,Ki,0,0,0,=,,,,11012895,Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,mozavaptan,2197,,,135650774,Antagonist,Inverse agonist,,f,,,pKi,8.2,0,7.4,,0,0,0,,,,,9864265,O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,mozavaptan,2197,,,135650774,Antagonist,Inverse agonist,,f,f,,pKi,8.100000381,0,7.400000095,-,0,0,0,=,,,,9884074,O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C
V-type ATPase V<sub>1</sub> motor B2 subunit,812,ATP6V1B2,P21281,,,,,,Human,enoxacin,8882,,,252827539,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,=,Measuring  inhibition of the interaction between the profilin-like domain of the B2 subunit and F-actin.,,,19630402,CCn1cc(C(=O)O)c(=O)c2c1nc(N1CCNCC1)c(c2)F
WD repeat domain 5,2831,WDR5,P61964,,,,,,Human,OICR-9429,8231,,,249565911,Antagonist,Antagonist,,f,t,,pKd,0,7.619999886,0,Kd,0,24,0,=,Binding affinity determined by BIACore analysis.,,,0,CN1CCN(CC1)c1ccc(cc1NC(=O)c1c[nH]c(=O)cc1C(F)(F)F)c1cccc(c1)CN1CCOCC1
WEE1 G2 checkpoint kinase,2278,WEE1,P30291,,,,,,Human,PD166285,8183,,,249565863,Inhibitor,Inhibition,,f,f,,pIC50,0,7.619999886,0,IC50,0,24,0,=,,,,11719452,CCN(CCOc1ccc(cc1)Nc1ncc2c(n1)n(C)c(=O)c(c2)c1c(Cl)cccc1Cl)CC
WNK lysine deficient protein kinase 1,2280,WNK1,Q9H4A3,,,,,,Human,PP1,8836,,,252827493,Inhibitor,Inhibition,,f,f,,pKi,0,4.900000095,0,Ki,0,12700,0,=,,,,19739668,Cc1ccc(cc1)c1nn(c2c1c(N)ncn2)C(C)(C)C
xanthine dehydrogenase,2646,,,,,,,,Bovine,febuxostat,6817,,,178103423,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,<i>In vitro</i> assay using purified bovine enzyme,,,23122864,N#Cc1cc(ccc1OCC(C)C)c1nc(c(s1)C(=O)O)C
xanthine dehydrogenase,2646,,,,,,,,Bovine,febuxostat,6817,,,178103423,Inhibitor,Inhibition,,f,t,,pKi,0,9.920000076,0,Ki,0,0.119999997,0,=,<i>In vitro</i> assay using purified bovine enzyme,,,12421831,N#Cc1cc(ccc1OCC(C)C)c1nc(c(s1)C(=O)O)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,GDC-0152,7733,,,223366066,Antagonist,Antagonist,,f,t,,pKi,0,7.550000191,0,Ki,0,28,0,=,BIR3 domain of hXIAP,,,22413863,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1c1ccccc1)C1CCCCC1)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,SM-337,7732,,,223366065,Antagonist,Antagonist,,f,t,,pKi,0,7.590000153,0,Ki,0,26,0,=,Fluorescence polarization assay using hXIAP BIR3 domain (residues 241-356),,,19049347,CN[C@H](C(=O)N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)Cc1ccccc1)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,LCL161,7912,,,249565595,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,Assay uses recombinantly expressed BIR3 domain of XIAP,,,24083782,CN[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1c1scc(n1)C(=O)c1ccc(cc1)F)C1CCCCC1)C
X-linked inhibitor of apoptosis,2790,XIAP,P98170,,,,,,Human,SM-122,8855,,,252827512,Inhibitor,Inhibition,,f,f,,pKi,0,7.590000153,0,Ki,0,26,0,=,,,,19049347,CN[C@H](C(=O)N[C@H]1CCCC[C@@H]2N(C1=O)[C@@H](CC2)C(=O)NC(c1ccccc1)c1ccccc1)C
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,eCF506,9186,,,315661265,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,<,,,,27115835,COc1cc(ccc1NC(=O)OC(C)(C)C)c1nn(c2c1c(N)ncn2)CCN1CCC(CC1)N(C)C
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,ibrutinib,6912,,,178103494,Inhibitor,Inhibition,,f,f,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,26641137,C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,rebastinib,9173,,,315661256,Inhibitor,Inhibition,,f,f,,pIC50,8.819999695,0,8.600000381,IC50,2.5,0,1.5,=,,,,23787099,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1cc(nn1c1ccc2c(c1)cccn2)C(C)(C)C
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,saracatinib,7731,,,223366064,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,17064066,CN1CCN(CC1)CCOc1cc(OC2CCOCC2)c2c(c1)ncnc2Nc1c(Cl)ccc2c1OCO2
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,spebrutinib,7837,,,223366168,Inhibitor,Inhibition,,f,f,,pIC50,0,6.139999866,0,IC50,0,723,0,=,,,,0,COCCOc1ccc(cc1)Nc1ncc(c(n1)Nc1cccc(c1)NC(=O)C=C)F
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Agonist,,f,f,,pEC50,0,7.099999905,0,EC50,0,78.69999695,0,=,,,,8590988,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,peptide YY,1514,PYY,Human,135651873,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pIC50,8.6,0,8,,0,0,0,,,,,1316999,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY (pig)",1524,,,135652264,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,10694200,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (pig)",1526,,,135652265,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,10694200,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,10.5,0,-,0,0,0,=,,,,9145427,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pIC50,8.8,0,8.6,-,0,0,0,=,,,,1316999,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,NPY,1505,NPY,Pig,135652342,Agonist,Full agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,NPY,1505,NPY,Pig,135652342,Agonist,Full agonist,,f,,,pKi,0,9.7,0,,0,0,0,,,,,16097949,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pKi,0,9.2,0,-,0,0,0,=,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,NPY-(2-36) (pig),1508,,,135652353,Agonist,Full agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,10694200,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,t,,,pKi,0,7,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,pancreatic polypeptide,1511,PPY,Bovine,135652404,Agonist,Full agonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,t,,,pKi,0,10.2,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,peptide YY,1514,PYY,Human,135651873,Agonist,Full agonist,,f,,,pIC50,8.5,0,7.6,,0,0,0,,,,,1316999,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,[Pro<sup>34</sup>]NPY,3848,,,178100688,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,[Pro<sup>34</sup>]PYY (human),1546,,,135652413,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,PYY-(3-36),1517,PYY,Human,135651876,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,GR231118,1529,,,135652175,Antagonist,Antagonist,,f,,,pKi,0,10.9,0,,0,0,0,,,,,9145427,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,GR231118,1529,,,135652175,Antagonist,Antagonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,10694200,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,SR120819A,1530,,,135651070,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,16097949,CN(C[C@@H]1CC[C@@H](CC1)C/N=C(/c1ccc(cc1)C[C@H](C(=O)N1CCCC1)NC(=O)[C@H](NS(=O)(=O)c1ccc2c(c1)cccc2)Cc1ccccc1)N)C
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,peptide YY,1514,PYY,Human,135651873,Agonist,Agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,[D-Trp<sup>32</sup>]NPY,1544,,,135652133,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,[D-Trp<sup>32</sup>]NPY,1544,,,135652133,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11408607,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,<i>N</i>-&alpha;-Ac-PYY-(22-36) (rat),1532,,,135652211,Agonist,Full agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,11408607,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,<i>N</i>-&alpha;-Ac-PYY-(25-36) (rat),1533,,,135652212,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,11408607,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY (pig)",1524,,,135652264,Agonist,Full agonist,,f,,,pKi,0,6.1,0,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,f,,pKi,9.5,0,9.300000191,-,0,0,0,=,,,,8632753,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,9.4,0,-,0,0,0,=,,,,11408607,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,neuropeptide Y-(3-36),3627,NPY|Npy|Npy,Human|Mouse|Rat,135651844,Agonist,Full agonist,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY,1505,NPY,Pig,135652342,Agonist,Full agonist,,f,,,pKi,9.3,0,9.1,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,NPY-(13-36) (human),1535,,,135652344,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,11408607,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,8.7,0,8.6,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(16-36) (pig),1536,,,135652346,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(20-36) (pig),1538,,,135652348,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(22-36) (pig),1539,,,135652349,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pKi,0,8.8,0,-,0,0,0,=,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(2-36) (pig),1508,,,135652353,Agonist,Full agonist,,f,,,pKi,9.3,0,8.6,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(26-36) (pig),1540,,,135652355,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,7592910,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,11408607,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,peptide YY,1514,PYY,Human,135651873,Agonist,Full agonist,,t,,,pKi,9.8,0,9.5,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,f,,,pKi,0,9.5,0,-,0,0,0,=,,,,7592910,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,f,,,pKi,0,10,0,-,0,0,0,=,,,,11408607,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,[Pro<sup>34</sup>]PYY (human),1546,,,135652413,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,9.4,0,8.8,-,0,0,0,=,,,,8632753,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,PYY-(3-36),1517,PYY,Human,135651876,Agonist,Full agonist,,t,f,,pKi,9.699999809,0,9.199999809,-,0,0,0,=,,,,8632753,
Y<sub>2</sub> receptor,306,Npy2r,Q9ERC0,,,,,,Rat,PYY-(3-36) (pig),1543,,,135652427,Agonist,Full agonist,,f,,,pKi,0,9.9,0,,0,0,0,,,,,11408607,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,JNJ-5207787,3504,,,178100491,Antagonist,Antagonist,,f,f,,pIC50,7.099999905,0,6.900000095,-,0,0,0,=,,,,14617685,N#Cc1cccc(c1)/C=C/C(=O)N(c1ccc2c(c1)N(CC2)C(=O)C)C1CCN(CC1)CCC1CCCC1
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,GR231118,1529,,,135652175,Agonist,Full agonist,,f,,,pIC50,0,9.5,0,,0,0,0,,,,,10694200,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,GR231118,1529,,,135652175,Agonist,Full agonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,GR231118,1529,,,135652175,Agonist,Full agonist,,f,,,pKi,0,9.8,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Ile<sup>31</sup>,Gln<sup>34</sup>]PP (human)",1555,,,135652197,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pIC50,9.5,0,8.4,,0,0,0,,,,,8641440,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pKi,10.7,0,8.3,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,7493937,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",1545,,,135652263,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY (pig)",1524,,,135652264,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,10694200,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (pig)",1526,,,135652265,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,10694200,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,8.8,0,6.4,-,0,0,0,=,,,,9145427,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,8,0,,0,0,0,,,,,7493937,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,6.4,0,-,0,0,0,=,,,,9210181,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,NPY,1505,NPY,Pig,135652342,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,7493937,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,8.2,0,6.3,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pKi,0,7.9,0,-,0,0,0,=,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pIC50,7.1,0,5.6,,0,0,0,,,,,8641440,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,NPY-(2-36) (pig),1508,,,135652353,Agonist,Full agonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,7493937,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,f,,,pKi,0,10.7,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,f,,,pKi,10.9,0,10.5,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,f,,,pKi,0,10,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,pancreatic polypeptide,1511,PPY,Bovine,135652404,Agonist,Full agonist,,f,,,pKi,10.7,0,10.2,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,pancreatic polypeptide,1511,PPY,Bovine,135652404,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,8643460,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,t,,,pKi,10.8,0,10.3,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,f,,,pKi,0,10.6,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,t,,,pKi,10.9,0,8.7,-,0,0,0,=,,,,8643460,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,t,,,pIC50,8.5,0,6.3,-,0,0,0,=,,,,8641440,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,peptide YY,1514,PYY,Human,135651873,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,t,,,pKi,8.5,0,6.3,-,0,0,0,=,,,,9145427,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,peptide YY,1514,PYY,Human,135651873,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,7493937,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,f,,,pKi,0,6.3,0,-,0,0,0,=,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,PP-(13-36) (human),1550,,,135652407,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,PP-(20-36) (human),1552,,,135652408,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,PP-(2-36) (human),1551,,,135652409,Agonist,Full agonist,,f,,,pKi,0,10.4,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,[Pro<sup>34</sup>]PYY (human),1546,,,135652413,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,[Pro<sup>34</sup>]PYY (human),1546,,,135652413,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q61041,,,,,,Mouse,[Pro<sup>34</sup>]PYY (human),1546,,,135652413,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,16807358,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,0,6.2,0,-,0,0,0,=,,,,9210181,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,PYY-(3-36),1517,PYY,Human,135651876,Agonist,Full agonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9145427,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,PYY-(3-36),1554,Pyy|Pyy,Mouse|Rat,135651875,Agonist,Full agonist,,t,,,pKi,0,6.2,0,,0,0,0,,,,,9210181,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,niclosamide,8494,,,252166702,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,<i>In vitro</i> elevation of agonist-induced accumulation of inositol phosphate to 185% of control.,,,27294784,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,GR231118,1529,,,135652175,Antagonist,Antagonist,,f,,,pKi,0,10.8,0,,0,0,0,,,,,9145427,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,[D-Trp<sup>32</sup>]NPY,1544,,,135652133,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,[D-Trp<sup>32</sup>]NPY,1544,,,135652133,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,GR231118,1529,,,135652175,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,12890716,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY (pig)",1524,,,135652264,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]NPY (pig)",1524,,,135652264,Agonist,Full agonist,,f,,,pKi,9.3,0,8.6,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[Leu<sup>31</sup>,Pro<sup>34</sup>]PYY (human)",1527,,,135652266,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,9.3,0,-,0,0,0,=,,,,8824284,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,neuropeptide Y,1504,NPY|Npy|Npy,Human|Mouse|Rat,135651843,Agonist,Full agonist,,t,,,pKi,0,9.1,0,-,0,0,0,=,,,,8824284,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,NPY-(13-36) (pig),1507,,,135652345,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"NPY-(18-36) (human, pig)",1557,,,135652347,Agonist,Full agonist,,f,,,pKi,0,6.2,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"NPY-(18-36) (human, pig)",1557,,,135652347,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,NPY-(2-36),1549,,,135652350,Agonist,Full agonist,,f,,,pKi,0,8.9,0,-,0,0,0,=,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,NPY-(3-36) (pig),1510,,,135652356,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,pancreatic polypeptide,1513,Ppy,Rat,135651856,Agonist,Full agonist,,t,,,pKi,0,6.5,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,t,,,pKi,0,8,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,pancreatic polypeptide,1512,PPY,Human,135651855,Agonist,Full agonist,,f,,,pKi,9.3,0,8.4,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,t,,,pKi,0,9,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,peptide YY,1515,Pyy|Pyy|PYY,Mouse|Pig|Rat,135651874,Agonist,Full agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"[PP<sub>1-17</sub>,Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (human)",1561,,,135652406,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,12890716,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"PYY-(13-36) (mouse, rat, pig)",1516,,,135652426,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,PYY-(3-36),1554,Pyy|Pyy,Mouse|Rat,135651875,Agonist,Full agonist,,f,,,pKi,0,8,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,PYY-(3-36),1554,Pyy|Pyy,Mouse|Rat,135651875,Agonist,Full agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,8824284,
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,FMS586,1563,,,135650281,Antagonist,Antagonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,16436501,O=C(N(CCc1ccncc1)C)Nc1ccc2c(c1)c1CCCCc1n2C(C)C
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,JCF 109,1564,,,135650444,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12890716,O=N(=O)c1ccccc1S(=O)(=O)NC[C@@H]1CC[C@H](CC1)CNc1ccc2c(c1)cccc2
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"L-152,804",1565,,,135650463,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,10872822,OC1=C(C(=O)CC(C1)(C)C)C1C2=C(Oc3c1cccc3)CC(CC2=O)(C)C
Y<sub>5</sub> receptor,308,NPY5R,Q15761,,,,,,Human,"L-152,804",1565,,,135650463,Antagonist,Antagonist,,f,f,,pKi,0,7.599999905,0,-,0,0,0,=,,,,10872822,OC1=C(C(=O)CC(C1)(C)C)C1C2=C(Oc3c1cccc3)CC(CC2=O)(C)C
ZAC ,587,ZACN,Q401N2,,,,,,Human,Cu<sup>2+</sup>,4164,,,178100984,Agonist,Agonist,,t,f,,pEC50,0,5.400000095,0,-,0,0,0,=,,,,26872532,
ZAC ,587,ZACN,Q401N2,,,,,,Human,H<sup>+</sup>,2346,,,135652738,Agonist,Agonist,,t,f,,pEC50,0,5.599999905,0,-,0,0,0,=,,,,26872532,
Zika virus genome polyprotein,2953,,A0A140DLX4,,,,,,Zika virus,NSC157058,9652,,,340590282,Allosteric modulator,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,820,0,=,,,,28461069,Clc1nc2n[nH]nc2nc1Cl
,0,,,activin A,4857,INHBA,P08476,178101558,Human,STM 434,8991,,,310264769,Antibody,Binding,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,~,,,,0,
,0,,,&alpha;-CGRP,681,CALCA,P06881,135651608,Human,fremanezumab,9208,,,315661284,Antibody,Binding,,f,t,,pKd,0,10.30000019,0,Kd,0,0.050000001,0,<,,,,0,
,0,,,&alpha;-CGRP,681,CALCA,P06881,135651608,Human,galcanezumab,8967,,,310264747,Antibody,Binding,,f,t,,pKd,0,8.659999847,0,Kd,0,2.200000048,0,=,,,,0,
,0,,,&alpha;-CGRP,695,Calca,P01256,135651609,Rat,galcanezumab,8967,,,310264747,Antibody,Binding,,f,f,,pKd,0,9.899999619,0,Kd,0,0.127000004,0,=,,,,0,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,crenezumab,6934,,,178103516,Antibody,Binding,,f,t,,pKd,0,7.699999809,0,Kd,0,20,0,<,Binding affinity to A&beta; monomer,,,22871696,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,gantenerumab,6933,,,178103515,Antibody,Binding,,f,t,,pKd,9.619999886,0,9.149999619,Kd,0.699999988,0,0.239999995,=,Binding to A&beta;40 and A&beta;42,,,0,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,solanezumab,6932,,,178103514,Antibody,Binding,,f,t,,pKd,0,10.39999962,0,Kd,0,0.039999999,0,=,Binding affinity for A&beta;<sub>1-42</sub> measured using proprietary BIAcore technology,,,0,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,P4 [PMID: 25923432],8344,,,252166556,Inhibitor,Binding,,f,t,,pKd,0,7.789999962,0,Kd,0,16.10000038,0,=,Assessed using biolayer interferometry measuring the binding of the test peptide to the soluble ectodomain of APP.,,,25923432,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,P8 [PMID: 25923432],8345,,,252166557,Inhibitor,Binding,,f,t,,pKd,0,8.460000038,0,Kd,0,3.450000048,0,=,Assessed using biolayer interferometry measuring the binding of the test peptide to the soluble ectodomain of APP.,,,25923432,
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,florbetaben,7769,,,223366102,None,Binding,PET imaging agent for A&beta; plaques in brain,f,t,,pKi,0,8.649999619,0,Ki,0,2.220000029,0,=,Inhibition of <sup>18</sup>F-AV-45 binding to A&beta; plaques in postmortem AD brain homogenates.,,,19837759,[18F]CCOCCOCCOc1ccc(cc1)/C=C/c1ccc(cc1)NC
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,florbetapir,7344,,,178103916,None,Binding,PET imaging agent for A&beta; plaques in brain,f,t,,pKi,0,8.539999962,0,Ki,0,2.869999886,0,=,,,,23047223,[18F]CCOCCOCCOc1ccc(cn1)/C=C/c1ccc(cc1)NC
,0,,,amyloid &beta;,4865,APP,P05067,178101566,Human,flutemetamol,7342,,,178103914,None,Binding,PET imaging agent for A plaques in brain,f,t,,pKi,0,9.130000114,0,Ki,0,0.74000001,0,=,,,,22011144,CNc1ccc(cc1[18F])c1nc2c(s1)cc(cc2)O
,0,,,angiopoietin-2,5316,ANGPT2,O15123,53801019,Human,nesvacumab,8457,,,252166667,Antibody,Binding,,f,t,,pKd,0,10.73999977,0,Kd,0,0.017999999,0,=,,,,23149917,
,0,,,angiopoietin-like 3,8716,ANGPTL3,Q9Y5C1,252827374,Human,evinacumab,8717,,,252827375,Antibody,Binding,,f,t,,pKd,0,8.869999886,0,Kd,0,1.350000024,0,=,,,,0,
,0,,,CCL20,808,CCL20,P78556,135651668,Human,GSK3050002,9623,,,340590253,Antibody,Binding,,f,t,,pKd,0,10.31999969,0,Kd,0,0.048,0,=,Binding to human CCL20.,,,28295451,
,0,,,complement C5,8712,C5,,252827370,Human,eculizumab,6884,,,178103466,Antibody,Binding,,f,t,,pKd,0,10.52000046,0,Kd,0,0.029999999,0,=,,,,0,
,0,,,connective tissue growth factor,8927,CTGF,,310264708,Human,pamrevlumab,8928,,,310264709,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,21284856,
,0,,,connective tissue growth factor,8927,,,310264708,Rat,pamrevlumab,8928,,,310264709,Antibody,Binding,,f,f,,pKd,0,9.520000458,0,Kd,0,0.300000012,0,=,,,,21284856,
,0,,,CXCL10,835,CXCL10,P02778,135651705,Human,eldelumab,9047,,,315661132,Antibody,Binding,,f,t,,pKd,0,9.140000343,0,Kd,0,0.720000029,0,=,,,,0,
,0,,,CXCL12&alpha;,4358,CXCL12,P48061,135651881,Human,olaptesed pegol,9674,,,348353633,Inhibitor,Binding,,f,t,,pIC50,0,7.170000076,0,IC50,0,67.93000031,0,=,Inhibition of CXCL12 binding to immobilised heparin in a Biacore competition assay.,,,24277076,
,0,,,dabigatran,6380,,,178102998,None,idarucizumab,8298,,,252166510,Antibody,Binding,,f,t,,pKd,0,11.68000031,0,Kd,0,0.0021,0,=,,,,23476049,
,0,,,delta-like 4 (Drosophila),8452,DLL4,Q9NR61,252166662,Human,demcizumab,8451,,,252166661,Antibody,Binding,,f,t,,pKi,0,9.479999542,0,Ki,0,0.330000013,0,=,,,,0,
,0,,,GM-CSF,4942,CSF2,P04141,178101640,Human,gimsilumab,9624,,,340590254,Antibody,Binding,,f,t,,pKd,10.96000004,0,10.77000046,Kd,0.017000001,0,0.011,=,Binding affinity to recombinant hGM-CSF measured by BIACORE surface plasmon resonance.,,,0,
,0,,,GM-CSF,4942,CSF2,P04141,178101640,Human,lenzilumab,8935,,,310264716,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,,,,0,
,0,,,hepatocyte growth factor,4949,HGF,P14210|P14210|P14210,178101647,Human,rilotumumab,7986,,,249565667,Antibody,Binding,,f,t,,pKd,10.27000046,0,9.659999847,Kd,0.219999999,0,0.054000001,=,Dissociation equilibrium constant calculated using two different  assay methods (kinetic <i>vs.</i> equilibrium/solution),,,0,
,0,,,IFN-&alpha;10,4956,IFNA10,P01566,178101654,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,7.449999809,0,Kd,0,35.40000153,0,=,,,,26099203,
,0,,,IFN-&alpha;1/13,4955,IFNA13|IFNA1,P01562,178101653,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,9.079999924,0,Kd,0,0.829999983,0,=,,,,26099203,
,0,,,IFN-&alpha;1/13,4955,IFNA13|IFNA1,P01562,178101653,Human,sifalimumab,8257,,,249565937,Antibody,Binding,,f,f,,pEC50,0,8.340000153,0,EC50,0,4.599999905,0,=,Inhibition of the antiproliferative effect of IFNA1 on Daudi cells in culture.,,,0,
,0,,,IFN-&alpha;14,4957,IFNA14,P01570,178101655,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,9.279999733,0,Kd,0,0.519999981,0,=,,,,26099203,
,0,,,IFN-&alpha;16,4958,IFNA16,P05015,178101656,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,9.140000343,0,Kd,0,0.720000029,0,=,,,,26099203,
,0,,,IFN-&alpha;17,4959,IFNA17,P01571,178101657,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,9.479999542,0,Kd,0,0.330000013,0,=,,,,26099203,
,0,,,IFN-&alpha;2,4960,IFNA2,P01563,178101658,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,10.73999977,0,Kd,0,0.017999999,0,=,,,,26099203,
,0,,,IFN-&alpha;2,4960,IFNA2,P01563,178101658,Human,sifalimumab,8257,,,249565937,Antibody,Binding,,f,f,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,0,
,0,,,IFN-&alpha;21,4961,IFNA21,P01568,178101659,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,10.34000015,0,Kd,0,0.046,0,=,,,,26099203,
,0,,,IFN-&alpha;4,4962,IFNA4,P05014,178101660,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,8.18999958,0,Kd,0,6.5,0,=,,,,26099203,
,0,,,IFN-&alpha;5,4963,IFNA5,P01569,178101661,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,10.51000023,0,Kd,0,0.030999999,0,=,,,,26099203,
,0,,,IFN-&alpha;6,4964,IFNA6,P05013,178101662,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,7.960000038,0,Kd,0,10.89999962,0,=,,,,26099203,
,0,,,IFN-&alpha;7,4965,IFNA7,P01567,178101663,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,8.890000343,0,Kd,0,1.299999952,0,=,,,,26099203,
,0,,,IFN-&alpha;8,4966,IFNA8,P32881,178101664,Human,rontalizumab,9640,,,340590270,Antibody,Binding,,f,f,,pKd,0,10.69999981,0,Kd,0,0.02,0,=,,,,26099203,
,0,,,IFN-&gamma;,4968,IFNG,P01579,178101666,Human,emapalumab,9295,,,318164814,Antibody,Binding,,f,t,,pKd,0,9.140000343,0,Kd,0,0.731999993,0,=,Measured using Biacore technology,,,0,
,0,,,IL-13,4980,IL13,P35225,178101677,Human,dectrekumab,8714,,,252827372,Antibody,Binding,,f,t,,pKd,0,9.319999695,0,Kd,0,0.479999989,0,=,,,,0,
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,ixekizumab,7541,,,187051842,Antibody,Binding,,f,t,,pKd,0,11.69999981,0,Kd,0,0.002,0,<,"Binding affinity of mAbs 104, 121 and 126 from patent US7838638",,,0,
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,remtolumab,9597,,,340590227,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,secukinumab,8078,,,249565758,Antibody,Binding,,f,t,,pIC50,0,8.680000305,0,IC50,0,2.099999905,0,=,Inhibition of IL-17-induced IL-6 production by human dermal fibroblasts.,,,0,
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,secukinumab,8078,,,249565758,Antibody,Binding,,f,t,,pKd,0,9.909999847,0,Kd,0,0.122000001,0,=,Binding affinity for recombinant human IL-17,,,0,
,0,,,IL-1&alpha;,4973,IL1A,P01583,178101671,Human,lutikizumab,9297,,,318164816,Antibody,Binding,,f,t,,pKd,0,11.11999989,0,Kd,0,0.0076,0,=,,,,25764208,
,0,,,IL-1&alpha;,4973,,,178101671,Monkey,lutikizumab,9297,,,318164816,Antibody,Binding,,f,f,,pKd,0,9.390000343,0,Kd,0,0.411000013,0,=,,,,25764208,
,0,,,IL-1&alpha;,4973,IL1A,P01583,178101671,Human,lutikizumab,9297,,,318164816,Antibody,Binding,,f,t,,pEC50,0,11.18999958,0,EC50,0,0.0064,0,=,,,,25764208,
,0,,,IL-1&alpha;,4973,IL1A,P01583,178101671,Human,MABp1,8089,,,249565769,Antibody,Binding,,f,t,,pKd,0,10.69999981,0,Kd,0,0.02,0,=,,,,0,
,0,,,IL-1&beta;,4974,IL1B,P01584,178101672,Human,gevokizumab,7394,,,178103966,Antibody,Binding,,f,t,,pKd,0,12.52000046,0,Kd,0,0.0003,0,=,,,,24194526,
,0,,,IL-1&beta;,4974,,,178101672,Monkey,lutikizumab,9297,,,318164816,Antibody,Binding,,f,f,,pKd,0,10.81999969,0,Kd,0,0.0153,0,=,,,,25764208,
,0,,,IL-1&beta;,4974,IL1B,P01584,178101672,Human,lutikizumab,9297,,,318164816,Antibody,Binding,,f,t,,pEC50,0,11.11999989,0,EC50,0,0.0075,0,=,,,,25764208,
,0,,,IL-1&beta;,4974,IL1B,P01584,178101672,Human,lutikizumab,9297,,,318164816,Antibody,Binding,,f,t,,pKd,0,10.68000031,0,Kd,0,0.021,0,=,,,,25764208,
,0,,,IL-1&beta;,4974,IL1B,P01584,178101672,Human,rilonacept,6790,,,178103396,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,18668535,
,0,,,IL-22,4988,IL22,Q9GZX6,178101685,Human,fezakinumab,9281,,,318164800,Antibody,Binding,,f,t,,pKd,0,10.27000046,0,Kd,0,0.054000001,0,=,Binding in an ELISA using immobilized human IL-22,,,0,
,0,,,IL-23A,4989,IL23A,,178101686,Human,risankizumab,8922,,,310264703,Antibody,Binding,,f,t,,pKd,0,11,0,Kd,0,0.01,0,<,,,,25905918,
,0,,,IL-33,5880,IL33,O95760,178102504,Human,HpARI,9685,,,348353644,Inhibitor,Binding,,f,f,,pKd,0,6.590000153,0,Kd,0,260,0,=,Evaluated by surface plasmon resonance (SPR).,,,29045903,
,0,,,IL-33,5880,,,178102504,Mouse,HpARI,9685,,,348353644,Inhibitor,Binding,,f,f,,pKd,0,9.25,0,Kd,0,0.560000002,0,=,Evaluated by surface plasmon resonance (SPR).,,,29045903,
,0,,,IL-4,4996,IL4,P05112,178101693,Human,pascolizumab,7786,,,223366118,Antibody,Binding,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,12296858,
,0,,,IL-5,4997,IL5,P05113,178101694,Human,reslizumab,8091,,,249565771,Antibody,Binding,,f,t,,pKd,0,8.050000191,0,Kd,0,8.899999619,0,=,,,,0,
,0,,,IL-6,4998,IL6,P05231,178101695,Human,siltuximab,7396,,,178103968,Antibody,Binding,,f,t,,pKd,0,10.23999977,0,Kd,0,0.057,0,=,,,,0,
,0,,,IL-6,4998,IL6,P05231,178101695,Human,sirukumab,7989,,,249565670,Antibody,Binding,,f,t,,pKd,0,13.43000031,0,Kd,0,3.7E-05,0,=,,,,0,
,0,,,IL-6,4998,IL6,P05231,178101695,Human,olamkicept,9729,,,0,None,Binding,,f,f,,pKd,0,8.380000114,0,Kd,0,4.199999809,0,=,Binding of hIL-6 to immobilized sgp130-Fc (olamkicept).,,,0,
,0,,,IL-9,5000,IL9,P15248,178101697,Human,enokizumab,8934,,,310264715,Antibody,Binding,,f,t,,pKd,0,11.22000027,0,Kd,0,0.006,0,=,,,,0,
,0,,,insulin-like growth factor 1,4971,IGF1,P05019,178101669,Human,dusigitumab,7749,,,223366082,Antibody,Binding,,f,t,,pKd,0,9.670000076,0,Kd,0,0.216000006,0,=,,,,0,
,0,,,insulin-like growth factor 2,4972,IGF2,P01344,178101670,Human,dusigitumab,7749,,,223366082,Antibody,Binding,,f,t,,pKd,0,11.53999996,0,Kd,0,0.0029,0,=,,,,0,
,0,,,landogrozumab,8730,,,252827388,Human,myostatin,5025,MSTN,Human,178101722,Antibody,Binding,,f,t,,pKd,0,11.85999966,0,Kd,0,0.00139,0,=,Measured using the Sapidyne KINEXA assay.,,,0,
,0,,,M-CSF,4905,CSF1,P09603,178101604,Human,MCS110,9110,,,315661195,Antibody,Binding,,f,t,,pKd,9.800000191,0,8.520000458,Kd,3,0,0.159999996,=,,,,0,
,0,,,microtubule associated protein tau,9275,MAPT,,318164794,Human,leucomethylthioninium,9274,,,318164793,Inhibitor,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,25320049,C[NH+](c1ccc2c(c1)Sc1c(N2)ccc(c1)[NH+](C)C)C
,0,,,microtubule associated protein tau,9275,MAPT,,318164794,Human,flortaucipir (18F),9100,,,315661185,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,26892233,[18F]c1ccc(cn1)c1ccc2c(c1)[nH]c1c2cncc1
,0,,,myostatin,5025,MSTN,O14793,178101722,Human,domagrozumab,9096,,,315661181,Antibody,Binding,,f,t,,pKd,0,11.59000015,0,Kd,0,0.00259,0,=,,,,0,
,0,,,NGF,5026,NGF,P01138,178101723,Human,fasinumab,8965,,,310264745,Antibody,Binding,,f,t,,pKd,0,12.73999977,0,Kd,0,0.00018,0,=,,,,0,
,0,,,NGF,5026,NGF,P01138,178101723,Human,fulranumab,8964,,,310264744,Antibody,Binding,,f,t,,pKd,0,11.39999962,0,Kd,0,0.004,0,=,,,,0,
,0,,,PF-00547659,9340,,,328083443,Human,mucosal addressin cell adhesion molecule 1,9339,MADCAM1,Human,328083442,Antibody,Binding,,f,t,,pKd,0,9.81000042,0,Kd,0,0.155000001,0,=,Measured in a back-scattering interferometry (BSI) assay using membrane-bound MAdCAM1.,,,27760281,
,0,,,PF-00547659,9340,,,328083443,Human,mucosal addressin cell adhesion molecule 1,9339,MADCAM1,Human,328083442,Antibody,Binding,,f,t,,pKd,0,9.680000305,0,Kd,0,0.207000002,0,=,Measured in a back-scattering interferometry (BSI) assay using soluble MAdCAM1.,,,27760281,
,0,,,PF-00547659,9340,,,328083443,Human,mucosal addressin cell adhesion molecule 1,9339,MADCAM1,Human,328083442,Antibody,Binding,,f,t,,pKd,0,10.78999996,0,Kd,0,0.016100001,0,=,Measured in a SPR assay using recombinant human MAdCAM1.,,,27760281,
,0,,,programmed cell death 1 ligand 1,9606,CD274,Q9NZQ7,340590236,Human,durvalumab,7985,,,249565666,Antibody,Binding,,f,t,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,0,
,0,,,RANK ligand,5066,TNFSF11,O14788,178101759,Human,denosumab,6886,,,178103468,Antibody,Binding,,f,t,,pIC50,0,9.640000343,0,IC50,0,0.230000004,0,<,,,,0,
,0,,,sclerostin,3704,SOST,Q9BQB4,178100593,Human,romosozumab,8092,,,249565772,Antibody,Binding,,f,t,,pKd,12.22000027,0,11.22000027,Kd,0.006,0,0.0006,=,"Affinity across a range of antibodies tested, as the lead antibody is not indicated in the patent.",,,0,
,0,,,SP-4206,9037,,,315661122,Human,IL-2,4985,IL2,Human,178101682,None,Binding,,f,t,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,12656598,
,0,,,SP-4206,9037,,,315661122,Human,SP-4206,9037,,,315661122,None,Binding,,f,t,,pKd,0,7,0,Kd,0,100,0,=,,,,12656598,CC(C[C@H](C(=O)NCC(=O)N1CCC(CC1)c1cc(nn1C)c1ccc(c(c1Cl)Cl)OCc1ccc(o1)C(=O)O)N=C(N)N)C
,0,,,TGF&beta;1,5060,TGFB1,P01137,178101753,Human,fresolimumab,8264,,,252166476,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,etanercept,6789,,,178103395,Antagonist,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,9865320,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,golimumab,6776,,,178103382,Antibody,Binding,,f,t,,pIC50,0,10.73999977,0,IC50,0,0.017999999,0,=,Affinity for soluble TNF&alpha; measured by surface plasmon resonance,,,20519961,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,infliximab,5004,,,178101701,Antibody,Binding,,f,t,,pKd,0,8.739999771,0,Kd,0,1.799999952,0,=,Binding affinity of antibody cA2 to recombinant human TNF&alpha;,,,0,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,ozoralizumab,9638,,,340590268,Antibody,Binding,,f,t,,pEC50,0,9.010000229,0,EC50,0,0.985000014,0,=,,,,0,
,0,,,tumour necrosis factor shed form,5074,TNF,P01375,178101767,Human,remtolumab,9597,,,340590227,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,pegaptanib,6836,,,178103442,Antagonist,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,15625332,COCCOC(=O)N[C@H](C(=O)NCCCCCCCOP(=O)(O)C)CCCCNC(=O)OCCOC
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,ranibizumab,6779,,,178103385,Antibody,Binding,,f,t,,pKd,0,9.819999695,0,Kd,0,0.150000006,0,=,,,,0,
4-1BB,1878,TNFRSF9,Q07011,,,,,,Human,urelumab,9311,,,318164830,Antibody,Agonist,,f,t,,pKd,0,7.78000021,0,Kd,0,16.61000061,0,=,Dissociation constant for the 20H4-9-IgG4 clone binding to human 4-1BB,,,0,
4-1BB,1878,TNFRSF9,Q07011,,,,,,Human,utomilumab,9244,,,315661319,Antibody,Agonist,,f,t,,pKd,0,8.06000042,0,Kd,0,8.699999809,0,=,Binding to 4-1BB extracellular domain measured using a surface plasmon resonance (SPR) biosensor assay.,,,22406983,
4-aminobutyrate aminotransferase,2464,ABAT,P80404,,,,,,Human,vigabatrin,4821,,,178101523,Inhibitor,Irreversible inhibition,,f,t,,pKi,0,3.069999933,0,Ki,0,850000,0,=,,,,856582,NC(C=C)CCC(=O)O
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,10193663,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]8-OH-DPAT,31,,,135651130,Agonist,Full agonist,,f,,,pKd,9.4,0,6,Kd,1000,0,0.398,=,,,,10431754,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]NLX-112,3925,,,178100754,Agonist,Full agonist,,f,,,pKd,0,8.9,0,Kd,0,1.4,0,=,,,,20799027,Cc1ccc(nc1)CNCC1(F)CCN(CC1)C(=O)c1ccc(c(c1)Cl)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,tandospirone,55,,,135651235,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9760039,O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,U92016A,30,,,135651294,Agonist,Full agonist,,f,,,pKi,0,9.7,0,-,0,0,0,=,,,,7965808,CCCN([C@@H]1CCc2c(C1)c1cc([nH]c1cc2)C#N)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,zalospirone,58,,,135651354,Agonist,Full agonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9760039,O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)[C@@H]2[C@H]1[C@@H]1C=C[C@H]2[C@@H]2[C@H]1C=C2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,zolmitriptan,60,,,135651366,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,10193663,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]S-15535,32,,,135651202,Agonist,Partial agonist,,f,,,pKd,5.9,0,5.8,,0,0,0,,,,,9550290,C1COc2c(O1)cccc2N1CCN(CC1)C1Cc2c(C1)cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Partial agonist,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,Binding of vilazodone to human 5-HT<sub>1A</sub> receptors against [<sup></sup>3H]8-OH-DPAT (DPAT),,,19499624,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Partial agonist,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,15341484,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,vortioxetine,7351,,,178103923,Agonist,Partial agonist,,f,t,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,ziprasidone,59,,,135651359,Agonist,Partial agonist,,f,,,pKi,8.9,0,7.9,,0,0,0,,,,,9760039,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(S)-UH 301,61,,,135651091,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,Ki,0,13.5,0,=,,,,9760039,CCCN([C@H]1CCc2c(C1)c(O)ccc2F)CCC
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>11</sup>C]WAY100635,3252,,,178100297,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15689356,COc1ccccc1N1CCN(CC1)CCN([11C](=O)C1CCCCC1)c1ccccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]<i>p</i>-MPPF,81,,,135651164,Antagonist,Antagonist,,f,,,pKd,0,8.4,0,-,0,0,0,=,,,,15628665,COc1ccccc1N1CCN(CC1)CCN(C(=O)c1ccc(cc1)F)c1ccccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]robalzotan,82,,,135651184,Antagonist,Antagonist,,f,,,pKd,0,9.8,0,Kd,0,0.158,0,=,,,,9851589,NC(=O)c1c([3H])cc(c2c1C[C@H](CO2)N(C1CCC1)C1CCC1)F
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,[<sup>3</sup>H]WAY100635,3251,,,135651215,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,Kd,0,0.3,0,=,,,,9048968,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,(-)-tertatolol,64,,,135651248,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9760039,O[C@@H](COc1cccc2c1SCCC2)CNC(C)(C)C
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9760039,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,tiospirone,101,,,135651264,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,9760039,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,WAY-100135,79,,,135651320,Antagonist,Antagonist,,f,,,pKi,0,8,0,,0,0,0,,,,,9550290,COc1ccccc1N1CCN(CC1)CC(C(=O)NC(C)(C)C)c1ccccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,WAY-100635,80,,,135651321,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,7.900000095,Ki,12.60000038,0,0.630999982,=,,,,9760039,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,10611634,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1A</sub> receptor,1,HTR1A,P08908,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>1B</sub> receptor,2,Htr1b,P28564,,,,,,Rat,[<sup>125</sup>I]GTI,3250,,,135651108,Agonist,Agonist,,f,f,,pKd,0,8.899999619,0,Kd,0,1.299999952,0,=,,,,1738002,NCCc1c[nH]c2c1cc(OCC(=O)NCC(=O)N[C@H](C(=O)N)Cc1ccc(c(c1)[125I])O)cc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>3</sup>H]8-OH-DPAT,31,,,135651130,Agonist,Full agonist,,f,f,,pKd,0,8.899999619,0,-,0,0,0,=,,,,10431754,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>3</sup>H]alniditan,117,,,135651134,Agonist,Full agonist,,f,,,pKd,9,0,8.6,Kd,2.51,0,1,=,,,,9605573,C(NC[C@H]1CCc2c(O1)cccc2)CCNC1=NCCCN1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,6.9,0,6.2,,0,0,0,,,,,1565658,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,t,,,pKi,0,6.3,0,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,ziprasidone,59,,,135651359,Agonist,Full agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,8935801,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Partial agonist,,f,t,,pKi,8.100000381,0,6.5,Ki,316,0,7.940000057,=,,,,10611634,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>11</sup>C]AZ10419369,3926,,,178100755,Agonist,Partial agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,20424633,[11CH3]N1CCN(CC1)c1ccc(c2c1oc(cc2=O)C(=O)Nc1ccc(cc1)N1CCOCC1)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>3</sup>H]eletriptan,118,,,135651151,Agonist,Partial agonist,,f,,,pKd,0,8.5,0,Kd,0,3,0,=,,,,10193663,C([3H])(N1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1)([3H])[3H]
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>3</sup>H]N-methyl-AZ10419369,3219,,,135651189,Agonist,Partial agonist,,f,f,,pKd,0,9.399999619,0,Kd,0,0.370000005,0,=,,,,19401496,O=C(c1cc(=O)c2c(o1)c(ccc2C)N1CCN(CC1)C([3H])([3H])[3H])Nc1ccc(cc1)N1CCOCC1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,[<sup>3</sup>H]sumatriptan,119,,,135651211,Agonist,Partial agonist,,f,,,pKd,0,8,0,Kd,0,11,0,=,,,,10193663,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C([3H])([3H])[3H])C([3H])([3H])[3H])c[nH]2
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,vortioxetine,7351,,,178103923,Agonist,Partial agonist,,f,t,,pKi,0,7.480000019,0,Ki,0,33,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,zolmitriptan,60,,,135651366,Agonist,Partial agonist,,f,t,,pKi,0,7.699999809,0,-,0,0,0,=,,,,10193663,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,"[<sup>3</sup>H]GR 125,743",131,,,135651155,Antagonist,Antagonist,,f,,,pKd,9.2,0,8.6,Kd,2.6,0,0.71,=,,,,10513577,COc1ccc(cc1N1CCN(CC1)C([3H])([3H])[3H])NC(=O)c1ccc(c(c1)C)c1ccncc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,(+)-WAY 100135,126,,,135651319,Antagonist,Antagonist,,f,,,pKi,0,5.8,0,,0,0,0,,,,,9208142,COc1ccccc1N1CCN(CC1)C[C@@H](C(=O)NC(C)(C)C)c1ccccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,7.6,0,6.8,,0,0,0,,,,,10611634,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1B</sub> receptor,2,Htr1b,P28334,,,,,,Mouse,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,1557407,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1B</sub> receptor,2,HTR1B,P28222,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>1D</sub> receptor,3,Htr1d,P28565,,,,,,Rat,[<sup>125</sup>I]GTI,3250,,,135651108,Agonist,Agonist,,f,f,,pKd,0,8.899999619,0,Kd,0,1.299999952,0,=,,,,1738002,NCCc1c[nH]c2c1cc(OCC(=O)NCC(=O)N[C@H](C(=O)N)Cc1ccc(c(c1)[125I])O)cc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]5-CT,262,,,135651128,Agonist,Agonist,,f,,,pKd,0,9.1,0,Kd,0,0.9,0,=,,,,10452531,NC(=O)c1ccc2c(c1)c(c[nH]2)C(C(N)([3H])[3H])([3H])[3H]
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,t,,pKi,8.699999809,0,8,Ki,10,0,1.99000001,=,,,,10611634,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]5-HT,3248,,,135651129,Agonist,Full agonist,,f,,,pKd,8.6,0,8.2,-,0,0,0,=,,,,1565658,C([3H])(C(c1c[nH]c2c1cc(O)cc2)[3H])N
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]8-OH-DPAT,31,,,135651130,Agonist,Full agonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,10431754,CCCN(C1CCc2c(C1)c(O)ccc2)CCC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]alniditan,117,,,135651134,Agonist,Full agonist,,f,,,pKd,8.92,0,8.85,Kd,1.4,0,1.2,=,,,,9605573,C(NC[C@H]1CCc2c(O1)cccc2)CCNC1=NCCCN1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]eletriptan,118,,,135651151,Agonist,Full agonist,,f,,,pKd,0,9.1,0,Kd,0,0.9,0,=,,,,10193663,C([3H])(N1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1)([3H])[3H]
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,[<sup>3</sup>H]sumatriptan,119,,,135651211,Agonist,Full agonist,,f,,,pKd,0,8.2,0,Kd,0,7,0,=,,,,10193663,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C([3H])([3H])[3H])C([3H])([3H])[3H])c[nH]2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,7.2,0,7.1,,0,0,0,,,,,1565658,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,7.4,0,6.8,,0,0,0,,,,,1565658,NCCc1c[nH]c2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,ziprasidone,59,,,135651359,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,8935801,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,zolmitriptan,60,,,135651366,Agonist,Full agonist,,f,t,,pKi,0,8.899999619,0,-,0,0,0,=,,,,10193663,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,"[<sup>3</sup>H]GR 125,743",131,,,135651155,Antagonist,Antagonist,,f,,,pKd,0,8.6,0,Kd,0,2.8,0,=,,,,10452531,COc1ccc(cc1N1CCN(CC1)C([3H])([3H])[3H])NC(=O)c1ccc(c(c1)C)c1ccncc1
5-HT<sub>1D</sub> receptor,3,Htr1d,P28565,,,,,,Rat,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,15341484,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,(+)-WAY 100135,126,,,135651319,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,9208142,COc1ccccc1N1CCN(CC1)C[C@@H](C(=O)NC(C)(C)C)c1ccccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.2,,0,0,0,,,,,10611634,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1D</sub> receptor,3,HTR1D,P28221,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,,,pKi,5.8,0,5.6,,0,0,0,,,,,10193663,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,[<sup>3</sup>H]5-HT,3248,,,135651129,Agonist,Full agonist,,f,,,pKd,8.2,0,8.1,Kd,7.94,0,6.31,=,,,,8863519,C([3H])(C(c1c[nH]c2c1cc(O)cc2)[3H])N
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,5.4,0,5.2,,0,0,0,,,,,8863519,FC(c1cccc(c1)N1CCNCC1)(F)F
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,t,,,pKi,6.5,0,5.6,-,0,0,0,=,,,,8380639,NCCc1c[nH]c2c1cccc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,ziprasidone,59,,,135651359,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8935801,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,zolmitriptan,60,,,135651366,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,10193663,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,8380639,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-ht<sub>1e</sub> receptor,4,HTR1E,P28566,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>1F</sub> receptor,5,Htr1f,Q02284,,,,,,Mouse,[<sup>125</sup>I]LSD,261,,,135651112,Agonist,Agonist,,f,,,pKd,0,9,0,Kd,0,0.98,0,=,,,,1328180,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)[125I])CC
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,f,,pKi,7.900000095,0,7.199999809,-,0,0,0,=,,,,15900510,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,f,,pIC50,0,7.199999809,0,-,0,0,0,=,,,,8384716,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,[<sup>3</sup>H]LY334370,151,,,135651171,Agonist,Full agonist,,f,,,pKd,0,9.4,0,Kd,0,0.398,0,=,,,,15900510,CN1CCC(CC1)c1c[nH]c2c1cc(cc2)NC(=O)c1ccc(cc1)F
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8380639,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8380639,NCCc1c[nH]c2c1cccc2
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,zolmitriptan,60,,,135651366,Agonist,Full agonist,,f,,,pKi,7.5,0,7.4,,0,0,0,,,,,15900510,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
5-HT<sub>1F</sub> receptor,5,HTR1F,P30939,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8380639,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>1F</sub> receptor,5,Htr1f,P30940,,,,,,Rat,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pIC50,0,6.2,0,,0,0,0,,,,,8384716,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,[<sup>125</sup>I]DOI,169,,,135651107,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,11101361,COc1cc([125I])c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,[<sup>3</sup>H](+)DOB,155,,,135651149,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,11562430,COc1cc(Br)c(cc1CC(N)C)OC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15322733,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,tryptamine,125,,,135651581,Agonist,Full agonist,,t,,,pKi,0,7.1,0,,0,0,0,,,,,8114677,NCCc1c[nH]c2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,t,,,pKi,7.6,0,5.5,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,VER-3323,168,,,135651304,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,15322733,C[C@@H](CN1CCc2c1cc(Br)cc2)N
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,[<sup>11</sup>C]GSK215083,8430,,,252166640,Antagonist,Antagonist,,f,f,,pKi,0,9.100000381,0,Ki,0,0.790000021,0,=,,,,22223878,[11CH3]N1CCN(CC1)c1cccc2c1ncc(c2)S(=O)(=O)c1cccc(c1)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,[<sup>11</sup>C]volinanserin,3249,,,135651096,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,11044889,[11CH3]Oc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,[<sup>18</sup>F]altanserin,3242,,,135651121,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,9027929,[18F]c1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=S)[nH]c2c(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,[<sup>3</sup>H]fananserin,3229,,,178100286,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,Kd,0,0.13,0,=,,,,8472747,Fc1ccc(cc1)N1CCN(CC1)CCCN1c2cccc3c2c(S1(=O)=O)ccc3
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,[<sup>3</sup>H]<i>N</i>-methylspiperone,196,,,135651163,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,11040033,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,[<sup>3</sup>H]ketanserin,197,,,135651169,Antagonist,Antagonist,,f,,,pKd,9.7,0,8.6,Kd,2.9,0,0.2,=,,,,15322733,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,[<sup>3</sup>H]ketanserin,197,,,135651169,Antagonist,Antagonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,11040033,Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,t,,pKi,8,0,7.400000095,-,0,0,0,=,,,,12629531,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,thiothixene,212,,,135651260,Antagonist,Antagonist,,f,t,,pKi,0,7.300000191,0,-,0,0,0,=,,,,12629531,CN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C
5-HT<sub>2A</sub> receptor,6,Htr2a,P14842,,,,,,Rat,trazodone,213,,,135651275,Antagonist,Antagonist,,f,,,pKi,8.2,0,7.7,,0,0,0,,,,,11104741,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,trazodone,213,,,135651275,Antagonist,Antagonist,,f,t,,pKi,0,7.400000095,0,-,0,0,0,=,,,,15322733,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,trifluoperazine,214,,,135651279,Antagonist,Antagonist,,f,f,,pKi,0,7.900000095,0,-,0,0,0,=,,,,12629531,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,volinanserin,185,,,135650573,Antagonist,Antagonist,,f,,,pIC50,9.3,0,6.5,-,0,0,0,=,,,,15322733,COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,f,,pKi,0,6.739999771,0,Ki,0,180,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,xanomeline,57,,,135651331,Antagonist,Antagonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,ziprasidone,59,,,135651359,Antagonist,Antagonist,,f,t,,pKi,9.510000229,0,8.800000191,-,0,0,0,=,,,,8935801,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>2A</sub> receptor,6,HTR2A,P28223,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,[<sup>125</sup>I]DOI,169,,,135651107,Agonist,Full agonist,,f,f,,pKd,7.699999809,0,7.599999905,Kd,25,0,20,=,,,,0,COc1cc([125I])c(cc1CC(N)C)OC
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,[<sup>3</sup>H]5-HT,3248,,,135651129,Agonist,Full agonist,,f,,,pKd,0,8.1,0,Kd,0,8,0,=,,,,8450835,C([3H])(C(c1c[nH]c2c1cc(O)cc2)[3H])N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Full agonist,,f,,,pKd,0,8.7,0,Kd,0,2.1,0,=,,,,12738034,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8450835,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,15322733,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,8450835,NCCc1c[nH]c2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,VER-3323,168,,,135651304,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,15322733,C[C@@H](CN1CCc2c1cc(Br)cc2)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,[<sup>3</sup>H]rauwolscine,223,,,135651198,Antagonist,Antagonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,9459568,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,tegaserod,226,,,135651238,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15466450,CCCCCN=C(NN/C=C/1C=Nc2c1cc(OC)cc2)N
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,trazodone,213,,,135651275,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,15322733,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,volinanserin,185,,,135650573,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15322733,COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,xanomeline,57,,,135651331,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>2B</sub> receptor,7,Htr2b,P30994,,,,,,Rat,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,8450835,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,7.9,0,7.4,,0,0,0,,,,,8078486,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>2B</sub> receptor,7,HTR2B,P41595,,,,,,Human,[<sup>3</sup>H]mesulergine,232,,,135651175,Antagonist,Inverse agonist,,f,f,,pKd,0,7.900000095,0,Kd,0,12.89999962,0,=,,,,15322733,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)CS(=O)(=O)N(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,[<sup>125</sup>I]DOI,169,,,135651107,Agonist,Full agonist,,f,f,,pKd,9,0,8.699999809,Kd,2,0,1.100000024,=,,,,10217294,COc1cc([125I])c(cc1CC(N)C)OC
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,[<sup>125</sup>I]DOI,169,,,135651107,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,11101361,COc1cc([125I])c(cc1CC(N)C)OC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,7.8,0,6.5,,0,0,0,,,,,15322733,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,7.2,0,5.6,,0,0,0,,,,,15322733,NCCc1c[nH]c2c1cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,VER-3323,168,,,135651304,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,15322733,C[C@@H](CN1CCc2c1cc(Br)cc2)N
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,WAY-163909,229,,,135651322,Agonist,Full agonist,,f,f,,pKi,8,0,6.699999809,Ki,199,0,10,=,,,,15705738,C1C[C@@H]2[C@H](C1)c1c3N2CCNCc3ccc1
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,YM348,230,,,135651344,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,14709324,CCc1oc2c(c1)c1c(cc2)cnn1C[C@@H](N)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,t,,pKi,7.300000191,0,7.199999809,-,0,0,0,=,,,,12629531,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>2C</sub> receptor,8,Htr2c,P08909,,,,,,Rat,trazodone,213,,,135651275,Antagonist,Antagonist,,f,,,pKi,6.7,0,6.4,,0,0,0,,,,,11104741,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,trazodone,213,,,135651275,Antagonist,Antagonist,,f,t,,pKi,0,6.599999905,0,-,0,0,0,=,,,,15322733,Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,trifluoperazine,214,,,135651279,Antagonist,Antagonist,,f,f,,pKi,0,6.400000095,0,-,0,0,0,=,,,,12629531,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,volinanserin,185,,,135650573,Antagonist,Antagonist,,f,,,pKi,7.7,0,7.5,,0,0,0,,,,,15322733,COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,xanomeline,57,,,135651331,Antagonist,Antagonist,,f,,,pKi,0,7.4,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,[<sup>3</sup>H]mesulergine,232,,,135651175,Antagonist,Inverse agonist,,f,,,pKd,9.3,0,8.7,Kd,2.2,0,0.5,=,,,,12738034,CN1CC(CC2C1Cc1cn(c3c1c2ccc3)C)CS(=O)(=O)N(C)C
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,tiospirone,101,,,135651264,Antagonist,Inverse agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,10991983,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,ziprasidone,59,,,135651359,Antagonist,Inverse agonist,,f,t,,pKi,9.010000229,0,7.900000095,-,0,0,0,=,,,,12629531,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>2C</sub> receptor,8,HTR2C,P28335,,,,,,Human,zotepine,103,,,135651367,Antagonist,Inverse agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,10991983,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,[<sup>3</sup>H]<i>meta</i>-chlorophenylbiguanide,2304,,,135651162,Agonist,Partial agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,9517385,Clc1cccc(c1)N=C(N=C(N)N)N
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Biphasic,"Positive (1-10&mu;M): increased potency of 5-HT, decreased desensitization rate, reduced effect in the presence of Mg<sup>2+</sup> or Ca<sup>2+</sup>.
Negative (30-300&mu;M). ",t,,1-300,-,0,0,0,,0,0,0,,,,,7620711,
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,trichloroethanol,2293,,,135651278,Allosteric modulator,Positive,"increased channel activation rate, decreased desensitization rate, decreased deactivation rate. ",f,,250-10000,-,0,0,0,,0,0,0,,,,,16257471,OCC(Cl)(Cl)Cl
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,[<sup>3</sup>H]GR65630,2303,,,135651156,Antagonist,Antagonist,,f,f,,pKd,9.319999695,0,8.590000153,Kd,2.559999943,0,0.479999989,=,,,,9463477,O=C(c1cn(c2c1cccc2)C)CCc1nc[nH]c1C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,[<sup>3</sup>H]granisetron,2292,,,135651157,Antagonist,Antagonist,,f,,,pKd,0,8.9,0,Kd,0,1.2,0,,,,,11489465,CN1C2CCCC1CC(C2)NC(=O)c1nn(c2c1cccc2)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,[<sup>3</sup>H](<i>S</i>)-zacopride,4074,,,178100897,Antagonist,Antagonist,,f,,,pKd,0,8.7,0,Kd,0,2,0,=,,,,8994113,C([3H])(Oc1cc(N)c(cc1C(=O)N[C@@H]1CN2CCC1CC2)Cl)([3H])[3H]
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,[<sup>3</sup>H]LY278584,4087,,,178100910,Antagonist,Antagonist,,f,,,pKd,0,8.51,0,Kd,0,3.08,0,=,,,,8419547,CN1[C@@H]2CC[C@H]1CC(C2)NC(=O)c1nn(c2c1cccc2)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,[<sup>3</sup>H]ramosetron,2305,,,135651197,Antagonist,Antagonist,,f,,,pKd,0,9.8,0,Kd,0,0.15,0,,,,,7565620,O=C(c1cn(c2c1cccc2)C([3H])([3H])[3H])[C@@H]1CCc2c(C1)[nH]cn2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,t,,pKi,8.800000191,0,8.5,Ki,3,0,1.5,=,,,,7565620,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,tubocurarine,2294,,,135652723,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,11489465,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,tubocurarine,2294,,,135652723,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.6,,0,0,0,,,,,7790853,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,t,,pKi,0,8.430000305,0,Ki,0,3.700000048,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>3</sub>A,379,HTR3A,P46098,,,,,,Human,TMB-8,4323,,,178101140,Channel blocker,None,,f,,,pIC50,0,4.93,0,IC50,0,11760,0,=,,,,10381768,CCN(CCCCCCCCOC(=O)c1cc(OC)c(c(c1)OC)OC)CC
5-HT<sub>3</sub>A,379,Htr3a,P23979,,,,,,Mouse,TMB-8,4323,,,178101140,Channel blocker,None,,f,,,pIC50,5.35,0,5.08,IC50,8400,0,4500,=,,,,10381768,CCN(CCCCCCCCOC(=O)c1cc(OC)c(c(c1)OC)OC)CC
5-HT<sub>3</sub>AB,378,Htr3b|Htr3a,P23979|Q9JHJ5,,,,,,Mouse,trichloroethanol,2293,,,135651278,Allosteric modulator,Positive,increased rate of channel activation,f,,250-10000,-,0,0,0,,0,0,0,,,,,16257471,OCC(Cl)(Cl)Cl
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,[<sup>3</sup>H]granisetron,2292,,,135651157,Antagonist,Antagonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,11489465,CN1C2CCCC1CC(C2)NC(=O)c1nn(c2c1cccc2)C
5-HT<sub>3</sub>AB,378,HTR3B|HTR3A,P46098|O95264,,,,,,Human,tubocurarine,2294,,,135652723,Antagonist,Antagonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,11489465,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,TD-8954,8426,,,252166636,Agonist,Agonist,,f,t,,pKi,0,9.399999619,0,-,0,0,0,=,,,,23756062,COC(=O)N1CCC(CC1)CN1CCC(CC1)CNC(=O)c1cccc2c1nc([nH]2)C(C)C
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,velusetrag,8425,,,252166635,Agonist,Agonist,,f,t,,pKi,0,7.699999809,0,-,0,0,0,=,,,,22959244,O[C@@H](CN(S(=O)(=O)C)C)CN1[C@@H]2CC[C@H]1CC(C2)NC(=O)c1cc2ccccc2n(c1=O)C(C)C
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Agonist,,f,f,,pIC50,0,6.599999905,0,IC50,0,252,0,=,,,,15341484,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,zacopride,245,,,135651353,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,8946946,COc1cc(N)c(cc1C(=O)NC1CN2CCC1CC2)Cl
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,zacopride,245,,,135651353,Agonist,Full agonist,,f,,,pKi,6.9,0,5.9,,0,0,0,,,,,8813606,COc1cc(N)c(cc1C(=O)NC1CN2CCC1CC2)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,zacopride,245,,,135651353,Agonist,Full agonist,,f,,,pKi,6.6,0,4.9,,0,0,0,,,,,7796807,COc1cc(N)c(cc1C(=O)NC1CN2CCC1CC2)Cl
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,[<sup>3</sup>H]RS 57639,239,,,135651199,Agonist,Partial agonist,,f,f,,pKd,0,9.300000191,0,-,0,0,0,=,,,,9225293,COc1cc(N)c(cc1C(=O)OCC1CCN(CC1)CCCc1ccc2c(c1)OCCO2)Cl
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,tegaserod,226,,,135651238,Agonist,Partial agonist,,f,,,pKi,8.4,0,7.6,,0,0,0,,,,,15466450,CCCCCN=C(NN/C=C/1C=Nc2c1cc(OC)cc2)N
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,[<sup>11</sup>C]SB207145,3244,,,178100293,Antagonist,Antagonist,,f,f,,pKd,0,8.600000381,0,Kd,0,2.799999952,0,=,,,,21831646,[11C]N1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N
5-HT<sub>4</sub> receptor,9,,,,,,,,Pig,[<sup>123</sup>I]SB 207710,3243,,,135651099,Antagonist,Antagonist,,f,f,,pKd,0,10.06999969,0,Kd,0,0.086000003,0,=,,,,0,CCCCN1CCC(CC1)COC(=O)c1cc([123I])c(c2c1OCCO2)N
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,[<sup>3</sup>H]GR 113808,259,,,135651154,Antagonist,Antagonist,,f,f,,pKd,9.300000191,0,9,-,0,0,0,=,,,,8813606,O=C(c1cn(c2c1cccc2)C([3H])([3H])[3H])OCC1CCN(CC1)CCNS(=O)(=O)C
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,[<sup>3</sup>H]GR 113808,259,,,135651154,Antagonist,Antagonist,,f,,,pKd,10.3,0,9.7,Kd,0.2,0,0.05,=,,,,9349523,O=C(c1cn(c2c1cccc2)C([3H])([3H])[3H])OCC1CCN(CC1)CCNS(=O)(=O)C
5-HT<sub>4</sub> receptor,9,,,,,,,,Guinea pig,[<sup>3</sup>H]RS 57639,239,,,135651199,Antagonist,Antagonist,,f,f,,pKd,0,9.699999809,0,Kd,0,0.200000003,0,=,,,,9225293,COc1cc(N)c(cc1C(=O)OCC1CCN(CC1)CCCc1ccc2c(c1)OCCO2)Cl
5-HT<sub>4</sub> receptor,9,Htr4,Q62758,,,,,,Rat,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8813606,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
5-HT<sub>4</sub> receptor,9,HTR4,Q13639,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.3,,0,0,0,,,,,9349523,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
5-HT<sub>4</sub> receptor,9,Htr4,P97288,,,,,,Mouse,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,8946946,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,8450829,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,sumatriptan,54,,,135651095,Agonist,Full agonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,7988681,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,[<sup>125</sup>I]LSD,261,,,135651112,Agonist,Full agonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,11343685,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)[125I])CC
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,[<sup>3</sup>H]5-CT,262,,,135651128,Agonist,Full agonist,,f,,,pKd,0,8.6,0,Kd,0,2.5,0,=,,,,11343685,NC(=O)c1ccc2c(c1)c(c[nH]2)C(C(N)([3H])[3H])([3H])[3H]
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8450829,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,f,,pKi,0,6.659999847,0,Ki,0,220,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>5A</sub> receptor,10,Htr5a,P30966,,,,,,Mouse,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,6,0,4.9,,0,0,0,,,,,8450829,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>5A</sub> receptor,10,HTR5A,P47898,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,5.3,0,,0,0,0,,,,,7988681,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-ht<sub>5b</sub> receptor,648,Htr5b,P31387,,,,,,Mouse,[<sup>125</sup>I]LSD,261,,,135651112,Agonist,Full agonist,,f,f,,pKd,0,9.329999924,0,Kd,0,0.469999999,0,=,,,,8450829,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)[125I])CC
5-ht<sub>5b</sub> receptor,648,Htr5b,P31387,,,,,,Mouse,[<sup>3</sup>H]5-CT,262,,,135651128,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,9928243,NC(=O)c1ccc2c(c1)c(c[nH]2)C(C(N)([3H])[3H])([3H])[3H]
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,[<sup>3</sup>H]5-CT,262,,,135651128,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)c1ccc2c(c1)c(c[nH]2)C(C(N)([3H])[3H])([3H])[3H]
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,WAY-181187,3240,,,178100291,Agonist,Agonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,17625499,NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,WAY-208466,8429,,,252166639,Agonist,Agonist,,f,t,,pKi,0,8.319999695,0,Ki,0,4.800000191,0,=,,,,19523834,CN(CCn1cc(c2c1nccc2)S(=O)(=O)c1cccc(c1)F)C
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Full agonist,,f,,,pKd,0,8.7,0,Kd,0,2,0,=,,,,9284367,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Full agonist,,f,,,pKd,8.7,0,8.6,,0,0,0,,,,,9225298,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,7680751,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,8522988,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,6.8,0,5.8,,0,0,0,,,,,7680751,NCCc1c[nH]c2c1cccc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,5.9,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,sumatriptan,54,,,135651095,Antagonist,Antagonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9798944,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,sumatriptan,54,,,135651095,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8522988,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,[<sup>11</sup>C]GSK215083,8430,,,252166640,Antagonist,Antagonist,,f,f,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,,,,22223878,[11CH3]N1CCN(CC1)c1cccc2c1ncc(c2)S(=O)(=O)c1cccc(c1)F
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,[<sup>125</sup>I]SB258585,3245,,,178100294,Antagonist,Antagonist,,f,f,,pKd,0,9,0,Kd,0,1,0,=,,,,17069795,COc1ccc(cc1N1CCN(CC1)C)NS(=O)(=O)c1ccc(cc1)[125I]
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,[<sup>3</sup>H]Ro 63-0563,3246,,,178100295,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,Kd,0,5,0,=,,,,9730917,CNc1cc(cc(n1)NC)NS(=O)(=O)c1ccc(cc1)N
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,tiospirone,101,,,135651264,Antagonist,Antagonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,7908055,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,tiospirone,101,,,135651264,Antagonist,Antagonist,,f,,,pKi,0,6,0,,0,0,0,,,,,8522988,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,f,,pKi,0,6.480000019,0,Ki,0,330,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Inverse agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,15821958,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,thioridazine,100,,,135651259,Antagonist,Inverse agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,7908055,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>6</sub> receptor,11,HTR6,P50406,,,,,,Human,zotepine,103,,,135651367,Antagonist,Inverse agonist,,f,,,pKi,0,8.3,0,,0,0,0,,,,,15821958,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>6</sub> receptor,11,Htr6,P31388,,,,,,Rat,zotepine,103,,,135651367,Antagonist,Inverse agonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,7908055,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,[<sup>3</sup>H]5-CT,262,,,135651128,Agonist,Agonist,,f,,,pKd,0,9.4,0,Kd,0,0.4,0,=,,,,10807680,NC(=O)c1ccc2c(c1)c(c[nH]2)C(C(N)([3H])[3H])([3H])[3H]
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,[<sup>125</sup>I]LSD,261,,,135651112,Agonist,Full agonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,8398139,CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)[125I])CC
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,[<sup>3</sup>H]5-HT,3248,,,135651129,Agonist,Full agonist,,f,,,pKd,9,0,8.1,Kd,7.94,0,1,=,,,,9303561,C([3H])(C(c1c[nH]c2c1cc(O)cc2)[3H])N
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Full agonist,,f,,,pKd,0,8.2,0,-,0,0,0,=,,,,10327430,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,[<sup>3</sup>H]LSD,219,,,135651170,Agonist,Full agonist,,f,,,pKd,8.6,0,8.5,Kd,3.16,0,2.51,=,,,,9303561,CCN(C(=O)[C@H]1CN([C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C([3H])([3H])[3H])CC
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,TFMPP,115,,,135651253,Agonist,Full agonist,,f,,,pKi,6.6,0,6.3,,0,0,0,,,,,8394362,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,7.8,0,7.5,,0,0,0,,,,,8394362,NCCc1c[nH]c2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,tryptamine,125,,,135651581,Agonist,Full agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,8226867,NCCc1c[nH]c2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,0,6.9,0,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,sumatriptan,54,,,135651095,Antagonist,Antagonist,,f,,,pKi,6,0,5.7,,0,0,0,,,,,9298538,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,sumatriptan,54,,,135651095,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.2,,0,0,0,,,,,8394362,CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,[<sup>3</sup>H]SB269970,3247,,,178100296,Antagonist,Antagonist,,f,,,pKd,0,8.92,0,Kd,0,1.2,0,=,,,,10807680,CC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1cccc(c1)O
5-HT<sub>7</sub> receptor,12,Htr7,P32304,,,,,,Mouse,TFMPP,115,,,135651253,Antagonist,Antagonist,,f,,,pKi,0,6.3,0,,0,0,0,,,,,8394987,FC(c1cccc(c1)N1CCNCC1)(F)F
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,tiospirone,101,,,135651264,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,7908055,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,vortioxetine,7351,,,178103923,Antagonist,Antagonist,,f,t,,pKi,0,6.349999905,0,Ki,0,450,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,8226867,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,thioridazine,100,,,135651259,Antagonist,Inverse agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,7908055,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Inverse agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,15821958,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,ziprasidone,59,,,135651359,Antagonist,Inverse agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15821958,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
5-HT<sub>7</sub> receptor,12,HTR7,P34969,,,,,,Human,zotepine,103,,,135651367,Antagonist,Inverse agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,15821958,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-HT<sub>7</sub> receptor,12,Htr7,P32305,,,,,,Rat,zotepine,103,,,135651367,Antagonist,Inverse agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,7908055,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
5-LOX,1385,ALOX5,P09917,,,,,,Human,zileuton,5297,,,178101979,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,ON(C(c1cc2c(s1)cccc2)C)C(=O)N
ABCC1,779,ABCC1,P33527,,,,,,Human,WP814,8762,,,252827420,Inhibitor,Inhibition,,f,f,,pKi,0,7.150000095,0,Ki,0,70,0,=,,,,9647783,COc1cccc2c1C(=O)c1c(O)c3[C@@H](O)C[C@](Cc3c(c1C2=O)O)(O)C(=O)CSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N
acetylcholinesterase (Cartwright blood group),2465,ACHE,P22303,,,,,,Human,tacrine,6687,,,178103299,Inhibitor,Inhibition,,f,t,,pKi,0,7.5,0,Ki,0,30,0,=,,,,18479118,Nc1c2CCCCc2nc2c1cccc2
Acetyl-CoA carboxylase 1,1263,ACACA,Q13085,,,,,,Human,TOFA,5280,,,178101963,Inhibitor,Inhibition,,f,f,,pIC50,0,4.909999847,0,IC50,0,12300,0,=,,,,14612531,CCCCCCCCCCCCCCOc1ccc(o1)C(=O)O
Acetyl-CoA carboxylase 2,1264,ACACB,O00763,,,,,,Human,TOFA,5280,,,178101963,Inhibitor,Inhibition,,f,f,,pIC50,0,4.909999847,0,IC50,0,12300,0,=,,,,14612531,CCCCCCCCCCCCCCOc1ccc(o1)C(=O)O
AcetylCoA transporter,1134,SLC33A1,O00400,,,,,,Human,[<sup>14</sup>C]acetylCoA,4541,,,178101262,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C(NCCS[14C](=O)C)CCNC(=O)[C@@H](C(COP(=O)(OP(=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1OP(=O)(O)O)O)n1cnc2c1ncnc2N)O)O)(C)C)O
ACKR3,80,ACKR3,P25106,,,,,,Human,TC14012,2902,,,135652600,Agonist,Agonist,,f,,,pEC50,0,6.46,0,,0,0,0,,,,,20956518,
activin A receptor type 1B,1787,ACVR1B,P36896,,,,,,Human,vactosertib,8107,,,249565787,Inhibitor,Inhibition,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,Measured using Reaction Biology Corporation's HotSpot kinase assay,,,24786585,Cc1cccc(n1)c1[nH]c(nc1c1ccc2n(c1)ncn2)CNc1ccccc1F
AKR1C3,1382,AKR1C3,P42330,,,,,,Human,tolfenamic acid,8769,,,252827427,Inhibitor,Inhibition,,f,f,,pKi,0,8.100000381,0,Ki,0,8,0,=,,,,17166832,OC(=O)c1ccccc1Nc1cccc(c1C)Cl
AKT serine/threonine kinase 1,1479,AKT1,P31749,,,,,,Human,uprosertib,7902,,,249565585,Inhibitor,Inhibition,,f,t,,pKi,0,10.18000031,0,Ki,0,0.066,0,=,,,,24978597,NC[C@@H](NC(=O)c1oc(c(c1)c1c(Cl)cnn1C)Cl)Cc1ccc(c(c1)F)F
AKT serine/threonine kinase 2,1480,AKT2,P31751,,,,,,Human,uprosertib,7902,,,249565585,Inhibitor,Inhibition,,f,t,,pKi,0,8.850000381,0,Ki,0,1.399999976,0,=,,,,24978597,NC[C@@H](NC(=O)c1oc(c(c1)c1c(Cl)cnn1C)Cl)Cc1ccc(c(c1)F)F
AKT serine/threonine kinase 3,2286,AKT3,Q9Y243,,,,,,Human,uprosertib,7902,,,249565585,Inhibitor,Inhibition,,f,t,,pKi,0,8.819999695,0,Ki,0,1.5,0,=,,,,24978597,NC[C@@H](NC(=O)c1oc(c(c1)c1c(Cl)cnn1C)Cl)Cc1ccc(c(c1)F)F
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,tolrestat,7404,,,178103976,Inhibitor,Inhibition,,f,t,,pIC50,0,7.329999924,0,IC50,0,47,0,=,,,,10737739,COc1ccc2c(c1C(F)(F)F)cccc2C(=S)N(CC(=O)O)C
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,zenarestat,7418,,,178103990,Inhibitor,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,9900,0,=,<i>In vitro</i> inhibition of recombinant human aldehyde reductase,,,15857120,Brc1ccc(c(c1)F)Cn1c(=O)c2ccc(cc2n(c1=O)CC(=O)O)Cl
aldo-keto reductase family 1 member B,2768,AKR1B1,P15121,,,,,,Human,zopolrestat,7419,,,178103991,Inhibitor,Inhibition,,f,f,,pIC50,0,4.409999847,0,IC50,0,38600,0,=,<i>In vitro</i> inhibition of recombinant human aldehyde reductase,,,15857120,OC(=O)Cc1nn(Cc2nc3c(s2)ccc(c3)C(F)(F)F)c(=O)c2c1cccc2
&alpha;&beta;-Hydrolase 6,2919,ABHD6,Q9BV23,,,,,,Human,WWL123,9480,,,329968420,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,-,0,0,0,=,,,,21084632,O=C(N(Cc1cccc(c1)c1ccccc1)C)Oc1cccc(c1)c1ccc(cc1)C(=O)N
&alpha;&beta;-Hydrolase 6,2919,ABHD6,Q9BV23,,,,,,Human,WWL70,5289,,,178101972,Inhibitor,Inhibition,,f,f,,pIC50,0,7.199999809,0,-,0,0,0,=,,,,17629278,O=C(N(Cc1cccc(c1)c1ccncc1)C)Oc1ccc(cc1)c1ccc(cc1)C(=O)N
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,[<sup>125</sup>I]HEAT,482,,,135651109,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,7651358,Oc1ccc(c(c1)[125I])CCNCC1CCc2c(C1=O)cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,[<sup>125</sup>I]BE-2254,500,,,135651103,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,11337028,O=C1C(CNCCc2ccc(c(c2)[125I])O)CCc2c1cccc2
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,tamsulosin,488,,,135651350,Antagonist,Antagonist,,f,t,,pKi,10.69999981,0,10,-,0,0,0,=,,,,9249248,CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,terazosin,7302,,,178103875,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,=,,,,9379432,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,upidosin,496,,,135650891,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C
&alpha;<sub>1A</sub>-adrenoceptor,22,ADRA1A,P35348,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,9.8,0,9.7,,0,0,0,,,,,9249248,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>1A</sub>-adrenoceptor,22,Adra1a,P43140,,,,,,Rat,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,0,10.2,0,,0,0,0,,,,,11331292,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,[<sup>125</sup>I]HEAT,482,,,135651109,Agonist,Full agonist,,f,,,pKd,0,10.2,0,,0,0,0,,,,,7651358,Oc1ccc(c(c1)[125I])CCNCC1CCc2c(C1=O)cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,terazosin,7302,,,178103875,Antagonist,Antagonist,,f,t,,pKi,0,8.600000381,0,Ki,0,2.680000067,0,=,,,,9379432,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,upidosin,496,,,135650891,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,9,0,8.5,,0,0,0,,,,,9249248,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,[<sup>125</sup>I]BE-2254,500,,,135651103,Antagonist,Inverse agonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,11337028,O=C1C(CNCCc2ccc(c(c2)[125I])O)CCc2c1cccc2
&alpha;<sub>1B</sub>-adrenoceptor,23,ADRA1B,P35368,,,,,,Human,tamsulosin,488,,,135651350,Antagonist,Inverse agonist,,f,t,,pKi,9.699999809,0,9.5,-,0,0,0,=,,,,9249248,CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,[<sup>125</sup>I]HEAT,482,,,135651109,Agonist,Full agonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,7651358,Oc1ccc(c(c1)[125I])CCNCC1CCc2c(C1=O)cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,Adra1d,P23944,,,,,,Rat,xylometazoline,517,,,135651336,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,7969082,Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,[<sup>125</sup>I]BE-2254,500,,,135651103,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,7815325,O=C1C(CNCCc2ccc(c(c2)[125I])O)CCc2c1cccc2
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,tamsulosin,488,,,135651350,Antagonist,Antagonist,,f,t,,pKi,10.19999981,0,9.800000191,-,0,0,0,=,,,,9249248,CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,terazosin,7302,,,178103875,Antagonist,Antagonist,,f,t,,pKi,0,9.100000381,0,Ki,0,0.850000024,0,=,,,,9379432,COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,upidosin,496,,,135650891,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9249248,COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C
&alpha;<sub>1D</sub>-adrenoceptor,24,ADRA1D,P25100,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,9249248,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,xylazine,523,,,135651335,Agonist,Partial agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9605427,Cc1cccc(c1NC1=NCCCS1)C
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,[<sup>3</sup>H]MK-912,527,,,135651177,Antagonist,Antagonist,,f,f,,pKd,0,8.899999619,0,Kd,0,1.25,0,=,,,,7996470,O=C1N(C)[C@]2(CCN3[C@H](C2)c2oc4c(c2CC3)cccc4)CCN1C([3H])([3H])[3H]
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,[<sup>3</sup>H]rauwolscine,223,,,135651198,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,8819505,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,[<sup>3</sup>H]RX821002,528,,,135651200,Antagonist,Antagonist,,f,,,pKd,9.5,0,8.8,,0,0,0,,,,,8819505,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,tolazoline,7310,,,178103883,Antagonist,Antagonist,,f,t,,pKi,0,7.599999905,0,Ki,0,229,0,=,Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding,,,9605427,c1ccc(cc1)CC1=NCCN1
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,8.9,0,7.6,,0,0,0,,,,,7996470,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>2A</sub>-adrenoceptor,25,ADRA2A,P08913,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,t,,pKi,9.199999809,0,8.399999619,-,0,0,0,=,,,,7996470,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,xylazine,523,,,135651335,Agonist,Partial agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,9605427,Cc1cccc(c1NC1=NCCCS1)C
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,[<sup>3</sup>H]MK-912,527,,,135651177,Antagonist,Antagonist,,f,f,,pKd,0,8.899999619,0,Kd,0,1.360000014,0,=,,,,7996470,O=C1N(C)[C@]2(CCN3[C@H](C2)c2oc4c(c2CC3)cccc4)CCN1C([3H])([3H])[3H]
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,[<sup>3</sup>H]rauwolscine,223,,,135651198,Antagonist,Antagonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,8819505,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,[<sup>3</sup>H]RX821002,528,,,135651200,Antagonist,Antagonist,,f,,,pKd,9.1,0,8,,0,0,0,,,,,8819505,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,tolazoline,7310,,,178103883,Antagonist,Antagonist,,f,t,,pKi,0,5.5,0,Ki,0,3162,0,=,Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding,,,9605427,c1ccc(cc1)CC1=NCCN1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,,,pKi,8.4,0,7,,0,0,0,,,,,7996470,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,t,,pKi,8.899999619,0,7.900000095,-,0,0,0,=,,,,7996470,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2B</sub>-adrenoceptor,26,ADRA2B,P18089,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,f,,pKi,0,8.199999809,0,Ki,0,5.699999809,0,=,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,xylazine,523,,,135651335,Agonist,Partial agonist,,f,,,pKi,5.9,0,4.8,,0,0,0,,,,,9605427,Cc1cccc(c1NC1=NCCCS1)C
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,[<sup>3</sup>H]MK-912,527,,,135651177,Antagonist,Antagonist,,f,f,,pKd,0,10.10000038,0,Kd,0,0.086000003,0,=,,,,7996470,O=C1N(C)[C@]2(CCN3[C@H](C2)c2oc4c(c2CC3)cccc4)CCN1C([3H])([3H])[3H]
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,[<sup>3</sup>H]rauwolscine,223,,,135651198,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,8819505,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,[<sup>3</sup>H]RX821002,528,,,135651200,Antagonist,Antagonist,,f,,,pKd,9.2,0,8.2,,0,0,0,,,,,8819505,COC1(COc2c(O1)cccc2)C1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,tolazoline,7310,,,178103883,Antagonist,Antagonist,,f,t,,pKi,0,5.429999828,0,Ki,0,3715,0,=,Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding,,,9605427,c1ccc(cc1)CC1=NCCN1
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,WB 4101,499,,,135651323,Antagonist,Antagonist,,f,f,,pKi,9.399999619,0,8.399999619,-,0,0,0,=,,,,7996470,COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC
&alpha;<sub>2C</sub>-adrenoceptor,27,ADRA2C,P18825,,,,,,Human,yohimbine,102,,,135652727,Antagonist,Antagonist,,f,t,,pKi,9.5,0,8.5,-,0,0,0,=,,,,7996470,COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1
"amine oxidase, copper containing 3",2767,AOC3,Q16853,,,,,,Human,timolumab,9097,,,315661182,Antibody,Binding,,f,t,,pKd,9.890000343,0,9.420000076,Kd,0.379999995,0,0.129999995,=,Value varies slightly between a time-resolved immunofluorometric assay and real time direct binding assay using a BIACORE&reg; surface plasmon resonance assay.,,,0,
Ammonium transporter Rh type A,1198,RHAG,Q02094,,,,,,Human,[<sup>14</sup>C]methylamine,4624,,,178101342,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,12846905,[14C]N
Ammonium transporter Rh type C,1200,Rhcg,Q9QXP0,,,,,,Mouse,[<sup>14</sup>C]methylamine,4624,,,178101342,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,16131648,[14C]N
AM<sub>1</sub> receptor,49,CALCRL|RAMP2,Q16602|O60895,,,,,,Human,[<sup>125</sup>I]AM (rat),3768,,,178100618,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
AM<sub>2</sub> receptor,50,RAMP3|CALCRL,Q16602|O60896,,,,,,Human,[<sup>125</sup>I]AM (rat),3768,,,178100618,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,[<sup>125</sup>I]<i>&alpha;</i>CGRP (human),3766,,,178100616,Agonist,Agonist,,f,f,,pKd,10,0,9,-,0,0,0,=,,,,0,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,"[<sup>125</sup>I]BH-AMY (rat, mouse)",3770,,,178100620,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
AMY<sub>1</sub> receptor,44,CALCR|RAMP1,P30988|O60894,,,,,,Human,Tyr<sup>0</sup>&alpha;-CGRP (human),692,,,135652618,Agonist,Full agonist,,f,,,pEC50,9.5,0,7.6,,0,0,0,,,,,15692146,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,"[<sup>125</sup>I]BH-AMY (rat, mouse)",3770,,,178100620,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
AMY<sub>2</sub> receptor,45,CALCR|RAMP2,P30988|O60895,,,,,,Human,Tyr<sup>0</sup>&alpha;-CGRP (human),692,,,135652618,Agonist,Full agonist,,f,,,pEC50,0,8.3,0,,0,0,0,,,,,14722252,
AMY<sub>3</sub> receptor,46,CALCR|RAMP3,P30988|O60896,,,,,,Human,"[<sup>125</sup>I]BH-AMY (rat, mouse)",3770,,,178100620,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
Androgen receptor,628,AR,P10275,,,,,,Human,[<sup>3</sup>H]dihydrotestosterone,3455,,,178100453,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,[<sup>3</sup>H]methyltrienolone,3457,,,178100455,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CCC2=C3C=C[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C)O)C
Androgen receptor,628,AR,P10275,,,,,,Human,[<sup>3</sup>H]mibolerone,3456,,,178100454,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C1CC[C@H]2C(=C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C)C
Androgen receptor,628,Ar,P15207,,,,,,Rat,testosterone,2858,,,135651576,Agonist,Agonist,,t,,,pIC50,0,7.8,0,,0,0,0,,,,,14565775,O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C
Androgen receptor,628,AR,P10275,,,,,,Human,testosterone propionate,7100,,,178103678,Agonist,Agonist,,f,t,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,,,,17574413,CCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,trandolapril,6453,,,178103069,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,15,0,=,,,,7527095,CCOC(=O)[C@@H](N[C@H](C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(=O)O)C)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,trandolaprilat,6455,,,178103070,Inhibitor,Inhibition,,f,t,,pIC50,0,8.5,0,IC50,0,3.200000048,0,=,,,,7527095,C[C@@H](C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(=O)O)N[C@H](C(=O)O)CCc1ccccc1
Angiotensin-converting enzyme,1613,ACE,P12821,,,,,,Human,zofenopril,6462,,,178103076,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C(N1C[C@H](C[C@H]1C(=O)O)Sc1ccccc1)[C@@H](CSC(=O)c1ccccc1)C
Angiotensin-converting enzyme,1613,,,,,,,,Rabbit,zofenoprilat,6463,,,178103077,Inhibitor,Inhibition,,f,f,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,2836590,SC[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)O)Sc1ccccc1)C
Angiotensin-converting enzyme,1613,Ace,P47820,,,,,,Rat,zofenoprilat,6463,,,178103077,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,2836590,SC[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)O)Sc1ccccc1)C
Angiotensin-converting enzyme 2,1614,ACE2,Q9BYF1,,,,,,Human,XNT [PMID: 18391097],7867,,,223366197,Activator,Activation,,f,f,,pEC50,0,4.699999809,0,EC50,0,20100,0,=,,,,18391097,OCc1ccc(c2c1oc1ccc(cc1c2=O)OS(=O)(=O)c1ccc(cc1)C)NCCN(C)C
apelin receptor,36,APLNR,P35414,,,,,,Human,[<sup>125</sup>I]apelin-13,602,,,135652485,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.7,0,=,,,,12939143,
apelin receptor,36,APLNR,P35414,,,,,,Human,"[<sup>125</sup>I][Glp<sup>65</sup>Nle<sup>75</sup>,Tyr<sup>77</sup>]apelin-13",3761,,,178100612,Agonist,Full agonist,,f,,,pKd,0,10.7,0,Kd,0,0.0223,0,=,,,,10777510,
apelin receptor,36,APLNR,P35414,,,,,,Human,"[<sup>125</sup>I][Nle<sup>75</sup>,Tyr<sup>77</sup>]apelin-36 (human)",603,,,135652534,Agonist,Full agonist,,f,,,pKd,0,11.2,0,Kd,0,0.0063,0,=,,,,11336787,
apelin receptor,36,APLNR,P35414,,,,,,Human,[<sup>125</sup>I](Pyr<sup>1</sup>)apelin-13,601,,,135652548,Agonist,Full agonist,,f,,,pKd,0,9.5,0,Kd,0,0.3,0,=,,,,11250876,
apelin receptor,36,APLNR,P35414,,,,,,Human,[<sup>3</sup>H](Pyr<sup>1</sup>)[Met(0)11]-apelin-13,604,,,135652591,Agonist,Full agonist,,f,,,pKd,0,8.6,0,Kd,0,2.7,0,=,,,,12603839,
AQP1,688,AQP1,P29972,,,,,,Human,tetraethylammonium,2343,,,135651249,Inhibitor,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CC[N+](CC)(CC)CC
Aryl hydrocarbon receptor,2951,AHR,P35869,,,,,,Human,tapinarof,9686,,,348353645,Agonist,Agonist,,f,t,,pKd,7,0,6.699999809,Kd,200,0,100,=,Direct binding of tapinarof to the AhR-ARNT heterodimer by fluorescence assay.,,,28595996,CC(c1c(O)cc(cc1O)/C=C/c1ccccc1)C
Aryl hydrocarbon receptor,2951,AHR,P35869,,,,,,Human,TCDD,9642,,,340590272,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cc2Oc3cc(Cl)c(cc3Oc2cc1Cl)Cl
ASIC1,684,ASIC1,P78348,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,ASIC1a,f,,,pIC50,0,8.2,0,IC50,0,7,0,~,,,,0,
ASIC1,684,ASIC1,P78348,,,,,,Human,[<sup>125</sup>I]psalmotoxin 1,4073,,,178100896,None,None,ASIC1a,f,,,pKd,0,9.7,0,Kd,0,0.213,0,,,,,0,
ASIC3,686,ASIC3,Q9UHC3,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,pIC50,0,4.2,0,IC50,0,61000,0,,,,,0,
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,TCPA,5590,,,178102225,Agonist,Agonist,,f,f,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,,,,12672250,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=N/C(=O)Nc1ccccc1)nc2NC1CCCC1
A<sub>1</sub> receptor,18,,,,,,,,Pig,tecadenoson,5592,,,178102227,Agonist,Agonist,,f,t,,pKi,0,8.18999958,0,Ki,0,6.5,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,[<sup>3</sup>H]CCPA,379,,,135651141,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.631,0,=,,,,9920910,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,VPC171,8895,,,310264676,Allosteric modulator,Positive,,f,t,,-,0,0,0,-,0,0,0,=,,,,19514747,Nc1scc(c1C(=O)c1ccccc1)c1cccc(c1)C(F)(F)F
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,[<sup>3</sup>H]DPCPX,406,,,135651150,Antagonist,Antagonist,,f,,,pKd,9.2,0,8.4,Kd,1.2,0,0.6,,,,,9920910,C([3H])CC(n1c2nc([nH]c2c(=O)n(c1=O)C(CC[3H])[3H])C1CCCC1)[3H]
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,5.2,0,4.9,-,0,0,0,=,,,,7798201,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,5.06,0,4.85,Ki,14000,0,8740,=,,,,8230124,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,8.13,0,Ki,0,7.4,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,vipadenant,5612,,,178102246,Antagonist,Antagonist,,f,,,pKi,0,7.17,0,Ki,0,68,0,=,,,,19072055,Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N
A<sub>1</sub> receptor,18,Adora1,P25099,,,,,,Rat,VUF5574,3280,,,178100321,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,<,,,,9767636,COc1ccccc1NC(=O)Nc1nc(nc2c1cccc2)c1cccnc1
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,WRC-0571,8419,,,252166629,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,8632314,OC1CC2CC1C[C@H]2Nc1ncnc2c1nc(n2C)N(C(C)C)C
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKd,0,7.5,0,-,0,0,0,=,,,,19317449,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,7798201,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>1</sub> receptor,18,ADORA1,P30542,,,,,,Human,ZM-241385,405,,,135651364,Antagonist,Antagonist,,f,,,pKi,6.6,0,6.1,-,0,0,0,=,,,,9933143,Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,TCPA,5590,,,178102225,Agonist,Agonist,,f,,,pKi,0,6.68,0,Ki,0,210,0,=,,,,12672250,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=N/C(=O)Nc1ccccc1)nc2NC1CCCC1
A<sub>2A</sub> receptor,19,,,,,,,,Pig,tecadenoson,5592,,,178102227,Agonist,Agonist,,f,f,,pKi,0,5.639999866,0,Ki,0,2315,0,=,,,,16518376,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,"UK-432,097",8420,,,252166630,Agonist,Agonist,,f,f,,pKi,8.300000191,0,7.659999847,-,0,0,0,=,,,,21393508,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2NCC(c1ccccc1)c1ccccc1)C(=O)NCCNC(=O)NC1CCN(CC1)c1ccccn1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,[<sup>3</sup>H]CGS 21680,424,,,135651144,Agonist,Full agonist,,f,,,pKd,7.8,0,7.7,Kd,22,0,16,=,,,,2213023,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,[<sup>3</sup>H]NECA,425,,,135651187,Agonist,Full agonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,9459566,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,[<sup>125</sup>I]ZM-241385,430,,,135651119,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,-,0,0,0,=,,,,8848012,Oc1ccc(cc1[125I])CCNc1nc(N)n2c(n1)nc(n2)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,[<sup>3</sup>H]SCH 58261,431,,,135651205,Antagonist,Antagonist,,f,,,pKd,9,0,8.6,,0,0,0,,,,,9933143,Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,[<sup>3</sup>H]XAC,432,,,135651217,Antagonist,Antagonist,,f,,,pKd,0,8,0,,0,0,0,,,,,7775460,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,[<sup>3</sup>H]ZM 241385,455,,,135651218,Antagonist,Antagonist,,f,,,pKd,9.1,0,8.7,Kd,1.8,0,0.8,=,,,,11164377,c1([3H])cc(CCNc2nc(N)n3c(n2)nc(n3)c2ccco2)ccc1O
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,4.66,0,4.6,Ki,25300,0,22000,=,,,,8230124,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,theophylline,413,,,135651254,Antagonist,Antagonist,,f,t,,pKi,5.800000191,0,5.170000076,-,0,0,0,=,,,,9459566,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,5.61,0,Ki,0,2440,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,5.19,0,Ki,0,6410,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,tozadenant,5611,,,178102245,Antagonist,Antagonist,,f,t,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,24164628,COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,vipadenant,5612,,,178102246,Antagonist,Antagonist,,f,,,pKi,0,8.89,0,Ki,0,1.3,0,=,,,,19072055,Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,visnagin,433,,,135652726,Antagonist,Antagonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,8691424,COc1c2c(=O)cc(oc2cc2c1cco2)C
A<sub>2A</sub> receptor,19,Adora2a,P30543,,,,,,Rat,VUF5574,3280,,,178100321,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,<,,,,9767636,COc1ccccc1NC(=O)Nc1nc(nc2c1cccc2)c1cccnc1
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKi,9,0,8.4,-,0,0,0,=,,,,9459566,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>2A</sub> receptor,19,ADORA2A,P29274,,,,,,Human,ZM-241385,405,,,135651364,Antagonist,Antagonist,,f,,,pKi,9.1,0,8.8,-,0,0,0,=,,,,9933143,Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,TCPA,5590,,,178102225,Agonist,Agonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,9384502,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=N/C(=O)Nc1ccccc1)nc2NC1CCCC1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>125</sup>I]ABOPX,452,,,135651101,Antagonist,Antagonist,,f,,,pKd,0,7.4,0,,0,0,0,,,,,10496952,CCCn1c(=O)c2[nH]c(nc2n(c1=O)Cc1ccc(c(c1)[125I])N)c1ccc(cc1)OCC(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>3</sup>H]DPCPX,406,,,135651150,Antagonist,Antagonist,,f,,,pKd,0,7.4,0,,0,0,0,,,,,15194002,C([3H])CC(n1c2nc([nH]c2c(=O)n(c1=O)C(CC[3H])[3H])C1CCCC1)[3H]
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>3</sup>H]MRS1754,453,,,135651182,Antagonist,Antagonist,,f,,,pKd,0,9.8,0,Kd,0,0.158,0,=,,,,11266650,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>3</sup>H]OSIP339391,454,,,135651191,Antagonist,Antagonist,,f,,,pKd,0,9.8,0,,0,0,0,,,,,15194002,CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>3</sup>H]PSB603,5728,,,178102354,Antagonist,Antagonist,,f,,,pKd,0,9.4,0,-,0,0,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,[<sup>3</sup>H]PSB603,5728,,,178102354,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,-,0,0,0,=,,,,19569717,CCCn1c(=O)[nH]c2c(c1=O)[nH]c(n2)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(cc1)Cl
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,[<sup>3</sup>H]ZM 241385,455,,,135651218,Antagonist,Antagonist,,f,,,pKd,7.9,0,6.5,,0,0,0,,,,,11705449,c1([3H])cc(CCNc2nc(N)n3c(n2)nc(n3)c2ccco2)ccc1O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,theophylline,413,,,135651254,Antagonist,Antagonist,,f,t,,pKi,5.039999962,0,4.130000114,Ki,74000,0,9070,=,,,,16219300,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>2B</sub> receptor,20,Adora2b,Q60614,,,,,,Mouse,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,0,5.25,0,Ki,0,5630,0,=,,,,19141710,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,7.05,0,Ki,0,90,0,=,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,vipadenant,5612,,,178102246,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,Ki,0,63,0,=,,,,19072055,Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKi,8.8,0,6.9,-,0,0,0,=,,,,9459566,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,f,,pA2,0,7.900000095,0,-,0,0,0,=,,,,8937736,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,XCC,451,,,135651332,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,11266650,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O
A<sub>2B</sub> receptor,20,ADORA2B,P29275,,,,,,Human,ZM-241385,405,,,135651364,Antagonist,Antagonist,,f,,,pKi,8.2,0,6.8,,0,0,0,,,,,10496952,Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,TCPA,5590,,,178102225,Agonist,Agonist,,f,,,pKi,0,6.22,0,Ki,0,600,0,=,,,,12672250,OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=N/C(=O)Nc1ccccc1)nc2NC1CCCC1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,[<sup>125</sup>I]AB-MECA,436,,,135651100,Agonist,Full agonist,,f,,,pKd,0,8.9,0,-,0,0,0,=,,,,7929142,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(c(c1)[125I])N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>125</sup>I]AB-MECA,436,,,135651100,Agonist,Full agonist,,f,,,pKd,9.1,0,9,Kd,1,0,0.6,=,,,,9933143,CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1ccc(c(c1)[125I])N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>125</sup>I]APNEA,462,,,135651138,Agonist,Full agonist,,f,,,pKd,0,7.8,0,,0,0,0,,,,,1323836,OCC1OC(C(C1O)O)n1cnc2c1ncnc2NCCc1ccc(cc1)N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>3</sup>H]HEMADO,5736,,,178102362,Agonist,Full agonist,,f,,,pKd,0,9,0,-,0,0,0,=,,,,17126322,CCCCC#Cc1nc(NC)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>3</sup>H]NECA,425,,,135651187,Agonist,Full agonist,,f,,,pKd,8.2,0,7.9,,0,0,0,,,,,9459566,CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>3</sup>H]MRE 3008F20,477,,,135651181,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,10779381,CCCn1cc2c(n1)nc(n1c2nc(n1)c1ccco1)NC(=O)Nc1ccc(cc1)OC
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,[<sup>3</sup>H]PSB-11,5729,,,178102355,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,-,0,0,0,=,,,,11814828,CCC1Cn2c(=N1)c1[nH]c(nc1n(c2=O)C)c1ccccc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,4.65,0,4.06,Ki,86400,0,22300,=,,,,9459566,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,theophylline,413,,,135651254,Antagonist,Antagonist,,f,,,pKi,4.07,0,4,Ki,100000,0,85000,=,,,,8022403,Cn1c(=O)n(C)c2c(c1=O)[nH]cn2
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,tonapofylline,5605,,,178102239,Antagonist,Antagonist,,f,,,pKi,0,5,0,Ki,0,10000,0,>,,,,17125264,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,vipadenant,5612,,,178102246,Antagonist,Antagonist,,f,,,pKi,0,6,0,Ki,0,1005,0,=,,,,19072055,Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,visnagin,433,,,135652726,Antagonist,Antagonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,8691424,COc1c2c(=O)cc(oc2cc2c1cco2)C
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,VUF5574,3280,,,178100321,Antagonist,Antagonist,,f,,,pKi,0,8.39,0,Ki,0,4.03,0,=,,,,10841801,COc1ccccc1NC(=O)Nc1nc(nc2c1cccc2)c1cccnc1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,VUF8504,475,,,135651315,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,9767637,COc1ccc(cc1)C(=O)Nc1nc(nc2c1cccc2)c1ccccn1
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,VUF8507,476,,,135651316,Antagonist,Antagonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,9767637,O=C(c1ccccc1)Nc1nc(cc2c1cccc2)c1ccccn1
A<sub>3</sub> receptor,21,Adora3,P28647,,,,,,Rat,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,7929142,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,xanthine amine congener,404,,,135651329,Antagonist,Antagonist,,f,,,pKi,7.4,0,7,-,0,0,0,=,,,,8234299,CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN
A<sub>3</sub> receptor,21,ADORA3,P0DMS8,,,,,,Human,ZM-241385,405,,,135651364,Antagonist,Antagonist,,f,,,pKi,0,6.13,0,Ki,0,743,0,=,,,,16518376,Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1
ATR serine/threonine kinase,1935,ATR,Q13535,,,,,,Human,VE-821,8042,,,249565722,Inhibitor,Inhibition,,f,t,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,21490603,O=C(c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C)Nc1ccccc1
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>125</sup>I][Sar<sup>1</sup>]Ang-II,6897,,,178103479,Agonist,Full agonist,,f,f,,pKd,0,9.479999542,0,Kd,0,0.330000013,0,=,,,,7759541,
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,"[<sup>125</sup>I][Sar<sup>1</sup>,Ile<sup>8</sup>]Ang-II",6906,,,178103488,Agonist,Partial agonist,,f,f,,pKd,0,9.430000305,0,Kd,0,0.370000005,0,=,,,,7759541,
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>125</sup>I]EXP985,3942,,,178100770,Antagonist,Antagonist,,f,,,pKd,0,8.83,0,Kd,0,1.49,0,=,,,,1445340,CCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1[nH]nnn1)C(=O)NCCc1ccc(c(c1)[125I])O)Cl
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>3</sup>H]A81988,3938,,,178100766,Antagonist,Antagonist,,f,,,pKd,0,9.24,0,Kd,0,0.57,0,=,,,,8206129,CCCN(c1ncccc1C(=O)O)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,[<sup>3</sup>H]candesartan,6907,,,178103489,Antagonist,Antagonist,,f,,,pKd,0,10.28999996,0,-,0,0,0,=,,,,10079018,CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>3</sup>H]eprosartan,3940,,,178100768,Antagonist,Antagonist,,f,f,,pKd,0,9.100000381,0,Kd,0,0.829999983,0,=,,,,8463997,CCCCc1ncc(n1Cc1ccc(cc1)C(=O)O)/C=C(/C(=O)O)Cc1cccs1
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,[<sup>3</sup>H]irbesartan,6908,,,178103490,Antagonist,Antagonist,,f,,,pKd,0,8.710000038,0,-,0,0,0,=,,,,11967808,CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>3</sup>H]L158809,3939,,,178100767,Antagonist,Antagonist,,f,,,pKd,0,9.18,0,Kd,0,0.66,0,=,,,,1480133,CCc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1[nH]nnn1)nc(cc2C)C
AT<sub>1</sub> receptor,34,Agtr1b|Agtr1a,P29089|P25095,,,,,,Rat,[<sup>3</sup>H]losartan,3941,,,178100769,Antagonist,Antagonist,,f,,,pKd,0,8.21,0,Kd,0,6.2,0,=,,,,8282008,CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,[<sup>3</sup>H]valsartan,593,,,135651214,Antagonist,Antagonist,,f,,,pIC50,9,0,8.8,IC50,1.58,0,1,=,,,,11206708,CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,tasosartan,6898,,,178103480,Antagonist,Antagonist,,f,,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,11046101,Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,telmisartan,592,,,135651242,Antagonist,Antagonist,,f,t,,pIC50,0,8.399999619,0,-,0,0,0,=,,,,9878991,CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,TRV120027,6902,,,178103484,Antagonist,Antagonist,,f,,,pKd,0,7.71999979,0,Kd,0,19,0,=,,,,20801892,
AT<sub>1</sub> receptor,34,AGTR1,P30556,,,,,,Human,valsartan,3937,,,178100765,Antagonist,Antagonist,,f,t,,pIC50,0,8.609999657,0,IC50,0,2.430000067,0,=,,,,8577935,CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1
AT<sub>1</sub> receptor,34,,,,,,,,Guinea pig,ZD-7155,8324,,,252166536,Antagonist,Antagonist,,f,f,,pIC50,0,8.420000076,0,IC50,0,3.799999952,0,=,,,,8576904,CCc1nc(CC)c2c(c1)N(Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)C(=O)CC2
AT<sub>2</sub> receptor,35,AGTR2,P50052,,,,,,Human,[<sup>125</sup>I]CGP42112,594,,,135652503,Agonist,Full agonist,,f,,,pKd,0,10.6,0,Kd,0,0.0251,0,=,,,,2775266,CC[C@@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cccnc1)Cc1ccc(cc1)O)CCCCNC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)Cc1[nH]cnc1)C
AT<sub>2</sub> receptor,35,Agtr2,P35351,,,,,,Rat,"[<sup>125</sup>I][Sar<sup>1</sup>,Ile<sup>8</sup>]Ang-II",6906,,,178103488,Agonist,Full agonist,,f,f,,pKd,8.770000458,0,7.760000229,Kd,17.39999962,0,1.700000048,=,,,,10024318,
aurora kinase A,1936,AURKA,O14965,,,,,,Human,tozasertib,5718,,,178102344,Inhibitor,Inhibition,,f,t,,pKd,0,8.409999847,0,Kd,0,3.900000095,0,=,,,,22037378,CN1CCN(CC1)c1nc(Sc2ccc(cc2)NC(=O)C2CC2)nc(c1)Nc1[nH]nc(c1)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,tozasertib,5718,,,178102344,Inhibitor,Inhibition,,f,t,,pKi,0,9.220000267,0,Ki,0,0.600000024,0,=,,,,14981513,CN1CCN(CC1)c1nc(Sc2ccc(cc2)NC(=O)C2CC2)nc(c1)Nc1[nH]nc(c1)C
aurora kinase A,1936,AURKA,O14965,,,,,,Human,TP-0903,8863,,,252827520,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,22247788,CN1CCN(CC1)Cc1ccc(cc1)Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)N(C)C)Cl
aurora kinase A,1936,AURKA,O14965,,,,,,Human,VTX-11e,9375,,,328083477,Inhibitor,Inhibition,,f,f,,pKi,0,6.269999981,0,Ki,0,540,0,=,,,,19827834,OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1nc(ncc1C)Nc1ccc(cc1Cl)F
aurora kinase A,1936,AURKA,O14965,,,,,,Human,ZM447439,8353,,,252166565,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,12719470,COc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(cc1)NC(=O)c1ccccc1
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,17850214,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,tozasertib,5718,,,178102344,Inhibitor,Inhibition,,f,t,,pKi,0,7.739999771,0,Ki,0,18,0,=,,,,14981513,CN1CCN(CC1)c1nc(Sc2ccc(cc2)NC(=O)C2CC2)nc(c1)Nc1[nH]nc(c1)C
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,TP-0903,8863,,,252827520,Inhibitor,Inhibition,,f,f,,pIC50,0,7.909999847,0,IC50,0,12.39999962,0,=,,,,22247788,CN1CCN(CC1)Cc1ccc(cc1)Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)N(C)C)Cl
aurora kinase B,1937,AURKB,Q96GD4,,,,,,Human,ZM447439,8353,,,252166565,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,12719470,COc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(cc1)NC(=O)c1ccccc1
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,7.769999981,0,IC50,0,17,0,=,,,,17850214,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
aurora kinase C,1938,AURKC,Q9UQB9,,,,,,Human,tozasertib,5718,,,178102344,Inhibitor,Inhibition,,f,t,,pKi,0,8.340000153,0,Ki,0,4.599999905,0,=,,,,14981513,CN1CCN(CC1)c1nc(Sc2ccc(cc2)NC(=O)C2CC2)nc(c1)Nc1[nH]nc(c1)C
AXL receptor tyrosine kinase,1835,AXL,P30530,,,,,,Human,TP-0903,8863,,,252827520,Inhibitor,Inhibition,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,22247788,CN1CCN(CC1)Cc1ccc(cc1)Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)N(C)C)Cl
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,"[<sup>125</sup>I]BH-NMB (human, mouse, rat)",3771,,,178100621,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
BB<sub>1</sub> receptor,38,NMBR,P28336,,,,,,Human,[<sup>125</sup>I][Tyr<sup>4</sup>]bombesin,623,,,135652568,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[<sup>125</sup>I]GRP (human),3788,,,178100638,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
BB<sub>2</sub> receptor,39,GRPR,P30550,,,,,,Human,[<sup>125</sup>I][Tyr<sup>4</sup>]bombesin,623,,,135652568,Agonist,Full agonist,,f,,,pKd,0,8.2,0,Kd,0,6.31,0,=,,,,7838118,
BB<sub>2</sub> receptor,39,Grpr,P52500,,,,,,Rat,[<sup>125</sup>I][D-Tyr<sup>6</sup>]bombesin-(6-13)-methyl ester,628,,,135652512,Antagonist,Antagonist,,f,,,pKd,0,8.96,0,Kd,0,1.1,0,=,,,,7684815,
BB<sub>2</sub> receptor,39,Grpr,P21729,,,,,,Mouse,[<sup>125</sup>I][D-Tyr<sup>6</sup>]bombesin-(6-13)-methyl ester,628,,,135652512,Antagonist,Antagonist,,f,f,,pKd,0,9.279999733,0,Kd,0,0.529999971,0,=,,,,7684815,
BB<sub>3</sub> receptor,40,Brs3,O54798,,,,,,Mouse,[<sup>3</sup>H]bag-2,8506,,,252166714,Agonist,Agonist,,f,t,,pKd,0,8.590000153,0,Kd,0,2.599999905,0,=,,,,20096642,OC(=O)c1ccccc1c1ccc(cc1)CCc1ncc([nH]1)CC1CCCC1
BB<sub>3</sub> receptor,40,BRS3,P32247,,,,,,Human,"[<sup>125</sup>I][D-Tyr<sup>6</sup>,&beta;-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin-(6-14)",631,,,135652511,Agonist,Full agonist,,f,f,,pKd,8.399999619,0,8,Kd,10,0,3.980000019,=,,,,9325344,
"BCL2, apoptosis regulator",2844,BCL2,P10415,,,,,,Human,venetoclax,8318,,,252166530,Antagonist,Antagonist,,f,t,,pKi,0,11,0,Ki,0,0.01,0,<,Note that this Ki is below the detection limit of the assay.,,,23291630,Clc1ccc(cc1)C1=C(CCC(C1)(C)C)CN1CCN(CC1)c1ccc(c(c1)Oc1cnc2c(c1)cc[nH]2)C(=O)NS(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NCC1CCOCC1
Bcl-2-like 1,2845,BCL2L1,Q07817,,,,,,Human,venetoclax,8318,,,252166530,Antagonist,Antagonist,,f,f,,pKi,0,7.320000172,0,Ki,0,48,0,=,,,,23291630,Clc1ccc(cc1)C1=C(CCC(C1)(C)C)CN1CCN(CC1)c1ccc(c(c1)Oc1cnc2c(c1)cc[nH]2)C(=O)NS(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NCC1CCOCC1
Bcl-2-like 2,2846,BCL2L2,Q92843,,,,,,Human,venetoclax,8318,,,252166530,Antagonist,Antagonist,,f,f,,pKi,0,6.610000134,0,Ki,0,245,0,=,,,,23291630,Clc1ccc(cc1)C1=C(CCC(C1)(C)C)CN1CCN(CC1)c1ccc(c(c1)Oc1cnc2c(c1)cc[nH]2)C(=O)NS(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NCC1CCOCC1
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,verubecestat,8699,,,252166899,Inhibitor,Competitive,,f,t,,pKi,0,8.760000229,0,Ki,0,1.753000021,0,=,,,,0,Fc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]1(C)N=C(N)N(S(=O)(=O)C1)C)F
beta-secretase 1,2330,BACE1,P56817,,,,,,Human,TAK-070,6940,,,178103522,Inhibitor,Non-competitive,,f,t,,pKi,0,4.71999979,0,Ki,0,19000,0,=,,,,20720123,CN(CC[C@@H]1CCc2c(C1)ccc(c2)OCc1ccc(cc1)c1ccccc1)C
beta-site APP-cleaving enzyme 2,2331,BACE2,Q9Y5Z0,,,,,,Human,verubecestat,8699,,,252166899,Inhibitor,Competitive,,f,t,,pKi,0,9.430000305,0,Ki,0,0.370000005,0,=,,,,0,Fc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@@]1(C)N=C(N)N(S(=O)(=O)C1)C)F
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,T-0509,533,,,135651221,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,8982677,COc1cc(CCNCC(c2ccc(c(c2)O)O)O)ccc1OC
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,[<sup>3</sup>H](-)CGP 12177,531,,,135651142,Agonist,Partial agonist,,f,,,pKd,9.9,0,6.6,,0,0,0,,,,,15060759,O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,xamoterol,538,,,135651330,Agonist,Partial agonist,,f,f,,pKi,0,7,0,Ki,0,100,0,=,,,,10531390,OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,[<sup>125</sup>I]ICYP,562,,,135651110,Antagonist,Antagonist,It is necessary to use an excess of a &beta;<sub>2</sub>-AR-selective ligand such as ICI 118551 in combination with this radioligand in order to allow visualisation of &beta;<sub>1</sub>-AR binding in native tissue.,f,f,,pKd,11.30000019,0,10.39999962,Kd,0.039000001,0,0.00499,=,,,,8982677,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,[<sup>125</sup>I](-)ICYP,540,,,135651111,Antagonist,Antagonist,,f,f,,pKd,11.30000019,0,10,-,0,0,0,=,,,,8982677,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>1</sub>-adrenoceptor,28,ADRB1,P08588,,,,,,Human,[<sup>3</sup>H](-)CGP 12177,531,,,135651142,Antagonist,Antagonist,,f,,,pKd,9.2,0,6.6,,0,0,0,,,,,15060759,O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,vilanterol,7353,,,178103925,Agonist,Agonist,,f,t,,pEC50,0,9.399999619,0,EC50,0,0.398000002,0,=,,,,20462258,OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,zinterol,3466,,,178100460,Agonist,Agonist,,f,,,pEC50,0,9.48,0,-,0,0,0,=,,,,20590599,OC(c1ccc(c(c1)NS(=O)(=O)C)O)CNC(Cc1ccccc1)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,terbutaline,560,,,135651244,Agonist,Partial agonist,,f,t,,pKi,0,5.599999905,0,Ki,0,2510,0,=,,,,15655528,OC(c1cc(O)cc(c1)O)CNC(C)(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Negative,,t,,,pKi,0,3.3,0,,0,0,0,,,,,12409304,
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Positive,,t,,,pKi,0,5.3,0,,0,0,0,,,,,12409304,
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,[<sup>125</sup>I]ICYP,562,,,135651110,Antagonist,Antagonist,It is necessary to use an excess of a &beta;<sub>1</sub>-AR-selective ligand such as CGP20712A in combination with this radioligand in order to allow visualisation of &beta;<sub>2</sub>-AR binding in native tissues.,f,f,,pKd,0,11.10000038,0,Kd,0,0.0079,0,=,,,,8982677,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>2</sub>-adrenoceptor,29,ADRB2,P07550,,,,,,Human,timolol,565,,,135651263,Antagonist,Antagonist,,f,t,,pKi,0,9.699999809,0,-,0,0,0,=,,,,15655528,O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,[<sup>125</sup>I]ICYP,562,,,135651110,Agonist,Partial agonist,,f,,,pKd,9.8,0,9.2,Kd,0.631,0,0.158,=,,,,8982677,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,[<sup>125</sup>I]ICYP,562,,,135651110,Agonist,Partial agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,14744619,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,[<sup>125</sup>I]ICYP,562,,,135651110,Agonist,Partial agonist,,f,,,pKd,9.4,0,9.3,,0,0,0,,,,,14744619,OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P25962,,,,,,Mouse,tertatolol,571,,,135651247,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,14744619,OC(COc1cccc2c1SCCC2)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,Adrb3,P26255,,,,,,Rat,tertatolol,571,,,135651247,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,14744619,OC(COc1cccc2c1SCCC2)CNC(C)(C)C
&beta;<sub>3</sub>-adrenoceptor,30,ADRB3,P13945,,,,,,Human,tertatolol,571,,,135651247,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,14744619,OC(COc1cccc2c1SCCC2)CNC(C)(C)C
"BLK proto-oncogene, Src family tyrosine kinase",1940,BLK,P51451,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,6.699999809,0,Kd,0,200,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,[<sup>3</sup>H]LTB<sub>4</sub>,3413,,,178100419,Agonist,Full agonist,,f,,,pKd,0,9.8,0,Kd,0,0.15,0,=,,,,9177352,CCCCC/C=CC[C@H](/C=C/C=CC=C[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,Ltb4r,Q9R0Q2,,,,,,Rat,[<sup>3</sup>H]LTB<sub>4</sub>,3413,,,178100419,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.67,0,=,,,,10471406,CCCCC/C=CC[C@H](/C=C/C=CC=C[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,Ltb4r1,O88855,,,,,,Mouse,[<sup>3</sup>H]LTB<sub>4</sub>,3413,,,178100419,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.6,0,=,,,,9743525,CCCCC/C=CC[C@H](/C=C/C=CC=C[C@H](CCCC(=O)O)O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,[<sup>3</sup>H]CGS23131,3415,,,178100421,Antagonist,Antagonist,,f,,,pKd,0,7.9,0,Kd,0,13,0,=,,,,1320692,COc1ccc(cc1)/C=C/CCCCOc1ccc(cc1CCC(=O)O)C(=O)c1cccc(c1)C(=O)O
BLT<sub>1</sub> receptor,267,LTB4R,Q15722,,,,,,Human,U75302,3325,,,178100358,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,Ki,0,444,0,=,,,,10513580,CCCCC/C=CC[C@H](/C=C/c1cccc(n1)C[C@H](CCCCO)O)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,ZK-158252,6162,,,178102783,Antagonist,Antagonist,,f,,,pIC50,0,6,0,IC50,0,1000,0,=,,,,11278893,OC(=O)CCC/C=C/1CCCCC1/C=C/C=C/C(C1(CCC1)CC#Cc1ccccc1)O
BLT<sub>2</sub> receptor,268,LTB4R2,Q9NPC1,,,,,,Human,[<sup>3</sup>H]LTB<sub>4</sub>,3413,,,178100419,None,None,,f,,,pKd,9.7,0,7.64,Kd,23,0,0.2,=,,,,0,CCCCC/C=CC[C@H](/C=C/C=CC=C[C@H](CCCC(=O)O)O)O
"B-Raf proto-oncogene, serine/threonine kinase",1943,BRAF,P15056,,,,,,Human,vemurafenib,5893,,,178102516,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,22808911,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F
bromodomain containing 2,1944,BRD2,P25440,,,,,,Human,XD14,7524,,,187051825,Inhibitor,Inhibition,,f,f,,pKd,0,6.769999981,0,Kd,0,170,0,=,Assay using recombinant BRD2-BD1.,,,24272870,CCN(S(=O)(=O)c1ccc(c(c1)NC(=O)c1[nH]c(c(c1CC)C(=O)C)C)O)CC
bromodomain containing 3,2725,BRD3,Q15059,,,,,,Human,XD14,7524,,,187051825,Inhibitor,Inhibition,,f,f,,pKd,0,6.420000076,0,Kd,0,380,0,=,Assay using recombinant BRD3-BD1.,,,24272870,CCN(S(=O)(=O)c1ccc(c(c1)NC(=O)c1[nH]c(c(c1CC)C(=O)C)C)O)CC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,XD1,7525,,,187051826,Inhibitor,Inhibition,,f,f,,pKd,0,4.340000153,0,Kd,0,46000,0,=,,,,24272870,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)O
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,XD14,7524,,,187051825,Inhibitor,Inhibition,,f,f,,pKd,0,6.800000191,0,Kd,0,160,0,=,Assay using recombinant BRD4-BD1.,,,24272870,CCN(S(=O)(=O)c1ccc(c(c1)NC(=O)c1[nH]c(c(c1CC)C(=O)C)C)O)CC
bromodomain containing 4,1945,BRD4,O60885,,,,,,Human,XD25,7526,,,187051827,Inhibitor,Inhibition,,f,f,,pKd,0,4.699999809,0,Kd,0,20000,0,=,,,,24272870,O=CN[C@H]1CCc2c(c3c1cc(=O)c(cc3)OC)c(OC)c(c(c2)OC)OC
bromodomain containing 7,2726,BRD7,Q9NPI1,,,,,,Human,TP-472,9522,,,336446908,Inhibitor,Inhibition,,f,t,,pIC50,0,6.46999979,0,IC50,0,340,0,=,By isothermal titration calorimetry (ITC).,,,0,Cc1ccc(cc1c1cc(n2c1nccc2)C(=O)C)C(=O)NC1CC1
bromodomain containing 9,2728,BRD9,Q9H8M2,,,,,,Human,TP-472,9522,,,336446908,Inhibitor,Inhibition,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,By isothermal titration calorimetry.,,,0,Cc1ccc(cc1c1cc(n2c1nccc2)C(=O)C)C(=O)NC1CC1
bromodomain testis associated,2729,BRDT,Q58F21,,,,,,Human,XD14,7524,,,187051825,Inhibitor,Inhibition,,f,f,,pKd,0,5.920000076,0,Kd,0,1200,0,=,Assay using recombinant BRDT-BD1.,,,24272870,CCN(S(=O)(=O)c1ccc(c(c1)NC(=O)c1[nH]c(c(c1CC)C(=O)C)C)O)CC
BR serine/threonine kinase 2,1947,BRSK2,Q8IWQ3,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,17850214,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
Bruton tyrosine kinase,1948,BTK,Q06187,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,7.369999886,0,Kd,0,43,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[<sup>3</sup>H]Lys-[des-Arg<sup>9</sup>]BK,3825,,,178100669,Agonist,Full agonist,,f,,,pKd,0,9.4,0,Kd,0,0.4,0,,,,,0,
B<sub>1</sub> receptor,41,Bdkrb1,P97583,,,,,,Rat,T-kinin,639,KNG1|Kng2,Human|Rat,135651895,Agonist,Full agonist,,t,,,pKi,5.2,0,5,-,0,0,0,=,,,,10422787,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)N)CO)CCCN=C(N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,T-kinin,639,KNG1|Kng2,Human|Rat,135651895,Agonist,Full agonist,,t,,,pKi,0,5.2,0,-,0,0,0,=,,,,10422787,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)N)CO)CCCN=C(N)N
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[<sup>3</sup>H]Lys-[Leu<sup>8</sup>][des-Arg<sup>9</sup>]BK,3826,,,178100670,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
B<sub>1</sub> receptor,41,BDKRB1,P46663,,,,,,Human,[<sup>125</sup>I]Hpp-desArg<sup>10</sup>HOE140,3791,,,178100640,None,None,,f,,,pKd,0,10,0,Kd,0,0.1,0,,,,,0,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,[<sup>125</sup>I][Tyr<sup>8</sup>]bradykinin,3765,,,178100615,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,"[<sup>3</sup>H]BK (human, mouse, rat)",3812,,,178100659,Agonist,Full agonist,,f,,,pKd,0,9.4,0,Kd,0,0.399,0,=,,,,9333122,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,[Tyr<sup>8</sup>]bradykinin,671,,,135652624,Agonist,Full agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,8302267,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,[Tyr<sup>8</sup>]bradykinin,671,,,135652624,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,8302267,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,[<sup>3</sup>H]NPC17731,3831,,,178100675,Antagonist,Antagonist,,f,,,pKd,9.4,0,9.1,Kd,0.77,0,0.39,=,,,,11379050,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,"[Thi<sup>5,8</sup>,D-Phe<sup>7</sup>]bradykinin",678,,,135652602,Antagonist,Antagonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,8302267,
B<sub>2</sub> receptor,42,Bdkrb2,P32299,,,,,,Mouse,"[Thi<sup>5,8</sup>,D-Phe<sup>7</sup>]bradykinin",678,,,135652602,Antagonist,Antagonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,8302267,
B<sub>2</sub> receptor,42,BDKRB2,P30411,,,,,,Human,WIN 64338,677,,,135651328,Antagonist,Antagonist,,f,,,pKi,7.2,0,6.2,,0,0,0,,,,,8197121,CCCC[P+](Cc1ccc(cc1)NC(=O)[C@H](Cc1ccc2c(c1)cccc2)NC(=NC1CCCCC1)NC1CCCCC1)(CCCC)CCCC.[Cl-]
butyrylcholinesterase,2471,BCHE,P06276,,,,,,Human,tacrine,6687,,,178103299,Inhibitor,Inhibition,,f,t,,pKi,0,7.199999809,0,Ki,0,70,0,=,,,,18479118,Nc1c2CCCCc2nc2c1cccc2
C3a receptor,31,C3AR1,Q16581,,,,,,Human,[<sup>125</sup>I]C3a (human),3773,,,178100623,Agonist,Full agonist,,f,,,pKd,0,8.4,0,Kd,0,3.85,0,=,,,,10092660,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,WWGKKYRASKLGLAR,5760,,,178102385,Agonist,Full agonist,,f,,,pIC50,0,8.7,0,IC50,0,2,0,=,,,,20527893,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,WWGKKYRASKLGLAR,5760,,,178102385,Agonist,Full agonist,,f,,,pEC50,0,5.9,0,EC50,0,1300,0,=,,,,20527893,
C3a receptor,31,C3AR1,Q16581,,,,,,Human,YSFKPMPLaR,5776,,,178102401,Agonist,Full agonist,,f,,,pEC50,0,6.7,0,EC50,0,220,0,=,,,,20527893,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,YSFKPMPLaR,5776,,,178102401,Agonist,Agonist,,f,,,pEC50,0,5.5,0,EC50,0,3240,0,=,,,,11403208,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,[<sup>125</sup>I]C5a (human),3774,,,178100624,Agonist,Full agonist,,f,,,pKd,0,8.7,0,Kd,0,2,0,=,,,,4020139,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,YSFKPMPLaR,5776,,,178102401,Agonist,Full agonist,,f,,,pIC50,6.7,0,5.4,IC50,4200,0,200,=,,,,9083476,
C5a<sub>1</sub> receptor,32,C5AR1,P21730,,,,,,Human,W54011,581,,,178100221,Antagonist,Antagonist,,f,,,pKi,0,8.7,0,-,0,0,0,=,,,,12384495,COc1ccc2c(c1)C(CCC2)C(=O)N(c1ccc(cc1)C(C)C)Cc1ccc(cc1)N(C)C
C5a<sub>2</sub> receptor,33,C5AR2,Q9P296,,,,,,Human,[<sup>125</sup>I]C5a (human),3774,,,178100624,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CaCC,708,ANO1,Q5XXA6,,,,,,Human,tannic acid,4319,,,178101136,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(c1cc(O)c(c(c1)OC(=O)c1cc(O)c(c(c1)O)O)O)O[C@@H]1[C@@H](COC(=O)c2cc(O)c(c(c2)OC(=O)c2cc(O)c(c(c2)O)O)O)O[C@H]([C@@H]([C@H]1OC(=O)c1cc(O)c(c(c1)OC(=O)c1cc(O)c(c(c1)O)O)O)OC(=O)c1cc(O)c(c(c1)OC(=O)c1cc(O)c(c(c1)O)O)O)OC(=O)c1cc(O)c(c(c1)OC(=O)c1cc(O)c(c(c1)O)O)O
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,sulpiride,5501,,,178102147,Inhibitor,Inhibition,,f,f,,pKi,0,5.920000076,0,Ki,0,1200,0,=,,,,15686894,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,topiramate,6849,,,178103455,Inhibitor,Inhibition,,f,f,,pKi,0,6.599999905,0,Ki,0,250,0,=,,,,15686894,NS(=O)(=O)OC[C@]12OC[C@@H]3[C@H]([C@@H]2OC(O1)(C)C)OC(O3)(C)C
carbonic anhydrase 1,2597,CA1,P00915,,,,,,Human,zonisamide,7047,,,178103626,Inhibitor,Inhibition,,f,f,,pKi,0,7.25,0,Ki,0,56,0,=,,,,23965175,NS(=O)(=O)Cc1noc2c1cccc2
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,sulpiride,5501,,,178102147,Inhibitor,Inhibition,,f,f,,pKi,0,8.409999847,0,Ki,0,3.900000095,0,=,,,,15686894,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,topiramate,6849,,,178103455,Inhibitor,Inhibition,,f,f,,pKi,0,8.420000076,0,Ki,0,3.799999952,0,=,,,,15686894,NS(=O)(=O)OC[C@]12OC[C@@H]3[C@H]([C@@H]2OC(O1)(C)C)OC(O3)(C)C
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,valdecoxib,2894,,,178100243,Inhibitor,Inhibition,,f,f,,pKi,0,7.889999866,0,Ki,0,13,0,=,,,,23965175,Cc1onc(c1c1ccc(cc1)S(=O)(=O)N)c1ccccc1
carbonic anhydrase 12,2747,CA12,O43570,,,,,,Human,zonisamide,7047,,,178103626,Inhibitor,Inhibition,,f,f,,pKi,0,4.960000038,0,Ki,0,11000,0,=,,,,23965175,NS(=O)(=O)Cc1noc2c1cccc2
carbonic anhydrase 4,2599,CA4,P22748,,,,,,Human,topiramate,6849,,,178103455,Inhibitor,Inhibition,,f,f,,pKi,0,7.369999886,0,Ki,0,43,0,=,,,,16039848,NS(=O)(=O)OC[C@]12OC[C@@H]3[C@H]([C@@H]2OC(O1)(C)C)OC(O3)(C)C
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,sulpiride,5501,,,178102147,Inhibitor,Inhibition,,f,f,,pKi,0,5.440000057,0,Ki,0,3630,0,=,,,,23965175,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,topiramate,6849,,,178103455,Inhibitor,Inhibition,,f,f,,pKi,0,9.050000191,0,Ki,0,0.899999976,0,=,,,,23965175,NS(=O)(=O)OC[C@]12OC[C@@H]3[C@H]([C@@H]2OC(O1)(C)C)OC(O3)(C)C
carbonic anhydrase 7,2749,CA7,P43166,,,,,,Human,zonisamide,7047,,,178103626,Inhibitor,Inhibition,,f,f,,pKi,0,6.929999828,0,Ki,0,117,0,=,,,,23965175,NS(=O)(=O)Cc1noc2c1cccc2
Carboxypeptidase B2 (plasma),1594,CPB2,Q96IY4,,,,,,Human,"UK-396,082",8657,,,252166857,Inhibitor,Inhibition,,f,t,,pKi,0,8,0,Ki,0,10,0,=,,,,17990866,CCCn1cnc(c1)C[C@@H](C(=O)O)CCCN
Casein kinase 2,1548,,,,,,,,Rat,TBBt,9372,,,328083474,Inhibitor,Inhibition,,f,f,,pKi,0,6.400000095,0,Ki,0,400,0,=,,,,12816539,Brc1c(Br)c(Br)c2c(c1Br)n[nH]n2
Casein kinase 2,1548,,,,,,,,Human,XL413,8113,,,249565793,Inhibitor,Inhibition,,f,f,,pIC50,0,6.670000076,0,IC50,0,215,0,=,,,,22560567,Clc1ccc2c(c1)c1[nH]c(nc(=O)c1o2)[C@@H]1CCCN1
Caspase 1,1617,CASP1,P29466,,,,,,Human,VRT-043198,9034,,,315661119,Inhibitor,Inhibition,Derived from pro-drug belnacasan,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,,,,17289835,O=C[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)(C)C)NC(=O)c1ccc(c(c1)Cl)N)CC(=O)O
Caspase 1,1617,CASP1,P29466,,,,,,Human,Z-YVAD-FMK,5302,,,178101984,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,12097652,COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)OCc1ccccc1)C
Caspase 2,1618,CASP2,P42575,,,,,,Human,Z-VDVAD-FMK,5299,,,178101981,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,10912804,
Caspase 3,1619,CASP3,P42574,,,,,,Human,Z-DEVD-FMK,5294,,,53801033,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,9774422,
Caspase 3,1619,CASP3,P42574,,,,,,Human,Z-DQMD-FMK,5295,,,178101977,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,11301346,
Caspase 4,1620,CASP4,P49662,,,,,,Human,VRT-043198,9034,,,315661119,Inhibitor,Inhibition,,f,f,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,17289835,O=C[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)(C)C)NC(=O)c1ccc(c(c1)Cl)N)CC(=O)O
Caspase 5,1621,CASP5,P51878,,,,,,Human,Z-WEHD-FMK,5301,,,178101983,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,12903195,
Caspase 6,1622,CASP6,P55212,,,,,,Human,Z-VEID-FMK,5300,,,178101982,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,11953316,
Caspase 8,1624,CASP8,Q14790,,,,,,Human,Z-IETD-FMK,5296,,,178101978,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,10048577,
Caspase 9,1625,CASP9,P55211,,,,,,Human,Z-LEHD-FMK,5298,,,178101980,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,10807653,
CaS receptor,54,CASR,P41180,,,,,,Human,tecalcet,718,,,135650741,Allosteric modulator,Positive,,f,f,,pKB,6.599999905,0,6.199999809,-,0,0,0,=,Ca<sup>2+</sup><sub>i</sub> release,,,22210744,COc1cccc(c1)[C@H](NCCCc1ccccc1Cl)C
CaS receptor,54,CASR,P41180,,,,,,Human,tecalcet,718,,,135650741,Allosteric modulator,Positive,,f,f,,pKd,0,6.5,0,-,0,0,0,=,,,,9520489,COc1cccc(c1)[C@H](NCCCc1ccccc1Cl)C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,SZ(+)-(<i>S</i>)-202-791,4318,,,178101135,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(OC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)[N+](=O)[O-])C)C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.1,528,,,,,,,,Rabbit,[<sup>3</sup>H](-)devapamil,2515,,,53801064,Gating inhibitor,Antagonist,,f,f,,pKd,8.699999809,0,8.199999809,-,0,0,0,=,,,,9103495,COc1cccc(c1)CCN(CCC[C@@](c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.1,528,Cacna1s,Q02485,,,,,,Rat,[<sup>3</sup>H](+)-isradipine,2733,,,135651166,Gating inhibitor,Antagonist,,f,f,,pKd,0,9.199999809,0,-,0,0,0,=,,,,7476334,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.1,528,CACNA1S,Q13698,,,,,,Human,[<sup>3</sup>H](+)-isradipine,2733,,,135651166,Gating inhibitor,Antagonist,,f,,,pKd,0,9.7,0,,0,0,0,,,,,2411596,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.1,528,,,,,,,,Rabbit,[<sup>3</sup>H](+)-<i>cis</i>-diltiazem,2512,,,135651160,Gating inhibitor,None,,f,f,,pKd,7.400000095,0,6.5,-,0,0,0,=,,,,8395510,COc1ccc(cc1)C1Sc2ccccc2N(C(=O)C1OC(=O)C)CCN(C)C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,SZ(+)-(<i>S</i>)-202-791,4318,,,178101135,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(OC(=O)C1=C(C)NC(=C(C1c1cccc2c1non2)[N+](=O)[O-])C)C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,Antagonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,[<sup>3</sup>H](-)devapamil,2515,,,53801064,Gating inhibitor,Antagonist,,f,f,,pKd,8.399999619,0,8.199999809,-,0,0,0,=,,,,2147036,COc1cccc(c1)CCN(CCC[C@@](c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,[<sup>3</sup>H](+)-<i>cis</i>-diltiazem,2512,,,135651160,Gating inhibitor,Antagonist,,f,f,,pKd,0,7.199999809,0,-,0,0,0,=,,,,2147036,COc1ccc(cc1)C1Sc2ccccc2N(C(=O)C1OC(=O)C)CCN(C)C
Ca<sub>v</sub>1.2,529,CACNA1C,Q13936,,,,,,Human,[<sup>3</sup>H](+)-isradipine,2733,,,135651166,Gating inhibitor,None,,f,,,pKd,11,0,10.1,,0,0,0,,,,,10072735,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.2,529,Cacna1c,Q01815,,,,,,Mouse,[<sup>3</sup>H](+)-isradipine,2733,,,135651166,Gating inhibitor,None,,f,f,,pKd,0,10.10000038,0,-,0,0,0,=,,,,15146240,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.2,529,Cacna1c,P22002,,,,,,Rat,verapamil,2406,,,135651305,Gating inhibitor,None,,f,,,pIC50,6.5,0,5.3,,0,0,0,,,,,8913371,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>1.3,530,CACNA1D,Q01668,,,,,,Human,[<sup>3</sup>H](+)-isradipine,2733,,,135651166,Gating inhibitor,None,,f,,,pKd,0,9.4,0,,0,0,0,,,,,11285265,COC(=O)C1=C(C)NC(=C([C@H]1c1cccc2c1non2)C(=O)OC(C)C)C
Ca<sub>v</sub>1.4,531,Cacna1f,Q9JIS7,,,,,,Mouse,verapamil,2406,,,135651305,Channel blocker,None,,f,f,100,-,0,0,0,-,0,0,0,=,,,,14744918,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Ca<sub>v</sub>2.2,533,CACNA1B,Q00975,,,,,,Human,TROX-1,7766,,,223366099,Gating inhibitor,None,,f,f,,pIC50,6.400000095,0,5.400000095,-,0,0,0,=,,,,22188924,O=C1N(c2n[nH]cn2)c2c([C@@]1(C)Cc1cncnc1)cc(cc2)c1ccc(c(c1)Cl)F
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,TTA-A2,7724,,,223366057,Channel blocker,Pore blocker,,f,f,,pIC50,7,0,5.099999905,-,0,0,0,=,,,,23257507,O=C(N[C@@H](c1ccc(cn1)OCC(F)(F)F)C)Cc1ccc(cc1)C1CC1
Ca<sub>v</sub>3.1,535,Cacna1g,O54898,,,,,,Rat,TTA-P2,7723,,,223366056,Channel blocker,Pore blocker,,f,f,,pIC50,0,7,0,-,0,0,0,=,,,,21821734,Clc1cc(Cl)cc(c1)C(=O)NCC1(F)CCN(CC1)C[C@H]1CCOC(C1)(C)C
Ca<sub>v</sub>3.1,535,CACNA1G,O43497,,,,,,Human,Z944,7718,,,223366051,Channel blocker,Pore blocker,,f,f,,pIC50,0,7.300000191,0,-,0,0,0,=,,,,22344687,O=C(NC(C)(C)C)CN1CCC(CC1)CNC(=O)c1cc(F)cc(c1)Cl
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,TTA-A2,7724,,,223366057,Channel blocker,Pore blocker,,f,f,,pIC50,7,0,5.099999905,-,0,0,0,=,,,,23257507,O=C(N[C@@H](c1ccc(cn1)OCC(F)(F)F)C)Cc1ccc(cc1)C1CC1
Ca<sub>v</sub>3.2,536,Cacna1h,Q9EQ60,,,,,,Rat,TTA-P2,7723,,,223366056,Channel blocker,Pore blocker,,f,f,,pIC50,0,7,0,-,0,0,0,=,,,,21821734,Clc1cc(Cl)cc(c1)C(=O)NCC1(F)CCN(CC1)C[C@H]1CCOC(C1)(C)C
Ca<sub>v</sub>3.2,536,CACNA1H,O95180,,,,,,Human,Z944,7718,,,223366051,Channel blocker,Pore blocker,,f,f,,pIC50,0,6.800000191,0,-,0,0,0,=,,,,22344687,O=C(NC(C)(C)C)CN1CCC(CC1)CNC(=O)c1cc(F)cc(c1)Cl
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,TTA-A2,7724,,,223366057,Channel blocker,Pore blocker,,f,f,,pIC50,7,0,5.099999905,-,0,0,0,=,,,,23257507,O=C(N[C@@H](c1ccc(cn1)OCC(F)(F)F)C)Cc1ccc(cc1)C1CC1
Ca<sub>v</sub>3.3,537,Cacna1i,Q9Z0Y8,,,,,,Rat,TTA-P2,7723,,,223366056,Channel blocker,Pore blocker,,f,f,,pIC50,0,7,0,-,0,0,0,=,,,,21821734,Clc1cc(Cl)cc(c1)C(=O)NCC1(F)CCN(CC1)C[C@H]1CCOC(C1)(C)C
Ca<sub>v</sub>3.3,537,CACNA1I,Q9P0X4,,,,,,Human,Z944,7718,,,223366051,Channel blocker,Pore blocker,,f,f,,pIC50,0,7,0,-,0,0,0,=,,,,22344687,O=C(NC(C)(C)C)CN1CCC(CC1)CNC(=O)c1cc(F)cc(c1)Cl
catalase,2979,,,,,,,,Hamster,tectorigenin,9738,,,0,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,Activation of catalase in V79-4 cell in culture.,,,28053960,COc1c(O)cc2c(c1O)c(=O)c(co2)c1ccc(cc1)O
Catechol-O-methyltransferase,2472,COMT,P21964,,,,,,Human,tolcapone,6646,,,178103259,Inhibitor,Inhibition,soluble enzyme,f,t,,pKi,0,9.569999695,0,Ki,0,0.270000011,0,=,soluble enzyme,,,7703232,Cc1ccc(cc1)C(=O)c1cc(O)c(c(c1)[N+](=O)[O-])O
Catechol-O-methyltransferase,2472,COMT,P21964,,,,,,Human,tolcapone,6646,,,178103259,Inhibitor,Inhibition,membrane-bound enzyme,f,t,,pKi,0,9.539999962,0,Ki,0,0.289999992,0,=,membrane-bound enzyme,,,7703232,Cc1ccc(cc1)C(=O)c1cc(O)c(c(c1)[N+](=O)[O-])O
Cathepsin A,1581,CTSA,P10619,,,,,,Human,telaprevir,7871,,,223366200,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,0,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C1CCCCC1)NC(=O)c1nccnc1
cathepsin B,2343,CTSB,P07858,,,,,,Human,Z-Arg-Leu-Val-Agly-Ile-Val-OMe,6534,,,178103148,Inhibitor,Inhibition,,f,,,pKi,0,10.1,0,Ki,0,0.088,0,,,,,12213061,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)OC)C(C)C)NC(=O)NNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)CC(C)C)C
CBR1,1383,CBR1,P16152,,,,,,Human,wedelolactone,5551,,,178102193,Inhibitor,Inhibition,,f,f,,pIC50,0,5.420000076,0,IC50,0,3780,0,=,,,,19097799,COc1cc(O)c2c(c1)oc(=O)c1c2oc2c1cc(c(c2)O)O
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,[<sup>3</sup>H]CP55940,734,,,135651145,Agonist,Full agonist,,f,,,pKd,9.4,0,8.5,,0,0,0,,,,,7775459,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,[<sup>3</sup>H]HU-243,735,,,135651159,Agonist,Full agonist,,f,,,pKd,0,10.4,0,,0,0,0,,,,,1317925,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2C[C@]([3H])(CO)C(C1)[3H])(C)C)(C)C
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,[<sup>3</sup>H]WIN55212-2,736,,,135651216,Agonist,Full agonist,,f,,,pKd,7.9,0,7.8,,0,0,0,,,,,8622639,O=C(c1c(C)n2c3c1cccc3OCC2CN1CCOCC1)c1cccc2c1cccc2
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,WIN55212-2,733,,,135651326,Agonist,Full agonist,,f,f,,pKi,8.699999809,0,6.900000095,-,0,0,0,=,,,,7565624,O=C(c1c(C)n2c3c1cccc3OC[C@H]2CN1CCOCC1)c1cccc2c1cccc2
CB<sub>1</sub> receptor,56,Cnr1,P47746,,,,,,Mouse,ZCZ011,9239,,,315661314,Allosteric modulator,Positive,,f,f,,pEC50,0,6.309999943,0,-,0,0,0,=,"Equilibrium binding experiment versus [<sup>3</sup>HWIN55212, to mouse brain membranes.",,,26052038,[O-][N+](=O)CC(c1c([nH]c2c1ccc(c2)C)c1ccccc1)c1cccs1
CB<sub>1</sub> receptor,56,Cnr1,P47746,,,,,,Mouse,ZCZ011,9239,,,315661314,Allosteric modulator,Positive,,f,f,,pEC50,0,6.900000095,0,-,0,0,0,=,"Equilibrium binding experiment versus [<sup>3</sup>H]CP55940, to mouse brain membranes.",,,26052038,[O-][N+](=O)CC(c1c([nH]c2c1ccc(c2)C)c1ccccc1)c1cccs1
CB<sub>1</sub> receptor,56,Cnr1,P47746,,,,,,Mouse,[<sup>123</sup>I]AM251,744,,,135651097,Antagonist,Antagonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,9335234,[123I]c1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,Cnr1,P20272,,,,,,Rat,[<sup>3</sup>H]rimonabant,745,,,135651209,Antagonist,Antagonist,,f,,,pKd,10,0,8.92,Kd,1.2,0,0.1,=,,,,8614277,Clc1ccc(cc1)c1n(nc(c1C([3H])([3H])[3H])C(=O)NN1CCCCC1)c1ccc(cc1Cl)Cl
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,surinabant,9233,,,315661308,Antagonist,Antagonist,,f,t,,pKi,0,8.460000038,0,Ki,0,3.5,0,=,Inhibition of [3H]CP-55940 binding to human cannabinoid receptor 1 expressed in CHO cells,,,15131245,CCc1c(nn(c1c1ccc(cc1)Br)c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,TM-38837,8705,,,252166905,Antagonist,Antagonist,,f,t,,pIC50,0,8.069999695,0,IC50,0,8.5,0,=,,,,20652930,CCc1c(nn(c1c1ccc(s1)C#Cc1ccc(cc1)C(F)(F)F)c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>1</sub> receptor,56,CNR1,P21554,,,,,,Human,taranabant,9231,,,315661306,Antagonist,Inverse agonist,,f,t,,pKi,0,9.520000458,0,Ki,0,0.300000012,0,=,Displacement of [3H]rimonabant from human CB1 receptor expressed in HEK293 cells by liquid scintillation counting.,,,19520572,N#Cc1cccc(c1)[C@@H]([C@@H](NC(=O)C(Oc1ccc(cn1)C(F)(F)F)(C)C)C)Cc1ccc(cc1)Cl
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,[<sup>3</sup>H]CP55940,734,,,135651145,Agonist,Full agonist,,f,,,pKd,9.7,0,8.1,,0,0,0,,,,,7565624,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,[<sup>3</sup>H]HU-243,735,,,135651159,Agonist,Full agonist,,f,,,pKd,0,10.2,0,,0,0,0,,,,,7498464,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2C[C@]([3H])(CO)C(C1)[3H])(C)C)(C)C
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,[<sup>3</sup>H]WIN55212-2,736,,,135651216,Agonist,Full agonist,,f,,,pKd,8.7,0,8.4,,0,0,0,,,,,7689702,O=C(c1c(C)n2c3c1cccc3OCC2CN1CCOCC1)c1cccc2c1cccc2
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,WIN55212-2,733,,,135651326,Agonist,Full agonist,,f,f,,pKi,9.600000381,0,8.399999619,-,0,0,0,=,,,,7565624,O=C(c1c(C)n2c3c1cccc3OC[C@H]2CN1CCOCC1)c1cccc2c1cccc2
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,taranabant,9231,,,315661306,Agonist,None,,f,f,,pKi,0,6.539999962,0,Ki,0,290,0,=,,,,19520572,N#Cc1cccc(c1)[C@@H]([C@@H](NC(=O)C(Oc1ccc(cn1)C(F)(F)F)(C)C)C)Cc1ccc(cc1)Cl
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,TM-38837,8705,,,252166905,Antagonist,Antagonist,,f,f,,pIC50,0,6.21999979,0,IC50,0,605,0,=,,,,20652930,CCc1c(nn(c1c1ccc(s1)C#Cc1ccc(cc1)C(F)(F)F)c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CB<sub>2</sub> receptor,57,CNR2,P34972,,,,,,Human,surinabant,9233,,,315661308,Antagonist,Full agonist,,f,f,,pKi,0,6.349999905,0,Ki,0,442,0,=,"Inhbition of [3H]-CP 55,940 binding to human CB2 receptors expressed in CHO cells",,,15131245,CCc1c(nn(c1c1ccc(cc1)Br)c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,"[<sup>125</sup>I]DTyr-Gly-[(Nle28,31)CCK-26-33",6666,,,178103278,Agonist,Full agonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,3410633,
CCK<sub>1</sub> receptor,76,CCKAR,P32238,,,,,,Human,[<sup>3</sup>H]devazepide,3476,,,178100467,Antagonist,Antagonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,3018478,O=C(c1cc2c([nH]1)cccc2)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,T-0632,884,,,135651222,Antagonist,Antagonist,,f,f,,pIC50,0,9.600000381,0,IC50,0,0.25,0,=,,,,8813597,COc1ccc2c(c1)N(c1ccccc1F)C(=O)[C@@]2(CCC(=O)O)NC(=O)C1CCc2c(C1)cccc2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,TP-680,885,,,135651271,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,8730754,O=C([C@@H](NC(=O)c1cc2c([nH]1)cccc2)CSc1ncccc1C(=O)O)N1CCN(CC1)C(c1ccccc1)c1ccccc1
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,VL-0395,886,,,135651307,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,12538004,OC(=O)CC(c1ccccc1)NC(=O)c1cccc(c1)NC(=O)c1cc2c([nH]1)ccc(c2)C(=N)N
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,YF-476,887,,,135651338,Antagonist,Antagonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,9022799,CNc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccn2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2
CCK<sub>1</sub> receptor,76,Cckar,P30551,,,,,,Rat,YM-022,888,,,135651339,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,7910212,Cc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccc2)c2c(N(C1=O)CC(=O)c1ccccc1C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,"[<sup>125</sup>I]DTyr-Gly-[(Nle28,31)CCK-26-33",6666,,,178103278,Agonist,Full agonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,3410633,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,[<sup>125</sup>I]gastrin,3781,,,178100631,Agonist,Full agonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,0,
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,[<sup>3</sup>H]gastrin,3821,,,178100665,Agonist,Full agonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,0,
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,[<sup>3</sup>H]PBC-264,899,,,135652590,Agonist,Full agonist,,f,f,,pKd,0,9.699999809,0,Kd,0,0.200000003,0,=,,,,1614411,CCCC[C@H](NC(=O)[C@@H](NC(=O)C(C([3H])([3H])[3H])([3H])[3H])Cc1ccc(cc1)OS(=O)(=O)O)NCC(=O)C(=O)N[C@H](C(=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCC)NC)CC(=O)O)Cc1ccccc1)Cc1c[nH]c2c1cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,[<sup>125</sup>I]-BDZ<sub>2</sub>,6667,,,178103279,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,Ki,0,3.98,0,=,,,,19271701,[125I]c1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>2</sub> receptor,77,,,,,,,,Guinea pig,[<sup>125</sup>I]PD142308,3472,,,53801061,Antagonist,Antagonist,,f,f,,pKd,0,9.600000381,0,Kd,0,0.25,0,=,,,,0,OC(=O)C[C@@H](NC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1ccc(c(c1)[125I])N
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,[<sup>3</sup>H]JB-93182,908,,,135651167,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,10217546,O=C([C@@H](NC(=O)c1cc2cc[nH]c2cc1C(=O)NCC12CC3CC(C2)CC(C1)C3)Cc1ccccc1)Nc1cc(cc(c1)C(=O)O)C(=O)O
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,[<sup>3</sup>H]L365260,3477,,,178100468,Antagonist,Antagonist,,f,,,pKd,8.5,0,8.2,Kd,5.7,0,2.9,=,,,,11738246,Cc1cccc(c1)NC(=O)NC1N=C(c2ccccc2)c2c(N(C1=O)C)cccc2
CCK<sub>2</sub> receptor,77,,,,,,,,Guinea pig,[<sup>3</sup>H]PD140376,3478,,,178100469,Antagonist,Antagonist,,f,,,pKi,10,0,9.7,Ki,0.2,0,0.1,=,,,,8474432,OC(=O)C[C@@H](NC(=O)[C@@](Cc1c[nH]c2c1cccc2)(NC(=O)OC1C2CC3CC1CC(C2)C3)C)Cc1cc([3H])c(c(c1)[3H])N
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,tetronothiodin,910,,,135651252,Antagonist,Antagonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,8233061,OC1C/C=C/CC(C)C2C(SCC2C(=O)C2=C(OC3(C(C/C=C/C=C/C1)C=C(C)C(C3)C)C2=O)O)C(=O)C(=O)O
CCK<sub>2</sub> receptor,77,Cckbr,P30553,,,,,,Rat,TP-680,885,,,135651271,Antagonist,Antagonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,8730754,O=C([C@@H](NC(=O)c1cc2c([nH]1)cccc2)CSc1ncccc1C(=O)O)N1CCN(CC1)C(c1ccccc1)c1ccccc1
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,YF-476,887,,,135651338,Antagonist,Antagonist,,f,,,pIC50,0,9.7,0,-,0,0,0,=,,,,22607579,CNc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccn2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,YF-476,887,,,135651338,Antagonist,Antagonist,,f,,,pKi,0,9.6,0,,0,0,0,,,,,11738246,CNc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccn2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,YM-022,888,,,135651339,Antagonist,Antagonist,,f,f,,pIC50,0,9.199999809,0,IC50,0,0.629999995,0,=,,,,11738246,Cc1cccc(c1)NC(=O)N[C@@H]1N=C(c2ccccc2)c2c(N(C1=O)CC(=O)c1ccccc1C)cccc2
CCK<sub>2</sub> receptor,77,CCKBR,P32239,,,,,,Human,Z-360,907,,,135651352,Antagonist,Antagonist,,f,,,pKi,0,9.3,0,,0,0,0,,,,,17901954,O=C(N[C@@H]1CN(C2CCCCC2)c2c(N(C1=O)CC(=O)C(C)(C)C)cccc2)Nc1cccc(c1)C(=O)O
CCR1,58,CCR1,P32246,,,,,,Human,[<sup>125</sup>I]CCL2 (human),762,,,135652495,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,9336350,
CCR1,58,CCR1,P32246,,,,,,Human,[<sup>125</sup>I]CCL3 (human),763,,,135652496,Agonist,Full agonist,,f,,,pKd,8.8,0,8,Kd,10,0,1.58,=,,,,9336350,
CCR1,58,CCR1,P32246,,,,,,Human,[<sup>125</sup>I]CCL5 (human),764,,,135652498,Agonist,Full agonist,,f,,,pKd,0,8.2,0,Kd,0,7,0,=,,,,9336350,
CCR1,58,CCR1,P32246,,,,,,Human,[<sup>125</sup>I]CCL7 (human),765,,,135652499,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.7,0,=,,,,7545673,
CCR1,58,CCR1,P32246,,,,,,Human,[<sup>125</sup>I]CCL8 (human),766,,,135652500,Agonist,Full agonist,,f,,,pKd,0,8.3,0,,0,0,0,,,,,9115216,
CCR1,58,CCR1,P32246,,,,,,Human,UCB35625,3536,,,178100515,Antagonist,Antagonist,,f,f,,pIC50,0,8.020000458,0,IC50,0,9.600000381,0,=,Measuring antagonism of CCL3-induced chemotaxis <i>in vitro</i>.,,,10854442,CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1
CCR1,58,CCR1,P32246,,,,,,Human,viral macrophage inflammatory protein-II,768,,,135652636,Antagonist,Antagonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,9287217,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C
CCR2,59,CCR2,P41597,,,,,,Human,[<sup>125</sup>I]CCL7 (human),765,,,135652499,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR2,59,CCR2,P41597,,,,,,Human,[<sup>125</sup>I]CCL2 (human),762,,,135652495,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR2,59,CCR2,P41597,,,,,,Human,vCCL4,774,,,135652633,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,12554737,
CCR2,59,CCR2,P41597,,,,,,Human,TAK-779,783,,,135651230,Antagonist,Antagonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,12954060,Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C
CCR2,59,CCR2,P41597,,,,,,Human,TAK-779,783,,,135651230,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12954060,Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C
CCR2,59,CCR2,P41597,,,,,,Human,Teijin-lead_cmp_5,785,,,135651241,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,12954060,O=C(N[C@@H]1CCN(C1)Cc1ccc(cc1C)C)CNC(=O)c1cccc(c1)C(F)(F)F
CCR2,59,CCR2,P41597,,,,,,Human,viral macrophage inflammatory protein-II,768,,,135652636,Antagonist,Antagonist,,f,,,pIC50,0,9.1,0,,0,0,0,,,,,9287217,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C
CCR3,60,CCR3,P51677,,,,,,Human,[<sup>125</sup>I]CCL5 (human),764,,,135652498,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,[<sup>125</sup>I]CCL7 (human),765,,,135652499,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR3,60,CCR3,P51677,,,,,,Human,[<sup>125</sup>I]CCL11 (human),794,,,135652493,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,Kd,0,5.01,0,=,,,,12450563,
CCR3,60,CCR3,P51677,,,,,,Human,UCB35625,3536,,,178100515,Antagonist,Antagonist,,f,f,,pIC50,0,7.03000021,0,IC50,0,93.59999847,0,=,Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.,,,10854442,CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1
CCR3,60,CCR3,P51677,,,,,,Human,YM-355179,793,,,135651345,Antagonist,Antagonist,,f,,,pIC50,8.1,0,7.6,,0,0,0,,,,,16339911,O=C(C=C1CCN(CC1)C(=O)c1ncc(cc1O)C)N[C@@H]1CCN(C1)Cc1ccc2c(c1)ccc(c2)F
CCR3,60,CCR3,P51677,,,,,,Human,[<sup>3</sup>H]banyu (I),795,,,135651139,Antagonist,Inverse agonist,,f,,,pKd,0,8.3,0,,0,0,0,,,,,12450563,O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N
CCR4,61,CCR4,P51679,,,,,,Human,[<sup>125</sup>I]CCL27 (human),3653,,,178100549,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR4,61,CCR4,P51679,,,,,,Human,vMIP-III,4359,,,178101175,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CCR4,61,CCR4,P51679,,,,,,Human,[<sup>125</sup>I]CCL17 (human),3652,,,178100548,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>125</sup>I]CCL3 (human),763,,,135652496,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>125</sup>I]CCL5 (human),764,,,135652498,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>125</sup>I]CCL8 (human),766,,,135652500,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>125</sup>I]CCL4 (human),799,,,135652497,Agonist,Full agonist,,f,,,pKd,0,9.6,0,Kd,0,0.251,0,=,,,,16298345,
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>3</sup>H]ancriviroc,802,,,135651135,Antagonist,Antagonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,16304152,CCO/N=C(c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-]
CCR5,62,CCR5,P51681,,,,,,Human,[<sup>3</sup>H]maraviroc,803,,,135651174,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,16298345,O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C
CCR5,62,CCR5,P51681,,,,,,Human,TAK-220,800,,,135651227,Antagonist,Antagonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,16640339,CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N
CCR5,62,CCR5,P51681,,,,,,Human,TAK-779,783,,,135651230,Antagonist,Antagonist,,f,,,pKi,0,7.5,0,-,0,0,0,=,,,,16476734,Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C
CCR5,62,CCR5,P51681,,,,,,Human,vicriviroc,807,,,135651306,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,-,0,0,0,=,,,,16304152,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F
CCR5,62,CCR5,P51681,,,,,,Human,viral macrophage inflammatory protein-II,768,,,135652636,Antagonist,Antagonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,9287217,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C
CCR6,63,CCR6,P51684,,,,,,Human,[<sup>125</sup>I]CCL20 (human),3654,,,178100550,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,~,,,,9294138,
CCR7,64,CCR7,P32248,,,,,,Human,[<sup>125</sup>I]CCL19 (human),3655,,,178100551,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
CCR7,64,CCR7,P32248,,,,,,Human,[<sup>125</sup>I]CCL21 (human),3656,,,178100552,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,10201891,
CCR8,65,CCR8,P51685,,,,,,Human,[<sup>125</sup>I]CCL1 (human),814,,,135652492,Agonist,Full agonist,,f,,,pKd,9.7,0,8.9,Kd,1.2,0,0.213,=,,,,11154210,
CCR8,65,Ccr8,P56484,,,,,,Mouse,[<sup>125</sup>I]CCL1 (mouse),5546,,,178102188,Agonist,Full agonist,,f,,,pKd,0,8.7,0,-,0,0,0,=,,,,9469461,
CCR8,65,CCR8,P51685,,,,,,Human,vMIP-I,815,,,135652635,Agonist,Full agonist,,f,,,pIC50,9.9,0,8.9,-,0,0,0,=,,,,11154210,
CCR8,65,CCR8,P51685,,,,,,Human,ZK 756326,813,,,135651363,Agonist,Full agonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16221874,OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1
CCR8,65,CCR8,P51685,,,,,,Human,viral macrophage inflammatory protein-II,768,,,135652636,Antagonist,Antagonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,10419462,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C
CCR8,65,CCR8,P51685,,,,,,Human,vMCC-I,816,,,135652634,Antagonist,Antagonist,,f,f,,pIC50,0,9.409999847,0,IC50,0,0.389999986,0,=,,,,10419462,
CCR9,66,CCR9,P51686,,,,,,Human,[<sup>125</sup>I]CCL25 (human),3657,,,178100553,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CCR9,66,CCR9,P51686,,,,,,Human,vercirnon,9046,,,315661131,Allosteric modulator,Antagonist,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,Measuring inhibition of antagonist tracer [<sup>3</sup>H]CCX807 binding to human Molt-4 cells.,,,20660125,Clc1ccc(c(c1)C(=O)c1cc[n+](cc1)[O-])NS(=O)(=O)c1ccc(cc1)C(C)(C)C
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,tositumomab,6781,,,178103387,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,ublituximab,8920,,,310264701,Antibody,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,20975664,
"CD20 (membrane-spanning 4-domains, subfamily A, member 1)",2628,MS4A1,P11836,,,,,,Human,veltuzumab,8268,,,252166480,Antibody,Binding,,f,t,,pKd,0,8.43999958,0,Kd,0,3.599999905,0,=,,,,15102696,
CD33,2601,CD33,P20138,,,,,,Human,vadastuximab talirine,9434,,,329968375,Antibody,Binding,,f,t,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,Saturation binding in HEL 92.1.7 cells endogenously expressing human CD33.,,,23770776,
CDC like kinase 2,1991,CLK2,P49760,,,,,,Human,Takinib,9655,,,348353615,Inhibitor,Inhibition,,f,f,,pIC50,0,6.369999886,0,IC50,0,430,0,=,,,,28820959,CCCn1/c(=N/C(=O)c2cccc(c2)C(=O)N)/[nH]c2c1cccc2
cell division cycle 7,1960,CDC7,O00311,,,,,,Human,XL413,8113,,,249565793,Inhibitor,Inhibition,,f,t,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,22560567,Clc1ccc2c(c1)c1[nH]c(nc(=O)c1o2)[C@@H]1CCCN1
CFTR,707,CFTR,P13569,,,,,,Human,sulfonamide-01,4313,,,178101130,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,C=CCNC(=O)c1c[nH]c2c(c1=O)cc(cc2)S(=O)(=O)N(c1ccccc1OCC)C
CFTR,707,CFTR,P13569,,,,,,Human,UCCF-029,4335,,,178101152,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=c1cc(oc2c1ccc1c2cccc1)c1ccncc1
CFTR,707,CFTR,P13569,,,,,,Human,UCCF-339,4337,,,178101154,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=c1cc(oc2c1cc(c1ccco1)c1c2cccc1)c1ccncc1
CFTR,707,CFTR,P13569,,,,,,Human,UCCF-853,4338,,,178101155,Activator,Potentiation,,f,,,-,0,0,0,-,0,0,0,=,,,,0,Clc1cccc(c1)n1c(=O)[nH]c2c1ccc(c2)C(F)(F)F
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,"[<sup>125</sup>I]&alpha;CGRP (mouse, rat)",6567,,,178103181,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,[<sup>125</sup>I]<i>&alpha;</i>CGRP (human),3766,,,178100616,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,,,,,0,
CGRP receptor,48,CALCRL|RAMP1,Q16602|O60894,,,,,,Human,telcagepant,703,,,135650613,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,-,0,0,0,,,,,18039958,O=C(N1CCC(CC1)n1c(=O)[nH]c2c1cccn2)N[C@@H]1CC[C@H](CN(C1=O)CC(F)(F)F)c1cccc(c1F)F
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,[<sup>3</sup>H]resolvin E1,2901,,,135651571,Agonist,Agonist,,f,,,pKd,0,7.95,0,Kd,0,11,0,=,,,,15753205,CC[C@@H](/C=C/C=CC[C@H](/C=C/C=C/C=C[C@H](CCCC(=O)O)O)O)O
chemerin receptor 1,79,CMKLR1,Q99788,,,,,,Human,tethered chemerin 9,9784,,,0,Agonist,Agonist,,f,f,,pIC50,0,8.260000229,0,IC50,0,5.5,0,~,Binding affinity in a radioligand displacement assay using membranes prepared from chemerinR-expressing CHO-K1 cells and <sup>125</sup>I-YHSFFFPGQFAFS as tracer.,,,14530373,
CHT,914,SLC5A7,Q9GZV3,,,,,,Human,[<sup>3</sup>H]hemicholinium-3,4493,,,178101221,None,None,,f,,,pKd,8.4,0,8.2,Kd,6,0,4,,,,,0,OC1(OCC[N+](C1)(C)C)c1ccc(cc1)c1ccc(cc1)C1(O)OCC[N+](C1)(C)C.[Br-].[Br-]
chymase 1,2340,CMA1,P23946,,,,,,Human,TY-51469,9779,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,,,,21128860,Fc1ccc2c(c1)c(C)c(s2)S(=O)(=O)Nc1ccc(cc1S(=O)(=O)C)c1scc(n1)C(=O)O
chymotrypsin like elastase family member 1,2338,CELA1,Q9UNI1,,,,,,Human,telaprevir,7871,,,223366200,Inhibitor,Inhibition,,f,f,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,19841155,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C1CCCCC1)NC(=O)c1nccnc1
ClC-1,698,CLCN1,P35523,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
ClC-2,699,CLCN2,P51788,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
ClC-4,703,CLCN4,P51793,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,pIC50,0,4.3,0,IC50,0,50000,0,,,,,18658230,
"coagulation factor II, thrombin",2362,F2,P00734,,,,,,Human,ximelagatran,6381,,,178102999,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)/C(=N/O)/N)C1CCCCC1
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,tandutinib,5695,,,178102322,Inhibitor,Inhibition,,f,f,,pIC50,0,5.460000038,0,IC50,0,3430,0,=,,,,12124172,COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
colony stimulating factor 1 receptor,1806,CSF1R,P07333,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
complement C1s,2335,C1S,P09871,,,,,,Human,TNT009,9807,,,0,Antibody,Binding,,f,t,,pKd,0,9.590000153,0,Kd,0,0.25999999,0,=,,,,0,
Constitutive androstane receptor,607,Nr1i3,Q3V008,,,,,,Mouse,TCPOBOP,2756,,,135651237,Agonist,Agonist,,f,f,,pEC50,0,7.699999809,0,-,0,0,0,=,,,,10757780,Clc1cnc(c(c1)Cl)Oc1ccc(cc1)Oc1ncc(cc1Cl)Cl
COX-1 ,1375,PTGS1,P23219,,,,,,Human,suprofen,7298,,,178103871,Inhibitor,Inhibition,,f,t,,pIC50,0,6.25,0,IC50,0,560,0,=,,,,18667313,OC(=O)C(c1ccc(cc1)C(=O)c1cccs1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,suprofen,7298,,,178103871,Inhibitor,Inhibition,,f,t,,pIC50,0,5.559999943,0,IC50,0,2750,0,=,,,,18667313,OC(=O)C(c1ccc(cc1)C(=O)c1cccs1)C
COX-2 ,1376,PTGS2,P35354,,,,,,Human,valdecoxib,2894,,,178100243,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,10715145,Cc1onc(c1c1ccc(cc1)S(=O)(=O)N)c1ccccc1
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,[<sup>125</sup>I]CRF (ovine),915,,,135652504,Agonist,Full agonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,7692441,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,[<sup>125</sup>I]sauvagine (frog),916,,,135652554,Agonist,Full agonist,,f,,,pKd,10,0,9.8,,0,0,0,,,,,15450949,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,"[<sup>125</sup>I]Tyr<sup>0</sup>-CRF (human, rat, mouse)",914,,,135652561,Agonist,Full agonist,,f,,,pKd,0,9.3,0,,0,0,0,,,,,11123370,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,"[<sup>125</sup>I]urocortin 1 (mouse, rat)",917,,,135652574,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,9918582,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,urocortin 1,920,Ucn|Ucn,Mouse|Rat,135651903,Agonist,Full agonist,,f,f,,pKd,9.800000191,0,8.300000191,-,0,0,0,=,,,,11123370,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,urocortin 1,919,UCN,Human,135651904,Agonist,Full agonist,,t,,,pKd,9.5,0,8.6,,0,0,0,,,,,15450949,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,urocortin 2,921,UCN2,Human,135651906,Agonist,Full agonist,,t,,,pKd,5.4,0,5.3,,0,0,0,,,,,15450949,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,urotensin 1 (fish),922,,,135652630,Agonist,Full agonist,,f,,,pKd,9.4,0,7.8,,0,0,0,,,,,11123370,
CRF<sub>1</sub> receptor,212,CRHR1,P34998,,,,,,Human,[<sup>125</sup>I]astressin,924,,,135652486,Antagonist,Antagonist,,f,,,pKd,9.3,0,9.2,,0,0,0,,,,,15450949,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,[<sup>125</sup>I]sauvagine (frog),916,,,135652554,Agonist,Full agonist,,f,,,pKd,9.8,0,9.6,,0,0,0,,,,,15450949,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,"[<sup>125</sup>I]urocortin 1 (mouse, rat)",917,,,135652574,Agonist,Full agonist,,f,,,pKd,0,10,0,-,0,0,0,=,,,,9918582,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,urocortin 1,920,Ucn|Ucn,Mouse|Rat,135651903,Agonist,Full agonist,,f,,,pKd,9.4,0,8.6,,0,0,0,,,,,11123370,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 1,920,Ucn|Ucn,Mouse|Rat,135651903,Agonist,Full agonist,,t,,,pKd,9.4,0,9,,0,0,0,,,,,11123370,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,urocortin 1,919,UCN,Human,135651904,Agonist,Full agonist,,f,,,pKd,0,8.7,0,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 1,920,Ucn|Ucn,Mouse|Rat,135651903,Agonist,Full agonist,,t,,,pKd,9.2,0,8.7,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,urocortin 1,919,UCN,Human,135651904,Agonist,Full agonist,,t,,,pKd,9.6,0,9,,0,0,0,,,,,15450949,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 1,919,UCN,Human,135651904,Agonist,Full agonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,8612563,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,urocortin 2,921,UCN2,Human,135651906,Agonist,Full agonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 2,921,UCN2,Human,135651906,Agonist,Full agonist,,f,,,pKd,0,9.3,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,urocortin 2,927,Ucn2,Mouse,135651905,Agonist,Full agonist,,f,,,pKd,0,8.7,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,urocortin 2,921,UCN2,Human,135651906,Agonist,Full agonist,,t,,,pKd,8.6,0,8.5,-,0,0,0,=,,,,15450949,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 2,927,Ucn2,Mouse,135651905,Agonist,Full agonist,,t,,,pKd,0,9.2,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,urocortin 3,928,UCN3,Human,135651909,Agonist,Full agonist,,t,,,pKd,8,0,7.9,-,0,0,0,=,,,,15450949,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 3,929,Ucn3|Ucn3,Mouse|Rat,135651908,Agonist,Full agonist,,t,,,pKd,0,8.7,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urocortin 3,928,UCN3,Human,135651909,Agonist,Full agonist,,f,,,pKd,0,7.9,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,urocortin 3,928,UCN3,Human,135651909,Agonist,Full agonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,P47866,,,,,,Rat,urocortin 3,929,Ucn3|Ucn3,Mouse|Rat,135651908,Agonist,Full agonist,,t,,,pKd,0,8.3,0,,0,0,0,,,,,11416224,
CRF<sub>2</sub> receptor,213,Crhr2,Q60748,,,,,,Mouse,urotensin 1 (fish),922,,,135652630,Agonist,Full agonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,7477349,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,urotensin 1 (fish),922,,,135652630,Agonist,Full agonist,,f,,,pKd,8.9,0,7.3,,0,0,0,,,,,11123370,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,[<sup>125</sup>I]antisauvagine,930,,,135652484,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,11123370,
CRF<sub>2</sub> receptor,213,CRHR2,Q13324,,,,,,Human,[<sup>125</sup>I]astressin,924,,,135652486,Antagonist,Antagonist,,f,,,pKi,9.7,0,9.6,,0,0,0,,,,,15450949,
CT receptor,43,CALCR,P30988,,,,,,Human,[<sup>125</sup>I]CT (human),3776,,,178100626,Agonist,Full agonist,,f,,,pKd,10,0,9,Kd,1,0,0.1,=,,,,0,
CT receptor,43,CALCR,P30988,,,,,,Human,[<sup>125</sup>I]CT (salmon),3777,,,178100627,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,=,,,,0,
CXCR1,68,CXCR1,P25024,,,,,,Human,vCXCL1,8496,,,252166704,Agonist,Agonist,,f,f,,pIC50,0,7.360000134,0,IC50,0,44,0,=,,,,20044480,
CXCR1,68,CXCR1,P25024,,,,,,Human,[<sup>125</sup>I]CXCL8 (human),822,,,135652505,Agonist,Full agonist,,f,,,pKd,9.6,0,8.9,Kd,1.2,0,0.251,=,,,,10188995,
CXCR1,68,CXCR1,P25024,,,,,,Human,[<sup>125</sup>I]mini-TyrRS,818,,,135652530,Agonist,Full agonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,10102815,
CXCR2,69,CXCR2,P25025,,,,,,Human,vCXCL1,8496,,,252166704,Agonist,Agonist,,f,f,,pIC50,0,8.25,0,IC50,0,5.599999905,0,=,,,,20044480,
CXCR2,69,CXCR2,P25025,,,,,,Human,[<sup>125</sup>I]CXCL1 (human),3677,,,178100567,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CXCR2,69,CXCR2,P25025,,,,,,Human,[<sup>125</sup>I]CXCL5 (human),3659,,,178100555,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CXCR2,69,CXCR2,P25025,,,,,,Human,[<sup>125</sup>I]CXCL7 (human),3658,,,178100554,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CXCR2,69,CXCR2,P25025,,,,,,Human,[<sup>125</sup>I]CXCL8 (human),822,,,135652505,Agonist,Full agonist,,f,,,pKd,9.4,0,9,Kd,1.02,0,0.398,=,,,,10188995,
CXCR2,69,Cxcr2,P35343,,,,,,Mouse,[<sup>125</sup>I]KC-Tyr,832,,,135652525,Agonist,Full agonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,7961909,
CXCR2,69,CXCR2,P25025,,,,,,Human,SX-517,8501,,,252166709,Antagonist,Antagonist,,f,f,,pIC50,0,7.21999979,0,IC50,0,60,0,=,,,,25254640,Fc1ccc(cc1)NC(=O)c1ccc(nc1)SCc1ccccc1B(O)O
CXCR3,70,CXCR3,P49682,,,,,,Human,[<sup>125</sup>I]CXCL10 (human),3660,,,178100556,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CXCR3,70,CXCR3,P49682,,,,,,Human,[<sup>125</sup>I]CXCL11 (human),3661,,,178100557,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CXCR4,71,CXCR4,P61073,,,,,,Human,X4-HIV-1 gp120,3919,,,178100751,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
CXCR4,71,CXCR4,P61073,,,,,,Human,[<sup>125</sup>I]CXCL12&alpha; (human),849,,,135652555,Agonist,Full agonist,,f,,,pKd,8.4,0,8.1,Kd,7.94,0,3.98,=,,,,9551924,
CXCR4,71,CXCR4,P61073,,,,,,Human,[<sup>125</sup>I]CXCL12&alpha; (human),849,,,135652555,Agonist,Full agonist,,f,f,,pKd,0,7.449999809,0,Kd,0,35.79999924,0,=,,,,18768385,
CXCR4,71,CXCR4,P61073,,,,,,Human,[<sup>125</sup>I]CXCL12&beta; (human),850,,,135652556,Agonist,Full agonist,,f,,,pKd,0,7.9,0,,0,0,0,,,,,9551924,
CXCR4,71,CXCR4,P61073,,,,,,Human,T134,852,,,135652592,Antagonist,Antagonist,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.980000019,0,=,,,,9918823,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)O)CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N
CXCR4,71,CXCR4,P61073,,,,,,Human,T22,854,,,135652594,Antagonist,Antagonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,9918823,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](C(=O)N)CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c3c1cccc3)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N)CCCCN)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N2)Cc1ccc(cc1)O)CCCCN
CXCR4,71,CXCR4,P61073,,,,,,Human,viral macrophage inflammatory protein-II,768,,,135652636,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,9287217,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C
CXCR4,71,CXCR4,P61073,,,,,,Human,X4P-001,8580,,,252166781,Antagonist,Antagonist,,f,t,,pIC50,0,7.889999866,0,IC50,0,13,0,=,CXCR4 <sup>125</sup>I-SDF inhibition binding assay.,,,20297846,NCCCCN([C@H]1CCCc2c1nccc2)Cc1nc2c([nH]1)cccc2
CXCR4,71,CXCR4,P61073,,,,,,Human,X4P-001,8580,,,252166781,Antagonist,Antagonist,,f,f,,pKi,0,7.960000038,0,Ki,0,11,0,=,"Assay using <sup>125</sup>I-SDF-1&alpha; as tracer, in Cf2Th cells expressing hCXCR4.",,,18768385,NCCCCN([C@H]1CCCc2c1nccc2)Cc1nc2c([nH]1)cccc2
CXCR4,71,CXCR4,P61073,,,,,,Human,T140,853,,,135652593,Antagonist,Inverse agonist,,f,,,pIC50,8.6,0,7.8,,0,0,0,,,,,11923301,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)O)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N)Cc1ccc2c(c1)cccc2
CXCR4,71,CXCR4,P61073,,,,,,Human,ulocuplumab,9161,,,315661244,Antibody,Binding,,f,t,,pEC50,0,8.649999619,0,EC50,0,2.25999999,0,=,Measuring displacement of iodinated SDF-1 from exogenously expressed CXCR4 <i>in vitro</i>.,,,0,
CXCR5,72,Cxcr5,Q04683,,,,,,Mouse,[<sup>125</sup>I]CXCL13 (mouse),8631,,,252166831,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,24190631,
CXCR6,73,CXCR6,O00574,,,,,,Human,[<sup>125</sup>I]CXCL16 (human),3662,,,178100558,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
CX<sub>3</sub>CR1,74,CX3CR1,P49238,,,,,,Human,[<sup>125</sup>I]CX<sub>3</sub>CL1 (human),3664,,,178100560,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,SU9516,6045,,,178102667,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,CDK1/cyclin B complex used in assay,,,11507069,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)/C(=O)N2
cyclin dependent kinase 1,1961,CDK1,P06493,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,SU9516,6045,,,178102667,Inhibitor,Inhibition,,f,t,,pIC50,0,7.659999847,0,IC50,0,22,0,=,CDK2/cyclin A complex used in assay,,,11507069,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)/C(=O)N2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,8.300000191,0,7.889999866,IC50,13,0,5,=,,,,22148278,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1290,0,=,Inhibition of CDK2/cyclinA,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase 2,1973,CDK2,P24941,,,,,,Human,VTX-11e,9375,,,328083477,Inhibitor,Inhibition,,f,f,,pKi,0,6.070000172,0,Ki,0,852,0,=,,,,19827834,OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1nc(ncc1C)Nc1ccc(cc1Cl)F
cyclin dependent kinase 3,1975,CDK3,Q00526,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,8.100000381,0,IC50,0,8,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,SU9516,6045,,,178102667,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,CDK4/cyclin D1 complex used in assay,,,11507069,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)/C(=O)N2
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,Inhibition of CDK4/cyclin D1,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase 4,1976,CDK4,P11802,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pKd,0,10,0,Kd,0,0.100000001,0,=,Inhibition of CDK4/cyclin D3,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase 5,1977,CDK5,Q00535,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
cyclin dependent kinase 6,1978,CDK6,Q00534,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,Inhibition of CDK6/cyclin D3,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,THZ1,8052,,,249565732,Inhibitor,Inhibition,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,,,,25043025,CN(C/C=C/C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(c1)Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)C
cyclin dependent kinase 7,1979,CDK7,P50613,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pIC50,0,5.329999924,0,IC50,0,4640,0,=,Inhibition of CDK7/cyclinM/Mat1,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
cyclin dependent kinase 9,1981,CDK9,P50750,,,,,,Human,trilaciclib,9626,,,340590256,Inhibitor,Inhibition,,f,f,,pIC50,0,7.300000191,0,IC50,0,50,0,=,Inhibition of CDK9/cyclinT,,,26826116,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2
cyclin dependent kinase like 2,1983,CDKL2,Q92772,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
CYP19A1,1362,CYP19A1,P11511,,,,,,Human,testolactone,7303,,,178103876,Inhibitor,Inhibition,,f,t,,pKi,0,4.460000038,0,Ki,0,35000,0,=,,,,7083195,O=C1C=C[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CCC(=O)O2)C)C
CYP2B6,1324,CYP2B6,P20813,,,,,,Human,ticlopidine,7307,,,178103880,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,16248836,Clc1ccccc1CN1CCc2c(C1)ccs2
CYP2J2,1332,CYP2J2,P51589,,,,,,Human,terfenadine,2608,,,135651245,Inhibitor,Inhibition,,f,f,,pIC50,0,5.090000153,0,IC50,0,8100,0,=,Measuring CYP2J2-induced inhibition ebastine hydroxylation.,,,16495056,OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
CYP3A4,1337,CYP3A4,P08684,,,,,,Human,verapamil,2406,,,135651305,Inhibitor,Inhibition,,f,f,,pKi,0,6.21999979,0,Ki,0,600,0,=,Inhibition of testosterone 6&beta;-hydroxylation.,,,11422004,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,[<sup>3</sup>H]LTD<sub>4</sub>,3412,,,178100418,Agonist,Agonist,,f,,,pKd,10.7,0,8,Kd,9.3,0,0.02,=,,,,0,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,[<sup>3</sup>H]LTD<sub>4</sub>,3412,,,178100418,Agonist,Full agonist,K<sub>d1</sub> and K<sub>d2</sub> in human lung parenchyma,f,,,pKd,10.6,0,8.6,-,0,0,0,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,[<sup>3</sup>H]LTD<sub>4</sub>,3412,,,178100418,Agonist,Full agonist,K<sub>d1</sub> and K<sub>d2</sub> in COS-7 cells,f,,,pKd,10.22,0,8.21,Kd,0,0,0,=,,,,10391245,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,[<sup>3</sup>H]LTD<sub>4</sub>,3412,,,178100418,Agonist,Full agonist,in U937 cells,f,,,pKd,0,9.3,0,Kd,0,0.5,0,=,,,,14518564,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,sulukast,3327,,,178100360,Antagonist,Antagonist,,f,,,pKi,0,8.3,0,-,0,0,0,=,,,,0,CCCCCCCCC/C=CC=C[C@H]([C@H](c1cccc(c1)c1nnn[nH]1)O)SCCC(=O)O
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,[<sup>3</sup>H]ICI-198615,3414,,,178100420,Antagonist,Antagonist,in human lung parenchyma,f,,,pKd,0,10.6,0,Kd,0,0.025,0,=,,,,1329767,COc1cc(ccc1Cn1ncc2c1cc(cc2)NC(=O)OC1CCCC1)C(=O)NS(=O)(=O)c1ccccc1
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,verlukast,6193,,,178102814,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 cells,f,,,pIC50,0,8,0,IC50,0,10,0,=,,,,10391245,OC(=O)CCS[C@H](c1cccc(c1)/C=C/c1ccc2c(n1)cc(cc2)Cl)SCCC(=O)N(C)C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in human lung parenchyma,f,t,,pKi,0,8.899999619,0,-,0,0,0,=,,,,11996896,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,20423349,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 or HEK-293 cells,f,t,,pIC50,8.739999771,0,8.590000153,IC50,2.599999905,0,1.799999952,=,,,,10391245,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>1</sub> receptor,269,CYSLTR1,Q9Y271,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against 33nM LTD<sub>4</sub> Ca<sup>2+</sup> mobilization assay in HEK-293,f,t,,pIC50,0,9.590000153,0,IC50,0,0.25999999,0,=,,,,10462554,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,[<sup>3</sup>H]LTC<sub>4</sub>,6195,,,178102816,Agonist,Full agonist,K<sub>d1</sub> and K<sub>d2</sub> in human lung parenchyma,f,,,pKd,10.8,0,6.97,-,107,0,0.0158,=,,,,9547367,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[CH]C(=O)NCC(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,[<sup>3</sup>H]LTC<sub>4</sub>,6195,,,178102816,Agonist,Full agonist,in HUVEC,f,,,pKd,0,10.54,0,Kd,0,0.029,0,=,,,,21753081,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[CH]C(=O)NCC(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,[<sup>3</sup>H]LTC<sub>4</sub>,6195,,,178102816,Agonist,Full agonist,in COS-1 cells,f,,,pKd,0,8.52,0,Kd,0,3,0,=,,,,10913337,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[CH]C(=O)NCC(=O)O
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,[<sup>3</sup>H]LTD<sub>4</sub>,3412,,,178100418,Agonist,Full agonist,K<sub>d1</sub> and K<sub>d-2</sub> in COS-7 cells,f,,,pKd,9.4,0,7.3,Kd,50.1,0,0.398,=,,,,10851239,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,[<sup>3</sup>H]ICI-198615,3414,,,178100420,Antagonist,Antagonist,in human lung parenchyma,f,,,pKd,0,5.2,0,-,0,0,0,=,,,,1329767,COc1cc(ccc1Cn1ncc2c1cc(cc2)NC(=O)OC1CCCC1)C(=O)NS(=O)(=O)c1ccccc1
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against 10nM LTD<sub>4</sub> aequorin-based Ca<sup>2+</sup> assay in CHO cells,f,,,pIC50,0,5.15,0,IC50,0,7000,0,=,,,,20423349,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,against LTC<sub>4</sub> Ca<sup>2+</sup> mobilisation assay in HUVEC,f,,,pA2,0,6.9,0,-,0,0,0,=,,,,0,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
CysLT<sub>2</sub> receptor,270,CYSLTR2,Q9NS75,,,,,,Human,zafirlukast,3322,,,178100355,Antagonist,Antagonist,againist [<sup>3</sup>H]LTD<sub>4</sub> in COS-7 cells,f,,,pIC50,0,5.13,0,IC50,0,7397,0,=,,,,10851239,COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C
cytotoxic T-lymphocyte-associated protein 4 (CD152),2743,CTLA4,P16410,,,,,,Human,tremelimumab,8462,,,252166672,Antibody,Binding,,f,t,,pKd,0,8.909999847,0,Kd,0,1.24000001,0,=,"Average Kd from associated patent, for a competition ELISA assessing binding of the antibody to CTLA4.",,,0,
DAT,927,SLC6A3,Q01959,,,,,,Human,[<sup>3</sup>H]GBR12935,4638,,,178101356,Inhibitor,Inhibition,,f,f,,pKd,0,8.5,0,Kd,0,3,0,=,,,,8302271,c1ccc(cc1)CCCN1CCN(CC1)CCOC(c1ccccc1)c1ccccc1
DAT,927,SLC6A3,Q01959,,,,,,Human,[<sup>3</sup>H]WIN35428,4605,,,178101325,Inhibitor,Inhibition,,f,f,,pKd,0,8,0,Kd,0,10,0,=,,,,8302271,COC(=O)[C@@H]1[C@H]2CC[C@H](N2C)C[C@@H]1c1ccc(cc1)F
DAT,927,SLC6A3,Q01959,,,,,,Human,trimipramine,7317,,,178103890,Inhibitor,Inhibition,,f,t,,pKi,0,5.420000076,0,Ki,0,3780,0,=,,,,9537821,CN(CC(CN1c2ccccc2CCc2c1cccc2)C)C
DAT,927,SLC6A3,Q01959,,,,,,Human,WIN35428,4606,,,178101326,Inhibitor,Inhibition,,f,f,,pKi,0,7.900000095,0,Ki,0,12.5,0,=,,,,8878059,COC(=O)[C@@H]1[C@H]2CC[C@H](N2C)C[C@@H]1c1ccc(cc1)F
death associated protein kinase 3,2004,DAPK3,O43293,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
death receptor 3,1883,TNFRSF25,Q93038,,,,,,Human,TL1A,5071,TNFSF15,Human,178101764,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
death receptor 4,1879,TNFRSF10A,O00220,,,,,,Human,TRAIL,5065,TNFSF10,Human,178101758,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
death receptor 5,1880,TNFRSF10B,O14763,,,,,,Human,TRAIL,5065,TNFSF10,Human,178101758,Agonist,Agonist,,t,f,,pKd,0,7.230000019,0,Kd,0,59,0,=,,,,0,
death receptor 5,1880,TNFRSF10B,O14763,,,,,,Human,tigatuzumab,9334,,,318164853,Antibody,Agonist,,f,t,,pKd,0,8.520000458,0,Kd,0,3,0,~,,,,0,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[<sup>3</sup>H][D-Ala2]deltorphin I,9065,,,315661150,Agonist,Agonist,,f,f,,pKd,0,9.350000381,0,Kd,0,0.449999988,0,=,,,,1329092,
&delta; receptor,317,Oprd1,P32300,,,,,,Mouse,TAN-67,9567,,,336446953,Agonist,Agonist,,f,f,,pIC50,0,8.43999958,0,IC50,0,3.650000095,0,=,Bioassay using mouse vas deferens.,,,11765135,CN1CC[C@]2([C@H](C1)Cc1c(C2)nc2c(c1)cccc2)c1cccc(c1)O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,tramadol,8286,,,252166498,Agonist,Agonist,,f,f,,pKi,0,8.029999733,0,Ki,0,9.399999619,0,=,Displacement of the delta antagonist naltrindole from the delta receptor expressed in CHO cells.,,,19027293,COc1cccc(c1)C1(O)CCCCC1CN(C)C
&delta; receptor,317,OPRD1,P41143,,,,,,Human,UFP-512,9006,,,310264784,Agonist,Agonist,,f,t,,pKi,0,10.19999981,0,-,0,0,0,=,Measuring displacement of [<sup>3</sup>H]-diprenorphine <i>in vitro</i>,,,18069089,Oc1cc(C)c(c(c1)C)C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@H](c1[nH]c2c(n1)cccc2)CC(=O)O)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[<sup>3</sup>H]deltorphin II,3816,,,178100662,Agonist,Full agonist,,f,f,,pKd,0,8.699999809,0,-,0,0,0,=,,,,1313131,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[<sup>3</sup>H]diprenorphine,1612,,,135651148,Agonist,Full agonist,,f,f,,pKi,0,9.300000191,0,Ki,0,0.500999987,0,=,,,,9686407,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(C(C1[3H])[3H])CC1CC1)ccc2O
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[<sup>3</sup>H]DPDPE,3819,,,178100664,Agonist,Full agonist,,f,f,,pKd,0,8.899999619,0,-,0,0,0,=,,,,2986120,
&delta; receptor,317,OPRD1,P41143,,,,,,Human,[<sup>3</sup>H]naltriben,3828,,,178100672,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,9696425,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1
&delta; receptor,317,Oprd1,P33533,,,,,,Rat,[<sup>3</sup>H]naltrindole,3829,,,178100673,Antagonist,Antagonist,,f,f,,pKd,0,10.43000031,0,Kd,0,0.037,0,=,,,,1313133,Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1[nH]c1c2cccc1)CC1CC1
&delta; receptor,317,OPRD1,P41143,,,,,,Human,zyklophin,9193,,,315661272,Antagonist,Antagonist,,f,f,,pKi,0,5,0,Ki,0,10000,0,>,,,,15999987,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NCc2ccccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(CC)C)CCCN=C(N)N)CCCN=C(N)N
&delta; receptor,317,OPRD1,P41143,,,,,,Human,TIPP&psi;,1637,,,135651267,Antagonist,Inverse agonist,,f,f,,pKi,0,9,0,-,0,0,0,=,,,,9686407,Oc1ccc(cc1)C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1CN[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1ccccc1)N
diacylglycerol O-acyltransferase 1,2821,DGAT1,O75907,,,,,,Human,T863,7828,,,223366159,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,19256504,OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)C1=Nc2c(N)ncnc2OC1(C)C
dihydrofolate reductase,2603,DHFR,P00374,,,,,,Human,trimetrexate,7613,,,223365948,Inhibitor,Inhibition,,f,f,,pKi,0,7.889999866,0,Ki,0,13,0,=,<i>In vitro</i> inhibition of wild-type human DHFR,,,7877140,COc1cc(NCc2ccc3c(c2C)c(N)nc(n3)N)cc(c1OC)OC
dihydroorotate dehydrogenase (quinone),2604,DHODH,Q02127,,,,,,Human,teriflunomide,6844,,,178103450,Inhibitor,Inhibition,,f,t,,pKi,0,7.519999981,0,Ki,0,30,0,=,,,,17228860,N#C/C(=C(/O)C)/C(=O)Nc1ccc(cc1)C(F)(F)F
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,ZY15557,9627,,,340590257,Inhibitor,Competitive,,f,t,,pKi,0,8.260000229,0,Ki,0,5.53000021,0,=,,,,28452143,N[C@H]1C[C@H](CO[C@@H]1c1cc(F)ccc1F)N1CC2=C(C1)CS(=O)(=O)C2
dipeptidyl peptidase 4,1612,DPP4,P27487,,,,,,Human,vildagliptin,6310,,,178102929,Inhibitor,Inhibition,,f,t,,pKi,0,7.800000191,0,Ki,0,17,0,=,,,,19149538,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(C1)CC(C2)(C3)O
Dipeptidyl-peptidase 7,1605,DPP7,Q9UHL4,,,,,,Human,UAMC00039,6538,,,178103152,Inhibitor,Inhibition,,f,,,pKi,0,10.1,0,Ki,0,0.082,0,,,,,16725115,N[C@H](C(=O)N1CCCCC1)CCNCc1ccc(cc1)Cl
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
DNA-dependent protein kinase catalytic subunit,2800,PRKDC,P78527,,,,,,Human,wortmannin,6060,,,178102681,Inhibitor,Inhibition,,f,f,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,22835870,COC[C@H]1OC(=O)c2c3[C@@]1(C)C1=C(C(=O)c3oc2)[C@H]2[C@@](C[C@H]1OC(=O)C)(C)C(=O)CC2
DNA topoisomerase II alpha,2637,Top2a,Q01320,,,,,,Mouse,teniposide,6843,,,178103449,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,"Inhibition of purified mouse topoisomerase II&alpha;, 170kDa isoform",,,2557897,COc1cc(cc(c1O)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2[C@@H](c2c1cc1OCOc1c2)O[C@@H]1O[C@@H]2CO[C@H](O[C@H]2[C@@H]([C@H]1O)O)c1cccs1
doublecortin like kinase 2,2006,DCLK2,Q8N568,,,,,,Human,XMD8-92,8057,,,249565737,Inhibitor,Inhibition,,f,f,,pKd,0,6.71999979,0,Kd,0,190,0,=,,,,20832753,CCOc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)N1CCC(CC1)O
DP<sub>1</sub> receptor,338,,,,,,,,Unknown,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Agonist,,f,,,pKd,7.9,0,7.5,Kd,34,0,13,=,,,,0,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,[<sup>3</sup>H]PGD<sub>2</sub>,1891,,,135651568,Agonist,Full agonist,,f,,,pKd,9.5,0,7.9,Kd,13,0,0.3,=,,,,9579725,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,,f,f,,pKi,0,8.399999619,0,-,0,0,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,5.9,0,5.4,,0,0,0,,,,,9579725,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,ZK110841,1889,,,135651360,Agonist,Full agonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,9579725,OC(=O)CCC/C=CCC1[C@H](Cl)C[C@H]([C@@H]1/C=C/[C@H](C1CCCCC1)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,ZK118182,1890,,,135651361,Agonist,Full agonist,,f,f,,pKi,0,7.300000191,0,Ki,0,50.09999847,0,=,,,,10772998,OC(=O)COC/C=CC[C@H]1[C@H](Cl)C[C@H]([C@@H]1/C=C/[C@H](C1CCCCC1C)O)O
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,[<sup>3</sup>H]BWA868C,1899,,,135651140,Antagonist,Antagonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,11082108,OC(=O)CCCCCCC1N(NCC(C2CCCCC2)O)C(=O)N(C1=O)Cc1ccccc1
DP<sub>1</sub> receptor,338,PTGDR,Q13258,,,,,,Human,TG6-129,9283,,,318164802,Antagonist,Antagonist,,f,f,,pKB,0,4.840000153,0,KB,0,14600,0,=,,,,23914286,CCc1nnc(s1)NS(=O)(=O)c1ccc(cc1)NC(=S)NC(=O)/C=C/c1ccc(cc1)F
DP<sub>2</sub> receptor,339,Ptgdr2,Q6XKD3,,,,,,Rat,[<sup>3</sup>H]PGD<sub>2</sub>,1891,,,135651568,Agonist,Full agonist,,f,,,pKd,0,8,0,,0,0,0,,,,,12975488,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,[<sup>3</sup>H]PGD<sub>2</sub>,1891,,,135651568,Agonist,Full agonist,,f,,,pKd,8.2,0,7.8,Kd,16,0,6,=,,,,12975488,CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=CCCCC(=O)O)O)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,5.5,0,,0,0,0,,,,,12466225,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,[<sup>3</sup>H]ramatroban,1910,,,135651196,Antagonist,Antagonist,,f,,,pKd,0,8.1,0,,0,0,0,,,,,16256979,OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
DP<sub>2</sub> receptor,339,PTGDR2,Q9Y5Y4,,,,,,Human,timapiprant,9277,,,318164796,Antagonist,Antagonist,,f,t,,pKi,0,7.889999866,0,Ki,0,13,0,=,Displacement of  [3H]PGD<sub>2</sub> from human recombinant DP<sub>2</sub>,,,22106101,Fc1ccc2c(c1)c(Cc1ccc3c(n1)cccc3)c(n2CC(=O)O)C
DP<sub>2</sub> receptor,339,Ptgdr2,Q6XKD3,,,,,,Rat,timapiprant,9277,,,318164796,Antagonist,Antagonist,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,Displacement of  [3H]PGD<sub>2</sub> from rat recombinant DP<sub>2</sub>,,,22106101,Fc1ccc2c(c1)c(Cc1ccc3c(n1)cccc3)c(n2CC(=O)O)C
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,[<sup>125</sup>I]SCH23982,945,,,135651117,Antagonist,Antagonist,,f,f,,pKd,0,9.5,0,Kd,0,0.349999994,0,=,,,,2144334,CN1CCc2c([C@H](C1)c1ccccc1)cc(c(c2)[125I])O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,[<sup>3</sup>H]SCH-23390,946,,,135651204,Antagonist,Antagonist,,f,f,,pKd,0,9.5,0,Kd,0,0.300000012,0,=,,,,2168520,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
D<sub>1</sub> receptor,214,DRD1,P21728,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,1826762,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Agonist,,f,f,,pIC50,0,6.179999828,0,IC50,0,666,0,=,,,,15341484,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC0006,7651,,,223365986,Agonist,Biased agonist,,f,f,,pKi,0,8.300000191,0,Ki,0,5,0,=,&beta;-arrestin 2 biased agonist.,,,22025698,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC0006,7651,,,223365986,Agonist,Biased agonist,,f,f,,pEC50,0,8.920000076,0,EC50,0,1.200000048,0,=,Biased agonist of D<sub>2</sub>-mediated &beta;-arrestin-2 translocation measured using the Tango assay.,,,22025698,O=C1CCc2c(N1)cc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC9975,7650,,,223365985,Agonist,Biased agonist,,f,f,,pKi,0,8.590000153,0,Ki,0,2.599999905,0,=,&beta;-arrestin 2 biased agonist.,,,22025698,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC9975,7650,,,223365985,Agonist,Biased agonist,,f,f,,pEC50,0,8.960000038,0,EC50,0,1.100000024,0,=,This compound shows biased agonism towards D<sub>2</sub>-mediated &beta;-arrestin-2 translocation measured using the Tango assay.,,,22025698,O=C1CCc2c(N1)nc(cc2)OCCCCN1CCCN(CC1)c1cccc(c1Cl)Cl
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC9994,7652,,,223365987,Agonist,Biased agonist,,f,f,,pEC50,0,8.210000038,0,EC50,0,6.099999905,0,=,This compound shows biased agonism towards D<sub>2</sub>-mediated &beta;-arrestin-2 translocation measured using the Tango assay.,,,22025698,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,UNC9994,7652,,,223365987,Agonist,Biased agonist,,f,f,,pKi,0,7.099999905,0,Ki,0,79,0,=,&beta;-arrestin 2 biased agonist.,,,22025698,Clc1cccc(c1Cl)C1CCN(CC1)CCCOc1ccc2c(c1)ncs2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,sumanirole,3949,,,178100776,Agonist,Full agonist,,f,,,pKi,0,8.1,0,Ki,0,9,0,=,,,,15980060,CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,sulpiride,5501,,,178102147,Antagonist,Antagonist,,f,t,,pKi,7.920000076,0,7.21999979,Ki,60,0,12,=,,,,7576010,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(-)-sulpiride,958,,,135651093,Antagonist,Antagonist,,f,t,,pKi,8,0,6.28000021,Ki,520,0,10,=,,,,8301582,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(+)-sulpiride,960,,,135651092,Antagonist,Antagonist,,f,,,pKi,0,8.22,0,Ki,0,6,0,=,,,,8301582,CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,(+)-sulpiride,960,,,135651092,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,1975644,CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,[<sup>3</sup>H]<i>N</i>-methylspiperone,196,,,135651163,Antagonist,Antagonist,,f,,,pKi,0,10.7,0,,0,0,0,,,,,10617689,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,[<sup>3</sup>H]nemonapride,962,,,135651188,Antagonist,Antagonist,,f,,,pKd,0,10.9,0,,0,0,0,,,,,14535946,COc1cc(NC)c(cc1C(=O)N[C@@H]1CCN([C@@H]1C)Cc1ccccc1)Cl
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,[<sup>3</sup>H]raclopride,3299,,,178100336,Antagonist,Antagonist,,f,,,pKd,0,8.9,0,Kd,0,1.2,0,=,,,,4015674,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(c1OC)Cl
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,[<sup>3</sup>H]spiperone,3300,,,178100337,Antagonist,Antagonist,,f,,,pKd,0,10.2,0,Kd,0,0.057,0,=,,,,2974511,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,trifluoperazine,214,,,135651279,Antagonist,Antagonist,,f,t,,pKi,9.020000458,0,8.890000343,Ki,1.299999952,0,0.959999979,=,,,,12629531,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,(+)-UH232,957,,,135651297,Antagonist,Antagonist,,f,,,pKi,7.1,0,6.4,,0,0,0,,,,,8301582,CCCN([C@@H]1C=Cc2c([C@@H]1C)cccc2OC)CCC
D<sub>2</sub> receptor,215,Drd2,P61169,,,,,,Rat,(+)-UH232,957,,,135651297,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,1975644,CCCN([C@@H]1C=Cc2c([C@@H]1C)cccc2OC)CCC
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,ziprasidone,59,,,135651359,Antagonist,Antagonist,,f,t,,pKi,0,8.550000191,0,Ki,0,2.799999952,0,=,,,,9430133,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
D<sub>2</sub> receptor,215,DRD2,P14416,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,f,,pKi,0,7.960000038,0,Ki,0,11,0,=,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,[<sup>3</sup>H]7-OH-DPAT,3296,,,178100333,Agonist,Agonist,,f,f,,pKd,0,9.100000381,0,Kd,0,0.79400003,0,=,,,,1518841,CCCN(C1CCc2c(C1)cc(cc2)O)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,[<sup>3</sup>H]7-OH-DPAT,3296,,,178100333,Agonist,Agonist,,f,,,pKd,0,9.6,0,Kd,0,0.27,0,=,,,,7759603,CCCN(C1CCc2c(C1)cc(cc2)O)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,[<sup>3</sup>H]PD128907,3298,,,178100335,Agonist,Agonist,,f,,,pKd,0,9,0,Kd,0,0.99,0,=,,,,7674830,CCCN1CCO[C@@H]2[C@@H]1COc1c2cc(cc1)O
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Agonist,,f,f,,pIC50,0,7.150000095,0,IC50,0,71,0,=,,,,15341484,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,terguride,56,,,135651246,Agonist,Partial agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,sulpiride,5501,,,178102147,Antagonist,Antagonist,,f,f,,pKi,7.849999905,0,6.849999905,Ki,142,0,14,=,,,,7576010,CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(-)-sulpiride,958,,,135651093,Antagonist,Antagonist,,f,t,,pKi,7.699999809,0,6.679999828,Ki,207,0,20,=,,,,8301582,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,(+)-sulpiride,960,,,135651092,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,-,0,0,0,=,,,,1975644,CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(+)-sulpiride,960,,,135651092,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,Ki,0,7.99,0,=,,,,8099194,CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,[<sup>3</sup>H]nemonapride,962,,,135651188,Antagonist,Antagonist,,f,,,pKd,0,10.3,0,,0,0,0,,,,,14535946,COc1cc(NC)c(cc1C(=O)N[C@@H]1CCN([C@@H]1C)Cc1ccccc1)Cl
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,[<sup>3</sup>H]spiperone,3300,,,178100337,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,Kd,0,0.125,0,=,,,,20122961,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>3</sub> receptor,216,Drd3,P19020,,,,,,Rat,(+)-UH232,957,,,135651297,Antagonist,Antagonist,,f,,,pKi,0,7,0,,0,0,0,,,,,1975644,CCCN([C@@H]1C=Cc2c([C@@H]1C)cccc2OC)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,(+)-UH232,957,,,135651297,Antagonist,Antagonist,,f,,,pKi,7.4,0,7,,0,0,0,,,,,8301582,CCCN([C@@H]1C=Cc2c([C@@H]1C)cccc2OC)CCC
D<sub>3</sub> receptor,216,DRD3,P35462,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,f,,pKi,0,8.18999958,0,Ki,0,6.400000095,0,=,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,WAY-100635,80,,,135651321,Agonist,Full agonist,,f,f,,pKi,0,7.800000191,0,Ki,0,16,0,=,,,,21520940,COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,(-)-sulpiride,958,,,135651093,Antagonist,Antagonist,,f,,,pKi,7.7,0,5.72,Ki,1900,0,20,=,,,,8301592,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,(+)-sulpiride,960,,,135651092,Antagonist,Antagonist,,f,,,pKi,0,5.66,0,Ki,0,2200,0,=,,,,8967990,CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,[<sup>125</sup>I]L750667,3295,,,178100332,Antagonist,Antagonist,,f,,,pKd,0,9.8,0,Kd,0,0.16,0,=,,,,8967990,[125I]c1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2
D<sub>4</sub> receptor,217,Drd4,P30729,,,,,,Rat,[<sup>3</sup>H]<i>N</i>-methylspiperone,196,,,135651163,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,10617689,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(C2=O)C)c1ccccc1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,[<sup>3</sup>H]NGD941,3297,,,178100334,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,Kd,0,5,0,=,,,,9262371,c1ccc(cc1)c1ncc([nH]1)CN1CCN(CC1)c1ncccn1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,[<sup>3</sup>H]spiperone,3300,,,178100337,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,Kd,0,0.3,0,=,,,,1840645,Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,terguride,56,,,135651246,Antagonist,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,12388666,CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,trifluoperazine,214,,,135651279,Antagonist,Antagonist,,f,f,,pKi,0,7.360000134,0,Ki,0,44,0,=,,,,9015795,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,U101958,5781,,,178102406,Antagonist,Antagonist,,f,f,,pKi,0,8.899999619,0,Ki,0,1.399999976,0,=,,,,9098699,CC(Oc1cccnc1N(C1CCN(CC1)Cc1ccccc1)C)C
D<sub>4</sub> receptor,217,DRD4,P21917,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,f,,pKi,0,7.409999847,0,Ki,0,39,0,=,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
D<sub>5</sub> receptor,218,,,,,,,,Unknown,[<sup>125</sup>I]SCH23982,945,,,135651117,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,Kd,0,0.8,0,=,,,,0,CN1CCc2c([C@H](C1)c1ccccc1)cc(c(c2)[125I])O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,[<sup>3</sup>H]SCH-23390,946,,,135651204,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,Kd,0,0.58,0,=,,,,8051291,CN1CCc2c(C(C1)c1ccccc1)cc(c(c2)Cl)O
D<sub>5</sub> receptor,218,DRD5,P21918,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,1826762,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
ENaC&alpha;&beta;&gamma;,742,SCNN1B|SCNN1G|SCNN1A,P37088|P51168|P51170,,,,,,Human,triamterene,4329,,,178101146,Channel blocker,None,,f,t,,pIC50,0,5.300000191,0,IC50,0,5000,0,~,,,,8107805,Nc1nc(N)c2c(n1)nc(c(n2)c1ccccc1)N
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,tazemetostat,7011,,,178103590,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,23620515,CCN(c1cc(cc(c1C)C(=O)NCc1c(C)cc([nH]c1=O)C)c1ccc(cc1)CN1CCOCC1)C1CCOCC1
enhancer of zeste 2 polycomb repressive complex 2 subunit,2654,EZH2,Q15910,,,,,,Human,UNC1999,8237,,,249565917,Inhibitor,Inhibition,,f,f,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,23614352,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2c1cnn2C(C)C)c1ccc(nc1)N1CCN(CC1)C(C)C
EPH receptor B4,1833,EPHB4,P54760,,,,,,Human,tesevatinib,7944,,,249565627,Inhibitor,Inhibition,,f,t,,pIC50,0,8.850000381,0,IC50,0,1.399999976,0,=,,,,17575237,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,tarloxotinib,9409,,,328083511,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,26811177,O=C(Nc1ncc2c(c1)c(ncn2)Nc1ccc(c(c1)Br)Cl)/C=C/C[N+](Cc1n(C)cnc1[N+](=O)[O-])(C)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,tesevatinib,7944,,,249565627,Inhibitor,Inhibition,,f,t,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,=,,,,17575237,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,vandetanib,5717,,,178102343,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,12499271,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,7.340000153,0,Kd,0,46,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,ZM-306416,8245,,,249565925,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,10,0,=,,,,22573732,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1F)Cl
epidermal growth factor receptor,1797,EGFR,P00533,,,,,,Human,TGF&alpha;,5059,TGFA,Human,178101752,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
EP<sub>1</sub> receptor,340,Ptger1,P35375,,,,,,Mouse,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,9313928,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,7,0,6.9,,0,0,0,,,,,10634944,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,0,7,0,,0,0,0,,,,,9537820,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,f,,pKd,7.900000095,0,7.599999905,Kd,25,0,1,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,7.6,0,7.3,,0,0,0,,,,,8940129,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,,f,f,,pKi,0,6.699999809,0,-,0,0,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,4.5,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>1</sub> receptor,340,Ptger1,P70597,,,,,,Rat,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,ZK110841,1889,,,135651360,Agonist,Partial agonist,,f,,,pKi,0,6.8,0,,0,0,0,,,,,11999132,OC(=O)CCC/C=CCC1[C@H](Cl)C[C@H]([C@@H]1/C=C/[C@H](C1CCCCC1)O)O
EP<sub>1</sub> receptor,340,PTGER1,P34995,,,,,,Human,ZK118182,1890,,,135651361,Agonist,Partial agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,11999132,OC(=O)COC/C=CC[C@H]1[C@H](Cl)C[C@H]([C@@H]1/C=C/[C@H](C1CCCCC1C)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,7.9,0,7.7,Kd,19.9,0,12.5,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62053,,,,,,Mouse,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,14699136,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,8.3,0,7.8,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,taprenepag,5816,,,178102441,Agonist,Full agonist,,f,,,pIC50,0,8,0,-,0,0,0,=,,,,21376717,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)n1cccn1
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,taprenepag,5816,,,178102441,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,-,0,0,0,=,,,,21376717,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)n1cccn1
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,,f,f,,pKi,0,8.399999619,0,-,0,0,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>2</sub> receptor,341,Ptger2,Q62928,,,,,,Rat,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,5.1,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,TG4-155,5818,,,178102443,Antagonist,Antagonist,TG4-155 also has affinity for the human DP1 receptor (p<i>K</i><sub>b</sub> = 7.8),f,f,,pKB,0,8.619999886,0,-,0,0,0,=,,,,22323596,COc1cc(/C=C/C(=O)NCCn2c(C)cc3c2cccc3)cc(c1OC)OC
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,TG6-129,9283,,,318164802,Antagonist,Antagonist,,f,f,,pKB,0,8.06000042,0,KB,0,8.800000191,0,=,,,,23914286,CCc1nnc(s1)NS(=O)(=O)c1ccc(cc1)NC(=S)NC(=O)/C=C/c1ccc(cc1)F
EP<sub>2</sub> receptor,341,PTGER2,P43116,,,,,,Human,TG7-171,8546,,,252166747,Antagonist,Antagonist,,f,f,,pKB,0,8.569999695,0,KB,0,2.690000057,0,=,,,,24937185,CCN(c1ccc(cc1)CC(=O)NCCCn1c(C)cc2c1cccc2)CC
EP<sub>3</sub> receptor,342,Ptger3,P30557,,,,,,Mouse,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,0,9.2,0,-,0,0,0,=,,,,9313928,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,sulprostone,1919,,,135651094,Agonist,Full agonist,EP<sub>3</sub>-III isoform,f,f,,pKi,0,9.460000038,0,Ki,0,0.349999994,0,=,,,,10634944,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pEC50,0,8.85,0,EC50,0,1.4,0,=,,,,9694973,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pEC50,0,9.38,0,EC50,0,0.42,0,=,,,,9537820,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,0,9.15,0,Ki,0,0.7,0,=,,,,9537820,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,f,,pKd,9.5,0,8.199999809,Kd,7,0,0.300000012,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,EP<sub>3</sub>-I isoform,f,,,pKi,0,5.6,0,Ki,0,2500,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
EP<sub>3</sub> receptor,342,PTGER3,P43115,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,4.9,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,U46619,1888,,,135651289,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pEC50,0,6.83,0,EC50,0,149,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>3</sub> receptor,342,Ptger3,P34980,,,,,,Rat,U46619,1888,,,135651289,Agonist,Full agonist,EP<sub>3</sub>&alpha; isoform,f,,,pKi,0,4.79,0,Ki,0,16200,0,=,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,TCS 2510,5859,,,178102483,Agonist,Agonist,,f,,,pKi,0,8.92,0,Ki,0,1.2,0,=,,,,0,O[C@@H](Cc1ccccc1)/C=C/[C@H]1CCC(=O)N1CCCCCCc1nnn[nH]1
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Agonist,,f,,,pKi,0,6.1,0,Ki,0,800,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Agonist,,f,,,pEC50,0,6.7,0,EC50,0,200,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,9.52,0,7.62,Kd,24,0,0.3,=,,,,16604093,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,Agonist,Full agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,5.7,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,5.6,0,,0,0,0,,,,,9537820,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
EP<sub>4</sub> receptor,343,Ptger4,P43114,,,,,,Rat,THG213.29,5860,,,178102484,Allosteric modulator,Negative,,f,,,pIC50,0,5.52,0,IC50,0,3000,0,=,,,,23152113,
EP<sub>4</sub> receptor,343,PTGER4,P35408,,,,,,Human,TG6-129,9283,,,318164802,Antagonist,Antagonist,,f,f,,pKB,0,5.409999847,0,KB,0,3900,0,=,,,,23914286,CCc1nnc(s1)NS(=O)(=O)c1ccc(cc1)NC(=S)NC(=O)/C=C/c1ccc(cc1)F
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,ticagrelor,1765,,,135649975,Inhibitor,Inhibition,,f,f,,pKi,0,7.300000191,0,-,0,0,0,=,,,,24414167,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO
Equilibrative nucleoside transporter 1,1117,SLC29A1,Q99808,,,,,,Human,[<sup>3</sup>H]nitrobenzylmercaptopurine ribonucleoside,4511,,,178101237,None,None,,f,,,pKd,0,9.3,0,Kd,0,0.5,0,,,,,0,OC[C@H]1O[C@@]([C@@H]([C@@H]1O)O)(SCc1ccccc1[N+](=O)[O-])n1cnc2c1ncnc2O
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,trastuzumab,5082,,,178101775,Antibody,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
erb-b2 receptor tyrosine kinase 2,2019,ERBB2,P04626,,,,,,Human,tesevatinib,7944,,,249565627,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,17575237,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,TX2-121-1,9242,,,315661317,Inhibitor,Binding,,f,t,,pIC50,0,7.309999943,0,IC50,0,49,0,=,,,,26094118,C=CC(=O)Nc1cc(ccc1Oc1ccccc1)c1nn(c2c1c(N)ncn2)C1CCN(CC1)CCNC(=O)[C@@H](CCC12CC3CC(C2)CC(C1)C3)C
erb-b2 receptor tyrosine kinase 3,1798,ERBB3,P21860,,,,,,Human,TX1-85-1,9241,,,315661316,None,Binding,,f,t,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,26094118,C=CC(=O)Nc1cc(ccc1Oc1ccccc1)c1nn(c2c1c(N)ncn2)C1CCC(CC1)N1CCN(CC1)C(=O)C
erb-b2 receptor tyrosine kinase 4,1799,ERBB4,Q15303,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,7.550000191,0,Kd,0,28,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,tamoxifen,1016,,,135651233,Agonist,Agonist,,f,t,,pKi,0,7.820000172,0,-,0,0,0,=,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,tibolone,9711,,,348353670,Agonist,Agonist,,f,f,,pEC50,0,8.399999619,0,EC50,0,4,0,=,,,,19464167,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](C)CC2=C1CCC(=O)C2
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,WAY200070,4052,,,178100876,Agonist,Agonist,,f,f,,pEC50,0,6.809999943,0,EC50,0,155,0,=,,,,18423777,Oc1ccc(cc1)c1oc2c(n1)cc(cc2Br)O
Estrogen receptor-&alpha;,620,ESR1,P03372,,,,,,Human,tamoxifen,1016,,,135651233,Antagonist,Antagonist,,f,t,,pKi,0,7.800000191,0,-,0,0,0,=,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,tamoxifen,1016,,,135651233,Agonist,Agonist,,f,,,pKi,0,7.16,0,,0,0,0,,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,WAY200070,4052,,,178100876,Agonist,Agonist,,f,f,,pEC50,0,8.699999809,0,EC50,0,2,0,=,,,,18423777,Oc1ccc(cc1)c1oc2c(n1)cc(cc2Br)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,WAY200070,4052,,,178100876,Agonist,Full agonist,,f,,,pIC50,9,0,8.52,IC50,3,0,1,=,,,,15456246,Oc1ccc(cc1)c1oc2c(n1)cc(cc2Br)O
Estrogen receptor-&beta;,621,ESR2,Q92731,,,,,,Human,tamoxifen,1016,,,135651233,Antagonist,Antagonist,,f,,,pKi,0,7.17,0,,0,0,0,,,,,9048584,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Estrogen-related receptor-&alpha;,622,Esrra,O08580,,,,,,Mouse,toxaphene,2830,,,135650755,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,10493499,ClCC1(CCl)C(=C)C2(C(C1(Cl)C(C2Cl)Cl)(Cl)Cl)Cl
Estrogen-related receptor-&alpha;,622,ESRRA,P11474,,,,,,Human,XCT790,2832,,,135651333,Antagonist,Antagonist,,f,f,,pIC50,6.5,0,6.099999905,IC50,0,0,0,=,,,,15184675,N#C/C(=Cc1ccc(c(c1)OC)OCc1ccc(cc1C(F)(F)F)C(F)(F)F)/C(=O)Nc1nnc(s1)C(F)(F)F
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,"[<sup>125</sup>I]ET-1 (human, mouse, rat)",991,,,135652513,Agonist,Full agonist,,f,,,pKd,10.5,0,9.1,,0,0,0,,,,,7620699,
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>125</sup>I]ET-2 (human),992,,,135652514,Agonist,Full agonist,,f,,,pKd,9.1,0,8.9,,0,0,0,,,,,8851522,
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>125</sup>I]sarafotoxin S6b,993,,,135652553,Agonist,Full agonist,,f,,,pKd,9.8,0,9.6,,0,0,0,,,,,8851522,
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,"[<sup>18</sup>F]ET-1 (human, mouse, rat)",994,,,135652579,Agonist,Full agonist,,f,,,pKd,0,8.2,0,,0,0,0,,,,,12193043,
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>125</sup>I]PD151242,1001,,,135652545,Antagonist,Antagonist,,f,,,pKd,9.1,0,9,Kd,1,0,0.79,=,,,,8012722,CC(C[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)O)Cc1ccc(cc1)O)Cc1cn(c2c1cccc2)C)NC(=O)N1CCCCCC1)C
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>125</sup>I]PD164333,1002,,,135651113,Antagonist,Antagonist,,f,,,pKd,9.8,0,9.6,Kd,0.25,0,0.158,=,,,,9489609,COc1ccc(cc1)C(=O)/C(=C(/c1ccc2c(c1)OCO2)C(=O)O)/Cc1cc(OCCCC(=O)NCCc2ccc(c(c2)[125I])O)c(c(c1)OC)OC
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>3</sup>H]BQ123,1003,,,135652583,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,Kd,0,3.2,0,=,,,,7768260,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)C(C(=O)O)[3H])C(C)C)C
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,[<sup>3</sup>H]S0139,3479,,,178100470,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,Kd,0,0.6,0,,,,,0,O=C(OC[C@@]12CC[C@@]3([C@H](C1=CCC1[C@@]2(C)CCC2[C@]1(C)CCC(=O)C2(C)C)CC(CC3)(C)C)C(=O)[O-])/C=C/c1cc(O)ccc1NC(=O)/C=C/C(=O)[O-]
ET<sub>A</sub> receptor,219,Ednra,P26684,,,,,,Rat,TAK 044,3913,,,178100745,Antagonist,Antagonist,,f,,,pA2,0,8.4,0,-,0,0,0,=,,,,7780649,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)CC(=O)O)CC(=O)N1CCC(CC1)c1ccccc1)c1cccs1)C
ET<sub>A</sub> receptor,219,EDNRA,P25101,,,,,,Human,zibotentan,3539,,,178100518,Antagonist,Antagonist,,f,t,,pIC50,0,8.300000191,0,IC50,0,5.010000229,0,=,,,,15956965,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1c1ccc(cc1)c1nnco1
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,"[<sup>125</sup>I][Ala<sup>1,3,11,15</sup>]ET-1",3760,,,178100611,Agonist,Full agonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,1472961,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,[<sup>125</sup>I]BQ3020,1005,,,135652489,Agonist,Full agonist,,f,f,,pKd,10,0,8.300000191,Kd,5,0,0.100000001,=,,,,7881728,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,"[<sup>125</sup>I]ET-1 (human, mouse, rat)",991,,,135652513,Agonist,Full agonist,,f,,,pKd,10,0,9.2,-,0,0,0,=,,,,7620699,
ET<sub>B</sub> receptor,220,EDNRB,P24530,,,,,,Human,[<sup>125</sup>I]IRL1620,1007,,,135652524,Agonist,Full agonist,,f,,,pKd,10.1,0,9.9,Kd,0.126,0,0.079,=,,,,8301559,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C)Cc1ccc(cc1)O)Cc1ccccc1)C)Cc1[nH]cnc1)CC(C)C)CC(=O)O)C
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,[<sup>125</sup>I]IRL1620,1007,,,135652524,Agonist,Full agonist,,f,,,pKd,10.1,0,9.8,-,0,0,0,=,,,,8301559,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C)Cc1ccc(cc1)O)Cc1ccccc1)C)Cc1[nH]cnc1)CC(C)C)CC(=O)O)C
ET<sub>B</sub> receptor,220,Ednrb,P21451,,,,,,Rat,TAK 044,3913,,,178100745,Antagonist,Antagonist,,f,,,pA2,0,8.4,0,-,0,0,0,=,,,,7780649,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)CC(=O)O)CC(=O)N1CCC(CC1)c1ccccc1)c1cccs1)C
euchromatic histone lysine methyltransferase 1,2651,EHMT1,Q9H9B1,,,,,,Human,UNC0638,7015,,,178103594,Inhibitor,Inhibition,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,Measuring conversion of cofactor SAM to product SAH (S-adenosyl-l-homocysteine).,,,21743462,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1
euchromatic histone lysine methyltransferase 1,2651,EHMT1,Q9H9B1,,,,,,Human,UNC0642,7017,,,178103596,Inhibitor,Inhibition,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,<,,,,24102134,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)N1CCC(CC1)(F)F
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,UNC0321,8389,,,252166600,Inhibitor,Inhibition,,f,f,,pKi,0,10.19999981,0,Ki,0,0.063000001,0,=,,,,20614940,COc1cc2c(cc1OCCOCCN(C)C)nc(nc2NC1CCN(CC1)C)N1CCCN(CC1)C
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,UNC0638,7015,,,178103594,Inhibitor,Inhibition,,f,f,,pIC50,0,7.820000172,0,IC50,0,15,0,<,Measuring conversion of the cofactor SAM to product SAH (S-adenosyl-l-homocysteine).,,,21743462,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,UNC0638,7015,,,178103594,Inhibitor,Inhibition,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,21743462,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1
euchromatic histone lysine methyltransferase 2,2652,EHMT2,Q96KQ7,,,,,,Human,UNC0642,7017,,,178103596,Inhibitor,Inhibition,,f,f,,pIC50,0,8.600000381,0,IC50,0,2.5,0,<,,,,24102134,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)N1CCC(CC1)(F)F
Excitatory amino acid transporter 1,868,SLC1A3,P43003,,,,,,Human,UCPH-101,4609,,,178101329,Inhibitor,Inhibition,membrane potential assay,f,,,pIC50,0,6.9,0,IC50,0,120,0,,,,,19161278,COc1ccc(cc1)C1C2=C(OC(=C1C#N)N)CC(CC2=O)c1cccc2c1cccc2
Excitatory amino acid transporter 1,868,Slc1a3,P24942,,,,,,Rat,[<sup>3</sup>H]ETB-TBOA,4492,,,178101220,None,Binding,,f,f,,pKd,0,7.800000191,0,Kd,0,15.5,0,=,,,,17047096,C([3H])C(c1ccc(cc1)C(=O)Nc1cccc(c1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O)[3H]
Excitatory amino acid transporter 1,868,SLC1A3,P43003,,,,,,Human,[<sup>3</sup>H]D-aspartic acid,4698,,,178101410,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@H](C(=O)O)N
Excitatory amino acid transporter 1,868,SLC1A3,P43003,,,,,,Human,[<sup>3</sup>H]L-aspartic acid,4534,,,178101255,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@@H](C(=O)O)N
Excitatory amino acid transporter 1,868,SLC1A3,P43003,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,SYM2081,4317,,,178101134,Inhibitor,Inhibition,,f,,,pKB,0,5.5,0,KB,0,3400,0,,,,,9145919,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,threo-3-methylglutamate,4573,,,178101294,Inhibitor,Inhibition,,f,,,pKB,0,4.7,0,KB,0,18000,0,,,,,9145919,OC(=O)CC(C(C(=O)O)N)C
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,WAY-213613,4531,,,178101252,Inhibitor,Inhibition,,f,f,,pIC50,0,7.099999905,0,IC50,0,85,0,=,,,,16014807,O=C(C[C@@H](C(=O)O)N)Nc1ccc(cc1)Oc1cc(F)c(cc1Br)F
Excitatory amino acid transporter 2,869,Slc1a2,P31596,,,,,,Rat,[<sup>3</sup>H]ETB-TBOA,4492,,,178101220,None,Binding,,f,f,,pKd,0,7.800000191,0,Kd,0,16.20000076,0,=,,,,17047096,C([3H])C(c1ccc(cc1)C(=O)Nc1cccc(c1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O)[3H]
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,[<sup>3</sup>H]D-aspartic acid,4698,,,178101410,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@H](C(=O)O)N
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,[<sup>3</sup>H]L-aspartic acid,4534,,,178101255,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@@H](C(=O)O)N
Excitatory amino acid transporter 2,869,SLC1A2,P43004,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
Excitatory amino acid transporter 3,870,Slc1a1,P51907,,,,,,Rat,[<sup>3</sup>H]ETB-TBOA,4492,,,178101220,None,Binding,,f,f,,pKd,0,6.5,0,Kd,0,320,0,=,,,,17047096,C([3H])C(c1ccc(cc1)C(=O)Nc1cccc(c1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O)[3H]
Excitatory amino acid transporter 3,870,SLC1A1,P43005,,,,,,Human,[<sup>3</sup>H]D-aspartic acid,4698,,,178101410,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@H](C(=O)O)N
Excitatory amino acid transporter 3,870,SLC1A1,P43005,,,,,,Human,[<sup>3</sup>H]L-aspartic acid,4534,,,178101255,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@@H](C(=O)O)N
Excitatory amino acid transporter 4,871,SLC1A6,P48664,,,,,,Human,threo-3-methylglutamate,4573,,,178101294,Inhibitor,Inhibition,,f,,,pKi,0,4.3,0,Ki,0,50000,0,,,,,11299317,OC(=O)CC(C(C(=O)O)N)C
Excitatory amino acid transporter 4,871,Slc1a6,O35921,,,,,,Rat,[<sup>3</sup>H]ETB-TBOA,4492,,,178101220,None,Binding,,f,f,,pKd,0,7.900000095,0,Kd,0,11.39999962,0,=,,,,17047096,C([3H])C(c1ccc(cc1)C(=O)Nc1cccc(c1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O)[3H]
Excitatory amino acid transporter 4,871,SLC1A6,P48664,,,,,,Human,[<sup>3</sup>H]D-aspartic acid,4698,,,178101410,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@H](C(=O)O)N
Excitatory amino acid transporter 4,871,SLC1A6,P48664,,,,,,Human,[<sup>3</sup>H]L-aspartic acid,4534,,,178101255,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@@H](C(=O)O)N
Excitatory amino acid transporter 5,872,Slc1a7,,,,,,,Rat,[<sup>3</sup>H]ETB-TBOA,4492,,,178101220,None,Binding,,f,f,,pKd,0,7.599999905,0,Kd,0,24.79999924,0,=,,,,17047096,C([3H])C(c1ccc(cc1)C(=O)Nc1cccc(c1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O)[3H]
Excitatory amino acid transporter 5,872,SLC1A7,O00341,,,,,,Human,[<sup>3</sup>H]D-aspartic acid,4698,,,178101410,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@H](C(=O)O)N
Excitatory amino acid transporter 5,872,SLC1A7,O00341,,,,,,Human,[<sup>3</sup>H]L-aspartic acid,4534,,,178101255,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C[C@@H](C(=O)O)N
Farnesoid X receptor,603,NR1H4,Q96RI1,,,,,,Human,tropifexor,9725,,,0,Agonist,Agonist,,f,f,,pEC50,0,9.699999809,0,EC50,0,0.200000003,0,=,In a HTRF assay.,,,29148806,OC(=O)c1cc(F)c2c(c1)sc(n2)N1[C@@H]2CC[C@H]1C[C@H](C2)OCc1c(onc1c1ccccc1OC(F)(F)F)C1CC1
Farnesoid X receptor-&beta;,604,Nr1h5,,,,,,,Mouse,vitamin D3,2747,,,135651594,Agonist,Agonist,,t,,,pEC50,0,5,0,,0,0,0,,,,,12529392,CC(CCC[C@H]([C@H]1CCC2[C@]1(C)CCC/C/2=CC=C/1C[C@@H](O)CCC1=C)C)C
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,t,,pIC50,0,6.320000172,0,IC50,0,475.2999878,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
farnesyl diphosphate synthase,644,Fdps,P05369,,,,,,Rat,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,,,pIC50,0,6.3,0,IC50,0,500,0,=,in vitro using kidney cell lines,,,18325729,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,t,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,Inhibition of human FPP synthase expressed in Escherichia coli BL21 (DE3),,,18937434,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,t,,pKi,0,10.14999962,0,Ki,0,0.07,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,t,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
farnesyl diphosphate synthase,644,FDPS,P14324,,,,,,Human,zoledronic acid,3177,,,135651365,Inhibitor,Inhibition,,f,t,,pKi,0,7.070000172,0,Ki,0,85.90000153,0,=,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,,,18327899,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
"farnesyltransferase, CAAX box, beta",2826,FNTB,P49356,,,,,,Human,tipifarnib,8025,,,249565705,Inhibitor,Inhibition,,f,t,,pIC50,0,9.069999695,0,IC50,0,0.860000014,0,=,Inhibition of [3H]FPP incorporation into biotinylated laminB peptide by farnesyltransferase protein complex,,,12699751,Clc1ccc(cc1)[C@](c1cncn1C)(c1ccc2c(c1)c(cc(=O)n2C)c1cccc(c1)Cl)N
Fatty acid amide hydrolase,1400,FAAH,O00519,,,,,,Human,URB597,4339,,,178101156,Inhibitor,Inhibition,,f,,,pIC50,7,0,6.3,IC50,501,0,100,=,,,,17015445,O=C(Oc1cccc(c1)c1cccc(c1)C(=O)N)NC1CCCCC1
Fatty acid amide hydrolase-2,1401,FAAH2,Q6GMR7,,,,,,Human,URB597,4339,,,178101156,Inhibitor,Inhibition,,f,f,,pIC50,8.300000191,0,7.5,IC50,31.60000038,0,5.010000229,=,,,,17015445,O=C(Oc1cccc(c1)c1cccc(c1)C(=O)N)NC1CCCCC1
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,TUG-905,9149,,,315661234,Agonist,Agonist,,f,t,,pEC50,0,8.050000191,0,EC50,0,9,0,=,,,,22724451,OC(=O)CCc1ccc(cc1F)NCc1cccc(c1)c1ccc(cc1C)OCCCS(=O)(=O)C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,TUG-424,3952,,,178100779,Agonist,Full agonist,,f,,,pEC50,0,7.5,0,-,0,0,0,=,,,,18947221,OC(=O)CCc1ccc(cc1)C#Cc1ccccc1C
FFA1 receptor,225,FFAR1,O14842,,,,,,Human,TUG-770,6483,,,178103097,Agonist,Full agonist,,f,,,pEC50,0,8.2,0,-,0,0,0,=,,,,23687558,N#CCc1ccccc1C#Cc1ccc(c(c1)F)CCC(=O)O
FFA4 receptor,127,,,,,,,,Unknown,TUG-891,6490,,,178103104,Agonist,Full agonist,,f,,,pEC50,0,7,0,-,0,0,0,=,,,,22519963,OC(=O)CCc1ccc(cc1)OCc1cc(F)ccc1c1ccc(cc1)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,SU11652,6043,,,178102665,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,12646019,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(Cl)cc2)CC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,f,,pIC50,0,5.460000038,0,IC50,0,3500,0,=,,,,16891463,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,f,,pKi,0,6.079999924,0,Ki,0,830,0,=,,,,12538485,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,TAS-120,9786,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.43999958,0,IC50,0,3.599999905,0,=,,,,0,C=CC(=O)N1CC[C@@H](C1)n1nc(c2c1ncnc2N)C#Cc1cc(OC)cc(c1)OC
fibroblast growth factor receptor 1,1808,FGFR1,P11362,,,,,,Human,VEGFR2 inhibitor [WO2011060746],9769,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.28000021,0,IC50,0,53,0,=,Using a Transcreener FP technology assay.,,,0,CN(CCNS(=O)(=O)Cc1cccc(c1)Nc1nccc(n1)Oc1ccc2c(c1)cc([nH]2)C)C
fibroblast growth factor receptor 2,1809,FGFR2,P21802,,,,,,Human,TAS-120,9786,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.960000038,0,IC50,0,1.100000024,0,=,,,,0,C=CC(=O)N1CC[C@@H](C1)n1nc(c2c1ncnc2N)C#Cc1cc(OC)cc(c1)OC
fibroblast growth factor receptor 3,1810,FGFR3,P22607,,,,,,Human,TAS-120,9786,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,,,,0,C=CC(=O)N1CC[C@@H](C1)n1nc(c2c1ncnc2N)C#Cc1cc(OC)cc(c1)OC
fibroblast growth factor receptor 4,1811,FGFR4,P22455,,,,,,Human,TAS-120,9786,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,8.470000267,0,IC50,0,3.400000095,0,=,,,,0,C=CC(=O)N1CC[C@@H](C1)n1nc(c2c1ncnc2N)C#Cc1cc(OC)cc(c1)OC
FK506 binding protein 1A,2609,FKBP1A,P62942,,,,,,Human,zotarolimus,7974,,,249565657,Inhibitor,Binding,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,,,,16449248,CO[C@@H]1C[C@@H](CC[C@@H]1n1cnnn1)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
FK506 binding protein 1A,2609,FKBP1A,P62942,,,,,,Human,tacrolimus,6784,,,178103390,Inhibitor,Inhibition,,f,t,,pKi,0,9.399999619,0,Ki,0,0.400000006,0,=,,,,9857082,C=CC[C@@H]1/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@@H](C[C@@H]2OC)C)C(=O)C(=O)N2[C@H](C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]1CC[C@H]([C@@H](C1)OC)O)/C)CCCC2
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16891463,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,tivozanib,6058,,,178102679,Inhibitor,Inhibition,,f,t,,pIC50,0,9.680000305,0,IC50,0,0.209999993,0,=,,,,23098265,COc1cc2c(ccnc2cc1OC)Oc1ccc(c(c1)Cl)NC(=O)Nc1noc(c1)C
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,vatalanib,5705,,,178102332,Inhibitor,Inhibition,,f,f,,pIC50,0,6.849999905,0,IC50,0,140,0,=,,,,16321531,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,VEGF receptor tyrosine kinase inhibitor III,6057,,,178102678,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,18077363,CCCNC(=O)Nc1ccc(cc1Cl)Oc1ncnc2c1cc(OC)c(c2)OC
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,ZM-306416,8245,,,249565925,Inhibitor,Inhibition,,f,f,,pIC50,6.480000019,0,5.699999809,IC50,2000,0,330,=,,,,22573732,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1F)Cl
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,VEGFA,5085,VEGFA,Human,178101778,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
fms related tyrosine kinase 1,1812,FLT1,P17948,,,,,,Human,VEGFB,5086,VEGFB,Human,178101779,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,f,,pIC50,0,8.18999958,0,IC50,0,6.5,0,=,,,,20570526,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,f,,pIC50,0,8.340000153,0,IC50,0,4.599999905,0,=,<i>In vitro</i> potency,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,tandutinib,5695,,,178102322,Inhibitor,Inhibition,,f,t,,pKd,0,8.520000458,0,Kd,0,3,0,=,,,,22037378,COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,tandutinib,5695,,,178102322,Inhibitor,Inhibition,,f,t,,pIC50,0,6.659999847,0,IC50,0,220,0,=,,,,12124172,COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,7.71999979,0,7.25,IC50,56,0,19,=,,,,22148278,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
fms related tyrosine kinase 3,1807,FLT3,P36888,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,8.899999619,0,=,,,,20570526,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,tesevatinib,7944,,,249565627,Inhibitor,Inhibition,,f,t,,pIC50,0,8.06000042,0,IC50,0,8.699999809,0,=,,,,17575237,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,tivozanib,6058,,,178102679,Inhibitor,Inhibition,,f,t,,pIC50,0,9.619999886,0,IC50,0,0.239999995,0,=,,,,23098265,COc1cc2c(ccnc2cc1OC)Oc1ccc(c(c1)Cl)NC(=O)Nc1noc(c1)C
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,vatalanib,5705,,,178102332,Inhibitor,Inhibition,,f,f,,pIC50,0,6.710000038,0,IC50,0,195,0,=,,,,12477352,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,VEGF receptor tyrosine kinase inhibitor III,6057,,,178102678,Inhibitor,Inhibition,,f,f,,pIC50,0,6.900000095,0,IC50,0,125,0,=,,,,18077363,CCCNC(=O)Nc1ccc(cc1Cl)Oc1ncnc2c1cc(OC)c(c2)OC
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,VEGFC,5087,VEGFC,Human,178101780,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,VEGFD,5088,VEGFD,Human,178101781,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
fms related tyrosine kinase 4,1814,FLT4,P35916,,,,,,Human,VEGFE,5089,PDGFC,Human,178101782,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
FPR1,222,FPR1,P21462,,,,,,Human,[<sup>125</sup>I]cathepsin G (human),1017,,,135652491,Agonist,Full agonist,,f,,,pKd,0,7,0,-,0,0,0,=,,,,15210802,
FPR1,222,FPR1,P21462,,,,,,Human,[<sup>3</sup>H]fMet-Leu-Phe,1018,,,135652586,Agonist,Full agonist,,f,,,pKd,9.3,0,7.6,Kd,25.1,0,0.5,=,,,,6285921,
FPR1,222,FPR1,P21462,,,,,,Human,T20(DP178),5838,,,178102463,Agonist,Full agonist,,f,,,pEC50,0,8.3,0,-,0,0,0,=,,,,10339497,
FPR1,222,FPR1,P21462,,,,,,Human,WKYMVm,1048,,,135652638,Agonist,Full agonist,,f,,,pEC50,0,9,0,-,0,0,0,=,,,,10586077,
FPR1,222,Fpr1,P33766,,,,,,Mouse,WKYMVm,1048,,,135652638,Agonist,Full agonist,,f,,,pEC50,0,9,0,-,0,0,0,=,,,,23160941,
FPR1,222,FPR1,P21462,,,,,,Human,sufinpyrazone,5826,,,178102451,Antagonist,Antagonist,,f,,,pIC50,0,5,0,-,0,0,0,=,,,,15964939,O=C1N(c2ccccc2)N(C(=O)C1CCS(=O)c1ccccc1)c1ccccc1
FPR1,222,FPR1,P21462,,,,,,Human,[<sup>125</sup>I]CHIPS,1027,,,135651954,Antagonist,Antagonist,,f,,,pKd,0,7.5,0,,0,0,0,,,,,15494522,
FPR1,222,FPR1,P21462,,,,,,Human,t-Boc-FLFLF,1030,,,135652599,Antagonist,Antagonist,,f,,,pKi,6.5,0,6,Ki,0,0,0,=,,,,8387097,
FPR1,222,FPR1,P21462,,,,,,Human,t-Boc-FLFLF,1030,,,135652599,Antagonist,Antagonist,,f,,,pIC50,0,6.6,0,-,0,0,0,=,,,,1653806,
FPR1,222,FPR1,P21462,,,,,,Human,t-Boc-Met-Leu-Phe,1029,,,135652598,Antagonist,Antagonist,,f,,,pIC50,0,6.2,0,-,0,0,0,=,,,,1653806,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,[<sup>125</sup>I-Tyr]Ac2-26,6198,,,178102819,Agonist,Agonist,,f,,,pKd,0,5.89,0,Kd,0,1300,0,=,,,,12368905,
FPR2/ALX,223,Fpr2,,,,,,,Rat,[<sup>125</sup>I-Tyr]Ac2-26,6198,,,178102819,Agonist,Full agonist,,f,,,pKd,0,6.09,0,Kd,0,820,0,=,,,,12746227,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,[<sup>3</sup>H]LXA<sub>4</sub>,3411,,,178100417,Agonist,Full agonist,,f,,,pKd,9.3,0,9.15,Kd,0.7,0,0.5,=,,,,8006586,CCCCC[C@@H](/C=C/[CH](=[CH](/C=C/C=C/[C@H]([C@H](CCCC(=O)O)O)O)[3H])[3H])O
FPR2/ALX,223,Fpr2,,,,,,,Rat,[<sup>3</sup>H]LXA<sub>4</sub>,3411,,,178100417,Agonist,Full agonist,,f,,,pKd,0,8.3,0,Kd,0,5,0,=,,,,12746227,CCCCC[C@@H](/C=C/[CH](=[CH](/C=C/C=C/[C@H]([C@H](CCCC(=O)O)O)O)[3H])[3H])O
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,[<sup>3</sup>H]LXA<sub>4</sub>,3411,,,178100417,Agonist,Full agonist,,f,,,pKd,0,8.82,0,Kd,0,1.5,0,=,,,,9151906,CCCCC[C@@H](/C=C/[CH](=[CH](/C=C/C=C/[C@H]([C@H](CCCC(=O)O)O)O)[3H])[3H])O
FPR2/ALX,223,FPR2,P25090,,,,,,Human,T21/DP107,6245,,,178102865,Agonist,Full agonist,,f,,,pEC50,0,7.3,0,EC50,0,50,0,=,,,,10229829,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,uPar fragment,6249,,,178102869,Agonist,Full agonist,,f,,,pEC50,0,7.08,0,-,0,0,0,=,,,,11818541,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,V3 peptide,6248,,,178102868,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,10872839,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,WKYMVm,1048,,,135652638,Agonist,Full agonist,,f,,,pKd,0,10.13,0,-,0,0,0,=,,,,10586077,
FPR2/ALX,223,Fpr2,O88536,,,,,,Mouse,WKYMVm,1048,,,135652638,Agonist,Full agonist,,f,,,pEC50,10.13,0,9,-,0,0,0,=,,,,23160941,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,t-Boc-FLFLF,1030,,,135652599,Antagonist,Antagonist,,f,f,,pIC50,6,0,4.300000191,-,0,0,0,=,,,,10882119,
FPR2/ALX,223,FPR2,P25090,,,,,,Human,WRWWWW,1040,,,135652639,Antagonist,Antagonist,,f,f,,pIC50,0,6.639999866,0,-,0,0,0,=,,,,15210823,
FPR3,224,FPR3,P25089,,,,,,Human,WKYMVm,1048,,,135652638,Agonist,Full agonist,,f,,,pEC50,0,8.52,0,EC50,0,3,0,=,,,,11285256,
FPR3,224,FPR3,P25089,,,,,,Human,WRWWWW,1040,,,135652639,Antagonist,Antagonist,,f,,,pIC50,0,6,0,,0,0,0,,,,,16476585,
FP receptor,344,,,,,,,,Unknown,[<sup>3</sup>H](+)-fluprostenol,3417,,,178100423,Agonist,Agonist,,f,,,pKd,0,7.5,0,Kd,0,34,0,,,,,0,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,tafluprost,7451,,,187051754,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,15037111,CC(OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C
FP receptor,344,PTGFR,P43088,,,,,,Human,tafluprost acid,7452,,,187051755,Agonist,Agonist,,f,f,,pEC50,0,9.279999733,0,EC50,0,0.529999971,0,=,Affinity measured in a cell line stably expressing the recombinant human prostanoid FP receptor.,,,15037111,OC(=O)CCC/C=CC[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O
FP receptor,344,PTGFR,P43088,,,,,,Human,sulprostone,1919,,,135651094,Agonist,Full agonist,,f,,,pKi,0,6.7,0,,0,0,0,,,,,10634944,O=C(NS(=O)(=O)C)CCC/C=CC[C@H]1C(=O)C[C@H]([C@@H]1/C=C/[C@H](COc1ccccc1)O)O
FP receptor,344,PTGFR,P43088,,,,,,Human,[<sup>3</sup>H]PGF<sub>2&alpha;</sub>,1957,,,135651570,Agonist,Full agonist,,f,,,pKd,9,0,8.1,Kd,7.9,0,1,=,,,,16604093,CCCCC[C@@](/C(=C/[C@@]1([3H])[C@]([3H])(O)C[C@]([C@]1([3H])C/C(=C(CCCC(=O)O)/[3H])/[3H])([3H])O)/[3H])(O)[3H]
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,[<sup>3</sup>H]PGF<sub>2&alpha;</sub>,1957,,,135651570,Agonist,Full agonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,8288601,CCCCC[C@@](/C(=C/[C@@]1([3H])[C@]([3H])(O)C[C@]([C@]1([3H])C/C(=C(CCCC(=O)O)/[3H])/[3H])([3H])O)/[3H])(O)[3H]
FP receptor,344,Ptgfr,P43117,,,,,,Mouse,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
FP receptor,344,PTGFR,P43088,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,6.6,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
FSH receptor,253,FSHR,P23945,,,,,,Human,[<sup>125</sup>I]FSH (human),3780,,,178100630,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
FZD<sub>6</sub>,234,FZD6,O60353,,,,,,Human,Wnt-3a,3549,WNT3A,Human,135651914,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,21665003,
FZD<sub>6</sub>,234,FZD6,O60353,,,,,,Human,Wnt-4,3547,WNT4,Human,135651915,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,21541287,
FZD<sub>6</sub>,234,FZD6,O60353,,,,,,Human,Wnt-5a,3548,WNT5A,Human,135651916,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,21665003,
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,ZK93423,4346,,,178101163,Agonist,Partial agonist,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,9651158,COCc1c(ncc2c1c1cc(OCc3ccccc3)ccc1[nH]2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,TP003,4326,,,178101143,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,N#Cc1cc(F)ccc1c1cc(ccc1F)c1cnc2n1ccc(c2F)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,TPA023,4327,,,178101144,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCn1ncnc1COc1nn2c(cc1C(C)(C)C)nnc2c1ccccc1F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,ZK93426,4347,,,178101164,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncc2c(c1C)c1c(cccc1[nH]2)OC(C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>3</sup>H]flunitrazepam,4360,,,178101176,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>3</sup>H]zolpidem,4362,,,178101177,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKd,0,9,0,Kd,0,1,0,=,Binding affinity to GABA<sub>A</sub> &alpha;1&beta;2&gamma;2 receptor.,,,18537233,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKi,0,9.100000381,0,Ki,0,0.800000012,0,=,"Binding affinity for human recombinant GABA<sub>A</sub> receptor &alpha;1&beta;3&gamma,2.",,,10633039,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,zolpidem,4348,,,178101165,Allosteric modulator,Positive,,f,t,,pKi,7.679999828,0,7.389999866,Ki,41,0,20.70000076,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;3&gamma;2.,,,8719414,Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;1 subunit,404,GABRA1,P14867,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,ZK93423,4346,,,178101163,Agonist,Partial agonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4.199999809,0,=,,,,9651158,COCc1c(ncc2c1c1cc(OCc3ccccc3)ccc1[nH]2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,TP003,4326,,,178101143,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,N#Cc1cc(F)ccc1c1cc(ccc1F)c1cnc2n1ccc(c2F)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,ZK93426,4347,,,178101164,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncc2c(c1C)c1c(cccc1[nH]2)OC(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>3</sup>H]flunitrazepam,4360,,,178101176,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,TPA023,4327,,,178101144,Allosteric modulator,Partial agonist,low efficacy,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCn1ncnc1COc1nn2c(cc1C(C)(C)C)nnc2c1ccccc1F
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKi,0,9.229999542,0,Ki,0,0.589999974,0,=,Binding affinity to human recombinant GABA<sub>A</sub> receptor &alpha;2&beta;3&gamma;2.,,,10633039,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,zolpidem,4348,,,178101165,Allosteric modulator,Positive,,f,f,,pKi,0,6.119999886,0,Ki,0,760.5999756,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;2&beta;1&gamma;2.,,,8391122,Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;2 subunit,405,GABRA2,P47869,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,ZK93423,4346,,,178101163,Agonist,Full agonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4.5,0,=,,,,9651158,COCc1c(ncc2c1c1cc(OCc3ccccc3)ccc1[nH]2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,ZK93426,4347,,,178101164,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncc2c(c1C)c1c(cccc1[nH]2)OC(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>3</sup>H]flunitrazepam,4360,,,178101176,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,TP003,4326,,,178101143,Allosteric modulator,Partial agonist,high efficacy,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,N#Cc1cc(F)ccc1c1cc(ccc1F)c1cnc2n1ccc(c2F)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,TPA023,4327,,,178101144,Allosteric modulator,Partial agonist,low efficacy,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCn1ncnc1COc1nn2c(cc1C(C)(C)C)nnc2c1ccccc1F
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKi,0,8.840000153,0,Ki,0,1.429999948,0,=,Binding affinity to human recombinant GABA<sub>A</sub> receptor &alpha;3&beta;3&gamma;2.,,,10633039,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,zolpidem,4348,,,178101165,Allosteric modulator,Positive,,f,f,,pKi,0,5.670000076,0,Ki,0,2149.5,0,=,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;3&beta;1&gamma;2.,,,8391122,Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;3 subunit,406,GABRA3,P34903,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>3</sup>H]Ro154513,4365,,,178101180,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Partial agonist,low affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;4 subunit,407,GABRA4,P48169,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,ZK93423,4346,,,178101163,Agonist,Partial agonist,,f,f,,pKi,0,8.399999619,0,Ki,0,4.5,0,=,,,,9651158,COCc1c(ncc2c1c1cc(OCc3ccccc3)ccc1[nH]2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,TP003,4326,,,178101143,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,N#Cc1cc(F)ccc1c1cc(ccc1F)c1cnc2n1ccc(c2F)C(O)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,TPA023,4327,,,178101144,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCn1ncnc1COc1nn2c(cc1C(C)(C)C)nnc2c1ccccc1F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,ZK93426,4347,,,178101164,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncc2c(c1C)c1c(cccc1[nH]2)OC(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>3</sup>H]flunitrazepam,4360,,,178101176,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CN1C(=O)CN=C(c2c1ccc(c2)[N+](=O)[O-])c1ccccc1F
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>3</sup>H]L655708,4363,,,178101178,Allosteric modulator,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1C1CCCN1C(=O)c1c2ccc(c1)OC
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKd,0,8.399999619,0,Kd,0,4,0,=,Binding affinity to GABA<sub>A</sub> receptor &alpha;5&beta;2&gamma;2.,,,18537233,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,triazolam,7313,,,178103886,Allosteric modulator,Positive,,f,t,,pKi,0,8.81000042,0,Ki,0,1.539999962,0,=,Binding affinity for human recombinant GABA<sub>A</sub> receptor &alpha;5&beta;3&gamma;2.,,,10633039,Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,GABRA5,P31644,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;5 subunit,408,Gabra5,P19969,,,,,,Rat,[<sup>3</sup>H]RY80,4364,,,178101179,None,Binding,,f,f,,pKd,0,9.199999809,0,Kd,0,0.699999988,0,=,,benzodiazepine site,,9353361,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)C#C
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>3</sup>H]muscimol,4090,,,178100913,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,NCc1cc(=O)[nH]o1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>18</sup>F]fluoroethylflumazenil,4368,,,178101183,Allosteric modulator,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,[18F]CCN1Cc2c(ncn2c2c(C1=O)cc(F)cc2)C(=O)OCC
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>3</sup>H]Ro154513,4365,,,178101180,Allosteric modulator,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)N=[N+]=[N-]
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>3</sup>H]CGS8216,4366,,,178101181,Allosteric modulator,Mixed,agonist and antagonist,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,O=c1n([nH]c2c1cnc1c2cccc1)c1ccccc1
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>11</sup>C]flumazenil,4367,,,178101182,Allosteric modulator,Partial agonist,low affinity,f,f,,-,0,0,0,-,0,0,0,=,,benzodiazepine site,,0,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,tetrahydrodeoxycorticosterone,4321,,,178101138,Allosteric modulator,Potentiation,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CC[C@H](C2)O
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>3</sup>H]gabazine,4083,,,178100906,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,COc1ccc(cc1)c1ccc(=N)n(n1)CCCC(=O)O
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,[<sup>35</sup>S]TBPS,4369,,,178101184,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,anion channel,,0,CC(C12COP(=[35S])(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &alpha;6 subunit,409,GABRA6,Q16445,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &beta;1 subunit,410,GABRB1,P18505,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &beta;2 subunit,411,GABRB2,P47870,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &beta;3 subunit,412,GABRB3,P28472,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &delta; subunit,416,GABRD,O14764,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &epsilon; subunit,417,GABRE,P78334,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &gamma;1 subunit,413,GABRG1,Q8N1C3,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &gamma;2 subunit,414,GABRG2,P18507,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &gamma;3 subunit,415,GABRG3,Q99928,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &pi; subunit,419,GABRP,O00591,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,TPMPA,4328,,,178101145,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,[O-]P(=O)(C1=CC[NH2+]CC1)C
GABA<sub>A</sub> receptor &rho;1 subunit,420,GABRR1,P24046,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,TPMPA,4328,,,178101145,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,[O-]P(=O)(C1=CC[NH2+]CC1)C
GABA<sub>A</sub> receptor &rho;2 subunit,421,GABRR2,P28476,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,TPMPA,4328,,,178101145,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,GABA site,,0,[O-]P(=O)(C1=CC[NH2+]CC1)C
GABA<sub>A</sub> receptor &rho;3 subunit,422,GABRR3,A8MPY1,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>A</sub> receptor &theta; subunit,418,GABRQ,Q9UN88,,,,,,Human,TBPS,4320,,,178101137,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC(C12COP(=S)(OC1)OC2)(C)C
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,[<sup>125</sup>I]CGP 64213,1076,,,135651105,Antagonist,Antagonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,9069281,O=C(CCc1ccc(c(c1)[125I])O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B1</sub>,240,Gabbr1,Q9Z0U4,,,,,,Rat,[<sup>125</sup>I]CGP 71872,1077,,,135651106,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,9069281,[N-]=[N+]=Nc1cc(O)c(cc1[125I])C(=O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B</sub> receptor,242,,,,,,,,None,[<sup>3</sup>H](R)-(-)-baclofen,3428,,,178100431,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,NC[C@@H](c1ccc(cc1)Cl)CC(=O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,[<sup>125</sup>I]CGP 64213,1076,,,135651105,Antagonist,Antagonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,10692480,O=C(CCc1ccc(c(c1)[125I])O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,[<sup>125</sup>I]CGP 71872,1077,,,135651106,Antagonist,Antagonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,9069281,[N-]=[N+]=Nc1cc(O)c(cc1[125I])C(=O)NCCCCCP(=O)(C[C@H](CN[C@@H](c1cccc(c1)C(=O)O)C)O)O
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,[<sup>3</sup>H]CGP 54626,1090,,,135651143,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,Ki,0,0.79,0,=,,,,9872315,O[C@H](CP(=O)(CC1CCCCC1)O)CN[C@H](c1ccc(c(c1)Cl)Cl)C
GABA<sub>B</sub> receptor,242,Gabbr1|Gabbr2|Kctd16|Kctd8|Kctd12,O88871|Q9Z0U4,,,,,,Rat,[<sup>3</sup>H]CGP 62349,3429,,,178100432,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,Kd,0,0.9,0,=,,,,10521582,COc1ccc(cc1)CP(=O)(C[C@H](CN([C@@H](c1cccc(c1)C(=O)O)C)C)O)O
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human),5391,,,178102049,Agonist,Agonist,High affinity receptors,f,f,,pKd,0,10.31000042,0,Kd,0,0.048900001,0,=,,,,9808667,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human),5391,,,178102049,Agonist,Agonist,Low affinity receptors,f,f,,pKd,0,7.829999924,0,Kd,0,14.69999981,0,=,,,,9808667,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,Two populations of binding sites have been identified in transfected cells with K<sub>d</sub>s of 0.3 and 0.019nM.,f,,,pKd,10.72,0,9.52,Kd,0.3,0,0.019,=,,,,9305929,
GAL<sub>1</sub> receptor,243,GALR1,P47211,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,f,,pKd,0,9.819999695,0,Kd,0,0.150000006,0,=,,,,9880084,
GAL<sub>1</sub> receptor,243,Galr1,P56479,,,,,,Mouse,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (rat/mouse),5390,,,178102048,Agonist,Agonist,,f,,,pKd,0,9.87,0,Kd,0,0.134,0,=,,,,9271210,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,"[<sup>19</sup>Lys,<sup>26</sup>Leu]-galparan",6097,,,178102718,Agonist,Agonist,,f,,,pKd,0,9.15,0,Kd,0,0.71,0,=,,,,8738882,
GAL<sub>1</sub> receptor,243,Galr1,Q62805,,,,,,Rat,[<sup>2</sup>Ala]-galparan,6098,,,178102719,Agonist,Agonist,,f,,,pKd,0,5.8,0,Kd,0,1585,0,=,,,,8738882,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human),5391,,,178102049,Agonist,Agonist,,t,f,,pKd,9.619999886,0,9.510000229,Kd,0.310000002,0,0.239999995,=,,,,9480833,
GAL<sub>2</sub> receptor,244,Galr2,O88854,,,,,,Mouse,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human),5391,,,178102049,Agonist,Agonist,,f,,,pKd,0,9.33,0,Kd,0,0.47,0,=,,,,9832122,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human),5391,,,178102049,Agonist,Agonist,,f,f,,pKd,0,9.229999542,0,Kd,0,0.589999974,0,=,,,,9281594,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,f,,pKd,0,9.510000229,0,Kd,0,0.310000002,0,=,,,,9880084,
GAL<sub>2</sub> receptor,244,GALR2,O43603,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,,,pKd,0,9.92,0,Kd,0,0.12,0,=,,,,9685625,
GAL<sub>2</sub> receptor,244,Galr2,O08726,,,,,,Rat,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,,,pKd,9.89,0,8.4,Kd,4,0,0.13,=,,,,9722565,
GAL<sub>3</sub> receptor,245,Galr3,O88626,,,,,,Rat,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,,,pKd,9.26,0,9.01,Kd,0.97,0,0.55,=,,,,9722565,
GAL<sub>3</sub> receptor,245,GALR3,O60755,,,,,,Human,[<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig),6117,,,178102738,Agonist,Agonist,,f,f,,pKd,0,8.649999619,0,Kd,0,2.24000001,0,=,,,,9722565,
GAT1,929,SLC6A1,P30531,,,,,,Human,[<sup>3</sup>H]tiagabine,4685,,,178101399,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@@H]1CCCN(C1)CC/C=C(/c1sccc1C)c1sccc1C
GAT1,929,SLC6A1,P30531,,,,,,Human,tiagabine,4818,,,178101520,Inhibitor,Inhibition,,f,t,,pIC50,0,7.199999809,0,IC50,0,70,0,=,,,,7851497,OC(=O)[C@@H]1CCCN(C1)CC/C=C(/c1sccc1C)c1sccc1C
GDNF family receptor &alpha;1,1743,GFRA1,P56159,,,,,,Human,[<sup>125</sup>I]GDNF (rat),4851,,,178101552,None,None,,f,,,pKd,11.52,0,10.2,Kd,0.063,0,0.003,,,,,8657309,
ghrelin receptor,246,Ghsr,O08725,,,,,,Rat,[<sup>125</sup>I][His<sup>9</sup>]ghrelin (human),1094,,,135652521,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,11522606,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,[<sup>125</sup>I][His<sup>9</sup>]ghrelin (human),1094,,,135652521,Agonist,Full agonist,,f,,,pKd,0,9.4,0,Kd,0,0.4,0,=,,,,11522606,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,[<sup>125</sup>I]Tyr-Ala-hexarelin,1095,,,135652560,Agonist,Full agonist,,f,,,pKd,0,8.2,0,,0,0,0,,,,,11061542,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,[<sup>125</sup>I][Tyr<sup>4</sup>]ghrelin (human),1096,,,135652569,Agonist,Full agonist,,f,,,pKd,0,9.4,0,Kd,0,0.4,0,=,,,,11314756,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,[<sup>35</sup>S]ibutamoren,1097,,,135651124,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,9092793,O=C([C@H](NC(=O)C(N)(C)C)COCc1ccccc1)N1CCC2(CC1)CN(c1c2cccc1)[35S](=O)(=O)C
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,wFw-Isn-NH<sub>2</sub>,5869,,,178102493,Agonist,Partial agonist,"IP<sub>3</sub> accumulation, ERK phosphotylation, binding",f,,,pEC50,8.41,0,5.92,EC50,1200,0,3.9,=,,,,21402696,
ghrelin receptor,246,GHSR,Q92847,,,,,,Human,YIL781,3538,,,178100517,Antagonist,Antagonist,,f,,,pKi,0,7.77,0,Ki,0,17,0,=,,,,17656463,Fc1ccc(cc1)Oc1ccc2c(c1)c(=O)n(c(n2)C)C[C@H]1CCCN(C1)C(C)C
GHRH receptor,247,GHRHR,Q02643,,,,,,Human,tesamorelin,6959,,,178103540,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
GHRH receptor,247,Ghrhr,Q02644,,,,,,Rat,[<sup>125</sup>I]GHRH (human),3783,,,178100633,Agonist,Full agonist,,f,,,pKd,0,7.6,0,Kd,0,28,0,=,,,,11814616,
GIP receptor,248,Gipr,P43219,,,,,,Rat,[<sup>125</sup>I]GIP (human),1131,,,135652517,Agonist,Full agonist,,f,,,pKd,0,8.6,0,Kd,0,2.51,0,=,,,,8795084,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,WB4-24,8544,,,252166745,Agonist,Agonist,,f,f,,pA2,0,4.920000076,0,-,0,0,0,=,,,,25176008,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,[<sup>125</sup>I]GLP-1-(7-36)-amide,1134,,,135652518,Agonist,Full agonist,,f,,,pKd,0,9.3,0,Kd,0,0.5,0,=,,,,15528268,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,[<sup>125</sup>I]GLP-1-(7-37) (human),3784,,,178100634,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,[<sup>125</sup>I]exendin-(9-39),1137,,,135652515,Antagonist,Antagonist,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,15528268,
GLP-1 receptor,249,GLP1R,P43220,,,,,,Human,T-0632,884,,,135651222,Antagonist,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,21000,0,=,,,,11498540,COc1ccc2c(c1)N(c1ccccc1F)C(=O)[C@@]2(CCC(=O)O)NC(=O)C1CCc2c(C1)cccc2
GLP-2 receptor,250,GLP2R,O95838,,,,,,Human,teduglutide,7049,,,178103628,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,25859983,
GLP-2 receptor,250,Glp2r,Q9Z0W0,,,,,,Rat,[Tyr<sup>34</sup>]GLP-2 (human),1145,,,135652619,Agonist,Full agonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,9990065,
GluA1,444,GRIA1,P42261,,,,,,Human,[<sup>3</sup>H]AMPA,4077,,,178100900,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA1,444,GRIA1,P42261,,,,,,Human,[<sup>3</sup>H]CNQX,4081,,,178100904,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N#Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-]
GluA1,444,GRIA1,P42261,,,,,,Human,tezampanel,4245,,,178101062,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1NC[C@H]2[C@@H](C1)C[C@H](CC2)CCc1nnn[nH]1
GluA2,445,GRIA2,P42262,,,,,,Human,[<sup>3</sup>H]AMPA,4077,,,178100900,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA2,445,GRIA2,P42262,,,,,,Human,[<sup>3</sup>H]CNQX,4081,,,178100904,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N#Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-]
GluA2,445,Gria2,P19491,,,,,,Rat,talampanel,8279,,,252166491,Antagonist,Antagonist,,f,f,,pKi,7.820000172,0,7.519999981,Ki,30,0,15,=,,,,23402301,Nc1ccc(cc1)C1=NN(C(=O)C)[C@@H](Cc2c1cc1OCOc1c2)C
GluA2,445,GRIA2,P42262,,,,,,Human,tezampanel,4245,,,178101062,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1NC[C@H]2[C@@H](C1)C[C@H](CC2)CCc1nnn[nH]1
GluA3,446,GRIA3,P42263,,,,,,Human,tezampanel,4245,,,178101062,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1NC[C@H]2[C@@H](C1)C[C@H](CC2)CCc1nnn[nH]1
GluA3,446,GRIA3,P42263,,,,,,Human,[<sup>3</sup>H]AMPA,4077,,,178100900,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA3,446,GRIA3,P42263,,,,,,Human,[<sup>3</sup>H]CNQX,4081,,,178100904,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,N#Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-]
GluA4,447,GRIA4,P48058,,,,,,Human,[<sup>3</sup>H]AMPA,4077,,,178100900,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)C(Cc1c(C)o[nH]c1=O)N
GluA4,447,GRIA4,P48058,,,,,,Human,tezampanel,4245,,,178101062,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)[C@H]1NC[C@H]2[C@@H](C1)C[C@H](CC2)CCc1nnn[nH]1
GluA4,447,GRIA4,P48058,,,,,,Human,[<sup>3</sup>H]CNQX,4081,,,178100904,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,N#Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-]
glucagon receptor,251,GCGR,P47871,,,,,,Human,"[<sup>125</sup>I]glucagon (human, mouse, rat)",3785,,,178100635,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
glucocorticoid-induced TNF receptor,1890,TNFRSF18,Q9Y5U5,,,,,,Human,TL6,5072,TNFSF18,Human,178101765,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,[<sup>3</sup>H]dexamethasone,3447,,,178100447,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,triamcinolone,2870,,,135651276,Agonist,Agonist,,f,t,,pIC50,0,7.699999809,0,-,0,0,0,=,,,,10747884,OCC(=O)[C@@]1(O)[C@H](O)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,triamcinolone acetonide,2867,,,135651277,Agonist,Agonist,,f,f,,pIC50,0,8.199999809,0,-,0,0,0,=,,,,7472274,OCC(=O)[C@@]12OC(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1CCC1=CC(=O)C=C[C@]21C)F)(C)C
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,ZK216348,8643,,,252166843,Agonist,Agonist,,f,f,,pIC50,0,7.690000057,0,IC50,0,20.29999924,0,=,,,,14694204,O=C(C(C(F)(F)F)(CC(c1cccc2c1OCC2)(C)C)O)Nc1ccc2c(c1)c(C)noc2=O
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,ZK112993,3448,,,178100448,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC#C[C@]1(O)CC[C@H]2[C@]1(C)C[C@H](c1ccc(cc1)C(=O)C)C1=C3CCC(=O)C=C3CC[C@@H]21
Glucocorticoid receptor,625,NR3C1,P04150,,,,,,Human,vamorolone,9247,,,315661322,None,Binding,,f,t,,-,0,0,0,-,0,0,0,=,,,,24014378,OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)CC=C1[C@H]2CCC2=CC(=O)C=C[C@]12C
Glucose transporter  1,875,SLC2A1,P11166,,,,,,Human,[<sup>3</sup>H]2-deoxyglucose,4643,,,178101360,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC[C@H]1OC(O)C[C@H]([C@@H]1O)O
Glucose transporter  2,876,SLC2A2,P11168,,,,,,Human,[<sup>3</sup>H]2-deoxyglucose,4643,,,178101360,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1OC(O)C[C@H]([C@@H]1O)O
Glucose transporter  3,877,SLC2A3,P11169,,,,,,Human,[<sup>3</sup>H]2-deoxyglucose,4643,,,178101360,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1OC(O)C[C@H]([C@@H]1O)O
Glucose transporter  4,878,SLC2A4,P14672,,,,,,Human,[<sup>3</sup>H]2-deoxyglucose,4643,,,178101360,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@H]1OC(O)C[C@H]([C@@H]1O)O
GluK1,450,Grik1,P22756,,,,,,Rat,SYM2081,4317,,,178101134,Agonist,Agonist,,f,f,,pKi,0,9.180000305,0,Ki,0,0.662999988,0,=,,,,18578478,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK1,450,GRIK1,P39086,,,,,,Human,[<sup>3</sup>H]kainate,4085,,,178100908,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK1,450,GRIK1,P39086,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK1,450,GRIK1,P39086,,,,,,Human,SYM2081,4317,,,178101134,Agonist,Full agonist,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,10821708,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK1,450,GRIK1,P39086,,,,,,Human,[<sup>3</sup>H]UBP310,4092,,,178100915,Antagonist,Antagonist,,f,f,,pKd,0,7.699999809,0,Kd,0,21,0,=,,,,20837679,N[C@H](C(=O)O)Cn1cc(C)c(=O)n(c1=O)Cc1ccsc1C(=O)O
GluK1,450,GRIK1,P39086,,,,,,Human,UBP302,4333,,,178101150,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N[C@H](C(=O)O)Cn1ccc(=O)n(c1=O)Cc1ccccc1C(=O)O
GluK1,450,GRIK1,P39086,,,,,,Human,UBP310,4334,,,178101151,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N[C@H](C(=O)O)Cn1cc(C)c(=O)n(c1=O)Cc1ccsc1C(=O)O
GluK2,451,GRIK2,Q13002,,,,,,Human,SYM2081,4317,,,178101134,Agonist,Agonist,,f,f,,pKi,0,8,0,Ki,0,10,0,=,,,,10821708,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK2,451,Grik2,P42260,,,,,,Rat,SYM2081,4317,,,178101134,Agonist,Agonist,,f,f,,pKi,8.010000229,0,7.769999981,Ki,17,0,9.800000191,=,Measuring displacement of [<sup>3</sup>H]kainate binding to recombinant rGluR6 receptors.,,,8996224,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK2,451,Grik2,P42260,,,,,,Rat,[<sup>3</sup>H]kainate,4085,,,178100908,Agonist,Full agonist,,f,f,,pKd,0,8.180000305,0,Kd,0,6.599999905,0,=,,,,8996224,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK2,451,GRIK2,Q13002,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK2,451,Grik2,P42260,,,,,,Rat,SYM2081,4317,,,178101134,Agonist,Full agonist,,f,f,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,8996224,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK3,452,GRIK3,Q13003,,,,,,Human,[<sup>3</sup>H]kainate,4085,,,178100908,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK3,452,GRIK3,Q13003,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK3,452,Grik3,P42264,,,,,,Rat,SYM2081,4317,,,178101134,Agonist,Full agonist,,f,f,,pKi,0,8.239999771,0,Ki,0,5.690000057,0,=,,,,18578478,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK3,452,GRIK3,Q13003,,,,,,Human,[<sup>3</sup>H]UBP310,4092,,,178100915,Antagonist,Antagonist,,f,f,,pKd,0,6.300000191,0,Kd,0,560,0,=,,,,20837679,N[C@H](C(=O)O)Cn1cc(C)c(=O)n(c1=O)Cc1ccsc1C(=O)O
GluK4,453,GRIK4,Q16099,,,,,,Human,[<sup>3</sup>H]kainate,4085,,,178100908,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK4,453,GRIK4,Q16099,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK4,453,GRIK4,Q16099,,,,,,Human,SYM2081,4317,,,178101134,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK5,454,GRIK5,Q16478,,,,,,Human,[<sup>3</sup>H]kainate,4085,,,178100908,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)C[C@H]1[C@H](CN[C@@H]1C(=O)[O-])C(=C)C
GluK5,454,GRIK5,Q16478,,,,,,Human,[<sup>3</sup>H]SYM2081,4075,,,178100898,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluK5,454,GRIK5,Q16478,,,,,,Human,SYM2081,4317,,,178101134,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[O-]C(=O)[C@@H](C[C@@H](C(=O)[O-])N)C
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]CGP39653,4078,,,178100901,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CCCC(=CC(C(=O)O)N)CP(=O)(O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]CGP61594,4079,,,178100902,Antagonist,Antagonist,photoaffinity ligand,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,[N-]=[N+]=Nc1ccc(cc1)CC(=O)NC1CC(Nc2c1c(Cl)cc(c2)Cl)C(=O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]CGS19755,4080,,,178100903,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCC(C1)CP(=O)(O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]CPP,4082,,,178100905,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)CCCP(=O)(O)O
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]dizocilpine,4089,,,178100912,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,cation channel,,0,CC12NC(c3c2cccc3)Cc2c1cccc2
GluN1,455,GRIN1,Q05586,,,,,,Human,[<sup>3</sup>H]L689560,4086,,,178100909,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN1,455,Grin1,P35439,,,,,,Rat,[<sup>3</sup>H]MDL105519,4088,,,178100911,Antagonist,Antagonist,,f,f,,pKd,0,8.520000458,0,Kd,0,3,0,~,,glycine site,,9721050,Clc1cc(Cl)c2c(c1)[nH]c(c2C=C(c1ccccc1)C(=O)O)C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,TCN-201,7846,,,223366176,Allosteric modulator,Negative,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,Inhibition of glycine-induced (1&micro;M) NMDA receptor responses measured in <i>Xenopus</i> oocytes co-expressing hGluN1 and hGluN2A NMDA receptor subunits,,,22553026,O=C(c1ccc(cc1)CNS(=O)(=O)c1ccc(c(c1)Cl)F)NNC(=O)c1ccccc1
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]CGP39653,4078,,,178100901,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CCCC(=CC(C(=O)O)N)CP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]CGP61594,4079,,,178100902,Antagonist,Antagonist,[<sup>3</sup>H]CGP61594 is a photoaffinity ligand,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,[N-]=[N+]=Nc1ccc(cc1)CC(=O)NC1CC(Nc2c1c(Cl)cc(c2)Cl)C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]CGS19755,4080,,,178100903,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCC(C1)CP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]CPP,4082,,,178100905,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)CCCP(=O)(O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]L689560,4086,,,178100909,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]MDL105519,4088,,,178100911,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2C=C(c1ccccc1)C(=O)O)C(=O)O
GluN2A,456,GRIN2A,Q12879,,,,,,Human,UBP141,4332,,,178101149,Antagonist,Antagonist,GluN2D &ge; GluN2C > GluN2A &ge; GluN2B,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,15801853,O=C(N1CCN[C@@H]([C@@H]1C(=O)O)C(=O)O)c1ccc2c(c1)c1ccccc1cc2
GluN2A,456,GRIN2A,Q12879,,,,,,Human,[<sup>3</sup>H]dizocilpine,4089,,,178100912,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,cation channel,,0,CC12NC(c3c2cccc3)Cc2c1cccc2
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]CGP39653,4078,,,178100901,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CCCC(=CC(C(=O)O)N)CP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]CGP61594,4079,,,178100902,Antagonist,Antagonist,photoaffinity ligand,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,[N-]=[N+]=Nc1ccc(cc1)CC(=O)NC1CC(Nc2c1c(Cl)cc(c2)Cl)C(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]CGS19755,4080,,,178100903,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCC(C1)CP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]CPP,4082,,,178100905,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)CCCP(=O)(O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]L689560,4086,,,178100909,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]MDL105519,4088,,,178100911,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2C=C(c1ccccc1)C(=O)O)C(=O)O
GluN2B,457,GRIN2B,Q13224,,,,,,Human,UBP141,4332,,,178101149,Antagonist,Antagonist,GluN2D &ge; GluN2C > GluN2A &ge; GluN2B,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,15801853,O=C(N1CCN[C@@H]([C@@H]1C(=O)O)C(=O)O)c1ccc2c(c1)c1ccccc1cc2
GluN2B,457,GRIN2B,Q13224,,,,,,Human,[<sup>3</sup>H]dizocilpine,4089,,,178100912,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,cation channel,,0,CC12NC(c3c2cccc3)Cc2c1cccc2
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]CGP39653,4078,,,178100901,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CCCC(=CC(C(=O)O)N)CP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]CGP61594,4079,,,178100902,Antagonist,Antagonist,[<sup>3</sup>H]CGP61594 is a photoaffinity ligand,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,[N-]=[N+]=Nc1ccc(cc1)CC(=O)NC1CC(Nc2c1c(Cl)cc(c2)Cl)C(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]CGS19755,4080,,,178100903,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCC(C1)CP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]CPP,4082,,,178100905,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)CCCP(=O)(O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]L689560,4086,,,178100909,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]MDL105519,4088,,,178100911,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2C=C(c1ccccc1)C(=O)O)C(=O)O
GluN2C,458,GRIN2C,Q14957,,,,,,Human,UBP141,4332,,,178101149,Antagonist,Antagonist,GluN2D &ge; GluN2C > GluN2A &ge; GluN2B,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,15801853,O=C(N1CCN[C@@H]([C@@H]1C(=O)O)C(=O)O)c1ccc2c(c1)c1ccccc1cc2
GluN2C,458,GRIN2C,Q14957,,,,,,Human,[<sup>3</sup>H]dizocilpine,4089,,,178100912,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,cation channel,,0,CC12NC(c3c2cccc3)Cc2c1cccc2
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,NCC(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]CGP39653,4078,,,178100901,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,CCCC(=CC(C(=O)O)N)CP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]CGP61594,4079,,,178100902,Antagonist,Antagonist,[<sup>3</sup>H]CGP61594 is a photoaffinity ligand,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,[N-]=[N+]=Nc1ccc(cc1)CC(=O)NC1CC(Nc2c1c(Cl)cc(c2)Cl)C(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]CGS19755,4080,,,178100903,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCC(C1)CP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]CPP,4082,,,178100905,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,0,OC(=O)C1NCCN(C1)CCCP(=O)(O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]L689560,4086,,,178100909,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,O=C(N[C@@H]1C[C@H](Nc2c1c(Cl)cc(c2)Cl)C(=O)O)Nc1ccccc1
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]MDL105519,4088,,,178100911,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,glycine site,,0,Clc1cc(Cl)c2c(c1)[nH]c(c2C=C(c1ccccc1)C(=O)O)C(=O)O
GluN2D,459,GRIN2D,O15399,,,,,,Human,UBP141,4332,,,178101149,Antagonist,Antagonist,GluN2D &ge; GluN2C > GluN2A &ge; GluN2B,f,f,,-,0,0,0,-,0,0,0,=,,glutamate site,,15801853,O=C(N1CCN[C@@H]([C@@H]1C(=O)O)C(=O)O)c1ccc2c(c1)c1ccccc1cc2
GluN2D,459,GRIN2D,O15399,,,,,,Human,[<sup>3</sup>H]dizocilpine,4089,,,178100912,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,cation channel,,0,CC12NC(c3c2cccc3)Cc2c1cccc2
Glycine Receptor (All subtypes),428,,,,,,,,Human,taurine,2379,,,135651575,Agonist,Agonist,,t,,,pEC50,0,3.84,0,,0,0,0,,,,,9009272,NCCS(=O)(=O)O
Glycine Receptor (All subtypes),428,,,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,,t,,10,-,0,0,0,,0,0,0,,,,,16144831,
Glycine Receptor (All subtypes),428,,,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Potentiation,,t,,0.02-10,-,0,0,0,,0,0,0,,,,,16144831,
Glycine Receptor (All subtypes),428,,,,,,,,Human,[<sup>3</sup>H]strychnine,2360,,,135652720,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,3037383,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
Glycine Receptor (All subtypes),428,,,,,,,,Rat,[<sup>3</sup>H]strychnine,2360,,,135652720,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,1326295,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
Glycine Receptor (All subtypes),428,,,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,,,pIC50,0,4.1,0,,0,0,0,,,,,10428078,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
Glycine Receptor (All subtypes),428,,,,,,,,None,WIN55212-2,733,,,135651326,Subunit-specific,Inhibition,"&alpha;3>&alpha;2, no inhibition of &alpha;1",f,,<1,pIC50,7,0,6.7,,0,0,0,,,,,18755158,O=C(c1c(C)n2c3c1cccc3OC[C@H]2CN1CCOCC1)c1cccc2c1cccc2
Glycine Receptor (All subtypes),428,,,,,,,,None,Zn<sup>2+</sup>,566,,,135652747,Subunit-specific,Inhibition,"1, 2 >> 1, 2 ",t,,<1,-,0,0,0,,0,0,0,,,,,15905212,
Glycine Receptor (All subtypes),428,,,,,,,,None,tropisetron,260,,,135651284,Subunit-specific,Potentiation,"1, 2 , 1, no effect on 2",f,,<0.01,-,0,0,0,,0,0,0,,,,,10999946,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
Glycine Receptor (All subtypes),428,,,,,,,,None,Zn<sup>2+</sup>,566,,,135652747,Subunit-specific,Potentiation,"1, 1 > 2, 2",t,,<0.01,-,0,0,0,,0,0,0,,,,,16144831,
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,endogenous,t,f,,pIC50,0,4.800000191,0,IC50,0,15000,0,=,,,,0,
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Potentiation,endogenous; not affected by &beta; subunit co-expression,t,f,,pEC50,0,7.400000095,0,EC50,0,37,0,=,,,,0,
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,[<sup>3</sup>H]strychnine,2360,,,135652720,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;1 subunit,423,GLRA1,P23415,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,f,,pKi,0,4.099999905,0,Ki,0,84000,0,=,,,,0,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,endogenous,t,f,,pIC50,0,3.400000095,0,IC50,0,360000,0,=,,,,0,
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Potentiation,endogenous; not affected by &beta; subunit co-expression,t,f,,pEC50,0,6.300000191,0,EC50,0,540,0,=,,,,0,
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,[<sup>3</sup>H]strychnine,2360,,,135652720,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,,f,f,,pKi,0,4.900000095,0,Ki,0,13000,0,=,,,,0,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
glycine receptor &alpha;2 subunit,424,GLRA2,P23416,,,,,,Human,WIN55212-2,733,,,135651326,Antagonist,Antagonist,,f,f,,pIC50,0,6.699999809,0,IC50,0,220,0,=,,,,0,O=C(c1c(C)n2c3c1cccc3OC[C@H]2CN1CCOCC1)c1cccc2c1cccc2
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,endogenous,t,f,,pIC50,0,3.799999952,0,IC50,0,150000,0,=,,,,0,
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,[<sup>3</sup>H]strychnine,2360,,,135652720,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1C[C@@H]2OCC=C3[C@H]4[C@@H]2[C@@H]2N1c1ccccc1[C@]12CCN([C@H]1C4)C3
glycine receptor &alpha;3 subunit,425,GLRA3,O75311,,,,,,Human,WIN55212-2,733,,,135651326,Antagonist,Antagonist,,f,f,,pIC50,0,7,0,IC50,0,97,0,=,,,,0,O=C(c1c(C)n2c3c1cccc3OC[C@H]2CN1CCOCC1)c1cccc2c1cccc2
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,endogenous; when co-expressed with the &alpha;2 subunit,t,f,,pIC50,0,3.700000048,0,IC50,0,180000,0,=,,,,0,
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Allosteric modulator,Inhibition,endogenous; when co-expressed with the &alpha;1 subunit,t,f,,pIC50,0,4.900000095,0,IC50,0,13000,0,=,,,,0,
glycine receptor &beta; subunit,427,GLRB,P48167,,,,,,Human,tropisetron,260,,,135651284,Antagonist,Antagonist,when co-expressed with the &alpha;2 subunit,f,f,,pKi,0,5.300000191,0,Ki,0,5400,0,=,,,,0,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,TWS119,5980,,,178102603,Inhibitor,Inhibition,,f,t,,pIC50,0,7.519999981,0,IC50,0,30,0,=,,,,12794184,Oc1cccc(c1)Oc1ncnc2c1cc([nH]2)c1cccc(c1)N
glycogen synthase kinase 3 beta,2030,GSK3B,P49841,,,,,,Human,tideglusib,6929,,,178103511,Inhibitor,Irreversible inhibition,,f,f,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,22102280,O=c1sn(c(=O)n1Cc1ccccc1)c1cccc2c1cccc2
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>35</sup>S]ACPPB,4584,,,178101305,None,Binding,,f,f,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,18355687,CCC[35S](=O)(=O)N1CCC(CC1)(c1ccccc1)[C@@H](NC(=O)c1c(N)cccc1Cl)C
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>3</sup>H]GSK931145,4490,,,178101218,None,Binding,,f,f,,pKd,0,8.800000191,0,Kd,0,1.700000048,0,=,,,,20691713,O=C(c1c(C)cccc1C)N[C@H](C1(CCCC1)N(C([3H])([3H])[3H])C)c1ccccc1
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>3</sup>H](R)-NPTS,4602,,,178101322,None,Binding,,f,f,,pKd,0,9,0,Kd,0,1,0,=,,,,12657266,CN(CC(=O)O)CC[C@H](c1ccccc1)Oc1ccc(cc1)C(=O)c1ccc(cc1)C
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>3</sup>H]SB-733993,4491,,,178101219,None,Binding,,f,f,,pKd,0,8.699999809,0,Kd,0,2.200000048,0,=,,,,20691713,O[C@@H](CN1[C@H](C)CCC[C@@H]1C)CNS(=O)(=O)c1ccc(c2c1cccc2)[3H]
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>3</sup>H]NFPS,4619,,,178101337,None,None,,f,,,pKd,8.2,0,7.7,Kd,21,0,7,,,,,0,CN(CC(=O)O)CCC(c1ccc(cc1)F)Oc1ccc(cc1)c1ccccc1
GlyT1,935,SLC6A9,P48067,,,,,,Human,[<sup>3</sup>H]N-methyl-SSR504734,4603,,,178101323,None,None,,f,,,pKd,8.5,0,8.1,Kd,8.1,0,3.3,,,,,0,CN1CCCC[C@H]1[C@H](c1ccccc1)NC(=O)c1cccc(c1Cl)C(F)(F)F
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,[<sup>125</sup>I]buserelin,1167,,,135652490,Agonist,Full agonist,,f,,,pKd,0,7.4,0,Kd,0,40,0,=,,,,8013367,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"[<sup>125</sup>I][des-Gly<sup>10</sup>,<small>D</small>-Ala<sup>6</sup>]GnRH <i>N</i>-ethylamide",1166,,,135652510,Agonist,Full agonist,,f,,,pKd,0,9.3,0,,0,0,0,,,,,12606616,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"[<sup>125</sup>I]GnRH I (human, mouse, rat)",3786,,,178100636,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,[<sup>125</sup>I]triptorelin,1168,,,135652559,Agonist,Full agonist,,f,f,,pKd,0,9.300000191,0,-,0,0,0,=,,,,9484907,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,"[<sup>125</sup>I][Tyr<sup>5</sup>,DAla<sup>6</sup>,NMeLeu<sup>7</sup>,Pro<sup>9</sup>-NEt]GnRH",1165,,,135652570,Agonist,Full agonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,6346049,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,triptorelin,1177,,,135652611,Agonist,Full agonist,,f,f,,pKi,9.489999771,0,9.289999962,Ki,0.50999999,0,0.319999993,=,,,,11726197,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,triptorelin,1177,,,135652611,Agonist,Full agonist,,f,,,pKi,8.8,0,8.5,,0,0,0,,,,,11726197,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[Trp<sup>8</sup>]GnRH,1172,,,135652616,Agonist,Full agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,17452338,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[Tyr<sup>8</sup>]GnRH,1173,,,135652625,Agonist,Full agonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,17452338,
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,sufugolix,1185,,,135651226,Antagonist,Antagonist,,f,,,pKi,0,10,0,,0,0,0,,,,,12502365,CONC(=O)Nc1ccc(cc1)c1sc2c(c1CN(Cc1ccccc1)C)c(=O)n(c(=O)n2Cc1c(F)cccc1F)c1ccccc1
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[<sup>125</sup>I]cetrorelix,1186,,,135652501,Antagonist,Antagonist,,f,f,,pKd,0,9.699999809,0,-,0,0,0,=,,,,10894158,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(cc1)[125I])NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,[<sup>3</sup>H]NBI-49202,1187,,,135651186,Antagonist,Antagonist,,f,,,pKd,0,9.7,0,,0,0,0,,,,,16930559,COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)N)c(=O)n(c1C)Cc1c(F)cccc1F
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,T-98475,1184,,,135651225,Antagonist,Antagonist,,f,,,pIC50,0,9.7,0,,0,0,0,,,,,9784092,CC(OC(=O)c1cn(Cc2c(F)cccc2F)c2c(c1=O)c(CN(Cc1ccccc1)C)c(s2)c1ccc(cc1)NC(=O)C(C)C)C
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,TAK-385,5586,,,178102221,Antagonist,Antagonist,,f,,,pIC50,0,9.48,0,IC50,0,0.33,0,=,,,,21657270,CONC(=O)Nc1ccc(cc1)c1sc2c(c1CN(C)C)c(=O)n(c(=O)n2Cc1c(F)cccc1F)c1ccc(nn1)OC
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,TAK-385,5586,,,178102221,Antagonist,Antagonist,,f,,,pIC50,0,9.48,0,IC50,0,0.33,0,=,,,,21657270,CONC(=O)Nc1ccc(cc1)c1sc2c(c1CN(C)C)c(=O)n(c(=O)n2Cc1c(F)cccc1F)c1ccc(nn1)OC
GnRH<sub>1</sub> receptor,256,GNRHR,P30968,,,,,,Human,WAY-207024,5582,,,178102217,Antagonist,Antagonist,,f,,,pIC50,0,7.92,0,IC50,0,12,0,=,,,,19271735,CC(c1ccc(cc1)c1[nH]c2c(n1)cccc2N1CCN(CC1)Cc1ccc2c(c1)nccn2)(C)C
GnRH<sub>1</sub> receptor,256,Gnrhr,P30969,,,,,,Rat,WAY-207024,5582,,,178102217,Antagonist,Antagonist,,f,,,pIC50,0,7.15,0,IC50,0,71,0,=,,,,19271735,CC(c1ccc(cc1)c1[nH]c2c(n1)cccc2N1CCN(CC1)Cc1ccc2c(c1)nccn2)(C)C
GnRH<sub>2</sub> receptor,257,,,,,,,,Monkey,trptorelix-1,3916,,,178100748,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,14651258,
GPER,221,GPER1,Q99527,,,,,,Human,[<sup>3</sup>H]17&beta;-estradiol,1012,,,135651382,Agonist,Full agonist,,f,,,pKd,8.6,0,8.5,Kd,3.3,0,2.7,=,,,,15539556,Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
GPER,221,GPER1,Q99527,,,,,,Human,tamoxifen,1016,,,135651233,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,15539556,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
G protein subunit alpha q,2914,,,,,,,,Hamster,YM-254890,9335,,,318164854,Inhibitor,Inhibition,,f,f,,pIC50,0,7.019999981,0,IC50,0,95,0,=,,,,0,CO[C@@H]([C@H]1C(=O)O[C@H](C)[C@H](NC(=O)C)C(=O)O[C@H](Cc2ccccc2)C(=O)N(C)C(=C)C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N1C)[C@@H](C(C)C)OC(=O)[C@H]([C@@H](C(C)C)O)NC(=O)C)C)C)C)C
Guanylyl cyclase-A,1747,NPR1,P16066,,,,,,Human,[<sup>125</sup>I]ANP (human),4845,,,178101546,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
"Guanylyl cyclase, &alpha;<sub>1</sub>&beta;<sub>1</sub>",1287,GUCY1B1|GUCY1A1,Q02108|Q02153,,,,,,Human,YC-1,5291,,,178101974,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,9003762,OCc1ccc(o1)c1nn(c2c1cccc2)Cc1ccccc1
"Guanylyl cyclase, &alpha;<sub>2</sub>&beta;<sub>1</sub>",2897,GUCY1B1|GUCY1A2,P33402|Q02153,,,,,,Human,YC-1,5291,,,178101974,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,9742221,OCc1ccc(o1)c1nn(c2c1cccc2)Cc1ccccc1
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,vosoritide,9068,,,315661153,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,23200862,
Guanylyl cyclase-B,1748,NPR2,P20594,,,,,,Human,[<sup>125</sup>I]CNP (human),4847,,,178101548,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,[<sup>125</sup>I]St<sub>a</sub>,4850,,,178101551,Agonist,Agonist,,f,f,,pKd,0,7.820000172,0,Kd,0,15,0,=,,,,9122260,
Guanylyl cyclase-C,1750,GUCY2C,P25092,,,,,,Human,uroguanylin,5084,GUCA2B,Human,178101777,None,Binding,,t,f,,-,0,0,0,-,0,0,0,=,,,,0,
HCA<sub>2</sub> receptor,312,HCAR2,Q8TDS4,,,,,,Human,[<sup>3</sup>H]nicotinic acid,1594,,,135651566,Agonist,Full agonist,,f,,,pKd,7.3,0,7,Kd,100,0,50.1,=,,,,12522134,OC(=O)c1cccnc1
HCN1,400,HCN1,O60741,,,,,,Human,zatebradine,2358,,,135651356,Channel blocker,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN1,400,HCN1,O60741,,,,,,Human,ZD7288,2359,,,135651358,Channel blocker,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,16043489,CCN(c1cc(=NC)n(c(n1)C)C)c1ccccc1
HCN2,401,HCN2,Q9UL51,,,,,,Human,zatebradine,2358,,,135651356,Channel blocker,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN2,401,HCN2,Q9UL51,,,,,,Human,ZD7288,2359,,,135651358,Channel blocker,Antagonist,,f,f,,pIC50,0,4.400000095,0,IC50,0,41000,0,=,,,,16043489,CCN(c1cc(=NC)n(c(n1)C)C)c1ccccc1
HCN3,402,HCN3,Q9P1Z3,,,,,,Human,zatebradine,2358,,,135651356,Channel blocker,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN3,402,HCN3,Q9P1Z3,,,,,,Human,ZD7288,2359,,,135651358,Channel blocker,Antagonist,,f,f,,pIC50,0,4.5,0,IC50,0,34000,0,=,,,,16043489,CCN(c1cc(=NC)n(c(n1)C)C)c1ccccc1
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,zatebradine,2358,,,135651356,Channel blocker,Antagonist,,f,,,pIC50,0,5.7,0,,0,0,0,,,,,16387796,COc1ccc(cc1OC)CCN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
HCN4,403,HCN4,Q9Y3Q4,,,,,,Human,ZD7288,2359,,,135651358,Channel blocker,Antagonist,,f,f,,pIC50,0,4.699999809,0,IC50,0,21000,0,=,,,,16043489,CCN(c1cc(=NC)n(c(n1)C)C)c1ccccc1
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,tacedinaline,8367,,,252166579,Inhibitor,Inhibition,,f,t,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,20139990,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,tacedinaline,8367,,,252166579,Inhibitor,Inhibition,,f,f,,pIC50,0,6.239999771,0,IC50,0,570,0,=,,,,18182289,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,tubastatin A,9702,,,348353661,Inhibitor,Inhibition,,f,f,,pIC50,0,4.860000134,0,IC50,0,13800,0,=,,,,0,ONC(=O)c1ccc(cc1)Cn1c2ccccc2c2c1CCN(C2)C
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,tucidinostat,8305,,,252166517,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,20060381,O=C(C=Cc1cccnc1)NCc1ccc(cc1)C(=O)Nc1cc(F)ccc1N
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,valproic acid,7009,,,178103588,Inhibitor,Inhibition,,f,f,,pIC50,0,6.400000095,0,IC50,0,400,0,=,,,,11473107,CCCC(C(=O)O)CCC
histone deacetylase 1,2658,HDAC1,Q13547,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,t,,pKi,0,8.890000343,0,Ki,0,1.299999952,0,=,,,,20139990,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 10,2614,HDAC10,Q969S8,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,7.300000191,0,Ki,0,50,0,=,,,,20451378,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 11,2615,HDAC11,Q96DB2,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,7.440000057,0,Ki,0,36,0,=,,,,20451378,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,tacedinaline,8367,,,252166579,Inhibitor,Inhibition,,f,f,,pKi,0,6.820000172,0,Ki,0,150,0,=,,,,20139990,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,9.18999958,0,Ki,0,0.649999976,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 2,2616,HDAC2,Q92769,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,20139990,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,tacedinaline,8367,,,252166579,Inhibitor,Inhibition,,f,f,,pKi,0,6.260000229,0,Ki,0,550,0,=,,,,20139990,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,9.300000191,0,Ki,0,0.5,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 3,2617,HDAC3,O15379,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,8.300000191,0,Ki,0,5,0,=,,,,20139990,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,tasquinimod,8098,,,249565778,Allosteric modulator,Inhibition,,f,f,,pKd,8,0,7.519999981,Kd,30,0,10,=,,,,23149916,COc1cccc2c1c(O)c(C(=O)N(c1ccc(cc1)C(F)(F)F)C)c(=O)n2C
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,TMP269,7491,,,187051794,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,157,0,=,,,,23524983,O=C(c1cccc(c1)c1noc(n1)C(F)(F)F)NCC1(CCOCC1)c1scc(n1)c1ccccc1
histone deacetylase 4,2659,HDAC4,P56524,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,5.849999905,0,Ki,0,1400,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,TMP269,7491,,,187051794,Inhibitor,Inhibition,,f,f,,pIC50,0,7.010000229,0,IC50,0,97,0,=,,,,23524983,O=C(c1cccc(c1)c1noc(n1)C(F)(F)F)NCC1(CCOCC1)c1scc(n1)c1ccccc1
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,6.590000153,0,Ki,0,260,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 5,2660,HDAC5,Q9UQL6,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,5.440000057,0,Ki,0,3600,0,=,,,,20139990,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,9,0,Ki,0,1,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,tubacin,7374,,,178103946,Inhibitor,Inhibition,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,12677000,ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@H]1O[C@@H](CSc2nc(c(o2)c2ccccc2)c2ccccc2)C[C@H](O1)c1ccc(cc1)CO
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,tubastatin A,9702,,,348353661,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,0,ONC(=O)c1ccc(cc1)Cn1c2ccccc2c2c1CCN(C2)C
histone deacetylase 6,2618,HDAC6,Q9UBN7,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,20139990,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,TMP269,7491,,,187051794,Inhibitor,Inhibition,,f,f,,pIC50,0,7.369999886,0,IC50,0,43,0,=,,,,23524983,O=C(c1cccc(c1)c1noc(n1)C(F)(F)F)NCC1(CCOCC1)c1scc(n1)c1ccccc1
histone deacetylase 7,2661,HDAC7,Q8WUI4,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,6.710000038,0,Ki,0,195,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,8.350000381,0,Ki,0,4.5,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,tubastatin A,9702,,,348353661,Inhibitor,Inhibition,,f,f,,pIC50,0,6.090000153,0,IC50,0,814,0,=,,,,0,ONC(=O)c1ccc(cc1)Cn1c2ccccc2c2c1CCN(C2)C
histone deacetylase 8,2619,HDAC8,Q9BY41,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,6.690000057,0,6.320000172,Ki,480,0,205,=,,,,20451378,ONC(=O)CCCCCCC(=O)Nc1ccccc1
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,TMP269,7491,,,187051794,Inhibitor,Inhibition,,f,f,,pIC50,0,7.639999866,0,IC50,0,23,0,=,,,,23524983,O=C(c1cccc(c1)c1noc(n1)C(F)(F)F)NCC1(CCOCC1)c1scc(n1)c1ccccc1
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,trichostatin A,7005,,,178103584,Inhibitor,Inhibition,,f,f,,pKi,0,6.099999905,0,Ki,0,800,0,=,,,,20139990,ONC(=O)/C=C/C(=C/[C@H](C(=O)c1ccc(cc1)N(C)C)C)/C
histone deacetylase 9,2620,HDAC9,Q9UKV0,,,,,,Human,vorinostat,6852,,,178103458,Inhibitor,Inhibition,,f,f,,pKi,0,7.190000057,0,Ki,0,65,0,=,,,,20451378,ONC(=O)CCCCCCC(=O)Nc1ccccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,vilazodone,7427,,,178103999,Agonist,Agonist,,f,f,,pIC50,0,6.5,0,IC50,0,317,0,=,,,,15341484,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,UR-PG131A,1198,,,135651298,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,16394198,O=C(CC(c1ccc(c(c1)F)F)c1ncc[nH]1)NC(=NCCCc1cnc[nH]1)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,UR-PG146,1200,,,135651300,Agonist,Full agonist,,f,,,pKi,0,4.4,0,,0,0,0,,,,,16394198,O=C(NC(=NCCCc1cnc[nH]1)N)CSCc1nc[nH]c1C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,UR-PG153,1201,,,135651301,Agonist,Full agonist,,f,,,pKi,0,4.7,0,,0,0,0,,,,,16394198,O=C(CC(c1ccccc1)c1ccccc1)NC(=NCCc1cnc[nH]1)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,UR-PG55B,1202,,,135651302,Agonist,Full agonist,,f,,,pKi,0,5.2,0,,0,0,0,,,,,16394198,O=C(CC(c1ccc(cc1)F)c1ccc(cc1)F)NC(=NCCCc1cnc[nH]1)N
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,[<sup>11</sup>C]doxepin,3958,,,178100785,Antagonist,Antagonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,15093820,CN(CC/C=C1/c2ccccc2OCc2c1cccc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,terfenadine,2608,,,135651245,Antagonist,Antagonist,,f,t,,pKi,0,7.400000095,0,Ki,0,40,0,=,,,,19660947,OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,thioridazine,100,,,135651259,Antagonist,Antagonist,,f,,,pKi,0,7.7,0,,0,0,0,,,,,12629531,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,thiothixene,212,,,135651260,Antagonist,Antagonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12629531,CN1CCN(CC1)CC/C=C1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,trifluoperazine,214,,,135651279,Antagonist,Antagonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,12629531,CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,tripelennamine,7318,,,178103891,Antagonist,Antagonist,,f,t,,pIC50,0,7.400000095,0,IC50,0,39.79999924,0,=,,,,14667234,CN(CCN(c1ccccn1)Cc1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,tripelennamine,7318,,,178103891,Antagonist,Antagonist,,f,t,,pKd,0,8,0,Kd,0,10,0,=,,,,14667234,CN(CCN(c1ccccn1)Cc1ccccc1)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,triprolidine,1228,,,135651281,Antagonist,Antagonist,,f,t,,pKi,9,0,8.5,Ki,3.160000086,0,1,=,,,,7925364,Cc1ccc(cc1)/C(=CCN1CCCC1)/c1ccccn1
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,ziprasidone,59,,,135651359,Antagonist,Antagonist,,f,,,pKi,7.8,0,7.4,,0,0,0,,,,,8935801,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,zotepine,103,,,135651367,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,8935801,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,[<sup>11</sup>C]pyrilamine,3957,,,178100784,Antagonist,Inverse agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1)CN(c1ccccn1)CCN(C)C
H<sub>1</sub> receptor,262,HRH1,P35367,,,,,,Human,[<sup>3</sup>H]pyrilamine,1220,,,135651192,Antagonist,Inverse agonist,,f,,,pKd,9.1,0,8.4,Kd,4,0,0.79,=,,,,8935801,COc1ccc(cc1)CN(c1ccc(cn1)[3H])CCN(C)C
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,UR-PG146,1200,,,135651300,Agonist,Full agonist,,f,,,pKi,0,6,0,,0,0,0,,,,,16394198,O=C(NC(=NCCCc1cnc[nH]1)N)CSCc1nc[nH]c1C
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,[<sup>125</sup>I]iodoaminopotentidine,1230,,,135651102,Antagonist,Antagonist,,f,,,pKd,0,8.7,0,Kd,0,2,0,=,,,,8961278,N#CNC(=NCCCOc1cccc(c1)CN1CCCCC1)NCCNC(=O)c1ccc(c(c1)[125I])N
H<sub>2</sub> receptor,263,HRH2,P25021,,,,,,Human,[<sup>3</sup>H]tiotidine,3959,,,178100786,Antagonist,Antagonist,,f,,,pKd,8.7,0,7.7,Kd,20,0,2.2,=,,,,12869657,N#CNC(=NC)NCCSCc1csc(n1)N=C(N)N
H<sub>2</sub> receptor,263,Hrh2,P25102,,,,,,Rat,tiotidine,1235,,,135651265,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,,,,9384502,N#CNC(=NC)NCCSCc1csc(n1)N=C(N)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,[<sup>3</sup>H]histamine,1247,,,135651565,Agonist,Full agonist,,f,,,pKd,0,8,0,,0,0,0,,,,,11179434,NCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,[<sup>3</sup>H](<i>R</i>)-&alpha;-methylhistamine,1237,,,135651165,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.6,0,=,,,,11179434,C[C@H](Cc1cnc[nH]1)N
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,VUF 5207,1245,,,135651312,Agonist,Full agonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,11714875,CN(CCCCCc1[nH]cnc1)C
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,VUF 8328,1246,,,135651313,Agonist,Partial agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,11714875,NC(=N)SCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,[<sup>123</sup>I]iodoproxyfan,1264,,,135651098,Antagonist,Antagonist,,f,,,pKd,0,10.3,0,,0,0,0,,,,,11090094,[123I]c1ccc(cc1)COCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,[<sup>123</sup>I]iodoproxyfan,1264,,,135651098,Antagonist,Antagonist,,f,,,pKd,0,10.2,0,Kd,0,0.063,0,=,,,,11090094,[123I]c1ccc(cc1)COCCCc1cnc[nH]1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,[<sup>125</sup>I]iodophenpropit,3960,,,178100787,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,Kd,0,0.6,0,=,,,,7834183,N[C@H](SCCCc1cnc[nH]1)NCCc1ccc(cc1)I
H<sub>3</sub> receptor,264,Hrh3,P58406,,,,,,Mouse,thioperamide,1267,,,135651258,Antagonist,Antagonist,,f,,,pKi,8.8,0,8.6,,0,0,0,,,,,15341517,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>3</sub> receptor,264,Hrh3,Q9QYN8,,,,,,Rat,thioperamide,1267,,,135651258,Antagonist,Antagonist,,f,,,pKi,8.8,0,7.7,,0,0,0,,,,,12606603,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,thioperamide,1267,,,135651258,Antagonist,Antagonist,Selective for H<sub>3</sub>/H<sub>4</sub> compared to H<sub>1</sub> and H<sub>3</sub>.,f,f,,pKi,7.699999809,0,7.099999905,Ki,79.40000153,0,19.89999962,=,,,,12606603,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,UCL-2138,1257,,,135649791,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11179434,N#Cc1ccc(cc1)OCCCN1CCCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,VUF 4904,1263,,,135651311,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,11714875,C(CCc1cnc[nH]1)CCNC1CCCCC1
H<sub>3</sub> receptor,264,HRH3,Q9Y5N1,,,,,,Human,ZPL-3893787,8985,,,310264765,Antagonist,Antagonist,,f,f,,pKi,0,6.730000019,0,-,0,0,0,=,,,,26084539,CN[C@@H]1CCN(C1)c1cc(NCC2CC2)nc(n1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,[<sup>125</sup>I]CCL16 (human),1275,,,135652494,Agonist,Full agonist,,f,,,pKd,0,7.8,0,,0,0,0,,,,,15265943,
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,[<sup>3</sup>H]histamine,1247,,,135651565,Agonist,Full agonist,,f,,,pKd,0,6.9,0,,0,0,0,,,,,11561071,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,[<sup>3</sup>H]histamine,1247,,,135651565,Agonist,Full agonist,,f,,,pKd,8.4,0,7.4,,0,0,0,,,,,11179434,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,[<sup>3</sup>H]histamine,1247,,,135651565,Agonist,Full agonist,,f,,,pKd,0,7.4,0,,0,0,0,,,,,11561071,NCCc1cnc[nH]1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,[<sup>3</sup>H](<i>R</i>)-&alpha;-methylhistamine,1237,,,135651165,Agonist,Full agonist,,f,,,pKd,0,7.2,0,,0,0,0,,,,,11179434,C[C@H](Cc1cnc[nH]1)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,VUF 8430,1274,,,135651314,Agonist,Full agonist,,f,f,,pKi,0,7.5,0,Ki,0,31.60000038,0,=,,,,17154494,NC(=N)SCCN=C(N)N
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,[<sup>3</sup>H]JNJ 7777120,1279,,,135651168,Antagonist,Antagonist,,f,,,pKd,0,8.4,0,Kd,0,3.6,0,=,,,,14722321,CN1CCN(CC1)C(=O)c1cc2c([nH]1)ccc(c2)Cl
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,[<sup>3</sup>H]pyrilamine,1220,,,135651192,Antagonist,Antagonist,,f,,,pKd,0,7.5,0,,0,0,0,,,,,11179435,COc1ccc(cc1)CN(c1ccc(cn1)[3H])CCN(C)C
H<sub>4</sub> receptor,265,Hrh4,Q91ZY1,,,,,,Rat,thioperamide,1267,,,135651258,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11561071,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,thioperamide,1267,,,135651258,Antagonist,Antagonist,Selective for H<sub>3</sub>/H<sub>4</sub> compared to H<sub>1</sub> and H<sub>3</sub>.,f,f,,pKi,7.599999905,0,6.300000191,-,0,0,0,=,,,,12606603,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>4</sub> receptor,265,Hrh4,Q91ZY2,,,,,,Mouse,thioperamide,1267,,,135651258,Antagonist,Antagonist,,f,,,pKi,0,7.6,0,,0,0,0,,,,,11561071,S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,toreforant,9276,,,318164795,Antagonist,Antagonist,,f,f,,pKi,0,7.079999924,0,Ki,0,83,0,=,Displacament of histamine from human H4 recepotor expressed in mammalian cells.,,,0,CN1CCC(CC1)CCCNc1ncc(c(n1)C)c1nc2c([nH]1)cc(cc2C)C
H<sub>4</sub> receptor,265,HRH4,Q9H3N8,,,,,,Human,ZPL-3893787,8985,,,310264765,Antagonist,Antagonist,,f,f,,pKi,0,8.31000042,0,-,0,0,0,=,,,,26084539,CN[C@@H]1CCN(C1)c1cc(NCC2CC2)nc(n1)N
H<sub>v</sub>1,746,HVCN1,Q96D96,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,pIC50,6.3,0,5.7,IC50,2000,0,500,~,,,,0,
"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",2622,,,,,,,,None,trilostane,6850,,,178103456,Inhibitor,Inhibition,Note that the species is not specified in the referenced article.,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,<i>In vitro</i> enzyme inhibition,,,6574022,N#CC1=C(O)[C@@H]2[C@]3([C@@](C1)(C)[C@H]1CC[C@]4([C@H]([C@@H]1CC3)CC[C@@H]4O)C)O2
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,UDP-galactose,1782,,,135651585,Agonist,Agonist,,t,,,pEC50,8.92,0,5.96,EC50,1100,0,1.2,=,[<sup>35</sup>S]GTP&gamma;S binding to 1321N1 cell membranes expressing hGPR17.,,,20148890,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@H]1O)O)O
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,UDP-galactose,1782,,,135651585,Agonist,Agonist,,t,,,pEC50,0,7.17,0,EC50,0,68,0,=,,,,18974869,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@H]1O)O)O
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,UDP-glucose,1783,,,135651586,Agonist,Agonist,,t,,,pEC50,9.52,0,5.92,EC50,1200,0,0.3,=,[<sup>35</sup>S]GTP&gamma;S binding to 1321N1 cell membranes expressing hGPR17.,,,20148890,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
<i>GPR17</i>,88,Gpr17,Q6NS65,,,,,,Mouse,UDP-glucose,1783,,,135651586,Agonist,Agonist,,t,,,pEC50,7.26,0,7.06,EC50,88,0,55,=,,,,18974869,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
<i>GPR17</i>,88,GPR17,Q13304,,,,,,Human,uridine diphosphate,1749,,,135651583,Agonist,Agonist,,t,,,pEC50,8.8,0,5.97,EC50,1060,0,1.6,=,[<sup>35</sup>S]GTP&gamma;S binding to 1321N1 cell membranes expressing hGPR17.,,,20148890,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
<i>GPR32</i>,99,GPR32,O75388,,,,,,Human,[<sup>3</sup>H]resolvin D1,4356,,,178101173,Agonist,Agonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,20080636,CC/C=CC[C@@H](/C=C/C=CC=CC=C[C@@H]([C@H](C/C=CCCC(=O)O)O)O)O
<i>GPR35</i>,102,GPR35,Q9HC97,,,,,,Human,zaprinast,2919,,,135651355,Agonist,Agonist,,f,,,pEC50,0,6.1,0,,0,0,0,,,,,16934253,CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2
<i>GPR35</i>,102,Gpr35,Q33BM1,,,,,,Rat,zaprinast,2919,,,135651355,Agonist,Agonist,,f,,,pEC50,0,7.8,0,,0,0,0,,,,,16934253,CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2
<i>GPR39</i>,105,GPR39,O43194,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,16959833,
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,[<sup>3</sup>H]CP55940,734,,,135651145,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,17876302,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,T1117,5560,,,178102198,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,20136833,Clc1ccc(c(c1)Cl)n1nc(c(c1c1ccc(cc1)c1ccc(cc1)CCCNC(=O)c1ccc2c(c1)C(=O)OC12c2ccc(cc2Oc2c1ccc(c2)N(C)C)N(C)C)C)C(=O)NN1CCCCC1
<i>GPR55</i>,109,GPR55,Q9Y2T6,,,,,,Human,[<sup>3</sup>H]rimonabant,745,,,135651209,Agonist,Partial agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,17876302,Clc1ccc(cc1)c1n(nc(c1C([3H])([3H])[3H])C(=O)NN1CCCCC1)c1ccc(cc1Cl)Cl
<i>GPR83</i>,119,Gpr83,P30731,,,,,,Mouse,Zn<sup>2+</sup>,566,,,135652747,Agonist,Full agonist,,f,f,,pEC50,0,5,0,EC50,0,10200,0,=,,,,23335960,
<i>GPR84</i>,120,GPR84,Q9NQS5,,,,,,Human,undecanoic acid,5533,,,178102175,Agonist,Agonist,,f,,,pEC50,0,5.1,0,EC50,0,8000,0,=,,,,16966319,CCCCCCCCCCC(=O)O
IL2 inducible T cell kinase,2046,ITK,Q08881,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,7.369999886,0,Kd,0,43,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
<i>MAS1</i>,150,Mas1,P30554,,,,,,Mouse,"[<sup>125</sup>I]angiotensin-(1-7) (human, mouse, rat)",5578,,,178102214,Agonist,Full agonist,,f,,,pKd,0,9.08,0,Kd,0,0.83,0,=,,,,12829792,
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,substance P,2098,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651888,Agonist,Agonist,,f,f,,pEC50,0,5.96999979,0,EC50,0,1071,0,=,In a calcium mobilisation asay.,,,28288109,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
<i>MRGPRX2</i>,157,MRGPRX2,Q96LB1,,,,,,Human,TAN-67,9567,,,336446953,Agonist,Agonist,,f,f,,pEC50,0,5.739999771,0,EC50,0,1820,0,=,"Assayed using racemic TAN-67, the more active stereoisomer is the (4aS,12aR).",,,23396314,CN1CC[C@]2([C@H](C1)Cc1c(C2)nc2c(c1)cccc2)c1cccc(c1)O
"indoleamine 2,3-dioxygenase 1",2829,IDO1,P14902,,,,,,Human,tryptanthrin,8224,,,249565904,Inhibitor,Inhibition,,f,f,,pKi,0,5.320000172,0,Ki,0,4810,0,=,,,,24099220,O=C1c2nc3ccccc3c(=O)n2c2c1cccc2
inosine monophosphate dehydrogenase 1,2624,IMPDH1,P20839,,,,,,Human,thioguanine,6845,,,178103451,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,18609073,Nc1nc(=S)c2c([nH]1)nc[nH]2
inosine monophosphate dehydrogenase 2,2625,IMPDH2,P12268,,,,,,Human,thioguanine,6845,,,178103451,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,18609073,Nc1nc(=S)c2c([nH]1)nc[nH]2
integrin &alpha;2&beta;1,2578,ITGA2|ITGB1,P05556|P08514,,,,,,Human,TCI15,6582,,,178103196,Inhibitor,Inhibition,,f,,,pIC50,0,7.9,0,-,0,0,0,=,,,,19141632,O=C(NC[C@@H](C(=O)O)NC(=O)[C@@H]1N(CSC1(C)C)S(=O)(=O)c1ccccc1)NCc1ccccc1
integrin &alpha;4&beta;1,2580,ITGA4|ITGB1,P05556|P13612,,,,,,Human,TCS2314,6590,,,178103203,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(Nc1ccccc1C)Nc1ccc(cc1)CC(=O)N1CCOC[C@H]1C(=O)N1CCC(CC1)CC(=O)O
integrin &alpha;4&beta;7,2770,ITGA4|ITGB7,P13612|P26010,,,,,,Human,vedolizumab,7437,,,178104009,Antibody,Antagonist,,f,t,,pIC50,0,8.270000458,0,IC50,0,5.340000153,0,=,Binding to HuT-78 cells,,,0,
integrin &alpha;IIb&beta;3,2579,ITGA2B|ITGB3,P05106|P17301,,,,,,Human,tirofiban,6586,,,178103199,Inhibitor,Inhibition,,f,t,,pIC50,0,9.430000305,0,IC50,0,0.370000005,0,=,Displacement of biotinylated fibrinogen from human integrin &alpha;IIb&beta;3.,,,23644213,CCCCS(=O)(=O)N[C@H](C(=O)O)Cc1ccc(cc1)OCCCCC1CCNCC1
integrin &alpha;V&beta;3,2583,ITGAV|ITGB3,P05106|P06756,,,,,,Human,TP508,9284,,,318164803,Activator,Activation,,f,f,,pKd,0,7.860000134,0,Kd,0,13.80000019,0,=,Measured using imobilised TP508 in surface plasmon resonance studies.,,,20508901,
interleukin 1 receptor associated kinase 1,2042,IRAK1,P51617,,,,,,Human,Takinib,9655,,,348353615,Inhibitor,Inhibition,,f,f,,pIC50,0,6.409999847,0,IC50,0,390,0,=,,,,28820959,CCCn1/c(=N/C(=O)c2cccc(c2)C(=O)N)/[nH]c2c1cccc2
interleukin 1 receptor associated kinase 4,2045,IRAK4,Q9NWZ3,,,,,,Human,Takinib,9655,,,348353615,Inhibitor,Inhibition,,f,f,,pIC50,0,6.920000076,0,IC50,0,120,0,=,,,,28820959,CCCn1/c(=N/C(=O)c2cccc(c2)C(=O)N)/[nH]c2c1cccc2
Interleukin-5 receptor,2308,CSF2RB|IL5RA,P32927|Q01344,,,,,,Human,YM90709,5090,,,178101783,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,12469943,COc1cc2c(cc1OC)CC(n1c2cc2c1nc1c(n2)cccc1)(C)C
Interleukin-6 receptor,2310,IL6R|IL6ST,P40189|P08887,,,,,,Human,tocilizumab,6881,,,178103463,Antibody,Binding,,f,t,,pKd,0,8.600000381,0,Kd,0,2.539999962,0,=,,,,0,
Interleukin-6 receptor,2310,IL6R|IL6ST,P40189|P08887,,,,,,Human,vobarilizumab,8363,,,252166575,Antibody,Binding,,f,t,,pKd,0,12.72000027,0,Kd,0,0.00019,0,=,,,,25994180,
IP receptor,345,Ptgir,P43253,,,,,,Rat,[<sup>3</sup>H]iloprost,1966,,,135651161,Agonist,Full agonist,,f,f,,pKd,0,8.899999619,0,-,0,0,0,=,,,,7803522,CC#CCC([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2[3H])O)C
IP receptor,345,Ptgir,P43252,,,,,,Mouse,[<sup>3</sup>H]iloprost,1966,,,135651161,Agonist,Full agonist,,f,,,pKd,0,8.3,0,,0,0,0,,,,,7511597,CC#CCC([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2[3H])O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,[<sup>3</sup>H]iloprost,1966,,,135651161,Agonist,Full agonist,,f,f,,pKd,9,0,7.699999809,Kd,20,0,1,=,,,,16604093,CC#CCC([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2[3H])O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,taprostene,1968,,,135651236,Agonist,Full agonist,,f,,,pIC50,0,6.9,0,,0,0,0,,,,,9156364,O[C@@H]1C[C@H]2[C@@H]([C@H]1/C=C/[C@H](C1CCCCC1)O)C/C(=C/c1cccc(c1)C(=O)O)/O2
IP receptor,345,PTGIR,P43119,,,,,,Human,TEI-9063,1965,,,135651239,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,9156364,CCCC[C@@H](C[C@@H](/C=C/[C@H]1[C@H](O)CC2C1CC(=C2)CCCCC(=O)O)O)C
IP receptor,345,PTGIR,P43119,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,,f,t,,pEC50,0,8.720000267,0,-,0,0,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
IP receptor,345,PTGIR,P43119,,,,,,Human,treprostinil,5820,,,178102445,Agonist,Full agonist,,f,t,,pKi,0,7.489999771,0,-,0,0,0,=,,,,22480736,CCCCC[C@@H](CC[C@H]1[C@H](O)C[C@H]2[C@@H]1Cc1cccc(c1C2)OCC(=O)O)O
IP receptor,345,PTGIR,P43119,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,4.2,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
IP receptor,345,PTGIR,P43119,,,,,,Human,taprostene,1968,,,135651236,Agonist,Partial agonist,,f,,,pKd,0,9.11,0,Kd,0,0.769,0,=,,,,22480736,O[C@@H]1C[C@H]2[C@@H]([C@H]1/C=C/[C@H](C1CCCCC1)O)C/C(=C/c1cccc(c1)C(=O)O)/O2
IP receptor,345,PTGIR,P43119,,,,,,Human,TG6-129,9283,,,318164802,Antagonist,Antagonist,,f,f,,pKB,0,6.699999809,0,KB,0,199,0,=,,,,23914286,CCc1nnc(s1)NS(=O)(=O)c1ccc(cc1)NC(=S)NC(=O)/C=C/c1ccc(cc1)F
IP<sub>3</sub>R1,743,ITPR1,Q14643,,,,,,Human,xestospongin C,4344,,,178101161,Antagonist,Antagonist,&mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,C1CCC[C@@H]2CCCN3[C@@H]2O[C@@H](CCCCCC[C@@H]2[C@H]4O[C@@H](CC1)CCN4CCC2)CC3
<i>TAAR4P </i>,169,Taar4,Q5QD15,,,,,,Mouse,xylometazoline,517,,,135651336,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,20559446,Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C
<i>TAAR5</i>,170,Taar5,Q5QD14,,,,,,Mouse,trimethylamine,5521,,,178102164,Agonist,Full agonist,,f,,,pEC50,0,6.52,0,EC50,0,300,0,=,,,,16878137,CN(C)C
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,7.230000019,0,IC50,0,59,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,upadacitinib,9246,,,315661321,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,at 1uM ATP in a biochemical assay,,,0,CC[C@@H]1CN(C[C@@H]1c1cnc2n1c1cc[nH]c1nc2)C(=O)NCC(F)(F)F
Janus kinase 1,2047,JAK1,P23458,,,,,,Human,XL019,7971,,,249565654,Inhibitor,Inhibition,,f,f,,pIC50,0,6.869999886,0,IC50,0,134.3000031,0,=,,,,23127890,O=C([C@@H]1CCCN1)Nc1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,7.71999979,0,7.139999866,IC50,73,0,19,=,,,,22148278,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
Janus kinase 2,2048,JAK2,O60674,,,,,,Human,XL019,7971,,,249565654,Inhibitor,Inhibition,,f,t,,pIC50,0,8.659999847,0,IC50,0,2.200000048,0,=,,,,23127890,O=C([C@@H]1CCCN1)Nc1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,f,,pIC50,0,6.940000057,0,IC50,0,115,0,=,,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,tofacitinib,5677,,,178102304,Inhibitor,Inhibition,,f,t,,pIC50,9,0,6.679999828,IC50,210,0,1,=,,,,21105711,N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,tofacitinib,5677,,,178102304,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,27572962,N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C
Janus kinase 3,2049,JAK3,P52333,,,,,,Human,XL019,7971,,,249565654,Inhibitor,Inhibition,,f,f,,pIC50,0,6.670000076,0,IC50,0,214.1999969,0,=,,,,23127890,O=C([C@@H]1CCCN1)Nc1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,tramadol,8286,,,252166498,Agonist,Agonist,,f,f,,pKi,0,7.849999905,0,Ki,0,14,0,=,Displacement of the kappa agonist U69593  from the kappa receptor expressed in CHO cells.,,,19282177,COc1cccc(c1)C1(O)CCCCC1CN(C)C
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,U50488,1652,,,135651290,Agonist,Agonist,,f,f,,pKi,9.699999809,0,7.800000191,-,0,0,0,=,,,,9686407,O=C(N([C@@H]1CCCC[C@H]1N1CCCC1)C)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,UFP-512,9006,,,310264784,Agonist,Agonist,,f,f,,pKi,0,6.659999847,0,-,0,0,0,=,Measuring displacement of [<sup>3</sup>H]-diprenorphine <i>in vitro</i>,,,18069089,Oc1cc(C)c(c(c1)C)C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@H](c1[nH]c2c(n1)cccc2)CC(=O)O)N
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,[<sup>3</sup>H]enadoline,3475,,,178100466,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,11239918,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1cccc2c1cco2
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,[<sup>3</sup>H]U69593,1656,,,135651213,Agonist,Full agonist,,f,,,pKd,8.8,0,8.7,Kd,2,0,1.6,=,,,,7624359,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccccc1
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,tifluadom,1667,,,135651262,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,9262330,O=C(c1ccsc1)NCC1CN=C(c2c(N1C)cccc2)c1ccccc1F
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,U69593,1655,,,135651293,Agonist,Full agonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,9686407,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccccc1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,U69593,1655,,,135651293,Agonist,Full agonist,,f,,,pIC50,0,8.6,0,,0,0,0,,,,,8393575,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccccc1
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,U69593,1655,,,135651293,Agonist,Full agonist,,f,,,pKi,8.7,0,8,,0,0,0,,,,,8240267,O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccccc1
&kappa; receptor,318,Oprk1,P33534,,,,,,Mouse,U50488,1652,,,135651290,Agonist,Partial agonist,,f,,,pIC50,0,9,0,,0,0,0,,,,,8393575,O=C(N([C@@H]1CCCC[C@H]1N1CCCC1)C)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,Oprk1,P34975,,,,,,Rat,U50488,1652,,,135651290,Agonist,Partial agonist,,f,,,pKi,8.7,0,8.2,,0,0,0,,,,,8240267,O=C(N([C@@H]1CCCC[C@H]1N1CCCC1)C)Cc1ccc(c(c1)Cl)Cl
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,[<sup>3</sup>H]diprenorphine,1612,,,135651148,Antagonist,Antagonist,,f,f,,pKd,0,9.100000381,0,Kd,0,0.79400003,0,=,,,,7624359,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(C(C1[3H])[3H])CC1CC1)ccc2O
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,zyklophin,9193,,,315661272,Antagonist,Antagonist,,f,t,,pKB,0,7.079999924,0,KB,0,83.90000153,0,=,Schild analysis of zyklophin vs. Dynorphin A-(1-13)NH2,,,15999987,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NCc2ccccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(CC)C)CCCN=C(N)N)CCCN=C(N)N
&kappa; receptor,318,OPRK1,P41145,,,,,,Human,zyklophin,9193,,,315661272,Antagonist,Antagonist,,f,t,,pKi,0,7.519999981,0,Ki,0,30.29999924,0,=,,,,15999987,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NCc2ccccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(CC)C)CCCN=C(N)N)CCCN=C(N)N
K-Cl cotransporter 2,972,SLC12A5,Q9H2X9,,,,,,Human,VU0240551,4665,,,178101380,Inhibitor,Inhibition,,f,f,,pIC50,0,6.25,0,IC50,0,560,0,=,,,,19279215,O=C(Nc1scc(n1)C)CSc1ccc(nn1)c1ccccc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,SU11652,6043,,,178102665,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,12646019,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(Cl)cc2)CC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,16891463,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,t,,pKd,0,8.640000343,0,Kd,0,2.299999952,0,=,,,,22037378,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,f,,pIC50,0,7.650000095,0,IC50,0,22.60000038,0,=,,,,20570526,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,f,,pIC50,0,6.869999886,0,IC50,0,135,0,=,Measured in a caliper-based electrophoretic mobility shift assay.,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,tesevatinib,7944,,,249565627,Inhibitor,Inhibition,,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,17575237,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,tivozanib,6058,,,178102679,Inhibitor,Inhibition,,f,t,,pIC50,0,9.800000191,0,IC50,0,0.159999996,0,=,,,,23098265,COc1cc2c(ccnc2cc1OC)Oc1ccc(c(c1)Cl)NC(=O)Nc1noc(c1)C
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,vandetanib,5717,,,178102343,Inhibitor,Inhibition,,f,f,,pIC50,0,8,0,IC50,0,9,0,=,,,,15743202,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,vatalanib,5705,,,178102332,Inhibitor,Inhibition,,f,t,,pIC50,0,7.679999828,0,IC50,0,21,0,=,,,,16321531,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,vatalanib,5705,,,178102332,Inhibitor,Inhibition,,f,t,,pKd,0,7.210000038,0,Kd,0,62,0,=,,,,22037378,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGFR2 inhibitor [WO2011060746],9769,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,7.679999828,0,IC50,0,21,0,=,In a biochemical assay using recombinant KDR kinase catalytic domain.,,,0,CN(CCNS(=O)(=O)Cc1cccc(c1)Nc1nccc(n1)Oc1ccc2c(c1)cc([nH]2)C)C
kinase insert domain receptor,1813,Kdr,P35918,,,,,,Mouse,VEGF receptor 2 kinase inhibitor I,6053,,,178102674,Inhibitor,Inhibition,,f,t,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,9651163,CCOC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cccc2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGF receptor 2 kinase inhibitor II,6054,,,178102675,Inhibitor,Inhibition,,f,t,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,10893303,Brc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)/C(=O)N2
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGF receptor 2 kinase inhibitor IV,6055,,,178102676,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,12443771,COc1ccc(cc1)c1cnc2n(c1)ncc2c1cscc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGF receptor tyrosine kinase inhibitor II,6056,,,178102677,Inhibitor,Inhibition,,f,f,,pKi,0,7.820000172,0,Ki,0,15,0,=,,,,17869515,Clc1ccc(cc1)NC(=O)c1ccccc1NCc1ccncc1
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGF receptor tyrosine kinase inhibitor III,6057,,,178102678,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,18077363,CCCNC(=O)Nc1ccc(cc1Cl)Oc1ncnc2c1cc(OC)c(c2)OC
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,ZM-306416,8245,,,249565925,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,10639280,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1F)Cl
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGFA,5085,VEGFA,Human,178101778,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGFC,5087,VEGFC,Human,178101780,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
kinase insert domain receptor,1813,KDR,P35968,,,,,,Human,VEGFE,5089,PDGFC,Human,178101782,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,[<sup>125</sup>I]kisspeptin-10 (human),1281,,,135652526,Agonist,Full agonist,,f,,,pKd,0,8.7,0,Kd,0,1.9,0,=,,,,11457843,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,[<sup>125</sup>I]kisspeptin-13 (human),3792,,,178100641,Agonist,Full agonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,17023533,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,[<sup>125</sup>I]kisspeptin-14 (human),4013,,,178100839,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,17023533,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,[<sup>125</sup>I]kisspeptin-54 (human),1282,,,135652527,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,11385580,
kisspeptin receptor,266,KISS1R,Q969F8,,,,,,Human,[<sup>125</sup>I]Tyr<sup>45</sup>-kisspeptin-15,1280,,,135652567,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,=,,,,11385580,
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,SU11652,6043,,,178102665,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,,,,18077363,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(Cl)cc2)CC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,t,,pIC50,0,7.820000172,0,IC50,0,15,0,=,,,,16891463,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,f,,pIC50,0,7.880000114,0,IC50,0,13.10000038,0,=,,,,20570526,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,t,,pKd,0,9.430000305,0,Kd,0,0.370000005,0,=,,,,22037378,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
KIT proto-oncogene receptor tyrosine kinase,1805,KIT,P10721,,,,,,Human,tandutinib,5695,,,178102322,Inhibitor,Inhibition,,f,f,,pIC50,0,6.769999981,0,IC50,0,170,0,=,,,,12124172,COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
K<sub>Ca</sub>1.1,380,KCNMA1,Q12791,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CC[N+](CC)(CC)CC
K<sub>Ca</sub>1.1,380,Kcnma1,Q62976,,,,,,Rat,toxin BmP09,2306,,,135652671,Channel blocker,None,,f,,,pEC50,0,7.6,0,,0,0,0,,,,,15695820,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,tamapin,2319,,,135652595,Channel blocker,Antagonist,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,,,,12239213,
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,tubocurarine,2294,,,135652723,Channel blocker,Antagonist,,f,f,,pIC50,4.599999905,0,4.099999905,IC50,80000,0,25000,=,,,,8781233,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,UCL1848,2321,,,135651296,Channel blocker,Antagonist,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,10683185,C1CCNc2cc[n+](c3c2cccc3)CCCCC[n+]2ccc(NCC1)c1ccccc21
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,2.700000048,0,-,0,0,0,=,,,,20359520,CC[N+](CC)(CC)CC
K<sub>Ca</sub>2.1,381,KCNN1,Q92952,,,,,,Human,UCL1684,2320,,,135651295,Inhibitor,None,,f,f,,pIC50,0,9.100000381,0,IC50,0,0.800000012,0,=,,,,10696100,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,zoxazolamine,2327,,,135651368,Activator,Agonist,,f,f,100-600,pEC50,0,3.200000048,0,-,0,0,0,=,,,,10712246,Clc1ccc2c(c1)nc(o2)N
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,tamapin,2319,,,135652595,Channel blocker,Antagonist,,f,f,,pIC50,0,10.60000038,0,-,0,0,0,=,,,,12239213,
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,tubocurarine,2294,,,135652723,Channel blocker,Antagonist,,f,f,,pIC50,0,5.699999809,0,-,0,0,0,=,,,,10713270,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,tubocurarine,2294,,,135652723,Channel blocker,Antagonist,,f,f,,pIC50,5.599999905,0,4.800000191,-,0,0,0,=,,,,8781233,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,UCL1684,2320,,,135651295,Channel blocker,Antagonist,,f,f,,pIC50,0,9.399999619,0,-,0,0,0,=,,,,10696100,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1
K<sub>Ca</sub>2.2,382,Kcnn2,P70604,,,,,,Rat,UCL1848,2321,,,135651296,Channel blocker,Antagonist,,f,f,,pIC50,10,0,9.899999619,-,0,0,0,=,,,,14559917,C1CCNc2cc[n+](c3c2cccc3)CCCCC[n+]2ccc(NCC1)c1ccccc21
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,UCL1848,2321,,,135651296,Channel blocker,Antagonist,,f,f,,pIC50,0,9.600000381,0,-,0,0,0,=,,,,11278890,C1CCNc2cc[n+](c3c2cccc3)CCCCC[n+]2ccc(NCC1)c1ccccc21
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,2.700000048,0,-,0,0,0,=,,,,20359520,CC[N+](CC)(CC)CC
K<sub>Ca</sub>2.2,382,KCNN2,Q9H2S1,,,,,,Human,UCL1684,2320,,,135651295,Inhibitor,None,,f,f,,pIC50,0,9.600000381,0,-,0,0,0,=,,,,11278890,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,tamapin,2319,,,135652595,Channel blocker,Antagonist,,f,f,,pIC50,0,8.800000191,0,-,0,0,0,=,,,,12239213,
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,tubocurarine,2294,,,135652723,Channel blocker,Antagonist,,f,f,,pIC50,4.5,0,3.700000048,-,0,0,0,=,,,,11369031,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,UCL1684,2320,,,135651295,Channel blocker,Antagonist,,f,f,,pIC50,0,8.199999809,0,-,0,0,0,=,,,,11533126,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1
K<sub>Ca</sub>2.3,383,Kcnn3,P70605,,,,,,Rat,UCL1848,2321,,,135651296,Channel blocker,Antagonist,,f,f,,pIC50,0,8.699999809,0,-,0,0,0,=,,,,11533126,C1CCNc2cc[n+](c3c2cccc3)CCCCC[n+]2ccc(NCC1)c1ccccc21
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,2.700000048,0,-,0,0,0,=,,,,20359520,CC[N+](CC)(CC)CC
K<sub>Ca</sub>2.3,383,KCNN3,Q9UGI6,,,,,,Human,UCL1684,2320,,,135651295,Inhibitor,None,,f,f,,pIC50,9,0,8,-,0,0,0,=,,,,11278890,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1
K<sub>Ca</sub>3.1,384,KCNN4,O15554,,,,,,Human,TRAM-34,2336,,,135651273,Inhibitor,None,,f,f,,pKd,8,0,7.599999905,-,0,0,0,=,,,,10884437,Clc1ccccc1C(n1cccn1)(c1ccccc1)c1ccccc1
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,[<sup>125</sup>I]tertiapin Y1/K12/Q13,2382,,,135652558,Channel blocker,Antagonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,16906771,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,,f,f,,pKi,8.899999619,0,8.199999809,-,0,0,0,=,,,,16906771,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,,f,f,,pKi,0,8.699999809,0,-,0,0,0,=,,,,10572003,
K<sub>ir</sub>1.1,429,KCNJ1,P48048,,,,,,Human,tertiapin-Q,2383,,,135652601,Channel blocker,Inhibition,,f,f,,pIC50,0,8.899999619,0,-,0,0,0,=,,,,10572003,
K<sub>ir</sub>1.1,429,Kcnj1,P35560,,,,,,Rat,VU591,7696,,,223366029,Channel blocker,Inhibition,,f,f,"3000-30,000",pKi,0,6.599999905,0,Ki,0,240,0,=,,,,20926757,[O-][N+](=O)c1ccc2c(c1)[nH]c(n2)COCc1nc2c([nH]1)cc(cc2)[N+](=O)[O-]
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,tenidap,2395,,,135651243,Activator,Agonist,,f,,,pEC50,6.4,0,5.89,,0,0,0,,,,,11821021,Clc1ccc2c(c1)/C(=C(c1cccs1)/O)/C(=O)N2C(=O)N
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,Antagonist,,f,,,pKi,0,4.21,0,,0,0,0,,,,,8051145,CC[N+](CC)(CC)CC
K<sub>ir</sub>2.3,432,KCNJ4,P48050,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,Antagonist,,f,,50-300,-,0,0,0,,0,0,0,,,,,7576658,
K<sub>ir</sub>3.1,434,Kcnj3,P63251,,,,,,Rat,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,,f,f,,pEC50,0,8,0,EC50,0,10,0,=,,,,9748337,
K<sub>ir</sub>3.1,434,,,,,,,,None,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,K<sub>ir</sub>3.1/3.4; expression in <i>Xenopus oocytes</i>,f,f,,pIC50,0,7.900000095,0,-,0,0,0,=,,,,10572004,
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,thioridazine,100,,,135651259,Gating inhibitor,Antagonist,,f,,,pEC50,0,4.2,0,,0,0,0,,,,,10780978,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1
K<sub>ir</sub>3.2,435,Kcnj6,P48542,,,,,,Mouse,verapamil,2406,,,135651305,Gating inhibitor,Antagonist,,f,f,,pIC50,0,3.900000095,0,-,0,0,0,=,,,,8630252,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
K<sub>ir</sub>3.4,437,,,,,,,,None,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,K<sub>ir</sub>3.1/3.4,f,f,,pIC50,0,7.900000095,0,-,0,0,0,=,,,,10572004,
K<sub>ir</sub>3.4,437,Kcnj5,P48548,,,,,,Rat,tertiapin-Q,2383,,,135652601,Channel blocker,Antagonist,,f,,,pKi,0,8.1,0,,0,0,0,,,,,9748337,
K<sub>ir</sub>6.1,441,Kcnj8,P97794,,,,,,Mouse,uridine diphosphate,1749,,,135651583,Activator,Agonist,,f,,1000,-,0,0,0,,0,0,0,,,,,9130167,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
K<sub>ir</sub>6.1,441,KCNJ8,Q15842,,,,,,Human,tolbutamide,6848,,,178103454,Inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C
K<sub>ir</sub>6.2,442,Kcnj11,Q61743,,,,,,Mouse,tolbutamide,6848,,,178103454,Channel blocker,Antagonist,,f,f,,pIC50,0,4.5,0,-,0,0,0,=,,,,7502040,CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C
K<sub>ir</sub>6.2,442,Kcnj11,P70673,,,,,,Rat,tolbutamide,6848,,,178103454,Channel blocker,Antagonist,,f,f,500,-,0,0,0,-,0,0,0,=,,,,8798681,CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C
K<sub>ir</sub>6.2,442,KCNJ11,Q14654,,,,,,Human,tolbutamide,6848,,,178103454,Inhibitor,None,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C
K<sub>Na</sub>1.1,385,Kcnt1,Q9Z258,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,Antagonist,,f,f,,pIC50,2,0,1.700000048,-,0,0,0,=,,,,15979166,CC[N+](CC)(CC)CC
K<sub>Na</sub>1.2,386,Kcnt2,Q6UVM4,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,Inhibition,,f,f,1000-20000,-,0,0,0,-,0,0,0,=,,,,16687497,CC[N+](CC)(CC)CC
K<sub>Na</sub>1.2,386,KCNT2,Q6UVM3,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,Inhibition,,f,f,70000-150000,-,0,0,0,-,0,0,0,=,,,,16687497,CC[N+](CC)(CC)CC
K<SUB>v</SUB>10.1,570,KCNH1,O95259,,,,,,Human,terfenadine,2608,,,135651245,Channel blocker,None,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,15102940,OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
K<SUB>v</SUB>1.1,538,Kcna1,P16388,,,,,,Mouse,tetraethylammonium,2343,,,135651249,Channel blocker,Inhibition,,f,f,,pKd,0,3.5,0,Kd,0,300000,0,=,,,,7517498,CC[N+](CC)(CC)CC
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,VU0405601,7662,,,223365997,Activator,Activation,,f,f,,pEC50,5,0,4.900000095,-,0,0,0,=,,,,23033485,O=C(Nc1cccnc1)COc1ccc2c(c1Br)cccc2
K<SUB>v</SUB>11.1,572,KCNH2,Q12809,,,,,,Human,terfenadine,2608,,,135651245,Channel blocker,None,,f,f,,pIC50,0,7.300000191,0,IC50,0,56,0,=,,,,9395068,OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O
K<SUB>v</SUB>12.1,575,Kcnh8,P59111,,,,,,Mouse,Zn<sup>2+</sup>,566,,,135652747,Gating inhibitor,None,,f,f,,-,0,0,0,-,0,0,0,=,1 mM Zn<sup>2+</sup> slows activation 10-fold and shifts V0.5 for activation by ~+47 mV,,,19580749,
K<SUB>v</SUB>1.3,540,Kcna3,P16390,,,,,,Mouse,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pKd,0,2,0,Kd,0,10000000,0,=,,,,7517498,CC[N+](CC)(CC)CC
K<SUB>v</SUB>1.6,543,Kcna6,P17659,,,,,,Rat,[<sup>125</sup>I]&alpha;-DTX,2564,,,53801048,Channel blocker,None,,f,,,pKd,0,10.4,0,,0,0,0,,,,,11707459,
K<SUB>v</SUB>1.6,543,Kcna6,P17659,,,,,,Rat,[<sup>125</sup>I]BgK (W5Y / Y26F),2565,,,135652488,Channel blocker,None,,f,,,pKd,0,11.4,0,,0,0,0,,,,,11707459,
K<SUB>v</SUB>1.6,543,KCNA6,P17658,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,2.200000048,0,IC50,0,7000000,0,=,,,,2347305,CC[N+](CC)(CC)CC
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,tedisamil,2567,,,53801046,Channel blocker,None,,f,,,pIC50,0,4.7,0,,0,0,0,,,,,9488722,C1CCC2(C1)C1CN(CC2CN(C1)CC1CC1)CC1CC1
K<SUB>v</SUB>1.7,544,KCNA7,Q96RP8,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pKd,0,4.1,0,,0,0,0,,,,,11896454,CC[N+](CC)(CC)CC
K<SUB>v</SUB>1.7,544,Kcna7,Q17ST2,,,,,,Mouse,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pIC50,0,1.1,0,,0,0,0,,,,,9488722,CC[N+](CC)(CC)CC
K<SUB>v</SUB>1.7,544,KCNA7,Q96RP8,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,None,,f,,,pKd,0,4.8,0,,0,0,0,,,,,11896454,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pIC50,0,1.3,0,,0,0,0,,,,,10836990,CC[N+](CC)(CC)CC
K<SUB>v</SUB>1.8,545,KCNA10,Q16322,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,None,,f,,,pIC50,0,4.3,0,,0,0,0,,,,,10836990,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
K<SUB>v</SUB>2.1,546,Kcnb1,P15387,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,Pore blocker,,f,f,,pIC50,0,2,0,IC50,0,10000000,0,=,,,,16478442,CC[N+](CC)(CC)CC
K<SUB>v</SUB>2.2,547,KCNB2,Q92953,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,2.599999905,0,IC50,0,2600000,0,=,,,,9612272,CC[N+](CC)(CC)CC
K<SUB>v</SUB>3.1,548,Kcnc1,P15388,,,,,,Mouse,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,3.700000048,0,IC50,0,200000,0,=,,,,7517498,CC[N+](CC)(CC)CC
K<SUB>v</SUB>3.2,549,Kcnc2,P22462,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,4.199999809,0,IC50,0,63000,0,=,,,,11790809,CC[N+](CC)(CC)CC
K<SUB>v</SUB>3.2,549,Kcnc2,P22462,,,,,,Rat,verapamil,2406,,,135651305,Channel blocker,None,,f,,,pEC50,0,4.9,0,,0,0,0,,,,,10670415,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
K<SUB>v</SUB>3.3,550,Kcnc3,Q01956,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,3.900000095,0,IC50,0,140000,0,=,,,,1381835,CC[N+](CC)(CC)CC
K<SUB>v</SUB>3.4,551,Kcnc4,Q63734,,,,,,Rat,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,3.5,0,IC50,0,300000,0,=,,,,1840526,CC[N+](CC)(CC)CC
K<SUB>v</SUB>3.4,551,Kcnc4,Q63734,,,,,,Rat,thiopental,2579,,,135651257,Gating inhibitor,None,,f,,,pIC50,0,4,0,,0,0,0,,,,,16217144,CCCC(C1(CC)C(=O)NC(=S)NC1=O)C
K<SUB>v</SUB>4.1,552,KCND1,Q9NSA2,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pIC50,0,2,0,,0,0,0,,,,,12349911,CC[N+](CC)(CC)CC
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,zinc pyrithione,2597,,,135652752,Activator,None,,f,,10,pEC50,0,5,0,,0,0,0,,,,,17435769,[S-]c1cccc[n+]1[O-].[S-]c1cccc[n+]1[O-].[Zn+2]
K<SUB>v</SUB>7.1,560,KCNQ1,P51787,,,,,,Human,XE991,2596,,,135651334,Channel blocker,Antagonist,,f,f,,pKd,0,6.099999905,0,Kd,0,780,0,=,,,,10825393,O=C1c2ccccc2C(c2c1cccc2)(Cc1ccncc1)Cc1ccncc1
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,zinc pyrithione,2597,,,135652752,Activator,None,,f,,,pEC50,0,5.8,0,,0,0,0,,,,,17435769,[S-]c1cccc[n+]1[O-].[S-]c1cccc[n+]1[O-].[Zn+2]
K<SUB>v</SUB>7.2,561,,,,,,,,Unknown,ztz240,7668,,,223366003,Activator,None,,f,f,,pEC50,0,6.699999809,0,-,0,0,0,=,,,,20584905,Fc1ccc(cc1)C(=O)Nc1ccc(nc1)Cl
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,3.900000095,0,3.5,IC50,300000,0,130000,=,,,,10711337,CC[N+](CC)(CC)CC
K<SUB>v</SUB>7.2,561,KCNQ2,O43526,,,,,,Human,XE991,2596,,,135651334,Channel blocker,None,,f,f,,pIC50,0,6.150000095,0,IC50,0,710,0,=,,,,9836639,O=C1c2ccccc2C(c2c1cccc2)(Cc1ccncc1)Cc1ccncc1
K<SUB>v</SUB>7.3,562,KCNQ3,O43525,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pIC50,0,1.5,0,,0,0,0,,,,,10711337,CC[N+](CC)(CC)CC
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,zinc pyrithione,2597,,,135652752,Activator,None,,f,,,pEC50,0,5,0,,0,0,0,,,,,17435769,[S-]c1cccc[n+]1[O-].[S-]c1cccc[n+]1[O-].[Zn+2]
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,f,,pIC50,0,1.299999952,0,IC50,0,52000000,0,=,,,,18786918,CC[N+](CC)(CC)CC
K<SUB>v</SUB>7.4,563,KCNQ4,P56696,,,,,,Human,XE991,2596,,,135651334,Channel blocker,None,,f,f,,pIC50,0,5.300000191,0,IC50,0,5500,0,=,,,,11245603,O=C1c2ccccc2C(c2c1cccc2)(Cc1ccncc1)Cc1ccncc1
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,zinc pyrithione,2597,,,135652752,Activator,None,,f,,,pEC50,0,5,0,,0,0,0,,,,,17435769,[S-]c1cccc[n+]1[O-].[S-]c1cccc[n+]1[O-].[Zn+2]
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,tetraethylammonium,2343,,,135651249,Channel blocker,None,,f,,,pIC50,1.5,0,1.1,,0,0,0,,,,,10787416,CC[N+](CC)(CC)CC
K<SUB>v</SUB>7.5,564,KCNQ5,Q9NR82,,,,,,Human,XE991,2596,,,135651334,Channel blocker,None,,f,f,,pIC50,0,4.199999809,0,IC50,0,65000,0,=,,,,10816588,O=C1c2ccccc2C(c2c1cccc2)(Cc1ccncc1)Cc1ccncc1
"L3MBTL3, histone methyl-lysine binding protein",2830,L3MBTL3,Q96JM7,,,,,,Human,UNC1215,8232,,,249565912,Agonist,Agonist,,f,t,,pKd,0,6.920000076,0,Kd,0,120,0,=,,,,23292653,O=C(c1ccc(c(c1)Nc1ccccc1)C(=O)N1CCC(CC1)N1CCCC1)N1CCC(CC1)N1CCCC1
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,6.820000172,0,IC50,0,150,0,=,,,,17850214,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
"LCK proto-oncogene, Src family tyrosine kinase",2053,LCK,P06239,,,,,,Human,WH-4-023,8068,,,249565748,Inhibitor,Inhibition,,f,t,,pIC50,0,8.699999809,0,IC50,0,2,0,=,,,,16884310,COc1cc(OC)ccc1N(C(=O)Oc1c(C)cccc1C)c1ccnc(n1)Nc1ccc(cc1)N1CCN(CC1)C
leucine rich repeat kinase 2,2059,LRRK2,Q5S007,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,pIC50,0,7.960000038,0,IC50,0,11,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
Leukotriene C4 synthase,1391,LTC4S,Q16873,,,,,,Human,TK05,9556,,,336446942,Inhibitor,Inhibition,,f,t,,pKi,0,8.220000267,0,Ki,0,6,0,=,Using isolated human enzyme.,,,26283693,COc1ccc(cc1)C(=O)c1ccc(cc1C(=O)O)C(=O)c1ccc(cn1)N(c1ccc(cc1)Cl)CC1CC1
LH receptor,254,LHCGR,P22888,,,,,,Human,[<sup>125</sup>I]chorionic gonadotropin (human),3775,,,178100625,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
LH receptor,254,LHCGR,P22888,,,,,,Human,[<sup>125</sup>I]LH,3793,,,178100642,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
Liver X receptor-&alpha;,602,NR1H3,Q13133,,,,,,Human,T0901317,2755,,,135651223,Agonist,Agonist,,f,,,pEC50,0,7.3,0,,0,0,0,,,,,11090131,FC(CN(S(=O)(=O)c1ccccc1)c1ccc(cc1)C(C(F)(F)F)(C(F)(F)F)O)(F)F
Liver X receptor-&beta;,601,NR1H2,P55055,,,,,,Human,T0901317,2755,,,135651223,Agonist,Agonist,,f,,,pEC50,0,7.3,0,,0,0,0,,,,,11090131,FC(CN(S(=O)(=O)c1ccccc1)c1ccc(cc1)C(C(F)(F)F)(C(F)(F)F)O)(F)F
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,T13,6984,,,178103563,Agonist,Partial agonist,,f,f,,pEC50,0,6.300000191,0,EC50,0,500,0,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)O[C@@H]1COCC[C@@H]1OP(=O)(S[Na])O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,syn-BrP-LPA,6986,,,178103565,Antagonist,Antagonist,,f,f,,pIC50,0,6.190000057,0,IC50,0,648,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](C[C@H](P(=O)(O)O)Br)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,syn-BrP-LPA,6986,,,178103565,Antagonist,Antagonist,,f,f,,pKi,0,6.559999943,0,Ki,0,273,0,=,,,,19509223,CCCCCCCCCCCCCCCC(=O)OC[C@H](C[C@H](P(=O)(O)O)Br)O
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,VPC12249,2909,,,135651308,Antagonist,Antagonist,,f,f,,pKi,6.860000134,0,5.239999771,Ki,5700,0,137,=,,,,11723223,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,VPC32179,5450,,,178102101,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccn1)COP(=O)(O)[O-].[NH4+]
LPA<sub>1</sub> receptor,272,LPAR1,Q92633,,,,,,Human,VPC32183,2908,,,135651309,Antagonist,Antagonist,,f,,,pKi,0,7.75,0,,0,0,0,,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1cccnc1)COP(=O)(O)O
LPA<sub>1</sub> receptor,272,Lpar1,P61793,,,,,,Mouse,VPC32183,2908,,,135651309,Antagonist,Antagonist,,f,f,,pIC50,0,6.960000038,0,IC50,0,109,0,=,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1cccnc1)COP(=O)(O)O
LPA<sub>3</sub> receptor,274,Lpar3,Q9EQ31,,,,,,Mouse,T13,6984,,,178103563,Agonist,Agonist,,f,f,,pEC50,0,9.300000191,0,EC50,0,0.5,0,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)O[C@@H]1COCC[C@@H]1OP(=O)(S[Na])O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,VPC12249,2909,,,135651308,Antagonist,Antagonist,,f,f,,pKi,0,6.369999886,0,-,0,0,0,=,,,,11723223,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,VPC12249,2909,,,135651308,Antagonist,Antagonist,,f,f,,pIC50,6.369999886,0,5.190000057,IC50,6400,0,428,=,,,,18781939,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,VPC32179,5450,,,178102101,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccn1)COP(=O)(O)[O-].[NH4+]
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,VPC32183,2908,,,135651309,Antagonist,Antagonist,,f,f,,pIC50,0,6.760000229,0,IC50,0,175,0,=,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1cccnc1)COP(=O)(O)O
LPA<sub>3</sub> receptor,274,LPAR3,Q9UBY5,,,,,,Human,VPC32183,2908,,,135651309,Antagonist,Antagonist,,f,,,pIC50,0,6.76,0,,0,0,0,,,,,15125924,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1cccnc1)COP(=O)(O)O
LPA<sub>5</sub> receptor,124,LPAR5,Q9H1C0,,,,,,Human,TCLPA5,9500,,,329968439,Antagonist,Antagonist,,f,t,,pIC50,0,6.099999905,0,IC50,0,800,0,=,Inhibitor of KI6425-induced activation of a LPA5-RH7777 cell line.,,,22801643,COc1cccc(c1)n1nc(cc1c1ccc(c(c1)Cl)C1CCCCC1)C(=O)O
L-Tryptophan hydroxylase 1,1241,TPH1,P17752,,,,,,Human,telotristat ethyl,9490,,,329968430,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,26206858,CCOC(=O)[C@H](Cc1ccc(cc1)c1cc(nc(n1)N)O[C@@H](C(F)(F)F)c1ccc(cc1n1ccc(n1)C)Cl)N
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,tolimidone,9433,,,329968374,Allosteric modulator,Activation,,f,f,,pEC50,0,7.199999809,0,EC50,0,63,0,=,Measuring  induced increased the V(max) of Lyn.,,,22473614,Cc1cccc(c1)Oc1cnc(=O)[nH]c1
"LYN proto-oncogene, Src family tyrosine kinase",2060,LYN,P07948,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,6.889999866,0,IC50,0,130,0,=,,,,18077363,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
lysine demethylase 1A,2669,KDM1A,O60341,,,,,,Human,tranylcypromine,5281,,,178101964,Inhibitor,Inhibition,,f,f,,pIC50,0,4.400000095,0,IC50,0,39660,0,=,<i>In vitro</i> KDM1A demethylation assay using purified human KDM1A protein and dimethylated H3K4 peptide as substrate.,,,23386436,NC1CC1c1ccccc1
MATE2,1217,SLC47A2,Q86VL8,,,,,,Human,[<sup>14</sup>C]metformin,4503,,,178101231,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,17509534,CN(C(=N)N=C(N)N)C
MATE2,1217,SLC47A2,Q86VL8,,,,,,Human,[<sup>14</sup>C]TEA,4575,,,178101296,None,None,,f,,,-,0,0,0,,0,0,0,,,,,17509534,CC[N+](CC)(CC)CC
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,tamoxifen,1016,,,135651233,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,extracellular,0,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,toremifene,4325,,,178101142,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,extracellular,0,ClCC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,triflupromazine,4330,,,178101147,Activator,None,,f,,,-,0,0,0,,0,0,0,,,,extracellular,0,CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F)C
Maxi Cl<sup>-</sup>,709,,,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,f,,,pIC50,0,4.3,0,IC50,0,50000,0,,,,extracellular,18658230,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"[<sup>125</sup>I]MCH (human, mouse, rat)",1296,,,135652529,Agonist,Full agonist,,f,,,pKd,10.8,0,9.7,Kd,0.2,0,0.016,=,,,,10421367,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"[<sup>125</sup>I][Phe<sup>13</sup>,Tyr<sup>19</sup>]MCH",3844,,,178100685,Agonist,Full agonist,,f,,,pKd,0,9.2,0,Kd,0,0.7,0,=,,,,9434758,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,"[<sup>3</sup>H]MCH (human, mouse, rat)",3827,,,178100671,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,9434758,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,variant MCH,1302,,,135652632,Agonist,Full agonist,,f,,,pKi,6.6,0,6.5,,0,0,0,,,,,10421367,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,[<sup>125</sup>I](3-iodo-Tyr<sup>13</sup>)-MCH,1316,,,135652482,Antagonist,Antagonist,,f,,,pKd,9.4,0,9.2,-,0,0,0,=,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,[<sup>125</sup>I]S36057,1317,,,135652552,Antagonist,Antagonist,,f,,,pKd,9.5,0,9.2,Kd,0.63,0,0.32,=,,,,11375253,
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,[<sup>3</sup>H]SNAP-7941,1318,,,135651206,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,,0,0,0,,,,,12118247,COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)CC)c1ccc(c(c1)F)F
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,T-226296,1314,,,135651224,Antagonist,Antagonist,,f,f,,pIC50,0,8.300000191,0,IC50,0,5.010000229,0,=,,,,11909603,CN(CC1CCc2c(C1)ccc(c2)NC(=O)c1ccc(cc1)c1ccc(cc1)F)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,tetralin_urea analogue (7o),1319,,,135651251,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,17251014,N#Cc1ccc2c(c1)CC(CC2)N(C(=O)Nc1ccc(c(c1)Cl)F)CCCN1CCN(CC1)C
MCH<sub>1</sub> receptor,280,MCHR1,Q99705,,,,,,Human,TPI 1361-17,1315,,,135651272,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,19041642,Fc1cccc(c1)CCN1[C@@H](CCCN=C(N)N)CN(C1=S)[C@H](CNCc1ccccc1)C
"MCL1, BCL2 family apoptosis regulator",2847,MCL1,Q07820,,,,,,Human,venetoclax,8318,,,252166530,Antagonist,Antagonist,,f,f,,pKi,0,6.349999905,0,Ki,0,444,0,>,,,,23291630,Clc1ccc(cc1)C1=C(CCC(C1)(C)C)CN1CCN(CC1)c1ccc(c(c1)Oc1cnc2c(c1)cc[nH]2)C(=O)NS(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NCC1CCOCC1
MC<sub>1</sub> receptor,282,MC1R,Q01726,,,,,,Human,[<sup>125</sup>I]NDP-MSH,1326,,,135652532,Agonist,Full agonist,,f,,,pKd,0,9.5,0,Kd,0,0.33,0,=,,,,15840392,
MC<sub>2</sub> receptor,283,MC2R,Q01718,,,,,,Human,[<sup>125</sup>I]ACTH-(1-24),3767,,,178100617,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,[<sup>125</sup>I]NDP-MSH,1326,,,135652532,Agonist,Full agonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,15840392,
MC<sub>3</sub> receptor,284,MC3R,P41968,,,,,,Human,[<sup>125</sup>I]SHU9119,3804,,,178100651,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,12604699,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,[<sup>125</sup>I]NDP-MSH,1326,,,135652532,Agonist,Full agonist,,f,,,pKd,8.9,0,8.4,Kd,4,0,1.2,=,,,,15840392,
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,THIQ,1338,,,135651261,Agonist,Full agonist,,f,f,,pIC50,0,8.899999619,0,IC50,0,1.25999999,0,=,,,,12361385,O=C([C@@H]1NCc2c(C1)cccc2)N[C@@H](C(=O)N1CCC(CC1)(Cn1cncn1)C1CCCCC1)Cc1ccc(cc1)Cl
MC<sub>4</sub> receptor,285,MC4R,P32245,,,,,,Human,[<sup>125</sup>I]SHU9119,3804,,,178100651,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,Kd,0,0.7,0,=,,,,12604699,
MC<sub>5</sub> receptor,286,MC5R,P33032,,,,,,Human,[<sup>125</sup>I]NDP-MSH,1326,,,135652532,Agonist,Full agonist,,f,,,pKd,0,8.6,0,Kd,0,2.8,0,=,,,,15840392,
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,temsirolimus,5892,,,178102515,Inhibitor,Inhibition,,f,t,,pIC50,0,5.800000191,0,IC50,0,1760,0,=,,,,21438579,CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(CO)(CO)C)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,torin 1,8004,,,249565684,Inhibitor,Inhibition,,f,t,,pIC50,0,9.539999962,0,IC50,0,0.289999992,0,=,Assayed using mTORC1 complex,,,20860370,CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)n1c(=O)ccc2c1c1cc(ccc1nc2)c1cnc2c(c1)cccc2
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.809999943,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,vistusertib,7699,,,223366032,Inhibitor,Inhibition,,f,t,,pIC50,0,8.550000191,0,IC50,0,2.799999952,0,=,Assay using FLAG-tagged human mTOR(1362-2549),,,23375793,CNC(=O)c1cccc(c1)c1ccc2c(n1)nc(nc2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,VS-5584,8382,,,252166594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.429999828,0,IC50,0,37,0,=,,,,23270925,Nc1ncc(cn1)c1nc(nc2c1nc(n2C(C)C)C)N1CCOCC1
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,WYE-354,9361,,,328083463,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,DELFIA assay measuring His6-S6K1 T389 phosphorylation.,,,19584280,COC(=O)Nc1ccc(cc1)c1nc(N2CCOCC2)c2c(n1)n(nc2)C1CCN(CC1)C(=O)OC
mechanistic target of rapamycin kinase,2109,MTOR,P42345,,,,,,Human,XL388,7973,,,249565656,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,9.899999619,0,=,,,,23394126,Nc1ccc(cn1)c1ccc2c(c1)CN(CCO2)C(=O)c1ccc(c(c1C)F)S(=O)(=O)C
Methionyl aminopeptidase 2,1573,METAP2,P50579,,,,,,Human,XMT-1191,6486,,,178103100,Inhibitor,Inhibition,,f,,,pIC50,0,8,0,IC50,0,9,0,=,,,,0,CO[C@@H]1[C@@H](CC[C@@]2([C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)CO2)OC(=O)NCc1ccc(cc1)NC(=O)CCCC(=O)O
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,SU11274,5057,,,178101751,Inhibitor,Inhibition,,f,t,,pIC50,0,8,0,IC50,0,10,0,=,Assay used a GST fusion with the cytoplasmic domain of human Met.,,,14617781,CN1CCN(CC1)C(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(cc2)S(=O)(=O)N(c1cccc(c1)Cl)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,tanespimycin,7751,,,223366084,Inhibitor,Inhibition,,f,f,,pIC50,0,18,0,-,0,0,0,=,Measuring downstream uPA-plasmin inhibition.,,,15978816,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(C)/[C@@H]([C@H](/C=C/C=C(/C(=O)NC(=CC1=O)C2=O)C)OC)OC(=O)N
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,tepotinib,8293,,,252166505,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,Measured in a flash-plate assay using recombinant human c-Met kinase domain and a biotinylated peptide substrate.,,,23553846,N#Cc1cccc(c1)c1ccc(=O)n(n1)Cc1cccc(c1)c1ncc(cn1)OCC1CCN(CC1)C
"MET proto-oncogene, receptor tyrosine kinase",1815,MET,P08581,,,,,,Human,tivantinib,7948,,,249565631,Inhibitor,Inhibition,,f,t,,pKi,0,6.449999809,0,Ki,0,355,0,=,,,,20484018,O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2c1cccc2)c1cn2c3c1cccc3CCC2
mevalonate kinase,640,Mvk,P17256,,,,,,Rat,"trans,trans-farnesyl diphosphate",3050,,,135651580,Inhibitor,Feedback inhibition,,t,,,pKi,0,6.46,0,Ki,0,348,0,=,spectrophotometric in vitro assay,,,14679225,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CC/C=C(/CCC=C(C)C)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,"trans,trans-farnesyl diphosphate",3050,,,135651580,Inhibitor,Feedback inhibition,,t,,,pKi,0,7,0,Ki,0,101,0,=,recombinant enzyme expressed in E coli cells. Spectrophotometric assay,,,9392419,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CC/C=C(/CCC=C(C)C)C
mevalonate kinase,640,MVK,Q03426,,,,,,Human,"trans,trans-farnesyl diphosphate",3050,,,135651580,Inhibitor,Feedback inhibition,,t,,,pKi,0,7.47,0,Ki,0,34,0,=,"recombinant wild type enzyme expressed in E coli, in vitro spectrophotometric assay",,,18302342,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CC/C=C(/CCC=C(C)C)C
mevalonate kinase,640,Mvk,P17256,,,,,,Rat,"trans,trans-farnesyl diphosphate",3050,,,135651580,Inhibitor,Feedback inhibition,,t,,,pKi,0,5.6,0,Ki,0,2500,0,=,"in vitro, spectrophotometric assay",,,2153681,C/C(=CCOP(=O)(OP(=O)(O)O)O)/CC/C=C(/CCC=C(C)C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>3</sup>H]quisqualate,1370,,,135651194,Agonist,Full agonist,,f,,,pKd,7.7,0,7.5,,0,0,0,,,,,12695537,OC(=O)[C@H](Cn1oc(=O)[nH]c1=O)N
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>11</sup>C]MMTP,6212,,,178102833,Allosteric modulator,Negative,,f,,,pKi,0,9.22,0,Ki,0,0.6,0,=,,,,20494576,[11CH3]Oc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,[<sup>11</sup>C]MMTP,6212,,,178102833,Allosteric modulator,Negative,,f,,,pIC50,0,8.02,0,IC50,0,9.5,0,=,,,,20494576,[11CH3]Oc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(ccn1)N(C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,[<sup>18</sup>F]FITM,6213,,,178102834,Allosteric modulator,Negative,,f,,,pIC50,0,8.29,0,IC50,0,5.1,0,=,,,,21470858,CC(Nc1ncnc(c1)c1csc(n1)N(C(=O)c1ccc(cc1)[18F])C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>18</sup>F]FITM,6213,,,178102834,Allosteric modulator,Negative,,f,,,pKi,0,9.06,0,Ki,0,0.87,0,=,,,,21470858,CC(Nc1ncnc(c1)c1csc(n1)N(C(=O)c1ccc(cc1)[18F])C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>18</sup>F]FPIT,6392,,,178103008,Allosteric modulator,Negative,,f,,,pIC50,0,8.27,0,IC50,0,5.4,0,=,,,,21668889,CC(N1Cc2c(C1=O)ccc(c2)c1nnn(c1C)c1cccnc1[18F])C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,[<sup>18</sup>F]MK-1312,6334,,,178102952,Allosteric modulator,Negative,,f,,,pIC50,0,8.44,0,IC50,0,3.6,0,=,,,,20524178,CCCN1Cc2c(C1=O)ccc(c2)c1nnn(c1C)c1cccnc1[18F]
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,[<sup>3</sup>H]R214127,1391,,,135651195,Allosteric modulator,Negative,,f,,,pKd,0,9,0,,0,0,0,,,,,12695537,O=C(c1ccc2c(c1)cc1c(n2)OCCC1)Cc1ccccc1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>3</sup>H]YM298198,5392,,,178102050,Allosteric modulator,Negative,,f,,,pKd,0,7.49,0,Kd,0,32,0,=,,,,15976016,CN(C(=O)c1sc2n(c1C)c1c(n2)ccc(c1)N)C1CCCCC1
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,VU0469650,6337,,,178102955,Allosteric modulator,Negative,,f,,,pIC50,0,7,0,IC50,0,99,0,=,,,,23727046,N#Cc1ncccc1N1CCN([C@@H](C1)C)C(=O)C12CC3CC(C2)C(C(C1)C3)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,YM-202074,6361,,,178102979,Allosteric modulator,Negative,,f,,,pIC50,0,8.07,0,IC50,0,8.6,0,=,,,,18164695,COCCN(Cc1ccc2c(c1)nc1n2cc(s1)C(=O)N(C1CCCCC1)C)C
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,YM-202074,6361,,,178102979,Allosteric modulator,Negative,,f,,,pKi,0,7.7,0,Ki,0,20,0,=,,,,18164695,COCCN(Cc1ccc2c(c1)nc1n2cc(s1)C(=O)N(C1CCCCC1)C)C
mGlu<sub>1</sub> receptor,289,GRM1,Q13255,,,,,,Human,YM298198,1389,,,135651343,Allosteric modulator,Negative,,f,,,pIC50,0,6.92,0,IC50,0,120,0,=,,,,19559036,CN(C(=O)c1sc2n(c1C)c1c(n2)ccc(c1)N)C1CCCCC1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,YM298198,1389,,,135651343,Allosteric modulator,Negative,,f,f,,pIC50,0,7.800000191,0,-,0,0,0,=,,,,15976016,CN(C(=O)c1sc2n(c1C)c1c(n2)ccc(c1)N)C1CCCCC1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>3</sup>H]EM-TBPC,1390,,,135651152,Allosteric modulator,Positive,,f,,,pKd,0,8.2,0,,0,0,0,,,,,12509432,CCn1c(C)nc(c(c1=O)C#N)N1CCc2c(CC1)cccc2
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,VU-71,6207,,,178102828,Allosteric modulator,Positive,,f,,,pEC50,0,5.62,0,EC50,0,2400,0,=,,,,16099654,O=C(c1ccc(cc1)N(=O)=O)Nc1c(cnn1c1ccccc1)c1ccccc1
mGlu<sub>1</sub> receptor,289,Grm1,P23385,,,,,,Rat,[<sup>11</sup>C]JNJ-16567083,3418,,,178100424,Antagonist,Antagonist,,f,t,,pKi,0,9.06000042,0,Ki,0,0.870000005,0,=,,,,16078827,COC1CCC(CC1)C(=O)c1ccc2c(c1)cc(c(n2)[11CH3])CC
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,[<sup>3</sup>H]eglumegad,1396,,,135651173,Agonist,Full agonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,10884552,OC(=O)[C@H]1[C@H]2[C@@H]1[C@](CC2)(N)C(=O)O
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,"[<sup>3</sup>H]2,2,2-TEMPS",6328,,,178102946,Allosteric modulator,Positive,,f,,,pKd,0,8.38,0,Kd,0,4.2,0,=,,,,21470207,CCCC(Oc1cccc(c1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1)C
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,[<sup>3</sup>H]JNJ-40068782,6331,,,178102949,Allosteric modulator,Positive,,f,,,pKd,0,8,0,Kd,0,10,0,=,,,,23766542,N#Cc1c(ccn(c1=O)CC1CC1)N1CCC(CC1)c1ccccc1
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,[<sup>3</sup>H]JNJ-40068782,6331,,,178102949,Allosteric modulator,Positive,,f,,,pKd,0,7.92,0,Kd,0,12,0,=,,,,23766542,N#Cc1c(ccn(c1=O)CC1CC1)N1CCC(CC1)c1ccccc1
mGlu<sub>2</sub> receptor,290,Grm2,P31421,,,,,,Rat,THIIC,6259,,,178102879,Allosteric modulator,Positive,,f,,,pEC50,0,7.89,0,EC50,0,12.8,0,=,,,,20947638,Cn1cnc(c1)C(=O)NCc1ccc(cc1)COc1ccc(c(c1C(F)(F)F)O)C(=O)C(C)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,THIIC,6259,,,178102879,Allosteric modulator,Positive,,f,,,pEC50,0,7.65,0,EC50,0,22.5,0,=,,,,20947638,Cn1cnc(c1)C(=O)NCc1ccc(cc1)COc1ccc(c(c1C(F)(F)F)O)C(=O)C(C)C
mGlu<sub>2</sub> receptor,290,GRM2,Q14416,,,,,,Human,[<sup>3</sup>H]LY341495,1399,,,135651172,Antagonist,Antagonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,10530814,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,[<sup>3</sup>H]LY341495,1399,,,135651172,Agonist,Full agonist,,f,,,pKd,0,7.3,0,,0,0,0,,,,,10884552,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>3</sub> receptor,291,Grm3,P31422,,,,,,Rat,VU0463597,6225,,,178102846,Allosteric modulator,Negative,,f,,,pIC50,6.2,0,5.8,IC50,1500,0,660,=,,,,22607673,OC[C@@H]1CCCN(C1)C(=O)c1ccc(cc1)C#Cc1ccc(cc1)OC
mGlu<sub>3</sub> receptor,291,GRM3,Q14832,,,,,,Human,[<sup>3</sup>H]LY341495,1399,,,135651172,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,10530814,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,[<sup>3</sup>H]AP4,1412,,,135651136,Agonist,Full agonist,,f,,,pKd,0,6.3,0,,0,0,0,,,,,10187777,OC(=O)[C@H](CCP(=O)(O)O)N
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0001171,6228,,,178102849,Allosteric modulator,Positive,,f,,,pEC50,0,6.2,0,EC50,0,650,0,=,,,,19097893,Oc1ccc(cc1)/C=N/Nc1nc2ccccc2nc1C
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0080241,6227,,,178102848,Allosteric modulator,Positive,,f,,,pEC50,0,5.3,0,EC50,0,4600,0,=,,,,18793851,CC1CCCN(C1)c1ncnc2c1cnn2c1ccc(cc1C)C
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0092145,6229,,,178102850,Allosteric modulator,Positive,,f,,,pEC50,5.7,0,5.5,EC50,3000,0,1800,=,,,,19097893,Cc1ccc(cc1)N1C(Nc2c(C1=O)cccc2)C(c1ccccc1)C
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0155041,3323,,,178100356,Allosteric modulator,Positive,,f,f,,pEC50,0,6.099999905,0,EC50,0,798,0,=,,,,18664603,O=C([C@H]1CCCC[C@H]1C(=O)O)Nc1cc(Cl)cc(c1)Cl
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0359516,6230,,,178102851,Allosteric modulator,Positive,,f,,,pEC50,0,6.4,0,EC50,0,380,0,=,,,,20582156,O/N=C1/c2ccccc2OC2(C1C2)C(=O)Nc1ccccn1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0361737,3956,,,178100783,Allosteric modulator,Positive,,f,,,pEC50,0,6.6,0,EC50,0,240,0,=,,,,19469556,COc1cc(ccc1Cl)NC(=O)c1ccccn1
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,VU0364770,6234,,,178102855,Allosteric modulator,Positive,,f,,,pEC50,0,6.5,0,EC50,0,290,0,=,,,,22088953,Clc1cccc(c1)NC(=O)c1ccccn1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0364770,6234,,,178102855,Allosteric modulator,Positive,,f,,,pEC50,0,6,0,EC50,0,1100,0,=,,,,22088953,Clc1cccc(c1)NC(=O)c1ccccn1
mGlu<sub>4</sub> receptor,292,GRM4,Q14833,,,,,,Human,VU0400195,6233,,,178102854,Allosteric modulator,Positive,,f,,,pEC50,0,6.5,0,EC50,0,291,0,=,,,,21966889,O=C1C2[C@H]3C=C[C@@H]([C@H]2C(=O)N1c1ccc(cc1Cl)NC(=O)c1ccccn1)C3
mGlu<sub>4</sub> receptor,292,Grm4,P31423,,,,,,Rat,VU0400195,6233,,,178102854,Allosteric modulator,Positive,,f,,,pEC50,0,6.4,0,EC50,0,376,0,=,,,,21966889,O=C1C2[C@H]3C=C[C@@H]([C@H]2C(=O)N1c1ccc(cc1Cl)NC(=O)c1ccccn1)C3
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0092273,6421,,,178103037,Agonist,Agonist,,f,,,pEC50,0,5.89,0,EC50,0,1300,0,=,,,,22021324,OC1CCN(CC1)C(=O)c1ccc(cc1)C#Cc1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0424465,6411,,,178103027,Agonist,Agonist,,f,,,pEC50,0,6.77,0,EC50,0,171,0,=,,,,23140665,Fc1cccc(c1)C#Cc1ccc(nc1)C(=O)N[C@@H](C(O)(C)C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>14</sup>C]MTEP,1429,,,135651120,Allosteric modulator,Negative,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,12438526,Cc1sc[14c](n1)C#Cc1cccnc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>3</sup>H]CTEP,6408,,,178103024,Allosteric modulator,Negative,,f,,,pKd,0,8.82,0,Kd,0,1.5,0,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,Grm5,Q3UVX5,,,,,,Mouse,[<sup>3</sup>H]CTEP,6408,,,178103024,Allosteric modulator,Negative,,f,,,pKd,0,8.74,0,Kd,0,1.8,0,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,[<sup>3</sup>H]CTEP,6408,,,178103024,Allosteric modulator,Negative,,f,,,pKd,0,8.77,0,Kd,0,1.7,0,=,,,,21849627,Clc1nccc(c1)C#Cc1nc(n(c1C)c1ccc(cc1)OC(F)(F)F)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>3</sup>H]fenobam,1433,,,135651153,Allosteric modulator,Negative,,f,,,pKd,0,7.3,0,,0,0,0,,,,,16040814,O=C(NC1=NC(=O)CN1C)Nc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,[<sup>3</sup>H]fenobam,1433,,,135651153,Allosteric modulator,Negative,,f,,,pKd,0,7.5,0,,0,0,0,,,,,16040814,O=C(NC1=NC(=O)CN1C)Nc1cccc(c1)Cl
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>3</sup>H]methoxymethyl-MTEP,5394,,,178102051,Allosteric modulator,Negative,,f,,,pKd,0,7.7,0,Kd,0,20,0,=,,,,12565928,COCc1cncc(c1)C#Cc1csc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>3</sup>H]methoxy-PEPy,6425,,,178103041,Allosteric modulator,Negative,,f,,,pKd,0,8.47,0,Kd,0,3.4,0,=,,,,12565928,C([3H])(Oc1cncc(c1)C#Cc1ccccn1)([3H])[3H]
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,[<sup>3</sup>H]M-MPEP,1425,,,135651179,Allosteric modulator,Negative,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,12920211,COc1cccc(c1)C#Cc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,[<sup>3</sup>H]M-MPEP,1425,,,135651179,Allosteric modulator,Negative,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,11814808,COc1cccc(c1)C#Cc1cccc(n1)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0285683,6398,,,178103014,Allosteric modulator,Negative,,f,,,pKi,0,7.8,0,Ki,0,16,0,=,,,,20923853,N#Cc1cc(F)cc(c1)c1onc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0285683,6398,,,178103014,Allosteric modulator,Negative,,f,,,pIC50,0,7.61,0,IC50,0,24.4,0,=,,,,20923853,N#Cc1cc(F)cc(c1)c1onc(n1)c1ccccn1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0366058,6438,,,178103054,Allosteric modulator,Negative,,f,,,pKi,0,7.08,0,Ki,0,84,0,=,,,,22267125,N#Cc1cnc(nc1c1ccc(cc1)F)Nc1nc2c(o1)cccc2
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0366058,6438,,,178103054,Allosteric modulator,Negative,,f,,,pIC50,0,7.04,0,IC50,0,91,0,=,,,,22267125,N#Cc1cnc(nc1c1ccc(cc1)F)Nc1nc2c(o1)cccc2
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0463841,6393,,,178103009,Allosteric modulator,Negative,,f,,,pEC50,0,7.89,0,EC50,0,13,0,=,,,,23682684,N#Cc1cc(NC(=O)Nc2ccc(cn2)Cl)cc(c1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0463841,6393,,,178103009,Allosteric modulator,Negative,,f,,,pIC50,0,7.9,0,IC50,0,13,0,=,,,,23682684,N#Cc1cc(NC(=O)Nc2ccc(cn2)Cl)cc(c1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0092273,6421,,,178103037,Allosteric modulator,Positive,,f,,,pEC50,0,7.46,0,EC50,0,35,0,=,,,,22021324,OC1CCN(CC1)C(=O)c1ccc(cc1)C#Cc1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0240382,6422,,,178103038,Allosteric modulator,Positive,,f,,,pEC50,0,7.41,0,EC50,0,39,0,=,,,,22021324,O=C1NCCc2c1ccc(c2)C#Cc1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0357121,6399,,,178103015,Allosteric modulator,Positive,,f,,,pEC50,0,7.48,0,EC50,0,33,0,=,,,,20981342,CCCCOc1ccc(cc1)C(=O)Nc1ccc(cc1F)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0360172,6400,,,178103016,Allosteric modulator,Positive,,f,,,pKi,0,6.71,0,Ki,0,195,0,=,,,,20923853,Fc1cccc(c1)C#Cc1ccc(cn1)C(=O)NC1CCC1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0360172,6400,,,178103016,Allosteric modulator,Positive,,f,,,pEC50,0,7.8,0,EC50,0,16,0,=,,,,20923853,Fc1cccc(c1)C#Cc1ccc(cn1)C(=O)NC1CCC1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0361747,6423,,,178103039,Allosteric modulator,Positive,,f,,,pEC50,0,6.9,0,EC50,0,126,0,=,,,,22021324,OC1CCN(CC1)C(=O)c1ccc(nc1)C#Cc1cccc(c1)F
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0364289,6424,,,178103040,Allosteric modulator,Positive,,f,,,pEC50,0,5.8,0,EC50,0,1600,0,=,,,,23308336,N#Cc1ccccc1N1CCN(CC1)C(=O)COCc1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,VU0404251,6410,,,178103026,Allosteric modulator,Positive,,f,,,pEC50,0,7.15,0,EC50,0,70,0,=,,,,22981332,Fc1cccc(c1)COc1ccc(cn1)C(=O)N[C@@H](C(C)(C)C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0404251,6410,,,178103026,Allosteric modulator,Positive,,f,,,pEC50,0,8.14,0,EC50,0,7.2,0,=,,,,22981332,Fc1cccc(c1)COc1ccc(cn1)C(=O)N[C@@H](C(C)(C)C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU0424465,6411,,,178103027,Allosteric modulator,Positive,,f,,,pEC50,0,8.82,0,EC50,0,1.5,0,=,,,,23140665,Fc1cccc(c1)C#Cc1ccc(nc1)C(=O)N[C@@H](C(O)(C)C)C
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU-1545,4059,,,178100883,Allosteric modulator,Positive,,f,,,pKi,0,6.81,0,Ki,0,156,0,=,,,,16722652,O=C(c1ccc(cc1)[N+](=O)[O-])Nc1cc(nn1c1ccccc1F)c1ccccc1
mGlu<sub>5</sub> receptor,293,GRM5,P41594,,,,,,Human,VU-1545,4059,,,178100883,Allosteric modulator,Positive,,f,,,pEC50,0,8,0,EC50,0,9.6,0,=,,,,16722652,O=C(c1ccc(cc1)[N+](=O)[O-])Nc1cc(nn1c1ccccc1F)c1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU-29,6403,,,178103019,Allosteric modulator,Positive,,f,,,pEC50,0,8.05,0,EC50,0,9,0,=,,,,17303702,O=C(c1ccc(cc1)N(=O)=O)Nc1cc(nn1c1ccccc1)c1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,VU-29,6403,,,178103019,Allosteric modulator,Positive,,f,,,pKi,0,6.61,0,Ki,0,244,0,=,,,,17303702,O=C(c1ccc(cc1)N(=O)=O)Nc1cc(nn1c1ccccc1)c1ccccc1
mGlu<sub>5</sub> receptor,293,Grm5,P31424,,,,,,Rat,[<sup>11</sup>C]JNJ-16567083,3418,,,178100424,Antagonist,Antagonist,,f,f,,pKi,0,5.630000114,0,Ki,0,2366,0,=,,,,16078827,COC1CCC(CC1)C(=O)c1ccc2c(c1)cc(c(n2)[11CH3])CC
mGlu<sub>6</sub> receptor,294,GRM6,O15303,,,,,,Human,[<sup>3</sup>H]LY341495,1399,,,135651172,Antagonist,Antagonist,,f,,,pEC50,0,4.5,0,,0,0,0,,,,,11138847,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>6</sub> receptor,294,,,,,,,,Unknown,THPG,3326,,,178100359,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,9144637,OC(=O)CNc1cc(O)c(c(c1)O)O
mGlu<sub>7</sub> receptor,295,Grm7,P35400,,,,,,Rat,VU6010608,9703,,,348353662,Allosteric modulator,Negative,,f,t,,pIC50,0,6.119999886,0,IC50,0,759,0,=,IN a clacium mobilization assay using rat mGlu<sub>7</sub>/G<sub>&alpha;15</sub>/HEK cells activated by the agonist L-AP4.,,,0,COc1ccc(cc1OC)C(=O)Nc1cc(ccc1n1ncnc1)OC(F)(F)F
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,XAP044,8545,,,252166746,Allosteric modulator,Negative,,f,t,,pIC50,0,5.550000191,0,IC50,0,2800,0,=,Inhibition of agonist-induced [<sup>35</sup>S]GTP&gamma;S binding.,,,24596089,Ic1ccc(cc1)Oc1coc2c(c1=O)ccc(c2)O
mGlu<sub>7</sub> receptor,295,GRM7,Q14831,,,,,,Human,[<sup>3</sup>H]LY341495,1399,,,135651172,Antagonist,Antagonist,,f,,,pKd,0,7.1,0,,0,0,0,,,,,11138847,O=c1[nH]c(=O)c2c([nH]1)n(cn2)C[C@@]([C@H]1C[C@@H]1C(=O)O)(C(=O)O)N
mGlu<sub>8</sub> receptor,296,GRM8,O00222,,,,,,Human,[<sup>3</sup>H]AP4,1412,,,135651136,Agonist,Full agonist,,f,,,pKd,6.7,0,6.6,,0,0,0,,,,,10216218,OC(=O)[C@H](CCP(=O)(O)O)N
Mineralocorticoid receptor,626,Nr3c2,P22199,,,,,,Rat,[<sup>3</sup>H]aldosterone,3452,,,178100450,Agonist,Agonist,,f,,,pKd,9.52,0,9.4,Kd,0.4,0,0.3,=,,,,6320679,OCC(=O)[C@H]1CC[C@@H]2[C@]1(C=O)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
Mineralocorticoid receptor,626,NR3C2,P08235,,,,,,Human,ZK112993,3448,,,178100448,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC#C[C@]1(O)CC[C@H]2[C@]1(C)C[C@H](c1ccc(cc1)C(=O)C)C1=C3CCC(=O)C=C3CC[C@@H]21
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,ulixertinib,9210,,,315661286,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,<,Biochemical assay determination,,,25977981,OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1cc(ncc1Cl)NC(C)C
mitogen-activated protein kinase 1,1495,MAPK1,P28482,,,,,,Human,VTX-11e,9375,,,328083477,Inhibitor,Inhibition,,f,t,,pKi,0,8.699999809,0,Ki,0,2,0,<,,,,19827834,OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1nc(ncc1C)Nc1ccc(cc1Cl)F
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,TAK-715,9328,,,318164847,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,16162000,CCc1nc(c(s1)c1ccnc(c1)NC(=O)c1ccccc1)c1cccc(c1)C
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,talmapimod,7817,,,223366148,Inhibitor,Inhibition,,f,t,,pIC50,0,7.010000229,0,IC50,0,98,0,=,,,,20071169,Fc1ccc(cc1)CN1C[C@@H](C)N(C[C@@H]1C)C(=O)c1cc2c(cn(c2cc1Cl)C)C(=O)C(=O)N(C)C
mitogen-activated protein kinase 11,1500,MAPK11,Q15759,,,,,,Human,VX-702,6059,,,178102680,Inhibitor,Inhibition,,f,t,,pKd,0,7.769999981,0,Kd,0,17,0,=,,,,19950901,Fc1ccc(c(c1)F)c1nc(ccc1C(=O)N)N(c1c(F)cccc1F)C(=O)N
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,TAK-715,9328,,,318164847,Inhibitor,Inhibition,,f,t,,pIC50,0,8.149999619,0,IC50,0,7.099999905,0,=,,,,16162000,CCc1nc(c(s1)c1ccnc(c1)NC(=O)c1ccccc1)c1cccc(c1)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,talmapimod,7817,,,223366148,Inhibitor,Inhibition,,f,t,,pIC50,0,8.050000191,0,IC50,0,9,0,=,,,,20071169,Fc1ccc(cc1)CN1C[C@@H](C)N(C[C@@H]1C)C(=O)c1cc2c(cn(c2cc1Cl)C)C(=O)C(=O)N(C)C
mitogen-activated protein kinase 14,1499,MAPK14,Q16539,,,,,,Human,VX-702,6059,,,178102680,Inhibitor,Inhibition,,f,t,,pKd,0,8.430000305,0,Kd,0,3.700000048,0,=,,,,19950901,Fc1ccc(c(c1)F)c1nc(ccc1C(=O)N)N(c1c(F)cccc1F)C(=O)N
mitogen-activated protein kinase 3,1494,MAPK3,P27361,,,,,,Human,ulixertinib,9210,,,315661286,Inhibitor,Inhibition,,f,f,,pIC50,0,9.520000458,0,IC50,0,0.300000012,0,<,Biochemical assay determination,,,25977981,OC[C@H](c1cccc(c1)Cl)NC(=O)c1[nH]cc(c1)c1cc(ncc1Cl)NC(C)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,XMD17-109,9406,,,328083508,Inhibitor,Inhibition,,f,t,,pIC50,0,6.789999962,0,IC50,0,162,0,=,In a cell-free biochemical assay.,,,24239623,CCOc1cc(ccc1Nc1ncc2c(n1)n(C1CCCC1)c1ccccc1c(=O)n2C)C(=O)N1CCC(CC1)N1CCN(CC1)C
mitogen-activated protein kinase 7,2093,MAPK7,Q13164,,,,,,Human,XMD8-92,8057,,,249565737,Inhibitor,Inhibition,,f,t,,pKd,0,7.099999905,0,Kd,0,80,0,=,,,,20832753,CCOc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)N1CCC(CC1)O
mitogen-activated protein kinase kinase 1,2062,MAP2K1,Q02750,,,,,,Human,trametinib,6495,,,178103109,Inhibitor,Inhibition,,f,t,,pIC50,9.149999619,0,9.039999962,IC50,0.920000017,0,0.699999988,=,Inhibition of unphosphorylated MEK1.,,,21245089,CC(=O)Nc1cccc(c1)n1c(=O)n(C2CC2)c(=O)c2c1c(C)c(=O)n(c2Nc1ccc(cc1F)I)C
mitogen-activated protein kinase kinase 2,2063,MAP2K2,P36507,,,,,,Human,trametinib,6495,,,178103109,Inhibitor,Inhibition,,f,t,,pIC50,0,8.739999771,0,IC50,0,1.799999952,0,=,,,,21523318,CC(=O)Nc1cccc(c1)n1c(=O)n(C2CC2)c(=O)c2c1c(C)c(=O)n(c2Nc1ccc(cc1F)I)C
mitogen-activated protein kinase kinase kinase 10,2070,MAP3K10,Q02779,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,t,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
mitogen-activated protein kinase kinase kinase 11,2071,MAP3K11,Q16584,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
mitogen-activated protein kinase kinase kinase 2,2077,MAP3K2,Q9Y2U5,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,pIC50,0,6.179999828,0,IC50,0,661,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
mitogen-activated protein kinase kinase kinase 7,2082,MAP3K7,O43318,,,,,,Human,Takinib,9655,,,348353615,Inhibitor,Inhibition,,f,t,,pIC50,0,8.020000458,0,IC50,0,9.5,0,=,"<i>In vitro</i> kinase activity assay, measuring phosphorylation of a peptide substrate by a purified recombinant TAK1 kinase domain fused to TAB1 c-terminal domain.",,,28820959,CCCn1/c(=N/C(=O)c2cccc(c2)C(=O)N)/[nH]c2c1cccc2
mitogen-activated protein kinase kinase kinase 8,2083,MAP3K8,P41279,,,,,,Human,Tpl2 kinase inhibitor,6051,,,178102673,Inhibitor,Inhibition,,f,t,,pIC50,0,7.300000191,0,IC50,0,50,0,=,,,,16165349,N#Cc1cnc2c(c1Nc1ccc(c(c1)Cl)F)cc(nc2)NCc1cccnc1
mitogen-activated protein kinase kinase kinase 9,2084,MAP3K9,P80192,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,t,,pIC50,0,7.71999979,0,IC50,0,19,0,=,,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
MMP13,1637,MMP13,P45452,,,,,,Human,WAY170523,5288,,,178101971,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,ONC(=O)c1cc(C)cc(c1N(S(=O)(=O)c1ccc(cc1)OCCNC(=O)c1cc2c(o1)cccc2)Cc1ccccc1)C
MMP2,1629,MMP2,P08253,,,,,,Human,tanomastat,6468,,,178103082,Inhibitor,Inhibition,,f,,,pKi,0,8,0,Ki,0,10,0,,,,,16680577,OC(=O)[C@H](CC(=O)c1ccc(cc1)c1ccc(cc1)Cl)CSc1ccccc1
MMP2,1629,MMP2,P08253,,,,,,Human,tiludronic acid,7604,,,223365939,Inhibitor,Inhibition,,f,f,,pIC50,0,5.139999866,0,IC50,0,7200,0,=,,,,24071448,Clc1ccc(cc1)SC(P(=O)(O)O)P(=O)(O)O
MMP3,1630,MMP3,P08254,,,,,,Human,UK-356618,6528,,,178103142,Inhibitor,Inhibition,,f,,,pIC50,0,8.2,0,IC50,0,5.9,0,,,,,11229774,ONC(=O)C[C@H](C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](c1ccccc1)C)CCCc1ccc(c(c1)C)c1ccccc1
Monoamine oxidase A,2489,MAOA,P21397,,,,,,Human,tranylcypromine,5281,,,178101964,Inhibitor,Inhibition,,f,t,,pIC50,0,4.699999809,0,IC50,0,20000,0,=,,,,15110846,NC1CC1c1ccccc1
Monoamine oxidase B,2490,MAOB,P27338,,,,,,Human,tranylcypromine,5281,,,178101964,Inhibitor,Inhibition,,f,t,,pIC50,0,4.71999979,0,IC50,0,19000,0,=,,,,15110846,NC1CC1c1ccccc1
motilin receptor,297,MLNR,O43193,,,,,,Human,[<sup>125</sup>I]motilin (human),3794,,,178100643,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,=,,,,10381885,
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>11</sup>C]butylthio-TZTP,3268,,,178100311,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8835881,[11CH3]CCCSc1nsnc1C1=CCCN(C1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>11</sup>C]xanomeline,3278,,,178100319,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8835881,CCCCCCOc1nsnc1C1=CCCN(C1)[11CH3]
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,xanomeline,57,,,135651331,Agonist,Partial agonist,,f,,,pKi,7.9,0,6.7,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,(-)-YM796,287,,,135651351,Agonist,Partial agonist,,f,,,pKi,4.8,0,4.3,,0,0,0,,,,,1310135,CN1CCC2(CC1)CC(=C)[C@H](O2)C
M<sub>1</sub> receptor,13,Chrm1,P12657,,,,,,Mouse,tacrine,6687,,,178103299,Allosteric modulator,Negative,,f,f,,pIC50,0,5.699999809,0,IC50,0,2000,0,=,,,,1552502,Nc1c2CCCCc2nc2c1cccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,"WIN 51,708",339,,,135651325,Allosteric modulator,Negative,,f,,,pKd,0,5.8,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c(nc1C2)nc1c3cccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,"WIN 62,577",340,,,135651327,Allosteric modulator,Negative,,f,,,pKd,0,5.5,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=Cc3c(C[C@]12C)cn1c(n3)nc2c1cccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,thiochrome,348,,,135651256,Allosteric modulator,Neutral,,f,,,pKd,0,4.1,0,,0,0,0,,,,,14722259,OCCc1sc2=Nc3c(Cn2c1C)cnc(n3)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,vinburnine,345,,,135650219,Allosteric modulator,Neutral,,f,,,pKd,0,5.1,0,,0,0,0,,,,,9224827,CC[C@]12CCCN3[C@@H]2c2n(C(=O)C1)c1c(c2CC3)cccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,vincamine,349,,,135652725,Allosteric modulator,Neutral,,f,,,pKd,0,4.8,0,,0,0,0,,,,,9224827,COC(=O)[C@@]1(O)C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,VU0029767,3261,,,178100304,Allosteric modulator,Positive,,f,,,-,0,0,0,-,0,0,0,=,,,,19047481,CCOc1ccc(cc1)NCC(=O)N/N=C/c1c(O)ccc2c1cccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,VU0090157,3259,,,178100302,Allosteric modulator,Positive,,f,,,-,0,0,0,-,0,0,0,=,,,,19047481,O=C1NC(C(=C(N1C)C)C(=O)OC1CCCC1)c1cc2OCOc2cc1[N+](=O)[O-]
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,VU0119498,7632,,,223365967,Allosteric modulator,Positive,,f,f,,pEC50,0,5.199999809,0,EC50,0,6040,0,=,,,,19438238,Brc1ccc(cc1)CN1c2ccccc2C(=O)C1=O
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,"[<sup>18</sup>F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate",3275,,,178100316,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,9313861,[18F]Cc1ccc(cc1)[C@](c1ccccc1)(C(=O)O[C@H]1CN2CCC1CC2)O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>3</sup>H]darifenacin,319,,,135651146,Antagonist,Antagonist,,f,,,pKd,0,8.8,0,-,0,0,0,=,,,,9029489,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,f,,pKd,10.30000019,0,9.399999619,Kd,0.419999987,0,0.050000001,=,,,,7651370,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,,,pKd,0,9.7,0,,0,0,0,,,,,7687290,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>3</sup>H]pirenzepine,3272,,,178100313,Antagonist,Antagonist,,f,,,pKd,0,7.9,0,Kd,0,14,0,=,,,,6546354,O=C(n1c2ccccc2c(=O)[nH]c2c1nccc2)CN1CCN(CC1)C([3H])([3H])[3H]
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,[<sup>3</sup>H]pirenzepine,3272,,,178100313,Antagonist,Antagonist,,f,f,,pKd,7.900000095,0,7.699999809,-,0,0,0,=,,,,2704371,O=C(n1c2ccccc2c(=O)[nH]c2c1nccc2)CN1CCN(CC1)C([3H])([3H])[3H]
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,[<sup>3</sup>H]QNB,318,,,135651193,Antagonist,Antagonist,,f,,,pKd,10.8,0,10.6,Kd,0.0251,0,0.0158,=,,,,3443095,O=C(C(c1ccccc1)(c1ccccc1)O)OC1CN2CCC1CC2
M<sub>1</sub> receptor,13,Chrm1,P08482,,,,,,Rat,[<sup>3</sup>H](+)telenzepine,8594,,,252166795,Antagonist,Antagonist,,f,f,,pKi,0,9.399999619,0,-,0,0,0,=,,,,2704371,CN1CCN(CC1)CC(=O)n1c2ccccc2[nH]c(=O)c2c1c(C)sc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,tiotropium,367,,,135651266,Antagonist,Antagonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,8441333,O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,tolterodine,360,,,135651269,Antagonist,Antagonist,,f,f,,pKi,8.699999809,0,8.5,-,0,0,0,=,,,,20590605,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,trihexyphenidyl,7315,,,178103888,Antagonist,Antagonist,,f,t,,pKi,0,8.869999886,0,Ki,0,1.350000024,0,=,,,,0,OC(c1ccccc1)(C1CCCCC1)CCN1CCCCC1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,tripitramine,361,,,135651280,Antagonist,Antagonist,,f,f,,pKi,0,8.800000191,0,-,0,0,0,=,,,,7805774,CN(CCCCCCNCC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CCCCCCCCN(CCCCCCN(CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)C
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,UH-AH 37,8583,,,252166784,Antagonist,Antagonist,,f,f,,pKi,8.699999809,0,8.600000381,-,0,0,0,=,,,,2043926,CN1CCC(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1c(Cl)ccc2
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,umeclidinium,7354,,,178103926,Antagonist,Antagonist,,f,f,,pKi,0,9.800000191,0,Ki,0,0.159999996,0,=,,,,19317446,OC(C12CC[N+](CC1)(CC2)CCOCc1ccccc1)(c1ccccc1)c1ccccc1
M<sub>1</sub> receptor,13,CHRM1,P11229,,,,,,Human,VU0255035,3274,,,178100315,Antagonist,Antagonist,,f,,,pKi,0,7.8,0,Ki,0,14.87,0,=,,,,19407080,O=C(N1CCN(CC1)c1ccncc1)CCNS(=O)(=O)c1cccc2c1nsn2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]acetylcholine,8593,,,252166794,Agonist,Agonist,,f,f,,pKd,0,8.800000191,0,-,0,0,0,=,,,,14722259,CC(=O)OCC[N+](C)(C)C
M<sub>2</sub> receptor,14,Chrm2,Q9ERZ4,,,,,,Mouse,[<sup>18</sup>F]FP-TZTP,3266,,,178100309,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,12668051,CN1CC(=CCC1)c1nsnc1SCCC[18F]
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]oxotremorine-M,8595,,,252166796,Agonist,Full agonist,,f,f,,pKd,0,8.699999809,0,-,0,0,0,=,,,,6478115,O=C1CCCN1CC#CC[N+](C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,xanomeline,57,,,135651331,Agonist,Full agonist,,f,,,pKi,7.4,0,6.9,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
M<sub>2</sub> receptor,14,Chrm2,Q9ERZ4,,,,,,Mouse,tacrine,6687,,,178103299,Allosteric modulator,Negative,,f,f,,pIC50,0,5.679999828,0,IC50,0,2100,0,=,,,,1552502,Nc1c2CCCCc2nc2c1cccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,W-84,362,,,135651318,Allosteric modulator,Negative,,f,f,,pKd,7.5,0,6,-,0,0,0,=,,,,12815174,O=C1N(CCC[N+](CCCCCC[N+](CCCN2C(=O)c3c(C2=O)cccc3)(C)C)(C)C)C(=O)c2c1cccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,"WIN 51,708",339,,,135651325,Allosteric modulator,Negative,,f,,,pKd,0,5.9,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c(nc1C2)nc1c3cccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,"WIN 62,577",340,,,135651327,Allosteric modulator,Negative,,f,,,pKd,0,5.3,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=Cc3c(C[C@]12C)cn1c(n3)nc2c1cccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,thiochrome,348,,,135651256,Allosteric modulator,Neutral,,f,,,pKd,0,3.9,0,,0,0,0,,,,,14722259,OCCc1sc2=Nc3c(Cn2c1C)cnc(n3)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,vinburnine,345,,,135650219,Allosteric modulator,Neutral,,f,,,pKd,0,4.2,0,,0,0,0,,,,,9224827,CC[C@]12CCCN3[C@@H]2c2n(C(=O)C1)c1c(c2CC3)cccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,vincamine,349,,,135652725,Allosteric modulator,Neutral,,f,,,pKd,0,5.1,0,,0,0,0,,,,,9224827,COC(=O)[C@@]1(O)C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]dimethyl-W84,364,,,135651147,Allosteric modulator,Positive,,f,f,,pKd,0,8.5,0,-,0,0,0,=,,,,12815174,Cc1cccc2c1C(=O)N(C2=O)CCC[N+](CCCCCC[N+](CCCN1C(=O)c2c(C1=O)c(C)ccc2)(C)C)(C)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,W-84,362,,,135651318,Allosteric modulator,Positive,,f,,,pKi,0,7.6,0,,0,0,0,,,,,12815174,O=C1N(CCC[N+](CCCCCC[N+](CCCN2C(=O)c3c(C2=O)cccc3)(C)C)(C)C)C(=O)c2c1cccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,WDuo3,363,,,135651324,Allosteric modulator,Positive,,f,,,pKi,0,6.9,0,,0,0,0,,,,,12815174,O=C1N(CO/N=Cc2cc[n+](cc2)CCC[n+]2ccc(cc2)/C=NOCN2C(=O)c3c(C2=O)cccc3)C(=O)c2c1cccc2
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,[<sup>3</sup>H]4NMPB,352,,,135651126,Antagonist,Antagonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,2846274,CN1CCC(CC1)OC(=O)C(c1ccccc1)(c1ccccc1)O
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]AF DX-384,368,,,135651133,Antagonist,Antagonist,,f,,,pKd,0,8.7,0,,0,0,0,,,,,1941609,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,[<sup>3</sup>H]clidinium,351,,,135651180,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,9454790,O=C(C(c1ccccc1)(c1ccccc1)O)OC1C[N+]2(C)CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]clidinium,351,,,135651180,Antagonist,Antagonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,9454790,O=C(C(c1ccccc1)(c1ccccc1)O)OC1C[N+]2(C)CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,f,,pKd,9.899999619,0,9.300000191,Kd,0.519999981,0,0.140000001,=,,,,7687290,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>2</sub> receptor,14,Chrm2,P10980,,,,,,Rat,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,2846274,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]QNB,318,,,135651193,Antagonist,Antagonist,,f,,,pKd,10.6,0,10.1,Kd,0.0794,0,0.0251,=,,,,3443095,O=C(C(c1ccccc1)(c1ccccc1)O)OC1CN2CCC1CC2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,[<sup>3</sup>H]tiotropium,8592,,,252166793,Antagonist,Antagonist,,f,f,,pKd,0,10.30000019,0,-,0,0,0,=,,,,23435542,O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,THRX160209,3255,,,178100298,Antagonist,Antagonist,,f,f,,pKi,0,9.5,0,-,0,0,0,=,,,,17478612,CCCN(C1CCN(CC1)Cc1c(OC)cccc1OC)CCCCCCCN1CC[C@H](C1)C(c1ccccc1)(c1ccccc1)C(=O)N
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,tiotropium,367,,,135651266,Antagonist,Antagonist,,f,f,,pKi,0,9.899999619,0,-,0,0,0,=,,,,8441333,O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,tripitramine,361,,,135651280,Antagonist,Antagonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,7805774,CN(CCCCCCNCC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CCCCCCCCN(CCCCCCN(CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)C
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,UH-AH 37,8583,,,252166784,Antagonist,Antagonist,,f,f,,pKi,7.400000095,0,7.300000191,-,0,0,0,=,,,,2043926,CN1CCC(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1c(Cl)ccc2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,umeclidinium,7354,,,178103926,Antagonist,Antagonist,,f,f,,pKi,0,9.819999695,0,Ki,0,0.150000006,0,=,,,,19317446,OC(C12CC[N+](CC1)(CC2)CCOCc1ccccc1)(c1ccccc1)c1ccccc1
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,VU0255035,3274,,,178100315,Antagonist,Antagonist,,f,f,,pKi,0,6.199999809,0,-,0,0,0,=,,,,19407080,O=C(N1CCN(CC1)c1ccncc1)CCNS(=O)(=O)c1cccc2c1nsn2
M<sub>2</sub> receptor,14,CHRM2,P08172,,,,,,Human,tolterodine,360,,,135651269,Antagonist,Inverse agonist,,f,f,,pKi,8.600000381,0,8.399999619,-,0,0,0,=,,,,16188951,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,xanomeline,57,,,135651331,Agonist,Partial agonist,,f,,,pKi,7.4,0,7.2,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,"WIN 51,708",339,,,135651325,Allosteric modulator,Negative,,f,,,pKd,0,5.5,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c(nc1C2)nc1c3cccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,thiochrome,348,,,135651256,Allosteric modulator,Neutral,,f,,,pKd,0,4.4,0,,0,0,0,,,,,14722259,OCCc1sc2=Nc3c(Cn2c1C)cnc(n3)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,vinburnine,345,,,135650219,Allosteric modulator,Neutral,,f,,,pKd,0,5.2,0,,0,0,0,,,,,9224827,CC[C@]12CCCN3[C@@H]2c2n(C(=O)C1)c1c(c2CC3)cccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,vincamine,349,,,135652725,Allosteric modulator,Neutral,,f,,,pKd,0,5.7,0,,0,0,0,,,,,9224827,COC(=O)[C@@]1(O)C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,VU0119498,7632,,,223365967,Allosteric modulator,Positive,,f,f,,pEC50,0,5.199999809,0,EC50,0,6380,0,=,,,,19438238,Brc1ccc(cc1)CN1c2ccccc2C(=O)C1=O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,"WIN 62,577",340,,,135651327,Allosteric modulator,Positive,,f,f,,pKd,0,5.099999905,0,Kd,0,7940,0,=,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=Cc3c(C[C@]12C)cn1c(n3)nc2c1cccc2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,[<sup>3</sup>H]darifenacin,319,,,135651146,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,Kd,0,0.316,0,=,,,,9029489,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2
M<sub>3</sub> receptor,15,Chrm3,P08483,,,,,,Rat,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,,,pKd,0,10,0,,0,0,0,,,,,7687290,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,f,,pKd,10.22000027,0,9.659999847,Kd,0.219999999,0,0.059999999,=,,,,7651370,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,[<sup>3</sup>H]QNB,318,,,135651193,Antagonist,Antagonist,,f,,,pKd,0,10.4,0,Kd,0,0.0398,0,=,,,,3443095,O=C(C(c1ccccc1)(c1ccccc1)O)OC1CN2CCC1CC2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,[<sup>3</sup>H]tiotropium,8592,,,252166793,Antagonist,Antagonist,,f,f,,pKd,0,10.69999981,0,-,0,0,0,=,,,,23435542,O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,tiotropium,367,,,135651266,Antagonist,Antagonist,,f,t,,pKi,11.10000038,0,9.5,-,0,0,0,=,,,,16847442,O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,tolterodine,360,,,135651269,Antagonist,Antagonist,,f,f,,pKi,8.5,0,8.399999619,-,0,0,0,=,,,,20590605,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,tripitramine,361,,,135651280,Antagonist,Antagonist,,f,f,,pKi,0,6.829999924,0,-,0,0,0,=,,,,18595721,CN(CCCCCCNCC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CCCCCCCCN(CCCCCCN(CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)C
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,tropicamide,7319,,,178103892,Antagonist,Antagonist,,f,t,,pKi,0,7.519999981,0,Ki,0,30,0,=,,,,0,CCN(C(=O)C(c1ccccc1)CO)Cc1ccncc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,UH-AH 37,8583,,,252166784,Antagonist,Antagonist,,f,f,,pKi,8.199999809,0,8.100000381,-,0,0,0,=,,,,2043926,CN1CCC(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1c(Cl)ccc2
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,umeclidinium,7354,,,178103926,Antagonist,Antagonist,,f,f,,pKi,0,10.22000027,0,Ki,0,0.059999999,0,=,,,,19317446,OC(C12CC[N+](CC1)(CC2)CCOCc1ccccc1)(c1ccccc1)c1ccccc1
M<sub>3</sub> receptor,15,CHRM3,P20309,,,,,,Human,VU0255035,3274,,,178100315,Antagonist,Antagonist,,f,,,pKi,0,6.1,0,-,0,0,0,=,,,,19407080,O=C(N1CCN(CC1)c1ccncc1)CCNS(=O)(=O)c1cccc2c1nsn2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,[<sup>3</sup>H]acetylcholine,8593,,,252166794,Agonist,Agonist,,f,f,,pKd,0,8.199999809,0,-,0,0,0,=,,,,14722259,CC(=O)OCC[N+](C)(C)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,xanomeline,57,,,135651331,Agonist,Partial agonist,,f,,,pKi,7.7,0,7.4,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,"WIN 51,708",339,,,135651325,Allosteric modulator,Negative,,f,,,pKd,0,6.2,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c(nc1C2)nc1c3cccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,"WIN 62,577",340,,,135651327,Allosteric modulator,Negative,,f,,,pKd,0,5.9,0,,0,0,0,,,,,12435818,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=Cc3c(C[C@]12C)cn1c(n3)nc2c1cccc2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,thiochrome,348,,,135651256,Allosteric modulator,Positive,,f,f,,pKd,0,4,0,-,0,0,0,=,,,,14722259,OCCc1sc2=Nc3c(Cn2c1C)cnc(n3)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,vinburnine,345,,,135650219,Allosteric modulator,Positive,,f,,,pKd,0,4.6,0,,0,0,0,,,,,9224827,CC[C@]12CCCN3[C@@H]2c2n(C(=O)C1)c1c(c2CC3)cccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,vincamine,349,,,135652725,Allosteric modulator,Positive,,f,,,pKd,0,4.2,0,,0,0,0,,,,,9224827,COC(=O)[C@@]1(O)C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,VU0010010,7633,,,223365968,Allosteric modulator,Positive,,f,f,,-,0,0,0,-,0,0,0,=,,,,19201489,Clc1ccc(cc1)CNC(=O)C1Sc2c(C1N)cc(c(n2)C)C
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,VU0152099,3256,,,178100299,Allosteric modulator,Positive,,f,f,,pEC50,0,6.389999866,0,EC50,0,403,0,=,,,,18772318,Cc1cc(C)c2c(n1)sc(c2N)C(=O)NCc1ccc2c(c1)OCO2
M<sub>4</sub> receptor,16,Chrm4,P08485,,,,,,Rat,VU0152100,3263,,,178100306,Allosteric modulator,Positive,,f,f,,pEC50,0,6.420000076,0,EC50,0,380,0,=,,,,18772318,COc1ccc(cc1)CNC(=O)c1sc2c(c1N)c(C)cc(n2)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,[<sup>3</sup>H]AF DX-384,368,,,135651133,Antagonist,Antagonist,,f,,,pKd,0,8.6,0,,0,0,0,,,,,1941609,CCCN(CC1CCCCN1CCNC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2)CCC
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,f,,pKd,10.22000027,0,9.850000381,Kd,0.140000001,0,0.059999999,=,,,,7687290,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,[<sup>3</sup>H]QNB,318,,,135651193,Antagonist,Antagonist,,f,,,pKd,10.5,0,9.7,Kd,0.2,0,0.0316,=,,,,3443095,O=C(C(c1ccccc1)(c1ccccc1)O)OC1CN2CCC1CC2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,tolterodine,360,,,135651269,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,8.300000191,-,0,0,0,=,,,,20590605,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,tripitramine,361,,,135651280,Antagonist,Antagonist,,f,f,,pKi,0,7.940000057,0,-,0,0,0,=,,,,18595721,CN(CCCCCCNCC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CCCCCCCCN(CCCCCCN(CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)C
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,UH-AH 37,8583,,,252166784,Antagonist,Antagonist,,f,f,,pKi,8.399999619,0,8.300000191,-,0,0,0,=,,,,2043926,CN1CCC(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1c(Cl)ccc2
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,umeclidinium,7354,,,178103926,Antagonist,Antagonist,,f,f,,pKi,0,10.30000019,0,-,0,0,0,=,,,,23435542,OC(C12CC[N+](CC1)(CC2)CCOCc1ccccc1)(c1ccccc1)c1ccccc1
M<sub>4</sub> receptor,16,CHRM4,P08173,,,,,,Human,VU0255035,3274,,,178100315,Antagonist,Antagonist,,f,,,pKi,0,5.9,0,-,0,0,0,=,,,,19407080,O=C(N1CCN(CC1)c1ccncc1)CCNS(=O)(=O)c1cccc2c1nsn2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,xanomeline,57,,,135651331,Agonist,Partial agonist,,f,,,pKi,7.4,0,6.7,,0,0,0,,,,,9884068,CCCCCCOc1nsnc1C1=CCCN(C1)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,VU0119498,7632,,,223365967,Allosteric modulator,Positive,,f,f,,pEC50,0,5.400000095,0,EC50,0,4080,0,=,,,,19438238,Brc1ccc(cc1)CN1c2ccccc2C(=O)C1=O
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,VU0238429,3257,,,178100300,Allosteric modulator,Positive,,f,f,,pEC50,0,5.940000057,0,EC50,0,1160,0,=,,,,19438238,COc1ccc(cc1)CN1c2ccc(cc2C(=O)C1=O)OC(F)(F)F
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,[<sup>3</sup>H]N-methyl scopolamine,317,,,135651190,Antagonist,Antagonist,,f,f,,pKd,9.699999809,0,9.300000191,Kd,0.479999989,0,0.200000003,=,,,,7687290,OC[C@H](c1ccccc1)C(=O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,[<sup>3</sup>H]QNB,318,,,135651193,Antagonist,Antagonist,,f,f,,pKd,10.69999981,0,10.22000027,Kd,0.059999999,0,0.02,=,,,,0,O=C(C(c1ccccc1)(c1ccccc1)O)OC1CN2CCC1CC2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,tolterodine,360,,,135651269,Antagonist,Antagonist,,f,f,,pKi,8.800000191,0,8.5,-,0,0,0,=,,,,20590605,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,tripitramine,361,,,135651280,Antagonist,Antagonist,,f,f,,pKi,0,7.5,0,-,0,0,0,=,,,,7805774,CN(CCCCCCNCC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CCCCCCCCN(CCCCCCN(CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)CC(=O)n1c2ncccc2[nH]c(=O)c2c1cccc2)C
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,UH-AH 37,8583,,,252166784,Antagonist,Antagonist,,f,f,,pKi,0,8.300000191,0,-,0,0,0,=,,,,2043926,CN1CCC(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1c(Cl)ccc2
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,umeclidinium,7354,,,178103926,Antagonist,Antagonist,,f,f,,pKi,0,9.899999619,0,-,0,0,0,=,,,,23435542,OC(C12CC[N+](CC1)(CC2)CCOCc1ccccc1)(c1ccccc1)c1ccccc1
M<sub>5</sub> receptor,17,CHRM5,P08912,,,,,,Human,VU0255035,3274,,,178100315,Antagonist,Antagonist,,f,f,,pKi,0,5.599999905,0,-,0,0,0,=,,,,19407080,O=C(N1CCN(CC1)c1ccncc1)CCNS(=O)(=O)c1cccc2c1nsn2
MTB polyketide synthase Pks13,2950,,I6X8D2,,,,,,Mycobacterium tuberculosis,TAM16,9645,,,340590275,Inhibitor,Inhibition,,f,t,,pIC50,0,6.71999979,0,IC50,0,190,0,=,,,,28669536,CNC(=O)c1c(oc2c1c(CN1CCCCC1)c(cc2)O)c1ccc(cc1)O
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,[<sup>125</sup>I]SD6,7770,,,223366103,Agonist,Full agonist,,f,f,,pKd,0,10.89999962,0,Kd,0,0.014,0,=,,,,23698757,COc1cc2c(CCNC(=O)C[125I])c[nH]c2cc1
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,[<sup>3</sup>H]melatonin,1357,,,135651178,Agonist,Full agonist,,f,,,pKd,9.9,0,9.4,Kd,0.4,0,0.13,=,,,,10696085,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,tasimelteon,7393,,,178103965,Agonist,Full agonist,,f,t,,pKi,0,9.5,0,Ki,0,0.30399999,0,=,,,,0,CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,UCM 793,7777,,,223366110,Agonist,Full agonist,,f,f,,pKi,0,9.100000381,0,-,0,0,0,=,,,,18052314,COc1cccc(c1)N(CCNC(=O)C)C
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,UCM 549,7772,,,223366105,Antagonist,Antagonist,,f,f,,pKi,8.199999809,0,7.599999905,-,0,0,0,=,,,,15293992,COc1ccc2c(c1)C(CNC(=O)C)Cc1c(C2)cccc1
MT<sub>1</sub> receptor,287,MTNR1A,P48039,,,,,,Human,UCM 724,7773,,,223366106,Antagonist,Antagonist,,f,f,,pKi,0,6.900000095,0,-,0,0,0,=,,,,17907131,COc1ccc2c(c1)C(CNC(=O)N)Cc1c(C2)cccc1
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,[<sup>125</sup>I]SD6,7770,,,223366103,Agonist,Full agonist,,f,f,,pKd,0,10.19999981,0,Kd,0,0.066,0,=,,,,23698757,COc1cc2c(CCNC(=O)C[125I])c[nH]c2cc1
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,[<sup>3</sup>H]melatonin,1357,,,135651178,Agonist,Full agonist,,f,,,pKd,9.6,0,9,Kd,0.912,0,0.28,=,,,,10696085,COc1ccc2c(c1)c(CCNC(=O)C)c[nH]2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,tasimelteon,7393,,,178103965,Agonist,Full agonist,,f,t,,pKi,0,10.19999981,0,Ki,0,0.069200002,0,=,,,,0,CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM1014,9226,,,315661301,Agonist,Full agonist,,f,t,,pKi,0,12,0,Ki,0,0.001,0,=,,,,26334942,CCC(=O)NCC1CCc2c(N1Cc1ccccc1)cccc2OC
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM 765,7923,,,249565606,Agonist,Full agonist,,f,f,,pKi,0,10.19999981,0,-,0,0,0,=,,,,18052314,COc1ccc(cc1)N(c1ccccc1)CCNC(=O)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM 793,7777,,,223366110,Agonist,Full agonist,,f,f,,pKi,0,9.199999809,0,-,0,0,0,=,,,,18052314,COc1cccc(c1)N(CCNC(=O)C)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,[<sup>125</sup>I]DIV880,7771,,,223366104,Agonist,Partial agonist,,f,f,,pKd,0,9.699999809,0,Kd,0,0.224000007,0,=,,,,23698757,COc1cc(Cc2cc(OC)c(cc2[125I])OC)c(cc1OC)CC(=O)OC(C)(C)C
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,[<sup>125</sup>I]S70254,7779,,,223366112,Agonist,Partial agonist,,f,f,,pKd,0,9.600000381,0,-,0,0,0,=,,,,23698757,[125I]CC(=O)NCCc1c2nc(OC)ccc2[nH]c1c1cccc2c1cccc2
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM 454,7783,,,223366116,Antagonist,Antagonist,,f,f,,pKi,0,8.100000381,0,-,0,0,0,=,,,,15943478,CCC(=O)NCc1cc2c(n1Cc1ccc(cc1)Cl)cccc2OC
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM 549,7772,,,223366105,Antagonist,Antagonist,,f,f,,pKi,9.199999809,0,8.899999619,-,0,0,0,=,,,,15293992,COc1ccc2c(c1)C(CNC(=O)C)Cc1c(C2)cccc1
MT<sub>2</sub> receptor,288,MTNR1B,P49286,,,,,,Human,UCM 724,7773,,,223366106,Antagonist,Antagonist,,f,f,,pKi,0,8,0,-,0,0,0,=,,,,15293992,COc1ccc2c(c1)C(CNC(=O)N)Cc1c(C2)cccc1
Multidrug and toxin extrusion,1216,SLC47A1,Q96FL8,,,,,,Human,[<sup>14</sup>C]metformin,4503,,,178101231,None,None,,f,,,-,0,0,0,-,0,0,0,=,,,,17509534,CN(C(=N)N=C(N)N)C
Multidrug and toxin extrusion,1216,SLC47A1,Q96FL8,,,,,,Human,[<sup>14</sup>C]TEA,4575,,,178101296,None,None,,f,,,-,0,0,0,-,0,0,0,=,,,,16330770,CC[N+](CC)(CC)CC
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,[<sup>3</sup>H]PL017,3832,,,178100676,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,3030778,
&mu; receptor,319,OPRM1,P35372,,,,,,Human,tapentadol,7477,,,187051780,Agonist,Agonist,,f,t,,pKi,0,6.800000191,0,Ki,0,160,0,=,,,,17656655,CC[C@@H](c1cccc(c1)O)[C@H](CN(C)C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,tramadol,8286,,,252166498,Agonist,Agonist,,f,f,,pKi,0,5.800000191,0,Ki,0,1600,0,=,Displacement of the mu aginist peptide DAMGO from the mu receptor expressed in CHO cells.,,,19282177,COc1cccc(c1)C1(O)CCCCC1CN(C)C
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,U-47700,9282,,,318164801,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,2999404,CN([C@@H]1CCCC[C@H]1N(C(=O)c1ccc(c(c1)Cl)Cl)C)C
&mu; receptor,319,OPRM1,P35372,,,,,,Human,UFP-512,9006,,,310264784,Agonist,Agonist,,f,f,,pKi,0,8,0,-,0,0,0,=,Measuring displacement of [<sup>3</sup>H]-diprenorphine <i>in vitro</i>,,,18069089,Oc1cc(C)c(c(c1)C)C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@H](c1[nH]c2c(n1)cccc2)CC(=O)O)N
&mu; receptor,319,OPRM1,P35372,,,,,,Human,sufentanil,3534,,,178100513,Agonist,Full agonist,,f,t,,pKi,0,9.899999619,0,Ki,0,0.137999997,0,=,,,,21215785,COCC1(CCN(CC1)CCc1cccs1)N(c1ccccc1)C(=O)CC
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,sufentanil,3534,,,178100513,Agonist,Full agonist,,f,,,pKi,0,9.1,0,Ki,0,0.77,0,=,,,,2843777,COCC1(CCN(CC1)CCc1cccs1)N(c1ccccc1)C(=O)CC
&mu; receptor,319,Oprm1,P33535,,,,,,Rat,[<sup>3</sup>H]DAMGO,3815,,,178100661,Agonist,Full agonist,,f,f,,pKd,0,9.199999809,0,Kd,0,0.569999993,0,=,,,,8114680,
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,[<sup>3</sup>H]diprenorphine,1612,,,135651148,Antagonist,Antagonist,,f,f,,pKd,0,10.10000038,0,Kd,0,0.079400003,0,=,,,,8114680,CO[C@]12CC[C@]3(C[C@@H]1C(O)(C)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(C(C1[3H])[3H])CC1CC1)ccc2O
&mu; receptor,319,Oprm1,P42866,,,,,,Mouse,[<sup>3</sup>H]naloxone,1676,,,135651185,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,8114680,C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
&mu; receptor,319,OPRM1,P35372,,,,,,Human,zyklophin,9193,,,315661272,Antagonist,Antagonist,,f,f,,pKi,0,5.230000019,0,Ki,0,5880,0,=,,,,15999987,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NCc2ccccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(CC)C)CCCN=C(N)N)CCCN=C(N)N
Na<sub>vi</sub>2.1,750,NALCN,Q8IZF0,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,None,,f,,,pIC50,0,3.4,0,IC50,0,380000,0,,,,,0,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,veratridine,2626,,,135652724,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.1,578,SCN1A,P35498,,,,,,Human,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,0.01,-,0,0,0,-,0,0,0,=,,,,0,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.1,578,Scn1a,P04774,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pKd,0,8,0,-,0,0,0,=,,,,9437003,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,veratridine,2626,,,135652724,Activator,Partial agonist,,f,f,,pKd,0,5.199999809,0,Kd,0,6310,0,=,,,,6114956,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.2,579,Scn2a,P04775,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,8,0,IC50,0,11.19999981,0,=,,,,15815630,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,veratridine,2626,,,135652724,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.3,580,SCN3A,Q9NY46,,,,,,Human,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,11122339,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,veratridine,2626,,,135652724,Activator,Partial agonist,,f,f,200,-,0,0,0,-,0,0,0,=,,,,9482942,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.4,581,Scn4a,P15390,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.300000191,0,-,0,0,0,=,,,,2559760,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.4,581,SCN4A,P35499,,,,,,Human,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,8058462,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,veratridine,2626,,,135652724,Activator,Partial agonist,,f,f,,pEC50,0,6.300000191,0,EC50,0,501,0,=,,,,2154667,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.5,582,Scn5a,P15389,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pKd,0,5.800000191,0,Kd,0,1520,0,=,,,,8967455,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.6,583,SCN8A,Q9UQD0,,,,,,Human,veratridine,2626,,,135652724,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.6,583,Scn8a,Q9WTU3,,,,,,Mouse,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.199999809,0,-,0,0,0,=,,,,9698304,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.6,583,Scn8a,O88420,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,9,0,IC50,0,1,0,=,,,,9603190,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,veratridine,2626,,,135652724,Activator,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,XEN907,5732,,,178102358,Channel blocker,Inhibition,,f,f,,pIC50,0,8.5,0,IC50,0,3,0,=,[<sup>14</sup>C]guanidinium influx,,,21570288,CCCCCN1c2ccccc2C2(C1=O)COc1c2cc2OCOc2c1
Na<sub>v</sub>1.7,584,Scn9a,O08562,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,8.399999619,0,-,0,0,0,=,,,,9169448,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.7,584,SCN9A,Q15858,,,,,,Human,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,7.599999905,0,IC50,0,24.5,0,=,,,,7720699,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.8,585,Scn10a,Q62968,,,,,,Rat,veratridine,2626,,,135652724,Activator,None,,f,,0.5-50,-,0,0,0,,0,0,0,,,,,17962978,COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@]2([C@H]3[C@]1(O)O[C@]12C[C@@]2([C@@]([C@@H]1CC3)(O)C[C@@H]([C@]1([C@H]2CN2C[C@@H](C)CC[C@H]2[C@@]1(C)O)O)O)O)C
Na<sub>v</sub>1.8,585,Scn10a,Q62968,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,4.199999809,0,IC50,0,59600,0,=,,,,8538791,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
Na<sub>v</sub>1.9,586,Scn11a,O88457,,,,,,Rat,tetrodotoxin,2616,,,135652722,Channel blocker,Pore blocker,,f,f,,pIC50,0,4.400000095,0,IC50,0,39000,0,=,,,,10594087,OC[C@@]1(O)[C@H]2O[C@]3(O[C@@H]1[C@H]1[C@@]([C@H]2O)([C@@H]3O)NC(=N[C@@H]1O)N)O
natriuretic peptide receptor 3,1749,NPR3,P17342,,,,,,Human,[<sup>125</sup>I]ANP (human),4845,,,178101546,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
NET,926,Slc6a2,,,,,,,Rat,[<sup>3</sup>H]mazindol,4591,,,178101312,Inhibitor,Inhibition,,f,f,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,,,,15300361,Clc1ccc(cc1)C1(O)c2ccccc2C2=NCCN12
NET,926,SLC6A2,P23975,,,,,,Human,[<sup>3</sup>H]nisoxetine,4636,,,178101354,Inhibitor,Inhibition,,f,f,,pKd,0,8.399999619,0,Kd,0,4,0,=,,,,0,COc1ccccc1OC(c1ccccc1)CCNC([3H])([3H])[3H]
NET,926,SLC6A2,P23975,,,,,,Human,tapentadol,7477,,,187051780,Inhibitor,Inhibition,,f,t,,pKi,0,5.059999943,0,Ki,0,8800,0,=,,,,17656655,CC[C@@H](c1cccc(c1)O)[C@H](CN(C)C)C
NET,926,SLC6A2,P23975,,,,,,Human,trimipramine,7317,,,178103890,Inhibitor,Inhibition,,f,t,,pKi,0,5.610000134,0,Ki,0,2450,0,=,,,,9537821,CN(CC(CN1c2ccccc2CCc2c1cccc2)C)C
NET,926,SLC6A2,P23975,,,,,,Human,venlafaxine,7321,,,178103894,Inhibitor,Inhibition,,f,t,,pIC50,0,6.269999981,0,IC50,0,535,0,=,,,,20378347,COc1ccc(cc1)C(C1(O)CCCCC1)CN(C)C
NET,926,Slc6a2,,,,,,,Rat,ziprasidone,59,,,135651359,Inhibitor,Inhibition,,f,f,,pKi,0,7.320000172,0,Ki,0,48,0,=,,,,18595716,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
NET,926,SLC6A2,P23975,,,,,,Human,zotepine,103,,,135651367,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,71,0,=,,,,20223878,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
Neutral endopeptidase,1611,MME,P08473,,,,,,Human,thiorphan,5278,,,178101961,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,SC[C@H](C(=O)NCC(=O)O)Cc1ccccc1
nicotinic acetylcholine receptor &alpha;10 subunit,470,CHRNA10,Q9GZZ6,,,,,,Human,[<sup>3</sup>H]methyllycaconitine,3980,,,178100806,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,pKd,0,8.119999886,0,Kd,0,7.5,0,=,,,,0,CCN1C[C@@]2(CC[C@@H]([C@]34[C@H]1[C@](O)([C@H]([C@H]23)OC)[C@@]1([C@@H]2[C@H]4C[C@@H]([C@@H]2OC)[C@H](C1)OC)O)OC)COC(=O)c1ccccc1N1C(=O)C[C@@H](C1=O)C
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,succinylcholine,4004,,,178100830,Agonist,Full agonist,selective for (&alpha;1)<sub>2</sub>&beta;1&gamma;&delta;,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=C(OCC[N+](C)(C)C)CCC(=O)OCC[N+](C)(C)C
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,[<sup>125</sup>I]&alpha;-bungarotoxin,3972,,,178100798,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,[<sup>3</sup>H]&alpha;-bungarotoxin,3981,,,178100807,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;1 subunit,462,CHRNA1,P02708,,,,,,Human,waglerin-1,3984,,,178100810,Antagonist,Antagonist,selective for (&alpha;1)<sub>2</sub>&beta;1&delta;&epsilon;,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;2 subunit,463,Chrna2,P12389,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;2&beta;4,f,f,,pKd,10.07999992,0,10.06000042,Kd,0.086999997,0,0.083999999,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;2 subunit,463,Chrna2,P12389,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;2&beta;2,f,f,,pKd,11,0,10.68000031,Kd,0.021,0,0.01,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;2&beta;4,f,f,,pKd,0,10.38000011,0,Kd,0,0.041999999,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,[<sup>3</sup>H]cytisine,3979,,,178100805,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,c1([3H])cc([3H])c(=O)n2c1[C@H]1CNC[C@H](C1)C2
nicotinic acetylcholine receptor &alpha;2 subunit,463,Chrna2,P12389,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;2&beta;2,f,f,,pKd,11,0,10.68000031,Kd,0.021,0,0.01,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;2 subunit,463,CHRNA2,Q15822,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;2&beta;4,f,f,,pKd,0,10.38000011,0,Kd,0,0.041999999,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;2 subunit,463,Chrna2,P12389,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;2&beta;4,f,f,,pKd,10.07999992,0,10.06000042,Kd,0.086999997,0,0.083999999,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;3&beta;4,f,f,,pKd,0,9.640000343,0,Kd,0,0.230000004,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,Chrna3,P04757,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;3&beta;2,f,f,,pKd,10.85000038,0,10.47000027,Kd,0.034000002,0,0.014,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;3&beta;2,f,f,,pKd,0,11.14999962,0,Kd,0,0.007,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,Chrna3,P04757,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;3&beta;4,f,f,,pKd,9.539999962,0,9.520000458,Kd,0.30399999,0,0.289999992,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,[<sup>3</sup>H]cytisine,3979,,,178100805,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,c1([3H])cc([3H])c(=O)n2c1[C@H]1CNC[C@H](C1)C2
nicotinic acetylcholine receptor &alpha;3 subunit,464,Chrna3,P04757,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;3&beta;4,f,f,,pKd,9.539999962,0,9.520000458,Kd,0.30399999,0,0.289999992,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;3&beta;4,f,f,,pKd,0,9.640000343,0,Kd,0,0.230000004,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,CHRNA3,P32297,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;3&beta;2,f,f,,pKd,0,11.14999962,0,Kd,0,0.007,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;3 subunit,464,Chrna3,P04757,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;3&beta;2,f,f,,pKd,10.85000038,0,10.47000027,Kd,0.034000002,0,0.014,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,varenicline,5459,,,178102109,Agonist,Agonist,,f,t,,pKi,0,9.960000038,0,Ki,0,0.109999999,0,=,Binding affinity to human nicotinic acetylcholine receptor &alpha;4&beta;2 expressed in IMR32 cells using [<sup>3</sup>H]epibatidine radioligand.,,,16171993,N1C[C@@H]2C[C@H](C1)c1c2cc2c(c1)nccn2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;4&beta;4,f,f,,pKd,0,9.729999542,0,Kd,0,0.187000006,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,9.520000458,0,9.340000153,Kd,0.460000008,0,0.300000012,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;4&beta;4,f,f,,pKd,9.069999695,0,9.029999733,Kd,0.939999998,0,0.850000024,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>125</sup>I]epibatidine,3976,,,178100802,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,11,0,10.47999954,Kd,0.033,0,0.01,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>3</sup>H]cytisine,3979,,,178100805,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,9.369999886,0,9.199999809,Kd,0.629999995,0,0.430000007,=,,,,0,c1([3H])cc([3H])c(=O)n2c1[C@H]1CNC[C@H](C1)C2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>3</sup>H]cytisine,3979,,,178100805,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,0,c1([3H])cc([3H])c(=O)n2c1[C@H]1CNC[C@H](C1)C2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>3</sup>H]cytisine,3979,,,178100805,Agonist,Full agonist,&alpha;4&beta;4,f,f,,pKd,0,10,0,Kd,0,0.100000001,0,=,,,,0,c1([3H])cc([3H])c(=O)n2c1[C@H]1CNC[C@H](C1)C2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,11,0,10.47999954,Kd,0.033,0,0.01,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;4&beta;4,f,f,,pKd,0,9.729999542,0,Kd,0,0.187000006,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;4&beta;4,f,f,,pKd,9.069999695,0,9.029999733,Kd,0.939999998,0,0.850000024,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,9.520000458,0,9.340000153,Kd,0.460000008,0,0.300000012,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,[<sup>3</sup>H]nicotine,3978,,,178100804,Agonist,Full agonist,&alpha;4&beta;2,f,f,,pKd,0,9.399999619,0,Kd,0,0.400000006,0,=,,,,0,CN1CCCC1c1cccnc1
nicotinic acetylcholine receptor &alpha;4 subunit,465,CHRNA4,P43681,,,,,,Human,TC-2559,3987,,,178100813,Agonist,Full agonist,&alpha;4&beta;2,f,f,,-,0,0,0,-,0,0,0,=,,,,12871651,CNCC/C=C/c1cncc(c1)OCC
nicotinic acetylcholine receptor &alpha;4 subunit,465,Chrna4,P09483,,,,,,Rat,tebanicline,3989,,,178100815,Agonist,Partial agonist,,f,f,,pKi,0,10.43000031,0,Ki,0,0.037,0,=,,,,9580626,Clc1ccc(cn1)OC[C@H]1CCN1
nicotinic acetylcholine receptor &alpha;6 subunit,467,,,,,,,,Chicken,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,native &alpha;6&beta;4*,f,f,,pKd,0,10.46000004,0,Kd,0,0.035,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;6 subunit,467,CHRNA6,Q15825,,,,,,Human,[<sup>125</sup>I]&alpha;-conotoxin MII,3975,,,178100801,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,[<sup>3</sup>H]A-585539,3974,,,178100800,Agonist,Full agonist,native &alpha;7,f,f,,pKd,0,10.14999962,0,Kd,0,0.07,0,=,,,,17959745,C[N+]1(C)CC2CC1CN2c1ccc(nn1)c1ccccc1
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,[<sup>3</sup>H]AZ11637326,3971,,,178100797,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,pKd,0,9.640000343,0,Kd,0,0.230000004,0,=,,,,20674564,Fc1cccc(c1)c1cnc2c(c1)C[C@]1(O2)CN2CCC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,Agonist,Full agonist,(&alpha;7)<sub>5</sub>,f,f,,pKd,0,12.22000027,0,Kd,0,0.0006,0,=,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,[<sup>125</sup>I]&alpha;-bungarotoxin,3972,,,178100798,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,pKd,9.149999619,0,8.300000191,Kd,5,0,0.699999988,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,CHRNA7,P36544,,,,,,Human,[<sup>3</sup>H]&alpha;-bungarotoxin,3981,,,178100807,Antagonist,Antagonist,(&alpha;7)<sub>5</sub>,f,f,,pKd,9.149999619,0,8.300000191,Kd,5,0,0.699999988,=,,,,0,
nicotinic acetylcholine receptor &alpha;7 subunit,468,Chrna7,Q05941,,,,,,Rat,[<sup>3</sup>H]methyllycaconitine,3980,,,178100806,Antagonist,Antagonist,native &alpha;7*,f,f,,pKd,0,8.720000267,0,Kd,0,1.899999976,0,=,,,,0,CCN1C[C@@]2(CC[C@@H]([C@]34[C@H]1[C@](O)([C@H]([C@H]23)OC)[C@@]1([C@@H]2[C@H]4C[C@@H]([C@@H]2OC)[C@H](C1)OC)O)OC)COC(=O)c1ccccc1N1C(=O)C[C@@H](C1=O)C
nicotinic acetylcholine receptor &alpha;8 subunit (avian),752,,,,,,,,Human,[<sup>125</sup>I]&alpha;-bungarotoxin,3972,,,178100798,None,None,native &alpha;8*,f,,,pKd,0,8.26,0,Kd,0,5.5,0,,,,,0,
nicotinic acetylcholine receptor &alpha;8 subunit (avian),752,,,,,,,,Human,[<sup>3</sup>H]&alpha;-bungarotoxin,3981,,,178100807,None,None,native &alpha;8*,f,,,pKd,0,8.26,0,Kd,0,5.5,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;8 subunit (avian),752,,,,,,,,Human,[<sup>3</sup>H]epibatidine,3977,,,178100803,None,None,(&alpha;8)<sub>5</sub>,f,,,pKd,0,9.7,0,Kd,0,0.2,0,,,,,0,Clc1ccc(cn1)C1CC2NC1CC2
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,[<sup>125</sup>I]&alpha;-bungarotoxin,3972,,,178100798,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,[<sup>3</sup>H]&alpha;-bungarotoxin,3981,,,178100807,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
nicotinic acetylcholine receptor &alpha;9 subunit,469,CHRNA9,Q9UGM1,,,,,,Human,[<sup>3</sup>H]methyllycaconitine,3980,,,178100806,Antagonist,Antagonist,&alpha;9&alpha;10,f,f,,pKd,0,8.119999886,0,Kd,0,7.5,0,=,,,,0,CCN1C[C@@]2(CC[C@@H]([C@]34[C@H]1[C@](O)([C@H]([C@H]23)OC)[C@@]1([C@@H]2[C@H]4C[C@@H]([C@@H]2OC)[C@H](C1)OC)O)OC)COC(=O)c1ccccc1N1C(=O)C[C@@H](C1=O)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,substance P,2098,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651888,Agonist,Full agonist,,t,,,pKi,10.3,0,8.5,,0,0,0,,,,,11786503,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,substance P-(4-11),2099,,,135652478,Agonist,Full agonist,,f,,,pIC50,8,0,7.7,,0,0,0,,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,substance P-(6-11),2100,,,135652479,Agonist,Full agonist,,f,,,pIC50,6.5,0,6.3,,0,0,0,,,,,8702757,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,substance P-OMe,2101,,,135652480,Agonist,Full agonist,,f,,,pIC50,7.5,0,7.4,-,0,0,0,=,,,,8702757,
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,"[<sup>125</sup>I]BH-[Sar<sup>9</sup>,Met(O<sub>2</sub>)<sup>11</sup>]SP",3769,,,178100619,Agonist,Full agonist,,f,,,pKd,0,9,0,Kd,0,1,0,=,,,,1705465,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"[<sup>125</sup>I]SP (human, mouse, rat)",3805,,,178100652,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
NK<sub>1</sub> receptor,360,Tacr1,P14600,,,,,,Rat,"[<sup>3</sup>H]BH-[Sar<sup>9</sup>,Met(O<sub>2</sub>)<sup>11</sup>]SP",3811,,,178100658,Agonist,Full agonist,,f,f,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,1722129,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"[<sup>3</sup>H]SP (human, mouse, rat)",3835,,,178100678,Agonist,Full agonist,,f,f,,pKd,0,8.600000381,0,Kd,0,2.799999952,0,=,,,,2410593,
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,"[<sup>125</sup>I]L703,606",3471,,,53801063,Antagonist,Antagonist,,f,f,,pKd,0,9.5,0,Kd,0,0.300000012,0,=,,,,8287060,[125I]c1ccccc1CN[C@@H]1C2CCN([C@@H]1C(c1ccccc1)c1ccccc1)CC2
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,[<sup>18</sup>F]SPA-RQ,3473,,,53801060,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,[18F]COc1ccc(cc1CN[C@H]1CCCN[C@H]1c1ccccc1)n1nnnc1C(F)(F)F
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,T2328,5746,,,178102372,Antagonist,Antagonist,,f,,,pKi,0,10.1,0,Ki,0,0.08,0,=,,,,18187929,COc1ccc(cc1CN[C@H]1CCCN[C@H]1c1ccccc1)c1ccc(cc1F)C#N
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,TAK-637,9329,,,318164848,Antagonist,Antagonist,,f,f,,pIC50,0,9.350000381,0,IC50,0,0.449999988,0,=,Inhibition of [<sup>125</sup>I]BH-SP binding in human IM-9 cells.,,,10508446,C[C@@H]1CCn2c(C(=O)N(C1)Cc1cc(cc(c1)C(F)(F)F)C(F)(F)F)c(c1ccc(cc1)C)c1c(c2=O)nccc1
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,tradipitant,9278,,,318164797,Antagonist,Antagonist,,f,f,,pKi,0,7,0,Ki,0,100,0,<,Measuring displacement of [125I]-substance P binding to membranes from IM-9 cells (human B lymphocytes),,,0,Clc1ccccc1C(=O)c1cccnc1c1nnn(c1c1ccncc1)Cc1cc(cc(c1)C(F)(F)F)C(F)(F)F
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,vestipitant,5757,,,178102382,Antagonist,Antagonist,,f,f,,pKi,0,9.369999886,0,-,0,0,0,=,,,,18657401,Fc1ccc(c(c1)C)[C@H]1CNCCN1C(=O)N([C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)C
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,vofopitant,5752,,,178102378,Antagonist,Antagonist,,f,,,pKi,0,10.6,0,Ki,0,0,0,=,,,,8876035,COc1ccc(cc1CN[C@H]1CCCN[C@H]1c1ccccc1)n1nnnc1C(F)(F)F
NK<sub>1</sub> receptor,360,TACR1,P25103,,,,,,Human,ZD6021,2109,,,135651357,Antagonist,Antagonist,,f,,,pIC50,0,9.9,0,,0,0,0,,,,,11408556,N#Cc1cc2ccccc2c(c1)C(=O)N(C[C@H](c1ccc(c(c1)Cl)Cl)CCN1CCC(CC1)c1ccccc1[S@@](=O)C)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,substance P,2098,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651888,Agonist,Full agonist,,t,,,pKi,6.9,0,5.9,,0,0,0,,,,,11786503,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,"[<sup>125</sup>I]NKA (human, mouse, rat)",3795,,,178100644,Agonist,Full agonist,,f,f,,pKd,0,9.300000191,0,Kd,0,0.469999999,0,=,,,,10455255,
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,[<sup>3</sup>H]GR100679,3822,,,178100666,Antagonist,Antagonist,,f,f,,pKd,0,9.199999809,0,Kd,0,0.600000024,0,=,,,,8210508,
NK<sub>2</sub> receptor,361,Tacr2,P16610,,,,,,Rat,[<sup>3</sup>H]saredutant,3481,,,178100472,Antagonist,Antagonist,,f,,,pKd,0,9.7,0,Kd,0,0.2,0,=,,,,7719707,CC(=O)NC1(CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C)c1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,talnetant,2132,,,135650992,Antagonist,Antagonist,,f,f,,pKi,6.900000095,0,6.800000191,-,0,0,0,=,,,,9190866,CC[C@@H](c1ccccc1)NC(=O)c1c(O)c(nc2c1cccc2)c1ccccc1
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,YM44778,2120,,,135651346,Antagonist,Antagonist,,f,,,pKi,0,8.6,0,-,0,0,0,=,,,,11937780,COc1cc(cc(c1OC)OC)C(=O)N(CC(c1ccc(c(c1)Cl)Cl)CCN1CCC2(CC1)NC(=O)Cc1c2cccc1)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,YM44781,2121,,,135651347,Antagonist,Antagonist,,f,,,pKi,0,9.9,0,-,0,0,0,=,,,,11937780,O=C1Cc2ccccc2C2(N1)CCN(CC2)CCC(c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccc(cc1)F)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,YM49598,2122,,,135651349,Antagonist,Antagonist,,f,,,pKi,0,6.8,0,-,0,0,0,=,,,,11937780,CC(Oc1cccc(c1)CC(=O)N1CCCC(C1)(CC[N+]1(C)CCC(CC1)c1ccccc1)c1ccc(c(c1)Cl)Cl)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,ZM 253270,5771,,,178102396,Antagonist,Antagonist,,f,,,pKi,0,3.8,0,Ki,0,150000,0,=,,,,7562491,O/N=C(/C(=O)N1CCN(CC1)c1nc(Nc2ccc(cc2)Cl)c2c(n1)C(=O)N(C2)C(C)C)C
NK<sub>2</sub> receptor,361,,,,,,,,Guinea pig,ZM 253270,5771,,,178102396,Antagonist,Antagonist,,f,,,pKi,0,5.05,0,Ki,0,9000,0,=,,,,7562491,O/N=C(/C(=O)N1CCN(CC1)c1nc(Nc2ccc(cc2)Cl)c2c(n1)C(=O)N(C2)C(C)C)C
NK<sub>2</sub> receptor,361,TACR2,P21452,,,,,,Human,ZM-274773,5778,,,178102403,Antagonist,Antagonist,,f,,,pKi,0,8.62,0,Ki,0,2.4,0,=,,,,22149761,O=C1NCCCN1C1CCN(CC1)CC[C@@H](c1ccc(c(c1)Cl)Cl)CN(C(=O)c1ccccc1)C
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,substance P,2098,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651888,Agonist,Full agonist,,t,,,pKi,6,0,5,,0,0,0,,,,,9190866,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
NK<sub>3</sub> receptor,362,Tacr3,P47937,,,,,,Mouse,substance P,2098,TAC1|Tac1|Tac1,Human|Mouse|Rat,135651888,Agonist,Full agonist,,t,,,pKi,0,5.3,0,-,0,0,0,=,,,,11226387,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,[<sup>125</sup>I][MePhe<sup>7</sup>]NKB,3763,,,178100614,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
NK<sub>3</sub> receptor,362,,,,,,,,Guinea pig,[<sup>3</sup>H]senktide,3834,,,178100677,Agonist,Full agonist,,f,f,,pKd,8.699999809,0,8.100000381,Kd,8.520000458,0,2.210000038,=,,,,1694464,
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,[<sup>3</sup>H]osanetant,3480,,,178100471,Antagonist,Antagonist,,f,f,,pKd,0,9.899999619,0,Kd,0,0.129999995,0,=,,,,0,O=C(N1CCC[C@](C1)(CCCN1CCC(CC1)(c1ccccc1)N(C(=O)C)C)c1ccc(c(c1)Cl)Cl)c1ccccc1
NK<sub>3</sub> receptor,362,Tacr3,P16177,,,,,,Rat,talnetant,2132,,,135650992,Antagonist,Antagonist,,f,,,pKi,7.4,0,7.3,,0,0,0,,,,,11226387,CC[C@@H](c1ccccc1)NC(=O)c1c(O)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,TACR3,P29371,,,,,,Human,talnetant,2132,,,135650992,Antagonist,Antagonist,,f,f,,pKi,9,0,7.400000095,-,0,0,0,=,,,,9190866,CC[C@@H](c1ccccc1)NC(=O)c1c(O)c(nc2c1cccc2)c1ccccc1
NK<sub>3</sub> receptor,362,Tacr3,P16177,,,,,,Rat,"[Trp<sup>7</sup>, &beta;-Ala<sup>8</sup>] neurokinin A-(4-10)",5782,,,178102407,Antagonist,Antagonist,,f,,,pA2,0,7.46,0,-,0,0,0,=,,,,2176308,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,[<sup>125</sup>I]neuromedin U-23 (rat),1475,,,135652536,Agonist,Agonist,,f,,,pKd,9.5,0,9.1,-,0,0,0,=,,,,10894543,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,[<sup>125</sup>I]neuromedin U-25 (human),1474,,,135652538,Agonist,Agonist,,f,,,pKd,10.1,0,9.9,-,0,0,0,=,,,,15292653,
NMU1 receptor,298,NMUR1,Q9HB89,,,,,,Human,[<sup>125</sup>I]neuromedin U-8 (pig),1476,,,135652537,Agonist,Agonist,,f,,,pKd,0,8.6,0,-,0,0,0,=,,,,10899166,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,[<sup>125</sup>I]neuromedin U-23 (rat),1475,,,135652536,Agonist,Agonist,,f,,,pKd,0,9.1,0,-,0,0,0,=,,,,10899166,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,[<sup>125</sup>I]neuromedin U-25 (human),1474,,,135652538,Agonist,Agonist,,f,,,pKd,0,9.8,0,-,0,0,0,=,,,,15292653,
NMU2 receptor,299,NMUR2,Q9GZQ4,,,,,,Human,[<sup>125</sup>I]neuromedin U-8 (pig),1476,,,135652537,Agonist,Agonist,,f,,,pKd,0,9.1,0,-,0,0,0,=,,,,10899166,
NOP receptor,320,OPRL1,P41146,,,,,,Human,[<sup>3</sup>H]Leu-N/OFQ,3824,,,178100668,Agonist,Full agonist,,f,f,,pKd,0,10.19999981,0,Kd,0,0.059999999,0,=,,,,12967935,
NOP receptor,320,OPRL1,P41146,,,,,,Human,[<sup>3</sup>H]N/OFQ,1688,,,135652587,Agonist,Full agonist,,f,f,,pKd,10.19999981,0,9.819999695,Kd,0.150000006,0,0.063000001,=,,,,9353393,
NOP receptor,320,Oprl1,P35377,,,,,,Mouse,[<sup>3</sup>H]Tyr<sup>14</sup>-N/OFQ,1687,,,135652581,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,9413015,
NOP receptor,320,OPRL1,P41146,,,,,,Human,UFP-102,1685,,,135652627,Agonist,Full agonist,,f,,,pKd,0,10.7,0,,0,0,0,,,,,15509719,
NOP receptor,320,OPRL1,P41146,,,,,,Human,UFP-112,3917,,,178100749,Agonist,Full agonist,,f,f,,pEC50,9.710000038,0,8.390000343,-,0,0,0,=,,,,17532097,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CC(=O)N)CCCCN)CCCNC(=N)N)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)C(NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccc(cc1)F)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)(C)C)CCCNC(=N)N
NOP receptor,320,OPRL1,P41146,,,,,,Human,UFP-101,1694,,,135652626,Antagonist,Antagonist,,f,f,,pKi,0,10.19999981,0,-,0,0,0,=,,,,12010780,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)CCCCN)CCCN=C(N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)CNCc1ccccc1)C)CCCN=C(N)N
notch 2,2859,NOTCH2,Q04721,,,,,,Human,tarextumab,8453,,,252166663,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,,,,0,
notch 3,2860,NOTCH3,Q9UM47,,,,,,Human,tarextumab,8453,,,252166663,Antibody,Binding,,f,t,,pKd,0,9.920000076,0,Kd,0,0.119999997,0,=,,,,0,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,[<sup>125</sup>I]NPW-23 (human),1497,,,135652540,Agonist,Agonist,,f,,,pKd,0,9.4,0,Kd,0,0.44,0,,,,,15261118,
NPBW1 receptor,303,Npbwr1,Q56UD9,,,,,,Rat,[<sup>125</sup>I]NPW-23 (human),1497,,,135652540,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,15261118,
NPBW1 receptor,303,NPBWR1,P48145,,,,,,Human,[<sup>125</sup>I][Tyr<sup>11</sup>]des-Br-NPB-23,1498,,,135652564,Agonist,Full agonist,,f,,,pKd,0,10.4,0,,0,0,0,,,,,12118011,
NPBW2 receptor,304,NPBWR2,P48146,,,,,,Human,[<sup>125</sup>I]NPW-23 (human),1497,,,135652540,Agonist,Agonist,,f,,,pKd,0,7.7,0,Kd,0,19.9,0,=,,,,12130646,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,[<sup>125</sup>I]1DMe,1483,,,135652481,Agonist,Full agonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,11024015,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,[<sup>125</sup>I]NPFF,3797,,,178100646,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,17011599,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,[<sup>125</sup>I]Y-RFRP-3,1484,,,135652577,Agonist,Full agonist,,f,,,pKd,0,9.7,0,Kd,0,8,0,=,,,,12421602,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,[<sup>3</sup>H]NPVF,4019,,,178100845,Agonist,Full agonist,,f,,,pKd,0,8.6,0,Kd,0,2.65,0,=,,,,19682524,
NPFF1 receptor,300,NPFFR1,Q9GZQ6,,,,,,Human,Y-RFRP-3,1482,,,135652644,Agonist,Full agonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,12242085,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,[<sup>125</sup>I]EYF,1488,,,135652516,Agonist,Full agonist,,f,,,pKd,0,10.2,0,Kd,0,0.063,0,=,,,,12242085,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,[<sup>125</sup>I]NPFF,3797,,,178100646,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,17011599,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,[<sup>3</sup>H]EYF,4021,,,178100847,Agonist,Full agonist,,f,,,pKd,0,9.3,0,Kd,0,0.54,0,=,,,,19682524,
NPFF2 receptor,301,NPFFR2,Q9Y5X5,,,,,,Human,Y-RFRP-3,1482,,,135652644,Agonist,Full agonist,,f,,,pKi,0,8,0,-,0,0,0,=,,,,12242085,
NPS receptor,302,NPSR1,Q6W5P4,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>NPS (human),1493,,,135652563,Agonist,Full agonist,,f,,,pKd,0,9.5,0,Kd,0,0.33,0,=,,,,15312648,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,"[<sup>125</sup>I]neurotensin (human, mouse, rat)",1574,,,135652533,Agonist,Full agonist,,f,,,pKd,9.9,0,9.6,,0,0,0,,,,,7746272,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,Thr<sup>10</sup>contulakin-G,1573,,,135652603,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,10318778,
NTS<sub>1</sub> receptor,309,NTSR1,P30989,,,,,,Human,Thr<sup>10</sup>contulakin-G,1573,,,135652603,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,10318778,
NTS<sub>1</sub> receptor,309,Ntsr1,P20789,,,,,,Rat,[<sup>3</sup>H]meclinertant,1583,,,135651210,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,Kd,0,3.2,0,=,,,,7746272,Clc1ccc2c(c1)nccc2n1nc(cc1c1c(cccc1OC([3H])([3H])[3H])OC([3H])([3H])[3H])C(=O)NC1(C(=O)O)C2CC3CC1CC(C2)C3
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,"[<sup>125</sup>I]neurotensin (human, mouse, rat)",1574,,,135652533,Agonist,Full agonist,,f,,,pIC50,0,9.1,0,,0,0,0,,,,,8647296,
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,"[<sup>125</sup>I]neurotensin (human, mouse, rat)",1574,,,135652533,Agonist,Full agonist,,f,,,pKd,0,8.6,0,,0,0,0,,,,,8795617,
NTS<sub>2</sub> receptor,310,Ntsr2,Q63384,,,,,,Rat,Thr<sup>10</sup>contulakin-G,1573,,,135652603,Agonist,Full agonist,,f,,,pIC50,0,6.8,0,,0,0,0,,,,,10318778,
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,Trp<sup>11</sup>-neurotensin,1585,,,135652613,Agonist,Full agonist,,f,,,pIC50,9,0,8.8,,0,0,0,,,,,9480852,
NTS<sub>2</sub> receptor,310,Ntsr2,P70310,,,,,,Mouse,xenin,1587,COPA|Copa|Copa,Human|Mouse|Rat,135651922,Agonist,Full agonist,,t,,,pIC50,8.8,0,8.7,,0,0,0,,,,,9480852,NCCCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)CCCCN)Cc1[nH]cnc1)Cc1ccccc1)CO)CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)N)CC(C)C)CCCCN)Cc1ccccc1)CCC(=O)O)CCCCN)CO)C)CCCNC(=N)N
NUAK family kinase 1,2129,NUAK1,O60285,,,,,,Human,WZ4002,9176,,,315661259,Inhibitor,Inhibition,,f,f,,pKd,0,7.039999962,0,Kd,0,91,0,=,,,,20033049,C=CC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
NUAK family kinase 1,2129,NUAK1,O60285,,,,,,Human,WZ4003,8047,,,249565727,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,24171924,CCC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
"NUAK family, SNF1-like kinase, 2",2130,NUAK2,Q9H093,,,,,,Human,WZ4003,8047,,,249565727,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,24171924,CCC(=O)Nc1cccc(c1)Oc1nc(ncc1Cl)Nc1ccc(cc1OC)N1CCN(CC1)C
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,[<sup>3</sup>H]BSP,4505,,,178101232,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Brc1c(Br)c(Br)c2c(c1Br)C(=O)OC2(c1ccc(c(c1)S(=O)(=O)[O-])O)c1ccc(c(c1)S(=O)(=O)[O-])O.[Na+].[Na+]
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,[<sup>3</sup>H]DPDPE,3819,,,178100664,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
OATP1A2,1219,SLCO1A2,P46721,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,[<sup>3</sup>H]estradiol-17&beta;-glucuronide,4687,,,178101401,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@@H]3[C@]2(C)CC[C@H]2[C@H]3CCc3c2ccc(c3)O)[C@@H]([C@H]([C@@H]1O)O)O
OATP1B1,1220,SLCO1B1,Q9Y6L6,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,[<sup>3</sup>H]BSP,4505,,,178101232,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Brc1c(Br)c(Br)c2c(c1Br)C(=O)OC2(c1ccc(c(c1)S(=O)(=O)[O-])O)c1ccc(c(c1)S(=O)(=O)[O-])O.[Na+].[Na+]
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,"[<sup>3</sup>H]CCK-8 (human, mouse, rat)",4765,,,178101474,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,
OATP1B3,1221,SLCO1B3,Q9NPD5,,,,,,Human,[<sup>3</sup>H]estradiol-17&beta;-glucuronide,4687,,,178101401,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)[C@H]1O[C@@H](O[C@H]2CC[C@@H]3[C@]2(C)CC[C@H]2[C@H]3CCc3c2ccc(c3)O)[C@@H]([C@H]([C@@H]1O)O)O
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,taurocholic acid,4547,,,178101268,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)NCCS(=O)(=O)O)C)C)O)C
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,[<sup>125</sup>I]thyroxine,4627,,,178101345,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc([125I])c(c(c1)I)O)N
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,[<sup>3</sup>H]BSP,4505,,,178101232,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Brc1c(Br)c(Br)c2c(c1Br)C(=O)OC2(c1ccc(c(c1)S(=O)(=O)[O-])O)c1ccc(c(c1)S(=O)(=O)[O-])O.[Na+].[Na+]
OATP1C1,1222,SLCO1C1,Q9NYB5,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP2A1,1223,SLCO2A1,Q92959,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,9506966,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,verlukast,6193,,,178102814,Inhibitor,Inhibition,,f,f,,pKi,0,5.550000191,0,Ki,0,2800,0,=,,,,22541068,OC(=O)CCS[C@H](c1cccc(c1)/C=C/c1ccc2c(n1)cc(cc2)Cl)SCCC(=O)N(C)C
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,[<sup>3</sup>H]BSP,4505,,,178101232,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,Brc1c(Br)c(Br)c2c(c1Br)C(=O)OC2(c1ccc(c(c1)S(=O)(=O)[O-])O)c1ccc(c(c1)S(=O)(=O)[O-])O.[Na+].[Na+]
OATP2B1,1224,SLCO2B1,O94956,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP3A1,1225,SLCO3A1,Q9UIG8,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP3A1,1225,SLCO3A1,Q9UIG8,,,,,,Human,[<sup>3</sup>H]PGE<sub>2</sub>,1916,,,135651569,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=CCCCC(=O)O)O
OATP4A1,1226,SLCO4A1,Q96BD0,,,,,,Human,[<sup>3</sup>H]estrone-3-sulphate,4748,,,178101458,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
OATP4C1,1227,SLCO4C1,Q6ZQN7,,,,,,Human,[<sup>3</sup>H]digoxin,4725,,,178101436,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O=C1OCC(=C1)[C@H]1CC[C@]2([C@]1(C)[C@H](O)C[C@H]1[C@H]2CC[C@H]2[C@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O[C@H]1C[C@H](O)[C@@H]([C@H](O1)C)O)O
OT receptor,369,OXTR,P30559,,,,,,Human,"[<sup>3</sup>H]OT (human, mouse, rat)",2176,,,135652589,Agonist,Full agonist,,f,f,,pKd,9.5,0,8.199999809,Kd,6.309999943,0,0.316000015,=,,,,7774575,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
OT receptor,369,OXTR,P30559,,,,,,Human,"[Thr<sup>4</sup>,Gly<sup>7</sup>]OT",2179,,,135652604,Agonist,Full agonist,,f,f,,pKi,8.399999619,0,8.199999809,-,0,0,0,=,,,,7475979,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C
OT receptor,369,OXTR,P30559,,,,,,Human,"[<sup>3</sup>H]AVP (human, mouse, rat)",2175,,,135652582,Agonist,Partial agonist,,f,,,pKd,8.9,0,8.8,,0,0,0,,,,,7774575,
OT receptor,369,OXTR,P30559,,,,,,Human,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Partial agonist,,t,,,pKi,9.3,0,7.3,,0,0,0,,,,,12446593,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
OT receptor,369,OXTR,P30559,,,,,,Human,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Orn<sup>8</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT",3778,,,178100628,Antagonist,Antagonist,,f,,,pKd,0,10,0,Kd,0,0.09,0,,,,,0,
OT receptor,369,OXTR,P30559,,,,,,Human,[<sup>35</sup>S]non-peptide OT antagonist,3484,,,178100475,Antagonist,Antagonist,,f,f,,pKd,0,10.38000011,0,Kd,0,0.041999999,0,=,,,,12176104,O=C(N1CCC(CC1)N1C(=O)CCc2c1cccc2)Cc1ccc(cc1OCC(F)(F)F)OC1CCN(CC1)[35S](=O)(=O)C
OT receptor,369,OXTR,P30559,,,,,,Human,[<sup>111</sup>In]DOTA-dLVT,3756,,,178100609,None,None,,f,,,pKd,0,8.3,0,Kd,0,4.5,0,=,,,,12942128,
OXE receptor,271,OXER1,Q8TDS5,,,,,,Human,[<sup>3</sup>H]5-oxo-ETE,3416,,,178100422,Agonist,Agonist,,f,,,pKd,0,8.4,0,Kd,0,3.8,0,=,,,,9829988,CCCCC/C=CC/C=CC/C=CC=CC(=O)CCCC(=O)O
oxoglutarate receptor,162,Oxgr1,Q6IYF8,,,,,,Mouse,[<sup>3</sup>H]LTE<sub>4</sub>,5863,,,178102487,Agonist,Agonist,,f,,,pKd,0,8.6,0,Kd,0,2.5,0,=,,,,23504326,CCCCC/C=CC/C=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,[<sup>3</sup>H]SB-674042,1706,,,135651203,Antagonist,Antagonist,,f,f,,pKd,9.100000381,0,8.300000191,Kd,5.03000021,0,0.74000001,=,,,,14691055,Cc1nc(c(s1)c1ccccc1F)C(=O)N1CCC[C@H]1Cc1nnc(o1)c1c([3H])cccc1[3H]
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,suvorexant,2890,,,135650615,Antagonist,Antagonist,,f,t,,pKi,0,9.300000191,0,Ki,0,0.500999987,0,=,,,,20565075,Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1
OX<sub>1</sub> receptor,321,HCRTR1,O43613,,,,,,Human,TCS 1102,9304,,,318164823,Antagonist,Antagonist,,f,t,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,18207395,O=C([C@@H]1CCCN1C(=O)CSc1nc2c(n1C)cccc2)Nc1ccccc1c1ccccc1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,[<sup>125</sup>I]-orexin-A,9464,,,329968404,Agonist,Agonist,Useful working concentration sub nM-low nM.,f,f,,-,0,0,0,-,0,0,0,=,,,,9491897,
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,[<sup>3</sup>H]-almorexant,9465,,,329968405,Antagonist,Antagonist,,f,f,,pKd,9.800000191,0,8.899999619,Kd,1.25,0,0.158000007,=,,,,19542319,CNC(=O)[C@@H](c1c([3H])cccc1[3H])N1CCc2c([C@@H]1CCc1ccc(cc1)C(F)(F)F)cc(c(c2)OC)OC
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,[<sup>3</sup>H]Cp-1,9466,,,329968406,Antagonist,Antagonist,,f,f,,pKd,9.399999619,0,9.199999809,Kd,0.629999995,0,0.400000006,=,,,,19542319,CNC(=O)[C@H](N1CCc2c([C@@H]1CCc1ccc(nc1[3H])C(F)(F)F)cc(c(c2)OC)OC)c1ccccc1[3H]
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,[<sup>3</sup>H]EMPA,9467,,,329968407,Antagonist,Antagonist,,f,f,,pKd,9,0,8.600000381,Kd,2.50999999,0,1,=,,,,19751316,CCN(C(=O)CN(S(=O)(=O)c1ccccc1C)c1ccc(nc1)OC([3H])([3H])[3H])Cc1ccc(nc1)[3H]
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,[<sup>3</sup>H]SB-674042,1706,,,135651203,Antagonist,Antagonist,,f,,,pKd,0,6.9,0,-,0,0,0,=,,,,14691055,Cc1nc(c(s1)c1ccccc1F)C(=O)N1CCC[C@H]1Cc1nnc(o1)c1c([3H])cccc1[3H]
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,suvorexant,2890,,,135650615,Antagonist,Antagonist,,f,t,,pKi,0,9.460000038,0,Ki,0,0.349999994,0,=,,,,20565075,Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,TCS 1102,9304,,,318164823,Antagonist,Antagonist,,f,t,,pKi,0,9.699999809,0,Ki,0,0.200000003,0,=,,,,18207395,O=C([C@@H]1CCCN1C(=O)CSc1nc2c(n1C)cccc2)Nc1ccccc1c1ccccc1
OX<sub>2</sub> receptor,322,HCRTR2,O43614,,,,,,Human,TCS-OX2-29,4038,,,178100862,Antagonist,Antagonist,,f,f,,pKi,0,7.400000095,0,-,0,0,0,=,,,,14643355,COc1cc2CN(CCc2cc1OC)C(=O)[C@H](C(C)(C)C)NCc1ccncc1
P2X1,478,P2rx1,P47824,,,,,,Rat,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,12213051,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2X1,478,P2RX1,P51575,,,,,,Human,TNP-ATP,4324,,,178101141,Antagonist,Antagonist,,f,f,,pIC50,0,8.899999619,0,IC50,0,1.299999952,0,~,,,,9614197,NC1=NC=NC2=[N+](C=NC12)c1oc(c2c1OC1(O2)C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])COP(=O)(OP(=O)(OP(=O)([O-])[O-])O)O
P2X2,479,P2rx2,P49653,,,,,,Rat,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,4.980000019,0,IC50,0,10400,0,=,,,,12213051,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2X3,480,P2rx3,P49654,,,,,,Rat,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,5.519999981,0,IC50,0,3000,0,=,,,,12213051,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2X3,480,P2RX3,P56373,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,4.829999924,0,IC50,0,14900,0,=,,,,12213051,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2X3,480,P2RX3,P56373,,,,,,Human,TNP-ATP,4324,,,178101141,Antagonist,Antagonist,,f,,,pIC50,0,8.9,0,IC50,0,1.3,0,~,,,,9614197,NC1=NC=NC2=[N+](C=NC12)c1oc(c2c1OC1(O2)C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])COP(=O)(OP(=O)(OP(=O)([O-])[O-])O)O
P2X5,482,P2rx5,P51578,,,,,,Rat,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,5.400000095,0,IC50,0,4000,0,=,,,,12213051,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,uridine triphosphate,1734,,,135651592,Agonist,Full agonist,,t,,,pEC50,0,5.2,0,,0,0,0,,,,,12761346,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>11</sub> receptor,327,P2RY11,Q96G91,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,6,0,4.800000191,-,0,0,0,=,,,,10578132,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,[<sup>3</sup>H]2MeSADP,1763,,,135651125,Agonist,Full agonist,,f,,,pIC50,9.6,0,7.5,IC50,31.6,0,0.25,=,,,,11502873,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,[<sup>3</sup>H]PSB-0413,6147,,,178102768,Antagonist,Antagonist,,f,,,pKd,8.5,0,8.3,Kd,4.57,0,3.16,=,,,,22892887,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1nc(SCC(C([3H])([3H])[3H])([3H])[3H])nc2N)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ticagrelor,1765,,,135649975,Antagonist,Antagonist,,f,t,,pKi,0,8.699999809,0,Ki,0,1.99000001,0,=,"Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.",,,17827008,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ticagrelor,1765,,,135649975,Antagonist,Antagonist,,f,t,,pKi,0,7.849999905,0,Ki,0,14,0,=,,,,22984835,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO
P2Y<sub>12</sub> receptor,328,P2RY12,Q9H244,,,,,,Human,ticagrelor,1765,,,135649975,Antagonist,Antagonist,,f,t,,pKB,0,8.590000153,0,-,0,0,0,=,,,,25186974,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,[<sup>33</sup>P]2MeSADP,1774,,,135651123,Agonist,Full agonist,,f,f,,pKd,0,9.600000381,0,-,0,0,0,=,,,,12815166,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO[33P](=O)(O[33P](=O)(O)O)O
P2Y<sub>13</sub> receptor,329,P2RY13,Q9BPV8,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,,,pIC50,0,5.6,0,,0,0,0,,,,,12815166,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,UDP-galactose,1782,,,135651585,Agonist,Full agonist,,t,,,pEC50,0,7,0,,0,0,0,,,,,19339661,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2ry14,Q9ESG6,,,,,,Mouse,UDP-galactose,1782,,,135651585,Agonist,Full agonist,,t,,,pEC50,0,7.6,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2ry14,O35881,,,,,,Rat,UDP-galactose,1782,,,135651585,Agonist,Full agonist,,t,,,pEC50,0,7.1,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2ry14,Q9ESG6,,,,,,Mouse,UDP-glucose,1783,,,135651586,Agonist,Full agonist,,t,,,pEC50,0,7.7,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2ry14,O35881,,,,,,Rat,UDP-glucose,1783,,,135651586,Agonist,Full agonist,,t,,,pEC50,0,7.6,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,UDP-glucose,1783,,,135651586,Agonist,Full agonist,,f,,,pIC50,0,7.1,0,,0,0,0,,,,,19339661,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
P2Y<sub>14</sub> receptor,330,P2ry14,Q9ESG6,,,,,,Mouse,UDP-glucuronic acid,1784,,,135651587,Agonist,Full agonist,,t,,,pEC50,0,7.2,0,,0,0,0,,,,,11735218,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O[C@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>14</sub> receptor,330,P2ry14,O35881,,,,,,Rat,UDP-glucuronic acid,1784,,,135651587,Agonist,Full agonist,,t,,,pEC50,0,7,0,,0,0,0,,,,,11735218,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O[C@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,UDP-glucuronic acid,1784,,,135651587,Agonist,Full agonist,,f,,,pEC50,0,7.2,0,,0,0,0,,,,,19339661,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O[C@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>14</sub> receptor,330,P2ry14,Q9ESG6,,,,,,Mouse,UDP N-acetyl-glucosamine,1779,,,135651588,Agonist,Full agonist,,t,,,pEC50,0,7,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C
P2Y<sub>14</sub> receptor,330,P2ry14,O35881,,,,,,Rat,UDP N-acetyl-glucosamine,1779,,,135651588,Agonist,Full agonist,,t,,,pEC50,0,6.8,0,,0,0,0,,,,,11735218,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,UDP N-acetyl-glucosamine,1779,,,135651588,Agonist,Full agonist,,f,,,pEC50,0,6,0,,0,0,0,,,,,19339661,OC[C@H]1O[C@H](OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(=O)[nH]c2=O)O)O)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C
P2Y<sub>14</sub> receptor,330,P2RY14,Q15391,,,,,,Human,uridine diphosphate,1749,,,135651583,Agonist,Full agonist,,t,,,pEC50,0,7.13,0,EC50,0,74,0,=,,,,19759354,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>14</sub> receptor,330,P2ry14,O35881,,,,,,Rat,uridine diphosphate,1749,,,135651583,Agonist,Full agonist,,t,,,pIC50,0,6.5,0,,0,0,0,,,,,18252808,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>1</sub> receptor,323,,,,,,,,Unknown,[<sup>35</sup>S]ADP&beta;S,3408,,,178100415,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H](COP(=O)(OP(=[35S])(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,[<sup>3</sup>H]2MeSADP,1763,,,135651125,Agonist,Agonist,,f,f,,pKd,0,7.300000191,0,Kd,0,49,0,=,,,,11502873,CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,[<sup>32</sup>P]MRS2500,1726,,,135651122,Antagonist,Antagonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,16299552,CNc1nc(I)nc2c1ncn2[C@H]1C[C@@H]([C@]2([C@@H]1C2)CO[32P](=O)(O)O)OP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,[<sup>3</sup>H]MRS2279,1727,,,135651183,Antagonist,Antagonist,,f,,,pKd,0,8.1,0,Kd,0,8,0,=,,,,12391289,CNc1nc(Cl)nc2c1ncn2C[C@H]1C[C@@H]([C@H](C1)COP(=O)(O)O)OP(=O)(O)O
P2Y<sub>1</sub> receptor,323,P2RY1,P47900,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pKi,0,5.300000191,0,-,0,0,0,=,,,,12391289,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,uridine triphosphate,1734,,,135651592,Agonist,Full agonist,,t,f,,pEC50,0,8.100000381,0,-,0,0,0,=,,,,8564228,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,UTP&gamma;S,1735,,,135651593,Agonist,Full agonist,,f,f,,pEC50,0,5.800000191,0,-,0,0,0,=,,,,8564228,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>2</sub> receptor,324,P2RY2,P41231,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pIC50,0,4.300000191,0,-,0,0,0,=,,,,9154346,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
P2Y<sub>4</sub> receptor,325,,,,,,,,Unknown,UTP&gamma;S,1735,,,135651593,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,8825364,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>4</sub> receptor,325,P2RY4,P51582,,,,,,Human,uridine triphosphate,1734,,,135651592,Agonist,Full agonist,,t,,,pEC50,0,6.3,0,,0,0,0,,,,,10779375,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>4</sub> receptor,325,P2ry4,O35811,,,,,,Rat,uridine triphosphate,1734,,,135651592,Agonist,Partial agonist,,t,,,pEC50,0,5.6,0,,0,0,0,,,,,9647463,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,UDP-&beta;-S,1750,,,135651584,Agonist,Full agonist,,f,,,pEC50,0,7.55,0,,0,0,0,,,,,16475938,O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,Up<sub>3</sub>U,1751,,,135651589,Agonist,Full agonist,,f,,,pEC50,0,6.7,0,-,0,0,0,=,,,,16475938,O[C@@H]1[C@H](COP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2ccc(=O)[nH]c2=O)[O-])[O-])[O-])O[C@H](C1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,uridine diphosphate,1749,,,135651583,Agonist,Full agonist,,t,f,,pEC50,0,6.5,0,-,0,0,0,=,,,,8670200,O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,uridine triphosphate,1734,,,135651592,Agonist,Partial agonist,,f,,,pEC50,0,5.2,0,,0,0,0,,,,,8670200,O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
P2Y<sub>6</sub> receptor,326,P2RY6,Q15077,,,,,,Human,suramin,1728,,,135651219,Antagonist,Antagonist,,f,f,,pKB,0,4,0,KB,0,100000,0,=,,,,26519900,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,[<sup>125</sup>I][Ac-His<sup>1</sup>]PACAP-27,2260,,,178100224,Agonist,Agonist,,f,f,,pKd,0,9.300000191,0,Kd,0,0.5,0,=,,,,1321043,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,[<sup>125</sup>I]PACAP-27,2261,,,135652544,Agonist,Agonist,,f,,,pKd,0,9.1,0,Kd,0,0.87,0,=,Binding to NIH/3T3 cells stably expressing recombinant receptor,,,11193823,
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,8.4,0,Ki,0,4.4,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.1,0,EC50,0,80,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,5.7,0,IC50,0,2000,0,=,Inhibition of [125I]-Ac-His1-PACAP-27 binding in membranes from CHO cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.1,0,EC50,0,80,0,=,stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor  isoform lacking the hip and hop exons,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,6.4,0,EC50,0,389,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,5.5,0,Ki,0,3500,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,6.4,0,EC50,0,373,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,6.3,0,Ki,0,458,0,=,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,Adcyap1r1,P32215,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,5.8,0,Ki,0,1500,0,=,inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor  isoform including the hop1 exon,,,7774670,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.8,0,EC50,0,15.1,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,6,0,IC50,0,1000,0,>,inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,8.7,0,EC50,0,2.1,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,6,0,EC50,0,1000,0,>,stimulation of cyclic AMP formation in NIH/3T3 cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,6.7,0,EC50,0,186,0,=,stimulation of cyclic AMP formation in HEK293 cells stably expressing the full length receptor (ENST00000304166),,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,6,0,Ki,0,1000,0,>,inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 very short receptor,,,10583729,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
PAC<sub>1</sub> receptor,370,ADCYAP1R1,P41586,,,,,,Human,"[<sup>125</sup>I]VIP (human, mouse, rat)",2277,,,135652575,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
PAF receptor,334,PTAFR,P25105,,,,,,Human,[<sup>3</sup>H]PAF,1833,,,135651567,Agonist,Full agonist,,f,,,pKd,8.9,0,8.8,Kd,1.6,0,1.3,=,,,,1657923,CCCCCCCCCCCCCCCCOC[C@@H](OC(=O)C)COP(=O)(OCC[N+](C)(C)C)[O-]
PAF receptor,334,PTAFR,P25105,,,,,,Human,[<sup>3</sup>H]52770 RP,1858,,,135651127,Antagonist,Antagonist,,f,,,pKd,0,8.4,0,,0,0,0,,,,,2831350,Clc1cccc(c1)NC(=O)c1ccn2c1CSC2c1cccnc1
PAF receptor,334,PTAFR,P25105,,,,,,Human,[<sup>3</sup>H]apafant,1859,,,135651137,Antagonist,Antagonist,,f,,,pKd,8,0,7.4,,0,0,0,,,,,1657923,O=C(N1CCOCC1)CCc1sc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1Cl
PAR1,347,F2R,P25116,,,,,,Human,[<sup>3</sup>H]haTRAP,3823,,,178100667,Agonist,Agonist,,f,,,pKd,0,7.82,0,Kd,0,15,0,=,,,,9203642,
PAR1,347,F2R,P25116,,,,,,Human,TFLLR-NH<sub>2</sub>,3742,,,178100606,Agonist,Full agonist,,f,f,,pEC50,0,5.409999847,0,EC50,0,3900,0,=,,,,11877318,
PAR1,347,F2R,P25116,,,,,,Human,vorapaxar,4047,,,178100871,Antagonist,Antagonist,,f,t,,pKi,0,8.090000153,0,Ki,0,8.100000381,0,=,,,,18447380,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C
PAR2,348,F2RL1,P55085,,,,,,Human,[<sup>3</sup>H]2-furoyl-LIGRL-NH<sub>2</sub>,6660,,,178103272,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15765104,
PAR2,348,F2RL1,P55085,,,,,,Human,trans-cinnamoyl-LIGRLO [N-[<sup>3</sup>H]propionyl]-NH<sub>2</sub>,3914,,,178100746,Agonist,Agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,10411588,
PAR4,350,F2RL3,Q96RI0,,,,,,Human,YD-3,9458,,,329968398,Antagonist,Antagonist,,f,f,,pIC50,0,6.889999866,0,IC50,0,130,0,=,Antagonism of PAR4-AP-stimulated human platelet aggregation.,,,25176330,CCOC(=O)c1ccc(cc1)c1nn(c2c1cccc2)Cc1ccccc1
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,[<sup>11</sup>C]GlySar,4489,,,178101217,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,18344442,[11CH3]N(C(=O)CN)CC(=O)O
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,[<sup>14</sup>C]GlySar,4599,,,178101319,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,11284702,CN([14C](=O)CN)CC(=O)O
Peptide transporter 1,984,SLC15A1,P46059,,,,,,Human,[<sup>3</sup>H]GlySar,4659,,,178101375,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,9706043,CN(C(=O)CN)CC(=O)O
Peptide transporter 2,985,SLC15A2,Q16348,,,,,,Human,[<sup>11</sup>C]GlySar,4489,,,178101217,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,[11CH3]N(C(=O)CN)CC(=O)O
Peptide transporter 2,985,SLC15A2,Q16348,,,,,,Human,[<sup>14</sup>C]GlySar,4599,,,178101319,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CN([14C](=O)CN)CC(=O)O
Peptide transporter 2,985,SLC15A2,Q16348,,,,,,Human,[<sup>3</sup>H]GlySar,4659,,,178101375,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CN(C(=O)CN)CC(=O)O
Peptide transporter 3,986,SLC15A3,Q8IY34,,,,,,Human,[<sup>14</sup>C]histidine,4623,,,178101341,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,11336635,N[14C@H](C(=O)O)Cc1c[nH]cn1
Peptide transporter 3,986,SLC15A3,Q8IY34,,,,,,Human,[<sup>3</sup>H]histidine,4670,,,178101385,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,11336635,N[C@H](C(=O)O)Cc1c[nH]cn1
Peptide transporter 4,987,SLC15A4,Q8N697,,,,,,Human,[<sup>14</sup>C]histidine,4623,,,178101341,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,9092568,N[14C@H](C(=O)O)Cc1c[nH]cn1
Peptide transporter 4,987,SLC15A4,Q8N697,,,,,,Human,[<sup>3</sup>H]histidine,4670,,,178101385,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,16289537,N[C@H](C(=O)O)Cc1c[nH]cn1
Peroxisome proliferator-activated receptor-&alpha;,593,PPARA,Q07869,,,,,,Human,TZD18,2665,,,135651287,Agonist,Agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,14701675,CCCc1cc(ccc1OCCCOc1cccc(c1)C1SC(=O)NC1=O)Oc1ccccc1
Peroxisome proliferator-activated receptor-&beta;/&delta;,594,PPARD,Q03181,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Full agonist,,t,f,,pKd,0,7.800000191,0,-,0,0,0,=,,,,12963727,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,tagitinin A,8701,,,252166901,Agonist,Agonist,,f,f,,pIC50,0,4.260000229,0,IC50,0,55000,0,=,Measuring PPAR&gamma; transactivation in response to compound binding directly to the receptor's ligand binding domain.,,,22424975,O=C(C(C)C)O[C@@H]1C[C@@]2(C)O[C@](C[C@@H]2O)([C@H](C[C@@H]2[C@@H]1C(=C)C(=O)O2)C)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,tirotundin,8700,,,252166900,Agonist,Agonist,,f,f,,pIC50,0,4.570000172,0,IC50,0,27000,0,=,Measuring PPAR&gamma; transactivation in response to compound binding directly to the receptor's ligand binding domain.,,,22424975,O=C(C(C)C)O[C@@H]1C[C@]2(C)CC[C@@](O2)([C@H](C[C@@H]2[C@@H]1C(=C)C(=O)O2)C)O
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,[<sup>125</sup>I]SB-236636,2710,,,135651116,Agonist,Full agonist,,f,,,pKd,0,7.1,0,,0,0,0,,,,,9454824,CCO[C@H](C(=O)O)Cc1ccc(c(c1)[125I])OCCN(c1nc2c(o1)cccc2)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,[<sup>3</sup>H]AD5075,2702,,,135651132,Agonist,Full agonist,,f,,,pKi,0,7.66,0,,0,0,0,,,,,8828476,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC(c1nc(oc1C)c1ccccc1)O
Peroxisome proliferator-activated receptor-&gamma;,595,,,,,,,,Unknown,[<sup>3</sup>H]GW2331,2706,,,135651158,Agonist,Full agonist,,f,,,pKd,0,6.52,0,,0,0,0,,,,,9113987,CCCCCCCN(C(=O)Nc1c([3H])cc(cc1F)F)CCc1ccc(cc1)OC(C(=O)O)(CC)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,troglitazone,2693,,,135651283,Agonist,Full agonist,,f,f,,pIC50,0,6.300000191,0,-,0,0,0,=,,,,9836620,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,troglitazone,2693,,,135651283,Agonist,Full agonist,,f,t,,pKi,0,5.800000191,0,-,0,0,0,=,,,,8828476,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,TZD18,2665,,,135651287,Agonist,Full agonist,,f,,,pIC50,0,7.24,0,,0,0,0,,,,,14701675,CCCc1cc(ccc1OCCCOc1cccc(c1)C1SC(=O)NC1=O)Oc1ccccc1
Peroxisome proliferator-activated receptor-&gamma;,595,PPARG,P37231,,,,,,Human,T0070907,3444,,,178100444,Antagonist,Antagonist,,f,,,pKi,0,9,0,Ki,0,1,0,=,,,,11877444,Clc1ccc(cc1C(=O)Nc1ccncc1)[N+](=O)[O-]
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,8.069999695,0,IC50,0,8.579999924,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
phosphatidylinositol 3-kinase catalytic subunit type 3,2152,PIK3C3,Q8NEB9,,,,,,Human,VPS34-IN-1,9378,,,328083480,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,0,Clc1nccc(c1)Nc1nccc(n1)c1cnc(nc1CC1CC1)NCC(O)(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,9.539999962,0,Ki,0,0.289999992,0,=,,,,23662903,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,10.05000019,0,Ki,0,0.090000004,0,=,,,,0,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,TG-100-115,5715,,,178102341,Inhibitor,Inhibition,,f,f,,pIC50,0,5.889999866,0,IC50,0,1300,0,=,,,,17685602,Oc1cccc(c1)c1nc2nc(N)nc(c2nc1c1cccc(c1)O)N
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,VS-5584,8382,,,252166594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,23270925,Nc1ncc(cn1)c1nc(nc2c1nc(n2C(C)C)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,wortmannin,6060,,,178102681,Inhibitor,Inhibition,,f,t,,pKi,0,6.920000076,0,Ki,0,120,0,=,,,,15658870,COC[C@H]1OC(=O)c2c3[C@@]1(C)C1=C(C(=O)c3oc2)[C@H]2[C@@](C[C@H]1OC(=O)C)(C)C(=O)CC2
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2153,PIK3CA,P42336,,,,,,Human,ZSTK474,7965,,,249565648,Inhibitor,Inhibition,,f,t,,pIC50,0,7.800000191,0,IC50,0,16,0,=,,,,0,FC(c1nc2c(n1c1nc(nc(n1)N1CCOCC1)N1CCOCC1)cccc2)F
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,7.28000021,0,Ki,0,53,0,=,,,,0,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,8.039999962,0,Ki,0,9.100000381,0,=,,,,23662903,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,TG-100-115,5715,,,178102341,Inhibitor,Inhibition,,f,f,,pIC50,0,5.920000076,0,IC50,0,1200,0,=,,,,17685602,Oc1cccc(c1)c1nc2nc(N)nc(c2nc1c1cccc(c1)O)N
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,TGX-221,8244,,,249565924,Inhibitor,Inhibition,,f,t,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,15834429,Cc1cc(C(Nc2ccccc2)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,VS-5584,8382,,,252166594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.170000076,0,IC50,0,68,0,=,,,,23270925,Nc1ncc(cn1)c1nc(nc2c1nc(n2C(C)C)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2154,PIK3CB,P42338,,,,,,Human,ZSTK474,7965,,,249565648,Inhibitor,Inhibition,,f,t,,pIC50,7.769999981,0,7.360000134,IC50,44,0,17,=,,,,16622124,FC(c1nc2c(n1c1nc(nc(n1)N1CCOCC1)N1CCOCC1)cccc2)F
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,10.10000038,0,Ki,0,0.079000004,0,=,,,,0,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,t,,pKi,0,9.680000305,0,Ki,0,0.209999993,0,=,,,,23662903,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,TG-100-115,5715,,,178102341,Inhibitor,Inhibition,,f,t,,pIC50,0,6.630000114,0,IC50,0,235,0,=,,,,17685602,Oc1cccc(c1)c1nc2nc(N)nc(c2nc1c1cccc(c1)O)N
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,TGX-221,8244,,,249565924,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,=,,,,15834429,Cc1cc(C(Nc2ccccc2)C)c2n(c1)c(=O)cc(n2)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,8.25,0,IC50,0,5.670000076,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,VS-5584,8382,,,252166594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,23270925,Nc1ncc(cn1)c1nc(nc2c1nc(n2C(C)C)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2155,PIK3CD,O00329,,,,,,Human,ZSTK474,7965,,,249565648,Inhibitor,Inhibition,,f,t,,pIC50,8.300000191,0,8.220000267,IC50,6,0,5,=,,,,16622124,FC(c1nc2c(n1c1nc(nc(n1)N1CCOCC1)N1CCOCC1)cccc2)F
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,9.010000229,0,Ki,0,0.970000029,0,=,,,,23662903,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,taselisib,7794,,,223366125,Inhibitor,Inhibition,,f,f,,pKi,0,8.840000153,0,Ki,0,1.429999948,0,=,,,,0,Cc1nn(c(n1)c1cn2c(n1)c1ccc(cc1OCC2)c1cnn(c1)C(C(=O)N)(C)C)C(C)C
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,TG-100-115,5715,,,178102341,Inhibitor,Inhibition,,f,t,,pIC50,0,7.079999924,0,IC50,0,83,0,=,,,,17685602,Oc1cccc(c1)c1nc2nc(N)nc(c2nc1c1cccc(c1)O)N
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,VS-5584,8382,,,252166594,Inhibitor,Inhibition,,f,t,,pIC50,0,7.599999905,0,IC50,0,25,0,=,,,,23270925,Nc1ncc(cn1)c1nc(nc2c1nc(n2C(C)C)C)N1CCOCC1
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2156,PIK3CG,P48736,,,,,,Human,ZSTK474,7965,,,249565648,Inhibitor,Inhibition,,f,t,,pIC50,7.309999943,0,7.28000021,IC50,53,0,49,=,,,,16622124,FC(c1nc2c(n1c1nc(nc(n1)N1CCOCC1)N1CCOCC1)cccc2)F
phosphatidylinositol 4-kinase alpha,2148,PI4KA,P42356,,,,,,Human,wortmannin,6060,,,178102681,Inhibitor,Inhibition,,f,,,pIC50,6.8,0,6.7,-,0,0,0,=,,,,9020160,COC[C@H]1OC(=O)c2c3[C@@]1(C)C1=C(C(=O)c3oc2)[C@H]2[C@@](C[C@H]1OC(=O)C)(C)C(=O)CC2
phosphatidylinositol 4-kinase beta,2149,PI4KB,Q9UBF8,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,7.739999771,0,IC50,0,18.29999924,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
phosphatidylinositol 4-kinase beta,2149,PI4KB,Q9UBF8,,,,,,Human,wortmannin,6060,,,178102681,Inhibitor,Inhibition,,f,,,pIC50,6.8,0,6.7,-,0,0,0,=,,,,9020160,COC[C@H]1OC(=O)c2c3[C@@]1(C)C1=C(C(=O)c3oc2)[C@H]2[C@@](C[C@H]1OC(=O)C)(C)C(=O)CC2
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,2150,PIK3C2A,O00443,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,7.550000191,0,IC50,0,28.10000038,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,2151,PIK3C2B,O00750,,,,,,Human,torin 2,8839,,,252827496,Inhibitor,Inhibition,,f,f,,pIC50,0,7.610000134,0,IC50,0,24.5,0,=,,,,21322566,Nc1ccc(cn1)c1ccc2c(c1)c1c(cn2)ccc(=O)n1c1cccc(c1)C(F)(F)F
phosphodiesterase 11A,1311,PDE11A,Q9HCR9,,,,,,Human,tadalafil,7299,,,178103872,Inhibitor,Inhibition,,f,f,,pIC50,0,6.519999981,0,IC50,0,300,0,=,,,,21189023,O=C1N(C)CC(=O)N2[C@@H]1Cc1c([C@H]2c2ccc3c(c2)OCO3)[nH]c2c1cccc2
phosphodiesterase 1A,1294,PDE1A,P54750,,,,,,Human,vinpocetine,5285,,,178101968,Inhibitor,Inhibition,,f,,,pIC50,0,5.1,0,IC50,0,7940,0,,,,,8557689,CCOC(=O)C1=C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
phosphodiesterase 1C,1296,PDE1C,Q14123,,,,,,Human,vinpocetine,5285,,,178101968,Inhibitor,Inhibition,,f,,,pIC50,0,4.3,0,IC50,0,50100,0,,,,,8557689,CCOC(=O)C1=C[C@]2(CC)CCCN3[C@@H]2c2n1c1ccccc1c2CC3
phosphodiesterase 4A,1300,PDE4A,P27815,,,,,,Human,YM976,5292,,,178101975,Inhibitor,Inhibition,,f,,,pIC50,0,8.3,0,IC50,0,5.01,0,,,,,10991987,CCc1ccc2c(n1)n(CC)c(=O)nc2c1cccc(c1)Cl
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,T0156,5275,,,178101958,Inhibitor,Inhibition,,f,f,,pIC50,0,9.5,0,IC50,0,0.316000015,0,=,,,,12450574,COC(=O)c1c(c2cc(OC)c(c(c2)OC)OC)c2ccnc(c2c(=O)n1Cc1ccnc(c1)C)OCc1ncccn1
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,tadalafil,7299,,,178103872,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,21189023,O=C1N(C)CC(=O)N2[C@@H]1Cc1c([C@H]2c2ccc3c(c2)OCO3)[nH]c2c1cccc2
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,vardenafil,7320,,,178103893,Inhibitor,Inhibition,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,15837326,CCOc1ccc(cc1c1nc(=O)c2n([nH]1)c(CCC)nc2C)S(=O)(=O)N1CCN(CC1)CC
phosphodiesterase 5A,1304,PDE5A,O76074,,,,,,Human,zaprinast,2919,,,135651355,Inhibitor,Inhibition,,f,f,,pIC50,0,6.800000191,0,IC50,0,158,0,=,,,,10385692,CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2
phosphodiesterase 9A,1309,PDE9A,O76083,,,,,,Human,zaprinast,2919,,,135651355,Inhibitor,Inhibition,,f,,,pIC50,0,4.5,0,IC50,0,31600,0,,,,,9624146,CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2
"Pim-1 proto-oncogene, serine/threonine kinase",2158,PIM1,P11309,,,,,,Human,XL413,8113,,,249565793,Inhibitor,Inhibition,,f,f,,pIC50,0,7.380000114,0,IC50,0,42,0,=,,,,22560567,Clc1ccc2c(c1)c1[nH]c(nc(=O)c1o2)[C@@H]1CCCN1
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,[<sup>125</sup>I]BH-MIT1,8522,,,252166724,Agonist,Agonist,,f,f,,pIC50,0,8.390000343,0,IC50,0,4.099999905,0,=,,,,12054613,
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,triazine compound PC1,6064,,,178102685,Antagonist,Antagonist,,f,f,,pKi,0,7.659999847,0,Ki,0,22,0,=,,,,19006379,CCc1ccc(cc1)Cn1c(=O)nc(n(c1=O)Cc1ccc(cc1)OC)NCCN=C(N)N
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,triazine compound PC10,6433,,,178103049,Antagonist,Antagonist,,f,f,,pIC50,0,6.960000038,0,IC50,0,109.6999969,0,=,,,,21421710,COc1ccc(cc1)Cn1c(NCCNC(=N)NC(=O)c2ccc(cc2)F)nc(=O)n(c1=O)Cc1ccc(cc1)F
PKR<sub>1</sub>,335,PROKR1,Q8TCW9,,,,,,Human,triazine compound PC7,6431,,,178103047,Antagonist,Antagonist,,f,f,,pIC50,0,7.480000019,0,IC50,0,33,0,=,,,,19375913,COc1ccc(cc1)Cn1c(NCCNC(=N)N)nc(=O)n(c1=O)Cc1ccc(cc1)F
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,[<sup>125</sup>I]BH-MIT1,8522,,,252166724,Agonist,Agonist,,f,f,,pIC50,0,9.170000076,0,IC50,0,0.670000017,0,=,,,,12054613,
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,triazine compound PC1,6064,,,178102685,Antagonist,Antagonist,,f,,,pKi,0,5.79,0,Ki,0,1610,0,=,,,,19006379,CCc1ccc(cc1)Cn1c(=O)nc(n(c1=O)Cc1ccc(cc1)OC)NCCN=C(N)N
PKR<sub>2</sub>,336,PROKR2,Q8NFJ6,,,,,,Human,triazine compound PC10,6433,,,178103049,Antagonist,Antagonist,,f,,,pIC50,0,5.92,0,IC50,0,1200,0,=,,,,21421710,COc1ccc(cc1)Cn1c(NCCNC(=N)NC(=O)c2ccc(cc2)F)nc(=O)n(c1=O)Cc1ccc(cc1)F
Plasma membrane monoamine transporter,1120,SLC29A4,Q7RTT9,,,,,,Human,verapamil,2406,,,135651305,Inhibitor,Inhibition,,f,f,,pKi,0,4.730000019,0,Ki,0,18600,0,=,,,,16099839,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
plasminogen,2394,PLG,P00747,,,,,,Human,tranexamic acid,6573,,,178103187,Inhibitor,Binding,,f,t,,pIC50,0,3.599999905,0,IC50,0,241000,0,=,,,,17666018,NC[C@@H]1CC[C@H](CC1)C(=O)O
"plasminogen activator, urokinase",2393,PLAU,P00749,,,,,,Human,UK-356202,6543,,,178103157,Inhibitor,Inhibition,,f,,,pIC50,0,7.4,0,IC50,0,37,0,,,,,15149680,NC(=Nc1ncc(c2c1cc(cc2)c1cccc(c1)C(=O)O)Cl)N
"plasminogen activator, urokinase",2393,PLAU,P00749,,,,,,Human,upamostat,6497,,,178103111,Inhibitor,Inhibition,,f,,,-,0,0,0,,0,0,0,,,,,0,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NS(=O)(=O)c1c(cc(cc1C(C)C)C(C)C)C(C)C)Cc1cccc(c1)/C=N/NO
"plasminogen activator, urokinase",2393,PLAU,P00749,,,,,,Human,WX-UK1,6498,,,178103112,Inhibitor,Inhibition,,f,,,pIC50,0,6.4,0,IC50,0,410,0,,,,,10560742,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NS(=O)(=O)c1c(cc(cc1C(C)C)C(C)C)C(C)C)Cc1cccc(c1)C(=N)N
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,SU11652,6043,,,178102665,Inhibitor,Inhibition,,f,t,,pIC50,0,8.520000458,0,IC50,0,3,0,=,,,,12646019,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(Cl)cc2)CC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,SU-14813,5712,,,178102338,Inhibitor,Inhibition,,f,t,,pIC50,0,8.399999619,0,IC50,0,4,0,=,,,,16891463,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1C(=O)Nc2c1cc(F)cc2)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,t,,pIC50,0,8.199999809,0,IC50,0,5.699999809,0,=,,,,23279183,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,t,,pKi,0,8.100000381,0,Ki,0,8,0,=,,,,12538485,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,tandutinib,5695,,,178102322,Inhibitor,Inhibition,,f,f,,pIC50,0,6.699999809,0,IC50,0,200,0,=,,,,12124172,COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
platelet derived growth factor receptor beta,1804,PDGFRB,P09619,,,,,,Human,vatalanib,5705,,,178102332,Inhibitor,Inhibition,,f,f,,pIC50,0,6.21999979,0,IC50,0,600,0,=,,,,10882357,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1
PLD2,1434,PLD2,O14939,,,,,,Human,VU0364739,5287,,,178101970,Inhibitor,Inhibition,,f,,,pIC50,0,7.7,0,IC50,0,19.9,0,=,,,,20735042,Fc1cccc(c1)N1CNC(=O)C21CCN(CC2)CCNC(=O)c1ccc2c(c1)cccc2
polo like kinase 1,2168,PLK1,P53350,,,,,,Human,volasertib,7947,,,249565630,Inhibitor,Inhibition,,f,t,,pIC50,0,9.06000042,0,IC50,0,0.870000005,0,=,,,,23103095,CC[C@H]1N(C(C)C)c2nc(ncc2N(C1=O)C)Nc1ccc(cc1OC)C(=O)N[C@@H]1CC[C@H](CC1)N1CCN(CC1)CC1CC1
polo like kinase 4,2171,PLK4,O00444,,,,,,Human,XMD8-92,8057,,,249565737,Inhibitor,Inhibition,,f,f,,pKd,0,6.21999979,0,Kd,0,600,0,=,,,,20832753,CCOc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)N1CCC(CC1)O
poly(ADP-ribose) polymerase 1,2771,PARP1,P09874,,,,,,Human,talazoparib,8313,,,252166525,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,25195882,Fc1ccc(cc1)[C@H]1N=c2cc(F)cc3c2c([C@@H]1c1ncnn1C)[nH][nH]c3=O
poly(ADP-ribose) polymerase 2,2772,PARP2,Q9UGN5,,,,,,Human,talazoparib,8313,,,252166525,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,25195882,Fc1ccc(cc1)[C@H]1N=c2cc(F)cc3c2c([C@@H]1c1ncnn1C)[nH][nH]c3=O
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,vitamin K2,2771,,,135651595,Agonist,Agonist,,f,,,-,0,0,0,,0,0,0,,,,,12920130,C/C(=CCC1=C(C)C(=O)c2c(C1=O)cccc2)/CCC=C(C)C
Pregnane X receptor,606,Nr1i2,O54915,,,,,,Mouse,trabectedin,2774,,,135652680,Antagonist,Antagonist,,f,,,pIC50,0,8.52,0,,0,0,0,,,,,11329060,COc1cc2c(cc1O)CCN[C@@]12CS[C@@H]2c3c(OC(=O)C)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@@H]2N([C@H]([C@@H]1O)Cc1c2c(O)c(c(c1)C)OC)C)OCO4
Progesterone receptor,627,PGR,P06401,,,,,,Human,[<sup>3</sup>H]ORG2058,3454,,,178100452,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC[C@@H]1C[C@@H]2[C@]([C@H]1C(=O)CO)(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12
Progesterone receptor,627,PGR,P06401,,,,,,Human,tanaproget,7416,,,178103988,Agonist,Agonist,,f,f,,pIC50,0,9.300000191,0,IC50,0,0.5,0,=,Displacement of [<sup>3</sup>H]R5020 from human progesterone receptor expressed in T47D cells.,,,18318463,N#Cc1ccc(n1C)c1ccc2c(c1)C(C)(C)OC(=S)N2
Progesterone receptor,627,PGR,P06401,,,,,,Human,ulipristal acetate,7460,,,187051763,Agonist,Partial agonist,,f,f,,pEC50,0,7,0,EC50,0,100,0,>,,,,18243712,CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21)C(=O)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,ulipristal acetate,7460,,,187051763,Antagonist,Antagonist,,f,t,,pIC50,0,9.699999809,0,IC50,0,0.200000003,0,=,,,,18243712,CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21)C(=O)C
Progesterone receptor,627,PGR,P06401,,,,,,Human,WAY-255348,8664,,,252166864,Antagonist,Antagonist,,f,f,,pIC50,8.390000343,0,7.920000076,IC50,12.10000038,0,4.099999905,=,,,,18318463,N#Cc1ccc(n1C)c1cc(F)c2c(c1)C(C)(C)C(=O)N2
Progesterone receptor,627,PGR,P06401,,,,,,Human,ZK112993,3448,,,178100448,Antagonist,Antagonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC#C[C@]1(O)CC[C@H]2[C@]1(C)C[C@H](c1ccc(cc1)C(=O)C)C1=C3CCC(=O)C=C3CC[C@@H]21
protein kinase A,1694,PRKACB|PRKAR1B|PRKAR2B|PRKAR2A|PRKACA|PRKACG|PRKAR1A,P17612|P22612|P22694|P10644|P31321|P13861|P31323,,,,,,Human,[<sup>3</sup>H]cAMP,5096,,,178101789,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1ncnc2N
protein kinase C epsilon,1486,PRKCE,Q02156,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,f,,pIC50,0,6.46999979,0,IC50,0,335,0,=,,,,20462760,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
protein kinase N1,1520,PKN1,Q16512,,,,,,Human,tofacitinib,5677,,,178102304,Inhibitor,Inhibition,,f,f,,pIC50,0,6.909999847,0,IC50,0,122,0,=,,,,27572962,N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C
protein kinase N2,1521,PKN2,Q16513,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,f,,pIC50,0,7.150000095,0,IC50,0,70,0,=,,,,20462760,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
protein tyrosine kinase 2,2180,PTK2,Q05397,,,,,,Human,VS-4718,8742,,,252827400,Inhibitor,Inhibition,,f,t,,pIC50,0,8.819999695,0,IC50,0,1.5,0,=,,,,20234191,CNC(=O)c1ccccc1Nc1cc(ncc1C(F)(F)F)Nc1ccc(cc1OC)N1CCOCC1
protein tyrosine kinase 6,2182,PTK6,Q13882,,,,,,Human,tilfrinib,9051,,,315661136,Inhibitor,Inhibition,,f,t,,pIC50,0,8.5,0,IC50,0,3.150000095,0,=,,,,24650640,Oc1cccc(c1)NC1=CC=NC2C1C1C=CC=CC1N2
"protein tyrosine phosphatase, non-receptor type 1",2976,PTPN1,P18031,,,,,,Human,trodusquemine,9733,,,0,Inhibitor,Inhibition,,f,f,,pIC50,0,6,0,IC50,0,1000,0,=,In a cell-free assay using recombinant enzyme.,,,20075852,NCCCNCCCCNCCCN[C@H]1CC[C@]2([C@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CC[C@H](C(C)C)OS(=O)(=O)O)C)C)O)C
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,sulfasalazine,4840,,,178101542,Inhibitor,Inhibition,,f,,,pIC50,0,4.2,0,IC50,0,60000,0,=,,,,17129779,OC(=O)c1cc(/N=N/c2ccc(cc2)S(=O)(=O)Nc2ccccn2)ccc1O
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,[<sup>3</sup>H]folinic acid,6690,,,178103302,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=CN1C(CNc2ccc(cc2)C(=O)N[C@H](C(=O)O)CCC(=O)O)CNc2c1c(=O)nc([nH]2)N
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,[<sup>3</sup>H]N<sup>5</sup>-methylfolate,6689,,,178103301,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)CCC(C(=O)O)NC(=O)c1ccc(cc1)NCC1CNc2c(N1C)c(=O)nc([nH]2)N
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,[<sup>3</sup>H]pemetrexed,6688,,,178103300,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,OC(=O)CCC(C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)nc([nH]2)N
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,[<sup>3</sup>H]folic acid,4562,,,178101283,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)NCc1cnc2c(n1)c(=O)nc([nH]2)N
Proton-coupled folate transporter,1213,SLC46A1,Q96NT5,,,,,,Human,[<sup>3</sup>H]methotrexate,4674,,,178101388,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(Cc1cnc2c(n1)c(N)nc(n2)N)C
PrRP receptor,337,PRLHR,P49683,,,,,,Human,[<sup>125</sup>I]PrRP-20 (human),1875,,,135652547,Agonist,Full agonist,,f,,,pKd,10.6,0,9.2,Kd,0.57,0,0.026,=,,,,11030716,
PrRP receptor,337,PRLHR,P49683,,,,,,Human,[<sup>125</sup>I]PrRP31,4022,,,178100848,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,15752583,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[<sup>125</sup>I][Nle<sup>8,21</sup>,Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (rat)",1791,,,135652535,Agonist,Full agonist,,f,,,pKd,0,8,0,,0,0,0,,,,,9360953,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,teriparatide,4448,,,135652417,Agonist,Full agonist,,f,t,,pIC50,0,7.400000095,0,-,0,0,0,=,,,,8702701,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,teriparatide,4448,,,135652417,Agonist,Full agonist,,f,,,pIC50,8.7,0,8.1,,0,0,0,,,,,7896796,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[Trp<sup>23</sup>]PTHrP-(1-36) (human),1809,,,135652614,Agonist,Full agonist,,f,,,pIC50,0,7.3,0,,0,0,0,,,,,8702701,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,"[Trp<sup>23</sup>,Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human)",1808,,,135652615,Agonist,Full agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,9360953,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[Tyr<sup>34</sup>]PTH-(1-34) (human),1810,,,135652620,Agonist,Full agonist,,f,,,pIC50,8.5,0,8.1,,0,0,0,,,,,11159842,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,[Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (human),1811,,,135652621,Agonist,Full agonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,8662729,
PTH1 receptor,331,Pth1r,P25961,,,,,,Rat,[Tyr<sup>34</sup>]PTH-(3-34)-NH<sub>2</sub> (human),1812,,,135652622,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,8662729,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,[Tyr<sup>36</sup>]-PTHrP-(1-36) amide (human),1813,,,135652623,Agonist,Full agonist,,f,,,pIC50,7.4,0,7.1,,0,0,0,,,,,11159842,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,TIP39,1815,PTH2|PTH2,Bovine|Human,135651893,Antagonist,Antagonist,,t,,,pIC50,7.2,0,6.6,,0,0,0,,,,,11159842,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,TIP39-(3-39) (human/bovine),1816,,,135652605,Antagonist,Antagonist,,f,,,pIC50,7.2,0,7,,0,0,0,,,,,11159842,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,TIP39-(7-39) (human/bovine),1827,,,135652606,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,-,0,0,0,=,,,,11046116,
PTH1 receptor,331,PTH1R,Q03431,,,,,,Human,TIP39-(9-39) (human/bovine),1818,,,135652608,Antagonist,Antagonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,11159842,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[<sup>125</sup>I][Nle<sup>8,21</sup>,Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (rat)",1791,,,135652535,Agonist,Full agonist,,f,,,pKd,0,8.1,0,,0,0,0,,,,,9360953,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,teriparatide,4448,,,135652417,Agonist,Full agonist,,f,,,pIC50,0,6.3,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,teriparatide,4448,,,135652417,Agonist,Full agonist,,f,,,pIC50,7.8,0,7.7,-,0,0,0,=,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,TIP39,3624,Pth2|Pth2,Mouse|Rat,135651894,Agonist,Full agonist,,f,,,pIC50,0,8.8,0,-,0,0,0,=,,,,11602681,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,TIP39,3624,Pth2|Pth2,Mouse|Rat,135651894,Agonist,Full agonist,,t,,,pIC50,0,8.1,0,-,0,0,0,=,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,TIP39,1815,PTH2|PTH2,Bovine|Human,135651893,Agonist,Full agonist,,f,f,,pIC50,9.199999809,0,7.599999905,-,0,0,0,=,,,,10854439,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,TIP39,1815,PTH2|PTH2,Bovine|Human,135651893,Agonist,Full agonist,,f,,,pIC50,0,7,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,[Trp<sup>23</sup>]PTHrP-(1-36) (human),1809,,,135652614,Agonist,Full agonist,,f,,,pIC50,0,7.5,0,,0,0,0,,,,,8702701,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,"[Trp<sup>23</sup>,Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human)",1808,,,135652615,Agonist,Full agonist,,f,,,pIC50,0,7.4,0,,0,0,0,,,,,9360953,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,TIP39-(7-39) (human/bovine),1827,,,135652606,Antagonist,Antagonist,,f,,,pIC50,0,6.1,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,TIP39-(7-39) (human/bovine),1827,,,135652606,Antagonist,Antagonist,,f,,,pIC50,7.2,0,7,,0,0,0,,,,,11046116,
PTH2 receptor,332,Pth2r,P70555,,,,,,Rat,TIP39-(7-39) (mouse),1828,,,135652607,Antagonist,Antagonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,11602681,
PTH2 receptor,332,PTH2R,P49190,,,,,,Human,TIP39-(7-39) (mouse),1828,,,135652607,Antagonist,Antagonist,,f,,,pIC50,0,8.2,0,,0,0,0,,,,,11602681,
pyruvate dehydrogenase kinase 1,2915,PDK1,Q15118,,,,,,Human,VER-246608,9350,,,328083452,Inhibitor,Inhibition,,f,f,,pIC50,0,7.460000038,0,IC50,0,35,0,=,<i>In vitro</i> functional assay,,,25404640,O=C(C(F)F)NCc1ccc(cc1)CN(C(=O)c1ccc(cc1O)O)c1ccc(cc1)c1nc(Cl)ncc1C
pyruvate dehydrogenase kinase 2,2142,PDK2,Q15119,,,,,,Human,VER-246608,9350,,,328083452,Inhibitor,Inhibition,,f,f,,pIC50,0,7.079999924,0,IC50,0,84,0,=,<i>In vitro</i> functional assay,,,25404640,O=C(C(F)F)NCc1ccc(cc1)CN(C(=O)c1ccc(cc1O)O)c1ccc(cc1)c1nc(Cl)ncc1C
pyruvate dehydrogenase kinase 3,2143,PDK3,Q15120,,,,,,Human,VER-246608,9350,,,328083452,Inhibitor,Inhibition,,f,f,,pIC50,0,7.400000095,0,IC50,0,40,0,=,<i>In vitro</i> functional assay,,,25404640,O=C(C(F)F)NCc1ccc(cc1)CN(C(=O)c1ccc(cc1O)O)c1ccc(cc1)c1nc(Cl)ncc1C
pyruvate dehydrogenase kinase 4,2144,PDK4,Q16654,,,,,,Human,VER-246608,9350,,,328083452,Inhibitor,Inhibition,,f,f,,pIC50,0,7.039999962,0,IC50,0,91,0,=,<i>In vitro</i> functional assay,,,25404640,O=C(C(F)F)NCc1ccc(cc1)CN(C(=O)c1ccc(cc1O)O)c1ccc(cc1)c1nc(Cl)ncc1C
QRFP receptor,333,QRFPR,Q96P65,,,,,,Human,[<sup>125</sup>I]QRFP43 (human),3803,,,178100650,Agonist,Full agonist,,f,,,pKd,10.3,0,7.8,Kd,15.8,0,0.0501,=,,,,16648250,
QRFP receptor,333,Qrfpr,P83861,,,,,,Mouse,[<sup>125</sup>I]QRFP43 (human),3803,,,178100650,Agonist,Full agonist,This is the binding range comparing the A and B isoforms of mouse Qrfpr.,f,,,pIC50,7.49,0,7.42,IC50,38,0,32,=,,,,16648250,
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,vemurafenib,5893,,,178102516,Inhibitor,Inhibition,,f,f,,pIC50,7.320000172,0,6.380000114,IC50,414,0,48,=,,,,22808911,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F
"Raf-1 proto-oncogene, serine/threonine kinase",2184,RAF1,P04049,,,,,,Human,ZM336372,9130,,,315661215,Inhibitor,Inhibition,,f,f,,pIC50,7.510000229,0,7.150000095,IC50,70,0,31,=,,,,18077363,Oc1ccc(cc1)C(=O)Nc1cc(ccc1C)NC(=O)c1cccc(c1)N(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,tretinoin,2644,,,135651435,Antagonist,Antagonist,,t,,,pIC50,0,9.82,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
RAR-related orphan receptor-&beta;,599,RORB,Q92753,,,,,,Human,tretinoin,2644,,,135651435,Antagonist,Antagonist,,t,,,pKi,0,6.55,0,,0,0,0,,,,,12958591,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Reduced folate transporter 1,1014,SLC19A1,P41440,,,,,,Human,[<sup>3</sup>H]folic acid,4562,,,178101283,None,None,,f,,,-,0,0,0,,0,0,0,,,,,9525913,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)NCc1cnc2c(n1)c(=O)nc([nH]2)N
Reduced folate transporter 1,1014,SLC19A1,P41440,,,,,,Human,[<sup>3</sup>H]methotrexate,4674,,,178101388,None,None,,f,,,-,0,0,0,,0,0,0,,,,,9525913,OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(Cc1cnc2c(n1)c(N)nc(n2)N)C
regulator of G-protein signaling 4,2811,Rgs4,P49799,,,,,,Rat,YJ34,8722,,,252827380,Inhibitor,Inhibition,,f,f,,pIC50,5.050000191,0,4.590000153,IC50,26000,0,9000,=,Inhibition of G&alpha;<sub>o</sub> binding.,,,15009535,
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,tamibarotene,2648,,,135649930,Agonist,Agonist,,f,t,,pEC50,0,7.349999905,0,EC50,0,45,0,=,,,,20925433,O=C(c1ccc(cc1)C(=O)O)Nc1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,tamibarotene,2648,,,135649930,Agonist,Agonist,,f,t,,pIC50,0,6.900000095,0,-,0,0,0,=,,,,3184125,O=C(c1ccc(cc1)C(=O)O)Nc1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,tazarotene,6952,,,178103534,Agonist,Agonist,,f,t,,pEC50,0,7.199999809,0,EC50,0,63,0,=,,,,19058965,CCOC(=O)c1ccc(nc1)C#Cc1ccc2c(c1)C(C)(C)CCS2
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,t,,,pKd,0,9.4,0,,0,0,0,,,,,8380496,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,f,t,,pEC50,0,7.769999981,0,EC50,0,17,0,=,,,,19058965,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&alpha;,590,RARA,P10276,,,,,,Human,TTNPB,2646,,,135651285,Agonist,Agonist,,f,,,pIC50,0,7.44,0,,0,0,0,,,,,8264595,C/C(=Cc1ccc(cc1)C(=O)O)/c1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&alpha;,590,Rara,P11416,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,9.600000381,0,Kd,0,0.239999995,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,tamibarotene,2648,,,135649930,Agonist,Agonist,,f,f,,pEC50,0,6.630000114,0,EC50,0,235,0,=,,,,20925433,O=C(c1ccc(cc1)C(=O)O)Nc1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,tazarotene,6952,,,178103534,Agonist,Agonist,,f,t,,pEC50,0,9.100000381,0,EC50,0,0.800000012,0,=,,,,19058965,CCOC(=O)c1ccc(nc1)C#Cc1ccc2c(c1)C(C)(C)CCS2
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,t,t,,pKi,0,9.399999619,0,-,0,0,0,=,,,,8264595,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,f,t,,pEC50,0,7.920000076,0,EC50,0,12,0,=,,,,19058965,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&beta;,591,RARB,P10826,,,,,,Human,TTNPB,2646,,,135651285,Agonist,Agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,8264595,C/C(=Cc1ccc(cc1)C(=O)O)/c1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&beta;,591,Rarb,P22605,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,9.399999619,0,Kd,0,0.400000006,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,tamibarotene,2648,,,135649930,Agonist,Agonist,,f,f,,pEC50,0,6.230000019,0,EC50,0,591,0,=,,,,20925433,O=C(c1ccc(cc1)C(=O)O)Nc1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,tazarotene,6952,,,178103534,Agonist,Agonist,,f,t,,pEC50,0,7.400000095,0,EC50,0,40,0,=,,,,19058965,CCOC(=O)c1ccc(nc1)C#Cc1ccc2c(c1)C(C)(C)CCS2
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,t,t,,pKd,0,9.600000381,0,-,0,0,0,=,,,,8380496,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Agonist,,f,t,,pEC50,0,9.699999809,0,EC50,0,0.200000003,0,=,,,,19058965,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Retinoic acid receptor-&gamma;,592,RARG,P13631,,,,,,Human,TTNPB,2646,,,135651285,Agonist,Agonist,,f,,,pIC50,0,7.82,0,,0,0,0,,,,,8264595,C/C(=Cc1ccc(cc1)C(=O)O)/c1ccc2c(c1)C(C)(C)CCC2(C)C
Retinoic acid receptor-&gamma;,592,Rarg,P18911,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,9.199999809,0,Kd,0,0.699999988,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&alpha;,610,Rxra,P28700,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,7.800000191,0,Kd,0,15.69999981,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&alpha;,610,Rxra,P28700,,,,,,Mouse,UVI3003,2816,,,135651303,Antagonist,Antagonist,,f,,,-,0,0,0,,0,0,0,,,,,15528208,CCCCCOc1cc2c(cc1c1cc(/C=C/C(=O)O)ccc1O)C(C)(C)CCC2(C)C
Retinoid X receptor-&beta;,611,Rxrb,P28704,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,7.699999809,0,Kd,0,18.29999924,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
Retinoid X receptor-&beta;,611,RXRB,P28702,,,,,,Human,UVI3003,2816,,,135651303,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,Assessed as inhibition of agonist induced transactivation of human RXR&beta;.,,,19408900,CCCCCOc1cc2c(cc1c1cc(/C=C/C(=O)O)ccc1O)C(C)(C)CCC2(C)C
Retinoid X receptor-&gamma;,612,Rxrg,P28705,,,,,,Mouse,[<sup>3</sup>H]9-cis-retinoic acid,5383,,,178102041,Agonist,Full agonist,,f,f,,pKd,0,7.900000095,0,Kd,0,14.10000038,0,=,,,,8380496,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
ret proto-oncogene,2185,RET,P07949,,,,,,Human,sunitinib,5713,,,178102339,Inhibitor,Inhibition,,f,f,,pIC50,0,8.800000191,0,IC50,0,1.700000048,0,=,,,,23279183,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1C(=O)Nc2c1cc(F)cc2)CC
ret proto-oncogene,2185,RET,P07949,,,,,,Human,tamatinib,5706,,,178102333,Inhibitor,Inhibition,,f,f,,pIC50,0,8.300000191,0,IC50,0,5,0,=,,,,19107952,COc1cc(Nc2ncc(c(n2)Nc2ccc3c(n2)NC(=O)C(O3)(C)C)F)cc(c1OC)OC
ret proto-oncogene,2185,RET,P07949,,,,,,Human,vandetanib,5717,,,178102343,Inhibitor,Inhibition,,f,t,,pKd,0,7.46999979,0,Kd,0,34,0,=,,,,22037378,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br
ret proto-oncogene,2185,RET,P07949,,,,,,Human,vandetanib,5717,,,178102343,Inhibitor,Inhibition,,f,t,,pIC50,0,7,0,IC50,0,100,0,=,,,,12499271,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br
Rev-Erb-&beta;,597,NR1D2,Q14995,,,,,,Human,zinc protoporphyrin IX,8903,,,310264684,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,Increases transcription by inhibiting corepressor recruitment to REV-ERB <i>in vitro</i>.,,,24872411,C=CC1=C(C)C2=NC1=Cc1[n-]c(c(c1C)CCC(=O)O)C=C1N=C(C=c3[n-]c(=C2)c(C=C)c3C)C(=C1CCC(=O)O)C.[Zn+2]
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,verosudil,8911,,,310264692,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,21794845,CN(C(c1cscc1)C(=O)Nc1ccc2c(c1)cc[nH]c2=O)C
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,t,,pKi,0,6.849999905,0,Ki,0,140,0,=,,,,9353125,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
Rho associated coiled-coil containing protein kinase 1,1503,ROCK1,Q13464,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,t,,pIC50,7.340000153,0,5.889999866,IC50,1290,0,46,=,,,,20462760,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,verosudil,8911,,,310264692,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,21794845,CN(C(c1cscc1)C(=O)Nc1ccc2c(c1)cc[nH]c2=O)C
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,t,,pIC50,7.210000038,0,6.309999943,IC50,487,0,61,=,,,,20462760,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
Rho associated coiled-coil containing protein kinase 2,1504,ROCK2,O75116,,,,,,Human,Y27632,5290,,,178101973,Inhibitor,Inhibition,,f,t,,pKi,6.940000057,0,6.849999905,Ki,140,0,114,=,,,,9353125,C[C@H]([C@@H]1CC[C@H](CC1)C(=O)Nc1ccncc1)N
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,[<sup>125</sup>I]relaxin (human),5398,,,178102054,Agonist,Full agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
RXFP1,351,RXFP1,Q9HBX9,,,,,,Human,[<sup>33</sup>P]relaxin (human),1991,,,135652580,Agonist,Full agonist,,f,,,pKd,9.7,0,9.3,Kd,0.5,0,0.2,=,,,,12506116,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,[<sup>125</sup>I]INSL3 (human),1996,,,135652522,Agonist,Full agonist,,f,,,pKd,0,10,0,Kd,0,0.1,0,,,,,16051677,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,[<sup>125</sup>I]INSL3 (human),1996,,,135652522,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,16051677,
RXFP2,352,RXFP2,Q8WXD0,,,,,,Human,[<sup>33</sup>P]relaxin (human),1991,,,135652580,Agonist,Full agonist,,f,,,pKd,9.2,0,8.97,Kd,1.06,0,0.63,=,,,,12506116,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,[<sup>125</sup>I]relaxin-3-B/INSL5 A chimera,3789,,,178100639,Agonist,Agonist,,f,,,pKd,0,9.3,0,Kd,0,0.5,0,=,,,,15465925,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,[<sup>125</sup>I]relaxin-3 (human),1999,,,135652520,Agonist,Full agonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,14522968,
RXFP3,353,RXFP3,Q9NSD7,,,,,,Human,[<sup>125</sup>I]relaxin-3 (human),1999,,,135652520,Agonist,Full agonist,,f,,,pKd,0,9.5,0,Kd,0,0.3,0,,,,,14522968,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,[<sup>125</sup>I]relaxin-3-B/INSL5 A chimera,3789,,,178100639,Agonist,Agonist,,f,,,pKd,0,8.9,0,Kd,0,1.2,0,=,,,,15465925,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,[<sup>125</sup>I]INSL5 (human),2001,,,135652523,Agonist,Full agonist,,f,,,pKd,0,8.6,0,,0,0,0,,,,,15525639,
RXFP4,354,RXFP4,Q8TDU9,,,,,,Human,[<sup>125</sup>I]relaxin-3 (human),1999,,,135652520,Agonist,Full agonist,,f,,,pKd,9.7,0,8.7,Kd,2,0,0.2,=,,,,14522967,
RyR1,747,RYR1,P21817,,,,,,Human,suramin,1728,,,135651219,Activator,None,pharmacological; &mu;M range,f,,,-,0,0,0,-,0,0,0,=,,,,0,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
RyR2,748,RYR2,Q92736,,,,,,Human,suramin,1728,,,135651219,Activator,None,pharmacological; &mu;M range,f,,,-,0,0,0,,0,0,0,,,,,0,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
S1P<sub>1</sub> receptor,275,S1pr1,O08530,,,,,,Mouse,VPC03090-P,6992,,,178103571,Antagonist,Antagonist,,f,f,,pKi,7.849999905,0,7.670000076,Ki,21.29999924,0,14,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,VPC03090-P,6992,,,178103571,Antagonist,Antagonist,,f,f,,pKi,7.679999828,0,7.619999886,Ki,24,0,21,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,VPC23019,3324,,,178100357,Antagonist,Antagonist,,f,f,,pKi,0,7.860000134,0,-,0,0,0,=,,,,15590668,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,VPC44116,2930,,,135651310,Antagonist,Antagonist,,f,f,,pKi,0,8.520000458,0,Ki,0,3,0,=,,,,17113298,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,VPC44116,2930,,,135651310,Antagonist,Antagonist,,f,f,,pIC50,0,7.570000172,0,-,0,0,0,=,,,,17113298,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N
S1P<sub>1</sub> receptor,275,S1PR1,P21453,,,,,,Human,W146,2931,,,135651317,Antagonist,Antagonist,,f,f,,pKi,0,7.110000134,0,Ki,0,77,0,=,,,,16829954,CCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,VPC12249,2909,,,135651308,Agonist,Agonist,,f,,,pEC50,0,6.5,0,,0,0,0,,,,,17113298,CCCCCCCC/C=CCCCCCCCC(=O)N[C@H](Cc1ccc(cc1)OCc1ccccc1)COP(=O)(O)O
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,VPC03090-P,6992,,,178103571,Antagonist,Antagonist,,f,f,,pKi,7.289999962,0,7.230000019,Ki,58.70000076,0,51,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,VPC23019,3324,,,178100357,Antagonist,Antagonist,,f,f,,pKi,0,5.929999828,0,-,0,0,0,=,,,,15590668,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](COP(=O)(O)O)N
S1P<sub>3</sub> receptor,277,S1PR3,Q99500,,,,,,Human,VPC44116,2930,,,135651310,Antagonist,Antagonist,,f,f,,pKi,0,6.519999981,0,Ki,0,300,0,=,,,,17113298,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,VPC03090-P,6992,,,178103571,Agonist,Full agonist,,f,f,,pEC50,0,7.75,0,EC50,0,17.70000076,0,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>4</sub> receptor,278,S1PR4,O95977,,,,,,Human,VPC03090-P,6992,,,178103571,Agonist,Full agonist,,f,f,,pKd,0,7.760000229,0,Kd,0,17.29999924,0,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,VPC03090-P,6992,,,178103571,Agonist,Partial agonist,,f,f,,pKd,0,8.640000343,0,Kd,0,2.299999952,0,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,VPC03090-P,6992,,,178103571,Agonist,Partial agonist,,f,f,,pEC50,0,8.619999886,0,EC50,0,2.400000095,0,=,,,,21632869,CCCCCCCCc1cccc(c1)C1CC(C1)(N)COP(=O)(O)O
S1P<sub>5</sub> receptor,279,S1PR5,Q9H228,,,,,,Human,VPC44116,2930,,,135651310,Agonist,Partial agonist,,f,,,pEC50,0,7.5,0,,0,0,0,,,,,17113298,CCCCCCCCc1cccc(c1)NC(=O)[C@@H](CCP(=O)(O)O)N
secretin receptor,252,Sctr,P23811,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,6.2,0,IC50,0,600,0,=,Inhibition of [125I]Tyr25 secretin binding in membranes from CHO cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
secretin receptor,252,Sctr,P23811,,,,,,Rat,[<sup>125</sup>I]secretin (pig),1153,,,135652557,Agonist,Full agonist,,f,,,pKd,9.2,0,7.7,,0,0,0,,,,,1646711,
secretin receptor,252,Sctr,P23811,,,,,,Rat,[<sup>125</sup>I](Tyr<sup>10</sup>)secretin-27 (rat),3759,,,178100610,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,9843782,
secretin receptor,252,SCTR,P47872,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Partial agonist,,t,,,pIC50,0,5.4,0,-,0,0,0,=,,,,1646711,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
semaphorin 4D (CD100),2883,SEMA4D,Q92854,,,,,,Human,VX15/2503,8932,,,310264713,Antibody,Binding,,f,t,,pKd,0,9.350000381,0,Kd,0,0.449999988,0,=,Measuring binding to native SEMA4D expressed on human peripheral blood T lymphocytes.,,,26431358,
SERCA1,840,ATP2A1,O14983,,,,,,Human,TGN4,8822,,,252827479,Allosteric modulator,Negative,,f,f,,pIC50,0,8.920000076,0,IC50,0,1.200000048,0,=,,,,15828839,CCCCCCCC(=O)O[C@@H]1C(=O)C(=C2[C@H]1[C@@](C)(OC(=O)C)C[C@@H]([C@]1([C@H]2OC(=O)[C@@]1(C)O)O)OC(=O)CCCCCCCCCCCNC(=O)CCC(C(=O)O)N)C
serpin family C member 1,2632,SERPINC1,P01008,,,,,,Human,tinzaparin,6846,,,178103452,Activator,Activation,,f,t,,-,0,0,0,-,0,0,0,=,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,,,7528134,
SERT,928,SLC6A4,P31645,,,,,,Human,[<sup>3</sup>H]citalopram,4621,,,178101339,Inhibitor,Inhibition,,f,f,,pKd,0,8.300000191,0,Kd,0,5,0,=,,,,0,N#Cc1ccc2c(c1)COC2(CCCN(C)C)c1ccc(cc1)F
SERT,928,SLC6A4,P31645,,,,,,Human,[<sup>3</sup>H]paroxetine,4561,,,178101282,Inhibitor,Inhibition,,f,f,,pKd,0,9.699999809,0,Kd,0,0.200000003,0,=,,,,0,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1cc2OCOc2cc1[3H]
SERT,928,SLC6A4,P31645,,,,,,Human,trimipramine,7317,,,178103890,Inhibitor,Inhibition,,f,t,,pKi,0,6.829999924,0,Ki,0,149,0,=,,,,9537821,CN(CC(CN1c2ccccc2CCc2c1cccc2)C)C
SERT,928,SLC6A4,P31645,,,,,,Human,venlafaxine,7321,,,178103894,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,20378347,COc1ccc(cc1)C(C1(O)CCCCC1)CN(C)C
SERT,928,SLC6A4,P31645,,,,,,Human,vilazodone,7427,,,178103999,Inhibitor,Inhibition,,f,t,,pIC50,9.300000191,0,8.800000191,IC50,1.580000043,0,0.5,=,,,,19499624,N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2
SERT,928,SLC6A4,P31645,,,,,,Human,vortioxetine,7351,,,178103923,Inhibitor,Inhibition,,f,t,,pKi,0,8.800000191,0,Ki,0,1.600000024,0,=,,,,21486038,Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1
SERT,928,SLC6A4,P31645,,,,,,Human,ziprasidone,59,,,135651359,Inhibitor,Inhibition,,f,f,,pKi,0,7.28000021,0,Ki,0,53,0,=,,,,0,O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2
SERT,928,SLC6A4,P31645,,,,,,Human,zotepine,103,,,135651367,Inhibitor,Inhibition,,f,f,,pIC50,0,5.139999866,0,IC50,0,7270,0,=,,,,20223878,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C
&sigma;2,2553,TMEM97,Q5BJF2,,,,,,Human,[<sup>3</sup>H]-di-o-tolylguanidine,6685,,,178103297,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,NC(=Nc1ccccc1C)Nc1ccccc1C
sigma non-opioid intracellular receptor 1,2552,SIGMAR1,Q99720,,,,,,Human,[<sup>3</sup>H]pentazocine,6683,,,178103295,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,CC(=CCN1CC[C@]2([C@@H]([C@@H]1Cc1c2c([3H])c(c(c1)[3H])O)C)C)C
SMO,239,Smo,P56726,,,,,,Mouse,TAK-441,8200,,,249565880,Antagonist,Antagonist,,f,f,,pIC50,0,8.359999657,0,IC50,0,4.400000095,0,=,,,,22898254,OCC(=O)N1CCC(CC1)NC(=O)c1c(OCC(F)(F)F)c2c(n1C)cc(n(c2=O)CC(=O)c1ccccc1)CC
SMO,239,SMO,Q99835,,,,,,Human,vismodegib,6975,,,178103554,Antagonist,Antagonist,,f,t,,pKi,0,7.789999962,0,Ki,0,16.20000076,0,=,,,,23063522,O=C(c1ccc(cc1Cl)S(=O)(=O)C)Nc1ccc(c(c1)c1ccccn1)Cl
Sodium/bile acid and sulphated solute cotransporter 2,960,SLC10A2,Q12908,,,,,,Human,[<sup>3</sup>H]taurocholic acid,4546,,,178101267,None,None,,f,,,-,0,0,0,,0,0,0,,,,,9458785,O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)NCCS(=O)(=O)O)C)C)O)C
Sodium/calcium exchanger 3,947,SLC8A3,P57103,,,,,,Human,YM-244769,9484,,,329968424,Inhibitor,Inhibition,,f,t,,pIC50,0,7.739999771,0,IC50,0,18,0,=,Inhibition of intracellular Na(+)-dependent [<sup>45</sup>]Ca(2+) uptake <i>via</i> NCX3.,,,16973719,Nc1cccc(c1)CNC(=O)c1ccc(nc1)Oc1ccc(cc1)OCc1cccc(c1)F
sodium-coupled neutral amino acid transporter 1,1169,SLC38A1,Q9H2H9,,,,,,Human,[<sup>14</sup>C]alanine,4542,,,178101263,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 1,1169,SLC38A1,Q9H2H9,,,,,,Human,[<sup>3</sup>H]alanine,4543,,,178101264,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 2,1170,SLC38A2,Q96QD8,,,,,,Human,[<sup>14</sup>C]alanine,4542,,,178101263,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 2,1170,SLC38A2,Q96QD8,,,,,,Human,[<sup>3</sup>H]alanine,4543,,,178101264,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
Sodium-coupled neutral amino acid transporter 3,1172,SLC38A3,Q99624,,,,,,Human,[<sup>14</sup>C]glutamine,4633,,,178101351,None,None,,f,,,-,0,0,0,-,0,0,0,=,,,,0,NC(=O)CC[C@@H](C(=O)O)N
Sodium-coupled neutral amino acid transporter 3,1172,SLC38A3,Q99624,,,,,,Human,[<sup>3</sup>H]glutamine,4634,,,178101352,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,NC(=O)CC[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 4,1171,SLC38A4,Q969I6,,,,,,Human,[<sup>14</sup>C]alanine,4542,,,178101263,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 4,1171,SLC38A4,Q969I6,,,,,,Human,[<sup>14</sup>C]glycine,4635,,,178101353,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,NCC(=O)O
sodium-coupled neutral amino acid transporter 4,1171,SLC38A4,Q969I6,,,,,,Human,[<sup>3</sup>H]alanine,4543,,,178101264,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,C[C@@H](C(=O)O)N
sodium-coupled neutral amino acid transporter 4,1171,SLC38A4,Q969I6,,,,,,Human,[<sup>3</sup>H]glycine,4084,,,178100907,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,NCC(=O)O
Sodium-coupled neutral amino acid transporter 5,1173,SLC38A5,Q8WUX1,,,,,,Human,[<sup>14</sup>C]histidine,4623,,,178101341,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,N[14C@H](C(=O)O)Cc1c[nH]cn1
Sodium-coupled neutral amino acid transporter 5,1173,SLC38A5,Q8WUX1,,,,,,Human,[<sup>3</sup>H]histidine,4670,,,178101385,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,N[C@H](C(=O)O)Cc1c[nH]cn1
Sodium-dependent vitamin C transporter 1,1041,SLC23A1,Q9UHI7,,,,,,Human,[<sup>14</sup>C]ascorbic acid,4532,,,178101253,None,Binding,,f,f,,-,0,0,0,-,0,0,0,=,,,,11895172,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O
Sodium-dependent vitamin C transporter 2,1042,SLC23A2,Q9UGH3,,,,,,Human,[<sup>14</sup>C]ascorbic acid,4532,,,178101253,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O
Sodium/glucose cotransporter 1,915,SLC5A1,P13866,,,,,,Human,tofogliflozin,9395,,,328083497,Inhibitor,Inhibition,,f,f,,pIC50,0,5.070000172,0,IC50,0,8444,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing hSGLT1.,,,22889351,OC[C@H]1O[C@]2(OCc3c2cc(cc3)Cc2ccc(cc2)CC)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/glucose cotransporter 2,916,SLC5A2,P31639,,,,,,Human,tofogliflozin,9395,,,328083497,Inhibitor,Inhibition,,f,t,,pIC50,0,8.539999962,0,IC50,0,2.900000095,0,=,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing hSGLT2.,,,22889351,OC[C@H]1O[C@]2(OCc3c2cc(cc3)Cc2ccc(cc2)CC)[C@@H]([C@H]([C@@H]1O)O)O
Sodium/hydrogen exchanger 3,950,Slc9a3,P26433,,,,,,Rat,tenapanor,8449,,,252166659,Inhibitor,Inhibition,,f,f,,pIC50,0,7,0,IC50,0,100,0,<,,,,0,O=C(NCCOCCOCCNS(=O)(=O)c1cccc(c1)[C@@H]1CN(C)Cc2c1cc(Cl)cc2Cl)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c1cccc(c1)[C@@H]1CN(C)Cc2c1cc(Cl)cc2Cl
sPLA<sub>2</sub>-2A,1417,PLA2G2A,P14555,,,,,,Human,varespladib,9657,,,348353616,Inhibitor,Inhibition,,f,f,,pIC50,0,8.050000191,0,IC50,0,9,0,=,IC50 from a chromogenic <i>in vitro</i> assay.,,,8978844,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)cccc2OCC(=O)O
sPLA<sub>2</sub>-2A,1417,PLA2G2A,P14555,,,,,,Human,varespladib,9657,,,348353616,Inhibitor,Inhibition,,f,f,,pIC50,0,8.149999619,0,IC50,0,7,0,=,IC50 from a radiometric deoxycholate/phosphatidylcholine assay.,,,8978844,CCc1c(C(=O)C(=O)N)c2c(n1Cc1ccccc1)cccc2OCC(=O)O
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,Syk inhibitor,6046,,,178102668,Inhibitor,Inhibition,,f,t,,pIC50,0,7.849999905,0,IC50,0,14,0,=,Assayed using N-Flag tagged catalytic domain of human SYK (Ala340-Asn635),,,12941345,O=C1Nc2c(/C/1=C/c1cn(c3c1cccc3)C)cc(cc2)S(=O)(=O)N
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,Syk inhibitor II,6047,,,178102669,Inhibitor,Inhibition,,f,t,,pIC50,0,7.389999866,0,IC50,0,41,0,=,,,,15990316,NCCNc1ncc(c(n1)Nc1cccc(c1)C(F)(F)F)C(=O)N
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,Syk inhibitor III,6048,,,178102670,Inhibitor,Inhibition,,f,t,,pIC50,0,5.550000191,0,IC50,0,2800,0,=,,,,17601492,[O-][N+](=O)/C=C/c1ccc2c(c1)OCO2
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,t,,pIC50,0,8.489999771,0,IC50,0,3.200000048,0,=,Enzyme inhibition <i>in vitro</i>.,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,t,,pEC50,0,8.010000229,0,EC50,0,9.800000191,0,=,Cellular potency,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,tamatinib,5706,,,178102333,Inhibitor,Inhibition,,f,t,,pKd,0,7.71999979,0,Kd,0,19,0,=,,,,22037378,COc1cc(Nc2ncc(c(n2)Nc2ccc3c(n2)NC(=O)C(O3)(C)C)F)cc(c1OC)OC
spleen associated tyrosine kinase,2230,SYK,P43405,,,,,,Human,tamatinib,5706,,,178102333,Inhibitor,Inhibition,,f,t,,pIC50,7.519999981,0,7.389999866,IC50,41,0,30,=,,,,16946104,COc1cc(Nc2ncc(c(n2)Nc2ccc3c(n2)NC(=O)C(O3)(C)C)F)cc(c1OC)OC
squalene synthase ,645,FDFT1,P37268,,,,,,Human,YM-75440,3137,,,135649654,Inhibitor,Inhibition,,f,,,pIC50,0,7.2,0,-,0,63,0,=,in vitro . Rat and human liver microsomes assayed using the Amin techinique,,,15498666,C=CCc1c(OCCCNCc2ccccc2)ccc2c1[nH]c1c2cccc1
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,zaragozic acid A,3057,,,135652728,Inhibitor,Inhibition,,f,,,pKi,0,10.11,0,Ki,0,0.078,0,=,Compound was tested for inhibition of squalene synthase in rat liver.,,,8419946,CC[C@@H](C[C@@H](/C=C/C(=O)O[C@@H]1[C@@H](O)[C@@]2(O[C@@]1(C(=O)O)[C@](O)(C(=O)O)[C@H](O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C)C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,zaragozic acid A,3057,,,135652728,Inhibitor,Inhibition,,f,,,pIC50,0,9.15,0,-,0,0.7,0,=,"in vitro, soluable microsomal enzymes purified from rat and human liver microsomes",,,9473303,CC[C@@H](C[C@@H](/C=C/C(=O)O[C@@H]1[C@@H](O)[C@@]2(O[C@@]1(C(=O)O)[C@](O)(C(=O)O)[C@H](O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C)C)C
squalene synthase ,645,FDFT1,P37268,,,,,,Human,zaragozic acid A,3057,,,135652728,Inhibitor,Inhibition,,f,f,,pKi,0,9.600000381,0,Ki,0,0.25,0,=,"Human enzyme expressed in yeast, in vitro assay",,,7864626,CC[C@@H](C[C@@H](/C=C/C(=O)O[C@@H]1[C@@H](O)[C@@]2(O[C@@]1(C(=O)O)[C@](O)(C(=O)O)[C@H](O2)C(=O)O)CCC(=C)[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C)C)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,zaragozic acid B,6061,,,178102682,Inhibitor,Inhibition,,f,,,pKi,0,10.5,0,Ki,0,0.029,0,=,,,,8419946,C/C=C/CCCC/C=C/CCCCC(=O)O[C@@H]1[C@@H](O)[C@@]2(O[C@@]1(C(=O)O)[C@](O)(C(=O)O)[C@H](O2)C(=O)O)CCC(C(C(C/C=C/c1ccccc1)C)O)C
squalene synthase ,645,Fdft1,Q02769,,,,,,Rat,zaragozic acid C,3073,,,135649677,Inhibitor,Inhibition,,f,,,pKi,0,10.4,0,Ki,0,0.045,0,=,Inhibition of rat squalene synthase,,,8419946,C[C@H](CCCc1ccccc1)/C=C/CCC(=O)O[C@@H]1[C@@H](O)[C@@]2(O[C@@]1(C(=O)O)[C@](O)(C(=O)O)[C@H](O2)C(=O)O)CCC[C@H]([C@@H](Cc1ccccc1)C)OC(=O)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,7.139999866,0,IC50,0,73,0,=,,,,22818848,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,Syk inhibitor III,6048,,,178102670,Inhibitor,Inhibition,,f,f,,pIC50,0,4.559999943,0,IC50,0,27300,0,=,,,,17601492,[O-][N+](=O)/C=C/c1ccc2c(c1)OCO2
"SRC proto-oncogene, non-receptor tyrosine kinase",2206,SRC,P12931,,,,,,Human,WH-4-023,8068,,,249565748,Inhibitor,Inhibition,,f,t,,pIC50,0,8.220000267,0,IC50,0,6,0,=,,,,16884310,COc1cc(OC)ccc1N(C(=O)Oc1c(C)cccc1C)c1ccnc(n1)Nc1ccc(cc1)N1CCN(CC1)C
SRSF protein kinase 2,2209,SRPK2,P78362,,,,,,Human,URMC-099,8106,,,249565786,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,Measured as % inhibition using 1&mu;M compound.,,,24044867,CN1CCN(CC1)Cc1ccc(cc1)c1cnc2c(c1)c(c[nH]2)c1ccc2c(c1)cc[nH]2
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,9.6,0,8.9,,0,0,0,,,,,8100350,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,9650799,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,8.8,0,-,0,0,0,=,,,,9784130,
SST<sub>1</sub> receptor,355,SSTR1,P30872,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,9650799,
SST<sub>1</sub> receptor,355,Sstr1,P30873,,,,,,Mouse,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,9.2,0,-,0,0,0,=,,,,8769370,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Tyr<sup>3</sup>-octreotide,5649,,,178102277,Agonist,Agonist,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>111</sup>In]DOTA-BOC-ATE,2063,,,135652213,Agonist,Full agonist,,f,,,pIC50,0,8.8,0,,0,0,0,,,,,15709181,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>111</sup>In]DOTA-NOC,2045,,,135652214,Agonist,Full agonist,,f,,,pIC50,0,8.5,0,,0,0,0,,,,,12937948,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>111</sup>In]DOTA-NOC-ATE,2064,,,135652215,Agonist,Full agonist,,f,,,pIC50,0,8.7,0,,0,0,0,,,,,15709181,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-LAN",2056,,,135652640,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,12937948,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-NOC",2057,,,135652641,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,12937948,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-OC",2058,,,135652642,Agonist,Full agonist,,f,,,pIC50,0,7.7,0,,0,0,0,,,,,12937948,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-TOC",2059,,,135652643,Agonist,Full agonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,12937948,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,[<sup>125</sup>I]BIM23027,3772,,,178100622,Agonist,Full agonist,,f,,,pIC50,0,9.7,0,IC50,0,0.22,0,=,,,,9121614,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.8,0,,0,0,0,,,,,10598788,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,10,0,9.9,-,0,0,0,=,,,,9784130,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,9.34,0,9.02,Kd,0.95,0,0.46,=,,,,6114372,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,[<sup>125</sup>I]MK-678,2061,,,135652531,Agonist,Full agonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,8100350,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,9650799,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,8.96,0,Kd,0,1.09,0,=,,,,6125148,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,8769370,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995,2062,,,135652566,Agonist,Full agonist,,f,,,pIC50,0,8.89,0,IC50,0,1.3,0,=,,,,11807604,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,[<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995,2062,,,135652566,Agonist,Full agonist,,f,,,pKd,0,9.54,0,Kd,0,0.29,0,=,,,,2859510,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995,2062,,,135652566,Agonist,Full agonist,,f,,,pKd,0,9.9,0,Kd,0,0.13,0,=,,,,10598788,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,"[<sup>125</sup>I][Tyr<sup>3</sup>,Thr<sup>8</sup>]octreotide",5630,,,178102259,Agonist,Full agonist,,f,,,pIC50,0,9.33,0,IC50,0,0.47,0,=,,,,11807604,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,[<sup>67</sup>Ga]NODAGA-[Tyr<sup>3</sup>]octreotide,5628,,,178102258,Agonist,Full agonist,,f,,,pIC50,0,8.46,0,IC50,0,3.5,0,=,,,,12009943,
SST<sub>2</sub> receptor,356,Sstr2,P30680,,,,,,Rat,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,Sstr2,P30875,,,,,,Mouse,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,,,pKi,9.2,0,6.1,,0,0,0,,,,,9600011,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,t,,pKi,10.10000038,0,8.300000191,-,0,0,0,=,,,,8769372,
SST<sub>2</sub> receptor,356,SSTR2,P30874,,,,,,Human,Y-KE88,5641,,,178102269,Agonist,Full agonist,,f,,,pIC50,0,8,0,IC50,0,9.9,0,=,,,,18381940,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>111</sup>In]DOTA-BOC-ATE,2063,,,135652213,Agonist,Full agonist,,f,,,pIC50,0,8.3,0,,0,0,0,,,,,15709181,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>111</sup>In]DOTA-NOC,2045,,,135652214,Agonist,Full agonist,,f,,,pIC50,0,8.1,0,,0,0,0,,,,,12937948,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>111</sup>In]DOTA-NOC-ATE,2064,,,135652215,Agonist,Full agonist,,f,,,pIC50,0,7.9,0,,0,0,0,,,,,15709181,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-LAN",2056,,,135652640,Agonist,Full agonist,,f,,,pIC50,0,6.5,0,,0,0,0,,,,,12937948,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-NOC",2057,,,135652641,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,12937948,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-OC",2058,,,135652642,Agonist,Full agonist,,f,,,pIC50,0,7.6,0,,0,0,0,,,,,12937948,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-TOC",2059,,,135652643,Agonist,Full agonist,,f,,,pIC50,0,6.4,0,,0,0,0,,,,,12937948,
SST<sub>3</sub> receptor,357,Sstr3,P30935,,,,,,Mouse,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,8100350,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.8,0,-,0,0,0,=,,,,10598788,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,9.4,0,-,0,0,0,=,,,,9784130,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,10.3,0,9.7,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,10.1,0,,0,0,0,,,,,9650799,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,[<sup>125</sup>I]Tyr<sup>7</sup>-Sst3-ODN-8,2075,,,135652571,Agonist,Full agonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,11095748,
SST<sub>3</sub> receptor,357,Sstr3,P30936,,,,,,Rat,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,,,pKi,0,7.1,0,,0,0,0,,,,,9600011,
SST<sub>3</sub> receptor,357,SSTR3,P32745,,,,,,Human,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,t,,pKi,7.900000095,0,7.400000095,-,0,0,0,=,,,,8769372,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,10598788,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pIC50,0,9.6,0,,0,0,0,,,,,9650799,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,8.4,0,-,0,0,0,=,,,,9784130,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,10598788,
SST<sub>4</sub> receptor,358,SSTR4,P31391,,,,,,Human,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,9,0,,0,0,0,,,,,8483934,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>111</sup>In]DOTA-BOC-ATE,2063,,,135652213,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,15709181,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>111</sup>In]DOTA-NOC,2045,,,135652214,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,12937948,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>111</sup>In]DOTA-NOC-ATE,2064,,,135652215,Agonist,Full agonist,,f,,,pIC50,0,8.4,0,,0,0,0,,,,,15709181,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-LAN",2056,,,135652640,Agonist,Full agonist,,f,,,pIC50,0,7.8,0,,0,0,0,,,,,12937948,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-NOC",2057,,,135652641,Agonist,Full agonist,,f,,,pIC50,0,8,0,,0,0,0,,,,,12937948,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-OC",2058,,,135652642,Agonist,Full agonist,,f,,,pIC50,0,7.2,0,,0,0,0,,,,,12937948,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,"[<sup>111</sup>In,<sup>90</sup>Y]DOTA-TOC",2059,,,135652643,Agonist,Full agonist,,f,,,pIC50,0,6.7,0,,0,0,0,,,,,12937948,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,10598788,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[<sup>125</sup>I]CGP 23996,2022,,,135652502,Agonist,Full agonist,,f,,,pKd,0,9.8,0,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,9.2,0,-,0,0,0,=,,,,9784130,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,10.5,0,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[<sup>125</sup>I]LTT-SRIF-28,2023,,,135652528,Agonist,Full agonist,,f,,,pKd,0,11,0,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,10.3,0,,0,0,0,,,,,9650799,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[<sup>125</sup>I]Tyr<sup>10</sup>-CST14,2024,,,135652562,Agonist,Full agonist,,f,,,pKd,0,10.2,0,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,8078491,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,[<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14,2060,,,135652578,Agonist,Full agonist,,f,,,pKd,0,10,0,,0,0,0,,,,,8078491,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,[<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995,2062,,,135652566,Agonist,Full agonist,,f,,,pKd,0,9.64,0,Kd,0,0.23,0,=,,,,10598788,
SST<sub>5</sub> receptor,359,Sstr5,O08858,,,,,,Mouse,[<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995,2062,,,135652566,Agonist,Full agonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,10818261,
SST<sub>5</sub> receptor,359,SSTR5,P35346,,,,,,Human,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,t,,pKi,9.199999809,0,7.300000191,-,0,0,0,=,,,,8769372,
SST<sub>5</sub> receptor,359,Sstr5,P30938,,,,,,Rat,vapreotide,2054,,,135652433,Agonist,Full agonist,,f,,,pKi,0,8.2,0,,0,0,0,,,,,9600011,
succinate receptor,166,SUCNR1,Q9BXA5,,,,,,Human,succinic acid,3637,,,178100544,Agonist,Full agonist,,t,f,,pEC50,4.699999809,0,3.099999905,EC50,91000,0,20000,=,,,,15141213,OC(=O)CCC(=O)O
taspase 1,2419,TASP1,Q9H6P5,,,,,,Human,yzm18,8853,,,252827510,Inhibitor,Inhibition,,f,f,,pIC50,0,4.53000021,0,IC50,0,29400,0,=,,,,19631530,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)/C=C/S(=O)(=O)C)CC(C)C)CCC(=O)N)CO)NC(=O)C)C
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,tyramine,2150,,,135651582,Agonist,Agonist,,t,,,pKi,0,6.4,0,Ki,0,404,0,=,,,,19892733,NCCc1ccc(cc1)O
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,[<sup>3</sup>H]tyramine,2148,,,135651572,Agonist,Full agonist,,f,f,,pKd,0,7.699999809,0,Kd,0,20,0,=,,,,11459929,NCCc1ccc(cc1)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,tyramine,2150,,,135651582,Agonist,Full agonist,,t,,,pEC50,7.2,0,6.9,-,0,0,0,=,,,,17218486,NCCc1ccc(cc1)O
TA<sub>1</sub> receptor,364,TAAR1,Q96RJ0,,,,,,Human,tyramine,2150,,,135651582,Agonist,Full agonist,,t,,,pEC50,6.7,0,5.8,-,0,0,0,=,,,,11459929,NCCc1ccc(cc1)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y9,,,,,,Rat,tyramine,2150,,,135651582,Agonist,Full agonist,,t,,,pKi,0,7.2,0,Ki,0,70,0,=,,,,19892733,NCCc1ccc(cc1)O
TA<sub>1</sub> receptor,364,Taar1,Q923Y8,,,,,,Mouse,tyramine,2150,,,135651582,Agonist,Full agonist,,t,,,pEC50,7.1,0,6.2,-,0,0,0,=,,,,17218486,NCCc1ccc(cc1)O
Testicular receptor 4,614,NR2C2,P49116,,,,,,Human,tretinoin,2644,,,135651435,Agonist,Full agonist,,t,f,,pEC50,0,4.619999886,0,EC50,0,23800,0,=,,,,21068381,C/C(=CC=CC(=CC(=O)O)C)/C=C/C1=C(C)CCCC1(C)C
Thiamine transporter 1,1015,SLC19A2,O60779,,,,,,Human,[<sup>3</sup>H]thiamine,4628,,,178101346,None,None,,f,,,-,0,0,0,,0,0,0,,,,,10542220,OCCc1sc[n+](c1C)Cc1cnc(nc1N)C
Thiamine transporter 2,1016,SLC19A3,Q9BZV2,,,,,,Human,[<sup>3</sup>H]thiamine,4628,,,178101346,None,None,,f,,,-,0,0,0,,0,0,0,,,,,11731220,OCCc1sc[n+](c1C)Cc1cnc(nc1N)C
Thrombopoietin receptor,1722,MPL,P40238,,,,,,Human,thrombopoietin,5063,THPO,Human,178101756,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Thymic stromal lymphopoietin receptor,2305,IL7R|CRLF2,P16871|Q9HC73,,,,,,Human,thymic stromal lymphopoietin,5083,TSLP,Human,178101776,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,tiratricol,2637,,,135651405,Agonist,Agonist,,f,,,pIC50,0,0,0,-,0,0,0,=,,,,2158622,OC(=O)Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,triiodothyronine,2634,,,135651573,Agonist,Agonist,,t,t,,pKd,0,10,0,-,0,0,0,=,,,,12109914,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O)N
Thyroid hormone receptor-&alpha;,588,THRA,P10827,,,,,,Human,T<sub>4</sub>,2635,,,135651574,Agonist,Agonist,,t,t,,pIC50,0,0,0,-,0,0,0,=,,,,2158622,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,tiratricol,2637,,,135651405,Agonist,Agonist,,f,,,pKd,0,10.7,0,-,0,0,0,=,,,,2158622,OC(=O)Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,triiodothyronine,2634,,,135651573,Agonist,Agonist,,t,t,,pKd,0,10.10000038,0,-,0,0,0,=,,,,12109914,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O)N
Thyroid hormone receptor-&beta;,589,THRB,P10828,,,,,,Human,T<sub>4</sub>,2635,,,135651574,Agonist,Agonist,,t,t,,pIC50,0,8.520000458,0,-,0,0,0,=,,,,2158622,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N
TPC1,392,TPCN1,Q9ULQ1,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,Inhibition,,f,f,,pIC50,0,4.639999866,0,IC50,0,23000,0,=,,,,24776928,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
TPC2,393,TPCN2,Q8NHX9,,,,,,Human,verapamil,2406,,,135651305,Channel blocker,Inhibition,,f,f,,pIC50,0,5,0,IC50,0,10000,0,=,,,,23063126,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>125</sup>I]BOP,1973,,,135651104,Agonist,Full agonist,,f,,,pKd,0,8.7,0,Kd,0,2,0,=,,,,2530338,OC(=O)CCC/C=C/C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)[125I])O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>3</sup>H]U46619,1974,,,135651212,Agonist,Full agonist,,f,,,pKd,0,7.8,0,,0,0,0,,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,U46609,1972,,,135651288,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,1434130,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,U46619,1888,,,135651289,Agonist,Full agonist,,f,f,,pKi,0,7.5,0,-,0,0,0,=,,,,10634944,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,U46619,1888,,,135651289,Agonist,Full agonist,,f,,,pKi,0,7.2,0,,0,0,0,,,,,9313928,CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=CCCCC(=O)O)C2)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>125</sup>I]PTA-OH,1981,,,135651114,Antagonist,Antagonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,3594077,OC(Cc1ccc(c(c1)[125I])O)CNC1CC2CC(C1C/C=C/CCCC(=O)O)C2(C)C
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>125</sup>I]SAP,1982,,,135651115,Antagonist,Antagonist,,f,,,pKd,9.3,0,7.7,Kd,20,0,0.5,=,,,,1386885,OC(=O)CCC/C=CC[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)[125I]
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>125</sup>I]SQ-29548,1983,,,135651118,Antagonist,Antagonist,,f,,,pKd,0,8.3,0,,0,0,0,,,,,2968449,O=C(Nc1ccc(cc1)[125I])NNC[C@@H]1[C@H]2CC[C@@H]([C@@H]1C/C=CCCCC(=O)O)O2
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,[<sup>3</sup>H]S-145,1984,,,135651201,Antagonist,Antagonist,,f,,,pKd,0,8.5,0,,0,0,0,,,,,1375456,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>3</sup>H]S-145,1984,,,135651201,Antagonist,Antagonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,1825698,OC(=O)CCC/C=CC[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2
TP receptor,346,Tbxa2r,P34978,,,,,,Rat,[<sup>3</sup>H]SQ-29548,1985,,,135651207,Antagonist,Antagonist,,f,,,pKd,0,9,0,,0,0,0,,,,,7635958,O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=CCCCC(=O)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,[<sup>3</sup>H]SQ-29548,1985,,,135651207,Antagonist,Antagonist,,f,,,pKd,8.2,0,7.4,Kd,40,0,6.3,=,,,,16604093,O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=CCCCC(=O)O)O2
TP receptor,346,TBXA2R,P21731,,,,,,Human,terutroban,6073,,,178102694,Antagonist,Antagonist,,f,,,pIC50,0,6.49,0,IC50,0,320,0,=,,,,9871769,OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl
TP receptor,346,Tbxa2r,P30987,,,,,,Mouse,vapiprost,1976,,,135650318,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9313928,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O
TP receptor,346,TBXA2R,P21731,,,,,,Human,vapiprost,1976,,,135650318,Antagonist,Antagonist,,f,f,,pKi,9.399999619,0,8.300000191,-,0,0,0,=,,,,8242228,OC(=O)CC/C=CCC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O
Transforming growth factor &beta; receptor,2585,TGFBR1|TGFBR3|TGFBR2,P36897|P37173|Q03167,,,,,,Human,TGF&beta;1,5060,TGFB1,Human,178101753,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Transforming growth factor &beta; receptor,2585,TGFBR1|TGFBR3|TGFBR2,P36897|P37173|Q03167,,,,,,Human,TGF&beta;2,5061,TGFB2,Human,178101754,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
Transforming growth factor &beta; receptor,2585,TGFBR1|TGFBR3|TGFBR2,P36897|P37173|Q03167,,,,,,Human,TGF&beta;3,5062,TGFB3,Human,178101755,Agonist,Agonist,,t,,,-,0,0,0,-,0,0,0,=,,,,0,
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,TGF-beta RI inhibitor III,6049,,,178102671,Inhibitor,Inhibition,,f,t,,pIC50,0,7.269999981,0,IC50,0,54,0,=,Assay used purified human TGF&beta;R1 kinase domain produced in Sf9 insect cells.,,,21696866,Cc1cccc(n1)c1[nH]c(nc1c1ccc2c(c1)OCO2)C(C)(C)C
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,TGF-beta RI kinase inhibitor,6050,,,178102672,Inhibitor,Inhibition,,f,t,,pIC50,0,7.570000172,0,IC50,0,27,0,=,,,,19035792,c1ccc(nc1)c1[nH]ncc1c1ccnc2c1cccc2
transforming growth factor beta receptor 1,1788,TGFBR1,P36897,,,,,,Human,vactosertib,8107,,,249565787,Inhibitor,Inhibition,,f,t,,pIC50,0,7.960000038,0,IC50,0,11,0,=,Measured using Reaction Biology Corporation's HotSpot kinase assay.,,,24786585,Cc1cccc(n1)c1[nH]c(nc1c1ccc2n(c1)ncn2)CNc1ccccc1F
transforming growth factor beta receptor 2,1795,TGFBR2,P37173,,,,,,Human,TGF&beta;3,5062,TGFB3,Human,178101755,Agonist,Agonist,,t,f,,pKd,0,6.53000021,0,Kd,0,294,0,=,Using a SPR assay and immobilised ligand.,,,29170498,
transthyretin,2851,TTR,P02766,,,,,,Human,tafamidis,8378,,,252166590,None,Binding,,f,f,,pKd,0,8.699999809,0,Kd,0,2,0,=,,,,22645360,Clc1cc(Cl)cc(c1)c1nc2c(o1)cc(cc2)C(=O)O
TRH<sub>1</sub> receptor,363,TRHR,P34981,,,,,,Human,taltirelin,2143,,,135651232,Agonist,Full agonist,,f,,,pKi,0,6.5,0,-,0,0,0,=,,,,23087672,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N)Cc1[nH]cnc1
TRH<sub>1</sub> receptor,363,Trhr,Q01717,,,,,,Rat,TRH,2139,TRH|Trh|Trh,Human|Mouse|Rat,135651896,Agonist,Full agonist,,t,t,,pKi,0,7.400000095,0,-,0,0,0,=,,,,8592728,O=C1CC[C@H](N1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N)Cc1nc[nH]c1
TRH<sub>1</sub> receptor,363,Trhr,Q01717,,,,,,Rat,[<sup>3</sup>H]MeTRH,2141,,,135651176,Agonist,Partial agonist,,f,,,pKd,0,8.5,0,-,0,0,0,=,,,,6264336,O=C(N1CCC[C@H]1C(=O)N)[C@@H](NC(=O)[C@@H]1CCC(=O)N1C)Cc1[nH]cnc1
TRH<sub>2</sub> receptor,754,Trhr2,,,,,,,Mouse,taltirelin,2143,,,135651232,Agonist,Full agonist,,f,,,pKi,0,6.9,0,-,0,0,0,=,,,,23303050,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N)Cc1[nH]cnc1
TRH<sub>2</sub> receptor,754,Mlnr,,,,,,,Rat,TRH,2139,TRH|Trh|Trh,Human|Mouse|Rat,135651896,Agonist,Full agonist,,f,,,pKi,0,7.4,0,-,0,0,0,=,,,,8592728,O=C1CC[C@H](N1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N)Cc1nc[nH]c1
TRH<sub>2</sub> receptor,754,Mlnr,,,,,,,Rat,[<sup>3</sup>H]MeTRH,2141,,,135651176,Agonist,Partial agonist,,f,,,pKd,0,8.5,0,-,0,0,0,=,,,,6264336,O=C(N1CCC[C@H]1C(=O)N)[C@@H](NC(=O)[C@@H]1CCC(=O)N1C)Cc1[nH]cnc1
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,super cinnamaldehyde,6270,,,178102890,Activator,Activation,,f,,,pEC50,0,6.1,0,EC50,0,800,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,17237762,CC(=O)/C=C/1c2ccccc2N(C1=O)C
TRPA1,485,TRPA1,O75762,,,,,,Human,thymol,2499,,,135651578,Activator,Activation,non-covalent,f,f,6.25-25,pEC50,0,4.699999809,0,EC50,0,20000,0,=,FLIPR calcium influx assay,,,18334983,Cc1ccc(c(c1)O)C(C)C
TRPA1,485,Trpa1,Q8BLA8,,,,,,Mouse,Zn<sup>2+</sup>,566,,,135652747,Activator,Activation,Zinc has similar activity at the human TRPA1,f,f,,pEC50,0,2.299999952,0,-,0,0,0,=,Calcium imaging,,,19202543,
TRPA1,485,TRPA1,O75762,,,,,,Human,URB597,4339,,,178101156,Activator,Agonist,non-covalent,f,f,,pEC50,0,4.599999905,0,EC50,0,24000,0,=,Fluorometric Imaging Plate Reader (FLIRP) calcium-influx assay,,,17314320,O=C(Oc1cccc(c1)c1cccc(c1)C(=O)N)NC1CCCCC1
TRPA1,485,TRPA1,O75762,,,,,,Human,TCS 5861528,6276,,,178102896,Gating inhibitor,Inhibition,,f,,,pIC50,0,4.8,0,-,0,0,0,=,Calcium imaging,,,19512877,CCC(c1ccc(cc1)NC(=O)Cn1cnc2c1c(=O)n(C)c(=O)n2C)C
TRPC2,487,Trpc2,Q9R244,,,,,,Mouse,U73122,5283,,,178101966,Channel blocker,Antagonist,may be indirect,f,f,10,-,0,0,0,-,0,0,0,=,,,,0,COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2NCCCCCCN1C(=O)C=CC1=O)C
TRPM1,493,TRPM1,Q7Z4N2,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,t,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,0,
TRPM2,494,TRPM2,O94759,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Channel blocker,None,,t,f,,pIC50,0,6,0,IC50,0,1000,0,=,,,,0,
TRPM3,495,TRPM3,Q9HCF6,,,,,,Human,troglitazone,2693,,,135651283,Channel blocker,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C
TRPM7,499,Trpm7,Q923J1,,,,,,Mouse,waixenicin A,6359,,,178102977,Channel blocker,Inhibition,"Irreversible, [Mg<sup>2+</sup>]<sub>i</sub> dependent: IC<sub>50</sub>=7&micro;M in the absence of free [Mg<sup>2+</sup>]<sub>i</sub>), IC<sub>50</sub>=16&micro;M at 700&micro;M free [Mg<sup>2+</sup>]<sub>i</sub>),",f,f,,pIC50,5.150000095,0,4.800000191,IC50,16000,0,7000,=,,,,21926172,CC(=O)OC/C(=C/C[C@@H](C1=CO[C@@H]([C@@H]2[C@@H]1CCC(=CCCC2=C)C)OC(=O)C)OC(=O)C)/C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,WS-12,4343,,,178101160,Activator,Full agonist,,f,f,,pEC50,0,4.900000095,0,EC50,0,12500,0,=,"Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8",,,18930858,COc1ccc(cc1)NC(=O)[C@@H]1C[C@H](C)CC[C@H]1C(C)C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,WS-5,6368,,,178102986,Activator,Full agonist,,f,,,pEC50,0,4.6,0,-,0,0,0,=,"Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK, CHO, and <i>Xenopus</i> oocytes) expressing TRPM8",,,20816009,CCOC(=O)NC(=O)[C@@H]1C[C@H](C)CC[C@H]1C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,WS-23,2474,,,53800994,Activator,Partial agonist,,f,,,pEC50,0,4.4,0,,0,0,0,,,,,14757700,CNC(=O)C(C(C)C)(C(C)C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,WS-3,2475,,,53800993,Activator,Partial agonist,,f,,,pEC50,0,5.4,0,,0,0,0,,,,,14757700,CCNC(=O)C1CC(C)CCC1C(C)C
TRPM8,500,Trpm8,Q8R4D5,,,,,,Mouse,thio-BCTC,2473,,,53800995,Channel blocker,Antagonist,,f,,,pIC50,0,5.5,0,,0,0,0,,,,,14757700,S=C(N1CCN(CC1)c1ncccc1Cl)Nc1ccc(cc1)C(C)(C)C
TRPM8,500,Trpm8,Q8R455,,,,,,Rat,thio-BCTC,2473,,,53800995,Channel blocker,Inhibition,,f,,,pIC50,0,5.5,0,-,0,0,0,=,Whole-cell voltage-clamp recordings or Ca2<sup>+</sup>-microfluorimetry in heterologous cells (HEK) expressing TRPM8,,,14757700,S=C(N1CCN(CC1)c1ncccc1Cl)Nc1ccc(cc1)C(C)(C)C
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,[<sup>3</sup>H]resiniferatoxin,4091,,,178100914,Activator,Activation,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1cc(ccc1O)CC(=O)OCC1=C[C@H]2[C@H]3O[C@]4(O[C@]2([C@H]2[C@@](C1)(O)C(=O)C(=C2)C)[C@@H](C[C@@]3(O4)C(=C)C)C)Cc1ccccc1
TRPV1,507,Trpv1,O35433,,,,,,Rat,vanillotoxin-1,5542,,,178102184,Activator,Agonist,,f,,,pEC50,0,5,0,EC50,0,9900,0,=,,,,17093448,
TRPV1,507,Trpv1,O35433,,,,,,Rat,vanillotoxin-2,5543,,,178102185,Activator,Agonist,,f,,,pEC50,0,5.87,0,EC50,0,1350,0,=,,,,17093448,
TRPV1,507,Trpv1,O35433,,,,,,Rat,vanillotoxin-3,5544,,,178102186,Activator,Agonist,,f,,,pEC50,0,6.35,0,EC50,0,450,0,=,,,,17093448,
TRPV1,507,Trpv1,O35433,,,,,,Rat,[<sup>125</sup>I]resiniferatoxin,2492,,,135652719,Channel blocker,Antagonist,,f,f,,pIC50,0,8.399999619,0,IC50,0,3.980000019,0,=,,,,11125018,COc1cc(CC(=O)OCC2=C[C@H]3[C@H]4O[C@]5(O[C@]3([C@H]3[C@@](C2)(O)C(=O)C(=C3)C)[C@@H](C[C@@]4(O5)C(=C)C)C)Cc2ccccc2)cc(c1O)[125I]
TRPV1,507,TRPV1,Q8NER1,,,,,,Human,[<sup>3</sup>H]A778317,4076,,,178100899,Channel blocker,None,,f,f,,pKd,0,8.5,0,Kd,0,3.400000095,0,=,,,,17660385,O=C(Nc1c([3H])cc(c2c1ccnc2)[3H])N[C@@H]1CCc2c1ccc(c2)C(C)(C)C
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,tetraethylammonium,2343,,,135651249,Channel blocker,Inhibition,,f,,10000,-,0,0,0,-,0,0,0,=,,,,17673572,CC[N+](CC)(CC)CC
TRPV2,508,Trpv2,Q9WTR1,,,,,,Mouse,TRIM,4331,,,178101148,Channel blocker,Inhibition,,f,f,500,-,0,0,0,-,0,0,0,=,,,,17673572,FC(c1ccccc1n1cncc1)(F)F
TRPV3,509,Trpv3,,,,,,,Rat,tetrahydrocannabivarin,6418,,,178103034,Activator,Activation,,f,,,pEC50,0,5.42,0,EC50,0,3800,0,=,Calcium imaging,,,21726418,CCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,vanillin,6412,,,178103028,Activator,Activation,,f,f,10000,-,0,0,0,-,0,0,0,=,Two-electrode voltage-clamp,,,16617338,COc1cc(C=O)ccc1O
TRPV3,509,Trpv3,Q8K424,,,,,,Mouse,thymol,2499,,,135651578,Activator,Full agonist,,f,f,500,-,0,0,0,-,0,0,0,=,Patch clamp electrophysiology,,,16617338,Cc1ccc(c(c1)O)C(C)C
tryptase gamma 1,2425,,,,,,,,Unknown,WX-UK1,6498,,,178103112,Inhibitor,Inhibition,,f,f,,pKi,0,5.199999809,0,Ki,0,6300,0,=,,,,10560742,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NS(=O)(=O)c1c(cc(cc1C(C)C)C(C)C)C(C)C)Cc1cccc(c1)C(=N)N
TSH receptor,255,TSHR,P16473,,,,,,Human,TSH,3920,CGA|TSHB,Human,135651899,Agonist,Agonist,,t,t,,-,0,0,0,-,0,0,0,=,,,,0,
TSH receptor,255,TSHR,P16473,,,,,,Human,[<sup>125</sup>I]TSH (human),3806,,,178100653,Agonist,Full agonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,vinblastine,6851,,,178103457,Inhibitor,Inhibition,,f,t,,pIC50,0,9,0,IC50,0,1,0,=,,,,0,COc1cc2N(C)[C@@H]3[C@@]4(c2cc1[C@]1(C[C@H]2CN(CCc5c1[nH]c1c5cccc1)C[C@](C2)(O)CC)C(=O)OC)CCN1[C@H]4[C@@]([C@H]([C@]3(O)C(=O)OC)OC(=O)C)(CC)C=CC1
tubulin beta class I,2640,TUBB,P07437,,,,,,Human,vincristine,6785,,,178103391,Inhibitor,Inhibition,,f,t,,-,0,0,0,-,0,0,0,=,,,,0,O=CN1c2cc(OC)c(cc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC
tumor necrosis factor receptor 1,1870,TNFRSF1A,P19438,,,,,,Human,tumour necrosis factor membrane form,5073,TNF,Human,178101766,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
tumor necrosis factor receptor 1,1870,TNFRSF1A,P19438,,,,,,Human,tumour necrosis factor shed form,5074,TNF,Human,178101767,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
tumor necrosis factor receptor 2,1871,TNFRSF1B,P20333,,,,,,Human,tumour necrosis factor membrane form,5073,TNF,Human,178101766,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
TWEAK receptor,1884,TNFRSF12A,Q9NP84,,,,,,Human,TWEAK,5067,TNFSF12,Human,178101760,None,None,,t,,,-,0,0,0,,0,0,0,,,,,0,
tyrosine kinase 2,2269,TYK2,P29597,,,,,,Human,TG02,9095,,,315661180,Inhibitor,Inhibition,,f,f,,pIC50,0,7.849999905,0,IC50,0,14,0,=,,,,21860433,CN1C/C=C/CCOc2cccc(c2)c2nc(Nc3cc(C1)ccc3)ncc2
tyrosine kinase non receptor 1,2245,TNK1,Q13470,,,,,,Human,XMD8-92,8057,,,249565737,Inhibitor,Inhibition,,f,f,,pKd,0,6.050000191,0,Kd,0,890,0,=,,,,20832753,CCOc1cc(ccc1Nc1ncc2c(n1)n(C)c1ccccc1c(=O)n2C)N1CCC(CC1)O
ubiquitin specific peptidase 14,2429,USP14,P54578,,,,,,Human,VLX1570,9413,,,328083515,Inhibitor,Inhibition,,f,t,,pKd,5.820000172,0,4.739999771,Kd,18000,0,1500,=,Surface plasmon resonance assay using recombinant human USP14.,,,27264969,C=CC(=O)N1CC/C(=C/c2ccc(c(c2)[N+](=O)[O-])F)/C(=O)/C(=Cc2ccc(c(c2)[N+](=O)[O-])F)/C1
ubiquitin specific peptidase 5,2431,USP5,P45974,,,,,,Human,vialinin A,8669,,,252166869,Inhibitor,Inhibition,,f,f,,pKi,0,5.400000095,0,Ki,0,4000,0,=,,,,23791076,O=C(Oc1c(c2ccc(cc2)O)c(O)c(c(c1OC(=O)Cc1ccccc1)c1ccc(cc1)O)O)Cc1ccccc1
Urate anion exchanger 1,1031,SLC22A12,Q96S37,,,,,,Human,sufinpyrazone,5826,,,178102451,Inhibitor,Inhibition,,f,t,,pIC50,0,4,0,IC50,0,100000,0,=,,,,17325024,O=C1N(c2ccccc2)N(C(=O)C1CCS(=O)c1ccccc1)c1ccccc1
Urate anion exchanger 1,1031,SLC22A12,Q96S37,,,,,,Human,verinurad,9327,,,318164846,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,N#Cc1ccc(c2c1cccc2)c1cnccc1SC(C(=O)O)(C)C
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,Urolinin,9441,,,329968381,Agonist,Agonist,,f,f,,pEC50,0,8.300000191,0,-,0,0,0,=,,,,27791374,
UT receptor,365,Uts2r,P49684,,,,,,Rat,[<sup>125</sup>I]U-II (human),2158,,,135652573,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,10499587,
UT receptor,365,Uts2r,Q8VIH9,,,,,,Mouse,[<sup>125</sup>I]U-II (human),2158,,,135652573,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,11976263,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,[<sup>125</sup>I]U-II (human),2158,,,135652573,Agonist,Full agonist,,f,f,,pKd,9.619999886,0,9.399999619,Kd,0.400000006,0,0.239999995,=,,,,10499587,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,U-II-(4-11) (human),2152,,,135652628,Agonist,Full agonist,,f,f,,pKi,0,9.600000381,0,-,0,0,0,=,,,,12238917,
UT receptor,365,Uts2r,P49684,,,,,,Rat,urotensin-II,2155,Uts2,Rat,135651901,Agonist,Full agonist,,t,,,pKi,0,8.8,0,,0,0,0,,,,,15852036,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urotensin-II,2155,Uts2,Rat,135651901,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,15852036,
UT receptor,365,Uts2r,P49684,,,,,,Rat,urotensin-II,2153,UTS2,Human,135651902,Agonist,Full agonist,,f,,,pKi,0,8.7,0,,0,0,0,,,,,15852036,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urotensin-II,2154,Uts2,Mouse,135651900,Agonist,Full agonist,,f,,,pKi,0,8.5,0,,0,0,0,,,,,15852036,
UT receptor,365,Uts2r,Q8VIH9,,,,,,Mouse,urotensin-II,2155,Uts2,Rat,135651901,Agonist,Full agonist,,f,,,pKi,0,8.6,0,,0,0,0,,,,,11976263,
UT receptor,365,Uts2r,Q8VIH9,,,,,,Mouse,urotensin-II,2154,Uts2,Mouse,135651900,Agonist,Full agonist,,t,,,pKi,8.6,0,8.4,,0,0,0,,,,,11976263,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urotensin-II,2153,UTS2,Human,135651902,Agonist,Full agonist,,t,,,pKi,0,8.6,0,-,0,0,0,=,,,,11976263,
UT receptor,365,Uts2r,P49684,,,,,,Rat,urotensin-II,2154,Uts2,Mouse,135651900,Agonist,Full agonist,,f,,,pKi,0,8.8,0,,0,0,0,,,,,15852036,
UT receptor,365,Uts2r,Q8VIH9,,,,,,Mouse,urotensin-II,2153,UTS2,Human,135651902,Agonist,Full agonist,,f,,,pKi,9,0,8.2,,0,0,0,,,,,11976263,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urotensin II-related peptide,2156,UTS2B|Uts2b|Uts2b,Human|Mouse|Rat,135651910,Agonist,Full agonist,,t,,,pIC50,0,8.6,0,,0,0,0,,,,,14550283,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](N)C)Cc1c[nH]c2c1cccc2
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urotensin II-related peptide,2156,UTS2B|Uts2b|Uts2b,Human|Mouse|Rat,135651910,Agonist,Full agonist,,t,f,,pKd,0,9.600000381,0,Kd,0,0.239999995,0,=,,,,11015293,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](N)C)Cc1c[nH]c2c1cccc2
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide,2166,,,135652609,Antagonist,Antagonist,,f,,,pKd,0,7.7,0,,0,0,0,,,,,12535707,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,urantide,2167,,,135652629,Antagonist,Antagonist,,f,f,,pKi,0,8.300000191,0,Ki,0,0,0,=,,,,14645137,
UT receptor,365,UTS2R,Q9UKP6,,,,,,Human,"[<sup>125</sup>I]N-biotin-[Ahx<sup>0</sup>, Bpa<sup>3</sup>]U-II (human)",9440,,,329968380,None,None,,f,f,,-,0,0,0,-,0,0,0,=,,,,22044114,
Vesicular acetylcholine transporter,1013,SLC18A3,Q16572,,,,,,Human,vesamicol,4759,,,178101469,Inhibitor,Inhibition,,f,,,pKi,0,8.7,0,Ki,0,2,0,,,,,7702637,OC1CCCCC1N1CCC(CC1)c1ccccc1
Vesicular acetylcholine transporter,1013,SLC18A3,Q16572,,,,,,Human,[<sup>123</sup>I]iodobenzovesamicol,4762,,,178101471,None,None,,f,,,-,0,0,0,,0,0,0,,,,,0,O[C@@H]1Cc2cccc(c2C[C@H]1N1CCC(CC1)c1ccccc1)[123I]
Vesicular acetylcholine transporter,1013,SLC18A3,Q16572,,,,,,Human,[<sup>3</sup>H]vesamicol,4758,,,178101468,None,None,,f,,,pKd,0,8.4,0,Kd,0,4.1,0,,,,,8910293,O([3H])C1CCCCC1N1CCC(CC1)c1ccccc1
Vesicular inhibitory amino acid transporter,1133,SLC32A1,Q9H598,,,,,,Human,vigabatrin,4821,,,178101523,Inhibitor,Inhibition,,f,,,pIC50,0,2.1,0,IC50,0,7500000,0,,,,,9349821,NC(C=C)CCC(=O)O
Vesicular monoamine transporter 1,1011,SLC18A1,P54219,,,,,,Human,tetrabenazine,4834,,,178101536,Inhibitor,Inhibition,,f,,,pKi,0,4.7,0,Ki,0,20000,0,,,,,8643547,COc1cc2c(cc1OC)CCN1C2CC(=O)C(C1)CC(C)C
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,[<sup>11</sup>C]DTBZ,4608,,,178101328,Inhibitor,Inhibition,,f,,,-,0,0,0,-,0,0,0,=,,,,0,COc1cc2c(cc1O[11C])CCN1[C@@]2(C)C[C@H](O)[C@H](C1)CC(C)C
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,[<sup>125</sup>I]7-azido-8-iodoketanserine,4763,,,178101472,Inhibitor,Inhibition,,f,f,,-,0,0,0,-,0,0,0,=,,,,9325342,[N-]=[N+]=Nc1ccc2c(c1[125I])[nH]c(=O)n(c2=O)CCN1CCC(CC1)C(=O)c1ccc(cc1)F
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,[<sup>125</sup>I]iodovinyl-TBZ,4764,,,178101473,Inhibitor,Inhibition,,f,,,pKd,0,8.1,0,Kd,0,8.2,0,=,,,,7855735,
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,[<sup>3</sup>H]TBZOH,4766,,,178101475,Inhibitor,Inhibition,,f,,,pKd,0,8.2,0,Kd,0,6.6,0,=,,,,8910293,COc1cc2c(cc1OC)CCN1C2CC(O)C(C1)CC(C)C
Vesicular monoamine transporter 2,1012,SLC18A2,Q05940,,,,,,Human,tetrabenazine,4834,,,178101536,Inhibitor,Inhibition,,f,t,,pKi,0,7,0,Ki,0,97,0,=,,,,8643547,COc1cc2c(cc1OC)CCN1C2CC(=O)C(C1)CC(C)C
Vesicular monoamine transporter 2,1012,Slc18a2,Q01827,,,,,,Rat,valbenazine,8694,,,252166894,Inhibitor,Inhibition,,f,t,,pKi,0,6.730000019,0,Ki,0,187,0,=,Displacement binding assay using rat brain homogenate.,,,0,COc1cc2c(cc1OC)CCN1[C@@H]2C[C@@H](OC(=O)[C@H](C(C)C)N)[C@@H](C1)CC(C)C
Vitamin D receptor,605,VDR,P11473,,,,,,Human,tacalcitol,2780,,,135651286,Agonist,Agonist,,f,f,,pKd,0,8.5,0,-,0,0,0,=,,,,7976510,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CC[C@H](C(C)C)O)C)C)/C1
Vitamin D receptor,605,,,,,,,,Chicken,TEI-9647,2788,,,135651240,Antagonist,Antagonist,,f,f,,pIC50,0,8.199999809,0,IC50,0,6.300000191,0,=,,,,17125259,O[C@H]1C[C@H](O)C(=C)/C(=CC=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](C[C@@H]2OC(=O)C(=C)C2)C)C)/C1
Vitamin D receptor,605,VDR,P11473,,,,,,Human,ZK159222,2789,,,135651362,Antagonist,Antagonist,,f,f,,pIC50,0,7.5,0,IC50,0,29,0,=,,,,12901907,CCCCOC(=O)C1(CC1)[C@@H](/C=C/[C@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=CC=C/1C[C@@H](O)C[C@@H](C1=C)O)C)O
vitamin K epoxide reductase complex subunit 1,2645,VKORC1,Q9BQB6,,,,,,Human,warfarin,6853,,,178103459,Inhibitor,Inhibition,,f,t,,pKi,0,5.579999924,0,Ki,0,2633,0,=,,,,23618698,CC(=O)CC(c1c(=O)oc2c(c1O)cccc2)c1ccccc1
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,[<sup>125</sup>I]PACAP-27,2261,,,135652544,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,"[<sup>125</sup>I]VIP (human, mouse, rat)",2277,,,135652575,Agonist,Agonist,,f,,,pKd,0,9.4,0,Kd,0,0.4,0,=,binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9.1,0,Ki,0,0.82,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8074647,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9.8,0,Ki,0,0.16,0,=,inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor,,,8074647,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,10,0,EC50,0,0.11,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,8.5,0,EC50,0,3,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,9,0,IC50,0,1,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9,0,Ki,0,0.9,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,8791009,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.9,0,EC50,0,14.1,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,9.4,0,EC50,0,0.4,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,10801840,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.7,0,IC50,0,2,0,=,Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9.7,0,Ki,0,0.2,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,8074647,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,9.3,0,IC50,0,0.5,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10570056,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.7,0,IC50,0,2,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.7,0,IC50,0,2,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,8.5,0,Ki,0,3.4,0,=,inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor,,,9152366,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.7,0,IC50,0,2,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,8.9,0,Ki,0,1.4,0,=,inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor,,,9454823,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,8.9,0,EC50,0,1.2,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,9152366,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9,0,Ki,0,0.9,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,9.3,0,EC50,0,0.5,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,10570056,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9.1,0,Ki,0,0.8,0,=,inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor,,,8390245,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,Vipr1,P30083,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.7,0,IC50,0,2,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>1</sub> receptor,371,VIPR1,P32241,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,9.7,0,Ki,0,0.2,0,=,cyclic AMP formation in HEK293 cells stably expressing recombinant receptor,,,8074647,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,[<sup>125</sup>I]BAY 55-9837,2281,,,135652487,Agonist,Agonist,,f,,,pKd,0,9.2,0,Kd,0,0.65,0,=,binding to membranes from CHO cells stably expressing the recombinant receptor,,,11978642,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,[<sup>125</sup>I]PACAP-27,2261,,,135652544,Agonist,Agonist,,f,,,-,0,0,0,-,0,0,0,=,,,,0,
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,"[<sup>125</sup>I]VIP (human, mouse, rat)",2277,,,135652575,Agonist,Agonist,,f,,,pKd,0,9.2,0,Kd,0,0.7,0,=,binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.4,0,IC50,0,4,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,9.2,0,EC50,0,0.63,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,8.8,0,Ki,0,1.7,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,10801840,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,7.8,0,Ki,0,16,0,=,inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor,,,9152366,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.8,0,EC50,0,15,0,=,cyclic AMP formation in CHO cells stably expressing recombinant receptor,,,10570056,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,9.3,0,EC50,0,0.5,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,10801840,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,8.5,0,EC50,0,3,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pKi,0,8.7,0,Ki,0,1.8,0,=,inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor,,,9454823,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.4,0,IC50,0,4,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,10570056,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.3,0,EC50,0,50.9,0,=,calcium influx in CHO cells stably expressing recombinant receptor,,,16930633,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pEC50,0,7.9,0,EC50,0,14,0,=,stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor,,,9152366,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.5,0,IC50,0,3,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9928018,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,7.7,0,IC50,0,20,0,=,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,,,11931347,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,VIPR2,P41587,,,,,,Human,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8.3,0,IC50,0,5,0,=,Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor,,,9437714,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VPAC<sub>2</sub> receptor,372,Vipr2,P35000,,,,,,Rat,VIP,1152,VIP|Vip|Vip,Human|Mouse|Rat,135651911,Agonist,Agonist,,t,,,pIC50,0,8,0,IC50,0,10,0,=,inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor,,,9726637,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
VRAC,710,,,,,,,,Human,tamoxifen,1016,,,135651233,Channel blocker,None,,f,,,-,0,0,0,,0,0,0,,,,,0,CC/C(=C(c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[<sup>3</sup>H]AVP (human, mouse, rat)",2175,,,135652582,Agonist,Full agonist,,f,,,pKd,10.2,0,8.6,Kd,2.51,0,0.063,=,,,,8106369,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[<sup>3</sup>H]OT (human, mouse, rat)",2176,,,135652589,Agonist,Full agonist,,f,,,pKd,0,6.9,0,,0,0,0,,,,,9334232,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[Thr<sup>4</sup>,Gly<sup>7</sup>]OT",2179,,,135652604,Agonist,Full agonist,,f,,,pKi,6.8,0,6.5,,0,0,0,,,,,9884074,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,[Val<sup>4</sup>]AVP,2180,,,135652631,Agonist,Full agonist,,f,,,pKi,0,7.5,0,,0,0,0,,,,,12446593,NC(=O)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)NCC(=O)N)CCCN=C(N)N)N)Cc1ccc(cc1)O)Cc1ccccc1)C(C)C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Full agonist,,t,t,,pKi,9.300000191,0,8.5,-,0,0,0,=,,,,8106369,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Full agonist,,t,,,pKi,0,8.4,0,,0,0,0,,,,,7774575,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,[<sup>125</sup>I]3-N<sub>3</sub>-Phpa-LVA,2206,,,135652483,Antagonist,Antagonist,,f,,,pKd,0,9.9,0,,0,0,0,,,,,9334232,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,[<sup>125</sup>I]OH-LVA,2207,,,135652542,Antagonist,Antagonist,,f,,,pKd,10.4,0,10.3,Kd,0.05,0,0.0399,=,,,,9334232,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,[<sup>3</sup>H]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP,3813,,,178100660,Antagonist,Antagonist,,f,,,pKd,0,9,0,Kd,0,1.1,0,,,,,0,
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,[<sup>3</sup>H]relcovaptan,3482,,,178100473,Antagonist,Antagonist,,f,f,,pKd,0,8.5,0,Kd,0,2.950000048,0,=,,,,8123034,COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,"[tBaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Arg-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2212,,,135652596,Antagonist,Antagonist,,f,,,pKi,0,9.1,0,,0,0,0,,,,,9322919,
V<sub>1A</sub> receptor,366,Avpr1a,P30560,,,,,,Rat,tolvaptan,2226,,,135651270,Antagonist,Antagonist,,f,,,pKi,0,6.5,0,,0,0,0,,,,,9864265,Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,tolvaptan,2226,,,135651270,Antagonist,Antagonist,,f,,,pKi,0,7.9,0,,0,0,0,,,,,9864265,Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,YM 218,2204,,,135651342,Antagonist,Antagonist,,f,,,pKi,0,9.5,0,,0,0,0,,,,,15661579,O=C(N1CCC(CC1)N1CCCCC1)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C
V<sub>1A</sub> receptor,366,AVPR1A,P37288,,,,,,Human,YM 471,2205,,,135651348,Antagonist,Antagonist,,f,,,pKi,0,9.2,0,,0,0,0,,,,,11429400,CN(C1CCN(CC1)C(=O)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[<sup>3</sup>H]AVP (human, mouse, rat)",2175,,,135652582,Agonist,Full agonist,,f,,,pKd,9.6,0,8.6,Kd,2.51,0,0.25,=,,,,8106369,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,[<sup>3</sup>H]d[Cha<sup>4</sup>]AVP,2227,,,135652584,Agonist,Full agonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,12446593,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[<sup>3</sup>H]OT (human, mouse, rat)",2176,,,135652589,Agonist,Full agonist,,f,,,pKd,0,5.8,0,,0,0,0,,,,,9322919,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,[Val<sup>4</sup>]AVP,2180,,,135652631,Agonist,Full agonist,,f,,,pKi,0,9,0,,0,0,0,,,,,12446593,NC(=O)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)NCC(=O)N)CCCN=C(N)N)N)Cc1ccc(cc1)O)Cc1ccccc1)C(C)C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Full agonist,,t,t,,pKi,9.5,0,9,-,0,0,0,=,,,,9884074,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
V<sub>1B</sub> receptor,367,Avpr1b,P48974,,,,,,Rat,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Full agonist,,t,,,pKi,0,9.9,0,,0,0,0,,,,,9264324,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,[<sup>3</sup>H]nelivaptan,3483,,,178100474,Antagonist,Antagonist,,f,f,,-,0,0,0,-,0,0,0,=,,,,0,COc1ccccc1[C@]1(N2C[C@@H](C[C@H]2C(=O)N(C)C)O)c2cc(Cl)ccc2N(C1=O)S(=O)(=O)c1ccc(cc1OC([3H])([3H])[3H])OC([3H])([3H])[3H]
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,"[tBaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Arg-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2212,,,135652596,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,9322919,
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,YM 218,2204,,,135651342,Antagonist,Antagonist,,f,,,pKi,0,4.6,0,,0,0,0,,,,,15661579,O=C(N1CCC(CC1)N1CCCCC1)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C
V<sub>1B</sub> receptor,367,AVPR1B,P47901,,,,,,Human,YM 471,2205,,,135651348,Antagonist,Antagonist,,f,,,pKi,0,4.8,0,,0,0,0,,,,,11429400,CN(C1CCN(CC1)C(=O)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[<sup>3</sup>H]AVP (human, mouse, rat)",2175,,,135652582,Agonist,Full agonist,,f,,,pKd,9.4,0,8.4,Kd,3.98,0,0.399,=,,,,9884074,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"[<sup>3</sup>H]AVP (human, mouse, rat)",2175,,,135652582,Agonist,Full agonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,[<sup>3</sup>H]dDAVP,2228,,,135652585,Agonist,Full agonist,,f,,,pKd,9.1,0,7.2,Kd,63,0,0.8,=,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[<sup>3</sup>H]OT (human, mouse, rat)",2176,,,135652589,Agonist,Full agonist,,f,,,pKd,0,5.8,0,,0,0,0,,,,,0,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,[Val<sup>4</sup>]AVP,2180,,,135652631,Agonist,Full agonist,,f,,,pKi,0,8.4,0,,0,0,0,,,,,12446593,NC(=O)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)NCC(=O)N)CCCN=C(N)N)N)Cc1ccc(cc1)O)Cc1ccccc1)C(C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,vasopressin,2168,AVP|Avp|Avp,Human|Mouse|Rat,135651625,Agonist,Full agonist,,t,t,,pKi,9.100000381,0,7.900000095,-,0,0,0,=,,,,9884074,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,VNA932,3537,,,178100516,Agonist,Full agonist,,f,f,,pIC50,0,7.099999905,0,IC50,0,80,0,=,,,,16297621,Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Ile<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2230,,,135652506,Antagonist,Antagonist,,f,,,pKd,0,9.5,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2231,,,135652507,Antagonist,Antagonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Ile<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2232,,,135652508,Antagonist,Antagonist,,f,,,pKd,0,9.3,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Ile<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2232,,,135652508,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2233,,,135652509,Antagonist,Antagonist,,f,,,pKd,0,9.1,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,"[<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]AVP",2233,,,135652509,Antagonist,Antagonist,,f,,,pKd,0,9.4,0,,0,0,0,,,,,9792651,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[tBaa<sup>1</sup>,<small>D</small>-Tyr(Et)<sup>2</sup>,Val<sup>4</sup>,Lys<sup>6</sup>,Arg-NH<sub>2</sub><sup>8</sup>,des-Gly<sup>9</sup>]AVP",2212,,,135652596,Antagonist,Antagonist,,f,,,pKi,0,7.3,0,,0,0,0,,,,,9322919,
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,tolvaptan,2226,,,135651270,Antagonist,Antagonist,,f,,,pKi,0,9.4,0,,0,0,0,,,,,9864265,Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C
V<sub>2</sub> receptor,368,Avpr2,Q00788,,,,,,Rat,tolvaptan,2226,,,135651270,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,9864265,Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,tolvaptan,2226,,,135651270,Antagonist,Antagonist,,f,t,,pKi,0,9.369999886,0,Ki,0,0.430000007,0,=,,,,9864265,Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,YM 218,2204,,,135651342,Antagonist,Antagonist,,f,,,pKi,0,6.4,0,,0,0,0,,,,,15661579,O=C(N1CCC(CC1)N1CCCCC1)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,YM 471,2205,,,135651348,Antagonist,Antagonist,,f,,,pKi,0,8.9,0,,0,0,0,,,,,11429400,CN(C1CCN(CC1)C(=O)/C=C1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,[<sup>3</sup>H]SR 121463A,2234,,,135651208,Antagonist,Inverse agonist,,f,f,,pKd,9.300000191,0,8.390000343,Kd,4.099999905,0,0.5,=,,,,9792651,CCOc1ccc2c(c1)C1(CCC(CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C
V<sub>2</sub> receptor,368,AVPR2,P30518,,,,,,Human,"[<sup>3</sup>H]desGly-NH<sub>2</sub>[D-Ile<sup>2</sup>,Ile<sup>4</sup>]VP",3817,,,178100663,None,None,,f,,,pKd,0,8.6,0,Kd,0,2.8,0,,,,,0,
XCR1,75,XCR1,P46094,,,,,,Human,XCL1,3647,XCL1,Human,135651920,Agonist,Agonist,,t,f,,pEC50,0,7.300000191,0,EC50,0,50,0,~,Measuring Ca<sup>2+</sup> flux,,,25497737,
XCR1,75,XCR1,P46094,,,,,,Human,XCL2,4370,XCL2,Human,135651921,Agonist,Agonist,,t,f,,pEC50,0,7.300000191,0,EC50,0,50,0,~,Measuring Ca<sup>2+</sup> flux,,,25497737,
XCR1,75,XCR1,P46094,,,,,,Human,[<sup>125</sup>I]XCL1 (human),857,,,135652576,Agonist,Full agonist,,f,,,pKd,0,8,0,,0,0,0,,,,,9632725,
"YES proto-oncogene 1, Src family tyrosine kinase",2284,YES1,P07947,,,,,,Human,SU6656,6044,,,178102666,Inhibitor,Inhibition,,f,t,,pIC50,0,7.699999809,0,IC50,0,20,0,=,,,,18077363,O=C1Nc2c(/C/1=C/c1cc3c([nH]1)CCCC3)cc(cc2)S(=O)(=O)N(C)C
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,"[<sup>125</sup>I][Leu<sup>31</sup>,Pro<sup>34</sup>]NPY",3762,,,178100613,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,"[<sup>125</sup>I]NPY (human, mouse, rat)",1518,,,135652541,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,1316999,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,[<sup>125</sup>I]PYY (pig),1520,,,135652551,Agonist,Full agonist,,f,,,pKd,0,9.1,0,-,0,0,0,=,,,,1317848,
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,[<sup>125</sup>I]PYY (pig),1520,,,135652551,Agonist,Full agonist,,f,,,pKd,0,10.2,0,,0,0,0,,,,,16097949,
Y<sub>1</sub> receptor,305,Npy1r,Q04573,,,,,,Mouse,"[<sup>3</sup>H]NPY (human, mouse, rat)",1521,,,135652588,Agonist,Full agonist,,f,,,pKd,0,8.8,0,,0,0,0,,,,,7623780,
Y<sub>1</sub> receptor,305,Npy1r,P21555,,,,,,Rat,[<sup>125</sup>I]GR231118,1531,,,135652519,Antagonist,Antagonist,,f,,,pKd,0,10,0,,0,0,0,,,,,10694200,CC[C@@H]([C@@H](C(=N[C@@H]1CCC(=NC[C@@H](N=C(O)[C@@H]2CCCN2C(=O)[C@H](CCC(=NC[C@H](N=C([C@H]2N(C1=O)CCC2)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)N=C([C@H]([C@H](CC)C)N)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)O)N)C
Y<sub>1</sub> receptor,305,NPY1R,P25929,,,,,,Human,[<sup>3</sup>H]BIBP3226,3474,,,178100465,Antagonist,Antagonist,,f,,,pKd,0,8.7,0,Kd,0,2.1,0,=,,,,0,O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)O
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,"[<sup>125</sup>I]NPY (human, mouse, rat)",1518,,,135652541,Agonist,Full agonist,,f,,,pKd,0,9.2,0,,0,0,0,,,,,7559383,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,[<sup>125</sup>I]PYY,1519,,,135652550,Agonist,Full agonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,7559383,
Y<sub>2</sub> receptor,306,NPY2R,P49146,,,,,,Human,[<sup>125</sup>I]PYY-(3-36) (human),3802,,,178100649,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
Y<sub>4</sub> receptor,307,Npy4r,Q63447,,,,,,Rat,[<sup>125</sup>I]GR231118,1531,,,135652519,Agonist,Full agonist,,f,,,pKd,0,9.6,0,,0,0,0,,,,,10694200,CC[C@@H]([C@@H](C(=N[C@@H]1CCC(=NC[C@@H](N=C(O)[C@@H]2CCCN2C(=O)[C@H](CCC(=NC[C@H](N=C([C@H]2N(C1=O)CCC2)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)N=C([C@H]([C@H](CC)C)N)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)O)N)C
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,[<sup>125</sup>I]PP (human),3800,,,178100648,Agonist,Full agonist,,f,,,-,0,0,0,,0,0,0,,,,,0,
Y<sub>4</sub> receptor,307,NPY4R,P50391,,,,,,Human,[<sup>125</sup>I]PYY (pig),1520,,,135652551,Agonist,Full agonist,,f,,,pKd,0,9.8,0,,0,0,0,,,,,7493937,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[<sup>125</sup>I][cPP(1-7), NPY(19-23), Ala<sup>31</sup>, Aib<sup>32</sup>, Gln<sup>34</sup>]hPP",3921,,,178100752,Agonist,Agonist,,f,,,pKd,9.3,0,9.2,Kd,0.7,0,0.5,=,,,,15337369,
Y<sub>5</sub> receptor,308,Npy5r,Q63634,,,,,,Rat,"[<sup>125</sup>I][PP<sub>1-17</sub>,Ala<sup>31</sup>,Aib<sup>32</sup>]NPY (human)",1559,,,135652546,Agonist,Full agonist,,f,,,pKd,0,8.9,0,,0,0,0,,,,,12890716,
ZAC ,587,ZACN,Q401N2,,,,,,Human,Zn<sup>2+</sup>,566,,,135652747,Agonist,Agonist,,t,f,,pEC50,3.700000048,0,3.299999952,EC50,0,0,0,=,,,,12381728,
ZAC ,587,ZACN,Q401N2,,,,,,Human,tubocurarine,2294,,,135652723,Antagonist,Antagonist,,f,f,,pIC50,0,5.199999809,0,IC50,0,6300,0,=,,,,12381728,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C
zeta chain of T cell receptor associated protein kinase 70,2285,ZAP70,P43403,,,,,,Human,Syk inhibitor II,6047,,,178102669,Inhibitor,Inhibition,,f,f,,pIC50,0,4.949999809,0,IC50,0,11200,0,=,,,,15990316,NCCNc1ncc(c(n1)Nc1cccc(c1)C(F)(F)F)C(=O)N
zeta chain of T cell receptor associated protein kinase 70,2285,ZAP70,P43403,,,,,,Human,TAK-659,9600,,,340590230,Inhibitor,Inhibition,,f,f,,pIC50,0,7.130000114,0,IC50,0,75,0,=,Measured in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.,,,27839918,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O
,0,,,angiopoietin-2,5316,ANGPT2,O15123,53801019,Human,trebananib,8414,,,252166624,Antibody,Binding,,f,t,,pKd,0,9.170000076,0,Kd,0,0.670000017,0,=,,,,0,
,0,,,angiopoietin-2,5316,ANGPT2,O15123,53801019,Human,vanucizumab,9132,,,315661217,Antibody,Binding,,f,t,,pKd,0,9.619999886,0,Kd,0,0.239999995,0,=,,,,0,
,0,,,BAFF,5069,TNFSF13B,Q9Y275,178101762,Human,tabalumab,8000,,,249565680,Antibody,Binding,,f,t,,pKd,0,8,0,Kd,0,10,0,=,,,,0,
,0,,,complement C5,8712,C5,,252827370,Human,tesidolumab,8711,,,252827369,Antibody,Binding,,f,t,,pKd,11.69999981,0,10.92000008,Kd,0.012,0,0.002,=,Binding to full length human C5.,,,0,
,0,,,hsp90&alpha;<sub>1</sub>,7752,HSP90AA1,P07900,223366085,Human,tanespimycin,7751,,,223366084,Inhibitor,Inhibition,,f,t,,pIC50,0,6.110000134,0,IC50,0,780,0,=,fluorescence polarization assay,,,25105924,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(C)/[C@@H]([C@H](/C=C/C=C(/C(=O)NC(=CC1=O)C2=O)C)OC)OC(=O)N
,0,,,IL-12B,5002,IL12B,P29460,178101699,Human,ustekinumab,6885,,,178103467,Antibody,Inhibition,,f,t,,pKd,11.14999962,0,9,Kd,1,0,0.007,<,,,,0,
,0,,,IL-13,4980,IL13,P35225,178101677,Human,tralokinumab,8001,,,249565681,Antibody,Binding,,f,t,,pKd,0,9.789999962,0,Kd,0,0.164000005,0,=,,,,22094818,
,0,,,IL-13,4980,IL13,P35225,178101677,Human,UCB4144,9806,,,0,Antibody,Binding,,f,t,,pKd,0,10.81999969,0,Kd,0,0.015,0,=,In a BiaCore assay with immobilised antibody and recombinant hIL-13 as the analyte.,,,0,
,0,,,IL-17A,4982,IL17A,Q16552,178101679,Human,vunakizumab,9296,,,318164815,Antibody,Binding,,f,t,,pKd,0,12,0,Kd,0,0.001,0,<,Measured using Biacore technology,,,0,
,0,,,IL-23A,4989,IL23A,,178101686,Human,tildrakizumab,8093,,,249565773,Antibody,Binding,,f,t,,pKd,0,9.529999733,0,Kd,0,0.296999991,0,=,Binding affinity constant for clone 13B8-b CDRH2-b.,,,0,
,0,,,myostatin,5025,MSTN,O14793,178101722,Human,trevogrumab,8929,,,310264710,Antibody,Binding,,f,t,,pKd,0,10.61999989,0,Kd,0,0.024,0,=,,,,26457176,
,0,,,NGF,5026,NGF,P01138,178101723,Human,tanezumab,8415,,,252166625,Antibody,Binding,,f,t,,pKd,0,10.14999962,0,Kd,0,0.07,0,=,Affinity of NGF of antibody E3 for human NGF.,,,0,
,0,,,thymic stromal lymphopoietin,5083,TSLP,Q969D9,178101776,Human,tezepelumab,8933,,,310264714,Antibody,Binding,,f,t,,pKd,10.80000019,0,10.52999973,Kd,0.029200001,0,0.015799999,=,,,,24846652,
,0,,,VEGFA,5085,VEGFA,P15692,178101778,Human,vanucizumab,9132,,,315661217,Antibody,Binding,,f,t,,pKd,0,10,0,Kd,0,0.100000001,0,<,,,,0,
